PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shi, Q; Zhuang, F; Liu, JT; Li, N; Chen, YX; Su, XB; Yao, AH; Yao, QP; Han, Y; Li, SS; Qi, YX; Jiang, ZL				Shi, Qian; Zhuang, Fei; Liu, Ji-Ting; Li, Na; Chen, Yuan-Xiu; Su, Xian-Bin; Yao, Ai-Hong; Yao, Qing-Ping; Han, Yue; Li, Shan-Shan; Qi, Ying-Xin; Jiang, Zong-Lai			Single-cell analyses reveal functional classification of dendritic cells and their potential roles in inflammatory disease	FASEB JOURNAL			English	Article						functional heterogeneity; single-cell qPCR; antigen-presenting cell; atherosclerotic mouse models	SCAVENGER-RECEPTORS; STEADY-STATE; RNA-SEQ; IDENTIFICATION; MACROPHAGES; POPULATION; SUBSETS; TISSUES; MYD88; MICE	Dendritic cells (DCs) have crucial roles in immune-related diseases. However, it is difficult to explore DCs because of their rareness and heterogeneity. Although previous studies had been performed to detect the phenotypic characteristics of DC populations, the functional diversity has been ignored. Using a combination of flow cytometry, single-cell quantitative PCR, and bioinformatic analysis, we depicted the DC panorama with not only phenotypic but also functional markers. Functional classification of DCs in mouse lymphoid tissue (spleen) and nonlymphoid tissue (liver) was performed. The results revealed that expression of macrophage scavenger receptor 1 (MSR1) and C-C motif chemokine receptors (CCR)1, CCR2, and CCR4 were elevated in liver DCs, suggesting increased lipid uptake and migration abilities. The enriched expression of costimulatory molecule CD80, TLR9, and TLR adaptor MYD88 in spleen DCs indicated a more-mature phenotype, enhanced pathogen recognition, and T-cell stimulation abilities. Furthermore, we compared DCs in the atherosclerotic mouse models with healthy controls. In addition to the quantitative increase in DCs in the liver and spleen of the apolipoprotein E-knockout (ApoE(-/-)) mice, the functional expression patterns of the DCs also changed at the single-cell level. These results promote our understanding of the participation of DCs in inflammatory diseases and have potential applications in DC clinical assessment.Shi, Q., Zhuang, F., Liu, J.-T., Li, N., Chen, Y.-X., Su, X.-B., Yao, A.-H., Yao, Q.-P., Han, Y., Li, S.-S., Qi, Y.-X., Jiang, Z.-L. Single-cell analyses reveal functional classification of dendritic cells and their potential roles in inflammatory disease.	[Shi, Qian; Zhuang, Fei; Liu, Ji-Ting; Li, Na; Chen, Yuan-Xiu; Yao, Qing-Ping; Han, Yue; Li, Shan-Shan; Qi, Ying-Xin; Jiang, Zong-Lai] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, 800 Dongchuan Rd,POB 888, Shanghai 200240, Peoples R China; [Su, Xian-Bin] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Shanghai, Peoples R China; [Yao, Ai-Hong] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harbin Engineering University	Qi, YX (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, 800 Dongchuan Rd,POB 888, Shanghai 200240, Peoples R China.	qiyx@sjtu.edu.cn		Su, Xianbin/0000-0001-5705-6062	National Natural Science Foundation of China [11625209, 11232010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Yu-Meng Tan and Qian Luo (Shanghai Jiao Tong University) for flow cytometry service. The authors thank Ling Di (Shanghai Jiao Tong University) for her assistance with confocal microscope. This research was supported by the National Natural Science Foundation of China (Grants 11625209 and 11232010). The authors declare no conflicts of interest.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Busch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088452; Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Comrie WA, 2015, J CELL BIOL, V208, P457, DOI 10.1083/jcb.201406120; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657; Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Muzaki ARBM, 2016, MUCOSAL IMMUNOL, V9, P336, DOI 10.1038/mi.2015.64; National Research Council, 2010, GUIDE CARE USE LAB A; Nickel T, 2009, ATHEROSCLEROSIS, V205, P442, DOI 10.1016/j.atherosclerosis.2009.01.002; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Poltorak MP, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00199; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Schraml BU, 2015, CURR OPIN IMMUNOL, V32, P13, DOI 10.1016/j.coi.2014.11.001; SCHULER G, 1985, J INVEST DERMATOL, V85, pS99, DOI 10.1111/1523-1747.ep12275566; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; STEINMAN RM, 1975, J EXP MED, V141, P804; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Wang D, 2015, HUM IMMUNOL, V76, P442, DOI 10.1016/j.humimm.2015.03.012; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zheng, 2015, F1000 RES, V4	44	6	6	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3784	3794		10.1096/fj.201801489R	http://dx.doi.org/10.1096/fj.201801489R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496701	Bronze			2022-12-26	WOS:000459794800056
J	Kanamoto, M; Tsuchiya, Y; Nakao, Y; Suzuki, T; Motohashi, H; Yamamoto, M; Kamata, H				Kanamoto, Mayu; Tsuchiya, Yoshihiro; Nakao, Yuki; Suzuki, Takafumi; Motohashi, Hozumi; Yamamoto, Masayuki; Kamata, Hideaki			Structural instability of I kappa B kinase beta promotes autophagic degradation through enhancement of Keap1 binding	PLOS ONE			English	Article							IKK-BETA; DOWN-REGULATION; PROTEIN; NRF2; ACTIVATION; HSP90; UBIQUITINATION; ANTIOXIDANT; RECRUITMENT; INHIBITION	IKK beta, an essential kinase of NF-kappa B signaling, is composed of an N-terminal kinase domain (KD) and a C-terminal scaffolding domain, containing a ubiquitin-like domain (ULD). The Hsp90 chaperon has special responsibility for folding of protein kinases including IKK beta. Here, we found that Hsp90 inhibition induced IKK beta degradation, which is partially mediated by Keap1. Geldanamycin (GA), a Hsp90 inhibitor, enhances association of IKK beta with Keap1 through the binding site in KD, and translocates IKK beta to detergent-insoluble fractions leading to its autophagic degradation. An electrophile tBHQ suppressed Keap1-mediated proteasomal Nrf2 degradation but not autophagic IKK beta degradation. Substitution mutation of Leu353 to Ala in the ULD destabilizes IKK beta, enhances its association with Keap1, translocates it to detergent-insoluble fractions, and causes its autophagic degradation. These results suggest that Keap1 is involved in the degradation of structural destabilized IKK beta and negative regulation of NF-kappa B under proteotoxic stress.	[Kanamoto, Mayu; Tsuchiya, Yoshihiro; Nakao, Yuki; Kamata, Hideaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Med Sci, Hiroshima, Japan; [Kanamoto, Mayu] Mazuda Hosp, Dept Dermatol, Hiroshima, Japan; [Tsuchiya, Yoshihiro] Hiroshima Jogakuin Univ, Dept Nutr & Hlth Promot, Hiroshima, Japan; [Suzuki, Takafumi; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi, Japan; [Motohashi, Hozumi] Tohoku Univ, Dept Gene Express Regulat, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Hiroshima University; Tohoku University; Tohoku University	Kamata, H (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Med Sci, Hiroshima, Japan.	hkamata@hiroshima-u.ac.jp	Motohashi, Hozumi/AAZ-2628-2020; Yamamoto, Masayuki/A-4873-2010; Suzuki, Takafumi/ABC-6582-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Suzuki, Takafumi/0000-0002-3425-8208	KAKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H01406, 15H01382, 23370062]	KAKEN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	H.K. was supported, in whole or in part, by KAKEN Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (#15H01406, #15H01382, and #23370062), https://kaken.nii.ac.jp/en/search/.	Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fliss PM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002517; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Niida M, 2010, MOL IMMUNOL, V47, P2378, DOI 10.1016/j.molimm.2010.05.004; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Tusco R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01287-9; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zotti T, 2014, MOL IMMUNOL, V58, P27, DOI 10.1016/j.molimm.2013.10.015	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0203978	10.1371/journal.pone.0203978	http://dx.doi.org/10.1371/journal.pone.0203978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500824	Green Submitted, gold, Green Published			2022-12-26	WOS:000451883700003
J	Martin, AE				Martin, Andrea E.			Cue integration during sentence comprehension: Electrophysiological evidence from ellipsis	PLOS ONE			English	Article							WORKING-MEMORY; RETRIEVAL INTERFERENCE; TIME-COURSE; AGREEMENT; POTENTIALS; PREDICTION; DISCOURSE; INFORMATION; ATTRACTION; MECHANISM	Language processing requires us to integrate incoming linguistic representations with representations of past input, often across intervening words and phrases. This computational situation has been argued to require retrieval of the appropriate representations from memory via a set of features or representations serving as retrieval cues. However, even within in a cue-based retrieval account of language comprehension, both the structure of retrieval cues and the particular computation that underlies direct-access retrieval are still underspecified. Evidence from two event-related brain potential (ERP) experiments that show cue-based interference from different types of linguistic representations during ellipsis comprehension are consistent with an architecture wherein different cue types are integrated, and where the interaction of cue with the recent contents of memory determines processing outcome, including expression of the interference effect in ERP componentry. I conclude that retrieval likely includes a computation where cues are integrated with the contents of memory via a linear weighting scheme, and I propose vector addition as a candidate formalization of this computation. I attempt to account for these effects and other related phenomena within a broader cue-based framework of language processing.	[Martin, Andrea E.] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh, Midlothian, Scotland; [Martin, Andrea E.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	University of Edinburgh; Max Planck Society	Martin, AE (corresponding author), Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh, Midlothian, Scotland.; Martin, AE (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	andrea.martin@mpi.nl		Martin, Andrea E./0000-0002-3395-7234	Economic and Social Research Council of the United Kingdom [ES/K009095/1]; ESRC [ES/K009095/1] Funding Source: UKRI	Economic and Social Research Council of the United Kingdom(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by grant ES/K009095/1 from the Economic and Social Research Council of the United Kingdom (https://esrc.ukri.org/) to AEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2015, CONVERGENCE, V12; Bates E., 1989, CROSSLINGUISTIC STUD, V3, P73; BOCK K, 1991, COGNITIVE PSYCHOL, V23, P45, DOI 10.1016/0010-0285(91)90003-7; Clark SE, 1996, PSYCHON B REV, V3, P37, DOI 10.3758/BF03210740; Cunnings I, 2013, LANG COGNITIVE PROC, V28, P188, DOI 10.1080/01690965.2010.548391; Dillon B, 2013, J MEM LANG, V69, P85, DOI 10.1016/j.jml.2013.04.003; DOSHER BA, 1989, J EXP PSYCHOL GEN, V118, P191, DOI 10.1037/0096-3445.118.2.191; Doumas L.A.A., 2005, CAMBRIDGE HDB THINKI, P73, DOI DOI 10.1007/S13398-014-0173-7.2; Eberhard KM, 2005, PSYCHOL REV, V112, P531, DOI 10.1037/0033-295X.112.3.531; EICH JM, 1982, PSYCHOL REV, V89, P627, DOI 10.1037/0033-295X.89.6.627; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Etienne AS, 1998, NATURE, V396, P161, DOI 10.1038/24151; Filik R, 2008, J COGNITIVE NEUROSCI, V20, P1315, DOI 10.1162/jocn.2008.20090; Foraker S, 2007, J MEM LANG, V56, P357, DOI 10.1016/j.jml.2006.07.004; Fukumura K, 2011, LANG COGNITIVE PROC, V26, P1472, DOI 10.1080/01690965.2010.506444; Gordon PC, 2004, J MEM LANG, V51, P97, DOI 10.1016/j.jml.2004.02.003; Gordon PC, 2001, J EXP PSYCHOL LEARN, V27, P1411, DOI 10.1037/0278-7393.27.6.1411; Ito A, 2017, J EXP PSYCHOL LEARN, V43, P635, DOI 10.1037/xlm0000315; Jager LA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00617; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kaan E, 2004, BRAIN LANG, V89, P584, DOI 10.1016/j.bandl.2004.02.004; Kaan E, 2002, J PSYCHOLINGUIST RES, V31, P165, DOI 10.1023/A:1014978917769; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kaan E, 2016, BILING-LANG COGN, V19, P1, DOI 10.1017/S1366728914000844; Kush D, 2015, J MEM LANG, V82, P18, DOI 10.1016/j.jml.2015.02.003; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Lewis RL, 2006, TRENDS COGN SCI, V10, P447, DOI 10.1016/j.tics.2006.08.007; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; Mancini S, 2011, BRAIN RES, V1410, P64, DOI 10.1016/j.brainres.2011.06.055; Martin AE, 2008, J MEM LANG, V58, P879, DOI 10.1016/j.jml.2007.06.010; Martin AE, 2017, LANG SPEECH, V60, P356, DOI 10.1177/0023830916650714; Martin AE, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00120; Martin AE, 2014, BRAIN LANG, V135, P42, DOI 10.1016/j.bandl.2014.05.001; Martin AE, 2012, NEUROIMAGE, V59, P1859, DOI 10.1016/j.neuroimage.2011.08.057; Martin AE, 2011, J MEM LANG, V64, P327, DOI 10.1016/j.jml.2010.12.006; Martin AE, 2009, J EXP PSYCHOL LEARN, V35, P1231, DOI 10.1037/a0016271; MCELREE B, 1993, J EXP PSYCHOL GEN, V122, P291; MCELREE B, 1989, J EXP PSYCHOL GEN, V118, P346, DOI 10.1037/0096-3445.118.4.346; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; McElree B, 2003, J MEM LANG, V48, P67, DOI 10.1016/S0749-596X(02)00515-6; McElree B, 2000, J PSYCHOLINGUIST RES, V29, P111, DOI 10.1023/A:1005184709695; McElree B, 2006, PSYCHOL LEARN MOTIV, V46, P155, DOI 10.1016/S0079-7421(06)46005-9; Miller GA, FINITARY MODELS LANG; MURDOCK BB, 1992, J MATH PSYCHOL, V36, P68, DOI 10.1016/0022-2496(92)90053-A; MURDOCK BB, 1982, PSYCHOL REV, V89, P609, DOI 10.1037/0033-295X.89.6.609; Nairne JS, 2002, MEMORY, V10, P389, DOI 10.1080/09658210244000216; Nieuwand MS, 2005, COGNITIVE BRAIN RES, V24, P691, DOI 10.1016/j.cogbrainres.2005.04.003; Nieuwland MS, 2017, J COGNITIVE NEUROSCI, V29, P896, DOI 10.1162/jocn_a_01091; Oztekin I, 2007, J MEM LANG, V57, P126, DOI 10.1016/j.jml.2006.08.011; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Parker D, 2017, J MEM LANG, V94, P272, DOI 10.1016/j.jml.2017.01.002; Parker D, 2017, TOP COGN SCI, V9, P51, DOI 10.1111/tops.12246; Patil U, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00329; Phillips C, 2011, SYNTAX SEMANTICS, V37, P147, DOI 10.1108/S0092-4563(2011)0000037009; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sturt P, 2003, J MEM LANG, V48, P542, DOI 10.1016/S0749-596X(02)00536-3; Tanner D, 2012, PROC ANN BUCLD, P594; Trommershauser J., 2011, SENSORY CUE INTEGRAT; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; Van Dyke JA, 2007, J EXP PSYCHOL LEARN, V33, P407, DOI 10.1037/0278-7393.33.2.407; Van Dyke JA, 2006, J MEM LANG, V55, P157, DOI 10.1016/j.jml.2006.03.007; Van Dyke JA, 2014, COGNITION, V131, P373, DOI 10.1016/j.cognition.2014.01.007; Van Dyke JA, 2012, LANG LINGUIST COMPAS, V6, P193, DOI 10.1002/lnc3.330; Van Dyke JA, 2011, J MEM LANG, V65, P247, DOI 10.1016/j.jml.2011.05.002; Vasishth S, 2008, COGNITIVE SCI, V32, P685, DOI 10.1080/03640210802066865; Wagers MW, 2009, J MEM LANG, V61, P206, DOI 10.1016/j.jml.2009.04.002; Xiang M, 2009, BRAIN LANG, V108, P40, DOI 10.1016/j.bandl.2008.10.002	73	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0206616	10.1371/journal.pone.0206616	http://dx.doi.org/10.1371/journal.pone.0206616			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496297	Green Published, gold			2022-12-26	WOS:000451763800017
J	Meuti, ME; Bautista-Jimenez, R; Reynolds, JA				Meuti, Megan E.; Bautista-Jimenez, Robin; Reynolds, Julie A.			Evidence that microRNAs are part of the molecular toolkit regulating adult reproductive diapause in the mosquito, Culex pipiens	PLOS ONE			English	Article							NORTHERN HOUSE MOSQUITO; FAT-BODY; OVERWINTERING DIAPAUSE; CELL-PROLIFERATION; FLESH FLY; TARGET; BLOOD; METABOLISM; EXPRESSION; DIPTERA	For many insects, diapause is the primary mechanism for surviving unfavorable seasons. Some aspects of diapause regulation are well known, but we still lack a mechanistic understanding of molecular mechanisms that control the diapause pathway. Accumulating evidence suggests microRNAs regulate diapause in evolutionarily diverse insect species including flesh flies and moths, and, it is likely that microRNAs regulate multiple characteristics of diapause, including arrested egg follicle development and fat hypertrophy, in females of the Northern house mosquito, Culex pipiens. To investigate microRNA regulation of diapause in this species, we measured changes in egg follicle development and total lipid content over 22 days following adult emergence. We also evaluated changes in the abundance of candidate microRNAs associated with these physical changes during the same time frame. We found egg follicle size and lipid content were nearly the same in diapausing and nondiapausing females on the day of adult emergence, and then diverged over time such that by day 22 diapausing females had significantly smaller egg follicles and higher total lipids than their nondiapausing counterparts. Several microRNAs associated with lipid metabolism in insects, including miR-14-3p, miR-277-3p, and miR-305-5p, were underexpressed in diapausing females compared to nondiapausing females on the day of adult emergence, which suggests microRNA regulation occurs ahead of observed changes in these two features of the diapause phenotype. We also found miR-309-3p, miR-375-3p which stimulate ovarian development in other mosquito species, were underexpressed in diapausing females of Cx. pipiens at times after diapause is fully established and may be responsible for the arrest in ovarian development in this species. Taken together, our results demonstrate that changes in the abundance of some microRNAs is associated with phenotypic changes in diapause Cx. pipiens and suggests this epigenetic mechanism is part of the molecular toolkit regulating diapause.	[Meuti, Megan E.; Bautista-Jimenez, Robin] Ohio State Univ, Dept Entomol, 1735 Neil Ave, Columbus, OH 43210 USA; [Reynolds, Julie A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Reynolds, JA (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.	reynolds.473@osu.edu			NSF [IOS-1354377]	NSF(National Science Foundation (NSF))	During the time these studies were conducted, MM and RB received salary support from the Department of Entomology at The Ohio State University. JR received salary support from NSF Grant IOS-1354377 which was awarded to David L Denlinger, who is mentioned in the acknowledgements section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Amsalem E, 2015, MOL ECOL, V24, P5596, DOI 10.1111/mec.13410; Barrio L, 2014, CELL REP, V8, P527, DOI 10.1016/j.celrep.2014.06.020; Batz ZA, 2017, INSECT MOL BIOL, V26, P721, DOI 10.1111/imb.12332; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit JB, 2007, J EXP BIOL, V210, P217, DOI 10.1242/jeb.02630; BOWEN MF, 1992, J MED ENTOMOL, V29, P843, DOI 10.1093/jmedent/29.5.843; BOWEN MF, 1988, J INSECT PHYSIOL, V34, P805, DOI 10.1016/0022-1910(88)90155-2; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Bryon A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-815; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098145; Crown SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145850; Ezcurra ALD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006073; Denlinger DL, 2016, ADV INSECT PHYSIOL, V51, P329, DOI 10.1016/bs.aiip.2016.05.002; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Esslinger SM, 2013, RNA BIOL, V10, P1042, DOI 10.4161/rna.24810; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Foronda D, 2014, GENE DEV, V28, P2421, DOI 10.1101/gad.241588.114; Fukaya T, 2014, MOL CELL, V56, P67, DOI 10.1016/j.molcel.2014.09.004; Garaulet DL, 2016, J NEUROSCI, V36, P3414, DOI 10.1523/JNEUROSCI.3287-15.2016; Hammell CM, 2009, P NATL ACAD SCI USA, V106, P18668, DOI 10.1073/pnas.0908131106; Hu W, 2015, INSECT MOL BIOL, V24, P240, DOI 10.1111/imb.12152; Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Jain S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098402; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kang DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154892; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Kostal V, 2016, PHYSIOL ENTOMOL, V41, P344, DOI 10.1111/phen.12159; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lampe L, 2018, G3-GENES GENOM GENET, V8, P185, DOI 10.1534/g3.117.300170; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Li AH, 2013, FEBS LETT, V587, P2455, DOI 10.1016/j.febslet.2013.06.018; Ling L, 2017, P NATL ACAD SCI USA, V2017, P10970; Liu ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27443; Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112; Mansfeld J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10043; Meuti ME, 2015, J MED ENTOMOL, V52, P131, DOI 10.1093/jme/tju016; Meuti ME, 2015, J EXP BIOL, V218, P412, DOI 10.1242/jeb.113233; Meuti ME, 2013, INTEGR COMP BIOL, V53, P131, DOI 10.1093/icb/ict023; MITCHELL CJ, 1989, J MED ENTOMOL, V26, P318, DOI 10.1093/jmedent/26.4.318; Morin MD, 2017, INSECT MOL BIOL, V26, P574, DOI 10.1111/imb.12320; Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143; Puthiyakunnon S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-230; Ragland GJ, 2017, PHYSIOL ENTOMOL, V42, P246, DOI 10.1111/phen.12193; Ramirez CM, 2013, MOL CELL BIOL, V33, P2891, DOI 10.1128/MCB.00016-13; Reynolds J.A., 2018, GEN COMP ENDOCRINOL; Reynolds JA, 2017, INSECT BIOCHEM MOLEC, V84, P1, DOI 10.1016/j.ibmb.2017.03.002; Reynolds JA, 2013, INSECT BIOCHEM MOLEC, V43, P982, DOI 10.1016/j.ibmb.2013.07.005; Rinehart JP, 2006, J MED ENTOMOL, V43, P713, DOI 10.1603/0022-2585(2006)43[713:ECADTI]2.0.CO;2; Roberts APE, 2011, PROG MOL BIOL TRANSL, V102, P101, DOI 10.1016/B978-0-12-415795-8.00002-7; Robich RM, 2005, P NATL ACAD SCI USA, V102, P15912, DOI 10.1073/pnas.0507958102; Romney AL, 2017, EVODEVO, V8, DOI 10.1186/s13227-017-0069-7; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; SANBURG LL, 1973, J INSECT PHYSIOL, V19, P1173, DOI 10.1016/0022-1910(73)90202-3; Shaw WR, 2015, CURR OPIN INSECT SCI, V10, P142, DOI 10.1016/j.cois.2015.05.001; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sim C, 2015, P NATL ACAD SCI USA, V112, P3811, DOI 10.1073/pnas.1502751112; Sim C, 2013, INSECT MOL BIOL, V22, P1, DOI 10.1111/j.1365-2583.2012.01166.x; Sim C, 2009, PHYSIOL GENOMICS, V39, P202, DOI 10.1152/physiolgenomics.00095.2009; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; SPIELMAN A, 1973, ANN ENTOMOL SOC AM, V66, P905, DOI 10.1093/aesa/66.4.905; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tormey D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1937-y; Tu XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11402; Ueda M, 2018, GENES CELLS, V23, P80, DOI 10.1111/gtc.12555; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; Varghese J, 2010, GENE DEV, V24, P2748, DOI 10.1101/gad.1995910; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wadsworth CB, 2015, J EXP BIOL, V218, P3611, DOI 10.1242/jeb.126136; Wang LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107030; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yocum GD, 2015, PHYSIOL ENTOMOL, V40, P103, DOI 10.1111/phen.12093; Zhang XF, 2017, P NATL ACAD SCI USA, V114, pE1895, DOI 10.1073/pnas.1701474114; Zhang Y, 2016, J NEUROSCI, V36, P2007, DOI 10.1523/JNEUROSCI.3286-15.2016; Zhao LL, 2015, BIOCHEM J, V470, P223, DOI 10.1042/BJ20150116; Zhou GL, 2009, J INSECT PHYSIOL, V55, P40, DOI 10.1016/j.jinsphys.2008.10.002	84	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0203015	10.1371/journal.pone.0203015	http://dx.doi.org/10.1371/journal.pone.0203015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496183	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800007
J	Shokur, S; Donati, ARC; Campos, DSF; Gitti, C; Bao, G; Fischer, D; Almeida, S; Braga, VAS; Augusto, P; Petty, C; Alho, EJL; Lebedev, M; Song, AW; Nicolelis, MAL				Shokur, Solaiman; Donati, Ana R. C.; Campos, Debora S. F.; Gitti, Claudia; Bao, Guillaume; Fischer, Dora; Almeida, Sabrina; Braga, Vania A. S.; Augusto, Patricia; Petty, Chris; Alho, Eduardo J. L.; Lebedev, Mikhail; Song, Allen W.; Nicolelis, Miguel A. L.			Training with brain-machine interfaces, visuotactile feedback and assisted locomotion improves sensorimotor, visceral, and psychological signs in chronic paraplegic patients	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MOTOR CORTEX STIMULATION; SACRAL NERVE-STIMULATION; OPEN-SOURCE SOFTWARE; QUALITY-OF-LIFE; COMPUTER INTERFACES; NEUROGENIC BLADDER; NEUROPATHIC PAIN; RECOVERY; REHABILITATION	Spinal cord injury (SCI) induces severe deficiencies in sensory-motor and autonomic functions and has a significant negative impact on patients' quality of life. There is currently no systematic rehabilitation technique assuring recovery of the neurological impairments caused by a complete SCI. Here, we report significant clinical improvement in a group of seven chronic SCI patients (six AIS A, one AIS B) following a 28-month, multi-step protocol that combined training with non-invasive brain-machine interfaces, visuo-tactile feedback and assisted locomotion. All patients recovered significant levels of nociceptive sensation below their original SCI (up to 16 dermatomes, average 11 dermatomes), voluntary motor functions (lower-limbs muscle contractions plus multi-joint movements) and partial sensory function for several modalities (proprioception, tactile, pressure, vibration). Patients also recovered partial intestinal, urinary and sexual functions. By the end of the protocol, all patients had their AIS classification upgraded (six from AIS A to C, one from B to C). These improvements translated into significant changes in the patients' quality of life as measured by standardized psychological instruments. Reexamination of one patient that discontinued the protocol after 12 months of training showed that the 16-month break resulted in neurological stagnation and no reclassification. We suggest that our neurorehabilitation protocol, based uniquely on non-invasive technology (therefore necessitating no surgical operation), can become a promising therapy for patients diagnosed with severe paraplegia (AIS A, B), even at the chronic phase of their lesion.	[Shokur, Solaiman; Donati, Ana R. C.; Campos, Debora S. F.; Bao, Guillaume; Fischer, Dora; Almeida, Sabrina; Braga, Vania A. S.; Augusto, Patricia; Alho, Eduardo J. L.; Nicolelis, Miguel A. L.] AASDAP, Neurorehabil Lab, Sao Paulo, Brazil; [Donati, Ana R. C.; Gitti, Claudia; Fischer, Dora; Almeida, Sabrina] AACD, Sao Paulo, Brazil; [Petty, Chris; Song, Allen W.] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC USA; [Alho, Eduardo J. L.] Univ Sao Paulo, Dept Neurosurg, Med Sch, Sao Paulo, Brazil; [Lebedev, Mikhail; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Lebedev, Mikhail; Nicolelis, Miguel A. L.] Duke Univ, Duke Ctr Neuroengn, Durham, NC 27708 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Neurol, Durham, NC 27708 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Neurosurg, Durham, NC 27708 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Nicolelis, Miguel A. L.] Edmond & Lily Safra Int Inst Neurosci, Macaiba, Brazil	Duke University; Universidade de Sao Paulo; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Nicolelis, MAL (corresponding author), AASDAP, Neurorehabil Lab, Sao Paulo, Brazil.; Nicolelis, MAL (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.; Nicolelis, MAL (corresponding author), Duke Univ, Duke Ctr Neuroengn, Durham, NC 27708 USA.; Nicolelis, MAL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Nicolelis, MAL (corresponding author), Duke Univ, Dept Neurol, Durham, NC 27708 USA.; Nicolelis, MAL (corresponding author), Duke Univ, Dept Neurosurg, Durham, NC 27708 USA.; Nicolelis, MAL (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA.; Nicolelis, MAL (corresponding author), Edmond & Lily Safra Int Inst Neurosci, Macaiba, Brazil.	nicoleli@neuro.duke.edu	Lebedev, Mikhail A/H-5066-2016	Lebedev, Mikhail A/0000-0003-0355-8723; Shokur, Solaiman/0000-0003-2251-7142	Brazilian Financing Agency for Studies and Projects [FINEP 01.12.0514.00]; Brazilian Ministry of Science, Technology, Innovation and Communication (MCTIC); Itau Unibanco S.A.; National Institute of Science and Technology Program (INCT) of the National Council of Scientific and Technological Development (CNPq/MCTIC) [INCEMAQ 610009/2009-5]	Brazilian Financing Agency for Studies and Projects; Brazilian Ministry of Science, Technology, Innovation and Communication (MCTIC); Itau Unibanco S.A.; National Institute of Science and Technology Program (INCT) of the National Council of Scientific and Technological Development (CNPq/MCTIC)	This study was funded by grants from the Brazilian Financing Agency for Studies and Projects (FINEP 01.12.0514.00), Brazilian Ministry of Science, Technology, Innovation and Communication (MCTIC), and the Itau Unibanco S.A. We also acknowledge the support from the National Institute of Science and Technology Program (INCT INCEMAQ 610009/2009-5) of the National Council of Scientific and Technological Development (CNPq/MCTIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2011, SPINAL CORD, V49, P795, DOI 10.1038/sc.2010.192; Alexander MS, 2011, SPINAL CORD, V49, P787, DOI 10.1038/sc.2011.7; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Aujoulat I, 2008, SOC SCI MED, V66, P1228, DOI 10.1016/j.socscimed.2007.11.034; Aujoulat I, 2007, PATIENT EDUC COUNS, V66, P13, DOI 10.1016/j.pec.2006.09.008; Barbeau H, 2003, NEUROREHAB NEURAL RE, V17, P3, DOI 10.1177/0888439002250442; Basso DM, 2000, PHYS THER, V80, P808, DOI 10.1093/ptj/80.8.808; Benevento BT, 2002, PHYS THER, V82, P601, DOI 10.1093/ptj/82.6.601; Biering-Sorensen F, 2008, SPINAL CORD, V46, P325, DOI 10.1038/sj.sc.3102145; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Bonizzato M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05282-6; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cairns DM, 1996, ARCH PHYS MED REHAB, V77, P329, DOI 10.1016/S0003-9993(96)90079-9; Canzoneri E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02844; Chang LC, 2004, APPL NURS RES, V17, P41, DOI 10.1016/j.apnr.2003.10.006; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; Dimitrijevic M R, 1983, Adv Neurol, V39, P915; Dimitrijevic M R, 1988, Adv Neurol, V47, P138; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Donati ARC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30383; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Field-Fote EC, 2011, PHYS THER, V91, P48, DOI 10.2522/ptj.20090359; Fontaine D, 2009, J NEUROSURG, V110, P251, DOI 10.3171/2008.6.17602; Fouad K, 2011, BRAIN RES BULL, V84, P337, DOI 10.1016/j.brainresbull.2010.04.017; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Funnel M, 2003, PATIENT EMPOWERMENT, DOI [10.1177/014572170302900310, DOI 10.1177/014572170302900310]; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Gstaltner K, 2008, SPINAL CORD, V46, P644, DOI 10.1038/sc.2008.6; Hammell KW, 2007, SPINAL CORD, V45, P124, DOI 10.1038/sj.sc.3101992; Hammell KW, 2004, SPINAL CORD, V42, P491, DOI 10.1038/sj.sc.3101636; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1588, DOI 10.1016/j.apmr.2012.04.032; Harrop JS, 2011, SPINE, V36, P21, DOI 10.1097/BRS.0b013e3181fd6b36; Hess MJ, 2012, J SPINAL CORD MED, V35, P211, DOI 10.1179/2045772312Y.0000000025; Hill MR, 2010, SPINAL CORD, V48, P438, DOI 10.1038/sc.2009.164; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Hospital TW, 2012, EDITORIAL ASSESSING, P27, DOI [10.3171/2012.6.AOSPINE12568.28, DOI 10.3171/2012.6.AOSPINE12568.28]; Ionta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20144; James ND, 2018, LANCET NEUROL, V17, P905, DOI 10.1016/S1474-4422(18)30287-4; Jang Y, 2004, ARCH PHYS MED REHAB, V85, P1890, DOI 10.1016/j.apmr.2004.02.032; Kakulas BA, 1998, SPINAL CORD MONITORING, P395; Kawano O, 2018, SPINAL CORD, V56, P996, DOI 10.1038/s41393-018-0153-4; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Krogh K, 2009, SPINAL CORD, V47, P230, DOI 10.1038/sc.2008.102; Lebedev MA, 2000, CEREB CORTEX, V10, P23, DOI 10.1093/cercor/10.1.23; Lebedev MA, 2017, BRAIN MACHINE INTERF, P767, DOI [10.1152/PHYSREV.00027.2016, DOI 10.1152/PHYSREV.00027.2016]; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lenggenhager B, 2007, VIDEO ERGO SUM MANIP, V1096, P1095, DOI [10.1126/SCIENCE.114.3439, DOI 10.1126/SCIENCE.114.3439]; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lude P, QUALITY LIFE SPINAL; Mahmoudi B, 2006, MED BIOL ENG COMPUT, V44, P959, DOI 10.1007/s11517-006-0111-8; Manella KJ, 2013, J NEUROPHYSIOL, V109, P2666, DOI 10.1152/jn.01039.2011; McAllister M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-157; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Murillo N, 2012, NEUROREHABILITATION, V31, P401, DOI 10.3233/NRE-2012-00810; NATHAN PW, 1994, BRAIN, V117, P337, DOI 10.1093/brain/117.2.337; National Spinal Cord Injury Statistical Center and others, 2015, FACTS FIG GLANC; Nicolelis MAL, 2014, 44 SOC NEUR M WASH D; Oh Sun Kyu, 2016, Korean J Neurotrauma, V12, P40, DOI 10.13004/kjnt.2016.12.2.40; Pazzaglia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058312; Petraglia FW, 2016, NEUROMODULATION, V19, P85, DOI 10.1111/ner.12370; Possover Marc, 2017, Spinal Cord Ser Cases, V3, P16034, DOI 10.1038/scsandc.2016.34; Pulvirenti M, 2014, HEALTH EXPECT, V17, P303, DOI 10.1111/j.1369-7625.2011.00757.x; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Redshaw JD, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0383-y; Rejc E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14003-w; Renard Y, 2010, PRESENCE-TELEOP VIRT, V19, P35, DOI 10.1162/pres.19.1.35; Romo PGB, 2017, UROL CLIN N AM, V44, P453, DOI 10.1016/j.ucl.2017.04.011; SHERWOOD AM, 1992, J NEUROL SCI, V110, P90, DOI 10.1016/0022-510X(92)90014-C; Shokur S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32293; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Soekadar SR, 2015, NEUROBIOL DIS, V83, P172, DOI 10.1016/j.nbd.2014.11.025; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Taub E, 1999, J REHABIL RES DEV, V36, P237; Thompson AK, 2013, J NEUROSCI, V33, P2365, DOI 10.1523/JNEUROSCI.3968-12.2013; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsubokawa T, 1991, Acta Neurochir Suppl (Wien), V52, P137; Tucker MR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-1; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WHO, 2013, INTERNATIONAL PERSPECTIVES ON SPINAL CORD INJURY, P1; WU L, 1992, ARCH PHYS MED REHAB, V73, P40; Yoshida Naoki, 2016, Spinal Cord Ser Cases, V2, P16021, DOI 10.1038/scsandc.2016.21	88	20	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0206464	10.1371/journal.pone.0206464	http://dx.doi.org/10.1371/journal.pone.0206464			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496189	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800015
J	Shultzaberger, RK; Abrams, RE; Sullivan, CJ; Schmitt, AD; Thompson, TWJ; Dresios, J				Shultzaberger, Ryan K.; Abrams, Rachel E.; Sullivan, Challise J.; Schmitt, Anthony D.; Thompson, Thomas W. J.; Dresios, John			Agnostic detection of genomic alterations by holistic DNA structural interrogation	PLOS ONE			English	Article							CONTACT MAPS; CHROMATIN; METHYLATION; REVEALS; CAS9; SEQ; EXPRESSION; PRINCIPLES; LANDSCAPE; NUCLEASES	There is an established relationship between primary DNA sequence, secondary and tertiary chromatin structure, and transcriptional activity, suggesting that observed differences in one of these properties may reflect changes in the others. Here, we exploit these relationships to show that variations in DNA structure can be used to identify a wide range of genomic alterations in mammalian samples. In this proof-of-concept study we characterized and compared genome-wide histone occupancy by ChIP-Seq, DNA accessibility by ATAC-Seq, and chromosomal conformation by Hi-C for five CRISPR/Cas9-modified mammalian cell lines and their unmodified parent strains, as well as in one modified tissue sample and its parent strain. The results showed that the impact of genomic alterations on each of the levels of DNA organization varied depending on mutation type (insertion or deletion), size, and genomic location. The largest genomic alterations we identified included chromosomal rearrangements and deletions (greater than 200 Kb) in four of the modified cell lines, which can be difficult to identify by standard whole genome sequencing analysis. This multi-level DNA organizational analysis provides a sensitive approach for identifying a wide range of genomic and epigenomic perturbations that can be utilized for biomedical and biosecurity applications.	[Shultzaberger, Ryan K.; Abrams, Rachel E.; Sullivan, Challise J.; Thompson, Thomas W. J.; Dresios, John] Leidos Inc, San Diego, CA 92121 USA; [Schmitt, Anthony D.] Arima Genom Inc, San Diego, CA USA		Dresios, J (corresponding author), Leidos Inc, San Diego, CA 92121 USA.	john.dresios@leidos.com		Sullivan, Challise/0000-0001-6467-5670	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) [2016-16071200002]	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA)	Leidos Inc. and Arima Genomics Inc. provided no direct funding for these studies. This research is based upon work supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) (Contract number: 2016-16071200002) (JD). The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of ODNI, IARPA, or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for governmental purposes notwithstanding any copyright annotation therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Seth Rubin and Drs. Paul Labhart and Brian Egan from Active Motif, and Dr. Siddarth Selvaraj from Arima Genomics for experimental and computational input. We thank Dr. Bing Ren (The Ludwig Institute for Cancer Research, La Jolla, CA), Dr. Linda Foit (The Ludwig Institute for Cancer Research, New York, NY), and The Whitehead Institute for Biomedical Research for providing access to the mESC lines. We also thank Dr. Michael Jablecki (Leidos) for critical reading of the manuscript and valuable discussions. We thank Dr. John Julias (IARPA) for his encouragement and feedback throughout this effort. This research is based upon work supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) (Contract number: 2016-16071200002) (JD). The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of ODNI, IARPA, or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for governmental purposes notwithstanding any copyright annotation therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2002, TRENDS BIOTECHNOL, V20, P215, DOI 10.1016/S0167-7799(01)01920-5; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Backman TWH, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1241-0; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bouwman BAM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0730-1; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; BUENROSTRO JD, 2015, CURR PROTOC MOL BIOL, V109, DOI DOI 10.1002/0471142727.MB2129S109; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Cameron P, 2017, NAT METHODS, V14, P600, DOI [10.1038/nmeth.4284, 10.1038/NMETH.4284]; Chuang YH, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0466-5; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon J.R., 2017, INTEGRATIVE FRAMEWOR, DOI [10.1101/119651, DOI 10.1101/119651]; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garrison E., ARXIV12073907; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Koo T, 2015, MOL CELLS, V38, P475, DOI 10.14348/molcells.2015.0103; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Lareau C., 2017, BIORXIV, DOI [10.1101/159707, DOI 10.1101/159707]; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114485; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu XS, 2018, CELL, V172, P979, DOI 10.1016/j.cell.2018.01.012; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lun ATL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0683-0; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nestler EJ, 2012, NATURE, V490, P171, DOI 10.1038/490171a; Paul KC, 2018, SCI TOTAL ENVIRON, V645, P1135, DOI 10.1016/j.scitotenv.2018.07.143; Preissl S, 2015, CIRC RES, V117, P413, DOI 10.1161/CIRCRESAHA.115.306337; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rouhani FJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005932; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Shenker NS, 2013, EPIDEMIOLOGY, V24, P712, DOI 10.1097/EDE.0b013e31829d5cb3; Sullivan Challise J, 2015, Biochem Biophys Rep, V2, P143, DOI 10.1016/j.bbrep.2015.06.002; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/nmeth.3733, 10.1038/NMETH.3733]; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Weissbein U, 2014, J CELL BIOL, V204, P153, DOI 10.1083/jcb.201310135; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208054	10.1371/journal.pone.0208054	http://dx.doi.org/10.1371/journal.pone.0208054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496256	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800088
J	Silva-Cardoso, L; Dias, FA; Fampa, P; Pereira, MG; Atella, GC				Silva-Cardoso, Livia; Dias, Felipe A.; Fampa, Patricia; Pereira, Miria G.; Atella, Georgia C.			Evaluating the effects of anticoagulants on Rhodnius prolixus artificial blood feeding	PLOS ONE			English	Article							INFESTANS KLUG HET; TRIATOMA-INFESTANS; TRYPANOSOMA-CRUZI; EGG-PRODUCTION; LIVE HOST; LIFE-SPAN; IN-VITRO; REDUVIIDAE; HEMIPTERA; AMPLIFICATION	Blood-sucking insects are responsible for the transmission of several important disease-causing organisms such as viruses, bacteria, and protozoans. The hematophagous hemipteran Rhodnius prolixus is one of the most important vectors of Trypanosoma cruzi, the etiological agent of Chagas disease. Due to the medical importance of this insect, it has been used as a study model in physiology and biochemistry since the 1930s. Artificial feeding has been recognized as a feasible and a more ethical alternative method of feeding these hematophagous insects. To prevent clotting after blood collection defibrination or treatment with anticoagulants are necessary. Although anticoagulants have been routinely used for stabilizing the collected blood, there is a gap in demonstration of the effects of using anticoagulants on the feeding and development of the hematophagous insect Rhodnius prolixus. In this study, we compared the survival rate, molting efficiency, fertility, and infection development between insects that were fed on blood containing three different anticoagulants (citrate, EDTA, and heparin). We observed that fifth instar nymphs that were fed on blood containing EDTA and citrate could not perform digestion properly, which resulted in molting inefficiency. Adult insects that were fed on EDTA-containing blood laid lower number of eggs, and also had a diminished egg hatch percentage. When we delivered T. cruzi parasites in blood containing citrate or EDTA to the insects, a lower number of parasites and metacyclic trypomastigotes was observed in the intestine compared to the group fed on heparin-containing blood. Since heparin could potentially inhibit DNA polymerase activity in DNA samples extracted from the intestine, we analyzed different heparin concentrations to determine which one is the best for use as an anticoagulant. Concentrations ranging between 2.5 and 5 U/mL were able to inhibit coagulation without severely impairing DNA polymerase activity, thus indicating that this should be considered as the range of use for feeding experiments. Our results suggest that among the three anticoagulants tested, heparin can be recommended as the anticoagulant of choice for R. prolixus feeding experiments.	[Silva-Cardoso, Livia; Dias, Felipe A.; Atella, Georgia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil; [Fampa, Patricia] Univ Fed Rural Rio de Janeiro, Dept Ciencias Farmaceut, Inst Ciencias Biol & Saude, Seropedica, RJ, Brazil; [Pereira, Miria G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal do Rio de Janeiro	Atella, GC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.	atella@bioqmed.ufrj.br	Lima, Patricia F N/A-5165-2014; Pereira, Miria G/AAJ-9998-2021; Atella, Georgia/AAK-7897-2020; Fampa, Patricia/AAA-2515-2019	Fampa, Patricia/0000-0003-3440-1622	Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FAPERJ; CNPq; Coordenacao de Aperfeicoamento de Pessoas de Nivel Superior	Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoas de Nivel Superior	This research was funded by Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. Furthermore, Livia Silva Cardoso received fellowships from FAPERJ and CNPq, during the research time; Felipe A. Dias received a fellowship from FAPERJ; and Miria G. Pereira received a joint fellowship from CNPq together with Coordenacao de Aperfeicoamento de Pessoas de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aak A, 2014, MED VET ENTOMOL, V28, P50, DOI 10.1111/mve.12015; Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; Aldana E, 2001, REV BIOL TROP, V49, P689; Azambuja P. de, 1997, The molecular biology of insect disease vectors: a methods manual., P56; Bauerfeind SS, 2007, J INSECT PHYSIOL, V53, P964, DOI 10.1016/j.jinsphys.2007.01.013; BENZON GL, 1987, J AM MOSQUITO CONTR, V3, P322; BEUTLER E, 1990, BIOTECHNIQUES, V9, P166; BUXTON P. A., 1930, TRANS ENT SOC LONDON, V78, P227; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; Chiyaka C, 2013, SCIENCE, V339, P909, DOI 10.1126/science.1229509; Chorna T, 2012, BBA-GEN SUBJECTS, V1820, P1269, DOI 10.1016/j.bbagen.2011.11.002; Coelho HSL, 1997, ARCH INSECT BIOCHEM, V35, P301, DOI 10.1002/(SICI)1520-6327(199705)35:3<301::AID-ARCH4>3.0.CO;2-W; Coura JR, 2010, NATURE, V465; De Beer CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168799; De Beer CJ, 2012, QUALITY CONTROL EXPA, P140; DESOUZAGARCIA E, 1975, AN ACAD BRAS CIENC, V47, P537; Dias FD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004186; FRIEND W. G., 1963, CANADIAN ENTOMOL, V95, P362; FRIEND W G, 1987, Memorias do Instituto Oswaldo Cruz, V82, P11, DOI 10.1590/S0074-02761987000700005; FRIEND WG, 1982, J INSECT PHYSIOL, V28, P371, DOI 10.1016/0022-1910(82)90050-6; FRIEND WG, 1977, ANNU REV ENTOMOL, V22, P309, DOI 10.1146/annurev.en.22.010177.001521; FRIEND WG, 1965, CAN J ZOOLOG, V43, P125, DOI 10.1139/z65-010; GARCIA ES, 1985, BRAZ J MED BIOL RES, V18, P195; GARDINER BO, 1972, B ENTOMOL RES, V61, P505, DOI 10.1017/S0007485300047350; GOMES JEPL, 1990, MEM I OSWALDO CRUZ, V85, P299, DOI 10.1590/S0074-02761990000300006; Guarneri AA, 2000, J INSECT PHYSIOL, V46, P1121, DOI 10.1016/S0022-1910(99)00222-X; Guarneri AA, 2017, J INSECT PHYSIOL, V97, P66, DOI 10.1016/j.jinsphys.2016.07.005; Gullan P. J., 2005, INSECTS OUTLINE ENTO, P1; HOLODNIY M, 1991, J CLIN MICROBIOL, V29, P676, DOI 10.1128/JCM.29.4.676-679.1991; HUEBNER E, 1994, CAN J ZOOL, V72, P2244, DOI 10.1139/z94-299; Issmer AE, 2008, ALTERNATIVES ANIMAL, P125; IZRAELI S, 1991, NUCLEIC ACIDS RES, V19, P6051; LANGLEY PA, 1969, NATURE, V221, P855, DOI 10.1038/221855a0; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112; MEWS AR, 1976, B ENTOMOL RES, V65, P631, DOI 10.1017/S0007485300006325; Molleman F, 2008, ENTOMOL EXP APPL, V129, P54, DOI 10.1111/j.1570-7458.2008.00752.x; Nattero J, 2011, ACTA TROP, V119, P183, DOI 10.1016/j.actatropica.2011.05.015; NUNEZ JA, 1990, J APPL ENTOMOL, V109, P87, DOI 10.1111/j.1439-0418.1990.tb00023.x; Nunez JA, 1996, J APPL ENTOMOL, V120, P541, DOI 10.1111/j.1439-0418.1996.tb01649.x; Orchard I, 2006, COMP BIOCHEM PHYS A, V144, P316, DOI 10.1016/j.cbpa.2005.11.010; PATTERSON JW, 1979, J INSECT PHYSIOL, V25, P311, DOI 10.1016/0022-1910(79)90018-0; Peterson JK, 2015, AM J TROP MED HYG, V93, P564, DOI 10.4269/ajtmh.15-0218; PIMENTA PFP, 1994, P NATL ACAD SCI USA, V91, P9155, DOI 10.1073/pnas.91.19.9155; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; SCHAUB GA, 1988, T ROY SOC TROP MED H, V82, P94, DOI 10.1016/0035-9203(88)90273-8; SCHAUB GA, 1989, EXP PARASITOL, V68, P260, DOI 10.1016/0014-4894(89)90108-2; Schofield CJ, 1996, P INT WORKSH POP GEN, P45; SMITH JJB, 1979, J EXP BIOL, V82, P93; Solarte Y, 2007, AM J TROP MED HYG, V77, P242, DOI 10.4269/ajtmh.2007.77.242; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x; UBIERGO GO, 1982, J MED ENTOMOL, V19, P109, DOI 10.1093/jmedent/19.1.109; VALLE D, 1987, J INSECT PHYSIOL, V33, P249, DOI 10.1016/0022-1910(87)90045-X; VOIGT WP, 1993, PARASITOLOGY, V107, P257, DOI 10.1017/S0031182000079233; WALADDE SM, 1993, PARASITOLOGY, V107, P249, DOI 10.1017/S0031182000079221; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; Wigglesworth VB, 1943, QJ MICROSC SCI, V77, P191; WILLEMS M, 1993, J VIROL METHODS, V42, P127, DOI 10.1016/0166-0934(93)90184-S; Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156	62	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0206979	10.1371/journal.pone.0206979	http://dx.doi.org/10.1371/journal.pone.0206979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496298	Green Submitted, gold, Green Published			2022-12-26	WOS:000451763800019
J	Cennamo, G; Montorio, D; Breve, MA; Morra, VB; Menna, F; Cennamo, G				Cennamo, Gilda; Montorio, Daniela; Breve, Maria Angelica; Morra, Vincenzo Brescia; Menna, Feliciana; Cennamo, Giovanni			Evaluation of optic nerve subarachnoid space in primary open angle glaucoma using ultrasound examination	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; NORMAL-TENSION GLAUCOMA; SHEATH DIAMETER; INTRACRANIAL-PRESSURE; ECHOGRAPHIC MEASUREMENT; PREVALENCE; SYSTEM; RISK	Objectives To measure Optic Nerve Subarachnoid Space (ONSAS) in patients with primary open-angle glaucoma (POAG) and controls using A-scan ultrasound and to evaluate the measurement of the ONSAS in relation to age patient and OCT parameters. Methods This retrospective study included 53 consecutive eyes of 27 patients with POAG and 64 normal eyes of 32 controls. Both glaucomatous and control groups were divided into 2 subgroups according to age: < 60 age (glaucomatous and control group 1) and 61-90 age (glaucomatous and control group 2). Results The ONSAS was significantly lower in all glaucomatous eyes (3.54 +/- 0.38) versus normal eyes (3.87 +/- 0.32) (p = 0.001). Significant reduction of ONSAS was showed in control group 2 (3.63 mm +/- 0.37) compared to control group 1 (3.87 mm +/- 0.32) (p = 0.014) and between glaucoma group 1 (3.54 mm +/- 0.38) and control group 1 (p = 0.001). While no significant differences were observed between glaucomatous group 2 (3.48 mm +/- 0.41) and control group 2 (p = 0.17) and between glaucoma group 1 and glaucoma group 2 (p = 0.609). Lastly, the ONSAS was not significantly associated with GCC and RNFL parameters except for Focal Loss Volume (FLV), Superior RNFL and ONSAS in glaucoma group 1 and for FLV and ONSAS in all glaucomatous group. Conclusion Standardized A-scan ultrasound is a non invasive imaging technique with which it is possible to monitor ONSAS changes in glaucomatous patients. The reduction of ONSAS confirm the importance of the lower orbital CSFP as further risk factor in the progression of glaucoma disease.	[Cennamo, Gilda] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Montorio, Daniela; Breve, Maria Angelica; Morra, Vincenzo Brescia; Menna, Feliciana; Cennamo, Giovanni] Univ Naples Federico II, Dept Neurosci Reprod Sci & Dent, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Cennamo, G (corresponding author), Univ Naples Federico II, Dept Publ Hlth, Naples, Italy.	xgilda@hotmail.com	Montorio, Daniela/AAJ-8687-2020	CENNAMO, Gilda/0000-0003-4253-1929; Montorio, Daniela/0000-0003-1423-9621				Bauerle J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-187; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; CENNAMO G, 1985, ORBIT, V4, P231, DOI 10.3109/01676838509021756; CENNAMO G, 1992, ACTA OPHTHALMOL, V70, P87; Cennamo G, 1987, DOC OPHTHALMOL P SER, V48, P603, DOI [10.1007/978-94-009-3315-6_99, DOI 10.1007/978-94-009-3315-6_99]; Copetti R, 2009, INTENS CARE MED, V35, P1488, DOI 10.1007/s00134-009-1494-4; Dallow R. L., 1979, INT OPHTHAL CLIN, V19; De Bernardo M, 2017, J ULTRASOUND MED; De Bernardo M, 2017, JAMA OPHTHALMOL, V135, P1004, DOI 10.1001/jamaophthalmol.2017.2597; Dichtl A, 1996, AM J OPHTHALMOL, V122, P514, DOI 10.1016/S0002-9394(14)72111-7; DRANCE SM, 1972, BRIT J OPHTHALMOL, V56, P229, DOI 10.1136/bjo.56.3.229; FARACI FM, 1990, AM J PHYSIOL, V258, pR94, DOI 10.1152/ajpregu.1990.258.1.R94; Fleischman D, 2013, SAUDI J OPHTHALMOL, V27, P97, DOI 10.1016/j.sjopt.2013.03.002; Fleischman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052664; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Frolkis VV, 1990, ARCH GERONT GER, V29, P109; GANGEMI M, 1987, NEUROCHIRURGIA, V30, P53; Gass A, 1996, NEURORADIOLOGY, V38, P769, DOI 10.1007/s002340050344; Gherghel D, 2004, SURV OPHTHALMOL, V49, P491, DOI 10.1016/j.survophthal.2004.06.003; Grieshaber Matthias C, 2005, Curr Opin Ophthalmol, V16, P79, DOI 10.1097/01.icu.0000156134.38495.0b; Hirashima T, 2013, GRAEF ARCH CLIN EXP, V251, P129, DOI 10.1007/s00417-012-2076-7; HITCHINGS RA, 1976, BRIT J OPHTHALMOL, V60, P778, DOI 10.1136/bjo.60.11.778; Hou RW, 2016, BRAIN RES, V1635, P201, DOI 10.1016/j.brainres.2016.01.011; Imamura Y, 1996, J NEUROL NEUROSUR PS, V60, P108, DOI 10.1136/jnnp.60.1.108; Jaggi GP, 2012, BRIT J OPHTHALMOL, V96, P53, DOI 10.1136/bjo.2010.199224; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Liu HR, 2018, AM J OPHTHALMOL, V186, P128, DOI 10.1016/j.ajo.2017.11.024; MAY C, 1990, NEUROLOGY, V40, P500, DOI 10.1212/WNL.40.3_Part_1.500; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; Nakamura M, 2005, OPHTHALMOLOGICA, V219, P1, DOI 10.1159/000081775; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Ossoinig K.C., 1990, OPHTHALMIC ECHOGRAPH, V55, P3; Ossoinig K.C., 1981, DOC OPHTHALMOL PROC, V29, P327, DOI DOI 10.1007/978-94-009-8659-6_51; Pinto LA, 2012, GRAEF ARCH CLIN EXP, V250, P1075, DOI 10.1007/s00417-011-1878-3; Pircher A, 2017, EYE, V31, P1365, DOI 10.1038/eye.2017.70; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Rosa N, 2017, J CRIT CARE, V40, P279, DOI 10.1016/j.jcrc.2017.03.018; Rosa N, 2017, J NEUROSCI RURAL PRA, V8, P310, DOI 10.4103/0976-3147.203830; Schwartz KM, 2013, AM J NEURORADIOL, V34, P904, DOI 10.3174/ajnr.A3313; Serot JM, 2006, FRONT BIOSCI, V8, ps515; Steinborn M, 2011, ULTRASCHALL MED; Volkov V V, 1976, Oftalmol Zh, V31, P500; Wang LJ, 2018, JAMA OPHTHALMOL, V136, P250, DOI 10.1001/jamaophthalmol.2017.6560; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Watanabe A, 2008, J NEUROSURG, V109, P255, DOI 10.3171/JNS/2008/109/8/0255; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yoshida M, 2001, J CLIN EPIDEMIOL, V54, P1151, DOI 10.1016/S0895-4356(01)00388-2	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208064	10.1371/journal.pone.0208064	http://dx.doi.org/10.1371/journal.pone.0208064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485355	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800101
J	Ganyaglo, GYK; Ryan, N; Park, J; Lassey, AT				Ganyaglo, Gabriel Y. K.; Ryan, Nessa; Park, Joonhee; Lassey, A. T.			Feasibility and acceptability of the menstrual cup for non-surgical management of vesicovaginal fistula among women at a health facility in Ghana	PLOS ONE			English	Article							OBSTETRIC FISTULA; URINARY-INCONTINENCE; CARE	Objective To assess the feasibility of the menstrual cup for short-term management of urinary leakage among women with vesicovaginal fistula (VVF) Methods A repeated measures design compared volume of leakage with and without the cup via a 2-hr pad test among women with VVF seeking surgical repair at a health facility in Ghana. Subsequently a gynecological exam was administered to assess safety outcomes, followed by a questionnaire to assess acceptability and perceived efficacy. A paired t-test was used to analyze reduction of leakage in ml, and percent reduction was reported. Study limitations include observer bias while evaluating adverse outcomes and the possibility of social desirability bias during questionnaire administration that might overestimate the effect of the cup and women's acceptability. Results Of the 32 patients screened, 11 were eligible (100% consent rate). At baseline, mean (+/- SD) leakage in ml was 63.2 (+/- 49.2) (95% CI: 30.2-96.3) over two hours, while the mean leakage over two hours of use of the cup was 16.8 (+/- 16.5) (95% CI: 5.7-27.9). The mean difference of 46.4 (+/- 52.1) ml with use of the cup (95% CI: 11.4-81.4) was statistically significant (p = 0.02). With the cup, women experienced an average 61.0% (+/- 37.4) (95% CI: 35.9-86.2) leakage reduction, a difference 10/11 users (91.0%) perceived in reduced leakage. One participant, reporting four previous surgical attempts, experienced a 78.7% leakage reduction. Acceptability was high-women could easily insert (8/11), remove (8/11), and comfortably wear (11/11) the cup and most (10/11) would recommend it. No adverse effects attributable to the intervention were observed on exam, although some women perceived difficulties with insertion and removal. Data collection tools were appropriate with slight modification advised. Conclusion A larger trial is warranted for a more robust evaluation of the menstrual cup for management of urinary leakage due to VVF among women who have not yet accessed surgery or for whom surgery was not successful.	[Ganyaglo, Gabriel Y. K.] Korle Bu Teaching Hosp, Dept Obstet & Gynaecol, Accra, Ghana; [Ryan, Nessa; Park, Joonhee] NYU, Dept Obstet & Gynecol, Langone Med Ctr, New York, NY 10016 USA; [Ryan, Nessa] NYU, Coll Global Publ Hlth, New York, NY 10003 USA; [Ryan, Nessa] NYU, NYU HHC Clin & Translat Sci Inst, New York, NY 10003 USA; [Lassey, A. T.] Univ Ghana, Coll Hlth Sci, Sch Med & Dent, Dept Obstet & Gynaecol, Legon, Ghana	New York University; NYU Langone Medical Center; New York University; New York University; University of Ghana	Ryan, N (corresponding author), NYU, Dept Obstet & Gynecol, Langone Med Ctr, New York, NY 10016 USA.; Ryan, N (corresponding author), NYU, Coll Global Publ Hlth, New York, NY 10003 USA.; Ryan, N (corresponding author), NYU, NYU HHC Clin & Translat Sci Inst, New York, NY 10003 USA.	ryann01@nyu.edu		Ryan, Nessa/0000-0002-8051-0021	New York University Stern Business School Social Entrepreneurs Challenge; New York University Department of Obstetrics and Gynecology (NYU Langone Medical Center); NYU CTSA from the National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR0001445, TL1 TR001447]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, TL1TR001447] Funding Source: NIH RePORTER	New York University Stern Business School Social Entrepreneurs Challenge; New York University Department of Obstetrics and Gynecology (NYU Langone Medical Center); NYU CTSA from the National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this research was provided by a first prize award in the New York University Stern Business School Social Entrepreneurs Challenge, a school-wide social entrepreneurship incubator competition. Additional funding was provided by the New York University Department of Obstetrics and Gynecology (NYU Langone Medical Center). This work was supported in part by the NYU CTSA grants UL1 TR0001445 and TL1 TR001447 from the National Center for Advancing Translational Sciences, National Institutes of Health.	Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Arrowsmith SD, 2013, CURR OPIN OBSTET GYN, V25, P399, DOI 10.1097/GCO.0b013e3283648d60; Baker Z, 2017, TROP MED INT HEALTH, V22, P938, DOI 10.1111/tmi.12893; Beksinska ME, 2015, J WOMENS HEALTH, V24, P151, DOI 10.1089/jwh.2014.5021; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; De Ridder D, 2009, CURR OPIN UROL, V19, P358, DOI 10.1097/MOU.0b013e32832ae1b7; Ghana Health Service, 2015, REP FIST REP BURD GH; Goh JTW, 2004, AUST NZ J OBSTET GYN, V44, P502, DOI 10.1111/j.1479-828X.2004.00315.x; Goldberg L, 2016, FEMALE PELVIC MED RE, V22, pE29, DOI 10.1097/SPV.0000000000000301; Juma J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015429; Mwini-Nyaledzigbor PP, 2013, HEALTH CARE WOMEN IN, V34, P440, DOI 10.1080/07399332.2012.755981; NCAA, 2017, FACTSH STUD ATHL ASS; NIH U. S. National Library of Medicine, FDAAA 801 FIN RUL; Polan ML, 2015, OBSTET FISTULA; Pope R, 2011, GLOB PUBLIC HEALTH, V6, P859, DOI 10.1080/17441692.2010.551519; Russell KW, 2016, OBSTET GYNECOL, V128, P1365, DOI 10.1097/AOG.0000000000001745; StataCorp, 2013, STATA STAT SOFTW REL; Sullivan G, 2016, MIDWIFERY, V40, P162, DOI 10.1016/j.midw.2016.07.005; Tebeu PM, 2012, INT UROGYNECOL J, V23, P387, DOI 10.1007/s00192-011-1622-x; Tellier S, 2018, MENSTRUAL HLTH MANAG; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; United Nations, 2014, REP SECR GEN SUPP EF; Vision Reporter, 2012, NEW VISION; Wall LL, 2006, LANCET, V368, P1201, DOI 10.1016/S0140-6736(06)69476-2	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207925	10.1371/journal.pone.0207925	http://dx.doi.org/10.1371/journal.pone.0207925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485344	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800085
J	Yang, Y; Dong, GZ; Wang, Z; Wang, J; Zhang, Z; Liu, JH				Yang, You; Dong, Guozhong; Wang, Zhi; Wang, Jian; Zhang, Zhu; Liu, Junhui			Rumen and plasma metabolomics profiling by UHPLC-QTOF/MS revealed metabolic alterations associated with a high-corn diet in beef steers	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; DAIRY-COWS; GAS-CHROMATOGRAPHY; SPECTROMETRY DATA; GRAIN; IDENTIFICATION; BIOMARKERS; ENDOTOXIN; HEALTH; SARA	High-grain diets are strongly associated with metabolic disorders in beef steers. Metabolomics can be used to explore the relationship between diet and metabolic changes, but no study has reported rumen and plasma metabolomics profiling associated with increasing dietary corn proportions in the diet of beef steers. Therefore, 12 steers paired according to similar body weights and body condition scores were randomly allocated to one of two diets: a low-corn (28.76%) diet (LCD) with a 40:60 ratio of concentrate to roughage and a high-corn (48.76%) diet (HCD) with a 60: 40 ratio of concentrate to roughage. Metabolomics profiling by ultra-high-performance liquid tandem chromatography quadrupole time of flight mass spectrometry (UHPLC-QTOF/MS) showed that steers fed the HCD had increased rumen and plasma carbohydrate metabolites and amino acids, which contributed to the growth of the beef steers. However, the rumen acidity and ruminal and plasma lipopolysaccharide (LPS) concentrations significantly increased with the increase amounts of corn in the diet. In total, 717 rumen metabolites and 386 plasma metabolites were identified. By multivariate analysis, 144 rumen and 56 plasma metabolites were further identified that were significantly different between the two groups (P < 0.05 and variable influence on projection > 1). The differential metabolites in the rumen and plasma were associated with different metabolic pathways, and phenylalanine, tyrosine and tryptophan biosynthesis and phenylalanine metabolism were common key metabolic pathways for the two biofluids. In conclusion, the high-corn diet improved the growth performance of beef steers but decreased the ruminal pH and increased the LPS and harmful metabolites in the rumen and blood, which has implications for the incidence of metabolic diseases. The identified differential metabolites in both the rumen and plasma and the related metabolic pathways may contribute to the exploration of potential biomarkers for high-corn diet-based metabolic diseases.	[Yang, You; Dong, Guozhong; Wang, Zhi; Wang, Jian; Zhang, Zhu; Liu, Junhui] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Southwest University - China	Dong, GZ (corresponding author), Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.	gzdong@swu.edu.cn			Chongqing Municipal Committee of Science and Technology [1: cstc2016shmszx80078, 2: cstc2017jcyjBX0015]	Chongqing Municipal Committee of Science and Technology	This work was supported by funds from Chongqing Municipal Committee of Science and Technology (Grant 1: cstc2016shmszx80078; Grant 2: cstc2017jcyjBX0015).	Ametaj BN, 2009, J DAIRY SCI, V92, P1084, DOI 10.3168/jds.2008-1465; Ametaj B.N., 2015, ADV FUNDAMENTAL RES, P78; Ametaj BN, 2010, METABOLOMICS, V6, P583, DOI 10.1007/s11306-010-0227-6; Calsamiglia S, 2012, ANIM FEED SCI TECH, V172, P42, DOI 10.1016/j.anifeedsci.2011.12.007; Chen YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25552-z; Dervilly-Pinel G, 2015, METABOLOMICS, V11, P403, DOI 10.1007/s11306-014-0705-3; Dijkstra J, 2012, ANIM FEED SCI TECH, V172, P22, DOI 10.1016/j.anifeedsci.2011.12.005; Dong GZ, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-48; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Goldansaz SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177675; Gonzalez LA, 2012, ANIM FEED SCI TECH, V172, P66, DOI 10.1016/j.anifeedsci.2011.12.009; Gozho GN, 2006, J DAIRY SCI, V89, P4404, DOI 10.3168/jds.S0022-0302(06)72487-0; Gressley TF, 2011, J ANIM SCI, V89, P1120, DOI 10.2527/jas.2010-3460; Gu L, 2018, MOL GENET GENOMICS, V293, P635, DOI 10.1007/s00438-017-1409-y; Hailemariam D, 2014, J DAIRY SCI, V97, P2680, DOI 10.3168/jds.2013-6803; Imhasly S, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-122; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kleen JL, 2012, ANIM FEED SCI TECH, V172, P4, DOI 10.1016/j.anifeedsci.2011.12.003; Kleen JL, 2003, J VET MED A, V50, P406, DOI 10.1046/j.1439-0442.2003.00569.x; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; NAGARAJA TG, 1978, J ANIM SCI, V47, P1329, DOI 10.2527/jas1978.4761329x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parveen I, 2007, J AGR FOOD CHEM, V55, P1129, DOI 10.1021/jf062995w; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; Saccenti E, 2014, METABOLOMICS, V10, P361, DOI 10.1007/s11306-013-0598-6; Saleem F, 2012, J DAIRY SCI, V95, P6606, DOI 10.3168/jds.2012-5403; Saleem F, 2013, METABOLOMICS, V9, P360, DOI 10.1007/s11306-012-0458-9; Shen JS, 2012, J DAIRY SCI, V95, P5978, DOI 10.3168/jds.2012-5499; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sun HZ, 2015, J PROTEOME RES, V14, P1287, DOI 10.1021/pr501305g; Sun LW, 2014, J DAIRY SCI, V97, P1552, DOI 10.3168/jds.2013-6757; Tao SY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01764; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Turlin E, 2005, RES MICROBIOL, V156, P312, DOI 10.1016/j.resmic.2004.10.012; Wang JL, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1050-5; Wang WB, 2018, J ETHNOPHARMACOL, V219, P299, DOI 10.1016/j.jep.2018.03.026; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wishart DS, 2008, TRENDS FOOD SCI TECH, V19, P482, DOI 10.1016/j.tifs.2008.03.003; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu G.-W., 2008, METABOLOMICS METHODS; Yang CY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00944; Zebeli Q, 2011, J DAIRY SCI, V94, P2374, DOI 10.3168/jds.2010-3860; Zhang HY, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-186; Zhao S, 2014, LETT APPL MICROBIOL, V59, P79, DOI 10.1111/lam.12247; Zhou J, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0172-0	46	23	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208031	10.1371/journal.pone.0208031	http://dx.doi.org/10.1371/journal.pone.0208031			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485366	Green Published, gold			2022-12-26	WOS:000451755800097
J	Abass, A; Lopes, BT; Eliasy, A; Wu, R; Jones, S; Clamp, J; Ambrosio, R; Elsheikh, A				Abass, Ahmed; Lopes, Bernardo T.; Eliasy, Ashkan; Wu, Richard; Jones, Steve; Clamp, John; Ambrosio, Renato, Jr.; Elsheikh, Ahmed			Three-dimensional non-parametric method for limbus detection	PLOS ONE			English	Article							WHITE-TO-WHITE; CORNEAL DIAMETER MEASUREMENTS; CHAMBER INTRAOCULAR-LENS; ANGLE; IMPLANTATION; TOPOGRAPHY; DISTANCE	Purpose To present a novel non-parametric algorithm for detecting the position of the human eye limbus in three dimensions and a new dynamic method for measuring the full 360 degrees visible iris boundary known as white-to-white distance along the eye horizontal line. Methods The study included 88 participants aged 23 to 65 years (37.7 +/- 9.7), 47 females and 41 males. Clinical characteristics, height data and the apex coordinates and 1024x1280 pixel digital images of the eyes were taken by an Eye Surface Profiler and processed by custom-built MATLAB codes. A dynamic light intensity frequency based white-to-white detection process and a novel three-dimensional method for limbus detection is presented. Results Evidence of significant differences (p< 0.001) between nasal-temporal and superior-inferior white-to-white distances in both right and left eyes were found (nasal-temporal direction; 11.74 +/- 0.42 mm in right eyes and 11.82 +/- 0.47 mm in left eyes & superior-inferior direction; 11.52 +/- 0.45 mm in right eyes and 11.55 +/- 0.46 mm in left eyes). Average limbus nasal-temporal diameters were 13.64 +/- 0.55 mm for right eyes, and 13.74 +/- 0.40 mm for left eyes, however the superior-inferior diameters were 13.65 +/- 0.54 mm, 13.75 +/- 0.38 mm for right and left eyes, respectively. No significant difference in limbus contours has been observed either between the nasal-temporal direction (p = 0.91) and the superior-inferior direction (p = 0.83) or between the right (p = 0.18) and left eyes (p = 0.16). Evidence of tilt towards the nasal-temporal side in the three-dimensional shape of the limbus was found. The right eyes mean limbus contour tilt around the X-axis was -0.3 +/- 1.35 degrees however, their mean limbus contour tilt around the Y-axis was 1.76 +/- 0.9 degrees. Likewise, the left eyes mean limbus contour tilt around the X-axis was 0.77 +/- 1.25 degrees and the mean limbus contour tilt around the Y-axis was -1.54 +/- 0.89 degrees. Conclusions The white-to-white distance in the human eye is significantly larger in the nasal-temporal direction than in the superior-inferior direction. The human limbus diameter was found not to vary significantly in these directions. The 3D measures show that the limbus contour does not lay in one plane and tends to be higher on the nasal-inferior side of the eye.	[Abass, Ahmed; Lopes, Bernardo T.; Eliasy, Ashkan; Jones, Steve; Elsheikh, Ahmed] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Lopes, Bernardo T.; Ambrosio, Renato, Jr.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Wu, Richard] Cent Taiwan Univ Sci & Technol, Taichung, Taiwan; [Wu, Richard] Pacific Univ, Coll Optometry, Forest Grove, OR USA; [Clamp, John] UltraVis CLPL, Leighton Buzzard, England; [Elsheikh, Ahmed] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Ctr, London, England; [Elsheikh, Ahmed] UCL Inst Ophthalmol, London, England	University of Liverpool; Universidade Federal de Sao Paulo (UNIFESP); Central Taiwan University Science & Technology; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Abass, A (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.	A.Abass@liverpool.ac.uk	Abass, Ahmed/S-3107-2019; Eliasy, Ashkan/AAF-4941-2019; Elsheikh, Ahmed/AAT-1476-2020	Abass, Ahmed/0000-0002-8622-4632; Eliasy, Ashkan/0000-0002-4473-1900; Elsheikh, Ahmed/0000-0001-7456-1749	Innovate UK Knowledge Transfer Partnership programme grant [009521/UVP016]	Innovate UK Knowledge Transfer Partnership programme grant(UK Research & Innovation (UKRI)Innovate UK)	This work was funded by an Innovate UK Knowledge Transfer Partnership programme grant 009521/UVP016.; This work was funded by an Innovate UK Knowledge Transfer Partnership programme grant 009521/UVP016. The funder provided support in the form of salaries but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfonso JF, 2012, J CATARACT REFR SURG, V38, P46, DOI 10.1016/j.jcrs.2011.07.035; Arvacheh EM, 2006, 2006 INT C IM PROC; Barry J-C, 1997, INVEST OPHTHALMOL VI, V38; Barry JC, 1997, COMPUT BIOL MED, V27, P515, DOI 10.1016/S0010-4825(97)00023-1; Baumeister M, 2004, J CATARACT REFR SURG, V30, P374, DOI 10.1016/j.jcrs.2003.06.004; Bergmanson JPG, 2017, CLIN EXP OPTOM, V100, P522, DOI 10.1111/cxo.12583; Bylsma SS, 2002, J CATARACT REFR SURG, V28, P2222, DOI 10.1016/S0886-3350(02)01303-2; Consejo A, 2017, J CATARACT REFR SURG, V43, P667, DOI 10.1016/j.jcrs.2017.02.027; Consejo A, 2016, CONTACT LENS ANTERIO, V39, P450, DOI 10.1016/j.clae.2016.05.001; EDMUND C, 1988, ACTA OPHTHALMOL, V66, P376; Everitt B.S., 2010, CAMBRIDGE DICT STAT, DOI DOI 10.1017/CBO9780511779633; Goldsmith JA, 2005, OPHTHALMOLOGY, V112, P238, DOI 10.1016/j.ophtha.2004.09.019; Hickson-Curran S, 2014, OPTOMETRY VISION SCI, V91, P1396, DOI 10.1097/OPX.0000000000000413; Huang PY, 2012, CLIN IMAG, V36, P797, DOI 10.1016/j.clinimag.2012.01.031; Jesus DA, 2014, 7 EUR WORLD M VIS PH; Jogi R, 2008, BASIC OPHTHALMOLOGY; Kodjikian L, 2002, J CATARACT REFR SURG, V28, P2217, DOI 10.1016/S0886-3350(02)01213-0; Lim KL, 2006, J CATARACT REFR SURG, V32, P1814, DOI 10.1016/j.jcrs.2006.08.022; Maeng HS, 2011, J CATARACT REFR SURG, V37, P881, DOI 10.1016/j.jcrs.2010.11.037; MARTIN DK, 1982, AM J OPTOM PHYS OPT, V59, P436; Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X; Morelande MR, 2002, IEEE T BIO-MED ENG, V49, P1617, DOI 10.1109/TBME.2002.805481; Nappi M, 2010, JAIHC, V2, P153; Nemeth G, 2010, J CATARACT REFR SURG, V36, P1862, DOI 10.1016/j.jcrs.2010.05.017; Patel DV, 2006, INVEST OPHTH VIS SCI, V47, P2823, DOI 10.1167/iovs.05-1492; Pinero DP, 2008, J CATARACT REFR SURG, V34, P126, DOI 10.1016/j.jcrs.2007.10.010; Reinstein DZ, 2009, J REFRACT SURG, V25, P185, DOI 10.3928/1081597X-20090201-03; Rickmann A, 2016, GRAEF ARCH CLIN EXP, V254, P1419, DOI 10.1007/s00417-016-3292-3; Ronneburger A, 2006, OPHTHAL PHYSL OPT, V26, P80, DOI 10.1111/j.1475-1313.2005.00362.x; Rossen J, 2016, OCUL SURF, V14, P419, DOI 10.1016/j.jtos.2016.06.003; Rufer F, 2005, CORNEA, V24, P259; Ryan WJ, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P61, DOI 10.1145/1344471.1344487; Salouti R, 2009, CLIN EXP OPTOM, V92, P429, DOI 10.1111/j.1444-0938.2009.00407.x; Siddiqui AA, 2017, INDIAN J OPHTHALMOL, V65, P1289, DOI 10.4103/ijo.IJO_834_17; Smit G., 1970, EYE VISUAL OPTICAL I; Trivedi RH, 2011, J CATARACT REFR SURG, V37, P1239, DOI 10.1016/j.jcrs.2011.01.021; Turuwhenua J, 2014, VISION RES, V103, P75, DOI 10.1016/j.visres.2014.07.016; Werner L, 2004, J CATARACT REFR SURG, V30, P1982, DOI 10.1016/j.jcrs.2003.10.041; Wong Miu Kit, 2002, Clin Exp Optom, V85, P350	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207710	10.1371/journal.pone.0207710	http://dx.doi.org/10.1371/journal.pone.0207710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475843	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700056
J	Cerny, V; Hrdy, J; Novotna, O; Petrakova, P; Borakova, K; Kolarova, L; Prokesova, L				Cerny, Viktor; Hrdy, Jiri; Novotna, Olga; Petraskova, Petra; Borakova, Kristyna; Kolarova, Libuse; Prokesova, Ludmila			Distinct characteristics of Tregs of newborns of healthy and allergic mothers	PLOS ONE			English	Article							REGULATORY T-CELLS; CORD BLOOD; IMMUNE-RESPONSE; TGF-BETA; EXPRESSION; FOXP3; DISEASE; CTLA-4; IGE; POLYMORPHISMS	Allergic diseases represent a major issue in clinical and experimental immunology due to their high and increasing incidence worldwide. Allergy status of the mother remains the best predictor of an individual's increased risk of allergy development. Dysregulation of the balance between different branches of immune response, chiefly excessive polarization towards Th2, is the underlying cause of allergic diseases. Regulatory T cells (Tregs) play a pivotal role in the timely establishment of physiological immune polarization and are crucial for control of allergy. In our study we used flow cytometry to assess Tregs in cord blood of newborns of healthy (n = 121) and allergic (n = 108) mothers. We observed a higher percentage of Tregs (CD4(+) CD25(+) CD127(low) FoxP3(+)) in cord blood of children of allergic mothers. However, the percentage of cells expressing extracellular (PD-1, CTLA-4, GITR) and intracellular (IL-10, TGF-beta) markers of function was lower (significantly for PD-1 and IL-10) within Tregs of these children. Furthermore, Helios - induced Tregs in the cord blood of children of allergic mothers were decreased. These results were supported by a decrease in plasma levels of IL-10 and TGF-beta in cord blood of newborns of allergic mothers, implying lower tolerogenic capacity on the systemic level. Taken together, these findings reflect deficient function of Tregs in the group with higher risk of allergy development. This may be caused by a lower maturation status of the immune system, specifically Tregs, at birth. Such immaturity may represent an important mechanism involved in the increased risk of allergy in children of allergic mothers.	[Cerny, Viktor; Hrdy, Jiri; Novotna, Olga; Petraskova, Petra; Kolarova, Libuse; Prokesova, Ludmila] Charles Univ Prague, Inst Immunol & Microbiol, Fac Med 1, Prague, Czech Republic; [Cerny, Viktor; Hrdy, Jiri; Novotna, Olga; Petraskova, Petra; Kolarova, Libuse; Prokesova, Ludmila] Gen Univ Hosp Prague, Prague, Czech Republic; [Borakova, Kristyna] Inst Care Mother & Child, Prague, Czech Republic	Charles University Prague; General University Hospital Prague	Hrdy, J (corresponding author), Charles Univ Prague, Inst Immunol & Microbiol, Fac Med 1, Prague, Czech Republic.; Hrdy, J (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	jiri.hrdy@lf1.cuni.cz	Hrdy, Jiri/L-5368-2013; Černý, Viktor/I-3230-2017; Kolarova, Libuse/J-4216-2017; Prokešová, Ludmila/R-2089-2017	Hrdy, Jiri/0000-0003-0612-4509; Černý, Viktor/0000-0002-8319-7827; Kolarova, Libuse/0000-0002-2745-0015; Prokešová, Ludmila/0000-0002-4610-6973	Czech Health Research Council of the Czech Republic [AZV CR 15-26877A]; Univerzita Karlova v Praze [Q25/LF1]	Czech Health Research Council of the Czech Republic; Univerzita Karlova v Praze	This research was funded by Czech Health Research Council of the Czech Republic (AZV CR 15-26877A to JH) and the Univerzita Karlova v Praze (Progres Q25/LF1 to LK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0063-2; Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Battaglia A, 2008, IMMUNOLOGY, V123, P129, DOI 10.1111/j.1365-2567.2007.02737.x; Bundhoo A, 2015, CLIN EXP ALLERGY, V45, P1085, DOI 10.1111/cea.12508; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chung EK, 2007, ARCH DIS CHILD-FETAL, V92, pF68, DOI 10.1136/adc.2006.106492; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Edwards JP, 2016, EUR J IMMUNOL, V46, P1480, DOI 10.1002/eji.201546204; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Fu YJ, 2013, PEDIAT ALLERG IMM-UK, V24, P178, DOI 10.1111/pai.12050; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Hinz D, 2012, ALLERGY, V67, P380, DOI 10.1111/j.1398-9995.2011.02767.x; Hrdy J, 2016, BENEF MICROBES, V7, P639, DOI 10.3920/BM2016.0030; Hrdy J, 2012, CLIN EXP IMMUNOL, V170, P10, DOI 10.1111/j.1365-2249.2012.04630.x; Hrdy J, 2010, FOLIA MICROBIOL, V55, P515, DOI 10.1007/s12223-010-0085-7; Hrdy J, 2012, FOLIA MICROBIOL, V57, P215, DOI 10.1007/s12223-012-0112-y; Ito A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/605478; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Jutel M, 2011, CURR ALLERGY ASTHM R, V11, P139, DOI 10.1007/s11882-011-0178-7; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kitagawa Y, 2015, EUR J IMMUNOL, V45, P11, DOI 10.1002/eji.201444577; Kmieciak M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-89; Konkel JE, 2017, IMMUNITY, V46, P660, DOI 10.1016/j.immuni.2017.03.015; Konkel JE, 2011, TRENDS MOL MED, V17, P668, DOI 10.1016/j.molmed.2011.07.002; Kumar S, 2013, IMMUNOL LETT, V149, P101, DOI 10.1016/j.imlet.2012.12.003; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; Lodinova-Zadnikova R, 2010, INT ARCH ALLERGY IMM, V153, P201, DOI 10.1159/000312638; McAlees JW, 2015, EUR J IMMUNOL, V45, P1019, DOI 10.1002/eji.201444778; McGee HS, 2010, AM J RESP CELL MOL, V43, P432, DOI 10.1165/rcmb.2009-0258OC; McLoughlin RM, 2012, CLIN EXP ALLERGY, V42, P392, DOI 10.1111/j.1365-2222.2011.03882.x; Meng SS, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0430-8; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Munthe-Kaas MC, 2004, J ALLERGY CLIN IMMUN, V114, P280, DOI 10.1016/j.jaci.2004.03.050; Nocentini G, 2009, ADV EXP MED BIOL, V647, P156, DOI 10.1007/978-0-387-89520-8_11; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Peters JL, 2012, ALLERGY, V67, P545, DOI 10.1111/j.1398-9995.2012.02791.x; Prescott SL, 2003, ALLERGY, V58, P1187, DOI 10.1034/j.1398-9995.2003.00263.x; Prokesova L, 2008, FOLIA MICROBIOL, V53, P67, DOI 10.1007/s12223-008-0010-5; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Rindsjo E, 2010, ALLERGY, V65, P822, DOI 10.1111/j.1398-9995.2009.02266.x; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Ronchetti S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/171520; Schaub B, 2008, ALLERGY, V63, P1438, DOI 10.1111/j.1398-9995.2008.01685.x; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schroder PC, 2016, PEDIAT ALLERG IMM-UK, V27, P687, DOI 10.1111/pai.12597; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Singh K, 2015, SCI REP-UK, V5, DOI 10.1038/srep07767; Smaldini PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141116; Steinborn A, 2010, CLIN IMMUNOL, V134, P188, DOI 10.1016/j.clim.2009.09.003; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Strombeck A, 2014, CLIN EXP ALLERGY, V44, P940, DOI 10.1111/cea.12290; Sukenikova L, 2017, IMMUNOL LETT, V189, P82, DOI 10.1016/j.imlet.2017.05.013; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629; Szurek E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141161; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Watanabe N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/269756; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wing JB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00178; Zizka J, 2007, PEDIATR ALLERGY IMMU, V18, P486, DOI 10.1111/j.1399-3038.2007.00563.x	67	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207998	10.1371/journal.pone.0207998	http://dx.doi.org/10.1371/journal.pone.0207998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475891	Green Published, gold			2022-12-26	WOS:000451325700099
J	Granger, BL				Granger, Bruce L.			Propeptide genesis by Kex2-dependent cleavage of yeast wall protein 1 (Ywp1) of Candida albicans	PLOS ONE			English	Article							KEX2 PROTEASE; CELL-WALL; SACCHAROMYCES-CEREVISIAE; MATING PHEROMONE; SILVER STAIN; KILLER TOXIN; ALPHA-FACTOR; ENZYME; SPECIFICITY; EXPRESSION	Candida albicans is a prevalent fungal resident and opportunistic pathogen of humans, exhibiting a variety of ovoid and filamentous morphologies. Anchored within the cell wall of the ovoid yeast form of C. albicans is an abundant glycoprotein termed yeast wall protein 1 (Ywp1). Ywp1 has an antiadhesive effect that may facilitate yeast cell dispersal; it also contributes to the masking of the glucan matrix of the yeast cell wall, potentially providing shielding from recognition by the human immune system. Mature Ywp1 consists of an O-glycosylated core of 378 amino acids associated with an N-glycosylated propeptide that originates from an N-terminal segment of Ywp1. A tribasic (-RRR-) sequence in the immature Ywp1 polypeptide is separated by 8 amino acids from a dibasic (-KR-) sequence that is a canonical site for cleavage by the intracellular endopeptidase Kex2, and cleavage occurs at both of these sites to generate an 11 kilodalton (kDa) propeptide that remains strongly associated with the mature core of Ywp1. Previous studies demonstrated an absence of the 11 kDa propeptide in strains lacking Kex2, but the presence of lesser amounts of a 12 kDa propeptide ostensibly (and paradoxically) arising from cleavage at the dibasic site. Subsequent studies of wild type strains, however, suggested that post-secretion cleavages were carried out in vitro by acid proteases in unbuffered cultures to generate the 12 kDa propeptide. Here, intact and Gfp-tagged Ywp1 are utilized to show that neither of the two multibasic sites is normally cleaved in the absence of Kex2, but that uncleaved Ywp1 is still N-glycosylated and subsequently anchored to the cell wall. This furthers our understanding of the multistep cleavage of this highly conserved sequence, as well as the possible contributions of the cleaved propeptide to the maturation and functioning of Ywp1.	[Granger, Bruce L.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Granger, BL (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	bgranger@montana.edu		Granger, Bruce/0000-0002-9308-0331				Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Allert S, 2018, MBIO, V9, DOI 10.1128/mBio.00915-18; Bader O, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-116; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; Bevan A, 1998, P NATL ACAD SCI USA, V95, P10384, DOI 10.1073/pnas.95.18.10384; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRYANT NJ, 1993, J CELL SCI, V106, P815; CHAMBERS RS, 1993, J GEN MICROBIOL, V139, P325, DOI 10.1099/00221287-139-2-325; COOPER A, 1989, MOL CELL BIOL, V9, P2706, DOI 10.1128/MCB.9.6.2706; COOPER A, 1992, J CELL BIOL, V119, P1459, DOI 10.1083/jcb.119.6.1459; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; DENOBEL JG, 1990, YEAST, V6, P491, DOI 10.1002/yea.320060606; DIEFENBACHJAGGER H, 1995, EUR J BIOCHEM, V229, P91, DOI 10.1111/j.1432-1033.1995.tb20442.x; DMOCHOWSKA A, 1987, CELL, V50, P573, DOI 10.1016/0092-8674(87)90030-4; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; FONZI WA, 1993, GENETICS, V134, P717; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Granger BL, 2005, MICROBIOL-SGM, V151, P1631, DOI 10.1099/mic.0.27663-0; Granger BL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191194; Granger BL, 2012, EUKARYOT CELL, V11, P795, DOI 10.1128/EC.00026-12; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Komath SS, 2018, IUBMB LIFE, V70, P355, DOI 10.1002/iub.1734; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; La Valle R, 2000, INFECT IMMUN, V68, P6777, DOI 10.1128/IAI.68.12.6777-6784.2000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesage G, 2001, FEBS LETT, V508, P332, DOI 10.1016/S0014-5793(01)03096-4; Lesage G, 2000, MOL BIOL CELL, V11, P1947, DOI 10.1091/mbc.11.6.1947; Li Q, 2017, ACS CHEM BIOL, V12, P510, DOI 10.1021/acschembio.6b00547; Magee BB, 2002, MOL MICROBIOL, V46, P1345, DOI 10.1046/j.1365-2958.2002.03263.x; MERRIL CR, 1981, ANAL BIOCHEM, V110, P201, DOI 10.1016/0003-2697(81)90136-6; Moosa MYS, 2004, ANTIMICROB AGENTS CH, V48, P161, DOI 10.1128/AAC.48.1.161-167.2004; Mora-Montes HM, 2008, MICROBIOL-SGM, V154, P3782, DOI 10.1099/mic.0.2008/019315-0; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Newport G, 1997, J BIOL CHEM, V272, P28954, DOI 10.1074/jbc.272.46.28954; Newport G, 2003, J BIOL CHEM, V278, P1713, DOI 10.1074/jbc.M209713200; Noble SM, 2017, NAT REV MICROBIOL, V15, P96, DOI 10.1038/nrmicro.2016.157; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Panwar SL, 2003, EUKARYOT CELL, V2, P1350, DOI 10.1128/EC.2.6.1350-1360.2003; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Puri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046020; REDDING K, 1991, J CELL BIOL, V113, P527, DOI 10.1083/jcb.113.3.527; Richardson JP, 2018, MBIO, V9, DOI [10.1128/mBio.02178-17, 10.1128/mbio.02178-17]; Rockwell NC, 2004, TRENDS BIOCHEM SCI, V29, P80, DOI 10.1016/j.tibs.2003.12.006; Rockwell NC, 1998, BIOCHEMISTRY-US, V37, P3386, DOI 10.1021/bi972534r; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; SHEPHERD MG, 1976, J GEN MICROBIOL, V93, P361, DOI 10.1099/00221287-93-2-361; Sosinska GJ, 2011, MICROBIOL-SGM, V157, P136, DOI 10.1099/mic.0.044206-0; Staib P, 2008, ANTIMICROB AGENTS CH, V52, P146, DOI 10.1128/AAC.01072-07; Szafranski-Schneider E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002501; TAO JS, 1990, MOL CELL BIOL, V10, P1373, DOI 10.1128/MCB.10.4.1373; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VIDOTTO V, 1987, MYCOPATHOLOGIA, V100, P7, DOI 10.1007/BF00769562; WAGNER JC, 1987, FEBS LETT, V221, P423, DOI 10.1016/0014-5793(87)80967-5; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xin H, 2006, INFECT IMMUN, V74, P4310, DOI 10.1128/IAI.00234-06; ZHU YS, 1992, MOL MICROBIOL, V6, P511, DOI 10.1111/j.1365-2958.1992.tb01496.x	67	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207955	10.1371/journal.pone.0207955	http://dx.doi.org/10.1371/journal.pone.0207955			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475911	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700095
J	Newcombe, G; Muchero, W; Busby, PE				Newcombe, George; Muchero, Wellington; Busby, Posy E.			Resistance to an eriophyid mite in an interspecific hybrid pedigree of Populus	PLOS ONE			English	Article							MAJOR GENE; POPLAR; MEDUSAE	Schizoempodium mesophyllincola is an eriophyid mite that feeds in leaves of Populus trichocarpa in the central part of this cottonwood tree's range (i. e., coastal British Columbia, Washington and Oregon) in the Pacific Northwest (PNW) of North America, and on some interspecific hybrids planted in short-rotation, intensive forestry in the region. The mite, a leaf vagrant, sucks the contents of spongy mesophyll cells, causing leaf discoloration, or " bronzing." Here, we investigate the inheritance pattern of resistance to leaf bronzing using a three-generation Populus trichocarpa x P. deltoides hybrid pedigree. We found that resistance to the mite is an exaptation in that its source in two related F2 families of the TxD hybrid pedigree was the non-native host, P. deltoides. Two grandparental genotypes of the latter, 'ILL-5' and 'ILL-129', were completely free of the bronzing symptom and that phenotype was inherited in a Mendelian manner in the F1 and F2. Resistance to S. mesophyllincola is similar to resistance to many other regional pathogens of P. trichocarpa (e. g., Melampsora occidentalis, Venturia inopina, Sphaerulina populicola, and Taphrina sp.) in that it is inherited from the non-native grandparent (e. g., P. deltoides, P. nigra, or P. maximowiczii) in three-generation, hybrid pedigrees. In addition to finding evidence for Mendelian inheritance, we found two QTLs with LOD scores 5.03 and 3.12 mapped on linkage groups (LG) III and I, and they explained 6.7 and 4.2% of the phenotypic variance, respectively. The LG I QTL is close to, or synonymous with, one for resistance to sap-feeding arthropods and leaf developmental traits as expressed in a British study utilizing the same pedigree.	[Newcombe, George] Univ Idaho, Coll Nat Resources, Moscow, ID 83843 USA; [Muchero, Wellington] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Busby, Posy E.] Oregon State Univ, Bot & Plant Pathol Dept, Cordley Hall, Corvallis, OR 97331 USA	Idaho; University of Idaho; United States Department of Energy (DOE); Oak Ridge National Laboratory; Oregon State University	Newcombe, G (corresponding author), Univ Idaho, Coll Nat Resources, Moscow, ID 83843 USA.	georgen@uidaho.edu		Newcombe, George/0000-0002-9330-7356	Department of Energy Feedstock Genomics Award [219086]; National Science Foundation Science Engineering and Education for Sustainability Award [1314095]; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-68005-30407]	Department of Energy Feedstock Genomics Award; National Science Foundation Science Engineering and Education for Sustainability Award; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This research was supported by the Department of Energy Feedstock Genomics Award 219086 (GN, WM, PEB), the National Science Foundation Science Engineering and Education for Sustainability Award 1314095 (PEB), and the Agriculture and Food Research Initiative Competitive Grant no. 2011-68005-30407 from the USDA National Institute of Food and Agriculture (GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, SOFTWARE MAPPING QUA; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P167, DOI 10.1007/BF00225137; Busby PE, 2016, NEW PHYTOL, V209, P1681, DOI 10.1111/nph.13742; Czesak ME, 2004, HEREDITY, V93, P619, DOI 10.1038/sj.hdy.6800587; DeWoody J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079925; FURNISS RL, 1977, USDA FOREST SERVICE, V1339; Hunt AE., 1998, THESIS; James RR, 2000, CAN J FOREST RES, V30, P85, DOI 10.1139/cjfr-30-1-85; Muchero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054468; Newcombe G, 2005, PHYTOPATHOLOGY, V95, P779, DOI 10.1094/PHYTO-95-0779; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; Newcombe G, 1996, CAN J FOREST RES, V26, P1943, DOI 10.1139/x26-219; Newcombe G, 1998, EUR J FOREST PATHOL, V28, P209; Newcombe G, 1996, PHYTOPATHOLOGY, V86, P87, DOI 10.1094/Phyto-86-87; Newcombe G, 2001, PHYTOPATHOLOGY, V91, P1081, DOI 10.1094/PHYTO.2001.91.11.1081; NEWCOMBE G, 2001, POPLAR CULTURE N AM, P249, DOI DOI 10.1139/9780660181455; Nischwitz C, 2005, MYCOL RES, V109, P421, DOI 10.1017/S0953756205002431; Oldfield G. N., 1998, International Journal of Acarology, V24, P307; Raghavendra AKH, 2013, NEW PHYTOL, V197, P909, DOI 10.1111/nph.12066; Rossman AY, 2008, FUNGAL PLANET, V24, P1; Stirling B, 2001, THEOR APPL GENET, V103, P1129, DOI 10.1007/s001220100721; Yin TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014021	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207839	10.1371/journal.pone.0207839	http://dx.doi.org/10.1371/journal.pone.0207839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475884	gold, Green Submitted, Green Published			2022-12-26	WOS:000451325700078
J	Qi, Y; Shao, YX; Rao, JX; Shen, WP; Yin, Q; Li, XL; Chen, HX; Li, JM; Zeng, WW; Zheng, SL; Liu, SY; Li, YX				Qi, Yong; Shao, Yinxiu; Rao, Jixian; Shen, Wanpeng; Yin, Qiong; Li, Xiaoling; Chen, Hongxia; Li, Jiameng; Zeng, Wenwen; Zheng, Shulong; Liu, Suyun; Li, Yuexi			Development of a rapid and visual detection method for Rickettsia rickettsii combining recombinase polymerase assay with lateral flow test	PLOS ONE			English	Article							MOUNTAIN-SPOTTED-FEVER; PROTECTIVE IMMUNITY; UNITED-STATES; INFECTION; DIAGNOSIS; SPECIMENS; DISEASES; MEXICO; BLOOD	Objectives Rickettsia rickettsii is the causative agent of Rocky Mountain spotted fever, which is the most severe spotted fever group (SFG) rickettsiosis. Developing a simple and reliable detection method is required. Methods A detection method for R. rickettsii was established based on a recombinase polymerase amplification (RPA) assay and the lateral flow (LF) test. A specific target sequence was screened, and corresponding primers and probes were designed, synthesized, and screened for establishing an RPA assay with high amplification efficiency. Reagent concentrations, amplification time, and loading volume for strip development were optimized. The detection limit, analytic sensitivity and specificity were evaluated. Results A rapid, visual, sensitive and specific method for the detection of R. rickettsii based on RPA and the LF test was successfully established. The novel method had a limit of detection of 10 to 50 copies/reaction without recognizing other organisms. Analytical sensitivity and specificity were. 90% and 100%, respectively, as evaluated by animal and simulative human samples. Conclusions Using the established method, detection could be completed in 30 min with visually detectable results by the naked eye, without requirement of any instrument except a constant temperature equipment. The technique shows superior detection performance and is promising for wide use in the field as well as resource-limited areas for R. rickettsii detection.	[Qi, Yong; Rao, Jixian; Shen, Wanpeng; Chen, Hongxia; Li, Jiameng; Li, Yuexi] Huadong Res Inst Med & Biotech, Nanjing, Jiangsu, Peoples R China; [Shao, Yinxiu; Yin, Qiong; Li, Xiaoling; Zeng, Wenwen; Zheng, Shulong; Liu, Suyun; Li, Yuexi] China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Li, YX (corresponding author), Huadong Res Inst Med & Biotech, Nanjing, Jiangsu, Peoples R China.; Li, YX (corresponding author), China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China.	liyxi2007@126.com	Qi, Yong/AAK-8798-2021	Qi, Yong/0000-0001-6186-9023	National Natural Science Foundation of China [31600151]; Natural Science Foundation of Jiangsu Province [BK20160130, BK20160131]; Social Development Foundation of Jiangsu Province [BE2016622]; China Key Project of New Medicine Development [2014ZX09304314-003]; Medical Science and Technology Projects [17QNP052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Jiangsu Province; China Key Project of New Medicine Development; Medical Science and Technology Projects	This research was funded by National Natural Science Foundation of China (grant number: 31600151; YQ received the funding; URL: http://www.nsfc.gov.cn/), Natural Science Foundation of Jiangsu Province (grant numbers: BK20160130 and BK20160131; YQ and HC received the funding; URL: http://kxjst.jiangsu.gov.cn/), Social Development Foundation of Jiangsu Province (grant numbers: BE2016622; YL received the funding; URL: http://kxjst.jiangsu.gov.cn/), China Key Project of New Medicine Development (grant numbers: 2014ZX09304314-003; YL received the funding; URL: http://www.most.gov.cn/), and Medical Science and Technology Projects (grant numbers: 17QNP052; YQ received the funding; no URL is available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerami RN, 2006, ANN NY ACAD SCI, V1078, P170, DOI 10.1196/annals.1374.030; Biggs HM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6502a1; Chao CC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003884; Dahlgren FS, 2012, AM J TROP MED HYG, V86, P713, DOI 10.4269/ajtmh.2012.11-0453; Del Fiol FD, 2010, REV PANAM SALUD PUBL, V27, P461, DOI 10.1590/S1020-49892010000600008; Denison AM, 2014, CLIN INFECT DIS, V59, P635, DOI 10.1093/cid/ciu358; Gong WP, 2015, HUM VACC IMMUNOTHER, V11, P642, DOI 10.1080/21645515.2015.1011572; Horta MC, 2007, MEM I OSWALDO CRUZ, V102, P793, DOI 10.1590/S0074-02762007000700003; Kato CY, 2013, J CLIN MICROBIOL, V51, P314, DOI 10.1128/JCM.01723-12; Levin ML, 2016, TICKS TICK-BORNE DIS, V7, P1029, DOI 10.1016/j.ttbdis.2016.05.011; Martinez-Medina MA, 2007, GAC MED MEX, V143, P137; Niu D, 2008, MED J CHINESE PEOPLE; Openshaw JJ, 2010, AM J TROP MED HYG, V83, P174, DOI 10.4269/ajtmh.2010.09-0752; Paris DH, 2016, CURR OPIN INFECT DIS, V29, P433, DOI 10.1097/QCO.0000000000000298; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Qi Y, 2018, INT J INFECT DIS, V70, P42, DOI 10.1016/j.ijid.2018.03.003; Qi Y, 2013, VACCINE, V31, P5643, DOI 10.1016/j.vaccine.2013.09.064; Straily A, 2016, MMWR-MORBID MORTAL W, V65, P1302, DOI 10.15585/mmwr.mm6546a6; [苏裕心 SU Yu-xin], 2010, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V34, P25; Wilson LB, 1904, J INFECT DIS, V1, P31, DOI 10.1093/infdis/1.1.31; Xiong XL, 2017, J INFECT DIS, V215, P1580, DOI 10.1093/infdis/jiw470; Xiong XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087206; Zavala-Castro JE, 2008, AM J TROP MED HYG, V79, P907, DOI 10.4269/ajtmh.2008.79.907; Zhu Jing, 2012, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V7, P325	25	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207811	10.1371/journal.pone.0207811	http://dx.doi.org/10.1371/journal.pone.0207811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475889	Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700073
J	Adachi, M; Shimizu, R; Shibazaki, C; Satoh, K; Fujiwara, S; Arai, S; Narumi, I; Kuroki, R				Adachi, Motoyasu; Shimizu, Rumi; Shibazaki, Chie; Satoh, Katsuya; Fujiwara, Satoru; Arai, Shigeki; Narumi, Issay; Kuroki, Ryota			Extended structure of pleiotropic DNA repair-promoting protein PprA from Deinococcus radiodurans	FASEB JOURNAL			English	Article						crystallography; binding protein; double-strand break; radiation; resistance	CELL-DIVISION; STRANDED-DNA; BREAK REPAIR; RADIATION; RECA; GENOME; RADIORESISTANCE; RECOMBINATION; MICROCOCCUS; RESISTANCE	Pleiotropic protein promoting DNA repair A (PprA) is a key protein facilitating the extreme radiation resistance of Deinococcus radiodurans. PprA is a unique protein to the genus Deinococcus and exists as an oligomer ranging from a tetramer to an approximate to 100-mer depending on protein concentrations. Here, the X-ray crystal structure of PprA was determined to clarify how PprA confers radiation resistance. The tertiary structure of dimeric PprA was elucidated by using mutants obtained with random and site-directed mutagenesis methods (W183R and A139R); these mutants have disabled DNA binding and polymerization functions. Because the mutant A139R and W183R proteins have dimeric assemblies with 2 different interfaces (Interfaces 1 and 2), the linear and oligomerized PprA model was constructed as a left-handed face-to-face periodic screw structure. In addition, the linear structure in solution was confirmed by small-angle scattering experiments. The site-directed mutational analysis identified essential basic amino acids for DNA binding. These analytical data support the hypothesis that a complex assembly of PprA molecules, which are extended and have a screw structure, surrounds and stretches the DNA strand, acting as a novel guide to colocalize the DNA strands for efficient DNA repairs.Adachi, M., Shimizu, R., Shibazaki, C., Satoh, K., Fujiwara, S., Arai, S., Narumi, I., Kuroki, R. Extended structure of pleiotropic DNA repair-promoting protein PprA from Deinococcus radiodurans.	[Adachi, Motoyasu; Shimizu, Rumi; Shibazaki, Chie; Fujiwara, Satoru; Arai, Shigeki] Tokai Quantum Beam Sci Ctr, Natl Inst Quantum & Radiol Sci & Technol, Tokai, Ibaraki, Japan; [Satoh, Katsuya] Natl Inst Quantum & Radiol Sci & Technol, Dept Radiat Appl Biol, Takasaki, Gunma, Japan; [Narumi, Issay; Kuroki, Ryota] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan; [Narumi, Issay] Toyo Univ, Gunma, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Japan Atomic Energy Agency; Toyo University	Adachi, M (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, 2-4 Shirakata, Tokai, Ibaraki 3191106, Japan.	adachi.motoyasu@qst.go.jp	Narumi, Issay/ABA-6740-2021	Narumi, Issay/0000-0001-9770-9574	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19370046, 19380054, JP16KT0063]; Photon Factory Program Advisory Committee [2008G524, 2011G088, 2012G672, 2014G645, 2016G510]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Photon Factory Program Advisory Committee(High Energy Accelerator Research Organization (KEK))	This research was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan through Grants-in-Aid for Scientific Research (B) (19370046 to R.K., 19380054 to I.N., and JP16KT0063 to M.A.). The synchrotron radiation experiments were performed at the BL38B1 and BL41XU beamlines of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (proposal numbers 2014B1313, and 2011A1124) and under the approval of the Photon Factory Program Advisory Committee (proposal numbers 2008G524, 2011G088, 2012G672, 2014G645, and 2016G510). The authors declare no conflicts of interest.	Adachi M, 2014, PROTEIN SCI, V23, P1349, DOI 10.1002/pro.2519; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; de la Tour CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177751; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Devigne A, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00036-15; Devigne A, 2015, MOL MICROBIOL, V96, P1069, DOI 10.1111/mmi.12991; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glatter O., 1982, ACTA PHY AUSTRIACA; Guinier  A., 1995, SMALL ANGLE SCATTERI; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Kikuchi M, 1999, FEMS MICROBIOL LETT, V174, P151, DOI 10.1016/S0378-1097(99)00135-4; Kota S, 2006, APPL MICROBIOL BIOT, V72, P790, DOI 10.1007/s00253-006-0340-7; Kota S, 2016, EXTREMOPHILES, V20, P195, DOI 10.1007/s00792-016-0814-1; Kota S, 2008, BIOCHEM CELL BIOL, V86, P448, DOI [10.1139/O08-122, 10.1139/o08-122]; KRASIN F, 1977, J MOL BIOL, V116, P81, DOI 10.1016/0022-2836(77)90120-6; Kratky O., 1948, ACTA PHYS AUSTRIACA, V2, P113; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lockhart JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071651; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Maurya GK, 2016, MICROBIOL-SGM, V162, P1321, DOI 10.1099/mic.0.000330; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSELEY BEB, 1971, J BACTERIOL, V105, P976, DOI 10.1128/JB.105.3.976-983.1971; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rajan R, 2004, J MOL BIOL, V344, P951, DOI 10.1016/j.jmb.2004.09.087; Repar J, 2010, DNA REPAIR, V9, P1151, DOI 10.1016/j.dnarep.2010.08.003; Sage E, 2017, FREE RADICAL BIO MED, V107, P125, DOI 10.1016/j.freeradbiomed.2016.12.008; Samadder P, 2016, PHARMACOL THERAPEUT, V161, P111, DOI 10.1016/j.pharmthera.2016.02.007; Sambrook J., 2001, MOL CLONING LAB MANU, pA2; Selvam K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069007; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Sugiman-Marangos SN, 2016, P NATL ACAD SCI USA, V113, P4308, DOI 10.1073/pnas.1520847113; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Toma M., 2018, CURR MED CHEM, V25, P1; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Wang YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122071; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Xu GZ, 2010, DNA REPAIR, V9, P805, DOI 10.1016/j.dnarep.2010.04.006; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	57	5	5	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3647	3658		10.1096/fj.201801506R	http://dx.doi.org/10.1096/fj.201801506R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481062	Bronze			2022-12-26	WOS:000459794800045
J	Kamsoi, O; Belles, X				Kamsoi, Orathai; Belles, Xavier			Myoglianin triggers the premetamorphosis stage in hemimetabolan insects	FASEB JOURNAL			English	Article						juvenile hormone; ecdysone; corpora allata; prothoracic gland; MEKRE93 pathway	DEPENDENT KINASE INHIBITOR; PROGRAMMED CELL-DEATH; JUVENILE-HORMONE; MICE LACKING; METAMORPHOSIS; TRANSCRIPTION; BIOSYNTHESIS; EXPRESSION; COCKROACH; PATHWAY	Insect metamorphosis is triggered by a decrease in juvenile hormone (JH) in the final juvenile instar. What induces this decrease is therefore a relevant question. Working with the cockroach Blattella germanica, we found that myoglianin (Myo), a ligand in the TGF- signaling pathway, is highly expressed in the corpora allata (CA, the JH-producing glands) and the prothoracic gland [(PG), which produce ecdysone] during the penultimate (fifth) nymphal instar (N5). In the CA, high Myo levels during N5 repress the expression of juvenile hormone acid methyl transferase, a JH biosynthesis gene. In the PG, decreasing JH levels trigger gland degeneration, regulated by the factors Kruppel homolog 1, FTZ-F1, E93, and inhibitor of apoptosis-1. Also in the PG, a peak of myo expression in N5 indirectly stimulates the expression of ecdysone biosynthesis genes, such as neverland, enhancing the production of the metamorphic ecdysone pulse in N6. The Myo expression peak in N5 also represses cell proliferation, which can enhance ecdysone production. The data indicate that Myo triggers the premetamorphic nymphal instar in B. germanica and possibly in other hemimetabolan insects.Kamsoi, O., Belles, X. Myoglianin triggers the premetamorphosis stage in hemimetabolan insects.	[Kamsoi, Orathai; Belles, Xavier] Univ Pompeu Fabra, CSIC, Spanish Natl Res Council, Inst Evolutionary Biol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Belles, X (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Passeig Maritim Barceloneta 37, Barcelona 08003, Spain.	xavier.belles@ibe.upf-csic.es	Belles, Xavier/G-2354-2015	Belles, Xavier/0000-0002-1566-303X	Spanish Ministry of Economy and Competitiveness [CGL2012-36251, CGL2015-64727-P]; Catalan Government [2017 SGR 1030]; European Fund for Economic and Regional Development (FEDER funds); Royal Thai Government	Spanish Ministry of Economy and Competitiveness(Spanish Government); Catalan Government; European Fund for Economic and Regional Development (FEDER funds); Royal Thai Government	The authors thank Guillem Ylla and Jose Carlos Montanes [both from the Institute of Evolutionary Biology (IBE), Spanish National Research Council-Universitat Pompeu Fabra] for helping with transcriptome comparisons and searching for genes in the B. germanica genome (available at https://www.hgsc.bcm.edu/arthropods/german-cockroach-genomeproject) as provided by the Baylor College of Medicine Human Genome Sequencing Center; Alba Ventos-Alfonso (IBE) for helping with different experiments and image treatment; and Maria-Dolors Piulachs and Jose-Luis Maestro (IBE) for helpful discussions. This work was supported by Spanish Ministry of Economy and Competitiveness Grants CGL2012-36251 and CGL2015-64727-P (to X.B.), by Catalan Government Grant 2017 SGR 1030 (to X.B.), and by the European Fund for Economic and Regional Development (FEDER funds). O.K. received a Royal Thai Government Scholarship to do a PhD thesis in X.B. laboratory, Barcelona. The authors declare no conflicts of interest.	Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; BAEHRECKE EH, 1995, DEV BIOL, V171, P85, DOI 10.1006/dbio.1995.1262; Barr AR, 2016, CELL SYST, V2, P27, DOI 10.1016/j.cels.2016.01.001; Belles X., 2011, ENCY LIFE SCI ELS; Belles X, 2017, ANNU REV ENTOMOL, V62, P111, DOI 10.1146/annurev-ento-031616-034925; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; CHIANG AS, 1995, MOL CELL ENDOCRINOL, V115, P51, DOI 10.1016/0303-7207(95)03669-X; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Cruz J, 2003, INSECT BIOCHEM MOLEC, V33, P1219, DOI 10.1016/j.ibmb.2003.06.004; Cruz J, 2008, DEV DYNAM, V237, P3179, DOI 10.1002/dvdy.21728; Cruz J, 2007, MECH DEVELOP, V124, P180, DOI 10.1016/j.mod.2006.12.003; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Ishimaru Y, 2016, P NATL ACAD SCI USA, V113, P5634, DOI 10.1073/pnas.1600612113; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lee CY, 2001, DEVELOPMENT, V128, P1443; Liu SN, 2018, P NATL ACAD SCI USA, V115, P139, DOI 10.1073/pnas.1716897115; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; Lozano J, 2015, P NATL ACAD SCI USA, V112, P3740, DOI 10.1073/pnas.1418522112; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Mane-Padros D, 2008, DEV BIOL, V315, P147, DOI 10.1016/j.ydbio.2007.12.015; Mane-Padros D, 2010, DEV BIOL, V346, P150, DOI 10.1016/j.ydbio.2010.07.012; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nijhout H.F., 1994, INSECT HORMONES; Niwa R, 2014, BIOSCI BIOTECH BIOCH, V78, P1283, DOI 10.1080/09168451.2014.942250; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Peterson AJ, 2014, METHODS, V68, P183, DOI 10.1016/j.ymeth.2014.03.016; Peterson AJ, 2013, DEVELOPMENT, V140, P649, DOI 10.1242/dev.085605; ROMANA I, 1995, EUR J ENTOMOL, V92, P93; Sakurai S., 2005, P409; Santos CG, 2016, DEV BIOL, V417, P104, DOI 10.1016/j.ydbio.2016.07.006; Swanson CI, 2015, DEVELOPMENT, V142, P4288, DOI 10.1242/dev.115006; Treiblmayr K, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.4301; Urena E, 2014, P NATL ACAD SCI USA, V111, P7024, DOI 10.1073/pnas.1401478111; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Ylla G, 2018, ISCIENCE, V4, P164, DOI 10.1016/j.isci.2018.05.017; Zhang TL, 2018, P NATL ACAD SCI USA, V115, P3960, DOI 10.1073/pnas.1800435115; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	47	17	17	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3659	3669		10.1096/fj.201801511R	http://dx.doi.org/10.1096/fj.201801511R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481489	Green Submitted, Bronze			2022-12-26	WOS:000459794800046
J	Long, YX; Sou, WH; Yung, KWY; Liu, HZ; Wan, SWC; Li, QY; Zeng, CY; Law, COK; Chan, GHC; Lau, TCK; Ngo, JCK				Long, Yunxin; Sou, Weng Hong; Yung, Kristen Wing Yu; Liu, Haizhen; Wan, Stephanie Winn Chee; Li, Qingyun; Zeng, Chuyue; Law, Carmen Oi Kwan; Chan, Gordon Ho Ching; Lau, Terrence Chi Kong; Ngo, Jacky Chi Ki			Distinct mechanisms govern the phosphorylation of different SR protein splicing factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoryl transfer; protein kinase; protein phosphorylation; serine/threonine protein kinase; RNA splicing; post-translational modification (PTM); localization; speckles; SR protein; SRPK; SRSF; processive phosphorylation; kinase-substrate interaction; post-translational mechanism; regulatory mechanism; nuclear speckle; subcellular localization	CRYO-EM STRUCTURE; MESSENGER-RNA; PROCESSIVE PHOSPHORYLATION; NUCLEAR IMPORT; FACTOR ASF/SF2; RS DOMAIN; SRP20; KINASES; SPLICEOSOME; TRANSPORTIN-SR2	Serine-arginine (SR) proteins are essential splicing factors containing a canonical RNA recognition motif (RRM), sometimes followed by a pseudo-RRM, and a C-terminal arginine/serine-rich (RS) domain that undergoes multisite phosphorylation. Phosphorylation regulates the localization and activity of SR proteins, and thus may provide insight into their differential biological roles. The phosphorylation mechanism of the prototypic SRSF1 by serine-arginine protein kinase 1 (SRPK1) has been well-studied, but little is known about the phosphorylation of other SR protein members. In the present study, interaction and kinetic assays unveiled how SRSF1 and the single RRM-containing SRSF3 are phosphorylated by SRPK2, another member of the SRPK family. We showed that a conserved SRPK-specific substrate-docking groove in SRPK2 impacts the binding and phosphorylation of both SR proteins, and the localization of SRSF3. We identified a nonconserved residue within the groove that affects the kinase processivity. We demonstrated that, in contrast to SRSF1, for which SRPK-mediated phosphorylation is confined to the N-terminal region of the RS domain, SRSF3 phosphorylation sites are spread throughout its entire RS domain in vitro. Despite this, SRSF3 appears to be hypophosphorylated in cells at steady state. Our results suggest that the absence of a pseudo-RRM renders the single RRM-containing SRSF3 more susceptible to dephosphorylation by phosphatase. These findings suggest that the single RRM- and two RRM-containing SR proteins represent two subclasses of phosphoproteins in which phosphorylation statuses are maintained by unique mechanisms, and pose new directions to explore the distinct roles of SR proteins in vivo.	[Long, Yunxin; Sou, Weng Hong; Yung, Kristen Wing Yu; Liu, Haizhen; Wan, Stephanie Winn Chee; Li, Qingyun; Zeng, Chuyue; Chan, Gordon Ho Ching; Ngo, Jacky Chi Ki] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Law, Carmen Oi Kwan; Lau, Terrence Chi Kong] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Sou, Weng Hong] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	Chinese University of Hong Kong; City University of Hong Kong; University of Macau	Ngo, JCK (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	jackyngo@cuhk.edu.hk	Lau, Terrence/ABB-7900-2021; Ngo, Jacky C/O-8093-2017	Lau, Terrence/0000-0002-7505-7306; Ngo, Jacky C/0000-0002-6004-7041; Yung, Kristen Wing Yu/0000-0001-7389-3012; Wan, Stephanie Winn Chee/0000-0001-5395-4746	Hong Kong SAR Research Grant Council General Research Fund [473310, 14122615, 3132811]	Hong Kong SAR Research Grant Council General Research Fund	This work was supported by Hong Kong SAR Research Grant Council General Research Fund Grants 473310 and 14122615 and The Chinese University of Hong Kong direct grant scheme Grant 3132811 (to J. C. K. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajiro M, 2016, NUCLEIC ACIDS RES, V44, P1854, DOI 10.1093/nar/gkv1500; Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Aubol BE, 2018, BIOCHEM J, V475, P677, DOI 10.1042/BCJ20170672; Aubol BE, 2017, J MOL BIOL, V429, P2178, DOI 10.1016/j.jmb.2017.05.022; Aubol BE, 2016, MOL CELL, V63, P218, DOI 10.1016/j.molcel.2016.05.034; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bertram K, 2017, NATURE, V542, P318, DOI 10.1038/nature21079; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cao WH, 1997, RNA, V3, P1456; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Clery A, 2013, P NATL ACAD SCI USA, V110, pE2802, DOI 10.1073/pnas.1303445110; Corbo C, 2013, BIOCHEM BIOPH RES CO, V436, P1, DOI 10.1016/j.bbrc.2013.05.027; Cvitkovic I, 2013, NUCLEIC ACIDS RES, V41, pD132, DOI 10.1093/nar/gks999; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Hamelberg D, 2007, P NATL ACAD SCI USA, V104, P14947, DOI 10.1073/pnas.0703151104; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Liang N, 2014, BIOCHEM J, V459, P181, DOI 10.1042/BJ20131091; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; Lukasiewicz R, 2007, J BIOL CHEM, V282, P23036, DOI 10.1074/jbc.M611305200; Ma CT, 2008, J MOL BIOL, V376, P55, DOI 10.1016/j.jmb.2007.08.029; Ma CT, 2009, J MOL BIOL, V390, P618, DOI 10.1016/j.jmb.2009.05.060; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Saeki K, 2005, AM J PHYSIOL-ENDOC M, V289, pE419, DOI 10.1152/ajpendo.00512.2004; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Sen S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2342; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Serrano P, 2016, J MOL BIOL, V428, P2430, DOI 10.1016/j.jmb.2016.04.009; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Walsh CM, 2013, J BIOL CHEM, V288, P2816, DOI 10.1074/jbc.M112.410803; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	53	31	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1312	1327		10.1074/jbc.RA118.003392	http://dx.doi.org/10.1074/jbc.RA118.003392			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30478176	Green Published, hybrid			2022-12-26	WOS:000457879500022
J	Wollenberg, RD; Taft, MH; Giese, S; Thiel, C; Balazs, Z; Giese, H; Manstein, DJ; Sondergaard, TE				Wollenberg, Rasmus D.; Taft, Manuel H.; Giese, Sven; Thiel, Claudia; Balazs, Zoltan; Giese, Henriette; Manstein, Dietmar J.; Sondergaard, Teis E.			Phenamacril is a reversible and noncompetitive inhibitor of Fusarium class I myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; myosin; ATPase; inhibitor; allosteric regulation; inhibition mechanism; cytoskeleton; fungicide; motor protein; phenamacril	ADENOSINE-TRIPHOSPHATASE; BLEBBISTATIN INHIBITION; FUNGICIDE JS399-19; CRYSTAL-STRUCTURE; MOTOR DOMAIN; DICTYOSTELIUM; MECHANISM; SPECIFICITY; PROTEIN; RESISTANCE	The cyanoacrylate compound phenamacril (also known as JS399-19) is a recently identified fungicide that exerts its antifungal effect on susceptible Fusarium species by inhibiting the ATPase activity of their myosin class I motor domains. Although much is known about the antifungal spectrum of phenamacril, the exact mechanism behind the phenamacril-mediated inhibition remains to be resolved. Here, we describe the characterization of the effect of phenamacril on purified myosin motor constructs from the model plant pathogen and phenamacril-susceptible species Fusarium graminearum, phenamacril-resistant Fusarium species, and the mycetozoan model organism Dictyostelium discoideum. Our results show that phenamacril potently (IC50 similar to 360 nm), reversibly, and noncompetitively inhibits ATP turnover, actin binding during ATP turnover, and motor activity of F. graminearum myosin-1. Phenamacril also inhibits the ATPase activity of Fusarium avenaceum myosin-1 but has little or no inhibitory effect on the motor activity of Fusarium solani myosin-1, human myosin-1c, and D. discoideum myosin isoforms 1B, 1E, and 2. Our findings indicate that phenamacril is a species-specific, noncompetitive inhibitor of class I myosin in susceptible Fusarium sp.	[Wollenberg, Rasmus D.; Balazs, Zoltan; Giese, Henriette; Sondergaard, Teis E.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Taft, Manuel H.; Giese, Sven; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE4350, D-30623 Hannover, Germany; [Thiel, Claudia; Manstein, Dietmar J.] Hannover Med Sch, Div Struct Biochem, OE8830, D-30623 Hannover, Germany	Aalborg University; Hannover Medical School; Hannover Medical School	Sondergaard, TE (corresponding author), Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark.; Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE4350, D-30623 Hannover, Germany.; Manstein, DJ (corresponding author), Hannover Med Sch, Div Struct Biochem, OE8830, D-30623 Hannover, Germany.	manstein.dietmar@mh-hannover.de; tes@bio.aau.dk	Manstein, Dietmar J./AAG-2640-2019; Taft, Manuel H/T-2508-2017; Taft, Manuel/O-1396-2019; Manstein, Dietmar J. J/M-1034-2013; Sondergaard, Teis/F-4122-2014	Manstein, Dietmar J./0000-0003-0763-0147; Taft, Manuel H/0000-0001-5853-8629; Taft, Manuel/0000-0001-5853-8629; Manstein, Dietmar J. J/0000-0003-0763-0147; Wollenberg, Rasmus/0000-0002-8320-2497; Sondergaard, Teis/0000-0002-4455-7498; Giese, Sven/0000-0003-0984-0543	Danish Ministry of Higher Education and Science [4005-00204B]; Deutsche Forschungsgemeinschaft [MA1081/22-01]; Volkswagen Foundation [VWZN3012]	Danish Ministry of Higher Education and Science; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by The Danish Ministry of Higher Education and Science Grant 4005-00204B (to T. E. S.), Deutsche Forschungsgemeinschaft Grant MA1081/22-01 (to D. J. M), and Volkswagen Foundation Grant VWZN3012 (to M. H. T. and D. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; BAGSHAW CR, 1975, FEBS LETT, V58, P197, DOI 10.1016/0014-5793(75)80258-4; Behrens VA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07933-y; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Chen Y, 2008, PHYTOPARASITICA, V36, P326, DOI 10.1007/BF02980812; Chen Y, 2011, AGR SCI CHINA, V10, P1906, DOI 10.1016/S1671-2927(11)60191-0; Chinthalapudi K, 2011, J BIOL CHEM, V286, P29700, DOI 10.1074/jbc.M111.239210; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Donau SS, 2017, EUR J ORG CHEM, V2017, P6408, DOI 10.1002/ejoc.201701235; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Fedorov R, 2009, NAT STRUCT MOL BIOL, V16, P80, DOI 10.1038/nsmb.1542; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Hou YP, 2018, PEST MANAG SCI, V74, P607, DOI 10.1002/ps.4742; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Li B, 2016, PLANT DIS, V100, P1754, DOI 10.1094/PDIS-02-16-0169-RE; Li HK, 2008, CROP PROT, V27, P90, DOI 10.1016/j.cropro.2007.04.010; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lysoe E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112703; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Makowska KA, 2015, CELL REP, V13, P2118, DOI 10.1016/j.celrep.2015.11.012; MANSTEIN DJ, 1989, SCIENCE, V246, P656, DOI 10.1126/science.2530629; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Planelles-Herrero VJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00176-5; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Preller M, 2011, J MED CHEM, V54, P3675, DOI 10.1021/jm200259f; Salvesen GS, 2007, STRUCTURE, V15, P513, DOI 10.1016/j.str.2007.04.006; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schweizer A, 2007, STRUCTURE, V15, P625, DOI 10.1016/j.str.2007.03.014; Sirigu S, 2016, P NATL ACAD SCI USA, V113, pE7448, DOI 10.1073/pnas.1609342113; Song B, 2013, FUNGAL GENET BIOL, V54, P60, DOI 10.1016/j.fgb.2013.02.010; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Vallotton P, 2013, MICROSC MICROANAL, V19, P451, DOI 10.1017/S1431927612014328; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; Wollenberg RD, 2016, PESTIC BIOCHEM PHYS, V134, P24, DOI 10.1016/j.pestbp.2016.05.002; Zhang CQ, 2015, ENVIRON MICROBIOL, V17, P2735, DOI 10.1111/1462-2920.12711; Zheng ZT, 2018, PESTIC BIOCHEM PHYS, V147, P119, DOI 10.1016/j.pestbp.2017.12.007; Zheng ZT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154058; Zheng ZT, 2015, SCI REP-UK, V5, DOI 10.1038/srep08248	54	8	9	7	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1328	1337		10.1074/jbc.RA118.005408	http://dx.doi.org/10.1074/jbc.RA118.005408			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504222	Green Published, hybrid			2022-12-26	WOS:000457879500023
J	Prasad, Y; Kumar, R; Chaudhary, AK; Dhanaraju, R; Majumdar, S; Rao, DN				Prasad, Yedu; Kumar, Ritesh; Chaudhary, Awanish Kumar; Dhanaraju, Rajkumar; Majumdar, Soneya; Rao, Desirazu N.			Kinetic and catalytic properties of M.HpyAXVII, a phase-variable DNA methyltransferase from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA methyltransferase; enzyme kinetics; enzyme mechanism; S-adenosylmethionine (AdoMet); bioinformatics; allosteric regulation; DNA binding; M.HpyAXVII; ordered Bi Bi mechanism; phase variation	AMINO-ACID-RESIDUES; FUNCTIONAL ROLES; SEQUENCE; MECHANISM; METHYLATION; PROTEINS; TRANSCRIPTION; RECOGNITION; MUTAGENESIS; SYSTEM	The bacterium Helicobacter pylori is one of the most common infectious agents found in the human stomach. H. pylori has an unusually large number of DNA methyltransferases (MTases), prompting speculation that they may be involved in the cancerization of epithelial cells. The mod-4a/4b locus, consisting of the hp1369 and hp1370 ORFs, encodes for a truncated and inactive MTase in H. pylori strain 26695. However, slipped-strand synthesis within the phase-variable polyguanine tract in hp1369 results in expression of an active HP1369-1370 fusion N-6-adenine methyltransferase, designated M.HpyAXVII. Sequence analysis of the mod-4a/4b locus across 74 H. pylori strain genomes has provided insights into the regulation of M.HpyAXVII expression. To better understand the role of M.HpyAXVII in the H. pylori biology, here we cloned and overexpressed the hp1369-70 fusion construct in Escherichia coli BL21(DE3) cells. Results from size-exclusion chromatography and multi-angle light scattering (MALS) analyses suggested that M.HpyAXVII exists as a dimer in solution. Kinetic studies, including product and substrate inhibition analyses, initial velocity dependence between substrates, and isotope partitioning, suggested that M.HpyAXVII catalyzes DNA methylation in an ordered Bi Bi mechanism in which the AdoMet binding precedes DNA binding and AdoMet's methyl group is then transferred to an adenine within the DNA recognition sequence. Altering the highly conserved catalytic motif (DPP(Y/F)) as well as the AdoMet-binding motif (FXGXG) by site-directed mutagenesis abolished the catalytic activity of M.HpyAXVII. These results provide insights into the enzyme kinetic mechanism of M.HpyAXVII. We propose that AdoMet binding conformationally "primes" the enzyme for DNA binding.	[Prasad, Yedu; Kumar, Ritesh; Chaudhary, Awanish Kumar; Dhanaraju, Rajkumar; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Majumdar, Soneya] Indian Inst Technol, Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Prasad, Yedu] CSIR, Shyama Prasad Mukherjee Fellowship Program, New Delhi, India; [Kumar, Ritesh] CSIR, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Council of Scientific & Industrial Research (CSIR) - India; Council of Scientific & Industrial Research (CSIR) - India	Rao, DN (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	dnrao@iisc.ac.in	KUMAR, RITESH/P-1265-2019	KUMAR, RITESH/0000-0001-7170-8645; Prasad, Yedu/0000-0002-1481-9071	Department of Science and Technology; DBT-IISc Partnership Program	Department of Science and Technology(Department of Science & Technology (India)); DBT-IISc Partnership Program	This work was supported by grants from the Department of Science and Technology (J. C. Bose fellowship) and the DBT-IISc Partnership Program (to D. N. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari S, 2016, FEMS MICROBIOL REV, V40, P575, DOI 10.1093/femsre/fuw023; Ahmad I, 1996, CRIT REV BIOCHEM MOL, V31, P361, DOI 10.3109/10409239609108722; AHMAD I, 1995, GENE, V157, P143, DOI 10.1016/0378-1119(95)00671-R; BALDWIN GS, 1994, J MOL BIOL, V235, P545, DOI 10.1006/jmbi.1994.1012; Bhattacharya SK, 1999, J BIOL CHEM, V274, P14743, DOI 10.1074/jbc.274.21.14743; Bheemanaik S, 2003, J BIOL CHEM, V278, P7863, DOI 10.1074/jbc.M211458200; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chung D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043844; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Vries N, 2002, J BACTERIOL, V184, P6615, DOI 10.1128/JB.184.23.6615-6624.2002; DELACAMPA AG, 1987, J MOL BIOL, V196, P457, DOI 10.1016/0022-2836(87)90024-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRLICH M, 1987, J BACTERIOL, V169, P939, DOI 10.1128/jb.169.3.939-943.1987; Evdokimov AA, 2002, J BIOL CHEM, V277, P279, DOI 10.1074/jbc.M108864200; Furuta Y, 2012, NUCLEIC ACIDS RES, V40, P9218, DOI 10.1093/nar/gks681; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Humbert O, 2008, NUCLEIC ACIDS RES, V36, P6893, DOI 10.1093/nar/gkn718; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042303; Kumar R, 2012, FEBS J, V279, P1080, DOI 10.1111/j.1742-4658.2012.08502.x; Kumar R, 2010, FEBS J, V277, P1666, DOI 10.1111/j.1742-4658.2010.07593.x; Kumar S, 2018, NUCLEIC ACIDS RES, V46, P3429, DOI 10.1093/nar/gky126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Minton AP, 2016, ANAL BIOCHEM, V501, P4, DOI 10.1016/j.ab.2016.02.007; Pues H, 1999, BIOCHEMISTRY-US, V38, P1426, DOI 10.1021/bi9818016; RAO DN, 1989, J MOL BIOL, V209, P599, DOI 10.1016/0022-2836(89)90597-4; REICH NO, 1991, BIOCHEMISTRY-US, V30, P2933, DOI 10.1021/bi00225a029; Roth M, 1998, J BIOL CHEM, V273, P17333, DOI 10.1074/jbc.273.28.17333; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; Sankpal UT, 2002, NUCLEIC ACIDS RES, V30, P2628, DOI 10.1093/nar/gkf380; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Scarlato V, 2001, INT J MED MICROBIOL, V291, P107, DOI 10.1078/1438-4221-00107; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shier VK, 2001, J BIOL CHEM, V276, P14744, DOI 10.1074/jbc.M010688200; Sitaraman R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00115; Srikhanta YN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15721-x; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Szegedi SS, 2000, NUCLEIC ACIDS RES, V28, P3962, DOI 10.1093/nar/28.20.3962; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WILLEMS R, 1990, EMBO J, V9, P2803, DOI 10.1002/j.1460-2075.1990.tb07468.x; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200	49	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1019	1034		10.1074/jbc.RA118.003769	http://dx.doi.org/10.1074/jbc.RA118.003769			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478171	hybrid, Green Published			2022-12-26	WOS:000458670200025
J	Yan, Y; Zhou, XE; Novick, SJ; Shaw, SJ; Li, YW; Brunzelle, JS; Hitoshi, Y; Griffin, PR; Xu, HE; Melcher, K				Yan, Yan; Zhou, X. Edward; Novick, Scott J.; Shaw, Simon J.; Li, Yingwu; Brunzelle, Joseph S.; Hitoshi, Yasumichi; Griffin, Patrick R.; Xu, H. Eric; Melcher, Karsten			Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); AMP; hydrogen exchange mass spectrometry; X-ray crystallography; phosphorylation; activation loop phosphorylation; ADaM site; CBS3; R734; R739; metabolic disorder; energy sensor	GAMMA-SUBUNIT ISOFORMS; UPSTREAM KINASE; ENERGY SENSOR; METFORMIN; MECHANISM; DRUGS; BETA; IDENTIFICATION; HEPATOCYTES; A-769662	AMP-activated protein kinase (AMPK) is an attractive therapeutic target for managing metabolic diseases. A class of pharmacological activators, including Merck 991, binds the AMPK ADaM site, which forms the interaction surface between the kinase domain (KD) of the alpha-subunit and the carbohydrate-binding module (CBM) of the beta-subunit. Here, we report the development of two new 991-derivative compounds, R734 and R739, which potently activate AMPK in a variety of cell types, including beta(2)-specific skeletal muscle cells. Surprisingly, we found that they have only minor effects on direct kinase activity of the recombinant alpha(1)beta(2)gamma(1) isoform yet robustly enhance protection against activation loop dephosphorylation. This mode of activation is reminiscent of that of ADP, which activates AMPK by binding to the nucleotide-binding sites in the gamma-subunit, more than 60 A away from the ADaM site. To understand the mechanisms of full and partial AMPK activation, we determined the crystal structures of fully active phosphorylated AMPK alpha(1)beta(1)gamma(1) bound to AMP and R734/R739 as well as partially active nonphosphorylated AMPK bound to R734 and AMP and phosphorylated AMPK bound to R734 in the absence of added nucleotides at <3-A resolution. These structures and associated analyses identified a novel conformational state of the AMPK autoinhibitory domain associated with partial kinase activity and provide new insights into phosphorylation-dependent activation loop stabilization in AMPK.	[Yan, Yan; Zhou, X. Edward; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Yan, Yan; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Materia Med VARI SIMM Ctr, Shanghai Inst Materia Med,CAS Key Lab Receptor Re, Ctr Struct & Funct Drug Targets,Van Andel Res Ins, Shanghai 201203, Peoples R China; [Yan, Yan] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Novick, Scott J.; Griffin, Patrick R.] Scripps Res Inst, Scripps Florida, Dept Mol Med, Jupiter, FL 33458 USA; [Shaw, Simon J.; Li, Yingwu; Hitoshi, Yasumichi] Rigel Pharmaceut Inc, San Francisco, CA 94080 USA; [Brunzelle, Joseph S.] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA	Van Andel Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Scripps Research Institute; State University System of Florida; University of Florida; Northwestern University	Melcher, K (corresponding author), Van Andel Res Inst, Ctr Canc & Cell Biol, Lab Struct Biol & Biochem, 333 Bostwick Ave Northeast, Grand Rapids, MI 49503 USA.	karsten.melcher@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Brunzelle, Joseph/0000-0001-9197-0018	Van Andel Research Institute; National Institutes of Health [R01 GM102545, R01 GM129436, DK071662]; National Natural Science Foundation of China [31300245]; Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM129436] Funding Source: NIH RePORTER	Van Andel Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Amway (China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Van Andel Research Institute (to H.E.X. and K.M.); National Institutes of Health Grants R01 GM102545 and R01 GM129436 (to K. M.) and DK071662 (to H.E.X.); National Natural Science Foundation of China Grant 31300245 (to H. E. X.); Ministry of Science and Technology (China) Grants 2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001 (to H.E.X.); and Amway (China) (to H. E. X.). S.J.S., Y.L., and Y.H. are or have been employees and shareholders of Rigel Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; Chen L, 2013, NATURE, V498, pE8, DOI 10.1038/nature12189; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng DQ, 2018, ACS MED CHEM LETT, V9, P39, DOI 10.1021/acsmedchemlett.7b00417; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gu X, 2017, J BIOL CHEM, V292, P12653, DOI 10.1074/jbc.M117.793018; Hardie DG, 2017, SCIENCE, V357, P455, DOI 10.1126/science.aao1913; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Hutcheson M. C., 1995, THESIS; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Ngoei KRW, 2018, CELL CHEM BIOL, V25, P728, DOI 10.1016/j.chembiol.2018.03.008; Oligschlaeger Y, 2015, J BIOL CHEM, V290, P11715, DOI 10.1074/jbc.M114.633271; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Willows R, 2017, BIOCHEM J, V474, P3059, DOI 10.1042/BCJ20170458; Willows R, 2017, BIOCHEM J, V474, P1741, DOI 10.1042/BCJ20170046; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xin FJ, 2013, CELL RES, V23, P1237, DOI 10.1038/cr.2013.121; Yan Y, 2018, METHOD PROTOCOL, V1, DOI 10.3390/mps1010003; Zhang CS, 2016, CELL METAB, V24, P521, DOI 10.1016/j.cmet.2016.09.003	48	16	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					953	967		10.1074/jbc.RA118.004883	http://dx.doi.org/10.1074/jbc.RA118.004883			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478170	Green Published, hybrid			2022-12-26	WOS:000458670200020
J	Asan, A; Skoko, JJ; Woodcock, CSC; Wingert, BM; Woodcock, SR; Normolle, D; Huang, Y; Stark, JM; Camacho, CJ; Freeman, BA; Neumann, CA				Asan, Alparslan; Skoko, John J.; Woodcock, Chen-Shan Chen; Wingert, Bentley M.; Woodcock, Steven R.; Normolle, Daniel; Huang, Yi; Stark, Jeremy M.; Camacho, Carlos J.; Freeman, Bruce A.; Neumann, Carola A.			Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homologous recombination; breast cancer; drug action; drug discovery; DNA repair; signal transduction; cysteine-mediated cross-linking; homologous recombination; nitro fatty acid; Rad51; triple negative breast cancer; nitroalkene; PARP1	HOMOLOGOUS RECOMBINATION; REPAIR; PHOSPHORYLATION; INSIGHTS; REVEALS	Homologous recombination (HR)-directed DNA double-strand break (DSB) repair enables template-directed DNA repair to maintain genomic stability. RAD51 recombinase (RAD51) is a critical component of HR and facilitates DNA strand exchange in DSB repair. We report here that treating triple-negative breast cancer (TNBC) cells with the fatty acid nitroalkene 10-nitro-octadec-9-enoic acid (OA-NO2) in combination with the antineoplastic DNA-damaging agents doxorubicin, cisplatin, olaparib, and -irradiation (IR) enhances the antiproliferative effects of these agents. OA-NO2 inhibited IR-induced RAD51 foci formation and enhanced H2A histone family member X (H2AX) phosphorylation in TNBC cells. Analyses of fluorescent DSB reporter activity with both static-flow cytometry and kinetic live-cell studies enabling temporal resolution of recombination revealed that OA-NO2 inhibits HR and not nonhomologous end joining (NHEJ). OA-NO2 alkylated Cys-319 in RAD51, and this alkylation depended on the Michael acceptor properties of OA-NO2 because nonnitrated and saturated nonelectrophilic analogs of OA-NO2, octadecanoic acid and 10-nitro-octadecanoic acid, did not react with Cys-319. Of note, OA-NO2 alkylation of RAD51 inhibited its binding to ssDNA. RAD51 Cys-319 resides within the SH3-binding site of ABL proto-oncogene 1, nonreceptor tyrosine kinase (ABL1), so we investigated the effect of OA-NO2-mediated Cys-319 alkylation on ABL1 binding and found that OA-NO2 inhibits RAD51-ABL1 complex formation both in vitro and in cell-based immunoprecipitation assays. The inhibition of the RAD51-ABL1 complex also suppressed downstream RAD51 Tyr-315 phosphorylation. In conclusion, RAD51 Cys-319 is a functionally significant site for adduction of soft electrophiles such as OA-NO2 and suggests further investigation of lipid electrophile-based combinational therapies for TNBC.	[Asan, Alparslan; Skoko, John J.; Woodcock, Chen-Shan Chen; Woodcock, Steven R.; Huang, Yi; Freeman, Bruce A.; Neumann, Carola A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Asan, Alparslan; Skoko, John J.; Huang, Yi; Neumann, Carola A.] UPMC, Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA 15213 USA; [Asan, Alparslan; Skoko, John J.; Huang, Yi; Neumann, Carola A.] Univ Pittsburgh, Med Ctr, Magee Womens Res Hosp, Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Stark, Jeremy M.] Beckman Res Inst City Hope, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA; [Wingert, Bentley M.; Camacho, Carlos J.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Normolle, Daniel] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; City of Hope; Beckman Research Institute of City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Skoko, JJ; Neumann, CA (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Dept Pharmacol & Chem Biol, 204 Craft Ave, Pittsburgh, PA 15213 USA.	jskoko@pitt.edu; neumannc@upmc.edu	Woodcock, Steven/AAE-9199-2020; Skoko, John/AAL-1885-2021; Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X; Neumann, Carola/0000-0003-2801-9531; Asan, Alparslan/0000-0003-2495-5875	National Institutes of Health [R01-CA131350, P30-CA047904, T32-EB009403, R01-CA197506, R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455]; Basic Biology of Aging, University of Pittsburgh; University of Pittsburgh Department of Pharmacology and Chemical Biology; William C. de Groat predoctoral fellowships; Cotswold Foundation postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA197506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103455, R01HL132550, R37HL058115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Biology of Aging, University of Pittsburgh; University of Pittsburgh Department of Pharmacology and Chemical Biology(University of Pittsburgh); William C. de Groat predoctoral fellowships; Cotswold Foundation postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-CA131350 and P30-CA047904 (to the UPMC Hillman Cancer Center and D.N.), T32-EB009403 (to B.M.W.), R01-CA197506 (to J.M.S), and R01-HL058115, R01-HL64937, P30-DK072506, and P01-HL103455 (to B.A.F.); Basic Biology of Aging, University of Pittsburgh (to C.A.N.); University of Pittsburgh Department of Pharmacology and Chemical Biology and William C. de Groat predoctoral fellowships (to A. A.); and a Cotswold Foundation postdoctoral fellowship (to J.J.S.). B.A.F. and C.-S.C.W. acknowledge an interest in Complexa, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alagpulinsa DA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00289; Asakawa H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2486; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Chen JH, 2015, NUCLEIC ACIDS RES, V43, P1098, DOI 10.1093/nar/gku1337; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Delmastro-Greenwood M, 2014, ANNU REV PHYSIOL, V76, P79, DOI 10.1146/annurev-physiol-021113-170341; Dunphy Karen A, 2010, J Vis Exp, DOI 10.3791/1849; Godin SK, 2016, BIOCHEM CELL BIOL, V94, P407, DOI 10.1139/bcb-2016-0012; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Grover P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133590; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hopkins BL, 2018, ANTIOXID REDOX SIGN, V28, P62, DOI 10.1089/ars.2016.6871; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100993; Lamont KR, 2013, J EXP MED, V210, P1021, DOI 10.1084/jem.20121258; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Popova M, 2009, FEBS LETT, V583, P1867, DOI 10.1016/j.febslet.2009.04.044; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Robert M, 2017, EXPERT OPIN INV DRUG, V26, P751, DOI 10.1080/13543784.2017.1318847; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Sharma P, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0539-8; Slupianek A, 2011, BLOOD, V118, P1062, DOI 10.1182/blood-2010-09-307256; Subramanyam S, 2016, P NATL ACAD SCI USA, V113, pE6045, DOI 10.1073/pnas.1604807113; Wiegmans AP, 2014, ONCOTARGET, V5, P3261, DOI 10.18632/oncotarget.1923; Woodcock CSC, 2018, J BIOL CHEM, V293, P1120, DOI 10.1074/jbc.M117.814368; Zhu JW, 2013, EMBO MOL MED, V5, P353, DOI 10.1002/emmm.201201760	37	7	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					397	404		10.1074/jbc.AC118.005899	http://dx.doi.org/10.1074/jbc.AC118.005899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30478172	Green Published, hybrid			2022-12-26	WOS:000456263600001
J	Danov, O; Delgado, SMJ; Obernolte, H; Seehase, S; Dehmel, S; Braubach, P; Fieguth, HG; Matschiner, G; Fitzgerald, M; Jonigk, D; Knauf, S; Pfennig, O; Warnecke, G; Wichmann, J; Braun, A; Sewald, K				Danov, Olga; Delgado, Sharon Melissa Jimenez; Obernolte, Helena; Seehase, Sophie; Dehmel, Susann; Braubach, Peter; Fieguth, Hans-Gerd; Matschiner, Gabriele; Fitzgerald, Mary; Jonigk, Danny; Knauf, Sascha; Pfennig, Olaf; Warnecke, Gregor; Wichmann, Judy; Braun, Armin; Sewald, Katherina			Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugs	PLOS ONE			English	Article							ACTIVATION-REGULATED CHEMOKINE; HUMAN INTERLEUKIN-13 RECEPTOR; DOUBLE-BLIND; AIRWAY HYPERRESPONSIVENESS; UNCONTROLLED ASTHMA; PERSISTENT ASTHMA; ALLERGIC RESPONSE; SAFETY; CELLS; IL-13	Subgroups of patients with severe asthma are insensitive to inhaled corticosteroids and require novel therapies on top of standard medical care. IL-13 is considered one of the key cytokines in the asthma pathogenesis, however, the effect of IL-13 was mostly studied in rodents. This study aimed to assess IL-13 effect in human lung tissue for the development of targeted therapy approaches such as inhibition of soluble IL-13 or its receptor IL-4R alpha subunit. Precision-cut lung slices (PCLS) were prepared from lungs of rodents, non-human primates (NHP) and humans. Direct effect of IL-13 on human lung tissue was observed on inflammation, induction of mucin5AC, and airway constriction induced by methacholine and visualized by videomicroscopy. Anti-inflammatory treatment was evaluated by co-incubation of IL-13 with increasing concentrations of IL-13/IL-13 receptor inhibitors. IL-13 induced a two-fold increase in mucin5AC secretion in human bronchial tissue. Additionally, IL-13 induced release of proinflammatory cytokines eotaxin-3 and TARC in human PCLS. Anti-inflammatory treatment with four different inhibitors acting either on the IL-13 ligand itself (anti-IL-13 antibody, similar to Lebrikizumab) or the IL-4R alpha chain of the IL-13/IL-4 receptor complex (anti-IL-4R alpha #1, similar to AMG 317, and #2, similar to REGN668) and #3 PRS-060 (a novel anticalin directed against this receptor) could significantly attenuate IL-13 induced inflammation. Contrary to this, IL-13 did not induce airway hyperresponsiveness (AHR) in human and NHP PCLS, although it was effective in rodent PCLS. Overall, this study demonstrates that IL-13 stimulation induces production of mucus and biomarkers of allergic inflammation in human lung tissue ex-vivo but no airway hyperresponsiveness. The results of this study show a more distinct efficacy than known from animals models and a clear discrepancy in AHR induction. Moreover, it allows a translational approach in inhibitor profiling in human lung tissue.	[Danov, Olga; Delgado, Sharon Melissa Jimenez; Obernolte, Helena; Dehmel, Susann; Knauf, Sascha; Wichmann, Judy; Braun, Armin; Sewald, Katherina] Fraunhofer Inst Toxicol & Expt Med ITEM, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Danov, Olga; Delgado, Sharon Melissa Jimenez; Obernolte, Helena; Dehmel, Susann; Braubach, Peter; Jonigk, Danny; Knauf, Sascha; Warnecke, Gregor; Wichmann, Judy; Braun, Armin; Sewald, Katherina] German Ctr Lung Res DZL, Hannover, Germany; [Seehase, Sophie] Airway Res Ctr North ARCN, Res Ctr Borstel, Borstel, Germany; [Seehase, Sophie] German Ctr Lung Res DZL, Borstel, Germany; [Braubach, Peter; Jonigk, Danny] Hannover Med Sch, Inst Pathol, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Fieguth, Hans-Gerd; Pfennig, Olaf] KRH Klinikum Siloah Oststadt Heidehaus, Hannover, Germany; [Matschiner, Gabriele; Fitzgerald, Mary] Pieris AG, Freising Weihenstephan, Germany; [Knauf, Sascha; Wichmann, Judy] German Primate Ctr, Pathol Unit, Leibniz Inst, Gottingen, Germany; [Warnecke, Gregor] Hannover Med Sch, Div Cardiac Thorac Transplantat & Vasc Surg, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Braun, Armin] Hannover Med Sch, Inst Immunol, Hannover, Germany	Fraunhofer Gesellschaft; Forschungszentrum Borstel; Hannover Medical School; Deutsches Primatenzentrum (DPZ); Hannover Medical School; Hannover Medical School	Sewald, K (corresponding author), Fraunhofer Inst Toxicol & Expt Med ITEM, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany.; Sewald, K (corresponding author), German Ctr Lung Res DZL, Hannover, Germany.	katherina.sewald@item.fraunhofer.de	Braun, Armin/B-8750-2009; Knauf, Sascha/F-1661-2017	Braun, Armin/0000-0002-1142-1463; Knauf, Sascha/0000-0001-5744-4946	German Centre for Lung Research	German Centre for Lung Research	The study was funded by the national public funded German Centre for Lung Research (DZL). DZL provided support in the form of salaries for authors (OD, KS, AB, PB, DJ), but did not influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The commercial partner Pieris did not fund the performance of the study. They only provided financial support in the form of authors' salaries (GM, MF) and research materials. They did not play a role in the study design, data collection, analysis, and decision to publish. They contributed as authors to the preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abonyo BO, 2005, AM J PHYSIOL-LUNG C, V289, pL478, DOI 10.1152/ajplung.00032.2005; Akaiwa M, 2001, CYTOKINE, V13, P75, DOI 10.1006/cyto.2000.0814; Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Berkman N, 2001, AM J RESP CELL MOL, V24, P682, DOI 10.1165/ajrcmb.24.6.4301; Beste G, 1999, P NATL ACAD SCI USA, V96, P1898, DOI 10.1073/pnas.96.5.1898; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; CERKEZ V, 1986, ARCH OTOLARYNGOL, V112, P316; Charavaryamath C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-50; Charriot J, 2016, EUR RESPIR REV, V25, DOI 10.1183/16000617.0069-2015; CHIBA Y, 1995, COMP BIOCHEM PHYS C, V111, P351, DOI 10.1016/0742-8413(95)00061-5; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; De Boever EH, 2014, J ALLERGY CLIN IMMUN, V133, P989, DOI 10.1016/j.jaci.2014.01.002; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hanania NA, 2016, LANCET RESP MED, V4, P781, DOI 10.1016/S2213-2600(16)30265-X; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; Henjakovic M, 2008, TOXICOL APPL PHARM, V231, P68, DOI 10.1016/j.taap.2008.04.003; Hohlbaum Andreas M, 2007, Expert Rev Clin Immunol, V3, P491, DOI 10.1586/1744666X.3.4.491; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; Kakkar T, 2011, PHARM RES-DORDR, V28, P2530, DOI 10.1007/s11095-011-0481-y; Kondo Mitsuko, 2006, Allergol Int, V55, P329, DOI 10.2332/allergolint.55.329; Korenblat P, 2018, RESP MED, V134, P143, DOI 10.1016/j.rmed.2017.12.006; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Macklem PT, 1998, AM J RESP CRIT CARE, V157, pS181, DOI 10.1164/ajrccm.157.5.rsaa-2; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nasu K, 2004, FERTIL STERIL, V82, P1014, DOI 10.1016/j.fertnstert.2004.04.029; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Neuhaus V, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-017-0158-5; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Prieto J, 2000, RESP MED, V94, P806, DOI 10.1053/rmed.2000.0826; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Seehase S, 2011, J APPL PHYSIOL, V111, P791, DOI 10.1152/japplphysiol.00162.2011; Sekiya T, 2002, ALLERGY, V57, P173, DOI 10.1034/j.1398-9995.2002.1s3256.x; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; Skerra A, 2001, J Biotechnol, V74, P257, DOI 10.1016/S1389-0352(01)00020-4; Stokes JR, 2014, INT IMMUNOPHARMACOL, V23, P373, DOI 10.1016/j.intimp.2014.05.032; Switalla S, 2010, TOXICOL APPL PHARM, V246, P107, DOI 10.1016/j.taap.2010.04.010; Syed F, 2007, BIOMARKERS, V12, P414, DOI 10.1080/13547500701192652; Townley RG, 2003, CLIN REV ALLERG IMMU, V24, P85, DOI 10.1385/CRIAI:24:1:85; van Wetering S, 2007, MOL IMMUNOL, V44, P803, DOI 10.1016/j.molimm.2006.04.008; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2013, NEW ENGL J MED, V369, P1276, DOI 10.1056/NEJMc1309809; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wohlsen A, 2003, EUR RESPIR J, V21, P1024, DOI 10.1183/09031936.03.00027502; Wohlsen A, 2001, AM J RESP CRIT CARE, V163, P1462, DOI 10.1164/ajrccm.163.6.2007138; Yang M, 2001, AM J RESP CELL MOL, V25, P522, DOI 10.1165/ajrcmb.25.4.4620; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	57	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207767	10.1371/journal.pone.0207767	http://dx.doi.org/10.1371/journal.pone.0207767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500834	gold, Green Published			2022-12-26	WOS:000451883700014
J	Lin, JL; Zhang, T; Bai, C; Liang, JP; Ye, JP; Yao, ZJ				Lin, Jialing; Zhang, Ting; Bai, Chan; Liang, Jianping; Ye, Jiaping; Yao, Zhenjiang			School environmental contamination of methicillin-sensitive Staphylococcus aureus as an independent risk factor for nasal colonization in schoolchildren: An observational, cross-sectional study	PLOS ONE			English	Article							PRECLINICAL MEDICAL-STUDENTS; MOLECULAR CHARACTERISTICS; RESISTANT; CARRIAGE; SURFACES; PREVALENCE; HOUSEHOLDS; OBESITY	Objective We aim to assess the similarities of proportional, phenotypic, and molecular characteristics between the school environment and schoolchildren on methicillin-sensitive S. aureus (MSSA) isolates. Methods A cross-sectional study was conducted between March 2016 and August 2016 in eight elementary schools in Guangzhou, China. Nasal swabs from students and environmental swabs from school environments were collected. Univariate and multivariate logistic regression analyses under a multistage stratified cluster cross-sectional survey design were performed to access the prevalence relationship and influencing factors, respectively. Phenotypic and molecular characterizations of MSSA isolates were conducted using the Kirby-Bauer disk diffusion method and polymerase chain reaction assays, respectively. Results In total, 1705 schoolchildren and 1240 environmental samples from 40 classes in eight elementary schools obtained between March and August 2016 were include in this study. The rates of MSSA prevalence among schoolchildren and the environment were 11.44% (195/1705) and 4.60% (57/1240), respectively. The odds ratios and 95% confidence intervals (CIs) on the prevalence of MSSA isolates were 1.11 (95% CI, 1.05-1.29; P = 0.010) and 1.04 (95% CI, 1.01-1.07; P = 0.003) for the school or class environment and students, respectively. Similar phenotypic and molecular characteristics were identified between schoolchildren and the environment. A cause and effect relationship could not be established because the study design was cross-sectional. Conclusions Because of the cross-sectional design, we can reveal the association between school environment and schoolchildren on MSSA, but it is not a cause and effect relationship.	[Lin, Jialing; Zhang, Ting; Bai, Chan; Ye, Jiaping; Yao, Zhenjiang] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Guangzhou, Guangdong, Peoples R China; [Liang, Jianping] Guangzhou Primary & Secondary Sch Hlth Promot Ctr, Dept Hlth Educ, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University	Yao, ZJ (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Guangzhou, Guangdong, Peoples R China.	zhjyao2001@yahoo.com	yao, zhenjiang/N-7450-2016	yao, zhenjiang/0000-0002-2156-7896; Lin, Jialing/0000-0002-0643-9191	Guangdong Science and Technology Planning Project [2014A020213013]	Guangdong Science and Technology Planning Project	The work was supported by the Guangdong Science and Technology Planning Project (No. 2014A020213013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari Shamshul, 2016, BMC Res Notes, V9, P214, DOI 10.1186/s13104-016-2021-7; Ayeni FA, 2015, AFR HEALTH SCI, V15, P1282, DOI 10.4314/ahs.v15i4.30; Befus M, 2015, AM J EPIDEMIOL, V182, P494, DOI 10.1093/aje/kwv062; Chen YE, 2013, J AM ACAD DERMATOL, V69, P143, DOI 10.1016/j.jaad.2013.01.016; Conceicao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077812; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Esposito S, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0723-9; Frana TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053738; Fritz SA, 2014, JAMA PEDIATR, V168, P1030, DOI 10.1001/jamapediatrics.2014.1218; Garcia Stephen A, 2012, Clin Lab Sci, V25, P156; Gijon M, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.04.004; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kassem II, 2007, ISME J, V1, P265, DOI 10.1038/ismej.2007.36; Kejela T, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-11; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Knox J, 2016, JAMA INTERN MED, V176, P807, DOI 10.1001/jamainternmed.2016.1500; Knox J, 2015, TRENDS MICROBIOL, V23, P437, DOI 10.1016/j.tim.2015.03.007; Lin JL, 2017, LETT APPL MICROBIOL, V64, P131, DOI 10.1111/lam.12700; Lin JL, 2017, POL J MICROBIOL, V66, P439, DOI 10.5604/01.3001.0010.7038; Ma XX, 2011, DIAGN MICR INFEC DIS, V70, P22, DOI 10.1016/j.diagmicrobio.2010.12.004; Martinez-Ruiz FJ, 2014, J HOSP INFECT, V86, P216, DOI 10.1016/j.jhin.2013.12.007; Mbogori C., 2013, OPEN J MED MICROBIOL, V03, P248, DOI DOI 10.4236/0JMM.2013.34037; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Miko BA, 2013, INFECT CONT HOSP EP, V34, P540, DOI 10.1086/670218; Mirzaii M, 2015, J INFECT PUBLIC HEAL, V8, P202, DOI 10.1016/j.jiph.2014.09.002; Nowak JE, 2017, AM J INFECT CONTROL, V45, P29, DOI 10.1016/j.ajic.2016.07.013; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Petti S, 2015, AM J INFECT CONTROL, V43, pE89, DOI 10.1016/j.ajic.2015.08.008; Piechowicz L, 2011, FOLIA MICROBIOL, V56, P225, DOI 10.1007/s12223-011-0041-1; Roberts MC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00074; Roberts MC, 2011, AM J INFECT CONTROL, V39, P628, DOI 10.1016/j.ajic.2010.11.007; Shah M, 2011, J WOMENS HEALTH, V20, P1737, DOI 10.1089/jwh.2011.2888; Smyth DS, 2012, J INFECT DIS, V206, P1168, DOI 10.1093/infdis/jis483; Su Liting L J, 2011, J ZHONGKAI U AGR ENG, V24, P15; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11	39	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208183	10.1371/journal.pone.0208183	http://dx.doi.org/10.1371/journal.pone.0208183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500843	Green Submitted, gold, Green Published			2022-12-26	WOS:000451883700028
J	Biscarini, F; Palazzo, F; Castellani, F; Masetti, G; Grotta, L; Cichelli, A; Martino, G				Biscarini, Filippo; Palazzo, Fiorentina; Castellani, Federica; Masetti, Giulia; Grotta, Lisa; Cichelli, Angelo; Martino, Giuseppe			Rumen microbiome in dairy calves fed copper and grape-pomace dietary supplementations: Composition and predicted functional profile	PLOS ONE			English	Article							METHANE EMISSIONS; GENE; COMMUNITY; CAPACITY; NUMBER; CATTLE; PROTEIN; SAMPLE	The rumen microbiome is fundamental for the productivity and health of dairy cattle and diet is known to influence the rumen microbiota composition. In this study, grape-pomace, a natural source of polyphenols, and copper sulfate were provided as feed supplementation in 15 Holstein-Friesian calves, including 5 controls. After 75 days of supplementation, genomic DNA was extracted from the rumen liquor and prepared for 16S rRNA-gene sequencing to characterize the composition of the rumen microbiota. From this, the rumen metagenome was predicted to obtain the associated gene functions and metabolic pathways in a cost-effective manner. Results showed that feed supplementations did alter the rumen microbiome of calves. Copper and grape-pomace increased the diversity of the rumen microbiota: the Shannon's and Fisher's alpha indices were significantly different across groups (p-values 0.045 and 0.039), and Bray-Curtis distances could separate grape-pomace calves from the other two groups. Differentially abundant taxa were identified: in particular, an uncultured Bacteroidales UCG-001 genus and OTUs from genus Sarcina were the most differentially abundant in pomace-supplemented calves compared to controls (p-values 0.003 and 0.0002, respectively). Enriched taxonomies such as Ruminiclostridium and Eubacterium sp., whose functions are related to degradation of the grape-pomace constituents (e.g. flavonoids or xyloglucan) have been described (p-values 0.027/0.028 and 0.040/0.022 in Pomace vs Copper and Controls, respectively). The most abundant predicted metagenomic genes belonged to the arginine and proline metabolism and the two-component (sensor/responder) regulatory system, which were increased in the supplemented groups. Interestingly, the lipopolysaccharide biosynthetic pathway was decreased in the two supplemented groups, possibly as a result of antimicrobial effects. Methanogenic taxa also responded to the feed supplementation, and methane metabolism in the rumen was the second most different pathway (up-regulated by feed supplementations) between experimental groups.	[Biscarini, Filippo] CNR, IBBA, Milan, Italy; [Biscarini, Filippo; Masetti, Giulia] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Palazzo, Fiorentina; Castellani, Federica; Grotta, Lisa; Martino, Giuseppe] Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Teramo, Italy; [Masetti, Giulia] PTP Sci Pk, Bioinformat Unit, Lodi, Italy; [Cichelli, Angelo] Univ Gabriele dAnnunzio, Dept Med & Oral Sci & Biotechnol, Chieti, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Biotecnologia Agraria (IBBA-CNR); Cardiff University; University of Teramo; G d'Annunzio University of Chieti-Pescara	Martino, G (corresponding author), Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Teramo, Italy.	gmartino@unite.it	Biscarini, Filippo/H-3334-2019; Castellani, Federica/AAC-3118-2019; martino, Giuseppe/T-5579-2018	Biscarini, Filippo/0000-0002-3901-2354; martino, Giuseppe/0000-0002-7878-9318; Castellani, Federica/0000-0002-5722-2056; CICHELLI, Angelo/0000-0002-2987-5738; MASETTI, GIULIA/0000-0002-8513-2509	Rural Development Plan [DH26/40]; EU-FP7 project INDIGO [612116]	Rural Development Plan; EU-FP7 project INDIGO	This work is part of the project VINCARN ("Miglioramento delle carni bovine, suine e avicole attraverso l'utilizzo di sottoprodotti della filiera enologica per fini mangimistici") supported by a grant from the Rural Development Plan 2007 2013 - MISURA 1.2.4 - Regione Abruzzo - Italy DH26/40 (Project manager Prof. Giuseppe Martino). The authors are grateful to the company "Mario Maesa," Casoli (CH), Italy, for the kind cooperation. The work of FB and G. Masetti was supported by the EU-FP7 project INDIGO, in the framework of People Marie Sklodowska-Curie Actions, Marie Curie Industry-Academia Partnerships and Pathways (grant agreement number: 612116).; This work is part of the project VINCARN "Miglioramento delle carni bovine, suine e avicole attraverso l'utilizzo di sottoprodotti della filiera enologica per fini mangimistici" supported by a grant from the Rural Development Plan 2007-2013-MISURA 1.2.4-Regione Abruzzo-Italy (Project manager Prof. Giuseppe Martino). The authors are grateful to the company "Mario Maesa", Casoli (CH), Italy, for the kind cooperation. The work of FB and G. Masetti was supported by the EU-FP7 project INDIGO, in the framework of People Marie Sklodowska-Curie Actions, Marie Curie Industry-Academia Partnerships and Pathways (grant agreement number: 612116).	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrews S., 2010, FASTQC QUALITY CONTR; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Asshauer KP, 2013, ESTIMATION METABOLIC; Blaut M, 2003, INT J VITAM NUTR RES, V73, P79, DOI 10.1024/0300-9831.73.2.79; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chaucheyras-Durand F., 2014, Professional Animal Scientist, V30, P1; De Nardi R, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0653-4; Draman MS, 2016, EXPERT REV OPHTHALMO, V11, P273, DOI 10.1080/17469899.2016.1202113; Faulkner MJ, 2017, J DAIRY SCI, V100, P1037, DOI 10.3168/jds.2016-11680; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gao Y, 2016, CARBOHYD POLYM, V152, P510, DOI 10.1016/j.carbpol.2016.05.115; Golder HM, 2014, J DAIRY SCI, V97, P5763, DOI 10.3168/jds.2014-8049; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; John J. S, 2011, SEQPREP TOOL STRIPPI; Kafantaris I, 2017, J ANIM PHYSIOL AN N, V101, pe108, DOI 10.1111/jpn.12569; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kasparovska J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154642; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kim M, 2014, J MICROBIOL, V52, P355, DOI 10.1007/s12275-014-3443-3; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lima FS, 2015, APPL ENVIRON MICROB, V81, P1327, DOI 10.1128/AEM.03138-14; Long M, 2014, RES VET SCI, V96, P28, DOI 10.1016/j.rvsc.2013.11.013; Lu YR, 1999, FOOD CHEM, V65, P1, DOI 10.1016/S0308-8146(98)00245-3; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5; McCann JC, 2014, BIOINFORM BIOL INSIG, V8, P109, DOI 10.4137/BBI.S15389; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moate PJ, 2014, J DAIRY SCI, V97, P5073, DOI 10.3168/jds.2013-7588; Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808; Morgavi DP, 2013, ANIMAL, V7, P184, DOI 10.1017/S1751731112000419; Negussie E, 2017, J DAIRY SCI, V100, P2433, DOI 10.3168/jds.2016-12030; Nisbet DJ, 2009, CURR MICROBIOL, V58, P488, DOI 10.1007/s00284-008-9351-1; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Popova M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00937; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ravachol J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22770; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Spanghero M, 2009, ANIM FEED SCI TECH, V152, P243, DOI 10.1016/j.anifeedsci.2009.04.015; Tapio I, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0141-0; Team R, 2016, LANG ENV STAT COMP; Thoetkiattikul H, 2013, CURR MICROBIOL, V67, P130, DOI 10.1007/s00284-013-0336-3; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Z, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00159; Wickham H., 2009, ELEGANT GRAPHICS DAT, V35; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	62	26	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0205670	10.1371/journal.pone.0205670	http://dx.doi.org/10.1371/journal.pone.0205670			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496201	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800013
J	de Rooi, J; Norgaard, SK; Rasmussen, MA; Bonnelykke, K; Bisgaard, H; Smilde, AK				de Rooi, Johan; Norgaard, Sarah K.; Rasmussen, Morten A.; Bonnelykke, Klaus; Bisgaard, Hans; Smilde, Age K.			Data representations and -analyses of binary diary data in pursuit of stratifying children based on common childhood illnesses	PLOS ONE			English	Article								In this article we analyse diary reports concerning childhood symptoms of illness, these data are part of a larger study with other types of measurements on childhood asthma. The children are followed for three years and the diaries are updated, by the parents, on a daily basis. Here we focus on the methodological implications of analysing such data. We investigate two ways of representing the data and explore which tools are applicable given both representations. The first representation relies on proper alignment and point by point comparison of the signals. The second approach takes into account combinations of symptoms on a day by day basis and boils down to the analysis of counts. In the present case both methods are well applicable. However, more generally, when symptom episodes are occurring more at random locations in time, a point by point comparison becomes less applicable and shape based approaches will fail to come up with satisfactory results. In such cases, pattern based methods will be of much greater use. The pattern based representation focuses on reoccurring patterns and ignores ordering in time. With this representation we stratify the data on the level of years, so that possibly yearly differences can still be detected.	[de Rooi, Johan; Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal Grp, Amsterdam, Netherlands; [Norgaard, Sarah K.; Rasmussen, Morten A.; Bonnelykke, Klaus; Bisgaard, Hans] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Copenhagen, Denmark; [Rasmussen, Morten A.] Univ Copenhagen, Fac Sci, Dept Food Sci, Copenhagen, Denmark	University of Amsterdam; University of Copenhagen; University of Copenhagen	Smilde, AK (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal Grp, Amsterdam, Netherlands.	A.K.Smilde@uva.nl	Rasmussen, Morten/AAE-9517-2020; Bisgaard, Hans/N-4761-2016	Rasmussen, Morten/0000-0001-7431-5206; Bonnelykke, Klaus/0000-0003-2003-1018; Bisgaard, Hans/0000-0003-4131-7592; Smilde, Age/0000-0002-3052-4644				Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Bisgaard H, 2013, CLIN EXP ALLERGY, V43, P1384, DOI 10.1111/cea.12213; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V127, P1155, DOI 10.1016/j.jaci.2011.02.007; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bro R, 1997, CHEMOMETR INTELL LAB, V38, P149, DOI 10.1016/S0169-7439(97)00032-4; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Erosheva E, 2004, P NATL ACAD SCI USA, V101, P5220, DOI 10.1073/pnas.0307760101; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Grun B, 2011, J STAT SOFTW, V40, P1; Harshman R.A., 1970, WORKING PAPERS PHONE; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Keogh E.J., 2004, P 10 ACM SIGKDD INT, P206, DOI [10.1145/1014052.1014077, DOI 10.1145/1014052.1014077]; Kiers HAL, 2000, J CHEMOMETR, V14, P105, DOI 10.1002/1099-128X(200005/06)14:3<105::AID-CEM582>3.0.CO;2-I; Kroonenberg P.M., 2008, APPL MULTIWAY DATA A, V702; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lin J, 2007, DATA MIN KNOWL DISC, V15, P107, DOI 10.1007/s10618-007-0064-z; Little R., 2014, STAT ANAL MISSING DA, V2; McLachlan GJ, 2004, FINITE MIXTURE MODEL, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Novembre E, 2004, J ALLERGY CLIN IMMUN, V114, P851, DOI 10.1016/j.jaci.2004.07.012; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Smilde A., 2005, MULTIWAY ANAL APPL C; Srivastava A., 2009, TEXT MINING CLASSIFI; Team RC, 2014, R LANG ENV STAT COMP; Wallach Hanna M., 2009, P 26 INT C MACH LEAR, P1105, DOI DOI 10.1145/1553374.1553515	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207177	10.1371/journal.pone.0207177	http://dx.doi.org/10.1371/journal.pone.0207177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496197	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800025
J	Ikram, M; Ali, N; Jan, G; Jan, FG; Rahman, IU; Iqbal, A; Hamayun, M				Ikram, Muhammad; Ali, Niaz; Jan, Gui; Jan, Farzana Gul; Rahman, Inayat Ur; Iqbal, Amjad; Hamayun, Muhammad			IAA producing fungal endophyte Penicillium roqueforti Thom., enhances stress tolerance and nutrients uptake in wheat plants grown on heavy metal contaminated soils	PLOS ONE			English	Article							PHOSPHATE SOLUBILIZING FUNGI; ARBUSCULAR MYCORRHIZAL FUNGI; PROMOTING RHIZOBACTERIA; OXIDATIVE STRESS; RESISTANT; ZINC; PHYTOREMEDIATION; BIOAUGMENTATION; ALLEVIATION; GLUTATHIONE	Heavy metals contaminated soil is a serious environmental concern that has a negative impact on agriculture and ecosystem. Economical and efficient ways are needed to address this problem worldwide. In this regard, exploration and application of proficient microbial strains that can help the crop plants to thrive in agricultural soils that are greatly contaminated with heavy metals. The present study mainly focused on the effect of IAA producing endophytic fungi Penicillium ruqueforti Thom., on wheat plants cultivated in soil rich in heavy metals (Ni, Cd, Cu, Zn, and Pb). P. ruqueforti has induced great resistance in wheat inoculated plants grown in heavy metal contaminated soil. Application of the isolated strain of P. ruqueforti restricted the transfer of heavy metals from soil to the plants by secreting indole acetic acid (IAA). Furthermore, P. ruqueforti inoculated wheat seedlings watered with waste water had higher plant growth, nutrient uptake and low concentrations of heavy metals in shoot and roots. On the contrary, non-inoculated wheat plants under heavy metal stress had stunted growth with symptoms of chlorosis. From the results, it is concluded that P. ruqueforti inoculation can establish a symbiotic relationship with host plants, which is useful for phytostabilization of heavy metals or in other words helping the host crops to flourish through soil that are highly contaminated with heavy metals.	[Ikram, Muhammad; Ali, Niaz; Rahman, Inayat Ur] Hazara Univ, Dept Bot, Mansehra, Khyber Pakhtunk, Pakistan; [Jan, Gui; Jan, Farzana Gul; Hamayun, Muhammad] Abdul Wali Khan Univ Mardan, Dept Bot, Khyber Pakhtunkhwa, Pakistan; [Iqbal, Amjad] Abdul Wali Khan Univ Mardan, Dept Agr, Khyber Pakhtunkhwa, Pakistan	Hazara University	Ali, N (corresponding author), Hazara Univ, Dept Bot, Mansehra, Khyber Pakhtunk, Pakistan.	niazalitk25@gmail.com	Hamayun, Muhammad/B-1694-2010; Ali, Niaz/AAD-1367-2020; Iqbal, Amjad/E-2010-2014; Rahman, Inayat Ur/D-5420-2015	Hamayun, Muhammad/0000-0003-4264-5870; Ali, Niaz/0000-0003-3814-5531; Iqbal, Amjad/0000-0001-6141-8337; 				Abou-Shanab RAI, 2006, SOIL BIOL BIOCHEM, V38, P2882, DOI 10.1016/j.soilbio.2006.04.045; Ahmad N, 2010, J MICROBIOL BIOTECHN, V20, P1744, DOI 10.4014/jmb.1005.05018; Ali N, 2016, HEREDITY, V117, P114, DOI 10.1038/hdy.2016.36; Andrades-Moreno L, 2014, ENVIRON SCI POLLUT R, V21, P3713, DOI 10.1007/s11356-013-2364-8; Babu AG, 2011, WATER AIR SOIL POLL, V219, P3, DOI 10.1007/s11270-010-0679-3; Balkhair KS, 2016, SAUDI J BIOL SCI, V23, pS32, DOI 10.1016/j.sjbs.2015.09.023; Bashan Y., 2005, ENCY SOILS ENV, V1, P103, DOI DOI 10.1016/B0-12-348530-4/00513-0; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Brader G, 2014, CURR OPIN BIOTECH, V27, P30, DOI 10.1016/j.copbio.2013.09.012; Bradl H.B., 2005, HEAVY METALS ENV ORI; Cambrolle J, 2008, MAR POLLUT BULL, V56, P2037, DOI 10.1016/j.marpolbul.2008.08.008; Cardoso Patrícia Felippe, 2005, Braz. J. Plant Physiol., V17, P267, DOI 10.1590/S1677-04202005000200010; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Cavagnaro TR, 2008, PLANT SOIL, V304, P315, DOI 10.1007/s11104-008-9559-7; CERVANTESVEGA C, 1986, MICROBIOS, V48, P159; Chandrasekaran M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01246; Chen BD, 2007, ENVIRON POLLUT, V147, P374, DOI 10.1016/j.envpol.2006.04.027; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Cheplick GP, 2004, AM J BOT, V91, P1960, DOI 10.3732/ajb.91.12.1960; Corticeiro SC, 2006, ENZYME MICROB TECH, V40, P132, DOI 10.1016/j.enzmictec.2005.10.053; Cui YJ, 2005, ENVIRON INT, V31, P784, DOI 10.1016/j.envint.2005.05.025; Dermont G, 2008, J HAZARD MATER, V152, P1, DOI 10.1016/j.jhazmat.2007.10.043; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUXBURY AC, 1956, J MAR RES, V15, P92; El Aafi N, 2012, INT J PHYTOREMEDIAT, V14, P261, DOI 10.1080/15226514.2011.604693; Elhindi KM, 2017, SAUDI J BIOL SCI, V24, P170, DOI 10.1016/j.sjbs.2016.02.010; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; GARGAS A, 1992, MYCOLOGIA, V84, P589, DOI 10.2307/3760327; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Goel A, 2003, BIOL PLANTARUM, V46, P429, DOI 10.1023/A:1024398724076; GORIN N, 1976, J AGR FOOD CHEM, V24, P200, DOI 10.1021/jf60203a043; Hamayun M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00686; Hamayun M, 2010, J MICROBIOL BIOTECHN, V20, P202, DOI 10.4014/jmb.0905.05040; Kabata-Pendias Alina, 2010, P1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-86; Khan Mohammad Saghir, 2010, Archives of Agronomy and Soil Science, V56, P73, DOI 10.1080/03650340902806469; Khan MS, 2009, ENVIRON CHEM LETT, V7, P1, DOI 10.1007/s10311-008-0155-0; Khan S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-147; Khan Z., 2011, Current Topics in Plant Biology, Volume 12, P97; Kidd P, 2009, ENVIRON EXP BOT, V67, P243, DOI 10.1016/j.envexpbot.2009.06.013; Kuffner M, 2010, J APPL MICROBIOL, V108, P1471, DOI 10.1111/j.1365-2672.2010.04670.x; Kumar A, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0393-y; Lebeau T, 2008, ENVIRON POLLUT, V153, P497, DOI 10.1016/j.envpol.2007.09.015; Liu WH, 2005, ENVIRON INT, V31, P805, DOI 10.1016/j.envint.2005.05.042; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo SL, 2011, CHEMOSPHERE, V85, P1130, DOI 10.1016/j.chemosphere.2011.07.053; Ma YH, 2016, INT CONF ADV COMMUN, P7, DOI 10.1109/ICACT.2016.7423252; Mateos-Naranjo E, 2008, PLANT BIOLOGY, V10, P754, DOI 10.1111/j.1438-8677.2008.00098.x; Mei Chuansheng, 2010, Recent Pat Biotechnol, V4, P81, DOI 10.2174/187220810790069523; Mesa J, 2015, MAR POLLUT BULL, V90, P150, DOI 10.1016/j.marpolbul.2014.11.002; Mesa J, 2015, J HAZARD MATER, V300, P263, DOI 10.1016/j.jhazmat.2015.07.006; Miransari M, 2011, BIOTECHNOL ADV, V29, P645, DOI 10.1016/j.biotechadv.2011.04.006; Mujeeb-Kazi A., 2017, Plant Tissue Culture & Biotechnology, V27, P89; Nagamani A., 2006, HDB SOIL FUNGI; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Orlowska E, 2011, ENVIRON POLLUT, V159, P3730, DOI 10.1016/j.envpol.2011.07.008; Oses R, 2008, FUNGAL DIVERS, V33, P77; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Redondo-Gomez S, 2013, FUNCT PLANT BIOL, V40, P913, DOI 10.1071/FP12271; Rizvi A, 2017, CHEMOSPHERE, V185, P942, DOI 10.1016/j.chemosphere.2017.07.088; Ryan J., 2007, SOIL PLANT ANAL LAB; Schulz B, 1998, ENDOPHYTE HOST INTER; Thounaojam TC, 2012, PLANT PHYSIOL BIOCH, V53, P33, DOI 10.1016/j.plaphy.2012.01.006; Turkdogan MK, 2003, ENVIRON TOXICOL PHAR, V13, P175, DOI 10.1016/S1382-6689(02)00156-4; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; Vandenbussche F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-65; Vieira C, 2011, FOOD CHEM TOXICOL, V49, P923, DOI 10.1016/j.fct.2010.12.016; Wang Q, 2011, J APPL MICROBIOL, V111, P1065, DOI 10.1111/j.1365-2672.2011.05142.x; Wenzel WW, 2009, PLANT SOIL, V321, P385, DOI 10.1007/s11104-008-9686-1; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang Q, 2012, INT J PHYTOREMEDIAT, V14, P89, DOI 10.1080/15226510903567471; Zahoor M, 2017, ECOTOX ENVIRON SAFE, V142, P139, DOI 10.1016/j.ecoenv.2017.04.005; Zarei M, 2008, ENVIRON POLLUT, V156, P1277, DOI 10.1016/j.envpol.2008.03.006	80	71	76	11	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208150	10.1371/journal.pone.0208150	http://dx.doi.org/10.1371/journal.pone.0208150			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496253	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800102
J	Kao, PC; Srivastava, S				Kao, Pei-Chun; Srivastava, Shraddha			Mediolateral footpath stabilization during walking in people following stroke	PLOS ONE			English	Article							JOINT COORDINATION; GAIT; STABILITY; BALANCE	Community dwelling stroke survivors most often fall while walking. Understanding how post-stroke individuals control mediolateral footpath during walking may help elucidate the mechanisms that contribute to walking instability. By applying the Uncontrolled Manifold (UCM) approach, we investigated (1) how post-stroke individuals coordinate lower-extremity joint motions to stabilize mediolateral footpath of the swing leg, and (2) how the inter-joint coordination in footpath stabilization correlates to their walking stability. Nine stroke subjects and nine healthy controls walked on a treadmill at four different speeds. UCM analysis partitions the variance of kinematic configurations across gait cycles into "good variance" (i.e., the variance component leading to a consistent footpath) or "bad variance" (i.e., the variance component leading to an inconsistent footpath). We found that both groups had a significantly greater "good" than "bad" variance (p<0.05) for most of the swing phase, suggesting that mediolateral footpath is an important variable stabilized by the central nervous system during walking. Stroke subjects had significantly greater relative variance difference (Delta V) (i.e. normalized difference between "good" and "bad" variance) (p<0.05), indicating a stronger kinematic synergy in footpath stabilization, than the controls. In addition, the kinematic synergy in mediolateral footpath stabilization is strongest during mid-swing but weakest during late swing in healthy gait. However, this phase-dependent strategy is preserved for mid-swing but not for late swing in stroke gait. Moreover, stroke and healthy subjects demonstrated different relationships between UCM and walking stability measures. A stronger kinematic synergy in healthy gait is associated with better walking stability whereas having more "good variance" or stronger kinematic synergy in stroke gait is associated with less walking stability. The current findings suggest that walking with too much "good variance" in people following stroke, despite no effect on the footpath, may adversely affect their walking stability to some extent.	[Kao, Pei-Chun] Univ Massachusetts, Dept Phys Therapy, Lowell, MA 01854 USA; [Srivastava, Shraddha] Med Univ South Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA	University of Massachusetts System; University of Massachusetts Lowell; Medical University of South Carolina	Kao, PC (corresponding author), Univ Massachusetts, Dept Phys Therapy, Lowell, MA 01854 USA.	PeiChun_Kao@uml.edu		Kao, Pei-Chun/0000-0001-8603-3898				Asaka T, 2008, EXP BRAIN RES, V184, P323, DOI 10.1007/s00221-007-1101-2; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Balasubramanian CK, 2010, CLIN BIOMECH, V25, P483, DOI 10.1016/j.clinbiomech.2010.02.003; Balasubramanian CK, 2009, GAIT POSTURE, V29, P408, DOI 10.1016/j.gaitpost.2008.10.061; Batchelor FA, 2012, INT J STROKE, V7, P482, DOI 10.1111/j.1747-4949.2012.00796.x; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Black DP, 2007, EXP BRAIN RES, V183, P511, DOI 10.1007/s00221-007-1066-1; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; De Bujanda Eva, 2004, J Stroke Cerebrovasc Dis, V13, P58; de Freitas SMSF, 2007, NEUROSCI LETT, V417, P66, DOI 10.1016/j.neulet.2007.02.037; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Ellis RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141694; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; Kao PC, 2014, GAIT POSTURE, V40, P457, DOI 10.1016/j.gaitpost.2014.05.014; Krishnamoorthy V, 2005, EXP BRAIN RES, V164, P1, DOI 10.1007/s00221-004-2205-6; Krishnan V, 2013, GAIT POSTURE, V38, P923, DOI 10.1016/j.gaitpost.2013.04.023; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Lamontagne A, 2007, CLIN NEUROPHYSIOL, V118, P717, DOI 10.1016/j.clinph.2006.12.013; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Milanese C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192046; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; Papi E, 2015, J BIOMECH, V48, P324, DOI 10.1016/j.jbiomech.2014.11.024; Rankin BL, 2014, J NEUROPHYSIOL, V112, P374, DOI 10.1152/jn.00138.2014; Reisman DS, 2003, BRAIN, V126, P2510, DOI 10.1093/brain/awg246; Robert T, 2009, EXP BRAIN RES, V197, P185, DOI 10.1007/s00221-009-1904-4; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Srivastava S, 2016, EXP BRAIN RES, V234, P1903, DOI 10.1007/s00221-016-4593-9; Verrel J, 2010, EXP BRAIN RES, V207, P13, DOI 10.1007/s00221-010-2424-y; WINTER DA, 1992, PHYS THER, V72, P45, DOI 10.1093/ptj/72.1.45; Wu YH, 2014, EXERC SPORT SCI REV, V42, P37, DOI 10.1249/JES.0000000000000002; Wu YH, 2013, EXP BRAIN RES, V226, P273, DOI 10.1007/s00221-013-3433-4; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027; Young PMM, 2012, GAIT POSTURE, V35, P472, DOI 10.1016/j.gaitpost.2011.11.010; Zeni JA, 2010, CLIN BIOMECH, V25, P383, DOI 10.1016/j.clinbiomech.2009.11.002	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208120	10.1371/journal.pone.0208120	http://dx.doi.org/10.1371/journal.pone.0208120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496257	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800095
J	Lovsletten, NG; Bakke, SS; Kase, ET; Ouwens, DM; Thoresen, GH; Rustan, AC				Lovsletten, Nils G.; Bakke, Siril S.; Kase, Eili T.; Ouwens, D. Margriet; Thoresen, G. Hege; Rustan, Arild C.			Increased triacylglycerol - Fatty acid substrate cycling in human skeletal muscle cells exposed to eicosapentaenoic acid	PLOS ONE			English	Article							GLUCOSE-UPTAKE; TRIGLYCERIDE; METABOLISM; MITOCHONDRIAL; OXIDATION; LIPOLYSIS; OBESITY; LIPASE; BIOENERGETICS; HEALTH	It has previously been shown that pretreatment of differentiated human skeletal muscle cells (myotubes) with eicosapentaenoic acid (EPA) promoted increased uptake of fatty acids and increased triacylglycerol accumulation, compared to pretreatment with oleic acid (OA) and palmitic acid (PA). The aim of the present study was to examine whether EPA could affect substrate cycling in human skeletal muscle cells by altering lipolysis rate of intracellular TAG and re-esterification of fatty acids. Fatty acid metabolism was studied in human myotubes using a mixture of fatty acids, consisting of radiolabelled oleic acid as tracer (C-14-OA) together with EPA or PA. Co-incubation of myotubes with EPA increased cell-accumulation and incomplete fatty acid oxidation of C-14-OA compared to co-incubation with PA. Lipid distribution showed higher incorporation of C-14-OA into all cellular lipids after co-incubation with EPA relative to PA, with most markedly increases (3 to 4-fold) for diacylglycerol and triacylglycerol. Further, the increases in cellular lipids after co-incubation with EPA were accompanied by higher lipolysis and fatty acid re-esterification rate. Correspondingly, basal respiration, proton leak and maximal respiration were significantly increased in cells exposed to EPA compared to PA. Microarray and Gene Ontology (GO) enrichment analysis showed that EPA, related to PA, significantly changed i.e. the GO terms "Neutral lipid metabolic process" and "Regulation of lipid storage". Finally, an inhibitor of diacylglycerol acyltransferase 1 decreased the effect of EPA to promote fatty acid accumulation. In conclusion, incubation of human myotubes with EPA, compared to PA, increased processes of fatty acid turnover and oxidation suggesting that EPA may activate futile substrate cycling of fatty acids in human myotubes. Increased TAG-FA cycling may be involved in the potentially favourable effects of long-chain polyunsaturated n-3 fatty acids on skeletal muscle and whole-body energy metabolism.	[Lovsletten, Nils G.; Kase, Eili T.; Thoresen, G. Hege; Rustan, Arild C.] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Bakke, Siril S.] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Trondheim, Norway; [Bakke, Siril S.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway; [Ouwens, D. Margriet] Heinrich Heine Univ, Med Fac, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Ouwens, D. Margriet] German Ctr Diabet Res DZD, Munich, Germany; [Ouwens, D. Margriet] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium; [Thoresen, G. Hege] Univ Oslo, Inst Clin Med, Dept Pharmacol, Oslo, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ghent University; Ghent University Hospital; University of Oslo	Lovsletten, NG (corresponding author), Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway.	n.g.lovsletten@farmasi.uio.no	Løvsletten, Nils Gunnar/AAC-6346-2020; Ouwens, Margriet/H-2442-2013	Løvsletten, Nils Gunnar/0000-0001-5940-6644; Ouwens, Margriet/0000-0001-6709-2702	Anders Jahres Fond til Vitenskapens Fremme (NO); Diabetesforbundet; Norges Forskningsrad	Anders Jahres Fond til Vitenskapens Fremme (NO); Diabetesforbundet; Norges Forskningsrad	The work was supported by Anders Jahres Fond til Vitenskapens Fremme (NO), Diabetesforbundet, and Norges Forskningsrad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas V, 2006, J LIPID RES, V47, P366, DOI 10.1194/jlr.M500300-JLR200; Badin PM, 2012, J LIPID RES, V53, P839, DOI 10.1194/jlr.M019182; Bakke SS, 2012, BBA-MOL CELL BIOL L, V1821, P1323, DOI 10.1016/j.bbalip.2012.07.001; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley JD, 2010, NUTRIENTS, V2, P1212, DOI 10.3390/nu2121212; Burdge GC, 2015, WORLD REV NUTR DIET, V112, P1, DOI 10.1159/000365423; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; HAMMOND VA, 1987, METABOLISM, V36, P308, DOI 10.1016/0026-0495(87)90199-5; Herbst EAF, 2014, J PHYSIOL-LONDON, V592, P1341, DOI 10.1113/jphysiol.2013.267336; Hessvik NP, 2010, J LIPID RES, V51, P2090, DOI 10.1194/jlr.M003319; Howe P, 2014, MIL MED, V179, P138, DOI 10.7205/MILMED-D-14-00154; Huang CW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101689; Janovska P, 2013, PHYSIOL RES, V62, P153, DOI 10.33549/physiolres.932464; Jeromson S, 2018, AM J PHYSIOL-ENDOC M, V314, pE605, DOI 10.1152/ajpendo.00438.2015; Johnson ML, 2015, AGING CELL, V14, P734, DOI 10.1111/acel.12352; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210; Lalia AZ, 2015, DIABETES CARE, V38, P1228, DOI 10.2337/dc14-3101; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Mazzucotelli A, 2007, DIABETES, V56, P2467, DOI 10.2337/db06-1465; Newsholme E A, 1976, Biochem Soc Symp, P61; Periasamy M, 2017, DIABETES METAB J, V41, P327, DOI 10.4093/dmj.2017.41.5.327; Philp LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117494; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; SKREDE S, 1994, J LIPID RES, V35, P1395; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043; WOLFE RR, 1990, AM J PHYSIOL, V258, pE382, DOI 10.1152/ajpendo.1990.258.2.E382; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	41	13	13	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208048	10.1371/journal.pone.0208048	http://dx.doi.org/10.1371/journal.pone.0208048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496314	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800085
J	Valt, C; Huber, D; Erhardt, I; Sturmer, B				Valt, Christian; Huber, Dorothea; Erhardt, Ingrid; Stuermer, Birgit			Internal and external signal processing in patients with panic disorder: An event-related potential (ERP) study	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ERROR-RELATED NEGATIVITY; SELF-FOCUSED ATTENTION; FEEDBACK NEGATIVITY; REDUCED SENSITIVITY; REWARD PREDICTION; BRAIN ACTIVITY; NEURAL SYSTEM; TIME-COURSE; ANXIETY	Self-absorption describes a pathological tendency towards the internal mental world (internalization) that often conflicts with the accurate monitoring of the external world. In performance monitoring, an augmented electrophysiological response evoked by internal signals in patients with anxiety or depressive disorder seems to reflect this tendency. Specifically, the error-related negativity (Ne/ERN), an index of error processing based on internal signals, is larger in patients compared to controls. In the present experiment, we investigated whether the preferential processing of internal signals in patients is linked to diminished and inflexible external signal processing. To this end, the electrophysiological response evoked by external signals was analysed in patients with panic disorder and healthy controls. Participants performed a choice-response task, where informative or uninformative feedback followed each response, and a passive viewing task. As a replication of previous studies, patients presented an augmented Ne/ERN, indexing enhanced processing of internal signals related to errors. Furthermore, the vertex positive potential (VPP) evoked by visual stimuli was larger in patients than in controls, suggesting enhanced attention to external signals. Moreover, patients and controls showed similar sensitivity to the feedback information content, indicating a normal flexibility in the allocation of monitoring resources to external signals depending on how informative these signals are for performance monitoring. These results suggest that the tendency towards internal signals in patients with panic disorder does not hinder the flexible processing of external signals. On the contrary, external signals seem to attract enhanced processing in patients compared to controls.	[Valt, Christian; Huber, Dorothea; Stuermer, Birgit] Int Psychoanalyt Univ Berlin, Berlin, Germany; [Huber, Dorothea; Erhardt, Ingrid] Klinikum Munchen, Dept Psychosomat Med & Psychotherapy, Munich, Germany		Valt, C (corresponding author), Int Psychoanalyt Univ Berlin, Berlin, Germany.	christian.valt@ipu-berlin.de			Deutsche Forschungsgemeinschaft [STU 248/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by funding of the Deutsche Forschungsgemeinschaft (STU 248/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts K, 2012, NEUROPSYCHOLOGIA, V50, P1286, DOI 10.1016/j.neuropsychologia.2012.02.012; Barsaglini A, 2014, PROG NEUROBIOL, V114, P1, DOI 10.1016/j.pneurobio.2013.10.006; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Benecke C, 2016, Z PSYCHOSOM MED PSYC, V62, P252, DOI 10.13109/zptm.2016.62.3.252; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bress JN, 2012, BIOL PSYCHOL, V89, P156, DOI 10.1016/j.biopsycho.2011.10.004; Burkhouse KL, 2017, J AFFECT DISORDERS, V217, P73, DOI 10.1016/j.jad.2017.03.061; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Endrass T, 2014, NEUROSCI BIOBEHAV R, V46, P124, DOI 10.1016/j.neubiorev.2014.03.024; Endrass T, 2013, J ABNORM PSYCHOL, V122, P387, DOI 10.1037/a0031496; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Fisher JE, 2010, EMOTION, V10, P486, DOI 10.1037/a0018691; Foti D, 2014, NEUROIMAGE, V101, P50, DOI 10.1016/j.neuroimage.2014.06.058; Foti D, 2009, BIOL PSYCHOL, V81, P1, DOI 10.1016/j.biopsycho.2008.12.004; Fukushima H, 2009, SOC NEUROSCI-UK, V4, P261, DOI 10.1080/17470910802625009; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gibbons H, 2016, J COGNITIVE NEUROSCI, V28, P542, DOI 10.1162/jocn_a_00921; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; Grundler TOJ, 2009, NEUROPSYCHOLOGIA, V47, P1978, DOI 10.1016/j.neuropsychologia.2009.03.010; Gu RL, 2010, BIOL PSYCHOL, V85, P200, DOI 10.1016/j.biopsycho.2010.07.001; Gu RL, 2010, PSYCHOPHYSIOLOGY, V47, P961, DOI 10.1111/j.1469-8986.2010.00997.x; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2008, AM J PSYCHIAT, V165, P116, DOI 10.1176/appi.ajp.2007.07010143; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Hautzinger M, 1994, BECK DEPRESSIONS INV; Heldmann M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-33; Henriques JB, 2000, COGNITION EMOTION, V14, P711, DOI 10.1080/02699930050117684; Hildebrandt A, 2013, PSYCHOL AGING, V28, P243, DOI 10.1037/a0031490; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; INGRAM RE, 1990, PSYCHOL BULL, V107, P156, DOI 10.1037/0033-2909.107.2.156; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Koban L, 2014, NEUROSCI BIOBEHAV R, V46, P71, DOI 10.1016/j.neubiorev.2014.02.014; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Kujawa A, 2016, PROG NEURO-PSYCHOPH, V71, P162, DOI 10.1016/j.pnpbp.2016.07.010; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Laux L., 1981, STATE TRAIT ANGSTINV; Li P, 2015, BRAIN COGNITION, V100, P15, DOI 10.1016/j.bandc.2015.08.004; Liu WH, 2014, NEUROPSYCHOLOGIA, V53, P213, DOI 10.1016/j.neuropsychologia.2013.11.023; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mies GW, 2011, PSYCHOL MED, V41, P2515, DOI 10.1017/S0033291711000778; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moran TP, 2017, INT J PSYCHOPHYSIOL, V111, P17, DOI 10.1016/j.ijpsycho.2016.07.001; Moser JS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00466; Mueller EM, 2015, DEPRESS ANXIETY, V32, P296, DOI 10.1002/da.22338; Nieuwenhuis S, 2005, PSYCHIAT RES, V134, P111, DOI 10.1016/j.psychres.2005.02.005; O'Toole SAL, 2012, BIOL PSYCHOL, V91, P221, DOI 10.1016/j.biopsycho.2012.06.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olvet DM, 2009, COGN AFFECT BEHAV NE, V9, P427, DOI 10.3758/CABN.9.4.427; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Pauli P, 2005, INT J PSYCHOPHYSIOL, V57, P33, DOI 10.1016/j.ijpsycho.2005.01.009; Paulus MP, 2010, BRAIN STRUCT FUNCT, V214, P451, DOI 10.1007/s00429-010-0258-9; Riesel A, 2015, AM J PSYCHIAT, V172, P665, DOI 10.1176/appi.ajp.2014.14070886; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Santesso DL, 2008, NEUROREPORT, V19, P1045, DOI 10.1097/WNR.0b013e3283036e73; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; Spielberger C. D., 1983, MIND GARDEN; Stahl J, 2010, INT J PSYCHOPHYSIOL, V77, P43, DOI 10.1016/j.ijpsycho.2010.04.005; Stober J., 1995, Z DIFF DIAGN PSYCHOL, V16, P50; Tucker DM, 2003, J ABNORM PSYCHOL, V112, P667, DOI 10.1037/0021-843X.112.4.667; Ullsperger M, 2014, TRENDS COGN SCI, V18, P259, DOI 10.1016/j.tics.2014.02.009; Valt C, PSYCHOPHYSIOLOGY; Valt C, 2017, ADV COGN PSYCHOL, V13, P190, DOI 10.5709/acp-0219-5; Valt C, 2017, INT J PSYCHOPHYSIOL, V117, P26, DOI 10.1016/j.ijpsycho.2017.04.005; Weinberg A, 2017, CLIN PSYCHOL SCI, V5, P14, DOI 10.1177/2167702616633158; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Woodruff-Borden J, 2001, BEHAV COGN PSYCHOTH, V29, P169, DOI 10.1017/S1352465801002041; Zhu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090874	73	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208257	10.1371/journal.pone.0208257	http://dx.doi.org/10.1371/journal.pone.0208257			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496321	Green Submitted, gold, Green Published			2022-12-26	WOS:000451763800118
J	Khoza, MN; Delany-Moretlwe, S; Scorgie, F; Hove, J; Selin, A; Imrie, J; Twine, R; Kahn, K; Pettifor, A; MacPhail, C				Khoza, Makhosazane Nomhle; Delany-Moretlwe, Sinead; Scorgie, Fiona; Hove, Jennifer; Selin, Amanda; Imrie, John; Twine, Rhian; Kahn, Kathleen; Pettifor, Audrey; MacPhail, Catherine			Men's perspectives on the impact of female-directed cash transfers on gender relations: Findings from the HPTN 068 qualitative study	PLOS ONE			English	Article							HIV-INFECTION; PREVENTION; AFRICA; WOMEN; RISK; PREVALENCE; PROGRAM; HEALTH; POWER; BOYS	Background HIV is an inherently gendered disease in eastern and southern Africa, not only because more women than men are infected, but also because socially constructed gender norms work to increase women's HIV-infection risk. The provision of cash transfers to young women alone in such a context adds another dimension to already existing complex social relations where patriarchal values are entrenched, gender inequality is the norm, and violence against women and girls is pervasive. It raises concerns about complicating young women's relationships with their male partners or possibly even setting them up for more violence. In our attempt to understand how cash transfers influence social relations in the context of a trial among young women in South Africa, we used qualitative data collected during the trial to explore men's perceptions of the impact of cash transfers on male-female relationships, both intimate and platonic, peer relationships. Method Between April 2012 and August 2015, we conducted focus group discussions (n = 12) and interviews (n = 20) with the male peers and intimate partners of young women aged 13-20 years, who were participating in a phase III randomised controlled trial of CTs for HIV prevention in Mpumalanga, South Africa. A thematic content analysis approach was used to analyse the data. The codebook was developed on the basis of the topic guides, with additional codes added inductively as they emerged from the data. Results Intimate partners were older (range 20-32 years) and more likely to be working than the male peers. Both intimate partners and male peers were supportive of the CT trial targeting young women; younger peers however expressed some concerns that the money might diminish their power and status in relationships. HIV testing requirements associated with the trial appeared to have improved communication about sex and HIV in intimate relationships, with some women even encouraging their partners to go for an HIV test. Conclusion CTs provide AGYW with a measure of autonomy and power to contribute in their gendered relationships, albeit in limited ways. However, there is potential for CTs to have a negative impact on male-female relationships if the cash received by AGYW is equal to or greater than the income earned by their male counterparts or sexual partners.	[Khoza, Makhosazane Nomhle; Delany-Moretlwe, Sinead; Scorgie, Fiona; Imrie, John; MacPhail, Catherine] Univ Witwatersrand, Fac Hlth Sci, Wits RHI, Johannesburg, South Africa; [Hove, Jennifer; Twine, Rhian; Kahn, Kathleen; Pettifor, Audrey; MacPhail, Catherine] Univ Witwatersrand, Fac Hlth Sci, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Johannesburg, South Africa; [Selin, Amanda; Pettifor, Audrey] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Pettifor, Audrey] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [MacPhail, Catherine] Univ Wollongong, Sch Hlth & Soc, Wollongong, NSW, Australia	University of Witwatersrand; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Wollongong	Khoza, MN (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Wits RHI, Johannesburg, South Africa.	nkhoza@wrhi.ac.za	Ndimande-Khoza, Makhosazane Nomhle/ADP-8797-2022; MacPhail, Catherine/N-4234-2014	MacPhail, Catherine/0000-0002-0614-0157; Scorgie, Fiona/0000-0003-2560-8234; Kahn, Kathleen/0000-0003-3339-3931; Twine, Rhian/0000-0002-0766-6556; Pettifor, Audrey/0000-0002-3387-0817	National Institute of Allergy and Infectious Diseases [UM1 AI068619, UM1AI068617, UM1AI068613]; National Institute of Mental Health; National Institute on Drug Abuse of the National Institutes of Health; NIMH [R01MH087118]; Carolina Population Center; NIH Center grant [P2C HD050924]; Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK) [087547/Z/08/Z]; Carnegie Corporation of the New York [B8606.R02]; Sida [54100029]; UKaid from the Department for International Development (DfID) through the STRIVE Research Programme Consortium [Po 5244]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068613, UM1AI068619, UM1AI069423, UM1AI068617] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Carolina Population Center; NIH Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK)(Wellcome Trust); Carnegie Corporation of the New York; Sida; UKaid from the Department for International Development (DfID) through the STRIVE Research Programme Consortium; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by award numbers UM1 AI068619 to KK (HPTN Leadership and Operations Center), UM1AI068617 to AP (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center) from the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health and the National Institute on Drug Abuse of the National Institutes of Health. This work was also supported by NIMH R01 (R01MH087118 to CM) and the Carolina Population Center and its NIH Center grant (P2C HD050924). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The analysis and write-up of this research was also supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Wellcome Trust (UK) (Grant No: 087547/Z/08/Z to MNK), the Carnegie Corporation of the New York (Grant No-B8606.R02 to MNK, Sida (Grant No: 54100029). MNK, FS and SD were also supported in part by UKaid from the Department for International Development (DfID) through the STRIVE Research Programme Consortium (Ref: Po 5244). However, the statements made and views expressed do not necessarily reflect the department's official policies; they are solely the responsibility of the fellow.	Abdool Karim Q., 2015, 8 IAS C HIV PATH TRE; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Bhatia DS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00188; Brady C., 2011, WALKING TALK CASH TR; Buller AM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3129-3; Cluver LD, 2016, J INT AIDS SOC, V19; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dworkin SL, 2012, GENDER SOC, V26, P97, DOI 10.1177/0891243211426425; Dworkin SL, 2009, AIDS BEHAV, V13, P462, DOI 10.1007/s10461-009-9532-3; Fiszbein A, 2009, CONDITIONAL CASH TRA; Garcia M, 2012, DIR DEV, P1, DOI 10.1596/978-0-8213-8897-6; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Heise L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18615; Hunter M., 2003, MASCULINITIES MULTIP; Hunter Mark., 2010, LOVE TIME AIDS INEQU; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kilburn K, 2017, J INT AIDS SOC; Klein C, 2002, BEYOND CONDOMS: ALTERNATIVE APPROACHES TO HIV PREVENTION, P17; Kohler HP, 2011, WORLD BANK ECON REV; Lee R, 2014, AIDS BEHAV, V18, P905, DOI 10.1007/s10461-013-0588-8; MacPhail C, 2015, QUALITATIVE RES; MacPhail C, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4513-3; Molyneux Maxine., 2009, CONDITIONAL CASH TRA; Morrell R, 1998, J S AFR STUD, V24, P605, DOI 10.1080/03057079808708593; Moyo W, 2008, AIDS BEHAV, V12, P431, DOI 10.1007/s10461-007-9343-3; Nglazi MD, 2012, JAIDS-J ACQ IMM DEF, V59, pE28, DOI 10.1097/QAI.0b013e31824445f0; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pettifor A, 2016, LANCET GLOB HEALTH, V4, pE978, DOI [10.1016/S2214-109X(16)30253-4, 10.1016/s2214-109x(16)30253-4]; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Shannon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028739; UNDP, 2014, CASH TRANSF HIV PREV; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Yotebieng M, 2016, LANCET HIV, V3, pE85, DOI 10.1016/S2352-3018(15)00247-7	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207654	10.1371/journal.pone.0207654	http://dx.doi.org/10.1371/journal.pone.0207654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475851	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700050
J	Nobre, T; Gomes, L; Rei, FT				Nobre, Tania; Gomes, Luis; Rei, Fernando Trindade			Uncovered variability in olive moth (Prays oleae) questions species monophyly	PLOS ONE			English	Article							DNA; BIODIVERSITY; LEPIDOPTERA; HYMENOPTERA; COMPLEX; LOSSES; CROP	The olive moth -Prays oleae Bern.-remains a significant pest of olive trees showing situation dependent changes in population densities and in severity of damages. The genetic variability of olive moth was assessed on three main olive orchards regions in Portugal by three different markers (COI, nad5 and RpS5), suggesting high species diversity albeit with no obvious relation with a regional pattern nor to an identified ecological niche. Selected COI sequences obtained in this study were combined with those available in the databases for Prays genus to generate a global dataset. The reconstruction of the Prays phylogeny based on this marker revealed the need to revise Prays oleae to confirm its status of single species: COI data suggests the co-existence of two sympatric evolutionary lineages of morphologically cryptic olive moth. We show, however, that the distinct mitochondrial subdivision observed in the partial COI gene fragment is not corroborated by the other DNA sequences. There is the need of understanding this paradigm and the extent of Prays variability, as the disclosure of lineage-specific differences in biological traits between the identified lineages is fundamental for the development of appropriate pest management practices.	[Nobre, Tania; Gomes, Luis; Rei, Fernando Trindade] Univ Evora, ICAAM, Entomol Lab, Evora, Portugal	University of Evora	Nobre, T (corresponding author), Univ Evora, ICAAM, Entomol Lab, Evora, Portugal.	tnobre@uevora.pt	Nobre, Tania/C-9925-2012	Nobre, Tania/0000-0002-1855-7451; Gomes, Luis/0000-0003-1997-182X; Rei, Fernando/0000-0001-7830-829X	project 'Integrated protection of the Alentejo olive grove; European Union through the European Regional Development Fund, under the ALENTEJO 2020 (Regional Operational Program of the Alentejo) [ALT20-03-0145-FEDER-000029]	project 'Integrated protection of the Alentejo olive grove; European Union through the European Regional Development Fund, under the ALENTEJO 2020 (Regional Operational Program of the Alentejo)	This work, including TN and LG research fellowships, was supported by the project 'Integrated protection of the Alentejo olive grove. Contributions to its innovation and improvement against its key enemies' with the reference ALT20-03-0145-FEDER-000029, co-financed by the European Union through the European Regional Development Fund, under the ALENTEJO 2020 (Regional Operational Program of the Alentejo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; [Anonymous], 2001, REV CIE TEC AGR; Delrio G., 2010, IOBC/WPRS Bulletin, V53, P85; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Feckler A, 2014, J APPL ECOL, V51, P958, DOI 10.1111/1365-2664.12246; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Haber Gilbert, 2007, Central Mediterranean Naturalist, V4, P143; Haniotakis G. E., 2005, Bulletin OILB/SROP, V28, P1; Hegazi E, 2007, BIOL CONTROL, V43, P171, DOI 10.1016/j.biocontrol.2007.07.009; Hunt G. J., 1997, P21; Kelly JK, 1997, GENETICS, V146, P1197; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larsson H, 2013, G3-GENES GENOM GENET, V3, P795, DOI 10.1534/g3.112.005462; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Mandal D. S. L., 2014, DNA BARCODES, V2, P1; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; Monteiro-Henriques T, 2016, INT J CLIMATOL, V36, P400, DOI 10.1002/joc.4357; Morris TI, 1999, DYNAMICS PREDATORY A; Nave A, 2017, TURK J ZOOL, V41, P502, DOI 10.3906/zoo-1603-50; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pelekassis CD, 1962, A CONTRIBUTION TO TH; QGIS Development Team, QGIS GEOGR INF SYST; Ramos P, 1998, CROP PROT, V17, P645, DOI 10.1016/S0261-2194(98)00065-9; Ramos P, 2008, PEST MANAG SCI, V64, P720, DOI 10.1002/ps.1548; Roy V, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-102; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt AEBC, 2009, DARK LARGE URBAN PAR, P3825, DOI [10.1007/s10531-009-9682-7, DOI 10.1007/S10531-009-9682-7]; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; TAJIMA F, 1989, GENETICS, V123, P585; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tzanakakis ME, 2003, NETH J ZOOL, V52, P87, DOI 10.1163/156854203764817670; van Asch B, 2016, MITOCHONDRIAL DNA A, V27, P2108, DOI 10.3109/19401736.2014.982579; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654	39	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207716	10.1371/journal.pone.0207716	http://dx.doi.org/10.1371/journal.pone.0207716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475839	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700058
J	Trattnig, C; Ucal, M; Tam-Amersdorfer, C; Bucko, A; Zefferer, U; Grunbacher, G; Absenger-Novak, M; Ohlinger, KA; Kraitsy, K; Hamberger, D; Schaefer, U; Patz, S				Trattnig, Christa; Uecal, Muammer; Tam-Amersdorfer, Carmen; Bucko, Angela; Zefferer, Ulrike; Gruenbacher, Gerda; Absenger-Novak, Markus; Oehlinger, Kristin Anna; Kraitsy, Klaus; Hamberger, Daniel; Schaefer, Ute; Patz, Silke			MicroRNA-451a overexpression induces accelerated neuronal differentiation of Ntera2/D1 cells and ablation affects neurogenesis in microRNA-451a(-/-) mice	PLOS ONE			English	Article							NEURAL STEM-CELLS; DOWN-REGULATION; ERYTHROID-DIFFERENTIATION; CARCINOMA-CELLS; MIR-451; EXPRESSION; GROWTH; PROLIFERATION; TARGET; PHOSPHORYLATION	MiR-451a is best known for its role in erythropoiesis and for its tumour suppressor features. Here we show a role for miR-451a in neuronal differentiation through analysis of endogenous and ectopically expressed or silenced miR-451a in Ntera2/D1 cells during neuronal differentiation. Furthermore, we compared neuronal differentiation in the dentate gyrus of hippocampus of miR-451a(-/-) and wild type mice. MiR-451a overexpression in lentiviral transduced Ntera2/D1 cells was associated with a significant shifting of mRNA expression of the developmental markers Nestin, beta III Tubulin, NF200, DCX and MAP2 to earlier developmental time points, compared to control vector transduced cells. In line with this, accelerated neuronal network formation in AB.G.miR-451a transduced cells, as well as an increase in neurite outgrowth both in number and length was observed. MiR-451a targets genes MIF, AKT1, CAB39, YWHAZ, RAB14, TSC1, OSR1, POU3F2, TNS4, PSMB8, CXCL16, CDKN2D and IL6R were, moreover, either constantly downregulated or exhibited shifted expression profiles in AB.G.miR-451a transduced cells. Lentiviral knockdown of endogenous miR-451a expression in Ntera2/D1 cells resulted in decelerated differentiation. Endogenous miR-451a expression was upregulated during development in the hippocampus of wildtype mice. In situ hybridization revealed intensively stained single cells in the subgranular zone and the hilus of the dentate gyrus of wild type mice, while genetic ablation of miR-451a was observed to promote an imbalance between proliferation and neuronal differentiation in neurogenic brain regions, suggested by Ki67 and DCX staining. Taken together, these results provide strong support for a role of miR-451a in neuronal maturation processes in vitro and in vivo.	[Trattnig, Christa; Uecal, Muammer; Bucko, Angela; Zefferer, Ulrike; Gruenbacher, Gerda; Kraitsy, Klaus; Hamberger, Daniel; Schaefer, Ute; Patz, Silke] Med Univ, Dept Neurosurg, Res Unit Expt Neurotraumatol, Graz, Austria; [Tam-Amersdorfer, Carmen] Med Univ, Inst Pathophysiol & Immunol, Graz, Austria; [Absenger-Novak, Markus; Oehlinger, Kristin Anna] Ctr Med Res, Core Facil Microscopy, Graz, Austria; [Trattnig, Christa] Heidelberg Univ, Inst Anat & Cell Biol, Div Med Cell Biol, Heidelberg, Germany; [Bucko, Angela] Jungbunzlauer Austria AG, Factory Pernhofen, Wulzeshofen, Austria; [Kraitsy, Klaus] Vienna Bioctr Core Facil GmbH, Vienna, Austria; [Hamberger, Daniel] Univ Hosp Heidelberg, Natl Ctr Tumour Dis NCT, Heidelberg, Germany	Medical University of Graz; Medical University of Graz; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Schaefer, U (corresponding author), Med Univ, Dept Neurosurg, Res Unit Expt Neurotraumatol, Graz, Austria.	ute.schaefer@medunigraz.at	Üçal, Muammer/AFS-9448-2022	Tam-Amersdorfer, Carmen/0000-0003-3123-6342				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Arno B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6611; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Barlind A, 2010, EXP BRAIN RES, V201, P781, DOI 10.1007/s00221-009-2095-8; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Bian HB, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-20; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Bruchova-Votavova H, 2010, LEUKEMIA LYMPHOMA, V51, P686, DOI 10.3109/10428191003629362; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041574; Conboy L, 2011, MOL PSYCHIATR, V16, P533, DOI 10.1038/mp.2010.15; Dirks PB, 2010, MOL ONCOL, V4, P420, DOI 10.1016/j.molonc.2010.08.001; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Du J, 2015, ONCOTARGET, V6, P14993, DOI 10.18632/oncotarget.3802; Du TT, 2009, BIOCHEM BIOPH RES CO, V381, P688, DOI 10.1016/j.bbrc.2009.02.122; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Germano I, 2010, NEUROPHARMACOLOGY, V58, P903, DOI 10.1016/j.neuropharm.2009.12.019; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Graham A, 2015, HUM REPROD, V30, P642, DOI 10.1093/humrep/dev005; Hashizume K, 2018, GENES BRAIN BEHAV, V17, P118, DOI 10.1111/gbb.12408; Hur W, 2015, INT J BIOCHEM CELL B, V64, P265, DOI 10.1016/j.biocel.2015.04.016; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Joshi NR, 2015, HUM REPROD, V30, P2881, DOI 10.1093/humrep/dev229; Karlsson N, 2011, RADIAT RES, V175, P336, DOI 10.1667/RR2231.1; Kouhkan F, 2014, APPL BIOCHEM BIOTECH, V172, P2055, DOI 10.1007/s12010-013-0633-0; Kuwabara Y, 2015, CIRC RES, V116, P279, DOI 10.1161/CIRCRESAHA.116.304707; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Legrier ME, 2001, CELL GROWTH DIFFER, V12, P591; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li HY, 2013, ASIAN PAC J CANCER P, V14, P3631, DOI 10.7314/APJCP.2013.14.6.3631; Liu D, 2014, CANCER EPIDEMIOL, V38, P85, DOI 10.1016/j.canep.2013.12.005; Liu N, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-123; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 2014, INT J BIOCHEM CELL B, V51, P150, DOI 10.1016/j.biocel.2014.04.003; Malatesta P, 2008, CELL TISSUE RES, V331, P165, DOI 10.1007/s00441-007-0481-8; Marchal-Victorion S, 2003, MOL CELL NEUROSCI, V24, P198, DOI 10.1016/S1044-7431(03)00161-1; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muharram G, 2014, DEV CELL, V29, P421, DOI 10.1016/j.devcel.2014.03.024; Murata K, 2014, ARTHRITIS RHEUMATOL, V66, P549, DOI 10.1002/art.38269; Nan Y, 2010, BRAIN RES, V1359, P14, DOI 10.1016/j.brainres.2010.08.074; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Paquet-Durand F, 2003, DEV BRAIN RES, V142, P161, DOI 10.1016/S0165-3806(03)00065-8; Parsons MJ, 2008, MAMM GENOME, V19, P552, DOI 10.1007/s00335-008-9116-y; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RIEDERER BM, 1995, J HISTOCHEM CYTOCHEM, V43, P1269, DOI 10.1177/43.12.8537643; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; Sarnat HB, 2013, CLIN NEUROPATHOL, V32, P340, DOI 10.5414/NP300638; Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055301; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song L, 2014, J CELL MOL MED, V18, P2266, DOI 10.1111/jcmm.12380; Takahashi N, 2012, ENDOCRINOLOGY, V153, P1990, DOI 10.1210/en.2011-2026; Tee AR, 2016, SEMIN CELL DEV BIOL, V52, P12, DOI 10.1016/j.semcdb.2016.01.040; Tian Y, 2012, INT J ONCOL, V40, P1105, DOI 10.3892/ijo.2011.1306; Toyo-oka K, 2014, J NEUROSCI, V34, P12168, DOI 10.1523/JNEUROSCI.2513-13.2014; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang T, 2013, DIGEST DIS SCI, V58, P706, DOI 10.1007/s10620-012-2395-x; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wu LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070457; Yin P, 2015, MOL BIOTECHNOL, V57, P1, DOI 10.1007/s12033-014-9796-3; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Zang WQ, 2015, WORLD J GASTROENTERO, V21, P5867, DOI 10.3748/wjg.v21.i19.5867; Zhang F, 2015, TUMOR BIOL, V36, P2041, DOI 10.1007/s13277-014-2811-2; Zhang T, 2014, TUMOR BIOL, V35, P12593, DOI 10.1007/s13277-014-2581-x; Zhang Z, 2012, FEBS LETT, V586, P20, DOI 10.1016/j.febslet.2011.07.042; Zindy F, 1999, P NATL ACAD SCI USA, V96, P13462, DOI 10.1073/pnas.96.23.13462	85	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207575	10.1371/journal.pone.0207575	http://dx.doi.org/10.1371/journal.pone.0207575			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462722	Green Submitted, gold, Green Published			2022-12-26	WOS:000451054800067
J	Zhao, H; Martin, E; Matalkah, F; Shah, N; Ivanov, A; Ruppert, JM; Lockman, PR; Agazie, YM				Zhao, Hua; Martin, Elisha; Matalkah, Fatimah; Shah, Neal; Ivanov, Alexey; Ruppert, J. Michael; Lockman, Paul R.; Agazie, Yehenew M.			Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; CRYSTAL-STRUCTURE; TYROSINE PHOSPHATASE; MOLECULAR-MECHANISM; BASAL-LIKE; MAMMARY; LEADS; PHOSPHORYLATION; TRANSITION; COMPLEX	Overexpression of the human epidermal growth factor receptor 2 (HER2) is the cause of HER2-positive breast cancer (BC). Although HER2-inactivating therapies have benefited BC patients, development of resistance and disease recurrence have been the major clinical problems, pointing to a need for alternative therapeutic strategies. For that to happen, proteins that play critical roles in the biology of HER2-induced tumorigenesis have to be identified and characterized. Here, we show that the Src homology phosphotyrosyl phosphatase 2 (Shp2) encoded by the Ptpn11 gene is a requisite for ErbB2-induced tumorigenesis. We report that conditional knockout of Shp2 alleles in the ErbB2 BC model mice abrogates mammary tumorigenesis by blocking the expression of the ErbB2 transgene. We also show that inhibition of SHP2 encoded by the PTPN11 gene in the HER2-amplified BC cells induces a normal-like cellular phenotype and suppresses tumorigenesis and metastasis by blocking HER2 overexpression. These findings demonstrate that ErbB2-induced tumors in mice or xenograft tumors induced by transplantation of HER2-amplified BC cells are vulnerable to SHP2 inhibition since it abrogates the expression of the very oncogene that causes of the disease. This report paves the way for developing SHP2-targeting therapies for BC treatment in the future.	[Zhao, Hua; Martin, Elisha; Matalkah, Fatimah; Ivanov, Alexey; Ruppert, J. Michael; Agazie, Yehenew M.] West Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Shah, Neal; Lockman, Paul R.] West Virginia Univ, Sch Med, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Ivanov, Alexey; Ruppert, J. Michael; Agazie, Yehenew M.] West Virginia Univ, Sch Med, WVU Canc Inst, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Agazie, YM (corresponding author), West Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA.; Agazie, YM (corresponding author), West Virginia Univ, Sch Med, WVU Canc Inst, Morgantown, WV 26506 USA.	yagazie@hsc.wvu.edu		Ivanov, Alexey/0000-0002-8617-4604; Ruppert, John/0000-0001-6004-6527; Lockman, Paul/0000-0002-6995-9944; Matalkah, Fatimah/0000-0002-0160-3757	National Cancer Institute (NCI), a component of the National Institute of Health (NIH) [CA124940]; NIH [GM103488, GM104842, GM103434, P20RR016440, P30RR032138/P30GM103488]; NATIONAL CANCER INSTITUTE [R01CA124940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	National Cancer Institute (NCI), a component of the National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (CA124940) from the National Cancer Institute (NCI), a component of the National Institute of Health (NIH) to YMA. The Flow Core and Imaging facilities are supported by grants from NIH (GM103488, GM104842, GM103434, P20RR016440, and P30RR032138/P30GM103488.). We would like to thank Dr. Benjamin Neel and Dr. Timothy Lane for providing the SHP2-floxed and the MMTV-Cre mice, respectively. Also, we thank Dr. Karen Martin, Dr. Amanda Ammer, and Mrs. Sarah McLaughlin for their support in microscopic and ultrasound imaging and Dr. Katherine Brundage for her support in FACS analyses.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Brandt BH, 1999, FASEB J, V13, P1939, DOI 10.1096/fasebj.13.14.1939; Burks J, 2006, ONCOGENE, V25, P7166, DOI 10.1038/sj.onc.1209728; Cleghon V, 1998, MOL CELL, V2, P719, DOI 10.1016/S1097-2765(00)80287-7; Deblois G, 2010, CANCER RES, V70, P10277, DOI 10.1158/0008-5472.CAN-10-2840; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dent S, 2013, CANCER TREAT REV, V39, P622, DOI 10.1016/j.ctrv.2013.01.002; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; FENG GS, 1994, ONCOGENE, V9, P1545; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Frearson JA, 1998, J EXP MED, V187, P1417, DOI 10.1084/jem.187.9.1417; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hartman Z, 2013, ONCOGENE, V32, P4169, DOI 10.1038/onc.2012.418; Hartman ZR, 2013, MOL CANCER RES, V11, P651, DOI 10.1158/1541-7786.MCR-12-0578; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Kim YS, 2014, J BREAST CANCER, V17, P121, DOI 10.4048/jbc.2014.17.2.121; Lan LX, 2015, EMBO J, V34, P1493, DOI 10.15252/embj.201489004; Li G, 2002, DEVELOPMENT, V129, P4159; Matalkah F, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0659-z; Muenst S, 2013, HISTOPATHOLOGY, V63, P74, DOI 10.1111/his.12140; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Pegram M D, 2000, Cancer Treat Res, V103, P57; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Zhao H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1131-2; Zhou X, 2008, HISTOPATHOLOGY, V53, P389, DOI 10.1111/j.1365-2559.2008.03103.x; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54; Zhou XD, 2009, J BIOL CHEM, V284, P12226, DOI 10.1074/jbc.M900020200	38	15	15	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2275	2290		10.1038/s41388-018-0574-8	http://dx.doi.org/10.1038/s41388-018-0574-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30467378	Green Submitted, Green Accepted			2022-12-26	WOS:000462588000004
J	Nobuta, H; Katagi, M; Kume, S; Terashima, T; Araki, S; Maegawa, H; Kojima, H; Nakagawa, T				Nobuta, Hiroshi; Katagi, Miwako; Kume, Shinji; Terashima, Tomoya; Araki, Shin-ichi; Maegawa, Hiroshi; Kojima, Hideto; Nakagawa, Takahiko			A role for bone marrow-derived cells in diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic kidney disease; hyperglycemia; glomerular endothelial cell; endothelial injury	ENDOTHELIAL GROWTH-FACTOR; AMELIORATES RENAL ALTERATIONS; PROGENITOR CELLS; KNOCKOUT MICE; MOUSE MODEL; EARLY-STAGE; ANGIOGENESIS; RETINOPATHY; REPAIR; INVOLVEMENT	Diabetes mellitus causes systemic disorders. We previously demonstrated that diabetic condition forced bone marrow-derived cells (BMDCs) to express TNF-, leading to the development of diabetic neuropathy in mice. Here, we hypothesized that these abnormal BMDCs are also involved in diabetic nephropathy. To test our hypothesis, mice were irradiated to receive total bone marrow (BM) from the transgenic mice expressing green fluorescent protein before diabetes was induced by streptozotocin. Confocal microscopy showed that the diabetic glomerulus had more BMDCs compared with the nondiabetic glomerulus. Most of these cells exhibited endothelial phenotypes, being negative for several markers, including podocin (a maker of podocyte), 8 integrin (mesangial cell), CD68, and F4/80 (macrophage). Next, the total BM of diabetic mice was transplanted into nondiabetic mice to examine if diabetic BM per se could cause glomerular injury. The recipient mice exhibiting normal glycemia developed albuminuria and mesangial expansion with an increase in capillary area. The number of BMDCs increased in the glomerulus of the recipient mice. These cells were found to exhibit the endothelial phenotype and to express TNF-. These data suggest that diabetic BMDCs per se could initiate glomerular disease. Finally, eNOS knockout mice were used to examine if residential endothelial injury could attract BMDCs into the glomerulus. However, endothelial dysfunction due to eNOS deficiency failed to attract BMDCs into the glomerulus. In summary, BMDCs may be involved in the development of diabetic nephropathy.Nobuta, H., Katagi, M., Kume, S., Terashima, T., Araki, S., Maegawa, H., Kojima, H., Nakagawa, T. A role for bone marrow-derived cells in diabetic nephropathy.	[Nobuta, Hiroshi; Kume, Shinji; Araki, Shin-ichi; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Nobuta, Hiroshi; Katagi, Miwako; Terashima, Tomoya; Kojima, Hideto] Shiga Univ Med Sci, Dept Stem Cell Biol & Regenerat Med, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Nakagawa, Takahiko] Nara Med Univ, Dept Future Basic Med, 840 Shijo Cho, Kashihara, Nara 6348521, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Nara Medical University	Kojima, H (corresponding author), Shiga Univ Med Sci, Dept Stem Cell Biol & Regenerat Med, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.; Nakagawa, T (corresponding author), Nara Med Univ, Dept Future Basic Med, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	kojima@belle.shiga-med.ac.jp; nakagawt@gmail.com		Maegawa, Hiroshi/0000-0002-4611-8149	SUMS President's Grant for the Encouragement of Young Researchers	SUMS President's Grant for the Encouragement of Young Researchers	The authors thank N. Yamanaka, K. Kosaka, Y. Nakae, and T. Yamamoto (Shiga University of Medical Science) and the Central Research Laboratory of Shiga University of Medical Science for technical assistance. This work was supported by the SUMS President's Grant for the Encouragement of Young Researchers (to H.N.). The funder had no role in any process of this work, including study design, data collection, data analysis, interpretation, and writing of the manuscript. The authors declare no conflicts of interest.	Abe-Yoshio Y, 2008, VIRCHOWS ARCH, V453, P97, DOI 10.1007/s00428-008-0618-5; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Cornacchia F, 2001, J CLIN INVEST, V108, P1649; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Fadini GP, 2014, STEM CELL TRANSL MED, V3, P949, DOI 10.5966/sctm.2014-0052; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; Galderisi Umberto, 2010, World J Stem Cells, V2, P5, DOI 10.4252/wjsc.v2.i1.5; Guo M, 2005, J ANAT, V207, P813, DOI 10.1111/j.1469-7580.2005.00492.x; Hinamoto N, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096932, 10.1371/journal.pone.0107934]; Ichinose K, 2006, DIABETES, V55, P1232, DOI 10.2337/db05-1367; Ichinose K, 2005, DIABETES, V54, P2891, DOI 10.2337/diabetes.54.10.2891; Katagi M, 2014, FEBS LETT, V588, P1080, DOI 10.1016/j.febslet.2014.02.030; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Kosugi T, 2010, AM J PATHOL, V176, P619, DOI 10.2353/ajpath.2010.090578; Lee IG, 2006, EYE, V20, P546, DOI 10.1038/sj.eye.6701920; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Lim JJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00191; Masuda K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195779; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; Perry TE, 2009, CARDIOVASC RES, V84, P317, DOI 10.1093/cvr/cvp215; Qian C, 2008, NETH HEART J, V16, P305, DOI 10.1007/BF03086169; Rookmaaker MB, 2003, AM J PATHOL, V163, P553, DOI 10.1016/S0002-9440(10)63683-8; Shinoda K, 1999, BRIT J OPHTHALMOL, V83, P834, DOI 10.1136/bjo.83.7.834; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Urabe H, 2015, DIABETOLOGIA, V58, P402, DOI 10.1007/s00125-014-3440-4; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831; Yamashita T, 2012, FASEB J, V26, P1559, DOI 10.1096/fj.11-183194; Zheng F, 2004, DIABETES, V53, P2420, DOI 10.2337/diabetes.53.9.2420	36	3	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4067	4076		10.1096/fj.201801825R	http://dx.doi.org/10.1096/fj.201801825R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496699	Bronze			2022-12-26	WOS:000459794800077
J	Schlotterer, A; Kolibabka, M; Lin, JH; Acunman, K; Dietrich, N; Sticht, C; Fleming, T; Nawroth, P; Hammes, HP				Schlotterer, Andrea; Kolibabka, Matthias; Lin, Jihong; Acunman, Kuebra; Dietrich, Nadine; Sticht, Carsten; Fleming, Thomas; Nawroth, Peter; Hammes, Hans-Peter			Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model	FASEB JOURNAL			English	Article						animal; glycation; AGE; retina	GLYCATION END-PRODUCTS; INCREASED SERUM-LEVELS; DIABETIC-RETINOPATHY; RETINAL PERICYTES; DICARBONYL STRESS; ALPHA-CRYSTALLIN; IN-VITRO; TNF-ALPHA; EXPRESSION; APOPTOSIS	The aim of this study was to evaluate whether damage to the neurovascular unit in diabetes depends on reactive metabolites such as methylglyoxal (MG), and to assess its impact on retinal gene expression. Male Wistar rats were supplied with MG (50 mM) by drinking water and compared with age-matched streptozotocin-diabetic animals and untreated controls. Retinal damage was evaluated for the accumulation of MG-derived advanced glycation end products, changes in hexosamine and PKC pathway activation, microglial activation, vascular alterations (pericyte loss and vasoregression), neuroretinal function assessed by electroretinogram, and neurodegeneration. Retinal gene regulation was studied by microarray analysis, and transcription factor involvement was identified by upstream regulator analysis. Systemic application of MG by drinking water increased retinal MG to levels comparable with diabetic animals. Elevated retinal MG resulted in MG-derived hydroimidazolone modifications in the ganglion cell layer, inner nuclear layer, and outer nuclear layer, a moderate activation of the hexosamine pathway, a pan-retinal activation of microglia, loss of pericytes, increased formation of acellular capillaries, decreased function of bipolar cells, and increased expression of the crystallin gene family. MG mimics important aspects of diabetic retinopathy and plays a pathogenic role in microglial activation, vascular damage, and neuroretinal dysfunction. In response to MG, the retina induces expression of neuroprotective crystallins.Schlotterer, A., Kolibabka, M., Lin, J., Acunman, K., Dietrich, N., Sticht, C., Fleming, T., Nawroth, P., Hammes, H.-P. Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model.	[Schlotterer, Andrea; Kolibabka, Matthias; Lin, Jihong; Acunman, Kuebra; Dietrich, Nadine; Hammes, Hans-Peter] Heidelberg Univ, Med Dept 5, Heidelberg, Germany; [Sticht, Carsten] Heidelberg Univ, Med Fac, Med Res Ctr, Heidelberg, Germany; [Fleming, Thomas; Nawroth, Peter] Heidelberg Univ, Dept Med & Clin Chem 1, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schlotterer, A (corresponding author), Heidelberg Univ, Med Dept 5, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	andrea.schlotterer@medma.uni-heidelberg.de	Kolibabka, Matthias/T-5812-2017; Hammes, Hans-Peter/S-3719-2019	Kolibabka, Matthias/0000-0001-6741-5436; 	German Research Foundation (Collaborative Research Center) [1118]	German Research Foundation (Collaborative Research Center)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (Collaborative Research Center 1118). The authors declare no conflicts of interest.	Alikhani M, 2010, MOL VIS, V16, P408; Andersson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077986; Barlovic DP, 2011, CLIN SCI, V121, P43, DOI 10.1042/CS20100501; Berlanga J, 2005, CLIN SCI, V109, P83, DOI 10.1042/CS20050026; Berner AK, 2012, DIABETOLOGIA, V55, P845, DOI 10.1007/s00125-011-2393-0; Cardoso S, 2014, J BIOENERG BIOMEMBR, V46, P347, DOI 10.1007/s10863-014-9551-2; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen M, 2013, CURR MED CHEM, V20, P3234, DOI 10.2174/09298673113209990025; CRAVEN PA, 1990, DIABETES, V39, P667, DOI 10.2337/diabetes.39.6.667; Crisostomo J, 2013, NUTR METAB CARDIOVAS, V23, P1223, DOI 10.1016/j.numecd.2013.01.005; Curtis TM, 2011, DIABETOLOGIA, V54, P690, DOI 10.1007/s00125-010-1971-x; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dietrich N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167853; Dietrich Nadine, 2012, Methods Mol Biol, V933, P291, DOI 10.1007/978-1-62703-068-7_19; Dong N, 2014, MOL VIS, V20, P616; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Dutescu RM, 2013, INVEST OPHTH VIS SCI, V54, P2582, DOI 10.1167/iovs.12-11446; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Fort PE, 2009, MOL CELL PROTEOMICS, V8, P767, DOI 10.1074/mcp.M800326-MCP200; Fosmark DS, 2009, ACTA OPHTHALMOL, V87, P498, DOI 10.1111/j.1755-3768.2008.01300.x; Fosmark DS, 2006, METABOLISM, V55, P232, DOI 10.1016/j.metabol.2005.08.017; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Golej J, 1998, LIFE SCI, V63, P801, DOI 10.1016/S0024-3205(98)00336-1; Hadas K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074401; Hammes HP, 2011, DIABETOLOGIA, V54, P1977, DOI 10.1007/s00125-011-2198-1; Hammes HP, 2018, DIABETOLOGIA, V61, P29, DOI 10.1007/s00125-017-4435-8; Hammes HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132492; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Heise EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082520; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Karachalias N, 2003, BIOCHEM SOC T, V31, P1423; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Kim J, 2012, FREE RADICAL BIO MED, V53, P357, DOI 10.1016/j.freeradbiomed.2012.04.030; Kim YS, 2015, BIOCHEM PHARMACOL, V93, P496, DOI 10.1016/j.bcp.2014.09.022; Kolibabka M, 2016, EXP CLIN ENDOCR DIAB, V124, P437, DOI 10.1055/s-0042-106081; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lecleire-Collet A, 2005, BRIT J OPHTHALMOL, V89, P1631, DOI 10.1136/bjo.2005.079491; Lecomte M, 2004, BBA-MOL BASIS DIS, V1689, P202, DOI 10.1016/j.bbadis.2004.03.010; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Liu GD, 2015, INT J MOL MED, V36, P1019, DOI 10.3892/ijmm.2015.2319; Losiewicz MK, 2011, INVEST OPHTH VIS SCI, V52, P5034, DOI 10.1167/iovs.10-6931; McVicar CM, 2015, DIABETOLOGIA, V58, P1129, DOI 10.1007/s00125-015-3523-x; Miller AG, 2010, DIABETES, V59, P3208, DOI 10.2337/db10-0552; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Morgenstern J, 2017, J BIOL CHEM, V292, P3224, DOI 10.1074/jbc.M116.760132; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Nigro C, 2014, DIABETOLOGIA, V57, P1485, DOI 10.1007/s00125-014-3243-7; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Pfister F, 2011, CELL PHYSIOL BIOCHEM, V28, P125, DOI 10.1159/000331721; Rabbani N, 2016, CLIN SCI, V130, P1677, DOI 10.1042/CS20160025; Rabbani N, 2016, GLYCOCONJUGATE J, V33, P553, DOI 10.1007/s10719-016-9709-8; Rabbani N, 2014, NAT PROTOC, V9, P1969, DOI 10.1038/nprot.2014.129; Rajamani D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21502; Rodrigues L, 2014, J PHYSIOL BIOCHEM, V70, P173, DOI 10.1007/s13105-013-0291-2; Safi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801269; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shimatani Y, 2015, CLIN NEUROPHYSIOL, V126, P2226, DOI 10.1016/j.clinph.2015.02.058; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; Sohn EH, 2016, P NATL ACAD SCI USA, V113, pE2655, DOI 10.1073/pnas.1522014113; Stitt AW, 2004, DIABETOLOGIA, V47, P1735, DOI 10.1007/s00125-004-1523-3; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tikellis C, 2014, DIABETES, V63, P3915, DOI 10.2337/db13-0932; Wang AG, 2002, MOL BRAIN RES, V101, P82, DOI 10.1016/S0169-328X(02)00171-7; Wang AL, 2007, EXP EYE RES, V84, P905, DOI 10.1016/j.exer.2007.01.011; Wang J, 2014, ACTA DIABETOL, V51, P813, DOI 10.1007/s00592-014-0616-9; WANG KY, 1994, J BIOL CHEM, V269, P13601; Wang Q, 2010, DIABETOLOGIA, V53, P1227, DOI 10.1007/s00125-010-1727-7; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wongchai K, 2016, HORM METAB RES, V48, P70, DOI 10.1055/s-0035-1549876; Xi JH, 2003, MOL VIS, V9, P410; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Yatoh S, 2006, DIABETES-METAB RES, V22, P38, DOI 10.1002/dmrr.562; Ying X, 2014, LIFE SCI, V111, P42, DOI 10.1016/j.lfs.2014.07.008; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	80	17	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4141	4153		10.1096/fj.201801146RR	http://dx.doi.org/10.1096/fj.201801146RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30485119	Bronze			2022-12-26	WOS:000459794800083
J	Bou-Dargham, MJ; Liu, YH; Sang, QXA; Zhang, JF				Bou-Dargham, Mayassa J.; Liu, Yuhang; Sang, Qing-Xiang Amy; Zhang, Jinfeng			Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ABERRANT EXPRESSION; T-CELLS; CHEMOTHERAPY; PROGRESSION; PATHWAY; MODELS	In the era of immunotherapy and personalized medicine, there is an urgent need for advancing the knowledge of immune evasion in different cancer types and identifying reliable biomarkers that guide both therapy selection and patient inclusion in clinical trials. Given the differential immune responses and evasion mechanisms in breast cancer, we expect to identify different breast cancer groups based on their expression of immune-related genes. For that, we used the sequential biclustering method on The Cancer Genome Atlas RNAseq breast cancer data and identified 7 clusters. We found that 77.4% of the clustered tumor specimens evade through transforming growth factor-beta (TGF-beta) immunosuppression, 57.7% through decoy receptor 3 (DcR3) counterattack, 48.0% through cytotoxic T-lymphocyte- associated protein 4 (CTLA4), and 34.3% through programmed cell death-1 (PD-1). TGF-beta and DcR3 are potential novel drug targets for breast cancer immunotherapy. Targeting TGF-beta and DcR3 may provide a powerful approach for treating breast cancer because 57.7% of patients overexpressed these two molecules. Furthermore, triple-negative breast cancer (TNBC) patients clustered equally into two subgroups: one with impaired antigen presentation and another with high leukocyte recruitment but four different evasion mechanisms. Thus, different TNBC patients may be treated with different immunotherapy approaches. We identified biomarkers to cluster patients into subgroups based on immune evasion mechanisms and guide the choice of immunotherapy. These findings provide a better understanding of patients' response to immunotherapies and shed light on the rational design of novel combination therapies.	[Bou-Dargham, Mayassa J.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Liu, Yuhang; Zhang, Jinfeng] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bou-Dargham, MJ; Sang, QXA (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.; Zhang, JF (corresponding author), Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA.; Sang, QXA (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	mdargham@chem.fsu.edu; qxsang@chem.fsu.edu; jinfeng@stat.fsu.edu	Bou-Dargham, Mayassa J./AAF-5982-2019	Bou-Dargham, Mayassa J./0000-0002-1551-8887	Florida State University; National Institute of General Medical Sciences of the National Institute of Health [R01GM126558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126558] Funding Source: NIH RePORTER	Florida State University; National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the Florida State University to J.Z. and Q.X.A.S. and an Endowed Chair Professorship in Cancer Research from anonymous donors to Q.X. A.S. J.Z. was also supported by the National Institute of General Medical Sciences of the National Institute of Health under award number R01GM126558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the researchers who have generated the data used in this study. This work was supported in part by grants from the Florida State University to J.Z. and Q.X.A.S. and an Endowed Chair Professorship in Cancer Research from anonymous donors to Q.X.A.S. J.Z. was also supported by the National Institute of General Medical Sciences of the National Institute of Health under award number R01GM126558. J.Z. and Q.X.A.S. conceived the ideas and directed the research; J.Z. designed the research approaches and selected the statistical methods for this study; M.J.B. carried out the scientific literature search, protein-protein interaction and pathway analyses, and selected immune-related genes; M.J.B. and Y.L. performed TCGA data mining, computational programming, statistical and bioinformatics analyses, and prepared the figures and tables; M.J.B., Y.L., J.Z., and Q.X. A.S. performed data analysis and interpretation; M.J.B. wrote the majority of the first draft of the manuscript text; and Q.X.A.S., M.J.B., Y.L., and J.Z. revised and re-wrote the manuscript.	Barroso-Sousa R, 2016, THER ADV MED ONCOL, V8, P261, DOI 10.1177/1758834016644156; Breiman L., 1984, CLASSIFICATION REGRE, V19; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; di Bari MG, 2009, CANCER IMMUNOL IMMUN, V58, P1811, DOI 10.1007/s00262-009-0692-9; Dieci MV, 2014, ANN ONCOL, V25, P611, DOI 10.1093/annonc/mdt556; Dirix LY, 2017, BREAST CANC RES TREA, V167, P1, DOI [10.1007/s10549-017-4490-3, DOI 10.1007/S10549-017-4490-3]; Ehrlich P, 1909, NON TRADITIONAL REF, P118; Emens LA, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2859; Garcia-Teijido P, 2016, CLIN MED INSIGHTS-ON, V10, P31, DOI 10.4137/CMO.S34540; Ge ZC, 2011, EXP THER MED, V2, P167, DOI 10.3892/etm.2011.206; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Kanbayashi Chizuko, 2014, World J Oncol, V5, P14, DOI 10.14740/wjon764w; Korkola JE, 2003, CANCER RES, V63, P7167; Lazzeroni L, 2002, STAT SINICA, V12, P61; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li JH, 1998, J IMMUNOL, V161, P3943; Li Y, 1999, TRANSPLANT P, V31, P2143, DOI 10.1016/S0041-1345(99)00288-2; Liu YP, 2016, ONCOTARGET, V7, P77306, DOI 10.18632/oncotarget.12639; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Michaut M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18517; Mittendorf EA, 2015, AM J HEMATOL, V11; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rugo HS, 2018, CLIN CANCER RES, V24, P2804, DOI 10.1158/1078-0432.CCR-17-3452; Santa-Maria Cesar August, 2018, Oncotarget, V9, P18985, DOI 10.18632/oncotarget.24867; Socinski M, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw435.39; Stagg J, 2013, THER ADV MED ONCOL, V5, P169, DOI 10.1177/1758834012475152; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Therneau TM., 2015, INTRO RECURSIVE PART; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; van der Most RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006982; Vonderheide RH, 2010, CLIN CANCER RES, V16, P3485, DOI 10.1158/1078-0432.CCR-10-0505; WALSH CM, 1994, J IMMUNOL, V153, P2506; Wang MZ, 2017, ONCOTARGETS THER, V10, P1561, DOI 10.2147/OTT.S126424; Wu QW, 2014, J SURG RES, V188, P459, DOI 10.1016/j.jss.2014.01.058; Yu MC, 2016, ONCOTARGET, V7, P13742, DOI 10.18632/oncotarget.7328; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	43	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207799	10.1371/journal.pone.0207799	http://dx.doi.org/10.1371/journal.pone.0207799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513096	Green Published, Green Submitted, gold			2022-12-26	WOS:000452204800016
J	Juanbeltz, R; Perez-Garcia, A; Aguinaga, A; Martinez-Baz, I; Casado, I; Burgui, C; Goni-Esarte, S; Reparaz, J; Zozaya, JPM; Miguel, RS; Ezpeleta, C; Castilla, J				Juanbeltz, Regina; Perez-Garcia, Alejandra; Aguinaga, Aitziber; Martinez-Baz, Ivan; Casado, Itziar; Burgui, Cristina; Goni-Esarte, Silvia; Reparaz, Jesus; Manuel Zozaya, Jose Prime; Miguel, Ramon San; Ezpeleta, Carmen; Castilla, Jesus		EIPT-VHC Study Grp	Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain	PLOS ONE			English	Article							DIRECT-ACTING ANTIVIRALS; HCV; ABT-450/R-OMBITASVIR; PREVALENCE; SOFOSBUVIR; COMMUNITY; DASABUVIR; NAVARRA	Background The World Health Organization set targets to eliminate hepatitis C virus (HCV) infection through detection and treatment of all cases by 2030. This study aimed to describe the progress and difficulties in the elimination of HCV infection in Navarra, Spain. Methods Using electronic healthcare databases, we performed a population-based prospective cohort study to describe changes in the prevalence of diagnosed active HCV infection at the beginning of 2015 and the end of 2017, the rate of new diagnoses and the rate of post-treatment viral clearance (PTVC) during this period. Results At the beginning of 2015 there were 1503 patients diagnosed with positive HCV-RNA, 2.4 per 1000 inhabitants, and at the end of 2017 the prevalence had decreased by 47%. In the study period, 333 (18 per 100,000 person-years) new positive HCV-RNA cases were detected, but only 76 (23%; 4.2 per 100,000 person-years) did not have anti-HCV antibodies previously detected. Prevalent cases and new diagnoses of active infection were more frequent in men, people born in 1950-1979, HIV-infected patients and in those with lower income levels. Among patients with HCV-RNA, 984 achieved PTVC (22.7 per 100 person-years). PTVC was less frequent in patients born before 1940, in immigrants and in patients with lower income levels. Conclusions The prevalence of diagnosed active HCV infection has dropped by almost half over three years, because the number of patients with PTVC was much higher than the number of new diagnoses. Interventions specifically targeted at population groups with less favourable trends may be necessary.	[Juanbeltz, Regina; Martinez-Baz, Ivan; Casado, Itziar; Castilla, Jesus] Inst Salud Publ Navarra IdiSNA, Pamplona, Spain; [Juanbeltz, Regina; Perez-Garcia, Alejandra; Martinez-Baz, Ivan; Casado, Itziar; Burgui, Cristina; Castilla, Jesus] CIBER Epidemiol & Salud Publ, Pamplona, Spain; [Perez-Garcia, Alejandra; Aguinaga, Aitziber; Ezpeleta, Carmen] Complejo Hosp Navarra IdiSNA, Dept Clin Microbiol, Pamplona, Spain; [Burgui, Cristina; Miguel, Ramon San] Complejo Hosp Navarra IdiSNA, Dept Pharm, Pamplona, Spain; [Goni-Esarte, Silvia; Manuel Zozaya, Jose Prime] Complejo Hosp Navarra IdiSNA, Dept Gastroenterol & Hepatol, Pamplona, Spain; [Reparaz, Jesus] Complejo Hosp Navarra IdiSNA, Dept Internal Med, Pamplona, Spain	Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Servicio Navarro de Salud - Osasunbidea; Servicio Navarro de Salud - Osasunbidea; Servicio Navarro de Salud - Osasunbidea; Servicio Navarro de Salud - Osasunbidea	Castilla, J (corresponding author), Inst Salud Publ Navarra IdiSNA, Pamplona, Spain.; Castilla, J (corresponding author), CIBER Epidemiol & Salud Publ, Pamplona, Spain.	jcastilc@navarra.es	Castilla, Jesus/B-9048-2008; Casado, Itziar/AAE-2973-2021; Martínez-Baz, Iván/H-4954-2017; Casado, Itziar/B-1341-2017; Juanbeltz, Regina/B-1456-2017	Castilla, Jesus/0000-0002-6396-7265; Casado, Itziar/0000-0001-6879-4984; Martínez-Baz, Iván/0000-0002-3405-2277; Casado, Itziar/0000-0001-6879-4984; Juanbeltz, Regina/0000-0003-3772-0442; , Cristina Burgui/0000-0002-9099-6117	Spanish Ministry of Health; Carlos III Institute of Health; European Regional Development Fund [CM17/00095, INT17/00066]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Carlos III Institute of Health(Instituto de Salud Carlos III); European Regional Development Fund(European Commission)	This work is part of the EIPT-VHC project, which was supported by the Spanish Ministry of Health in the context of the "Strategic Plan for Tackling Hepatitis C in the Spanish National Health System" and by the Carlos III Institute of Health with the European Regional Development Fund (CM17/00095 and INT17/00066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Aguinaga A, 2018, ENFERM INFEC MICR CL, V36, P325, DOI 10.1016/j.eimc.2016.12.008; Asselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027; Belmonte P, 2019, SEGURO SALUD 5G; Bolotin S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191184; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Bruguera M, 2006, MED CLIN-BARCELONA, V127, P113, DOI 10.1157/13090276; Caro-Murillo AM, 2007, REV ESP SALUD PUBLIC, V81, P387, DOI [10.1590/s1135-57272007000400006, 10.1590/S1135-57272007000400006]; Castilla J, 1997, AM J PUBLIC HEALTH, V87, P770, DOI 10.2105/AJPH.87.5.770; Dominguez A, 2001, J MED VIROL, V65, P688, DOI 10.1002/jmv.2091; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Comas LG, 2015, J MED VIROL, V87, P1697, DOI 10.1002/jmv.24219; Garriga C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187893; Gelson W, 2017, BRIT MED BULL, V123, P59, DOI 10.1093/bmb/ldx017; Hellard M, 2016, J EPIDEMIOL COMMUNIT; Hepatitis C, 2017, LANCET GASTROENTEROL, V2, P325; Janjua NZ, 2017, J VIRAL HEPATITIS, V24, P624, DOI 10.1111/jvh.12684; Jean-Luc R, 2018, SWISS MED WKLY, V148, DOI 10.4414/smw.2018.14619; Juanbeltz R, 2017, AN SIST SANIT NAVAR, V40, P57, DOI [10.23938/ASSN.0006, 10.23938/assn.0006]; Lazarus JV, 2019, ENFERM INFEC MICR CL, V37, P222, DOI 10.1016/j.eimc.2018.04.002; Lazarus JV, 2017, J HEPATOL, V67, P665, DOI 10.1016/j.jhep.2017.06.033; Marcus JL, 2018, PUBLIC HEALTH REP, V133, P452, DOI 10.1177/0033354918772059; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Papatheodoridis GV, 2018, J VIRAL HEPATITIS, V25, P6, DOI 10.1111/jvh.12875; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Saeed S, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25013; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; WHO, 2014, GUID SCREEN CAR TREA; World Health Organization, 2016, GLOB HLTH SECT STRAT; Younossi ZM, 2016, J VIRAL HEPATITIS, V23, P447, DOI 10.1111/jvh.12506	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208554	10.1371/journal.pone.0208554	http://dx.doi.org/10.1371/journal.pone.0208554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513107	gold, Green Published, Green Submitted			2022-12-26	WOS:000452204800040
J	Cui, AL; Mao, NY; Wang, HL; Xu, ST; Zhu, Z; Ji, YX; Ren, L; Gao, LY; Zhang, Y; Xu, WB				Cui, Aili; Mao, Naiying; Wang, Huiling; Xu, Songtao; Zhu, Zhen; Ji, Yixin; Ren, Li; Gao, Lingyu; Zhang, Yan; Xu, Wenbo			Importance of real-time RT-PCR to supplement the laboratory diagnosis in the measles elimination program in China	PLOS ONE			English	Article							MONITORING PROGRESS; SURVEILLANCE; VIRUSES; RASH	In addition to high vaccination coverage, timely and accurate laboratory confirmation of measles cases is critical to interrupt measles transmission. To evaluate the role of real-time reverse transcription-polymerase chain reaction (RT-PCR) in the diagnosis of measles cases, 46,363 suspected measles cases with rash and 395 suspected measles cases without rash were analyzed in this study; the cases were obtained from the Chinese measles surveillance system (MSS) during 2014-2017 and simultaneously detected by measlesspecific IgM enzyme-linked immunosorbent assay (ELISA) and real-time RT-PCR. However, some IgM-negative measles cases were identified by real-time RT-PCR. The proportion of these IgM-negative and viral nucleic acid-positive measles cases was high among measles cases with measles vaccination history, cases without rash symptoms, and cases within 3 days of specimen collection after onset. The proportion of IgM-negative and viral nucleic acid-positive measles cases in the 0-3 day group was up to 14.4% for measles cases with rash and 40% for measles cases without rash. Moreover, the proportions of IgM-negative and nucleic acid-positive measles cases gradually increased with the increase in the measles vaccination dose. Therefore, integrated with IgM ELISA, real-time RT-PCR would greatly improve the accurate diagnosis of measles cases and avoid missing the measles cases, especially for measles cases during the first few days after onset when the patients were highly contagious and for measles cases with secondary vaccine failure. In conclusion, our study reconfirmed that IgM ELISA is the gold-standard detection assay for measles cases confirmation. However, real-time RT-PCR should be introduced and used to supplement the laboratory diagnosis, especially in the setting of pre-elimination and/or elimination wherever appropriate.	[Zhang, Yan; Xu, Wenbo] Natl Inst Viral Dis Control & Prevent, Minist Hlth, WHO WPRO Reg Reference Lab Measles Rubella, Beijing, Peoples R China; Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, Y; Xu, WB (corresponding author), Natl Inst Viral Dis Control & Prevent, Minist Hlth, WHO WPRO Reg Reference Lab Measles Rubella, Beijing, Peoples R China.	zhangyan9876543@163.com; wenbo_xu1@aliyun.com			Key Technologies R&D Program of the National Ministry of Science [2018ZX10713002, 2018ZX10711001, 2017ZX10104001-002, 2018ZX10713001-003]	Key Technologies R&D Program of the National Ministry of Science	This work was supported by the Key Technologies R&D Program of the National Ministry of Science (2018ZX10713002, 2018ZX10711001, 2017ZX10104001-002, and 2018ZX10713001-003).	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P373; Bankamp B, 2013, J CLIN VIROL, V58, P176, DOI 10.1016/j.jcv.2013.05.018; Benamar T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147154; Centers for Disease Control and Prevention (CDC), 2015, EPIDEMIOLOGY PREVENT; Chen M, 2015, EMERG INFECT DIS, V21, P477, DOI 10.3201/eid2103.140646; de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490; Eom H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188957; Helfand RF, 1997, J INFECT DIS, V175, P195, DOI 10.1093/infdis/175.1.195; Hubschen JM, 2017, CLIN MICROBIOL INFEC, V23, P511, DOI 10.1016/j.cmi.2017.04.009; Jiang YG, 2012, SCI TECHNOLOGY FOOD, V7, P16, DOI DOI 10.1371/J0URNAL.P0NE.0034401; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Paunio M, 2000, EPIDEMIOL INFECT, V124, P263, DOI 10.1017/S0950268899003222; Qiu Qi, 2017, Chinese Journal of Virology, V33, P169; Ren Li, 2016, Bing Du Xue Bao, V32, P453; Rota PA, 2002, EMERG INFECT DIS, V8, P902, DOI 10.3201/eid0809.020206; Rota PA, 2011, J INFECT DIS, V204, pS506, DOI 10.1093/infdis/jir117; Santibanez S, 2014, EUROSURVEILLANCE, DOI DOI 10.2807/1560-7917.ES2014.19.35.20891; Sun Xiao-Dong, 2013, Bing Du Xue Bao, V29, P583; Thomas S, 2017, EMERG INFECT DIS, V23, P1063, DOI 10.3201/eid2307.161145; Wang Hui-ling, 2010, Chinese Journal of Virology, V26, P103; Wang Shu-Lei, 2014, Bing Du Xue Bao, V30, P535; Woods CR, 2013, J PEDIATR INFECT DIS, V2, P87, DOI 10.1093/jpids/pis133; World Health Organization, 2012, WORLD HLTH STAT; World Health Organization, 2003, WHO REC STAND SURV S; Xu CP, 2017, J MICROBIOL IMMUNOL, V50, P578, DOI 10.1016/j.jmii.2015.10.004; Xu ST, 2014, J GEN VIROL, V95, P1892, DOI 10.1099/vir.0.066746-0; Xu WB, 2017, INT HEALTH, V9, P184, DOI 10.1093/inthealth/ihx017; Yang TU, 2015, INT J INFECT DIS, V33, P12, DOI 10.1016/j.ijid.2014.09.016; Zhang Y, 2014, CLIN MICROBIOL INFEC, V20, pO566, DOI 10.1111/1469-0691.12530; Zhang Y, 2010, EMERG INFECT DIS, V16, P943, DOI 10.3201/eid1606.100089	30	5	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208161	10.1371/journal.pone.0208161	http://dx.doi.org/10.1371/journal.pone.0208161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500842	Green Published, Green Submitted, gold			2022-12-26	WOS:000451883700026
J	Baranyi, A; Meinitzer, A; Rothenhausler, HB; Amouzadeh-Ghadikolai, O; Lewinski, DV; Breitenecker, RJ; Herrmann, M				Baranyi, Andreas; Meinitzer, Andreas; Rothenhaeusler, Hans-Bernd; Amouzadeh-Ghadikolai, Omid; Lewinski, Dirk, V; Breitenecker, Robert J.; Herrmann, Markus			Metabolomics approach in the investigation of depression biomarkers in pharmacologically induced immune-related depression	PLOS ONE			English	Article							ALPHA-INDUCED DEPRESSION; INTERFERON-ALPHA; AMINO-ACIDS; TRYPTOPHAN DEPLETION; SYMPTOMS	Background The aim of this study was to identify previously unrecognised biological pathways and biomarkers that might expand the inflammatory hypothesis of depression. Methods Broad metabolomics analyses in plasma samples from 31 chronic hepatitis C-infected patients with and without immune-related depression were carried out using the Absolute IDQ p180 kit-a targeted metabolomics approach of combined direct flow injection and liquid chromatography that measures acylcarnitines, amino acids, biogenic amines, glycerophospholipids, sphingolipids, and sugars. Results The measurements showed that the average concentration of the branched-chain amino acid isoleucine was significantly lower in depressive HCV patients in comparison to non-depressive HCV patients [depression group: Median 51.35 (43.4-60.2 mu mol/L) vs. Median 62.10 (38.4-81.7 mu mol/L); U = -2.958; p = 0.002]. All other amino acids, acylcarnitines, biogenic amines, glycerophospholipids, sphingolipids, sugars, liver enzymes and thyroid levels showed no statistically significant differences. Conclusions The results of the present study suggest that the branched-chain amino acid isoleucine might play a role in the pathophysiology of immune-related major depression, which expands existing knowledge about inflammatory hypothesis of depression.	[Baranyi, Andreas; Rothenhaeusler, Hans-Bernd] Med Univ Graz, Dept Psychiat & Psychotherapeut Med, Graz, Austria; [Meinitzer, Andreas; Herrmann, Markus] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Amouzadeh-Ghadikolai, Omid] LKH Graz Sud West, Graz, Austria; [Lewinski, Dirk, V] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria; [Breitenecker, Robert J.] Johannes Kepler Univ Linz, Inst Innovat Management, Linz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Johannes Kepler University Linz	Baranyi, A (corresponding author), Med Univ Graz, Dept Psychiat & Psychotherapeut Med, Graz, Austria.; Meinitzer, A (corresponding author), Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria.	an.baranyi@medunigraz.at; andreas.meinitzer@klinikum-_graz.at	Breitenecker, Robert/AAC-8012-2022; Breitenecker, Robert J/A-5633-2011; Breitenecker, Robert/R-8753-2019	Breitenecker, Robert/0000-0003-4485-5388; Breitenecker, Robert J/0000-0003-4485-5388; Breitenecker, Robert/0000-0003-4485-5388; Rothenhausler, Hans-Bernd/0000-0002-8857-8557; von Lewinski, Dirk/0000-0001-9996-6128; Baranyi, Andreas/0000-0003-2389-1945				American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, P160; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Baranyi A, 2017, PEERJ, V5, DOI 10.7717/peerj.3968; Baranyi A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43642; Baranyi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160542; Baranyi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137022; Baranyi A, 2014, PSYCHOSOM MED, V76, P197, DOI 10.1097/PSY.0000000000000042; Baranyi A, 2013, PSYCHOTHER PSYCHOSOM, V82, P332, DOI 10.1159/000348587; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Biocrates Life Sciences, 2010, ASP1802 BIOCR LIF SC; Bonaccorso S, 2002, J AFFECT DISORDERS, V72, P237, DOI 10.1016/S0165-0327(02)00264-1; Bonaccorso S, 2002, J CLIN PSYCHOPHARM, V22, P86, DOI 10.1097/00004714-200202000-00014; Capuron L, 2002, MOL PSYCHIATR, V7, P468, DOI 10.1038/sj.mp.4000995; Chess AC, 2007, SCHIZOPHRENIA BULL, V33, P797, DOI 10.1093/schbul/sbl033; DiazGranados N, 2010, J CLIN PSYCHIAT, V71, P1605, DOI 10.4088/JCP.09m05327blu; Dyachok J, 2016, J BIOL CHEM, V291, P22414, DOI 10.1074/jbc.M116.732511; Ferrari F, 2017, MOL NEUROBIOL, V54, P4847, DOI 10.1007/s12035-016-0032-y; Hamilton M., 1967, BR J SOC CLIN PSYCHO, V6, P78; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; LUCCA A, 1994, NEUROPSYCHOBIOLOGY, V29, P108, DOI 10.1159/000119071; McDonald J.H., 2014, HDB BIOL STAT; Mudecins du Monde and Treatment Action Group, 2016, MAPCROWD ONL GLOB DA; Neumeister A, 2005, AM J PSYCHIAT, V162, P805, DOI 10.1176/appi.ajp.162.4.805; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Rothenhausler HB, 2008, PSYCHIAT DANUB, V20, P301; Sekine A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0826-9; Webhofer C, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.56; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Woo HI, 2015, CNS NEUROSCI THER, V21, P417, DOI 10.1111/cns.12372; Yang C, 2013, BIOL PSYCHIAT, V73, pE35, DOI 10.1016/j.biopsych.2012.07.022; Yu JJ, 2013, PSYCHOPHARMACOLOGY, V225, P361, DOI 10.1007/s00213-012-2823-9	31	9	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208238	10.1371/journal.pone.0208238	http://dx.doi.org/10.1371/journal.pone.0208238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496323	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800114
J	Fausti, S; Kolady, DE; Van der Sluis, E; Lundgren, J; Qasmi, BA				Fausti, Scott; Kolady, Deepthi E.; Van der Sluis, Evert; Lundgren, Jonathan; Qasmi, Bashir A.			Extensive usage of insecticide and changing crop rotation patterns: A South Dakota case study	PLOS ONE			English	Article							PEST-MANAGEMENT; ADOPTION	Driven by factors such as an increased reliance on genetically modified crops, government policies, and market forces, the crop mix in South Dakota and elsewhere in the United States has become less diverse and moved toward the production of corn and soybeans as the most predominant cash crops over the past two decades. Coinciding with a reduced complexity of crop rotation practices, the prevalence of mono-cropping has increased and crop chemical usage has changed as well. Overall, the reduced reliance on traditional crop rotation practices for mitigating pests corresponds with an increase in crop acres treated with insecticides, expressed as a proportion of total cropland acres, and referred to in the literature as the extensive usage of insecticides. In this paper, we identify how changing cropping patterns in South Dakota have affected the extensive usage of insecticides, an aspect often overlooked by producers and policy makers. Results indicate that increased corn production has contributed to an increase in the share of cropland acres treated with insecticides at the county level in eastern South Dakota.	[Fausti, Scott] Calif State Univ, Coll Business, Monterey, CA USA; [Kolady, Deepthi E.; Van der Sluis, Evert; Qasmi, Bashir A.] South Dakota State Univ, Dept Econ, Brookings, SD 57007 USA; [Lundgren, Jonathan] Ecdysis Fdn, Blue Dasher Farm, Estelline, SD USA	South Dakota State University	Kolady, DE (corresponding author), South Dakota State Univ, Dept Econ, Brookings, SD 57007 USA.	Deepthi.kolady@sdstate.edu		fausti, scott/0000-0002-5218-7335; Kolady, Deepthi/0000-0002-2345-1950	National Institute of Food and Agriculture, South Dakota Agriculture Experiment Station; USDA-Hatch grant [SD00H488-13, 3AH629]; South Dakota Agricultural Experiment Station	National Institute of Food and Agriculture, South Dakota Agriculture Experiment Station; USDA-Hatch grant; South Dakota Agricultural Experiment Station	SF acknowledges the financial support from National Institute of Food and Agriculture, South Dakota Agriculture Experiment Station for the project. DEK acknowledges support from USDA-Hatch grant 3AH629 and EVS acknowledges the support from USDA-Hatch grant SD00H488-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SF, DEK, and EVS acknowledge the support from South Dakota Agricultural Experiment Station for this research.	Allison PD, 2006, SAS US GROUP INT P M; Benbrook Charles M., 2012, Environmental Sciences Europe, V24, P24, DOI 10.1186/2190-4715-24-24; Brookes Graham, 2013, GM Crops Food, V4, P109, DOI 10.4161/gmcr.24459; Brown H, 2015, STRUCTURE S DAKOTA A; Dill GM, 2008, PEST MANAG SCI, V64, P326, DOI 10.1002/ps.1501; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; EPA US, 2018, BIOF ENV 2 TRIENN C; Fausti S, 2018, HARVARD DATAVERSE; Fausti SW, 2015, ENVIRON SCI POLICY, V52, P41, DOI 10.1016/j.envsci.2015.04.017; Fausti SW, 2012, RENEW AGR FOOD SYST, V27, P295, DOI 10.1017/S1742170511000561; Fernandez-Cornejo J, 2002, ADOPTION BIOENGINEER; Fernandez-Cornejo J, 2005, AM AGR EC ASS ANN M; FOSTER RE, 1986, J ECON ENTOMOL, V79, P303, DOI 10.1093/jee/79.2.303; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Herron C., 2017, EXTENT TILE DRAINAGE; Jakka SRK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27860; LAZARUS WF, 1983, AM J AGR ECON, V65, P738, DOI 10.2307/1240462; NASS, 2015, QUICK STAT US ALL ST; Perry ED, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600850; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; SAS, 2011, SAS I US GUID 2011; SAS, 1999, SAS I US GUID, P2087; Vialou A, 2008, AM AGR EC ASS ANN M; Wooldridge J.M., 2000, INTRO ECONOMETRICS M; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	25	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208222	10.1371/journal.pone.0208222	http://dx.doi.org/10.1371/journal.pone.0208222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496269	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800112
J	Lyu, JF; Yu, YF; Pan, CX; Zhou, J; Ren, XY				Lyu, Jiangfeng; Yu, Yuefeng; Pan, Caixia; Zhou, Jing; Ren, Xuyi			Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes	PLOS ONE			English	Article							HPV VACCINATION; YOUNG-WOMEN; PREVALENCE; IDENTIFICATION; PATHOGENS	We describe a new assaying system for the detection and genotyping of human papillomavirus (HPV) based on linear-after-the-exponential-PCR(LATE-PCR) and melting curve analysis. The 23 most prevalent HPV strains (types 6, 11, 16, 18, 31, 33, 35, 39, 42, 45, 51, 52, 53, 56, 58, 59, 66, 68, 70, 73, 81, 82, and 83) are assayed in two sealed reaction tubes within 2 h. Good sensitivity and specificity was evaluated by testing cloned HPV DNA and clinical samples. The detection limit was 5-500 copies/reaction depending on the genotype. No cross-reactivity was observed with the other HPV types that are not covered by our method or pathogens tested which were commonly found in female genital tract. When compared with the HPV GenoArray Diagnostic kit, the results from 1104 clinical samples suggest good overall agreement between the two methods,(98.37%, 95% CI: 97.44%-98.97%) and the kappa value was 0.954. Overall, this new HPV genotyping assay system presents a simple, rapid, universally applicable, sensitive, and highly specific detection methodology that should be useful for HPV detection and genotyping, therefore, is potentially of great value in clinical application.	[Lyu, Jiangfeng; Yu, Yuefeng; Pan, Caixia; Zhou, Jing; Ren, Xuyi] Hangzhou DiAn Med Lab, Res & Dev Ctr, Hangzhou, Zhejiang, Peoples R China		Ren, XY (corresponding author), Hangzhou DiAn Med Lab, Res & Dev Ctr, Hangzhou, Zhejiang, Peoples R China.	destinylv@163.com		Ren, Xuyi/0000-0001-5829-8055				Austin RM, 2014, CYTOJOURNAL, V11, DOI 10.4103/1742-6413.132997; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Bruni L., 2017, ICO IARC INFORM CTR; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Chakravorty S, 2010, J CLIN MICROBIOL, V48, P258, DOI 10.1128/JCM.01725-09; Chen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032149; Chiba N, 2009, J INFECT CHEMOTHER, V15, P92, DOI 10.1007/s10156-009-0670-3; Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; El-Hajj HH, 2009, J CLIN MICROBIOL, V47, P1190, DOI 10.1128/JCM.02043-08; Gharizadeh B, 2001, LAB INVEST, V81, P673, DOI 10.1038/labinvest.3780276; Hwang SJ, 2012, J ONCOL, V2012, DOI 10.1155/2012/507286; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008, IARC Monogr Eval Carcinog Risks Hum, V97, P3; Kitchener HC, 2006, VACCINE S3, V24, pS3, DOI [DOI 10.1016/J.VACCINE.2006.05, 10.1016/j.vaccine.2006.05.113]; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Laamiri N, 2018, VIROLOGY, V515, P29, DOI 10.1016/j.virol.2017.11.021; Li BG, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1123-2; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Powell SE, 2012, VACCINE, V31, P109, DOI 10.1016/j.vaccine.2012.10.092; Rahman M M, 2017, Mymensingh Med J, V26, P614; Rao A, 2013, J CLIN MICROBIOL, V51, P1478, DOI 10.1128/JCM.03386-12; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Sun ZR, 2010, INT J GYNECOL OBSTET, V109, P105, DOI 10.1016/j.ijgo.2009.11.026; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; Tyagi S, 1998, NAT BIOTECHNOL, V16, P49, DOI 10.1038/nbt0198-49; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Xu Y, 2014, ANAL CHEM, V86, P5611, DOI 10.1021/ac5010458; Zeng ZY, 2016, J CANCER, V7, P1037, DOI 10.7150/jca.14971	29	0	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207930	10.1371/journal.pone.0207930	http://dx.doi.org/10.1371/journal.pone.0207930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496224	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800065
J	Navarro, DM; Mender, BMW; Smithson, HE; Stringer, SM				Navarro, Daniel M.; Mender, Bedeho M. W.; Smithson, Hannah E.; Stringer, Simon M.			Self-organising coordinate transformation with peaked and monotonic gain modulation in the primate dorsal visual pathway	PLOS ONE			English	Article							OBJECT RECOGNITION; PARIETAL CORTEX; GAZE; NEURONS; INTEGRATION; INVARIANCE; DIRECTION; FIELDS; MEMORY	We study a self-organising neural network model of how visual representations in the primate dorsal visual pathway are transformed from an eye-centred to head-centred frame of reference. The model has previously been shown to robustly develop head-centred output neurons with a standard trace learning rule, but only under limited conditions. Specifically it fails when incorporating visual input neurons with monotonic gain modulation by eye-position. Since eye-centred neurons with monotonic gain modulation are so common in the dorsal visual pathway, it is an important challenge to show how efferent synaptic connections from these neurons may self-organise to produce head-centred responses in a subpopulation of postsynaptic neurons. We show for the first time how a variety of modified, yet still biologically plausible, versions of the standard trace learning rule enable the model to perform a coordinate transformation from eye-centred to head-centred reference frames when the visual input neurons have monotonic gain modulation by eye-position.	[Navarro, Daniel M.; Mender, Bedeho M. W.; Stringer, Simon M.] Univ Oxford, Oxford Ctr Theoret Neurosci & Artificial Intellig, Dept Expt Psychol, South Parks Rd, Oxford, Oxon, England; [Navarro, Daniel M.; Smithson, Hannah E.] Univ Oxford, Dept Expt Psychol, Oxford Percept Lab, South Parks Rd, Oxford, Oxon, England	University of Oxford; University of Oxford	Navarro, DM (corresponding author), Univ Oxford, Oxford Ctr Theoret Neurosci & Artificial Intellig, Dept Expt Psychol, South Parks Rd, Oxford, Oxon, England.; Navarro, DM (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford Percept Lab, South Parks Rd, Oxford, Oxon, England.	daniel.navarro@psy.ox.ac.uk	Smithson, Hannah E/C-3218-2008; de Moraes Navarro, Daniel/C-1985-2014	Smithson, Hannah E/0000-0001-8904-8315; Navarro, Daniel/0000-0003-0401-009X	Science Without Borders Program of the National Council for Scientific and Technological Development of Brazil	Science Without Borders Program of the National Council for Scientific and Technological Development of Brazil	We gratefully acknowledge support from the Science Without Borders Program of the National Council for Scientific and Technological Development of Brazil (http://www.cnpq.br/) to DMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; [Anonymous], 1998, NEURAL NETWORKS BRAI; Breveglieri R, 2009, LECT NOTES COMPUT SC, V5602, P324, DOI 10.1007/978-3-642-02267-8_35; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Daddaoua N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4047; Dayan P, 2001, COMPUTATIONAL NEUROS; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Eguchi A, 2018, PSYCHOL REV, V125, P545, DOI 10.1037/rev0000103; Evans BD, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00046; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1991, EUR J NEUROSCI, V3, P452, DOI 10.1111/j.1460-9568.1991.tb00832.x; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Isbister JB, 2018, INTERFACE FOCUS, V8, DOI 10.1098/rsfs.2018.0021; Koch G, 2013, J NEUROSCI, V33, P9725, DOI 10.1523/JNEUROSCI.4988-12.2013; Kohonen T., 2012, SPRINGER SERIES INFO, V8, DOI DOI 10.1007/978-3-662-00784-6_5; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Li N, 2008, SCIENCE, V321, P1502, DOI 10.1126/science.1160028; MAZZONI P, 1991, P NATL ACAD SCI USA, V88, P4433, DOI 10.1073/pnas.88.10.4433; Mender BMW, 2014, NETWORK-COMP NEURAL, V25, P116, DOI 10.3109/0954898X.2014.918671; Mender BMW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081406; Merriam EP, 2013, J NEUROSCI, V33, P9879, DOI 10.1523/JNEUROSCI.0500-12.2013; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; ODONOHUE TL, 1985, TRENDS PHARMACOL SCI, V6, P305, DOI 10.1016/0165-6147(85)90141-5; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Page HJI, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00010; Perry G, 2006, VISION RES, V46, P3994, DOI 10.1016/j.visres.2006.07.025; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Rolls ET, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00035; Rolls ET, 2001, NETWORK-COMP NEURAL, V12, P111, DOI 10.1088/0954-898X/12/2/302; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Ruan HY, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00038; SALINAS E, 1995, J NEUROSCI, V15, P6461; Spratling MW, 2009, IEEE T AUTON MENT DE, V1, P253, DOI 10.1109/TAMD.2009.2038494; SWADLOW HA, 1992, J NEUROPHYSIOL, V68, P605, DOI 10.1152/jn.1992.68.2.605; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P1346, DOI 10.1152/jn.1985.54.5.1346; Swadlow HA, J NEUROPHYSIOL, V88, P1162; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Walters D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058330; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207961	10.1371/journal.pone.0207961	http://dx.doi.org/10.1371/journal.pone.0207961			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496225	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800069
J	Masso, S; Lopez-Pujol, J; Vilatersana, R				Masso, Sergi; Lopez-Pujol, Jordi; Vilatersana, Roser			Reinterpretation of an endangered taxon based on integrative taxonomy: The case of Cynara baetica (Compositae)	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; EFFECTIVE POPULATION-SIZE; SOUTHERN MIDDLE ATLAS; CHLOROPLAST DNA; LINKAGE DISEQUILIBRIUM; STIRLING PROBABILITY; SPECIES DELIMITATION; GENETIC DIVERSITY; EVOLUTION; ASTERACEAE	The Strait of Gibraltar, the gateway between the Atlantic Ocean and the Mediterranean Sea, has a convulsive geological history, with recurring closing and opening events since the late Miocene. As a consequence, this region has played a major role in the evolutionary history of many species. Cynara baetica (Compositae) is a diploid perennial herb distributed in both sides of this strait. It is currently subdivided into two subspecies: C. baetica subsp. baetica for the Spanish populations, and C. baetica subsp. maroccana for the Moroccan ones. Following three different approximations of species delimitation, including phylogenetic and population genetic analyses (based on three AFLP primer combinations and two intergenic spacers of cpDNA), ecological niche modeling (ENM) and morphological studies, this taxon is investigated and reinterpreted. The results obtained showed a clear genetic, morphological and ecological differentiation between the two taxa and the important role played by the Strait of Gibraltar as a geographical barrier. Based on this evidence, the current taxonomic treatment is modified (both taxa should recover their specific rank) and specific conservation guidelines are proposed for the newly delimited taxa.	[Masso, Sergi; Lopez-Pujol, Jordi; Vilatersana, Roser] CSIC ICUB, Bot Inst Barcelona IBB, Barcelona, Catalonia, Spain; [Masso, Sergi] Univ Barcelona, Lab Bot, Fac Farm, BioC GReB, Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Botanic de Barcelona (ICUB); University of Barcelona	Masso, S (corresponding author), CSIC ICUB, Bot Inst Barcelona IBB, Barcelona, Catalonia, Spain.; Masso, S (corresponding author), Univ Barcelona, Lab Bot, Fac Farm, BioC GReB, Barcelona, Catalonia, Spain.	sergimasso@gmail.com	Massó, Sergi/AAB-3998-2021; Vilatersana, Roser/L-9472-2014	Massó, Sergi/0000-0003-3786-4331; Vilatersana, Roser/0000-0002-5106-8764	ADR fellowship (Universitat de Barcelona, Spain); Spanish Ministerio de Ciencia e Inovacion (Spanish Government) [CGL2007-60781, CGL2010/18631]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya) [2009SGR0439, 2014SGR514]	ADR fellowship (Universitat de Barcelona, Spain); Spanish Ministerio de Ciencia e Inovacion (Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	An ADR fellowship (Universitat de Barcelona, Spain) was awarded to S. Masso for his PhD studies. This work has been supported by the Financial support from the Spanish Ministerio de Ciencia e Inovacion (Spanish Government; projects CGL2007-60781 and CGL2010/18631) and the Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya) (2009SGR0439 and 2014SGR514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1997, J ARCHAEOL SCI, V24, P623, DOI 10.1006/jasc.1996.0146; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aleksic JM, 2018, PLANT SYST EVOL, V304, P549, DOI 10.1007/s00606-018-1490-7; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Arik M, 1998, J PHYS A-MATH GEN, V31, P1121, DOI 10.1088/0305-4470/31/4/003; Arroyo J, 2008, BIOL J LINN SOC, V93, P39, DOI 10.1111/j.1095-8312.2007.00916.x; Babault J, 2013, GEOL SOC SPEC PUBL, V377, P141, DOI 10.1144/SP377.14; Bachmann K, 1998, THEOR BIOSCI, V117, P213; Ball J., 1873, J BOT BRIT FOREIGN, V11, P364; Barres L, 2013, AM J BOT, V100, P867, DOI 10.3732/ajb.1200058; Beauchamp W, 1996, AAPG BULL, V80, P1459; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Blanca G., 2011, FLORA VASCULAR ANDAL, P184; Boissier E, 1839, VOYAGE BOT MIDI ESPA, VI; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Cabezudo B, 2005, LISTA ROJA FLORA VAS; Caujape-Castells J, 2003, MOL ECOL, V12, P1515, DOI 10.1046/j.1365-294X.2003.01839.x; Cheddadi R, 2009, J BIOGEOGR, V36, P1361, DOI 10.1111/j.1365-2699.2008.02063.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coart E, 2005, CONSERV GENET, V6, P259, DOI 10.1007/s10592-004-7833-7; Collina-Girard J., 2001, C R ACAD SCI PARIS A, VIIa, P233, DOI DOI 10.1016/S1251-8050(01)01629-9; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cullings KW, 1992, MOL ECOL, V1, P233, DOI 10.1111/j.1365-294X.1992.tb00182.x; Curci PL, 2016, MOL ECOL RESOUR, V16, P562, DOI 10.1111/1755-0998.12457; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Candolle A. P, 1838, PRODROMUS SYSTEMATIS, V6; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dixon CJ, 2006, MOL ECOL NOTES, V6, P650, DOI 10.1111/j.1471-8286.2006.01411.x; Donner LJ, 2011, J CLIMATE, V24, P3484, DOI 10.1175/2011JCLI3955.1; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El Azzouzi M, 2010, B SOC GEOL FR, V181, P243, DOI 10.2113/gssgfbull.181.3.243; England PR, 2006, CONSERV GENET, V7, P303, DOI 10.1007/s10592-005-9103-8; Escudero M, 2008, AM J BOT, V95, P745, DOI 10.3732/ajb.2007342; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fennane M., 2017, ELEMENTS LIVRE ROUGE; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; Foury C., 1984, Proceedings of the 5th International Symposium on Pollination, Versailles, 1983, P329; Fritz Uwe, 2005, Salamandra, V41, P97; Gallego M. J, 1981, LAGASCALIA, V10, P225; Garrett C., 1996, B LINSTITUT OCEANOGR, V17, P1; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gilbert J., 2003, Human Evolution, V18, P147; Hamilton MB, 1999, MOL ECOL, V8, P521; Hampe A, 2003, MOL ECOL, V12, P3415, DOI 10.1046/j.1365-294X.2003.02006.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hendrixson BE, 2013, MOL PHYLOGENET EVOL, V66, P327, DOI 10.1016/j.ympev.2012.10.004; Herrera CM, 2008, HEREDITY, V100, P275, DOI 10.1038/sj.hdy.6801072; Hershkovitz Mark A, 2006, Gayana Bot., V63, P13; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoogakker BAA, 2016, CLIM PAST, V12, P51, DOI 10.5194/cp-12-51-2016; Hublin J-J, 2012, MODERN ORIGINS N AFR; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jaramillo-Correa JP, 2010, MOL ECOL, V19, P5452, DOI 10.1111/j.1365-294X.2010.04912.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jimenez-Lopez FJ, 2016, ALPINE BOT, V126, P73, DOI 10.1007/s00035-016-0163-9; Jones KE, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0766-1; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Lagasca M., 1805, VARIED 101, V2, P212; Laville E, 2007, INT J EARTH SCI, V96, P497, DOI 10.1007/s00531-006-0113-7; LEROY S, 1994, PALAEOGEOGR PALAEOCL, V109, P295, DOI 10.1016/0031-0182(94)90181-3; Lumaret R, 2002, MOL ECOL, V11, P2327, DOI 10.1046/j.1365-294X.2002.01611.x; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Mairal M, 2017, J BIOGEOGR, V44, P911, DOI 10.1111/jbi.12930; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Maranon T, 1999, FOREST ECOL MANAG, V115, P147, DOI 10.1016/S0378-1127(98)00395-8; Marushia RG, 2006, BIOL INVASIONS, V8, P577, DOI 10.1007/s10530-005-1601-6; Masso S, LAB BOT FACULTAT FAR, V28, P1; McKay BD, 2013, MOL ECOL, V22, P4943, DOI 10.1111/mec.12446; McNEILL J., 2012, INT CODE NOMENCLATUR; McSweeney CF, 2015, CLIM DYNAM, V44, P3237, DOI 10.1007/s00382-014-2418-8; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Mikolajewicz U, 2011, CLIM PAST, V7, P161, DOI 10.5194/cp-7-161-2011; Molina-Venegas R, 2013, ECOL EVOL, V3, P3879, DOI 10.1002/ece3.762; Moreno J. C., 2008, LISTA ROJA 2008 FLOR; Morison N, 2000, APIDOLOGIE, V31, P115, DOI 10.1051/apido:2000110; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nassif Fatima, 2013, Lazaroa, V34, P117, DOI 10.5209/rev_LAZA.2013.v34.n1.40753; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ortiz MA, 2007, MOL ECOL, V16, P541, DOI 10.1111/j.1365-294X.2006.03157.x; Pau C., 1923, BOL REAL SOC ESP HIS, V23, P245; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Penas J, 2016, PEERJ, V4, DOI 10.7717/peerj.1474; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Mijarra JMP, 2009, J BIOGEOGR, V36, P2025, DOI 10.1111/j.1365-2699.2009.02142.x; Pritchard JK, 2000, GENETICS, V155, P945; QUEZEL P, 1978, ANN MO BOT GARD, V65, P479, DOI 10.2307/2398860; Rhattas M., 2016, Journal of Applied Biosciences, V97, P9187, DOI 10.4314/jab.v97i1.5; Rhoujjati A, 2010, J ARID ENVIRON, V74, P737, DOI 10.1016/j.jaridenv.2009.09.006; Robba L, 2005, PLANT SYST EVOL, V253, P53, DOI 10.1007/s00606-004-0259-3; Rodriguez-Sanchez F, 2008, GLOBAL ECOL BIOGEOGR, V17, P685, DOI 10.1111/j.1466-8238.2008.00410.x; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rottenberg A, 1996, GENET RESOUR CROP EV, V43, P53, DOI 10.1007/BF00126940; Rottenberg A, 2015, ISR J PLANT SCI, V62, P33, DOI 10.1080/07929978.2014.887379; Salicini I, 2013, J BIOGEOGR, V40, P1182, DOI 10.1111/jbi.12062; Sanchez-Robles JM, 2014, MOL PHYLOGENET EVOL, V79, P42, DOI 10.1016/j.ympev.2014.06.005; Sanmartin I, 2003, J BIOGEOGR, V30, P1883, DOI 10.1046/j.0305-0270.2003.00982.x; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Su X, 2015, ANN BOT-LONDON, V116, P35, DOI 10.1093/aob/mcv062; Tabel J, 2016, J QUATERNARY SCI, V31, P93, DOI 10.1002/jqs.2841; Tang CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43822; Tel-Zur N, 1999, PLANT MOL BIOL REP, V17, P249, DOI 10.1023/A:1007656315275; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thompson RS, 1996, MAR MICROPALEONTOL, V27, P27, DOI 10.1016/0377-8398(95)00051-8; Tignor M., 2013, CLIMATE CHANGE 2013; Tzedakis PC, 2007, QUATERNARY SCI REV, V26, P2042, DOI 10.1016/j.quascirev.2007.03.014; Valdes B., 1991, CHRON BOT, V10, P117; Valdes B., 1993, INTRO FLORA ANDALUZA, P19; Vargas P, 1999, AM J BOT, V86, P724, DOI 10.2307/2656582; Vekemans X., 2002, LABORATOIRE DE GENET; Vilatersana R, 2016, BIOL INVASIONS, V18, P2045, DOI 10.1007/s10530-016-1150-1; Vilatersana R, 2010, SYST BOT, V35, P907, DOI 10.1600/036364410X539952; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 1991, NMFSFNWC194 NW FISH; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; WIKLUND A, 1992, BOT J LINN SOC, V109, P75, DOI 10.1111/j.1095-8339.1992.tb00260.x; Wiklund A, 1989, LAZAROA, V11, P19; Woillez MN, 2011, CLIM PAST, V7, P557, DOI 10.5194/cp-7-557-2011; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	132	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207094	10.1371/journal.pone.0207094	http://dx.doi.org/10.1371/journal.pone.0207094			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485285	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800043
J	Piper, BJ; Ogden, CL; Simoyan, OM; Chung, DY; Caggiano, JF; Nichols, SD; McCall, KL				Piper, Brian J.; Ogden, Christy L.; Simoyan, Olapeju M.; Chung, Daniel Y.; Caggiano, James F.; Nichols, Stephanie D.; McCall, Kenneth L.			Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; MEDICATION USE; HEALTH-CARE; INSURED YOUTHS; ADHD; CHILDREN; PREVALENCE; DIAGNOSIS; ADOLESCENTS	Background Stimulants are considered the first-line treatment for Attention Deficit Hyperactivity Disorder (ADHD) in the US and they are used in other indications. Stimulants are also diverted for non-medical purposes. Ethnic and regional differences in ADHD diagnosis and in stimulant use have been identified in earlier research. The objectives of this report were to examine the pharmacoepidemiological pattern of these controlled substances over the past decade and to conduct a regional analysis. Methods Data (drug weights) reported to the US Drug Enforcement Administration's Automation of Reports and Consolidated Orders System for four stimulants (amphetamine, methylphenidate, lisdexamfetamine, and methamphetamine) were obtained from 2006 to 2016 for Unites States/Territories. Correlations between state level use (mg/person) and Hispanic population were completed. Results Amphetamine use increased 2.5 fold from 2006 to 2016 (7.9 to 20.0 tons). Methylphenidate use, at 16.5 tons in 2006, peaked in 2012 (19.4 tons) and subsequently showed a modest decline (18.6 tons in 2016). The consumption per municipality significantly increased 7.6% for amphetamine and 5.5% for lisdexamfetamine but decreased 2.7% for methylphenidate (all p < .0005) from 2015 to 2016. Pronounced regional differences were also observed. Lisdexamfetamine use in 2016 was over thirty-fold higher in the Southern US (43.8 mg/person) versus the Territories (1.4 mg/person). Amphetamine use was about one-third lower in the West (48.1 mg/person) relative to the Northeastern (75.4 mg/person, p < .05) or the Midwestern (69.9 mg/person, p <= .005) states. States with larger Hispanic populations had significantly lower methylphenidate (r(49) = -0.63), lisdexamfetamine (B, r(49) = -0.49), and amphetamine (r(49) = -0.43) use. Conclusions Total stimulant usage doubled in the last decade. There were dynamic changes but also regional disparities in the use of stimulant medications. Future research is needed to better understand the reasons for the sizable regional and ethnic variations in use of these controlled substances.	[Piper, Brian J.; Ogden, Christy L.; Simoyan, Olapeju M.; Chung, Daniel Y.; Caggiano, James F.] Geisinger Commonwealth Sch Med, Dept Med Educ, Scranton, PA 18510 USA; [Simoyan, Olapeju M.] Geisinger Marworth Alcohol & Chem Dependency Trea, Dept Addict Med, Waverly, PA USA; [Nichols, Stephanie D.] Husson Univ, Dept Pharm Practice, Sch Pharm, Bangor, ME USA; [Nichols, Stephanie D.] Tufts Univ, Sch Med, Dept Psychiat, Boston, MA 02111 USA; [McCall, Kenneth L.] Univ New England, Coll Pharm, Dept Pharm Practice, Portland, ME USA	Tufts University; University of New England - Maine	Piper, BJ (corresponding author), Geisinger Commonwealth Sch Med, Dept Med Educ, Scranton, PA 18510 USA.	bpiper@som.geisinger.edu	McCall, Kenneth/AAO-4562-2021; Pharmacy Practice, Binghamton University/AAD-2844-2022	Nichols, Stephanie/0000-0001-9035-5953; Chung, Daniel/0000-0002-3138-4145; Piper, Brian/0000-0002-2295-445X	National Institute of Environmental Health Sciences [T32 ES007060-31A1]; Husson University School of Pharmacy [2013-01]; Fahs-Beck Fund for Research and Experimentation [2017-01]; Fahs-Beck Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007060] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Husson University School of Pharmacy; Fahs-Beck Fund for Research and Experimentation; Fahs-Beck Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the National Institute of Environmental Health Sciences (T32 ES007060-31A1), Husson University School of Pharmacy to BJP (2013-01) and the Fahs-Beck Fund for Research and Experimentation to BJP (2017-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was completed using software provided by the NIEHS (T32 ES007060-31A1) and Husson University School of Pharmacy. BJP and DYC were supported by a Fahs-Beck Fellowship. The technical assistance of Iris Johnson and the DEA's commitment to making the ARCOS data publically available is gratefully appreciated. Melissa L. Danielson, MSPH and Brian V Entler, MS provided feedback on an earlier version of this manuscript.	Aldridge J, 2016, INT J DRUG POLICY, V35, P7, DOI 10.1016/j.drugpo.2016.04.020; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Anderson KN, 2018, MMWR-MORBID MORTAL W, V67, P66, DOI 10.15585/mmwr.mm6702a3; Bachmann CJ, 2017, EUR NEUROPSYCHOPHARM, V27, P484, DOI 10.1016/j.euroneuro.2017.03.002; Bachmann CJ, 2017, DTSCH ARZTEBL INT, V114, P141, DOI 10.3238/arztebl.2017.0141; Batstra L, 2012, J NERV MENT DIS, V200, P486, DOI 10.1097/NMD.0b013e318257c4b6; Bauermeister JJ, 2005, ADHD REPORT, V13, P5, DOI [10.1521/adhd.2005.13.3.5, DOI 10.1521/ADHD.2005.13.3.5]; Bird HR, 2008, J AM ACAD CHILD PSY, V47, P879, DOI 10.1097/CHI.0b013e318179963c; Boesen Kim, 2017, Evid Based Med, V22, P143, DOI 10.1136/ebmed-2017-110716; Bokhari FAS, 2011, J HEALTH ECON, V30, P355, DOI 10.1016/j.jhealeco.2011.01.007; Brault MC, 2012, CAN J PSYCHIAT, V57, P93, DOI 10.1177/070674371205700206; Brikell I, 2015, AM J MED GENET B, V168, P406, DOI 10.1002/ajmg.b.32335; Brown NM, 2017, ACAD PEDIATR, V17, P349, DOI 10.1016/j.acap.2016.08.013; Bui AL, 2017, JAMA PEDIATR, V171, P181, DOI 10.1001/jamapediatrics.2016.4086; Burcu M, 2016, JAMA PSYCHIAT, V73, P992, DOI 10.1001/jamapsychiatry.2016.1182; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Coker TR, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0407; Conrad P, 2014, SOC SCI MED, V122, P31, DOI 10.1016/j.socscimed.2014.10.019; Coon ER, 2014, PEDIATRICS, V134, P1013, DOI 10.1542/peds.2014-1778; Cosgrove L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001190; Dalsgaard S, 2014, J CHILD ADOL PSYCHOP, V24, P302, DOI 10.1089/cap.2014.0020; Danielson ML, 2018, J CLIN CHILD ADOLESC, V47, P199, DOI 10.1080/15374416.2017.1417860; Davidovitch M, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0971-0; Frankel Andrew Dathan, 2009, 2009 6 IEEE CONS COM, P1, DOI [10.1109/CCNC.2009.4784910, DOI 10.1109/CCNC.2009.4784910]; Franz AP, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1645; Fulton BD, 2015, PSYCHIAT SERV, V66, P1074, DOI 10.1176/appi.ps.201400145; Fusar-Poli P, 2012, AM J PSYCHIAT, V169, P264, DOI 10.1176/appi.ajp.2011.11060940; Gleeson D, 2018, INT J HEALTH POLICY, V7, P98, DOI 10.15171/ijhpm.2017.124; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Harrison, 2004, ADHD REPORT, V12, P8, DOI [DOI 10.1016/j.comppsych.2004.02.006, 10.1521/adhd.12.6.8.55256, DOI 10.1521/ADHD.12.6.8.55256]; Harrison AG, ADHD REPORT, V14, P1; Harrison AG, 2007, ARCH CLIN NEUROPSYCH, V22, P577, DOI 10.1016/j.acn.2007.03.008; Hinshaw SP, 2018, ANNU REV CLIN PSYCHO, V14, P291, DOI [10.1146/annurev-clinpsy-050817-084917, 10.1146/annurev-clinpsy-050817084917]; Hoagwood KE, 2016, HEALTH AFFAIR, V35, P1266, DOI 10.1377/hlthaff.2015.1423; Hobson WL, 2011, PEDIATRICS, V128, P1, DOI 10.1542/peds.2011-0662; Hulkower RL, 2015, PUBLIC HLTH REP, V132, P654; Jachimowicz G., 2004, COGNITIVE SCI ONLINE, V2, P6; Jasinski LJ, 2011, CLIN NEUROPSYCHOL, V25, P1415, DOI 10.1080/13854046.2011.630024; Jensen PS, 1999, J AM ACAD CHILD PSY, V38, P797, DOI 10.1097/00004583-199907000-00008; Ji X, 2018, PSYCHIAT SERV, V69, P322, DOI 10.1176/appi.ps.201600469; Kaland ME, 2015, CLIN TOXICOL, V53, P477, DOI 10.3109/15563650.2015.1027903; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lang HC, 2010, HEALTH POLICY, V97, P71, DOI 10.1016/j.healthpol.2010.03.005; Leon KS, 2017, J PSYCHOACTIVE DRUGS, V49, P22, DOI 10.1080/02791072.2016.1260187; Moll GH, 2011, J CHILD ADOL PSYCHOP, V11, P15; Moncrieff J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c547; Mueller AK, 2012, ADHD-ATTEND DEFICIT, V4, P101, DOI 10.1007/s12402-012-0085-3; National Academies of Sciences Engineering and Medicine, 2015, MENT DIS DIS LOW INC; NICE, 2018, ATTENTION DEFICIT HY; Nyarko KA, 2017, J CHILD ADOL PSYCHOP, V27, P731, DOI 10.1089/cap.2016.0196; Panther Shannon G, 2017, J Pediatr Pharmacol Ther, V22, P423, DOI 10.5863/1551-6776-22.6.423; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Paris J, 2015, CAN J PSYCHIAT, V60, P324, DOI 10.1177/070674371506000705; Piper BJ, 2018, AM J PREV MED, V54, P652, DOI 10.1016/j.amepre.2018.01.034; Piper BJ, 2016, J STUD ALCOHOL DRUGS, V77, P556, DOI 10.15288/jsad.2016.77.556; Piper BJ, 2012, NICOTINE TOB RES, V14, P191, DOI 10.1093/ntr/ntr181; Piper BJ, 2011, PHARMACOL BIOCHEM BE, V98, P432, DOI 10.1016/j.pbb.2011.02.013; Punja S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009996.pub2; Russell G, 2014, J CHILD PSYCHOL PSYC, V55, P436, DOI 10.1111/jcpp.12170; Safer DJ, 2016, J ATTEN DISORD, V20, P471, DOI 10.1177/1087054715605915; Scheffler RM, 2007, HEALTH AFFAIR, V26, P450, DOI 10.1377/hlthaff.26.2.450; Scheffler RM, 2009, PEDIATRICS, V123, P1273, DOI 10.1542/peds.2008-1597; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Schulenberg JE., 2018, MONITORING FUTURE NA, DOI [10.3998/2027.42/146531, DOI 10.3998/2027.42/146531]; Seth P, 2018, MMWR-MORBID MORTAL W, V67, P349, DOI 10.15585/mmwr.mm6712a1; Skinner AC, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-1916, 10.1542/peds.2017-3459, 10.1542/peds.2018-0725]; Smith ST, 2017, PSYCHOL ASSESSMENT, V29, P1447, DOI 10.1037/pas0000435; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Somkuwar SS, 2013, BIOCHEM PHARMACOL, V86, P309, DOI 10.1016/j.bcp.2013.04.013; Stettin, 2018, EXPRESS SCRIPTS 2017; Storebo OJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009885.pub2; Strawn Matthew N, 2003, J Contemp Health Law Policy, V19, P495; Substance Abuse and Mental Health Services Administration, 2017, KEY SUBST US MENT HL; Taras H, 2005, J SCHOOL HEALTH, V75, P248, DOI 10.1111/j.1746-1561.2005.00033.x; Visser S. N., 2010, Morbidity and Mortality Weekly Report, V59, P1439; VISSER SN, 2013, PREV CHRONIC DIS, V10; Visser SN, 2016, MMWR-MORBID MORTAL W, V65, P443, DOI 10.15585/mmwr.mm6517e1; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wang TT, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1187-9; Winterstein AG, 2017, J CLIN PSYCHIAT, V78, pE774, DOI 10.4088/JCP.16m10884; Yolton K, 2014, NEUROTOXICOL TERATOL, V44, P30, DOI 10.1016/j.ntt.2014.05.003	83	58	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206100	10.1371/journal.pone.0206100	http://dx.doi.org/10.1371/journal.pone.0206100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485268	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800014
J	Fu, YL; Han, DY; Wang, YJ; Di, XJ; Yu, HB; Mu, TW				Fu, Yan-Lin; Han, Dong-Yun; Wang, Ya-Juan; Di, Xiao-Jing; Yu, Hai-Bo; Mu, Ting-Wei			Remodeling the endoplasmic reticulum proteostasis network restores proteostasis of pathogenic GABA(A) receptors	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; GAMMA-AMINOBUTYRIC-ACID; CELL-SURFACE EXPRESSION; DE-NOVO MUTATIONS; QUALITY-CONTROL; EXTRACELLULAR AGGREGATION; MOLECULAR CHAPERONE; SIGNALING PATHWAYS; EPILEPSY MUTATION; DEGRADATION	Biogenesis of membrane proteins is controlled by the protein homeostasis (proteostasis) network. We have been focusing on protein quality control of.-aminobutyric acid type A (GABA(A)) receptors, the major inhibitory neurotransmitter-gated ion channels in mammalian central nervous system. Proteostasis deficiency in GABA(A) receptors causes loss of their surface expression and thus function on the plasma membrane, leading to epilepsy and other neurological diseases. One well-characterized example is the A322D mutation in the a1 subunit that causes its extensive misfolding and expedited degradation in the endoplasmic reticulum (ER), resulting in autosomal dominant juvenile myoclonic epilepsy. We aimed to correct misfolding of the a1(A322D) subunits in the ER as an approach to restore their functional surface expression. Here, we showed that application of BIX, a specific, potent ER resident HSP70 family protein BiP activator, significantly increases the surface expression of the mutant receptors in human HEK293T cells and neuronal SH-SY5Y cells. BIX attenuates the degradation of a1(A322D) and enhances their forward trafficking and function. Furthermore, because BiP is one major target of the two unfolded protein response (UPR) pathways: ATF6 and IRE1, we continued to demonstrate that modest activations of the ATF6 pathway and IRE1 pathway genetically enhance the plasma membrane trafficking of the a1(A322D) protein in HEK293T cells. Our results underlie the potential of regulating the ER proteostasis network to correct loss-of-function protein conformational diseases.	[Fu, Yan-Lin; Han, Dong-Yun; Di, Xiao-Jing; Mu, Ting-Wei] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wang, Ya-Juan] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Ya-Juan] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Yu, Hai-Bo] Univ Wollongong, Sch Chem & Mol Biosci, Wollongong, NSW, Australia; [Yu, Hai-Bo] Univ Wollongong, Mol Horizons, Wollongong, NSW, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Wollongong; University of Wollongong	Mu, TW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	tingwei.mu@case.edu	Yu, Haibo/B-9750-2008; Mu, Tingwei/AAU-8596-2020	Yu, Haibo/0000-0002-1099-2803; Mu, Tingwei/0000-0002-6419-9296; Wang, Yajuan (Megan)/0000-0002-3284-9012	National Institute of Health [R01NS105789]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105789] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health (R01NS105789 to TM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Arain F, 2015, NEUROBIOL DIS, V82, P164, DOI 10.1016/j.nbd.2015.05.016; Barnes EM, 2001, INT REV NEUROBIOL, V48, P1, DOI 10.1016/S0074-7742(01)48012-3; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Buck TM, 2017, BIOCHEM J, V474, P357, DOI 10.1042/BCJ20160760; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Chen JJ, 2014, CHEM BIOL, V21, P1564, DOI 10.1016/j.chembiol.2014.09.009; Chen XM, 2017, NEUROBIOL DIS, V108, P213, DOI 10.1016/j.nbd.2017.08.020; Chiang WC, 2012, INVEST OPHTH VIS SCI, V53, P7159, DOI 10.1167/iovs.12-10222; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cooley CB, 2014, P NATL ACAD SCI USA, V111, P13046, DOI 10.1073/pnas.1406050111; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Di XJ, 2016, J BIOL CHEM, V291, P9526, DOI 10.1074/jbc.M115.705004; Di XJ, 2013, CHEM BIOL, V20, P1456, DOI 10.1016/j.chembiol.2013.09.020; Ding L, 2010, J BIOL CHEM, V285, P26390, DOI 10.1074/jbc.M110.142299; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Eshaq RS, 2010, BRAIN RES, V1346, P1, DOI 10.1016/j.brainres.2010.05.030; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; Fu YL, 2016, ADV PROTEIN CHEM STR, V103, P1, DOI 10.1016/bs.apcsb.2015.11.002; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hamdan FF, 2017, AM J HUM GENET, V101, P664, DOI 10.1016/j.ajhg.2017.09.008; Han DY, 2015, ACS CHEM BIOL, V10, P2135, DOI 10.1021/acschembio.5b00479; Han DY, 2015, J BIOL CHEM, V290, P325, DOI 10.1074/jbc.M114.580324; Hirose S, 2014, PROG BRAIN RES, V213, P55, DOI 10.1016/B978-0-444-63326-2.00003-X; Inokuchi Y, 2009, INVEST OPHTH VIS SCI, V50, P334, DOI 10.1167/iovs.08-2123; Jefferson RE, 2018, J MOL BIOL, V430, P424, DOI 10.1016/j.jmb.2017.05.021; Johannesen K, 2016, NEUROLOGY, V87, P1140, DOI 10.1212/WNL.0000000000003087; Kodera H, 2016, EPILEPSIA, V57, P566, DOI 10.1111/epi.13344; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Lachance-Touchette P, 2011, EUR J NEUROSCI, V34, P237, DOI 10.1111/j.1460-9568.2011.07767.x; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Martenson J, 2017, ELIFE, V6, DOI 10.7554/eLife.27443; Merulla J, 2015, MOL BIOL CELL, V26, P1532, DOI 10.1091/mbc.E14-12-1615; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Morishima N, 2011, J BIOL CHEM, V286, P35227, DOI 10.1074/jbc.M111.233502; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; O'Donnell BM, 2017, CHANNELS, V11, P499, DOI 10.1080/19336950.2017.1357944; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Plate L, 2017, TRENDS CELL BIOL, V27, P722, DOI 10.1016/j.tcb.2017.05.006; Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003; Reinthaler EM, 2015, ANN NEUROL, V77, P972, DOI 10.1002/ana.24395; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Ryno LM, 2013, CURR OPIN CHEM BIOL, V17, P346, DOI 10.1016/j.cbpa.2013.04.009; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen DD, 2017, BRAIN, V140, P49, DOI 10.1093/brain/aww272; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Smith SE, 2011, J BIOL CHEM, V286, P41563, DOI 10.1074/jbc.M111.280073; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Steinlein OK, 2012, CHEM REV, V112, P6334, DOI 10.1021/cr300044d; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang YJ, 2014, PHARMACOL RES, V83, P3, DOI 10.1016/j.phrs.2014.04.002; Yamasaki T, 2017, NEURON, V93, P1138, DOI 10.1016/j.neuron.2017.02.023; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zhu ST, 2018, NATURE, V559, P67, DOI 10.1038/s41586-018-0255-3	72	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207948	10.1371/journal.pone.0207948	http://dx.doi.org/10.1371/journal.pone.0207948			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481215	Green Published, gold			2022-12-26	WOS:000451440000032
J	Mahanna-Gabrielli, E; Miano, TA; Augoustides, JG; Kim, C; Bavaria, JE; Kofke, WA				Mahanna-Gabrielli, Elizabeth; Miano, Todd A.; Augoustides, John G.; Kim, Cecilia; Bavaria, Joseph E.; Kofke, W. Andrew			Does the melatonin receptor 1B gene polymorphism have a role in postoperative delirium?	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; MELATONIN; MTNR1B; RISK; RS10830963; CONFUSION; VARIANTS; OUTCOMES; DISEASE; EVENTS	Introduction Patients undergoing cardiac surgery are at high risk for postoperative delirium, which is associated with longer hospital and intensive care lengths of stays, increased morbidity and mortality. Because sleep disturbances are common in delirium, melatonin has been an area of interest in the treatment of delirium. The rs10830963 single nucleotide polymorphism of the melatonin receptor 1B gene can cause pathological dysfunction of this receptor and is associated with delayed morning offset of melatonin. We hypothesized patients undergoing aortic cardiac surgery who have the risk genotype of a melatonin receptor 1B polymorphism would have a higher incidence of postoperative delirium. Methods Ninety-eight patients undergoing aortic root or valve surgery underwent analysis for melatonin receptor 1B single nucleotide polymorphism, rs10830963. Using a validated method, CHART-DEL, all charts were retrospectively reviewed and scored for the presence of delirium while blinded to the results of the melatonin receptor 1B gene polymorphism. Results Genotyping for melatonin receptor 1B polymorphism was acceptable in 76 subjects of European descent of which 18 (23.7%) had delirium. Four of seven subjects with the risk genotype had delirium versus only 20.3% of subjects without the risk genotype. This carried an odds ratio of 5.2 (1.0, 26.1), p = 0.050. Conclusion This observation suggests a role of the risk genotype of a melatonin receptor 1B polymorphism in the development of postoperative delirium. These hypotheses generating results warrant further prospective studies in a larger cohort group with delirium, circadian rhythm and melatonin assessments.	[Mahanna-Gabrielli, Elizabeth; Augoustides, John G.; Kofke, W. Andrew] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Miano, Todd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kim, Cecilia] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Bavaria, Joseph E.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Mahanna-Gabrielli, E; Kofke, WA (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	lizm@alumni.rice.edu; kofkea@uphs.upenn.edu	Mahanna-Gabrielli, Elizabeth/N-4870-2017	Mahanna-Gabrielli, Elizabeth/0000-0002-1297-1432; kofke, william/0000-0003-0718-3834; Miano, Todd/0000-0002-3832-6212	National Institutes of Health [1R21NS061074-01A2, T32GM112596]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health: 1R21NS061074-01A2 (WAK) and T32GM112596 (EMG).	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Augoustides JG, 2006, J CARDIOTHOR VASC AN, V20, P8, DOI 10.1053/j.jvca.2005.07.031; Augoustides JG, 2005, J CARDIOTHOR VASC AN, V19, P446, DOI 10.1053/j.jvca.2005.05.004; Bavaria JE, 2002, ANN THORAC SURG, V74, pS1848, DOI 10.1016/S0003-4975(02)04128-0; Bavaria JE, 2002, ANN THORAC SURG, V74, ps57; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Choy SW, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00242; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Jonghe A, 2012, DEMENT GERIATR COGN, V33, P306, DOI 10.1159/000339231; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Folstein MS, 2010, MINI MENTAL STATE EX; Guenther U, 2013, ANN SURG, V257, P1160, DOI 10.1097/SLA.0b013e318281b01c; Hirsch J, 2015, BRIT J ANAESTH; Hu C, 2016, DIABETES, V65, P1490, DOI 10.2337/dbi16-0012; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 2005, J AM GERIATR SOC, V53, P312, DOI 10.1111/j.1532-5415.2005.53120.x; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jaiswal SJ, 2018, AM J MED, V131, P1110, DOI 10.1016/j.amjmed.2018.04.009; Kazmierski J, 2010, J PSYCHOSOM RES, V69, P179, DOI 10.1016/j.jpsychores.2010.02.009; Kofke WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00497; Koster S, 2009, ANN THORAC SURG, V87, P1469, DOI 10.1016/j.athoracsur.2009.02.080; Lane JM, 2016, DIABETES, V65, P1741, DOI 10.2337/db15-0999; Li C, 2011, MOL HUM REPROD, V17, P193, DOI 10.1093/molehr/gaq087; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Miyazaki T, 2003, SURGERY, V133, P662, DOI 10.1067/msy.2003.149; Mundigler G, 2002, CRIT CARE MED, V30, P536, DOI 10.1097/00003246-200203000-00007; Natarajan R, 2012, J NEUROIMMUNOL, V250, P106, DOI 10.1016/j.jneuroim.2012.05.014; Nishikimi M, 2018, CRIT CARE MED, V46, P1099, DOI 10.1097/CCM.0000000000003132; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Raats JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136071; Radogna F, 2010, BIOCHEM PHARMACOL, V80, P1844, DOI 10.1016/j.bcp.2010.07.041; Saczynski JS, 2014, J AM GERIATR SOC, V62, P518, DOI 10.1111/jgs.12684; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Shriner D, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00324; Shriner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008398; Skoog I, 1998, J NEUROL NEUROSUR PS, V64, P37, DOI 10.1136/jnnp.64.1.37; Smulter N, 2013, INTERACT CARDIOV TH, V17, P790, DOI 10.1093/icvts/ivt323; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Vasunilashorn SM, 2015, J GERONTOL A-BIOL; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weinhouse GL, 2009, CRIT CARE, V13, DOI 10.1186/cc8131; Xu G, 2011, DELIRIUM IDENTIFICAT	46	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207941	10.1371/journal.pone.0207941	http://dx.doi.org/10.1371/journal.pone.0207941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481216	Green Published, Green Submitted, gold			2022-12-26	WOS:000451440000030
J	Korabel, N; Waigh, TA; Fedotov, S; Allan, VJ				Korabel, Nickolay; Waigh, Thomas A.; Fedotov, Sergei; Allan, Viki J.			Non-Markovian intracellular transport with sub-diffusion and run-length dependent detachment rate	PLOS ONE			English	Article							SINGLE-PARTICLE TRAJECTORIES; ANOMALOUS DIFFUSION; CYTOPLASMIC DYNEIN; MOLECULAR MOTORS; MODELS; DYNAMICS; PROTEINS; KINETICS	Intracellular transport of organelles is fundamental to cell function and health. The mounting evidence suggests that this transport is in fact anomalous. However, the reasons for the anomaly is still under debate. We examined experimental trajectories of organelles inside a living cell and propose a mathematical model that describes the previously reported transition from sub-diffusive to super-diffusive motion. In order to explain super-diffusive behaviour at long times, we introduce non-Markovian detachment kinetics of the cargo: the rate of detachment is inversely proportional to the time since the last attachment. Recently, we observed the non-Markovian detachment rate experimentally in eukaryotic cells. Here we further discuss different scenarios of how this effective non-Markovian detachment rate could arise. The non-Markovian model is successful in simultaneously describing the time averaged variance (the time averaged mean squared displacement corrected for directed motion), the mean first passage time of trajectories and the multiple peaks observed in the distributions of cargo velocities. We argue that non-Markovian kinetics could be biologically beneficial compared to the Markovian kinetics commonly used for modelling, by increasing the average distance the cargoes travel when a microtubule is blocked by other filaments. In turn, sub-diffusion allows cargoes to reach neighbouring filaments with higher probability, which promotes active motion along the microtubules.	[Korabel, Nickolay; Fedotov, Sergei] Univ Manchester, Sch Math, Manchester, Lancs, England; [Waigh, Thomas A.] Univ Manchester, Sch Phys & Astron, Biol Phys, Manchester, Lancs, England; [Waigh, Thomas A.] Univ Manchester, Photon Sci Inst, Manchester, Lancs, England; [Allan, Viki J.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Korabel, N (corresponding author), Univ Manchester, Sch Math, Manchester, Lancs, England.	nickolay.korabel@manchester.ac.uk	Korabel, Nickolay/H-8700-2012; Fedotov, Sergei/U-2968-2019	Korabel, Nickolay/0000-0001-7208-4555	Engineering and Physical Sciences Research Council [EP/J019526/1]; BBSRC [BB/H017828/1] Funding Source: UKRI; EPSRC [EP/P025021/1, EP/N018060/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council, grant No. EP/J019526/1.	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Allan V, 2014, SCIENCE, V345, P271, DOI 10.1126/science.1257245; Ando D, 2015, BIOPHYS J, V109, P1574, DOI 10.1016/j.bpj.2015.08.034; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Benichou O, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.260601; Berger F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208101; Berger F, 2011, BIOCHEM SOC T, V39, P1211, DOI 10.1042/BST0391211; Bouzat S, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.012401; Bouzat S, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062707; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Bressloff P. C., 2014, STOCHASTIC PROCESSES; Bressloff PC, 2013, REV MOD PHYS, V85, P135, DOI 10.1103/RevModPhys.85.135; Bruno L, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011912; Burov S, 2011, PHYS CHEM CHEM PHYS, V13, P1800, DOI 10.1039/c0cp01879a; Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655; Chechkin AV, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041101; Chechkin AV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.040105; Chen KJ, 2015, NAT MATER, V14, P589, DOI [10.1038/NMAT4239, 10.1038/nmat4239]; Chen Q, 2009, CHEM SOC REV, V38, P2671, DOI 10.1039/b903638e; Chou T, 2014, FIRST-PASSAGE PHENOMENA AND THEIR APPLICATIONS, P306; Cox D. R., 1965, THEORY STOCHASTIC PR; Fedotov S, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.042136; Fedotov S, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.030107; Fedotov S, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062127; Fedotov S, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042112; Feller W., 1968, WILEY SERIES PROBABI, V1; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Godec A, 2016, J PHYS A-MATH THEOR, V49, DOI 10.1088/1751-8113/49/36/364001; Godec A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.010701; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Goychuk I, 2014, PHYS CHEM CHEM PHYS, V16, P16524, DOI 10.1039/c4cp01234h; Goychuk I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091700; Goychuk I, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046125; Guerin T, 2012, NAT CHEM, V4, P568, DOI [10.1038/NCHEM.1378, 10.1038/nchem.1378]; Guigas G, 2008, BIOPHYS J, V94, P90, DOI 10.1529/biophysj.107.117044; Hafner AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep37162; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; HOSKING JRM, 1981, BIOMETRIKA, V68, P165, DOI 10.1093/biomet/68.1.165; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kafri Y, 2004, BIOPHYS J, V86, P3373, DOI 10.1529/biophysj.103.036152; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kenwright DA, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031910; Kepten E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117722; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Klafter J., 2011, 1 STEPRANDOM WALKS; Klein S, 2014, EUR PHYS J-SPEC TOP, V223, P3215, DOI 10.1140/epjst/e2014-02328-2; Klumpp S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.268102; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Klumpp S, 2015, MULTISCALE MODELING, P27; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Kou SC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180603; Kulic IM, 2008, P NATL ACAD SCI USA, V105, P10011, DOI 10.1073/pnas.0800031105; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Li QC, 2016, BIOPHYS J, V110, P2720, DOI 10.1016/j.bpj.2016.05.015; Lipowsky Reinhard, 2009, Biophysical Reviews and Letters, V4, P77, DOI 10.1142/S1793048009000946; Loverdo C, 2008, NAT PHYS, V4, P134, DOI 10.1038/nphys830; Lutz E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051106; Mallik R, 2013, TRENDS CELL BIOL, V23, P575, DOI 10.1016/j.tcb.2013.06.003; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Mendez V, 2010, SPRINGER SER SYNERG, P1, DOI 10.1007/978-3-642-11443-4; Meroz Y, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.062403; Meroz Y, 2015, PHYS REP, V573, P1, DOI 10.1016/j.physrep.2015.01.002; Metzler R, 2009, ACTA PHYS POL B, V40, P1315; Metzler R, 2004, J PHYS A-MATH GEN, V37, pR161, DOI 10.1088/0305-4470/37/31/R01; Metzler R, 2014, PHYS CHEM CHEM PHYS, V16, P24128, DOI 10.1039/c4cp03465a; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Nam W, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/37/375103; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Redner S, 2001, GUIDE 1 PASSAGE PROC; Reuveni S, 2010, P NATL ACAD SCI USA, V107, P13696, DOI 10.1073/pnas.1002018107; Reverey JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11690; Rogers SS, 2007, PHYS BIOL, V4, P220, DOI 10.1088/1478-3975/4/3/008; Rogers SS, 2010, PHYS CHEM CHEM PHYS, V12, P3753, DOI 10.1039/b921874b; Sancho JM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.250601; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Scholz M, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.011037; Singer B., 1973, SOCIOL METHODOL, V5, P356, DOI [10.2307/270841, DOI 10.2307/270841.]; Sliusarenko OY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041119; Sokolov IM, 2012, SOFT MATTER, V8, P9043, DOI 10.1039/c2sm25701g; Szymanski J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038102; Tabei SMA, 2013, P NATL ACAD SCI USA, V110, P4911, DOI 10.1073/pnas.1221962110; Tejedor V, 2010, BIOPHYS J, V98, P1364, DOI 10.1016/j.bpj.2009.12.4282; Tolic-Norrelykke IM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.078102; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Waigh T. A., 2017, SOME CRITICAL QUESTI; Waigh TA, 2014, PHYS LIVING PROCESSE; Waigh TA, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/7/074601; Wang B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.208102; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Weiss M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.010101; Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101; Wu WB, 2009, ANN APPL PROBAB, V19, P1529, DOI 10.1214/08-AAP587; Xie SN, 2001, SINGLE MOL, V2, P229, DOI 10.1002/1438-5171(200112)2:4<229::AID-SIMO229>3.0.CO;2-9; Zaburdaev V, 2015, REV MOD PHYS, V87, P483, DOI 10.1103/RevModPhys.87.483	100	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207436	10.1371/journal.pone.0207436	http://dx.doi.org/10.1371/journal.pone.0207436			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475848	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700031
J	Obolewski, K; Glinska-Lewczuk, K; Szymanska, M; Mrozinska, N; Bakowska, M; Astel, A; Lew, S; Paturej, E				Obolewski, Krystian; Glinska-Lewczuk, Katarzyna; Szymanska, Monika; Mrozinska, Natalia; Bakowska, Martyna; Astel, Aleksander; Lew, Sylwia; Paturej, Ewa			Patterns of salinity regime in coastal lakes based on structure of benthic invertebrates	PLOS ONE			English	Article							BALTIC SEA; BETA-DIVERSITY; SPECIES RICHNESS; BIOTIC INDEXES; WATER-QUALITY; SHALLOW; BIODIVERSITY; SUCCESSION; MACROFAUNA; FRAMEWORK	The macrozoobenthic diversity patterns along a brackish-freshwater salinity gradient have been identified, considering effects of differences in the level of hydrological connection of coastal lakes with the sea on the structure of benthic invertebrate communities. The study is based on samples from six coastal lakes located along the southern coast of the Baltic Sea in Poland. The analysis of environmental and biological data confirmed the existence of stable phases (brackish water vs. freshwater), but as a result of periodical intrusion of seawater, adaptation of animal communities takes place, which was reflected in low values of the predictors describing them (number of taxa, density and diversity). Redundancy analysis indicates that values of conductivity and salinity are the major factors that determine the abundance of dominant groups of benthic fauna. The gradient of hydrological connection of the lakes with the sea accounted for 50% of the variance in biological data, physico-chemical variables for 25%, trophic variables for 15%, and only 9% of the variance was unexplained. The major implication of our results is that coastal lakes that differ only slightly in salinity can have alternative, regional patterns of diversity of structure of benthic fauna. Periodical inflow of brackish waters initiates adaptive cycles of benthic fauna, and their frequency is strongly linked with the hydrological regime. The rhythm of the inflow of seawater is variable, so that management and protection of coastal lakes are extremely complicated.	[Obolewski, Krystian; Szymanska, Monika; Mrozinska, Natalia; Bakowska, Martyna] Kazimierz Wielki Univ, Dept Hydrobiol, Bydgoszcz, Poland; [Glinska-Lewczuk, Katarzyna] Univ Warmia & Mazury, Dept Water Resources Climatol & Environm Manageme, Olsztyn, Poland; [Astel, Aleksander] Pomeranian Univ Slupsk, Dept Environm Chem, Slupsk, Poland; [Lew, Sylwia] Univ Warmia & Mazury, Dept Microbiol, Olsztyn, Poland; [Paturej, Ewa] Univ Warmia & Mazury, Dept Tourism Recreat & Ecol, Olsztyn, Poland	Kazimierz Wielki University; University of Warmia & Mazury; University of Warmia & Mazury; University of Warmia & Mazury	Obolewski, K (corresponding author), Kazimierz Wielki Univ, Dept Hydrobiol, Bydgoszcz, Poland.	obolewsk@ukw.edu.pl	Astel, Aleksander/ADR-5692-2022	Astel, Aleksander/0000-0003-2077-7020; GLINSKA-LEWCZUK, KATARZYNA/0000-0002-7845-6353; Obolewski, Krystian/0000-0001-9361-0286; Szymanska, Monika/0000-0003-4319-4231; Paturej, Ewa/0000-0002-9459-9960; Bakowska, Martyna/0000-0001-5887-1456	National Science Centre in Krakow, Poland [UMO-2012/07/B/ST10/04359]	National Science Centre in Krakow, Poland	This study was supported by the National Science Centre in Krakow, Poland (grant no. UMO-2012/07/B/ST10/04359). https://www.ncn.gov.pl/? language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2000, OJEC L, V327; Astel AM, 2016, ESTUAR COAST SHELF S, V182, P47, DOI 10.1016/j.ecss.2016.09.010; Barros F, 2014, ESTUAR COAST SHELF S, V149, P223, DOI 10.1016/j.ecss.2014.08.025; Basset A., 2007, Transitional Waters Bulletin, V1, P48; Basset A, 2013, ESTUAR COAST SHELF S, V132, P5, DOI 10.1016/j.ecss.2012.04.012; Blanchet H, 2008, ECOL INDIC, V8, P360, DOI 10.1016/j.ecolind.2007.04.003; Bleich S, 2011, MAR ECOL PROG SER, V436, P101, DOI 10.3354/meps09219; Bonsdorff E, 2006, J EXP MAR BIOL ECOL, V330, P383, DOI 10.1016/j.jembe.2005.12.041; Canedo-Arguelles M, 2010, ESTUAR COAST SHELF S, V88, P190, DOI 10.1016/j.ecss.2010.03.025; Canedo-Arguelles M, 2009, J LIMNOL, V68, P229, DOI 10.3274/JL09-68-2-07; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter S R, 2003, REGIME SHIFTS LAKE E; Cartier V., 2011, Journal of Experimental Marine Biology and Ecology, V405, P93, DOI 10.1016/j.jembe.2011.05.019; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Collins DG, 2014, HYDROBIOLOGIA, V734, P97, DOI 10.1007/s10750-014-1872-y; Dobrowolski Zbigniew, 1994, Ekologia Polska, V42, P19; Duck RW, 2012, ESTUAR COAST SHELF S, V110, P2, DOI 10.1016/j.ecss.2012.03.007; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dunalska J., 2009, VARIABILITY ORGANIC; Formela K., 2011, PRACE STUDIA GEOGRAF, V47, P189; Glinska-Lewczuk K., 2017, ECOLOGICAL STATUS SO, P41; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; HELCOM, 1992, CONV PROT MAR ENV BA; Jansen JM, 2009, MAR FRESHW BEHAV PHY, V42, P157, DOI 10.1080/10236240902904348; JEPPESEN E, 1990, HYDROBIOLOGIA, V200, P205, DOI 10.1007/BF02530340; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Jeppesen E, 2007, ECOSYSTEMS, V10, P47, DOI 10.1007/s10021-006-9007-6; Josefson AB, 2004, GLOBAL ECOL BIOGEOGR, V13, P273, DOI 10.1111/j.1466-822X.2004.00091.x; Josefson AB, 2013, J BIOGEOGR, V40, P1000, DOI 10.1111/jbi.12047; Krauss W, 2001, ENCY OCEAN SCI, P236, DOI DOI 10.1006/RWOS.2001.0381; Kroncke I, 2010, MAR POLLUT BULL, V60, P58, DOI 10.1016/j.marpolbul.2009.09.001; McSweeney SL, 2017, GEOMORPHOLOGY, V292, P142, DOI 10.1016/j.geomorph.2017.04.022; Mota JF, 2010, CANDOLLEA, V65, P117, DOI 10.15553/c2010v651a13; Netto SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172366; Netto SA, 2012, ESTUAR COAST, V35, P1069, DOI 10.1007/s12237-012-9488-9; Newton A, 2005, ESTUAR COAST SHELF S, V62, P405, DOI 10.1016/j.ecss.2004.09.005; NICHOLS MM, 1989, MAR GEOL, V88, P201, DOI 10.1016/0025-3227(89)90098-4; Obolewski K, 2018, SCI TOTAL ENVIRON, V631-632, P951, DOI 10.1016/j.scitotenv.2018.03.112; Obolewski K, 2017, ESTUAR COAST SHELF S, V197, P150, DOI 10.1016/j.ecss.2017.08.036; Obolewski K, 2015, ESTUAR COAST SHELF S, V167, P147, DOI 10.1016/j.ecss.2015.06.016; Obolewski K, 2009, OCHR SR, V31, P17; Patricio J, 2009, MAR ENVIRON RES, V68, P25, DOI 10.1016/j.marenvres.2009.04.001; Perez-Ruzafa A., 2011, TRANSIT WATERS B, V5, P50, DOI [DOI 10.1285/I1825229XV5N1P50, 10.1285/i1825229Xv5n1p50]; Perez-Ruzafa A, 2011, J COAST CONSERV, V15, P369, DOI 10.1007/s11852-010-0095-2; Pinto R, 2009, ECOL INDIC, V9, P1, DOI 10.1016/j.ecolind.2008.01.005; Reizopoulou S, 2014, MAR ECOL-EVOL PERSP, V35, P78, DOI 10.1111/maec.12121; Remane A., 1934, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V37, P34; Roselli L, 2013, ESTUAR COAST SHELF S, V117, P29, DOI 10.1016/j.ecss.2012.09.014; Rosqvist K, 2010, AQUAT BOT, V93, P39, DOI 10.1016/j.aquabot.2010.03.002; Rumohr H, 1996, ARCH FISH MAR RES, V44, P179; Schallenberg M, 2010, ESTUAR COAST SHELF S, V86, P587, DOI 10.1016/j.ecss.2009.11.001; SCHEFFER M, 1990, HYDROBIOLOGIA, V200, P475, DOI 10.1007/BF02530365; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Vander Zanden MJ, 2005, CAN J FISH AQUAT SCI, V62, P1422, DOI 10.1139/F05-042; Zaldivar JM, 2008, MONOGRAPHS, V2, P1	59	14	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207825	10.1371/journal.pone.0207825	http://dx.doi.org/10.1371/journal.pone.0207825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475866	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700077
J	Hornychova, H; Kacerovsky, M; Musilova, I; Pliskova, L; Zemlickova, H; Matejkova, A; Vosmikova, H; Rozkosova, K; Cermakova, P; Bolehovska, R; Halada, P; Jacobsson, B; Laco, J				Hornychova, Helena; Kacerovsky, Marian; Musilova, Ivana; Pliskova, Lenka; Zemlickova, Helena; Matejkova, Adela; Vosmikova, Hana; Rozkosova, Katerina; Cermakova, Petra; Bolehovska, Radka; Halada, Petr; Jacobsson, Bo; Laco, Jan			Cervical human papillomavirus infection in women with preterm prelabor rupture of membranes	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; HERPES-SIMPLEX-VIRUS; REAL-TIME PCR; PREGNANT-WOMEN; AMNIOTIC-FLUID; PREMATURE RUPTURE; VIRAL-INFECTIONS; RISK-FACTORS; INTRAAMNIOTIC COMPLICATIONS; PLACENTAL INFLAMMATION	Objective To evaluate the association between cervical human papillomavirus (HPV) infection at the time of admission and the presence of microbial invasion of the amniotic cavity (MIAC) and intra-amniotic inflammation (IAI) in women with preterm prelabor rupture of membranes (PPROM) and to determine the association between cervical HPV infection and short-term neonatal morbidity. Methods One hundred women with singleton pregnancies complicated by PPROM between the gestational ages of 24+0 and 36+6 weeks were included in the study. The presence of HPV DNA was evaluated in scraped cervical cells using polymerase chain reaction (PCR). Amniotic fluid samples were obtained by transabdominal amniocentesis. Results The rate of cervical HPV infection in women with PPROM was 24%. The rates of MIAC and IAI were not different between women with cervical HPV infection and those without cervical HPV infection [MIAC: with HPV: 21% (5/24) vs. without HPV: 22% (17/76), p= 1.00; IAI: with HPV: 21% (5/24) vs. without HPV: 18% (14/76), p = 0.77]. There were no differences in the selected aspects of short-term neonatal morbidity between women with and without cervical HPV infection. Conclusions In women with PPROM, the presence of cervical HPV infection at the time of admission is not related to a higher risk of intra-amniotic infection-related and inflammatory complications or worse short-term neonatal outcomes.	[Hornychova, Helena; Matejkova, Adela; Vosmikova, Hana; Rozkosova, Katerina; Cermakova, Petra; Laco, Jan] Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Fingerland Dept Pathol, Hradec Kralove, Czech Republic; [Kacerovsky, Marian; Musilova, Ivana; Halada, Petr] Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Pliskova, Lenka; Bolehovska, Radka] Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Zemlickova, Helena] Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Dept Microbiol, Hradec Kralove, Czech Republic; [Jacobsson, Bo] Gothenburg Univ, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Inst Publ Hlth, Domain Hlth Data & Digitalisat, Dept Genet & Bioinformat, Oslo, Norway	Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University of Gothenburg	Kacerovsky, M (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Univ Hosp Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic.; Kacerovsky, M (corresponding author), Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic.	kacermar@fnhk.cz	Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/ABE-3437-2020; Laco, Jan/L-9715-2017; Kacerovsky, Marian/A-7586-2011	Jacobsson, Bo/0000-0001-5079-2374; Laco, Jan/0000-0002-9602-7501; Kacerovsky, Marian/0000-0001-9858-7900	University Hospital Hradec Kralove; Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic [P37/10, P37/11]	University Hospital Hradec Kralove; Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic	This work was supported by the University Hospital Hradec Kralove (long-term organization development plan) and by the Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic, project "PROGRES Q40" P37/10 and P37/11 to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambuhl LMM, 2017, ACTA OBSTET GYN SCAN, V96, P1188, DOI 10.1111/aogs.13190; Ambuhl Lea Maria Margareta, 2016, Infect Dis Obstet Gynecol, V2016, P3086036, DOI 10.1155/2016/3086036; Andrys C, 2018, J MATERN-FETAL NEO M, V31, P481, DOI 10.1080/14767058.2017.1288209; ARMBRUSTERMORAES E, 1994, GYNECOL ONCOL, V54, P152, DOI 10.1006/gyno.1994.1185; Avgil M, 2006, REPROD TOXICOL, V21, P436, DOI 10.1016/j.reprotox.2004.11.014; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bredeson S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113799; Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289; Caserta MT, 2007, J INFECT DIS, V196, P1296, DOI 10.1086/522430; Castellsague X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-74; Caughey Aaron B, 2008, Rev Obstet Gynecol, V1, P11; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P349, DOI 10.3109/14767058.2015.1006620; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P360, DOI 10.3109/14767058.2015.1006621; ChangClaude J, 1996, GYNECOL ONCOL, V60, P355, DOI 10.1006/gyno.1996.0055; Cho G, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-173; Cordeiro CN, 2015, OBSTET GYNECOL SURV, V70, P644, DOI 10.1097/OGX.0000000000000236; Deng Dongrui, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P343; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Dinc B, 2010, BRAZ J INFECT DIS, V14, P19, DOI 10.1590/S1413-86702010000100005; Domza G, 2011, ARCH GYNECOL OBSTET, V284, P1105, DOI 10.1007/s00404-010-1787-4; Eppel W, 2000, OBSTET GYNECOL, V96, P337, DOI 10.1016/S0029-7844(00)00953-4; Fife KH, 1996, AM J OBSTET GYNECOL, V174, P1487, DOI 10.1016/S0002-9378(96)70593-8; Freitas LB, 2009, EUR J OBSTET GYN R B, V145, P41, DOI 10.1016/j.ejogrb.2009.03.024; Gomez LM, 2008, HUM REPROD, V23, P709, DOI 10.1093/humrep/dem404; Greer C E, 1991, PCR Methods Appl, V1, P46; GREER CE, 1991, AM J CLIN PATHOL, V95, P117, DOI 10.1093/ajcp/95.2.117; Hahn HS, 2013, EUR J OBSTET GYN R B, V169, P202, DOI 10.1016/j.ejogrb.2013.02.024; Hernandez-Giron C, 2005, SEX TRANSM DIS, V32, P613, DOI 10.1097/01.olq.0000179888.47309.db; Hong Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-109; Jacobsson B, 2005, BJOG-INT J OBSTET GY, V112, P719, DOI 10.1111/j.1471-0528.2005.00536.x; Kacerovsky M, 2018, J MATERN-FETAL NEO M, V31, P2555, DOI 10.1080/14767058.2017.1347626; Kacerovsky M, 2018, FETAL DIAGN THER, V43, P175, DOI 10.1159/000477617; Kacerovsky M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126884; Kim YH, 2014, J OBSTET GYNAECOL RE, V40, P200, DOI 10.1111/jog.12155; Koskimaa HM, 2012, J PEDIATR-US, V160, P837, DOI 10.1016/j.jpeds.2011.10.027; KUDESIA G, 1995, LANCET, V345, P1122, DOI 10.1016/S0140-6736(95)90855-2; Lee ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057708; Li DK, 2014, AM J EPIDEMIOL, V180, P1109, DOI 10.1093/aje/kwu242; Liu B, 2014, BRIT J CANCER, V111, P1448, DOI 10.1038/bjc.2014.414; Matovina M, 2004, FERTIL STERIL, V81, P662, DOI 10.1016/j.fertnstert.2003.08.020; Medeiros Lidia Rosi, 2005, Cad. Saúde Pública, V21, P1006, DOI 10.1590/S0102-311X2005000400003; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Mercer BM, 2004, CLIN PERINATOL, V31, P765, DOI 10.1016/j.clp.2004.06.004; Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9; Pereira SMM, 2010, DIAGN CYTOPATHOL, V38, P397, DOI 10.1002/dc.21219; Morrison EAB, 1996, INT J GYNECOL OBSTET, V54, P125, DOI 10.1016/0020-7292(96)02694-X; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Musilova I, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12789; Musilova I, 2018, PEDIATR RES, V83, P630, DOI 10.1038/pr.2017.300; Musilova I, 2018, J MATERN-FETAL NEO M, V31, P827, DOI 10.1080/14767058.2017.1297792; Musilova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189394; Musilova I, 2017, J MATERN-FETAL NEO M, V30, P2529, DOI 10.1080/14767058.2016.1255192; Musilova I, 2016, J MATERN-FETAL NEO M, V29, P1, DOI 10.3109/14767058.2014.984606; Nimrodi M, 2018, EUR J OBSTET GYN R B, V225, P160, DOI 10.1016/j.ejogrb.2018.04.023; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Park H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-80; Puranen MH, 1997, AM J OBSTET GYNECOL, V176, P1039, DOI 10.1016/S0002-9378(97)70399-5; Racicot K, 2017, J CLIN INVEST, V127, P1591, DOI 10.1172/JCI87490; Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Ruffin Mack T 4th, 2006, BMC Pregnancy Childbirth, V6, P28, DOI 10.1186/1471-2393-6-28; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Sarkola M, 2008, ACTA OBSTET GYN SCAN, V87, P1181, DOI 10.1080/00016340802468308; Schmeink CE, 2012, J WOMENS HEALTH, V21, P1295, DOI 10.1089/jwh.2012.3502; SCHNEIDER A, 1987, INT J CANCER, V40, P198, DOI 10.1002/ijc.2910400212; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Skoczynski M, 2015, POSTEP HIG MED DOSW, V69, P1349; Skoczynski M, 2014, J MATERN-FETAL NEO M, V27, P239, DOI 10.3109/14767058.2013.807238; Smith Elaine M, 2010, Infect Dis Obstet Gynecol, V2010, P326369, DOI 10.1155/2010/326369; Srinivas SK, 2006, AM J OBSTET GYNECOL, V195, P797, DOI 10.1016/j.ajog.2006.05.049; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Takakuwa K, 2006, J PERINAT MED, V34, P77, DOI 10.1515/JPM.2006.010; Tanaka K, 2006, J MED VIROL, V78, P757, DOI 10.1002/jmv.20619; Tenti P, 1997, J INFECT DIS, V176, P277, DOI 10.1086/517266; Tseng CJ, 1998, OBSTET GYNECOL, V91, P92, DOI 10.1016/S0029-7844(97)00593-0; Uijterwaal MH, 2015, INT J CANCER, V136, P2361, DOI 10.1002/ijc.29290; Uribarren-Berrueta O, 2012, ARCH GYNECOL OBSTET, V285, P55, DOI 10.1007/s00404-011-1911-0; Veress G, 1996, MED MICROBIOL IMMUN, V185, P139, DOI 10.1007/s004300050023; WEINBERG ED, 1984, REV INFECT DIS, V6, P814; Worda C, 2005, J SOC GYNECOL INVEST, V12, P440, DOI 10.1016/j.jsgi.2005.03.003; Yamasaki K, 2011, J HUM GENET, V56, P313, DOI 10.1038/jhg.2011.11; Zuo Z, 2011, AM J CLIN PATHOL, V136, P260, DOI 10.1309/AJCP93JMIUEKRPIW	83	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207896	10.1371/journal.pone.0207896	http://dx.doi.org/10.1371/journal.pone.0207896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462728	gold, Green Published, Green Submitted			2022-12-26	WOS:000451054800093
J	Linge, CD; Antanaviciute, L; Abdelghafar, A; Arus, P; Bassi, D; Rossini, L; Ficklin, S; Gasic, K				Linge, Cassia da Silva; Antanaviciute, Laima; Abdelghafar, Asma; Arus, Pere; Bassi, Daniele; Rossini, Laura; Ficklin, Stephen; Gasic, Ksenija			High-density multi-population consensus genetic linkage map for peach	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MARKER-ASSISTED SELECTION; CONSTRUCTION; QTL; GENOME; RESISTANCE; IDENTIFICATION; DISCOVERY; ROSACEAE; SNP	Highly saturated genetic linkage maps are extremely helpful to breeders and are an essential prerequisite for many biological applications such as the identification of marker-trait associations, mapping quantitative trait loci (QTL), candidate gene identification, development of molecular markers for marker-assisted selection (MAS) and comparative genetic studies. Several high-density genetic maps, constructed using the 9K SNP peach array, are available for peach. However, each of these maps is based on a single mapping population and has limited use for QTL discovery and comparative studies. A consensus genetic linkage map developed from multiple populations provides not only a higher marker density and a greater genome coverage when compared to the individual maps, but also serves as a valuable tool for estimating genetic positions of unmapped markers. In this study, a previously developed linkage map from the cross between two peach cultivars 'Zin Dai' and 'Crimson Lady' (ZC(2)) was improved by genotyping additional progenies. In addition, a peach consensus map was developed based on the combination of the improved ZC(2) genetic linkage map with three existing high-density genetic maps of peach and a reference map of Prunus. A total of 1,476 SNPs representing 351 unique marker positions were mapped across eight linkage groups on the ZC(2) genetic map. The ZC(2) linkage map spans 483.3 cM with an average distance between markers of 1.38 cM/marker. The MergeMap and LPmerge tools were used for the construction of a consensus map based on markers shared across five genetic linkage maps. The consensus linkage map contains a total of 3,092 molecular markers, consisting of 2,975 SNPs, 116 SSRs and 1 morphological marker associated with slow ripening in peach (SR). The consensus map provides valuable information on marker order and genetic position for QTL identification in peach and other genetic studies within Prunus and Rosaceae.	[Linge, Cassia da Silva; Antanaviciute, Laima; Abdelghafar, Asma; Gasic, Ksenija] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA; [Arus, Pere] Univ Barcelona, Univ Autonoma Barcelona, Ctr Recerca Agrigen, IRTA,CSIC, Campus UAB, Barcelona, Cerdanyola Del, Spain; [Bassi, Daniele; Rossini, Laura] Univ Milan, Dept Agr & Environm Sci Prod Landscape Agroenergy, Milan, Italy; [Ficklin, Stephen] Washington State Univ, Dept Hort, Pullman, WA 99164 USA	Clemson University; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; University of Milan; Washington State University	Gasic, K (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA.	kgasic@clemson.edu	Gasic, Ksenija/AAN-6234-2021; Arús, Pere/F-6443-2015; Rossini, Laura/J-7873-2012; Bassi, Daniele/C-2952-2012; da Silva Linge, Cassia/C-9538-2019	Gasic, Ksenija/0000-0003-4391-5262; Arús, Pere/0000-0003-0939-8038; Rossini, Laura/0000-0001-6509-9177; da Silva Linge, Cassia/0000-0003-4760-1359	USDA-NIFA-Specialty Crop Research Initiative [2009-51181-05808, 2014-51181-22378]; Spanish Ministry of Economy and Competitiveness [RTA2015-00050-00-00, SEV2015-0533]; Ministero delle Politiche Agricole Alimentari e Forestali (MiPAAF, Italy) [DM14999/7303/08]; MAS.PES: apricot and peach breeding by molecular-assisted selection	USDA-NIFA-Specialty Crop Research Initiative; Spanish Ministry of Economy and Competitiveness(Spanish Government); Ministero delle Politiche Agricole Alimentari e Forestali (MiPAAF, Italy); MAS.PES: apricot and peach breeding by molecular-assisted selection	This project was supported in part by the USDA-NIFA-Specialty Crop Research Initiative project, RosBREED: Enabling marker-assisted breeding in Rosaceae (2009-51181-05808) to KG, and RosBREED 2: Combining disease resistance with horticultural quality in new rosaceous cultivars (2014-51181-22378) to KG. The Spanish Ministry of Economy and Competitiveness (project RTA2015-00050-00-00, Severo Ochoa Program for Centres of Excellence in R&D 201-2019 (SEV2015-0533) and CERCA Programme-Generalitat de Catalunya). This work was in part supported by the Ministero delle Politiche Agricole Alimentari e Forestali (MiPAAF, Italy) through the projects DRUPOMICS (grant DM14999/7303/08), and 'MAS.PES: apricot and peach breeding by molecular-assisted selection' a project funded by private and public agencies.	Alaba OA, 2015, G3-GENES GENOM GENET, V5, P133, DOI 10.1534/g3.114.015008; Bink MCAM, 2014, THEOR APPL GENET, V127, P1073, DOI 10.1007/s00122-014-2281-3; Bodenes C, 2016, DNA RES, V23, P115, DOI 10.1093/dnares/dsw001; Cirilli M, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2015.67; Clark MD, 2014, TREE GENET GENOMES, V10, P627, DOI 10.1007/s11295-014-0709-1; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; DONOSO JM, 2015, HORTIC RES-ENGLAND, V2, DOI DOI 10.1038/H0RTRES.2015.16; Eduardo I, 2013, TREE GENET GENOMES, V9, P189, DOI 10.1007/s11295-012-0546-z; Eduardo I, 2011, TREE GENET GENOMES, V7, P323, DOI 10.1007/s11295-010-0334-6; Endelman JB, 2014, BIOINFORMATICS, V30, P1623, DOI 10.1093/bioinformatics/btu091; Endelman JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-407; Fan S, 2010, NEW PHYTOL, V185, P917, DOI 10.1111/j.1469-8137.2009.03119.x; Foulongne M, 2003, MOL BREEDING, V12, P33, DOI 10.1023/A:1025417507358; Fresnedo-Ramirez J, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0985-z; Fresnedo-Ramirez J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0357-7; Frett TJ, 2014, TREE GENET GENOMES, V10, P367, DOI 10.1007/s11295-013-0692-y; Ghafar AA, 2018, J AM POMOL SOC, V72, P40; Mora JRH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3783-6; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Iezzoni A, 2010, ACTA HORTIC, V859, P389; Illa E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-9; Joobeur T, 1998, THEOR APPL GENET, V97, P1034, DOI 10.1007/s001220050988; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Jung S, 2019, NUCLEIC ACIDS RES, V47, pD1137, DOI 10.1093/nar/gky1000; Khan MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047864; Li LT, 2017, DNA RES, V24, P289, DOI 10.1093/dnares/dsw063; Linge CD, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0271-z; Longhi S, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.1; Zeballos JL, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0996-9; Martinez-Garcia PJ, 2013, TREE GENET GENOMES, V9, P19, DOI 10.1007/s11295-012-0522-7; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; N'Diaye A, 2008, TREE GENET GENOMES, V4, P727, DOI 10.1007/s11295-008-0146-0; Nunez-Lillo G, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0911-9; Pacheco I, 2014, TREE GENET GENOMES, V10, P1223, DOI 10.1007/s11295-014-0756-7; Patel JS, 2013, CROP SCI, V53, P842, DOI 10.2135/cropsci2012.01.0036; Pirona R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-166; Vendramin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090574; Verde I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3606-9; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Webb A, 2016, PLANT BIOTECHNOL J, V14, P177, DOI 10.1111/pbi.12371; Westbrook JW, 2015, G3-GENES GENOM GENET, V5, P1685, DOI 10.1534/g3.115.019588; Wu J, 2014, J EXP BOT, V65, P5771, DOI 10.1093/jxb/eru311; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Wu Yonghui, 2008, Comput Syst Bioinformatics Conf, V7, P285, DOI 10.1142/9781848162648_0025; Xu Y, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0604-4; Yagi M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-734; Yan Z, 2005, THEOR APPL GENET, V110, P766, DOI 10.1007/s00122-004-1903-6; Yang NN, 2013, TREE GENET GENOMES, V9, P573, DOI 10.1007/s11295-012-0580-x; Yu BY, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0521-8; Zeballos JL, 2015, ACTA HORTIC, V1084, P703, DOI 10.17660/ActaHortic.2015.1084.94	59	12	12	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207724	10.1371/journal.pone.0207724	http://dx.doi.org/10.1371/journal.pone.0207724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462743	Green Published, gold, Green Submitted			2022-12-26	WOS:000451054800079
J	Hirano, D; Hayakawa, F; Yasuda, T; Tange, N; Yamamoto, H; Kojima, Y; Morishita, T; Imoto, N; Tsuzuki, S; Mano, H; Naoe, T; Kiyoi, H				Hirano, Daiki; Hayakawa, Fumihiko; Yasuda, Takahiko; Tange, Naoyuki; Yamamoto, Hideyuki; Kojima, Yuki; Morishita, Takanobu; Imoto, Naoto; Tsuzuki, Shinobu; Mano, Hiroyuki; Naoe, Tomoki; Kiyoi, Hitoshi			Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity	ONCOGENE			English	Article							LYMPHOBLASTIC-LEUKEMIA; CELL; PHOSPHORYLATION; TARGET; GENES; DIFFERENTIATION; OVEREXPRESSION; REPRESSION; MYOGENESIS; REGULATOR	MEF2D fusion genes are newly discovered recurrent gene abnormalities that are detected in approximately 5% of acute lymphoblastic leukemia cases. We previously demonstrated that the vector-driven expression of MEF2D fusion proteins was markedly stronger than that of wild-type MEF2D; however, the underlying mechanisms and significance of this expression have yet to be clarified. We herein showed that the strong expression of MEF2D fusion proteins was caused by the loss of the target site of miRNA due to gene translocation. We identified the target region of miRNA located in the coding region and selected miR-122 as a candidate of the responsible miRNA. Mutations at a putative binding site of miR-122 increased MEF2D expression, while the transfection of its miRNA mimic reduced the expression of wild-type MEF2D, but not MEF2D fusion proteins. We also found that MEF2D fusion proteins inhibited the transcriptional activity of PAX5, a B-cell differentiation regulator in a manner that depended on fusion-specific strong expression and an association with histone deacetylase 4, which may lead to the differentiation disorders of B cells. Our results provide novel insights into the mechanisms underlying leukemia development by MEF2D fusion genes and the involvement of the deregulation of miRNA-mediated repression in cancer development.	[Hirano, Daiki; Hayakawa, Fumihiko; Tange, Naoyuki; Yamamoto, Hideyuki; Kojima, Yuki; Morishita, Takanobu; Kiyoi, Hitoshi] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan; [Hayakawa, Fumihiko] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi, Japan; [Yasuda, Takahiko] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Imoto, Naoto] Ogaki Municipal Hosp, Dept Hematol, Ogaki, Japan; [Tsuzuki, Shinobu] Aichi Med Univ, Sch Med, Dept Biochem, Nagakute, Aichi, Japan; [Mano, Hiroyuki] Univ Tokyo, Dept Cellular Signaling, Grad Sch Med, Tokyo, Japan; [Naoe, Tomoki] Nagoya Med Ctr, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya Medical Center; Ogaki Municipal Hospital; Aichi Medical University; University of Tokyo; Nagoya Medical Center	Hayakawa, F (corresponding author), Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan.; Hayakawa, F (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi, Japan.	bun-hy@med.nagoya-u.ac.jp	Naoe, Tomoki/I-1888-2012; Yasuda, Takahiko/AGQ-5448-2022; Imoto, Naoto/AAB-7504-2022	Yasuda, Takahiko/0000-0002-4686-0976; Imoto, Naoto/0000-0003-0567-8761; Tsuzuki, Shinobu/0000-0002-3209-3550	Japan Agency for Medical Research and Development; JSPS KAKENHI	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are very grateful to Yoko Matsuyama and Chika Wakamatsu for their technical assistance. We would thank to Yukie Konishi, Manami Kira, Rie Kojima, Yuko Kojima, Youko Okada, and Saori Kanamori for their secretarial assistance. This study was supported in part by grants for Practical Research for Innovative Cancer Control (to FH, HM, and HK), for Programs for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) (to TN), for Project for Cancer Research And Therapeutic Evolution (P-CREATE) (to TY), and for Leading Advanced Projects for Medical Innovation (LEAP) (to HM) from the Japan Agency for Medical Research and Development. This work was also supported by JSPS KAKENHI (to FH, TY, and HK).	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Gu Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13331; Hao NB, 2017, ONCOTARGET, V8, P81572, DOI 10.18632/oncotarget.19197; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Imoto N, 2016, J BIOL CHEM, V291, P4723, DOI 10.1074/jbc.M115.637835; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Kurahashi S, 2011, ONCOGENE, V30, P1822, DOI 10.1038/onc.2010.554; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu YF, 2016, EBIOMEDICINE, V8, P173, DOI 10.1016/j.ebiom.2016.04.038; Loher P, 2012, BIOINFORMATICS, V28, P3322, DOI 10.1093/bioinformatics/bts615; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Ma LN, 2014, CANCER RES, V74, P1452, DOI 10.1158/0008-5472.CAN-13-2171; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Schwieger M, 2009, BLOOD, V114, P2476, DOI 10.1182/blood-2008-05-158196; Suzuki K, 2016, J CLIN ONCOL, V34, P3451, DOI 10.1200/JCO.2016.66.5547; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Watamoto K, 2003, ONCOGENE, V22, P9176, DOI 10.1038/sj.onc.1206902; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yasuda T, 2016, NAT GENET, V48, P569, DOI 10.1038/ng.3535; Yasuda T, 2012, J IMMUNOL, V188, P6127, DOI 10.4049/jimmunol.1103039; Zhao YY, 2015, J NEUROSCI RES, V93, P1891, DOI 10.1002/jnr.23628	37	10	10	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2263	2274		10.1038/s41388-018-0573-9	http://dx.doi.org/10.1038/s41388-018-0573-9			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30478446				2022-12-26	WOS:000462588000003
J	Fontana, JM; Khodus, GR; Unnersjo-Jess, D; Blom, H; Aperia, A; Brismar, H				Fontana, Jacopo M.; Khodus, Georgiy R.; Unnersjo-Jess, David; Blom, Hans; Aperia, Anita; Brismar, Hjalmar			Spontaneous calcium activity in metanephric mesenchymal cells regulates branching morphogenesis in the embryonic kidney	FASEB JOURNAL			English	Article						organogenesis; nephron; calcium imaging	INTRACELLULAR CA2+; EGG; DIFFERENTIATION; BIOLOGY; GUDMAP	The central role of calcium signaling during development of early vertebrates is well documented, but little is known about its role in mammalian embryogenesis. We have used immunofluorescence and time-lapse calcium imaging of cultured explanted embryonic rat kidneys to study the role of calcium signaling for branching morphogenesis. In mesenchymal cells, we recorded spontaneous calcium activity that was characterized by irregular calcium transients. The calcium signals were dependent on release of calcium from intracellular stores in the endoplasmic reticulum. Down-regulation of the calcium activity, both by blocking the sarco-endoplasmic reticulum Ca2+-ATPase and by chelating cytosolic calcium, resulted in retardation of branching morphogenesis and a reduced formation of primitive nephrons but had no effect on cell proliferation. We propose that spontaneous calcium activity contributes with a stochastic factor to the self-organizing process that controls branching morphogenesis, a major determinant of the ultimate number of nephrons in the kidney.Fontana, J. M., Khodus, G. R., Unnersjo-Jess, D., Blom, H., Aperia, A., Brismar, H. Spontaneous calcium activity in metanephric mesenchymal cells regulates branching morphogenesis in the embryonic kidney.	[Fontana, Jacopo M.; Khodus, Georgiy R.; Unnersjo-Jess, David; Blom, Hans; Brismar, Hjalmar] Kungliga Tekniska Hogskolan KTH Royal Inst Techno, Sci Life Lab, Dept Appl Phys, Solna, Sweden; [Aperia, Anita; Brismar, Hjalmar] Karolinska Inst, Sci Life Lab, Dept Womens & Childrens Hlth, Solna, Sweden	Karolinska Institutet	Brismar, H (corresponding author), Sci Life Lab, Box 1031, S-17121 Solna, Sweden.	brismar@kth.se	Fontana, Jacopo Maria/AAC-4766-2022; Fontana, Jacopo Maria/GQP-4980-2022; Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Fontana, Jacopo Maria/0000-0003-4784-4713; Khodus, Georgiy/0000-0001-5372-9354	Swedish Research Council [K62102273, VR-2013-6041, VR-2015-04198]; Erling-Persson Family Foundation; Marta and Gunnar V. Philipsson Foundation; Soderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Erling-Persson Family Foundation; Marta and Gunnar V. Philipsson Foundation; Soderberg Foundation	This work was supported by Swedish Research Council Grants K62102273 (to A.A.), VR-2013-6041 (to H. Blom), and VR-2015-04198 (to H. Brismar); the Erling-Persson Family Foundation (to A.A.); the Marta and Gunnar V. Philipsson Foundation (to H. Brismar); and the Soderberg Foundation (to A.A.). The authors declare no conflicts of interest.	Blake J, 2014, SEMIN CELL DEV BIOL, V36, P2, DOI 10.1016/j.semcdb.2014.07.011; Chang LW, 2009, J NEUROSCI, V29, P7877, DOI 10.1523/JNEUROSCI.4264-08.2009; Deng HS, 2015, NATURE, V528, P212, DOI 10.1038/nature16170; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Dziarmaga A, 2006, J AM SOC NEPHROL, V17, P1568, DOI 10.1681/ASN.2005101074; Futel M, 2015, J CELL SCI, V128, P888, DOI 10.1242/jcs.155499; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; Hannezo E, 2017, CELL, V171, P242, DOI 10.1016/j.cell.2017.08.026; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Kim TJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04876; Leclerc C, 2008, DEV BIOL, V321, P357, DOI 10.1016/j.ydbio.2008.06.029; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Little MH, 2016, KIDNEY INT, V90, P289, DOI 10.1016/j.kint.2016.03.030; Luyckx VA, 2015, NAT REV NEPHROL, V11, P135, DOI 10.1038/nrneph.2014.251; Maeshima A, 2007, J AM SOC NEPHROL, V18, P3147, DOI 10.1681/ASN.2007060642; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Menshykau D, 2014, DEVELOPMENT, V141, P4526, DOI 10.1242/dev.116202; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; PERANTONI AO, 1995, P NATL ACAD SCI USA, V92, P4696, DOI 10.1073/pnas.92.10.4696; Pruitt BL, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001996; Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289; Rosenberg SS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004259; Sampogna RV, 2015, J AM SOC NEPHROL, V26, P2414, DOI 10.1681/ASN.2014090886; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Sebinger DDR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010550; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Varner VD, 2017, SEMIN CELL DEV BIOL, V67, P170, DOI 10.1016/j.semcdb.2016.06.003; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Xu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174946	33	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4089	4096		10.1096/fj.201802054R	http://dx.doi.org/10.1096/fj.201802054R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496703	Green Published, hybrid			2022-12-26	WOS:000459794800079
J	Sepulchre, JA; Reverchon, S; Gouze, JL; Nasser, W				Sepulchre, Jacques-Alexandre; Reverchon, Sylvie; Gouze, Jean-Luc; Nasser, William			Modeling the bioconversion of polysaccharides in a continuous reactor: A case study of the production of oligogalacturonates by Dickeya dadantii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polysaccharide; oligosaccharide; enzyme kinetics; gene regulation; microbiology; mathematical modeling; continuous reactor; Dickeya dadantii; galacturonate; pectate lyases; pectin; unsaturated oligogalacturonate; galacturonic acid; dimensionless parameter	EXTRACELLULAR PECTATE LYASE; BIOCHEMICAL-CHARACTERIZATION; ALKALIPHILIC STRAIN; GALACTURONIC ACID; PECTIN; PURIFICATION	In the quest for a sustainable economy of the Earth's resources and for renewable sources of energy, a promising avenue is to exploit the vast quantity of polysaccharide molecules contained in green wastes. To that end, the decomposition of pectin appears to be an interesting target because this polymeric carbohydrate is abundant in many fruit pulps and soft vegetables. To quantitatively study this degradation process, here we designed a bioreactor that is continuously fed with de-esterified pectin (PGA). Thanks to the pectate lyases produced by bacteria cultivated in the vessel, the PGA is depolymerized into oligogalacturonates (UGA), which are continuously extracted from the tank. A mathematical model of our system predicted that the conversion efficiency of PGA into UGA increases in a range of coefficients of dilution until reaching an upper limit where the fraction of UGA that is extracted from the bioreactor is maximized. Results from experiments with a continuous reactor hosting a strain of the plant pathogenic bacterium Dickeya dadantii and in which the dilution coefficients were varied quantitatively validated the predictions of our model. A further theoretical analysis of the system enabled an a priori comparison of the efficiency of eight other pectate lyase-producing microorganisms with that of D. dadantii. Our findings suggest that D. dadantii is the most efficient microorganism and therefore the best candidate for a practical implementation of our scheme for the bioproduction of UGA from PGA.	[Sepulchre, Jacques-Alexandre] Univ Cote Azur, Inst Phys Nice, UMR7010, CNRS, F-06560 Sophia Antipolis, France; [Reverchon, Sylvie; Nasser, William] Univ Claude Bernard Lyon 1, Univ Lyon, INSA Lyon, CNRS,UMR5240,Microbiol,Adaptat,Pathogenie, 10 Rue Raphael Dubois, F-69622 Villeurbanne, France; [Gouze, Jean-Luc] Univ Cote Azur, INRIA, INRA, CNRS,Sorbonne Univ,Biocore Team, F-06560 Sophia Antipolis, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); INRAE; Inria; UDICE-French Research Universities; Sorbonne Universite; Universite Cote d'Azur	Sepulchre, JA (corresponding author), Univ Cote Azur, Inst Phys Nice, Route Lucioles 1381, F-06560 Valbonne, France.	jacques-alexandre.sepulchre@univ-cotedazur.fr	NASSER, William/C-9611-2019; Sylvie, Reverchon/P-7932-2016	NASSER, William/0000-0001-9848-3597; Sylvie, Reverchon/0000-0002-0478-3474; Gouze, Jean-Luc/0000-0001-7156-7934	CNRS, France	CNRS, France(Centre National de la Recherche Scientifique (CNRS))	This work was initiated in the framework of the project PEPS BMI Pectolyse funded in 2013-2014 by the CNRS, France. The authors declare that they have no conflicts of interest with the contents of this article.	Bekri MA, 1999, J BACTERIOL, V181, P2440, DOI 10.1128/JB.181.8.2440-2447.1999; Berensmeier S, 2004, APPL MICROBIOL BIOT, V64, P560, DOI 10.1007/s00253-003-1446-9; BRUHLMANN F, 1995, APPL ENVIRON MICROB, V61, P3580; Burana-osot J, 2010, CARBOHYD POLYM, V81, P461, DOI 10.1016/j.carbpol.2010.03.001; Combo AMM, 2012, FOOD BIOPROD PROCESS, V90, P588, DOI 10.1016/j.fbp.2011.09.003; CRAWFORD MS, 1987, ARCH BIOCHEM BIOPHYS, V258, P196, DOI 10.1016/0003-9861(87)90336-5; Dochain D., 2008, AUTOMATIC CONTROL BI; Dubey A., 2016, BRIT BIOTECHNOLOGY J, V13, P1, DOI DOI 10.9734/BBJ/2016/24893; Edwards MC, 2012, APPL MICROBIOL BIOT, V95, P565, DOI 10.1007/s00253-012-4173-2; Eszter M, 2009, DESALINATION, V241, P81, DOI 10.1016/j.desal.2008.01.059; Hatada Y, 2000, EUR J BIOCHEM, V267, P2268, DOI 10.1046/j.1432-1327.2000.01243.x; Kapoor S, 2017, CARBOHYD POLYM, V160, P52, DOI 10.1016/j.carbpol.2016.12.046; Kepseu WD, 2010, J BIOL CHEM, V285, P28565, DOI 10.1074/jbc.M110.114710; KOTOUJANSKY A, 1982, J BACTERIOL, V150, P122, DOI 10.1128/JB.150.1.122-131.1982; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Liao CH, 1997, J APPL MICROBIOL, V83, P10, DOI 10.1046/j.1365-2672.1997.00158.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Monteiro AC., 2009, OPEN BIOTECHNOL J, V3, P9, DOI [10.2174/1874070700903010009, DOI 10.2174/1874070700903010009]; MORAN F, 1968, ARCH BIOCHEM BIOPHYS, V123, P298, DOI 10.1016/0003-9861(68)90138-0; Naqash F, 2017, CARBOHYD POLYM, V168, P227, DOI 10.1016/j.carbpol.2017.03.058; NASSER W, 1990, BIOCHIMIE, V72, P689, DOI 10.1016/0300-9084(90)90053-J; Nasser W, 1997, MOL MICROBIOL, V26, P1071, DOI 10.1046/j.1365-2958.1997.6472020.x; Gerschenson LN, 2017, FOOD HYDROCOLLOID, V68, P23, DOI 10.1016/j.foodhyd.2016.11.030; Payasi A, 2009, WORLD J MICROB BIOT, V25, P1, DOI 10.1007/s11274-008-9870-8; Rao MN, 1996, BIOCHEM J, V319, P159, DOI 10.1042/bj3190159; Sawada K, 2000, EUR J BIOCHEM, V267, P1510, DOI 10.1046/j.1432-1327.2000.01146.x; Sepulchre JA, 2017, AICHE J, V63, P4738, DOI 10.1002/aic.15853; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; Xiao CW, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00067; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Zhang WB, 2015, TRENDS FOOD SCI TECH, V44, P258, DOI 10.1016/j.tifs.2015.04.001	31	2	2	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1753	1762		10.1074/jbc.RA118.004615	http://dx.doi.org/10.1074/jbc.RA118.004615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30510137	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000457879200035
J	Carrasco, B; Gonzalez, M; Gebauer, M; Garcia-Gonzalez, R; Maldonado, J; Silva, H				Carrasco, Basilio; Gonzalez, Maximo; Gebauer, Marlene; Garcia-Gonzalez, Rolando; Maldonado, Jonathan; Silva, Herman			Construction of a highly saturated linkage map in Japanese plum (Prunus salicina L.) using GBS for SNP marker calling	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC DIVERSITY; ASSISTED SELECTION; PERSICA L.; GENOME; PEACH; IDENTIFICATION; CULTIVARS; DISCOVERY; QUALITY	This study reports the construction of high density linkage maps of Japanese plum (Prunus salicina Lindl.) using single nucleotide polymorphism markers (SNPs), obtained with a GBS strategy. The mapping population (An x Au) was obtained by crossing cv. "Angeleno" (An) as maternal line and cv. "Aurora" (Au) as the pollen donor. A total of 49,826 SNPs were identified using the peach genome V2.1 as a reference. Then a stringent filtering was carried out, which revealed 1,441 high quality SNPs in 137 An x Au offspring, which were mapped in eight linkage groups. Finally, the consensus map was built using 732 SNPs which spanned 617 cM with an average of 0.96 cM between adjacent markers. The majority of the SNPs were distributed in the intragenic region in all the linkage groups. Considering all linkage groups together, 85.6% of the SNPs were located in intragenic regions and only 14.4% were located in intergenic regions. The genetic linkage analysis was able to co-localize two to three SNPs over 37 putative orthologous genes in eight linkage groups in the Japanese plum map. These results indicate a high level of synteny and collinearity between Japanese plum and peach genomes.	[Carrasco, Basilio; Gonzalez, Maximo; Gebauer, Marlene] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Ciencias Vegetales, Santiago, Chile; [Garcia-Gonzalez, Rolando] Soc BioTECNOS Ltd, R&D Dept, Camino Pangal Km 2 1-2, San Javier, Region Del Maul, Chile; [Garcia-Gonzalez, Rolando] Univ Catolica Maule, Fac Ciencias Agr & Forestales, Ctr Biotecnol Recursos Nat CENBio, Talca, Chile; [Maldonado, Jonathan; Silva, Herman] Univ Chile, Lab Genom Func & Bioinformat, Dept Prod Agr, Fac Ciencias Agr, Santiago, Chile; [Gonzalez, Maximo] CEAZA, La Serena, Chile	Pontificia Universidad Catolica de Chile; Universidad Catolica del Maule; Universidad de Chile	Carrasco, B (corresponding author), Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Ciencias Vegetales, Santiago, Chile.; Silva, H (corresponding author), Univ Chile, Lab Genom Func & Bioinformat, Dept Prod Agr, Fac Ciencias Agr, Santiago, Chile.	bcarrasco@uc.cl; hesilva@uchile.cl	Silva, Herman P/C-7252-2012; Garcia-Gonzales, Rolando/AAI-9127-2020; Maldonado, Jonathan E/J-6429-2012	Silva, Herman P/0000-0003-1007-7442; Maldonado, Jonathan E/0000-0002-9967-0885; Carrasco, Basilio/0000-0003-4815-6840; Gonzalez, Maximo/0000-0003-3226-8936	Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT [1160600]	Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This research was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/), FONDECYT/Regular no 1160600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Rolando Garcia-Gonzalez is employed by Sociedad BioTECNOS Ltda. This affiliation commenced towards the end of this study. Sociedad BioTECNOS Ltda provided support in the form of salary for author RG-G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Arus P, 2012, TREE GENET GENOMES, V8, P531, DOI 10.1007/s11295-012-0493-8; Basantani MK, 2017, CURR PLANT BIOL, V11-12, P33, DOI 10.1016/j.cpb.2017.12.002; Bastien M, 2018, GENOME, V61, P449, DOI 10.1139/gen-2017-0236; Batley J., 2007, Association mapping in plants, P95, DOI 10.1007/978-0-387-36011-9_6; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Bielenberg DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139406; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Carrasco B, 2007, J AM SOC HORTIC SCI, V132, P501, DOI 10.21273/JASHS.132.4.501; Carrasco B, 2013, BIOL RES, V46, P219, DOI 10.4067/S0716-97602013000300001; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Di Pierro EA, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.57; Diez-de-Medina S., 2012, EJB, Electronic Journal of Biotechnology, V15, P9; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E, 2004, THEOR APPL GENET, V109, P827, DOI 10.1007/s00122-004-1694-9; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; El-Sharkawy I, 2007, J EXP BOT, V58, P3631, DOI 10.1093/jxb/erm213; El-Sharkawy I, 2009, J EXP BOT, V60, P907, DOI 10.1093/jxb/ern354; Elorriaga A, 2008, REV FRUT COOPEFRUT S, P4; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fumagalli M, 2014, BIOINFORMATICS, V30, P1486, DOI 10.1093/bioinformatics/btu041; Gardner Kyle M, 2014, G3 (Bethesda), V4, P1681, DOI 10.1534/g3.114.011023; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gonzalez M, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0491-x; Gonzalez M, 2016, GENE EXPR PATTERNS, V21, P54, DOI 10.1016/j.gep.2016.06.005; Gonzalez M, 2016, GENOM DATA, V9, P50, DOI 10.1016/j.gdata.2016.06.004; Gonzalez M, 2016, GENOM DATA, V9, P35, DOI 10.1016/j.gdata.2016.06.010; Goonetilleke SN, 2018, G3-GENES GENOM GENET, V8, P161, DOI 10.1534/g3.117.300376; Guajardo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127750; Gurcan K, 2016, BIOCHEM GENET, V54, P854, DOI 10.1007/s10528-016-9762-9; Hancock J. F., 2008, P1, DOI 10.1007/978-1-4020-6907-9_1; Jiang ZH, 2016, INT J BIOL SCI, V12, P100, DOI 10.7150/ijbs.13498; Klagges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054743; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDE R, 1990, GENETICS, V124, P743; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LT, 2017, DNA RES, V24, P289, DOI 10.1093/dnares/dsw063; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7914; Ma JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128798; Martinez-Garcia PJ, 2013, PLANT MOL BIOL, V81, P161, DOI 10.1007/s11103-012-9989-8; Minas IS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00316; Okie WR, 1995, FRUIT BREEDING TREE, P559; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Pootakham W, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0572-x; Ricciardi F, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080385; Robledo P, 2011, B INIA, V227, P95; Salazar JA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00476; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Sun LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059562; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; Tavassolian I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-551; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Verde I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3606-9; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vieira E. A., 2005, Crop Breeding and Applied Biotechnology, V5, P29; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Zhang J, 2015, DNA RES, V22, P183, DOI 10.1093/dnares/dsv003; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290	63	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208032	10.1371/journal.pone.0208032	http://dx.doi.org/10.1371/journal.pone.0208032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507961	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500017
J	Kharzinova, VR; Dotsev, AV; Deniskova, TE; Solovieva, AD; Fedorov, VI; Layshev, KA; Romanenko, TM; Okhlopkov, IM; Wimmers, K; Reyer, H; Brem, G; Zinovieva, NA				Kharzinova, Veronika Ruslanovna; Dotsev, Arsen Vladimirovich; Deniskova, Tatiana Evgenievna; Solovieva, Anastasiya Dmitrievna; Fedorov, Valeriy Ivanovich; Layshev, Kasim Anverovich; Romanenko, Tatiana Michailovna; Okhlopkov, Innokentiy Michailovich; Wimmers, Klaus; Reyer, Henry; Brem, Gottfried; Zinovieva, Natalia Anatolievna			Genetic diversity and population structure of domestic and wild reindeer (Rangifer tarandus L. 1758): A novel approach using BovineHD BeadChip	PLOS ONE			English	Article							CONTROL REGION; R PACKAGE; CARIBOU; DIFFERENTIATION; POLYMORPHISM; MARKERS; NUMBER; SET	Reindeer (Rangifer tarandus L. 1758) are an essential element of the Russian Far North, providing a significant source of nutrition for the representatives of 18 ethnicities. The species has wild and domestic forms, which are in constant interaction. The aim of our study was to characterize the genetic structure of domestic and wild reindeer populations, using a genome-wide bovine genotyping array (BovineHD BeadChip). The wild reindeer samples were obtained from the western Taymyr Peninsula population and from the taiga and tundra populations in the Sakha Republic (Yakutia). The domestic populations included the Evenk, Even, and Chukotka-Khargin breeds of Yakutia and the Nenets breed from the Nenets Autonomous district and Murmansk region. The level of genetic diversity was higher for the wild population. Analyzing Neighbor-Net tree, multidimensional scaling, and Structure results, we observed strong genetic population structure and clear differentiation between domestic and wild populations. All regional populations of domestic reindeer were clearly separated, while wild reindeer showed similar genetic backgrounds. Nevertheless, we found contrasting patterns in the genetic structure of the tundra and taiga reindeer, in accordance with their morphological and ecological differences. Thus, our study revealed a clear genetic differentiation between domestic and wild reindeer populations. It provides novel insights into the genetic diversity and structure of reindeer populations, to support resource utilization and aid in the development of genetic improvement strategies and conservation programs for this species.	[Kharzinova, Veronika Ruslanovna; Dotsev, Arsen Vladimirovich; Deniskova, Tatiana Evgenievna; Solovieva, Anastasiya Dmitrievna; Brem, Gottfried; Zinovieva, Natalia Anatolievna] Fed Agcy Sci Org, LK Ernst Fed Sci Ctr Anim Husb, Podolsk Region, Moscow Province, Russia; [Fedorov, Valeriy Ivanovich] Agr Fed Agcy Sci Inst, Yakut Sci Res Inst, Fed Govt Budget Sci Inst, Yakutsk, Russia; [Layshev, Kasim Anverovich] Fed Agcy Sci Org, North West Ctr Interdisciplinary Res Food Mainten, St Petersburg, Russia; [Romanenko, Tatiana Michailovna] Fed Agcy Sci Org, Agroexpt Stn, Nenets Div, Fed Ctr Integrated Arctic Res FCIARctic, Naryan Mar, Nenets Ao, Russia; [Okhlopkov, Innokentiy Michailovich] RAS, Inst Biol Problems Cryolithozone, Siberian Branch, Yakutsk, Russia; [Wimmers, Klaus; Reyer, Henry] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Brem, Gottfried] Univ Vet Med VMU, Inst Anim Breeding & Genet, Vienna, Austria	L.K. Ernst Federal Science Center for Animal Husbandry; Russian Academy of Sciences; Safronov Yakut Scientific Research Institute of Agriculture; Russian Academy of Sciences; St. Petersburg Federal Research Center of the Russian Academy of Sciences; N. Laverov Federal Center for Integrated Arctic Research; Naryan-Mar Agricultural Experimental Station; Institute for Biological Problems of Cryolithozone; Russian Academy of Sciences; Forschungsinstitut fur Nutztierbiologie (FBN)	Kharzinova, VR; Zinovieva, NA (corresponding author), Fed Agcy Sci Org, LK Ernst Fed Sci Ctr Anim Husb, Podolsk Region, Moscow Province, Russia.	veronika0784@mail.ru; n_zinovieva@mail.ru	Dotsev, Arsen/AAU-8331-2021; Dotsev, Arsen/AAC-2346-2019; Veronika, Kharzinova/D-9658-2014; Wimmers, Klaus/AAF-9434-2020; Deniskova, Tatiana/J-6070-2018; Федоров, Валерий Федоров В.И./J-4297-2018; Zinovieva, Natalia A/D-9194-2014; Soloveva, Anastasiya/ABD-2904-2020; Laishev, Kasim/U-9235-2019	Dotsev, Arsen/0000-0003-3418-2511; Федоров, Валерий Федоров В.И./0000-0002-8454-6531; Zinovieva, Natalia A/0000-0003-4017-6863; Kharzinova, Veronika/0000-0002-8067-0404; Deniskova, Tatiana/0000-0002-5809-1262; Wimmers, Klaus/0000-0002-9523-6790	Russian Science Foundation [14-36-00039, 16-16-10068]; Russian Science Foundation [17-36-00002] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation within Projects no. 14-36-00039 (the studies of the Chukotka, the Even and the Evenk reindeer breeds) and no. 16-16-10068 (the studies of the Nenets breed and wild reindeer populations). The URL is http://grant.rscf.ru. Grant receiver no. 14-36-00039 is Zinovieva NA. Grant receiver no. 16-16-10068 is Kharzinova VR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymov VK, 1928, SEVERNAYA AZIYA, V4, P84; Anderson DG, 2017, ECOL EVOL, V7, P6790, DOI 10.1002/ece3.3230; [Anonymous], 2017, EARTH J; Argunov AA, 2017, DINAMIKA CHISLENNOST, P3; Ball MC, 2010, CONSERV GENET, V11, P2131, DOI 10.1007/s10592-010-0099-3; Baranova AI, 2016, P C DED 70 ANN ZOOL; Baskin L.M., 1986, RANGIFER, V6, P333, DOI DOI 10.7557/2.6.2.667; Becker R.A., 2017, MAPS DRAW GEOGRAPHIC; Ben Jemaa S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1638-6; Borozdin E.K., 1990, SEVERNOE OLENEVODSTV; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bryzgalov G.Y, 2017, VESTNIK DVO RAN, V3, P75; Budovnits IU, 1931, OLENEVODCHESKIYE KOL; Colson KE, 2014, J HERED, V105, P585, DOI 10.1093/jhered/esu030; Cooney MD, 2014, THESIS; Cronin MA, 1995, ANIM GENET, V26, P427, DOI 10.1111/j.1365-2052.1995.tb02695.x; Cronin MA, 2006, J HERED, V97, P525, DOI 10.1093/jhered/esl012; Davydov A. V., 2007, Sel'skokhozyaistvennaya Biologiya, P48; Davydov AV, 1997, THESIS; Deniskova TE, 2016, DOKL BIOCHEM BIOPHYS, V469, P288, DOI 10.1134/S1607672916040141; Deniskova TE, 2016, RUSS J GENET+, V52, P79, DOI 10.1134/S1022795416010026; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EGOROV OV, 1965, WILD UNGULATES YAKUT; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flagstad O, 2003, EVOLUTION, V57, P658; Flerov K.K., 1952, FAUNA SSSR, V1; Govindaraj M, 2015, GENETICS RES INT, V2015, DOI [10.1155/2015/431487, DOI 10.1155/2015/431487]; Haynes GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036536; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jepsen BI, 2002, CONSERV GENET, V3, P401, DOI 10.1023/A:1020523303815; Jernsletten J-LL, 2002, SUSTAINABLE REINDEER, P3; Kasarda R, 2015, ARCH TIERZUCHT, V58, P57, DOI 10.5194/aab-58-57-2015; Kasarda R., 2014, ACTA FYTOTECHNICA ZO, V17, P65, DOI [10.15414/afz.2014.17.02.65-71, DOI 10.15414/AFZ.2014.17.02.65-71]; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kharzinova V. R., 2017, Sel'skokhozyaistvennaya Biologiya, P669, DOI 10.15389/agrobiology.2017.4.669rus; Kharzinova VR, 2016, J ANIM SCI, V94, P110, DOI 10.2527/jas2016.94supplement4110b; Kharzinova V. R., 2015, Sel'skokhozyaistvennaya Biologiya, P756; Kharzinova V.R., 2016, AGR BIOL, V51, P811, DOI DOI 10.15389/AGR0BI0L0GY.2016.6.811ENG); Kharzinova V.R, 2016, J ACTA FYTOTECHNICA, V19, P87, DOI [10.15414/afz.2016.19.03.87-92, DOI 10.15414/AFZ.2016.19.03.87-92]; Kharzinova VR, 2015, J HERED, V106, P758, DOI 10.1093/jhered/esv081; Kholodova MV, 2011, BIOL BULL+, V38, P42, DOI 10.1134/S1062359011010067; Klokov K., 2007, International Journal of Entrepreneurship & Small Business, V4, P726, DOI 10.1504/IJESB.2007.014981; Klokov KB, 2003, P 3 INT WORKSH ANTHR, P53; Kolesnikov AL, 2005, PROMYSEL DIKIKH SEVE; Kolpaschikov L, 2015, ECOL SOC, V20, DOI 10.5751/ES-07129-200109; Korolev AN, 2017, ZOOL ZH, V96, P106, DOI 10.7868/S0044513417010147; Krivoshapkin AA, 2016, VESTNIK SVFU, V6, P15; [ЛОГИНОВ В.Г. LOGINOV V.G.], 2014, [Аграрный вестник Урала, Agrarnyi vestnik Urala], P74; Mager KH, 2013, CONSERV GENET, V14, P1111, DOI 10.1007/s10592-013-0499-2; McDevitt AD, 2009, MOL ECOL, V18, P665, DOI 10.1111/j.1365-294X.2008.04050.x; Miller JM, 2011, MOL ECOL RESOUR, V11, P314, DOI 10.1111/j.1755-0998.2010.02918.x; Mukhachev AD, 1968, THESIS; NEI M, 1978, GENETICS, V89, P583; Olenski K, 2018, CONSERV GENET RESOUR, V10, P73, DOI 10.1007/s12686-017-0768-3; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Pertoldi C, 2010, CONSERV GENET, V11, P627, DOI 10.1007/s10592-009-9977-y; Petrov AN, 2009, RANGIFER, V32, P57; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pomishin SB, 1990, PROISKHOZHDENIYE OLE, P116; Pozzi A, 2017, P 36 INT SOC AN GEN, DOI [10.13140/RG.2.2.12691.99360, DOI 10.13140/RG.2.2.12691.99360]; Pritchard JK, 2000, GENETICS, V155, P945; Prokofieva ED, 1956, NENTSY SELKUPY NAROD; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; ROED K H, 1991, Rangifer, V11, P65; ROED KH, 1985, HEREDITAS, V102, P199, DOI 10.1111/j.1601-5223.1985.tb00616.x; Saburova L.Ya., 2022, VESTNIK YAKUTSKOGO G, V1, P5, DOI 10.25587/SVFU.2022.55.41.001; Safronov VM, 2005, ECOLOGY USING WILD R; Shubin P. N., 1988, GENETICS, V5, P37; SHUBIN PN, 1982, GENETIKA+, V18, P2030; Smith T., 2006, REAL RUDOLPH NATURAL, V1st; Smitz N, 2016, MAMM BIOL, V81, P595, DOI 10.1016/j.mambio.2016.07.047; Stammler F., 2005, REINDEER NOMADS MEET; STORSET A, 1978, HEREDITAS, V88, P113; Stremilov PI, 1973, THESIS; Syroechkovskii EE, 2000, RED DATA BOOK KRASNO; Vodopyanov BG, 1970, THESIS; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams TM, 2010, RANGIFER, V6, P19; Wilson GA, 1997, MOL ECOL, V6, P697, DOI 10.1046/j.1365-294X.1997.00237.x; Yuzhakov AA, 2000, ETNICHESKIE OCOBENNO; Yuzhakov AA, 2003, THESIS; Zabrodin V.A, 1979, SEVERNOE OLENEVODSTV; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	85	6	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207944	10.1371/journal.pone.0207944	http://dx.doi.org/10.1371/journal.pone.0207944			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500861	Green Published, Green Submitted, gold			2022-12-26	WOS:000451883700019
J	Chruszcz, M; Kapingidza, AB; Dolamore, C; Kowal, K				Chruszcz, Maksymilian; Kapingidza, A. Brenda; Dolamore, Coleman; Kowal, Krzysztof			A robust method for the estimation and visualization of IgE cross-reactivity likelihood between allergens belonging to the same protein family	PLOS ONE			English	Article							DUST-MITE ALLERGEN; BET V 1; LIPID-TRANSFER PROTEIN; GRASS-POLLEN ALLERGEN; BOVINE SERUM-ALBUMIN; PHL P 5; COMPONENT-RESOLVED DIAGNOSIS; MUTATIONAL EPITOPE ANALYSIS; CELERY APIUM-GRAVEOLENS; PLANT FOOD ALLERGENS	Among the vast number of identified protein families, allergens emanate from relatively few families which translates to only a small fraction of identified protein families. In allergy diagnostics and immunotherapy, interactions between immunoglobulin E and allergens are crucial because the formation of an allergen-antibody complex is necessary for triggering an allergic reaction. In allergic diseases, there is a phenomenon known as cross-reactivity. Cross-reactivity describes a situation where an individual has produced antibodies against a particular allergenic protein, but said antibodies fail to discriminate between the original sensitizer and other similar proteins that usually belong to the same family. To expound the concept of cross-reactivity, this study examines ten protein families that include allergens selected specifically for the analysis of cross-reactivity. The selected allergen families had at least 13 representative proteins, overall folds that differ significantly between families, and include relevant allergens with various potencies. The selected allergens were analyzed using information on sequence similarities and identities between members of the families as well as reports on clinically relevant cross-reactivities. Based on our analysis, we propose to introduce a new A-RISC index (Allergens'-Relative Identity, Similarity and Cross-reactivity) which describes homology between two allergens belonging to the same protein family and is used to predict the likelihood of cross-reactivity between them. Information on sequence similarities and identities, as well as on the values of the proposed A-RISC index is used to introduce four categories describing a risk of a cross-reactive reaction, namely: high, medium-high, medium-low and low. The proposed approach can facilitate analysis in component-resolved allergy diagnostics, generation of avoidance guidelines for allergic individuals, and help with the design of immunotherapy.	[Chruszcz, Maksymilian; Kapingidza, A. Brenda; Dolamore, Coleman] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Kowal, Krzysztof] Med Univ Bialystok, Dept Allergol & Internal Med, Bialystok, Poland; [Kowal, Krzysztof] Med Univ Bialystok, Dept Expt Allergol & Immunol, Bialystok, Poland	University of South Carolina System; University of South Carolina Columbia; Medical University of Bialystok; Medical University of Bialystok	Chruszcz, M (corresponding author), Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.	chruszcz@mailbox.sc.edu	Chruszcz, Maksymilian/E-6407-2011	Chruszcz, Maksymilian/0000-0001-7521-5485; /0000-0002-0910-1292; Dolamore, Coleman/0000-0002-7274-1014; Kapingidza, Anyway Brenda/0000-0001-8517-6299	National Institute of Allergy and Infectious Diseases [R01AI077653]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01AI077653 from National Institute of Allergy and Infectious Diseases.; The authors would like to thank Zuzanna E. Chruszcz and Sarah E. Pye for valuable discussion. This work was supported by grant R01AI077653 from National Institute of Allergy and Infectious Diseases.	Aalberse JA, 2013, ALLERGY, V68, P748, DOI 10.1111/all.12160; Aalberse RC, 2011, ALLERGY, V66, P1261, DOI 10.1111/j.1398-9995.2011.02656.x; Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Aalberse Rob C, 2007, Clin Mol Allergy, V5, P2, DOI 10.1186/1476-7961-5-2; Aalberse RC, 2006, MOL NUTR FOOD RES, V50, P625, DOI 10.1002/mnfr.200500270; Aalberse RC, 2015, J ALLER CL IMM-PRACT, V3, P863, DOI 10.1016/j.jaip.2015.09.013; Abdullah SU, 2016, SCI REP-UK, V6, DOI 10.1038/srep30279; Alvarado MI, 2014, ALLERGY, V69, P1610, DOI 10.1111/all.12509; Andersen MBS, 2011, CLIN REV ALLERG IMMU, V41, P4, DOI 10.1007/s12016-009-8177-3; ANDERSON LB, 1970, J ALLERGY, V45, P310, DOI 10.1016/0021-8707(70)90037-7; ANDERSON MC, 1985, J ALLERGY CLIN IMMUN, V76, P563, DOI 10.1016/0091-6749(85)90776-6; Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Apostolovic D, 2016, ALLERGY, V71, P1490, DOI 10.1111/all.12955; Arias-Irigoyen J, 2007, J ALLERGY CLIN IMMUN, V120, P98, DOI 10.1016/j.jaci.2007.02.028; Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361; Asero R, 1997, ALLERGY, V52, P560, DOI 10.1111/j.1398-9995.1997.tb02600.x; Asero R, 2018, CLIN EXP ALLERGY, V48, P6, DOI 10.1111/cea.13053; Asero R, 2015, INT ARCH ALLERGY IMM, V168, P25, DOI 10.1159/000441222; Asero R, 2014, ANN ALLERG ASTHMA IM, V113, P307, DOI 10.1016/j.anai.2014.06.009; Asero R, 2011, ALLERGY ASTHMA PROC, V32, P64, DOI 10.2500/aap.2011.32.3416; Asturias JA, 2003, CLIN EXP ALLERGY, V33, P518, DOI 10.1046/j.1365-2222.2003.01631.x; Ballmer-Weber BK, 2002, ALLERGY, V57, P873, DOI 10.1034/j.1398-9995.2002.23541.x; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beretta B, 2001, INT ARCH ALLERGY IMM, V126, P188, DOI 10.1159/000049513; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Blankestijn MA, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0177-4; Blume C, 2004, PROTEOMICS, V4, P1366, DOI 10.1002/pmic.200300706; Bolla M, 2014, INT ARCH ALLERGY IMM, V164, P112, DOI 10.1159/000362761; Bonura A, 2014, MOL IMMUNOL, V57, P220, DOI 10.1016/j.molimm.2013.09.004; Bordas-Le Floch V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136258; BOUTIN Y, 1989, CLIN EXP IMMUNOL, V77, P440; BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x; BREITENEDER H, 1993, EUR J BIOCHEM, V212, P355, DOI 10.1111/j.1432-1033.1993.tb17669.x; Breiteneder H, 2005, BIOTECHNOL ADV, V23, P395, DOI 10.1016/j.biotechadv.2005.05.004; Breiteneder H, 2005, J ALLERGY CLIN IMMUN, V115, P14, DOI 10.1016/j.jaci.2004.10.022; Breiteneder H, 2004, J ALLERGY CLIN IMMUN, V113, P821, DOI [10.1016/j.jaci.2004.01.779, 10.1016/j.jaci.2004.01.079]; Breiteneder H, 2006, MOL NUTR FOOD RES, V50, P628, DOI 10.1002/mnfr.200500274; Bush RK, 2003, ILAR J, V44, P28, DOI 10.1093/ilar.44.1.28; Cases B, 2010, INT ARCH ALLERGY IMM, V153, P215, DOI 10.1159/000314361; Chabre H, 2010, CLIN EXP ALLERGY, V40, P505, DOI 10.1111/j.1365-2222.2009.03380.x; Chapman MD, 2008, J ALLERGY CLIN IMMUN, V122, P882, DOI 10.1016/j.jaci.2008.07.030; Chapman MD, 2012, CURR ALLERGY ASTHM R, V12, P478, DOI 10.1007/s11882-012-0282-3; Chapman Martin D, 2009, Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess, V96, P21; CHAPMAN MD, 1984, J IMMUNOL, V133, P2488; Cheong N, 2003, ALLERGY, V58, P912, DOI 10.1034/j.1398-9995.2003.00215.x; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Chiu LL, 2008, PROTEOM CLIN APPL, V2, P33, DOI 10.1002/prca.200780050; Choi D, 2006, PHYSIOL PLANTARUM, V126, P511, DOI 10.1111/j.1399-3054.2005.00612.x; Choi GS, 2009, ALLERGY ASTHMA IMMUN, V1, P45, DOI 10.4168/aair.2009.1.1.45; Chruszcz M, 2013, BBA-GEN SUBJECTS, V1830, P5375, DOI 10.1016/j.bbagen.2013.06.016; Chruszcz M, 2013, MOL IMMUNOL, V56, P794, DOI 10.1016/j.molimm.2013.07.004; Chruszcz M, 2012, J BIOL CHEM, V287, P7388, DOI 10.1074/jbc.M111.311159; Chruszcz M, 2009, J MOL BIOL, V386, P520, DOI 10.1016/j.jmb.2008.12.049; Ciprandi G, 2016, J INVEST ALLERG CLIN, V26, P244, DOI 10.18176/jiaci.0041; Cistero-Bahima A, 2003, ALLERGY, V58, P161, DOI 10.1034/j.1398-9995.2003.00056_5.x; Cruz LM, 2008, P R HEALTH SCI J, V27, P163; Cuesta-Herranz J, 2000, CLIN EXP ALLERGY, V30, P1411, DOI 10.1046/j.1365-2222.2000.00868.x; Curin M, 2011, INT ARCH ALLERGY IMM, V154, P258, DOI 10.1159/000321113; Czerwinski EW, 2005, J BIOL CHEM, V280, P3740, DOI 10.1074/jbc.M409655200; D'Avino R, 2011, ALLERGY, V66, P870, DOI 10.1111/j.1398-9995.2011.02555.x; Dall'Antonia F, 2011, J ALLERGY CLIN IMMUN, V128, P872, DOI 10.1016/j.jaci.2011.07.007; Davies JM, 2014, CLIN EXP ALLERGY, V44, P790, DOI 10.1111/cea.12317; Davies JM, 2011, CLIN EXP ALLERGY, V41, P281, DOI 10.1111/j.1365-2222.2010.03670.x; de Silva R, 2017, VACCINE, V35, P1494, DOI 10.1016/j.vaccine.2017.02.009; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Dimitrov I, 2014, J CHEMOMETR, V28, P282, DOI 10.1002/cem.2597; Du ZP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12010; Edstam MM, 2011, MOL PLANT, V4, P947, DOI 10.1093/mp/ssr019; Egger C, 2008, CLIN EXP ALLERGY, V38, P1688, DOI 10.1111/j.1365-2222.2008.03092.x; Etto T, 2012, INT ARCH ALLERGY IMM, V159, P355, DOI 10.1159/000338290; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Flicker S, 2006, J ALLERGY CLIN IMMUN, V117, P1336, DOI 10.1016/j.jaci.2006.02.012; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P46, DOI 10.1016/S0167-4838(00)00147-3; Focke-Tejkl M, 2014, J ALLERGY CLIN IMMUN, V133, P836, DOI 10.1016/j.jaci.2013.08.038; Franz-Oberdorf K, 2016, J AGR FOOD CHEM, V64, P3688, DOI 10.1021/acs.jafc.6b00488; Fujimura T, 2017, ALLERGY, V72, P1728, DOI 10.1111/all.13192; Gadermaier E, 2010, INT ARCH ALLERGY IMM, V151, P17, DOI 10.1159/000232567; Gadermaier G, 2011, MOL NUTR FOOD RES, V55, P568, DOI 10.1002/mnfr.201000443; Gafvelin G, 2001, J ALLERGY CLIN IMMUN, V107, P511, DOI 10.1067/mai.2001.112264; Gaier S, 2008, MOL NUTR FOOD RES, V52, pS220, DOI 10.1002/mnfr.200700274; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gibbon BC, 1998, PLANT CELL, V10, P981, DOI 10.1105/tpc.10.6.981; Gobl C, 2017, J ALLERGY CLIN IMMUN, V140, P1187, DOI 10.1016/j.jaci.2017.05.005; Gough L, 2001, CLIN EXP ALLERGY, V31, P1594, DOI 10.1046/j.1365-2222.2001.01207.x; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; GREENE WK, 1991, J IMMUNOL, V147, P3768; Guhsl EE, 2015, ALLERGY, V70, P59, DOI 10.1111/all.12534; Guhsl EE, 2014, MOL NUTR FOOD RES, V58, P625, DOI 10.1002/mnfr.201300153; Gurlek F, 2018, INT ARCH ALLERGY IMM, V176, P1, DOI 10.1159/000486855; Gustchina A, 2005, J MOL BIOL, V348, P433, DOI 10.1016/j.jmb.2005.02.062; Halim A, 2015, MOL CELL PROTEOMICS, V14, P191, DOI 10.1074/mcp.M114.042614; Hauser M, 2011, CLIN EXP ALLERGY, V41, P1804, DOI 10.1111/j.1365-2222.2011.03866.x; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Hilger C, 1997, ALLERGY, V52, P179, DOI 10.1111/j.1398-9995.1997.tb00972.x; Hilger C, 2010, INT ARCH ALLERGY IMM, V151, P173, DOI 10.1159/000236008; Hilger C, 2012, CURR ALLERGY ASTHM R, V12, P438, DOI 10.1007/s11882-012-0283-2; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; HoffmannSommergruber K, 1997, GENE, V197, P91, DOI 10.1016/S0378-1119(97)00246-1; Hofmaier S, 2015, J ALLERGY CLIN IMMUN, V135, P1367, DOI 10.1016/j.jaci.2014.09.048; Hofmann C, 2013, J ALLERGY CLIN IMMUN, V131, P1384, DOI 10.1016/j.jaci.2012.10.037; Huertas AJ, 2014, ALLERGOL IMMUNOPATH, V42, P387, DOI 10.1016/j.aller.2013.09.005; Hufnagl K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19883-0; Hugouvieux-Cotte-Pattat N, 2014, ENV MICROBIOL REP, V6, P427, DOI 10.1111/1758-2229.12166; Husslik F, 2016, CLIN EXP ALLERGY, V46, P1484, DOI 10.1111/cea.12796; Ichikawa S, 1998, J BIOL CHEM, V273, P356, DOI 10.1074/jbc.273.1.356; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; Ichikawa S, 2009, GENES CELLS, V14, P1055, DOI 10.1111/j.1365-2443.2009.01334.x; Ivanciuc O, 2003, J AGR FOOD CHEM, V51, P4830, DOI 10.1021/jf034218r; Ivanciuc O, 2009, MOL IMMUNOL, V46, P559, DOI 10.1016/j.molimm.2008.07.034; Jahn-Schmid B, 2012, J IMMUNOL, V188, P1559, DOI 10.4049/jimmunol.1102445; Jakob T, 2013, ALLERGY, V68, P690, DOI 10.1111/all.12107; Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019; Jeong KY, 2016, J KOREAN MED SCI, V31, P1202, DOI 10.3346/jkms.2016.31.8.1202; Jimenez-Lopez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076066; Johannessen BR, 2005, FEBS LETT, V579, P1208, DOI 10.1016/j.febslet.2004.11.115; Johansen N, 2009, INT ARCH ALLERGY IMM, V150, P325, DOI 10.1159/000226233; Johansson E, 1997, CLIN EXP ALLERGY, V27, P691, DOI 10.1111/j.1365-2222.1997.tb01198.x; Kamata Y, 2007, INT ARCH ALLERGY IMM, V142, P301, DOI 10.1159/000097499; Karamloo F, 2001, J CHROMATOGR B, V756, P281, DOI 10.1016/S0378-4347(01)00087-1; Kelso JM, 2009, ANN ALLERG ASTHMA IM, V103, pS1, DOI 10.1016/S1081-1206(10)60350-X; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kikuchi Y, 2006, J IMMUNOL, V177, P1609, DOI 10.4049/jimmunol.177.3.1609; Kinaciyan T, 2007, J ALLERGY CLIN IMMUN, V119, P937, DOI 10.1016/j.jaci.2006.11.010; Kitzmuller C, 2012, ALLERGY, V67, P1375, DOI 10.1111/all.12016; Koistinen KM, 2002, PLANT CELL ENVIRON, V25, P707, DOI 10.1046/j.1365-3040.2002.00858.x; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Lauer I, 2007, CLIN EXP ALLERGY, V37, P261, DOI 10.1111/j.1365-2222.2007.02653.x; Le TM, 2013, J ALLERGY CLIN IMMUN, V131, P164, DOI 10.1016/j.jaci.2012.09.009; Lee AJ, 2002, PARASITE IMMUNOL, V24, P413, DOI 10.1046/j.1365-3024.2002.00480.x; Levin M, 2014, CLIN EXP ALLERGY, V44, P1409, DOI 10.1111/cea.12423; Li M, 2011, J IMMUNOL, V186, P333, DOI 10.4049/jimmunol.1002318; Liao EC, 2010, J CLIN IMMUNOL, V30, P830, DOI 10.1007/s10875-010-9446-x; Liccardi G, 2010, EUR ANN ALLERGY CLIN, V42, P127; Liccardi G, 2011, CURR ALLERGY ASTHM R, V11, P421, DOI 10.1007/s11882-011-0214-7; Lin J, 2017, METHODS MOL BIOL, V1592, P1, DOI 10.1007/978-1-4939-6925-8_1; Lombardero M, 2004, CLIN EXP ALLERGY, V34, P1415, DOI 10.1111/j.1365-2222.2004.02053.x; Lopez-Matas MA, 2015, J INVEST ALLERG CLIN, V25, P196; Lopez-Torrejon G, 2007, J ALLERGY CLIN IMMUN, V119, P1481, DOI 10.1016/j.jaci.2007.02.004; Lu WZ, 2018, MOL IMMUNOL, V99, P1, DOI 10.1016/j.molimm.2018.03.022; Ma SK, 2016, INT ARCH ALLERGY IMM, V169, P241, DOI 10.1159/000446156; Madritsch C, 2011, CLIN EXP ALLERGY, V41, P270, DOI 10.1111/j.1365-2222.2010.03666.x; Madritsch C, 2015, J IMMUNOL, V194, P2069, DOI 10.4049/jimmunol.1402185; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; Mares-Mejia I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32552; Mari A, 2009, CURR ALLERGY ASTHM R, V9, P376, DOI 10.1007/s11882-009-0055-9; Marin-Rodriguez MC, 2002, J EXP BOT, V53, P2115, DOI 10.1093/jxb/erf089; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; Martin-Pedraza L, 2016, MOL NUTR FOOD RES, V60, P1172, DOI 10.1002/mnfr.201500782; Mastrorilli C, 2016, ALLERGY, V71, P1181, DOI 10.1111/all.12888; Mattsson L, 2010, CLIN EXP ALLERGY, V40, P1276, DOI 10.1111/j.1365-2222.2010.03533.x; Mauro M, 2011, INT ARCH ALLERGY IMM, V156, P416, DOI 10.1159/000323909; McClain S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600676; McKenna ST, 2004, PLANTA, V218, P906, DOI 10.1007/s00425-003-1174-5; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; Meno KH, 2017, ALLERGY, V72, P665, DOI 10.1111/all.13111; METZLER WJ, 1995, PROTEIN SCI, V4, P450; Midoro-Horiuti T, 1999, J ALLERGY CLIN IMMUN, V104, P613, DOI 10.1016/S0091-6749(99)70332-5; Midoro-Horiuti T, 2006, MOL IMMUNOL, V43, P509, DOI 10.1016/j.molimm.2005.05.006; Mills ENC, 2004, CRIT REV FOOD SCI, V44, P379, DOI 10.1080/10408690490489224; Misas-Villamil JC, 2016, NEW PHYTOL, V212, P902, DOI 10.1111/nph.14117; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Morales M, 2014, FOOD CHEM, V165, P397, DOI 10.1016/j.foodchem.2014.05.101; Moverare R, 2008, INT ARCH ALLERGY IMM, V146, P203, DOI 10.1159/000115888; Mueller GA, 1998, BIOCHEMISTRY-US, V37, P12707, DOI 10.1021/bi980578+; Mueller GA, 2017, INT ARCH ALLERGY IMM, V174, P57, DOI 10.1159/000481078; Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Niederberger V, 1998, J ALLERGY CLIN IMMUN, V101, P258, DOI 10.1016/S0091-6749(98)70391-4; Niemi MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13841; Nilsson N, 2018, INT ARCH ALLERGY IMM, V177, P135, DOI 10.1159/000489610; Nilsson OB, 2012, ALLERGY, V67, P751, DOI 10.1111/j.1398-9995.2012.02826.x; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Nony E, 2015, ALLERGY, V70, P795, DOI 10.1111/all.12622; Offermann LR, 2016, J BIOL CHEM, V291, P15447, DOI 10.1074/jbc.M116.733659; Offermann LR, 2015, J AGR FOOD CHEM, V63, P9150, DOI 10.1021/acs.jafc.5b03534; Osinski T, 2015, J IMMUNOL, V195, P307, DOI 10.4049/jimmunol.1402199; Panzner P, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0207-x; Pascal M, 2012, CLIN EXP ALLERGY, V42, P1529, DOI 10.1111/j.1365-2222.2012.04071.x; Pastorello EA, 2002, J ALLERGY CLIN IMMUN, V110, P310, DOI 10.1067/mai.2002.125830; Patelis A, 2016, CLIN EXP ALLERGY, V46, P1022, DOI 10.1111/cea.12761; Pereira EAL, 2005, ALLERGY, V60, P401, DOI 10.1111/j.1398-9995.2005.00738.x; PETERSEN A, 1995, INT ARCH ALLERGY IMM, V108, P49, DOI 10.1159/000237117; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Pichler U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120038; Polet D, 2007, FEBS LETT, V581, P211, DOI 10.1016/j.febslet.2006.12.013; Pomes A, 2015, J ALLERGY CLIN IMMUN, V136, P29, DOI 10.1016/j.jaci.2015.05.016; Pomes Anna, 2015, Curr Allergy Asthma Rep, V15, P506, DOI 10.1007/s11882-014-0506-9; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Porta JC, 2012, J MOL BIOL, V418, P103, DOI 10.1016/j.jmb.2012.02.012; Posthumus J, 2013, J ALLERGY CLIN IMMUN, V131, P923, DOI 10.1016/j.jaci.2012.12.665; Puerta L, 2005, ALLERGY, V60, P41, DOI 10.1111/j.1398-9995.2004.00636.x; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Radauer C, 2006, J ALLERGY CLIN IMMUN, V117, P141, DOI 10.1016/j.jaci.2005.09.010; Radauer C, 2014, ALLERGY, V69, P413, DOI 10.1111/all.12348; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Ramos JDA, 2004, CLIN EXP ALLERGY, V34, P604, DOI 10.1111/j.1365-2222.2004.1922.x; Reese G, 2007, J ALLERGY CLIN IMMUN, V119, P944, DOI 10.1016/j.jaci.2006.11.699; Restani P, 2004, ALLERGY, V59, P21, DOI 10.1111/j.1398-9995.2004.00568.x; Romano A, 2012, CLIN EXP ALLERGY, V42, P1643, DOI 10.1111/cea.12011; Roth-Walter F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104803; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Salminen TA, 2016, PLANTA, V244, P971, DOI 10.1007/s00425-016-2585-4; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; San-Juan S, 2005, ALLERGY, V60, P839, DOI 10.1111/j.1398-9995.2005.00582.x; Sancho AI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169784; Santos A, 2011, INT ARCH ALLERGY IMM, V155, P191, DOI 10.1159/000321178; Schein CH, 2007, IMMUNOL ALLERGY CLIN, V27, P1, DOI 10.1016/j.iac.2006.11.005; Schenk MF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-168; Schenk MF, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-24; Scheurer S, 2004, J ALLERGY CLIN IMMUN, V114, P900, DOI 10.1016/j.jaci.2004.06.017; Schirmer T, 2005, J MOL BIOL, V351, P1101, DOI 10.1016/j.jmb.2005.06.054; Schramm G, 1998, EUR J BIOCHEM, V252, P200, DOI 10.1046/j.1432-1327.1998.2520200.x; Schulten V, 2011, ALLERGY, V66, P1005, DOI 10.1111/j.1398-9995.2011.02567.x; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sekerkova A, 2012, ALLERGOL INT, V61, P339, DOI 10.2332/allergolint.11-OA-0372; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirvent S, 2011, ANN ALLERG ASTHMA IM, V106, P429, DOI 10.1016/j.anai.2011.01.001; Smole U, 2010, ALLERGY, V65, P1388, DOI 10.1111/j.1398-9995.2010.02407.x; Spiric J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142404; Spitzauer S, 1999, INT ARCH ALLERGY IMM, V120, P259, DOI 10.1159/000024278; Spitzauer S, 1995, J ALLERGY CLIN IMMUN, V96, P951, DOI 10.1016/S0091-6749(95)70233-4; Stemeseder T, 2017, ALLERGY, V72, P754, DOI 10.1111/all.13071; Subbarayal B, 2013, ALLERGY, V68, P1377, DOI 10.1111/all.12236; Tawde P, 2006, J ALLERGY CLIN IMMUN, V118, P915, DOI 10.1016/j.jaci.2006.05.028; Thomas WR, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0432-x; Tiwari Ruby, 2009, Allergology International, V58, P557, DOI 10.2332/allergolint.09-OA-0094; Tordesillas L, 2009, MOL IMMUNOL, V47, P534, DOI 10.1016/j.molimm.2009.07.028; Trakultivakorn M, 2002, ASIAN PAC J ALLERGY, V20, P217; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tscheppe A, 2017, INT ARCH ALLERGY IMM, V172, P187, DOI 10.1159/000464104; Uasuf Carina Gabriela, 2015, Clin Mol Allergy, V13, P30, DOI 10.1186/s12948-015-0035-7; Uotila R, 2016, ALLERGY, V71, P514, DOI 10.1111/all.12826; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Valenta R, 2007, J INVEST ALLERG CLIN, V17, P36; Valenta R, 2002, CURR OPIN IMMUNOL, V14, P718, DOI 10.1016/S0952-7915(02)00402-8; van Oort E, 2002, EUR J BIOCHEM, V269, P671, DOI 10.1046/j.0014-2956.2001.02700.x; Van Ree R, 2008, ALLERGY, V63, P310, DOI 10.1111/j.1398-9995.2007.01612.x; van Ree R, 2002, BIOCHEM SOC T, V30, P910, DOI 10.1042/BST0300910; VANREE R, 1992, CLIN EXP ALLERGY, V22, P611; VANREE R, 1995, ALLERGY, V50, P281; Villalta D, 2010, J INVEST ALLERG CLIN, V20, P591; Virtanen T, 2012, CLIN EXP ALLERGY, V42, P494, DOI 10.1111/j.1365-2222.2011.03903.x; von Loetzen CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128677; WAHN U, 1981, MOL IMMUNOL, V18, P19, DOI 10.1016/0161-5890(81)90044-4; Wallner M, 2009, ALLERGY, V64, P452, DOI 10.1111/j.1398-9995.2008.01788.x; Wangorsch A, 2016, CLIN EXP ALLERGY, V46, P764, DOI 10.1111/cea.12721; Wangorsch A, 2012, CLIN EXP ALLERGY, V42, P156, DOI 10.1111/j.1365-2222.2011.03900.x; Wangorsch A, 2007, MOL IMMUNOL, V44, P2518, DOI 10.1016/j.molimm.2006.12.023; Welt K, 2005, ALLERGY, V60, P545, DOI 10.1111/j.1398-9995.2005.00716.x; Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P435, DOI 10.1067/mai.2002.126380; Westman M, 2015, J ALLERGY CLIN IMMUN, V135, P1199, DOI 10.1016/j.jaci.2014.10.042; White JM, 2009, OPEN ALLERGY J, V2, P27; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wolf M, 2017, ALLERGY, V72, P1874, DOI 10.1111/all.13196; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zhao L, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S6; Zhu J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00052	270	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208276	10.1371/journal.pone.0208276	http://dx.doi.org/10.1371/journal.pone.0208276			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496313	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800126
J	Schafermann, S; Wemakor, E; Hauk, C; Heide, L				Schaefermann, Simon; Wemakor, Emmanuel; Hauk, Cathrin; Heide, Lutz			Quality of medicines in southern Togo: Investigation of antibiotics and of medicines for non-communicable diseases from pharmacies and informal vendors	PLOS ONE			English	Article							DRUGS; TABLES	Substandard and falsified medicines represent a serious threat for public health and patient safety. Especially in low and middle-income countries, the prevalence of substandard and falsified medicines is reportedly high. However, reliable information on the prevalence of poor-quality medicines is scarce. In this study, 12 essential medicines, including antibiotics, antidiabetics, cardiac drugs and antiasthmatic drugs, were collected from six informal vendors and six licensed pharmacies in the southern part of Togo (regions Maritime and Plateaux). A mystery shopper approach was used in both types of outlets. In total, 64 samples were collected from licensed pharmacies and 30 from informal vendors. Both availability of medicines and prices of medicines were higher in licensed pharmacies than in informal vendors. 92 medicine samples were analyzed by visual examination, followed by chemical analysis for the content and for the dissolution of the active pharmaceutical ingredients according to the respective monographs of the United States Pharmacopoeia. 7 samples (8%) did not comply with the pharmacopoeial specifications, and one sample (1%) showed even extreme deviations. None of the samples was obviously falsified. However, one sample of amoxicillin capsules contained only 47% of the declared content of the active pharmaceutical ingredient, indicating that it may represent amoxicillin capsules 250 mg, rather than 500mg as declared on the label. Medicines stated to originate from Asia (i.e. mainly from India and China) showed a significantly higher proportion (24%) of non-compliant samples than those from Africa and Europe (4%, p = 0.007). High failure rates were observed in medicines both from informal vendors (13%) and from licensed pharmacies (5%), but the difference between both groups was not statistically significant (p = 0.152). The observed high prevalence of substandard medicines requires action from regulatory authorities and health care providers. Testing of selected samples for related substances indicated that inappropriate transport and storage conditions may have been an important cause for substandard quality.	[Schaefermann, Simon; Wemakor, Emmanuel; Hauk, Cathrin; Heide, Lutz] Eberhard Karls Univ Tuebingen, Pharmaceut Inst, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Heide, L (corresponding author), Eberhard Karls Univ Tuebingen, Pharmaceut Inst, Tubingen, Germany.	heide@uni-tuebingen.de		Heide, Lutz/0000-0001-7809-7453	Eberhard Karls University Tubingen; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen; University of Tuebingen	Eberhard Karls University Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; University of Tuebingen	This study was funded by the Eberhard Karls University Tubingen. We furthermore acknowledge support for open access publication by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the University of Tuebingen (management, faculty and staff) for support of research and training on pharmaceutical challenges in developing countries. Furthermore, they are grateful to Pharma Test Apparatebau AG, Hainburg, Germany, for the provision of a PTWS 610 Dissolution Testing apparatus at special conditions in support of efforts to improve medicine quality in Africa.	Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; Antignac M, 2017, INT J CARDIOL, V243, P523, DOI 10.1016/j.ijcard.2017.04.099; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Falvey M., 2008, MEASURING MED PRICES, P233; Fleiss J.L., 2013, STAT METHODS RATES P; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; ICH, 2014, ICH GUID VAL AN PROC; ICH, 2003, Q1C STAB TEST NEW DO; Kaur H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1096-x; Khuluza F, 2017, AM J TROP MED HYG; Management Sciences for Health (MSH)/WHO, INT MED PROD PRIC GU; MedCalc, 2018, COMP PROP CALC 2018; MedCalc, 2018, TEST ON PROP CALC 20; Mufusama JP, 2018, DRUG TEST ANAL, V10, P1599, DOI 10.1002/dta.2420; Mwangi John M., 2016, Pharmaceuticals Policy and Law, V18, P91, DOI 10.3233/PPL-160435; Nayyar GML, 2015, AM J TROP MED HYG, V92, P113, DOI 10.4269/ajtmh.14-0393; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Osei-Safo Dorcas, 2014, Malar Res Treat, V2014, P806416, DOI 10.1155/2014/806416; Petersen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184165; Raju CBVN, 2009, ACTA CHROMATOGR, V21, P57, DOI 10.1556/AChrom.21.2009.1.5; Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; Tchamdja E, 2016, PREV VET MED, V126, P151, DOI 10.1016/j.prevetmed.2016.02.001; Twagirumukiza M, 2009, AM J TROP MED HYG, V81, P776, DOI 10.4269/ajtmh.2009.09-0109; UN-DESA, 2017, SUST DEV GOAL 3 PROG; United Nations, 2012, MILL DEV GOAL 8 GLOB; United Nations, 2015, MDG GAP TASK FORC RE; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; WHO, 2016, WHO TECH REP SER, V996, P1; WHO, 2012, LIST NAT MED ESS SOU; WHO, 2016, REP INF TECHN WORK G; WHO, 2011, SURV QUAL SEL ANT ME; Wilsdon T, 2016, EVOLUTION ACCESS ESS; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization, 2011, TRAD MED GLOB SIT IS; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization (WHO), 2017, 1 10 MED PROD DEV CO; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	40	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207911	10.1371/journal.pone.0207911	http://dx.doi.org/10.1371/journal.pone.0207911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496234	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800063
J	Fuchs, AL; Weaver, AJ; Tripet, BP; Ammons, MCB; Teintze, M; Copie, V				Fuchs, Amanda L.; Weaver, Alan J., Jr.; Tripet, Brian P.; Ammons, Mary Cloud B.; Teintze, Martin; Copie, Valerie			Characterization of the antibacterial activity of Bald's eyesalve against drug resistant Staphylococcus aureus and Pseudomonas aeruginosa	PLOS ONE			English	Article							QUORUM-SENSING ACTIVITY; METHICILLIN-RESISTANT; NATURAL-PRODUCTS; ALLICIN; BIOFILM; L.; MEMBRANE; SULFIDES; ETHANOL	Bald's eyesalve is an Anglo-Saxon medicinal remedy that has been used through ancient times to treat eye sty infections and may represent a source of ancientbiotics. This study assessed the efficacy of Bald's eyesalve against several strains of Staphylococcus aureus and Pseudomonas aeruginosa, including a multi-drug resistant phenotype, and identified the principal compound conveying antibacterial activity. Bald's eyesalve formulations were produced by combining garlic, onion or leek, wine, bovine bile, and brass, with specific ingredient omissions in several formulations, followed by incubation at 4 degrees C for 9 days. Bald's eyesalve formulation ES-GBBr exhibited the greatest antibacterial activity against S. aureus and P. aeruginosa. Fractionation of ES-GBBr using molecular size exclusion and organic solvent partitioning isolated its antibacterial activity to the small molecule nonpolar fraction, and 1D H-1 NMR revealed the identity of the antibacterial agent to be allicin. Depletion of allicin from this fraction by addition of exogenous cysteine established that all observable growth inhibition originated from allicin. Quantification of allicin demonstrated that its concentration was significantly greater in ES-GBBr compared to the ES-O formulation; however, this was not due to greater yield. The antibacterial activity of allicin against S. aureus was antagonized by other ingredients within Bald's eyesalve, whereas they were additive or synergistic against P. aeruginosa. These results suggest that neither leek nor onion is necessary for the antibacterial efficacy of Bald's eyesalve against S. aureus or P. aeruginosa, and while allicin was identified as the principal antibacterial agent present, its activity is influenced differentially in the presence of additional Bald's eyesalve ingredients when used against S. aureus compared to P. aeruginosa. Ancientbiotics may provide a source of promising antibacterials; however, identifying the source of activity and assessing distinct formulations for cooperative effects are essential to using ancient remedies, such as Bald's eyesalve, effectively against drug resistant pathogens.	[Fuchs, Amanda L.; Weaver, Alan J., Jr.; Tripet, Brian P.; Ammons, Mary Cloud B.; Teintze, Martin; Copie, Valerie] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Weaver, Alan J., Jr.] US Army, Dent & Craniofacial Trauma Res & Tissue Regenerat, Inst Surg Res, Jbsa Ft Sam Houston, TX USA; [Ammons, Mary Cloud B.] Idaho Vet Res & Educ Fdn, Boise Vet Med Ctr, Boise, ID USA	Montana State University System; Montana State University Bozeman	Fuchs, AL; Copie, V (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	afuchs03143@gmail.com; vcopie@montana.edu	Copie, Valerie/GLT-8476-2022; Copie, Valerie/GPW-9767-2022	Copie, Valerie/0000-0002-2778-1463; Copie, Valerie/0000-0002-2778-1463; Fuchs, Amanda/0000-0002-7085-0727; Ammons, Mary Cloud/0000-0002-9717-0844	Montana Research Initiative [51040-MUSRI2015-03]; NSF [MCB-1714556]; NIH [1KO1GM103821-04]; NIH Shared Instrumentation Grant (SIG) program [1S10RR13878, 1S10RR026659]; National Science Foundation [NSF-MRI: DBI-1532078]; Murdock Charitable Trust Foundation [2015066: MNL]; MSU's Vice President for Research and Economic Development's office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K01GM103821, P20GM109007] Funding Source: NIH RePORTER	Montana Research Initiative; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Shared Instrumentation Grant (SIG) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Murdock Charitable Trust Foundation; MSU's Vice President for Research and Economic Development's office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded, in part, by the Montana Research Initiative Grant No. 51040-MUSRI2015-03 (VC, ALF, BPT), NSF Grant No. MCB-1714556 (VC, ALF), and NIH Grant No. 1KO1GM103821-04 (MCBA). The 1D 1H NMR spectra included in this manuscript were recorded at Montana State University's NMR Center on a Bruker AVANCE III 600 NMR spectrometer. Funding for the instrument and corresponding upgrade was provided by the NIH Shared Instrumentation Grant (SIG) program (Grant No. 1S10RR13878 and 1S10RR026659). Support for MSU's NMR Center and new NMR spectrometer has been provided by the National Science Foundation (Grant No. NSF-MRI: DBI-1532078), the Murdock Charitable Trust Foundation (Grant No. 2015066: MNL), and MSU's Vice President for Research and Economic Development's office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel U, 2002, CURR OPIN CHEM BIOL, V6, P453, DOI 10.1016/S1367-5931(02)00338-1; Abidi SH, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-57; Ammons MCB, 2014, J PROTEOME RES, V13, P2973, DOI 10.1021/pr500120c; [Anonymous], 2015, M07 A10 METHODS DILU; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Barrera NP, 2005, TRENDS PHARMACOL SCI, V26, P526, DOI 10.1016/j.tips.2005.08.003; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048; Chhabria S, 2018, SAUDI J BIOL SCI, V25, P1429, DOI 10.1016/j.sjbs.2016.01.003; Cockayne TO, 1864, ROLLS SERIES 35; Corral MJ, 2014, ANTIMICROB AGENTS CH, V58, P1596, DOI 10.1128/AAC.00710-13; Cutler RR, 2004, BRIT J BIOMED SCI, V61, P71, DOI 10.1080/09674845.2004.11732646; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Eldridge GR, 2002, ANAL CHEM, V74, P3963, DOI 10.1021/ac025534s; FEROCI G, 1995, ANAL CHEM, V67, P4077, DOI 10.1021/ac00118a008; FREEMAN F, 1995, J AGR FOOD CHEM, V43, P2332, DOI 10.1021/jf00057a004; FRIED VA, 1973, J BACTERIOL, V114, P239, DOI 10.1128/JB.114.1.239-248.1973; Fujisawa H, 2008, J AGR FOOD CHEM, V56, P4229, DOI 10.1021/jf8000907; Gruhlke MCH, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6010001; Harrison F, 2015, MBIO, V6, DOI 10.1128/mBio.01129-15; HUANG L, 1986, APPL ENVIRON MICROB, V51, P1230, DOI 10.1128/AEM.51.6.1230-1234.1986; Ilic D, 2012, SCI WORLD J, DOI 10.1100/2012/561823; Inui T, 2012, FITOTERAPIA, V83, P1218, DOI 10.1016/j.fitote.2012.06.012; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Kim JW, 2004, FOOD SCI BIOTECHNOL, V13, P235; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lanzotti V, 2013, PHYTOCHEM REV, V12, P751, DOI 10.1007/s11101-013-9295-3; Lee JH, 2013, BIOFOULING, V29, P491, DOI 10.1080/08927014.2013.788692; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Liu Zhijun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P112, DOI 10.2174/187153008784534358; Man A, 2017, REV ROMANA MED LAB, V25, P335, DOI 10.1515/rrlm-2017-0028; Marshakov IK, 2005, PROT MET+, V41, P205, DOI 10.1007/s11124-005-0031-2; Mazzola PG, 2009, BRAZ J PHARM SCI, V45, P241, DOI 10.1590/S1984-82502009000200008; Mnayer D, 2014, MOLECULES, V19, P20034, DOI 10.3390/molecules191220034; Muller A, 2016, J BIOL CHEM, V291, P11477, DOI 10.1074/jbc.M115.702308; Musthafa KS, 2010, CHEMOTHERAPY, V56, P333, DOI 10.1159/000320185; Natesan M, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/4/045002; O'Callaghan RJ, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010009; O'Neill J., 2016, REV ANTIMICROBIAL RE; Qiu F, 2013, J NAT PROD, V76, P413, DOI 10.1021/np3007809; Rahal JJ, 2006, CLIN INFECT DIS, V43, pS95, DOI 10.1086/504486; Santas J, 2010, INT J FOOD SCI TECH, V45, P403, DOI 10.1111/j.1365-2621.2009.02169.x; Sharifi-Rad J, 2014, ANN MED HEALTH SCI R, V4, P863, DOI 10.4103/2141-9248.144883; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Silveira MG, 2004, APPL ENVIRON MICROB, V70, P2748, DOI 10.1128/AEM.70.5.2748-2755.2004; Stewart PS, 2015, ANTIMICROB AGENTS CH, V59, P3838, DOI 10.1128/AAC.00433-15; Torella JP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000796; Tsao SM, 2001, J MED MICROBIOL, V50, P646, DOI 10.1099/0022-1317-50-7-646; Tsaoa SM, 2001, J ANTIMICROB CHEMOTH, V47, P665, DOI 10.1093/jac/47.5.665; Vandeputte OM, 2011, MICROBIOL-SGM, V157, P2120, DOI 10.1099/mic.0.049338-0; Vasavi HS, 2016, J MICROBIOL IMMUNOL, V49, P8, DOI 10.1016/j.jmii.2014.03.012; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Watkins F, 2011, DRUG DISCOV TODAY, V16, P1069, DOI 10.1016/j.drudis.2011.07.002; Wu XQ, 2015, FOOD SCI NUTR, V3, P158, DOI 10.1002/fsn3.199	55	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208108	10.1371/journal.pone.0208108	http://dx.doi.org/10.1371/journal.pone.0208108			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485362	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800108
J	Haile, B; Signorelli, S; Azzarri, C; Johnson, T				Haile, Beliyou; Signorelli, Sara; Azzarri, Carlo; Johnson, Timothy			Welfare effects of weather variability: Multi-country evidence from Africa south of the Sahara	PLOS ONE			English	Article							CLIMATE-CHANGE; FOOD SECURITY; VULNERABILITY; RAINFALL; DISASTERS; MIGRATION; VARIABLES; IMPACTS; SERIES; RISK	Climate change and weather variability pose serious threats to food and nutrition security as well as ecosystems, especially when livelihoods depend heavily on natural resources. This study examines the effect of weather variability (shock) occurring up to three planting and growing season prior on per capita monthly household expenditure in rural Tanzania, Uganda, and Ghana. The analyses combine monthly temperature (1950-2013) and precipitation (1981-2013) data with data from several rounds of household surveys conducted between 1998 and 2013. Substantial spatial and temporal heterogeneity is documented in the incidence of shocks, with effects dependent on both the study and lag period considered. Analysis of short panel data shows the cumulative effect of above-average precipitation on expenditure to be negative in Uganda - while positive in Tanzania-, but the relationship does not persist when pooling survey data spanning over a decade. The evidence from pooled data suggests a positive association between above-average temperature (heat wave) and expenditure in (historically cooler) Uganda, with the opposite effect observed in (the relatively warmer) Tanzania. For Ghana, the association between heat wave and expenditure is positive. There is no evidence of heterogeneous effects along several dimensions, except by agro-ecological condition. Further research into the effects of shocks on more direct outcomes-such as agricultural practices, yields, and dietary intake-is therefore recommended to shed light on possible impact pathways and appropriate localized adaptation strategies.	[Haile, Beliyou; Azzarri, Carlo] Int Food Policy Res Inst, Washington, DC 20036 USA; [Signorelli, Sara] Paris Sch Econ, Paris, France; [Johnson, Timothy] Duo Secur, Ann Arbor, MI USA	CGIAR; International Food Policy Research Institute (IFPRI); Paris School of Economics	Haile, B (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	b.haile@cgiar.org	Haile, Beliyou/ABG-5909-2021	Haile, Beliyou/0000-0003-4949-6740; Azzarri, Carlo/0000-0002-0345-1304; Signorelli, Sara/0000-0002-6256-3568	International Food Policy Research Institute (IFPRI); Bill and Melinda Gates Foundation (BMGF) [OPPGD1450]; IFPRI [500008.000.001]	International Food Policy Research Institute (IFPRI)(CGIAR); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); IFPRI	Financial support for this research came from the International Food Policy Research Institute (IFPRI) (https://www.ifpri.org/) and Bill and Melinda Gates Foundation (BMGF) (OPPGD1450) (https://www.gatesfoundation.org/). IFPRI's funding was part of the 2016 Strategic Innovations Fund (SIF) Award won by Beliyou Haile (500008.000.001). More information about the SIF can be found here. No other individual (besides the listed co-authors and those mentioned in the acknowledgments) or organizations played a role in the study design, analysis, or write-up. All data used in the study came from publicly available secondary sources.; We thank the International Food Policy Research Institute (IFPRI) and Bill and Melinda Gates Foundation (BMGF) for financially supporting this research and three anonymous reviewers for their invaluable feedback on an earlier version. We also thank Rebecca Pietrelli and Marco d'Errico of UN FAO for sharing partially processed socioeconomic secondary data and for helpful discussions during the early stages of the research. Melanie Bacou and Yating Ru (IFPRI) assisted with weather data processing and cartography, respectively. We thank Apurba Shee (Natural Resources Institute) and James Stevenson (CGIAR SPIA) for their feedback on the draft proposal and an earlier version, respectively. The views expressed here belong to the authors, and do not necessarily reflect those of IFPRI or BMGF.	Alderman H, 2010, J NUTR, V140, p148S, DOI 10.3945/jn.109.110825; ANGRIST JD, 1991, J ECONOMETRICS, V47, P243, DOI 10.1016/0304-4076(91)90101-I; [Anonymous], 2003, 21 SESS IPCC VIENN A, DOI DOI 10.4324/9781315270326-109; [Anonymous], 2015, LONG TERM ANN RAINF; [Anonymous], 2015, AEZ 16 CLASS 2009; [Anonymous], 2015, VAR LONG TERM ANN RA; ARELLANO M, 1993, J ECONOMETRICS, V59, P87, DOI 10.1016/0304-4076(93)90040-C; Armah FA, 2011, MITIG ADAPT STRAT GL, V16, P291, DOI 10.1007/s11027-010-9263-9; Asfaw S, 2016, WELFARE IMPACTS CLIM; Bremner J., 2010, INTERDISCIP SCI REV, V11, P112, DOI [10.1504/IER.2010.037902, DOI 10.1504/IER.2010.037902]; Cameron C., 2005, MICROECONOMETRICS US, P1056; Carter MR, 2007, WORLD DEV, V35, P835, DOI 10.1016/j.worlddev.2006.09.010; Carter MR, 2012, J DEV ECON, V99, P255, DOI 10.1016/j.jdeveco.2012.02.003; Connolly-Boutin L, 2016, REG ENVIRON CHANGE, V16, P385, DOI 10.1007/s10113-015-0761-x; DEATON A, 1985, J ECONOMETRICS, V30, P109, DOI 10.1016/0304-4076(85)90134-4; Derbile EK, 2016, JAMBA-J DISASTER RIS, V8, DOI 10.4102/jamba.v8i3.249; Devereux PJ, 2007, J BUS ECON STAT, V25, P278, DOI 10.1198/073500106000000189; Devereux PJ, 2007, J APPL ECONOM, V22, P839, DOI 10.1002/jae.938; Dzanku FM, 2015, WORLD DEV, V67, P336, DOI 10.1016/j.worlddev.2014.10.030; Essegbey G.O., 2017, AGR FOOD SECURITY, V6, P26, DOI [https://doi.org/10.1186/s40066-017-0104-x, DOI 10.1186/S40066-017-0104-X, 10.1186/s40066-017-0104-x]; Flato M, 2017, WORLD DEV, V90, P41, DOI 10.1016/j.worlddev.2016.08.015; Fraser AI, 1999, WATER SCI TECHNOL, V39, P41, DOI 10.1016/S0273-1223(99)00316-9; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; Gardes F, 2005, J BUS ECON STAT, V23, P242, DOI 10.1198/073500104000000587; Henderson V, 2011, AM ECON REV, V101, P194, DOI 10.1257/aer.101.3.194; Hulme M., 2005, Climate change and Africa, P29, DOI 10.1017/CBO9780511535864.013; John Bosco A, 2007, IMPLICATIONS RAINFAL, V168; Kang YH, 2009, PROG NAT SCI-MATER, V19, P1665, DOI 10.1016/j.pnsc.2009.08.001; Kotir Julius H., 2011, Environment Development and Sustainability, V13, P587, DOI 10.1007/s10668-010-9278-0; Krishnamurthy PK, 2014, GLOBAL ENVIRON CHANG, V25, P121, DOI 10.1016/j.gloenvcha.2013.11.004; Kubik Z, 2016, J DEV STUD, V52, P665, DOI 10.1080/00220388.2015.1107049; Lazzaroni S, 2014, WEATHER VARIABILITY, V583; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Ndamani F, 2013, RAINFALL VARIABILITY; Nsubuga FWN, 2014, HYDROLOG SCI J, V59, P278, DOI 10.1080/02626667.2013.804188; Owusu K, 2008, GEOJOURNAL, V71, P201, DOI 10.1007/s10708-008-9156-6; Papaioannou K, 2015, CLIMATE SHOCKS CASH, P76; Phalkey RK, 2015, P NATL ACAD SCI USA, V112, pE4522, DOI 10.1073/pnas.1409769112; Plumper T, 2007, POLIT ANAL, V15, P124, DOI 10.1093/pan/mpm002; ROSENZWEIG MR, 1993, ECON J, V103, P56, DOI 10.2307/2234337; Scheffran J, 2012, APPL GEOGR, V33, P119, DOI 10.1016/j.apgeog.2011.10.002; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Trenberth KE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022760; VERBEEK M, 1993, J ECONOMETRICS, V59, P125, DOI 10.1016/0304-4076(93)90042-4; Verbeek M., 1992, EMPIR ECON, V17, P9, DOI DOI 10.1007/BF01192471; Wheeler D., 2012, QUANTIFYING VULNERAB, DOI 10.2139/ssrn.1824611; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Willmott C.J., 2001, TERRESTRIAL AIR TEMP; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; World Bank, 2013, THE WORLD BANK GROUP; World Bank, 2011, TACKL POV NO GHAN; You LZ, 2011, FOOD POLICY, V36, P770, DOI 10.1016/j.foodpol.2011.09.001	53	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206415	10.1371/journal.pone.0206415	http://dx.doi.org/10.1371/journal.pone.0206415			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485274	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800020
J	Sullivan, JA; Zhang, XL; Sullivan, AP; Vose, LR; Moghadam, AA; Fried, VA; Stanton, PK				Sullivan, John A.; Zhang, Xiao-Lei; Sullivan, Arthur P.; Vose, Linnea R.; Moghadam, Alexander A.; Fried, Victor A.; Stanton, Patric K.			Zinc enhances hippocampal long-term potentiation at CA1 synapses through NR2B containing NMDA receptors	PLOS ONE			English	Article							SYNAPTICALLY RELEASED ZINC; ACTIVATION; SUBUNITS; MOSSY; TRANSMISSION; MODULATION; INHIBITION; INDUCTION; AFFINITY; SUBTYPES	The role of zinc (Zn2+), a modulator of N-methyl-D-aspartate (NMDA) receptors, in regulating long-term synaptic plasticity at hippocampal CA1 synapses is poorly understood. The effects of exogenous application of Zn2+ and of chelation of endogenous Zn2+ were examined on long-term potentiation (LTP) of stimulus-evoked synaptic transmission at Schaffer collateral (SCH) synapses in field CA1 of mouse hippocampal slices using whole-cell patch clamp and field recordings. Low micromolar concentrations of exogenous Zn2+ enhanced the induction of LTP, and this effect required activation of NMDA receptors containing NR2B subunits. Zn2+ elicited a selective increase in NMDA/NR2B fEPSPs, and removal of endogenous Zn2+ with high-affinity Zn2+ chelators robustly reduced the magnitude of stimulus-evoked LTP. Taken together, our data show that Zn2+ at physiological concentrations enhances activation of NMDA receptors containing NR2B subunits, and that this effect enhances the magnitude of LTP.	[Sullivan, John A.; Zhang, Xiao-Lei; Vose, Linnea R.; Moghadam, Alexander A.; Fried, Victor A.; Stanton, Patric K.] New York Med Coll, Cell Biol & Anat, Valhalla, NY 10595 USA; [Sullivan, Arthur P.] Touro Sch Hlth Sci, Psychol & Educ, New York, NY USA	New York Medical College	Sullivan, JA (corresponding author), New York Med Coll, Cell Biol & Anat, Valhalla, NY 10595 USA.	johnasullivan81@gmail.com		Sullivan, Arthur/0000-0002-8880-4446; Sullivan, John/0000-0001-7128-271X	NIH [NS44421]; Linden Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Linden Fund	This study was supported by NIH grant NS44421 and the Linden Fund. PKS was the principal investigator.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; BIRCHMACHIN MA, 1986, BIOCHIM BIOPHYS ACTA, V855, P277, DOI 10.1016/0005-2736(86)90175-6; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Erreger K, 2005, J PHYSIOL-LONDON, V569, P381, DOI 10.1113/jphysiol.2005.095497; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Francesconi A, 2004, J NEUROSCI RES, V75, P472, DOI 10.1002/jnr.10853; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Harvey-Girard E, 2003, J NEUROPHYSIOL, V89, P822, DOI 10.1152/jn.00629.2002; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Izumi Y, 2008, HIPPOCAMPUS, V18, P258, DOI 10.1002/hipo.20383; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Kash T. L., 2007, DEBATES NEUROSCI, V1, P79; Kay AR, 2003, J NEUROSCI, V23, P6847; Kim TY, 2002, SYNAPSE, V46, P49, DOI 10.1002/syn.10118; KOH JY, 1994, NEUROSCIENCE, V60, P1049, DOI 10.1016/0306-4522(94)90282-8; Kohr G, 2003, J NEUROSCI, V23, P10791; Lavoie N, 2007, J PHYSIOL-LONDON, V578, P275, DOI 10.1113/jphysiol.2006.121848; Li Y, 2001, J NEUROSCI, V21, P8015, DOI 10.1523/JNEUROSCI.21-20-08015.2001; Lin SY, 1998, MOL BRAIN RES, V55, P20, DOI 10.1016/S0169-328X(97)00349-5; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Manzerra P, 2001, P NATL ACAD SCI USA, V98, P11055, DOI 10.1073/pnas.191353598; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Morgan SL, 2001, J NEUROPHYSIOL, V86, P1289, DOI 10.1152/jn.2001.86.3.1289; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Shumaker DK, 1998, CELL CALCIUM, V23, P151, DOI 10.1016/S0143-4160(98)90114-2; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Takeda A, 2006, BRAIN RES BULL, V68, P442, DOI 10.1016/j.brainresbull.2005.10.001; Takeda A, 2009, NEUROSCIENCE, V158, P585, DOI 10.1016/j.neuroscience.2008.10.009; Takeda A, 2007, J NEUROSCI RES, V85, P3666, DOI 10.1002/jnr.21449; Takeda A, 2010, BRAIN RES, V1323, P59, DOI 10.1016/j.brainres.2010.01.085; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wenzel A, 2002, J NEUROCHEM, V68, P469; XIE XM, 1993, NEUROSCI LETT, V159, P46, DOI 10.1016/0304-3940(93)90795-M; Xiong ZG, 1999, J NEUROSCI, V19; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Zhang XL, 2008, NEUROPHARMACOLOGY, V55, P1238, DOI 10.1016/j.neuropharm.2008.08.018	50	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0205907	10.1371/journal.pone.0205907	http://dx.doi.org/10.1371/journal.pone.0205907			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485271	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800010
J	Riedl, HL; Stinson, L; Pejchar, L; Clements, WH				Riedl, Hannah L.; Stinson, Lani; Pejchar, Liba; Clements, William H.			An introduced plant affects aquatic-derived carbon in the diets of riparian birds	PLOS ONE			English	Article							INVASIVE PLANTS; STABLE-ISOTOPES; PREY SUBSIDIES; ALIEN PLANTS; TERRESTRIAL; CONSEQUENCES; IMPACTS; FOOD; COMMUNITIES; ECOSYSTEMS	Non-native plants can impact riparian ecosystem function through diverse terrestrial and aquatic pathways, with cascading effects on food webs. Invasion-mediated vegetation changes can depress terrestrial arthropod communities and alter arthropod flux across the aquatic-terrestrial interface. We investigated the effects of a non-native woody plant, Robinia neomexicana, on insect contributions to riparian songbird diets. This plant was introduced over 100 years ago to the Clear Creek drainage in northwestern Colorado (USA) from its native range, which extends into southern Colorado. We used stable isotope analysis of insects and avian feces to 1) assess whether the relative contributions of aquatic-and terrestrial-derived arthropod prey differed between reference sites and sites invaded by R. neomexicana, and 2) quantify the amount of aquatic-and terrestrial-derived resources consumed by an insectivorous songbird assemblage. Two species of insectivorous songbirds consumed more aquatic insects in invaded sites compared to reference sites. This change in terrestrial-and aquatic-derived prey in bird diets in response to a near-range plant invasion suggests that the introduction of novel species from more distant native ranges could produce similar or stronger effects. Overall, the songbird community consumed approximately 34% aquatic resources, which highlights the importance of these subsidies to riparian consumers. Our investigation of insect subsidies demonstrates how introduced species can indirectly affect food webs and provides insight into the plasticity of riparian consumer responses.	[Riedl, Hannah L.; Stinson, Lani; Pejchar, Liba; Clements, William H.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	Colorado State University	Riedl, HL (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	Hannah.Riedl@mt.gov	Clements, William/N-2686-2016	Pejchar, Liba/0000-0002-9253-9884; Stinson, Lani/0000-0002-2163-7938	Chevron; Colorado Field Ornithologists; Warner College of Natural Resources at Colorado State University; Chevron Corporation; Warner College of Natural Resources; Graduate Degree Program in Ecology at Colorado State University; Fish, Wildlife, and Conservation Biology Department, Graduate Degree Program in Ecology	Chevron; Colorado Field Ornithologists; Warner College of Natural Resources at Colorado State University; Chevron Corporation; Warner College of Natural Resources; Graduate Degree Program in Ecology at Colorado State University; Fish, Wildlife, and Conservation Biology Department, Graduate Degree Program in Ecology	This research was supported by Chevron (awarded to L.P. and W.C.; https://www.chevron.com/), the Colorado Field Ornithologists (awarded to L.S.; https://cobirds.org/CFO/Grants/), and the Fish, Wildlife, and Conservation Biology Department, Graduate Degree Program in Ecology, and Warner College of Natural Resources at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Kurt Fausch, Ruth Hufbauer, Boris Kondratieff and an anonymous reviewer for comments that greatly improved earlier drafts of this manuscript. We also thank Brian Wolff for comments and statistical guidance. This study would not have been possible without field assistance from Graham Buggs, Lorna McCallister, Richard Salas, and Shana Wieferich and lab assistance from Valerie Doebly. Chevron Corporation granted permission to access study sites, and High Lonesome Ranch generously provided field housing. This research was financially supported by Chevron Corporation, Colorado Field Ornithologists, the Warner College of Natural Resources, and the Graduate Degree Program in Ecology at Colorado State University. Funding provided by these partners does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ballard M, 2013, ENVIRON ENTOMOL, V42, P851, DOI 10.1603/EN12315; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Benjamin JR, 2011, OECOLOGIA, V167, P503, DOI 10.1007/s00442-011-2000-6; BUSBY DG, 1979, CAN J ZOOL, V57, P1670, DOI 10.1139/z79-218; Cadmus P, 2016, J FRESHWATER ECOL, V31, P653, DOI 10.1080/02705060.2016.1217944; DEGRAAF RM, 1985, ENVIRON MANAGE, V9, P493, DOI 10.1007/BF01867324; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durst SL, 2008, CONDOR, V110, P514, DOI 10.1525/cond.2008.8493; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Fry B, 2007, STABLE ISOTOPE ECOLO; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hladyz S, 2011, J APPL ECOL, V48, P443, DOI 10.1111/j.1365-2664.2010.01924.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Howe FP, 2000, WEST N AM NATURALIST, V60, P139; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kominoski JS, 2013, FRONT ECOL ENVIRON, V11, P423, DOI 10.1890/120056; Larsen S, 2016, GLOBAL CHANGE BIOL, V22, P2489, DOI 10.1111/gcb.13182; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Litt AR, 2014, CONSERV BIOL, V28, P1532, DOI 10.1111/cobi.12350; Little E. L., 1976, ATLAS US TREES MINOR; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Merritt RW, 1996, INTRO AQUATIC INSECT, DOI [10.1007/s00442-004-1737-6, DOI 10.1007/S00442-004-1737-6]; Mineau MM, 2012, ECOLOGY, V93, P1501, DOI 10.1890/11-1700.1; Murakami M, 2001, ECOL RES, V16, P913, DOI 10.1046/j.1440-1703.2001.00448.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Painter ML, 2009, CAN J ZOOL, V87, P865, DOI 10.1139/Z09-075; Pavek D.S., 1993, ROBINIA NEOMEXICANA; Podlesak DW, 2005, OECOLOGIA, V142, P501, DOI 10.1007/s00442-004-1737-6; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Riedl HL, CANADIAN J FISHERIES; Roon DA, 2016, CAN J FISH AQUAT SCI, V73, P1679, DOI 10.1139/cjfas-2015-0548; ROUNICK JS, 1986, BIOSCIENCE, V36, P171, DOI 10.2307/1310304; Salvarina I, 2013, RAPID COMMUN MASS SP, V27, P1945, DOI 10.1002/rcm.6649; Saunders WC, 2007, T AM FISH SOC, V136, P1216, DOI 10.1577/T06-260.1; Schirmel J, 2016, GLOBAL CHANGE BIOL, V22, P594, DOI 10.1111/gcb.13093; Simao MCM, 2010, OIKOS, V119, P1553, DOI 10.1111/j.1600-0706.2010.18382.x; Strong D., 1984, INSECTS PLANTS COMMU; Tallamy DW, 2004, CONSERV BIOL, V18, P1689, DOI 10.1111/j.1523-1739.2004.00512.x; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; Triplehorn CA, BORROR DELONGS INTRO; Uesugi A, 2007, ECOL RES, V22, P274, DOI 10.1007/s11284-006-0028-6; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Wipfli MS, 1997, CAN J FISH AQUAT SCI, V54, P1259, DOI 10.1139/cjfas-54-6-1259; Yard HK, 2004, CONDOR, V106, P106, DOI 10.1650/7242	51	4	4	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207389	10.1371/journal.pone.0207389	http://dx.doi.org/10.1371/journal.pone.0207389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481226	Green Submitted, Green Published, gold			2022-12-26	WOS:000451440000013
J	Cuesta, FA; Sequeiros, PG; Rojo, AL				Alcalde Cuesta, Fernando; Gonzalez Sequeiros, Pablo; Lozano Rojo, Alvaro			Evolutionary regime transitions in structured populations	PLOS ONE			English	Article							FIXATION PROBABILITY; DYNAMICS	The evolutionary dynamics of a finite population where resident individuals are replaced by mutant ones depends on its spatial structure. Usually, the population adopts the form of an undirected graph where the place occupied by each individual is represented by a vertex and it is bidirectionally linked to the places that can be occupied by its offspring. There are undirected graph structures that act as amplifiers of selection increasing the probability that the offspring of an advantageous mutant spreads through the graph reaching any vertex. But there also are undirected graph structures acting as suppressors of selection where this probability is less than that of the same individual placed in a homogeneous population. Here, firstly, we present the distribution of these evolutionary regimes for all undirected graphs with N <= 10 vertices. Some of them exhibit transitions between different regimes when the mutant fitness increases. In particular, as it has been already observed for small-order random graphs, we show that most graphs of order N <= 10 are amplifiers of selection. Secondly, we describe examples of amplifiers of order 7 that become suppressors from some critical value. In fact, for graphs of order N <= 7, we apply computer-aided techniques to symbolically compute their fixation probability and then their evolutionary regime, as well as the critical values for which they change their regime. Thirdly, the same technique is applied to some families of highly symmetrical graphs as a mean to explore methods of suppressing selection. The existence of suppression mechanisms that reverse an amplification regime when fitness increases could have a great interest in biology and network science. Finally, the analysis of all graphs from order 8 to order 10 reveals a complex and rich evolutionary dynamics, with multiple transitions between different regimes, which have not been examined in detail until now.	[Alcalde Cuesta, Fernando] Univ Santiago de Compostela, Inst Matemat, E-15782 Santiago De Compostela, Spain; [Gonzalez Sequeiros, Pablo] Univ Santiago de Compostela, Fac Formac Profesorado, Dept Didact Aplicadas, Avda Ramon Ferreiro S-N, E-27002 Lugo, Spain; [Lozano Rojo, Alvaro] Acad Gen Mil, Ctr Univ Def, Ctra Huesca S-N, E-50090 Zaragoza, Spain; [Lozano Rojo, Alvaro] Univ Zaragoza, IUMA, Pedro Cerbuna 12, E-50009 Zaragoza, Spain; [Alcalde Cuesta, Fernando; Gonzalez Sequeiros, Pablo; Lozano Rojo, Alvaro] GeoDynApp ECSING Grp, E-15782 Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Zaragoza	Cuesta, FA (corresponding author), Univ Santiago de Compostela, Inst Matemat, E-15782 Santiago De Compostela, Spain.; Cuesta, FA (corresponding author), GeoDynApp ECSING Grp, E-15782 Santiago De Compostela, Spain.	fernando.alcalde@usc.es	Rojo, Álvaro Lozano/AAA-8089-2019; Cuesta, Fernando Alcalde/D-8196-2012	Rojo, Álvaro Lozano/0000-0002-1184-5901; Cuesta, Fernando Alcalde/0000-0002-6863-4283; Gonzalez Sequeiros, Pablo/0000-0001-9486-814X	Agencia Estatal de Investigacion [MTM2016-77642-C2-2-P]; European Regional Development Fund [MTM2016-77642-C2-2-P]; Ministerio de Educacion, Cultura y Deporte (Jose Castillejos Grant) [CAS17/00258]; Gobierno de Aragon; European Regional Development Fund (Grant E15 Geometra)	Agencia Estatal de Investigacion; European Regional Development Fund(European Commission); Ministerio de Educacion, Cultura y Deporte (Jose Castillejos Grant); Gobierno de Aragon(Gobierno de Aragon); European Regional Development Fund (Grant E15 Geometra)	This work was supported by the Agencia Estatal de Investigacion (Grant MTM2016-77642-C2-2-P) and the European Regional Development Fund grant MTM2016-77642-C2-2-P to FAC, PGS and ALR. ALR was also supported by the Ministerio de Educacion, Cultura y Deporte (Jose Castillejos Grant CAS17/00258), the Gobierno de Aragon and the European Regional Development Fund (Grant E15 Geometra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam B, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2015.0114; Alcalde Cuesta F, 2017, MENDELEY DATA, V2; Cuesta FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180549; Cuesta FA, 2017, LECT N BIOINFORMAT, V10209, P209, DOI 10.1007/978-3-319-56154-7_20; Cuesta FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20666; Azulay A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005021; Broom M, 2011, J STAT THEORY PRACT, V5, P369, DOI 10.1080/15598608.2011.10412035; Choi JO, 2018, PHYSICA A, V492, P2129, DOI 10.1016/j.physa.2017.11.131; Hindersin L, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0140-7; Hindersin L, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004437; Kaveh K, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140465; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; MARUYAMA T, 1970, GENET RES, V15, P221, DOI 10.1017/S0016672300001543; MARUYAMA T, 1974, THEOR POPUL BIOL, V5, P148, DOI 10.1016/0040-5809(74)90037-9; Mertzios GB, 2013, THEOR COMPUT SCI, V477, P76, DOI 10.1016/j.tcs.2012.11.032; Monk T, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2013.0730; Moran P., 1958, MATH P CAMBRIDGE PHI, V54, P60, DOI DOI 10.1017/S0305004100033193; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Shakarian P, 2013, BIOSYSTEMS, V111, P136, DOI 10.1016/j.biosystems.2013.01.006; Voorhees B., 2013, P ROYAL SOC A, V469, P2154, DOI DOI 10.1098/RSPA.2012.0676; Wu B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003381	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0200670	10.1371/journal.pone.0200670	http://dx.doi.org/10.1371/journal.pone.0200670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475815	gold, Green Submitted, Green Published			2022-12-26	WOS:000451325700004
J	Kim, EH; Joo, JY; Lee, YJ; Koh, JK; Choi, JH; Shin, Y; Cho, J; Park, E; Kang, JH; Lee, K; Bhak, J; Kim, BC; Lee, JY				Kim, Eun-Hye; Joo, Ji-Young; Lee, Yong Joo; Koh, Jae-Kwon; Choi, Jung-Hyeok; Shin, Yerang; Cho, Juok; Park, Eunha; Kang, Jihoon; Lee, Kyusang; Bhak, Jong; Kim, Byung Chul; Lee, Ju-Youn			Grading system for periodontitis by analyzing levels of periodontal pathogens in saliva	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; DISEASE; RISK; DNA; CLASSIFICATION; INSOMNIA; SMOKING; FLUID	Periodontitis is an infectious disease that is associated with microorganisms that colonize the tooth surface. Clinically, periodontal condition stability reflects dynamic equilibrium between bacterial challenge and host response. Therefore, periodontal pathogen assessment can assist in the early detection of periodontitis. Here we developed a grading system called the periodontal pathogen index (PPI) by analyzing the copy numbers of multiple pathogens both in healthy and chronic periodontitis patients. We collected 170 mouthwash samples (64 periodontally healthy controls and 106 chronic periodontitis patients) and analyzed the salivary 16S rRNA levels of nine pathogens using multiplex, quantitative real-time polymerase chain reaction. Except for Aggregatibacter actinomycetemcomitans, copy numbers of all pathogens were significantly higher in chronic periodontitis patients. We classified the samples based on optimal cut-off values with maximum sensitivity and specificity from receiver operating characteristic curve analyses (AUC = 0.91, 95% CI: 0.87-0.96) into four categories of PPI: Healthy (1-40), Moderate (41-60), At Risk (61-80), and Severe (81-100). PPI scores were significantly higher in all chronic periodontitis patients than in the controls (odds ratio: 31.7, 95% CI: 13.41-61.61) and were associated with age, scaling as well as clinical characteristics including clinical attachment level and plaque index. Our PPI grading system can be clinically useful for the early assessment of pathogenic bacterial burden and follow-up monitoring after periodontitis treatment.	[Kim, Eun-Hye; Lee, Yong Joo; Shin, Yerang; Kang, Jihoon] Gerotech Inc, Ulsan, South Korea; [Joo, Ji-Young; Koh, Jae-Kwon; Choi, Jung-Hyeok; Lee, Ju-Youn] Pusan Natl Univ Dent Hosp, Dent Res Inst, Yangsan, South Korea; [Joo, Ji-Young; Lee, Ju-Youn] Pusan Natl Univ, Sch Dent, Dept Periodontol, Yangsan, South Korea; [Joo, Ji-Young; Lee, Ju-Youn] Pusan Natl Univ, Sch Dent, Inst Translat Dent Sci, Yangsan, South Korea; [Cho, Juok; Park, Eunha; Bhak, Jong] Ulsan Natl Inst Sci & Technol, Genom Inst, Ulsan, South Korea; [Bhak, Jong] Geromics Inc, Ulsan, South Korea; [Bhak, Jong] Genome Res Fdn, Aging Inst, Osong, South Korea; [Lee, Kyusang; Kim, Byung Chul] Clinomics Inc, Ulsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Ulsan National Institute of Science & Technology (UNIST)	Lee, JY (corresponding author), Pusan Natl Univ Dent Hosp, Dent Res Inst, Yangsan, South Korea.; Lee, JY (corresponding author), Pusan Natl Univ, Sch Dent, Dept Periodontol, Yangsan, South Korea.; Lee, JY (corresponding author), Pusan Natl Univ, Sch Dent, Inst Translat Dent Sci, Yangsan, South Korea.; Kim, BC (corresponding author), Clinomics Inc, Ulsan, South Korea.	bckim00@gmail.com; heroine@pusan.ac.kr	Kim, Eunhye/ABG-2184-2021	Kim, Eunhye/0000-0002-9225-5865	Technological Innovation R&D Program - Small and Medium Business Administration (South Korea) [C0445482]; National Research Foundation of Korea [NRF-2017M3A9B6062026]	Technological Innovation R&D Program - Small and Medium Business Administration (South Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Technological Innovation R&D Program (C0445482) funded by the Small and Medium Business Administration (South Korea) to JK and National Research Foundation of Korea, NRF-2017M3A9B6062026, to J-YL. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Gerotech Inc provided support in the form of salaries for authors (EHK, YJL, YS, JK), Clinomics Inc provided support in the form of salaries for authors (KL, BCK) and Geromics Inc provided support in the form of salary for author (JB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AINAMO J, 1982, INT DENT J, V32, P281; Al-Rawi N, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/2643079; Albandar JM, 1997, J PERIODONTOL, V68, P545, DOI 10.1902/jop.1997.68.6.545; [Anonymous], 1996, Ann Periodontol, V1, P926; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2003, J PERIODONTOL, V74, P1237, DOI 10.1902/jop.2003.74.8.1237; Beltran-Aguilar ED, 2012, PERIODONTOL 2000, V60, P40, DOI 10.1111/j.1600-0757.2012.00446.x; Caton JG, 2018, J PERIODONTOL, V89, pS1, DOI 10.1002/JPER.18-0157; Chiappin S, 2007, CLIN CHIM ACTA, V383, P30, DOI 10.1016/j.cca.2007.04.011; Costa FO, 2013, J ORAL SCI, V55, P245; Cuevas-Cordoba B, 2014, OMICS, V18, P87, DOI 10.1089/omi.2013.0064; Fonseca DC, 2015, J PERIODONTOL, V86, P1340, DOI 10.1902/jop.2015.150227; GENCO RJ, 1984, J DENT RES, V63, P441, DOI 10.1177/00220345840630031601; Glickman I, 1958, CLIN PERIODONTOLOGY, P794; Gohler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099244; Grover Vishakha, 2015, J Indian Soc Periodontol, V19, P304, DOI 10.4103/0972-124X.154173; HAMP S-E, 1975, Journal of Clinical Periodontology, V2, P126, DOI 10.1111/j.1600-051X.1975.tb01734.x; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Kononen E, 2007, J CLIN MICROBIOL, V45, P2446, DOI 10.1128/JCM.02560-06; Lang Niklaus P, 2003, Oral Health Prev Dent, V1, P7; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P701; Lee CF, 2014, J PERIODONTOL, V85, pE65, DOI 10.1902/jop.2013.130284; Lee HJ, 2012, CURR MICROBIOL, V65, P22, DOI 10.1007/s00284-012-0121-8; Loomer PM, 2004, PERIODONTOL 2000, V34, P49, DOI 10.1046/j.0906-6713.2002.003424.x; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Mager DL, 2003, J CLIN PERIODONTOL, V30, P1031, DOI 10.1046/j.0303-6979.2003.00418.x; Michalowicz BS, 2000, J PERIODONTOL, V71, P1699, DOI 10.1902/jop.2000.71.11.1699; Miller S.C., 1950, TXB PERIODONTIA; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Paju S, 2009, J CLIN MICROBIOL, V47, P235, DOI 10.1128/JCM.01824-08; PIHLSTROM BL, 1984, J PERIODONTOL, V55, P499, DOI 10.1902/jop.1984.55.9.499; Poole NM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-261; Pulikkotil SJ, 2016, AUST DENT J, V61, P440, DOI 10.1111/adj.12409; Sanz M, 2004, J CLIN PERIODONTOL, V31, P1034, DOI 10.1111/j.1600-051X.2004.00609.x; Nunes LAS, 2015, BIOCHEM MEDICA, V25, P177, DOI 10.11613/BM.2015.018; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Spielmann N, 2011, ORAL DIS, V17, P345, DOI 10.1111/j.1601-0825.2010.01773.x; Stabholz A, 2010, PERIODONTOL 2000, V53, P138, DOI 10.1111/j.1600-0757.2010.00340.x; Terasaki P, 1998, HUM IMMUNOL, V59, P597, DOI 10.1016/S0198-8859(98)00057-3; Tomita S, 2013, MICROB PATHOGENESIS, V61-62, P11, DOI 10.1016/j.micpath.2013.04.006; Torrungruang K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136646; Tsuchiya M, 2015, TOHOKU J EXP MED, V237, P83, DOI 10.1620/tjem.237.83; van der Velden U, 2005, PERIODONTOL 2000, V39, P13, DOI 10.1111/j.1600-0757.2005.00127.x; Zhu JF, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/9612421	47	15	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0200900	10.1371/journal.pone.0200900	http://dx.doi.org/10.1371/journal.pone.0200900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475813	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700005
J	Mekli, K; Stevens, A; Marshall, AD; Arpawong, TE; Phillips, DF; Tampubolon, G; Lee, J; Prescott, CA; Nazroo, JY; Pendleton, N				Mekli, Krisztina; Stevens, Adam; Marshall, Alan D.; Arpawong, Thalida E.; Phillips, Drystan F.; Tampubolon, Gindo; Lee, Jinkook; Prescott, Carol A.; Nazroo, James Y.; Pendleton, Neil			Frailty Index associates with GRIN2B in two representative samples from the United States and the United Kingdom	PLOS ONE			English	Article							RECEPTOR SUBUNIT NR2B; NMDA RECEPTORS; ALZHEIMERS-DISEASE; OLDER-ADULTS; PAIN; VARIANTS; MEMORY; POLYMORPHISMS; TRAFFICKING; DYSFUNCTION	The concept of frailty has been used in the clinical and research field for more than two decades. It is usually described as a clinical state of heightened vulnerability to poor resolution of homeostasis after a stressor event, which thereby increases the risk of adverse outcomes, including falls, delirium, disability and mortality. Here we report the results of the first genome-wide association scan and comparative gene ontology analyses where we aimed to identify genes and pathways associated with the deficit model of frailty. We used a discovery- replication design with two independent, nationally representative samples of older adults. The square-root transformed Frailty Index (FI) was the outcome variable, and age and sex were included as covariates. We report one hit exceeding genome-wide significance: the rs6765037 A allele was significantly associated with a decrease in the squareroot transformed FI score in the Discovery sample (beta =-0.01958, p = 2.14E-08), without confirmation in the Replication sample. We also report a nominal replication: the rs7134291 A allele was significantly associated with a decrease in the square-root transformed FI score (Discovery sample: beta =-0.01021, p = 1.85E-06, Replication sample: beta =-0.005013, p = 0.03433). These hits represent the KBTBD12 and the GRIN2B genes, respectively. Comparative gene ontology analysis identified the pathways ` Neuropathic pain signalling in dorsal horn neurons' and the 'GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells', exceeding the p = 0.01 significance in both samples, although this result does not survive correction for multiple testing. Considering the crucial role of GRIN2B in brain development, synaptic plasticity and cognition, this gene appears to be a potential candidate to play a role in frailty. In conclusion, we conducted genome-wide association scan and pathway analyses and have identified genes and pathways with potential roles in frailty. However, frailty is a complex condition. Therefore, further research is required to confirm our results and more thoroughly identify relevant biological mechanisms.	[Mekli, Krisztina; Nazroo, James Y.] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England; [Stevens, Adam] Univ Manchester, Div Dev Biol & Med, Manchester, Lancs, England; [Marshall, Alan D.] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland; [Arpawong, Thalida E.; Prescott, Carol A.] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Psychol, Los Angeles, CA USA; [Phillips, Drystan F.; Lee, Jinkook] Univ Southern Calif, Dornsife Ctr Econ & Social Res, Los Angeles, CA USA; [Phillips, Drystan F.; Lee, Jinkook] RAND Corp, Santa Monica, CA USA; [Tampubolon, Gindo] Univ Manchester, Inst Social Change, Manchester, Lancs, England; [Prescott, Carol A.] Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Pendleton, Neil] Univ Manchester, Div Neurosci & Expt Psychol, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Edinburgh; University of Southern California; University of Southern California; RAND Corporation; University of Manchester; University of Southern California; University of Manchester	Mekli, K (corresponding author), Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England.	Krisztina.Mekli@manchester.ac.uk	Stevens, Adam/AAB-6301-2020; Pendleton, Neil/F-2333-2015	Stevens, Adam/0000-0002-1950-7325; Pendleton, Neil/0000-0003-0794-2386; Tampubolon, Gindo/0000-0002-9081-2349; Arpawong, Thalida/0000-0001-9671-9535	Medical Research Council [G1001375]; University of Manchester Research Institute in the United Kingdom; National Institute on Aging in the United States [R01 AG030153, F32 AG048681]; NATIONAL INSTITUTE ON AGING [R01AG030153] Funding Source: NIH RePORTER; ESRC [ES/K005774/1] Funding Source: UKRI; MRC [G1001375] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Manchester Research Institute in the United Kingdom; National Institute on Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (https://www.mrc.ac.uk/) [grant number: G1001375] (KM, ADM, GT, JYN, NP) and University of Manchester Research Institute (http://www.staffnet.manchester.ac.uk/services/rbess/research-strategy/umri/) (KM, AS) in the United Kingdom and the National Institute on Aging (https://www.nia.nih.gov/) [grant numbers: R01 AG030153 (JL, DFP) and F32 AG048681 (TEA, CAP)] in the United States. The funding sources had no further role in conducting the research or in publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JL and DFP are affiliated with RAND Corporation, Santa Monica. However, the RAND provided no support in the form of salaries for authors [JL, DFP], and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section'.	Andreoli V, 2014, J NEURAL TRANSM, V121, P533, DOI 10.1007/s00702-013-1125-7; Bagasrawala I, 2017, CEREB CORTEX, V27, P5041, DOI 10.1093/cercor/bhw289; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Cappola AR, 2009, J GERONTOL A-BIOL, V64, P243, DOI 10.1093/gerona/gln026; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collerton J, 2012, MECH AGEING DEV, V133, P456, DOI 10.1016/j.mad.2012.05.005; Dimassi S, 2013, AM J MED GENET A, V161, P2564, DOI 10.1002/ajmg.a.36079; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Hu C, 2016, J PHARMACOL SCI, V132, P115, DOI 10.1016/j.jphs.2016.10.002; Hubbard RE, 2009, J CELL MOL MED, V13, P3103, DOI 10.1111/j.1582-4934.2009.00733.x; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jiang HQ, 2009, NEUROSCI LETT, V450, P356, DOI 10.1016/j.neulet.2008.10.075; Kennedy RB, 2012, HUM GENET, V131, P1403, DOI 10.1007/s00439-012-1174-2; Lin MY, 2004, J AM GERIATR SOC, V52, P1996, DOI 10.1111/j.1532-5415.2004.52554.x; Liu XJ, 2010, EUR J NEUROSCI, V32, P278, DOI 10.1111/j.1460-9568.2010.07351.x; Martone AM, 2013, NUTRIENTS, V5, P4126, DOI 10.3390/nu5104126; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mekli K, 2016, AGING CLIN EXP RES, V28, P413, DOI 10.1007/s40520-015-0419-z; Mekli K, 2015, AGE AGEING, V44, P938, DOI 10.1093/ageing/afv122; Morisada Naoya, 2016, Hum Genome Var, V3, P16029, DOI 10.1038/hgv.2016.29; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pijpers E, 2012, EUR J INTERN MED, V23, P118, DOI 10.1016/j.ejim.2011.09.003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019; Schuh-Huerta SM, 2012, HUM REPROD, V27, P594, DOI 10.1093/humrep/der391; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Tajar A, 2011, J AM GERIATR SOC, V59, P814, DOI 10.1111/j.1532-5415.2011.03398.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Theou O, 2012, ARCH GERONTOL GERIAT, V55, pE1, DOI 10.1016/j.archger.2012.03.001; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vina J, 2016, MOL ASPECTS MED, V50, P88, DOI 10.1016/j.mam.2016.04.005; Wade KF, 2017, J GERONTOL A-BIOL, V72, P403, DOI 10.1093/gerona/glw226; Wade KF, 2016, AGE AGEING, V45, P268, DOI 10.1093/ageing/afv170; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Walter S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.026; Walton HS, 2007, NEUROCHEM INT, V50, P1052, DOI 10.1016/j.neuint.2006.10.007; Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008; Yan XS, 2013, J PHYSIOL-LONDON, V591, P2001, DOI 10.1113/jphysiol.2012.250522; Zhang Y, 2016, NEUROL SCI, V37, P1039, DOI 10.1007/s10072-016-2546-5	47	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207824	10.1371/journal.pone.0207824	http://dx.doi.org/10.1371/journal.pone.0207824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475886	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700076
J	Vierboom, YC; Preston, SH; Stokes, A				Vierboom, Yana C.; Preston, Samuel H.; Stokes, Andrew			Patterns of weight change associated with disease diagnosis in a national sample	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; OLDER-ADULTS; OVERWEIGHT; OBESITY; PREVALENCE; CACHEXIA; SMOKING; DEATH	Background The incidence and/or diagnosis of a major disease may activate weight change. Patterns of weight change associated with diagnoses have not been systematically documented. Methods We use data on adults ages 30+ in the National Health and Nutrition Examination Survey (NHANES) from 1999-2014. Self-reported current weight and weight one year prior are used to estimate percent weight change in the last year. We use self-reported data on arthritis, diabetes, cancer, cardiovascular disease, liver conditions, and respiratory disease diagnoses to compare weight change among individuals never diagnosed with these conditions, individuals diagnosed 0-1 years ago, and individuals diagnosed 2+ years ago. Multinomial logistic regressions adjust for the presence of multiple conditions. Results 17.7% of the adult population experienced weight loss of 5.0% or more in the year prior to survey. Individuals diagnosed with any of the conditions were less likely to maintain their weight than those without a diagnosis. Arthritis, diabetes, cancer, cardiovascular disease, and liver conditions were associated with net weight loss, whereas respiratory diseases were associated with higher probabilities of both losing and gaining weight. Among those losing 10% or more, 56.7% had been diagnosed with one of the conditions. Cancer was associated with the highest probability of unintentional weight loss and diabetes with the highest probability of intentional weight loss. Conclusions Disease-associated weight changes leave a distinct imprint on patterns of weight change in the population. Individuals losing at least 10% of their weight in the last year have likely been diagnosed with one of the six conditions.	[Vierboom, Yana C.; Preston, Samuel H.] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA; [Vierboom, Yana C.; Preston, Samuel H.] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA; [Stokes, Andrew] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	University of Pennsylvania; University of Pennsylvania; Boston University	Vierboom, YC (corresponding author), Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA.; Vierboom, YC (corresponding author), Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA.	vierboom@sas.upenn.edu		Vierboom, Yana/0000-0002-7764-5689	National Institute of Aging [R03 AG055724]; National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development [NIH T32 HD007242]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG055724] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant R03 AG055724 from the National Institute of Aging and by Population Research Training Grant NIH T32 HD007242 from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti Alvar G N, 2005, Proc Am Thorac Soc, V2, P367, DOI 10.1513/pats.200504-026SR; Albanese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086282; Alley DE, 2010, AM J EPIDEMIOL, V172, P558, DOI 10.1093/aje/kwq168; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aucott LS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010836; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Bosch X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175125; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Ezeoke CC, 2015, J CACHEXIA SARCOPENI, V6, P287, DOI 10.1002/jcsm.12059; Ferrucci L, 2007, ARCH INTERN MED, DOI [10.1152/japplphysiol.00627.2006.12, DOI 10.1152/JAPPLPHYSIOL.00627.2006.12]; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Furman EF, 2006, J GERONTOL NURS, V32, P22, DOI 10.3928/0098-9134-20060101-11; Gregg EW, 2003, ANN INTERN MED, V138, P383, DOI 10.7326/0003-4819-138-5-200303040-00007; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P2419, DOI 10.1001/jama.2018.7270; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Ingram DD, 2010, INT J OBESITY, V34, P1044, DOI 10.1038/ijo.2010.41; Klenk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084817; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Martin L, 2015, J CLIN ONCOL, V33, P90, DOI 10.1200/JCO.2014.56.1894; National Center for Health Statistics, 2010, VITAL HLTH STAT, V1, P1999; Olivarius ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122219; Preston SH, 2018, P NATL ACAD SCI USA, V115, P957, DOI 10.1073/pnas.1716802115; Preston SH, 2015, ANN EPIDEMIOL, V25, P907, DOI 10.1016/j.annepidem.2015.07.012; Sanders KJC, 2016, J CACHEXIA SARCOPENI, V7, P5, DOI 10.1002/jcsm.12062; Sparks JA, 2018, ARTHRITIS RHEUMATOL, V70, P627, DOI 10.1002/art.40415; Stokes A, 2016, P NATL ACAD SCI USA, V113, P572, DOI 10.1073/pnas.1515472113; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wijnhoven HAH, 2014, J GERONTOL A-BIOL, V69, P1236, DOI 10.1093/gerona/glu005; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499	33	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207795	10.1371/journal.pone.0207795	http://dx.doi.org/10.1371/journal.pone.0207795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475881	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700069
J	Weir, SS; Figueroa, JP; Scott, M; Byfield, L; Cooper, CJ; Hobbs, MC				Weir, Sharon S.; Figueroa, J. Peter; Scott, Marion; Byfield, Lovette; Cooper, Carol Jones; Hobbs, Marcia C.			Reaching key populations through key venues: Insights from the Jamaica HIV Prevention Program	PLOS ONE			English	Article							SEX; KINGSTON; HIV/AIDS	Introduction HIV prevention strategies often include outreach to female sex workers at social venues identified as places where people meet new sexual partners. Patrons and staff at these venues may include female sex workers, their clients, as well as others who have high rates of new sexual partnerships. Few studies have compared HIV/STI among venue-based and general populations, across types of venues, or by sub-group of the venue population. Program planners often assume that the prevalence of infection is highest among female sex workers and considerably lower among other people at these venues, but there are few empiric studies assessing the prevalence of infection by sex worker status and type of venue. Methods In 2011, we used the PLACE method to identify public venues where people meet new sexual partners across Jamaica. The study team visited all venues with reported sex work as well as a 10% random sample of other venues and subsequently interviewed and tested a probability sample of 991 venue patrons and workers for HIV and other STI. Results Community informants identified 1207 venues. All venues where sex work was reported (735 venues) and a random sample of the remainder (134 of 472) were selected for onsite visits. Of these, 585 were found and operational. At a stratified random sample of venues, survey teams interviewed and tested 717 women and 274 men. 394 women reported recent sex work and 211 of these women reported soliciting clients on the street. Women exchanging sex for money were more likely to be infected with HIV (5.4% vs 1.0%; OR = 5.6, 95% CI = 1.8,17.3) or syphilis (11.7% vs. 5.8%, OR = 2.2, 95% CI = 1.7,4,0) than other women, but not significantly more likely to be infected with gonorrhea (8.4% vs 7.8%; OR = 1.1,95% CI = 0.6,1.9), chlamydia (16.2% vs 21.6%; OR = 0.7,95% CI = 0.5,1.0) or trichomoniasis (23.0% vs 17.0%, OR = 1.5,95% CI = 0.9,2.2). Women at venues were more likely to report sex work and multiple partners than women interviewed in a 2008 national population-based household survey commissioned by the Ministry of Health. Conclusions In Jamaica, although the highest HIV prevalence was among street-based sex workers, the risk of HIV and STI extends to men and women at high risk venues, even those who do not self-identify as sex workers. Findings confirm the appropriateness of outreach to all men and women at these venues.	[Weir, Sharon S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Figueroa, J. Peter; Byfield, Lovette] Univ West Indies, Dept Community Hlth & Psychiat, Kingston, Jamaica; [Scott, Marion] Minist Hlth, Kingston, Jamaica; [Cooper, Carol Jones] Epidemiol & Res Training Unit, Kingston, Jamaica; [Hobbs, Marcia C.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University West Indies Mona Jamaica; University of North Carolina; University of North Carolina Chapel Hill	Weir, SS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	sharon_weir@unc.edu		Weir, Sharon/0000-0001-6014-1460	USAID [AID-OAA-L-14-00004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER	USAID(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	USAID funded MEASURE Evaluation Project: Grant number AID-OAA-L-14-00004 helped to fund this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, RISK, V9, P1299; [Anonymous], 2014, JAMAICA GLOBAL AIDS; [Anonymous], 2014, ORGANIZATION; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Carolina Population Center and Ministry of Health Jamaica, 2003, PLACE IN JAMAICA MEA; Duncan J, 2014, CLIN RES, P5; Egger M, 2000, LANCET, V355, P2101, DOI 10.1016/S0140-6736(00)02376-X; Figueroa JP, 2008, W INDIAN MED J, V57, P562; Figueroa JP, 2014, CURR HIV-AIDS REP, V11, P158, DOI 10.1007/s11904-014-0199-7; Figueroa JP, 2010, TROP MED INT HEALTH, V15, P945, DOI 10.1111/j.1365-3156.2010.02556.x; Figueroa JP, 2006, SEX TRANSM DIS; Hira S, 1998, AM J PUBLIC HEALTH, V88, P471; Hope Enterprise, 2008, NATIONAL KAP SURVEY; Stadler J, 2006, CULT HEALTH SEX, V8, P451, DOI 10.1080/13691050600872107; UNAIDS UNFPA UNDP., 2012, SEX WORK AND THE LAW; Weir SS, 2008, TROP MED INT HEALTH, V13, P801, DOI 10.1111/j.1365-3156.2008.02057.x; Weir SS TJ, 2005, MEASURE EVALUATION P	17	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0206962	10.1371/journal.pone.0206962	http://dx.doi.org/10.1371/journal.pone.0206962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475802	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700015
J	Wu, SY; Zou, P; Mishra, S; Mchaourab, HS				Wu, Shu-Yu; Zou, Ping; Mishra, Sanjay; Mchaourab, Hassane S.			Transgenic zebrafish models reveal distinct molecular mechanisms for cataract-linked alpha A-crystallin mutants	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DISULFIDE CROSS-LINKS; B-CRYSTALLIN; CHAPERONE ACTIVITY; LENS CRYSTALLINS; 2-MODE BINDING; MOUSE MODEL; IN-VIVO; MUTATION; EYE	Mutations in the small heat shock proteins alpha-crystallins have been linked to autosomal dominant cataracts in humans. Extensive studies in vitro have revealed a spectrum of alterations to the structure and function of these proteins including shifts in the size of the oligomer, modulation of subunit exchange and modification of their affinity to client proteins. Although mouse models of these mutants were instrumental in identifying changes in cellular proliferation and lens development, a direct comparative analysis of their effects on lens proteostasis has not been performed. Here, we have transgenically expressed cataract-linked mutants of alpha A- and alpha B-crystallin in the zebrafish lens to dissect the underlying molecular changes that contribute to the loss of lens optical properties. Zebrafish lines expressing these mutants displayed a range of morphological lens defects. Phenotype penetrance and severity were dependent on the mutation even in fish lines lacking endogenous alpha-crystallin. The mechanistic origins of these differences were investigated by the transgenic co-expression of a destabilized human gamma D-crystallin mutant. We found that the R49C but not the R116C mutant of alpha A-crystallin drove aggregation of gamma D-crystallin, although both mutants have similar affinity to client proteins in vitro. Our working model attributes these differences to the propensity of R49C, located in the buried N-terminal domain of alpha A-crystallin, to disulfide crosslinking as previously demonstrated in vitro. Our findings complement and extend previous work in mouse models and emphasize the need of investigating chaperone/client protein interactions in appropriate cellular context.	[Wu, Shu-Yu; Zou, Ping; Mishra, Sanjay; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	hassane.mchaourab@Vanderbilt.Edu	Mishra, Sanjay/ABF-9252-2021	Mishra, Sanjay/0000-0002-7775-9600	National Eye Institute [R01 EY12018, P30 EY008126]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work has been funded by National Eye Institute (https://nei.nih.gov), R01 EY12018 and P30 EY008126 to HSM.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Andley UP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190817; Andley UP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017671; Bakthisaran R, 2016, BBA-GEN SUBJECTS, V1860, P167, DOI 10.1016/j.bbagen.2015.09.017; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Berengian AR, 1997, BIOCHEMISTRY-US, V36, P9951, DOI 10.1021/bi9712347; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Claxton DP, 2008, J MOL BIOL, V375, P1026, DOI 10.1016/j.jmb.2007.11.014; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Goishi K, 2006, DEVELOPMENT, V133, P2585, DOI 10.1242/dev.02424; Greiling TMS, 2012, INT REV CEL MOL BIO, V296, P1, DOI 10.1016/B978-0-12-394307-1.00001-1; Greiling TMS, 2009, DEV DYNAM, V238, P2254, DOI 10.1002/dvdy.21997; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harocopos GJ, 1998, INVEST OPHTH VIS SCI, V39, P2696; Hayes JM, 2012, MOL BIOL CELL, V23, P4725, DOI 10.1091/mbc.E12-09-0672; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kore R, 2012, MOL CELL BIOCHEM, V362, P93, DOI 10.1007/s11010-011-1131-8; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Kumar MS, 2009, FEBS LETT, V583, P175, DOI 10.1016/j.febslet.2008.11.047; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; LI WC, 1995, J CELL BIOL, V130, P169, DOI 10.1083/jcb.130.1.169; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; Mishra S, 2018, J BIOL CHEM, V293, P740, DOI 10.1074/jbc.M117.808634; Mishra S, 2012, FEBS LETT, V586, P330, DOI 10.1016/j.febslet.2012.01.019; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Okamura Nobuaki, 2002, Medical Electron Microscopy, V35, P234, DOI 10.1007/s007950200027; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pande A, 2009, BIOCHEMISTRY-US, V48, P4937, DOI 10.1021/bi9004182; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Posner M, 2008, MOL VIS, V14, P806; Posner M, 2013, EXP EYE RES, V116, P227, DOI 10.1016/j.exer.2013.09.007; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sharma KK, 1997, BIOCHEM BIOPH RES CO, V239, P217, DOI 10.1006/bbrc.1997.7460; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wu SY, 2016, J BIOL CHEM, V291, P25387, DOI 10.1074/jbc.M116.749606; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Zhang L, 2010, CURR MOL MED, V10, P864, DOI 10.2174/156652410793937741; Zou P, 2015, EXP EYE RES, V138, P104, DOI 10.1016/j.exer.2015.07.001	59	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207540	10.1371/journal.pone.0207540	http://dx.doi.org/10.1371/journal.pone.0207540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475834	Green Published, gold			2022-12-26	WOS:000451325700036
J	Fan, ZY; Yang, J; Zhang, D; Zhang, XL; Ma, X; Kang, L; Liu, Y; Yan, X; Ji, QB; Wang, JL; Li, Y; Zhang, SJ; Zhu, X; Hu, Y; Xu, XJ; Ye, QN; Jiao, SC				Fan, Zhongyi; Yang, Jing; Zhang, Dong; Zhang, Xuelin; Ma, Xiaoyan; Kang, Lei; Liu, Ying; Yan, Xiang; Ji, Quanbo; Wang, Jinliang; Li, Ying; Zhang, Sujie; Zhu, Xiang; Hu, Yi; Xu, Xiaojie; Ye, Qinong; Jiao, Shunchang			The risk variant rs884225 within EGFR impairs miR-103a-3p's anti-tumourigenic function in non-small cell lung cancer	ONCOGENE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; GENE COPY NUMBER; AMERICAN SOCIETY; EXPRESSION; POLYMORPHISM; STATISTICS; MUTATIONS; PROLIFERATION; PROGRESSION	Epidermal growth factor receptor (EGFR) status is the major determinant of non-small cell lung cancer (NSCLC) therapy selection. Studies have hinted that EGFR antibodies or tyrosine kinase inhibitors were beneficial in patients with EGFR mutation-negative but EGFR-overexpressing of NSCLC. However, the mechanisms underlying EGFR amplification and overexpression in NSCLC remain largely unknown. Here, we report that rs884225, a single nucleotide polymorphism in the EGFR 3'-terminal untranslated region, was significantly associated with EGFR expression level and contributed to NSCLC susceptibility. Mechanistically, the rs884225 C allele enhanced EGFR expression by altering the miR-103a-3p binding site, thus impairing miR-103a-3p's anti-tumourigenic function. As a tumour suppressor gene, miR-103a-3p expression correlated with overall and recurrence-free survival in NSCLC patients. Furthermore, miR-103a-3p inhibited growth and metastasis via effects on the KRAS pathway and epithelial-to-mesenchymal transition in EGFR wild-type NSCLC cell lines, respectively, which substantially reduced EGFR expression and activity. Thus, rs884225 may be a biomarker for NSCLC susceptibility, and miR-103a-3p may be a potential therapeutic target in NSCLC.	[Fan, Zhongyi; Yan, Xiang; Ji, Quanbo; Wang, Jinliang; Li, Ying; Zhang, Sujie; Hu, Yi; Jiao, Shunchang] Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China; [Yang, Jing; Zhang, Dong] Peoples Liberat Army Gen Hosp, Dept Nanlou Oncol, Beijing, Peoples R China; [Zhang, Xuelin] Peoples Liberat Army Gen Hosp, Dept Nanlou Respirat, Beijing, Peoples R China; [Ma, Xiaoyan] Changchun Univ Chinese Med, Sch Chinese Med, Dept Cardiovasc Dis, Changchun, Jilin, Peoples R China; [Kang, Lei] Peking Univ, Dept Nucl Med, Hosp 1, Beijing, Peoples R China; [Liu, Ying] Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Zhu, Xiang; Xu, Xiaojie; Ye, Qinong] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Changchun University of Chinese Medicine; Peking University; Chinese People's Liberation Army General Hospital	Jiao, SC (corresponding author), Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China.; Xu, XJ; Ye, QN (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China.	miraclexxj@126.com; yeqn66@yahoo.com; jiaosc301@163.com	yan, Xiang/ABI-1846-2020; wang, jinliang/AAA-2799-2021	yan, Xiang/0000-0002-3683-474X; wang, jinliang/0000-0001-6427-3487; Jiao, Shunchang/0000-0002-9120-5233; Kang, Lei/0000-0001-8729-4547	National Natural Science Foundation of China [81702936, 81672602, 81822037, 81472589, 81630067]; Scientific Research Project of Health Care [15BJZ43]; Natural Science Foundation of Beijing [7172199]; Logistics Scientific Research Project [BWS16J010]; Postdoctoral Science Foundation of China [2017M613389, 2018T111142, 2017T100809]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Health Care; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Logistics Scientific Research Project; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (81702936, 81672602, 81822037, 81472589 and 81630067), Scientific Research Project of Health Care (15BJZ43), the Natural Science Foundation of Beijing (7172199), Logistics Scientific Research Project (BWS16J010) and General Financial Grant from the Postdoctoral Science Foundation of China (2017M613389, 2018T111142 and 2017T100809). The PLA General Hospital and Beijing Institute of Biotechnology made equal contributions to this work.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Barlesi F, 2013, J CLIN ONCOL, V31, p486s; Baumgart A, 2010, CANCER RES, V70, P5368, DOI 10.1158/0008-5472.CAN-09-3763; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; Burstein HJ, 2017, J CLIN ONCOL, V35, P1341, DOI 10.1200/JCO.2016.71.5292; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Cavalleri T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176680; Chang JTH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168284; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chiyomaru T, 2015, INT J ONCOL, V46, P487, DOI 10.3892/ijo.2014.2752; Chu HY, 2013, MUTAGENESIS, V28, P49, DOI 10.1093/mutage/ges051; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Datta D, 2003, CHEST, V123, P2096, DOI 10.1378/chest.123.6.2096; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Grandis JR, 2004, PHARMACOL THERAPEUT, V102, P37, DOI 10.1016/j.pharmthera.2004.01.002; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Hirsch FR, 2005, J CLIN ONCOL, V23, P6838, DOI 10.1200/JCO.2005.01.2823; Izar B, 2014, J THORAC ONCOL, V9, P1363, DOI 10.1097/JTO.0000000000000266; Jiang XM, 2016, ONCOTARGET, V7, P36733, DOI 10.18632/oncotarget.9166; Jokinen E, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-612; Lee Y, 2012, CLIN CANCER RES, V18, P1760, DOI 10.1158/1078-0432.CCR-11-2582; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Liang JL, 2015, CELL PROLIFERAT, V48, P78, DOI 10.1111/cpr.12159; Lin YX, 2014, AM J CANCER RES, V4, P411; Liu WQ, 2005, CANCER RES, V65, P46; Liu XM, 2017, ONCOTARGET, V8, P50209, DOI 10.18632/oncotarget.16854; Merrick DT, 2006, CLIN CANCER RES, V12, P2281, DOI 10.1158/1078-0432.CCR-05-2291; Milas L, 2004, INT J RADIAT ONCOL, V58, P966, DOI 10.1016/j.ijrobp.2003.08.035; Morgillo F, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000060; Nomura M, 2007, PLOS MED, V4, P715, DOI 10.1371/journal.pmed.0040125; Ohe Y, 2008, CLIN CANCER RES, V14, P4206, DOI 10.1158/1078-0432.CCR-07-5143; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel JD, 2014, J CLIN ONCOL, V32, P129, DOI 10.1200/JCO.2013.53.7076; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Qin Q, 2016, J CELL MOL MED, V20, P1974, DOI 10.1111/jcmm.12889; Rizvi NA, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.tps8123; Ruan YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep23368; RUSCH V, 1993, CANCER RES, V53, P2379; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Shelton JG, 2005, CELL CYCLE, V4, P822, DOI 10.4161/cc.4.6.1724; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Wang F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-90; Weber DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114483; Xu NQ, 2016, ONCOTARGET, V7, P3884, DOI 10.18632/oncotarget.6461; Yu MJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0677-9; Yuan ZQ, 2009, CANCER RES, V69, P7811, DOI 10.1158/0008-5472.CAN-09-0986; Zhong ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30919; Zhou SJ, 2015, CELL PHYSIOL BIOCHEM, V36, P166, DOI 10.1159/000374061	52	11	11	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2291	2304		10.1038/s41388-018-0576-6	http://dx.doi.org/10.1038/s41388-018-0576-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30470824				2022-12-26	WOS:000462588000005
J	Chiba, Y; He, B; Yoshizaki, K; Rhodes, C; Ishijima, M; Bleck, CKE; Stempinski, E; Chu, EY; Nakamura, T; Iwamoto, T; de Vega, S; Saito, K; Fukumoto, S; Yamada, Y				Chiba, Yuta; He, Bing; Yoshizaki, Keigo; Rhodes, Craig; Ishijima, Muneaki; Bleck, Christopher K. E.; Stempinski, Erin; Chu, Emily Y.; Nakamura, Takashi; Iwamoto, Tsutomu; de Vega, Susana; Saito, Kan; Fukumoto, Satoshi; Yamada, Yoshihiko			The transcription factor AmeloD stimulates epithelial cell motility essential for tooth morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basic helix-loop-helix transcription factor (bHLH); cadherin-1 (CDH1); epithelial cadherin (E-cadherin); cell migration; epithelial-mesenchymal transition (EMT); gene knockout; tooth development; inner enamel epithelium; AmeloD; epiprofin; ectodermal organ	BRANCHING MORPHOGENESIS; MOLECULAR-MECHANISMS; FACTOR EPIPROFIN; EXPRESSION; CADHERIN; DIFFERENTIATION; PROLIFERATION; AMELOBLASTIN; DYNAMICS; TWIST1	The development of ectodermal organs, such as teeth, requires epithelial-mesenchymal interactions. Basic helix-loop-helix (bHLH) transcription factors regulate various aspects of tissue development, and we have previously identified a bHLH transcription factor, AmeloD, from a tooth germ cDNA library. Here, we provide both in vitro and in vivo evidence that AmeloD is important in tooth development. We created AmeloD-knockout (KO) mice to identify the in vivo functions of AmeloD that are critical for tooth morphogenesis. We found that AmeloD-KO mice developed enamel hypoplasia and small teeth because of increased expression of E-cadherin in inner enamel epithelial (IEE) cells, and it may cause inhibition of the cell migration. We used the CLDE dental epithelial cell line to conduct further mechanistic analyses to determine whether AmeloD overexpression in CLDE cells suppresses E-cadherin expression and promotes cell migration. Knockout of epiprofin (Epfn), another transcription factor required for tooth morphogenesis and development, and analysis of AmeloD expression and deletion revealed that AmeloD also contributed to multiple tooth formation in Epfn-KO mice by promoting the invasion of dental epithelial cells into the mesenchymal region. Thus, AmeloD appears to play an important role in tooth morphogenesis by modulating E-cadherin and dental epithelial-mesenchymal interactions. These findings provide detailed insights into the mechanism of ectodermal organ development.	[Chiba, Yuta; He, Bing; Yoshizaki, Keigo; Rhodes, Craig; Ishijima, Muneaki; Nakamura, Takashi; Iwamoto, Tsutomu; de Vega, Susana; Fukumoto, Satoshi; Yamada, Yoshihiko] NIDCR, Mol Biol Sect, NIH, Bethesda, MD 20892 USA; [Chiba, Yuta; Saito, Kan; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Nakamura, Takashi] Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Div Mol Pharmacol & Cell Biophys, Sendai, Miyagi 9808575, Japan; [He, Bing] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China; [Yoshizaki, Keigo] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Fukuoka, Fukuoka 8128582, Japan; [Ishijima, Muneaki] Juntendo Univ, Grad Sch Med, Dept Med Orthopaed & Motor Organ, Tokyo 1138421, Japan; [de Vega, Susana] Juntendo Univ, Grad Sch Med, Res Dept Pathophysiol Locomot & Neoplast Dis, Tokyo 1138421, Japan; [Bleck, Christopher K. E.; Stempinski, Erin] NHLBI, Electron Microscopy Core Facil, NIH, Bethesda, MD 20892 USA; [Chu, Emily Y.] NIAMS, Lab Oral Connect Tissue Biol, NIH, Bethesda, MD 20892 USA; [Iwamoto, Tsutomu] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Pediat Dent, Tokushima 7708504, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tohoku University; Tohoku University; Sichuan University; Kyushu University; Juntendo University; Juntendo University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Tokushima University	Yamada, Y (corresponding author), NIDCR, NIH, Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov	de Vega, Susana/AAH-4775-2020; Iwamoto, Tsutomu/AAI-8952-2021; Iwamoto, Tsutomu/AAA-6597-2019; He, Bing/V-5552-2019; Saito, Kan/AAG-3507-2020; Nakamura, Takashi/A-8931-2012; Ishijima, Muneaki/L-4816-2016; Saito, Kan/AFS-5564-2022	Iwamoto, Tsutomu/0000-0001-8472-605X; Saito, Kan/0000-0002-2151-6204; Nakamura, Takashi/0000-0001-9904-1037; Ishijima, Muneaki/0000-0002-0920-0805; Saito, Kan/0000-0002-2151-6204; Yoshizaki, Keigo/0000-0002-0598-5879; Chiba, Yuta/0000-0001-5414-4411; rhodes, craig/0000-0001-5440-587X; Fukumoto, Satoshi/0000-0002-5046-6891; Bleck, Christopher/0000-0003-1029-3444	NIDCR, National Institutes of Health Intramural Research Program [1ZIADE000720-07]; NIDCR, National Institutes of Health Transfer Core Facility Grant [ZIC DE000744-04]; Japan Society for the Promotion of Science (JSPS) KAKENHI [17H01606, 15J04116]; National Nature Science Foundation of China [NSFC81500811]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZICDE000744] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health Intramural Research Program; NIDCR, National Institutes of Health Transfer Core Facility Grant; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by NIDCR, National Institutes of Health Intramural Research Program Grant 1ZIADE000720-07 (to Y. Y.). and NIDCR, National Institutes of Health Transfer Core Facility Grant ZIC DE000744-04. This work was also supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-aid 17H01606 (to S. F.) and 15J04116 (to Y. C.) and National Nature Science Foundation of China Grant NSFC81500811 (to B. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe M, 2002, CELL TISSUE RES, V310, P201, DOI 10.1007/s00441-002-0611-2; Aurrekoetxea M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00025; Borkosky SS, 2008, BIOCELL, V32, P251; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Daley WP, 2017, DEVELOPMENT, V144, P2200, DOI 10.1242/dev.146894; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; He B, 2019, J DENT RES, V98, P234, DOI 10.1177/0022034518808254; Ibarretxe G, 2012, CELL TISSUE RES, V350, P95, DOI 10.1007/s00441-012-1459-8; Jimenez-Rojo L, 2010, HISTOL HISTOPATHOL, V25, P1621, DOI 10.14670/HH-25.1621; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li CY, 2012, DEV BIOL, V366, P357, DOI 10.1016/j.ydbio.2012.03.012; Li JY, 2017, DEVELOPMENT, V144, P374, DOI 10.1242/dev.137216; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Meng T, 2015, J BIOL CHEM, V290, P29593, DOI 10.1074/jbc.M115.680546; Nakamura T, 2004, J BIOL CHEM, V279, P626, DOI 10.1074/jbc.M307502200; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Nakamura T, 2017, J BONE MINER RES, V32, P601, DOI 10.1002/jbmr.3024; Nakamura T, 2016, INT J ORAL SCI, V8, P205, DOI 10.1038/ijos.2016.35; Nakamura T, 2014, J CELL SCI, V127, P5261, DOI 10.1242/jcs.156778; Nakamura T, 2011, J ORAL BIOSCI, V53, P22, DOI 10.2330/joralbiosci.53.22; Obara N, 1998, ANAT EMBRYOL, V197, P469, DOI 10.1007/s004290050157; Onodera T, 2010, SCIENCE, V329, P562, DOI 10.1126/science.1191880; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Rice R, 2005, DEV DYNAM, V234, P28, DOI 10.1002/dvdy.20501; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sakai T, 2013, J ORAL BIOSCI, V55, P73, DOI 10.1016/j.job.2013.03.002; Sohn WJ, 2014, J DENT RES, V93, P78, DOI 10.1177/0022034513511247; Sun Z, 2016, DEVELOPMENT, V143, P4115, DOI 10.1242/dev.138883; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200; Yoshizaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099991; Yuan XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20005; Zhang YP, 2012, DEV DYNAM, V241, P924, DOI 10.1002/dvdy.23776	36	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3406	3418		10.1074/jbc.RA118.005298	http://dx.doi.org/10.1074/jbc.RA118.005298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30504223	Green Published, hybrid			2022-12-26	WOS:000461853900009
J	Lin, SB; Haque, A; Raeman, R; Guo, LL; He, PJ; Denning, TL; El-Rayes, B; Moolenaar, WH; Yun, CC				Lin, Songbai; Haque, Abedul; Raeman, Reben; Guo, Leilei; He, Peijian; Denning, Timothy L.; El-Rayes, Bassel; Moolenaar, Wouter H.; Yun, C. Chris			Autotaxin determines colitis severity in mice and is secreted by B cells in the colon	FASEB JOURNAL			English	Article						lysophosphatidic acid; inflammation; lymphocytes	NA+/H+ EXCHANGER 3; ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID; ENTEROENDOCRINE CELLS; T-CELLS; LYSOPHOSPHOLIPASE-D; CANCER CELLS; BINDING; IDENTIFICATION; MACROPHAGES	Autotaxin (ATX or ENPP2) is a secreted lysophospholipase D that produces lysophosphatidic acid (LPA), a pleiotropic lipid mediator acting on specific GPCRs. ATX and LPA have been implicated in key (patho)physiologic processes, including embryonic development, lymphocyte homing, inflammation, and cancer progression. Using LPA receptor knockout mice, we previously uncovered a role for LPA signaling in promoting colitis and colorectal cancer. Here, we examined the role of ATX in experimental colitis through inducible deletion of Enpp2 in adult mice. ATX expression was increased upon induction of colitis, whereas ATX deletion reduced the severity of inflammation in both acute and chronic colitis, accompanied by transient weight loss. ATX expression in lymphocytes was strongly reduced in Rag1(-/-) and MT mice, suggesting B cells as a major ATX-producing source, which was validated by immunofluorescence and biochemical analyses. ATX secretion by B cells from control, but not Enpp2 knockout, mice led to ERK activation in colorectal cancer cells and promoted T cell migration. We conclude that ATX deletion suppresses experimental colitis and that B cells are a major source of ATX in the colon. Our study suggests that pharmacological inhibition of ATX could be a therapeutic strategy in colitis.Lin, S., Haque, A., Raeman, R., Guo, L., He, P., Denning, T. L., El-Rayes, B., Moolenaar, W. H., Yun, C. C. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon.	[Lin, Songbai; Haque, Abedul; He, Peijian; Yun, C. Chris] Atlanta Vet Adm Med Ctr, Decatur, GA USA; [Lin, Songbai; Haque, Abedul; Guo, Leilei; He, Peijian; Yun, C. Chris] Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA; [El-Rayes, Bassel] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [El-Rayes, Bassel; Yun, C. Chris] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Raeman, Reben] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Denning, Timothy L.] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA; [Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Emory University; Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Georgia State University; Netherlands Cancer Institute	Yun, CC (corresponding author), Emory Univ, Sch Med, Div Digest Dis, 615 Michael St,Whitehead Bldg,Suite 201, Atlanta, GA 30324 USA.	ccyun@emory.edu	Raeman, Reben/AAF-7282-2021; el-rayes, bassel/ABD-2901-2021	Raeman, Reben/0000-0002-3914-1797; el-rayes, bassel/0000-0002-2661-5746	Veterans Administration Merit Award [I01BX002540]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [K01DK110264]; NIH National Cancer Institute [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK110264] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002540] Funding Source: NIH RePORTER	Veterans Administration Merit Award; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The current study was supported by the Veterans Administration Merit Award I01BX002540 (to C.C.Y.). R.R. was supported by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases K01 Career Development Grant K01DK110264. Confocal microscopic analyses were supported in part by the Integrated Cellular Imaging Shared Resources of the Winship Cancer Institute of Emory University (Atlanta, GA, USA) and NIH National Cancer Institute under Award P30CA138292. The authors declare no conflicts of interest.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Aranda R, 1997, J IMMUNOL, V158, P3464; Ashley JW, 2016, J BIOL CHEM, V291, P23268, DOI 10.1074/jbc.M116.754945; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Bolier R, 2016, BBA-MOL BASIS DIS, V1862, P696, DOI 10.1016/j.bbadis.2016.01.012; Castagna D, 2016, J MED CHEM, V59, P5604, DOI 10.1021/acs.jmedchem.5b01599; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; COOPER HS, 1993, LAB INVEST, V69, P238; Cupi ML, 2014, J IMMUNOL, V192, P6083, DOI 10.4049/jimmunol.1302238; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Euer N, 2002, ANTICANCER RES, V22, P733; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Hausmann Jens, 2013, Advances in Biological Regulation, V53, P112, DOI 10.1016/j.jbior.2012.09.010; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; He PJ, 2015, J CLIN INVEST, V125, P3519, DOI 10.1172/JCI79552; Houben AJS, 2013, J BIOL CHEM, V288, P510, DOI 10.1074/jbc.M112.358416; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Hozumi H, 2013, LAB INVEST, V93, P508, DOI 10.1038/labinvest.2013.45; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Katsifa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143083; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Leblanc R, 2014, BLOOD, V124, P3141, DOI 10.1182/blood-2014-04-568683; Lee SJ, 2013, MOL CELL BIOL, V33, P2016, DOI 10.1128/MCB.00038-13; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Lin SB, 2018, AM J PATHOL, V188, P353, DOI 10.1016/j.ajpath.2017.10.006; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Lycke NY, 2017, MUCOSAL IMMUNOL, V10, P1361, DOI 10.1038/mi.2017.62; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Moran GW, 2012, J CROHNS COLITIS, V6, P871, DOI 10.1016/j.crohns.2012.01.013; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Nikolaou A, 2017, EXPERT OPIN THER PAT, V27, P815, DOI 10.1080/13543776.2017.1323331; O'Hara JR, 2004, AM J PHYSIOL-GASTR L, V287, pG998, DOI 10.1152/ajpgi.00090.2004; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Olson TS, 2004, J CLIN INVEST, V114, P389, DOI 10.1172/jci200420855; Rahman K, 2016, GASTROENTEROLOGY, V151, P733, DOI 10.1053/j.gastro.2016.06.022; Ray R, 2017, BLOOD, V129, P1177, DOI 10.1182/blood-2016-10-743757; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Stassar MJJG, 2001, BRIT J CANCER, V85, P1372, DOI 10.1054/bjoc.2001.2074; Sturm A, 1999, GASTROENTEROLOGY, V117, P368, DOI 10.1053/gast.1999.0029900368; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wang L, 2015, MUCOSAL IMMUNOL, V8, P1297, DOI 10.1038/mi.2015.20; Yoo BK, 2011, AM J PHYSIOL-CELL PH, V301, pC1008, DOI 10.1152/ajpcell.00231.2011; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhang R, 2011, CLIN EXP IMMUNOL, V164, P417, DOI 10.1111/j.1365-2249.2011.04374.x; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604	59	15	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3623	3635		10.1096/fj.201801415RR	http://dx.doi.org/10.1096/fj.201801415RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481488	Green Published, Bronze			2022-12-26	WOS:000459794800043
J	Yang, SJ; Allahverdian, S; Saunders, ADR; Liu, E; Dorscheid, DR				Yang, S. Jasemine; Allahverdian, Sima; Saunders, Angela D. R.; Liu, Emily; Dorscheid, Delbert R.			IL-13 signaling through IL-13 receptor 2 mediates airway epithelial wound repair	FASEB JOURNAL			English	Article						asthma; type 2 inflammation; barrier function; EGFR; HB-EGF	INTERLEUKIN (IL)-13 RESPONSES; UNCONTROLLED ASTHMA; ALPHA-1 EXPRESSION; DOUBLE-BLIND; T-CELLS; IL-13R-ALPHA-2; MECHANISM; EFFICACY; ISOFORMS; FIBROSIS	Asthma is an airway inflammatory disease characterized by epithelial barrier dysfunction and airway remodeling. Interleukin-13 (IL-13) is a pleiotropic cytokine shown to contribute to features of airway remodeling. We have previously demonstrated that IL-13 is an important mediator of normal airway epithelial repair and health. The role of IL-13 signaling via its receptor subunits (IL-13R1/IL-4R and IL-13R2) in airway epithelial repair and restoration of intact barrier function is not well understood and was investigated in this study using in vitro models. The blocking of IL-13 signaling via IL-13R2 significantly reduced airway epithelial repair by 24 h post-mechanical wounding in 1HAEo(-) cells. Expression and release of repair-mediating growth factor, heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF), and subsequent activation of EGF receptor (EGFR) were also significantly reduced in response to wounding when IL-13R2 was blocked. Our data support that IL-13 signals via IL-13R2 to mediate normal airway epithelial repair via HB-EGF-dependent activation of EGFR. In human donor lung tissues, we observed that airway epithelium of asthmatics expressed significantly decreased levels of IL-13R2 and increased levels of IL-13R1 compared with nonasthmatics. Dysregulated expression of IL-13 receptor subunits in the airways of asthmatics may thus contribute to the epithelial barrier dysfunction observed in asthma.Yang, S. J., Allahverdian, S., Saunders, A. D. R., Liu, E., Dorscheid, D. R. IL-13 signaling through IL-13 receptor 2 mediates airway epithelial wound repair.	[Yang, S. Jasemine; Allahverdian, Sima; Saunders, Angela D. R.; Liu, Emily; Dorscheid, Delbert R.] Univ British Columbia, Dept Med, Ctr Heart Lung Innovat, Providence Hlth Care, Vancouver, BC, Canada	University of British Columbia	Dorscheid, DR (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, Room 166,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	del.dorscheid@hli.ubc.ca			AllerGen-Networks of Centres of Excellence; Canadian Institutes of Health Research; British Columbia Lung Association	AllerGen-Networks of Centres of Excellence; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association	The authors thank the Centre for Heart Lung Innovation Lung Registry for lung tissue collection; Dr. W. Mark Elliott and Amrit Aitken for tissue processing and histology advice; and Beth Whalen for flow cytometry training and advice (W. M. Elliott, A. Aitken, and B. Whalen are members of the Centre for Heart Lung Innovation). This study was funded by AllerGen-Networks of Centres of Excellence, Canadian Institutes of Health Research, and the British Columbia Lung Association. The authors declare no conflicts of interest.	Akaiwa M, 2001, CYTOKINE, V13, P75, DOI 10.1006/cyto.2000.0814; Allahverdian S, 2008, AM J RESP CELL MOL, V38, P153, DOI 10.1165/rcmb.2007-0173OC; Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; Campbell-Harding G, 2013, J ALLERGY CLIN IMMUN, V131, P849, DOI 10.1016/j.jaci.2012.08.030; Chandriani S, 2014, J IMMUNOL, V193, P111, DOI 10.4049/jimmunol.1301761; Chen WG, 2009, J IMMUNOL, V183, P7870, DOI 10.4049/jimmunol.0901028; Cho WK, 2013, AM J PHYSIOL-LUNG C, V304, pL112, DOI 10.1152/ajplung.00101.2012; COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Daines MO, 2007, J ALLERGY CLIN IMMUN, V119, P375, DOI 10.1016/j.jaci.2006.09.039; Daines MO, 2006, J IMMUNOL, V176, P7495, DOI 10.4049/jimmunol.176.12.7495; Daines MO, 2002, J BIOL CHEM, V277, P10387, DOI 10.1074/jbc.M108109200; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Graber P, 1998, EUR J IMMUNOL, V28, P4286, DOI 10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286>3.0.CO;2-H; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hajoui O, 2007, J ALLERGY CLIN IMMUN, V120, P1425, DOI 10.1016/j.jaci.2007.07.011; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hall SL, 2017, J ALLERGY CLIN IMMUN, V139, P462, DOI 10.1016/j.jaci.2016.04.037; Hanania NA, 2016, LANCET RESP MED, V4, P781, DOI 10.1016/S2213-2600(16)30265-X; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Hecker M, 2010, AM J RESP CRIT CARE, V182, P805, DOI 10.1164/rccm.200909-1367OC; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; Ingram JL, 2011, AM J RESP CRIT CARE, V183, P1625, DOI 10.1164/rccm.201009-1452OC; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandal D, 2010, INFLAMM BOWEL DIS, V16, P753, DOI 10.1002/ibd.21133; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; O'Toole M, 2008, CLIN EXP ALLERGY, V38, P594, DOI 10.1111/j.1365-2222.2007.02921.x; Schmid-Grendelmeier P, 2002, J IMMUNOL, V169, P1021, DOI 10.4049/jimmunol.169.2.1021; Singhera GK, 2008, EXP LUNG RES, V34, P579, DOI 10.1080/01902140802369372; Tabata Y, 2007, CURR ALLERGY ASTHM R, V7, P338, DOI 10.1007/s11882-007-0051-x; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Toru H, 1998, J ALLERGY CLIN IMMUN, V102, P491, DOI 10.1016/S0091-6749(98)70140-X; White SR, 2010, AM J PHYSIOL-LUNG C, V299, pL681, DOI 10.1152/ajplung.00422.2009; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xu J, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0177-7; Yamada Y, 2004, PEDIAT ALLERG IMM-UK, V15, P159, DOI 10.1111/j.1399-3038.2004.00155.x; Ying S, 1997, J IMMUNOL, V158, P5050; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	52	13	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3746	3757		10.1096/fj.201801285R	http://dx.doi.org/10.1096/fj.201801285R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481486	Bronze			2022-12-26	WOS:000459794800053
J	Vargas, G; Bouchet, M; Bouazza, L; Reboul, P; Boyault, C; Gervais, M; Kan, C; Benetollo, C; Brevet, M; Croset, M; Mazel, M; Cayrefourcq, L; Geraci, S; Vacher, S; Pantano, F; Filipits, M; Driouch, K; Bieche, I; Gnant, M; Jacot, W; Aubin, JE; Duterque-Coquillaud, M; Alix-Panabieres, C; Clezardin, P; Bonnelye, E				Vargas, G.; Bouchet, M.; Bouazza, L.; Reboul, P.; Boyault, C.; Gervais, M.; Kan, C.; Benetollo, C.; Brevet, M.; Croset, M.; Mazel, M.; Cayrefourcq, L.; Geraci, S.; Vacher, S.; Pantano, F.; Filipits, M.; Driouch, K.; Bieche, I.; Gnant, M.; Jacot, W.; Aubin, J. E.; Duterque-Coquillaud, M.; Alix-Panabieres, C.; Clezardin, P.; Bonnelye, E.			ERR alpha promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors	ONCOGENE			English	Article							ESTROGEN-RELATED RECEPTOR; OSTEOCLAST DIFFERENTIATION; METASTASIS; ORPHAN; GAMMA; IDENTIFICATION; GENE; PGC-1-ALPHA; BIOMARKERS; ACTIVATOR	Bone is the most common metastatic site for breast cancer. Estrogen-related-receptor alpha (ERR alpha) has been implicated in cancer cell invasiveness. Here, we established that ERR alpha promotes spontaneous metastatic dissemination of breast cancer cells from primary mammary tumors to the skeleton. We carried out cohort studies, pharmacological inhibition, gain-of-function analyses in vivo and cellular and molecular studies in vitro to identify new biomarkers in breast cancer metastases. Meta-analysis of human primary breast tumors revealed that high ERR alpha expression levels were associated with bone but not lung metastases. ERR alpha expression was also detected in circulating tumor cells from metastatic breast cancer patients. ERR alpha overexpression in murine 4T1 breast cancer cells promoted spontaneous bone micro-metastases formation when tumor cells were inoculated orthotopically, whereas lung metastases occurred irrespective of ERR alpha expression level. In vivo, Rank was identified as a target for ERR alpha. That was confirmed in vitro in Rankl stimulated tumor cell invasion, in mTOR/pS6K phosphorylation, by transactivation assay, ChIP and bioinformatics analyses. Moreover, pharmacological inhibition of ERR alpha reduced primary tumor growth, bone micro-metastases formation and Rank expression in vitro and in vivo. Transcriptomic studies and meta-analysis confirmed a positive association between metastases and ERR alpha/RANK in breast cancer patients and also revealed a positive correlation between ERR alpha and BRCA1(mut) carriers. Taken together, our results reveal a novel ERR alpha/RANK axis by which ERR alpha in primary breast cancer promotes early dissemination of cancer cells to bone. These findings suggest that ERR alpha may be a useful therapeutic target to prevent bone metastases.	[Vargas, G.; Bouchet, M.; Bouazza, L.; Gervais, M.; Kan, C.; Brevet, M.; Croset, M.; Geraci, S.; Clezardin, P.; Bonnelye, E.] INSERM, UMR1033, Lyon, France; [Vargas, G.; Bouchet, M.; Bouazza, L.; Gervais, M.; Kan, C.; Benetollo, C.; Croset, M.; Geraci, S.; Clezardin, P.; Bonnelye, E.] Univ Lyon 1, Lyon, France; [Bouchet, M.] IGFL, Lyon, France; [Reboul, P.] Univ Lorraine, CNRS, UMR7365, Nancy, France; [Boyault, C.] Inst Adv Biosci, Grenoble, France; [Kan, C.] Univ Sydney, Ctr Canc Res, Sydney, NSW, Australia; [Benetollo, C.] CNRS, INSERM, U1028, UMR5292, Lyon, France; [Brevet, M.] Ctr Biol & Pathol Est, Bron, France; [Mazel, M.; Cayrefourcq, L.; Alix-Panabieres, C.] Inst Univ Rech Clin, EA2415, Montpellier, France; [Vacher, S.; Driouch, K.; Bieche, I.] Inst Curie, Dept Genet, Paris, France; [Pantano, F.] Univ Campus Biomed, I-00128 Rome, Italy; [Filipits, M.; Gnant, M.] Med Univ Vienna, Dept Surg, Vienna, Austria; [Filipits, M.; Gnant, M.] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Jacot, W.] Montpellier Canc Inst, Montpellier, France; [Aubin, J. E.] Univ Toronto, Toronto, ON, Canada; [Duterque-Coquillaud, M.] Inst Biol Lille, CNRS, UMR8161, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; University of Sydney; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University Campus Bio-Medico - Rome Italy; Medical University of Vienna; Medical University of Vienna; Universite de Montpellier; University of Toronto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Bonnelye, E (corresponding author), INSERM, UMR1033, Lyon, France.; Bonnelye, E (corresponding author), Univ Lyon 1, Lyon, France.	edith.bonnelye@inserm.fr	Gnant, Michael/AAN-7054-2020; Pantano, Francesco/D-8459-2012; Clezardin, Philippe/M-8071-2014; Bonnelye, Edith/AAT-9134-2021; Croset, Martine/S-4784-2019; REBOUL, Pascal/ABA-3774-2021	Gnant, Michael/0000-0003-1002-2118; Pantano, Francesco/0000-0002-2894-9686; Clezardin, Philippe/0000-0003-0149-4463; REBOUL, Pascal/0000-0003-3546-2152; Duterque-Coquillaud, Martine/0000-0003-3943-5629; Filipits, Martin/0000-0003-2847-4534; BREVET, Marie/0000-0003-2275-691X; VACHER, Sophie/0000-0002-0042-6023; Boyault, Cyril/0000-0001-9614-4292; Cayrefourcq, Laure/0000-0002-6124-7029; Bouazza, Lamia/0000-0001-8487-2655	National Center for Scientific Research (CNRS); National Institute of Health and Medical Research (INSERM); University of Lyon1, La Ligue Nationale (Drome), Inserm-Transfert; Labex DEVweCAN; French National Cancer Institute (INCa); Marie-Curie-Individual-Fellowship [655777-miR-OMeS]; CANCER-ID (FP7/2007-2013); EFPIA	National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Lyon1, La Ligue Nationale (Drome), Inserm-Transfert; Labex DEVweCAN; French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France); Marie-Curie-Individual-Fellowship; CANCER-ID (FP7/2007-2013); EFPIA	This work was supported by the National Center for Scientific Research (CNRS) to EB, the National Institute of Health and Medical Research (INSERM), the University of Lyon1, La Ligue Nationale (Drome), Inserm-Transfert (EB). GV was supported by the Labex DEVweCAN, MG, MB by the French National Cancer Institute (INCa), CK by the Marie-Curie-Individual-Fellowship (655777-miR-OMeS). CAP, LC, and MM by CANCER-ID (FP7/2007-2013) and EFPIA.	Ariazi EA, 2002, CANCER RES, V62, P6510; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Audet-Walsh E, 2015, ACTA PHARMACOL SIN, V36, P51, DOI 10.1038/aps.2014.121; Bae S, 2017, J CLIN INVEST, V127, P2555, DOI 10.1172/JCI89935; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartkowiak K, 2015, CANCER RES, V75, P5367, DOI 10.1158/0008-5472.CAN-14-3728; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bieche I, 2001, CANCER RES, V61, P1652; Blake ML, 2014, CLIN EXP METASTAS, V31, P233, DOI 10.1007/s10585-013-9624-3; Bonnelye E, 2013, J BONE MINER RES, V28, P225, DOI 10.1002/jbmr.1836; Bonnelye E, 2010, J MOL ENDOCRINOL, V45, P365, DOI 10.1677/JME-10-0024; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brodowicz T, 2017, CANCER TREAT REV, V61, P23, DOI 10.1016/j.ctrv.2017.09.008; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Carnesecchi J, 2017, P NATL ACAD SCI USA, V114, P3909, DOI 10.1073/pnas.1614664114; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; D'Oronzo S, 2017, J BONE ONCOL, V9, P1, DOI 10.1016/j.jbo.2017.09.001; David M, 2012, INT J ONCOL, V40, P1133, DOI 10.3892/ijo.2011.1309; Deblois G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12156; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Delhon I, 2009, ENDOCRINOLOGY, V150, P4463, DOI 10.1210/en.2009-0121; Delliaux C, 2018, CANCER LETT, V438, P32, DOI 10.1016/j.canlet.2018.08.027; Dirckx N, 2018, J CLIN INVEST, V128, P1087, DOI 10.1172/JCI97794; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Fradet A, 2016, ONCOTARGET, V7, P77071, DOI 10.18632/oncotarget.12787; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; GARCIA CMS, 2014, BRAZ J VET PATHOL, V7, P158; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Hong EJ, 2013, P NATL ACAD SCI USA, V110, P17975, DOI 10.1073/pnas.1315319110; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kan C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101674; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nolan E, 2016, NAT MED, V22, P933, DOI 10.1038/nm.4118; PANTEL K, 1995, JNCI-J NATL CANCER I, V87, P1162, DOI 10.1093/jnci/87.15.1162; Patch RJ, 2011, J MED CHEM, V54, P788, DOI 10.1021/jm101063h; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Salatino S, 2016, MOL ENDOCRINOL, V30, P809, DOI 10.1210/me.2016-1036; Santini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019234; Schmid M, 2003, J CLIN ONCOL, V21, P984, DOI 10.1200/JCO.2003.01.138; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sigl V, 2016, CELL RES, V26, P761, DOI 10.1038/cr.2016.69; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Sumi D, 2005, BIOCHEM BIOPH RES CO, V328, P165, DOI 10.1016/j.bbrc.2004.12.165; Takeno A, 2018, AM J PHYSIOL-ENDOC M, V314, pE115, DOI 10.1152/ajpendo.00159.2017; Tam IS, 2016, J STEROID BIOCHEM, V157, P13, DOI 10.1016/j.jsbmb.2015.06.009; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Wu DL, 2016, BBA-REV CANCER, V1866, P23, DOI 10.1016/j.bbcan.2016.06.001; Yevshin I, 2017, NUCLEIC ACIDS RES, V45, pD61, DOI 10.1093/nar/gkw951; Zeng R, 2015, J BONE MINER RES, V30, P2287, DOI 10.1002/jbmr.2584; Zhang LY, 2012, J CLIN PATHOL, V65, P36, DOI 10.1136/jclinpath-2011-200312; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	61	22	23	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 14	2019	38	7					950	964		10.1038/s41388-018-0579-3	http://dx.doi.org/10.1038/s41388-018-0579-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HL3OH	30478447	Green Published, Green Accepted			2022-12-26	WOS:000458624900003
J	Douillet, DC; Pinson, B; Ceschin, J; Hurlimann, HC; Saint-Marc, C; Laporte, D; Claverol, S; Konrad, M; Bonneu, M; Daignan-Fornier, B				Douillet, Delphine C.; Pinson, Benoit; Ceschin, Johanna; Huerlimann, Hans C.; Saint-Marc, Christelle; Laporte, Damien; Claverol, Stephane; Konrad, Manfred; Bonneu, Marc; Daignan-Fornier, Bertrand			Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						purine; yeast genetics; yeast metabolism; nucleoside/nucleotide analogue; proteomics; drug metabolism; small molecule	SACCHAROMYCES-CEREVISIAE; PURINE BIOSYNTHESIS; PROTEIN-KINASE; GENE ONTOLOGY; AMP; YEAST; IDENTIFICATION; PROLIFERATION; ACTIVATOR; PARADIGM	5-Aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR, or acadesine) is a precursor of the monophosphate derivative 5-amino-4-imidazole carboxamide ribonucleoside 5 '-phosphate (ZMP), an intermediate in de novo purine biosynthesis. AICAR proved to have promising anti-proliferative properties, although the molecular basis of its toxicity is poorly understood. To exert cytotoxicity, AICAR needs to be metabolized, but the AICAR-derived toxic metabolite was not identified. Here, we show that ZMP is the major toxic derivative of AICAR in yeast and establish that its metabolization to succinyl-ZMP, ZDP, or ZTP (di- and triphosphate derivatives of AICAR) strongly reduced its toxicity. Affinity chromatography identified 74 ZMP-binding proteins, including 41 that were found neither as AMP nor as AICAR or succinyl-ZMP binders. Overexpression of karyopherin-beta Kap123, one of the ZMP-specific binders, partially rescued AICAR toxicity. Quantitative proteomic analyses revealed 57 proteins significantly less abundant on nuclei-enriched fractions from AICAR-fed cells, this effect being compensated by overexpression of KAP123 for 15 of them. These results reveal nuclear protein trafficking as a function affected by AICAR.	[Douillet, Delphine C.; Pinson, Benoit; Ceschin, Johanna; Huerlimann, Hans C.; Saint-Marc, Christelle; Laporte, Damien; Daignan-Fornier, Bertrand] Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France; [Douillet, Delphine C.; Pinson, Benoit; Ceschin, Johanna; Huerlimann, Hans C.; Saint-Marc, Christelle; Laporte, Damien; Daignan-Fornier, Bertrand] CNRS, UMR 5095, IBGC, F-33077 Bordeaux, France; [Claverol, Stephane; Bonneu, Marc] Univ Bordeaux, Bordeaux INP, Plateforme Proteome, F-33076 Bordeaux, France; [Konrad, Manfred] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Douillet, Delphine C.] Northeastern Univ, Feinberg Sch Med, 320 East Super St, Chicago, IL 60611 USA; [Huerlimann, Hans C.] Martin Luther Univ Halle Wittenberg, Genet, Mol Genet, Weinbergweg 10, D-06120 Halle, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society; Northwestern University; Feinberg School of Medicine; Martin Luther University Halle Wittenberg	Daignan-Fornier, B (corresponding author), CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, 1 Rue C St Saens,CS 61390, F-33077 Bordeaux, France.	b.daignan-fornier@ibgc.cnrs.fr		Pinson, Benoit/0000-0003-2936-9058; Daignan-Fornier, Bertrand/0000-0003-2352-9700; ceschin, johanna/0000-0001-7771-531X; DOUILLET, Delphine/0000-0002-9529-1255	Ligue contre le Cancer Dordogne	Ligue contre le Cancer Dordogne	This work was supported by a Ligue contre le Cancer Dordogne 2016-2017 grant (to B.D.-F.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht D, 2018, CURR GENET, V64, P1275, DOI 10.1007/s00294-018-0843-7; Albrecht D, 2016, GENETICS, V204, P1447, DOI 10.1534/genetics.116.192518; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Ceballos-Picot I, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-014-0219-0; Ceschin J, 2015, J BIOL CHEM, V290, P23947, DOI 10.1074/jbc.M115.656017; Ceschin J, 2014, J BIOL CHEM, V289, P16844, DOI 10.1074/jbc.M114.551192; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Escusa S, 2006, MOL MICROBIOL, V60, P1014, DOI 10.1111/j.1365-2958.2006.05153.x; Guetsova ML, 1997, GENETICS, V147, P383; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hurlimann HC, 2011, J BIOL CHEM, V286, P30994, DOI 10.1074/jbc.M111.262659; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kim PB, 2015, MOL CELL, V57, P317, DOI 10.1016/j.molcel.2015.01.001; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Marie S, 2004, AM J HUM GENET, V74, P1276, DOI 10.1086/421475; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Nakamaru K, 2005, BIOCHEM BIOPH RES CO, V328, P449, DOI 10.1016/j.bbrc.2005.01.004; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rebora K, 2005, GENETICS, V170, P61, DOI 10.1534/genetics.104.039396; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; SCHRICKER R, 1992, GENE, V122, P111, DOI 10.1016/0378-1119(92)90038-Q; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tibbetts AS, 1997, ARCH BIOCHEM BIOPHYS, V340, P195, DOI 10.1006/abbi.1997.9919; Van Den Neste E, 2013, CANCER CHEMOTH PHARM, V71, P581, DOI 10.1007/s00280-012-2033-5	35	6	6	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					805	815		10.1074/jbc.RA118.004964	http://dx.doi.org/10.1074/jbc.RA118.004964			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478173	Green Published, hybrid			2022-12-26	WOS:000458670200007
J	Ebrahimi, A; Lawson, SS; Frank, GS; Coggeshall, MV; Woeste, KE; McKenna, JR				Ebrahimi, Aziz; Lawson, Shaneka S.; Frank, Graham S.; Coggeshall, Mark V.; Woeste, Keith E.; McKenna, James R.			Pollen flow and paternity in an isolated and non-isolated black walnut (Juglans nigra L.) timber seed orchard	PLOS ONE			English	Article							MATING PATTERNS; HETERODICHOGAMOUS TREE; GENETIC DIVERSITY; LOBLOLLY-PINE; DISPERSAL; MICROSATELLITE; POPULATION; TEMPERATE; SUCCESS; REGIA	Artificial pollination of black walnut (Juglans nigra L.) is not practical and timber breeders have historically utilized only open-pollinated half-sib families. An alternate approach called "breeding without breeding," consists of genotyping open-pollinated progeny using DNA markers to identify paternal parents and then constructing full-sib families. In 2014, we used 12 SSR markers to genotype 884 open-pollinated half-sib progeny harvested from two clonal orchards containing 206 trees, comprised of 52 elite timber selections. Seed was harvested in 2011 from each of two ramets of 23 clones, one upwind and one downwind, based on prevailing wind direction from the west-southwest. One orchard was isolated from wild black walnut and composed of forward selections while the other orchard was adjacent to a natural forest containing mature black walnut composed of backward selections. Isolation significantly increased within-orchard pollination (85%) of the progeny from the isolated orchard compared to 42% from the non-isolated orchard. Neither prevailing wind direction nor seed tree position in the orchard affected paternity patterns or wild pollen contamination. Genetic diversity indices revealed that progeny from both orchards were in Hardy-Weinberg equilibrium with very little inbreeding and no selfing. A significant level of inbreeding was present among the forward selected parents, but not the first generation (backward selected) parents. Some orchard clones failed to sire any progeny while other clones pollinated upwards of 20% of progeny.	[Ebrahimi, Aziz; Frank, Graham S.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Lawson, Shaneka S.; Coggeshall, Mark V.; Woeste, Keith E.; McKenna, James R.] US Forest Serv, USDA, Northern Res Stn, Hardwood Tree Improvement & Regenerat Ctr, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service	Ebrahimi, A (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	aebrahi@purdue.edu	lawson, shaneka/AAV-1569-2021; Ebrahimi, Aziz/AAY-9389-2020	Ebrahimi, Aziz/0000-0003-3122-0404; Frank, Graham/0000-0002-0151-3807	Nut and Fruit Growers Association (INFGA); Fred M. van Eck Foundation; Hardwood Tree improvement and Regeneration Center (HTIRC); Indiana Nut and Fruit Growers Association (INFGA); Fred M. van Eck Foundation of the Hardwood Tree improvement and Regeneration Center (HTIRC)	Nut and Fruit Growers Association (INFGA); Fred M. van Eck Foundation; Hardwood Tree improvement and Regeneration Center (HTIRC); Indiana Nut and Fruit Growers Association (INFGA); Fred M. van Eck Foundation of the Hardwood Tree improvement and Regeneration Center (HTIRC)	This work was supported by Nut and Fruit Growers Association (INFGA), the Fred M. van Eck Foundation, and the Hardwood Tree improvement and Regeneration Center (HTIRC).; The authors wish to thank Dr. Charles Michler, Dr. Carolyn Pike, Dr. Mohsen B Mesgaran, Dr. Kourush Vahdati, Brian Beheler, Donald Carlson, Michael Forgey, Aaron Forgey, Matt Paschen, Charles Hetrick, Marcia Kremer, Michael Loesch-Fries, Burk Thompson, Jack Seifert, Bob Hawkins, Phil O'Conner and James Warren. We thank the Indiana Nut and Fruit Growers Association (INFGA) and the Fred M. van Eck Foundation of the Hardwood Tree improvement and Regeneration Center (HTIRC) for financial support. Mention of a trademark, proprietary product, or vendor does not constitute a guarantee or warranty of the product by the U.S. Department of Agriculture and does not imply its approval to the exclusion of other products or vendors that also may be suitable.	Adams WT, 2000, FOREST CONSERVATION, P215; Alexander L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171598; Allard R.W., 1960, S REPORT; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Bai WN, 2007, NEW PHYTOL, V176, P699, DOI 10.1111/j.1469-8137.2007.02202.x; Beineke W. F., 1989, Northern Journal of Applied Forestry, V6, P68; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; Buiteveld J., 2001, Forest Genetics, V8, P331; Burczyk J, 1996, HEREDITY, V77, P251, DOI 10.1038/hdy.1996.139; CARON GE, 1992, FOREST ECOL MANAG, V53, P245, DOI 10.1016/0378-1127(92)90045-B; Chaix G, 2003, THEOR APPL GENET, V107, P705, DOI 10.1007/s00122-003-1294-0; Coggeshall MV, 2010, ACTA HORTIC, V859, P93; Cotterhill PP, 1986, SILVAE GENET, V35, P5; DEGEN B, 2006, GENETIC DATA ANAL NU; Doerksen TK, 2008, CAN J FOREST RES, V38, P1742, DOI 10.1139/X08-025; Dow BD, 1998, NEW FOREST, V15, P161, DOI 10.1023/A:1006557904751; Ebrahimi A, 2017, SCI HORTIC-AMSTERDAM, V220, P36, DOI 10.1016/j.scienta.2017.03.030; Ebrahimi A, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1075-y; Ebrahimi A, 2011, SCI HORTIC-AMSTERDAM, V130, P146, DOI 10.1016/j.scienta.2011.06.028; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; FRIEDMAN ST, 1985, THEOR APPL GENET, V69, P609, DOI 10.1007/BF00251112; Germain E, 1991, EVOLUTION INFLORESCE, P16; GRANT M., CVX MATLAB SOFTWARE; Grattapaglia D, 2004, THEOR APPL GENET, V109, P192, DOI 10.1007/s00122-004-1617-9; Hansen OK, 2008, FOREST ECOL MANAG, V256, P1167, DOI 10.1016/j.foreco.2008.06.032; Hansen OK, 2006, CAN J FOREST RES, V36, P1054, DOI 10.1139/X05-299; Hansen OK, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010028; Hijmans RJ, 2017, WRITING FUNCTIONS RA; Kimura MK, 2012, PLANT ECOL, V213, P1477, DOI 10.1007/s11258-012-0105-6; Lambeth C, 2001, THEOR APPL GENET, V103, P930, DOI 10.1007/s001220100627; LANNER RONALD M., 1966, SILVAE GENET, V15, P50; Lian CL, 2001, HEREDITY, V87, P88, DOI 10.1046/j.1365-2540.2001.00913.x; LUZA JG, 1985, SCI HORTIC-AMSTERDAM, V27, P303, DOI 10.1016/0304-4238(85)90035-4; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McKeand SE, 1998, SILVAE GENET, V47, P223; McKenna J. R., 2018, Plant Breeding Reviews, V41, P263; MCKENNA JR, 2014, US FOR SERV ROCKY MT, V72, P6; Namkoong G, 1979, TECHNICAL B USDA; OWENS JN, 1995, TREE PHYSIOL, V15, P477, DOI 10.1093/treephys/15.7-8.477; Polito VS, 2004, 5 INT WALN S, V705, P465; Robichaud RL, 2006, NEW FOREST, V32, P179, DOI 10.1007/s11056-005-5961-7; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; Schuster WSF, 2000, HEREDITY, V84, P348, DOI 10.1046/j.1365-2540.2000.00684.x; SHIFLEY SR, 1984, FOREST SCI, V30, P1066; Squillace AE, 1982, USDA AGR HDB, V587; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; V KOSKI, 1970, COMMUN I FOREST FENN, V70, P1; Victory E, 2004, HIST BLACK WALNUT GE, P1; Wang ZF, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0973-3; White T. L., 2007, FOREST GENETICS; Woeste K, 2002, J HERED, V93, P58, DOI 10.1093/jhered/93.1.58; WRIGHT JONATHAN W., 1953, JOUR FOREST, V51, P114; Zhao P, 2013, NEW FOREST, V44, P357, DOI 10.1007/s11056-012-9343-7	53	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207861	10.1371/journal.pone.0207861	http://dx.doi.org/10.1371/journal.pone.0207861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513103	Green Published, gold, Green Submitted			2022-12-26	WOS:000452204800017
J	Getahun, WT; Solomon, AA; Kassie, FY; Kasaye, HK; Denekew, HT				Getahun, Worku Taye; Solomon, Abayneh Aklilu; Kassie, Fisseha Yetewale; Kasaye, Habtamu Kebebe; Denekew, Habtamu Temesgen			Uterine rupture among mothers admitted for obstetrics care and associated factors in referral hospitals of Amhara regional state, institution-based cross-sectional study, Northern Ethiopia, 2013-2017	PLOS ONE			English	Article							PREVALENCE; WOMEN	Background Maternal morbidity and mortality have been one of the most challenging health problems that concern the globe over the years. Uterine rupture is one of the peripartum complications, which cause nearly about one out of thirteen maternal deaths. This study aimed to assess the prevalence and associated factors of uterine rupture among obstetric case in referral hospitals of Amhara Regional State, Northern Ethiopia. Methods Institution based cross sectional study was conducted from Dec 5-2017-Jan 5-2018 on uterine rupture. During the study randomly selected 750 charts were included by using simple random sampling method. Data were checked, coded and entered into Epi info version 7.2 and then exported to SPSS Version 20 for Analysis. Binary Logistic regression was used to identify the predictors of uterine rupture and 95% Confidence Interval of odds ratio at p-value less than 0.05 was taken as a significance level. Result The overall prevalence of uterine rupture was 16.68% (95% CI: 14%, 19.2%). Distance from health facility > 10km (Adjusted Odds Ratio (AOR) = 2.44; 95% CI: 1.13,5.28), parity between II and IV (AOR = 7.26; 95% (3.06,17.22)) and. V (AOR = 12.55; 95% CI 3.64,43.20), laboring for > 24hours(AO = 3.44; 95% CI: 1.49,7.92), with referral paper(AOR = 2.94; 95% CI: 1.28,6.55) diagnosed with obstructed labor (AOR = 4.88; 95% CI: 2.22,10.70), precipitated labor (AOR = 3.59; 95% CI: 1.10,11.77), destructive delivery (AOR = 5.18; 95%: 1.22,20.08), No partograph (AOR = 5.21; 95% CI: 2.72,9.97), CPD(AOR = 4.08; 95% CI: 1.99,8.33), morbidly adherent placenta (AOR = 9.00; 95%: 2.46,27.11), gestational diabetic militias (AOR = 5.78; 95% CI:1. 12,20.00), history of myomectomy(AOR = 5.00; 95% CI: 1.33,18.73), induction and augmentation of labor (AOR = 2.34;95%: 1.15,4.72) obstetric procedure (AOR = 2.54;95%: 1.09,5.91), previous caesarian deliveries 4.90 (2.13,11.26) were found to be significantly associated with uterine rupture. Conclusion This finding showed that the prevalence of uterine rupture is higher. A more vigilant approach to prevent prolonged and obstructed labor, use of partograph, quick referral to a well-equipped center and prevention of other obstetrics complications need to be focused on.	[Getahun, Worku Taye] Debremarkos Referral Hosp, Dept Midwifery, Debremarkos, Ethiopia; [Solomon, Abayneh Aklilu; Kassie, Fisseha Yetewale] Univ Gondar, Sch Midwifery, Gondar, Ethiopia; [Kasaye, Habtamu Kebebe] Wollega Univ, Inst Hlth Sci, Dept Midwifery, Nekemte, Ethiopia; [Denekew, Habtamu Temesgen] Debremarkos Univ, Dept Human Nutr, Debremarkos, Ethiopia	University of Gondar	Getahun, WT (corresponding author), Debremarkos Referral Hosp, Dept Midwifery, Debremarkos, Ethiopia.	worku384@gmail.com	Kasaye, Habtamu Kebebe/U-5762-2019	Kasaye, Habtamu Kebebe/0000-0003-3759-2604; taye, worku/0000-0003-4641-4105; Yetwale, Fisseha/0000-0002-7503-8447; Temesgen, Habtamu/0000-0001-5510-9204	University of Gondar	University of Gondar	The financial support for this research project obtained from University of Gondar (http://www.uog.edu.et/en/).The funder had no role in design of the study and collection, analysis, and interpretation of data and in writing the manuscript.; We would like to express our deepest and heartfelt appreciation to University of Gondar for providing the financial support. We are also glad to say thanks to Amhara Region Referral Hospitals administrative and community for their cooperativeness and their valuable information to do this work. Last but not least, we express our gratitude data collectors and supervisors for their contribution.	Adegbola O, 2017, J CLIN SCI, V14, P13; Al-Zirqi I, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.10.017; Alemayehu W, 2013, BJOG-INT J OBSTET GY, V120, P505, DOI 10.1111/1471-0528.12098; Aliyu S., 2016, INTERNAL MED, V6, P1000222; Astatikie G, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1302-z; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P15, DOI 10.4314/ejhs.v24i0.3S; Egbe Thomas Obinchemti, 2016, BMC Res Notes, V9, P492; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Guise JM, 2004, BMJ-BRIT MED J, V329, P19, DOI 10.1136/bmj.329.7456.19; Gyamfi-Bannerman C, 2012, OBSTET GYNECOL, V120, P1332, DOI [10.1097/AOG.0b013e318273695b, http://10.1097/AOG.0b013e318273695b]; Handady SO, 2015, ACTA MED, V2; Hofmeyr GJ, 2005, BJOG-INT J OBSTET GY, V112, P1221, DOI 10.1111/j.1471-0528.2005.00725.x; Kadowa I, 2010, SINGAP MED J, V51, P35; Legese T, 2016, AM J PUBLIC HLTH RES, V4, P120; Marie BT, 2017, OBSTET GYNECOLOGY IN, V2017; Mengistie H, 2016, MOJ WOMENS HLTH, V2; Motomura K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44093; Mukasa PK, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-29; Osemwenkha PA, 2016, NIGERIAN J SURG SCI, V26, P1, DOI DOI 10.4103/1116-5898.196256; Population Census Commission, 2007, NON TRADITIONAL REF; Shick S., 2015, OBSTET GYNECOL CASES, V2, P5; WHO, 2013, HLTH STAT STAT 2013; Wilmoth JR, 2012, STAT POLITICS POLICY, V3; World Health Organization, 2014, WORLD HLTH STAT 2014	24	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208470	10.1371/journal.pone.0208470	http://dx.doi.org/10.1371/journal.pone.0208470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513120	Green Published, gold, Green Submitted			2022-12-26	WOS:000452204800034
J	Bhaduri, S; Montemagno, C				Bhaduri, Swayamdipta; Montemagno, Carlo			Sporosarcina pasteurii can clog and strengthen a porous medium mimic	PLOS ONE			English	Article							INDUCED CALCITE PRECIPITATION; TRANSPORT; BACTERIA; IMPACT; FLOW	The bacterium Sporosarcina pasteurii can produce significant volumes of solid precipitation in the presence of specific chemical environments. These solid precipitate particles can enter a network of microscale pores and cause long-range clogging. As a result, the medium gains strength and exhibits superior mechanical properties. This concept is also known as Microbiologically Induced Calcite Precipitation (MICP). In this study, we have used sponge blocks as surrogate porous media mimics and analyzed several aspects of MICP. A synergistic approach involving electron microscopy (SEM), computerized X-Ray tomography (mu CT), quasi-static compressive load testing and chemical characterization (EDX) has been used to understand several physical and chemical aspects of MICP.	[Bhaduri, Swayamdipta; Montemagno, Carlo] Univ Alberta, Ingenu Lab, Fac Engn, Edmonton, AB, Canada; [Bhaduri, Swayamdipta] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada; [Montemagno, Carlo] Southern Illinois Univ, Dept Elect & Comp Engn, Coll Engn, Carbondale, IL USA	University of Alberta; University of Alberta; Southern Illinois University System; Southern Illinois University	Bhaduri, S (corresponding author), Univ Alberta, Ingenu Lab, Fac Engn, Edmonton, AB, Canada.; Bhaduri, S (corresponding author), Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada.	sbhaduri@ualberta.ca			Alberta Ingenuity Fund	Alberta Ingenuity Fund	This work was funded by the generous support from the Alberta Ingenuity Fund: http://www.innovationalberta.com/theme_ingenuity.php.	Achal V, 2009, J IND MICROBIOL BIOT, V36, P981, DOI 10.1007/s10295-009-0578-z; Bhaduri S, 2016, JOVE-J VIS EXP, DOI 10.3791/53253; Bray JM, 2017, ENVIRON SCI TECHNOL, V51, P1562, DOI 10.1021/acs.est.6b02999; Camesano TA, 1998, ENVIRON SCI TECHNOL, DOI [10.1016/S0006-3495(95)80256-0, DOI 10.1016/S0006-3495(95)80256-0]; Cunningham AB, 2009, ENRGY PROCED, V1, P3245, DOI 10.1016/j.egypro.2009.02.109; Cunningham a. B, 2011, ENERGY PROCEDIA, V4, P5178; Cunningham AB, 2010, MICROBIALLY ENHANCED, V44, P5270; De Muynck W, 2010, ECOL ENG, V36, P118, DOI 10.1016/j.ecoleng.2009.02.006; DUFFY KJ, 1995, BIOPHYS J, V68, P800, DOI 10.1016/S0006-3495(95)80256-0; FONTES DE, 1991, APPL ENVIRON MICROB, V57, P2473, DOI 10.1128/AEM.57.9.2473-2481.1991; Ghosh P, 2005, CEMENT CONCRETE RES, V35, P1980, DOI 10.1016/j.cemconres.2005.03.005; GOLLAPUDI UK, 1995, CHEMOSPHERE, V30, P695, DOI 10.1016/0045-6535(94)00435-W; Gorospe CM, 2013, BIOTECHNOL BIOPROC E, V18, P903, DOI 10.1007/s12257-013-0030-0; Jonkers HM, 2010, ECOL ENG, V36, P230, DOI 10.1016/j.ecoleng.2008.12.036; Kantza A., 1992, 43 ANN TECH M PET SO, P1; Li MD, 2018, GEOMICROBIOL J, V35, P15, DOI 10.1080/01490451.2017.1303553; Li MD, 2016, J MATER CIVIL ENG, V28, DOI 10.1061/(ASCE)MT.1943-5533.0001442; Lowenstam HA, 2011, ANNU REV FLUID MECH, V1, P1, DOI [10.1002/adma.200400767, DOI 10.1002/ADMA.200400767]; Minto JM, 2016, WATER RESOUR RES; Mitchell AC, 2009, INT J GREENH GAS CON, V3, P90, DOI 10.1016/j.ijggc.2008.05.002; Montemagno CD, 1999, PHYS CHEM EARTH PT A, V24, P575, DOI 10.1016/S1464-1895(99)00082-4; MONTEMAGNO CD, 1995, GEOPHYS RES LETT, V22, P1397, DOI 10.1029/95GL01098; Nemati M, 2003, ENZYME MICROB TECH, V33, P635, DOI 10.1016/S0141-0229(03)00191-1; Phillips AJ, 2013, ENVIRON SCI TECHNOL, V47, P142, DOI 10.1021/es301294q; PyrakNolte LJ, 1997, GEOPHYS RES LETT, V24, P2343, DOI 10.1029/97GL02057; PyrakNolte LJ, 1995, INTERNATIONAL CONGRESS ON ROCK MECHANICS - PROCEEDINGS, VOLS 1 AND 2, P855; Ramachandran SK, 2001, ACI MATER J, V98, P3; Sham E, 2013, J CONTAM HYDROL, V152, P35, DOI 10.1016/j.jconhyd.2013.06.003; Sherwood JL, 2003, ENVIRON SCI TECHNOL, V37, P781, DOI 10.1021/es011210u; Stoner DL, 2005, APPL STEREOLITHO GRA; Tagliaferri F, 2011, GRANUL MATTER, V13, P247, DOI 10.1007/s10035-011-0257-4; Tobler DJ, 2014, APPL GEOCHEM, V42, P38, DOI 10.1016/j.apgeochem.2014.01.004; von der Schulenburg DAG, 2007, J MATER SCI, V42, P6541, DOI 10.1007/s10853-007-1523-z; Wiktor V, 2011, CEMENT CONCRETE COMP, V33, P763, DOI 10.1016/j.cemconcomp.2011.03.012; Zhao Q, 2014, J MATER CIVIL ENG, V26, DOI 10.1061/(ASCE)MT.1943-5533.0001013	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207489	10.1371/journal.pone.0207489	http://dx.doi.org/10.1371/journal.pone.0207489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500841	gold, Green Published, Green Submitted			2022-12-26	WOS:000451883700010
J	Kische, H; Hoyer, J; Pieper, L; Venz, J; Klotsche, J; Marz, W; Koch-Gromus, U; Pittrow, D; Lehnert, H; Silber, S; Stalla, GK; Zeiher, AM; Wittchen, HU; Haring, R				Kische, Hanna; Hoyer, Juergen; Pieper, Lars; Venz, John; Klotsche, Jens; Maerz, Winfried; Koch-Gromus, Uwe; Pittrow, David; Lehnert, Hendrik; Silber, Sigmund; Stalla, Guenter K.; Zeiher, Andreas M.; Wittchen, Hans-Ulrich; Haring, Robin			Testosterone is not associated with traits of optimism or pessimism: Observational evidence from the prospective DETECT study	PLOS ONE			English	Article							LIFE ORIENTATION TEST; EXPOSURE; MOOD	Background Previous experimental research on testosterone (T) and psychological traits is inconclusive. Thus, we performed the first large-scale observational study of the association between T and dispositional optimism / pessimism. Methods We used prospective data from 6,493 primary-care patients (3,840 women) of the DETECT study (Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment), including repeated immunoassay-based measurement of serum T and optimism / pessimism assessed by the revised Life-Orientation Test (LOT-R). Cross-sectional and longitudinal associations of baseline T and one-year change in T with optimism and pessimism were investigated using age- and multivariable-adjusted regression models. Results Cross-sectional analyses showed no association of T with optimism or pessimism in both sexes. Longitudinal analyses also showed no association of baseline T with optimism or pessimism at four-year follow-up. Multivariable analyses of total LOT-R score yielded similarly non-significant results (beta-coefficient per unit change in T for men: -0.01 (95% CI: -0.24-0.22), women: 0.08 (-0.03-0.20)). Furthermore, change in T was not related to optimism or pessimism at four-year follow-up. Conclusions The present observational study of a large-scale prospective sample showed no association of T with optimism or pessimism. Integrating further experimental and interventional evidence from alternative methodological approaches would strengthen this conclusion and establish stronger evidence about the potential hormonal basis of psychological traits.	[Kische, Hanna; Pieper, Lars; Venz, John] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Behav Epidemiol, Dresden, Germany; [Hoyer, Juergen; Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Klotsche, Jens] German Rheumatism Res Ctr Berlin, Berlin, Germany; [Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Med Clin 5, Heidelberg, Germany; [Koch-Gromus, Uwe] Univ Med Ctr Eppendorf, Dept Med Psychol, Hamburg, Germany; [Pittrow, David] Tech Univ Dresden, Med Fac, Inst Clin Pharmacol, Dresden, Germany; [Lehnert, Hendrik] Univ Schleswig Holstein, Dept Med 1, Lubeck, Germany; [Silber, Sigmund] Cardiol Practice & Hosp, Munich, Germany; [Stalla, Guenter K.] Max Planck Inst Psychiat, Munich, Germany; [Zeiher, Andreas M.] Goethe Univ Frankfurt, Dept Med Cardiol 3, Frankfurt, Germany; [Haring, Robin] European Univ Appl Sci, Fac Appl Publ Hlth, Rostock, Germany; [Haring, Robin] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia	Technische Universitat Dresden; Technische Universitat Dresden; Deutsches Rheuma-Forschungszentrum (DRFZ); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technische Universitat Dresden; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; Goethe University Frankfurt; Monash University	Haring, R (corresponding author), European Univ Appl Sci, Fac Appl Publ Hlth, Rostock, Germany.; Haring, R (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	robin.haring@monash.edu	Hoyer, Juergen/AAP-6071-2020; Wittchen, Hans-Ulrich/ABA-8901-2020; Pittrow, David/AAY-5042-2021	Hoyer, Juergen/0000-0002-1697-6732; Wittchen, Hans-Ulrich/0000-0002-6311-7711; 	BMBF [01ER1303, 01ER1703]; Pfizer GmbH, Karlsruhe, Germany	BMBF(Federal Ministry of Education & Research (BMBF)); Pfizer GmbH, Karlsruhe, Germany	The current data analysis was conducted within BMBF Grants 01ER1303 & 01ER1703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DETECT (Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment) is a cross-sectional and prospective-longitudinal, nationwide clinical epidemiological study. DETECT is supported by an unrestricted educational grant of Pfizer GmbH, Karlsruhe, Germany. Members of the DETECT-Study group include: Principal investigator: Professor Dr. H.-U. Wittchen; Staff members: Dr. L. Pieper, Dr. J. Klotsche, Dr. T. Eichler, Dr. H. Glaesmer, E. Katze. Steering Committee: Professor Dr. H. Lehnert (Lu <spacing diaeresis> beck), Professor Dr. G. K. Stalla (Mu <spacing diaeresis> nchen), Professor Dr. A. M. Zeiher (Frankfurt); Advisory Board: Professor Dr. W. Ma <spacing diaeresis> rz (Heidelberg/Graz), Professor Dr. S. Silber (Mu <spacing diaeresis> nchen), Professor Dr. Dr. U. Koch-Gromus (Hamburg), Professor Dr. D. Pittrow (Mu <spacing diaeresis> nchen/Dresden), Professor Dr. M. Wehling (Mannheim), Dr. D. Leistner (Frankfurt), Professor Dr. H. J. Schneider (Mu <spacing diaeresis> nchen), Dr. C. Sievers (Mu <spacing diaeresis> nchen). The current data analysis was conducted within BMBF Grants 01ER1303 & 01ER1703.	ALTSCHULE MD, 1948, NEW ENGL J MED, V239, P1036, DOI 10.1056/NEJM194812302392704; Apicella CL, 2014, PSYCHONEUROENDOCRINO, V39, P58, DOI 10.1016/j.psyneuen.2013.09.025; Bosch-Domenech A, 2014, PSYCHONEUROENDOCRINO, V43, P1, DOI 10.1016/j.psyneuen.2014.01.023; Cueva C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11206; Dalton PS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00005; Duke SA, 2014, J ADOLESCENT HEALTH, V55, P315, DOI 10.1016/j.jadohealth.2014.05.007; Galizzi MM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00041; Gray PB, 2005, J CLIN ENDOCR METAB, V90, P3838, DOI 10.1210/jc.2005-0247; Herzberg PY, 2006, PSYCHOL ASSESSMENT, V18, P433, DOI 10.1037/1040-3590.18.4.433; Huo S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162480; Jeevanandam S, 2016, J CLIN DIAGN RES, V10, pCM1, DOI 10.7860/JCDR/2016/21952.9000; Kische H, 2018, PSYCHONEUROENDOCRINO, V89, P7, DOI 10.1016/j.psyneuen.2017.12.013; Millet K, 2018, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00254; Puig-Perez S, 2017, PSYCHOPHYSIOLOGY, V54, P536, DOI 10.1111/psyp.12806; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Snyder CR, 1996, J PERS SOC PSYCHOL, V70, P321, DOI 10.1037/0022-3514.70.2.321; Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119; Travison TG, 2008, J AM GERIATR SOC, V56, P831, DOI 10.1111/j.1532-5415.2008.01679.x; Vautier S, 2003, INT J PSYCHOL, V38, P390, DOI 10.1080/00207590344000222; Wittchen HU, 2005, CURR MED RES OPIN, V21, P619, DOI 10.1185/030079905X38187	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207870	10.1371/journal.pone.0207870	http://dx.doi.org/10.1371/journal.pone.0207870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496216	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800058
J	Oratis, AT; Subasic, JJ; Hernandez, N; Bird, JC; Eisner, BH				Oratis, Alexandros T.; Subasic, John J.; Hernandez, Natalia; Bird, James C.; Eisner, Brian H.			A simple fluid dynamic model of renal pelvis pressures during ureteroscopic kidney stone treatment	PLOS ONE			English	Article							URETERAL ACCESS SHEATH; WHITAKER TEST; FLOW	Ureteroscopy is an endoscopic kidney stone removal procedure which increases the internal pressure in the renal pelvis, the kidney's urinary collecting system. Elevated renal pelvic pressure may result in systemic absorption of irrigation fluid and urine, which can increase the risk of postoperative fever and sepsis. Urologists have investigated the effects of various surgical parameters on the renal pelvic pressure. However, it still remains unknown which surgical parameter has the most dominant effect on the renal pelvic pressure over time. Here we develop a physical model that computes the renal pelvic pressure as a function of time based on parameters that can be varied during ureteroscopy. The model is developed by applying pipe network analysis to the regions of the urinary tract that are involved in a representative ureteroscopic procedure. Our model unifies the findings of the previously published studies on this topic; an ex-vivo porcine study and an in-vivo human study. Furthermore it allows simulation of surgical procedures based on various techniques. Our simulation demonstrates that the two strong regulators of renal pelvis pressure during ureteroscopy are the size of the gap between ureteroscope and ureteral access sheath and the frequency and duration of ureteroscope withdrawal.	[Oratis, Alexandros T.; Subasic, John J.; Bird, James C.] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Hernandez, Natalia; Eisner, Brian H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA	Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Bird, JC (corresponding author), Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.; Eisner, BH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA.	jbird@bu.edu; beisner@mgh.harvard.edu						Auge BK, 2004, J ENDOUROL, V18, P33, DOI 10.1089/089277904322836631; Blew BDM, 2005, J ENDOUROL, V19, P562, DOI 10.1089/end.2005.19.562; Brown RKL, 1927, J AMER MED ASSOC, V89, P2094; Gigon C, 1856, UNION MED, V9, P297; Hinman F, 1924, J AMER MED ASSOC, V82, P607, DOI 10.1001/jama.1924.02650340017006; Hinman F, 1926, J AMER MED ASSOC, V87, P1287, DOI 10.1001/jama.1926.02680160035011; Holzapfel AG, 2000, NON TRADITIONAL REF, VII; JAFFE RB, 1980, AM J ROENTGENOL, V134, P9, DOI 10.2214/ajr.134.1.9; Johnston RB, 2014, UROL J, V11, P1727; Kourambas J, 2001, J UROLOGY, V165, P789, DOI 10.1016/S0022-5347(05)66527-5; Kruck S, 2011, UROL RES, V39, P483, DOI 10.1007/s00240-011-0373-y; Lupton EW, 2010, BJU INT, V105, P94, DOI 10.1111/j.1464-410X.2009.08609.x; LYKOUDIS PS, 1970, J FLUID MECH, V43, P661, DOI 10.1017/S0022112070002653; Marieb EN, 2007, HUMAN ANATOMY PHYSL; Michel MS, 2008, J ENDOUROL, V22, P1083, DOI 10.1089/end.2008.0016; MORTENSEN J, 1983, UROL RES, V11, P251, DOI 10.1007/BF00256340; Rehman J, 2003, UROLOGY, V61, P713, DOI 10.1016/S0090-4295(02)02440-8; Rizkala Emad R, 2013, Indian J Urol, V29, P244, DOI 10.4103/0970-1591.117287; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Shao Y, 2012, MINIM INVASIV THER, V21, P302, DOI 10.3109/13645706.2011.595419; Song HJ, 2010, KOREAN J UROL, V51, P198, DOI 10.4111/kju.2010.51.3.198; Traxer O, 2015, WORLD J UROL, V33, P2137, DOI 10.1007/s00345-015-1582-8; WILSON W T, 1990, Journal of Endourology, V4, P135, DOI 10.1089/end.1990.4.135; Yang PJ, 2014, P NATL ACAD SCI USA, V111, P11932, DOI 10.1073/pnas.1402289111	24	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208209	10.1371/journal.pone.0208209	http://dx.doi.org/10.1371/journal.pone.0208209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496287	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800109
J	Burford, BP; Schlining, KL; Reisenbichler, KR; Robison, BH				Burford, Benjamin P.; Schlining, Kyra L.; Reisenbichler, Kim R.; Robison, Bruce H.			Pelagic shrimp play dead in deep oxygen minima	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; DOSIDICUS-GIGAS; GELATINOUS ZOOPLANKTON; DOWNWELLING IRRADIANCE; BEHAVIOR; SQUID; RESPIRATION; CRUSTACEANS; DEPTH; LIFE	Pelagic crustaceans are arguably the most abundant group of metazoans on Earth, yet little is known about their natural behavior. The deep pelagic shrimp Hymenopenaeus doris is a common decapod that thrives in low oxygen layers of the eastern Pacific Ocean. When first observed in situ using a remotely operated vehicle, most specimens of H. doris appeared dead due to inactivity and inverted orientation. Closer inspection revealed that these animals were utilizing small, subtle shifts in appendage position to control their orientation and sink rate. In this mode, they resembled molted shrimp exoskeletons. We hypothesize that these shrimp may avoid capture by visually-cued predators with this characteristic behavior. The low metabolic rates of H. doris (0.55-0.81 mg O-2 kg(-1) min(-1)) are similar to other deep-living shrimp, and also align with their high hypoxia tolerance and reduced activity. We observed similar behavior in another deep pelagic decapod, Petalidium suspiriosum, which transiently inhabited Monterey Canyon, California, during a period of anomalously warm ocean conditions.	[Burford, Benjamin P.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Burford, Benjamin P.; Schlining, Kyra L.; Reisenbichler, Kim R.; Robison, Bruce H.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Stanford University; Monterey Bay Aquarium Research Institute	Burford, BP (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA.; Burford, BP (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	bburford@stanford.edu		Burford, Benjamin/0000-0002-2120-3769	David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	The David and Lucile Packard Foundation provided financial support for this research.	Barham E.G., 1971, P100; Burford BP, 2015, J MAR BIOL ASSOC UK, V95, P1221, DOI 10.1017/S0025315414001763; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Childress J.J., 1985, B BIOL SOC WASH, V6, P249; CHILDRESS JJ, 1975, COMP BIOCHEM PHYS A, V50, P787, DOI 10.1016/0300-9629(75)90146-2; CHILDRESS JJ, 1968, SCIENCE, V160, P1242, DOI 10.1126/science.160.3833.1242; Childress JJ, 1998, J EXP BIOL, V201, P1223; Christiansen S, 2018, LIMNOL OCEANOGR, V63, P2093, DOI 10.1002/lno.10926; COWLES DL, 1994, J CRUSTACEAN BIOL, V14, P247, DOI 10.2307/1548905; FARFANTE IP, 1977, FISH B-NOAA, V75, P261; Faxon W., 1893, B MUS COMP ZOOL HARV, V24, P149; Frank TM, 1997, J PLANKTON RES, V19, P1975, DOI 10.1093/plankt/19.12.1975; Gasca R, 2007, MAR BIOL, V151, P233, DOI 10.1007/s00227-006-0478-y; Gilly WF, 2012, J EXP BIOL, V215, P3175, DOI 10.1242/jeb.072538; GILMER RW, 1986, MAR BIOL, V91, P47, DOI 10.1007/BF00397570; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HAMNER WM, 1975, LIMNOL OCEANOGR, V20, P907, DOI 10.4319/lo.1975.20.6.0907; Hendrickx M.E., 1996, CAMARONES PELAGICOS; Hendrickx ME, 2008, CRUSTACEANA, V81, P999, DOI 10.1163/156854008X354957; Hendrickx ME, 2013, CRUSTACEANA, V86, P437, DOI 10.1163/15685403-00003171; Herring PJ, 2002, BIOL DEEP OCEAN; Hoving HJ, 2012, P R SOC B; Hunt JC, 2000, MAR BIOL, V136, P543, DOI 10.1007/s002270050714; JACKSON GA, 1993, LIMNOL OCEANOGR, V38, P1328, DOI 10.4319/lo.1993.38.6.1328; Lavin MF, 2003, NONLINEAR PROCESSES IN GEOPHYSICAL FLUID DYNAMICS, P173; Markaida U, 2003, J MAR BIOL ASSOC UK, V83, P507, DOI 10.1017/S0025315403007434h; Myslinski T, 2005, MAR BIOL, V147, P619, DOI 10.1007/s00227-005-1606-9; Osborn KJ, 2007, BIOL BULL-US, V212, P40, DOI 10.2307/25066579; R Core Team, 2013, R LANG ENV STAT COMP; Robinson CJ, 2016, FISH RES, V173, P128, DOI 10.1016/j.fishres.2015.08.014; Robison BH, 1999, MAR FRESHW BEHAV PHY, V32, P17, DOI 10.1080/10236249909379034; Sakuma K.M., 2016, 57 CAL COOP OC FISH, V57, P163; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Schlining B.M., 2006, OCEANS, V2006, P1, DOI DOI 10.1109/OCEANS.2006.306879; Seibel BA, 1997, BIOL BULL, V192, P262, DOI 10.2307/1542720; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; SMITH KL, 1974, SCIENCE, V184, P72, DOI 10.1126/science.184.4132.72; TEAL JM, 1967, LIMNOL OCEANOGR, V12, P548, DOI 10.4319/lo.1967.12.3.0548; TORRES JJ, 1979, DEEP-SEA RES, V26, P185, DOI 10.1016/0198-0149(79)90075-X; Vereshchaka AL, 2015, ZOOL J LINN SOC-LOND, V174, P459, DOI 10.1111/zoj.12243; Wicksten MK, 2012, ZOOTAXA, P1; Wilson G.D.F., 2015, NATURAL HIST CRUSTAC, V2, P279	42	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207249	10.1371/journal.pone.0207249	http://dx.doi.org/10.1371/journal.pone.0207249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485334	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800054
J	Montes, N; Swett, R; Ahrens, R				Montes, Nancy; Swett, Robert; Ahrens, Robert			Modeling the spatial and seasonal distribution of offshore recreational vessels in the southeast United States	PLOS ONE			English	Article							REGRESSION; CHLOROPHYLL; BOATS; RIVER	Understanding the distribution and intensity of recreational boating activities is key for managing safety as well as environmental and social impacts. Recreational boating is a very important component of the diverse maritime traffic in the southeastern United States. The seasonal distribution of offshore recreational vessels in waters off the coast of Northeast Florida and Southeast Georgia was modeled using several techniques (Poisson, negative binomial, hurdle and zero inflated modes, generalized additive models, and generalized mixed models) and by combining map-based information provided by recreational boaters with environmental and geographical variables to find the most parsimonious model. Based on model performance, the final model analysis was conducted using a GAM approach with a negative binomial distribution. The best seasonal models explained between 86.1%-88.6% of the total deviance. For most seasons, a model that included latitude, longitude, interaction between latitude and longitude, chlorophyll a concentration, and abundance of artificial reefs resulted in the best fit. The only exception was the model for the summer season, which did not include chlorophyll a concentration. Given the complexity of the study area, with a number of maritime activities and several marine species co-occurring, these models could provide information to analyze the distribution and overlap of recreational boating trips with other maritime activities (e.g., cargo ships, commercial vessels) and species (e.g., right whales, sea turtles, sharks). These analyses could be used to decrease harmful interactions among these groups and activities.	[Montes, Nancy; Swett, Robert] Univ Florida, Florida Sea Grant Coll Program, Gainesville, FL 32611 USA; [Swett, Robert; Ahrens, Robert] Univ Florida, Sch Forest Resources & Conservat, Fisheries & Aquat Sci Program, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Montes, N (corresponding author), Univ Florida, Florida Sea Grant Coll Program, Gainesville, FL 32611 USA.	nancymontes@ufl.edu		Ahrens, Robert/0000-0002-6791-9156; Montes, Nancy/0000-0002-1001-7979	Southeast Regional Office NOAA Fisheries Services pursuant to National Oceanic and Atmospheric Administration [NAI00R4170079]	Southeast Regional Office NOAA Fisheries Services pursuant to National Oceanic and Atmospheric Administration	The authors thank the Southeast Regional Office NOAA Fisheries Services pursuant to National Oceanic and Atmospheric Administration (NAI00R4170079) for the financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NAT VESS DOC CTR DAT; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauduin S, 2013, BIOL CONSERV, V159, P127, DOI 10.1016/j.biocon.2012.10.031; BOHNSACK JA, 1985, B MAR SCI, V37, P11; BOHNSACK JA, 1989, B MAR SCI, V44, P631; Box PW, 1997, THESIS; Buchanan CC, 1973, US NMFS MAR FISH REV, V35, P15; Cameron P, 1999, LONDON MATH SOC; Choudhury SB, 2007, INT J REMOTE SENS, V28, P2683, DOI 10.1080/01431160600987878; Dalton T, 2010, MAR POLICY, V34, P309, DOI 10.1016/j.marpol.2009.08.001; Dutilleul P, 2000, J AGRIC BIOL ENVIR S, V5, P131, DOI 10.2307/1400528; ESRI, 2015, ARCGIS DESKT REL 10; Etter JF, 1997, J CLIN EPIDEMIOL, V50, P1123, DOI 10.1016/S0895-4356(97)00166-2; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; FLHSMV, 2013, FLOR VESS OWN STAT; Fox J., 2018, R COMPANION APPL REG, VThird; GDNR (Georgia Department of Natural Resources), 2013, WILDL RES INF SYST; Gomes LC, 2002, FISH RES, V55, P335, DOI 10.1016/S0165-7836(01)00278-8; Gorzelany JF, 2013, CHARACTERIZATION REC; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Goslee SC, 2010, PLANT ECOL, V206, P279, DOI 10.1007/s11258-009-9641-0; Gray DL, 2011, MAR POLICY, V35, P286, DOI 10.1016/j.marpol.2010.10.005; Hain J, 1994, T94070460 MMC; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; MANTEL N, 1967, CANCER RES, V27, P209; Montes N, 2016, TP226 U FLOR; NASA Ocean Biology (OB), 2014 MOD RES IM SPEC; National Centers for Environmental Information, 2012, STAT CLIM HURR TROP; National Centers for Environmental Information, 2013, STAT CLIM HURR TROP; Parrott L, 2011, ENVIRON MODELL SOFTW, V26, P1403, DOI 10.1016/j.envsoft.2011.08.009; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; Pinheiro J, R PACKAGE VERSION; Pinheiro J, 2000, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; Sidman C, 2004, TP130 U FLOR FLOR SE; Sidman C, 2005, TP150 U FLOR FLOR SE; Sidman C, 2006, TP152 U FLOR FOR SEA; Sidman C, 2007, TP160 U FLOR FLOR SE; Sidman CF, 2005, LEIS SCI, V27, P1; SMITH EP, 1995, ECOL MODEL, V77, P49, DOI 10.1016/0304-3800(93)E0074-D; Suitor D, 1994, BOATING STUDY FACILI; Swett R, 2012, TP181 U FLOR FLOR SE; Swett RA, 2009, COAST MANAGE, V37, P405, DOI 10.1080/08920750902838416; Tixerant ML, 2011, COASTAL CONSERVATION, V5, P407; US Census Bureau, 2013, DATABASE; Vaske J., 2008, SURVEY RES ANAL APPL; Venables WN., 2002, MODERN APPL STAT S, V4; Wall CC, 2009, FISH OCEANOGR, V18, P185, DOI 10.1111/j.1365-2419.2009.00507.x; Widmer WM, 2004, LANDSCAPE URBAN PLAN, V66, P173, DOI 10.1016/S0169-2046(03)00099-9; Wood S.N., 2001, R NEWS, V1, P20; Wood SN, 2006, GEN ADDITIVE MODELS; Wu Y, 2009, RISK ANAL, V29, P985, DOI 10.1111/j.1539-6924.2009.01217.x; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	54	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208126	10.1371/journal.pone.0208126	http://dx.doi.org/10.1371/journal.pone.0208126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485361	gold, Green Submitted, Green Published			2022-12-26	WOS:000451755800110
J	Ouerfelli-Ethier, J; Elsaeid, B; Desgroseilliers, J; Munoz, DP; Blohm, G; Khan, AZ				Ouerfelli-Ethier, Julie; Elsaeid, Basma; Desgroseilliers, Julie; Munoz, Douglas P.; Blohm, Gunnar; Khan, Aarlenne Zein			Anti-saccades predict cognitive functions in older adults and patients with Parkinson's disease	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; WORKING-MEMORY; EYE-MOVEMENT; BASAL GANGLIA; VISUAL-SEARCH; RESPONSE-INHIBITION; ANTISACCADE PERFORMANCE; EXECUTIVE FUNCTIONS; PSYCHOTIC-PATIENTS; SCREENING TOOL	A major component of cognitive control is the ability to act flexibly in the environment by either behaving automatically or inhibiting an automatic behaviour. The interleaved pro/anti-saccade task measures cognitive control because the task relies on one's abilities to switch flexibly between pro and anti-saccades, and inhibit automatic saccades during anti-saccade trials. Decline in cognitive control occurs during aging or neurological illnesses such as Parkinson's disease (PD), and indicates decline in other cognitive abilities, such as memory. However, little is known about the relationship between cognitive control and other cognitive processes. Here we investigated whether anti-saccade performance can predict decision-making, visual memory, and pop-out and serial visual search performance. We tested 34 younger adults, 22 older adults, and 20 PD patients on four tasks: an interleaved pro/anti-saccade, a spatial visual memory, a decision-making and two types of visual search (pop-out and serial) tasks. Anti-saccade performance was a good predictor of decision-making and visual memory abilities for both older adults and PD patients, while it predicted visual search performance to a larger extent in PD patients. Our results thus demonstrate the suitability of the interleaved pro/anti-saccade task as a cognitive marker of cognitive control in aging and PD populations.	[Ouerfelli-Ethier, Julie; Khan, Aarlenne Zein] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Elsaeid, Basma; Munoz, Douglas P.; Blohm, Gunnar] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Desgroseilliers, Julie] Univ Sherbrooke, Dept Med & Hlth Sci, Sherbrooke, PQ, Canada	Universite de Montreal; Queens University - Canada; University of Sherbrooke	Khan, AZ (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	aarlenne.khan@umontreal.ca			master's excellence scholarship from Faculte des Etudes Superieures et Postdoctorales and ecole d'Optometrie de l'Universite de Montreal (FESP-eOUM); Canada Research Chair program; Natural Sciences and Engineering Research Council of Canada (NSERC)	master's excellence scholarship from Faculte des Etudes Superieures et Postdoctorales and ecole d'Optometrie de l'Universite de Montreal (FESP-eOUM); Canada Research Chair program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	JOE received support from a master's excellence scholarship from Faculte des Etudes Superieures et Postdoctorales and ecole d'Optometrie de l'Universite de Montreal (FESP-eOUM). AZK and GB were funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). AZK and DPM were additionally supported by the Canada Research Chair program.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amador SC, 2006, NEUROPSYCHOLOGIA, V44, P1475, DOI 10.1016/j.neuropsychologia.2005.11.015; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; BADDELEY A, 1996, PHILOS T R SOC LON B, V351, P1403, DOI DOI 10.1098/RSTB.1996.0123; Ballard CG, 2002, NEUROLOGY, V59, P1714, DOI 10.1212/01.WNL.0000036908.39696.FD; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Brainard DH, PSYCHOPHYSICS TOOLBO, V10, P433; Brown MRG, 2007, J NEUROPHYSIOL, V98, P1751, DOI 10.1152/jn.00460.2007; BROWN RG, 1991, BRAIN, V114, P215; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; Cameron IGM, 2012, NEUROIMAGE, V60, P1156, DOI 10.1016/j.neuroimage.2012.01.057; Cameron IGM, 2010, NEUROPSYCHOLOGIA, V48, P1948, DOI 10.1016/j.neuropsychologia.2010.03.015; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; Coe BC, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0192; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cormack F, 2004, INT J GERIATR PSYCH, V19, P763, DOI 10.1002/gps.1159; Costa A, 2003, DEMENT GERIATR COGN, V15, P55, DOI 10.1159/000067968; CRAWFORD TJ, 1995, PSYCHOL MED, V25, P473, DOI 10.1017/S0033291700033390; CRAWFORD TJ, 1995, PSYCHOL MED, V25, P461, DOI 10.1017/S0033291700033389; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; de Boer C, 2014, J PARKINSON DIS, V4, P599, DOI 10.3233/JPD-140401; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; Domagalik A, 2012, NEUROIMAGE, V62, P1325, DOI 10.1016/j.neuroimage.2012.06.006; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dyckman K, 2005, EXP BRAIN RES, V162, P63, DOI 10.1007/s00221-004-2105-9; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Fischer B., 2008, OPTOM VIS DEV, V39, P181; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; FRIEDMAN HR, 1994, J NEUROSCI, V14, P2775; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hellmuth J, 2012, NEUROLOGY, V78, P1824, DOI 10.1212/WNL.0b013e318258f785; HENIK A, 1993, CORTEX, V29, P589, DOI 10.1016/S0010-9452(13)80283-3; Herz DM, 2016, CURR BIOL, V26, pR671, DOI 10.1016/j.cub.2016.05.075; Hood AJ, 2007, J NEUROL NEUROSUR PS, V78, P565, DOI 10.1136/jnnp.2006.099754; Hu MTM, 2014, MOVEMENT DISORD, V29, P351, DOI 10.1002/mds.25748; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; ISSEROFF A, 1982, BRAIN RES, V232, P97, DOI 10.1016/0006-8993(82)90613-8; Jamadar SD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00749; Jantz JJ, 2013, J NEUROPHYSIOL, V109, P2767, DOI 10.1152/jn.00611.2012; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Johnston K, 2006, J NEUROSCI, V26, P12471, DOI 10.1523/JNEUROSCI.4101-06.2006; Karatekin C, 2006, EXP BRAIN RES, V174, P324, DOI 10.1007/s00221-006-0467-x; Karlawish J, 2013, NEUROLOGY, V81, P801, DOI 10.1212/WNL.0b013e3182a05ba5; Kiyota N, 2010, EUR J APPL PHYSIOL, V110, P1143, DOI 10.1007/s00421-010-1603-7; Klein C, 2010, EXP BRAIN RES, V203, P759, DOI 10.1007/s00221-010-2276-5; LANGE KW, 1992, PSYCHOPHARMACOLOGY, V107, P394, DOI 10.1007/BF02245167; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Matsumoto R, 2012, HUM BRAIN MAPP, V33, P2856, DOI 10.1002/hbm.21407; Miller EK, 1996, J NEUROSCI, V16, P5154; Mirsky JB, 2011, COGN BEHAV NEUROL, V24, P50, DOI 10.1097/WNN.0b013e318223f6c6; MITTENBERG W, 1989, J CLIN EXP NEUROPSYC, V11, P918, DOI 10.1080/01688638908400945; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OWEN AM, 1995, NEUROPSYCHOLOGY, V9, P126, DOI 10.1037/0894-4105.9.1.126; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; REVONSUO A, 1993, BRAIN COGNITION, V21, P87, DOI 10.1006/brcg.1993.1007; Rivaud-Pechoux S, 2007, BRAIN, V130, P256, DOI 10.1093/brain/awl315; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Rubin DC, 1999, AGING NEUROPSYCHOL C, V6, P241, DOI 10.1076/1382-5585(199912)06:04;1-B;FT241; Samuel M, 1997, BRAIN, V120; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sawamoto N, 2008, BRAIN, V131, P1294, DOI 10.1093/brain/awn054; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tales A, 2004, NEUROPSYCHOLOGIA, V42, P335, DOI 10.1016/j.neuropsychologia.2003.08.002; Tranel DW, 1994, HDB NEUROPSYCHOLOGY, P123; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TROSCIANKO T, 1993, CLIN VISION SCI, V8, P281; Trujillo JP, 2015, HUM BRAIN MAPP, V36, P3703, DOI 10.1002/hbm.22873; van Koningsbruggen MG, 2009, NEUROPSYCHOLOGIA, V47, P2909, DOI 10.1016/j.neuropsychologia.2009.06.018; West R, 2005, CORTEX, V41, P570, DOI 10.1016/S0010-9452(08)70197-7; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483; Wolfe JM, 2003, TRENDS COGN SCI, V7, P70, DOI 10.1016/S1364-6613(02)00024-4; Wu MT, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00280; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097; Zhou X, 2016, P NATL ACAD SCI USA, V113, P3353, DOI 10.1073/pnas.1518147113	100	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207589	10.1371/journal.pone.0207589	http://dx.doi.org/10.1371/journal.pone.0207589			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485332	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800074
J	Park, SH; Lim, YD; Jung, YH; Jeung, KW				Park, Se-hyeok; Lim, Yong Deok; Jung, Yong Hun; Jeung, Kyung Woon			Relationship between hemodynamic parameters and severity of ischemia-induced left ventricular wall thickening during cardiopulmonary resuscitation of consistent quality	PLOS ONE			English	Article							HEART-ASSOCIATION GUIDELINES; TIDAL CARBON-DIOXIDE; 2,3-BUTANEDIONE MONOXIME; CARDIAC RESUSCITATION; PIG MODEL; FIBRILLATION; CONTRACTURE; COMPRESSION; PRESSURE; OUTPUT	Ischemia-induced left ventricular (LV) wall thickening compromises the hemodynamic effectiveness of cardiopulmonary resuscitation (CPR). However, accurate assessment of the severity of ischemia-induced LV wall thickening during CPR is challenging. We investigated, in a swine model, whether hemodynamic parameters, including end-tidal carbon dioxide (ETCO2) level, are linearly associated with the severity of ischemia-induced LV wall thickening during CPR of consistent quality. We retrospectively analyzed 96 datasets for ETCO2 level, arterial pressure, LV wall thickness, and the percent of measured end-diastolic volume (%EDV) relative to EDV at the onset of ventricular fibrillation from eight pigs. Animals underwent advanced cardiovascular life support based on resuscitation guidelines. During CPR, LV wall thickness progressively increased while %EDV progressively decreased. Systolic and diastolic arterial pressure and ETCO2 level were significantly correlated with LV wall thickness and % EDV. Linear mixed effect models revealed that, after adjustment for significant covariates, systolic and diastolic arterial pressure were not associated with LV wall thickness or %EDV. ETCO2 level had a significant linear relationship with %EDV (P = 0.004). However, it could explain only 28.2% of the total variance of %EDV in our model. In conclusion, none of the hemodynamic parameters examined in this study appeared to provide sufficient information on the severity of ischemia-induced LV wall thickening.	[Park, Se-hyeok; Lim, Yong Deok; Jung, Yong Hun; Jeung, Kyung Woon] Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital	Jeung, KW (corresponding author), Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea.	neoneti@hanmail.net			National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF-2018R1A2B6001388]	National Research Foundation of Korea (NRF) - Korean government (MSIT)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF-2018R1A2B6001388). The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub IM, 2003, CIRCULATION, V107, P1804, DOI 10.1161/01.CIR.0000058704.45646.0D; Ayoub IM, 2007, CRIT CARE MED, V35, P2329, DOI 10.1097/01.CCM.0000280569.87413.74; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Berg RA, 2005, CIRCULATION, V111, P1136, DOI 10.1161/01.CIR.0000157147.26869.31; Cho YC, 2011, EMERG MED J, V28, P40, DOI 10.1136/emj.2010.099911; CRILEY JM, 1976, JAMA-J AM MED ASSOC, V236, P1246, DOI 10.1001/jama.236.11.1246; Gazmuri RJ, 2001, CIRCULATION, V104, P234, DOI 10.1161/01.CIR.104.2.234; GUDIPATI CV, 1988, CIRCULATION, V77, P234, DOI 10.1161/01.CIR.77.1.234; Heradstveit BE, 2012, RESUSCITATION, V83, P813, DOI 10.1016/j.resuscitation.2012.02.021; Jaeger BC, 2017, J APPL STAT, V44, P1086, DOI 10.1080/02664763.2016.1193725; Klouche K, 2002, CHEST, V122, P1006, DOI 10.1378/chest.122.3.1006; KLOUCHE K, 2000, CRIT CARE MED S, V28; KORETSUNE Y, 1990, AM J PHYSIOL, V258, pH9, DOI 10.1152/ajpheart.1990.258.1.H9; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Lah K, 2011, CRIT CARE, V15, DOI 10.1186/cc9417; Lee BK, 2016, AM J EMERG MED, V34, P1053, DOI 10.1016/j.ajem.2016.03.025; Lee BK, 2015, RESUSCITATION, V87, P26, DOI 10.1016/j.resuscitation.2014.11.011; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; MAIER GW, 1984, CIRCULATION, V70, P86, DOI 10.1161/01.CIR.70.1.86; Meaney PA, 2013, CIRCULATION, V128, P417, DOI 10.1161/CIR.0b013e31829d8654; MORIMOTO Y, 1993, CRIT CARE MED, V21, P1572, DOI 10.1097/00003246-199310000-00028; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; NIEMANN JT, 1981, CIRCULATION, V64, P985, DOI 10.1161/01.CIR.64.5.985; NIEMANN JT, 1985, ANN EMERG MED, V14, P521, DOI 10.1016/S0196-0644(85)80774-5; ORNATO JP, 1989, ANN EMERG MED, V18, P732, DOI 10.1016/S0196-0644(89)80005-8; Pfaffenberger S, 2013, CIRC-CARDIOVASC IMAG, V6, P1073, DOI 10.1161/CIRCIMAGING.113.000690; RUDIKOFF MT, 1980, CIRCULATION, V61, P345, DOI 10.1161/01.CIR.61.2.345; SANDERS AB, 1985, ANN EMERG MED, V14, P948, DOI 10.1016/S0196-0644(85)80235-3; Sheak KR, 2015, RESUSCITATION, V89, P149, DOI 10.1016/j.resuscitation.2015.01.026; Takino M, 1996, RESUSCITATION, V33, P101, DOI 10.1016/S0300-9572(96)00995-1; WEIL MH, 1985, CRIT CARE MED, V13, P907, DOI 10.1097/00003246-198511000-00011	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208140	10.1371/journal.pone.0208140	http://dx.doi.org/10.1371/journal.pone.0208140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485382	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800113
J	Sun, VC; Chen, CC				Sun, Vincent C.; Chen, Chien-Chung			Basic color categories and Mandarin Chinese color terms	PLOS ONE			English	Article							PERCEPTION	Basic color terms used in Mandarin Chinese have been controversial since first discussed by Berlin and Kay in 1969. Previous studies showed much inconsistency on what should be considered as basic color terms in Mandarin Chinese. In the present study, we investigated categories of color rather than merely the color terms used by Taiwanese native Mandarin speakers. Using samples conforming to the Berlin and Kay survey, various colors were chosen from a collection of Natural Color System (NCS) colored papers and mounted on a piece of neutral gray card. The card was then mounted on a touch-screen, under D65 illumination. Thirty-two single-character color related Mandarin terms were selected from a Chinese character database according to frequency of use. Participants were required to select the color sample that matched the term by pressing a virtual button on the touch screen. The results show that certain terms can be directly correlated to basic color terms in English, comparable with the results of Berlin and Kay's original study and those that followed. However, some terms, such as Mo (ink), Tie (iron), and Cai (vegetable), show a wide spread of term maps and inconsistent use among subjects. Principle component analysis (PCA) procedures were used to analysis the commodity of data among subjects. The findings suggest that the basic color categories among Mandarin Chinese speakers are similar to those found in the World Color Survey (WCS), but are represented by wide-spread and inconsistent color terms among speakers.	[Sun, Vincent C.] Chinese Culture Univ, Dept Mass Commun, Taipei, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Dept Psychol, Taipei, Taiwan	Chinese Culture University; National Taiwan University	Chen, CC (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei, Taiwan.	c3chen@ntu.edu.tw	Sun, Vincent C./AAG-7302-2019	Chen, Chien-Chung/0000-0002-3848-0180; Sun, Vincent/0000-0002-8793-0360	Minister of Science and Technology [103-2410-H002 -076 -MY3]	Minister of Science and Technology	Funded by Minister of Science and Technology 101-2410-H-034-036-MY2 to VCS. Minister of Science and Technology 103-2410-H002 -076 -MY3 to CCC. https://www.most.gov.tw/.	Berlin B, 1969, BASIC COLOR TERMS TH, Vxiii; Berlin B, 1968, 1 US DEP HLTH ED WEL; Biggam CP, 2012, SEMANTICS COLOUR HIS; Franklin A, 2008, P NATL ACAD SCI USA, V105, P3221, DOI 10.1073/pnas.0712286105; Gao JY, 2014, STUD LANG, V38, P335, DOI 10.1075/sl.38.2.03gao; Guest S, 2002, PERCEPTION, V31, P445, DOI 10.1068/p3134; Guest S, 2000, VISION RES, V40, P723, DOI 10.1016/S0042-6989(99)00221-7; Hardin CL, 1998, COLOR VISION PERSPEC; Kay P., 2009, WORLD COLOR SURVEY; Lin H, 2001, COLOR RES APPL, V26, P40, DOI 10.1002/1520-6378(200102)26:1<40::AID-COL5>3.0.CO;2-X; Lin H, 2001, COLOR RES APPL, V26, P193, DOI 10.1002/col.1017.abs; Lu CF, 1997, COLOR RES APPL, V22, P4, DOI 10.1002/(SICI)1520-6378(199702)22:1<4::AID-COL3>3.0.CO;2-Z; MACLAURY RE, 1987, AM ANTHROPOL, V89, P107, DOI 10.1525/aa.1987.89.1.02a00060; Maffi Luisa, 1997, COLOR CATEGORIES THO; Press AS, 1998, ACAD SINICA BALANCED; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Uchikawa K., 2006, CATEGORICAL COLOR PE, V26, P33; Zhou K, 2010, P NATL ACAD SCI USA, V107, P9974, DOI 10.1073/pnas.1005669107	18	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206699	10.1371/journal.pone.0206699	http://dx.doi.org/10.1371/journal.pone.0206699			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485289	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800027
J	Butikofer, L; Jones, B; Sacchi, R; Mangiacotti, M; Ji, WH				Butikofer, Luca; Jones, Beatrix; Sacchi, Roberto; Mangiacotti, Marco; Ji, Weihong			A new method for modelling biological invasions from early spread data accounting for anthropogenic dispersal	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS	Biological invasions are one of the major causes of biodiversity loss worldwide. In spite of human aided (anthropogenic) dispersal being the key element in the spread of invasive species, no framework published so far accounts for its peculiar characteristics, such as very rapid dispersal and independence from the existing species distribution. We present a new method for modelling biological invasions using historical spatio-temporal records. This method first discriminates between data points of anthropogenic origin and those originating from natural dispersal, then estimates the natural dispersal kernel. We use the expectation-maximisation algorithm for the first step; we then use Ripley's K-function as a spatial similarity metric to estimate the dispersal kernel. This is done accounting for habitat suitability and providing estimates of the inference precision. Tests on simulated data show good accuracy and precision for this method, even in the presence of challenging, but realistic, limitations of data in the invasion time series, such as gaps in the survey times and low number of records. We also provide a real case application of our method using the case of Litoria frogs in New Zealand. This method is widely applicable across the field of biological invasions, epidemics and climate change induced range shifts and provides a valuable contribution to the management of such issues. Functions to implement this methodology are made available as the R package Biolinv (https://cran.r-project.org/package=Biolinv).	[Butikofer, Luca; Jones, Beatrix; Ji, Weihong] Massey Univ, North Shore Mail Ctr, Inst Nat & Math Sci, NZ-0745 Auckland, New Zealand; [Sacchi, Roberto; Mangiacotti, Marco] Univ Pavia, Dept Earth & Environm Sci, Via Taramelli, Pavia, Italy	Massey University; University of Pavia	Butikofer, L (corresponding author), Massey Univ, North Shore Mail Ctr, Inst Nat & Math Sci, NZ-0745 Auckland, New Zealand.	lucabutikofer@gmail.com	MANGIACOTTI, MARCO/AAH-1282-2020; Sacchi, Roberto/E-2141-2011; Mangiacotti, Marco/AAZ-9550-2021	MANGIACOTTI, MARCO/0000-0001-7144-3851; Sacchi, Roberto/0000-0002-6199-0074; 				[Anonymous], 1988, STAT INFERENCE SPATI, DOI DOI 10.1017/CBO9780511624131; Becker RA, 1995, CONSTRUCTING GROGRAP; Becker RA, 1993, AT T BELL LAB REP; Caley P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116631; Catterall S, 2012, ECOGRAPHY, V35, P901, DOI 10.1111/j.1600-0587.2011.07190.x; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Cook A, 2007, B MATH BIOL, V69, P2005, DOI 10.1007/s11538-007-9202-4; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Hodkinson DJ, 1997, J APPL ECOL, V34, P1484, DOI 10.2307/2405264; Katsanevakis S, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00032; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pitt JPW, 2009, ECOL APPL, V19, P1176, DOI 10.1890/08-1777.1; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172	15	1	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0205591	10.1371/journal.pone.0205591	http://dx.doi.org/10.1371/journal.pone.0205591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481174	gold, Green Published, Green Submitted			2022-12-26	WOS:000451440000004
J	Duchini, PG; Guzatti, GC; Echeverria, JR; Americo, LF; Sbrissia, AF				Duchini, Paulo Goncalves; Guzatti, Gabriela Cristina; Echeverria, Joilson Roda; Americo, Luana Fidelis; Sbrissia, Andre Fischer			Experimental evidence that the perennial grass persistence pathway is linked to plant growth strategy	PLOS ONE			English	Article							BUD-BANK; PASTURE; PRODUCTIVITY; RESPONSES; CLASSIFICATION; FERTILIZATION; COMMUNITIES; POPULATIONS; FREQUENCY; NUTRIENTS	Grass species can be classified into different functional types based on their growth strategies, and contrasting persistence strategies are observed in different grass species. Excluding seedling recruitments, changes in populations of grasses are basically a trade-off between natality and mortality of tillers. We hypothesised that the persistence pathway of perennial grasses is linked to their growth strategy, regardless whether they are growing as monoculture or as a mixture. Species with contrasting growth strategies (Arrhenatherum elatius L., Dactylis glomerata L., and Festuca arundinacea Schreb.) were cultivated as monocultures and as a mixture and their tiller natality and mortality were evaluated for two years after swards establishment. All pastures maintained their population size during the experimental period, although decreases in tiller densities occurred during the warmer season. Arrhenatherum elatius had the highest tiller mortality and natality whereas the F. arundinacea had the lowest ones. Arrhenatherum elatius had many tillers appearing in all seasons but their tillers were short-lived. Conversely, F. arundinacea and D. glomerata developed numerous tillers during autumn and winter and their tillers survived, on average, almost six and three times longer than those of A. elatius, respectively. There were no differences in tillering dynamics among populations grown in monocultures or in the mixture. Regardless of whether they were cultivated in monocultures or as a mixture, the persistence pathway of perennial grasses is linked with their growth strategies with exploitative species presenting a high tiller turnover throughout the year whereas the persistence of more conservative species is based on a high tiller survival.	[Duchini, Paulo Goncalves; Guzatti, Gabriela Cristina; Echeverria, Joilson Roda; Americo, Luana Fidelis; Sbrissia, Andre Fischer] Santa Catarina State Univ UDESC CAV, Anim Prod & Food Sci Dept, Ave Luiz de Camoes, Lages, SC, Brazil	Universidade do Estado de Santa Catarina	Duchini, PG (corresponding author), Santa Catarina State Univ UDESC CAV, Anim Prod & Food Sci Dept, Ave Luiz de Camoes, Lages, SC, Brazil.	duchini_p_g@hotmail.com	Sbrissia, Andre/C-3324-2013	Sbrissia, Andre/0000-0003-3350-2288; Duchini, Paulo/0000-0002-5267-7959	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [456394/2014-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (URL: cnpq.br; grant #456394/2014-1). The financial resource was passed on to AFS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Americo LF, 2017, THESIS; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Briske DD, 1996, ECOLOGY MANAGEMENT G, P37; ComissAo de Quimica e Fertilidade do Solo-RS/SC (CQFS RS/SC), 2004, THESIS U FEDERAL RIO; Cruz P., 2002, FOURRAGES, V172, P335; da Silva SC, 2015, AGRICULTURE-BASEL, V5, P598, DOI 10.3390/agriculture5030598; DAVIES A, 1974, J AGR SCI, V82, P165, DOI 10.1017/S0021859600050334; Duchini PG, 2019, AGRON J, V111, P224, DOI 10.2134/agronj2018.03.0218; Echeverria JR, 2018, THESIS; Garnier E, 2016, PLANT FUNCTIONAL DIV, P44; Gatti ML, 2013, GRASS FORAGE SCI, V68, P151, DOI 10.1111/j.1365-2494.2012.00881.x; Gautier H, 1999, ANN BOT-LONDON, V83, P423, DOI 10.1006/anbo.1998.0840; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; Gross N, 2007, J ECOL, V95, P1296, DOI 10.1111/j.1365-2745.2007.01303.x; Harper J. L., 1977, Population biology of plants.; HEIDE OM, 1994, NEW PHYTOL, V128, P347, DOI 10.1111/j.1469-8137.1994.tb04019.x; KORTE CJ, 1986, NEW ZEAL J AGR RES, V29, P629; Laterra P, 1997, J VEG SCI, V8, P369, DOI 10.2307/3237326; Lemaire G., 1997, DIAGNOSIS NITROGEN S, P3, DOI [DOI 10.1007/978-3-642-60684-7, 10.1007/978-3-642-60684-7, DOI 10.1007/978-3-642-60684-7_1]; Liancourt P, 2005, J VEG SCI, V16, P713, DOI 10.1111/j.1654-1103.2005.tb02414.x; MacArthur RH, 1967, THEORY ISLAND BIOGEO, P2; Maire V, 2009, FUNCT ECOL, V23, P668, DOI 10.1111/j.1365-2435.2009.01557.x; Matthew C., 2000, Grassland ecophysiology and grazing ecology, P127, DOI 10.1079/9780851994529.0127; MATTHEW C, 1995, ANN BOT-LONDON, V76, P579, DOI 10.1006/anbo.1995.1135; MATTHEW C, 2011, PASTURE PERSISTENCE, V15, P63; Matthew C, 2013, P 22 INT GRASSL C 20; McKenzie FR, 1997, TROP GRASSLANDS, V31, P219; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; MURPHY JS, 1992, J RANGE MANAGE, V45, P419, DOI 10.2307/4002896; Nelson C. J., 2000, Grassland ecophysiology and grazing ecology, P101, DOI 10.1079/9780851994529.0101; ONG CK, 1978, J BRIT GRASSLAND SOC, V33, P205; Ott JP, 2017, J PLANT ECOL, V10, P518, DOI 10.1093/jpe/rtw045; Ott JP, 2015, AM J BOT, V102, P1462, DOI 10.3732/ajb.1500039; Ott JP, 2012, PLANT ECOL, V213, P1437, DOI 10.1007/s11258-012-0102-9; Pakiding W, 1999, TROP GRASSLANDS, V33, P170; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; Pembleton KG, 2015, ANIM PROD SCI, V55, P893, DOI 10.1071/AN14816; Pontes LS, 2007, GRASS FORAGE SCI, V62, P485, DOI 10.1111/j.1365-2494.2007.00604.x; Pontes LD, 2012, OECOLOGIA, V168, P761, DOI 10.1007/s00442-011-2129-3; Pontes LD, 2010, ANN BOT-LONDON, V105, P957, DOI 10.1093/aob/mcq066; Quetier F, 2007, ECOL MONOGR, V77, P33, DOI 10.1890/06-0054; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; RYLE G. J. A., 1964, J BRIT GRASSLAND SOC, V19, P281; Salguero-Gomez R, 2016, P NATL ACAD SCI USA, V113, P230, DOI 10.1073/pnas.1506215112; Saxena P, 2014, CROP SCI, V54, P1205, DOI 10.2135/cropsci2013.08.0565; Sbrissia AF, 2010, PLANT ECOL, V206, P349, DOI 10.1007/s11258-009-9647-7; Scheneiter O, 2012, GRASS FORAGE SCI, V67, P426, DOI 10.1111/j.1365-2494.2012.00861.x; Tracy BF, 2004, CROP SCI, V44, P2180, DOI 10.2135/cropsci2004.2180; Turchin P, 2001, OIKOS, V94, P17, DOI 10.1034/j.1600-0706.2001.11310.x; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; YEH RY, 1976, CROP SCI, V16, P409, DOI 10.2135/cropsci1976.0011183X001600030024x	54	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207360	10.1371/journal.pone.0207360	http://dx.doi.org/10.1371/journal.pone.0207360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475824	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700027
J	Katsiampoura, A; Toumpanakis, D; Konsta, K; Varkaris, A; Vassilakopoulos, T				Katsiampoura, Anastasia; Toumpanakis, Dimitrios; Konsta, Konstantina; Varkaris, Andreas; Vassilakopoulos, Theodoros			Prediction of dysnatremias in critically ill patients based on the law of conservation of mass. Comparison of existing formulae	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; HYPONATREMIA; HYPERNATREMIA; SODIUM	Background We aimed to examine the predictive value of a novel mathematical formula based on the law of conservation of mass in calculating sodium changes in intensive care unit patients and compare its performance with previously published formulae. Methods 178 patients were enrolled from 01/2010 to 10/2013. Plasma and urine were collected in two consecutive 8-hour intervals and the sodium was measured. The predicted sodium concentration was calculated based on previous equations and our formula. The two 8-hour period (epoch 1 and 2) results were compared. Variability of predicted values among the measured range of serum sodium levels were provided by Bland-Altman plots with bias and precision statistics. Comparison of the results was performed with the statistical model of the Percentage Similarity. Results 47.19% patients had dysnatremias. The bias +/- SD with 95% limits of agreement for sodium levels were -1.395 +/- 3.491 for epoch 1 and -1.623 +/- 11.1 for epoch 2 period. Bland-Altman analysis for the epoch 1 study period had the following results: -0.8079 +/- 3.447 for Adrogue ' Madias, 0.56 +/- 9.687 for Barsoum-Levine, 0.1412 +/- 3.824 for EFWC and 0.294 +/- 4.789 for Kurtz-Nguyen formula. The mean similarity, SD and coefficient variation for the methods compared with the measured sodium are: 99.56%, 3.873, 3.89% epoch 1, 99.56%, 1.255, 1.26% for epoch 2, 99.77%, 1.245, 1.26% for Adrogue-Madias, 100.1%, 1.337, 1.34% for Barsoum-Levine, 100.1%, 1.704, 1.7% for Nguyen, 100.1%, 1.370, 1.37% for ECFW formula. Conclusions The law of conservation of mass can be successfully applied for the prediction of sodium changes in critically ill patients.	[Katsiampoura, Anastasia; Toumpanakis, Dimitrios; Konsta, Konstantina; Vassilakopoulos, Theodoros] Univ Athens, Med Sch, Evangelismos Hosp, Dept Crit Care,Pulm Unit, Athens, Greece; [Katsiampoura, Anastasia] Tufts Med Sch, St Elizabeths Med Ctr, Anesthesiol Dept, Boston, MA USA; [Varkaris, Andreas] Tufts Med Sch, Lahey Clin, Dept Internal Med, Boston, MA USA; [Varkaris, Andreas] Univ Athens, Med Sch, Alexandra Hosp, Dept Therapeut, Athens, Greece	Evangelismos Hospital; National & Kapodistrian University of Athens; St. Elizabeth's Medical Center; Tufts Medical Center; Tufts University; Lahey Hospital & Medical Center; Tufts Medical Center; Tufts University; Alexandra Hospital; National & Kapodistrian University of Athens	Vassilakopoulos, T (corresponding author), Univ Athens, Med Sch, Evangelismos Hosp, Dept Crit Care,Pulm Unit, Athens, Greece.	tvassil@med.uoa.gr	Varkaris, Andreas/AAU-3262-2020; Katsiampoura, Anastasia/X-3804-2019; Toumpanakis, Dimitrios/AAR-2784-2020; varkaris, andreas/AAS-4833-2020					Adrogue HJ, 1997, INTENS CARE MED, V23, P309, DOI 10.1007/s001340050333; Barsoum NR, 2002, NEPHROL DIAL TRANSPL, V17, P1176, DOI 10.1093/ndt/17.7.1176; Bennani SL, 2003, REV MED INTERNE, V24, P224, DOI 10.1016/S0248-8663(02)00811-1; Bhaskar E, 2010, INDIAN J CRIT CARE M, V14, P170, DOI 10.4103/0972-5229.76079; BOLING EA, 1963, J APPL PHYSIOL, V18, P943, DOI 10.1152/jappl.1963.18.5.943; Darmon M, 2013, CRIT CARE, V17, DOI 10.1186/cc11937; EDELMAN IS, 1958, J CLIN INVEST, V37, P1236, DOI 10.1172/JCI103712; Freitag E, 2010, AUST CRIT CARE, V23, P197, DOI 10.1016/j.aucc.2010.04.003; Fried LF, 1997, MED CLIN N AM, V81, P585, DOI 10.1016/S0025-7125(05)70535-6; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Liamis G, 2006, NEPHROL DIAL TRANSPL, V21, P1564, DOI 10.1093/ndt/gfk090; Lindner G, 2008, NEPHROL DIAL TRANSPL, V23, P3501, DOI 10.1093/ndt/gfn476; Lindner G, 2013, J CRIT CARE, V28, P214, DOI 10.1016/j.jcrc.2012.11.017; Mallie JP, 2001, B ACAD NAT MED PARIS, V185, P119, DOI 10.1016/S0001-4079(19)34594-7; Mallie JP, 2001, B ACAD NATL MED, V185, P146; Nguyen Minhtri K, 2003, Clin Exp Nephrol, V7, P125, DOI 10.1007/s10157-003-0233-3; Polderman KH, 1999, CRIT CARE MED, V27, P1105, DOI 10.1097/00003246-199906000-00029; Ring T, 2006, KIDNEY INT, V69, P416, DOI 10.1038/sj.ki.5000126; ROSE BD, 1986, AM J MED, V81, P1033, DOI 10.1016/0002-9343(86)90401-8; Rose BD PT., 2001, CLIN PHYSL ACID BASE, P716; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207603	10.1371/journal.pone.0207603	http://dx.doi.org/10.1371/journal.pone.0207603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475894	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700043
J	Wasihun, AG; Dejene, TA; Teferi, M; Marugan, J; Negash, L; Yemane, D; McGuigan, KG				Wasihun, Araya Gebreyesus; Dejene, Tsehaye Asmelash; Teferi, Mekonen; Marugan, Javier; Negash, Letemichal; Yemane, Dejen; McGuigan, Kevin G.			Risk factors for diarrhoea and malnutrition among children under the age of 5 years in the Tigray Region of Northern Ethiopia	PLOS ONE			English	Article							SOLAR DISINFECTION; CHILDHOOD DIARRHEA; DRINKING-WATER; DETERMINANTS; PREVALENCE; MORBIDITY; UNDERNUTRITION; PREVENTION; SANITATION; NUTRITION	Background Diarrhoea and malnutrition are the leading cause of morbidity and mortality among children in areas with poor access to clean water, improved sanitation, and with low socioeconomic status. This study was designed to determine the prevalence of diarrhoea, malnutrition and risk factors among children aged 6-59 months in the Tigray Region of Northern Ethiopia. Methods A community based cross-sectional study design was conducted from June to August 2017 to assess the magnitude and factors associated with diarrhoea and malnutrition among children. A standardized questionnaire was used to collect data on diarrhoea, environmental, demographic and behavioural factors from 610 mother-child pairs. Anthropometric measurements were collected from the children. SPSS ver.21 statistical software was used for analysis. Factors associated with diarrhoea and nutritional status were identified using bivariate and multivariate logistic regression. A p-value. 0.05 was considered statistically significant. Results Of the 610 children monitored in this study, the incidence of diarrhoea among 6-59 month-old children in the two weeks preceding the day of the interview day was 27.2% (95% CI: 23.6-31%). Specifically, 35.9%, 9.7%, and 1.8% had 1-2, 3-4 and 5-6 times of diarrhoea episodes in a one year of time, respectively. The prevalence of stunting, underweight, wasting, and acute under-nutrition were 36.1% (95% CI: 31-38.6%), 37% (95% CI: 32-39.6%), 7.9% (95% CI: 5.5-9.7%), and 5.4% (95% CI: 3.8-7.4%), respectively. In a multivariate logistic regression analysis, type of drinking water source [AOR = 3.69; 95% CI: 2.03-6.71], mothers not hand washing at critical times [AOR = 15.42; 95% CI: 2.02-117.78], improper solid waste disposal [AOR = 12.81; 95% CI: 2.50-65.62], and child age (36-47 months) [AOR = 2.57; 95% CI: 1.45-4.55] were found to be predictors of diarrhoea. Being within the age range of 12-23 months was a predictor for wasting [AOR = 4.38; 95% CI: 1.61-11.90] and being underweight [AOR = 4.4; 95% CI: 1.7-11.2]. Similarly, the age range of 36-47 months was associated with wasting [AOR = 2.3; 95% CI: 1.45-3.85] and stunting [AOR = 1.7; 95% CI: 1.03-2.67]. Family size (less than 4) [AOR = 0.56; 95% CI: 0.368-0.959] was inversely associated for wasting. Conclusions Our study revealed that the problem of diarrhoea and malnutrition amongst 6-59 months children in the study area was significant. Access to clean water was the main problem in the study area. Hence, improving access to clean water and providing health education to mothers on personal and environmental hygiene, and proper waste disposal could improve diarrhoea in the study area. Intervention on children's nutrition should also be implemented to minimize the problem of malnutrition.	[Wasihun, Araya Gebreyesus; Dejene, Tsehaye Asmelash; Negash, Letemichal] Mekelle Univ, Dept Med Microbiol & Immunol, Coll Hlth Sci, Tigray, Ethiopia; [Dejene, Tsehaye Asmelash] Axum Univ, Dept Med Microbiol, Coll Hlth Sci, Tigray, Ethiopia; [Teferi, Mekonen] Mekelle Univ, Dept Biol, Coll Nat & Computat Sci, Tigray, Ethiopia; [Marugan, Javier] Univ Rey Juan Carlos, Dept Chem & Environm Technol, C Tulipan S-N, Madrid, Spain; [Yemane, Dejen] Mekelle Univ, Dept Environm Hlth, Sch Publ Hlth, Coll Hlth Sci, Tigray, Ethiopia; [McGuigan, Kevin G.] RCSI, Dept Physiol & Med Phys, Dublin 2, Ireland	Mekelle University; Mekelle University; Universidad Rey Juan Carlos; Mekelle University; Royal College of Surgeons - Ireland	Wasihun, AG (corresponding author), Mekelle Univ, Dept Med Microbiol & Immunol, Coll Hlth Sci, Tigray, Ethiopia.	araya13e25@gmail.com	Marugan, Javier/A-7370-2008; McGuigan, Kevin G/A-3656-2010; Tekle, Dejen/AAR-8865-2021	Marugan, Javier/0000-0003-1195-462X; McGuigan, Kevin G/0000-0002-3775-8339; Welekidan, letemichael Negash/0000-0003-0763-0841	European Project WATERSPOUTT H2020-Water-5c-2015 [688928]	European Project WATERSPOUTT H2020-Water-5c-2015	This work was funded by the European Project WATERSPOUTT H2020-Water-5c-2015 (GA 688928). The funder had no role in study design, data collection and analysis, decisions to publish, interpretation of the data and preparation of the manuscript for publication.	Abdiwahab Hashi, 2016, Open Journal of Preventive Medicine, V6, P233; Acharya A., 2008, ENV HLTH CHILD SURVI; Agustina R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-977; Ahmed SF, 2008, INT J HEALTH SCI-IJH, V2, P126; Amare D, 2007, ETHIOP J HEALTH DEV, V21, P2; Amare D., 2016, ADV PUBLIC HLTH, P1, DOI [DOI 10.1155/2016/7145708, 10.1155/2016/7145708]; [Anonymous], 2016, POPULATION HOUSING C; Anteneh A, 2010, ETHIOP J HLTH DEV, V24; Anteneh ZA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4021-5; Argaw H, 2007, HLTH EXTENSION PROGR, P3; Asfaw M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1370-9; Baker KK, 2014, AM J TROP MED HYG, V91, P181, DOI 10.4269/ajtmh.13-0509; Bezatu Mengistie, 2013, Open Journal of Preventive Medicine, V3, P446, DOI 10.4236/ojpm.2013.37060; Birke WA, 2008, E AFR J PUBLIC HLTH, V5, P193; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Central Statistical Authority and ORC Macro, 2011, ETH DEM GRAP; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Deshmukh P R, 2009, Indian J Med Sci, V63, P345; Dessalegn M, 2011, ETHIOP J HEALTH DEV, V25, P192; Diouf K, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24895; du Preez M, 2010, ENVIRON SCI TECHNOL, V44, P8744, DOI 10.1021/es103328j; Eduardo G, 2006, DIS CONTROL PRIORITI; Fentaw R, 2013, NUTR RES PRACT, V7, P122, DOI 10.4162/nrp.2013.7.2.122; Gebru T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-395; Gedefaw M, 2015, OPEN J EPIDEMIOLOGY, V5, P89, DOI DOI 10.4236/ojepi.2015.52012; Getaneh T, 1997, E AFR MED J, V74, P491; Gladstone BP, 2008, ARCH DIS CHILD, V93, P479, DOI 10.1136/adc.2006.114546; Godana W., 2013, SC J PUBLIC HLTH, V1, P119, DOI DOI 10.11648/J.SJPH.20130103.12; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Heller Léo, 2003, Rev. Soc. Bras. Med. Trop., V36, P41, DOI 10.1590/S0037-86822003000100007; Hoa N., 2009, NUTR STATUS DETERMIN, V8, DOI DOI 10.3923/PJN.2009.958.964; Hung BV., 2006, MASTER PHILOS INT CO; Joshi PC, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6355; Kazandjian S, 2009, BRAIN RES, V1247, P133, DOI 10.1016/j.brainres.2008.09.098; Lamirot A, 2017, INT J EQUITY HEALTH, V16, P11, DOI [10.1186/s12939-016-0502-x, DOI 10.1186/S12939-016-0502-X]; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luby SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001052; MARTORELL R, 1980, AM J CLIN NUTR, V33, P345, DOI 10.1093/ajcn/33.2.345; Masibo PK, 2012, PUBLIC HEALTH NUTR, V15, P1715, DOI 10.1017/S1368980012002856; Mazumder RN, 2000, BRIT J NUTR, V84, P775; McGuigan KG, 2011, ENVIRON SCI TECHNOL, V45, P7862, DOI 10.1021/es201313x; Mohammed A, 2016, SOUTH AFR J INFECT D, V31, P122, DOI 10.1080/23120053.2016.1156876; MOTARJEMI Y, 1993, B WORLD HEALTH ORGAN, V71, P79; Neumann CG, 2004, PEDIATR ANN, V33, P658, DOI 10.3928/0090-4481-20041001-09; Ngure FM, 2014, ANN NY ACAD SCI, V1308, P118, DOI 10.1111/nyas.12330; Root GPM, 2001, J HEALTH POPUL NUTR, V19, P73; Rose A, 2006, ARCH DIS CHILD, V91, P139, DOI 10.1136/adc.2005.077867; Shikur M, INT SCHOLARLY RES NO, V2014, DOI [10.1155/2014/654901, DOI 10.1155/2014/654901]; Shikur M, 2013, SCI J PUBLIC HLTH, V1, P102; Sinharoy SS, 2016, TROP MED INT HEALTH, V21, P956, DOI 10.1111/tmi.12725; Solomon Amsalu, 2008, Ethiopian Journal of Health Development, V22, P21; Sur D, 2004, J HEALTH POPUL NUTR, V22, P130; Tamiso A, 2013, SCI J PUBLIC HEALTH, V2, P243; Teklemariam S, 2000, ETHIOPIAN MED J, V38, P27; Teshome B, 2009, ETHIOP J HEALTH DEV, V23, P98; UNICEF, LEV TRENDS CHILD MOR; Vieira Graciete O., 2003, J. Pediatr. (Rio J.), V79, P449, DOI 10.1590/S0021-75572003000500013; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO, 2006, WHO CHILD GROWTH STA; Wilunda C, 2009, J HEALTH RES, V23, P17; Woldu W, 2016, TROP MED HEALTH, V44, DOI 10.1186/s41182-016-0040-7; Yimer G., 2000, Ethiopian Journal of Health Development, V14, P283	63	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207743	10.1371/journal.pone.0207743	http://dx.doi.org/10.1371/journal.pone.0207743			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475875	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700061
J	Navarro-Alvarez, N; Machaidze, Z; Schuetz, C; Zhu, A; Liu, WH; Shah, JA; Vagefi, PA; Elias, N; Buhler, L; Sachs, DH; Markmann, JF; Yeh, H				Navarro-Alvarez, Nalu; Machaidze, Zurab; Schuetz, Christian; Zhu, Alexander; Liu, Wei-hui; Shah, Jigesh A.; Vagefi, Parsia A.; Elias, Nahel; Buhler, Leo; Sachs, David H.; Markmann, James F.; Yeh, Heidi			Xenogeneic Heterotopic Auxiliary Liver transplantation (XHALT) promotes native liver regeneration in a Post-Hepatectomy Liver failure model	PLOS ONE			English	Article							MINIMUM GRAFT SIZE; COAGULATION-FACTORS; OXIDATIVE STRESS; SURVIVAL; XENOTRANSPLANTATION; BABOON; BRIDGE	The liver's regenerative capacity is unique, but too small a segment can overwhelm its ability to simultaneously regenerate and support the host, resulting in liver dysfunction and death. Here we tested a temporary Xenogeneic Heterotopic Auxiliary Liver Transplant (XHALT) from Gal-KO miniature swine in a baboon model of Post-Hepatectomy Liver Failure (PHLF) by 90%- hepatectomy. Immunosuppression consisted of CVF, ATG, FK 506 and steroids. 90%-hepatectomized animals died within 4-5 days with the clinical picture of PHLF, (high LFTs and bilirubin, ascites, encephalopathy and coagulopathy). The 10% remnants had macroscopic and histological evidence of severe steatosis and absence of hepatocyte replication. In contrast, the addition of XHALT prolonged survival up to 11 days, with the cause of death being sepsis, rather than liver failure. The remnant liver appeared grossly normal, and on histology, there was no evidence of fatty infiltration, but there was pronounced Ki-67 staining. In conclusion, temporary auxiliary xenografts have the potential to support a small for size liver graft while it grows to adequate size or provide an opportunity for organ recovery in acute liver failure.	[Navarro-Alvarez, Nalu; Machaidze, Zurab; Schuetz, Christian; Zhu, Alexander; Liu, Wei-hui; Shah, Jigesh A.; Vagefi, Parsia A.; Elias, Nahel; Sachs, David H.; Markmann, James F.; Yeh, Heidi] Harvard Med Sch, Ctr Transplantat Sci, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Buhler, Leo] Univ Geneva, Sch Med, Geneva, Switzerland	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Geneva	Yeh, H (corresponding author), Harvard Med Sch, Ctr Transplantat Sci, Massachusetts Gen Hosp, Boston, MA 02115 USA.	hyeh@partners.org	Navarro, Nalu/AAI-1034-2019; Elias, Nahel/AAO-8344-2020	Navarro, Nalu/0000-0003-0118-4676; Elias, Nahel/0000-0001-6466-7347; Buhler, Leo/0000-0002-9461-8498	Charles A. King Trust Postdoctoral Research Fellowship; Polsky Clinician-Scientist Award [222943]	Charles A. King Trust Postdoctoral Research Fellowship; Polsky Clinician-Scientist Award	This study was supported by The Charles A. King Trust Postdoctoral Research Fellowship (https://hria.org/tmf/king/) (NNA) and the Polsky Clinician-Scientist Award, fund #222943. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Akabayashi A, 2004, TRANSPLANTATION, V77, P634, DOI 10.1097/01.TP.0000115342.98226.7C; Ben-Haim M, 2001, LIVER TRANSPLANT, V7, P948, DOI 10.1053/jlts.2001.29033; Butler JR, 2015, INT J SURG, V23, P217, DOI 10.1016/j.ijsu.2015.07.684; Cheng YF, 2009, AM J TRANSPLANT, V9, P1382, DOI 10.1111/j.1600-6143.2009.02626.x; Coulon S, 2012, CYTOKINE, V59, P442, DOI 10.1016/j.cyto.2012.05.001; Ekser B, 2015, INT J SURG, V23, P240, DOI 10.1016/j.ijsu.2015.06.083; Ekser B, 2011, XENOTRANSPLANTATION, V18, P158, DOI 10.1111/j.1399-3089.2011.00642.x; Ekser B, 2009, TRANSPLANTATION, V88, P1041, DOI 10.1097/TP.0b013e3181ba0555; Gawrieh S, 2004, J INVEST MED, V52, P506, DOI 10.1136/jim-52-08-22; Golriz M, 2016, CLIN RES HEPATOL GAS, V40, P267, DOI 10.1016/j.clinre.2015.06.024; Hamano M, 2014, J GASTROENTEROL, V49, P305, DOI 10.1007/s00535-013-0780-7; Hara H, 2008, LIVER TRANSPLANT, V14, P425, DOI 10.1002/lt.21476; Hashikura Y, 2009, TRANSPLANTATION, V88, P110, DOI 10.1097/TP.0b013e3181aaccb0; Iwase H, 2015, XENOTRANSPLANTATION, V22, P302, DOI 10.1111/xen.12174; Kim K, 2012, XENOTRANSPLANTATION, V19, P256, DOI 10.1111/j.1399-3089.2012.00717.x; Kiuchi T, 2003, LIVER TRANSPLANT, V9, pS29, DOI 10.1053/jlts.2003.50198; Kolber-Simonds D, 2004, P NATL ACAD SCI USA, V101, P7335, DOI 10.1073/pnas.0307819101; Lo CM, 1999, TRANSPLANTATION, V68, P1112, DOI 10.1097/00007890-199910270-00009; Machaidze Z, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12297; MAKOWKA L, 1995, TRANSPLANTATION, V59, P1654, DOI 10.1097/00007890-199506270-00002; Marubashi S, 2016, LIVER TRANSPLANT, V22, P599, DOI 10.1002/lt.24388; Michalopoulos GK, 2014, EXPERT REV GASTROENT, V8, P897, DOI 10.1586/17474124.2014.934358; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Navarro-Alvarez N, 2016, AM J TRANSPLANT, V16, P1715, DOI 10.1111/ajt.13647; Olthoff KM, 2003, LIVER TRANSPLANT, V9, pS35, DOI 10.1053/jlts.2003.50229; Shah JA, 2017, AM J TRANSPLANT, V17, P2178, DOI 10.1111/ajt.14341; Shah JA, 2016, ANN SURG, V263, P1069, DOI 10.1097/SLA.0000000000001659; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462; Sumida Y, 2013, FREE RADICAL RES, V47, P869, DOI 10.3109/10715762.2013.837577; Wustefeld T, 2000, HEPATOLOGY, V32, P514, DOI 10.1053/jhep.2000.16604; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yeh H, 2014, XENOTRANSPLANTATION, V21, P454, DOI 10.1111/xen.12111	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207272	10.1371/journal.pone.0207272	http://dx.doi.org/10.1371/journal.pone.0207272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462716	Green Published, Green Submitted, gold			2022-12-26	WOS:000451054800050
J	Gas-Pascual, E; Ichikawa, HT; Sheikh, MO; Serji, MI; Deng, BW; Mandalasi, M; Bandini, G; Samuelson, J; Wells, L; West, CM				Gas-Pascual, Elisabet; Ichikawa, Hiroshi Travis; Sheikh, Mohammed Osman; Serji, Mariam Isabella; Deng, Bowen; Mandalasi, Msano; Bandini, Giulia; Samuelson, John; Wells, Lance; West, Christopher M.			CRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR/Cas; glycomics; Toxoplasma gondii; mass spectrometry (MS); parasitology; glycobiology; glycosyltransferase; glycan; glycogene; protein glycosylation	ASPARAGINE-LINKED GLYCANS; QUALITY-CONTROL; PLASMODIUM-FALCIPARUM; GONDII; PROTEIN; IDENTIFICATION; GLYCOSYLATION; DIVERSITY; SKP1; GLYCOPROTEIN	Infection with the protozoan parasite Toxoplasma gondii is a major health risk owing to birth defects, its chronic nature, ability to reactivate to cause blindness and encephalitis, and high prevalence in human populations. Unlike most eukaryotes, Toxoplasma propagates in intracellular parasitophorous vacuoles, but like nearly all other eukaryotes, Toxoplasma glycosylates many cellular proteins and lipids and assembles polysaccharides. Toxoplasma glycans resemble those of other eukaryotes, but species-specific variations have prohibited deeper investigations into their roles in parasite biology and virulence. The Toxoplasma genome encodes a suite of likely glycogenes expected to assemble N-glycans, O-glycans, a C-glycan, GPI-anchors, and polysaccharides, along with their precursors and membrane transporters. To investigate the roles of specific glycans in Toxoplasma, here we coupled genetic and glycomics approaches to map the connections between 67 glycogenes, their enzyme products, the glycans to which they contribute, and cellular functions. We applied a double-CRISPR/Cas9 strategy, in which two guide RNAs promote replacement of a candidate gene with a resistance gene; adapted MS-based glycomics workflows to test for effects on glycan formation; and infected fibroblast monolayers to assess cellular effects. By editing 17 glycogenes, we discovered novel Glc(0-2)-Man(6)-GlcNAc(2)-type N-glycans, a novel HexNAc-GalNAc-mucin-type O-glycan, and Tn-antigen; identified the glycosyltransferases for assembling novel nuclear O-Fuc-type and cell surface Glc-Fuc-type O-glycans; and showed that they are important for in vitro growth. The guide sequences, editing constructs, and mutant strains are freely available to researchers to investigate the roles of glycans in their favorite biological processes.	[Gas-Pascual, Elisabet; Ichikawa, Hiroshi Travis; Serji, Mariam Isabella; Deng, Bowen; Mandalasi, Msano; Wells, Lance; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, 120 E Green St,Davison Life Sci B129, Athens, GA 30602 USA; [Gas-Pascual, Elisabet; Deng, Bowen; Mandalasi, Msano; West, Christopher M.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Sheikh, Mohammed Osman; Wells, Lance; West, Christopher M.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Bandini, Giulia; Samuelson, John] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Ichikawa, Hiroshi Travis] Univ Georgia, New Mat Inst, Athens, GA 30602 USA; [Serji, Mariam Isabella] George Washington Univ, Sch Publ Hlth, Washington, DC 20009 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Boston University; University System of Georgia; University of Georgia; George Washington University	West, CM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 120 E Green St,Davison Life Sci B129, Athens, GA 30602 USA.	westcm@uga.edu	Bandini, Giulia/ABC-4413-2021	Wells, Lance/0000-0003-4956-5363; Sheikh, Mohammed/0000-0002-9481-8318; Mandalasi, Msano/0000-0002-5906-7387; Deng, Bowen/0000-0003-1423-4302; Bandini, Giulia/0000-0002-8885-3643	National Institutes of Health Common Fund [5R21 AI123161]; National Institutes of Health [R01-GM037539, R01-GM084383, P41-GM103490, 8P41-GM103390]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI123161, T32AI060546, R01AI110638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084383, P41GM103490, P41GM103390, R01GM037539] Funding Source: NIH RePORTER	National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health Common Fund to Promote the Glycosciences (Grant 5R21 AI123161) and received additional support from National Institutes of Health Grants R01-GM037539 (to C. M. W.), R01-GM084383 (to C. M. W.), P41-GM103490 (to L. W., senior investigator), and 8P41-GM103390 (Resource for Integrated Glycotechnology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; ALMEIDA IC, 1994, BIOCHEM J, V304, P793, DOI 10.1042/bj3040793; Alvarez-Manilla G, 2010, J PROTEOME RES, V9, P2062, DOI 10.1021/pr8007489; Anish C, 2014, CHEM BIOL, V21, P38, DOI 10.1016/j.chembiol.2014.01.002; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Aspinall TV, 2002, J INFECT DIS, V185, P1637, DOI 10.1086/340577; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Azzouz N, 2002, INT J PARASITOL, V32, P677, DOI 10.1016/S0020-7519(02)00009-7; Azzouz N, 2006, INT J BIOCHEM CELL B, V38, P1914, DOI 10.1016/j.biocel.2006.05.006; Baatz H, 2006, OCUL IMMUNOL INFLAMM, V14, P185, DOI 10.1080/09273940600659740; Bandini G., 2018, BIORXIV, DOI [10.1101/382515, DOI 10.1101/382515]; Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Bandini G, 2012, MOL MICROBIOL, V85, P513, DOI 10.1111/j.1365-2958.2012.08124.x; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Blader IJ, 2015, ANNU REV MICROBIOL, V69, P463, DOI 10.1146/annurev-micro-091014-104100; Blume M, 2015, CELL HOST MICROBE, V18, P210, DOI 10.1016/j.chom.2015.07.008; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Botte C, 2008, J LIPID RES, V49, P746, DOI 10.1194/jlr.M700476-JLR200; Bullard Whitney, 2014, J Biol Chem, V289, P20273, DOI 10.1074/jbc.M114.579821; Bushkin GG, 2012, MBIO, V3, DOI 10.1128/mBio.00258-12; Bushkin GG, 2010, EUKARYOT CELL, V9, P228, DOI 10.1128/EC.00197-09; Caffaro CE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003331; Coppin A, 2005, J MOL EVOL, V60, P257, DOI 10.1007/s00239-004-0185-6; Cova M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22441-3; Cova M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0949-z; Damerow S, 2010, J BIOL CHEM, V285, P878, DOI 10.1074/jbc.M109.067223; DANNEMANN B, 1992, ANN INTERN MED, V116, P33, DOI 10.7326/0003-4819-116-1-33; de Macedo CS, 2010, MEM I OSWALDO CRUZ, V105, P949, DOI 10.1590/S0074-02762010000800001; Debierre-Grockiego F, 2010, J BIOL CHEM, V285, P32744, DOI 10.1074/jbc.M110.137588; Esko Jeffrey D., 2017, ESSENTIALS GLYCOBIOL, V3rd; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Fauquenoy Sylvain, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M111.008953; Feasley CL, 2015, GLYCOCONJUGATE J, V32, P345, DOI 10.1007/s10719-015-9592-8; Feasley Christa L, 2013, Methods Mol Biol, V983, P205, DOI 10.1007/978-1-62703-302-2_11; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garenaux E, 2008, BIOCHEMISTRY-US, V47, P12270, DOI 10.1021/bi801090a; Ghiselli G, 2017, MED RES REV, V37, P1051, DOI 10.1002/med.21429; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Haserick JR, 2017, MOL CELL PROTEOMICS, V16, pS42, DOI [10.1074/mcp.M116.066035, 10.1074/mcp.m116.066035]; Heimburg-Molinaro J, 2013, INT J PARASITOL, V43, P901, DOI 10.1016/j.ijpara.2013.05.012; Hoppe CM, 2018, GLYCOBIOLOGY, V28, P333, DOI 10.1093/glycob/cwy013; Hutter Julia, 2015, Methods Mol Biol, V1331, P1, DOI 10.1007/978-1-4939-2874-3_1; Hykollari A, 2014, ELECTROPHORESIS, V35, P2116, DOI 10.1002/elps.201300612; Imada M, 2010, PARASITOL INT, V59, P206, DOI 10.1016/j.parint.2010.01.007; Katlama C, 1996, CLIN INFECT DIS, V22, P268, DOI 10.1093/clinids/22.2.268; Khurana S., 2018, BIORXIV, DOI [10.1101/391623, DOI 10.1101/391623]; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Koeller CM, 2014, EUKARYOT CELL, V13, P1312, DOI 10.1128/EC.00165-14; KOZULIC B, 1979, ANAL BIOCHEM, V94, P36, DOI 10.1016/0003-2697(79)90786-3; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lobo-Rojas AE, 2016, PARASITOL INT, V65, P472, DOI 10.1016/j.parint.2016.06.008; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long SJ, 2016, INFECT IMMUN, V84, P1262, DOI 10.1128/IAI.01173-15; Lopaticki S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00571-y; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Luk FCY, 2008, MOL BIOCHEM PARASIT, V157, P169, DOI 10.1016/j.molbiopara.2007.10.012; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; Masuishi Y, 2016, J PROTEOMICS, V139, P77, DOI 10.1016/j.jprot.2016.03.008; Niehus S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085386; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; Rahman K, 2017, J BIOL CHEM, V292, P18644, DOI 10.1074/jbc.M117.809301; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; Rodrigues JA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005169; Saha S, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00521-17; Saito T, 2002, INT J PARASITOL, V32, P961, DOI 10.1016/S0020-7519(02)00059-0; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Samuelson J, 2015, SEMIN CELL DEV BIOL, V41, P121, DOI 10.1016/j.semcdb.2014.11.008; Samuelson J, 2013, EUKARYOT CELL, V12, P1578, DOI 10.1128/EC.00213-13; Sanz S, 2013, J BIOL CHEM, V288, P16506, DOI 10.1074/jbc.M112.439828; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Seron K, 2000, EUR J BIOCHEM, V267, P6571, DOI 10.1046/j.1432-1327.2000.01749.x; Shams-Eldin H, 2005, MOL BIOCHEM PARASIT, V143, P6, DOI 10.1016/j.molbiopara.2005.04.008; Shcherbakova A, 2017, P NATL ACAD SCI USA, V114, P2574, DOI 10.1073/pnas.1613165114; Sheikh MO, 2017, J BIOL CHEM, V292, P18897, DOI 10.1074/jbc.M117.809160; Shen B, 2017, METHODS MOL BIOL, V1498, P79, DOI 10.1007/978-1-4939-6472-7_6; Shukla A, 2018, INT J PARASITOL, V48, P955, DOI 10.1016/j.ijpara.2018.05.013; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Stwora-Wojczyk MM, 2004, ARCH BIOCHEM BIOPHYS, V426, P231, DOI 10.1016/j.abb.2004.02.013; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Sugi T, 2017, MBIO, V8, DOI [10.1128/mBio.01289-17, 10.1128/mbio.01289-17]; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Tachibana K, 2006, GLYCOBIOLOGY, V16, P46, DOI 10.1093/glycob/cwj038; Tomita T, 2017, MBIO, V8, DOI [10.1128/mBio.02048-16, 10.1128/mbio.02048-16]; Tomita T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003823; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; Tyrrell BE, 2017, CRIT REV MICROBIOL, V43, P521, DOI 10.1080/1040841X.2016.1242868; Uboldi AD, 2015, CELL HOST MICROBE, V18, P670, DOI 10.1016/j.chom.2015.11.004; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150561; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; West C. M., 2017, ESSENTIALS GLYCOBIOL; West C. M., 2005, DICTYOSTELIUM GENOMI, P235; West CM, 2015, CURR OPIN MICROBIOL, V26, P41, DOI 10.1016/j.mib.2015.04.006; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Yang T, 2010, BIOCHEM J, V430, P275, DOI 10.1042/BJ20100315; Yang T, 2010, BIOCHEM J, V429, P533, DOI 10.1042/BJ20100238; Zentella R, 2017, NAT CHEM BIOL, V13, P479, DOI [10.1038/NCHEMBIO.2320, 10.1038/nchembio.2320]; Zinecker CF, 1998, MOL BIOCHEM PARASIT, V97, P241, DOI 10.1016/S0166-6851(98)00136-4	111	29	29	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1104	1125		10.1074/jbc.RA118.006072	http://dx.doi.org/10.1074/jbc.RA118.006072			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30463938	Green Published, hybrid			2022-12-26	WOS:000457879500004
J	Miao, K; Zhang, X; Su, SM; Zeng, JM; Huang, ZB; Chan, UI; Xu, XL; Deng, CX				Miao, Kai; Zhang, Xin; Su, Sek Man; Zeng, Jianming; Huang, Zebin; Chan, Un In; Xu, Xiaoling; Deng, Chu-Xia			Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor receptor (FGFR); CRISPR/Cas; gene therapy; genetic disease; bone	MOUSE MODEL; GENOME; EFFICIENT; DISEASE; GROWTH; MUSCLE	CRISPR/Cas9 is a powerful technology widely used for genome editing, with the potential to be used for correcting a wide variety of deleterious disease-causing mutations. However, the technique tends to generate more indels (insertions and deletions) than precise modifications at the target sites, which might not resolve the mutation and could instead exacerbate the initial genetic disruption. We sought to develop an improved protocol for CRISPR/Cas9 that would correct mutations without unintended consequences. As a case study, we focused on achondroplasia, a common genetic form of dwarfism defined by missense mutation in the Fgfr3 gene that results in glycine to arginine substitution at position 374 in mice in fibroblast growth factor receptor 3 (Fgfr3-G374R), which corresponds to G380R in humans. First, we designed a GFP reporter system that can evaluate the cutting efficiency and specificity of single guide RNAs (sgRNAs). Using the sgRNA selected based on our GFP reporter system, we conducted targeted therapy of achondroplasia in mice. We found that we achieved higher frequency of precise correction of the Fgfr3-G374R mutation using Cas9 protein rather than Cas9 mRNA. We further demonstrated that targeting oligos of 100 and 200 nucleotides precisely corrected the mutation at equal efficiency. We showed that our strategy completely suppressed phenotypes of achondroplasia and whole genome sequencing detected no off-target effects. These data indicate that improved protocols can enable the precise CRISPR/Cas9-mediated correction of individual mutations with high fidelity.	[Miao, Kai; Zhang, Xin; Su, Sek Man; Zeng, Jianming; Huang, Zebin; Chan, Un In; Xu, Xiaoling; Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Canc Ctr, Macau, Peoples R China; [Miao, Kai; Su, Sek Man; Zeng, Jianming; Huang, Zebin; Xu, Xiaoling; Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Ctr Precis Med Res & Training, Macau, Peoples R China; [Zhang, Xin; Chan, Un In; Xu, Xiaoling] Univ Macau, Fac Hlth Sci, Transgen & Knockout Core, Macau, Peoples R China	University of Macau; University of Macau; University of Macau	Xu, XL; Deng, CX (corresponding author), Univ Macau, Fac Hlth Sci, Canc Ctr, Macau, Peoples R China.; Xu, XL; Deng, CX (corresponding author), Univ Macau, Fac Hlth Sci, Ctr Precis Med Res & Training, Macau, Peoples R China.; Xu, XL (corresponding author), Univ Macau, Fac Hlth Sci, Transgen & Knockout Core, Macau, Peoples R China.	xiaolingx@umac.mo; cxdeng@umac.mo			University of Macau, Macau SAR, China [2016-00088-FHS]; Macao Science and Technology Development Fund (FDCT) Grants [065/2015/A2, 094/2015/A3, 027/2015/A1, 111/2017/A]	University of Macau, Macau SAR, China; Macao Science and Technology Development Fund (FDCT) Grants	This work was supported by a Chair Professor Grant (to C. D.) and multi-year research Grant (MYRG) 2016-00088-FHS (to X. X.) by the University of Macau, Macau SAR, China, Macao Science and Technology Development Fund (FDCT) Grants 065/2015/A2, 094/2015/A3 (to C. D.), 027/2015/A1 (to X. X.), and 111/2017/A (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	BELLUS GA, 1995, AM J HUM GENET, V56, P368; Chen S, 2016, INT J BIOL SCI, V12, P1427, DOI 10.7150/ijbs.17421; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui YB, 2018, INTERDISCIP SCI, V10, P455, DOI 10.1007/s12539-018-0298-z; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kim ST, 2018, NAT METHODS, V15, P239, DOI [10.1038/NMETH.4554, 10.1038/nmeth.4554]; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Lareau CA, 2018, NAT METHODS, V15, P238, DOI [10.1038/NMETH.4541, 10.1038/nmeth.4541]; Lescarbeau RM, 2018, NAT METHODS, V15, P237, DOI [10.1038/NMETH.4553, 10.1038/nmeth.4553]; Listgarten J, 2018, NAT BIOMED ENG, V2, P38, DOI 10.1038/s41551-017-0178-6; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Luther DC, 2018, EXPERT OPIN DRUG DEL, V15, P905, DOI 10.1080/17425247.2018.1517746; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091507; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nutter LMJ, 2018, NAT METHODS, V15, P234, DOI 10.1038/NMETH.4559; Ornitz DM, 2017, DEV DYNAM, V246, P291, DOI 10.1002/dvdy.24479; Ou ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32463; Rastogi A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1143-1; STOILOV I, 1995, AM J MED GENET, V55, P127, DOI 10.1002/ajmg.1320550132; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Wang Jian-min, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P537; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wilson CJ, 2018, NAT METHODS, V15, P235, DOI [10.1038/NMETH.4552, 10.1038/nmeth.4552, 10.1038/nmeth.4559]; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yao X, 2018, DEV CELL, V45, P526, DOI 10.1016/j.devcel.2018.04.021; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	34	8	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1142	1151		10.1074/jbc.RA118.006496	http://dx.doi.org/10.1074/jbc.RA118.006496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30487289	hybrid, Green Published			2022-12-26	WOS:000457879500007
J	Shioi, N; Tadokoro, T; Shioi, S; Okabe, Y; Matsubara, H; Kita, S; Ose, T; Kuroki, K; Terada, S; Maenaka, K				Shioi, Narumi; Tadokoro, Takashi; Shioi, Seijiro; Okabe, Yuki; Matsubara, Haruki; Kita, Shunsuke; Ose, Toyoyuki; Kuroki, Kimiko; Terada, Shigeyuki; Maenaka, Katsumi			Crystal structure of the complex between venom toxin and serum inhibitor from Viperidae snake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; crystal structure; snake venom; inhibitor; serum; protein complex	ANTIHEMORRHAGIC FACTOR; CDNA CLONING; PROTEIN; PROSTATE; MODEL; MICROSEMINOPROTEIN; METALLOPROTEINASE; IDENTIFICATION; SEQUENCE; BETA	Venomous snakes have endogenous proteins that neutralize the toxicity of their venom components. We previously identified five small serum proteins (SSP-1-SSP-5) from a highly venomous snake belonging to the family Viperidae as inhibitors of various toxins from snake venom. The endogenous inhibitors belong to the prostate secretory protein of 94 amino acids (PSP94) family. SSP-2 interacts with triflin, which is a member of the cysteine-rich secretory protein (CRISP) family that blocks smooth muscle contraction. However, the structural basis for the interaction and the biological roles of these inhibitors are largely unknown. Here, we determined the crystal structure of the SSP-2-triflin complex at 2.3 A resolution. A concave region centrally located in the N-terminal domain of triflin is fully occupied by the terminal beta-strands of SSP-2. SSP-2 does not bind tightly to the C-terminal cysteine-rich domain of triflin; this domain is thought to be responsible for its channel-blocker function. Instead, the cysteine-rich domain is tilted 7.7 degrees upon binding to SSP-2, and the inhibitor appears to sterically hinder triflin binding to calcium channels. These results help explain how an endogenous inhibitor prevents the venomous protein from maintaining homeostasis in the host. Furthermore, this interaction also sheds light on the binding interface between the human homologues PSP94 and CRISP-3, which are up-regulated in prostate and ovarian cancers.	[Shioi, Narumi; Okabe, Yuki; Terada, Shigeyuki] Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 19-1,8 Chome Nanakuma, Fukuoka, Fukuoka 8140180, Japan; [Tadokoro, Takashi; Matsubara, Haruki; Kita, Shunsuke; Ose, Toyoyuki; Kuroki, Kimiko; Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan; [Shioi, Seijiro] Fukuoka Univ, Radioisotope Ctr, Fukuoka, Fukuoka 8140180, Japan	Fukuoka University; Hokkaido University; Fukuoka University	Shioi, N (corresponding author), Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 19-1,8 Chome Nanakuma, Fukuoka, Fukuoka 8140180, Japan.; Tadokoro, T; Maenaka, K (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	anarumi@fukuoka-u.ac.jp; tadokorot@pharm.hokudai.ac.jp; maenaka@pharm.hokudai.ac.jp	Ose, Toyoyuki/AAW-7821-2020	Ose, Toyoyuki/0000-0002-2001-9388; maenaka, katsumi/0000-0002-5459-521X; Kita, Shunsuke/0000-0003-3969-302X	NMR Facility Yokohama Institute, RIKEN; Central Research Institute of Fukuoka University [131042]; Female Researcher Support Programme of Fukuoka University; JSPS KAKENHI [22121007]; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED [18am0101093j0002]; Hokkaido University; Global Facility Center (GFC); Pharma Science Open Unit (PSOU) - MEXT; Hokkaido University Biosurface Project; Takeda Science Foundation	NMR Facility Yokohama Institute, RIKEN; Central Research Institute of Fukuoka University; Female Researcher Support Programme of Fukuoka University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED; Hokkaido University; Global Facility Center (GFC); Pharma Science Open Unit (PSOU) - MEXT; Hokkaido University Biosurface Project; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the NMR Facility Yokohama Institute, RIKEN, to provide insight into structural information of the SSP-2-triflin complex. This work was supported in part by the Central Research Institute of Fukuoka University Grant 131042 and supported by the Female Researcher Support Programme of Fukuoka University (to N.S.). This work was partly supported by JSPS KAKENHI Grant 22121007, Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant 18am0101093j0002, Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU), funded by MEXT under "Support Program for Implementation of New Equipment Sharing System," Hokkaido University Biosurface Project, and Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki N, 2008, GENE, V426, P7, DOI 10.1016/j.gene.2008.08.021; Aoki N, 2008, BBA-PROTEINS PROTEOM, V1784, P621, DOI 10.1016/j.bbapap.2007.12.010; Aoki N, 2007, BIOCHEM BIOPH RES CO, V359, P330, DOI 10.1016/j.bbrc.2007.05.091; Asmann YW, 2002, CANCER RES, V62, P3308; Breed AA, 2013, BBA-GEN SUBJECTS, V1830, P3019, DOI 10.1016/j.bbagen.2013.01.015; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deshimaru M, 2005, TOXICON, V46, P937, DOI 10.1016/j.toxicon.2005.09.003; Dunn RD, 2001, BBA-MOL CELL BIOL L, V1533, P29, DOI 10.1016/S1388-1981(01)00138-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghasriani H, 2009, BIOCHEM BIOPH RES CO, V378, P235, DOI 10.1016/j.bbrc.2008.11.040; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grande G, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9142-4; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Hansson K, 2009, TOXICON, V54, P128, DOI 10.1016/j.toxicon.2009.03.023; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2010, J MOL BIOL, V397, P947, DOI 10.1016/j.jmb.2010.02.035; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Ma J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.64; Masuda S, 2001, EUR J BIOCHEM, V268, P3339, DOI 10.1046/j.1432-1327.2001.02246.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; Shioi N, 2015, J BIOCHEM, V158, P37, DOI 10.1093/jb/mvv017; Shioi N, 2014, BIOSCI BIOTECH BIOCH, V78, P410, DOI 10.1080/09168451.2014.890030; Suzuki N, 2008, ACTA CRYSTALLOGR D, V64, P1034, DOI 10.1107/S0907444908023512; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whitaker HC, 2010, PROSTATE, V70, P333, DOI 10.1002/pros.21059; YAMAKAWA Y, 1992, J BIOCHEM-TOKYO, V112, P583, DOI 10.1093/oxfordjournals.jbchem.a123944; Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023; Yamazaki Y, 2002, EUR J BIOCHEM, V269, P2708, DOI 10.1046/j.1432-1033.2002.02940.x; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224	35	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1250	1256		10.1074/jbc.RA118.006840	http://dx.doi.org/10.1074/jbc.RA118.006840			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504218	Green Published, hybrid			2022-12-26	WOS:000457879500016
J	Humaidan, D; Breinig, F; Helms, V				Humaidan, Dania; Breinig, Frank; Helms, Volkhard			Adding phosphorylation events to the core oscillator driving the cell cycle of fission yeast	PLOS ONE			English	Article							REGULATES MITOTIC ENTRY; TRANSCRIPTION FACTOR; KINASE; EXPRESSION; PROMOTES; DOMAIN; ROLES; ONSET; G(1)	Much is known about the regulatory elements controlling the cell cycle in fission yeast (Schizosaccharomyces pombe). This regulation is mainly done by the (cyclin-dependent kinase/cyclin) complex (Cdc2/Cdc13) that activates specific target genes and proteins via phosphorylation events during the cell cycle in a time-dependent manner. However, more work is still needed to complement the existing gaps in the current fission yeast gene regulatory network to be able to overcome abnormalities in its growth, repair and development, i.e. explain many phenomena including mitotic catastrophe. In this work we complement the previously presented core oscillator of the cell cycle of fission yeast by selected phosphorylation events and study their effects on the temporal evolution of the core oscillator based Boolean network. Thereby, we attempt to establish a regulatory link between the autonomous cell cycle oscillator and the remainder of the cell. We suggest the unclear yet regulatory effect of phosphorylation on the added components, and discuss many unreported points regarding the temporal evolution of the cell cycle and its components. To better visualize the results regardless of the programming background we developed an Android application that can be used to run the core and extended model of the fission yeast cell cycle step by step.	[Humaidan, Dania; Helms, Volkhard] Saarland Univ, Ctr Bioinformat, Saarbrucken, Germany; [Breinig, Frank] Saarland Univ, Mol & Cell Biol, Saarbrucken, Germany; [Breinig, Frank] Saarland Univ, Ctr Human & Mol Biol, Saarbrucken, Germany; [Humaidan, Dania] Tubingen Univ, Dept Comp Sci, Chair Cognit Modeling, Tubingen, Germany	Saarland University; Saarland University; Saarland University; Eberhard Karls University of Tubingen	Humaidan, D (corresponding author), Saarland Univ, Ctr Bioinformat, Saarbrucken, Germany.; Humaidan, D (corresponding author), Tubingen Univ, Dept Comp Sci, Chair Cognit Modeling, Tubingen, Germany.	dania.humaidan@uni-tuebingen.de	/AHE-2458-2022	Breinig, Frank/0000-0003-1557-4691; Humaidan, Dania/0000-0003-1381-257X; Helms, Volkhard/0000-0002-2180-9154	DAAD (German Academic Exchange Service) scholarship [57214223]; DAAD (German Academic Exchange Service) scholarship	DAAD (German Academic Exchange Service) scholarship; DAAD (German Academic Exchange Service) scholarship	Dania Humaidan was supported by a DAAD (German Academic Exchange Service) scholarship, funding program ID: 57214223.; DH was supported by a DAAD (German Academic Exchange Service) scholarship.	Bandyopadhyay S, 2014, EUKARYOT CELL, V13, P813, DOI 10.1128/EC.00059-14; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; CorreaBordes J, 1997, EMBO J, V16, P4657, DOI 10.1093/emboj/16.15.4657; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Davidich MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071786; Ewald JC, 2016, MOL CELL, V62, P532, DOI 10.1016/j.molcel.2016.02.017; Garcia-Garcia T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00184; Gerard C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004056; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; Morgan L., 2018, LETT BIOMATHEMATICS, V5, P113, DOI [10.1080/23737867.2018.1456366, DOI 10.1080/23737867.2018.1456366]; Ng SS, 2001, FEBS LETT, V503, P131, DOI 10.1016/S0014-5793(01)02720-X; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Shimada M, 2008, EMBO J, V27, P132, DOI 10.1038/sj.emboj.7601949; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SIMANIS V, 1989, J CELL SCI, V92, P51; Simonetti F., 2017, THESIS; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Swaffer MP, 2016, CELL, V167, P1750, DOI 10.1016/j.cell.2016.11.034; Tanaka K, 2000, MOL BIOL CELL, V11, P2845, DOI 10.1091/mbc.11.9.2845; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Zhao G, 2016, MOL CELL, V62, P546, DOI 10.1016/j.molcel.2016.04.026	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208515	10.1371/journal.pone.0208515	http://dx.doi.org/10.1371/journal.pone.0208515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513113	Green Published, gold, Green Submitted			2022-12-26	WOS:000452204800037
J	Tobi, D				Tobi, Dror			Dynamics based clustering of globin family members	PLOS ONE			English	Article							HUMAN HEMOGLOBIN; PROTEIN DYNAMICS; ALLOSTERIC TRANSITIONS; LIGAND-BINDING; BETA-SUBUNITS; TRUNCATED HEMOGLOBIN; QUATERNARY STRUCTURE; DOMAIN MOTIONS; ALIGNMENT; ALPHA	A methodology to cluster proteins based on their dynamics' similarity is presented. For each pair of proteins from a dataset, the structures are superimposed, and the Anisotropic Network Model modes of motions are calculated. The twelve slowest modes from each protein are matched using a local mode alignment algorithm based on the local sequence alignment algorithm of Smith-Waterman. The dynamical similarity distance matrix is calculated based on the top scoring matches of each pair and the proteins are clustered using a hierarchical clustering algorithm. The utility of this method is exemplified on a dataset of protein chains from the globin family and a dataset of tetrameric hemoglobins. The results demonstrate the effect of the quaternary structure of globin members on their intrinsic dynamics and show good ability to distinguish between different states of hemoglobin, revealing the dynamical relations between them.	[Tobi, Dror] Ariel Univ, Dept Mol Biol, Ariel, Israel; [Tobi, Dror] Ariel Univ, Dept Comp Sci, Ariel, Israel	Ariel University; Ariel University	Tobi, D (corresponding author), Ariel Univ, Dept Mol Biol, Ariel, Israel.; Tobi, D (corresponding author), Ariel Univ, Dept Comp Sci, Ariel, Israel.	drorto@ariel.ac.il	Tobi, Dror/V-5384-2019	Tobi, Dror/0000-0002-1125-2751				Aharoni R, 2018, PROTEINS, V86, P1176, DOI 10.1002/prot.25598; Altman R B, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P19; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Balog E, 2011, J PHYS CHEM B, V115, P6811, DOI 10.1021/jp108493g; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Birukou I, 2011, BIOCHEMISTRY-US, V50, P7361, DOI 10.1021/bi200923k; Chong KT, 1999, ACTA CRYSTALLOGR D, V55, P1291, DOI 10.1107/S0907444999005934; Dasgupta J, 2003, BIOCHEM BIOPH RES CO, V303, P619, DOI 10.1016/S0006-291X(03)00379-6; Dawson NL, 2017, NUCLEIC ACIDS RES, V45, pD289, DOI 10.1093/nar/gkw1098; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Doruker P, 2003, PROTEINS, V53, P174, DOI 10.1002/prot.10486; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esquerra RM, 2000, BIOPHYS J, V78, P3227, DOI 10.1016/S0006-3495(00)76859-7; Eyal E, 2007, BIOINFORMATICS, V23, pI175, DOI 10.1093/bioinformatics/btm186; Falzone CJ, 2002, J MOL BIOL, V324, P1015, DOI 10.1016/S0022-2836(02)01093-8; Fan JS, 2013, BIOCHEMISTRY-US, V52, P5809, DOI 10.1021/bi4005683; Lucas MF, 2012, BIOPHYS J, V102, P887, DOI 10.1016/j.bpj.2012.01.011; Fuglebakk E, 2015, BBA-GEN SUBJECTS, V1850, P911, DOI 10.1016/j.bbagen.2014.09.021; Gell DA, 2018, BLOOD CELL MOL DIS, V70, P13, DOI 10.1016/j.bcmd.2017.10.006; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gur M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816375; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hasegawa T, 2011, IUBMB LIFE, V63, P188, DOI 10.1002/iub.429; Hensen U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033931; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Hinsen K, 1999, PROTEINS, V34, P369, DOI 10.1002/(SICI)1097-0134(19990215)34:3<369::AID-PROT9>3.0.CO;2-F; HOLM L, 1993, FEBS LETT, V315, P301, DOI 10.1016/0014-5793(93)81183-Z; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Ilari A, 2007, ARCH BIOCHEM BIOPHYS, V457, P85, DOI 10.1016/j.abb.2006.09.033; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P6101, DOI 10.1021/bi047813a; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kleinekathofer U, 2011, J PHYS CHEM A, V115, P7267, DOI 10.1021/jp2005088; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168; LANCZOS C, 1950, J RES NAT BUR STAND, V45, P255, DOI 10.6028/jres.045.026; Lepeshkevich SV, 2004, BIOCHEMISTRY-US, V43, P1675, DOI 10.1021/bi034928q; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Lu MY, 2005, BIOPHYS J, V89, P2395, DOI 10.1529/biophysj.105.065904; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; Maguid S, 2005, BIOPHYS J, V89, P3, DOI 10.1529/biophysj.104.053041; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Meireles L, 2011, PROTEIN SCI, V20, P1645, DOI 10.1002/pro.711; Micheletti C, 2013, PHYS LIFE REV, V10, P1, DOI 10.1016/j.plrev.2012.10.009; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Munz M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-188; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P79, DOI 10.1016/B978-0-12-407693-8.00003-0; Pesce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066144; Ponzoni L, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0177; Qiu Y, NON TRADITIONAL REF; Ramanathan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015827; Schumacher MA, 1997, P NATL ACAD SCI USA, V94, P7841, DOI 10.1073/pnas.94.15.7841; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Storz JF, 2013, MOL PHYLOGENET EVOL, V66, P469, DOI 10.1016/j.ympev.2012.07.013; Tame JRH, 2000, ACTA CRYSTALLOGR D, V56, P805, DOI 10.1107/S0907444900006387; Tiwari SP, 2018, CURR OPIN STRUC BIOL, V50, P75, DOI 10.1016/j.sbi.2017.12.001; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tobi D, 2017, PROTEINS, V85, P1507, DOI 10.1002/prot.25311; Tobi D, 2013, PROTEINS, V81, P1910, DOI 10.1002/prot.24335; Tobi D, 2012, PROTEINS, V80, P1167, DOI 10.1002/prot.24017; Xu CY, 2003, J MOL BIOL, V333, P153, DOI 10.1016/j.jmb.2003.08.027; Yi J, 2011, BIOCHEMISTRY-US, V50, P8323, DOI 10.1021/bi2009322; Zen A, 2008, PROTEIN SCI, V17, P918, DOI 10.1110/ps.073390208; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zheng WJ, 2009, CURR PROTEIN PEPT SC, V10, P128, DOI 10.2174/138920309787847608; Zhuravlev PI, 2010, Q REV BIOPHYS, V43, P295, DOI 10.1017/S0033583510000119	79	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208465	10.1371/journal.pone.0208465	http://dx.doi.org/10.1371/journal.pone.0208465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513111	Green Submitted, Green Published, gold			2022-12-26	WOS:000452204800033
J	Bustillos, H; Leer, K; Kitten, A; Reveles, KR				Bustillos, Hannah; Leer, Kelsey; Kitten, Amanda; Reveles, Kelly R.			A cross-sectional study of national outpatient gastric acid suppressant prescribing in the United States between 2009 and 2015	PLOS ONE			English	Article							PROTON PUMP INHIBITOR; CLOSTRIDIUM-DIFFICILE INFECTION; RECEPTOR ANTAGONIST USE; RISK; DEMENTIA; PATTERNS; THERAPY; TRENDS	Purpose Gastric acid suppressants are commonly used in the United States, and while generally well-tolerated, long-term use has been associated with infection, bone fractures, and nutrient malabsorption. The purpose of this study was to describe national trends in gastric acid suppressant use over a 7-year period. Methods This was a cross-sectional study using data from the National Ambulatory Medical Care Survey from 2009 to 2015. Gastric acid suppressant use was defined as any outpatient visit with a documented prescription for a proton pump inhibitor or histamine-2 receptor antagonist documented during the outpatient visit. Sample data weights were used to extrapolate to national estimates. Use was calculated as the number of prescriptions per total outpatient visits per year. Appropriateness of prescribing was assessed using FDA-approved indications listed in each visit. Results These data represent 6.8 billion patient outpatient visits between 2009 and 2015, of which nearly 600 million (8.8%) had documented gastric acid suppressant use. The median (IQR) age of gastric acid suppressant users and non-gastric acid suppressant users was 62 (5073) and 49 (25-65), respectively. Gastric acid suppressant use decreased from 9.0% in 2009 to 7.7% in 2012, and then increased to 9.7% in 2015. Proton pump inhibitor use was slightly higher in the Midwest (8.3%). Only 15.8% of gastric acid suppressant users had a documented indication. Conclusions Proton pump inhibitor use increased after 2012, and the majority of gastric acid suppressant users did not have a documented indication. Judicious gastric acid suppressant prescribing needs to be exercised, especially in the context of new safety data regarding long-term proton pump inhibitor use.	[Bustillos, Hannah; Leer, Kelsey; Kitten, Amanda; Reveles, Kelly R.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Bustillos, Hannah; Leer, Kelsey; Kitten, Amanda; Reveles, Kelly R.] Univ Texas Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Reveles, KR (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.; Reveles, KR (corresponding author), Univ Texas Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA.	kdaniels46@utexas.edu	Reveles, Kelly/AAI-1575-2021					Boghossian TA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011969.pub2; Burdsall DP, 2013, J AM MED DIR ASSOC, V14, P429, DOI 10.1016/j.jamda.2013.01.021; Centers for Disease Control and Prevention, AMB HLTH CAR DAT; Centers for Disease Control and Prevention, NAT AMB MED CAR SURV; Cheung KS, 2018, GUT, V67, P28, DOI 10.1136/gutjnl-2017-314605; Delcher A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141779; Faden HS, 2016, CLIN PEDIATR, V55, P712, DOI 10.1177/0009922815604596; Friedenberg FK, 2010, DIGEST DIS SCI, V55, P1911, DOI 10.1007/s10620-009-1004-0; Gray SL, 2011, J AM GERIATR SOC, V59, P251, DOI 10.1111/j.1532-5415.2010.03275.x; Haenisch B, 2015, EUR ARCH PSY CLIN N, V265, P419, DOI 10.1007/s00406-014-0554-0; Halfdanarson OO, 2018, THER ADV GASTROENTER, V11, DOI 10.1177/1756284818777943; Harrison SL, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0704-8; Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Kim Judith, 2018, Curr Gastroenterol Rep, V20, P27, DOI 10.1007/s11894-018-0632-y; Kwok CS, 2012, AM J GASTROENTEROL, V107, P1011, DOI 10.1038/ajg.2012.108; Lam JR, 2013, JAMA-J AM MED ASSOC, V310, P2435, DOI 10.1001/jama.2013.280490; Lazarus B, 2016, JAMA INTERN MED, V176, P238, DOI 10.1001/jamainternmed.2015.7193; Nishtala PS, 2015, INTERN MED J, V45, P624, DOI 10.1111/imj.12757; Othman F, 2016, PHARMACOEPIDEM DR S, V25, P1079, DOI 10.1002/pds.4043; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Rotman SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056060; Thomas L, 2010, J MANAGE CARE PHARM, V16, P122, DOI 10.18553/jmcp.2010.16.2.122; U.S. Food and Drug Administration, FDA DRUG SAF COMM CL; US Food and Drug Administration, FDA DRUG SAF COMM PO; van der Pol R, 2014, JAMA PEDIATR, V168, P947, DOI 10.1001/jamapediatrics.2014.1273; Zhou B, 2016, OSTEOPOROSIS INT, V27, P339, DOI 10.1007/s00198-015-3365-x; Zirk-Sadowski J, 2018, J AM GERIATR SOC, V66, P1332, DOI 10.1111/jgs.15385	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208461	10.1371/journal.pone.0208461	http://dx.doi.org/10.1371/journal.pone.0208461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC6AO	30500865	Green Published, Green Submitted, gold			2022-12-26	WOS:000451883700038
J	Rossettini, G; Palese, A; Geri, T; Fiorio, M; Colloca, L; Testa, M				Rossettini, Giacomo; Palese, Alvisa; Geri, Tommaso; Fiorio, Mirta; Colloca, Luana; Testa, Marco			Physical therapists' perspectives on using contextual factors in clinical practice: Findings from an Italian national survey	PLOS ONE			English	Article							LOW-BACK-PAIN; PLACEBO INTERVENTIONS; STANDARDIZED PATIENTS; THERAPEUTIC ALLIANCE; PATIENT EXPECTATIONS; QUESTIONNAIRE SURVEY; INFORMED-CONSENT; MANUAL THERAPY; PRIMARY-CARE; MANAGEMENT	Background Contextual factors (CFs) represent a potential therapeutic tool to boost physiotherapy outcomes, triggering placebo effects. Nevertheless, no evidence about the use of CFs among physical therapists is currently available. Objective To investigate the use of CFs and the opinion of Italian physical therapists specialized in Orthopaedic Manual Therapy (OMTs) on their therapeutic benefits. Design An exploratory cross-sectional online survey. Methods A 17-item questionnaire and 2 clinical vignettes assessed the perspective of OMTs on the adoption of CFs in daily clinical practice. The target population was composed of 906 OMTs. An online survey was performed in 2016 using SurveyMonkey Software. Data were analyzed by descriptive and inferential statistics. Results A total of 558 volunteers (61.6% of the target OMT population) participated in the study. Half of the participants (52.0%) claimed to use CFs frequently in their practice. More of 50% of OMTs valued the therapeutic significance of CFs for different health problems as determined by a combined psychological and physiological effect. OMTs considered the use of CFs ethically acceptable when they exert beneficial therapeutic effects and their effectiveness has emerged in previous clinical experiences (30.6%). They disagreed on the adoption of CFs when they are deceptive (14.1%). Moreover, OMTs did not communicate the adoption of CFs to patients (38.2%), and CFs were usually used in addition to other interventions to optimize clinical responses (19.9%). Psychological mechanisms, patient's expectation and conditioning were believed to be the main components behind CFs (7.9%). Limitations Considering that the data collected were self-reported and retrospective, recall and response biases may limit the internal and external validity of the findings. Conclusions OMTs used CFs in their clinical practice and believed in their therapeutic effect. The knowledge of CFs, placebo and nocebo mechanisms and their clinical effects should be included in physical therapists' university studies.	[Rossettini, Giacomo; Geri, Tommaso; Testa, Marco] Univ Genova Campus Savona, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Savona, Italy; [Palese, Alvisa] Univ Udine, Dept Med & Biol Sci, Udine, Italy; [Fiorio, Mirta] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Colloca, Luana] Univ Maryland, Sch Nursing, Dept Pain Translat Symptom Sci, Baltimore, MD 21201 USA; [Colloca, Luana] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Colloca, Luana] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Colloca, Luana] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA	University of Udine; University of Verona; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Testa, M (corresponding author), Univ Genova Campus Savona, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Savona, Italy.	marco.testa@unige.it	Palese, Alvisa/J-9427-2015; Geri, Tommaso/AAJ-2669-2021	Palese, Alvisa/0000-0002-3508-844X; Geri, Tommaso/0000-0001-9198-900X; Rossettini, Giacomo/0000-0002-1623-7681; Testa, Marco/0000-0001-8643-7200; Fiorio, Mirta/0000-0002-6356-0211				A.I.FI, 2017, ECCO CENSIMENTO AIFI; A.I.FI, 2008, FORMAZIONE CORE FISI; Babel P, 2013, MED PRIN PRACT, V22, P484, DOI 10.1159/000351563; Baghcheghi N, 2011, NURS ETHICS, V18, P364, DOI 10.1177/0969733011398093; Baldwin MJ, 2016, BMC SURG, V16, DOI 10.1186/s12893-016-0142-5; Beeton K, 2008, ED STANDARDS ORTHOPA; Bentley M, 2016, J ADV NURS, V72, P1991, DOI 10.1111/jan.12929; Berthelot JM, 2001, JOINT BONE SPINE, V68, P65, DOI 10.1016/S1297-319X(00)00225-6; Bialosky JE, 2017, J MAN MANIP THER, V25, P115, DOI 10.1080/10669817.2017.1309344; Bialosky JE, 2014, J PAIN, V15, P136, DOI 10.1016/j.jpain.2013.10.005; Bishop MD, 2015, PAIN MANAG, V5, P455, DOI 10.2217/pmt.15.39; Bishop MD, 2013, J ORTHOP SPORT PHYS, V43, P457, DOI 10.2519/jospt.2013.4492; Bishop MD, 2011, J MAN MANIP THER, V19, P20, DOI 10.1179/106698110X12804993426929; Blease C, 2016, BIOETHICS, V30, P407, DOI 10.1111/bioe.12245; Bologna Working Group, 2005, FRAM QUAL EUR HIGH E; Brunner E, 2016, CLIN REHABIL, V30, P85, DOI 10.1177/0269215515570499; Carlino E, 2016, NEUROSCIENCE, V338, P19, DOI 10.1016/j.neuroscience.2016.01.053; Carlino E, 2014, NAT REV RHEUMATOL, V10, P348, DOI 10.1038/nrrheum.2014.17; Carvalho C, 2016, PAIN, V157, P2766, DOI 10.1097/j.pain.0000000000000700; Colloca L, 2015, AM J BIOETHICS, V15, P17, DOI 10.1080/15265161.2015.1074314; Converse L, 2015, J GEN INTERN MED, V30, P586, DOI 10.1007/s11606-015-3365-8; de Leeuw E. D., 2008, INT HDB SURVEY METHO; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Ferreira PH, 2013, PHYS THER, V93, P470, DOI 10.2522/ptj.20120137; Fuentes J, 2014, PHYS THER, V94, P477, DOI 10.2522/ptj.20130118; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Hammond R, 2016, PHYSIOTHERAPY, V102, P71, DOI 10.1016/j.physio.2015.04.002; Harris CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142804; Hassan Tabinda, 2011, Int J Health Sci (Qassim), V5, P45; Horing B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01079; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hush JM, 2011, PHYS THER, V91, P25, DOI 10.2522/ptj.20100061; Kampermann L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178719; Kermen R, 2010, FAM MED, V42, P636; Ladeira CE, 2017, J ORTHOP SPORT PHYS, V47, P347, DOI 10.2519/jospt.2017.6561; Lau C, 2016, PHYS THER, V96, P469, DOI 10.2522/ptj.20150117; Li LC, 2001, PHYS THER, V81, P1018, DOI 10.1093/ptj/81.4.1018; Linde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092938; Lipsitt DR, 2015, HARVARD REV PSYCHIAT, V23, P438, DOI 10.1097/HRP.0000000000000055; Lorenzetti RC, 2013, AM FAM PHYSICIAN, V87, P419; Lucassen P, 2016, SCAND J PRIM HEALTH, V34, P428, DOI 10.1080/02813432.2016.1249065; Meissner K, 2012, FAM PRACT, V29, P79, DOI 10.1093/fampra/cmr045; Miciak Maxi, 2018, Arch Physiother, V8, P3, DOI 10.1186/s40945-018-0044-1; Miciak M, 2012, SCAND J CARING SCI, V26, P394, DOI 10.1111/j.1471-6712.2011.00923.x; National Statistical Service, 2017, SAMPL SIZ CALC; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; O'Keeffe M, 2016, PHYS THER, V96, P609, DOI 10.2522/ptj.20150240; Ortiz R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-011012; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peek K, 2017, DISABIL REHABIL, V39, P1932, DOI 10.1080/09638288.2016.1212281; Petrilli CM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006578; Philbrick Jodi L., 2015, Medical Reference Services Quarterly, V34, P181, DOI 10.1080/02763869.2015.1019324; R Development Core Team, 2015, LANG ENV STAT COMP; Raz A, 2011, CAN J PSYCHIAT, V56, P198, DOI 10.1177/070674371105600403; Revelle William, 2020, CRAN; Riley SP, 2015, MANUAL THER, V20, P469, DOI 10.1016/j.math.2014.11.011; Rossettini G, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-1943-8; Rossettini G, 2016, WORK, V54, P159, DOI 10.3233/WOR-162289; Sahoo D, 2016, INT J HEALTH CARE Q, V29, P600, DOI 10.1108/IJHCQA-05-2015-0068; Schmidt WC, 1997, BEHAV RES METH INS C, V29, P274, DOI 10.3758/BF03204826; Scholte M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-266; Shah Kartik N, 2009, Indian J Med Sci, V63, P472, DOI 10.4103/0019-5359.57640; Shermon R, 2008, J GEN INTERN MED, V23, P7, DOI 10.1007/s11606-007-0332-z; Siminoff LA, 2011, PATIENT EDUC COUNS, V82, P318, DOI 10.1016/j.pec.2011.01.021; Testa M, 2016, MANUAL THER, V24, P65, DOI 10.1016/j.math.2016.04.006; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Unver S, 2013, AGRI, V25, P156, DOI 10.5505/agri.2013.82621; Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520; Vijapura S, 2016, ACAD PSYCHIATR, V40, P783, DOI 10.1007/s40596-015-0470-2; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wager TD, 2015, NAT REV NEUROSCI, V16, P403, DOI 10.1038/nrn3976; Wartolowska K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091699; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zadeh R, 2015, HERD-HEALTH ENV RES, V8, P58, DOI 10.1177/1937586715586393	80	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208159	10.1371/journal.pone.0208159	http://dx.doi.org/10.1371/journal.pone.0208159			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC6AO	30500838	Green Published, gold			2022-12-26	WOS:000451883700025
J	Guardia-Olmos, J; Gudayol-Ferre, E; Gallardo-Moreno, GB; Martinez-Ricart, M; Pero-Cebollero, M; Gonzalez-Garrido, AA				Guardia-Olmos, Joan; Gudayol-Ferre, Esteve; Gallardo-Moreno, Geisa B.; Martinez-Ricart, Mar; Pero-Cebollero, Maribel; Gonzalez-Garrido, Andres A.			Complex systems representing effective connectivity in patients with Type One diabetes mellitus	PLOS ONE			English	Article							HUMAN RED NUCLEUS; WORKING-MEMORY; BASAL GANGLIA; RESTING-STATE; FUNCTIONAL CONNECTIVITY; COGNITIVE PERFORMANCE; PREFRONTAL CORTEX; BRAIN ACTIVATION; YOUNG-CHILDREN; CEREBELLUM	Background Type 1 diabetes mellitus (T1D) affects the entire cellular network of the organism. Some patients develop cognitive disturbances due to the disease, but several authors have suggested that the brain develops compensatory mechanisms to minimize or prevent neuropsychological decline. The present study aimed to assess the effective connectivity underlying visuospatial working memory performance in young adults diagnosed with T1D using neuroimaging techniques (fMRI). Methods Fifteen T1D right-handed, young adults with sustained metabolic clinical stability and a control group matched by age, sex, and educational level voluntarily participated. All participants performed 2 visuospatial working memory tasks using a block design within an MRI scanner. Regions of interest and their signal values were obtained. Effective connectivity-by means of structural equations models-was evaluated for each group and task through maximum likelihood estimation, and the model with the best fit was chosen in each case. Results Compared to the control group, the patient group showed a significant reduction in brain activity in the two estimated networks (one for each group and task). The models of effective connectivity showed greater brain connectivity in healthy individuals, as well as a more complex network. T1D patients showed a pattern of connectivity mainly involving the cerebellum and the red nucleus. In contrast, the control group showed a connectivity network predominantly involving brain areas that are typically activated while individuals are performing working memory tasks. Conclusion Our results suggest a specific effective connectivity between the cerebellum and the red nucleus in T1D patients during working memory tasks, probably reflecting a compensatory mechanism to fulfill task demands.	[Guardia-Olmos, Joan; Pero-Cebollero, Maribel] Univ Barcelona, Inst Neurociencies, Fac Psicol, Inst Complex Syst UBICS, Barcelona, Spain; [Gudayol-Ferre, Esteve] Univ Michoacana, Fac Psicol, Francisco, Michoacan, Mexico; [Gallardo-Moreno, Geisa B.; Gonzalez-Garrido, Andres A.] Univ Guadalajara, Inst Neurociencias, Guadalajara, Jalisco, Mexico; [Martinez-Ricart, Mar] Univ Barcelona, Fac Psicol, Barcelona, Spain	University of Barcelona; Universidad Michoacana de San Nicolas de Hidalgo; Universidad de Guadalajara; University of Barcelona	Guardia-Olmos, J (corresponding author), Univ Barcelona, Inst Neurociencies, Fac Psicol, Inst Complex Syst UBICS, Barcelona, Spain.	jguardia@ub.edu	González-Garrido, Andrés A./T-3044-2019; Gallardo-Moreno, Geisa B/K-3070-2017; Peró-Cebollero, Maribel/K-2987-2017; GUARDIA-OLMOS, JOAN/K-6306-2017	González-Garrido, Andrés A./0000-0003-4594-5270; Gallardo-Moreno, Geisa B/0000-0001-5457-354X; Peró-Cebollero, Maribel/0000-0002-8793-5284; GUARDIA-OLMOS, JOAN/0000-0002-4275-9184	Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya; Grup de Recerca en Tecniques Estadistiques Avancades Aplicades a la Psicologia (GTEAAP);  [PSI2013-41400-P]	Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya(Generalitat de Catalunya); Grup de Recerca en Tecniques Estadistiques Avancades Aplicades a la Psicologia (GTEAAP); 	This study was funded by the Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya and the Grup de Recerca en Tecniques Estadistiques Avancades Aplicades a la Psicologia (GTEAAP). This research was made possible by the PSI2013-41400-P project and was carried out by members of the Generalitat de Catalunya's 2014 SGR 326 Consolidated Research Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Agencia de Gestio d'Ajuts Universitaris i de Recerca de la Generalitat de Catalunya and the Grup de Recerca en Tecniques Estadistiques Avancades Aplicades a la Psicologia (GTEAAP). This research was made possible by the PSI2013-41400-P project and was carried out by members of the Generalitat de Catalunya's 2014 SGR 326 Consolidated Research Group.	Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; Ashby FG, 2005, J COGNITIVE NEUROSCI, V17, P1728, DOI 10.1162/089892905774589271; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baier B, 2014, ANN NEUROL, V76, P754, DOI 10.1002/ana.24272; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Belger A, 1998, HUM BRAIN MAPP, V6, P14, DOI 10.1002/(SICI)1097-0193(1998)6:1<14::AID-HBM2>3.0.CO;2-O; Bergmann HC, 2016, COGN PROCESS, V17, P377, DOI 10.1007/s10339-016-0772-7; Bettencourt KC, 2016, NAT NEUROSCI, V19, P150, DOI 10.1038/nn.4174; Blasetti A, 2011, J CHILD NEUROL, V26, P1383, DOI 10.1177/0883073811406730; Bolo NR, 2011, DIABETES, V60, P3256, DOI 10.2337/db11-0506; Brismar T, 2007, PSYCHONEUROENDOCRINO, V32, P1041, DOI 10.1016/j.psyneuen.2007.08.002; Cato MA, 2014, J INT NEUROPSYCH SOC, V20, P238, DOI 10.1017/S1355617713001434; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Clark BJ, 2016, NEUROBIOL LEARN MEM, V133, P69, DOI 10.1016/j.nlm.2016.06.002; Cooray GK, 2011, CLIN NEUROPHYSIOL, V122, P1943, DOI 10.1016/j.clinph.2011.03.007; Ferguson SC, 2005, DIABETES CARE, V28, P1431, DOI 10.2337/diacare.28.6.1431; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Gallardo-Moreno GB, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/703512; Guardia-Olmos J, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00019; Guardia-Olmos J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178172; Habas C, 2007, NEURORADIOLOGY, V49, P777, DOI 10.1007/s00234-007-0260-y; Habas C, 2006, NEURORADIOLOGY, V48, P755, DOI 10.1007/s00234-006-0117-9; Habas C, 2010, CEREBELLUM, V9, P167, DOI 10.1007/s12311-009-0145-1; Hannonen R, 2003, DEV MED CHILD NEUROL, V45, P262, DOI 10.1017/S0012162203000501; Hautzel H, 2009, NEUROIMAGE, V47, P2073, DOI 10.1016/j.neuroimage.2009.06.005; Hirata K, 2015, J NUCL MED, V56, P1206, DOI 10.2967/jnumed.114.152504; Hughes TM, 2013, J DIABETES COMPLICAT, V27, P558, DOI 10.1016/j.jdiacomp.2013.07.001; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; J_oreskog K.G., 1984, LISREL 6 USERS GUIDE, Vthird; Japee S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00023; Libby LA, 2014, J NEUROSCI, V34, P14233, DOI 10.1523/JNEUROSCI.0655-14.2014; Ly TT, 2011, DIABETES CARE, V34, P2192, DOI 10.2337/dc11-0697; Lyoo IK, 2009, ARCH GEN PSYCHIAT, V66, P878, DOI 10.1001/archgenpsychiatry.2009.86; Marzelli MJ, 2014, DIABETES, V63, P343, DOI 10.2337/db13-0179; Massat I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049392; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Molinari M, 2008, CEREBELLUM, V7, P611, DOI 10.1007/s12311-008-0060-x; Naguib JM, 2009, J PEDIATR PSYCHOL, V34, P271, DOI 10.1093/jpepsy/jsn074; Nioche C, 2009, AM J NEURORADIOL, V30, P396, DOI 10.3174/ajnr.A1375; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Posner J, 2016, NEUROPSYCHOPHARMACOL, V41, P1759, DOI 10.1038/npp.2015.342; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Ryan CM, 2016, AM PSYCHOL, V71, P563, DOI 10.1037/a0040455; Saggar M, 2017, DIABETES, V66, P754, DOI 10.2337/db16-0414; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tupola S, 2004, EUR J PEDIATR, V163, P335, DOI 10.1007/s00431-004-1434-9; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van Duinkerken E, 2016, PSYCHOSOM MED, V78, P740, DOI 10.1097/PSY.0000000000000335; van Duinkerken E, 2016, HUM BRAIN MAPP, V37, P1194, DOI 10.1002/hbm.23096; van Duinkerken E, 2012, DIABETES, V61, P1814, DOI 10.2337/db11-1358; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wessels AM, 2006, DIABETES, V55, P334, DOI 10.2337/diabetes.55.02.06.db05-0680; Zhang J, 2014, J NEUROSCI, V34, P14919, DOI 10.1523/JNEUROSCI.1165-14.2014	55	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208247	10.1371/journal.pone.0208247	http://dx.doi.org/10.1371/journal.pone.0208247			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496324	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800115
J	Inomura, K; Bragg, J; Riemann, L; Follows, MJ				Inomura, Keisuke; Bragg, Jason; Riemann, Lasse; Follows, Michael J.			A quantitative model of nitrogen fixation in the presence of ammonium	PLOS ONE			English	Article							AZOTOBACTER-VINELANDII; ACETYLENE-REDUCTION; RESPIRATORY PROTECTION; DINITROGEN FIXATION; CONTINUOUS CULTURES; OXYGEN; CARBON; RATES; DENITRIFICATION; RHIZOSPHERE	Nitrogen fixation provides bioavailable nitrogen, supporting global ecosystems and influencing global cycles of other elements. It provides an additional source of nitrogen to organisms at a cost of lower growth efficiency, largely due to respiratory control of intra-cellular oxygen. Nitrogen-fixing bacteria can, however, utilize both dinitrogen gas and fixed nitrogen, decreasing energetic costs. Here we present an idealized metabolic model of the heterotrophic nitrogen fixer Azotobacter vinelandii which, constrained by laboratory data, provides quantitative predictions for conditions under which the organism uses either ammonium or nitrogen fixation, or both, as a function of the relative supply rates of carbohydrate, fixed nitrogen as well as the ambient oxygen concentration. The model reveals that the organism respires carbohydrate in excess of energetic requirements even when nitrogen fixation is inhibited and respiratory protection is not essential. The use of multiple nitrogen source expands the potential niche and range for nitrogen fixation. The model provides a quantitative framework which can be employed in ecosystem and biogeochemistry models.	[Inomura, Keisuke; Follows, Michael J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Bragg, Jason] Royal Bot Gardens & Domain Trust, Natl Herbarium New South Wales, Sydney, NSW, Australia; [Riemann, Lasse] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Inomura, Keisuke] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	Massachusetts Institute of Technology (MIT); University of Copenhagen; University of Washington; University of Washington Seattle	Inomura, K (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.; Inomura, K (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	ki24@uw.edu	Riemann, Lasse/J-7091-2014; Bragg, Jason/P-7675-2019	Riemann, Lasse/0000-0001-9207-2543; Bragg, Jason/0000-0002-7621-7295	Japan Student Service Organization [L11171020001]; Danish Council for Independent Research [6108-00013]; Simons Foundation [544338, 329108]; National Science Foundation [OCE-1558702]; Gordon and Betty Moore Foundation [3778]	Japan Student Service Organization; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Simons Foundation; National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was funded by the Japan Student Service Organization, L11171020001, K.I., http://www.jasso.go.jp/en/; Danish Council for Independent Research, 6108-00013, L.R., https://dff.dk/en/front-page?set_language=en; the Simons Foundation, 544338, K.I., and 329108, M.J.F., https://www.simonsfoundation.org/; National Science Foundation, OCE-1558702, M.J.F., https:// www.nsf.gov/;, and the Gordon and Betty Moore Foundation, GBMF#3778, M.J.F., https://www.moore.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benavides M, 2018, FRONT MAR SCI, V5, DOI [10.3389/fmars.2018.00043, DOI 10.3389/FMARS.2018.00043]; Benavides M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143775; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; Bentzon-Tilia M, 2015, MBIO, V6, DOI 10.1128/mBio.00929-15; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Bertics VJ, 2010, MAR ECOL PROG SER, V409, P1, DOI 10.3354/meps08639; Bonnet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081265; BUHLER T, 1987, ARCH MICROBIOL, V148, P247, DOI 10.1007/BF00414820; BUHLER T, 1987, ARCH MICROBIOL, V148, P242, DOI 10.1007/BF00414819; Capone D. G., 1988, NITROGEN CYCLING COA, P85; CAPONE DG, 1982, MAR ECOL PROG SER, V10, P67, DOI 10.3354/meps010067; CASSELMAN ME, 1981, SOIL SCI SOC AM J, V45, P51, DOI 10.2136/sssaj1981.03615995004500010012x; Currin CA, 1996, ESTUAR COAST SHELF S, V42, P597, DOI 10.1006/ecss.1996.0039; DALTON H, 1968, J GEN MICROBIOL, V54, P463, DOI 10.1099/00221287-54-3-463; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Dutkiewicz S., 2014, BIOGEOSCI DISCUSS, V11, P7113, DOI [10.5194/bgd-11-7113-2014, DOI 10.5194/BGD-11-7113-2014]; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Farnelid H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019223; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Fu FX, 2003, FEMS MICROBIOL ECOL, V45, P203, DOI 10.1016/S0168-6496(03)00157-0; GALLON JR, 1981, TRENDS BIOCHEM SCI, V6, P19, DOI 10.1016/0968-0004(81)90008-6; Grosskopf T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00236; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; HAINES JR, 1981, APPL ENVIRON MICROB, V41, P412, DOI 10.1128/AEM.41.2.412-421.1981; HANSON RB, 1977, APPL ENVIRON MICROB, V33, P846, DOI 10.1128/AEM.33.4.846-852.1977; HEIJNEN JJ, 1981, BIOTECHNOL BIOENG, V23, P739, DOI 10.1002/bit.260230407; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Hopkinson CS, 2005, NATURE, V433, P142, DOI 10.1038/nature03191; Inomura K, 2017, ISME J, V11, P166, DOI 10.1038/ismej.2016.97; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Klawonn I, 2015, ISME J, V9, P1456, DOI 10.1038/ismej.2014.232; Knapp AN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00374; KUHLA J, 1988, J BACTERIOL, V170, P5325, DOI 10.1128/jb.170.11.5325-5329.1988; KUHLA J, 1988, ARCH MICROBIOL, V149, P509, DOI 10.1007/BF00446753; LAANE C, 1980, EUR J BIOCHEM, V103, P39, DOI 10.1111/j.1432-1033.1980.tb04286.x; LAWS EA, 1989, DEEP-SEA RES, V36, P103, DOI 10.1016/0198-0149(89)90021-6; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; MURRY MA, 1989, ARCH MICROBIOL, V151, P469, DOI 10.1007/BF00454860; Noar JD, 2018, MICROBIOL-SGM, V164, P421, DOI 10.1099/mic.0.000643; Oelze J, 2000, FEMS MICROBIOL REV, V24, P321, DOI 10.1111/j.1574-6976.2000.tb00545.x; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Paerl RW, 2018, AQUAT MICROB ECOL, V81, P125, DOI 10.3354/ame01867; Peschek GA, 1991, PLANT SOIL, V48, P411; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Rahav E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00227; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; Rittmann BE., 2001, ENV BIOTECHNOLOGY PR, P126; ROBSON RL, 1980, ANNU REV MICROBIOL, V34, P183, DOI 10.1146/annurev.mi.34.100180.001151; Staal M, 2003, NATURE, V425, P504, DOI 10.1038/nature01999; Stukel MR, 2014, BIOGEOSCIENCES, V11, P3259, DOI 10.5194/bg-11-3259-2014; Turk-Kubo KA, 2014, ENVIRON MICROBIOL, V16, P3095, DOI 10.1111/1462-2920.12346; Voss M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020127; Wang D, 2017, ISME J, V11, P1602, DOI 10.1038/ismej.2017.30; WANG ZC, 1985, BIOCHEMISTRY-US, V24, P214, DOI 10.1021/bi00322a031; Welsh DT, 1996, MAR BIOL, V125, P619, DOI 10.1007/BF00349243; WILLIAMS PM, 1980, OCEANOL ACTA, V3, P471	60	28	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208282	10.1371/journal.pone.0208282	http://dx.doi.org/10.1371/journal.pone.0208282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496286	gold, Green Submitted, Green Published			2022-12-26	WOS:000451763800127
J	Chowdhury, P; Sahuc, ME; Rouille, Y; Riviere, C; Bonneau, N; Vandeputte, A; Brodin, P; Goswami, M; Bandyopadhyay, T; Dubuisson, J; Seron, K				Chowdhury, Pritom; Sahuc, Marie-Emmanuelle; Rouille, Yves; Riviere, Celine; Bonneau, Natacha; Vandeputte, Alexandre; Brodin, Priscille; Goswami, Manoranjan; Bandyopadhyay, Tanoy; Dubuisson, Jean; Seron, Karin			Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture	PLOS ONE			English	Article							INFECTION; GREEN; LOCALIZATION; REPLICATION; THERAPY; PROTEIN; SYSTEM	The treatment of hepatitis C virus (HCV) infection by combination of direct acting antivirals (DAA), with different mode of action, has made substantial progress in the past few years. However, appearance of resistance and high cost of the therapy is still an obstacle in the achievement of the therapy, more specifically in developing countries. In this context, search for affordable antivirals with new mechanisms of action is still needed. Tea, after water, is the most popular drink worldwide. Polyphenols extracted from green tea have already shown anti-HCV activity as entry inhibitors. Here, three different theaflavins, theaflavin (TF1), theaflavin-3'-monogallate (TF2), and theaflavin-3-3'-digallate (TF3), which are major polyphenols from black tea, were tested against HCV in cell culture. The results showed that all theaflavins inhibit HCV infection in a dose-dependent manner in an early step of infection. Results obtained with HCV pseudotyped virions confirmed their activity on HCV entry and demonstrated their pan-genotypic action. No effect on HCV replication was observed by using HCV replicon. Investigation on the mechanism of action of black tea theaflavins showed that they act directly on the virus particle and are able to inhibit cell-to-cell spread. Combination study with inhibitors most widely used in anti-HCV treatment regimen demonstrated that TF3 exerts additive effect. In conclusion, theaflavins, that are present in high quantity in black tea, are new inhibitors of HCV entry and hold promise for developing in therapeutic arsenal for HCV infection.	[Chowdhury, Pritom; Sahuc, Marie-Emmanuelle; Rouille, Yves; Vandeputte, Alexandre; Brodin, Priscille; Dubuisson, Jean; Seron, Karin] Univ Lille, CNRS, INSERM, CHU Lille,Inst Pasteur Lille,Ctr Infect & Immun L, Lille, France; [Chowdhury, Pritom; Bandyopadhyay, Tanoy] TRA, Tocklai Tea Res Inst, Dept Biotechnol, Jorhat, Assam, India; [Riviere, Celine; Bonneau, Natacha] Univ Lille, Univ Artois, INRA, Univ Littoral Cote Opale,ICV,ISA, Lille, France; [Goswami, Manoranjan] TRA, Tocklai Tea Res Inst, Dept Biochem, Jorhat, Assam, India	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; INRAE; Universite d'Artois; Universite de Lille - ISITE; Universite de Lille	Seron, K (corresponding author), Univ Lille, CNRS, INSERM, CHU Lille,Inst Pasteur Lille,Ctr Infect & Immun L, Lille, France.	karin.seron@ibl.cnrs.fr	Brodin, Priscille/E-5802-2014; Dubuisson, Jean/E-6813-2016; Seron, Karin/O-8481-2016	Brodin, Priscille/0000-0003-0991-7344; Rouille, Yves/0000-0003-0788-9271; Dubuisson, Jean/0000-0003-1626-7693; Seron, Karin/0000-0002-9667-133X; Riviere, Celine/0000-0002-8618-5530	European Community (ERC-STG INTRACELLTB) [260901]; Agence Nationale de la Recherche [ANR-10-EQPX-04-01]; Feder [12001407]; Region Nord Pas de Calais [12000080]; Department of Health Research, Ministry of Health and Family welfare, Government of India	European Community (ERC-STG INTRACELLTB); Agence Nationale de la Recherche(French National Research Agency (ANR)); Feder(European Commission); Region Nord Pas de Calais(Region Hauts-de-FranceEuropean Commission); Department of Health Research, Ministry of Health and Family welfare, Government of India	PB and AV received support from the European Community (ERC-STG INTRACELLTB Grant no 260901), the Agence Nationale de la Recherche (ANR-10-EQPX-04-01), the Feder (12001407 (D-AL) Equipex Imaginex BioMed) and the Region Nord Pas de Calais (convention no 12000080). PC received a post-doctoral overseas training fellowship from Department of Health Research, Ministry of Health and Family welfare, Government of India.	Ashfaq UA, 2014, WORLD J GASTROENTERO, V20, P2941, DOI 10.3748/wjg.v20.i11.2941; Asselah T, 2018, LIVER INT, V38, P7, DOI 10.1111/liv.13673; Asselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bartosch B, 2010, VIRUSES-BASEL, V2, P692, DOI 10.3390/v2030692; Baumert TF, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0815-7; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15; Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Castelain S, 2004, J CLIN VIROL, V31, P227, DOI 10.1016/j.jcv.2004.03.009; Chen C, 2012, ARCH VIROL, V157, P1301, DOI 10.1007/s00705-012-1304-0; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Colpitts CC, 2016, HEPATOL INT, V10, P741, DOI 10.1007/s12072-016-9724-7; de Oliveira A, 2015, ANTIVIR RES, V118, P56, DOI 10.1016/j.antiviral.2015.03.009; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Ganguly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163498; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Henning SM, 2006, J NUTR, V136, P1839, DOI 10.1093/jn/136.7.1839; Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P924, DOI 10.1016/j.cgh.2010.06.032; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kitazato K, 2007, DRUG DISCOV THER, V1, P14; Konerman MA, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.50; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Li GD, 2017, ANTIVIR RES, V142, P83, DOI 10.1016/j.antiviral.2017.02.014; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Liu SW, 2005, BBA-GEN SUBJECTS, V1723, P270, DOI 10.1016/j.bbagen.2005.02.012; Lynch SM, 2016, J CLIN TRANSL HEPATO, V4, P310, DOI 10.14218/JCTH.2016.00027; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Ohba M, 2017, J ANTIBIOT, V70, P443, DOI 10.1038/ja.2016.128; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Seron K, 2018, NATURAL ANTIMICROBIA; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; Stepanova M, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0551-z; Tanaka T, 2010, INT J MOL SCI, V11, P14, DOI 10.3390/ijms11010014; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Urbanowicz RA, 2016, J GEN VIROL, V97, P2265, DOI 10.1099/jgv.0.000537; Xiao F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004128; Yang J, 2012, FITOTERAPIA, V83, P348, DOI 10.1016/j.fitote.2011.11.016; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zu M, 2012, ANTIVIR RES, V94, P217, DOI 10.1016/j.antiviral.2012.04.001	43	43	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0198226	10.1371/journal.pone.0198226	http://dx.doi.org/10.1371/journal.pone.0198226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485282	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800002
J	Driciru, M; Rwego, IB; Asiimwe, B; Travis, DA; Alvarez, J; VanderWaal, K; Pelican, K				Driciru, Margaret; Rwego, Innocent B.; Asiimwe, Benon; Travis, Dominic A.; Alvarez, Julio; VanderWaal, Kimberly; Pelican, Katharine			Spatio-temporal epidemiology of anthrax in Hippopotamus amphibious in Queen Elizabeth Protected Area, Uganda	PLOS ONE			English	Article							NATIONAL-PARK; OUTBREAK; REGIONS; SPORES	Background Anthrax is a zoonotic disease primarily of herbivores, caused by Bacillus anthracis, a bacterium with diverse geographical and global distribution. Globally, livestock outbreaks have declined but in Africa significant outbreaks continue to occur with most countries still categorized as enzootic, hyper endemic or sporadic. Uganda experiences sporadic human and livestock cases. Severe large-scale outbreaks occur periodically in hippos (Hippopotamus amphibious) at Queen Elizabeth Protected Area, where in 2004/2005 and 2010 anthrax killed 437 hippos. Ecological drivers of these outbreaks and potential of hippos to maintain anthrax in the ecosystem remain unknown. This study aimed to describe spatio-temporal patterns of anthrax among hippos; examine significant trends associated with case distributions; and generate hypotheses for investigation of ecological drivers of anthrax. Methods Spatio-temporal patterns of 317 hippo cases in 2004/5 and 137 in 2010 were analyzed. QGIS was used to examine case distributions; Spearman's nonparametric tests to determine correlations between cases and at-risk hippo populations; permutation models of the spatial scan statistics to examine spatio-temporal clustering of cases; directional tests to determine directionality in epidemic movements; and standard epidemic curves to determine patterns of epidemic propagation. Key findings Results showed hippopotamus cases extensively distributed along water shorelines with strong positive correlations (p<0.01) between cases and at-risk populations. Significant (p<0.001) spatio-temporal clustering of cases occurred throughout the epidemics, pointing towards a defined source. Significant directional epidemic spread was detected along water flow gradient (206.6 degrees) in 2004/5 and against flow gradient (20.4 degrees) in 2010. Temporal distributions showed clustered pulsed epidemic waves. Conclusion These findings suggest mixed point-source propagated pattern of epidemic spread amongst hippos and points to likelihood of indirect spread of anthrax spores between hippos mediated by their social behaviour, forces of water flow, and persistent presence of infectious carcasses amidst schools. This information sheds light on the epidemiology of anthrax in highly social wildlife, can help drive insight into disease control, wildlife conservation, and tourism management, but highlights the need for analytical and longitudinal studies aimed at clarifying the hypotheses.	[Driciru, Margaret] Uganda Wildlife Author, Queen Elizabeth Natl Pk, Kampala, Uganda; [Rwego, Innocent B.] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Dept Biosecur Ecosyst & Vet Publ Hlth, Kampala, Uganda; [Rwego, Innocent B.; Travis, Dominic A.; VanderWaal, Kimberly; Pelican, Katharine] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, Minneapolis, MN 55455 USA; [Asiimwe, Benon] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Alvarez, Julio] Univ Complutense, VISAVET Hlth Surveillance Ctr, Madrid, Spain; [Alvarez, Julio] Univ Complutense, Fac Vet, Dept Sanidad Anim, Madrid, Spain	Makerere University; University of Minnesota System; University of Minnesota Twin Cities; Makerere University; Complutense University of Madrid; Complutense University of Madrid	Driciru, M (corresponding author), Uganda Wildlife Author, Queen Elizabeth Natl Pk, Kampala, Uganda.; Pelican, K (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, Minneapolis, MN 55455 USA.	margaret.driciru@ugandawildlife.org; pelicank@umn.edu	; Alvarez, Julio/H-8292-2013; Rwego, Innocent Bidason/I-5049-2013	VanderWaal, Kimberly/0000-0002-5764-6430; Alvarez, Julio/0000-0002-8999-9417; Rwego, Innocent Bidason/0000-0003-1274-7788	University of Minnesota's Institute on the Environment Discovery Grant	University of Minnesota's Institute on the Environment Discovery Grant	This study was funded internally by the University of Minnesota's Institute on the Environment Discovery Grant, received by KP, and the Uganda Wildlife Authority directly provided Non financial In-kind support for field work to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2016, PREV VET MED, V123, P155, DOI 10.1016/j.prevetmed.2015.11.003; Antwerpen M., 2012, BSL3 BSL4 AGENTS EPI, V1, P5; Bellan SE, 2013, APPL ENVIRON MICROB, V79, P3756, DOI 10.1128/AEM.00181-13; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Bezymennyi M, 2014, APPL GEOGR, V54, P129, DOI 10.1016/j.apgeog.2014.07.016; Blackburn JK, 2014, ANN ASSOC AM GEOGR, V104, P939, DOI 10.1080/00045608.2014.914834; [CDC Centers for Disease Control and Prevention (CDC)], 2012, PRINC EP PUBL HLTH P, V1, P75; CHOQUETTE L P E, 1972, Canadian Field-Naturalist, V86, P127; Cieslak TJ, 1999, EMERG INFECT DIS, V5, P552, DOI 10.3201/eid0504.990418; Clegg S., 2007, VET RECORD J BRIT VE, V160; Dragon DC, 2005, APPL ENVIRON MICROB, V71, P1610, DOI 10.1128/AEM.71.3.1610-1615.2005; Dragon DC, 2001, J APPL MICROBIOL, V91, P435, DOI 10.1046/j.1365-2672.2001.01389.x; Dudley JP, 2016, MAMMAL REV, V46, P191, DOI 10.1111/mam.12056; ELTRINGHAM SK, 1974, J APPL ECOL, V11, P855, DOI 10.2307/2401750; Epp T, 2010, CAN VET J, V51, P743; FAO, 2010, CAS DEF LIV DIS; FIELD C R, 1970, Zoologica Africana, V5, P71; FIELD CR, 1970, J APPL ECOL, V7, P273, DOI 10.2307/2401380; Friis RH, 2013, EPIDEMIOLOGY PUBLIC, p[1, 217]; GAINER RS, 1989, CAN VET J, V30, P953; GATES CC, 1995, CAN J VET RES, V59, P256; Hampson K, 2011, J APPL ECOL, V48, P1333, DOI 10.1111/j.1365-2664.2011.02030.x; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Hughes-Jones M, 1999, J APPL MICROBIOL, V87, P189, DOI 10.1046/j.1365-2672.1999.00867.x; Iftimi A, 2015, GEOSPATIAL HEALTH, V10, P54, DOI 10.4081/gh.2015.341; Jacquez G.M., 1994, USER MANUAL STAT STA; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Jones Susan D., 2010, DEATH SMALL PACKAGE; Kingdom J., 1979, E AFRICAN MAMMALS B, VIIIB, P250; Kulldorff, 2009, INFORM MANAGEMENT SE; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Lewis R, 2009, INT J SOC RES METHOD, V12, P405, DOI 10.1080/13645570802289104; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; LOCK JM, 1972, J ECOL, V60, P445, DOI 10.2307/2258356; Nass, 1992, PHYS SOCIAL RESPONSI, V2, P198; Ndyabahinduka D G, 1984, Ann Ist Super Sanita, V20, P205; Ndyabahinduka D. J. K, 1984, OUTBREAK HUMAN GASTR, P1936; Olivier RCD, 1990, MANAGEMENT PLAN QUEE; PETRIDES GEORGE A., 1965, ZOOL AFRICANA, V1, P209; Pickett S., 2012, ECOLOGICAL BASIS CON; Prins HHT, 1986, NORDIC SOC OIKOS COP, V49, P28; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; Shadonly SV, 2008, JAVMA-J AM VET MED A, V233, P63, DOI 10.2460/javma.233.1.63; Thrusfield M., 1995, PATTERNS DIS VET EPI, V31-45, P114; TURNBULL PCB, 1991, VET REC, V128, P399, DOI 10.1136/vr.128.17.399; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; Wafula MM, 2008, AFR J ECOL, V46, P24, DOI 10.1111/j.1365-2028.2007.00796.x; Waldner CL, 2006, VET CLIN N AM-FOOD A, V22, P75, DOI 10.1016/j.cvfa.2005.12.001; WHO, 2008, ANTHRAX HUMANS ANIMA; WHO, 2016, MAPP RISK DISTR EP W, P38	53	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206922	10.1371/journal.pone.0206922	http://dx.doi.org/10.1371/journal.pone.0206922			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485342	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800036
J	Kang, K; Pu, W; Ma, YF; Wang, XY				Kang, Kai; Pu, Wei; Ma, Yanfang; Wang, Xiaoyu			Bi-objective inventory allocation planning problem with supplier selection and carbon trading under uncertainty	PLOS ONE			English	Article							CHAIN NETWORK DESIGN; DIFFERENTIAL EVOLUTION; OPTIMIZATION; DECISIONS; MODEL; SYSTEM	Concern is growing that business enterprises focus primarily on their economic activities while disregarding the adverse environmental and social effects of these activities. To contribute to the literature on this matter, this study investigates a novel bi-objective inventory allocation planning problem with supplier selection and carbon trading across multiple periods under uncertainty. The concepts of a carbon credit price and a carbon cap are proposed to demonstrate the effect of carbon emissions costs on inventory allocation network costs. Demands of manufacturers, transport price, and defect rate of materials that should be rejected are set as random variables. We combine normalized normal constraint method, differential evolution algorithm, and uncertainty simulation to deal with the complex model. One representative case shows the effectiveness and practicability of this model and proposed method. The Pareto frontier is generated by solving the bi-objective model. We extend the results of numerical examples in large scale problems, and compare the solution method results with exact solutions. The environmental objective across the inventory allocation network varies with changes of the carbon cap and the carbon credit price.	[Kang, Kai; Pu, Wei; Ma, Yanfang; Wang, Xiaoyu] Hebei Univ Technol, Sch Econ & Management, Tianjin, Peoples R China	Hebei University of Technology	Pu, W (corresponding author), Hebei Univ Technol, Sch Econ & Management, Tianjin, Peoples R China.	weipu0214@163.com		kang, kai/0000-0003-4039-7690	National Social Science Foundation of China [14BGL055]; Tianjin Science and Technology Development Funds [15ZXCXSF00020]; System Science and Enterprise Development Research Center [Xq16C10]; Hebei Province Humanities and Social Science Funds [BJ2016057, zd201505]	National Social Science Foundation of China; Tianjin Science and Technology Development Funds; System Science and Enterprise Development Research Center; Hebei Province Humanities and Social Science Funds	This study is supported in part by National Social Science Foundation of China (NO. 14BGL055, Kai Kang received funding), the Tianjin Science and Technology Development Funds (NO. 15ZXCXSF00020, Kai Kang received funding), System Science and Enterprise Development Research Center (NO. Xq16C10, Yanfang Ma received funding) and the Hebei Province Humanities and Social Science Funds (NO. zd201505, Kai Kang received funding, NO. BJ2016057, Yanfang Ma received funding).; This study is supported in part by National Social Science Foundation of China (NO. 14BGL055), the Tianjin Science and Technology Development Funds (NO. 15ZXCXSF00020), the Hebei Province Humanities and Social Science Funds (NO. zd201505), the System Science and Enterprise Development Research Center (NO. Xq16C10), and the Hebei Province Humanities and Social Science Funds (NO. BJ2016057).	Abu Alhaj M, 2016, RESOUR CONSERV RECY, V108, P82, DOI 10.1016/j.resconrec.2015.11.011; Buqing Cao, 2020, IEEE Transactions on Services Computing, V13, P99, DOI 10.1109/TSC.2017.2686390; Cao B, 2017, IEEE ACCESS, V5, P8214, DOI 10.1109/ACCESS.2017.2702561; Chaabane A, 2012, INT J PROD ECON, V135, P37, DOI 10.1016/j.ijpe.2010.10.025; Cheraghalipour A, 2018, COMPUT IND ENG, V118, P237, DOI 10.1016/j.cie.2018.02.041; Das S, 2011, IEEE T EVOLUT COMPUT, V15, P4, DOI 10.1109/TEVC.2010.2059031; Dehghan E, 2018, COMPUT IND ENG, V123, P220, DOI 10.1016/j.cie.2018.06.030; Demir E, 2014, EUR J OPER RES, V232, P464, DOI 10.1016/j.ejor.2013.08.002; Goren HG, 2018, J CLEAN PROD, V183, P1156, DOI 10.1016/j.jclepro.2018.02.211; Gorji MH, 2014, APPL MATH MODEL, V38, P814, DOI 10.1016/j.apm.2013.07.012; Hariga M, 2017, J CLEAN PROD, V166, P1357, DOI 10.1016/j.jclepro.2017.08.105; Jafarkhan F, 2018, COMPUT IND ENG, P117; Kang K, 2018, MATH PROBL ENG, V2018, P1; Khan M, 2016, APPL MATH MODEL, V40, P7102, DOI 10.1016/j.apm.2016.02.035; Kunnapapdeelert S, 2013, DIFFERENTIAL EVOLUTI; Li J, 2017, J CLEAN PROD, V141, P1109, DOI 10.1016/j.jclepro.2016.09.157; Li SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168526; Lin TY, 2017, APPL MATH MODEL, V50, P450, DOI 10.1016/j.apm.2017.06.001; Lin TY, 2013, COMPUT IND ENG, V66, P53, DOI 10.1016/j.cie.2013.06.012; Ma YF, 2016, KNOWL-BASED SYST, V105, P119, DOI 10.1016/j.knosys.2016.05.007; Messac A, 2003, STRUCT MULTIDISCIP O, V25, P86, DOI 10.1007/s00158-002-0276-1; Mohajeri A, 2016, TRANSPORT RES D-TR E, V48, P425, DOI 10.1016/j.trd.2015.09.001; Moreno A, 2018, EUR J OPER RES, V269, P1050, DOI 10.1016/j.ejor.2018.02.022; Mousavi SM, 2015, COMPUT IND ENG, V87, P543, DOI 10.1016/j.cie.2015.05.022; Park K, 2018, J CLEAN PROD, V187, P590, DOI 10.1016/j.jclepro.2018.03.035; Pazhani S, 2016, APPL MATH MODEL, V40, P612, DOI 10.1016/j.apm.2015.06.008; Priyan S, 2015, J MANUF SYST, V36, P244, DOI 10.1016/j.jmsy.2014.06.006; Sethanan K, 2016, EXPERT SYST APPL, V45, P450, DOI 10.1016/j.eswa.2015.10.009; Shao LZ, 2016, EUR J OPER RES, V255, P687, DOI 10.1016/j.ejor.2016.05.001; Shaw K, 2016, COMPUT IND ENG, V98, P483, DOI 10.1016/j.cie.2016.06.011; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Turk S, 2017, EXPERT SYST APPL, V78, P51, DOI 10.1016/j.eswa.2017.02.014; United Nations U., 1998, REV EUROPEAN COMMUNI, V7, P214, DOI [10.1111/1467-9388.00150, DOI 10.1111/1467-9388.00150]; Vahidi F, 2018, J CLEAN PROD, V174, P1351, DOI 10.1016/j.jclepro.2017.11.012; Varsei M, 2017, OMEGA-INT J MANAGE S, V66, P236, DOI 10.1016/j.omega.2015.11.009; Wang JX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181165; Xu JT, 2018, APPL MATH MODEL, V56, P449, DOI 10.1016/j.apm.2017.12.018; Xu JP, 2013, ENG OPTIMIZ, V45, P851, DOI 10.1080/0305215X.2012.709514; Xu XY, 2016, J CLEAN PROD, V112, P4093, DOI 10.1016/j.jclepro.2015.08.081; Yang L, 2017, INT J PROD ECON, V191, P286, DOI 10.1016/j.ijpe.2017.06.021; Yang LH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196762; Zhang DZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192000; Zhang DZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185001; Zhao ST, 2016, EUR J OPER RES, V255, P364, DOI 10.1016/j.ejor.2016.04.027	44	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206282	10.1371/journal.pone.0206282	http://dx.doi.org/10.1371/journal.pone.0206282			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485273	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800017
J	Marton, M; Tihanyi, N; Gyulavari, P; Banhegyi, G; Kapuy, O				Marton, Margita; Tihanyi, Nikolett; Gyulavari, Pal; Banhegyi, Gabor; Kapuy, Orsolya			NRF2-regulated cell cycle arrest at early stage of oxidative stress response mechanism	PLOS ONE			English	Article							NRF2; ACTIVATION; PATHWAY; PROTEIN; D1; P21(CIP1/WAF1); DETERMINANT; TRANSITION; INHIBITORS; EFFECTOR	Oxidative stress results in activation of several signal transduction pathways controlled by the PERK-substrate NRF2 (nuclear factor erythroid 2-related factor 2); meanwhile the ongoing cell division cycle has to be blocked. It has been recently shown that Cyclin D1 got immediately down-regulated via PERK pathway in response to oxidative stress leading to cell cycle arrest. However, the effect of NRF2 on cell cycle regulation has not been explored yet. We aimed to reveal a crosstalk between PERK-substrate NRF2 and the key elements of cell cycle regulatory network upon oxidative stress using molecular biological techniques-Although Cyclin D1 level remained constant, its activity was blocked by various stoichiometric inhibitors (such as p15, p21 and p27) even at low level of oxidative stress. The activity of these CDK inhibitors completely disappeared, when the addition of oxidative agent was combined with silencing of either PERK or NRF2. This further confirms the important role of NRF2 in blocking Cyclin D1 with stoichiometric inhibitors at early stage of oxidative stress.	[Marton, Margita; Tihanyi, Nikolett; Banhegyi, Gabor; Kapuy, Orsolya] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Gyulavari, Pal; Banhegyi, Gabor] MTA SE Pathobiochem Res Grp, Budapest, Hungary	Semmelweis University; Semmelweis University	Kapuy, O (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary.	kapuy.orsolya@med.semmelweis-univ.hu	; Marton, Margita/R-2252-2016	Gabor, Banhegyi/0000-0001-7559-0066; Marton, Margita/0000-0002-3530-9695	Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University, Budapest; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-3-I-SE-30]; National Research, Development and Innovation Office [K 112696, 124813]	Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University, Budapest; New National Excellence Program of the Ministry of Human Capacities; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	Orsolya Kapuy was supported by the Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University, Budapest and by the New National Excellence Program of the Ministry of Human Capacities UNKP-17-4-III-SE-75. Orsolya Kapuy and Gabor Banhegyi were supported by the National Research, Development and Innovation Office (K 112696 and 124813). Margita Marton was supported by the New National Excellence Program of the Ministry of Human Capacities UNKP-17-3-I-SE-30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Di Gennaro E, 2003, J CELL PHYSIOL, V195, P139, DOI 10.1002/jcp.10239; Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008; Frade JM, 2015, CELL CYCLE, V14, P712, DOI 10.1080/15384101.2015.1004937; Gao L, 2012, INT J ONCOL, V41, P325, DOI 10.3892/ijo.2012.1455; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hine Christopher M, 2012, J Clin Exp Pathol, VS4; Holczer M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/319589; Ichiishi E, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3458276; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Kucera O, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/752506; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Marton M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010058; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; NASMYTH K, 1995, PHILOS T ROY SOC B, V349, P271, DOI 10.1098/rstb.1995.0113; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Park M S, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0801s00; Pyo CW, 2013, BBA-GEN SUBJECTS, V1830, P5316, DOI 10.1016/j.bbagen.2013.07.030; Rodic S, 2018, INT J CANCER, V142, P440, DOI 10.1002/ijc.31069; RUSH GF, 1985, TOXICOL APPL PHARM, V78, P473, DOI 10.1016/0041-008X(85)90255-8; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sarkar MK, 2010, TOXICOL IN VITRO, V24, P1711, DOI 10.1016/j.tiv.2010.05.014; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stacey Dennis W, 2010, Genes Cancer, V1, P1189, DOI 10.1177/1947601911403475; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; TAM SW, 1994, ONCOGENE, V9, P2663; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Ye WZ, 2010, BRAIN, V133, P2295, DOI 10.1093/brain/awq139	40	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207949	10.1371/journal.pone.0207949	http://dx.doi.org/10.1371/journal.pone.0207949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485363	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800090
J	Nighbor, TD; Doogan, NJ; Roberts, ME; Cepeda-Benito, A; Kurti, AN; Priest, JS; Johnson, HK; Lopez, AA; Stanton, CA; Gaalema, DE; Redner, R; Parker, MA; Keith, DR; Quisenberry, AJ; Higgins, ST				Nighbor, Tyler D.; Doogan, Nathan J.; Roberts, Megan E.; Cepeda-Benito, Antonio; Kurti, Allison N.; Priest, Jeff S.; Johnson, Harley K.; Lopez, Alexa A.; Stanton, Cassandra A.; Gaalema, Diann E.; Redner, Ryan; Parker, Maria A.; Keith, Diana R.; Quisenberry, Amanda J.; Higgins, Stephen T.			Smoking prevalence and trends among a US national sample of women of reproductive age in rural versus urban settings	PLOS ONE			English	Article							UNITED-STATES; NICOTINE DEPENDENCE; TOBACCO CONTROL; CIGARETTE-SMOKING; MORTALITY; DISPARITIES; CESSATION; CAMPAIGN; SUCCESS; IMPACT	U.S. smoking prevalence is declining at a slower rate in rural than urban settings and contributing to regional health disparities. Cigarette smoking among women of reproductive age is particularly concerning due to the potential for serious maternal and infant adverse health effects should a smoker become pregnant. The aim of the present study was to examine whether this rural-urban disparity impacts women of reproductive age (ages 15-44) including pregnant women. Data came from the ten most recent years of the U.S. National Survey on Drug Use and Health (2007-2016). We estimated prevalence of current smoking and nicotine dependence among women categorized by rural-urban residence, pregnancy status, and trends using chi-square testing and multivariable modeling while adjusting for common risk factors for smoking. Despite overall decreasing trends in smoking prevalence, prevalence was higher among rural than urban women of reproductive age overall (chi(2) (1) = 579.33, p < .0001) and among non-pregnant (chi(2) (1) = 578.0, p < .0001) and pregnant (chi(2) (1) = 79.69, p < .0001) women examined separately. An interaction between residence and pregnancy status showed adjusted odds of smoking among urban pregnant compared to non-pregnant women (AOR = .58, [.53-.63]) were lower than those among rural pregnant compared to non-pregnant women (AOR = 0.75, [.62-.92]), consistent with greater pregnancy-related smoking cessation among urban pregnant women. Prevalence of nicotine dependence was also higher in rural than urban smokers overall (chi(2) (2) = 790.42, p < .0001) and among non-pregnant (chi(2) (2) = 790.58, p < .0001) and pregnant women examined separately (chi(2) (2) = 63.69, p < .0001), with no significant changes over time. Associations involving residence and pregnancy status remained significant in models adjusting for covariates (ps < 0.05). Results document greater prevalence of smoking and nicotine dependence and suggest less pregnancy-related quitting among rural compared to urban women, disparities that have potential for direct, multi-generational adverse health impacts.	[Nighbor, Tyler D.; Cepeda-Benito, Antonio; Kurti, Allison N.; Johnson, Harley K.; Lopez, Alexa A.; Gaalema, Diann E.; Redner, Ryan; Parker, Maria A.; Keith, Diana R.; Higgins, Stephen T.] Univ Vermont, Vermont Ctr Behav & Hlth, Burlington, VT 05405 USA; [Nighbor, Tyler D.; Kurti, Allison N.; Johnson, Harley K.; Gaalema, Diann E.; Parker, Maria A.; Keith, Diana R.; Higgins, Stephen T.] Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA; [Doogan, Nathan J.; Roberts, Megan E.] Ohio State Univ, Ohio Coll Med Govt Resource Ctr, Columbus, OH 43210 USA; [Cepeda-Benito, Antonio; Kurti, Allison N.; Gaalema, Diann E.; Higgins, Stephen T.] Univ Vermont, Dept Psychol Sci, Burlington, VT 05405 USA; [Priest, Jeff S.] Univ Vermont, Med Biostat, Burlington, VT USA; [Stanton, Cassandra A.] Westat Corp, Ctr Evaluat & Coordinat Training & Res CECTR Toba, Rockville, MD USA; [Stanton, Cassandra A.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Redner, Ryan] Southern Illinois Univ, Rehabil Inst, Carbondale, IL USA; [Quisenberry, Amanda J.] Roswell Pk Comprehens Canc Ctr, Dept Hlth Behav, Buffalo, NY USA	University of Vermont; University of Vermont; University System of Ohio; Ohio State University; University of Vermont; University of Vermont; Westat; Georgetown University; Southern Illinois University System; Southern Illinois University	Higgins, ST (corresponding author), Univ Vermont, Vermont Ctr Behav & Hlth, Burlington, VT 05405 USA.; Higgins, ST (corresponding author), Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA.; Higgins, ST (corresponding author), Univ Vermont, Dept Psychol Sci, Burlington, VT 05405 USA.	stephen.higgins@uvm.edu	Benito, Antonio Cepeda/D-2066-2013; Quisenberry, Amanda/GNP-5578-2022; Parker, Maria/AAE-3802-2022	Parker, Maria/0000-0002-9763-1129; Cepeda-Benito, Antonio/0000-0001-9101-9951	National Institutes of Health (NIH); Food and Drug administration (FDA); TCORS from the National Institute on Drug Abuse (NIDA) [P50DA036114]; FDA, TCORS Award from the National Cancer Institute (NCI) [P50CA180908]; FDA, Center for Evaluation and Coordination of Training and Research award from NCI [U54CA189222]; FDA, Institutional Training Grant from NIDA [T32DA07242]; Centers of Biomedical Research Excellence from the National Institute on General Medical Sciences [P20GM103644]; National Institute of Child Health and Human Development (NICHD) [R01HD078332]; NICHD [R01HD075669]; Centers for Disease Control and Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078332, R01HD075669] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA180908, U54CA189222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA036114, P50DA036114, T32DA007242] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug administration (FDA); TCORS from the National Institute on Drug Abuse (NIDA); FDA, TCORS Award from the National Cancer Institute (NCI); FDA, Center for Evaluation and Coordination of Training and Research award from NCI; FDA, Institutional Training Grant from NIDA; Centers of Biomedical Research Excellence from the National Institute on General Medical Sciences; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All of the following awards are awarded to SH. This research was conducted as part of the activities of the Tobacco Centers of Regulatory Science (TCORS) Vulnerable Populations Working Group, which is a collaborative effort supported by the National Institutes of Health (NIH) https://www.nih. gov/health-information and Food and Drug administration (FDA) https://www.fda.gov/.Support came from TCORS award P50DA036114 from the National Institute on Drug Abuse (NIDA) https://www.drugabuse.gov/and FDA, TCORS Award P50CA180908 from the National Cancer Institute (NCI) https://www.cancer.gov/and FDA, Center for Evaluation and Coordination of Training and Research award U54CA189222 from NCI and FDA, Institutional Training Grant award T32DA07242 from NIDA, Centers of Biomedical Research Excellence P20GM103644 award from the National Institute on General Medical Sciences https://www.nigms.nih.gov, and Research awards R01HD078332 from the National Institute of Child Health and Human Development (NICHD) https://www.nichd.nih.gov/and R01HD075669 from NICHD and Centers for Disease Control and Prevention https://www.cdc.gov.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Lung Association, 2012, CUTT TOB RUR ROOTS T; Bader P, 2011, INT J ENV RES PUB HE, V8, P4118, DOI 10.3390/ijerph8114118; Balamurugan A, 2007, J RURAL HEALTH, V23, P270, DOI 10.1111/j.1748-0361.2007.00101.x; Berg CJ, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110110; Byun SY, 2012, AM EDUC RES J, V49, P412, DOI 10.3102/0002831211416344; Caldwell JT, 2016, AM J PUBLIC HEALTH, V106, P1463, DOI 10.2105/AJPH.2016.303212; Center for Behavioral Health Statistics and Quality, 2015, NAT SURV DRUG US HLT; Cepeda-Benito A, 2018, PREV MED, V117, P69, DOI 10.1016/j.ypmed.2018.04.008; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Dietz PM, 2010, AM J PREV MED, V39, P45, DOI 10.1016/j.amepre.2010.03.009; Doogan NJ, 2017, PREV MED, V104, P79, DOI 10.1016/j.ypmed.2017.03.011; Duke JC, 2009, AM J PUBLIC HEALTH, V99, P2210, DOI 10.2105/AJPH.2008.155127; Eriksen M, 2007, CA-CANCER J CLIN, V57, P367, DOI 10.3322/CA.57.6.367; Fagerstrom K, 2003, Monaldi Arch Chest Dis, V59, P91; Ferketich AK, 2010, AM J PUBLIC HEALTH, V100, P1313, DOI 10.2105/AJPH.2009.179242; Graham H, 2009, DRUG ALCOHOL DEPEN, V104, pS11, DOI 10.1016/j.drugalcdep.2009.02.009; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Higgins ST, 2016, PREV MED, V92, P110, DOI 10.1016/j.ypmed.2016.02.025; Higgins Stephen T, 2016, Curr Addict Rep, V3, P9; Higgins ST, 2012, PREV MED, V55, pS33, DOI 10.1016/j.ypmed.2011.12.016; Higgins ST, 2009, DRUG ALCOHOL DEPEN, V104, pS1, DOI 10.1016/j.drugalcdep.2009.06.006; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kefalides PT, 1999, ANN INTERN MED, V130, P333, DOI 10.7326/0003-4819-130-4-199902161-00001; Kurti AN, 2016, EXP CLIN PSYCHOPHARM, V24, P12, DOI 10.1037/pha0000056; Mansfield CJ, 1999, AM J PUBLIC HEALTH, V89, P893, DOI 10.2105/AJPH.89.6.893; McMillen R, 2004, J RURAL HEALTH, V20, P7, DOI 10.1111/j.1748-0361.2004.tb00002.x; Meit M, THE 2014 UPDATE OF T; Meit M., 2014, UPDATE RURAL URBAN C; Meit M, 2009, J PUBLIC HEALTH MAN, V15, P210, DOI 10.1097/01.PHH.0000349738.73619.f5; Mercincavage M, 2015, DRUG ALCOHOL DEPEN, V146, pe38; Northridge ME, 2008, J RURAL HEALTH, V24, P106, DOI 10.1111/j.1748-0361.2008.00146.x; Roberts ME, 2017, AM J PUBLIC HEALTH, V107, P1554, DOI [10.2105/AJPH.2017.303967, 10.2105/ajph.2017.303967]; Roberts ME, 2016, HEALTH PLACE, V39, P153, DOI 10.1016/j.healthplace.2016.04.001; Shiffman S, 2004, NICOTINE TOB RES, V6, P327, DOI 10.1080/1462220042000202481; Singh GK, 2012, J COMMUN HEALTH, V37, P412, DOI 10.1007/s10900-011-9458-3; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, 2007, Nicotine Tob Res, V9 Suppl 4, pS555, DOI 10.1080/14622200701673480; Vander Weg MW, 2011, ADDICT BEHAV, V36, P231, DOI 10.1016/j.addbeh.2010.11.005; Vangeli E, 2011, ADDICTION, V106, P2110, DOI 10.1111/j.1360-0443.2011.03565.x; Warner KE, 2014, AM J PUBLIC HEALTH, V104, P83, DOI 10.2105/AJPH.2013.301591; Weaver KE, 2013, CANCER CAUSE CONTROL, V24, P1481, DOI 10.1007/s10552-013-0225-x; Wewers ME, 2017, NICOTINE TOB RES, V19, P1499, DOI 10.1093/ntr/ntw265; York NL, 2010, J RURAL HEALTH, V26, P120, DOI 10.1111/j.1748-0361.2010.00273.x; Zollinger TW, 2006, J RURAL HEALTH, V22, P119, DOI 10.1111/j.1748-0361.2006.00019.x	45	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207818	10.1371/journal.pone.0207818	http://dx.doi.org/10.1371/journal.pone.0207818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485376	gold, Green Submitted, Green Published			2022-12-26	WOS:000451755800081
J	Abraham, PR; Devalraju, KP; Jha, V; Valluri, VL; Mukhopadhyay, S				Abraham, Philip Raj; Devalraju, Kamakshi Prudhula; Jha, Vishwanath; Valluri, Vijaya Lakshmi; Mukhopadhyay, Sangita			PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection	PLOS ONE			English	Article							B-CELL RESPONSE; ANTIBODY-RESPONSES; ASSAYS; DIAGNOSIS; RV0256C; GAMMA	Latent tuberculosis infection (LTBI) is a clinically distinct category of Mycobacterium tuberculosis (Mtb) infection that needs to be diagnosed at the initial stage. We have reported earlier that one of the Mtb proline-proline-glutamic acid (PPE) proteins, PPE17 (Rv1168c) is associated with stronger B-cell and T-cell responses and could be used to diagnose different clinical categories of active TB patients with higher specificity and sensitivity than PPD and ESAT-6. Based on these observations we further tested the potential of PPE17 for the diagnosis of LTBI. We tested 198 sera samples collected from LTBI individuals (n = 61), QFT-negative (n = 58) and active TB patients (n = 79). Individuals were defined as LTBI by QuantiFERON-TB Gold In-Tube test (QFT-GIT) positive results, while active TB patients were confirmed based on the guidelines of the Revised National TB Control Programme of India. The antibody responses against PPE17, ESAT-6: CFP-10 and PPD were compared in these subjects by enzyme-linked immunosorbent assay. We observed that LTBI individuals show a higher sero-reactivity to PPE17 as compared to currently used latent TB diagnostic antigens like ESAT-6, CFP-10 and PPD. The LTBI and active TB patients display almost similar sensitivity. Interestingly, PPE17 could discriminate LTBI positive subjects from the QFT-negative subjects (P < 0.001). Our study hints that PPE17 may be used as a novel serodiagnostic marker to screen the latently infected subjects and may also be used as a complimentary tool to the QFT-GIT.	[Abraham, Philip Raj; Jha, Vishwanath; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost CDFD, Mol Cell Biol Lab, Hyderabad, Telangana, India; [Devalraju, Kamakshi Prudhula; Valluri, Vijaya Lakshmi] LEPRA Soc Blue Peter Publ Hlth & Res Ctr, Div Immunol & Mol Biol, Hyderabad, Telangana, India; [Jha, Vishwanath] Manipal Acad Higher Educ, Grad Studies, Manipal, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Mol Cell Biol Lab, Hyderabad, Telangana, India.	sangita@cdfd.org.in	Valluri, Vijaya Lakshmi/S-9219-2019; Jha, Vishwanath/AAR-8225-2020	Jha, Vishwanath/0000-0001-6085-8138	Department of Biotechnology, Government of India [BT/PR20669/MED/29/1072/2016]; Indian Council of Medical Research, Government of India [80/796/2013-ECD]; Indian Council of Medical Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This study was supported by the Department of Biotechnology (BT/PR20669/MED/29/1072/2016), Government of India to SM. PRA was supported by the Research Associateship from the Indian Council of Medical Research, Government of India (80/796/2013-ECD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Suman Latha, Bhagwan Mahavir Medical Research Center, Hyderabad, India for providing the sera samples from active TB patients. We also thank Mr. Sanjeev for supporting in collection of samples from the LTBI subjects. P.R.A. was supported by the Research Associateship from the Indian Council of Medical Research, Government of India (80/796/ 2013-ECD). V.J. was supported by Senior Research Fellowship from the Indian Council of Medical Research, Government of India. This study was supported by the Department of Biotechnology (BT/PR20669/MED/29/1072/2016), Government of India.	Abraham PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179965; Abraham PR, 2016, INFECT GENET EVOL, V40, P339, DOI 10.1016/j.meegid.2015.09.005; Abraham PR, 2014, INFECT GENET EVOL, V22, P244, DOI 10.1016/j.meegid.2013.06.023; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dona V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057517; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Kaustova J, 1996, Eur J Med Res, V1, P393; Khalilullah SA, 2014, EGYPT J CHEST DIS TU, V63, P173, DOI 10.1016/j.ejcdt.2013.12.002; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Koh KW, 2009, INFECT IMMUN, V77, P3337, DOI 10.1128/IAI.01175-08; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; Maes R, 2016, CLIN MICROBIOL, V5, P254; Perez-Porcuna TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164181; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pourakbari B, 2015, MOL DIAGN THER, V19, P309, DOI 10.1007/s40291-015-0157-0; Longhi RMP, 2013, BRAZ J INFECT DIS, V17, P363, DOI 10.1016/j.bjid.2012.11.001; Rindi L, 2007, FEMS IMMUNOL MED MIC, V51, P381, DOI 10.1111/j.1574-695X.2007.00315.x; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Sreejit G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004446; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; World Health Organization, GLOB TUB REP 2017; World Health Organization, LAT TB INF FACT SHEE; Zhang Guoqiang, 2009, Genomics Proteomics & Bioinformatics, V7, P107, DOI 10.1016/S1672-0229(08)60039-X	31	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207787	10.1371/journal.pone.0207787	http://dx.doi.org/10.1371/journal.pone.0207787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475863	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700067
J	Gashu, Z; Jerene, D; Datiko, DG; Hiruy, N; Negash, S; Melkieneh, K; Bekele, D; Nigussie, G; Suarez, PG; Hadgu, A				Gashu, Z.; Jerene, D.; Datiko, D. G.; Hiruy, N.; Negash, S.; Melkieneh, K.; Bekele, D.; Nigussie, G.; Suarez, P. G.; Hadgu, A.			Seasonal patterns of tuberculosis case notification in the tropics of Africa: A six-year trend analysis in Ethiopia	PLOS ONE			English	Article							VITAMIN-D; PULMONARY TUBERCULOSIS; DISEASES; STATES	Objective Seasonal variations affect the health system's functioning, including tuberculosis (TB) services, but there is little evidence about seasonal variations in TB case notification in tropical countries, including Ethiopia. This study sought to fill this gap in knowledge using TB data reported from 10 zones, 5 each from Amhara and Oromia regions. Methods Notified TB cases for 2010-2016 were analyzed using SPSS version 20. We calculated the quarterly and annual average TB case notification rates and the proportion of seasonal amplitudes. We applied Winters' multiplicative method of exponential smoothing to break down the original time series into seasonal, trend, and irregular components and to build a suitable model for forecasting. Results A total of 205,575 TB cases were identified (47.8% from Amhara, 52.2% from Oromia), with a male-to-female ratio of 1.2:1. The means of 8,200 (24%), 7,992 (23%), 8,849 (26%), and 9,222 (27%) TB cases were reported during July-September, October-December, January-March, and April-June, respectively. The seasonal component of our model indicated a peak in April-June and a trough in October-December. The seasonal amplitude in Amhara region is 10% greater than that of Oromia (p < 0.05). Conclusions TB is shown to be a seasonal disease in Ethiopia, with a peak in quarter four and a low in quarter two of the fiscal year. The peak TB case notification rate corresponds with the end of the dry season in the two agrarian regions of Ethiopia. TB prevention and control interventions, such as efforts to increase community TB awareness about TB transmission and contact tracing, should consider seasonal variation. Regional variations in TB seasonality may require consideration of geographic-specific TB case-finding strategies. The mechanisms underlying the seasonal variation of TB are complex, and further study is needed.	[Gashu, Z.; Jerene, D.; Datiko, D. G.; Hiruy, N.; Negash, S.; Melkieneh, K.; Hadgu, A.] USAID Challenge TB Project, Management Sci Hlth, Addis Ababa, Ethiopia; [Bekele, D.] Oromia Reg Hlth Bur, Addis Ababa, Ethiopia; [Nigussie, G.] Amhara Reg Hlth Bur, Addis Ababa, Ethiopia; [Suarez, P. G.] Management Sci Hlth, Arlington, VA USA		Gashu, Z (corresponding author), USAID Challenge TB Project, Management Sci Hlth, Addis Ababa, Ethiopia.	zgashu@msh.org	Suarez, Pedro G/AAD-2278-2019; Datiko, Daniel G./AAE-6856-2020; Datiko, Daniel/AAE-7019-2020	Suarez, Pedro G/0000-0001-9825-1761; Datiko, Daniel/0000-0002-8556-3069	United State Agency for International Development (USAID) [AID-663-A-11-00011]	United State Agency for International Development (USAID)(United States Agency for International Development (USAID))	The United State Agency for International Development (USAID) supported this work through the Help Ethiopia Address the Low TB Performance (HEAL TB) Project, under cooperative agreement number AID-663-A-11-00011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi S, 2010, T ROY SOC TROP MED H, V104, P336, DOI 10.1016/j.trstmh.2009.12.009; Altes HK, 2012, INT J TUBERC LUNG D, V16, P639, DOI 10.5588/ijtld.11.0680; Ane-Anyangwe I N, 2006, East Afr Med J, V83, P588; Avert, 2018, GLOB INF ED HIV AIDS; Bogale S, 2017, ADDIS STANDARD  1006; Bras AL, 2014, INT J TUBERC LUNG D, V18, P1202, DOI 10.5588/ijtld.14.0158; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Federal Democratic Republic of Ethiopia. ETHIOPIAN GOVERNMNET PORTAL, 2018, REG STAT OR REG; Federal Democratic Republic of Ethiopia (FDRE). ETHIOPIAN GOVERNMNET PORTAL, 2018, REG STAT AMH REG; Federal Democratic Republic of Ethiopia Ministry of Health, 2016, HLTH HLTH REL IND; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, GUID CLIN PROGR MAN; Keflie TS, 2015, NUTRITION, V31, P1204, DOI 10.1016/j.nut.2015.05.003; Khaliq A, 2015, J EPIDEMIOL GLOB HEA, V5, P397, DOI 10.1016/j.jegh.2015.07.007; Kumar Varun, 2014, Tuberc Res Treat, V2014, P514093, DOI 10.1155/2014/514093; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; Mabaera B, 2009, INT HEALTH, V1, P53, DOI 10.1016/j.inhe.2009.06.006; Margalit I, 2016, INT J TUBERC LUNG D, V20, P1588, DOI 10.5588/ijtld.16.0306; Melese A, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0204-x; Misganaw A, 2014, J HEALTH POPUL NUTR, V32, P1; Moosazadeh M, 2014, INT J HEALTH POLICY, V2, P181, DOI 10.15171/ijhpm.2014.43; Moosazadeh Mahmood, 2013, Tanaffos, V12, P35; Narula P, 2015, J EPIDEMIOL GLOB HEA, V5, P337, DOI 10.1016/j.jegh.2015.02.004; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Sita-Lumsden A, 2007, THORAX, V62, P1003, DOI 10.1136/thx.2006.070060; Tadesse T, 2013, INT J TUBERC LUNG D, V17, P630, DOI 10.5588/ijtld.12.0449; Tessema B, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0211-3; Top R, 2013, INT J TUBERC LUNG D, V17, P1466, DOI 10.5588/ijtld.13.0226; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 UN POP DIV; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; World Health Organization, GLOBAL TUBERCULOSIS; Yang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108369	35	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207552	10.1371/journal.pone.0207552	http://dx.doi.org/10.1371/journal.pone.0207552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475836	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700039
J	Hassanat, ABA				Hassanat, Ahmad B. A.			Two-point-based binary search trees for accelerating big data classification using KNN	PLOS ONE			English	Article							NEAREST; CLASSIFIERS	Big data classification is very slow when using traditional machine learning classifiers, particularly when using a lazy and slow-by-nature classifier such as the k-nearest neighbors algorithm (KNN). This paper proposes a new approach which is based on sorting the feature vectors of training data in a binary search tree to accelerate big data classification using the KNN approach. This is done using two methods, both of which utilize two local points to sort the examples based on their similarity to these local points. The first method chooses the local points based on their similarity to the global extreme points, while the second method chooses the local points randomly. The results of various experiments conducted on different big datasets show reasonable accuracy rates compared to state-of-the-art methods and the KNN classifier itself. More importantly, they show the high classification speed of both methods. This strong trait can be used to further improve the accuracy of the proposed methods.	[Hassanat, Ahmad B. A.] Mutah Univ, IT Dept, Mutah Al Karak, Jordan	Mutah University	Hassanat, ABA (corresponding author), Mutah Univ, IT Dept, Mutah Al Karak, Jordan.	hasanat@mutah.edu.jo	Hassanat, Ahmad/L-3820-2018	Hassanat, Ahmad/0000-0002-9991-304X				Altarawnwh G. A., 2015, CAN J PURE APPL SCI, V9, P6; [Anonymous], 2014, J AM SCI; Bolon-Canedo V, 2017, EUR S ART NEUR NETW, P519; Deng ZY, 2016, NEUROCOMPUTING, V195, P143, DOI 10.1016/j.neucom.2015.08.112; Gallego AJ, 2018, PATTERN RECOGN, V74, P531, DOI 10.1016/j.patcog.2017.09.038; Hassanat A., 2016, J THEOR APPL INF TEC, V88; Hassanat AB., 2014, INT J COMPUT SCI INF, V12, P33, DOI DOI 10.1007/S00500-005-0503-Y; Hassanat AB., 2018, ADV DISTRIBUTED COMP, V7, P1; Hassanat ABA, 2018, COMPUTERS, V7, DOI 10.3390/computers7040054; Hassanat ABA, 2018, BIG DATA-US, V6, P225, DOI 10.1089/big.2018.0064; Lichman M, 2013, UCI MACHINE LEARNING; Lv X., 2018, CLUSTER COMPUT, DOI [10.1007/s10586-018-2206-z2, DOI 10.1007/S10586-018-2206-Z2]; Maillo J, 2017, KNOWL-BASED SYST, V117, P3, DOI 10.1016/j.knosys.2016.06.012; Maillo J, 2015, IEEE TRUST BIG, P167, DOI 10.1109/Trustcom.2015.577; Tarawneh AS, 2018, ICICS2018, DOI [10.1109/IACS.2018.8355452, DOI 10.1109/IACS.2018.8355452]; Wang F, 2018, NEUROCOMPUTING, V284, P70, DOI 10.1016/j.neucom.2017.12.061; Zhang SC, 2018, IEEE T NEUR NET LEAR, V29, P1774, DOI 10.1109/TNNLS.2017.2673241; Zhu DJ, 2019, CLUSTER COMPUT, V22, pS9169, DOI 10.1007/s10586-018-2097-z	18	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207772	10.1371/journaL.pone.0207772	http://dx.doi.org/10.1371/journaL.pone.0207772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475862	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700065
J	Manueldas, S; Benterud, T; Rueegg, CS; Garberg, HT; Huun, MU; Pankratov, L; Asegg-Atneosen, M; Solberg, R; Escobar, J; Saugstad, OD; Baumbusch, LO				Manueldas, Sophia; Benterud, Torkil; Rueegg, Corina Silvia; Garberg, Havard Tetlie; Huun, Marianne Ullestad; Pankratov, Leonid; Asegg-Atneosen, Monica; Solberg, Ronnaug; Escobar, Javier; Saugstad, Ola Didrik; Baumbusch, Lars Oliver			Temporal patterns of circulating cell-free DNA (cfDNA) in a newborn piglet model of perinatal asphyxia	PLOS ONE			English	Article							FREE PLASMA DNA; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; FREE NUCLEIC-ACIDS; FREE FETAL DNA; OXIDATIVE STRESS; DIAGNOSTIC MARKER; TUMOR DNA; BRAIN; CANCER; BIOMARKERS	Perinatal asphyxia is a severe medical condition resulting from oxygen deficiency (hypoxia) at the time of birth, causing worldwide approximately 680,000 newborn deaths every year. Better prediction of severity of damages including early biomarkers is highly demanded. Elevated levels of circulating cell-free DNA (cfDNA) in blood have been reported for a range of different diseases and conditions, including cancer and prematurity. The objective of this study was to validate methods for assessing cfDNA in blood and cerebrospinal fluid (CSF) and to explore temporal variations in a piglet model of neonatal hypoxia-reoxygenation. Different cfDNA extraction methods in combination with cfDNA detection systems were tested, including a fluorescent assay using SYBR Gold and a qRT-PCR-based technique. Newborn piglets (n = 55) were exposed to hypoxia-reoxygenation, hypoxia-reoxygenation and hypothermia, or were part of the sham-operated control group. Blood was sampled at baseline and at post-intervention, further at 30, 270, and 570 minutes after the end of hypoxia. Applying the fluorescent method, cfDNA concentration in piglets exposed to hypoxia (n = 32) increased from 36.8 +/- 27.6 ng/ml prior to hypoxia to a peak level of 61.5 +/- 54.9 ng/ml after the intervention and deceased to 32.3 +/- 19.1 ng/ml at 570 minutes of reoxygenation, whereas the group of sham-operated control animals (n = 11) revealed a balanced cfDNA profile. Animals exposed to hypoxia and additionally treated with hypothermia (n = 12) expressed a cfDNA concentration of 54.4 +/- 16.9 ng/ml at baseline, 39.2 +/- 26.9 ng/ml at the end of hypoxia, and of 41.1 +/- 34.2 ng/ml at 570 minutes post-intervention. Concentrations of cfDNA in the CSF of piglets exposed to hypoxia revealed at post-intervention higher levels in comparison to the controls. However, these observations were only tendencies and not significant. In a first methodological proof-of-principle study exploring cfDNA using a piglet model of hypoxia-reoxygenation variations in the temporal patterns suggest that cfDNA might be an early indicator for damages caused by perinatal asphyxia.	[Manueldas, Sophia; Benterud, Torkil; Garberg, Havard Tetlie; Huun, Marianne Ullestad; Pankratov, Leonid; Asegg-Atneosen, Monica; Solberg, Ronnaug; Escobar, Javier; Saugstad, Ola Didrik; Baumbusch, Lars Oliver] Oslo Univ Hosp, Rikshosp, Div Pediat & Adolescent Med, Dept Pediat Res, Oslo, Norway; [Benterud, Torkil; Garberg, Havard Tetlie; Huun, Marianne Ullestad; Pankratov, Leonid; Asegg-Atneosen, Monica; Saugstad, Ola Didrik] Univ Oslo, Oslo, Norway; [Rueegg, Corina Silvia] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Solberg, Ronnaug] Vestfold Hosp Trust, Dept Pediat, Tonsberg, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Baumbusch, LO (corresponding author), Oslo Univ Hosp, Rikshosp, Div Pediat & Adolescent Med, Dept Pediat Res, Oslo, Norway.	lars.o.baumbusch@rr-research.no	Saugstad, Ola/AAS-9041-2021; Rueegg, Corina Silvia/H-7128-2019; Pankratov, Leonid/S-1545-2018	Saugstad, Ola/0000-0002-3166-5254; Rueegg, Corina Silvia/0000-0003-3720-4659; Pankratov, Leonid/0000-0003-3962-6986; Baumbusch, Lars O./0000-0003-1290-312X	South-Eastern Norway Regional Health Authority [6051, 39570]; Lebara Foundation, London, UK; European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) [609020]	South-Eastern Norway Regional Health Authority; Lebara Foundation, London, UK; European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND)	The project was supported by grants from the South-Eastern Norway Regional Health Authority [https://www.helse-sorost.no/southeastern-norway-regional-health-authority](source number: 6051, project number: 39570) and by the Lebara Foundation, London, UK [www.lebara foundation. in] to ODS. CSR has received funding from the European Union Seventh Framework Programme [https://ec.europa.eu/research/fp7/index_en.cfm] (FP7-PEOPLE-2013-COFUND) under grant agreement no 609020 - Scientia Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2012, CANCER BIOMARK, V11, P89, DOI 10.3233/CBM-2012-0263; Ahearne Caroline E, 2016, World J Clin Pediatr, V5, P67, DOI 10.5409/wjcp.v5.i1.67; Altimari A, 2008, AM J CLIN PATHOL, V129, P756, DOI 10.1309/DBPX1MFNDDJBW1FL; Angert RM, 2004, AM J OBSTET GYNECOL, V190, P1087, DOI 10.1016/j.ajog.2003.10.562; Atamaniuk J, 2006, CLIN CHEM, V52, P523, DOI 10.1373/clinchem.2005.058883; Baumbusch LO, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-47; Benterud T, 2017, NEONATOLOGY, V111, P12, DOI 10.1159/000447255; Benterud T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140966; Breitbach S, 2014, J APPL PHYSIOL, V117, P119, DOI 10.1152/japplphysiol.00002.2014; Breitbach S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087838; Brucknerova I, 2014, NEUROENDOCRINOL LETT, V35, P201; Catarino R, 2008, DNA CELL BIOL, V27, P415, DOI 10.1089/dna.2008.0744; Chiappetta C, 2013, CLIN CHIM ACTA, V425, P93, DOI 10.1016/j.cca.2013.07.014; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Czeiger D, 2011, AM J CLIN PATHOL, V135, P264, DOI 10.1309/AJCP4RK2IHVKTTZV; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; de Kok JB, 1998, CLIN CHEM, V44, P2201; Devonshire AS, 2014, ANAL BIOANAL CHEM, V406, P6499, DOI 10.1007/s00216-014-7835-3; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Fattuoni C, 2015, MOLECULES, V20, P7000, DOI 10.3390/molecules20047000; Fleischhacker M, 2011, CLIN CHIM ACTA, V412, P2085, DOI 10.1016/j.cca.2011.07.011; Fong SL, 2009, CLIN CHEM, V55, P587, DOI 10.1373/clinchem.2008.110122; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Garberg HT, 2016, PEDIATR RES, V80, P710, DOI 10.1038/pr.2016.149; Garberg HT, 2017, NEONATOLOGY, V111, P133, DOI 10.1159/000449032; Garcia-Berrocoso T, 2013, J PROTEOMICS, V94, P138, DOI 10.1016/j.jprot.2013.09.005; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Gormally E, 2004, INT J CANCER, V111, P746, DOI 10.1002/ijc.20327; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Hahn S, 2011, PLACENTA, V32, pS17, DOI 10.1016/j.placenta.2010.06.018; Hashad D, 2012, J CLIN LAB ANAL, V26, P467, DOI 10.1002/jcla.21548; Hassell KJ, 2015, ARCH DIS CHILD-FETAL, V100, pF541, DOI 10.1136/archdischild-2014-306284; Hauser S, 2012, ANTICANCER RES, V32, P3119; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm477; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jung K, 2004, CANCER LETT, V205, P173, DOI 10.1016/j.canlet.2003.11.023; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; Jung M, 2003, CLIN CHEM, V49, P1028, DOI 10.1373/49.6.1028; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; LAPTOOK A, 1982, J PEDIATR-US, V100, P791, DOI 10.1016/S0022-3476(82)80595-7; Lu Q, 2015, REDOX BIOL, V6, P516, DOI 10.1016/j.redox.2015.06.016; Lv HY, 2015, CLIN CHIM ACTA, V450, P282, DOI 10.1016/j.cca.2015.08.021; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Massaro AN, 2018, J PEDIATR-US, V194, P67, DOI 10.1016/j.jpeds.2017.10.060; Mussolin L, 2013, J CANCER, V4, P323, DOI 10.7150/jca.6226; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Ozkaya O, 2009, NEPHRON CLIN PRACT, V113, pC258, DOI 10.1159/000235250; Perlman JM, 2006, CLIN THER, V28, P1353, DOI 10.1016/j.clinthera.2006.09.005; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Saugstad OD, 2012, NEONATOLOGY, V101, P315, DOI 10.1159/000337345; Schook LB, 2015, ANNU REV ANIM BIOSCI, V3, P219, DOI 10.1146/annurev-animal-022114-110815; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Serpero LD, 2013, J MATERN-FETAL NEO M, V26, P44, DOI 10.3109/14767058.2013.829688; Shankaran S, 2012, CLIN PERINATOL, V39, P919, DOI 10.1016/j.clp.2012.09.008; Sharma VK, 2011, INT J MASS SPECTROM, V304, P172, DOI 10.1016/j.ijms.2010.10.003; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; Solberg R, 2012, FREE RADICAL BIO MED, V53, P1061, DOI 10.1016/j.freeradbiomed.2012.07.022; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Stemmer C, 2003, CLIN CHEM, V49, P1953, DOI 10.1373/clinchem.2003.020750; Suzuki N, 2008, CLIN CHIM ACTA, V387, P55, DOI 10.1016/j.cca.2007.09.001; Szpechcinski A, 2008, J PHYSIOL PHARMACOL, V59, P675; Tataranno ML, 2015, CLIN PERINATOL, V42, P529, DOI 10.1016/j.clp.2015.04.011; Thoresen M, 2015, SEMIN FETAL NEONAT M, V20, P66, DOI 10.1016/j.siny.2015.01.002; Thornton C, 2017, BIOCHEM SOC T, V45, P1067, DOI 10.1042/BST20170017; Tjoa ML, 2006, AM J OBSTET GYNECOL, V195, P230, DOI 10.1016/j.ajog.2006.01.041; Tnaeva NO, 2008, ANN NY ACAD SCI, V1137, P27, DOI 10.1196/annals.1448.043; Tonni G, 2014, ARCH GYNECOL OBSTET, V290, P13, DOI 10.1007/s00404-014-3208-6; Tovbin D, 2012, NEPHROL DIAL TRANSPL, V27, P3929, DOI 10.1093/ndt/gfs255; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van der Vaart M, 2010, CLIN BIOCHEM, V43, P26, DOI 10.1016/j.clinbiochem.2009.08.027; Wagner J, 2012, BIOCHEM MEDICA, V22, P24; Wei CW, 2001, CLIN CHEM, V47, P336; World Health Organization, HLTH STAT INF SYST D; Wu TL, 2002, CLIN CHIM ACTA, V321, P77, DOI 10.1016/S0009-8981(02)00091-8; Xia P, 2009, GENET MOL BIOL, V32, P20, DOI 10.1590/S1415-47572009000100003; Xue XY, 2009, CLIN CHIM ACTA, V404, P100, DOI 10.1016/j.cca.2009.02.018	78	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0206601	10.1371/journal.pone.0206601	http://dx.doi.org/10.1371/journal.pone.0206601			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475817	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700010
J	Charboneau, AJ; Delaney, JP; Beilman, G				Charboneau, Alex J.; Delaney, John P.; Beilman, Greg			Fucoidans inhibit the formation of post-operative abdominal adhesions in a rat model	PLOS ONE			English	Article							MOLECULAR-WEIGHT FUCOIDAN; ARTERIAL THROMBOSIS; ANTICOAGULANT ACTIVITIES; UNLIKE HEPARIN; PREVENTION; BARRIER; AGENTS	Purpose Fibrin clot is essential for post-operative abdominal adhesion formation. Fucoidans, sulfated polysaccharides, inhibit fibrin clot formation. In addition, they inhibit inflammation and fibrosis, which also play important roles in adhesion formation. The purpose of this study was to evaluate fucoidans' potential for inhibiting post-operative abdominal adhesions and measure their effects on systemic coagulation parameters when administered intraperitoneally (IP). Methods and materials Female Sprague Dawley rats were studied. A 2.5x2.5cm full thickness segment of abdominal wall was excised. The skin edges were approximated. This model induces extensive adhesions and allows objective quantitation. Three fucoidans were evaluated- Sigma Fucoidan Crude (SFC), Fucus vesiculosis 95% (Sigma) and, Peridan. One protocol involved continuous infusion into the abdomen from a subcutaneous osmotic pump. Alternatively, boluses of the solutions were injected IP at the end of the operation. Rats were sacrificed a week later. Adhesion extent was scored. Systemic coagulation effects of fucoidans were also evaluated. INR and aPTT were measured following IP injection of the fucoidan solutions and after 7 days of continuous infusion. Results Animals given a continuous infusion of either SFC or Peridan yielded adhesion reduction of 80 to 90% from control. Bolus Peridan had no discernable influence on adhesion formation, but a single bolus of SFC caused significant adhesion reductions. Peridan resulted in prompt aPTT elevations which fell to nearly normal by 5 hours. The maximum peak value after SFC injection was seen in 15 hours. The maximal INR elevations were around 2. Measurement of INR and aPTT after a week of continuous infusion of either Peridan or SFC, were always in the normal control range. The third agent, Sigma, frequently yielded intraperitoneal infection found at autopsy. Conclusions These findings indicate that selected fucoidans infused intraperitoneally for a week after abdominal operations reduce adhesion extent by up to 90%.	[Charboneau, Alex J.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Delaney, John P.; Beilman, Greg] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Charboneau, AJ (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.	char0247@umn.edu			G.D.N. Holdings; Anhese, LLC	G.D.N. Holdings; Anhese, LLC	This work was supported by private investment by G.D.N. Holdings and Anhese, LLC. Author J.P.D. was a board member of Anhese, LLC at the time of these experiments. He participated in manuscript preparation, experimental design, and the decision to publish. G.D.N. Holdings did not have any role in experimental design, data collection, or preparation of this manuscript.	Ahmad G, 2015, COCHRANE DATABASE SY; Ahmad G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001298.pub4; Alonso JD, 2014, VET MED INT; [Anonymous], 2012, PERIDAN TECHNICAL RE; Arung W, 2011, WORLD J GASTROENTERO, V17, P4545, DOI 10.3748/wjg.v17.i41.4545; Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X; Becker JM, 1996, J AM COLL SURGEONS, V183, P297; Cashman J, 2009, FERTIL STERIL, V92, P58; Cashman J, [United States Patent Application, Kind Code: A1; Serial No.: 084660], Patent No. 20110250275; Cashman JD, 2009, P EUR SOC HUM REPR E, P102; Cashman JD, 2011, J SURG RES, V171, P495, DOI 10.1016/j.jss.2010.04.043; CHANDY J, 1950, ARCH SURG-CHICAGO, V60, P1151, DOI 10.1001/archsurg.1950.01250011176011; Claypool JR, 1910, J AMER MED ASSOC, V55, P312, DOI 10.1001/jama.1910.04330040048017; Colliec-Jouault S, 2003, J THROMB HAEMOST, V1, P1114, DOI 10.1046/j.1538-7836.2003.t01-1-00215.x; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; DIZEREGA GS, 1990, PROG CLIN BIOL RES, V358, P1; Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5; Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004; Fitton JH, 2015, MAR DRUGS, V13, P5920, DOI 10.3390/md13095920; Gaertner WB, 2008, J SURG RES, V146, P241, DOI 10.1016/j.jss.2007.08.012; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Hellebrekers BWJ, 2000, FERTIL STERIL, V74, P203, DOI 10.1016/S0015-0282(00)00656-7; Hindocha A, 2015, COCHRANE DB SYST REV, V6, P1; Holmdahl L, 1998, SURGERY, V123, P539, DOI 10.1067/msy.1998.86984; Imai A, 2010, EUR J OBSTET GYN R B, V149, P131, DOI 10.1016/j.ejogrb.2009.12.026; Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196; Jin WH, 2013, CARBOHYD POLYM, V91, P1, DOI 10.1016/j.carbpol.2012.07.067; Kumar S, 2009, COCHRANE DB SYST REV, V21, DOI [10.1002/14651858.CD005080.pub2/full, DOI 10.1002/14651858.CD005080.PUB2/FULL]; Lehman EP, 1940, ANN SURG, V112, P969, DOI 10.1097/00000658-194011000-00009; Maciver AH, 2011, INT J SURG, V9, P589, DOI 10.1016/j.ijsu.2011.08.008; Marana R, 2000, PERITONEAL SURG, P329; Millet J, 1999, THROMB HAEMOSTASIS, V81, P391; Min SK, 2012, BLOOD COAGUL FIBRIN, V23, P359, DOI 10.1097/MBC.0b013e3283518815; Min SK, 2012, PHYTOTHER RES, V26, P752, DOI 10.1002/ptr.3628; Morello S, 2012, VET SURG, V41, P568, DOI 10.1111/j.1532-950X.2012.00951.x; National Research Council, 2010, GUIDE CARE USE LAB A; Okabayashi K, 2014, SURG TODAY, V44, P405, DOI 10.1007/s00595-013-0591-8; Poman VH, 2009, BIOPOLYMERS, V93, P496; Preobrazhenskaya ME, 1997, BIOCHEM MOL BIOL INT, V43, P443; RAFTERY AT, 1973, J ANAT, V115, P375; Richardson EH, 1911, ANN SURG, V54, P758, DOI 10.1097/00000658-191112000-00004; Springate CMK., United States Patent Application, Patent No. [20110021457, Kind Code: A1, Application Number; 12/843992, 20110021457]; Ward BC, 2011, J SURG RES, V165, P91, DOI 10.1016/j.jss.2009.09.015	43	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207797	10.1371/journal.pone.0207797	http://dx.doi.org/10.1371/journal.pone.0207797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462732	Green Submitted, Green Published, gold			2022-12-26	WOS:000451054800086
J	Haapasalo, K; Wollman, AJM; de Haas, CJC; van Kessel, KPM; van Strijp, JAG; Leake, MC				Haapasalo, Karita; Wollman, Adam J. M.; de Haas, Carla J. C.; van Kessel, Kok P. M.; van Strijp, Jos A. G.; Leake, Mark C.			Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration	FASEB JOURNAL			English	Article						bacterial toxin; pore formation; single molecule; super-resolution; immune response	PANTON-VALENTINE LEUKOCIDIN; PORE-FORMING TOXINS; SINGLE-MOLECULE; CRYSTAL-STRUCTURE; POLYMORPHONUCLEAR LEUKOCYTES; C5A RECEPTOR; S-COMPONENT; PROTEIN; RESISTANT; STOICHIOMETRY	Staphylococcus aureus Panton-Valentine leukocidin is a pore-forming toxin targeting the human C5a receptor (hC5aR), enabling this pathogen to battle the immune response by destroying phagocytes through targeted lysis. The mechanisms that contribute to rapid cell lysis are largely unexplored. Here, we show that cell lysis may be enabled by a process of toxins targeting receptor clusters and present indirect evidence for receptor recycling that allows multiple toxin pores to be formed close together. With the use of live cell single-molecule super-resolution imaging, Forster resonance energy transfer and nanoscale total internal reflection fluorescence colocalization microscopy, we visualized toxin pore formation in the presence of its natural docking ligand. We demonstrate disassociation of hC5aR from toxin complexes and simultaneous binding of new ligands. This effect may free mobile receptors to amplify hyperinflammatory reactions in early stages of microbial infections and have implications for several other similar bicomponent toxins and the design of new antibiotics.Haapasalo, K., Wollman, A. J. M., de Haas, C. J. C., van Kessel, K. P. M., van Strijp, J. A. G., Leake, M. C. Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.	[Haapasalo, Karita; de Haas, Carla J. C.; van Kessel, Kok P. M.; van Strijp, Jos A. G.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Haapasalo, Karita] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Wollman, Adam J. M.; Leake, Mark C.] Univ York, Biol Phys Sci Inst, Dept Biol, York, N Yorkshire, England; [Leake, Mark C.] Univ York, Biol Phys Sci Inst, Dept Phys, York, N Yorkshire, England	Utrecht University; Utrecht University Medical Center; University of Helsinki; University of York - UK; University of York - UK	Leake, MC (corresponding author), Univ York, Biol Phys Sci Inst, York YO10 5DD, N Yorkshire, England.	mark.leake@york.ac.uk	Haapasalo, Karita/AAG-1215-2020; Wollman, Adam/F-2971-2015; van Strijp, Jos A.G./J-9549-2014	Wollman, Adam/0000-0002-5501-8131; van Strijp, Jos A.G./0000-0001-6253-0830; Leake, Mark/0000-0002-1715-1249; Haapasalo, Karita/0000-0002-9619-625X	Finnish Cultural Foundation [00131060, 00142390]; Biological Physical Sciences Institute; Royal Society; Medical Research Council (MRC) [MR/K01580X/1]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N006453/1]; Engineering and Physical Sciences Research Council (EPSRC) Physics of Life UK Network; Wellcome Trust through Centre for Future Health (CFH) at the University of York, United Kingdom [204829]; BBSRC [BB/N006453/1, BB/R001235/1, BB/P000746/1] Funding Source: UKRI; MRC [MR/K01580X/1] Funding Source: UKRI	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Biological Physical Sciences Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC) Physics of Life UK Network(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust through Centre for Future Health (CFH) at the University of York, United Kingdom; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Piet Aerts and Angelino Tromp (both from University Medical Center Utrecht) for assistance in sample preparation and labeling, Esther van't Veld and Richard Wubbolts [both from Utrecht University (UU)] for assistance with light microscopy, and Dr. Karin Strijbis (UU) for providing the sortase A enzyme. This work was supported by The Finnish Cultural Foundation (Grants 00131060 and 00142390); Biological Physical Sciences Institute, Royal Society, Medical Research Council (MRC; Grant MR/K01580X/1); Biotechnology and Biological Sciences Research Council (BBSRC; Grant BB/N006453/1); Engineering and Physical Sciences Research Council (EPSRC) Physics of Life UK Network; and Wellcome Trust (204829) through the Centre for Future Health (CFH) at the University of York, United Kingdom. The authors declare no conflicts of interest.	Amdahl H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172675; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Berends ETM, 2015, MOL IMMUNOL, V65, P328, DOI 10.1016/j.molimm.2015.01.020; Chiu SW, 2011, INT J MOL SCI, V12, P2518, DOI 10.3390/ijms12042518; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; Croker DE, 2013, IMMUNOL CELL BIOL, V91, P625, DOI 10.1038/icb.2013.48; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Delalez NJ, 2010, P NATL ACAD SCI USA, V107, P11347, DOI 10.1073/pnas.1000284107; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; EASMON CSF, 1976, INFECT IMMUN, V13, P399, DOI 10.1128/IAI.13.2.399-406.1976; FEARON DT, 1977, J EXP MED, V146, P22, DOI 10.1084/jem.146.1.22; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hirota N, 2010, J BIOL CHEM, V285, P5931, DOI 10.1074/jbc.M109.066282; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Koch G, 2014, CELL, V158, P1060, DOI 10.1016/j.cell.2014.06.046; LaChapelle S, 2009, J BIOL CHEM, V284, P12719, DOI 10.1074/jbc.M900772200; Laventie BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092094; Leake MC, 2014, PHYS CHEM CHEM PHYS, V16, P12635, DOI 10.1039/c4cp00219a; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Llorente-Garcia I, 2014, BBA-BIOENERGETICS, V1837, P811, DOI 10.1016/j.bbabio.2014.01.020; Meyer F, 2009, INFECT IMMUN, V77, P266, DOI 10.1128/IAI.00402-08; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Miller H, 2015, METHODS, V88, P81, DOI 10.1016/j.ymeth.2015.01.010; Moreno-Fernandez ME, 2016, AIDS RES HUM RETROV, V32, P399, DOI [10.1089/aid.2015.0099, 10.1089/AID.2015.0099]; Mullaly SC, 2006, J IMMUNOL, V177, P8154, DOI 10.4049/jimmunol.177.11.8154; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nocadello S, 2016, ACTA CRYSTALLOGR D, V72, P113, DOI 10.1107/S2059798315023207; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Pandya PH, 2014, AM J RESP CELL MOL, V51, P467, DOI 10.1165/rcmb.2013-0485TR; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Plank M, 2009, INTEGR BIOL-UK, V1, P602, DOI 10.1039/b907837a; Postma B, 2005, J BIOL CHEM, V280, P2020, DOI 10.1074/jbc.M412230200; Rabiet MJ, 2008, J BIOL CHEM, V283, P31038, DOI 10.1074/jbc.M805260200; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1; Robson A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0029; Spaan AN, 2017, NAT REV MICROBIOL, V15, P435, DOI 10.1038/nrmicro.2017.27; Spaan AN, 2015, J IMMUNOL, V195, P1034, DOI 10.4049/jimmunol.1500604; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Sugawara N, 1999, BIOSCI BIOTECH BIOCH, V63, P884, DOI 10.1271/bbb.63.884; Tromp AT, 2018, NAT MICROBIOL, V3, P708, DOI 10.1038/s41564-018-0159-x; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Unnewehr H, 2013, J IMMUNOL, V190, P4215, DOI 10.4049/jimmunol.1200534; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Veldkamp KE, 2000, INFECT IMMUN, V68, P5908, DOI 10.1128/IAI.68.10.5908-5913.2000; Veya L, 2015, J BIOL CHEM, V290, P27723, DOI 10.1074/jbc.M115.666677; von Kockritz-Blickwede M, 2010, J INNATE IMMUN, V2, P87, DOI 10.1159/000247157; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wollman AJM, 2015, FARADAY DISCUSS, V184, P401, DOI 10.1039/c5fd00077g; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yamashita D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5897; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	70	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3807	3824		10.1096/fj.201801910R	http://dx.doi.org/10.1096/fj.201801910R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509126	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-26	WOS:000459794800058
J	Ali, M; Roback, L; Mocarski, ES				Ali, Mohammad; Roback, Linda; Mocarski, Edward S.			Herpes simplex virus 1 ICP6 impedes TNF receptor 1-induced necrosome assembly during compartmentalization to detergent-resistant membrane vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid raft; caveolin; oligomerization; tumor necrosis factor (TNF); cell death; detergent-resistant membranes; necrosome; RHIM-signaling; RIPK1; RIPK3	MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; CELL-DEATH; PROGRAMMED NECROSIS; NECROPTOSIS; MLKL; PHOSPHORYLATION; SUPPRESSION; APOPTOSIS; REQUIRES	Receptor-interacting protein (RIP) kinase 3 (RIPK3)-dependent necroptosis directs inflammation and tissue injury, as well as anti-viral host defense. In human cells, herpes simplex virus 1 (HSV1) UL39-encoded ICP6 blocks RIP homotypic interacting motif (RHIM) signal transduction, preventing this leakage form of cell death and sustaining viral infection. TNF receptor 1 (TNFR1)-induced necroptosis is known to require the formation of a RIPK1-RIPK3-mixed lineage kinase domain-like pseudokinase (MLKL) signaling complex (necrosome) that we find compartmentalizes exclusively to caveolin-1-associated detergent-resistant membrane (DRM) vesicles in HT-29 cells. Translocation proceeds in the presence of RIPK3 kinase inhibitor GSK ' 840 or MLKL inhibitor necrosulfonomide but requires the kinase activity, as well as RHIM signaling of RIPK1. ICP6 impedes the translocation of RIPK1, RIPK3, and MLKL to caveolin-1-containing DRM vesicles without fully blocking the activation of RIPK3 or phosphorylation of MLKL. Consistent with the important contribution of RIPK1 RHIM-dependent recruitment of RIPK3, overexpression of RHIM-deficient RIPK3 results in phosphorylation of MLKL, but this does not lead to either translocation or necroptosis. Combined, these data reveal a critical role of RHIM signaling in the recruitment of the MLKL-containing necrosome to membrane vesicle-associated sites of aggregation. A similar mechanism is predicted for other RHIM-containing signaling adaptors, Z-nucleic acid-binding protein 1 (ZBP1) (also called DAI and DLM1), and TIR domain-containing adapter-inducing interferon-beta (TRIF).	[Ali, Mohammad; Roback, Linda; Mocarski, Edward S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Mocarski, ES (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	mocarski@emory.edu	Mocarski, Edward/ABC-2893-2020		Emory-Onyx (Amgen) Alliance Fund Award; Public Health Service from the National Institutes of Health [AI020211, AI118853]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118853, R01AI020211] Funding Source: NIH RePORTER	Emory-Onyx (Amgen) Alliance Fund Award(Amgen); Public Health Service from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an Emory-Onyx (Amgen) Alliance Fund Award (to M. A.) and Public Health Service Grants AI020211 and AI118853 from the National Institutes of Health (to E. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.451; Ali M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0371-x; Berger SB, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.9; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Daley-Bauer LP, 2017, P NATL ACAD SCI USA, V114, pE2786, DOI 10.1073/pnas.1616829114; Dovey CM, 2018, MOL CELL, V70, P936, DOI 10.1016/j.molcel.2018.05.010; Dufour F, 2011, J VIROL, V85, P8689, DOI 10.1128/JVI.00362-11; Dufour F, 2011, APOPTOSIS, V16, P256, DOI 10.1007/s10495-010-0560-2; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Guo HY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0868-3; Guo HY, 2015, MED MICROBIOL IMMUN, V204, P439, DOI 10.1007/s00430-015-0410-5; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Huang DL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00497-16; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Koehler H, 2017, P NATL ACAD SCI USA, V114, P11506, DOI 10.1073/pnas.1700999114; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li DR, 2017, ELIFE, V6, DOI 10.7554/eLife.27692.001; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Mocarski ES, 2015, VIROLOGY, V479, P160, DOI 10.1016/j.virol.2015.03.016; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Mompean M, 2018, CELL, V173, P1244, DOI 10.1016/j.cell.2018.03.032; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Omoto S, 2015, J BIOL CHEM, V290, P11635, DOI 10.1074/jbc.M115.646042; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Petrie EJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04714-7; Philipp S, 2010, P NATL ACAD SCI USA, V107, P1112, DOI 10.1073/pnas.0908486107; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tanzer MC, 2015, BIOCHEM J, V471, P255, DOI 10.1042/BJ20150678; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2008, J BIOL CHEM, V283, P16966, DOI 10.1074/jbc.C800051200; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vitiello G, 2015, SOFT MATTER, V11, P3003, DOI 10.1039/c4sm02769h; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Wertz IE, 2014, CURR OPIN CHEM BIOL, V23, P71, DOI 10.1016/j.cbpa.2014.10.011; WILLINGHAM MC, 1980, CELL, V21, P67, DOI 10.1016/0092-8674(80)90115-4; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Xie T, 2013, CELL REP, V5, P70, DOI 10.1016/j.celrep.2013.08.044; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001; Yu XL, 2016, J VIROL, V90, P1088, DOI 10.1128/JVI.02446-15	62	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					991	1004		10.1074/jbc.RA118.004651	http://dx.doi.org/10.1074/jbc.RA118.004651			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30504227	Green Published, hybrid			2022-12-26	WOS:000458670200023
J	Robertson, J; Yoshida, C; Gurnik, S; McGrogan, M; Davis, K; Arya, G; Murphy, SA; Nichani, A; Nash, JHE				Robertson, James; Yoshida, Catherine; Gurnik, Simone; McGrogan, Madison; Davis, Kristin; Arya, Gitanjali; Murphy, Stephanie A.; Nichani, Anil; Nash, John H. E.			An improved DNA array-based classification method for the identification of Salmonella serotypes shows high concordance between traditional and genotypic testing	PLOS ONE			English	Article								Previously we developed and tested the Salmonella GenoSerotyping Array (SGSA), which utilized oligonucleotide probes for O-and H-antigen biomarkers to perform accurate molecular serotyping of 57 Salmonella serotypes. Here we describe the development and validation of the ISO 17025 accredited second version of the SGSA (SGSA v. 2) with reliable and unambiguous molecular serotyping results for 112 serotypes of Salmonella which were verified both in silico and in vitro. Improvements included an expansion of the probe sets along with a new classifier tool for prediction of individual antigens and overall serotype from the array probe intensity results. The array classifier and probe sequences were validated in silico to high concordance using 36,153 draft genomes of diverse Salmonella serotypes assembled from public repositories. We obtained correct and unambiguous serotype assignments for 31,924 (88.30%) of the tested samples and a further 3,916 (10.83%) had fully concordant antigen predictions but could not be assigned to a single serotype. The SGSA v. 2 can directly use bacterial colonies with a limit of detection of 860 CFU/mL or purified DNA template at a concentration of 1.0 x 10(-1) ng/mu l. The SGSA v. 2 was also validated in the wet laboratory and certified using panel of 406 samples representing 185 different serotypes with correct antigen and serotype determinations for 60.89% of the panel and 18.31% correctly identified but an ambiguous overall serotype determination.	[Robertson, James; Gurnik, Simone; McGrogan, Madison; Davis, Kristin; Arya, Gitanjali; Murphy, Stephanie A.; Nichani, Anil; Nash, John H. E.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Guelph, ON, Canada; [Yoshida, Catherine] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, ON, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Robertson, J (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Guelph, ON, Canada.	james.robertson@canada.ca	Nash, John HE/P-2384-2017	Nash, John HE/0000-0003-2925-8710; Robertson, James/0000-0002-8534-5694	Public Health Agency of Canada; Government of Canada's Genomics RD Initiative	Public Health Agency of Canada; Government of Canada's Genomics RD Initiative	This work was funded by the Public Health Agency of Canada and the Government of Canada's Genomics R&D Initiative.	Braun SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046489; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465, DOI 10.1128/JCM.38.7.2465-2467.2000; Franklin K, 2011, J CLIN MICROBIOL, V49, P2954, DOI 10.1128/JCM.02347-10; Grimont P.A.D., ANTIGENIC FORMULAE S, V9th; Ke BX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-338; McQuiston JR, 2011, J CLIN MICROBIOL, V49, P565, DOI 10.1128/JCM.01323-10; Osman KM, 2014, PATHOG GLOB HEALTH, V108, P37, DOI 10.1179/2047773213Y.0000000118; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Robertson J, 2018, MICROBIAL GENOMICS, V4; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; World Health Organization, WHO EST GLOB BURD FO; Yoshida C, 2016, J CLIN MICROBIOL; Yoshida C, 2007, J MICROBIOL METH, V70, P261, DOI 10.1016/j.mimet.2007.04.018; Yoshida CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147101	14	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207550	10.1371/journal.pone.0207550	http://dx.doi.org/10.1371/journal.pone.0207550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513098	Green Published, Green Submitted, gold			2022-12-26	WOS:000452204800012
J	Ekundayo, TC; Okoh, AI				Ekundayo, Temitope Cyrus; Okoh, Anthony, I			A global bibliometric analysis of Plesiomonas-related research (1990-2017)	PLOS ONE			English	Article							SHIGELLOIDES SEPSIS; MENINGOENCEPHALITIS; INFECTIONS; DISEASE; TRENDS	Plesiomonas shigelloides is an emerging pathogen with damaging effects on human health such as gastroenteritis and extraintestinal infections. Here, we carried out a bibliometric survey that aimed to examine publication trends in Plesiomonas-related research by time and place, international collaborative works, identify gaps and suggest directions for future research. The search term "Plesiomonas shigelloides" was used to retrieve articles published between 1990 and 2017 from the Web of Science database. Only primary research articles were included in the analysis. A total of 155 articles were published within the survey period, with an average of 5.54 +/- 2.66 articles per year and an annual growth rate of -0.8%. Research output peaked in 2000 and 2006 (each accounting for 7.7% of the total). The United States ranked first in terms of numbers of articles (n = 29, 18.1%) and total citations (n = 451). Cameroon, Canada, Cuba, Switzerland and Turkey co-shared the 10th position each with 2 articles (1.3%). Research collaboration was low (collaboration index = 3.32). In addition to Plesiomonas shigelloides (n = 82, 52.9%), the top Authors Keywords and research focus included lipopolysaccharide and nuclear magnetic resonance (n = 13, 8.4%). Diarrhea (n = 43, 27.7%), Aeromonas species (n = 41, 26.5%) and infections (n = 31, 20.0%) were also highly represented in Keywords-Plus. Authors' collaborations and coupling networks formed two mega-clusters which nodes were shared solely by authors from high-income countries. The common conceptual framework in retrieved articles determined by K-means clustering revealed three clusters with sizes of 7, 16, and 29, representing research responses focused on extraintestinal and gastroenteritis, P. shigelloides lipopolysaccharide structure, and co-infections, respectively. Our bibliometric analysis revealed a global diminishing research in Plesiomonas; greater research outcomes from high-income countries compared to others and low collaboration with developing countries.	[Ekundayo, Temitope Cyrus; Okoh, Anthony, I] Univ Ft Hare, SAMRC Microbial Water Qual Monitoring Ctr, Alice, Eastern Cape, South Africa; [Ekundayo, Temitope Cyrus; Okoh, Anthony, I] Univ Ft Hare, Appl & Environm Microbiol Res Grp, Dept Biochem & Microbiol, Alice, Eastern Cape, South Africa; [Ekundayo, Temitope Cyrus] Univ Med Sci, Dept Biol Sci, Ondo City, Ondo State, Nigeria	University of Fort Hare; University of Fort Hare	Ekundayo, TC (corresponding author), Univ Ft Hare, SAMRC Microbial Water Qual Monitoring Ctr, Alice, Eastern Cape, South Africa.; Ekundayo, TC (corresponding author), Univ Ft Hare, Appl & Environm Microbiol Res Grp, Dept Biochem & Microbiol, Alice, Eastern Cape, South Africa.; Ekundayo, TC (corresponding author), Univ Med Sci, Dept Biol Sci, Ondo City, Ondo State, Nigeria.	cyruscyrusthem@gmail.com	CYRUS, EKUNDAYO/H-3302-2015; Okoh, Anthony I/P-1502-2016	CYRUS, EKUNDAYO/0000-0002-7781-3507; Okoh, Anthony/0000-0002-9770-085X	South Africa Medical Research Council (SAMRC); World Academy of Science; National Research Foundation	South Africa Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Academy of Science; National Research Foundation	We are grateful to the South Africa Medical Research Council (SAMRC), The World Academy of Science and the National Research Foundation for financial support. Conclusions arrived at, and opinions expressed are those of the authors and are not necessarily to be attributed to the NRF-TWAS or SAMRC.; The authors thank the South Africa Medical Research Council (SAMRC) and the National Research Foundation, The World Academy of Science (NRF-TWAS) for financial support. Conclusions arrived at and opinions expressed in this article are those of the authors and are not necessarily to be attributed to SAMRC or NRF-TWAS.	Al-Jabi SW, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0284-y; Albuquerque PC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005132; Alcaniz JP, 1995, AM J GASTROENTEROL; Aleixandre JL, 2005, SCIENTOMETRICS, DOI [10.1007/s11.92.015-1677-4, DOI 10.1007/S11.92.015-1677-4]; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Ampofo K, 2001, PEDIATR INFECT DIS J, V20, P1178, DOI 10.1097/00006454-200112000-00019; Aria M, 2017, J INFORMETR, V11, P959, DOI 10.1016/j.joi.2017.08.007; Auxiliadora-Martins M, 2010, HEART LUNG, V39, P335, DOI 10.1016/j.hrtlng.2009.06.015; Baker-Austin C, 2017, TRENDS MICROBIOL, V25, P76, DOI 10.1016/j.tim.2016.09.008; Bhavnani D, 2012, DIARRHEAL DIS NW ECU; Bonatti H, 2012, SURG INFECT, V13, P114, DOI 10.1089/sur.2010.018; Bowman JK, 2016, AM J EMERG MED, V34, DOI 10.1016/j.ajem.2015.12.046; Bruggmann D, 2016, CLIMACTERIC, V19, P463, DOI 10.1080/13697137.2016.1200548; Bundschuh M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-331; Chen M, 2016, GENE, V582, P47, DOI 10.1016/j.gene.2016.01.049; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077877; Chen Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.003; CLAESSON BEB, 1984, J CLIN MICROBIOL, V20, P985, DOI 10.1128/JCM.20.5.985-987.1984; CLARK RB, 1991, J INFECTION, V23, P89, DOI 10.1016/0163-4453(91)94217-8; Cruz-Calderon S, 2015, TRAVEL MED INFECT DI, V13, P202, DOI 10.1016/j.tmaid.2015.02.007; Ellegaard O, 2015, SCIENTOMETRICS, V105, P1809, DOI 10.1007/s11192-015-1645-z; Eschenbach DA, 2015, OBSTET GYNECOL, V125, P1042, DOI 10.1097/AOG.0000000000000795; FISCHER K, 1988, J CLIN MICROBIOL, V26, P2675, DOI 10.1128/JCM.26.12.2675-2677.1988; Fricke R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-454; Geaney F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133009; Glanzel W, 2001, SCIENTOMETRICS, V51, P69, DOI 10.1023/A:1010512628145; Gopal V, 1991, MIL MED; Groneberg DA, 2015, TUBERCULOSIS, V95, P515, DOI 10.1016/j.tube.2015.05.003; He Q., 1999, LIB TRENDS; Hustedt J.W., 2017, INFECT CONSUMPTION R, P32; Hustedt JW, 2017, AM J ORTHOP BELLE ME; Janda JM, 2016, CLIN MICROBIOL REV, V29, P349, DOI 10.1128/CMR.00103-15; Jonsson I, 1997, SCAND J INFECT DIS, V29, P631, DOI 10.3109/00365549709035909; KESSLER MM, 1963, AM DOC, V14, P10, DOI 10.1002/asi.5090140103; Klatte JM, 2012, PEDIATR INFECT DIS J, V31, P1200, DOI 10.1097/INF.0b013e318266b61f; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; LAW J, 1988, SCIENTOMETRICS, V14, P251, DOI 10.1007/BF02020078; Lewison G, 2008, ACTA TROP, V106, P96, DOI 10.1016/j.actatropica.2008.01.009; Li T, 2008, NEUROSCI LETT, V441, P248, DOI 10.1016/j.neulet.2008.06.044; Liu XJ, 2011, BIODIVERS CONSERV, V20, P807, DOI 10.1007/s10531-010-9981-z; Lotka AJ, 1926, J WASHINGT ACAD SCI; Aleixandre JL, 2015, SCIENTOMETRICS, V105, P295, DOI 10.1007/s11192-015-1677-4; Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005; Medema G, 1993, OCCURRENCE PLESIOMON; Newsom R., 1982, CLIN MICROBIOL NEWSL, V4, P158, DOI DOI 10.1016/S0196-4399(82)80049-4; Novoa-Farias O, 2016, REV GASTROENTEROL ME, V81, P3, DOI 10.1016/j.rgmx.2015.07.003; Ozdemir O, 2010, J MICROBIOL IMMUNOL, V43, P344, DOI 10.1016/S1684-1182(10)60053-9; Patel S, 2016, ACTA GASTROENTEROL B; Patino-Barbosa AM, 2016, J INFECT PUBLIC HEAL, V9, P532, DOI 10.1016/j.jiph.2015.10.001; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pence MA, 2016, J CLIN MICROBIOL, V54, P1180, DOI 10.1128/JCM.02651-15; Peng YL, 2015, SCIENTOMETRICS, V105, P347, DOI 10.1007/s11192-015-1666-7; Pfeiffer ML, 2012, J INFECTION, V64, P374, DOI 10.1016/j.jinf.2012.01.006; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Ramos JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-55; Roth T, 2002, CLIN MICROBIOL INFEC, V8, P803, DOI 10.1046/j.1469-0691.2002.00443.x; Rutala WA, 1982, LANCET, DOI [10.1016/S0140-6736(82)92647-2, DOI 10.1016/S0140-6736(82)92647-2]; Schneider F, 2009, MED MALADIES INFECT, V39, P397, DOI 10.1016/j.medmal.2008.11.010; Sweileh WM, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0233-9; Sweileh WM, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0076-7; Sweileh WM, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0214-4; Sweileh WM, 2017, GERMS, DOI [10.11599/germs.2017.1104, DOI 10.11599/GERMS.2017.1104]; Temitope C. E, 2017, RES J MED SCI, V11, P103; Tzanetea R, 2002, SCAND J INFECT DIS, V34, P687, DOI 10.1080/00365540210147877; Van Houten R, 1998, INFECT MED, V15, P495; Vanni T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093376; Vera-Polania F, 2015, J INFECT PUBLIC HEAL, V8, P386, DOI 10.1016/j.jiph.2015.03.006; Wong T. Y., 2000, Hong Kong Medical Journal, V6, P375; Wouafo M, 2006, FOODBORNE PATHOG DIS, V3, P209, DOI 10.1089/fpd.2006.3.209; Xia FQ, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-014-0107-1; Yi Fengyun, 2016, BMC Res Notes, V9, P221, DOI 10.1186/s13104-016-2026-2; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181; Zhang L, 2010, ECOL ENG, V36, P973, DOI 10.1016/j.ecoleng.2010.04.029; Zheng HC, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-28; Zyoud SH, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0178-8; Zyoud SH, 2017, SUBST ABUSE TREAT PR, V12, DOI 10.1186/s13011-017-0090-9; Zyoud SH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1600-5; Zyoud SH, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0534-2	79	56	59	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207655	10.1371/journal.pone.0207655	http://dx.doi.org/10.1371/journal.pone.0207655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496198	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800039
J	Grace, D; Gaspar, M; Paquette, R; Rosenes, R; Burchell, AN; Grennan, T; Salit, IE				Grace, Daniel; Gaspar, Mark; Paquette, Rachelle; Rosenes, Ron; Burchell, Ann N.; Grennan, Troy; Salit, Irving E.			HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study	PLOS ONE			English	Article							ANAL CANCER; YOUNG MEN; SEX; ATTITUDES; IMMUNOGENICITY; NARRATIVES; INFECTION; SAFETY; RISK	The human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Gay, bisexual, and other men who have sex with men (GBM) living with HIV are disproportionately impacted by HPV-associated anal cancer, with rates about 100-fold that of the general population. Fortunately, HPV vaccination has proven efficacy in preventing both anogenital warts (condyloma) in males and anal pre-cancers (anal intraepithelial neoplasia; AIN) in GBM up to the age of 26. We conducted in-depth, semi-structured interviews with 25 HIV-positive gay men in Toronto to gain an understanding of their knowledge and experiences related to HPV and the HPV vaccine. These participants were part of The HPV Screening and Vaccine Evaluation (HPV-SAVE) Study, and received invitations to have anal cancer screening from their primary care doctors. Interviews were analyzed following a Grounded Theory Approach. Most participants had not received the HPV vaccine. Men described a lack of prior knowledge of the health consequences of HPV for GBM living with HIV and financial barriers to vaccine access. Participants did not articulate concerns about vaccine safety. Men frequently reported initial beliefs that HPV was predominantly-or exclusively-a risk for females or young girls, and thus they had not considered the vaccine to be necessary. Some participants remained uncertain if the current availability of the vaccine, and their newly acquired knowledge of its importance, was "too little, too late" because of their age and/or HPV exposure. Improving access and uptake of HPV vaccination requires addressing both financial barriers to access as well as increasing HPV health literacy levels, particularly by reframing the long-standing gendered associations of HPV. Physicians should provide clear, tailored messages regarding HPV vaccination.	[Grace, Daniel; Gaspar, Mark] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Paquette, Rachelle; Salit, Irving E.] Toronto Gen Hosp, Toronto, ON, Canada; [Rosenes, Ron] Canadian HIV AIDS Legal Network, Toronto, ON, Canada; [Burchell, Ann N.] St Michaels Hosp, Toronto, ON, Canada; [Grennan, Troy] British Columbia Ctr Dis Control, Vancouver, BC, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Grace, D (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	daniel.grace@utoronto.ca	Grennan, Troy/AAH-5588-2020	Grace, Daniel/0000-0002-9032-3959	Canadian Institutes of Health Research (CIHR); Canadian HIV Trials network (CTN); Ontario HIV Treatment Network (OHTN)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials network (CTN); Ontario HIV Treatment Network (OHTN)	HPV-SAVE is funded by the Canadian Institutes of Health Research (CIHR), the Canadian HIV Trials network (CTN), and the Ontario HIV Treatment Network (OHTN). http://www.cihr-irsc.gc.ca/.IS is the NPI on this Award. DG was responsible for the qualitative study design and oversaw the data collection and the analysis of findings reported in this manuscript. The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Burchell AN, 2017, WORLD STI HIV C RIO; Charmaz C, 2006, GROUNDED THEORY PRAC, P4; Crum-Cianflone NF, 2010, AIDS, V24, P535, DOI 10.1097/QAD.0b013e328331f6e2; Dube E, 2016, Can Commun Dis Rep, V42, P246; Ellsworth GB, 2018, PAPILLOMAVIRUS RES, V6, P11, DOI 10.1016/j.pvr.2018.05.001; Fontenot HB, 2016, VACCINE, V34, P6209, DOI 10.1016/j.vaccine.2016.10.075; Gaspar M, 2018, HEALTH RISK SOC, V20, P276, DOI 10.1080/13698575.2018.1519114; Gay Men's Sexual Health Alliance, 2015, DOCT HIV AIDS ACT UR; Gerend MA, 2016, SEX TRANSM DIS, V43, P185, DOI 10.1097/OLQ.0000000000000408; Gilbert PA, 2011, J LOW GENIT TRACT DI, V15, P83, DOI 10.1097/LGT.0b013e3181f1a960; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Glaser B. G., 2004, FORUM QUALITATIVE SO, V5, P2, DOI DOI 10.17169/FQS-5.2.607]; Glaser BG, 2012, DISCOVERY GROUNDED T; Grace D, 2018, AIDS PATIENT CARE ST, V32, P24, DOI 10.1089/apc.2017.0153; Grace D, 2015, AIDS EDUC PREV, V27, P333, DOI 10.1521/aeap.2015.27.4.333; Grennan T, 2015, 30 INT PAP C LISB PO; Joint Committee on Vaccination and Immunisation, 2015, JCVI STAT HPV VACC M; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Levin MJ, 2010, JAIDS-J ACQ IMM DEF, V55, P197, DOI 10.1097/QAI.0b013e3181de8d26; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Moores A, 2015, CAN J HUM SEX, V24, P228, DOI 10.3138/cjhs.243-A6; Nadarzynski T, 2017, BRIT J HEALTH PSYCH, V22, P345, DOI 10.1111/bjhp.12233; Nadarzynski T, 2015, BRIT J CANCER, V113, P1599, DOI 10.1038/bjc.2015.403; Nadarzynski T, 2014, SEX TRANSM INFECT, V90, P515, DOI 10.1136/sextrans-2013-051357; National Advisory Committee on Immunization (NACI), 2012, CAN COMMUN DIS REP, V38, P1; Ontario Ministry of Health and Long-Term Care, 2017, GETT HPV VACC; Ontario Public Health Sexual Health Ontario, SEX HLTH ONT HPV GEN; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Public Health Agency of Canada, HUM PAP HPV PREV HPV; Rapley T., 2007, QUALITATIVE RES PRAC, P15; Remis RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158090; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Smith M, 2015, CAN MED ASSOC J, V187, pE337, DOI 10.1503/cmaj.109-5066; Swedish KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093393; Swedish KA, 2012, CLIN INFECT DIS, V54, P891, DOI 10.1093/cid/cir1036; Thomas EA, 2011, VACCINE, V29, P570, DOI 10.1016/j.vaccine.2010.09.101; Wheldon CW, 2017, HEALTH EDUC J, V76, P52, DOI 10.1177/0017896916647988; Wheldon CW, 2011, VACCINE, V29, P8060, DOI 10.1016/j.vaccine.2011.08.045; Wilkin T, 2010, J INFECT DIS, V202, P1246, DOI 10.1086/656320; Yang DY, 2016, CAN FAM PHYSICIAN, V62, P399	41	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207953	10.1371/journal.pone.0207953	http://dx.doi.org/10.1371/journal.pone.0207953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496221	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800068
J	Klein, DO; Rennenberg, RJMW; Koopmans, RP; Prins, MH				Klein, Dorthe O.; Rennenberg, Roger J. M. W.; Koopmans, Richard P.; Prins, Martin H.			Adverse event detection by medical record review is reproducible, but the assessment of their preventability is not	PLOS ONE			English	Review							GLOBAL TRIGGER TOOL; PATIENT SAFETY; HOSPITALS; RELIABILITY; HARM; CARE; METHODOLOGY; AGREEMENT; QUALITY; DEATHS	Objective To assess the reproducibility of adverse event evaluation by a medical record review committee. Design Cross-sectional reanalysis of medical records. Intervention Reviewers re-examined fifty medical records of deceased patients regarding the presence of adverse events, their potential preventability and their possible contribution to death. Also we investigated the root causes of the preventable AEs. Differences between the first and second assessment were calculated. Results The Kappa on the presence of an adverse event was 0.64 and 0.32 for the potential preventability. The intrarater agreement showed a Kappa of 0.61 on the adverse event presence and 0.64 for the potential preventability. Interrater agreement showed a Kappa of 0.66 for the adverse event presence and 0.03 for the potential preventability. Conclusion We found a fair reproducibility for the detection of adverse events, but a poor reproducibility for the potential preventability. Possibly this was caused by lack of a definition for the preventability of adverse events. We think giving feedback to professionals using the results of medical record review remains valuable, but an improvement of its reproducibility is essential. To our opinion an international consensus on what exactly constitutes preventability of adverse events and agreement on a definition is necessary. This would result in more comparable studies in this field and could then be more informative on the ideal procedure to avoid certain potentially preventable adverse events in the future.	[Klein, Dorthe O.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, Maastricht, Netherlands; [Rennenberg, Roger J. M. W.; Koopmans, Richard P.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Prins, Martin H.] Maastricht Univ, Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Klein, DO (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, Maastricht, Netherlands.	dorthe.klein@mumc.nl	Rennenberg, Roger/L-6552-2019					Baines RJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007380; Baines RJ, 2013, BMJ QUAL SAF, V22, P290, DOI 10.1136/bmjqs-2012-001126; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Brennan T A, 1991, Perspect Healthc Risk Manage, V11, P2; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BRENNAN TA, 1989, MED CARE, V27, P1148, DOI 10.1097/00005650-198912000-00006; Classen DC, 2008, J PATIENT SAF, V4, P169, DOI [DOI 10.1097/PTS.0B013E318183A475, 10.1097/pts.0b013e318183a475]; Contreary K, 2017, J COMP EFFECT RES, V6, P51, DOI 10.2217/cer-2016-0043; Coutts SB, 2003, STROKE, V34, P1681, DOI 10.1161/01.STR.0000078840.96473.20; Davis P. LYR, 2001, ADVERSE EVENTS NZ PU; de Wet C, 2009, POSTGRAD MED J, V85, P176, DOI 10.1136/pgmj.2008.075788; Forster AJ, 2004, CAN MED ASSOC J, V170, P1235, DOI 10.1503/cmaj.1030683; Hanskamp-Sebregts M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011078; He L, 2016, J NEUROSURG-PEDIATR, V18, P320, DOI 10.3171/2016.3.PEDS15648; Hofer TP, 2000, MED CARE, V38, P152, DOI 10.1097/00005650-200002000-00005; Hogan H, 2012, BMJ QUAL SAF, V21, P737, DOI 10.1136/bmjqs-2011-001159; Kessomboon Pattapong, 2005, Journal of the Medical Association of Thailand, V88, P1412; Klein Dorthe O, 2017, Prev Med Rep, V8, P250, DOI 10.1016/j.pmedr.2017.10.016; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Localio AR, 1996, ANN INTERN MED, V125, P457, DOI 10.7326/0003-4819-125-6-199609150-00005; Manaseki-Holland S, 2017, BMJ QUAL SAF, V26, P408, DOI 10.1136/bmjqs-2015-004849; Millwood Sinead, 2014, BMJ Qual Improv Rep, V3, DOI 10.1136/bmjquality.u203658.w2114; Mirza SK, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-53; Mooney MA, 2016, J NEUROSURG, P1, DOI [10.3171/2015.9.JNS152183.test, DOI 10.3171/2016.3.JNS153044]; Mortaro A, 2021, J PATIENT SAF, V17, P451, DOI 10.1097/PTS.0000000000000381; Najjar S, 2013, INT J QUAL HEALTH C, V25, P640, DOI 10.1093/intqhc/mzt066; O'Leary KJ, 2013, BMJ QUAL SAF, V22, P130, DOI 10.1136/bmjqs-2012-001102; Ramnarayan P, 2003, J AM MED INFORM ASSN, V10, P563, DOI 10.1197/jamia.M1338; Resar RK, 2003, QUAL SAF HEALTH CARE, V12, pII39, DOI 10.1136/qhc.12.suppl_2.ii39; Rutberg H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004879; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Sharek PJ, 2011, HEALTH SERV RES, V46, P654, DOI 10.1111/j.1475-6773.2010.01156.x; Soop M, 2009, INT J QUAL HEALTH C, V21, P285, DOI 10.1093/intqhc/mzp025; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Thomas EJ, 2002, ANN INTERN MED, V136, P812, DOI 10.7326/0003-4819-136-11-200206040-00009; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Wagner C, 2005, MED CONTACT, V60, P1888; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; Wolf ZR, 2008, PATIENT SAFETY QUALI; Zegers M, 2010, J CLIN EPIDEMIOL, V63, P94, DOI 10.1016/j.jclinepi.2009.03.004; Zwaan L, 2010, ARCH INTERN MED, V170, P1015, DOI 10.1001/archinternmed.2010.146	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208087	10.1371/journal.pone.0208087	http://dx.doi.org/10.1371/journal.pone.0208087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496243	gold, Green Submitted, Green Published			2022-12-26	WOS:000451763800092
J	Klein, R; Linciano, P; Celenza, G; Bellio, P; Papaioannou, S; Blazquez, J; Cendron, L; Brenk, R; Tondi, D				Klein, Raphael; Linciano, Pasquale; Celenza, Giuseppe; Bellio, Pierangelo; Papaioannou, Sofia; Blazquez, Jesus; Cendron, Laura; Brenk, Ruth; Tondi, Donatella			In silico identification and experimental validation of hits active against KPC-2 beta-lactamase	PLOS ONE			English	Article							CLASS-A; CARBAPENEM HYDROLYSIS; CRYSTAL-STRUCTURES; LIGAND EFFICIENCY; STRUCTURAL BASIS; BORONIC ACID; DOCKING; INHIBITORS; SUBSTRATE; COMPLEX	Bacterial resistance has become a worldwide concern, particularly after the emergence of resistant strains overproducing carbapenemases. Among these, the KPC-2 carbapenemase represents a significant clinical challenge, being characterized by a broad substrate spectrum that includes aminothiazoleoxime and cephalosporins such as cefotaxime. Moreover, strains harboring KPC-type beta-lactamases are often reported as resistant to available beta-lactamase inhibitors (clavulanic acid, tazobactam and sulbactam). Therefore, the identification of novel non beta-lactam KPC-2 inhibitors is strongly necessary to maintain treatment options. This study explored novel, non-covalent inhibitors active against KPC-2, as putative hit candidates. We performed a structure-based in silico screening of commercially available compounds for non-beta-lactam KPC-2 inhibitors. Thirty-two commercially available high-scoring, fragment-like hits were selected for in vitro validation and their activity and mechanism of action vs the target was experimentally evaluated using recombinant KPC-2. N-(3-(1H-tetrazol-5-yl)phenyl)-3-fluorobenzamide (11a), in light of its ligand efficiency (LE = 0.28 kcal/mol/non-hydrogen atom) and chemistry, was selected as hit to be directed to chemical optimization to improve potency vs the enzyme and explore structural requirement for inhibition in KPC-2 binding site. Further, the compounds were evaluated against clinical strains over-expressing KPC-2 and the most promising compound reduced the MIC of the beta-lactam antibiotic meropenem by four-fold.	[Klein, Raphael] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Mainz, Germany; [Linciano, Pasquale; Papaioannou, Sofia; Tondi, Donatella] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Modena, Italy; [Celenza, Giuseppe; Bellio, Pierangelo] Univ Aquila, Dipartimento Sci Clin Appl & Biotecnol, Laquila, Italy; [Blazquez, Jesus] Campus Univ Autonoma Cantoblanco, CSIC, Natl Ctr Biotechnol, Dept Microbial Biotechnol, Madrid, Spain; [Cendron, Laura] Univ Padua, Dipartimento Biol, Padua, Italy; [Brenk, Ruth] Univ Bergen, Dept Biomed, Bergen, Norway	Johannes Gutenberg University of Mainz; Universita di Modena e Reggio Emilia; University of L'Aquila; Consejo Superior de Investigaciones Cientificas (CSIC); University of Padua; University of Bergen	Tondi, D (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Modena, Italy.; Brenk, R (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	Ruth.Brenk@uib.no; donatella.tondi@unimore.it	Bellio, Pierangelo/AAM-7096-2020; Blazquez, Jesus/T-4680-2017; LINCIANO, PASQUALE/AAL-7527-2020; Tondi, Donatella/B-3856-2015; Celenza, Giuseppe/A-4940-2016	Blazquez, Jesus/0000-0003-0495-3848; LINCIANO, PASQUALE/0000-0003-0382-7479; Tondi, Donatella/0000-0002-5195-5531; Celenza, Giuseppe/0000-0003-2796-9228; Brenk, Ruth/0000-0002-6204-5488; Bellio, Pierangelo/0000-0001-6488-8027; Klein, Raphael/0000-0002-5087-8730	Fondo di Ricerca di Ateneo UNIMORE	Fondo di Ricerca di Ateneo UNIMORE	Funded by Fondo di Ricerca di Ateneo UNIMORE (DT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Babaoglu K, 2006, NAT CHEM BIOL, V2, P720, DOI 10.1038/nchembio831; Bembenek SD, 2009, DRUG DISCOV TODAY, V14, P278, DOI 10.1016/j.drudis.2008.11.007; Brem J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12406; Brenk R, 2005, J BIOMOL SCREEN, V10, P667, DOI 10.1177/1087057105281047; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Celenza G, 2018, CHEMMEDCHEM, V13, P713, DOI 10.1002/cmdc.201700788; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Crompton R, 2016, LAB INVEST, V96, P439, DOI 10.1038/labinvest.2015.160; Danishuddin M, 2015, METHODS, V71, P135, DOI 10.1016/j.ymeth.2014.10.019; Farina D, 2014, CURR MED CHEM, V21, P1405, DOI 10.2174/09298673113206660323; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Fonseca F, 2012, J AM CHEM SOC, V134, P18275, DOI 10.1021/ja304460j; Frere JM, 2016, CURR DRUG TARGETS, V17, P974, DOI 10.2174/1389450116666151001112859; Genovese F, 2017, MED CHEM RES, V26, P975, DOI 10.1007/s00044-017-1809-x; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Ito JI, 2012, NUCLEIC ACIDS RES, V40, P541, DOI [10.1093/nar/gkr701, DOI 10.1093/NAR/GKR701]; Ito J, 2015, NUCLEIC ACIDS RES, V43, pD392, DOI 10.1093/nar/gku1144; Ke W, 2012, ANTIMICROB AGENTS CH, V56, P2713, DOI 10.1128/AAC.06099-11; Khan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108246; Krishnan NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136813; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Lorber DM, 1998, PROTEIN SCI, V7, P938; Mpamhanga CP, 2009, J MED CHEM, V52, P4454, DOI 10.1021/jm900414x; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Naas T, 2016, CURR DRUG TARGETS, V17, P1006, DOI 10.2174/1389450117666160310144501; Nichols DA, 2012, J MED CHEM, V55, P2163, DOI 10.1021/jm2014138; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Pemberton OA, 2017, J MED CHEM, V60, P3525, DOI 10.1021/acs.jmedchem.7b00158; Popa-Burke IG, 2004, ANAL CHEM, V76, P7278, DOI 10.1021/ac0491859; Popa-Burke I, 2014, J BIOMOL SCREEN, V19, P1302, DOI 10.1177/1087057114541146; Quotadamo A, 2016, SYNLETT, V27, P2447, DOI 10.1055/s-0035-1562454; Santucci M, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Tomanicek SJ, 2013, J BIOL CHEM, V288, P4715, DOI 10.1074/jbc.M112.436238; Tondi D, 2016, CURR DRUG TARGETS, V17, P983, DOI 10.2174/1389450116666151001104448; Tondi D, 2014, J MED CHEM, V57, P5449, DOI 10.1021/jm5006572; Verdonk ML, 2011, J MED CHEM, V54, P5422, DOI 10.1021/jm200558u; Vijayadas KN, 2012, CHEM COMMUN, V48, P9747, DOI 10.1039/c2cc34533a; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0203241	10.1371/journal.pone.0203241	http://dx.doi.org/10.1371/journal.pone.0203241			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496182	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800008
J	Jimenez, V; Moreno, R; Settles, E; Currie, BJ; Keim, P; Monroy, FP				Jimenez, Victor, Jr.; Moreno, Ryan; Settles, Erik; Currie, Bart J.; Keim, Paul; Monroy, Fernando P.			A mouse model of binge alcohol consumption and Burkholderia infection	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; ETHANOL; EXPOSURE; INHIBITION; EXPRESSION; JUNCTIONS; RESPONSES; IMMUNITY; C57BL/6; SEPSIS	Background Binge drinking, an increasingly common form of alcohol consumption, is associated with increased mortality and morbidity; yet, its effects on the immune system's ability to defend against infectious agents are poorly understood. Burkholderia pseudomallei, the causative agent of melioidosis can occur in healthy humans, yet binge alcohol use is progressively being recognized as a major risk factor. Although our previous studies demonstrated that binge alcohol exposure results in reduced alveolar macrophage function and increased Burkholderia virulence in vitro, no experimental studies have investigated the outcomes of binge alcohol on Burkholderia spp. infection in vivo. Principal findings In this study, we used the close genetic relatives of B. pseudomallei, B. thailandensis E264 and B. vietnamiensis, as useful BSL-2 model systems. Eight-week-old female C57BL/6 mice were administered alcohol comparable to human binge drinking episodes (4.4 g/kg) or PBS intraperitoneally 30 min before a non-lethal intranasal infection. In an initial B. thailandensis infection (3 x 10(5)), bacteria accumulated in the lungs and disseminated to the spleen in alcohol administered mice only, compared with PBS treated mice at 24 h PI. The greatest bacterial load occurred with B. vietnamiensis (1 x 10(6)) in lungs, spleen, and brain tissue by 72 h PI. Pulmonary cytokine expression (TNF-alpha, GM-CSF) decreased, while splenic cytokine (IL-10) increased in binge drunk mice. Increased lung and brain permeability was observed as early as 2 h post alcohol administration in vivo. Trans-epithelial electrical resistance (TEER) was significantly decreased, while intracellular invasion of non-phagocytic cells increased with 0.2% v/v alcohol exposure in vitro. Conclusions Our results indicate that a single binge alcohol dose suppressed innate immune functions and increased the ability of less virulent Burkholderia strains to disseminate through increased barrier permeability and intracellular invasion of non-phagocytic cells.	[Jimenez, Victor, Jr.; Moreno, Ryan; Settles, Erik; Keim, Paul; Monroy, Fernando P.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Jimenez, Victor, Jr.; Settles, Erik; Keim, Paul; Monroy, Fernando P.] No Arizona Univ, PMI, Flagstaff, AZ 86011 USA; [Currie, Bart J.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia	Northern Arizona University; Northern Arizona University; Charles Darwin University; Menzies School of Health Research	Monroy, FP (corresponding author), No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA.	Fernando.monroy@nau.edu	Jimenez, Victor M./AAT-4951-2021	Keim, Paul/0000-0003-0089-5820; Monroy, Fernando/0000-0002-3466-7466; Currie, Bart/0000-0002-8878-8837; Settles, Erik/0000-0003-4331-3683	US Department of Defense Chemical and Biological Defense Program through the Defense Threat Reduction Agency [HDTRA1-14-C-0022]	US Department of Defense Chemical and Biological Defense Program through the Defense Threat Reduction Agency	This study was made possible by funding from the US Department of Defense Chemical and Biological Defense Program through the Defense Threat Reduction Agency (grant ID HDTRA1-14-C-0022; www.dtra.mil/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwood EM, 2011, FRONT MICROBIOL, V170, P1; ANTONY VB, 1993, ALCOHOL CLIN EXP RES, V17, P389, DOI 10.1111/j.1530-0277.1993.tb00781.x; Balda MS, 2007, S EX GEST TECN 4 200, P1; Basuroy S, 2005, AM J PHYSIOL-GASTR L, V289, pG367, DOI 10.1152/ajpgi.00464.2004; BERMUDEZ LE, 1993, J INFECT DIS, V168, P961, DOI 10.1093/infdis/168.4.961; Bhatty M, 2017, ALCOHOL, V63, P9, DOI 10.1016/j.alcohol.2016.11.007; Bhatty M, 2011, ALCOHOL, V45, P795, DOI 10.1016/j.alcohol.2011.07.003; Bhatty M, 2011, ALCOHOL, V45, P523, DOI 10.1016/j.alcohol.2011.02.305; Boe DM, 2001, J INFECT DIS, V184, P1134, DOI 10.1086/323661; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; Currie BJ, 2004, TROP MED INT HEALTH, V9, P1167, DOI 10.1111/j.1365-3156.2004.01328.x; DSouza El-Guindy N. K JE, 2010, ALCOHOL CLIN EXP RES, V34, P997, DOI [10.1016/j.micpath.2009.10.004, DOI 10.1016/J.MICPATH.2009.10.004]; Eysseric H, 1997, ALCOHOL, V14, P111, DOI 10.1016/S0741-8329(96)00112-7; Fehlner-Gardiner CC, 2002, MICROB PATHOGENESIS, V32, P249, DOI 10.1006/mpat.2002.0503; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Gordon SB, 2000, INFECT IMMUN, V68, P2286, DOI 10.1128/IAI.68.4.2286-2293.2000; Hall CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143254; JERRELLS TR, 1995, ALCOHOL CLIN EXP RES, V19, P11, DOI 10.1111/j.1530-0277.1995.tb01466.x; Jimenez V, 2017, ALCOHOL, V64, P55, DOI 10.1016/j.alcohol.2017.04.004; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Joshi PC, 2005, J IMMUNOL, V175, P6837, DOI 10.4049/jimmunol.175.10.6837; Kespichayawattana W, 2004, MICROB PATHOGENESIS, V36, P287, DOI 10.1016/j.micpath.2004.01.001; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Lim JP, 2012, BRAIN BEHAV, V2, P22, DOI 10.1002/brb3.29; Mir H, 2016, BBA-GEN SUBJECTS, V1860, P765, DOI 10.1016/j.bbagen.2015.12.013; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Morici LA, 2010, MICROB PATHOGENESIS, V48, P9, DOI 10.1016/j.micpath.2009.10.004; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Pruett SB, 2004, J IMMUNOL, V173, P2715, DOI 10.4049/jimmunol.173.4.2715; Samuelson DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006426; Sarovich DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091682; Settles EW, 2014, INFECT IMMUN, V82, P1343, DOI 10.1128/IAI.01259-13; Sibley D, 2000, J INFECT DIS, V182, P482, DOI 10.1086/315728; St John JA, 2016, INFECT IMMUN, V84, P2681, DOI 10.1128/IAI.00361-16; Steve Nelson, 1991, EFFECTS ETHANOL TUMO, P245; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Tuanyok A, 2017, APPL ENVIRON MICROB, V83, P1; Wang Y, 2014, MOL MED REP, V9, P2352, DOI 10.3892/mmr.2014.2126; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46	47	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208061	10.1371/journal.pone.0208061	http://dx.doi.org/10.1371/journal.pone.0208061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485380	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800100
J	Yao, CF; Wang, C; Li, YR; Zavortink, M; Archambault, V; Girton, J; Johansen, KM; Johansen, J				Yao, Changfu; Wang, Chao; Li, Yeran; Zavortink, Michael; Archambault, Vincent; Girton, Jack; Johansen, Kristen M.; Johansen, Jorgen			Evidence for a role of spindle matrix formation in cell cycle progression by antibody perturbation	PLOS ONE			English	Article							NUCLEAR-ENVELOPE; CHROMODOMAIN PROTEIN; PHASE-TRANSITION; MITOTIC MEMBRANE; JIL-1 KINASE; MITOSIS; APPARATUS; INTERACTS; CHROMATOR; LOCALIZES	In Drosophila it has recently been demonstrated that a spindle matrix in the form of a membrane-less macromolecular assembly embeds the microtubule-based spindle apparatus. In addition, two of its constituents, Megator and Chromator, were shown to function as spatial regulators of spindle checkpoint proteins. However, whether the spindle matrix plays a wider functional role in spatially regulating cell cycle progression factors was unknown. Here using a live imaging approach we provide evidence that a number of key cell cycle proteins such as Cyclin B, Polo, and Ran co-localize with the spindle matrix during mitosis. Furthermore, prevention of spindle matrix formation by injection of a function blocking antibody against the spindle matrix protein Chromator results in cell cycle arrest prior to nuclear envelope breakdown. In such embryos the spatial dynamics of Polo and Cyclin B enrichment at the nuclear rim and kinetochores is abrogated and Polo is not imported into the nucleus. This is in contrast to colchicine-arrested embryos where the wild-type dynamics of these proteins are maintained. Taken together these results suggest that spindle matrix formation may be a general requirement for the localization and proper dynamics of cell cycle factors promoting signaling events leading to cell cycle progression.	[Yao, Changfu; Wang, Chao; Li, Yeran; Zavortink, Michael; Girton, Jack; Johansen, Kristen M.; Johansen, Jorgen] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Archambault, Vincent] Inst Rech Immunol & Cancerol, Montreal, PQ, Canada	Iowa State University; Universite de Montreal	Johansen, KM; Johansen, J (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	kristen@iastate.edu; jorgen@iastate.edu			National Science Foundation [MCB0817107]; VA, Natural Sciences and Engineering Research Council of Canada; United States Department of Agriculture National Institute of Food and Agriculture, Hatch project [1006350]	National Science Foundation(National Science Foundation (NSF)); VA, Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States Department of Agriculture National Institute of Food and Agriculture, Hatch project	This work was supported by: KMJ and JJ, MCB0817107, National Science Foundation, www.nsf.gov < http://www.nsf.gov >; VA, Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca; JG, United States Department of Agriculture National Institute of Food and Agriculture, https://www.nifa.usda.gov, Hatch project 1006350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2007, PLOS GENET, V3; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bergman ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117859; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Brust-Mascher I, 2009, JOVE-J VIS EXP, V31, pe1382; Brust-Mascher Ingrid, 2009, J Vis Exp, DOI 10.3791/1382; Civelekoglu-Scholey G, 2010, J CELL BIOL, V188, P49, DOI 10.1083/jcb.200908150; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; De Souza CP, 2009, TRENDS GENET, V25, P545, DOI 10.1016/j.tig.2009.10.005; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Ding Y, 2009, DEV BIOL, V334, P253, DOI 10.1016/j.ydbio.2009.07.027; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HAREL A, 1989, J CELL SCI, V94, P463; Helmke KJ, 2013, INT REV CEL MOL BIO, V306, P83, DOI 10.1016/B978-0-12-407694-5.00003-1; HEPLER PK, 1980, J CELL BIOL, V86, P490, DOI 10.1083/jcb.86.2.490; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Johansen KM, 2011, CHROMOSOME RES, V19, P345, DOI 10.1007/s10577-011-9187-6; Kachaner D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01876-8; Knockenhauer KE, 2016, CELL, V164, P1162, DOI 10.1016/j.cell.2016.01.034; Kramer J, 2003, NAT CELL BIOL, V5, P261, DOI 10.1038/ncb944; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; McCleland ML, 2008, CURR BIOL, V18, P245, DOI 10.1016/j.cub.2008.01.041; McCleland ML, 2009, J CELL BIOL, V184, P639, DOI 10.1083/jcb.200810012; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Morris RL, 2001, METH MOL B, V164, P163; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027; Poirier CC, 2010, BIOPHYS J, V99, P3182, DOI 10.1016/j.bpj.2010.09.053; Qi HY, 2005, J CELL BIOCHEM, V95, P1284, DOI 10.1002/jcb.20495; Qi HY, 2004, MOL BIOL CELL, V15, P4854, DOI 10.1091/mbc.E04-07-0579; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Sambrook J., 2001, MOL CLONING LAB MANU; Schweizer N, 2014, CURR OPIN CELL BIOL, V28, P1, DOI 10.1016/j.ceb.2014.01.002; Schweizer N, 2013, J CELL BIOL, V203, P883, DOI 10.1083/jcb.201309076; STAFSTROM JP, 1984, EUR J CELL BIOL, V34, P179; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Walker DL, 2000, J CELL BIOL, V151, P1401, DOI 10.1083/jcb.151.7.1401; Wang P, 2013, J CELL BIOL, V202, P277, DOI 10.1083/jcb.201211141; WISE D, 1984, CHROMOSOMA, V90, P156, DOI 10.1007/BF00292453; Woodruff JB, 2018, J MOL BIOL; Wozniak R, 2010, CELL MOL LIFE SCI, V67, P2215, DOI 10.1007/s00018-010-0325-7; Yao CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103855; Yao CF, 2012, MOL BIOL CELL, V23, P3532, DOI 10.1091/mbc.E12-06-0429; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919	52	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208022	10.1371/journal.pone.0208022	http://dx.doi.org/10.1371/journal.pone.0208022			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485354	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800095
J	Leniowski, K; Wegrzyn, E				Leniowski, Konrad; Wegrzyn, Ewa			Equal division of parental care enhances nestling development in the Blackcap	PLOS ONE			English	Article							SYLVIA-ATRICAPILLA; SEXUAL CONFLICT; GREAT TITS; REPRODUCTIVE SUCCESS; BROOD SIZE; SURVIVAL; RATES; COMPATIBILITY; CONSEQUENCES; MANIPULATION	Because parental care is costly, conflict between mates over their roles in reproduction seems unavoidable unless they both benefit from parental labour split equally between partners. In the current paper we analyse the division of parental investment in the Blackcap (Sylvia atricapilla), a species that experiences high nest predation. We show that both sexes invest in the incubation of eggs as well as feeding and brooding nestlings at a similar level. We also found that pairs which divided feeding duties more equally produced nestlings that grew faster. Faster nestling development enables earlier fledging in case of predation attempts at the end of nesting period. Thus parents who more evenly participate in provisioning may benefit from higher breeding success. Our findings suggest that in species under high risk of nest predation disparity in parental investment may not provide much benefit to parent's residual reproductive value and that equality in parental duties constitutes a winning strategy.	[Leniowski, Konrad] Univ Rzeszow, Fac Biotechnol, Lab Bioacoust & Spectrophotometry, Rzeszow, Poland; [Wegrzyn, Ewa] Univ Rzeszow, Fac Biotechnol, Dept Zool, Rzeszow, Poland	University of Rzeszow; University of Rzeszow	Wegrzyn, E (corresponding author), Univ Rzeszow, Fac Biotechnol, Dept Zool, Rzeszow, Poland.	songbird.ewa@gmail.com		Leniowski, Konrad/0000-0002-1784-8978; Wegrzyn, Ewa/0000-0003-1459-6012				AlRashidi M, 2011, ANIM BEHAV, V82, P235, DOI 10.1016/j.anbehav.2011.04.019; AlRashidi M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-1; Amat JA, 1999, IBIS, V141, P596, DOI 10.1111/j.1474-919X.1999.tb07367.x; Apanius V., 1998, AVIAN GROWTH DEV EVO; Arnqvist Goran, 2005, pUnpaginated; Balshine-Earn S, 1998, P ROY SOC B-BIOL SCI, V265, P2217, DOI 10.1098/rspb.1998.0562; Banbura J, 2001, SEX DIFFERENCES PARE, P517; Barta ZN, 2002, AM NAT, V159, P687, DOI 10.1086/339995; BOSQUE C, 1995, AM NAT, V145, P234, DOI 10.1086/285738; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Bowers EK, 2014, BEHAV ECOL, V25, P1485, DOI 10.1093/beheco/aru153; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Christe P, 1996, ANIM BEHAV, V52, P1087, DOI 10.1006/anbe.1996.0256; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Conrad F, 1993, PATTERNS PARENTAL PR; Davies N.B., 1991, P263; Drent R., 1975, AVIAN BIOL, P333; Gabriel PO, 2012, ETHOLOGY, V118, P76, DOI 10.1111/j.1439-0310.2011.01990.x; Glutz Von Blotzheim U.N., 1993, HDB VOGEL MITTELEURO; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; Hua FY, 2014, BEHAV ECOL, V25, P509, DOI 10.1093/beheco/aru017; Hurtrez-Bousses S, 1998, ECOL LETT, V1, P17, DOI 10.1046/j.1461-0248.1998.00017.x; Ihle M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002248; Johnstone RA, 2014, BEHAV ECOL, V25, P216, DOI 10.1093/beheco/art109; Krystofkova M, 2006, PARENTAL FORAGING ST; Lack D., 1968, pvii; Leniowski K, 2013, BLACKCAPS WIN HOST E, P49; Lessells C, 1999, MONOGRAPHS BEHAV ECO, P97; Ligon JD, 1999, EVOLUTION AVIAN BREE; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; Mariette MM, 2012, J AVIAN BIOL, V43, P131, DOI 10.1111/j.1600-048X.2012.05555.x; Martin TE, 2002, P ROY SOC B-BIOL SCI, V269, P309, DOI 10.1098/rspb.2001.1879; Martin TE, 2011, EVOLUTION, V65, P1607, DOI 10.1111/j.1558-5646.2011.01227.x; MERINO S, 1995, OIKOS, V73, P95, DOI 10.2307/3545730; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; NUR N, 1988, EVOLUTION, V42, P351, DOI 10.1111/j.1558-5646.1988.tb04138.x; Olson VA, 2008, P ROY SOC B-BIOL SCI, V275, P301, DOI 10.1098/rspb.2007.1395; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Perrins C.M., 1979, BRIT TITS; PINKOWSKI BC, 1977, CONDOR, V79, P289, DOI 10.2307/1368006; Redfern Chris P. F., 2010, Ringing & Migration, V25, P27; Remes V, 2003, CONSERV BIOL, V17, P1127, DOI 10.1046/j.1523-1739.2003.01611.x; Remes Vladimir, 2003, Sylvia, V39, P25; RICKLEFS RE, 1969, ECOLOGY, V50, P1031, DOI 10.2307/1936894; ROBY DD, 1992, WILSON BULL, V104, P630; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Royle NJ, 2002, NATURE, V416, P733, DOI 10.1038/416733a; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Shouse B, 2003, SCIENCE, V299, P644, DOI 10.1126/science.299.5607.644; SILVER R, 1985, AM ZOOL, V25, P823; SILVERIN B, 1980, ANIM BEHAV, V28, P906, DOI 10.1016/S0003-3472(80)80152-7; Spoon TR, 2006, ANIM BEHAV, V71, P315, DOI 10.1016/j.anbehav.2005.03.034; Storch D, 1998, FOLIA ZOOL, V47, P181; Szekely T, 2007, J ORNITHOL, V148, pS211, DOI 10.1007/s10336-007-0218-1; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Wegrzyn E, 2015, IBIS, V157, P356, DOI 10.1111/ibi.12231; Wegrzyn E, 2013, J AVIAN BIOL, V44, P383, DOI 10.1111/j.1600-048X.2013.05846.x; Wegrzyn E, 2011, ARDEOLA, V58, P113; Weidinger K, 2000, ARDEA, V88, P225; Weidinger K, 2002, J ANIM ECOL, V71, P424, DOI 10.1046/j.1365-2656.2002.00611.x; WHITWORTH TL, 1992, CAN J ZOOL, V70, P2184, DOI 10.1139/z92-295; WRIGHT J, 1989, BEHAV ECOL SOCIOBIOL, V25, P171, DOI 10.1007/BF00302916	67	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207757	10.1371/journal.pone.0207757	http://dx.doi.org/10.1371/journal.pone.0207757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481200	Green Published, gold, Green Submitted			2022-12-26	WOS:000451440000022
J	Delos Santos, GB; Devine, MY; Wetterlin, J; Firmiss, PR; Kukulka, NA; Bowen, DK; Gong, EM; Dettman, RW				Delos Santos, Grace B.; Devine, Megan Y.; Wetterlin, Jessica; Firmiss, Paula R.; Kukulka, Natalie A.; Bowen, Diana K.; Gong, Edward M.; Dettman, Robert W.			Compensatory regrowth of the mouse bladder after partial cystectomy	PLOS ONE			English	Article							OUTLET OBSTRUCTION; REGENERATION; MUSCLE; LIVER	Cystectomy is the removal of all or part of the urinary bladder. It has been observed that there is significant regrowth of the bladder after partial cystectomy and this has been proposed to be through regeneration of the organ. Regrowth of tissue in mammals has been proposed to involve compensatory mechanisms that share many characteristics of true regeneration, like the growth of specialized structures such as blood vessels or nerves. However, the overall structure of the normal organ is not achieved. Here we tested if bladder growth after subtotal cystectomy (STC, removal of 50% of the bladder) was compensatory or regenerative. To do this we subjected adult female mouse bladders to STC and assessed regrowth using several established cellular parameters including histological, gene expression, cytokine accumulation and cell proliferation studies. Bladder function was analyzed using cystometry and the voiding stain on paper (VSOP) technique. We found that STC bladders were able to increase their ability to hold urine with the majority of volume restoration occurring within the first two weeks. Regenerating bladders had thinner walls with less mean muscle thickness, and they showed increased collagen deposition at the incision as well as throughout the bladder wall suggesting that fibrosis was occurring. Cell populations differed in their response to injury with urothelial regeneration complete by day 7, but stromal and detrusor muscle still incomplete after 8wks. Cells incorporated EdU when administered at the time of surgery and tracing of EdU positive cells over time indicated that many newborn cells originate at the incision and move mediolaterally. Basal urothelial cells and bladder mesenchymal stem cells but not smooth muscle cells significantly incorporated EdU after STC. Since anti-inflammatory cytokines play a role in regeneration, we analyzed expressed cytokines and found that no anti-inflammatory cytokines were present in the bladder 1wk after STC. Our findings suggest that bladder regrowth after cystectomy is compensatory and functions to increase the volume that the bladder can hold. This finding sets the stage for understanding how the bladder responds to cystectomy and how this can be improved in patients after suffering bladder injury.	[Delos Santos, Grace B.; Wetterlin, Jessica] Loyola Univ Hlth Syst, Dept Urol, Maywood, IL USA; [Devine, Megan Y.; Firmiss, Paula R.; Kukulka, Natalie A.; Gong, Edward M.; Dettman, Robert W.] Anne & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Dev Biol, Chicago, IL 60611 USA; [Bowen, Diana K.; Gong, Edward M.; Dettman, Robert W.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Loyola University Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Gong, EM; Dettman, RW (corresponding author), Anne & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Dev Biol, Chicago, IL 60611 USA.; Gong, EM; Dettman, RW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	emgong@northwestern.edu; r-dettman@northwestern.edu		Dettman, Robert/0000-0002-3074-5922	Individual Biomedical Research Award through the Hartwell Foundation	Individual Biomedical Research Award through the Hartwell Foundation	This work was supported by an Individual Biomedical Research Award to Edward M. Gong, through the Hartwell Foundation (http://www.thehartwellfoundation.org).	Andersen DC, 2014, STEM CELL REP, V2, P406, DOI 10.1016/j.stemcr.2014.02.008; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Burmeister D, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0094-6; Burmeister D, 2010, TISSUE ENG PT A, V16, P2541, DOI 10.1089/ten.TEA.2009.0697; Burmeister DM, 2013, AM J PATHOL, V183, P1585, DOI 10.1016/j.ajpath.2013.07.018; CHRISTENSEN HN, 1948, J BIOL CHEM, V175, P101; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Flum AS, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00132; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; GRINDLAY JH, 1952, SURG GYNECOL OBSTET, V94, P491; HOLDER N, 1981, BRIT MED BULL, V37, P227, DOI 10.1093/oxfordjournals.bmb.a071707; Kierdorf U, 2009, SEMIN CELL DEV BIOL, V20, P535, DOI 10.1016/j.semcdb.2008.11.011; Lai SL, 2017, ELIFE, V6, DOI 10.7554/eLife.25605; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Lilly MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141437; Maienschein J, 2011, DEV BIOL, V358, P278, DOI 10.1016/j.ydbio.2010.06.014; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Metcalfe PD, 2010, BJU INT, V106, P1686, DOI 10.1111/j.1464-410X.2010.09445.x; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020; Papafotiou G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11914; Peyton CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047414; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0; Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0206436	10.1371/journal.pone.0206436	http://dx.doi.org/10.1371/journal.pone.0206436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475828	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700009
J	Sverrisson, FA; Bateman, BT; Aspelund, T; Skulason, S; Zoega, H				Sverrisson, Fridgeir A.; Bateman, Brian T.; Aspelund, Thor; Skulason, Sigurgrimur; Zoega, Helga			Preeclampsia and academic performance in children: A nationwide study from Iceland	PLOS ONE			English	Article							MEDICAL BIRTH REGISTRY; HYPERTENSIVE DISORDERS; PREGNANCY; RISK; BORN; MORBIDITY; VALIDITY; MOTHERS; ABILITY; OBESITY	Background Hypertensive disorders complicate up to 10% of pregnancies. Evidence suggests a potential association between maternal hypertensive disorders during pregnancy, particularly preeclampsia, and adverse neurodevelopment in the offspring, but existing studies are subject to limitations. We aimed to assess whether in-utero exposure to preeclampsia/eclampsia negatively impacts academic performance at ages 9, 12 and 15 years. Methods Using individually linked, nationwide data from the Icelandic registries we followed all children born in 1989-2004 (N = 68,580), from birth until the end of 2014, thereof 63,014 (91.9%) took at least one standardized test. Using a stepwise, mixed-effects approach, we modelled the hypothesized relationship while adjusting for maternal, perinatal and childhood variables of interest. We compared test scores, measured on a normalized scale ranging from 0-60 with a mean of 30 and a standard deviation of 10, in the 4th, 7th and 10th grades, between children exposed to preeclampsia or eclampsia in-utero versus children from normotensive pregnancies in the population. Results Children exposed to preeclampsia/eclampsia scored lower than those unexposed in mathematics across all grade levels, corresponding to a difference of 0.44 points (95% CI: 0.00, 0.89), 0.59 points (95% CI: 0.13, 1.06) and 0.59 points (95% CI: 0.08, 1.10), respectively. No differences were observed in the language arts. Conclusions Our findings suggest a minimal effect of maternal preeclampsia/eclampsia on children's academic performance at ages 9, 12 and 15 years. The differences observed in mathematic scores between exposed and unexposed children were minimal, less than one tenth of a standard deviation per measurement occasion.	[Sverrisson, Fridgeir A.; Aspelund, Thor; Zoega, Helga] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Bateman, Brian T.] Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Bateman, Brian T.] Harvard Med Sch, Boston, MA USA; [Aspelund, Thor] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Skulason, Sigurgrimur] Directorate Educ, Kopavogur, Iceland; [Skulason, Sigurgrimur] Univ Iceland, Fac Psychol, Reykjavik, Iceland; [Zoega, Helga] Univ New South Wales, Ctr Big Data Res Hlth, Med Policy Res Unit, Sydney, NSW, Australia	University of Iceland; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Icelandic Heart Association; University of Iceland; University of New South Wales Sydney	Zoega, H (corresponding author), Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.; Zoega, H (corresponding author), Univ New South Wales, Ctr Big Data Res Hlth, Med Policy Res Unit, Sydney, NSW, Australia.	h.zoega@unsw.edu.au	Aspelund, Thor/K-7022-2019	Aspelund, Thor/0000-0002-7998-5433; Zoega, Helga/0000-0003-0761-9028; Skulason, Sigurgrimur/0000-0002-6261-0678	Icelandic Centre for Research, START - Reintegration fellowship [130814-051]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (Bethesda, Maryland, United States) [K08HD075831]; University of New South Wales; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER	Icelandic Centre for Research, START - Reintegration fellowship; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (Bethesda, Maryland, United States); University of New South Wales; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	HZ received financial support for this study from the Icelandic Centre for Research, START - Reintegration fellowship, under Award Number 130814-051, http://www.rannis.is. BTB was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (Bethesda, Maryland, United States) under Award Number K08HD075831. Dr. Helga Zoega was supported by a Scientia Fellowship awarded by the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2014, SEMIN PERINATOL, V38, P151, DOI 10.1053/j.semperi.2014.03.007; [Anonymous], 2016, ICD 10 VERS 2016; Anthopolos R, 2013, PAEDIATR PERINAT EP, V27, P564, DOI 10.1111/ppe.12081; BARKER DJP, 1967, BRIT MED J, V3, P695, DOI 10.1136/bmj.3.5567.695; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bohm S, 2019, J ATTEN DISORD, V23, P692, DOI 10.1177/1087054717690230; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Ehrenstein V, 2009, AM J EPIDEMIOL, V170, P1025, DOI 10.1093/aje/kwp223; Eiriksdottir VH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138534; Gudnadottir TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152187; Heikura U, 2013, PAEDIATR PERINAT EP, V27, P188, DOI 10.1111/ppe.12028; Icelandic Health Insurance, VINN FYNR UTG LYFJ M; Jo H, 2015, PEDIATRICS, V135, pE1198, DOI 10.1542/peds.2014-3058; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Klungsoyr K, 2014, PAEDIATR PERINAT EP, V28, P362, DOI 10.1111/ppe.12138; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; Lambert G, 2014, ACTA ANAESTH BELG, V65, P137; Langhoff-Roos J, 2014, ACTA OBSTET GYN SCAN, V93, P132, DOI 10.1111/aogs.12302; Leitner Y, 2012, J MATERN-FETAL NEO M, V25, P2206, DOI 10.3109/14767058.2012.684164; Leversen KT, 2011, PEDIATRICS, V127, pE630, DOI 10.1542/peds.2010-1001; Many A, 2003, HYPERTENS PREGNANCY, V22, P25, DOI 10.1081/PRG-120016791; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Morsing E, 2014, EARLY HUM DEV, V90, P99, DOI 10.1016/j.earlhumdev.2013.12.002; OUNSTED M, 1984, BMJ-BRIT MED J, V288, P1038, DOI 10.1136/bmj.288.6423.1038; Pohlabeln H, 2017, EUR CHILD ADOLES PSY, V26, P957, DOI 10.1007/s00787-017-0966-2; Pugh SJ, 2015, J NUTR, V145, P2562, DOI 10.3945/jn.115.215525; RCore Team, 2020, R LANG ENV STAT COMP; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Seely EW, 2014, CIRCULATION, V129, P1254, DOI 10.1161/CIRCULATIONAHA.113.003904; SEIDMAN DS, 1991, BRIT J OBSTET GYNAEC, V98, P1009, DOI 10.1111/j.1471-0528.1991.tb15339.x; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; Stone CD, 2007, J PERINAT MED, V35, P28, DOI 10.1515/JPM.2007.003; Stuart A, 2011, OBSTET GYNECOL, V118, P201, DOI 10.1097/AOG.0b013e31822200eb; Thomsen LCV, 2013, ACTA OBSTET GYN SCAN, V92, P943, DOI 10.1111/aogs.12159; Tuovinen S, 2014, J AM SOC HYPERTENS, V8, P832, DOI 10.1016/j.jash.2014.09.005; Tuovinen S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.017; Tuovinen S, 2012, NEUROLOGY, V79, P1578, DOI 10.1212/WNL.0b013e31826e2606; Whitehouse AJO, 2012, PAEDIATR PERINAT EP, V26, P101, DOI 10.1111/j.1365-3016.2011.01257.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2015, ATC DDD IND 2016; World Health Organization, 2011, WHO REC PREV TREATM; Zoega H, 2012, PEDIATRICS, V130, pE53, DOI 10.1542/peds.2011-3493	45	18	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207884	10.1371/journal.pone.0207884	http://dx.doi.org/10.1371/journal.pone.0207884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462738	Green Published, Green Submitted, gold			2022-12-26	WOS:000451054800091
J	Renziehausen, A; Wang, HX; Rao, B; Weir, L; Lo Nigro, C; Lattanzio, L; Merlano, M; Vega-Rioja, A; Fernandez-Carranco, MD; Hajji, N; Matin, R; Harwood, C; Li, S; Sim, VR; O'Neill, K; Evans, A; Thompson, A; Szlosarek, P; Fleming, C; Stebbing, J; Proby, C; Tzakos, AG; Syed, N; Crook, T				Renziehausen, Alexander; Wang, Hexiao; Rao, Bhavya; Weir, Lynda; Lo Nigro, Cristiana; Lattanzio, Laura; Merlano, Marco; Vega-Rioja, Antonio; del Carmen Fernandez-Carranco, Maria; Hajji, Nabil; Matin, Rubeta; Harwood, Catherine; Li, Su; Sim, Van Ren; O'Neill, Kevin; Evans, Alan; Thompson, Alastair; Szlosarek, Peter; Fleming, Colin; Stebbing, Justin; Proby, Charlotte; Tzakos, Andreas G.; Syed, Nelofer; Crook, Tim			The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention	ONCOGENE			English	Article							CONVERTING-ENZYME-INHIBITORS; II TYPE-1 RECEPTOR; IMPROVED SURVIVAL; BREAST-CANCER; SERUM; TUMOR; ANGIOGENESIS; ANTAGONIST; BIOMARKER; AGTR1	Despite emergence of new systemic therapies, metastatic melanoma remains a challenging and often fatal form of skin cancer. The renin-angiotensin system (RAS) is a major physiological regulatory pathway controlling salt-water equilibrium, intravascular volume and blood pressure. Biological effects of the RAS are mediated by the vasoactive hormone angiotensin II (AngII) via two receptor subtypes, AT1R (encoded by AGTR1) and AT2R (encoded by AGTR2). We report decreasing expression and increasing CpG island methylation of AGTR1 in metastatic versus primary melanoma and detection in serum of methylated genomic DNA from the AGTR1 CpG island in metastatic melanoma implying that AGTR1 encodes a tumour suppressor function in melanoma. Consistent with this hypothesis, antagonism of AT1R using losartan or shRNA-mediated knockdown in melanoma cell lines expressing AGTR1 resulted in acquisition of the ability to proliferate in serum-free conditions. Conversely, ectopic expression of AGTR1 in cell lines lacking endogenous expression inhibits proliferation irrespective of the presence of AngII implying a ligand-independent suppressor function for AT1R. Treatment of melanoma cell lines expressing endogenous AT2R with either AngII or the AT2R-selective agonist Y6AII induces proliferation in serum-free conditions whereas the AT2R-specific antagonists PD123319 and EMA401 inhibit melanoma growth and angiogenesis and potentiate inhibitors of BRAF and MEK in cells with BRAF V600 mutations. Our results demonstrate that the RAS has both oncogenic and tumour suppressor functions in melanoma. Pharmacological inhibition of AT2R may provide therapeutic opportunities in melanomas expressing this receptor and AGTR1 CpG island methylation in serum may serve as a novel biomarker of metastatic melanoma.	[Renziehausen, Alexander; Hajji, Nabil; Syed, Nelofer] Imperial Coll London, Div Brain Sci, John Fulcher Neurooncol Lab, London, England; [Wang, Hexiao] China Med Univ, Dept Dermatol, Hosp 1, Shenyang, Liaoning, Peoples R China; [Rao, Bhavya; Weir, Lynda; Proby, Charlotte] Ninewells Hosp, Med Res Inst, Dundee, Scotland; [Rao, Bhavya; Weir, Lynda; Proby, Charlotte] Med Sch, Dundee, Scotland; [Lo Nigro, Cristiana; Lattanzio, Laura; Merlano, Marco] Osped San Croce & Carle, Dept Oncol, Cuneo, Italy; [Vega-Rioja, Antonio; del Carmen Fernandez-Carranco, Maria] Hosp Univ Virgen Macarena, Seville, Spain; [Matin, Rubeta; Harwood, Catherine] Barts & London Queen Marys Sch Med & Dent, London, England; [Li, Su] Royal Marsden Hosp, Fulham Rd, London, England; [Sim, Van Ren] Maidstone Hlth Author, Kent Oncol Ctr, Maidstone ME16 9QQ, Kent, England; [O'Neill, Kevin] Charing Cross Hosp, Dept Neurosurg, London, England; [Evans, Alan] Ninewells Hosp, Dept Pathol, Dundee, Scotland; [Thompson, Alastair] MD Anderson Canc Ctr, Breast Surg Oncol, Houston, TX USA; [Szlosarek, Peter] Barts Canc Ctr, Dept Med Oncol, London, England; [Fleming, Colin; Proby, Charlotte] Ninewells Hosp, Dept Dermatol, Dundee, Scotland; [Stebbing, Justin] Imperial Coll, London, England; [Tzakos, Andreas G.] Univ Ioannina, Dept Chem, Ioannina, Greece; [Crook, Tim] St Lukes Canc Ctr, Guildford, Surrey, England	Imperial College London; China Medical University; University of Dundee; University of Dundee; Hospital Universitario Virgen Macarena; University of London; Queen Mary University London; Royal Marsden NHS Foundation Trust; Imperial College London; University of Dundee; University of Texas System; UTMD Anderson Cancer Center; University of Dundee; Imperial College London; University of Ioannina	Syed, N (corresponding author), Imperial Coll London, Div Brain Sci, John Fulcher Neurooncol Lab, London, England.; Crook, T (corresponding author), St Lukes Canc Ctr, Guildford, Surrey, England.	N.syed@imperial.ac.uk; timothycrook@nhs.net	Matin, Rubeta/AAB-1515-2019; merlano, marco/HHS-9397-2022; hajji, nabil/AAV-1435-2020; tzakos, Andreas/V-9624-2019; Renziehausen, Alexander/AAE-4907-2020	Matin, Rubeta/0000-0002-9695-5412; Stebbing, Justin/0000-0002-1117-6947; Tzakos, Andreas/0000-0001-6391-0288; Vega Rioja, Antonio/0000-0003-4698-9697	Anonymous Trust; Tenovus Scotland; Melanoma Focus; Leng Foundation; Brain Tumour Research Campaign; Economica y Competitividad [SAF2014-60649-JN]; Fondo Europeo de Regional-FEDER	Anonymous Trust; Tenovus Scotland; Melanoma Focus; Leng Foundation; Brain Tumour Research Campaign; Economica y Competitividad; Fondo Europeo de Regional-FEDER	The work was supported by They The Anonymous Trust, Tenovus Scotland (to Dr. T.C.), Melanoma Focus (to C.P.), The Leng Foundation (to C.P.) and The Brain Tumour Research Campaign (to N.S.). Antonio Vega-Rioja is under contract Proyectos I + D + I para jovenes investigadores from de Economica y Competitividad (SAF2014-60649-JN) and co-funded by Fondo Europeo de Regional-FEDER. Tim Crook is a Scottish Senior Clinical Fellow in Medical Oncology.	Anand U, 2013, EUR J PAIN, V17, P1012, DOI 10.1002/j.1532-2149.2012.00269.x; Ateeq B, 2009, CELL CYCLE, V8, P3794, DOI 10.4161/cc.8.23.9976; Bar J, 2015, CLIN LUNG CANCER, V16, pE189, DOI 10.1016/j.cllc.2015.05.002; Beaumont KA, 2014, HEALTHCARE-BASEL, V2, P27, DOI 10.3390/healthcare2010027; Brunner D, 2010, ALTEX-ALTERN ANIM EX, V27, P53; Campbell DJ, 1996, CLIN EXP PHARMACOL P, V23, pS125, DOI 10.1111/j.1440-1681.1996.tb03073.x; Carpentier AF, 2012, EUR J NEUROL, V19, P1337, DOI 10.1111/j.1468-1331.2012.03766.x; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen XS, 2013, CANCER LETT, V328, P318, DOI 10.1016/j.canlet.2012.10.006; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty Keith T, 2011, F1000 Med Rep, V3, P8, DOI 10.3410/M3-8; Guo RD, 2015, IUBMB LIFE, V67, P42, DOI 10.1002/iub.1342; Hanaizi Z, 2012, EUR J CANCER, V48, P237, DOI 10.1016/j.ejca.2011.09.018; Hatzimichael E, 2014, EXPERT REV MOL DIAGN, V14, P639, DOI 10.1586/14737159.2014.928204; Hesselink JMK, 2017, J PAIN RES, V10, P439, DOI 10.2147/JPR.S128520; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoshimoto S, 2012, J INVEST DERMATOL, V132, P1689, DOI 10.1038/jid.2012.36; Karnik SS, 2015, PHARMACOL REV, V67, P754, DOI 10.1124/pr.114.010454; Lo Nigro C, 2013, J INVEST DERMATOL, V133, P1278, DOI 10.1038/jid.2012.493; Magnani F, 2014, ACS CHEM BIOL, V9, P1420, DOI 10.1021/cb500063y; Miura S, 2005, J BIOL CHEM, V280, P18237, DOI 10.1074/jbc.M500639200; Moreno BH, 2015, SEMIN ONCOL, V42, P466, DOI 10.1053/j.seminoncol.2015.02.008; Moreno-Munoz D, 2015, EUR J CLIN INVEST, V45, P1325, DOI 10.1111/eci.12557; Nussberger J, 2002, HYPERTENSION, V39, pE1, DOI 10.1161/hy0102.102293; Otake AH, 2010, CANCER CHEMOTH PHARM, V66, P79, DOI 10.1007/s00280-009-1136-0; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; Reis IM, 2015, BRIT J CANCER, V113, P460, DOI 10.1038/bjc.2015.240; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Shah R, 2009, BRIT J CANCER, V100, P1687, DOI 10.1038/sj.bjc.6605042; Sullivan RJ, 2015, CLIN CANCER RES, V21, P2424, DOI 10.1158/1078-0432.CCR-14-1650; Syed N, 2006, BLOOD, V107, P250, DOI 10.1182/blood-2005-03-1194; Wolchok JD, 2015, CELL, V162, P937, DOI 10.1016/j.cell.2015.07.045; Yoon C, 2011, CAN MED ASSOC J, V183, pE1073, DOI 10.1503/cmaj.101497; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	35	26	26	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2320	2336		10.1038/s41388-018-0563-y	http://dx.doi.org/10.1038/s41388-018-0563-y			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30478450	Green Accepted			2022-12-26	WOS:000462588000007
J	Azevedo, IG; da Camara, SMA; Pirkle, CM; Maciel, ACC; Viana, EDR				Azevedo, Ingrid Guerra; Aires da Camara, Saionara Maria; Pirkle, Catherine McLean; Cavalcanti Maciel, Alvaro Campos; Ramalho Viana, Elizabel de Souza			Relationship between maximal respiratory pressures and multiple childbearing in Brazilian middle-aged and older women: A cross-sectional community-based study	PLOS ONE			English	Article							MUSCLE STRENGTH; FUNCTIONAL-CAPACITY; TRAJECTORIES; PERFORMANCE; SARCOPENIA; DECLINE; HEALTH; IMPACT; VALUES	Objective Previous studies show that multiparity and a number of chronic conditions are correlated among women. Also, low respiratory muscle strength has been associated to adverse health outcomes such as chronic lung disease and early mortality. This study aimed to investigate associations between the number of lifetime pregnancies and maximal inspiratory/expiratory pressures. Methods In a cross-sectional study, 204 women ages 41-80 years-old, from the rural community of Santa Cruz, Brazil, provided data regarding demographics, socioeconomic characteristics, health behaviors, and number of lifetime pregnancies (<= 3, 4-6 or >= 7). Maximal respiratory pressures were measured with a digital manometer. Multiple linear regression analysis was used to examine the association of multiple childbearing on maximal respiratory pressures. Results Of the participants, 44.1% had <= 3 pregnancies, 30.4% had 4-6 pregnancies and 25.5% had > 7 pregnancies. In the unadjusted analyses, maximal inspiratory and expiratory pressures varied significantly according to multiple childbearing categories. After adjustment, the values remained statistically significant only for maximal expiratory pressure. Compared to women with. 3 lifetime pregnancies, those who had >= 7 pregnancies had significantly lower maximal expiratory pressure values (beta = -18.07, p = 0.01) Conclusion Multiple childbearing appears to be negatively associated with maximal respiratory pressures; women with a higher number of lifetime pregnancies had lower values of maximal respiratory pressures when compared to those with fewer pregnancies. This association may be due to biomechanical changes in the respiratory muscles promoted by multiple lifetime pregnancies. This finding indicates a need to motivate women, from the prenatal to postpartum period, to safely exercise their respiratory muscles, including abdominal muscle exercises as well as respiratory muscle training.	[Azevedo, Ingrid Guerra; Cavalcanti Maciel, Alvaro Campos; Ramalho Viana, Elizabel de Souza] Univ Fed Rio Grande do Norte, Physiotherapy Dept, Natal, RN, Brazil; [Aires da Camara, Saionara Maria] Univ Fed Rio Grande do Norte, Fac Ciencias Saude Trairi, Santa Cruz, RN, Brazil; [Pirkle, Catherine McLean] Univ Hawaii Manoa, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Azevedo, Ingrid Guerra] Empresa Brasileira Serv Hosp, Hosp Univ Ana Bezerra, Rehabil Div, Santa Cruz, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; University of Hawaii System; University of Hawaii Manoa	Azevedo, IG (corresponding author), Univ Fed Rio Grande do Norte, Physiotherapy Dept, Natal, RN, Brazil.	ingridguerra@outlook.com	Maciel, Álvaro Campos Cavalcanti/AAM-8606-2020; Camara, S MA/M-7513-2015; Maciel, Alvaro ACCM/M-4003-2017; Azevedo, Ingrid/AAL-9413-2020	Maciel, Álvaro Campos Cavalcanti/0000-0002-8913-7868; Camara, S MA/0000-0002-3054-7213; Maciel, Alvaro ACCM/0000-0002-8913-7868; Azevedo, Ingrid/0000-0001-7305-7583	Fogarty International Center of the National Institutes of Health [R21TW010466]; FOGARTY INTERNATIONAL CENTER [R21TW010466] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Activities reported in this publication were supported by the Fogarty International Center of the National Institutes of Health under Award Number R21TW010466.	Camara SMA, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0214-1; Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; [Anonymous], 2017, NOMINAL NECESSARY MI; Axer H, 2001, J SURG RES, V96, P127, DOI 10.1006/jsre.2000.6070; Barcelar JDM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110959; Bem Saad H, 2006, REV MAL RESPIR, V23, P324, DOI DOI 10.1016/S0761-8425(06)71598-4.; Buchman AS, 2008, NEUROEPIDEMIOLOGY, V31, P174, DOI 10.1159/000154930; Costa D, 2010, J BRAS PNEUMOL, V36, P306, DOI 10.1590/S1806-37132010000300007; da Camara SMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119480; Sousa ACPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102299; Santos CAD, 2011, ARCH GERONTOL GERIAT, V53, P344, DOI 10.1016/j.archger.2010.12.019; de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947; Freitas Eliane Regina Ferreira Sernache de, 2012, Fisioter. Pesqui., V19, P326; GILROY RJ, 1988, AM REV RESPIR DIS, V137, P668, DOI 10.1164/ajrccm/137.3.668; Giua R, 2014, REJUV RES, V17, P366, DOI 10.1089/rej.2014.1549; Grundy E, 2015, DEMOGR RES, V32, P107, DOI 10.4054/DemRes.2015.32.4; Hajiahmadi M, 2015, MED PRIN PRACT, V24, P70, DOI 10.1159/000368358; Henretta JC, 2007, J HEALTH SOC BEHAV, V48, P254, DOI 10.1177/002214650704800304; Johan A, 1997, EUR RESPIR J, V10, P2825, DOI 10.1183/09031936.97.10122825; KARVONEN J, 1994, RESPIRATION, V61, P28; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Leenders M, 2013, J GERONTOL A-BIOL, V68, P769, DOI 10.1093/gerona/gls241; Leggett LE, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002759; Liu CK, 2014, J NUTR HEALTH AGING, V18, P59, DOI 10.1007/s12603-013-0369-0; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Mafort TT, 2016, MULTIDISCIP RESP MED, V11, DOI 10.1186/s40248-016-0066-z; MCELVANEY G, 1989, AM REV RESPIR DIS, V139, P277, DOI 10.1164/ajrccm/139.1.277; Murray ET, 2011, J GERONTOL A-BIOL, V66, P1350, DOI 10.1093/gerona/glr139; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Parentoni AN, 2015, J FRALITY AGING, V4, P64, DOI 10.14283/jfa.2015.41; Parikh NI, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.017; Parreira VF, 2007, BRAZ J PHYS THER, V11, P361, DOI 10.1590/S1413-35552007000500006; Peeters GMEE, 2008, CLIN ENDOCRINOL, V69, P673, DOI 10.1111/j.1365-2265.2008.03212.x; Pirkle CM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-293; Sachs MC, 2009, RESP CARE, V54, P1321; Sanches VS, 2014, RESP CARE, V59, P1838, DOI 10.4187/respcare.03063; Santiago-Recuerda A, 2007, OBES SURG, V17, P689, DOI 10.1007/s11695-007-9120-4; Schmertmann CP, 2008, POPUL RES POLICY REV, V27, P1, DOI 10.1007/s11113-007-9052-7; Simoes LA, 2010, BRAZ J PHYS THER, V14, P24, DOI 10.1590/S1413-35552010000100005; TOLEP K, 1995, AM J RESP CRIT CARE, V152, P677, DOI 10.1164/ajrccm.152.2.7633725; TOOHEY JS, 1995, AM J OBSTET GYNECOL, V172, P683, DOI 10.1016/0002-9378(95)90593-6; Umberson D, 2011, SOC SCI MED, V73, P1323, DOI 10.1016/j.socscimed.2011.08.014; UNDP, 2014, SUST HUM PROGR RED V; West JB, 2013, FISIOLOGIA RESP; World Health Organization, GLOB DAT BOD MASS IN	45	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208500	10.1371/journal.pone.0208500	http://dx.doi.org/10.1371/journal.pone.0208500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0NQ	30513117	Green Published, Green Submitted, gold			2022-12-26	WOS:000452204800036
J	Li, ZM; Zhang, YX; Hu, T; Likhodii, S; Sun, G; Zhai, GJ; Fan, ZZ; Xuan, CJ; Zhang, WD				Li, Zimin; Zhang, Yuxi; Hu, Ting; Likhodii, Sergei; Sun, Guang; Zhai, Guangju; Fan, Zhaozhi; Xuan, Chunji; Zhang, Weidong			Differential metabolomics analysis allows characterization of diversity of metabolite networks between males and females	PLOS ONE			English	Article							SEX-DIFFERENCES; KNEE; OSTEOARTHRITIS; OBESITY; INDEX; ACID	Females and males are known to have different abilities to cope with stress and disease. This study was designed to investigate the effect of sex on properties of a complex inter-linked network constructed of central biochemical metabolites. The study involved the blood collection and analysis of a large set of blood metabolic markers from a total of 236 healthy participants, which included 140 females and 96 males. Metabolic profiling yielded concentrations of 168 metabolites for each subject. A differential correlation network analysis approach was developed for this study that allowed detection and characterization of interconnection differences in metabolites in males and females. Through topological analysis of the differential network that depicted metabolite differences in the sexes, we identified metabolites with high centralities in this network. These key metabolites were identified as 10 phosphatidylcholines (PCaaC34:4, PCaaC36:6, PCaaC34:3, PCaaC42:2, PCaeC38:1, PCaeC38:2, PCaaC40:1, PCaeC34:1, PC aa C32:1 and PC aa C40:6) and 4 acylcarnitines (C3-OH, C7-DC, C3 and C0). Identification of these metabolites may help further studies of sex-specific differences in the metabolome that may underlie different responses to stress and disease in males and females.	[Li, Zimin; Zhang, Yuxi; Zhang, Weidong] Jilin Univ, Sch Pharmaceut Sci, Changchun, Jilin, Peoples R China; [Li, Zimin] Daqing Peoples Hosp, Dept Pharm, Daqing, Peoples R China; [Zhang, Yuxi] Daqing Oil Field Gen Hosp, Dept Pharm, Daqing, Peoples R China; [Hu, Ting] Mem Univ, Dept Comp Sci, St John, NF, Canada; [Likhodii, Sergei] Prov Hlth Serv Author, Prov Toxicol Ctr, Vancouver, BC, Canada; [Sun, Guang] Mem Univ, Discipline Med, Fac Med, St John, NF, Canada; [Zhai, Guangju; Zhang, Weidong] Mem Univ, Discipline Genet, Fac Med, St John, NF, Canada; [Fan, Zhaozhi] Mem Univ, Dept Math & Stat, St John, NF, Canada; [Xuan, Chunji] Jilin Univ, Northeast Asian Studies Coll, Changchun, Jilin, Peoples R China	Jilin University; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Jilin University	Zhang, WD (corresponding author), Jilin Univ, Sch Pharmaceut Sci, Changchun, Jilin, Peoples R China.; Zhang, WD (corresponding author), Mem Univ, Discipline Genet, Fac Med, St John, NF, Canada.	weidongzhang@med.mun.ca			Canadian Institutes of Health Research (CIHR) [MOP192552]; Science and Technology Development Plan of Jilin Province [20180101302JC]; Youth technology backbone training program of Health department of Jilin Province [2017Q020]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Science and Technology Development Plan of Jilin Province; Youth technology backbone training program of Health department of Jilin Province	This work was supported by the Canadian Institutes of Health Research (CIHR) (RNL-132178 to GZ) (http://webapps.cihr-irsc.gc.ca/cfdd/db_search); Science and Technology Development Plan of Jilin Province (20180101302JC to WZ); Youth technology backbone training program of Health department of Jilin Province (2017Q020 to WZ), China; Canadian Institutes of Health Research (CIHR) (operating grant: MOP192552 to GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; .	Bassuk SS, 2015, ANN EPIDEMIOL, V25, P193, DOI 10.1016/j.annepidem.2014.11.004; Brede M., 2012, ARTIF LIFE, V18, P241, DOI [10.1162/artlr00062, DOI 10.1162/ARTLR00062, DOI 10.1162/ARTL\00062]; DAVIS MA, 1988, AM J EPIDEMIOL, V127, P1019, DOI 10.1093/oxfordjournals.aje.a114878; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Emery RL, 2017, PSYCHOL BULL, V143, P868, DOI 10.1037/bul0000105; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Gao X, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0095-9; Hills BA, 2002, INTERN MED J, V32, P242, DOI 10.1046/j.1445-5994.2002.00201.x; Ingersoll MA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006688; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Klein SL, 2012, BIOESSAYS, V34, P1050, DOI 10.1002/bies.201200099; Le Menn G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061575; Leening MJG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5992; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Newbern D, 2014, J CLIN ENDOCR METAB, V99, P4730, DOI 10.1210/jc.2014-2080; Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008; Park JE, 2017, NEURORADIOLOGY, V59, P781, DOI 10.1007/s00234-017-1875-2; Paterson KL, 2017, CLIN BIOMECH, V49, P72, DOI 10.1016/j.clinbiomech.2017.08.013; Pina IL, 2018, CIRCULATION, V137, P771, DOI 10.1161/CIRCULATIONAHA.117.030526; Pinto Rui Climaco, 2017, Adv Exp Med Biol, V965, P163, DOI 10.1007/978-3-319-47656-8_7; Racioppi M, 2015, UROL INT, V94, P262, DOI 10.1159/000365292; Ramos-Roman MA, 2012, METABOLISM, V61, P202, DOI 10.1016/j.metabol.2011.06.008; Ruoppolo M, 2014, AM J TRANSL RES, V6, P614; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; SILVA CL, 1995, CLIN EXP IMMUNOL, V101, P314; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Tomita H, 2015, J STROKE CEREBROVASC, V24, P2613, DOI 10.1016/j.jstrokecerebrovasdis.2015.07.016; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Walley AJ, 2012, INT J OBESITY, V36, P137, DOI 10.1038/ijo.2011.22; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; Zammit VA, 2009, ADV DRUG DELIVER REV, V61, P1353, DOI 10.1016/j.addr.2009.04.024; Zhang L, 2018, CIRCULATION, V137, P1374, DOI 10.1161/CIRCULATIONAHA.117.031139; Zhang Q, 2014, MULTIVAR BEHAV RES, V49, P130, DOI 10.1080/00273171.2013.870877; Zhang W, 2016, OSTEOARTHR CARTILAGE, V24, P827, DOI 10.1016/j.joca.2015.12.004; Zhang WD, 2016, RHEUMATOLOGY, V55, P1566, DOI 10.1093/rheumatology/kew207; Zhang WD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0937-x; Zhang WD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006286	39	23	23	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207775	10.1371/journal.pone.0207775	http://dx.doi.org/10.1371/journal.pone.0207775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500833	Green Published, gold, Green Submitted			2022-12-26	WOS:000451883700015
J	Khan, B; Duncan, I; Saad, M; Schaefer, D; Jordan, A; Smith, D; Neaigus, A; Des Jarlais, D; Hagan, H; Dombrowski, K				Khan, Bilal; Duncan, Ian; Saad, Mohamad; Schaefer, Daniel; Jordan, Ashly; Smith, Daniel; Neaigus, Alan; Des Jarlais, Don; Hagan, Holly; Dombrowski, Kirk			Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment	PLOS ONE			English	Article							NEW-YORK-CITY; STOCHASTIC SIMULATION; FIBROSIS PROGRESSION; COST-EFFECTIVENESS; VIRUS-INFECTION; RISK BEHAVIORS; LIVER FIBROSIS; SOCIAL NETWORK; UNITED-STATES; HIV INCIDENCE	Hepatitis C virus (HCV) infection is endemic in people who inject drugs (PWID), with prevalence estimates above 60% for PWID in the United States. Previous modeling studies suggest that direct acting antiviral (DAA) treatment can lower overall prevalence in this population, but treatment is often delayed until the onset of advanced liver disease (fibrosis stage 3 or later) due to cost. Lower cost interventions featuring syringe access (SA) and medically assisted treatment (MAT) have shown mixed results in lowering HCV rates below current levels. However. little is known about the potential cumulative effects of combining DAA and MAT treatment. While simulation experiments can reveal likely long-term effects, most prior simulations have been performed on closed populations of model agents-a scenario quite different from the open, mobile populations known to most health agencies. This paper uses data from the Centers for Disease Control's National HIV Behavioral Surveillance project, IDU round 3, collected in New York City in 2012 to parameterize simulations of open populations. To test the effect of combining DAA treatment with SA/MAT participation, multiple, scaled implementations of the two intervention strategies were simulated. Our results show that, in an open population, SA/MAT by itself has only small effects on HCV prevalence, while DAA treatment by itself can lower both HCV and HCV-related advanced liver disease prevalence. More importantly, the simulation experiments suggest that combinations of the two strategies can, when implemented together and at sufficient levels, dramatically reduce HCV incidence. We conclude that adopting SA/MAT implementations alongside DAA interventions can play a critical role in reducing the long-term consequences of ongoing HCV infection.	[Khan, Bilal; Duncan, Ian; Saad, Mohamad; Schaefer, Daniel; Dombrowski, Kirk] Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA; [Jordan, Ashly; Smith, Daniel; Hagan, Holly] NYU, Rory Meyers Coll Nursing, New York, NY USA; [Jordan, Ashly; Hagan, Holly] NYU, Ctr Drug Use & HIV Res, New York, NY USA; [Neaigus, Alan] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Des Jarlais, Don] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	University of Nebraska System; University of Nebraska Lincoln; New York University; New York University; Columbia University; Icahn School of Medicine at Mount Sinai	Dombrowski, K (corresponding author), Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA.	kdombrowski2@unl.edu	Jordan, Ashly/GQR-1051-2022	Jordan, Ashly/0000-0001-9426-2869	National Institutes of Health [RO1DA034637]; New York University Center for Drug Use and HIV Research, NIH P30 Center [P30DA011041]; NIH/NIDA [R01DA037117]; Centers for Disease Control and Prevention, National HIV Behavioral Surveillance program [U62/CCU223595-03-1]; New York City Department of Health and Mental Hygiene [U62/CCU223595-03-1];  [RC1DA028476]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041, R01DA037117, RC1DA028476, R01DA034637, T32DA007233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Center for Drug Use and HIV Research, NIH P30 Center; NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Centers for Disease Control and Prevention, National HIV Behavioral Surveillance program; New York City Department of Health and Mental Hygiene; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The HCV Synthesis Project is supported by a grant from the National Institutes of Health (RO1DA034637). Support was also received from the New York University Center for Drug Use and HIV Research, NIH P30 Center (P30DA011041). The modeling research presented here is supported by NIH/NIDA (R01DA037117). The original simulation platform was developed under RC1DA028476. Data were obtained from the New York City Department of Health and Mental Hygiene, HIV Epidemiology and Field Services through a cooperative agreement. Funding for the data collection was provided via a cooperative agreement between the Centers for Disease Control and Prevention, National HIV Behavioral Surveillance program and the New York City Department of Health and Mental Hygiene, Grant U62/CCU223595-03-1. For the 2012 NHBS IDU Round 3 data collection, Alan Neaigus, MCRP, PhD, served as Principal Investigator and Kathleen H. Reilly, PhD, MPH, served as Project Director. None of these funders played any role in the design or implementation of the research described here.; The HCV Synthesis Project is supported by a grant from the National Institutes of Health (RO1DA034637). Support was also received from the New York University Center for Drug Use and HIV Research, NIH P30 Center (P30DA011041). The modeling research presented here is supported by NIH/NIDA (R01DA037117). The original simulation platform was developed under RC1DA028476. Data were obtained from the New York City Department of Health and Mental Hygiene, HIV Epidemiology and Field Services through a cooperative agreement. Special thanks to Sarah Braunstein, Director of HIV Epidemiology at NYC DOHMH for this collaboration. Funding for the data collection was provided via a cooperative agreement between the Centers for Disease Control and Prevention, National HIV Behavioral Surveillance program and the New York City Department of Health and Mental Hygiene, Grant U62/CCU223595-03-1. For the 2012 NHBS IDU Round 3 data collection, Alan Neaigus, MCRP, PhD, served as Principal Investigator and Kathleen H. Reilly, PhD, MPH, served as Project Director. Their work, and those of the NHBS NYC IDU Round 3 field team-Holly Hagan, Travis Wendel, David Marshall III, Roberto Abadie, and Carmen Anna Davila-is acknowledged and appreciated.	Beck EC, 2015, JAIDS-J ACQ IMM DEF, V70, P186, DOI 10.1097/QAI.0000000000000733; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Boelen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100749; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Burt RD, 2009, DRUG ALCOHOL DEPEN, V105, P215, DOI 10.1016/j.drugalcdep.2009.07.005; CDC, 2015, NAT HIV BEH SURV INJ, V2016, P11; Chhatwal J, 2016, HEPATOLOGY, V64, P1442, DOI 10.1002/hep.28571; Combellick J, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4518; CURTIS R, 1995, SOC NETWORKS, V17, P229, DOI 10.1016/0378-8733(95)00264-O; Czitrom V, 1999, AM STAT, V53, P126, DOI 10.2307/2685731; Des Jarlais DC, 2010, DRUG ALCOHOL DEPEN, V109, P154, DOI 10.1016/j.drugalcdep.2009.12.028; Dombrowski K, 2017, AIDS BEHAV, V21, P1004, DOI 10.1007/s10461-016-1568-6; Dombrowski K, 2013, SUBST USE MISUSE, V48, P1485, DOI 10.3109/10826084.2013.796987; Duncan Ian, 2017, Prev Med Rep, V6, P38, DOI 10.1016/j.pmedr.2017.02.001; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Escudero DJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4528-9; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Guizani Mohsen, 2010, NETWORK MODELING SIM; Gutfraind A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137993; Hellard M, 2015, INT J DRUG POLICY, V26, P958, DOI 10.1016/j.drugpo.2015.05.006; Hewitt C, 1996, POPUL RES POLICY REV, V15, P311, DOI 10.1007/BF00128427; Hickman M, 2015, CURR OPIN INFECT DIS, V28, P576, DOI 10.1097/QCO.0000000000000216; Holtzman D, 2009, PREV MED, V49, P68, DOI 10.1016/j.ypmed.2009.04.014; Hu KQ, 2017, GASTROENTEROLOGY, V152, pS1092, DOI 10.1016/S0016-5085(17)33680-6; Iversen J, 2017, INT J DRUG POLICY, V47, P77, DOI 10.1016/j.drugpo.2017.05.022; Jordan AE, 2015, DRUG ALCOHOL DEPEN, V152, P194, DOI 10.1016/j.drugalcdep.2015.03.039; Khan B, 2014, SIMUL-T SOC MOD SIM, V90, P460, DOI 10.1177/0037549714526947; Khan B, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/720818; Kretzschmar M., 2000, MATH POPUL STUD, V8, P109, DOI [10.1080/08898480009525478, DOI 10.1080/08898480009525478]; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Liang YF, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6757928; Liu S, 2014, LECT NOTES COMPUT SC, V8549, P148; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; MacGregor L, 2017, INT J EPIDEMIOL, V46, P1582, DOI 10.1093/ije/dyx075; Marshall BDL, 2014, HEALTH AFFAIR, V33, P401, DOI 10.1377/hlthaff.2013.0824; Martin N, 2017, AIDS REV, V19; Martin NK, 2015, J VIRAL HEPATITIS, V22, P399, DOI 10.1111/jvh.12338; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Mei S, 2010, MATH COMPUT SIMULAT, V80, P1018, DOI 10.1016/j.matcom.2009.12.008; Merli MG, 2015, DEMOGRAPHY, V52, P919, DOI 10.1007/s13524-015-0383-4; Monteiro JFG, 2016, EPIDEMIOL INFECT, V144, P1683, DOI 10.1017/S0950268815003180; Nakagawa F, 2016, EPIDEMIOLOGY, V27, P247, DOI 10.1097/EDE.0000000000000423; Neaigus A, 2006, JAIDS-J ACQ IMM DEF, V41, P493, DOI 10.1097/01.qai.0000186391.49205.3b; Neaigus A, 2017, JAIDS-J ACQ IMM DEF, V75, pS325, DOI 10.1097/qai.0000000000001407; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; PETERSON D, 1990, J ACQ IMMUN DEF SYND, V3, P1086; Platt L, 2016, COCHRANE LIB; Reniers G, 2015, DEMOGR RES, V33, P425, DOI 10.4054/DemRes.2015.33.15; Rolls DA, 2012, J THEOR BIOL, V297, P73, DOI 10.1016/j.jtbi.2011.12.008; Rolls DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078286; Sacks-Davis R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1197; Scott N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0440-2; Sloot PMA, 2008, INT J COMPUT MATH, V85, P1175, DOI 10.1080/00207160701750583; Smit C, 2008, JAIDS-J ACQ IMM DEF, V47, P221, DOI 10.1097/QAI.0b013e31815d2f59; Smith BD, 2013, J INFECT DIS, V208, P1934, DOI 10.1093/infdis/jit520; Smith DJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1807-5; Smith DJ, 2015, INT J DRUG POLICY, V26, P911, DOI 10.1016/j.drugpo.2015.07.004; Spiller M. W., 2012, RDS ANAL TOOL 7 1 US; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Wejnert C, 2017, JAIDS-J ACQ IMM DEF, V75, pS249, DOI 10.1097/QAI.0000000000001430; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091; Wong WWL, 2016, IEEE J BIOMED HEALTH, V20, P1538, DOI 10.1109/JBHI.2015.2471804	65	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0206356	10.1371/journal.pone.0206356	http://dx.doi.org/10.1371/journal.pone.0206356			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496209	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800014
J	Lin, TK; Yu, PT; Lin, LY; Liu, PY; Li, YD; Hsu, CT; Cheng, YR; Yeh, CY; Wong, SS; Pai, SA; Shee, HL; Weng, CY				Lin, Tin-Kwang; Yu, Pao-Ta; Lin, Lian-Yu; Liu, Ping-Yen; Li, Yi-Da; Hsu, Chiu-Tien; Cheng, Yih-Ru; Yeh, Chun-Yin; Wong, Shu-Shu; Pai, Shih-An; Shee, Huey-Ling; Weng, Chia-Ying			A pilot-study to assess the feasibility and acceptability of an Internet-based cognitive-behavior group therapy using video conference for patients with coronary artery heart disease	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; RISK-FACTORS; HOSTILITY; MANAGEMENT; ASSOCIATION; ANXIETY; EVENTS; ANGER	Background Many patients with coronary artery heart disease are unable to access traditional psychosocial rehabilitation conducted face to face due to excessive travel distance. Therefore, this study developed and assessed the feasibility and acceptability of an 8-week Internet-based cognitive-behavior group therapy program, described the patterns of use and measured change in risk factors. Methods This study adopted an online video conference system, JointNet, to maintain group interaction functions similar to face to face groups online, and also built an self-learning platform to deliver psychoeducation content and cognitive-behavior therapy related materials and homework. Forty-three out-patients were recruited in the pilot study, who then chose to participate in either the Internet-based cognitive-behavior group therapy or face to face group based on their preference. Fourteen patients were assigned to the waiting-list control. Results Seventeen participants (17/43 = 39.5%) chose the Internet-based cognitive-behavior group therapy program. Among them, thirteen participants (13/17 = 76.5%) finished the program and were more male (92.3% vs. 50%), employed (53.8% vs. 35.3%), and had longer education duration (13.9 vs. 12.5 years) than the counterparts of the face to face group. Furthermore, they were highly motivated with average number of log-ins (66.5 time), website surfing time (950.94 min), reading frequency (78.15 time) and reading time (355.90 min) for the self-learning platform during eight weeks; and also highly satisfied (97%) with visiting the self-learning platform and video conferences. The treatment effectiveness of Internet-based cognitive-behavior group therapy was comparable with face to face one in reducing anxiety, hostility, respiration rate, and in improving vasodilation but not depression compared with the waiting-list control. Conclusion These results indicated that the Internet-based group therapy program using video conference is feasible and acceptable for the psychosocial rehabilitation of patients with coronary artery heart disease, and provides an alternative for patients who are unable to obtain conventional psychosocial rehabilitation conducted face to face.	[Lin, Tin-Kwang; Li, Yi-Da] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lin, Tin-Kwang; Li, Yi-Da] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Cardiol, Chiayi, Taiwan; [Yu, Pao-Ta] Natl Chung Cheng Univ, Dept Comp Sci & Informat Engn, Chiayi, Taiwan; [Lin, Lian-Yu] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Lin, Lian-Yu] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liu, Ping-Yen] Natl Cheng Kung Univ, Inst Clin Med, Tainan, Taiwan; [Liu, Ping-Yen] Natl Cheng Kung Univ Hosp, Div Cardiol, Internal Med, Tainan, Taiwan; [Hsu, Chiu-Tien] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Psychol, Chiayi, Taiwan; [Cheng, Yih-Ru] Natl Taiwan Univ Hosp, Clin Psychol Ctr, Taipei, Taiwan; [Yeh, Chun-Yin] Natl Cheng Kung Univ Hosp, Tainan, Taiwan; [Wong, Shu-Shu] Wenzhou Univ, Dept Psychol, Wenzhou City, Peoples R China; [Pai, Shih-An; Weng, Chia-Ying] Natl Chung Cheng Univ, Dept Psychol, Chiayi, Taiwan; [Shee, Huey-Ling] Natl Chung Cheng Univ, Coll Law, Chiayi, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Chung Cheng University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Wenzhou University; National Chung Cheng University; National Chung Cheng University	Weng, CY (corresponding author), Natl Chung Cheng Univ, Dept Psychol, Chiayi, Taiwan.	psycyw@gmail.com			Ministry of Science and Technology, Taiwan [100-2410-H-194-040-MY2]; Buddhist Dalin Tzu-Chi General Hospital, Chia-Yi, Taiwan [DTCRD-102-E-10]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Buddhist Dalin Tzu-Chi General Hospital, Chia-Yi, Taiwan	This study was supported by funding from the Ministry of Science and Technology, Taiwan (Grant number: 100-2410-H-194-040-MY2 and the URLs: https://statistics.most.gov.tw/award/) awarded to C-Y W; and The Buddhist Dalin Tzu-Chi General Hospital, Chia-Yi, Taiwan (Grant number: DTCRD-102-E-10 and the URLs: http://dl.tzuchi.com.tw/res/node/163) awarded to Y-D L.	Andrews TM, 2011, CBE-LIFE SCI EDUC, V10, P394, DOI 10.1187/cbe.11-07-0061; Beck JS, 2011, COGNITIVE BEHAV THER; Bishop J. L., 2013, FLIPPED CLASSROOM SU; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Chen H. Y., 2000, GUIDEBOOK BECK DEPRE; Chung SK., 1984, PSYCHOL TESTING, V31, P27; Dale LP, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4944; Del Vecchio T, 2004, CLIN PSYCHOL REV, V24, P15, DOI 10.1016/j.cpr.2003.09.006; Gidron Y, 1999, HEALTH PSYCHOL, V18, P416, DOI 10.1037/0278-6133.18.4.416; Glozier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059139; Gunawardena C. N., 1995, INT J ED TELECOMMUNI, V1, P147, DOI DOI 10.1080/08923649709526970; Kuhl EA, 2006, HEART LUNG, V35, P374, DOI 10.1016/j.hrtlng.2006.02.004; Lin IM, 2015, ACTA CARDIOL SIN, V31, P308, DOI 10.6515/ACS20141027B; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Palacios J, 2017, J CARDIOVASC NURS, V32, pE9, DOI 10.1097/JCN.0000000000000392; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Roest AM, 2010, PSYCHOSOM MED, V72, P563, DOI 10.1097/PSY.0b013e3181dbff97; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Rozanski A, 2014, J AM COLL CARDIOL, V64, P100, DOI 10.1016/j.jacc.2014.03.047; Sloan RP, 2010, PSYCHOSOM MED, V72, P1, DOI 10.1097/PSY.0b013e3181c8a529; Steinmark AP, 2006, J CLIN PSYCHOL MED S, V13, P353, DOI 10.1007/s10880-006-9046-3; Tate DF, 2004, J CLIN PSYCHOL, V60, P209, DOI 10.1002/jclp.10247; Weng C. Y., 2008, PSYCHOL TESTING, V55, P463; Weng CY, 2012, BACK GOOD MOOD 8 PRA; Weng CY, 2016, CHINESE J PSYCHOL, V58, P55; Whalley B, 2014, INT J BEHAV MED, V21, P109, DOI 10.1007/s12529-012-9282-x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	29	0	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207931	10.1371/journal.pone.0207931	http://dx.doi.org/10.1371/journal.pone.0207931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496222	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800066
J	Sharifi, H; Mirzazadeh, A; Shokoohi, M; Karamouzian, M; Khajehkazemi, R; Navadeh, S; Fahimfar, N; Danesh, A; Osooli, M; McFarland, W; Gouya, MM; Haghdoost, AA				Sharifi, Hamid; Mirzazadeh, Ali; Shokoohi, Mostafa; Karamouzian, Mohammad; Khajehkazemi, Razieh; Navadeh, Soodabeh; Fahimfar, Noushin; Danesh, Ahmad; Osooli, Mehdi; McFarland, Willi; Gouya, Mohammad Mehdi; Haghdoost, Ali Akbar			Estimation of HIV incidence and its trend in three key populations in Iran	PLOS ONE			English	Article							FEMALE SEX WORKERS; INJECTION-DRUG USERS; RISK-FACTOR; SAN-FRANCISCO; PREVALENCE; INFECTION; MEN; AGE; BEHAVIORS; PROGRAMS	In Iran, People Who Inject Drugs (PWID), Female Sex Workers (FSW), and prisoners are the main key populations at risk of HIV infection. This study aimed to evaluate the trend of HIV incidence among PWID, FSW and prisoners as an impact measure of HIV harm reduction and prevention efforts in Iran. Data were obtained from the two rounds of national bio-behavioral surveillance surveys among FSW (2010 (n = 872), 2015 (n = 1339)), PWID (2010 (n = 2417), 2014 (n = 2307)), and prisoners (2009 (n = 4536), 2013 (n = 5390)) through facility-based (FSW and PWID surveys) and cluster sampling (prisoner surveys). Time-at-risk was calculated assuming the age at first sex or drug injection as the beginning of the at-risk period and the age at the time of the interview or date when they received a positive HIV test result as the end of this period, adjusted for interval censoring. HIV incidence among PWID in 2014 was 5.39 (95% CI 4.71, 6.16) per 1,000 person-years (PY), significantly lower than in 2009 (17.07, 95% CI 15.34, 19.34). Similarly, HIV incidence was 1.12 (95% CI 0.77, 1.64) per 1,000 PY among FSW in 2015, a significant drop from 2010 (2.38, 95% CI 1.66, 3.40). Also, HIV incidence decreased among prisoners from 1.34 (95% CI: 1.08, 1.67) in 2009 to 0.49 (95% CI: 0.39, 0.61) per 1,000 PY in 2013. Our findings suggest that after an increase in the 2000s, the HIV incidence may have been decreased and stabilized among key populations in Iran.	[Sharifi, Hamid; Mirzazadeh, Ali; Shokoohi, Mostafa; Karamouzian, Mohammad; Khajehkazemi, Razieh; Navadeh, Soodabeh; Osooli, Mehdi; Haghdoost, Ali Akbar] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Inst Futures Studies Hlth, Kerman, Iran; [Sharifi, Hamid; Mirzazadeh, Ali; Shokoohi, Mostafa; Karamouzian, Mohammad; Khajehkazemi, Razieh; Navadeh, Soodabeh; Osooli, Mehdi; Haghdoost, Ali Akbar] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran; [Mirzazadeh, Ali; McFarland, Willi] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mirzazadeh, Ali; Navadeh, Soodabeh; McFarland, Willi] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Shokoohi, Mostafa] Univ Western Ontario, Schulich Sch Med & Dent, Epidemiol & Biostat, London, ON, Canada; [Karamouzian, Mohammad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Fahimfar, Noushin] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Danesh, Ahmad] Golestan Univ Med Sci, Dept Hlth & Social Med, Gorgan, Iran; [Osooli, Mehdi] Lund Univ, Fac Med, Dept Translat Sci, Malmo, Sweden; [Gouya, Mohammad Mehdi] Iran Univ Med Sci, Tehran, Iran; [Haghdoost, Ali Akbar] Kerman Univ Med Sci, Modeling Hlth Res Ctr, Inst Futures Studies Hlth, Kerman, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Western University (University of Western Ontario); University of British Columbia; Tehran University of Medical Sciences; Golestan University of Medical Sciences; Lund University; Iran University of Medical Sciences; Kerman University of Medical Sciences	Mirzazadeh, A (corresponding author), Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Inst Futures Studies Hlth, Kerman, Iran.; Mirzazadeh, A (corresponding author), Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran.; Mirzazadeh, A (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Mirzazadeh, A (corresponding author), Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA.	ali.mirzazadeh@ucsf.edu	Gouya, Mohammad Mehdi/ABI-4325-2020; Karamouzian, Mohammad/C-9277-2018; Osooli, Mehdi/A-6457-2009; Mirzazadeh, Ali/AAJ-5907-2021; Haghdoost, Ali Akbar/C-2823-2009; Sharifi, Hamid/B-5493-2019; Fahimfar, Noushin/M-2310-2018	Karamouzian, Mohammad/0000-0002-5631-4469; Osooli, Mehdi/0000-0002-9862-3665; Haghdoost, Ali Akbar/0000-0003-4628-4849; Sharifi, Hamid/0000-0002-9008-7618; Mirzazadeh, Ali/0000-0002-0478-3220; Shokoohi, Mostafa/0000-0002-3810-752X; Fahimfar, Noushin/0000-0001-6205-9794	Global Fund to Fight AIDS, Tuberculosis and Malaria; University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH [R25 MH064712]; Iran Ministry of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	Global Fund to Fight AIDS, Tuberculosis and Malaria; University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH; Iran Ministry of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All surveys were funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria and Iran Ministry of Health. For this paper, we wish to acknowledge the support from the University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH, R25 MH064712.	Alam-Mehrjerdi Z, 2016, DARU, V24, DOI 10.1186/s40199-016-0141-1; Alam-mehrjerdi Z, 2015, ASIAN J PSYCHIATR, V16, P78, DOI 10.1016/j.ajp.2015.06.002; Centers for Disease Control and Prevention, 2016, HIV SURV REP, V27; Cui Y, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20609; Deschamps MM, 2016, JAIDS-J ACQ IMM DEF, V71, P70, DOI 10.1097/QAI.0000000000000796; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Gao ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161183; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gokengin D, 2016, INT J INFECT DIS, V44, P66, DOI 10.1016/j.ijid.2015.11.008; Haghdoost A., 2014, HIV BIOBEHAVIORAL SU; Haghdoost AA, 2011, J AIDS HIV RES, V3, P231, DOI [https://doi.org/10.5897/JAHR11.030, DOI 10.5897/JAHR11.030]; Haghdoost AA, 2013, HIV BIOBEHAVIORAL SU; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Joint United Nations Programme on HIV/AIDS, THE GAP REP 2014; Karamouzian M, 2017, INT J DRUG POLICY, V44, P86, DOI 10.1016/j.drugpo.2017.03.011; Karamouzian M, 2017, INT J HEALTH POLICY, V6, P65, DOI 10.15171/ijhpm.2016.112; Khajehkazemi R, 2013, SEX TRANSM INFECT, V89, P29, DOI 10.1136/sextrans-2013-051204; Kim AA, 2010, AIDS RES HUM RETROV, V26, P1051, DOI 10.1089/aid.2009.0218; Kozlov AP, 2006, AIDS, V20, P901, DOI 10.1097/01.aids.0000218555.36661.9c; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218; Mirzazadeh A, 2015, HIV BIOBEHAVIORAL SU; Mumtaz GR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001663; National AIDS Committee Secretariat Ministry of Health and Medical Education, 2015, ISL REP IR AIDS PROG; Navadeh S, 2013, SEX TRANSM INFECT, V89, P33, DOI 10.1136/sextrans-2013-051295; Nazari SSH, 2016, INT J DRUG POLICY, V27, P127, DOI 10.1016/j.drugpo.2015.10.011; Nissaramanesh B., 2005, 8 BECKL FDN DRUG POL; Noroozi M, 2017, INT J HIGH RISK BEHA, V6, DOI [10.5812/ijhrba.28929, DOI 10.5812/IJHRBA.28929]; OSMOND DH, 1994, AM J PUBLIC HEALTH, V84, P1933, DOI 10.2105/AJPH.84.12.1933; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Sajadi L, 2013, SEX TRANSM INFECT, V89, P37, DOI 10.1136/sextrans-2013-051028; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Shahbazi M, 2014, IRAN J PUBLIC HEALTH, V43, P471; Sharifi H, 2017, SUBST USE MISUSE, V52, P1214, DOI 10.1080/10826084.2017.1303509; Shokoohi M, 2017, AIDS BEHAV, V21, P2401, DOI 10.1007/s10461-017-1844-0; Shokoohi M, 2016, INT J DRUG POLICY, V32, P64, DOI 10.1016/j.drugpo.2016.03.009; Shokoohi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147587; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; Van Griensven F, 2016, ESTIMATING RECENT HI; van Griensven F, 2010, JAIDS-J ACQ IMM DEF, V53, P234, DOI 10.1097/QAI.0b013e3181c2fc86	42	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207681	10.1371/journal.pone.0207681	http://dx.doi.org/10.1371/journal.pone.0207681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496204	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800042
J	Beldick, SR; Hong, J; Altamentova, S; Khazaei, M; Hundal, A; Zavvarian, MM; Rumajogee, P; Chio, J; Fehlings, MG				Beldick, Stephanie R.; Hong, James; Altamentova, Svetlana; Khazaei, Mohamad; Hundal, Anisha; Zavvarian, Mohammad-Masoud; Rumajogee, Prakasham; Chio, Jonathon; Fehlings, Michael G.			Severe-combined immunodeficient rats can be used to generate a model of perinatal hypoxic-ischemic brain injury to facilitate studies of engrafted human neural stem cells	PLOS ONE			English	Article							TRANSPLANTATION; INTEGRITY; RECOVERY; THERAPY; DAMAGE	Cerebral palsy (CP) encompasses a group of non-progressive brain disorders that are often acquired through perinatal hypoxic-ischemic (HI) brain injury. Injury leads to a cascade of cell death events, resulting in lifetime motor and cognitive deficits. There are currently no treatments that can repair the resulting brain damage and improve functional outcomes. To date, preclinical research using neural precursor cell (NPC) transplantation as a therapy for HI brain injury has shown promise. To translate this treatment to the clinic, it is essential that human-derived NPCs also be tested in animal models, however, a major limitation is the high risk of xenograft rejection. A solution is to transplant the cells into immune-deficient rodents, but there are currently no models of HI brain injury established in such a cohort of animals. Here, we demonstrate that a model of HI brain injury can be generated in immunedeficient Prkdc knockout (KO) rats. Long-term deficits in sensorimotor function were similar between KO and wildtype (WT) rats. Interestingly, some aspects of the injury were more severe in KO rats. Additionally, human induced pluripotent stem cell derived (hiPSC)-NPCs had higher survival at 10 weeks post-transplant in KO rats when compared to their WT counterparts. This work establishes a reliable model of neonatal HI brain injury in Prkdc KO rats that will allow for future transplantation, survival, and long-term evaluation of the safety and efficacy of hiPSC-NPCs for neonatal brain damage. This model will enable critical preclinical translational research using human NPCs.	[Beldick, Stephanie R.; Hong, James; Zavvarian, Mohammad-Masoud; Chio, Jonathon; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Beldick, Stephanie R.; Hong, James; Altamentova, Svetlana; Khazaei, Mohamad; Zavvarian, Mohammad-Masoud; Rumajogee, Prakasham; Chio, Jonathon; Fehlings, Michael G.] Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Hundal, Anisha] Univ Toronto Mississauga, Life Sci Program, Mississauga, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada	University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Mississauga; University of Toronto	Fehlings, MG (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Div Neurosurg, Toronto, ON, Canada.	Michael.Fehlings@uhn.ca		Fehlings, Michael/0000-0002-5722-6364; Beldick, Stephanie/0000-0002-5349-0352; Chio, Jonathon Chon Teng/0000-0002-9914-5538	Ontario Brain Institute; Kids Brain Health Network; Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration; Dezwirek Family Foundation	Ontario Brain Institute; Kids Brain Health Network; Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration; Dezwirek Family Foundation	The authors would like to acknowledge the funding support from the Ontario Brain Institute and the Kids Brain Health Network (M.G.F.). These funding agencies provided monetary support to complete the project. M.G.F. is supported by the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration and the Dezwirek Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the funding support from the Ontario Brain Institute and the Kids Brain Health Network. These funding agencies provided monetary support to complete the project. M.G.F. is supported by the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration and the Dezwirek Family Foundation. The authors would also like to acknowledge Dr. Alex Laliberte for his sound advice and guidance.	Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Boltze J, 2014, J CEREBR BLOOD F MET, V34, P1420, DOI 10.1038/jcbfm.2014.94; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Braccioli L, 2017, PEDIATR RES, V81, P127, DOI 10.1038/pr.2016.172; Chen H, 2011, TRANSL STROKE RES, V2, P382, DOI 10.1007/s12975-011-0081-5; Chicha L, 2014, CHILD NERV SYST, V30, P37, DOI 10.1007/s00381-013-2304-4; Clowry GJ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00258; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Enriquez-Rios V, 2017, J NEUROSCI, V37, P893, DOI 10.1523/JNEUROSCI.4213-15.2016; Eunson P, 2015, DEV MED CHILD NEUROL, V57, P48, DOI 10.1111/dmcn.12727; Fan HC, 2015, CELL TRANSPLANT, V24, P471, DOI 10.3727/096368915X686931; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Graham HK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.82; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Herz J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01696; Hoornaert CJ, 2017, STEM CELL TRANSL MED, V6, P1434, DOI 10.1002/sctm.16-0434; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Ji G, 2015, CNS NEUROSCI THER, V21, P926, DOI 10.1111/cns.12441; Khazaei M, 2015, J CLIN MED, V4, P37, DOI 10.3390/jcm4010037; Li YB, 2015, NEURAL REGEN RES, V10, P753, DOI 10.4103/1673-5374.156971; Lin Y, 1998, J IMMUNOL, V160, P369; Liu FD, 2013, ACTA PHARMACOL SIN, V34, P1121, DOI 10.1038/aps.2013.89; Mallard C, 2015, STROKE, V46, P3006, DOI 10.1161/STROKEAHA.115.007776; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Massaro AN, 2015, DEV MED CHILD NEUROL, V57, P441, DOI 10.1111/dmcn.12646; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Qu Su-qing, 2005, Zhonghua Er Ke Za Zhi, V43, P576; Reid SM, 2015, DEV MED CHILD NEUROL, V57, P1159, DOI 10.1111/dmcn.12800; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rolstad B, 2001, IMMUNOL REV, V184, P136, DOI 10.1034/j.1600-065x.2001.1840113.x; Ruff CA, 2013, DEV MED CHILD NEUROL, V55, P689, DOI 10.1111/dmcn.12166; Rumajogee P, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0369-18.2018; Rumajogee P, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00057; Salewski RP, 2015, STEM CELL TRANSL MED, V4, P743, DOI 10.5966/sctm.2014-0236; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; Shinoyama M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00128; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; van der Kooij MA, 2010, BRAIN BEHAV IMMUN, V24, P850, DOI 10.1016/j.bbi.2009.09.003; Woodbine L, 2013, J CLIN INVEST, V123, P2969, DOI 10.1172/JCI67349; Zhao YD, 2013, J NEUROSCI RES, V91, P1165, DOI 10.1002/jnr.23247	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208105	10.1371/journal.pone.0208105	http://dx.doi.org/10.1371/journal.pone.0208105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485360	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800106
J	Lim, Y; Jung, ES; Lee, JH; Kim, EJ; Hong, SJ; Lee, YH; Lee, CH				Lim, Yonghwan; Jung, Eun Sung; Lee, Je Hyeon; Kim, Eun Joo; Hong, Sun Joo; Lee, Yeon Hee; Lee, Choong Hwan			Non-targeted metabolomics unravels a media-dependent prodiginines production pathway in Streptomyces coelicolor A3(2)	PLOS ONE			English	Article							SECONDARY METABOLISM; ANTIBIOTIC PRODUCTION; POLYKETIDE SYNTHASE; ESCHERICHIA-COLI; BIOSYNTHESIS; EXPRESSION; BACTERIA; PIGMENTS	The genus Streptomyces is the best-known source of therapeutic secondary metabolites, especially antibiotics with pharmaceutical applications. Here, we performed a comparative study based on the time-resolved metabolic disparity in S. coelicolor A3(2) subjected to fermentative cultivation in two different types of media (R2YE and RSM3) in order to investigate secondary metabolite production pathways. The relative abundance of secondary metabolites, such as prodiginines, indoles, germicidins, and selected diketopiperazines, was increased in S. coelicolor A3(2) cultivated in R2YE medium compared to that in RSM3 medium, variably at the late-log and stationary phases of fermentative growth. Correlation analysis indicated that "antibiotic prodiginines" contributed maximally to the absorption maxima (A(530)) of culture supernatants, indicating their optimal production at 96 hours in R2YE medium. A higher abundance of L-proline (48-72 hours) followed by prodiginines (96 hours) was evident, substantiating the intertwined links between precursor and activated prodiginines pathway. Similarly, the higher abundance of indoles was concurrent with tryptophan levels in the shikimate pathway, whereas diketopiperazines were synchronously abundant along with the levels of phenylalanine, leucine, and proline. Additionally, acetyl-CoA induced the acetate pathway, resulting in the production of germicidins. Thus, our results demonstrate that S. coelicolor A3(2) produces specific secondary metabolites by enhancing the dedicated metabolic pathway responsible for their production. In conclusion, our results from this study provide insight into the metabolic pathways of S. coelicolor A3(2), and can be applied to further optimize the production of prodiginines.	[Lim, Yonghwan; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Jung, Eun Sung; Lee, Choong Hwan] Konkuk Univ, Dept Syst Biotechnol, Seoul, South Korea; [Lee, Je Hyeon; Kim, Eun Joo; Hong, Sun Joo; Lee, Yeon Hee] Dynebio Inc, Gyeonggi Do, South Korea	Konkuk University; Konkuk University	Lee, CH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.; Lee, CH (corresponding author), Konkuk Univ, Dept Syst Biotechnol, Seoul, South Korea.	chlee123@konkuk.ac.kr			Rural Development Administration, Republic of Korea, [PJ01328802]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry(IPET) through High Value-added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs(MAFRA) [318027-04-1-HD030]	Rural Development Administration, Republic of Korea,(Rural Development Administration (RDA), Republic of Korea); Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry(IPET) through High Value-added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs(MAFRA)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ01328802)" Rural Development Administration, Republic of Korea, and funded by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry(IPET) through High Value-added Food Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs(MAFRA) (grant number 318027-04-1-HD030). Dynebio, Inc. provided support in the form of salaries for authors JHL, EJK, SJH, and YHL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Bordbar A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46249; Borodina I, 2005, APPL ENVIRON MICROB, V71, P2294, DOI 10.1128/AEM.71.5.2294-2302.2005; Borthwick AD, 2012, CHEM REV, V112, P3641, DOI 10.1021/cr200398y; Bundale S., 2015, ADV MICROBIOL-IRVINE, V05, P441, DOI DOI 10.4236/AIM.2015.56045; Bystrykh LV, 1996, J BACTERIOL, V178, P2238, DOI 10.1128/jb.178.8.2238-2244.1996; Cerdeno AM, 2001, CHEM BIOL, V8, P817, DOI 10.1016/S1074-5521(01)00054-0; Chemler JA, 2012, J AM CHEM SOC, V134, P7359, DOI 10.1021/ja2112228; Chouayekh H, 2002, MOL MICROBIOL, V43, P919, DOI 10.1046/j.1365-2958.2002.02557.x; Coisne S, 1999, LETT APPL MICROBIOL, V28, P199, DOI 10.1046/j.1365-2672.1999.00509.x; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; DAZA A, 1989, J GEN MICROBIOL, V135, P2483; Dynebio Inc, 2018, Korea patent KOR, Patent No. 1020160104141; Elibol M, 2004, PROCESS BIOCHEM, V39, P1057, DOI 10.1016/S0032-9592(03)00232-2; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Hamaki T, 2005, J BIOSCI BIOENG, V99, P485, DOI 10.1263/jbb.99.485; HOBBS G, 1990, J GEN MICROBIOL, V136, P2291, DOI 10.1099/00221287-136-11-2291; HOOD DW, 1992, GENE, V115, P5, DOI 10.1016/0378-1119(92)90533-U; Jung ES, 2015, METABOLOMICS, V11, P861, DOI 10.1007/s11306-014-0743-x; Kim HB, 2004, METAB ENG, V6, P313, DOI 10.1016/j.ymben.2004.04.001; Kim J, 2017, PROCESS BIOCHEM, V57, P64, DOI 10.1016/j.procbio.2017.04.003; Krivoruchko A, 2015, METAB ENG, V28, P28, DOI 10.1016/j.ymben.2014.11.009; Legault GS, 2011, PHYTOPATHOLOGY, V101, P1045, DOI 10.1094/PHYTO-03-11-0064; Leutou Alain S., 2015, Natural Product Sciences, V21, P248; Li J, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.46; Lin L, 2013, CURR MICROBIOL, V67, P209, DOI 10.1007/s00284-013-0348-z; Locatelli FM, 2016, METALLOMICS, V8, P469, DOI 10.1039/c5mt00324e; Martins MB, 2007, TETRAHEDRON, V63, P9923, DOI 10.1016/j.tet.2007.04.105; Pawlik K, 2010, J MOL MICROB BIOTECH, V19, P147, DOI 10.1159/000321501; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Robyt J. F., 2001, ENCY LIFE SCI, DOI DOI 10.1038/NPG.ELS.0000700; Rodriguez E, 2001, APPL ENVIRON MICROB, V67, P4166, DOI 10.1128/AEM.67.9.4166-4176.2001; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Ruiz B, 2010, CRIT REV MICROBIOL, V36, P146, DOI 10.3109/10408410903489576; Sanchez S, 2008, MICROB BIOTECHNOL, V1, P283, DOI 10.1111/j.1751-7915.2007.00015.x; Shepherd MD, 2010, CURR PROTOC MICROBIO, V1, P1, DOI DOI 10.1002/9780471729259.MC10E01S18; Suh DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149022; TANAKA WK, 1972, BIOCHEM BIOPH RES CO, V46, P731, DOI 10.1016/S0006-291X(72)80201-8; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Venil CK, 2013, PROCESS BIOCHEM, V48, P1065, DOI 10.1016/j.procbio.2013.06.006; WASSERMA.HH, 1973, J AM CHEM SOC, V95, P6874, DOI 10.1021/ja00801a080; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207541	10.1371/journal.pone.0207541	http://dx.doi.org/10.1371/journal.pone.0207541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485320	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800073
J	Reboleira, ASPS; Enghoff, H; Santamaria, S				Reboleira, Ana Sofia P. S.; Enghoff, Henrik; Santamaria, Sergi			Novelty upon novelty visualized by rotational scanning electron micrographs (rSEM): Laboulbeniales on the millipede order Chordeumatida	PLOS ONE			English	Article							DIPLOPODA; SPECIFICITY; ASCOMYCOTA; COLEOPTERA; BEHAVIOR	Laboulbeniales are highly specific ectoparasitic fungi of arthropods (insects, millipedes, and arachnids). The first Laboulbeniales parasitizing the millipede order Chordeumatida (Diplopoda) were discovered and described as a new dioecious genus of Laboulbeniales, Thaxterimyces, to accommodate the new species T. baliensis. Also the millipede host is a new species and is described as Metopidiothrix sheari. This is the first time Laboulbeniales fungus and its millipede host are described as new together. Males of Metopidiothrix have the most extensive secondary sexual modifications in the entire class Diplopoda. Although nothing is known about the function of these modifications, the unique pattern of Laboulbeniales infection in the new millipede species is obviously related to host sexual behavior. Rotational Scanning Electron Micrographs (rSEM) are used to create a 3D comprehensive model to examine the fungal-host interaction, a more advanced visualization of the ectoparasitic fungus on its host. Laboulbeniales diversity on millipedes is still understudied, and a consistent effort is needed to unveil and understand the extent and diversity of this biological interaction. Due to their minute size and apparently non-detrimental effect on their hosts, Laboulbeniales in general have been largely ignored by mycologists and neglected by generations of entomologists. As a result a significant component of global biodiversity has been strongly underestimated, and a wealth of new discoveries is still to be made both in the field and in existing museum collections.	[Reboleira, Ana Sofia P. S.; Enghoff, Henrik] Univ Copenhagen, Nat Hist Museum Denmark, Univ Pk 15, Copenhagen O, Denmark; [Santamaria, Sergi] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Unitat Bot, E-08193 Barcelona, Spain	University of Copenhagen; Autonomous University of Barcelona	Reboleira, ASPS (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Univ Pk 15, Copenhagen O, Denmark.	sreboleira@snm.ku.dk	Santamaria, Sergi/AAJ-9338-2020; Santamaria, Sergi/L-1678-2014; Reboleira, A./B-3459-2010	Santamaria, Sergi/0000-0001-7462-8923; Reboleira, A./0000-0002-4756-7034	Danish Council for Independent Research [DFF-FNU 4002-00269]; Villum Fonden [15471]; Villum Fonden [00015471] Funding Source: researchfish	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden); Villum Fonden(Villum Fonden)	Funded by 1. Danish Council for Independent Research, grant number: DFF-FNU 4002-00269 to ASPSR. https://ufm.dk/en/research-and-innovation/funding-programmes-for-research-and-innovation/who-has-received-funding/2014/postdoc-grants-from-the-danish-council-for-independent-research-natural-Dsciences-february-2014. 2. Villum Fonden, grant number 15471 to ASPSR. http://veluxfoundations.dk/en/content/young-investigator-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to David Koon-Bong Cheung for helping with the 3D rSEM rotating figure; to Jan Pedersen for collecting the millipede specimens; to William Shear, Dragan Antic, Peter Decker, Paul Marek and Derek Hennen for providing information on chordeumatidan behavior, to Josh Jenkins Shaw for English revision, and to Walter Rossi for helpful comments regarding Laboulbeniales. This project was funded by the Danish Council for Independent Research, ref. DFF-FNU 4002-00269. ASR is supported by a research grant (15471) from VILLUM FONDEN.	Cheung DKB, 2013, ZOOKEYS, P47, DOI 10.3897/zookeys.328.5768; de Kesel A, 2013, STERBEECKIA, V32, P6; DeKesel A, 1996, MYCOLOGIA, V88, P565, DOI 10.1080/00275514.1996.12026687; Enghoff H, 2015, THE MYRIAPODA, V2, P329, DOI [10.1163/9789004188273_014, DOI 10.1163/9789004188273_014]; Enghoff H, 2015, ORG DIVERS EVOL, V15, P249, DOI 10.1007/s13127-015-0208-8; Goldmann L, 2012, MYCOLOGIA, V104, P1143, DOI 10.3852/11-358; GOLOVATCH SI, 1984, ACTA ZOOL HUNG, V30, P53; HAACKER U, 1971, Forma et Functio, V4, P162; HAACKER U, 1971, NATURWISSENSCHAFTEN, V58, P59, DOI 10.1007/BF00620820; Hughes DP, 2016, ADV GENET, V94, P437, DOI 10.1016/bs.adgen.2016.01.004; MAURIES JP, 1989, REV SUISSE ZOOL, V96, P425; MEIJER J, 1975, OECOLOGIA, V19, P99, DOI 10.1007/BF00369094; Nieberding CM, 2008, MOL PHYLOGENET EVOL, V47, P538, DOI 10.1016/j.ympev.2008.01.028; Reboleira ASPS, 2015, EUR J TAXON, V146, P1, DOI 10.5852/ejt.2015.146; Reboleira ASPS, 2015, ZOOTAXA, V3957, P567, DOI 10.11646/zootaxa.3957.5.5; Rossi W., 1979, Fragmenta Entomologica, V15, P7; ROSSI W, 1977, REV MYCOL, V41, P525; Santamaria S, 2017, PHYTOTAXA, V305, P285, DOI 10.11646/phytotaxa.305.4.4; Santamaria S, 2016, PHYTOTAXA, V243, P101, DOI 10.11646/phytotaxa.243.2.1; Santamaria S, 2014, MYCOLOGIA, V106, P1027, DOI 10.3852/13-381; Shear WA, 2002, INVERTEBR SYST, V16, P849, DOI 10.1071/IS02005; TADLER A, 1993, ACTA ZOOL-STOCKHOLM, V74, P215, DOI 10.1111/j.1463-6395.1993.tb01236.x; Thaxter R, 1918, P AM ACAD ARTS SCI, V54, P207, DOI 10.2307/20025751; Thaxter R, 1915, P AM ACAD ARTS SCI, V51, P3, DOI 10.2307/20025560; Thaxter R, 1920, P AM ACAD ARTS SCI, V55, P209; Thaxter R., 1896, MEM AM ACAD ARTS, V12, P187, DOI DOI 10.2307/25058114; Weir A, 1997, BIODIVERS CONSERV, V6, P701, DOI 10.1023/A:1018318320019; Youngsteadt Norman W., 2008, Transactions of the Kansas Academy of Science, V111, P136, DOI 10.1660/0022-8443(2008)111[136:LOOTBO]2.0.CO;2	30	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206900	10.1371/journal.pone.0206900	http://dx.doi.org/10.1371/journal.pone.0206900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485308	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800033
J	Schweitzer, MH; Zheng, WX; Moyer, AE; Sjovall, P; Lindgren, J				Schweitzer, Mary Higby; Zheng, Wenxia; Moyer, Alison E.; Sjovall, Peter; Lindgren, Johan			Preservation potential of keratin in deep time	PLOS ONE			English	Article							BETA BETA KERATINS; ION MASS-SPECTROMETRY; SOFT-TISSUE; ALPHA-KERATIN; EVOLUTIONARY ORIGIN; SCUTATE SCALE; PROTEIN; FEATHERS; BIRD; DIVERSIFICATION	Multiple fossil discoveries and taphonomic experiments have established the durability of keratin. The utility and specificity of antibodies to identify keratin peptides has also been established, both in extant feathers under varying treatment conditions, and in feathers from extinct organisms. Here, we show localization of feather-keratin antibodies to control and heat-treated feathers, testifying to the repeatability of initial data supporting the preservation potential of keratin. We then show new data at higher resolution that demonstrates the specific response of these antibodies to the feather matrix, we support the presence of protein in heat-treated feathers using ToF-SIMS, and we apply these methods to a fossil feather preserved in the unusual environment of sinter hot springs. We stress the importance of employing realistic conditions such as sediment burial when designing experiments intended as proxies for taphonomic processes occurring in the fossil record. Our data support the hypothesis that keratin, particularly the beta-keratin that comprises feathers, has potential to preserve in fossil remains.	[Schweitzer, Mary Higby; Zheng, Wenxia] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Schweitzer, Mary Higby] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Schweitzer, Mary Higby; Lindgren, Johan] Lund Univ, Dept Geol, Lund, Sweden; [Moyer, Alison E.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Sjovall, Peter] RISE Res Inst Sweden, Chem & Mat, Boras, Sweden	University of North Carolina; North Carolina State University; Lund University; Drexel University; RISE Research Institutes of Sweden	Schweitzer, MH (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.; Schweitzer, MH (corresponding author), North Carolina Museum Nat Sci, Raleigh, NC 27601 USA.; Schweitzer, MH (corresponding author), Lund Univ, Dept Geol, Lund, Sweden.	schweitzer@ncsu.edu	Schweitzer, Mary/V-8143-2019; Sjovall, Peter/ABA-7172-2020; schweitzer, mary h/A-6756-2010	Sjovall, Peter/0000-0002-2696-7215; schweitzer, mary h/0000-0002-0427-3829	National Science Foundation, INSPIRE [EAR- 1344198]; David and Lucile Packard Foundation; Swedish Research Council [642-2014-3773]	National Science Foundation, INSPIRE(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by: National Science Foundation, INSPIRE, EAR- 1344198 and The David and Lucile Packard Foundation (MHS); Swedish Research Council, Grant for Distinguished Young Researchers, 642-2014-3773 (JL); Lynn and Susan Orr, Vance and Gayle Mullis (MHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L, 2017, PROTOPLASMA, V254, P1259, DOI 10.1007/s00709-016-1019-2; Allentoft ME, 2012, BIOL SCI, P4724, DOI DOI 10.1098/RSPB.2012.1745; Avci R, 2005, LANGMUIR, V21, P3584, DOI 10.1021/la047682e; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 2000, PALEOBIOLOGY, V26, P169, DOI 10.1666/0094-8373(2000)26[169:TBPOCF]2.0.CO;2; CARVER WE, 1988, J MORPHOL, V195, P31, DOI 10.1002/jmor.1051950104; Channing A, 2005, P ROY SOC B-BIOL SCI, V272, P905, DOI 10.1098/rspb.2004.2989; Cleland TP, 2015, J PROTEOME RES, V14, P5252, DOI 10.1021/acs.jproteome.5b00675; Cleland TP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0015; Damste JSS, 2000, J NAT PROD, V63, P381, DOI 10.1021/np990377m; Darwin C, 1859, ORIGIN SPECIES MEANS; Dekker MHA, 2000, LIPIDS, V35, P533, DOI 10.1007/s11745-000-553-7; DHOUAILLY D, 1983, EPITHELIAL MESENCHYM, P147; Evans SE, 2005, ACTA PALAEONTOL POL, V50, P725; Evans SE, 2010, J SYST PALAEONTOL, V8, P81, DOI 10.1080/14772010903537773; Fischer I, 2017, CHEMOECOLOGY, V27, P127, DOI 10.1007/s00049-017-0239-z; Fraser R.D.B., 1980, Symposia of the Society for Experimental Biology, P211; Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011; Greenwold MJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0249-1; Greenwold MJ, 2011, J EXP ZOOL PART B, V316B, P609, DOI 10.1002/jez.b.21436; Hitchcock E., 1841, FINAL REPORT GEOLOGY; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ichida JM, 2001, J MICROBIOL METH, V47, P199, DOI 10.1016/S0167-7012(01)00302-5; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jones TD, 2000, SCIENCE, V288, P2202, DOI 10.1126/science.288.5474.2202; Kellner A. W. A., 2002, MESOZOIC BIRDS HEADS, V2002, P529; Li QA, 2011, SPINE, V36, pE461, DOI 10.1097/BRS.0b013e3181dfd163; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindgren J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13520; Lindgren J, 2014, NATURE, V506, P484, DOI 10.1038/nature12899; Lindgren J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1819; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Meyer H.von., 1861, NEUES JB MINERALOGIE, V1861, P678; Moyer AE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1997; Moyer AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157699; Moyer AE, 2014, SCI REP-UK, V4, DOI [10.1038/srep04233, 10.1038/srep06191]; Muramoto S, 2011, J PHYS CHEM C, V115, P24247, DOI 10.1021/jp208035x; Nguyen RT, 2001, GEOCHIM COSMOCHIM AC, V65, P1467, DOI 10.1016/S0016-7037(00)00621-9; OGUIN WM, 1982, J EXP ZOOL, V220, P371, DOI 10.1002/jez.1402200312; Owen R., 1863, PHILOS T ROYAL SOC L, V153, P33; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pan YH, 2016, P NATL ACAD SCI USA, V113, pE7900, DOI 10.1073/pnas.1617168113; Saitta ET, 2017, PALAIOS, V32, P647, DOI 10.2110/palo.2017.051; Saitta ET, 2017, PALAEONTOLOGY, V60, P547, DOI 10.1111/pala.12299; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Sawyer RH, 2003, J EXP ZOOL PART B, V297B, P27, DOI 10.1002/jez.b.00017; Sawyer RH, 2000, AM ZOOL, V40, P530, DOI 10.1668/0003-1569(2000)040[0530:TEOBKI]2.0.CO;2; Sawyer RH, 1986, SKIN BIRDS EPIDERMIS; Schroeter ER, 2017, J PROTEOME RES, V16, P920, DOI 10.1021/acs.jproteome.6b00873; Schweitzer MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2741; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23099; Schweitzer MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150238; Schweitzer MH, 2013, BONE, V52, P414, DOI 10.1016/j.bone.2012.10.010; Schweitzer MH, 2011, ANNU REV EARTH PL SC, V39, P187, DOI 10.1146/annurev-earth-040610-133502; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Schweitzer MH, 1999, J VERTEBR PALEONTOL, V19, P712, DOI 10.1080/02724634.1999.10011183; Schweitzer MH, 2012, COMPLETE DINOSAUR, P1128; SHAMES RB, 1987, CURR TOP DEV BIOL, V22, P235; SHAMES RB, 1991, J EXP ZOOL, V260, P258, DOI 10.1002/jez.1402600215; SHAMES RB, 1989, CELL TISSUE RES, V257, P85; Strasser B, 2014, MOL BIOL EVOL, V31, P3194, DOI 10.1093/molbev/msu251; Sutton MD, 2006, P R SOC B, V273, P1039, DOI 10.1098/rspb.2005.3403; Theil V, 2015, RSC DETECTION SCI SE, V4; Thiel V, 2011, ANNU REV EARTH PL SC, V39, P125, DOI 10.1146/annurev-earth-040610-133525; Tuross N, 2002, ARCHAEOMETRY, V44, P427, DOI 10.1111/1475-4754.00075; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; WILLIAMS CM, 1990, APPL ENVIRON MICROB, V56, P1509, DOI 10.1128/AEM.56.6.1509-1515.1990	76	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206569	10.1371/journal.pone.0206569	http://dx.doi.org/10.1371/journal.pone.0206569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485294	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800022
J	Beskow, LM; Hammack, CM; Brelsford, KM				Beskow, Laura M.; Hammack, Catherine M.; Brelsford, Kathleen M.			Thought leader perspectives on benefits and harms in precision medicine research	PLOS ONE			English	Article							RESEARCH PARTICIPANTS; INFORMED-CONSENT; PRIVACY; BIOBANKS; CURRENTS; RETURN	Precision medicine research is underway to identify targeted approaches to improving health and preventing disease. However, such endeavors raise significant privacy and confidentiality concerns. The objective of this study was to elucidate the potential benefits and harms associated with precision medicine research through in-depth interviews with a diverse group of thought leaders, including primarily U.S.-based experts and scholars in the areas of ethics, genome research, health law, historically-disadvantaged populations, informatics, and participant-centric perspectives, as well as government officials and human subjects protections leaders. The results suggest the prospect of an array of individual and societal benefits, as well as physical, dignitary, group, economic, psychological, and legal harms. Relative to the way risks and harms are commonly described in consent forms for precision medicine research, the thought leaders we interviewed arguably emphasized a somewhat different set of issues. The return of individual research results, harm to socially-identifiable groups, the value-dependent nature of many benefits and harms, and the risks to the research enterprise itself emerged as important cross-cutting themes. Our findings highlight specific challenges that warrant concentrated care during the design, conduct, dissemination, and translation of precision medicine research and in the development of consent materials and processes.	[Beskow, Laura M.; Hammack, Catherine M.; Brelsford, Kathleen M.] Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Beskow, LM (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, 221 Kirkland Hall, Nashville, TN 37235 USA.	laura.m.beskow@vanderbilt.edu		Brelsford, Kathleen/0000-0002-9423-681X; Beskow, Laura/0000-0002-9314-1915; Hammack-Aviran, Catherine/0000-0002-1410-6231	National Human Genome Research Institute [R01-HG-007733]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007733] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant to L. M.B. from the National Human Genome Research Institute (R01-HG-007733). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Human Genome Research Institute or the National Institutes of Health. The funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Angrist M, 2013, NATURE, V494, P7, DOI 10.1038/494007a; Bernard H. R., 2016, ANAL QUALITATIVE DAT; Beskow Laura M., 2018, BIG DATA HLTH LAW BI; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Brehaut JC, 2010, CONTEMP CLIN TRIALS, V31, P218, DOI 10.1016/j.cct.2010.02.002; Brehaut JC, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-38; Brenner SE, 2013, NATURE, V498, P139, DOI 10.1038/498139a; Budin-Ljosne I, 2016, BIOPRESERV BIOBANK, V14, P241, DOI 10.1089/bio.2015.0115; Burke W, 2018, J LAW MED ETHICS, V46, P79, DOI 10.1177/1073110518766023; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hayden EC, 2013, NATURE, V502, P26, DOI 10.1038/502026a; Henderson GE, 2014, J LAW MED ETHICS, V42, P344, DOI 10.1111/jlme.12151; Hudson KL, 2017, NEW ENGL J MED, V376, P111, DOI 10.1056/NEJMp1615745; Jarvik GP, 2014, AM J HUM GENET, V94, P818, DOI 10.1016/j.ajhg.2014.04.009; Kaufman DJ, 2009, AM J HUM GENET, V85, P643, DOI 10.1016/j.ajhg.2009.10.002; Khan A, 2014, CLIN GENET, V86, P199, DOI 10.1111/cge.12384; Knoppers BM, 2013, EUR J HUM GENET, V21, P245, DOI 10.1038/ejhg.2012.152; Landau S, 2015, SCIENCE, V347, P504, DOI 10.1126/science.aaa4961; Langstrom N, 2015, INT J EPIDEMIOL, V44, P713, DOI 10.1093/ije/dyv029; McClellan M, 2018, ANNU REV MED, V69, P41, DOI 10.1146/annurev-med-061516-112359; McEwen JE, 2013, TRENDS GENET, V29, P375, DOI 10.1016/j.tig.2013.02.001; Meslin EM, 2010, PUBLIC HEALTH GENOM, V13, P378, DOI 10.1159/000319473; Namey Emily E., 2015, PUBLIC HLTH RES METH, P443; *NAT BIOETH ADV CO, 2001, ETH POL ISS RES INV, V1; National Institutes of Health, ALL US RES PROGR 201; O'Doherty KC, 2011, SOC SCI MED, V73, P367, DOI 10.1016/j.socscimed.2011.05.046; Oliphant EN, 2016, GENET TEST MOL BIOMA, V20, P339, DOI 10.1089/gtmb.2016.29017.sjt; Piffer D, 2015, INTELLIGENCE, V53, P43, DOI 10.1016/j.intell.2015.08.008; Pullman D, 2012, GENET MED, V14, P229, DOI [10.1038/GIM.0b013e31822e578f, 10.1038/gim.0b013e31822e578f]; Rodriguez LL, 2013, SCIENCE, V339, P275, DOI 10.1126/science.1234593; Rothstein MA, 2007, J LAW MED ETHICS, V35, P59, DOI 10.1111/j.1748-720X.2007.00154.x; Rothstein MA, 2016, J LAW MED ETHICS, V44, P352, DOI 10.1177/1073110516654128; Rothstein MA, 2015, J LAW MED ETHICS, V43, P425, DOI 10.1111/jlme.12258; Schadt EE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.47; Sulmasy DP, 2015, GENET MED, V17, P331, DOI 10.1038/gim.2014.111; Tiihonen J, 2015, MOL PSYCHIATR, V20, P786, DOI 10.1038/mp.2014.130; Underhill K, 2018, HASTINGS CENT REP, V48, P8, DOI 10.1002/hast.805; Weil CJ, 2013, GENET MED, V15, P997, DOI 10.1038/gim.2013.40; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207842	10.1371/journal.pone.0207842	http://dx.doi.org/10.1371/journal.pone.0207842			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475858	Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700079
J	Butler, CJ; Edwards, WH; Paterson, JT; Proffitt, KM; Jennings-Gaines, JE; Killion, HJ; Wood, ME; Ramsey, JM; Almberg, ES; Dewey, SR; McWhirter, DE; Courtemanch, AB; White, PJ; Rotella, JJ; Garrott, RA				Butler, Carson J.; Edwards, William H.; Paterson, J. Terrill; Proffitt, Kelly M.; Jennings-Gaines, Jessica E.; Killion, Halcyon J.; Wood, Mary E.; Ramsey, Jennifer M.; Almberg, Emily S.; Dewey, Sarah R.; McWhirter, Douglas E.; Courtemanch, Alyson B.; White, P. J.; Rotella, Jay J.; Garrott, Robert A.			Respiratory pathogens and their association with population performance in Montana and Wyoming bighorn sheep populations	PLOS ONE			English	Article							OVIS-CANADENSIS-CANADENSIS; DOMESTIC SHEEP; MANNHEIMIA-HAEMOLYTICA; MYCOPLASMA-OVIPNEUMONIAE; PNEUMONIA EPIZOOTICS; SINUS TUMORS; PASTEURELLACEAE; TRANSMISSION; DISEASE; INFECTION	Respiratory disease caused by Mycoplasma ovipneumoniae and Pasteurellaceae poses a formidable challenge for bighorn sheep (Ovis canadensis) conservation. All-age epizootics can cause 10-90% mortality and are typically followed by multiple years of enzootic disease in lambs that hinders post-epizootic recovery of populations. The relative frequencies at which these epizootics are caused by the introduction of novel pathogens or expression of historic pathogens that have become resident in the populations is unknown. Our primary objectives were to determine how commonly the pathogens associated with respiratory disease are hosted by bighorn sheep populations and assess demographic characteristics of populations with respect to the presence of different pathogens. We sampled 22 bighorn sheep populations across Montana and Wyoming, USA for Mycoplasma ovipneumoniae and Pasteurellaceae and used data from management agencies to characterize the disease history and demographics of these populations. We tested for associations between lamb: ewe ratios and the presence of different respiratory pathogen species. All study populations hosted Pasteurellaceae and 17 (77%) hosted Mycoplasma ovipneumoniae. Average lamb: ewe ratios for individual populations where both Mycoplasma ovipneumoniae and Pasteurellaceae were detected ranged from 0.14 to 0.40. However, average lamb: ewe ratios were higher in populations where Mycoplasma ovipneumoniae was not detected (0.37, 95% CI: 0.27-0.51) than in populations where it was detected (0.25, 95% CI: 0.21-0.30). These findings suggest that respiratory pathogens are commonly hosted by bighorn sheep populations and often reduce recruitment rates; however ecological factors may interact with the pathogens to determine population-level effects. Elucidation of such factors could provide insights for management approaches that alleviate the effects of respiratory pathogens in bighorn sheep. Nevertheless, minimizing the introduction of novel pathogens from domestic sheep and goats remains imperative to bighorn sheep conservation.	[Butler, Carson J.; Rotella, Jay J.; Garrott, Robert A.] Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA; [Edwards, William H.; Jennings-Gaines, Jessica E.; Killion, Halcyon J.] Wyoming Game & Fish Dept, Wildlife Hlth Lab, Laramie, WY USA; [Paterson, J. Terrill; Proffitt, Kelly M.] Montana Dept Fish Wildlife & Pk, Bozeman, MT USA; [Wood, Mary E.] Wyoming Game & Fish Dept, Laramie, WY USA; [Ramsey, Jennifer M.; Almberg, Emily S.] Montana Dept Fish Wildlife & Pk, Wildlife Hlth Lab, Bozeman, MT USA; [Butler, Carson J.; Dewey, Sarah R.] Natl Pk Serv, Fish & Wildlife Branch, Grand Teton Natl Pk, Moose, WY 83012 USA; [McWhirter, Douglas E.; Courtemanch, Alyson B.] Wyoming Game & Fish Dept, Jackson, WY USA; [White, P. J.] Natl Pk Serv, Yellowstone Natl Pk, Yellowstone Ctr Resources, Moose, WY USA	Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Department of the Interior	Butler, CJ (corresponding author), Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA.; Butler, CJ (corresponding author), Natl Pk Serv, Fish & Wildlife Branch, Grand Teton Natl Pk, Moose, WY 83012 USA.	carson.butler1@gmail.com			US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act [W-159-R, W-166-SI]; Wyoming Wildlife Foundation; Montana Department of Fish Wildlife Parks; Wyoming Game and Fish Department; National Park Service (Yellowstone National Park); National Park Service (Grand Teton National Park); Montana chapter of the Wild Sheep Foundation; Wyoming chapter of the Wild Sheep Foundation; Canon Inc. USA (Yellowstone Park Foundation); Montana State University; Kevin Hurley Wild Sheep Biology Award	US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act; Wyoming Wildlife Foundation; Montana Department of Fish Wildlife Parks; Wyoming Game and Fish Department; National Park Service (Yellowstone National Park); National Park Service (Grand Teton National Park); Montana chapter of the Wild Sheep Foundation; Wyoming chapter of the Wild Sheep Foundation; Canon Inc. USA (Yellowstone Park Foundation); Montana State University; Kevin Hurley Wild Sheep Biology Award	This study was funded by the US Fish and Wildlife Service through the Pittman-Robertson Federal Aid in Wildlife Restoration Act (grant #s W-159-R & W-166-SI; https://wdfw.wa.gov/grants/wildlife_restoration/), the Wyoming Wildlife Foundation (through the Wyoming Governor's Big Game License Coalition; http://wyomingwildlifefoundation.org), Montana Department of Fish Wildlife & Parks (http://fwp.mt.gov), Wyoming Game and Fish Department (https://wgfd.wyo.gov), National Park Service (Yellowstone and Grand Teton National Parks; https://nps.gov), Montana and Wyoming chapters of the Wild Sheep Foundation (https://www.wildsheepfoundation.org), and Canon Inc. USA (through Yellowstone Park Foundation; https://www.yellowstone.org/).Additional funding and scholarships were provided by Montana State University (https://montana.edu) and the Kevin Hurley Wild Sheep Biology Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Bates D.M., 2010, LME4 MIXED EFFECTS M; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178707; Besser TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110039; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Besser TE, 2012, J WILDLIFE DIS, V48, P168, DOI 10.7589/0090-3558-48.1.168; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Brewer C, 2014, BIGHORN SHEEP CONSER, P1; Brunner FS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0128; Buechner H. K., 1960, Wildlife Monographs.; Butler C, 2013, CORRELATES RECRUITME; Butler CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180689; Carlsen T, 2010, MONTANA BIGHORN SHEE; Cassirer EF, 2007, J WILDLIFE MANAGE, V71, P1080, DOI 10.2193/2006-002; Cassirer EF, 2018, J WILDLIFE MANAGE, V82, P32, DOI 10.1002/jwmg.21309; Cassirer EF, 2017, J WILDLIFE MANAGE, V81, P133, DOI 10.1002/jwmg.21172; Cassirer EF, 2013, J ANIM ECOL, V82, P518, DOI 10.1111/1365-2656.12031; Crawley MJ, 2012, R BOOK, V2, P449, DOI 10.1002/9781118448908.ch10; Dassanayake RP, 2013, VET MICROBIOL, V162, P166, DOI 10.1016/j.vetmic.2012.08.029; Dassanayake RP, 2010, VET MICROBIOL, V145, P354, DOI 10.1016/j.vetmic.2010.04.011; Dassanayake RP, 2009, VET MICROBIOL, V133, P366, DOI 10.1016/j.vetmic.2008.07.015; Downs CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125586; Drew ML, 2015, WAFWA WILDLIFE HLTH; Festa-Bianchet M, 1988, P 6 BIENN S NO WILD, V6, P66; Festa-Bianchet M, 2006, P ROY SOC B-BIOL SCI, V273, P1537, DOI 10.1098/rspb.2006.3467; FOREYT WJ, 1989, AM J VET RES, V50, P341; Fox KA, 2016, VET PATHOL, V53, P1164, DOI 10.1177/0300985816634810; Fox KA, 2015, J WILDLIFE DIS, V51, P19, DOI 10.7589/2014-05-130; George JL, 2008, J WILDLIFE DIS, V44, P388, DOI 10.7589/0090-3558-44.2.388; Grigg JL, 2017, J WILDLIFE DIS, V53, P596, DOI 10.7589/2016-10-239; Hall RJ, 2014, J ANIM ECOL, V83, P1068, DOI 10.1111/1365-2656.12204; Hanson TE, 2003, J AGR BIOL ENVIR ST, V8, P469, DOI 10.1198/1085711032561; Heinse LM, 2016, WILDLIFE SOC B, V40, P625, DOI 10.1002/wsb.718; Hogg JT, 2006, P ROY SOC B-BIOL SCI, V273, P1491, DOI 10.1098/rspb.2006.3477; Jaworski MD, 1998, J VET DIAGN INVEST, V10, P49, DOI 10.1177/104063879801000109; Johnson HE, 2013, OECOLOGIA, V171, P295, DOI 10.1007/s00442-012-2397-6; Kraabel BJ, 1997, J WILDLIFE DIS, V33, P558, DOI 10.7589/0090-3558-33.3.558; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742; Laake J, 2015, PACKAGE RMARK; Lawrence PK, 2010, J WILDLIFE DIS, V46, P706, DOI 10.7589/0090-3558-46.3.706; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manlove K, 2016, ECOLOGY, V97, P2593, DOI 10.1002/ecy.1520; Manlove KR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2331; Miller David S, 2012, Vet Med Int, V2012, P796527, DOI 10.1155/2012/796527; Miller MW, 2013, J WILDLIFE DIS, V49, P653, DOI 10.7589/2012-11-274; MILLER MW, 1991, J WILDLIFE DIS, V27, P534, DOI 10.7589/0090-3558-27.4.534; Picton H.D., 2008, MONTANAS WILDLIFE LE; Plowright RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061919; Poppenga RH, 2012, J VET DIAGN INVEST, V24, P531, DOI 10.1177/1040638712441936; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; RISENHOOVER KL, 1988, WILDLIFE SOC B, V16, P346; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Ryder TJ, 1992, P 8 BIENN S NO WILD, P136; Safaee S, 2006, J WILDLIFE DIS, V42, P545, DOI 10.7589/0090-3558-42.3.545; Schindler DE, 2015, FRONT ECOL ENVIRON, V13, P257, DOI 10.1890/140275; Sells SN, 2015, J WILDLIFE MANAGE, V79, P195, DOI 10.1002/jwmg.824; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Shanthalingam S, 2014, J WILDLIFE DIS, V50, P1, DOI 10.7589/2012-09-225; Singer FJ, 2000, RESTOR ECOL, V8, P75, DOI 10.1046/j.1526-100x.2000.80067.x; Singer FJ, 2000, RESTOR ECOL, V8, P14, DOI 10.1046/j.1526-100x.2000.80062.x; Stephen C, 2014, J WILDLIFE DIS, V50, P427, DOI 10.7589/2013-11-305; Stothart MR, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0875; Toweill D. D. E., 1999, RETURN ROYALTY WILD; USDA-NRCS, 2006, LAND RES REG MAJ LAN; Walsh DP, 2016, WILDLIFE SOC B, V40, P634, DOI 10.1002/wsb.721; Walsh DP, 2012, J WILDLIFE DIS, V48, P593, DOI 10.7589/0090-3558-48.3.593; Wehausen JD, 2011, CALIF FISH GAME, V97, P7; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wild Sheep Working Group-Disease Management Venture, W ASS FISH WILD LIFE; Wolfe LL, 2010, J WILDLIFE DIS, V46, P1262, DOI 10.7589/0090-3558-46.4.1262; Wolff P. L., 2014, BIENNIAL S NO WILD S, V19, P13; Wood ME, 2017, J WILDLIFE DIS, V53, P126, DOI 10.7589/2016-05-097	75	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207780	10.1371/journal.pone.0207780	http://dx.doi.org/10.1371/journal.pone.0207780			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475861	Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700066
J	Gekenidis, MT; Qi, WH; Hummerjohann, J; Zbinden, R; Walsh, F; Drissner, D				Gekenidis, Maria-Theresia; Qi, Weihong; Hummerjohann, Jorg; Zbinden, Reinhard; Walsh, Fiona; Drissner, David			Antibiotic-resistant indicator bacteria in irrigation water: High prevalence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli	PLOS ONE			English	Article							TO-EAT SALADS; ENTEROCOCCUS SPP.; ANTIMICROBIAL RESISTANCE; TREATMENT PLANTS; GENE CASSETTES; FECAL SAMPLES; FRESH PRODUCE; SEWAGE; ENTEROBACTERIACEAE; MECHANISMS	Irrigation water is a major source of fresh produce contamination with undesired microorganisms including antibiotic-resistant bacteria (ARB), and contaminated fresh produce can transfer ARB to the consumer especially when consumed raw. Nevertheless, no legal guidelines exist so far regulating quality of irrigation water with respect to ARB. We therefore examined irrigation water from major vegetable growing areas for occurrence of antibiotic-resistant indicator bacteria Escherichia coli and Enterococcus spp., including extended-spectrum beta-lactamase (ESBL)-producing E. coli and vancomycin-resistant Enterococcus spp. Occurrence of ARB strains was compared to total numbers of the respective species. We categorized water samples according to total numbers and found that categories with higher total E. coli or Enterococcus spp. numbers generally had an increased proportion of respective ARB-positive samples. We further detected high prevalence of ESBL-producing E. coli with eight positive samples of thirty-six (22%), while two presumptive vancomycin-resistant Enterococcus spp. were vancomycin-susceptible in confirmatory tests. In disk diffusion assays all ESBL-producing E. coli were multidrug-resistant (n = 21) and wholegenome sequencing of selected strains revealed a multitude of transmissible resistance genes (ARG), with blaCTX-M-1 (4 of 11) and blaCTX-M-15 (3 of 11) as the most frequent ESBL genes. Overall, the increased occurrence of indicator ARB with increased total indicator bacteria suggests that the latter might be a suitable estimate for presence of respective ARB strains. Finally, the high prevalence of ESBL-producing E. coli with transmissible ARG emphasizes the need to establish legal critical values and monitoring guidelines for ARB in irrigation water.	[Gekenidis, Maria-Theresia; Drissner, David] Agroscope, Microbiol Plant Foods, Wadenswil, Switzerland; [Gekenidis, Maria-Theresia] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Qi, Weihong] Swiss Fed Inst Technol, Funct Genom Ctr Zurich, Zurich, Switzerland; [Qi, Weihong] Univ Zurich, Zurich, Switzerland; [Hummerjohann, Jorg] Agroscope, Microbiol Safety Foods Anim Origin, Liebefeld, Switzerland; [Zbinden, Reinhard] SECB, Bern, Switzerland; [Walsh, Fiona] Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland; [Drissner, David] Albstadt Sigmaringen Univ, Dept Life Sci, Sigmaringen, Germany	Swiss Federal Research Station Agroscope; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Research Station Agroscope; Maynooth University	Drissner, D (corresponding author), Agroscope, Microbiol Plant Foods, Wadenswil, Switzerland.; Drissner, D (corresponding author), Albstadt Sigmaringen Univ, Dept Life Sci, Sigmaringen, Germany.	drissner@hs-albsig.de	Qi, Weihong/ABC-7380-2021	Qi, Weihong/0000-0001-8581-908X	Agroscope Research Programme "Reduction and Dynamics of Antibiotic-resistant and Persistent Microorganisms along Food Chains (REDYMO)"; National Research Programme "Antimicrobial Resistance" of the Swiss National Science Foundation [NRP 72]; COST Action "Control of Human Pathogenic Micro-organisms in Plant Production Systems HUPLANT control)" [CA16110]	Agroscope Research Programme "Reduction and Dynamics of Antibiotic-resistant and Persistent Microorganisms along Food Chains (REDYMO)"; National Research Programme "Antimicrobial Resistance" of the Swiss National Science Foundation; COST Action "Control of Human Pathogenic Micro-organisms in Plant Production Systems HUPLANT control)"	This work was funded by the Agroscope Research Programme "Reduction and Dynamics of Antibiotic-resistant and Persistent Microorganisms along Food Chains (REDYMO)", the National Research Programme "Antimicrobial Resistance" (NRP 72) of the Swiss National Science Foundation and the COST Action CA16110 "Control of Human Pathogenic Micro-organisms in Plant Production Systems HUPLANT control)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz MO, 2013, MICROBIOL IMMUNOL, V57, P391, DOI 10.1111/1348-0421.12046; Adefisoye MA, 2016, MICROBIOLOGYOPEN, V5, P143, DOI 10.1002/mbo3.319; agrosolution.ch, 2017, SWISSGAP RIS BEW; Amos GCA, 2014, J ANTIMICROB CHEMOTH, V69, P1785, DOI 10.1093/jac/dku079; Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005; [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.141r; Apostolakos I, 2017, J ANTIMICROB CHEMOTH, V72, P1915, DOI 10.1093/jac/dkx072; Araujo S, 2017, INT J FOOD MICROBIOL, V257, P192, DOI 10.1016/j.ijfoodmicro.2017.06.020; Bai XH, 2015, SCI TOTAL ENVIRON, V533, P24, DOI 10.1016/j.scitotenv.2015.06.082; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bergeron S, 2016, INT BIODETER BIODEGR, V113, P80, DOI 10.1016/j.ibiod.2016.02.008; Bessa LJ, 2014, J WATER HEALTH, V12, P426, DOI 10.2166/wh.2014.160; Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chattaway MA, 2014, EMERG INFECT DIS, V20, P1935, DOI 10.3201/eid2011.131845; Christou A, 2017, WATER RES, V123, P448, DOI 10.1016/j.watres.2017.07.004; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Czekalski N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00106; Dahmen S, 2013, J ANTIMICROB CHEMOTH, V68, P2797, DOI 10.1093/jac/dkt291; Ensink JHJ, 2007, TROP MED INT HEALTH, V12, P2, DOI 10.1111/j.1365-3156.2007.01935.x; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2587; Fahrenfeld N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00130; Falomir M.P., 2010, CUR RES TECH ED TOP, P1175; Farkas A, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2944-6; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Fonseca JM, 2011, J APPL MICROBIOL, V110, P893, DOI 10.1111/j.1365-2672.2011.04942.x; Franz CMAP, 1999, INT J FOOD MICROBIOL, V47, P1, DOI 10.1016/S0168-1605(99)00007-0; Gekenidis MT, 2017, J APPL MICROBIOL, V123, P916, DOI 10.1111/jam.13532; Gekenidis MT, 2014, APPL ENVIRON MICROB, V80, P4234, DOI 10.1128/AEM.00740-14; Gemmell ME, 2012, FOOD RES INT, V47, P300, DOI 10.1016/j.foodres.2011.07.016; Geser N, 2012, ANTIMICROB AGENTS CH, V56, P1609, DOI 10.1128/AAC.05539-11; Giger W, 2003, CHIMIA, V57, P485, DOI 10.2533/000942903777679064; Goldstein RER, 2014, SCI TOTAL ENVIRON, V466, P404, DOI 10.1016/j.scitotenv.2013.07.039; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Hassan SA, 2011, FOODBORNE PATHOG DIS, V8, P1011, DOI 10.1089/fpd.2010.0805; He SS, 2015, MBIO, V6, DOI 10.1128/mBio.00762-15; Holmstrup P, 2018, ORAL DIS, V24, P291, DOI 10.1111/odi.12610; Hombach M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-225; Jay J.M., 2005, MODERN FOOD MICROBIO, P473, DOI DOI 10.1007/0-387-23413-6_20; Jiang ZD, 2002, J CLIN MICROBIOL, V40, P4185, DOI 10.1128/JCM.40.11.4185-4190.2002; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P2360, DOI 10.1128/AEM.02634-07; Kalu M, 2017, 2017 AAAS ANN M FEBR; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Lee WC, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0986-7; Leisibach S., 2004, THESIS; Leveille S, 2006, INFECT IMMUN, V74, P3427, DOI 10.1128/IAI.00107-06; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maimon A, 2010, ENVIRON SCI TECHNOL, V44, P3213, DOI 10.1021/es902646g; MCKEON DM, 1995, WATER RES, V29, P1902, DOI 10.1016/0043-1354(95)00013-B; Messi P, 2005, SCI TOTAL ENVIRON, V346, P213, DOI 10.1016/j.scitotenv.2004.12.005; Nam S, 2013, INT J HYG ENVIR HEAL, V216, P421, DOI 10.1016/j.ijheh.2012.12.004; Nuesch-Inderbinen M, 2015, J FOOD PROTECT, V78, P1178, DOI 10.4315/0362-028X.JFP-15-018; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Palmer KL, 2010, CURR OPIN MICROBIOL, V13, P632, DOI 10.1016/j.mib.2010.08.004; Pappas EA, 2008, T ASABE, V51, P1567, DOI 10.13031/2013.25313; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Perry J, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025197; Perry JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00138; Pesavento G, 2014, FOOD MICROBIOL, V41, P1, DOI 10.1016/j.fm.2014.01.008; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4937, DOI 10.1128/AAC.00413-11; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Roberts MC, 2009, J APPL MICROBIOL, V107, P300, DOI 10.1111/j.1365-2672.2009.04207.x; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Santiago-Rodriguez TM, 2013, J WATER HEALTH, V11, P387, DOI 10.2166/wh.2013.005; Schauss T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119791; Scheutz F., 2015, BERGEYS MANUAL SYSTE, P1; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Szmolka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00258; Tacconelli E., 2017, GLOBAL PRIORITY LIST, P1; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tissera S, 2013, MALAYS J MED SCI, V20, P14; Uyttendaele M, 2015, COMPR REV FOOD SCI F, V14, P336, DOI 10.1111/1541-4337.12133; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; WHO,, 2020, WHO ANT RES; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; World Health Organization, 2006, GUID SAF US WAST EXC, V2; Xia S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100707; Young S, 2016, APPL ENVIRON MICROB, V82, P5653, DOI 10.1128/AEM.01927-16; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	92	31	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207857	10.1371/journal.pone.0207857	http://dx.doi.org/10.1371/journal.pone.0207857			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475879	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000451325700082
J	van Rijt, AM; Dik, JWH; Lokate, M; Postma, MJ; Friedrich, AW				van Rijt, Antonius M.; Dik, Jan-Willem H.; Lokate, Mariette; Postma, Maarten J.; Friedrich, Alex W.			Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF)	PLOS ONE			English	Article							INFECTION PREVENTION; NURSING-HOMES; INTEGRATED STEWARDSHIP; LOW-PREVALENCE; SETTINGS; SPREAD	Objectives Highly resistant microorganisms (HRMOs) are of high concern worldwide and are becoming increasingly less susceptible for antibiotics. To study the cost effectiveness of infection prevention measures in long-term care, it is essential to first fully understand the impact of HRMOs. The objective of this study is to identify the costs associated with outbreaks caused by Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF). Methods After an outbreak of MRSA, Dutch LTCF can submit a reimbursement form to the Dutch Healthcare Authority ("Nederlandse Zorgautoriteit"; NZa) to get a part of the total costs reimbursed. In this study, we requested NZa forms for financial impact analysis. Details regarding the costs of the outbreak have been extracted from these forms and additionally specific LTCF have been visited in person to validate the data. Results 34 complete reimbursement forms from the period between 2011 and 2016 were received from the NZa and have been included. The median cost per patient per day was estimated at (sic)83.80, varying between (sic)16.89 and (sic)1,820.09. We validated five reimbursement forms by visiting the facility and recalculating the costs. We found a non-significant positive difference of (sic)26.07 compared with the original data (p = 0.068). Conclusions This study is to our knowledge the first to give a national overview of total costs associated with an MRSA outbreak in LTCF in the Netherlands. Overall, costs per patient per day seem lower than in a hospital setting, although total costs are much higher due to the long term of care.	[van Rijt, Antonius M.; Dik, Jan-Willem H.; Lokate, Mariette; Friedrich, Alex W.] Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Fac Med Sci, Groningen, Netherlands	University of Groningen; University of Groningen	Friedrich, AW (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	alex.friedrich@umcg.nl	Friedrich, Alex/ABG-9823-2020	van Rijt, Antonius Mattheus/0000-0003-0662-7616; Postma, Maarten/0000-0002-6306-3653	INTERREG V A [202085]; European Commission; Dutch Ministry of Health, Welfare and Sport (VWS); Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North Rhine-Westphalia; German Federal State of Lower Saxony	INTERREG V A; European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health, Welfare and Sport (VWS); Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North Rhine-Westphalia; German Federal State of Lower Saxony	The work presented in this thesis, was performed at the Department of Medical Microbiology of the University of Groningen and the University Medical Center Groningen. It was supported by the INTERREG V A (202085) funded project EurHealth-1Health (http://www.eurhealth-1health.eu), part of a Dutch-German cross-border network supported by the European Commission, the Dutch Ministry of Health, Welfare and Sport (VWS), the Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North Rhine-Westphalia and the German Federal State of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, TACKLING DRUG RESIST; Batina NG, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0130-7; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Brink van den R, 2013, END ANTIBIOTICS; Capitano B, 2003, J AM GERIATR SOC, V51, P10, DOI 10.1034/j.1601-5215.2002.51003.x; Centraal Bureau voor de Statistiek (CBS), 2017, DUTCH CONS PRIC IND; Cohen CC, 2016, NURS ECON, V34, P16; Dik JH, 2017, J CLIN MICROBIOL, V55, P3306, DOI 10.1128/JCM.01283-17; Dik JWH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149226; Dik JWH, 2016, FUTURE MICROBIOL, V11, P93, DOI 10.2217/fmb.15.99; ECDC, 2017, SURV ANT RES EUR 201; Greenland K, 2011, J AM GERIATR SOC, V59, P768, DOI 10.1111/j.1532-5415.2011.03325.x; Hakkaart-van Roijen L., 2015, KOSTENHANDLEIDING ME; Hoogendoorn M, 2013, J AM MED DIR ASSOC, V14, P336, DOI 10.1016/j.jamda.2012.11.001; Hubner NO, 2017, J HOSP INFECT, V97, P234, DOI 10.1016/j.jhin.2017.08.002; Lee BY, 2013, MED CARE, V51, P205, DOI 10.1097/MLR.0b013e3182836dc2; Leendert van der Werff Hans Frederik, 2008, Tidsskr Nor Laegeforen, V128, P2734; Manzur A, 2009, CLIN MICROBIOL INFEC, V15, P26, DOI 10.1111/j.1469-0691.2009.03093.x; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; Millington K., 2007, EXCHANGE RATES EURO; Nederland Zorginstituut, 2016, RICHTL UITV EC EV GE; Pittet D, 2000, LANCET, V10, p[356, 1290]; Pogorzelska-Maziarz M, 2017, AM J INFECT CONTROL, V45, P597, DOI 10.1016/j.ajic.2017.03.020; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Travers J, 2015, GERIATR NURS, V36, P355, DOI 10.1016/j.gerinurse.2015.05.001; van den Dool C, 2016, INFECT CONT HOSP EP, V37, P761, DOI 10.1017/ice.2016.59; van der Bij Akke K, 2015, Ned Tijdschr Geneeskd, V159, pA8585; Werkgroep Infectiepreventie (WIP), 2012, RICHTL MET RES STAPH; Werkgroep Infectiepreventie (WIP), 2004, INF VERPL WOONZ AND; Werkgroep Infectiepreventie (WIP), 2007, MRSA VERZ; Werkgroep Infectiepreventie (WIP), 2007, MRSA VERPL; Willemsen I, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-26; 2012, EV THREAT ANT REOP, P1	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0208092	10.1371/journal.pone.0208092	http://dx.doi.org/10.1371/journal.pone.0208092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475904	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700104
J	Swieca, M; Kordowska-Wiater, M; Pytka, M; Gawlik-Dziki, U; Bochnak, J; Zlotek, U; Baraniak, B				Swieca, Michal; Kordowska-Wiater, Monika; Pytka, Monika; Gawlik-Dziki, Urszula; Bochnak, Justyna; Zlotek, Urszula; Baraniak, Barbara			Lactobacillus plantarum 299V improves the microbiological quality of legume sprouts and effectively survives in these carriers during cold storage and in vitro digestion	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; VEGETABLES; ELICITATION; PHENOLICS; LENTIL; FRESH; FRUIT	Probiotics improve consumers' health and additionally may positively influence the microbiological and organoleptic quality of food. In the study, legume sprouts were inoculated with Lactobacilllus plantarum 299V to produce a new functional product ensuring the growth and survival of the probiotic and high microbiological quality of the final product. Legume sprouts, which are an excellent source of nutrients, were proposed as alternative carriers for the probiotic. The key factors influencing the production of probiotic-rich sprouts include the temperature (25 degrees C) of sprouting and methods of inoculation (soaking seeds in a suspension of probiotics). Compared to the control sprouts, the sprouts enriched with the probiotic were characterized by lower mesophilic bacterial counts. In the case of fresh and stored probiotic-rich sprouts, lactic acid bacteria (LAB) accounted for a majority of total microorganisms. The Lb. plantarum population was also stable during the cold storage. The high count of LAB observed in the digest confirmed the fact that the studied sprouts are effective carriers for probiotics and ensure their survival in the harmful conditions of the digestive tract in an in vitro model. Enrichment of legume sprouts with probiotics is a successful attempt and yields products for a new branch of functional foods.	[Swieca, Michal; Gawlik-Dziki, Urszula; Bochnak, Justyna; Zlotek, Urszula; Baraniak, Barbara] Univ Life Sci Lublin, Dept Biochem & Food Chem, Lublin, Poland; [Kordowska-Wiater, Monika; Pytka, Monika] Univ Life Sci Lublin, Dept Biotechnol Microbiol & Human Nutr, Lublin, Poland	University of Life Sciences in Lublin; University of Life Sciences in Lublin	Swieca, M (corresponding author), Univ Life Sci Lublin, Dept Biochem & Food Chem, Lublin, Poland.	michal.swieca@up.lublin.pl	Bochnak-Niedźwiecka, Justyna/AAJ-6976-2020; Pytka, Monika/U-6148-2018; Kordowska-Wiater, Monika/U-6338-2018; Swieca, Michal/B-4286-2014	Bochnak-Niedźwiecka, Justyna/0000-0003-3938-1376; Pytka, Monika/0000-0001-5998-5156; Kordowska-Wiater, Monika/0000-0002-6255-7854; Gawlik-Dziki, Urszula/0000-0002-7308-4335; Zlotek, Urszula/0000-0001-6812-5596; Baraniak, Barbara/0000-0001-9653-9892; Swieca, Michal/0000-0002-6513-8399	National Science Centre, Poland (NCN) [2015/17/B/NZ9/01797]	National Science Centre, Poland (NCN)	This work was supported by National Science Centre, Poland (NCN) [Grant OPUS No. 2015/17/B/NZ9/01797 to MS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadias M, 2008, INT J FOOD MICROBIOL, V123, P121, DOI 10.1016/j.ijfoodmicro.2007.12.013; [Anonymous], 2013, 152142002 PNISO; [Anonymous], 2017, 1129012017 PNEN ISO; [Anonymous], 2007, 48322007 PNISO; [Anonymous], 2001, 688812001 PNEN ISO; [Anonymous], 2017, 657912017 PNEN ISO; [Anonymous], 1993, PNA86034101993; [Anonymous], 2005, 79322005 PNEN ISO; [Anonymous], 2017, 102732017 PNEN ISO; [Anonymous], 2009, 2152712009 PNISO; Berthold-Pluta A, 2017, FOOD MICROBIOL, V65, P221, DOI 10.1016/j.fm.2017.03.005; Charalampopoulos D, 2010, LWT-FOOD SCI TECHNOL, V43, P431, DOI 10.1016/j.lwt.2009.09.006; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Emser K, 2017, J FUNCT FOODS, V38, P519, DOI 10.1016/j.jff.2017.09.021; Erdozain MS, 2013, FOOD CONTROL, V30, P649, DOI 10.1016/j.foodcont.2012.08.022; Food and Agricuture Organization/World Health Organization, 2002, GUIDELINES EVALUATIO; Goossens D, 2003, ALIMENT PHARM THER, V18, P495, DOI 10.1046/j.1365-2036.2003.01708.x; Jablonska-Rys E, 2016, ACTA SCI POLON-TECHN, V15, P399, DOI 10.17306/J.AFS.2016.4.38; Jiang YJ, 2016, J FUNCT FOODS, V20, P215, DOI 10.1016/j.jff.2015.10.027; Le B, 2018, TOXICOL REP, V5, P314, DOI 10.1016/j.toxrep.2018.02.007; Losio MN, 2015, INT J FOOD MICROBIOL, V210, P88, DOI 10.1016/j.ijfoodmicro.2015.05.026; Markowiak P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091021; Messina V, 2014, AM J CLIN NUTR, V100, p437S, DOI 10.3945/ajcn.113.071472; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; Obdak A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6820369; Palmai M, 2002, FOOD MICROBIOL, V19, P195, DOI 10.1006/fmic.2001.0470; Pao S, 2005, J FOOD PROTECT, V68, P1648, DOI 10.4315/0362-028X-68.8.1648; PN-EN ISO 4833-2: 2013, 2013, 483322013 PNEN ISO; Possemiers S, 2010, INT J FOOD MICROBIOL, V141, P97, DOI 10.1016/j.ijfoodmicro.2010.03.008; Ragaert P, 2007, POSTHARVEST BIOL TEC, V44, P185, DOI 10.1016/j.postharvbio.2007.01.001; Saulnier DMA, 2008, FEMS MICROBIOL ECOL, V66, P516, DOI 10.1111/j.1574-6941.2008.00561.x; Sikora M, 2018, FOOD CHEM, V239, P1160, DOI 10.1016/j.foodchem.2017.07.067; Swieca M., 2017, Zywnosc, V24, P37, DOI 10.15193/zntj/2017/113/209; Swieca M, 2016, FOOD CHEM, V192, P625, DOI 10.1016/j.foodchem.2015.07.058; Swieca M, 2015, FOOD CHEM, V185, P99, DOI 10.1016/j.foodchem.2015.03.108; Swieca M, 2014, J AGR FOOD CHEM, V62, P3306, DOI 10.1021/jf403923x; Trias R, 2008, INT J FOOD MICROBIOL, V123, P50, DOI 10.1016/j.ijfoodmicro.2007.11.065; Trias R, 2009, INT MICROBIOL, V11, P231, DOI 10.2436/20.1501.01.66; Valero-Cases E, 2015, LWT-FOOD SCI TECHNOL, V64, P824, DOI 10.1016/j.lwt.2015.06.049; van Zanten GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047212; Vesterlund S, 2012, INT J FOOD MICROBIOL, V157, P319, DOI 10.1016/j.ijfoodmicro.2012.05.016; Wang B, 2010, INT J FOOD MICROBIOL, V142, P237, DOI 10.1016/j.ijfoodmicro.2010.05.024; Yang X, 2013, CHEMOSPHERE, V91, P1477, DOI 10.1016/j.chemosphere.2012.12.014	44	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207793	10.1371/journal.pone.0207793	http://dx.doi.org/10.1371/journal.pone.0207793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462723	Green Published, gold, Green Submitted			2022-12-26	WOS:000451054800085
J	Yan, BB; Zhang, HM; Dai, TQ; Gu, YC; Qiu, XY; Hu, C; Liu, Y; Wei, KW; Li, DH				Yan, Bingbing; Zhang, Hongmei; Dai, Taiqiang; Gu, Yongchun; Qiu, Xinyu; Hu, Cheng; Liu, Yan; Wei, Kewen; Li, Dehua			Necrostatin-1 promotes ectopic periodontal tissue like structure regeneration in LPS-treated PDLSCs	PLOS ONE			English	Article							CELL-DEATH; STEM-CELLS; DIFFERENTIATION; EXPRESSION; MICE	Necroptosis is a programmed necrosis, regulated by receptor interacting protein kinase 1 (RIP1) and receptor interacting protein kinase 3(RIP3), and could be inhibited by necrostatin-1(Nec-1) specifically. This study aims to evaluate the effect of Nec-1 on LPS-treated periodontal ligament stem cells (PDLSCs). In the research, three groups were established: normal cultured PDLSCs, Porphyromonas gingivalis (Pg)-LPS stimulated PDLSCs and Pg-LPS+Nec-1 treated PDLSCs. The expression of RIP1 and RIP3 and osteogenic differentiation of PDLSCs in three groups were analyzed. Then, we constructed cell aggregates (CA) using PDLSCs, then PDLSCs-CA were combined with Bio-Oss in three groups were transplanted subcutaneously in nude mice to assess their potentials of periodontal tissue regeneration. The results showed that RIP1 and RIP3 were fully expressed in Pg-LPS stimulated PDLSCs and the level increased significantly. Nec-1 inhibited RIP1-RIP3 interaction, and further inhibited necroptosis of PDLSCs in inflammatory state. Moreover, Nec-1 pretreatment ameliorates the osteogenic differentiation of LPS-treated PDLSCs and can effectively promote the cementum like structure ectopic regenerative ability of PDLSCs in nude mice. These findings show RIP1/RIP3-mediated necroptosis is an important mechanism of cell death in PDLSCs. Nec-1 has a protective effect in reducing cell death and promotes ectopic periodontal tissue like structure regeneration by inhibiting necroptosis. Nec-1 is a hopeful therapeutic agent which protects cells from necroptosis and ameliorates functional outcome.	[Yan, Bingbing; Dai, Taiqiang; Liu, Yan; Li, Dehua] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China; [Yan, Bingbing; Dai, Taiqiang; Liu, Yan; Li, Dehua] Fourth Mil Med Univ, Sch Stomatol, Natl Clin Res Ctr Oral Dis, Xian, Shaanxi, Peoples R China; [Yan, Bingbing; Li, Dehua] Fourth Mil Med Univ, Sch Stomatol, Shaanxi Engn Res Ctr Dent Mat & Adv Manufacture, Dept Oral Implants, Xian, Shaanxi, Peoples R China; [Zhang, Hongmei; Wei, Kewen] Fourth Mil Med Univ, Tangdu Hosp, Dept Burns & Plast Surg, Xian, Shaanxi, Peoples R China; [Dai, Taiqiang] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shaanxi Clin Res Ctr Oral Dis, Xian, Shaanxi, Peoples R China; [Gu, Yongchun] Nantong Univ, Peoples Hosp Wujiang Dist 1, Dept Dent, Suzhou, Peoples R China; [Qiu, Xinyu] Fourth Mil Med Univ, Sch Stomatol, Res & Dev Ctr Tissue Engn, Xian, Shaanxi, Peoples R China; [Hu, Cheng] Xi An Jiao Tong Univ, Coll Med, Stomatol Hosp, Dept Orthodont, Xian, Shaanxi, Peoples R China; [Liu, Yan] Fourth Mil Med Univ, Sch Stomatol, Shaanxi Key Lab Stomatol, Dept Prosthodont, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Nantong University; Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University	Li, DH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China.; Li, DH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Natl Clin Res Ctr Oral Dis, Xian, Shaanxi, Peoples R China.; Li, DH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Shaanxi Engn Res Ctr Dent Mat & Adv Manufacture, Dept Oral Implants, Xian, Shaanxi, Peoples R China.; Wei, KW (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Burns & Plast Surg, Xian, Shaanxi, Peoples R China.	weikewen@fmmu.edu.cn; lidehua@fmmu.edu.cn	Li, Dehua/AAW-5981-2020	Gu, Yongchun/0000-0001-6717-998X	National Natural Science Foundation of China [81500857]; Natural Science Foundation of Shaanxi Province, PR China [2017JM8090, 2017JC2-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province, PR China(Natural Science Foundation of Shaanxi Province)	This work was supported by grants from the National Natural Science Foundation of China [No. 81500857] and Natural Science Foundation of Shaanxi Province, PR China [Grant numbers 2017JM8090, 2017JC2-06].	Bostanci N, 2009, CLIN EXP IMMUNOL, V157, P415, DOI 10.1111/j.1365-2249.2009.03972.x; Hu DY, 2011, INT J ORAL SCI, V3, P7, DOI 10.4248/IJOS11006; Humphries F, 2015, CELL DEATH DIFFER, V22, P225, DOI 10.1038/cdd.2014.126; Kato H, 2014, ARCH ORAL BIOL, V59, P167, DOI 10.1016/j.archoralbio.2013.11.008; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Li CH, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt456; Liao CH, 2014, ASIAN PAC J TROP MED, V7, P412, DOI 10.1016/S1995-7645(14)60067-5; Liu ZY, 2015, AM J CANCER RES, V5, P3174; Menicanin D, 2014, STEM CELLS DEV, V23, P1001, DOI 10.1089/scd.2013.0490; Oates TW, 2002, J CLIN PERIODONTOL, V29, P137, DOI 10.1034/j.1600-051x.2002.290208.x; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Seo T, 2012, J MICROBIOL, V50, P311, DOI 10.1007/s12275-012-2146-x; Shang FQ, 2017, THERANOSTICS, V7, P4370, DOI 10.7150/thno.19888; Shangase SL, 2013, S AFRICAN DENT J, V68, P10; Su F, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0023-3; Su XF, 2015, NEUROCHEM RES, V40, P643, DOI 10.1007/s11064-014-1510-0; Tsuda H, 2010, J PERIODONTAL RES, V45, P626, DOI 10.1111/j.1600-0765.2010.01277.x; Tsuda H, 2012, J ORAL SCI, V54, P137, DOI 10.2334/josnusd.54.137; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Yang Y, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0039-0; Zhang J, 2014, DIFFERENTIATION, V88, P97, DOI 10.1016/j.diff.2014.10.001; Zhu WJ, 2013, ARCH ORAL BIOL, V58, P1791, DOI 10.1016/j.archoralbio.2013.09.012	22	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207760	10.1371/journal.pone.0207760	http://dx.doi.org/10.1371/journal.pone.0207760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462730	Green Published, Green Submitted, gold			2022-12-26	WOS:000451054800084
J	He, YF; Hooker, E; Yu, EJ; Cunha, GR; Liao, L; Xu, JM; Earl, A; Wu, HQ; Gonzalgo, ML; Sun, ZJ				He, Yongfeng; Hooker, Erika; Yu, Eun-Jeong; Cunha, Gerald R.; Liao, Lan; Xu, Jianming; Earl, Andrew; Wu, Huiqing; Gonzalgo, Michael L.; Sun, Zijie			Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells	ONCOGENE			English	Article							EPITHELIAL STEM-CELLS; BETA-CATENIN; MURINE PROSTATE; P53 HOMOLOG; RECEPTOR; ORIGIN; P63; REGENERATION; ACTIVATION; POLYPOSIS	Emerging evidence has shown that both prostatic basal and luminal cells are able to initiate oncogenic transformation. However, despite the diversity of tumor-initiating cells, most prostate cancer cells express the androgen receptor (AR) and depend on androgens for their growth and expansion, implicating an essential role of androgen signaling in prostate tumorigenesis. Prostatic basal cells express p63 and are able to differentiate into luminal, neuroendocrine, and basal cells. Here, we directly assessed the essential role of androgen signaling in prostatic p63-expressing cell initiated oncogenic transformation and tumor formation. Using novel and relevant mouse models, we demonstrated that, with stabilized beta-catenin expression, prostatic p63-expressing cells possess the ability to initiate oncogenic transformation and, in the presence of androgens, they further transdifferentiate into luminal-like tumor cells and develop adenocarcinomas. Castration prior to activating stabilized beta-catenin sensitizes p63-expressing cells and increases their sensitivity to androgens, resulting in aggressive and fast growing tumor phenotypes. These findings are consistent with what have been observed in human prostate cancers, demonstrating an essential role for androgen signaling in prostate cancer initiation and progression. This study also provides fresh insight into developing new therapeutic strategies for better treating prostate cancer patients.	[He, Yongfeng; Hooker, Erika; Yu, Eun-Jeong; Earl, Andrew; Sun, Zijie] Beckman Res Inst & Canc Ctr, Dept Canc Biol, Duarte, CA 91010 USA; [He, Yongfeng; Hooker, Erika; Yu, Eun-Jeong; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Cunha, Gerald R.] Univ Calif San Francisco, Dept Urol, Sch Med, San Francisco, CA 94143 USA; [Liao, Lan; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wu, Huiqing] Beckman Res Inst & Canc Ctr, Dept Pathol, Duarte, CA 91010 USA; [Gonzalgo, Michael L.] Univ Miami, Dept Urol, Sylvester Comprehens Canc Ctr, Sch Med, Miami, FL 33136 USA	Stanford University; University of California System; University of California San Francisco; Baylor College of Medicine; University of Miami	Sun, ZJ (corresponding author), Beckman Res Inst & Canc Ctr, Dept Canc Biol, Duarte, CA 91010 USA.; Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA.	zjsun@coh.org	He, Yongfeng/AAR-8257-2020	Hooker, Erika/0000-0002-4515-4041; Earl, Andrew/0000-0002-5732-954X	NIH [R01CA070297, R01CA151623, R01CA166894, R21CA190021, R01DK104941, R01CA193455, R01CA112403]; NATIONAL CANCER INSTITUTE [R01CA166894, R01CA112403, R01CA070297, R01CA151623, R01CA193455, R21CA190021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01CA070297 (Z.S.), R01CA151623 (Z.S.), R01CA166894 (Z.S.), R21CA190021 (Z.S.), R01DK104941 (Z.S.), R01CA193455 (J.X.), and R01CA112403 (J.X.).	Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lee DK, 2014, INT J BIOL SCI, V10, P1007, DOI 10.7150/ijbs.9997; Lee SH, 2016, ONCOGENE, V35, P702, DOI 10.1038/onc.2015.117; Lee SH, 2015, STEM CELLS, V33, P3356, DOI 10.1002/stem.2096; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Murillo-Garzon V, 2017, NAT REV UROL, V14, P683, DOI 10.1038/nrurol.2017.144; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Peng Y, 2011, J BIOL CHEM, V286, P40331, DOI 10.1074/jbc.M111.302059; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Sartor O, 2002, UROLOGY, V60, P138; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Truica CI, 2000, CANCER RES, V60, P4709; Truica CI, 2001, AACR ANN M P, V42, P693; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yu X, 2011, ONCOGENE, V30, P1868, DOI 10.1038/onc.2010.560; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	46	11	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2337	2350		10.1038/s41388-018-0583-7	http://dx.doi.org/10.1038/s41388-018-0583-7			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30510232	Green Accepted, Green Submitted			2022-12-26	WOS:000462588000008
J	Zhao, LJ; Wang, W; Xu, L; Yi, T; Zhao, X; Wei, YQ; Vermeulen, L; Goel, A; Zhou, ST; Wang, X				Zhao, Linjie; Wang, Wei; Xu, Lian; Yi, Tao; Zhao, Xia; Wei, Yuquan; Vermeulen, Louis; Goel, Ajay; Zhou, Shengtao; Wang, Xin			Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer	ONCOGENE			English	Article							MOLECULAR SUBTYPES; EARLY RELAPSE; EXPRESSION; PROGRESSION; TRANSITION; SIGNATURE; DISTINCT; CARCINOMA; APOPTOSIS; TARGETS	Ovarian cancer is a heterogeneous malignancy that poses tremendous clinical challenge. Based on unsupervised classification of whole-genome gene expression profiles, four molecular subtypes of ovarian cancer were recently identified. However, single-driver molecular events specific to these subtypes have not been clearly elucidated. We aim to characterize the regulatory mechanisms underlying the poor prognosis mesenchymal subtype of ovarian cancer using a systems biology approach, involving a variety of molecular modalities including gene and microRNA expression profiles. miR-508-3p emerged as the most powerful determinant that regulates a cascade of dysregulated genes in the mesenchymal subtype, including core genes involved in epithelial-mesenchymal transition (EMT) program. Moreover, miR-508-3p down-regulation, due to promoter hypermethylation, was directly correlated with metastatic behaviors in vitro and in vivo. Taken together, our multidimensional network analysis identified miR-508-3p as a master regulator that defines the mesenchymal subtype and provides a novel prognostic biomarker to improve management of this disease.	[Zhao, Linjie; Yi, Tao; Zhao, Xia; Wei, Yuquan; Zhou, Shengtao] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China; [Zhao, Linjie; Yi, Tao; Zhao, Xia; Wei, Yuquan; Zhou, Shengtao] Sichuan Univ, State Key Lab Biotherapy, West China Second Univ Hosp, Chengdu, Sichuan, Peoples R China; [Zhao, Linjie; Yi, Tao; Zhao, Xia; Wei, Yuquan; Zhou, Shengtao] Collaborat Innovat Ctr, Chengdu, Sichuan, Peoples R China; [Wang, Wei; Wang, Xin] City Univ Hong Kong, Dept Biomed Sci, Kowloon Tong, Hong Kong, Peoples R China; [Xu, Lian] Sichuan Univ, Dept Pathol, West China Second Univ Hosp, Chengdu, Sichuan, Peoples R China; [Vermeulen, Louis] Univ Amsterdam, Ctr Expt Mol Med, Acad Med Ctr, Lab Expt Oncol & Radiobiol LEXOR, NL-1105 AZ Amsterdam, Netherlands; [Goel, Ajay] Baylor Univ, Med Ctr, Ctr Gastrointestinal Res, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Ctr Translat Genom & Oncol, Baylor Scott & White Res Inst, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA; [Wang, Xin] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	Sichuan University; Sichuan University; City University of Hong Kong; Sichuan University; University of Amsterdam; Academic Medical Center Amsterdam; Baylor University; Baylor University Medical Center; Baylor Health Care System; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; City University of Hong Kong	Zhou, ST (corresponding author), Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China.; Zhou, ST (corresponding author), Sichuan Univ, State Key Lab Biotherapy, West China Second Univ Hosp, Chengdu, Sichuan, Peoples R China.; Zhou, ST (corresponding author), Collaborat Innovat Ctr, Chengdu, Sichuan, Peoples R China.; Wang, X (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon Tong, Hong Kong, Peoples R China.; Wang, X (corresponding author), City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	taotaovip2005@163.com; xin.wang@cityu.edu.hk	Wang, Xin/A-1130-2012	Wang, Xin/0000-0002-5122-2418; Vermeulen, Louis/0000-0002-6066-789X; Zhou, Shengtao/0000-0001-8322-5536	National Natural Science Foundation of China [81822034, 81773119, 81402396]; National Key Research and Development Program of China [2018YFA0109200, 2017YFA0106800]; Sichuan Science-Technology Soft Sciences Project [2016ZR0086]; West China Second Hospital, Sichuan University [KS021]; Research Grants Council of the Hong Kong Special Administrative Region, China [CityU 21101115, 11102317, 11103718]; Science Technology and Innovation Committee of Shenzhen Municipality [JCYJ20170307091256048]; Shenzhen Research Institute, City University of Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Sichuan Science-Technology Soft Sciences Project; West China Second Hospital, Sichuan University; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Science Technology and Innovation Committee of Shenzhen Municipality; Shenzhen Research Institute, City University of Hong Kong(City University of Hong Kong)	This work was supported by grants from the National Natural Science Foundation of China (grant#81822034, grant #81773119, and grant #81402396), National Key Research and Development Program of China (2018YFA0109200 and 2017YFA0106800), Sichuan Science-Technology Soft Sciences Project (grant #2016ZR0086), Direct Scientific Research Grants from West China Second Hospital, Sichuan University (grant #KS021) awarded to Shengtao Zhou and a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CityU 21101115, 11102317, 11103718), as well as a grant from The Science Technology and Innovation Committee of Shenzhen Municipality (JCYJ20170307091256048) awarded to Xin Wang, and partially supported by the Shenzhen Research Institute, City University of Hong Kong.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bagnoli M, 2016, LANCET ONCOL, V17, P1137, DOI 10.1016/S1470-2045(16)30108-5; Bagnoli M, 2011, ONCOTARGET, V2, P1265, DOI 10.18632/oncotarget.401; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bilyk O, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00145; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Ceppi P, 2014, ONCOGENE, V33, P269, DOI 10.1038/onc.2013.55; Chaisaingmongkol J, 2017, CANCER CELL, V32, P57, DOI 10.1016/j.ccell.2017.05.009; Chan CK, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160275; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Di Stefano V, 2016, AM J PATHOL, V186, P2473, DOI 10.1016/j.ajpath.2016.05.019; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Huang TT, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0493-7; Jiang JW, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.36; Karnezis AN, 2017, NAT REV CANCER, V17, P65, DOI 10.1038/nrc.2016.113; Konecny GE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju249; Kossai M, 2018, PATHOBIOLOGY, V85, P41, DOI 10.1159/000479006; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lin CY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5620; Liu N, 2017, ONCOTARGET, V8, P60015, DOI 10.18632/oncotarget.9623; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Nam EJ, 2016, ONCOTARGET, V7, P70524, DOI 10.18632/oncotarget.12045; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Pan YH, 2017, ONCOTARGET, V8, P17406, DOI 10.18632/oncotarget.15921; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Wang X, 2011, BIOINFORMATICS, V27, P879, DOI 10.1093/bioinformatics/btr028; Way GP, 2016, G3-GENES GENOM GENET, V6, P4097, DOI 10.1534/g3.116.033514; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yu XT, 2013, TUMOR BIOL, V34, P3501, DOI 10.1007/s13277-013-0928-3; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhao L, 2017, ONCOGENE, V36, P3384, DOI 10.1038/onc.2016.487; Zhao LJ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1412-6; Zhao LJ, 2017, CANCER RES, V77, P1369, DOI 10.1158/0008-5472.CAN-16-1615; Zhao LJ, 2013, HUM REPROD, V28, P1324, DOI 10.1093/humrep/det042; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459; Zhou ST, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017988; Zhou ST, 2012, CANCER LETT, V318, P14, DOI 10.1016/j.canlet.2011.10.038	55	37	37	4	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2305	2319		10.1038/s41388-018-0577-5	http://dx.doi.org/10.1038/s41388-018-0577-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30478449	Green Published, hybrid			2022-12-26	WOS:000462588000006
J	Raz, V; Raz, Y; van de Vijver, D; Bindellini, D; van Putten, M; Ben van den Akker, E				Raz, Vered; Raz, Yotam; van de Vijver, Davy; Bindellini, Davide; van Putten, Maaike; Ben van den Akker, Erik			High-throughput data-driven analysis of myofiber composition reveals muscle-specific disease and age-associated patterns	FASEB JOURNAL			English	Article						myosin heavy chain; limb girdle muscular dystrophy; ageing; SGCA-null; SGCD-null	HEAVY-CHAIN ISOFORMS; MUSCULAR-DYSTROPHY; MOUSE MODEL; INVOLVEMENT; ATROPHY; SLOW	Contractile properties of myofibers are dictated by the abundance of myosin heavy chain (MyHC) isoforms. MyHC composition designates muscle function, and its alterations could unravel differential muscle involvement in muscular dystrophies and aging. Current analyses are limited to visual assessments in which myofibers expressing multiple MyHC isoforms are prone to misclassification. As a result, complex patterns and subtle alterations are unidentified. We developed a high-throughput, data-driven myofiber analysis to quantitatively describe the variations in myofibers across the muscle. We investigated alterations in myofiber composition between genotypes, 2 muscles, and 2 age groups. We show that this analysis facilitates the discovery of complex myofiber compositions and its dependency on age, muscle type, and genetic conditions.Raz, V., Raz, Y., van de Vijver, D., Bindellini, D., van Putten, M., van den Akker, E. B. High-throughput data-driven analysis of myofiber composition reveals muscle-specific disease and age-associated patterns.	[Raz, Vered; van de Vijver, Davy; Bindellini, Davide; van Putten, Maaike] Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20,Bldg 2,Room R3-17, NL-2333 ZC Leiden, Netherlands; [Raz, Yotam; Ben van den Akker, Erik] Leiden Univ, Med Ctr, Mol Epidemiol, Leiden, Netherlands; [Ben van den Akker, Erik] Leiden Univ, Med Ctr, Leiden Computat Biol Ctr, Leiden, Netherlands; [Ben van den Akker, Erik] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology	Raz, V (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20,Bldg 2,Room R3-17, NL-2333 ZC Leiden, Netherlands.	V.raz@lumc.nl		van de Vijver, David/0000-0001-5877-8526; van Putten, Maaike/0000-0002-0683-8897; van den Akker, Erik/0000-0002-7693-0728	AFM [20251, 21160]	AFM(Association Francaise contre les Myopathies)	The authors thank M. Reinders (Department of Biomedical Data Sciences, Leiden University Medical Centre, and Delft Bioinformatics Lab, Delft University, The Netherlands) and A. Aartsma-Rus (Department of Human Genetics, Leiden University Medical Center, TheNetherlands) for helpful suggestions and comments on the analyses and the manuscript. This work was funded by AFM Grant 20251 (to M.V.P.) and AFM Grant 21160 (to V.R.). The authors declare no conflicts of interest.	Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Banks GB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004431; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Coley WD, 2016, HUM MOL GENET, V25, P130, DOI 10.1093/hmg/ddv460; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Hack AA, 2000, J CELL SCI, V113, P2535; HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I; Hooijmans MT, 2015, NMR BIOMED, V28, P1589, DOI 10.1002/nbm.3427; Huovinen S, 2015, AM J PATHOL, V185, P2833, DOI 10.1016/j.ajpath.2015.06.018; McDonald AA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12391; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Mul K, 2017, NEUROLOGY, V89, P2057, DOI 10.1212/WNL.0000000000004647; Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054; Pasteuning-Vuhman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182704; Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012; Raz V, 2018, FASEB J, V32, P1579, DOI 10.1096/fj.201700861R; Raz Y, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00236; Riaz M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006031; Riaz M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0064-4; Ruggiero L, 2015, MUSCLE NERVE, V51, P604, DOI 10.1002/mus.24467; Sawano S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166080; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; van der Sluijs BM, 2017, NEUROMUSCULAR DISORD, V27, P1099, DOI 10.1016/j.nmd.2017.09.010; Wang JF, 1999, NEUROMUSCULAR DISORD, V9, P150, DOI 10.1016/S0960-8966(98)00114-X; Wang JH, 2015, DEV BIOL, V402, P72, DOI 10.1016/j.ydbio.2015.02.025; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Willmann R, 2012, NEUROMUSCULAR DISORD, V22, P43, DOI 10.1016/j.nmd.2011.04.012; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Zhang D, 2014, J CELL BIOL, V207, P753, DOI 10.1083/jcb.201406068	35	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4046	4053		10.1096/fj.201801714R	http://dx.doi.org/10.1096/fj.201801714R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30485132	Green Submitted, Bronze			2022-12-26	WOS:000459794800075
J	Juhl, P; Bay-Jensen, AC; Karsdal, M; Siebuhr, AS; Franchimont, N; Chavez, J				Juhl, Pernille; Bay-Jensen, Anne-Christine; Karsdal, Morten; Siebuhr, Anne Sofie; Franchimont, Nathalie; Chavez, Juan			Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study	PLOS ONE			English	Article							CONNECTIVE-TISSUE; III COLLAGEN; LIVER; MARKER; CLASSIFICATION; MULTICENTER; PROPEPTIDE; CARTILAGE; DISEASE	Background Systemic sclerosis (SSc) is characterized by excessive fibrosis throughout the body. This leads to the release of extracellular matrix (ECM) fragments into circulation, where they may be quantified as biomarkers. The objectives were to investigate levels of ECM turnover biomarkers and the diagnostic power of these. Methods Diffuse SSc patients (n = 40) fulfilling the ACR/EULAR 2013 classification criteria and asymptomatic controls were included. Patients were divided into early (<2 years of symptoms; n = 20) and late (>10 years of symptoms; n = 20) diffuse SSc. Biomarkers of type I (C1M), III (C3A, C3M), IV (C4M), V (C5M) and VI (C6M) collagen degradation and type I (PRO-C1), II (PRO-C2), III (PRO-C3), IV (PRO-C4), V (PRO-05) and VI (PRO-C6) collagen formation were measured in serum. Repeated measures ANOVA was used to test for differences in biomarker levels and the area under the receiver operating characteristic curve (AUC) was used to investigate the ability of the biomarkers to separate groups. Results In early diffuse SSc, formation biomarkers of type III, IV, V and VI collagen were significantly increased compared to asymptomatic controls (p<0.0001). Moreover, in early diffuse SSc formation biomarkers of type III, V and VI collagen were significantly increased compared to late diffuse SSc (p = 0.0006, 0.003 and 0.004, respectively). Type I (p<0.0001), III (C3M: p = 0.001, and C3A: p = 0.02), IV (p<0.0001) and VI (p<0.0001) collagen degradation biomarkers significantly increased in early diffuse SSc compared to controls. C4M, C6M, PRO-C4, PRO-05 and PRO-C6 had an AUC of >0.85 when assessing asymptomatic controls vs. diffuse SSc. Biomarkers of type VI collagen (PRO-C6 and C6M) turnover had the best separation with an AUC's of >0.90. Conclusion Formation biomarkers of ECM turnover were shown to be significantly different between asymptomatic controls and diffuse SSc. This pilot study suggest that serological biomarkers of the ECM turnover is potentially applicable in SSc.	[Juhl, Pernille; Bay-Jensen, Anne-Christine; Karsdal, Morten; Siebuhr, Anne Sofie] Nord Biosci, Biomarkers & Res, Herlev, Denmark; [Juhl, Pernille] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Franchimont, Nathalie; Chavez, Juan] Biogen, Clin Dev, Cambridge, MA USA	Nordic Bioscience; University of Copenhagen; Biogen	Juhl, P (corresponding author), Nord Biosci, Biomarkers & Res, Herlev, Denmark.; Juhl, P (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	pju@nordicbio.com	Bay-Jensen, Anne-Christine/AEQ-7281-2022	Bay-Jensen, Anne-Christine/0000-0001-7952-9297; Karsdal, Morten/0000-0001-5026-8740	Biogen	Biogen(Biogen)	This study was funded by Biogen. Biogen (NF and JC) contributed to study design, interpretation and decision to publish the study. Nordic Bioscience (AB, MK and AS), contributed to study design, conducted the study and analyzed the data, contributed to interpretation of findings, decision to publish, and preparation of the manuscript.	Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Bay-Jensen AC, 2014, SEMIN ARTHRITIS RHEU, V43, P470, DOI 10.1016/j.semarthrit.2013.07.008; BIRK DE, 1990, J CELL SCI, V95, P649; Denton CP, 2009, ANN RHEUM DIS, V68, P1433, DOI 10.1136/ard.2008.096123; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Fazio M. J., 1989, J INVEST DERMATOL, V92; Gonzalez-Lopez L, 2015, ARCH BRONCONEUMOL, V51, P440, DOI 10.1016/j.arbres.2014.06.018; Gudmann NS, 2014, INT J MOL SCI, V15, P18789, DOI 10.3390/ijms151018789; Guo X, 2015, J INVEST DERMATOL, V135, P2402, DOI 10.1038/jid.2015.188; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hummers Laura K, 2010, Curr Rheumatol Rep, V12, P34, DOI 10.1007/s11926-009-0081-6; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Leeming DJ, 2011, BIOMARKERS, V16, P616, DOI 10.3109/1354750X.2011.620628; Leeming DJ, 2012, HEPATOL RES, V42, P482, DOI 10.1111/j.1872-034X.2011.00946.x; LEROY EC, 1988, J RHEUMATOL, V15, P202; Moinzadeh P, 2015, ANN RHEUM DIS, V74, P730, DOI 10.1136/annrheumdis-2013-204487; Mortensen JH, 2015, J CROHNS COLITIS, V9, P863, DOI 10.1093/ecco-jcc/jjv123; Nielsen MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137302; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; NIEMELA O, 1985, BIOCHEM J, V232, P145, DOI 10.1042/bj2320145; PELTONEN J, 1990, ARTHRITIS RHEUM-US, V33, P1829, DOI 10.1002/art.1780331211; Quillinan NP, 2014, ANN RHEUM DIS, V73, P56, DOI 10.1136/annrheumdis-2013-203674; Sand JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084934; Siebuhr AS, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4266; Simeon-Aznar CP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001728; Tao ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115825; Theocharidis G, 2016, J INVEST DERMATOL, V136, P74, DOI 10.1038/JID.2015.352; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Vassiliadis E, 2011, BIOMARKERS, V16, P426, DOI 10.3109/1354750X.2011.584131; Veidal SS, 2012, CLIN BIOCHEM, V45, P541, DOI 10.1016/j.clinbiochem.2012.02.007; Veidal SS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-5; Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Watt F M, 2011, COLD SPRING HARB PER, V3, P1, DOI DOI 10.1101/CSHPER-SPECT.A005124; WEBER L, 1984, J INVEST DERMATOL, V82, P156, DOI 10.1111/1523-1747.ep12259720; YAOITA H, 1978, J INVEST DERMATOL, V70, P191, DOI 10.1111/1523-1747.ep12541313	36	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207324	10.1371/journal.pone.0207324	http://dx.doi.org/10.1371/journal.pone.0207324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507931	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500006
J	Schlicht-Schmalzle, R; Chykina, V; Schmalzle, R				Schlicht-Schmalzle, Raphaela; Chykina, Volha; Schmalzle, Ralf			An attitude network analysis of post-national citizenship identities	PLOS ONE			English	Article							GLOBAL CITIZENSHIP; MODEL; IDENTIFICATION; ANTECEDENTS; IMMIGRATION; PATRIOTISM; CENTRALITY; NARCISSISM; EDUCATION; DYNAMICS	How are evaluative reactions pertaining post-national citizenship identities interrelated and what are the potential mechanisms how post-national identities evolve? Previous efforts to operationalize and measure post-national citizenship identities leave it open how people's stances on different issues are related and suffer from a variety of theoretical and methodological shortcomings regarding the nature of political attitudes and ideologies. A recently proposed approach conceptualizes ideologies as networks of causally connected evaluative reactions to individual issues. Individual evaluative reactions form the nodes in a network model, and these nodes can influence each other via linked edges, thereby giving rise to a dynamic thoughts system of networked political and identity-related views. To examine this system at large, we apply network analysis to data from the European Values Study. Specifically, we investigate 33 evaluative reactions regarding national and supra-national identity, diversity, global empathy, global environmentalism, immigration, and supra-national politics. The results reveal a strongly connected network of citizenship identity-related attitudes. A community analysis reveals larger clusters of strongly related evaluative reactions, which are connected via bridges and hub nodes. Centrality analysis identifies evaluative reactions that are strategically positioned in the network, and network simulations indicate that persuasion attempts targeted at such nodes have greater potential to influence the larger citizenship identity than changes of more peripheral attitude nodes. We lastly show that sociodemographic characteristics are not only associated with the overall level of post-national citizenship, but also with the network structure, suggesting that these structural differences can affect the network function as people develop national or post-national citizenship identities, or respond to external events. These results provide new insights into the structure of post-national identities and the mechanism how post-national identities might evolve. We end with a discussion of future opportunities to study networked attitudes in the context of civic and citizenship education.	[Schlicht-Schmalzle, Raphaela] Michigan State Univ, Coll Educ, E Lansing, MI 48824 USA; [Chykina, Volha] Univ Michigan, Donia Human Rights Ctr, Ann Arbor, MI 48109 USA; [Schmalzle, Ralf] Michigan State Univ, Dept Commun, E Lansing, MI 48824 USA	Michigan State University; University of Michigan System; University of Michigan; Michigan State University	Schlicht-Schmalzle, R (corresponding author), Michigan State Univ, Coll Educ, E Lansing, MI 48824 USA.	schlic21@msu.edu		Chykina, Volha/0000-0002-7612-9180; Schlicht-Schmaelze, Raphaela/0000-0002-6311-3606; Schmalzle, Ralf/0000-0002-0179-1364	Office of International Studies in Education; Neuroscience of Messages Lab at Michigan State University	Office of International Studies in Education; Neuroscience of Messages Lab at Michigan State University	We first of all thank Lynn Paine, Samantha Caughlan, Idris Abubakar, Charles Crabtree, Dan Bergan as well as the Office of International Studies in Education and the Neuroscience of Messages Lab at Michigan State University for productive advice and support. We also thank the attendees of the Annual Conference of the Mid-Western Political Science Association 2018, especially Alexa Bankert and Eric Uslaner, for helpful discussions as well as the participants of the Annual Conference Global Citizenship in Practice 2017 at the University of Michigan.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Andreotti V, 2014, SOFT VERSUS CRITICAL; Ashcroft R, 2016, POLIT QUART, V87, P355, DOI 10.1111/1467-923X.12293; Augusteijn J, 2012, REGION AND STATE IN NINETEENTH-CENTURY EUROPE: NATION-BUILDING, REGIONAL IDENTITIES AND SEPARATISM, P1; BAGOZZI RP, 1979, J CONSUM RES, V5, P297, DOI 10.1086/208741; Banks JA, 2008, EDUC RESEARCHER, V37, P129, DOI 10.3102/0013189X08317501; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Barrat A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.228701; Baughn CC, 1996, POLIT PSYCHOL, V17, P759, DOI 10.2307/3792137; Bizumic B, 2008, POLIT PSYCHOL, V29, P437, DOI 10.1111/j.1467-9221.2008.00638.x; Borsboom D, 2003, PSYCHOL REV, V110, P203, DOI 10.1037/0033-295X.110.2.203; Borsboom D., 2018, SOC PSYCHOL PERS SCI; Borsboom D, 2017, WORLD PSYCHIATRY, V16, P5, DOI 10.1002/wps.20375; Boschloo L, 2016, COMP NETWORK S UNPUB, P34, DOI DOI 10.13140/RG.2.2.29455.38569; Boutyline A, 2017, AM J SOCIOL, V122, P1371, DOI 10.1086/691274; Brandt M, WHAT IS CENTRAL POLI; BRECKLER SJ, 1984, J PERS SOC PSYCHOL, V47, P1191, DOI 10.1037/0022-3514.47.6.1191; Carey S., 2002, EUR UNION POLIT, V3, P387, DOI [10.1177/1465116502003004001, DOI 10.1177/1465116502003004001]; Carter A, 2016, RETHINK GLOB, P13; Carter April., 2001, POLITICAL THEORY GLO; Castles S, 1998, INT SOC SCI J, V50, P179, DOI 10.1111/1468-2451.00122; Castles S., 2000, CITIZENSHIP MIGRATIO; CONVERSE PE, 1964, IDEOLOGY DISCONTENT; Crano WD, 1998, J PERS SOC PSYCHOL, V74, P1437, DOI 10.1037/0022-3514.74.6.1437; Crano WD, 2015, SYD SYM SOC PSYCHOL, P21; Crepaz MML, 2014, SOC SCI QUART, V95, P938, DOI 10.1111/ssqu.12082; Dalege J, 2017, SOC PSYCHOL PERS SCI, V8, P528, DOI 10.1177/1948550617709827; Dalege J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05048-y; Dalege J, 2016, PSYCHOL REV, V123, P2, DOI 10.1037/a0039802; de Zavala AG, 2009, J PERS SOC PSYCHOL, V97, P1074, DOI 10.1037/a0016904; Delanty G., 2000, CITIZENSHIP GLOBAL A; Delanty G, 1997, CITIZENSHIP STUD, V1, P285, DOI DOI 10.1080/13621029708420660; Dinauer LD, 2005, HUM COMMUN RES, V31, P1, DOI 10.1093/hcr/31.1.1; Durkheim Emile, 1960, DIVISION LABOUR SOC, VFourth; Eade J., 1997, LIVING GLOBAL CITY; Edwards JR, 2011, ORGAN RES METHODS, V14, P370, DOI 10.1177/1094428110378369; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Esses VM, 2006, INT J INTERCULT REL, V30, P653, DOI 10.1016/j.ijintrel.2006.07.002; Feldman S, 2014, POLIT PSYCHOL, V35, P337, DOI 10.1111/pops.12055; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Fishbein M., 1975, BELIEF ATTITUDE INTE, P578; Fox J, 2005, ANNU REV POLIT SCI, V8, P171, DOI 10.1146/annurev.polisci.7.012003.104851; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fuchs D, 2002, WEST EUR POLIT, V25, P19, DOI 10.1080/713869598; Gawronski B., 2012, COGNITIVE CONSISTENC, P1; Glaser T, 2015, PERS SOC PSYCHOL REV, V19, P257, DOI 10.1177/1088868314546489; Goodwin M, 2017, BRIT J POLIT INT REL, V19, P450, DOI 10.1177/1369148117710799; Gormley-Heenan C, 2017, BRIT J POLIT INT REL, V19, P497, DOI 10.1177/1369148117711060; Habermas J, 2001, STUDIES CONT GERMAN, pxix; Habermas J., 2001, POSTNATIONALE KONSTE; Habermas J, 1999, INCLUSION OTHER STUD, P105; Haidt J., 2012, RIGHTEOUS MIND WHY G; Heater D., 1999, WHAT IS CITIZENSHIP; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Herrmann R., 2004, TRANSNATIONAL IDENTI; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Hobolt SB, 2016, J EUR PUBLIC POLICY, V23, P1259, DOI 10.1080/13501763.2016.1225785; Hooghe L, 2004, PS-POLIT SCI POLIT, V37, P415; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Inglehart R.F., 2016, FACULTY RES WP SERIE, DOI DOI 10.2139/SSRN.2818659; Isin E, 1999, CITIZENSHIP IDENTITY; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Johnston R, 2010, CAN J POLIT SCI, V43, P349, DOI 10.1017/S0008423910000089; Judd C.M., 1989, 3 OHIO STATE U VOL A, P99; Jung J, 2018, SOC INFLUENCE, V13, P18, DOI 10.1080/15534510.2017.1415961; Kaur R, 2013, SCI REP-UK, V3, DOI 10.1038/srep03008; Keating DM, 2017, COMMUN STUD, V68, P439, DOI 10.1080/10510974.2017.1360925; LaPiere RT, 1934, SOC FORCES, V13, P230, DOI 10.2307/2570339; Lavine H, 2000, POLIT PSYCHOL, V21, P81, DOI 10.1111/0162-895X.00178; Linssen Hub, 2001, INTERGROUP RELATIONS; Marshall TH, 1964, TITLE CLASS CITIZENS; Marx P, 2018, ELECT STUD, V52, P111, DOI 10.1016/j.electstud.2018.01.011; McClelland J, 1986, PSYCHOL BIOL MODELS; McFarland S, 2015, EUR J SOC PSYCHOL, V45, P806, DOI 10.1002/ejsp.2161; McFarland S, 2013, CURR DIR PSYCHOL SCI, V22, P194, DOI 10.1177/0963721412471346; McFarland S, 2012, J PERS SOC PSYCHOL, V103, P830, DOI 10.1037/a0028724; MCGUIRE WJ, 1960, J ABNORM SOC PSYCH, V60, P345, DOI 10.1037/h0048563; Miller D., 1995, NATIONALITY; Monroe BM, 2008, PSYCHOL REV, V115, P733, DOI 10.1037/0033-295X.115.3.733; Mummendey A, 2001, BRIT J SOC PSYCHOL, V40, P159, DOI 10.1348/014466601164740; Myers JP, 2009, TEACH COLL REC, V111, P2589; Newman M.E.J., 2010, NETWORKS INTRO; Norris P., 2000, GOVERNANCE GLOBALIZI, P156; Nussbaum Martha, 1996, LOVE COUNTRY DEBATIN, P3; O'Byrne Darren J, 2003, DIMENSIONS GLOBAL CI; O'Byrne DJ, 2016, HUMAN RIGHTS GLOBALI; O'Donnell MB, 2014, BEHAV BRAIN SCI, V37, P94, DOI 10.1017/S0140525X13001672; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Reysen S, 2013, INT J PSYCHOL, V48, P858, DOI 10.1080/00207594.2012.701749; Rosenberg M.J., 1960, ATTITUDE ORGAN CHANG, P1; Roudometof V, 2005, CURR SOCIOL, V53, P113, DOI DOI 10.1177/0011392105048291; Schmittmann VD, 2013, NEW IDEAS PSYCHOL, V31, P43, DOI 10.1016/j.newideapsych.2011.02.007; Shayo M, 2009, AM POLIT SCI REV, V103, P147, DOI 10.1017/S0003055409090194; Smith A., 2013, NATIONS NATL GLOBAL; Smith A.D., 1986, ETHNIC ORIGINS NATIO; Smith ER, 1996, J PERS SOC PSYCHOL, V70, P893, DOI 10.1037/0022-3514.70.5.893; Smith KB, 2017, AM J POLIT SCI, V61, P424, DOI 10.1111/ajps.12255; Smith WC, 2017, GLOB SOC EDUC, V15, P648, DOI 10.1080/14767724.2016.1222896; Stephan W. G., 2000, REDUCING PREJUDICE D, P23; Szelenyi K, 2007, COMP EDUC REV, V51, P25, DOI DOI 10.1086/508640; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tambini D, 2001, ETHNIC RACIAL STUD, V24, P195, DOI 10.1080/01419870020023418; Torney-Purta J, 1981, POLITICAL ED FLUX; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van Borkulo CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05918; van der Maas HLJ, 2006, PSYCHOL REV, V113, P842, DOI 10.1037/0033-295X.113.4.842; van Prooijen JW, 2017, SOCIAL PSYCHOL PERSO; Wagner U, 2015, EUROPEAN SOCIOLOGICA, V28, P319; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westheimer J, 2006, PHI DELTA KAPPAN, V87, P608, DOI 10.1177/003172170608700817; WHEELER L, 1991, J PERS, V59, P339, DOI 10.1111/j.1467-6494.1991.tb00252.x; Woelfel J., 2009, GALILEO COGNITIVE SY; Yogeeswaran K, 2014, EUR REV SOC PSYCHOL, V25, P189, DOI 10.1080/10463283.2014.972081; Zhou M, 2016, SOCIOL PERSPECT, V59, P153, DOI 10.1177/0731121415579281	116	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208241	10.1371/journal.pone.0208241	http://dx.doi.org/10.1371/journal.pone.0208241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC6BO	30507967	gold, Green Submitted, Green Published			2022-12-26	WOS:000451886500033
J	de Morais, DV; Costa, MAPD; Barbara, MFS; Silva, FD; Moreira, MM; Delerue-Mato, C; Dias, LAG; Estevinho, MLM; de Carvalho, CAL				de Morais, Daniel Vieira; Pereira de Carvalho Costa, Maria Angelica; Santa Barbara, Marivalda Figueredo; Silva, Fabiane de Lima; Moreira, Manuela M.; Delerue-Mato, Cristina; Guimaraes Dias, Luis Avelino; Miranda Estevinho, Maria Leticia; Lopes de Carvalho, Carlos Alfredo			Antioxidant, photoprotective and inhibitory activity of tyrosinase in extracts of Dalbergia ecastaphyllum	PLOS ONE			English	Article							FLAVONOID CONTENTS; CAROTENOIDS; PLANTS; CONSTITUENTS; PHENOLICS; PROPOLIS; HEALTH; ACID	Dalbergia ecastaphyllum is a native Brazil plant with importance for beekeeping, and widely used in folk medicine. For the first time, the extracts of this plant were assessed for the presence of hydrophilic and lipophilic antioxidants, as well as inhibition of tyrosinase, free radicals scavenging and sunscreen protection. The antioxidant activity was evaluated by free radical scavenging (DPPH) and beta-carotene bleaching assay. The tyrosinase inhibitory activity was evaluated and calculated the EC50. The photoprotective activity was measured using different concentrations of D. ecastaphyllum extracts. The Sun Protection Factor (SPF) of the samples was higher than 6, and the sample from Ilheus showed the most pronounced photoprotective effect. Sample from Canavieiras presented the highest antioxidant activity by free radical scavenging DPPH and beta-carotene bleaching method, with 92.41% and 48.34%, respectively. All samples inhibited the tyrosinase, especially the sample from Prado that was most effective (124.62 mu g.mL(-1)). Significant negative correlation was found between flavonoid contents and inhibition of tyrosinase. The overall results provide relevant information about the Dalbergia ecastaphyllum species, indicating as potential material to cosmetic and pharmaceutical industry.	[de Morais, Daniel Vieira; Pereira de Carvalho Costa, Maria Angelica; Santa Barbara, Marivalda Figueredo; Silva, Fabiane de Lima; Lopes de Carvalho, Carlos Alfredo] Fed Univ Reconcavo Bahia UFRB, Ctr Agr Environm & Biol Sci, Cruz Das Almas, BA, Brazil; [Moreira, Manuela M.; Delerue-Mato, Cristina] Super Inst Engn Porto, REQUIMTE LAQV, Porto, Portugal; [Guimaraes Dias, Luis Avelino; Miranda Estevinho, Maria Leticia] Polytech Inst Braganca, Mt Res Ctr, Campus Santa Apolonia, Braganca, Portugal; [de Morais, Daniel Vieira] Univ Sao Paulo, Dept Agri Food Ind Food & Nutr, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil	Polytechnic Institute of Porto; Instituto Politecnico de Braganca; Universidade de Sao Paulo	de Morais, DV (corresponding author), Fed Univ Reconcavo Bahia UFRB, Ctr Agr Environm & Biol Sci, Cruz Das Almas, BA, Brazil.; de Morais, DV (corresponding author), Univ Sao Paulo, Dept Agri Food Ind Food & Nutr, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil.	engagromorais@gmail.com	Morais, Daniel V./P-9638-2019; Carvalho, Carlos A L/N-3321-2016; Estevinho, Leticia M./L-2656-2017; COSTA, ANGELICA C/I-8247-2018; Dias, Luis/I-5756-2012	Morais, Daniel V./0000-0002-2737-7428; Carvalho, Carlos A L/0000-0002-3306-3003; Estevinho, Leticia M./0000-0002-9249-1948; Moreira, Manuela M./0000-0003-1500-9211; Dias, Luis/0000-0002-1210-4259	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [156870/2014-2, 305228/2013-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES [88881.062167/20140-1]; Fundacao de Amparo a Pesquisa do Estado da Bahia [PET0008/2016]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado da Bahia	This work was supported by Grant number: 156870/2014-2 to D.V. de Morais and 305228/2013-7 to C.A.L. de Carvalho - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Grant number: 88881.062167/20140-1 to M.L.M. Estevinho - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES; and Grant number: PET0008/2016 to L.A. G. Dias - Fundacao de Amparo a Pesquisa do Estado da Bahia.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Ahn MR, 2004, J AGR FOOD CHEM, V52, P7286, DOI 10.1021/jf048726s; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; Atoui AK, 2005, FOOD CHEM, V89, P27, DOI 10.1016/j.foodchem.2004.01.075; Aumeeruddy-Elalfi Z, 2016, S AFR J BOT, V103, P89, DOI 10.1016/j.sajb.2015.09.010; AYRES M., 2007, BIOESTAT; Ben Mohamed H, 2016, LWT-FOOD SCI TECHNOL, V74, P557, DOI 10.1016/j.lwt.2016.08.023; Bobin M.F., 1995, COSMET TOILETRIES, V7, P44; Bubols GB, 2013, MINI-REV MED CHEM, V13, P318; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Chen CY, 2010, J TAIWAN INST CHEM E, V41, P129, DOI 10.1016/j.jtice.2009.08.005; Cockell CS, 2000, ECOL ENG, V16, P293, DOI 10.1016/S0925-8574(99)00057-9; Costa SCC, 2015, REV BRAS FARMACOGN, V25, P413, DOI 10.1016/j.bjp.2015.07.013; Cotinguiba GGJ, 2013, UNOPAR CIENT CIENC B, V15, P231; de Oliveira RG, 2013, J YOUNG PHARM, V5, P102, DOI 10.1016/j.jyp.2013.08.005; Dimakou C, 2012, LWT-FOOD SCI TECHNOL, V46, P393, DOI 10.1016/j.lwt.2011.12.013; Dzoyem JP, 2015, J ETHNOPHARMACOL, V160, P194, DOI 10.1016/j.jep.2014.11.034; Faggio C, 2017, EUR J PHARMACOL, V807, P91, DOI 10.1016/j.ejphar.2017.04.009; Barbosa KBF, 2010, REV NUTR, V23, P629, DOI 10.1590/S1415-52732010000400013; Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466; Gupta VK, 2016, S AFR J BOT, V103, P49, DOI 10.1016/j.sajb.2015.08.007; Han RM, 2012, MOLECULES, V17, P2140, DOI 10.3390/molecules17022140; Hasegawa T, 2010, INT J MOL SCI, V11, P1082, DOI 10.3390/ijms11031082; Heleno SA, 2015, FOOD CHEM, V173, P501, DOI 10.1016/j.foodchem.2014.10.057; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Ko HH, 2014, J ETHNOPHARMACOL, V151, P386, DOI 10.1016/j.jep.2013.10.054; Liang CP, 2014, MOLECULES, V19, P4681, DOI 10.3390/molecules19044681; Lima CR, 2014, MOLECULES, V19, P9591, DOI 10.3390/molecules19079591; Lin YP, 2007, PHYTOCHEMISTRY, V68, P1189, DOI 10.1016/j.phytochem.2007.02.001; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; Mansur JDS, 1986, AN BRAS DERMATOL, V61, P121; NAGATA M, 1992, J JPN SOC FOOD SCI, V39, P925; Neagu E, 2015, J TAIWAN INST CHEM E, V52, P1, DOI 10.1016/j.jtice.2015.01.026; Nerya O, 2003, J AGR FOOD CHEM, V51, P1201, DOI 10.1021/jf020935u; Orhan IE, 2012, FOOD CHEM, V130, P882, DOI 10.1016/j.foodchem.2011.07.119; Passeron T, 2005, CLIN DERMATOL, V23, P56, DOI 10.1016/j.clindermatol.2004.09.013; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; R Core Team, 2021, R LANGUAGE ENV STAT; Rubilar M, 2007, J AGR FOOD CHEM, V55, P10101, DOI 10.1021/jf0721996; Sarkar Rashmi, 2013, J Cutan Aesthet Surg, V6, P4, DOI 10.4103/0974-2077.110089; Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018; Shin H, 2015, J MULTIVARIATE ANAL, V134, P1, DOI 10.1016/j.jmva.2014.10.001; Sousa CMDM, 2007, QUIM NOVA, V30, P351, DOI 10.1590/S0100-40422007000200021; Subedi L, 2014, J TRADIT CHIN MED, V34, P584, DOI 10.1016/S0254-6272(15)30067-4; Violante IMP, 2009, REV BRAS FARMACOGN, V19, P452, DOI 10.1590/S0102-695X2009000300020; Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a	46	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207510	10.1371/journal.pone.0207510	http://dx.doi.org/10.1371/journal.pone.0207510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500832	Green Submitted, Green Published, gold			2022-12-26	WOS:000451883700011
J	Mu, WD; Liu, J; Zhang, HB				Mu, Wendan; Liu, Jun; Zhang, Haibin			Complete mitochondrial genome of Benthodytes marianensis (Holothuroidea: Elasipodida: Psychropotidae): Insight into deep sea adaptation in the sea cucumber	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; HIGH-ALTITUDE ADAPTATION; CYTOCHROME-C-OXIDASE; DNA-SEQUENCE; PHYLOGENETIC-RELATIONSHIPS; CONCERTED EVOLUTION; GENE ORGANIZATION; CONTROL REGIONS; ARRANGEMENT; SELECTION	Complete mitochondrial genomes play important roles in studying genome evolution, phylogenetic relationships, and species identification. Sea cucumbers (Holothuroidea) are ecologically important and diverse members, living from the shallow waters to the hadal trench. In this study, we present the mitochondrial genome sequence of the sea cucumber Bentho-dytes marianensis collected from the Mariana Trench. To our knowledge, this is the first reported mitochondrial genome from the genus Benthodytes. This complete mitochondrial genome is 17567 bp in length and consists of 13 protein-coding genes, two ribosomal RNA genes and 22 transfer RNA genes (duplication of two tRNAs: trnL and trnS). Most of these genes are coded on the positive strand except for one protein-coding gene (nad6) and five tRNA genes which are coded on the negative strand. Two putative control regions (CRs) have been found in the B. marianensis mitogenome. We compared the order of genes from the 10 available holothurian mitogenomes and found a novel gene arrangement in B. marianensis. Phylogenetic analysis revealed that B. marianensis clustered with Peniagone sp. YYH-2013, forming the deep-sea Elasipodida clade. Positive selection analysis showed that eleven residues (24 S, 45 S, 185 S, 201 G, 211 F and 313 N in nad2; 108 S, 114 S, 322 C, 400 T and 427 S in nad4) were positively selected sites with high posterior probabilities. We predict that nad2 and nad4 may be the important candidate genes for the further investigation of the adaptation of B. marianensis to the deep-sea environment.	[Mu, Wendan; Liu, Jun; Zhang, Haibin] Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya, Peoples R China; [Mu, Wendan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, HB (corresponding author), Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya, Peoples R China.	hzhang@idsse.ac.cn			National Key Research and Development Program of China [2017YFC0306600]; Sanya Key Laboratory Program [L1501]; National Natural Science Foundation of China [41576127]; Hundred Talents Program of CAS [SIDSSE-BR-201401]	National Key Research and Development Program of China; Sanya Key Laboratory Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of CAS(Chinese Academy of Sciences)	This study was supported by The National Key Research and Development Program of China http://www.most.gov.cn/ (2017YFC0306600), Sanya Key Laboratory Program http://zwzx.sanya.gov.cn/ (L1501), National Natural Science Foundation of China http://www.nsfc.gov.cn/ (41576127), Hundred Talents Program of CAS http://www.cas.cn/ (SIDSSE-BR-201401), received by HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2005, MOL ECOL, V14, P3605, DOI 10.1111/j.1365-294X.2005.02672.x; ADKINS RM, 1994, J MOL EVOL, V38, P215; Arndt A, 1998, MOL BIOL EVOL, V15, P1009, DOI 10.1093/oxfordjournals.molbev.a025999; ASAKAWA S, 1995, GENETICS, V140, P1047; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bohlin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069878; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Bronstein O, 2019, GENOMICS, V111, P710, DOI 10.1016/j.ygeno.2018.04.008; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen WH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11334; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fan SG, 2011, SCI CHINA LIFE SCI, V54, P434, DOI 10.1007/s11427-011-4168-8; Gallo ND, 2015, DEEP-SEA RES PT I, V99, P119, DOI 10.1016/j.dsr.2014.12.012; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Jung G, 2015, MITOCHONDR DNA, V26, P883, DOI 10.3109/19401736.2013.861442; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kerr AM, 2001, ZOOL J LINN SOC-LOND, V133, P63, DOI 10.1006/zjls.2000.0280; Kilpert F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-241; Kumazawa Y, 1996, MOL BIOL EVOL, V13, P1242, DOI 10.1093/oxfordjournals.molbev.a025690; Kumazawa Y, 1998, GENETICS, V150, P313; Lacey KMJ, 2005, MAR BIOL, V147, P1149, DOI 10.1007/s00227-005-0009-2; Lee JS, 2001, GENE, V280, P1, DOI 10.1016/S0378-1119(01)00765-X; Lei RH, 2010, GENE, V464, P44, DOI 10.1016/j.gene.2010.06.001; Li DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134580; Li YN, 2018, ZOOTAXA, V4462, P443, DOI 10.11646/zootaxa.4462.3.10; Littlewood DTJ, 1997, BIOL J LINN SOC, V61, P409, DOI 10.1006/bijl.1996.0131; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo YJ, 2008, MITOCHONDRION, V8, P352, DOI 10.1016/j.mito.2008.07.005; Ma HY, 2012, BIOCHEM SYST ECOL, V41, P41, DOI 10.1016/j.bse.2011.12.016; Matsubara M, 2005, MOL PHYLOGENET EVOL, V36, P598, DOI 10.1016/j.ympev.2005.03.018; Miller AK, 2017, MOL PHYLOGENET EVOL, V111, P110, DOI 10.1016/j.ympev.2017.02.014; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Nagano Y, 2012, FUNGAL ECOL, V5, P463, DOI 10.1016/j.funeco.2012.01.004; Ning T, 2010, GENET MOL RES, V9, P144, DOI 10.4238/vol9-1gmr705; Ogoh K, 2004, GENE, V327, P131, DOI 10.1016/j.gene.2003.11.011; Ogoh K, 2007, MOL BIOL EVOL, V24, P74, DOI 10.1093/molbev/msl132; PAWSON DAVID L., 1965, BREVIORA MUS COMP ZOOL [HARVARD], V214, P1; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2008, MOL PHYLOGENET EVOL, V47, P855, DOI 10.1016/j.ympev.2007.11.034; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Petrov NB, 2016, BIOCHEMISTRY-MOSCOW+, V81, P972, DOI 10.1134/S0006297916090066; QURESHI SA, 1993, NUCLEIC ACIDS RES, V21, P2801, DOI 10.1093/nar/21.12.2801; Rambaut A, 2013, TRACER V1 6; Ren JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-394; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Rogacheva A, 2009, ZOOTAXA, P460, DOI 10.11646/zootaxa.2096.1.28; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SANDERS HL, 1969, SCIENCE, V163, P1419, DOI 10.1126/science.163.3874.1419; Schirtzinger EE, 2012, MOL PHYLOGENET EVOL, V64, P342, DOI 10.1016/j.ympev.2012.04.009; Scouras A, 2004, MOL PHYLOGENET EVOL, V31, P50, DOI 10.1016/j.ympev.2003.07.005; Scouras A, 2001, MOL BIOL EVOL, V18, P61, DOI 10.1093/oxfordjournals.molbev.a003720; Shao RF, 2005, MOL BIOL EVOL, V22, P620, DOI 10.1093/molbev/msi047; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Shen X, 2009, GENE, V439, P79, DOI 10.1016/j.gene.2009.03.008; Shi W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-352; Shi W, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-173; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smirnov AV, 2012, PALEONTOL J+, V46, P793, DOI 10.1134/S0031030112080126; SMITH MJ, 1990, J MOL EVOL, V31, P195, DOI 10.1007/BF02109496; Sun SE, 2018, COMP BIOCHEM PHYS D, V25, P42, DOI 10.1016/j.cbd.2017.11.002; Sun XJ, 2010, AQUACULTURE, V309, P280, DOI 10.1016/j.aquaculture.2010.08.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku917; Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169; Theel H., 1882, ZOOLOGY JENA GERMANY, V4, P1; Tomasco IH, 2011, MOL PHYLOGENET EVOL, V61, P64, DOI 10.1016/j.ympev.2011.06.014; Tyler PA, 2002, OCEANOL ACTA, V25, P227, DOI 10.1016/S0399-1784(02)01202-1; Umeda S, 2001, BIOCHEM BIOPH RES CO, V286, P681, DOI 10.1006/bbrc.2001.5436; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Woolley SNC, 2016, NATURE, V533, P393, DOI 10.1038/nature17937; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia JJ, 2016, MITOCHONDRIAL DNA A, V27, P4174, DOI 10.3109/19401736.2014.1003899; Xin Y, 2011, MAR GENOM, V4, P253, DOI 10.1016/j.margen.2011.06.005; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; Yamauchi MM, 2003, GENE, V311, P129, DOI 10.1016/S0378-1119(03)00582-1; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu L, 2011, MITOCHONDRION, V11, P497, DOI 10.1016/j.mito.2011.01.004; Zhang B, 2017, ECOL EVOL, V7, P4951, DOI 10.1002/ece3.3067; Zhang HX, 2015, MAR GENOM, V19, P59, DOI 10.1016/j.margen.2014.11.005; Zhou TC, 2014, MITOCHONDRION, V18, P70, DOI 10.1016/j.mito.2014.07.012	92	21	23	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208051	10.1371/journal.pone.0208051	http://dx.doi.org/10.1371/journal.pone.0208051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500836	Green Submitted, Green Published, gold			2022-12-26	WOS:000451883700020
J	Gondaliya, P; Dasare, A; Srivastava, A; Kalia, K				Gondaliya, Piyush; Dasare, Aishwarya; Srivastava, Akshay; Kalia, Kiran			miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells	PLOS ONE			English	Article							MICRORNA TARGET PREDICTION; PATHOGENETIC MECHANISMS; DNA METHYLATION; EXPRESSION; INJURY	The role of DNA methylation has not been enough explored in pathophysiology of diabetic nephropathy (DN). However, according to recent reports it has been inferred that hypermethylation could be one of the principle cause associated with the enhancement of DN. An interrelationship between miR29b and DNA methylation has been studied via in-silico analysis. We have validated that miR29b prominently targets DNA methyl transferase (DNMT), specifically DNMT1, DNMT3A and DNMT3B. We have developed in vitro DN model using renal proximal tubule epithelial cells (RPTECs), contributed to a significant alleviation in RNA and protein expression levels of DNMT3A, DNMT3B and DNMT1. The developed model has also demonstrated downregulation in expression of miR29b. Our studies have also suggested that miR29b targets DNMT1 via targeting its transcription factor SP1. In addition to this, downregulation of a specific biomarker for kidney injury, tubular kidney injury molecule-1 (KIM-1) and fibrosis causing glycoprotein i.e. fibronectin, was also demonstrated. Hence, the developed model revealed that hypermethylation is a key factor incorporated in DN, and miR29b could effectively ameliorate defensive actions in DN pathogenesis.	[Gondaliya, Piyush; Dasare, Aishwarya; Kalia, Kiran] Natl Inst Pharmaceut Educ & Res Ahmedabad, Dept Biotechnol, Ahmadabad, Gujarat, India; [Srivastava, Akshay] Natl Inst Pharmaceut Educ & Res Ahmedabad, Dept Med Devices, Ahmadabad, Gujarat, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research (NIPER)	Kalia, K (corresponding author), Natl Inst Pharmaceut Educ & Res Ahmedabad, Dept Biotechnol, Ahmadabad, Gujarat, India.; Srivastava, A (corresponding author), Natl Inst Pharmaceut Educ & Res Ahmedabad, Dept Med Devices, Ahmadabad, Gujarat, India.	akshay.srivastava@niperahm.ac.in; director@niperahm.ac.in		Srivastava, Akshay/0000-0001-5048-9420	National Institute of Pharmaceutical Education and Research, Department of Pharmaceutics, Ministry of Chemicals and Fertilizers, Government of India	National Institute of Pharmaceutical Education and Research, Department of Pharmaceutics, Ministry of Chemicals and Fertilizers, Government of India	The authors have received funding from National Institute of Pharmaceutical Education and Research, Department of Pharmaceutics, Ministry of Chemicals and Fertilizers, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bansal A, 2017, PEDIATR DIABETES, V18, P167, DOI 10.1111/pedi.12521; Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Chen HY, 2014, MOL THER, V22, P842, DOI 10.1038/mt.2013.235; Chung ACK, 2010, J AM SOC NEPHROL, V21, P249, DOI 10.1681/ASN.2009010018; Dooley J, 2016, DIABETES, V65, P53, DOI 10.2337/db15-0770; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Eisenreich A, 2016, J HYPERTENS, V34, P323, DOI 10.1097/HJH.0000000000000799; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fujita H, 2009, J AM SOC NEPHROL, V20, P1303, DOI 10.1681/ASN.2008080844; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Hollenberg NK, 2004, KIDNEY INT, V65, P1435, DOI 10.1111/j.1523-1755.2004.00524.x; Hsu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30575; Ilyas Z, 2017, REV ENDOCR METAB DIS, P1, DOI [10.1007/s11154-017-9419-y, DOI 10.1007/S11154-017-9419-Y]; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lu ZY, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/7805058; Maghbooli Z, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-69; Marumo T, 2015, J AM SOC NEPHROL; Massart J., 2017, DIABETES; Pan JL, 2014, INT J MOL MED, V34, P1381, DOI 10.3892/ijmm.2014.1935; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Reddy MA, 2013, SEMIN NEPHROL, V33, P341, DOI 10.1016/j.semnephrol.2013.05.006; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Serban AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152376; Stenvinkel P, 2009, J RENAL NUTR, V19, P82, DOI 10.1053/j.jrn.2008.10.022; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Watanabe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150897; Wing MR, 2014, NEPHROL DIAL TRANSPL, V29, P864, DOI 10.1093/ndt/gft537; Wing MR, 2014, NEPHROL DIAL TRANSPL; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu H, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/920134; Wu R, 2018, METABOLISM, V83, P18, DOI 10.1016/j.metabol.2018.01.002; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Zheng J, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160611; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033766; Zhou L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0710-y	39	11	11	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208044	10.1371/journal.pone.0208044	http://dx.doi.org/10.1371/journal.pone.0208044			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496316	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800083
J	Kim, D; Hwang, JM				Kim, Dongwon; Hwang, Jong-Moon			The center of pressure and ankle muscle co-contraction in response to anterior-posterior perturbations	PLOS ONE			English	Article							POSTURAL SWAY; BALANCE; ADAPTATION; STIFFNESS; QUIET; KNEE; FEAR; EMG; FEEDFORWARD; ACTIVATION	Though both contraction of agonist muscles and co-contraction of antagonistic muscle pairs across the ankle joint are essential to postural stability, they are perceived to operate independently of each other, In an antagonistic setup, agonist muscles contract generating moment about the joint, while antagonist muscles contract generating stiffness across the joint. While both work together in maintaining robustness in the face of external perturbations, contractions of agonist muscles and co-contractions of antagonistic muscle pairs across the ankle joint play different roles in responding to and adapting to external perturbations. To determine their respective roles, we exposed participants to repeated perturbations in both large and small magnitudes. The center of pressure (COP) and a co-contraction index (CCI) were used to quantify the activation of agonist muscles and antagonistic muscle pairs across the ankle joint. Our results found that participants generated moment of a large magnitude across the ankle joint-a large deviation in the COP curve-in response to perturbations of a large magnitude (p < 0.05), whereas the same participants generated higher stiffness about the ankle-a larger value in CCI-in response to perturbations of a small magnitude (p < 0.05). These results indicate that participants use different postural strategies pertaining to circumstances. Further, the moment across the ankle decreased with repetitions of the same perturbation (p < 0.05), and CCI tended to remain unchanged even in response to a different perturbation following repetition of the same perturbation (p < 0.05). These findings suggest that ankle muscle contraction and co-contraction play different roles in regaining and maintaining postural stability. This study demonstrates that ankle moment and stiffness are not correlated in response to external perturbations.	[Kim, Dongwon] Univ Maryland, Sch Engn, Dept Bioengn, College Pk, MD 20742 USA; [Kim, Dongwon] Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA; [Hwang, Jong-Moon] Kyungpook Natl Univ Hosp, Dept Rehabil Med, Daegu, South Korea; [Hwang, Jong-Moon] Kyungpook Natl Univ, Sch Med, Dept Rehabil Med, Daegu, South Korea	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University	Kim, D (corresponding author), Univ Maryland, Sch Engn, Dept Bioengn, College Pk, MD 20742 USA.; Kim, D (corresponding author), Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA.; Hwang, JM (corresponding author), Kyungpook Natl Univ Hosp, Dept Rehabil Med, Daegu, South Korea.; Hwang, JM (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Rehabil Med, Daegu, South Korea.	dongwonkim@som.umaryland.edu; hti82@knu.ac.kr		Kim, Dongwon/0000-0003-1051-0031; Hwang, Jong-Moon/0000-0002-9807-8783				Adkin AL, 2002, EXP BRAIN RES, V143, P160, DOI 10.1007/s00221-001-0974-8; AKAZAWA K, 1983, J NEUROPHYSIOL, V49, P16, DOI 10.1152/jn.1983.49.1.16; Bard C, 1999, EXP BRAIN RES, V125, P410, DOI 10.1007/s002210050697; Blomqvist S, 2014, GAIT POSTURE, V39, P904, DOI 10.1016/j.gaitpost.2013.11.018; Borg F, 2007, J ELECTROMYOGR KINES, V17, P622, DOI 10.1016/j.jelekin.2006.06.004; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Cenciarini M, 2009, IEEE ENG MED BIO, P7006, DOI 10.1109/IEMBS.2009.5333838; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Craig CE, 2016, NEUROSCIENCE, V322, P251, DOI 10.1016/j.neuroscience.2016.02.036; Darainy M, 2008, EXP BRAIN RES, V190, P153, DOI 10.1007/s00221-008-1457-y; DATTA AK, 1991, J PHYSIOL-LONDON, V432, P401, DOI 10.1113/jphysiol.1991.sp018391; DESERRES SJ, 1991, EXP BRAIN RES, V86, P451, DOI 10.1007/BF00228972; DESMURGET M, 1995, CAN J PHYSIOL PHARM, V73, P262, DOI 10.1139/y95-037; Doorenbosch CAM, 2003, CLIN BIOMECH, V18, P142, DOI 10.1016/S0268-0033(02)00183-3; Drillis R., 1969, BODY SEGMENT PARAMET; Ersal T, 2014, GAIT POSTURE, V39, P218, DOI 10.1016/j.gaitpost.2013.07.011; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; Finley JM, 2012, EXP BRAIN RES, V217, P53, DOI 10.1007/s00221-011-2972-9; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; HIROKAWA S, 1991, J ELECTROMYOGR KINES, V1, P199, DOI 10.1016/1050-6411(91)90035-4; Holl N, 2011, EXP BRAIN RES, V210, P229, DOI 10.1007/s00221-011-2618-y; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; Iwamoto Y, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0149-3; Kearney RE, 1997, IEEE T BIO-MED ENG, V44, P493, DOI 10.1109/10.581944; Kennedy A, 2013, NEUROSCI MED, V4, P45, DOI DOI 10.4236/NM.2013.41007; Kim D, 2015, INT C REHAB ROBOT, P422, DOI 10.1109/ICORR.2015.7281236; KUO AD, 1993, J BIOMECH, V26, P137, DOI 10.1016/0021-9290(93)90085-S; Laessoe U, 2008, GAIT POSTURE, V28, P62, DOI 10.1016/j.gaitpost.2007.10.001; Legrand A, 2016, EXP BRAIN RES, V234, P1667, DOI 10.1007/s00221-016-4565-0; Lewek MD, 2004, OSTEOARTHR CARTILAGE, V12, P745, DOI 10.1016/j.joca.2004.05.005; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Milner TE, 1995, EXP BRAIN RES, V107, P293; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; MULAVARA AP, 1994, PROCEEDINGS OF THE 16TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY - ENGINEERING ADVANCES: NEW OPPORTUNITIES FOR BIOMEDICAL ENGINEERS, PTS 1&2, P384, DOI 10.1109/IEMBS.1994.411992; Nelson-Wong E, 2012, EUR J APPL PHYSIOL, V112, P1379, DOI 10.1007/s00421-011-2094-x; Okada S, 2001, EUR J APPL PHYSIOL, V85, P501, DOI 10.1007/s004210100437; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Reynolds RF, 2010, GAIT POSTURE, V31, P78, DOI 10.1016/j.gaitpost.2009.09.001; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Schmid M, 2016, NEUROSCI LETT, V628, P110, DOI 10.1016/j.neulet.2016.06.021; Schmid M, 2011, HUM MOVEMENT SCI, V30, P262, DOI 10.1016/j.humov.2011.02.002; Scott SH, 2012, TRENDS COGN SCI, V16, P541, DOI 10.1016/j.tics.2012.09.008; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Smalley A, 2017, EFFECT AUGMENTED SOM; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; Trimble MH, 2001, INT J NEUROSCI, V106, P1, DOI 10.3109/00207450109149734; Vanderborght B, 2009, INT J ROBOT RES, V28, P90, DOI 10.1177/0278364908095333; Warnica MJ, 2014, GAIT POSTURE, V39, P1115, DOI 10.1016/j.gaitpost.2014.01.019; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Winter DA, 1995, ABC ANATOMY BIOMECHA; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Young WR, 2015, GAIT POSTURE, V41, P7, DOI 10.1016/j.gaitpost.2014.09.006	55	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207667	10.1371/journal.pone.0207667	http://dx.doi.org/10.1371/journal.pone.0207667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496202	Green Submitted, gold, Green Published			2022-12-26	WOS:000451763800041
J	Reindere, JD; Hitt, BD; Stroup, WW; French, BW; Meinke, LJ				Reindere, Jordan D.; Hitt, Brianna D.; Stroup, Walter W.; French, B. Wade; Meinke, Lance J.			Spatial variation in western corn rootworm (Coleoptera: Chrysomelidae) susceptibility to Cry3 toxins in Nebraska	PLOS ONE			English	Article							TRANSGENIC CORN; LARVAL INJURY; FITNESS COSTS; RESISTANCE; DIABROTICA; FIELD; POPULATIONS; BEHAVIOR; PLANT; VALIDATION	Repeated use of field corn (Zea mays L.) hybrids expressing the Cry3Bb1 and mCry3A traits in Nebraska has selected for field-evolved resistance in some western corn rootworm (WCR; Diabrotica virgifera virgifera LeConte) populations. Therefore, this study was conducted to characterize spatial variation in local WCR susceptibility to Cry3Bb1 and mCry3A traits in Keith and Buffalo counties, Nebraska, and determine the relationship between past management practices and current WCR susceptibility. Adult WCR populations were collected from sampling grids during 2015 and 2016 and single-plant larval bioassays conducted with F-1 progeny documented significant variation in WCR susceptibility to Cry3Bb1 and mCry3A on different spatial scales in both sampling grids. At the local level, results revealed that neighboring cornfields may support WCR populations with very different susceptibility levels, indicating that gene flow of resistant alleles from high trait survival sites is not inundating large areas. A field history index, comprised of additive and weighted variables including past WCR management tactics and agronomic practices, was developed to quantify relative selection pressure in individual fields. The field history index-Cry3 trait survivorship relationship from year 1 data was highly predictive of year 2 Cry3 trait survivorship when year 2 field history indices were inserted into the year 1 base model. Sensitivity analyses indicated years of trait use and associated selection pressure at the local level were the key drivers of WCR susceptibility to Cry3 traits in this system. Retrospective case histories from this study will inform development of optimal resistance management programs and increase understanding of plant-insect interactions that may occur when transgenic corn is deployed in the landscape. Results from this study also support current recommendations to slow or mitigate the evolution of resistance by using a multi-tactic approach to manage WCR densities in individual fields within an integrated pest management framework.	[Reindere, Jordan D.; Meinke, Lance J.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Hitt, Brianna D.; Stroup, Walter W.] Univ Nebraska, Dept Stat, Lincoln, NE USA; [French, B. Wade] USDA ARS, North Cent Agr Res Lab, Brookings, SD USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA)	Meinke, LJ (corresponding author), Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA.	lmeinke1@unl.edu	Hitt, Brianna/AAK-9869-2021; Reinders, Jordan D./GZH-1953-2022; Reinders, Jordan/AAV-9655-2021	Hitt, Brianna/0000-0002-0645-0067; Reinders, Jordan D./0000-0003-3937-6745; Reinders, Jordan/0000-0003-3937-6745	Nebraska Agricultural Experiment Station; Hatch Act through the USDA National Institute of Food and Agriculture [1007272]; USDA National Institute of Food and Agriculture, Biotechnology Risk Assessment Grant Program [2012-33522-20010]; Iowa State University	Nebraska Agricultural Experiment Station; Hatch Act through the USDA National Institute of Food and Agriculture; USDA National Institute of Food and Agriculture, Biotechnology Risk Assessment Grant Program; Iowa State University	This was partially supported by The Nebraska Agricultural Experiment Station with funding from the Hatch Act (Accession Number 1007272) through the USDA National Institute of Food and Agriculture, and the USDA National Institute of Food and Agriculture, Biotechnology Risk Assessment Grant Program Competitive Grant 2012-33522-20010 (https://nifa.usda.gov/program/biotechnology-risk-assessment-research-grants-brag-program), sub-award from Iowa State University. LJM was the recipient of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth LJ, 2011, CORN GROWTH DEV, DOI [10.1242/dev.058578, DOI 10.1242/DEV.058578]; Andow DA, 2016, J ECON ENTOMOL, V109, P1, DOI 10.1093/jee/tov238; BALL HJ, 1962, J ECON ENTOMOL, V55, P439, DOI 10.1093/jee/55.4.439; BRANSON TF, 1981, ENVIRON ENTOMOL, V10, P826, DOI 10.1093/ee/10.6.826; COATS SA, 1986, ENVIRON ENTOMOL, V15, P620, DOI 10.1093/ee/15.3.620; CULY MD, 1992, J ECON ENTOMOL, V85, P2440, DOI 10.1093/jee/85.6.2440; Dun Z, 2010, J APPL ENTOMOL, V134, P409, DOI 10.1111/j.1439-0418.2009.01487.x; EPA, 2011, BIOPESTICIDES REGIST; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; GODFREY LD, 1983, J ECON ENTOMOL, V76, P1028, DOI 10.1093/jee/76.5.1028; GODFREY LD, 1993, J ECON ENTOMOL, V86, P1557, DOI 10.1093/jee/86.5.1557; Gray M. E., 2012, B PEST MANAGEMENT CR; Gray ME, 1998, J ECON ENTOMOL, V91, P723, DOI 10.1093/jee/91.3.723; HILL RE, 1980, ENVIRON ENTOMOL, V9, P122, DOI 10.1093/ee/9.1.122; Hou X, 1997, AGRON J, V89, P709, DOI 10.2134/agronj1997.00021962008900050001x; Ingber DA, 2015, J ECON ENTOMOL, V108, P2421, DOI 10.1093/jee/tov199; James G., 2014, INTRO STAT LEARNING; KAHLER AL, 1985, AGRON J, V77, P769, DOI 10.2134/agronj1985.00021962007700050023x; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; Levine Eli, 2002, American Entomologist, V48, P94; Ludwick DC, 2017, J APPL ENTOMOL, V141, P28, DOI 10.1111/jen.12377; Martinez JC, 2016, ENVIRON ENTOMOL, V45, P747, DOI 10.1093/ee/nvw015; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Meinke LJ, 2009, AGR FOREST ENTOMOL, V11, P29, DOI 10.1111/j.1461-9563.2008.00419.x; Meinke LJ, 1998, J ECON ENTOMOL, V91, P594, DOI 10.1093/jee/91.3.594; Meinke LJ., CORN ROOTWORM MANAGE; Meinke LJ, 2014, P CROP PROT CLIN U N, P30; Miller NJ, 2017, CURR OPIN INSECT SCI, V21, P68, DOI 10.1016/j.cois.2017.04.005; Monsanto Company, 2018, CORN ROOTW CONTR MAN; Morrison L, 2013, CORN SOYBEAN DIGEST; MUMA MH, 1949, J ECON ENTOMOL, V42, P822, DOI 10.1093/jee/42.5.822; Nowatzki TM, 2008, J APPL ENTOMOL, V132, P177, DOI 10.1111/j.1439-0418.2008.01270.x; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Onstad DW, 2010, J ECON ENTOMOL, V103, P849, DOI 10.1603/EC09199; Oswald KJ, 2012, J APPL ENTOMOL, V136, P730, DOI 10.1111/j.1439-0418.2012.01704.x; Pereira AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142299; Pocock J, 2013, FARM IND NEWS; PRUESS KP, 1974, J ECON ENTOMOL, V67, P651, DOI 10.1093/jee/67.5.651; R Core Team, 2020, R LANG ENV STAT COMP; Rice M. E., 2004, Plant Health Progress, P1; Rickert Heinrich., 1986, LIMITS CONCEPT FORMA; Sappington Thomas W., 2006, American Entomologist, V52, P90; SAS Institute, 2013, SAS STAT US GUID 9 4; Shrestha Ram B., 2016, Journal of Economic Entomology, V109, P1399, DOI 10.1093/jee/tow087; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; Stebbing JA, 2005, J ECON ENTOMOL, V98, P1294, DOI 10.1603/0022-0493-98.4.1294; Stroup WW, 2015, AGRON J, V107, P811, DOI 10.2134/agronj2013.0342; Tinsley NA, 2013, J APPL ENTOMOL, V137, P161, DOI 10.1111/j.1439-0418.2012.01736.x; U.S. Environmental Protection Agency, 2012, PEST PROD LAB BT11 M; U.S. Environmental Protection Agency, 2012, PEST PROD LAB 5307 C; U.S. Environmental Protection Agency, 2016, FRAM DEL CORN ROOTW; Urias-Lopez MA, 2001, J ECON ENTOMOL, V94, P106, DOI 10.1603/0022-0493-94.1.106; US Environmental Protection Agency, 2013, PEST PROD LAB BT11 X; US Environmental Protection Agency, 2017, EPA REG INN TOOL CON; US Environmental Protection Agency, 2012, PEST PROD LAB OPT AC; US EPA, 2011, UPD BPPD IRM REV REP; US EPA, 2007, BIOP REG ACT DOC MOD; US-EPA, 2010, BIOP REG ACT DOC BAC; van Rozen K, 2010, J APPL ENTOMOL, V134, P376, DOI 10.1111/j.1439-0418.2009.01504.x; Wangila DS, 2017, J APPL ENTOMOL, V141, P372, DOI 10.1111/jen.12346; Wangila DS, 2015, J ECON ENTOMOL, V108, P742, DOI 10.1093/jee/tou063; Zukoff SN, 2016, J ECON ENTOMOL, V109, P1387, DOI 10.1093/jee/tow073	66	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208266	10.1371/journal.pone.0208266	http://dx.doi.org/10.1371/journal.pone.0208266			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496268	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800122
J	Walker, PF; Foster, AD; Rothberg, PA; Davis, TA; Bradley, MJ				Walker, Patrick F.; Foster, Anthony D.; Rothberg, Philip A.; Davis, Thomas A.; Bradley, Matthew J.			Tranexamic acid decreases rodent hemorrhagic shock-induced inflammation with mixed end-organ effects	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; MESENTERIC LYMPH; LUNG INJURY; TRAUMA; IMPACT; SURVIVAL; MODELS; DRUGS	Beyond its anti-fibrinolytic mechanism, tranexamic acid has been suggested to have anti-inflammatory properties which may contribute to the survival benefit it provides to trauma patients. The objective of this study was to assess possible immunomodulatory effects of tranexamic acid as well as potential amelioration of end-organ injury in a rodent hemorrhagic shock model. Controlled hemorrhagic shock was induced in adult Sprague Dawley rats to a mean arterial pressure of 30 mmHg. Groups of 10 rats were administered intravenous tranexamic acid (300mg/kg) or vehicle control (normal saline) intravenously 15 minutes after the induction of shock. After 60 minutes of hemorrhagic shock, resuscitation was started. Animals were euthanized at six, 24, or 72 hours from the start of shock. Serum laboratory values to include inflammatory biomarkers were measured, and end organ histology was evaluated. Tranexamic acid treatment was associated with a significant decrease in serum IL-1 beta at six and 24 hours and IL-10 at 24 hours from start of shock compared to vehicle control. Histologic analysis demonstrated mild decreases in both perivascular pulmonary edema and follicular mesenteric lymph node hyperplasia in the tranexamic acid treatment group but also increased myocardial lymphocytic infiltration with necrosis and degeneration. Tranexamic acid was also associated with a small but significant increase in peripheral neutrophil count as well as a significant decrease in neutrophil aggregation in pulmonary tissue at six hours post-injury. These data thus demonstrate a mixed effect of tranexamic acid. While there was an improvement in pulmonary edema and a suppressive effect on several key inflammatory mediators, there was also increased myocardial degeneration and necrosis, which is possibly related to the pro-thrombotic effect of tranexamic acid.	[Walker, Patrick F.; Foster, Anthony D.; Rothberg, Philip A.; Davis, Thomas A.; Bradley, Matthew J.] Naval Med Res Ctr, Dept Regenerat Med, Silver Spring, MD 20910 USA; [Walker, Patrick F.; Foster, Anthony D.; Rothberg, Philip A.; Davis, Thomas A.; Bradley, Matthew J.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Walker, Patrick F.; Foster, Anthony D.; Rothberg, Philip A.; Davis, Thomas A.; Bradley, Matthew J.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA	Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center	Walker, PF (corresponding author), Naval Med Res Ctr, Dept Regenerat Med, Silver Spring, MD 20910 USA.; Walker, PF (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA.; Walker, PF (corresponding author), Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA.	patrick.f.walker.mil@mail.mil		Walker, Patrick/0000-0002-0871-2702	Office of Naval Research [0601152N.0000.000.A1309, HU0001-15-2-0028]	Office of Naval Research(Office of Naval Research)	This work was supported by the Office of Naval Research (https://www.onr.navy.mil; work unit number 0601152N.0000.000.A1309; grant number HU0001-15-2-0028). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortolotti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01900; Boudreau RM, 2017, J SURG RES, V215, P47, DOI 10.1016/j.jss.2017.03.031; Cole E, 2015, ANN SURG, V261, P390, DOI 10.1097/SLA.0000000000000717; Department for Transport, 2012, TRANSPORT SOLUTIONS, P1; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Elg M, 2001, THROMB RES, V101, P159, DOI 10.1016/S0049-3848(00)00398-4; Garg J, 2014, AM J THER, V21, pE221, DOI 10.1097/MJT.0b013e31828fdb06; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gonzalez RJ, 2001, J TRAUMA, V51, P1069, DOI 10.1097/00005373-200112000-00008; Harvin JA, 2015, J TRAUMA ACUTE CARE, V78, P905, DOI 10.1097/TA.0000000000000612; Jimenez JJ, 2007, CRIT CARE, V11, DOI 10.1186/cc6173; Jordan JR, 2007, J SURG RES, V143, P130, DOI 10.1016/j.jss.2007.04.017; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Ker K, 2013, BRIT J SURG, V100, P1271, DOI 10.1002/bjs.9193; Later AFL, 2013, J THORAC CARDIOV SUR, V145, P1611, DOI 10.1016/j.jtcvs.2012.11.042; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Marcos-Contreras OA, 2016, BLOOD, V128, P2423, DOI 10.1182/blood-2016-03-705384; McCormack PL, 2012, DRUGS, V72, P585, DOI 10.2165/11209070-000000000-00000; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Murkin JM, 2010, ANESTH ANALG, V110, P350, DOI 10.1213/ANE.0b013e3181c92b23; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; O'Brien JG, 2000, INFLAMMATION, V24, P411, DOI 10.1023/A:1007060011553; Peng ZL, 2016, J TRAUMA ACUTE CARE, V81, P358, DOI 10.1097/TA.0000000000001056; Pusateri AE, 2013, SHOCK, V39, P121, DOI 10.1097/SHK.0b013e318280409a; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roy M, 2017, J SURG RES, V208, P104, DOI 10.1016/j.jss.2016.09.023; Ryan KL, 2006, RESUSCITATION, V70, P133, DOI 10.1016/j.resuscitation.2005.11.008; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stringham JR, 2014, J TRAUMA ACUTE CARE, V76, P1214, DOI 10.1097/TA.0000000000000231; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Teng Y, 2018, EXP ANIM TOKYO, V67, P313, DOI 10.1538/expanim.17-0143; Valle EJ, 2014, J TRAUMA ACUTE CARE, V76, P1373, DOI 10.1097/TA.0000000000000242; Valparaiso AP, 2015, J SURG RES, V194, P220, DOI 10.1016/j.jss.2014.10.025; Woudstra L, 2017, INT J CARDIOL, V232, P53, DOI 10.1016/j.ijcard.2017.01.052; Wu XW, 2017, SHOCK, V47, P500, DOI 10.1097/SHK.0000000000000758	37	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208249	10.1371/journal.pone.0208249	http://dx.doi.org/10.1371/journal.pone.0208249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496326	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800116
J	Carson, MA; Nelson, J; Cancela, ML; Laize, V; Gavaia, PJ; Rae, M; Heesch, S; Verzin, E; Gilmore, BF; Clarke, SA				Carson, Matthew A.; Nelson, John; Cancela, M. Leonor; Laize, Vincent; Gavaia, Paulo J.; Rae, Margaret; Heesch, Svenja; Verzin, Eugene; Gilmore, Brendan F.; Clarke, Susan A.			Screening for osteogenic activity in extracts from Irish marine organisms: The potential of Ceramium pallidum	PLOS ONE			English	Article							IN-VIVO; BONE; DIFFERENTIATION; WOMEN; OSTEOPOROSIS; MOLECULES; FUCOIDAN; PROTEIN; CELLS	Extracts and compounds derived from marine organisms have reportedly shown some osteogenic potential. As such, these bioactives may aid in the treatment of musculoskeletal conditions such as osteoporosis; helping to address inefficacies with current treatment options. In this study, 72 fractions were tested for their in vitro osteogenic activity using a human foetal osteoblast (hFOB) cell line and bone marrow derived mesenchymal stem cells (MSCs), focusing on their cytotoxic, proliferative and differentiation effects. Extracts dissolved in dimethyl sulfoxide and ethanol showed no significant osteogenic potential. However, two extracts derived from powder residues (left over from original organic extractions) caused a significant promotion of MSC differentiation. Bioactivity from powder residues derived from the epiphytic red algae Ceramium pallidum is described in detail to highlight its treatment potential. In vitro, C. pallidum was shown to promote MSC differentiation and extracellular matrix mineralisation. In vivo, this extract caused a significant increase in opercular bone growth of zebrafish larvae and a significant increase in bone density of regenerated adult caudal fins. Our findings therefore show the importance of continued screening efforts, particularly of novel extract sources, and the presence of bioactive compounds in C. pallidum extract.	[Carson, Matthew A.; Clarke, Susan A.] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland; [Nelson, John] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Cancela, M. Leonor; Laize, Vincent; Gavaia, Paulo J.] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal; [Cancela, M. Leonor] Univ Algarve, Dept Biomed Sci & Med, Faro, Portugal; [Cancela, M. Leonor] Univ Algarve, ABC, Faro, Portugal; [Rae, Margaret] Marine Inst & Seaweed Res Grp, Oranmore, Co Galway, Ireland; [Heesch, Svenja] Natl Univ Ireland Galway, Ryan Inst, Irish Seaweed Res Grp, Univ Rd, Galway, Ireland; [Verzin, Eugene] Royal Victoria Hosp, Orthopaed Dept, Belfast, Antrim, North Ireland; [Gilmore, Brendan F.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Universidade do Algarve; Universidade do Algarve; Universidade do Algarve; Ollscoil na Gaillimhe-University of Galway; Queens University Belfast	Clarke, SA (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland.	s.a.clarke@qub.ac.uk	Laizé, Vincent/B-4463-2008; Gavaia, Paulo/A-6470-2011; Cancela, M. Leonor/F-4665-2012	Laizé, Vincent/0000-0001-9565-9198; Gavaia, Paulo/0000-0002-9582-1957; Cancela, M. Leonor/0000-0003-3114-6662; Clarke, Susan A./0000-0002-7720-5405; Heesch, Svenja/0000-0002-4531-0921; Carson, Matthew/0000-0003-2733-939X	Marine Institute under the Marine Research Sub-Programme of the Irish National Development Plan 2007-2013; Santander (Bank, UK); Engineering and Physical Sciences Research Council (EPSRC) [EP/M027473/1]	Marine Institute under the Marine Research Sub-Programme of the Irish National Development Plan 2007-2013; Santander (Bank, UK); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Financial support for the Beaufort Marine Biodiscovery Project was received under the Irish Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the Irish National Development Plan 2007-2013. Santander (Bank, UK) contributed scholarship funding to support lab exchange work. This work was also supported by the Engineering and Physical Sciences Research Council (EPSRC) grant EP/M027473/1 'Building the Queen's University Belfast AMR Network.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RA, 2016, J BONE MINER RES, V31, P16, DOI 10.1002/jbmr.2708; Alves H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026678; [Anonymous], 2013, INT J FOOD SCI NUTR, V2, P9, DOI [10.19070/2326-3350-130003, DOI 10.19070/2326-3350-130003]; Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Bensimon-Brito A, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0102-4; Bilezikian JP, 2009, AM J MED, V122, P14, DOI 10.1016/j.amjmed.2008.12.003; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Boominathan VP, 2012, ZEBRAFISH, V9, P207, DOI 10.1089/zeb.2012.0741; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Cardeira J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39191; Carson MA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26024-0; Cho YS, 2009, FOOD CHEM, V116, P990, DOI 10.1016/j.foodchem.2009.03.051; Cian RE, 2015, MAR DRUGS, V13, P5358, DOI 10.3390/md13085358; Czekanska EM, 2014, J BIOMED MATER RES A, V102, P2636, DOI 10.1002/jbm.a.34937; Du Xiaoyi, 2006, Journal of Pharmacological and Toxicological Methods, V54, P164, DOI 10.1016/j.vascn.2006.03.002; Ensrud KE, 2004, J BONE MINER RES, V19, P1259, DOI 10.1359/JBMR.040326; Fleming A, 2005, J BIOMOL SCREEN, V10, P823, DOI 10.1177/1087057105279952; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Han CYE, 2009, BIOORG MED CHEM LETT, V19, P1442, DOI 10.1016/j.bmcl.2009.01.025; Harnedy PA, 2013, LWT-FOOD SCI TECHNOL, V51, P375, DOI 10.1016/j.lwt.2012.09.023; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hwang PA, 2016, CYTOTECHNOLOGY, V68, P1349, DOI 10.1007/s10616-015-9894-5; Jha R.K., 2004, MAR DRUGS, V2, P123, DOI DOI 10.3390/MD203123; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Karadeniz F, 2014, MAR DRUGS, V12, P5132, DOI 10.3390/md12105132; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.95; Laize V., 2014, DRUG DISCOV TODAY DI, V13, P29, DOI DOI 10.1016/J.DDMOD.2014.08.001; Maggs CA, 2002, PHYCOLOGIA, V41, P409, DOI 10.2216/i0031-8884-41-4-409.1; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Maurya R, 2009, BIOORG MED CHEM LETT, V19, P610, DOI 10.1016/j.bmcl.2008.12.064; Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260; O'Gorman DM, 2012, PHYTOTHER RES, V26, P375, DOI 10.1002/ptr.3561; Park MH, 2016, NUTR RES PRACT, V10, P148, DOI 10.4162/nrp.2016.10.2.148; Rae M, 2013, PHYTOCHEM REV, V12, P555, DOI 10.1007/s11101-012-9227-7; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Ryu B, 2015, J FUNCT FOODS, V19, P505, DOI 10.1016/j.jff.2015.09.022; Shen L, 2008, FOOD CHEM, V107, P929, DOI 10.1016/j.foodchem.2007.08.047; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Surget G, 2017, J APPL PHYCOL, V29, P575, DOI 10.1007/s10811-016-0968-3; Tarasco M, 2017, COMP BIOCHEM PHYS C, V197, P45, DOI 10.1016/j.cbpc.2017.04.006; Waybright TJ, 2009, J BIOMOL SCREEN, V14, P708, DOI 10.1177/1087057109335670; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Wijesekara I, 2011, CARBOHYD POLYM, V84, P14, DOI 10.1016/j.carbpol.2010.10.062; Zhang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124805	47	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207303	10.1371/journal.pone.0207303	http://dx.doi.org/10.1371/journal.pone.0207303			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485314	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800060
J	Kane, SA; Van Beveren, D; Dakin, R				Kane, Suzanne Amador; Van Beveren, Daniel; Dakin, Roslyn			Biomechanics of the peafowl's crest reveals frequencies tuned to social displays	PLOS ONE			English	Article							MODULATION TRANSFER-FUNCTIONS; VIBRATIONAL SENSITIVITY; RAT VIBRISSAE; FILOPLUMES; RESONANCE; SIGNALS; MORPHOLOGY; COURTSHIP; CRICKETS; PLUMAGE	Feathers act as vibrotactile sensors that can detect mechanical stimuli during avian flight and tactile navigation, suggesting that they may also detect stimuli during social displays. In this study, we present the first measurements of the biomechanical properties of the feather crests found on the heads of birds, with an emphasis on those from the Indian peafowl (Pavo cristatus). We show that in peafowl these crest feathers are coupled to filoplumes, small feathers known to function as mechanosensors. We also determined that airborne stimuli with the frequencies used during peafowl courtship and social displays couple efficiently via resonance to the vibrational response of their feather crests. Specifically, vibrational measurements showed that although different types of feathers have a wide range of fundamental resonant frequencies, peafowl crests are driven near-optimally by the shaking frequencies used by peacocks performing train-rattling displays. Peafowl crests were also driven to vibrate near resonance in a playback experiment that mimicked the effect of these mechanical sounds in the acoustic very near-field, reproducing the way peafowl displays are experienced at distances. <= 1.5m in vivo. When peacock wing-shaking courtship behaviour was simulated in the laboratory, the resulting airflow excited measurable vibrations of crest feathers. These results demonstrate that peafowl crests have mechanical properties that allow them to respond to airborne stimuli at the frequencies typical of this species' social displays. This suggests a new hypothesis that mechanosensory stimuli could complement acoustic and visual perception and/or proprioception of social displays in peafowl and other bird species. We suggest behavioral studies to explore these ideas and their functional implications.	[Kane, Suzanne Amador; Van Beveren, Daniel] Haverford Coll, Dept Phys, Haverford, PA 19041 USA; [Dakin, Roslyn] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Dakin, Roslyn] Smithsonian Conservat Biol Inst, Migratory Bird Ctr, Washington, DC USA	Haverford College; University of British Columbia; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Kane, SA (corresponding author), Haverford Coll, Dept Phys, Haverford, PA 19041 USA.	samador@haverford.edu		Kane, Suzanne Amador/0000-0001-7532-7532	Haverford College; National Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship	Haverford College; National Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship	Funded by Haverford College. www.haverford.edu.National Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship to Roslyn Dakin. www.nserc-crsng.gc.ca.	Barth F. G., 2014, FLOW SENSING AIR WAT, P169, DOI DOI 10.1007/978-3-642-41446-6_7; Barth FG, 2013, A SPIDERS WORLD SENS; Barth FG, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P251; Biewener A. A., 1992, BIOMECHANICS STRUCTU; BILO D, 1983, J COMP PHYSIOL, V153, P111, DOI 10.1007/BF00610348; BILO D, 1978, NATURWISSENSCHAFTEN, V65, P161, DOI 10.1007/BF00440356; Blackstock DT, 2000, FUNDAMENTALS PHYS AC; Bleckmann H., 2014, FLOW SENSING AIR WAT; Bostwick KS, 2010, P R SOC B, V277, P835, DOI 10.1098/rspb.2009.1576; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; BROWN RE, 1993, J EXP BIOL, V179, P13; Bruecker C., 2016, NAT RESOUR J, V7, P411; Burley NT, 1998, AM NAT, V152, P792, DOI 10.1086/286209; Childress RB, 2002, J AVIAN BIOL, V33, P23, DOI 10.1034/j.1600-048X.2002.330105.x; Clark CJ, 2017, J EXP BIOL, V220, P2697, DOI 10.1242/jeb.154609; Clark CJ, 2013, J EXP BIOL, V216, P3404, DOI 10.1242/jeb.085993; Clark CJ, 2016, SPRINGER HANDB AUDIT, V53, P83, DOI 10.1007/978-3-319-27721-9_4; CLARK GA, 1989, CONDOR, V91, P962, DOI 10.2307/1368080; Cornec C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170594; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; Cummins B, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P239; Cunningham SJ, 2011, J MORPHOL, V272, P118, DOI 10.1002/jmor.10908; Dakin R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152759; Dakin R, 2011, J AVIAN BIOL, V42, P405, DOI 10.1111/j.1600-048X.2011.05444.x; Dakin R, 2011, ANIM BEHAV, V82, P21, DOI 10.1016/j.anbehav.2011.03.016; Dakin R, 2009, BEHAV ECOL SOCIOBIOL, V63, P825, DOI 10.1007/s00265-009-0717-6; DAMBACH M, 1983, NATURWISSENSCHAFTEN, V70, P417, DOI 10.1007/BF01047183; De Bree H-E, 2004, VERY NEAR FIELD THEO; Dent ML, 2002, J COMP PHYSIOL A, V187, P937, DOI 10.1007/s00359-001-0259-5; Dirks JH, 2011, J MECH BEHAV BIOMED, V4, P2031, DOI 10.1016/j.jmbbm.2011.07.002; DOOLING RJ, 1981, J COMP PHYSIOL, V143, P383, DOI 10.1007/BF00611177; Ferrer B, 2013, OPT EXPRESS, V21, P26198, DOI 10.1364/OE.21.026198; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Freeman AR, 2015, ANIM BEHAV, V102, P241, DOI 10.1016/j.anbehav.2015.01.029; Gao JL, 2015, BIOINSPIR BIOMIM NAN, V4, P187, DOI 10.1680/bbn.15.00003; GERHARDT HC, 1992, NATO ADV SCI I A-LIF, V228, P59; Greenfield MD, 2002, SIGNALERS RECEIVERS; Hagelin JC, 2002, BEHAV ECOL, V13, P32, DOI 10.1093/beheco/13.1.32; Hans H, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036013; Hart NS, 2002, J EXP BIOL, V205, P3925; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Heidelbach J, 1997, ETHOLOGY, V103, P827; HEINZEL HG, 1987, J COMP PHYSIOL A, V160, P79, DOI 10.1007/BF00613443; Hillgarth N., 1984, World Pheasant Association Journal, V9, P47; HORSTER W, 1990, J COMP PHYSIOL A, V167, P545; IMBER M J, 1971, New Zealand Journal of Marine and Freshwater Research, V5, P396; JAMES PC, 1986, BIRD STUDY, V33, P117, DOI 10.1080/00063658609476907; JONES IL, 1992, BEHAV ECOL SOCIOBIOL, V30, P43; Kalmijn A.J., 1988, P83; KAMPER G, 1981, J COMP PHYSIOL, V141, P311; KIRCHNER WH, 1994, J COMP PHYSIOL A, V175, P261, DOI 10.1007/BF00192985; KLUMP GM, 1991, HEARING RES, V52, P1, DOI 10.1016/0378-5955(91)90182-9; Larsen ON, 2017, COMPARATIVE BIOACOUSTICS, P3; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lindow BEK, 2006, BIOL REV, V81, P483, DOI 10.1017/S146479310600707X; LOFVENBERG J, 1984, BRAIN RES, V301, P65, DOI 10.1016/0006-8993(84)90403-7; Lucas AM, 1972, STRUCTURE FEATHERS A, P341; Lunichkin A.M., 2016, ENTOMOL REV, V96, P537, DOI [10.1134/ S0013873816050031, DOI 10.1134/S0013873816050031]; Magal C, 2006, J THEOR BIOL, V241, P459, DOI 10.1016/j.jtbi.2005.12.009; Markl H., 1983, P332; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; NECKER R, 1985, J COMP PHYSIOL A, V156, P391, DOI 10.1007/BF00610731; Necker R., 1985, BIRD FLIGHT, P433; Neimark MA, 2003, J NEUROSCI, V23, P6499; O'Neil NP, 2018, ETHOLOGY, V124, P161, DOI 10.1111/eth.12718; Ota N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16614; PATON JA, 1977, J COMP PHYSIOL, V119, P221, DOI 10.1007/BF00656635; Paunescu G, 2015, PROC SPIE, V9649, DOI 10.1117/12.2194753; Persons WS, 2015, EVOLUTION, V69, P857, DOI 10.1111/evo.12634; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; R Core Team, 2017, R 3 3 3 LANG ENV STA; Rogers P.H., 1988, P131; Russell RA, 2011, ROBOT AUTON SYST, V59, P65, DOI 10.1016/j.robot.2010.11.002; Santer RD, 2008, P ROY SOC B-BIOL SCI, V275, P363, DOI 10.1098/rspb.2007.1466; Saxod R, 1978, DEV SENSORY SYSTEMS, P337; Seneviratne SS, 2008, BEHAV ECOL, V19, P784, DOI 10.1093/beheco/arn029; Seneviratne SS, 2010, ANIM BEHAV, V79, P637, DOI 10.1016/j.anbehav.2009.12.010; Shatz LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054876; SHEN JX, 1983, J COMP PHYSIOL, V152, P251, DOI 10.1007/BF00611189; Shimozawa T, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P145; Sisneros JA, 2015, FISH HEARING BIOACOU; Smith WF, 2010, WAVES OSCILLATIONS P; Sofroniew NJ, 2015, CURR BIOL, V25, pR137, DOI 10.1016/j.cub.2015.01.008; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Sueur J, 2010, J ACOUST SOC AM, V127, P1681, DOI 10.1121/1.3291036; Sullivan TN, 2017, MATER TODAY, V20, P377, DOI 10.1016/j.mattod.2017.02.004; TAUTZ J, 1978, BEHAV ECOL SOCIOBIOL, V4, P101, DOI 10.1007/BF00302564; Taylor AM, 2004, J MATER SCI, V39, P939, DOI 10.1023/B:JMSC.0000012925.92504.08; Toole F.E., 2008, SOUND REPROD LOUDSPE; Tsujiuchi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000234; Weaver W., 1990, VIBRATION PROBLEMS E; Weir KA, 2011, ANIM WELFARE SER, V11, P131, DOI 10.1007/978-3-642-19297-5_7; Weiss IM, 2010, J EXP ZOOL PART A, V313A, P690, DOI 10.1002/jez.641; Williams CL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2033; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Yorzinski JL, 2013, J EXP BIOL, V216, P3035, DOI 10.1242/jeb.087338; Yu YSW, 2016, J EXP BIOL, V219, P937, DOI 10.1242/jeb.126896	98	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207247	10.1371/journal.pone.0207247	http://dx.doi.org/10.1371/journal.pone.0207247			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485316	gold, Green Published			2022-12-26	WOS:000451755800053
J	Naves, J; Ordiz, A; Fernandez-Gil, A; Penteriani, V; Delgado, MD; Lopez-Bao, JV; Revilla, E; Delibes, M				Naves, Javier; Ordiz, Andres; Fernandez-Gil, Alberto; Penteriani, Vincenzo; del Mar Delgado, Maria; Vicente Lopez-Bao, Jose; Revilla, Eloy; Delibes, Miguel			Patterns of brown bear damages on apiaries and management recommendations in the Cantabrian Mountains, Spain	PLOS ONE			English	Article							POPULATION-DENSITY; LARGE CARNIVORES; URSUS-ARCTOS; BLACK BEARS; CONFLICT; RISK; DEPREDATION; EXTINCTION; WOLVES; FEAR	Large carnivores are often persecuted due to conflict with human activities, making their conservation in human-modified landscapes very challenging. Conflict-related scenarios are increasing worldwide, due to the expansion of human activities or to the recovery of carnivore populations. In general, brown bears Ursus arctos avoid humans and their settlements, but they may use some areas close to people or human infrastructures. Bear damages in human-modified landscapes may be related to the availability of food resources of human origin, such as beehives. However, the association of damage events with factors that may predispose bears to cause damages has rarely been investigated. We investigated bear damages to apiaries in the Cantabrian Mountains (Spain), an area with relatively high density of bears. We included spatial, temporal and environmental factors and damage prevention measures in our analyses, as factors that may influence the occurrence and intensity of damages. In 2006-2008, we located 61 apiaries, which included 435 beehives damaged in the study area (346 km(2)). The probability of an apiary being attacked was positively related to both the intensity of the damage suffered the year before and the distance to the nearest damaged apiary, and negatively related to the number of prevention measures employed as well as the intensity of the damage suffered by the nearest damage apiary. The intensity of damage to apiaries was positively related to the size of the apiary and to vegetation cover in the surroundings, and negatively related to the number of human settlements. Minimizing the occurrence of bear damages to apiaries seems feasible by applying and maintaining proper prevention measures, especially before an attack occurs and selecting appropriate locations for beehives (e.g. away from forest areas). This applies to areas currently occupied by bears, and to neighbouring areas where dispersing individuals may expand their range.	[Naves, Javier; Fernandez-Gil, Alberto; Revilla, Eloy; Delibes, Miguel] Estn Biol Donana, Dept Conservat Biol, Seville, Spain; [Ordiz, Andres] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Penteriani, Vincenzo; del Mar Delgado, Maria; Vicente Lopez-Bao, Jose] Oviedo Univ, Res Unit Biodivers, UMIB, UO CSIC PA, Campus Mieres, Mieres, Spain; [Penteriani, Vincenzo] CSIC, Pyrenean Inst Ecol IPE, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Norwegian University of Life Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC)	Naves, J (corresponding author), Estn Biol Donana, Dept Conservat Biol, Seville, Spain.	jnaves@ebd.csic.es	Revilla, Eloy/B-5100-2008; VICENTE, LIERN/B-6112-2008	Revilla, Eloy/0000-0001-5534-5581; VICENTE, LIERN/0000-0001-5883-9640; Delgado, Maria del Mar/0000-0002-3009-738X; Ordiz, Andres/0000-0002-6141-8457; Naves, Javier/0000-0003-3773-0288	Agencia Estatal de Investigacion from the Ministry of Economy, Industry and Competitiveness, Spain [CGL2017-83045-R, CGL2017-82782-P]; Regional Government of Asturias [18.07-443F-610.000]; Ramon & Cajal research contract, Agencia Estatal de Investigacion from the Ministry of Economy, Industry and Competitiveness, Spain [RYC-2014-16263, RYC-2015-18932, CGL2017-87528-R AEI/FEDER EU]	Agencia Estatal de Investigacion from the Ministry of Economy, Industry and Competitiveness, Spain; Regional Government of Asturias(Principality of Asturias); Ramon & Cajal research contract, Agencia Estatal de Investigacion from the Ministry of Economy, Industry and Competitiveness, Spain	This work received support from Agencia Estatal de Investigacion from the Ministry of Economy, Industry and Competitiveness, Spain. Project CGL2017-83045-R AEI/FEDER EU, Dr Eloy Revilla; Agencia Estatal de Investigacion from the Ministry of Economy, Industry and Competitiveness, Spain. Project CGL2017-82782-P AEI/FEDER EU, Dr Vincenzo Penteriani; Regional Government of Asturias. 2007-2010 Project: Demographic evolution of the brown bear population, identification of corridors of communication between subpopulations and analysis of the damages caused by the species to agriculture and livestock in Asturias Ref. Pres. PA 2007:, 18.07-443F-610.000, Dr Miguel Delibes; Ramon & Cajal research contract, Agencia Estatal de Investigacion from the Ministry of Economy, Industry and Competitiveness, Spain. RYC-2014-16263, Dr Maria del Mar Delgado; Ramon & Cajal research contract, Agencia Estatal de Investigacion from the Ministry of Economy, Industry and Competitiveness, Spain. RYC-2015-18932; project CGL2017-87528-R AEI/FEDER EU, Dr Jose Vicente Lopez-Bao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athreya V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142647; Barton K., 2017, PACKAGE MUMIN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bautista C, 2017, J APPL ECOL, V54, P282, DOI 10.1111/1365-2664.12708; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Breck SW, 2006, WILDLIFE SOC B, V34, P23, DOI 10.2193/0091-7648(2006)34[23:ASDFPO]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Can OE, 2014, CONSERV LETT, V7, P501, DOI 10.1111/conl.12117; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Clark JD, 2005, URSUS, V16, P234, DOI 10.2192/1537-6176(2005)016[0234:ABBABY]2.0.CO;2; Conover M., 2002, RESOLVING HUMAN WILD; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Di Vittorio M, 2016, CARNIVORE DAMAGE PRE, V12, P31; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dorresteijn I, 2014, LANDSCAPE ECOL, V29, P1145, DOI 10.1007/s10980-014-0048-5; Eklund A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02323-w; Fernandez-Gil A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151541; Gonzalez EG, 2016, PEERJ, V4, DOI 10.7717/peerj.1928; Jorgensen CJ, 1978, P 4 E WORKSH BLACK B, P297; Kolowski JM, 2007, J MAMMAL, V88, P1017, DOI 10.1644/06-MAMM-A-143R.1; Kuijper DPJ, 2015, BEHAV ECOL, V26, P1558, DOI 10.1093/beheco/arv107; Llaneza L, 2016, BIODIVERS CONSERV, V25, P1515, DOI 10.1007/s10531-016-1134-6; Martin J, 2010, CAN J ZOOL, V88, P875, DOI 10.1139/Z10-053; Cano IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1832; MATTSON DJ, 1990, INT C BEAR, V8, P33; McKinley BK, 2014, HUM-WILDL INTERACT, V8, P228; Mettler D., 2016, CARNIVORE DAMAGE PRE, V12, P18; Miller JRB, 2016, WILDLIFE SOC B, V40, P806, DOI 10.1002/wsb.720; Miller JRB, 2015, BIODIVERS CONSERV, V24, P2887, DOI 10.1007/s10531-015-0993-6; Molinari P, 2016, CARNIVORE DAMAGE PRE, V12, P9; Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x; Naves J, 2010, TECHNICAL REPORT; Naves J, 2006, J MAMMAL, V87, P899, DOI 10.1644/05-MAMM-A-318R2.1; Nellemann C, 2007, BIOL CONSERV, V138, P157, DOI 10.1016/j.biocon.2007.04.011; Ordiz A, 2017, ANIM CONSERV, V20, P51, DOI 10.1111/acv.12284; Ordiz A, 2014, BIOL CONSERV, V173, P1, DOI 10.1016/j.biocon.2014.03.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Otto TE, 2015, HUM-WILDL INTERACT, V9, P78; Palomero G, 2007, URSUS, V18, P145, DOI 10.2192/1537-6176(2007)18[145:TINADO]2.0.CO;2; Penteriani V, 2016, SCI REP-UK, V6, DOI 10.1038/srep20552; Perez T, 2014, WILDLIFE BIOL, V20, P300, DOI 10.2981/wlb.00069; R Development Core Team, R LANG ENV STAT COMP; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Santiago-Avila FJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189729; Seijas JM, 2017, TECHNICAL REPORT; Seijas JM, 2016, CARNIV DAMAGE PREV N, V12, P26; Stahl P, 2002, J APPL ECOL, V39, P204, DOI 10.1046/j.1365-2664.2002.00709.x; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Teel TL, 2010, CONSERV BIOL, V24, P128, DOI 10.1111/j.1523-1739.2009.01374.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2016, FRONT ECOL ENVIRON, V14, P380, DOI 10.1002/fee.1312; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; van Eeden LM, 2018, CONSERV BIOL, V32, P26, DOI 10.1111/cobi.12959; Lopez-Bao JV, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0140; Wiegand T, 1998, ECOL MONOGR, V68, P539, DOI 10.1890/0012-9615(1998)068[0539:ATROEF]2.0.CO;2; Wilson SM, 2005, URSUS, V16, P117, DOI 10.2192/1537-6176(2005)016[0117:NLFHAA]2.0.CO;2; Woodroffe R, 2005, PEOPLE WILDLIFE CONF, DOI [10.1016/j.jtbi.2005.03.003, DOI 10.1016/J.JTBI.2005.03.003]	62	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206733	10.1371/journal.pone.0206733	http://dx.doi.org/10.1371/journal.pone.0206733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485290	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800028
J	Pandey, A; Badola, HK; Rai, S; Singh, SP				Pandey, Aseesh; Badola, Hemant K.; Rai, Sandhya; Singh, Surendra P.			Timberline structure and woody taxa regeneration towards treeline along latitudinal gradients in Khangchendzonga National Park, Eastern Himalaya	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; COMMUNITY STRUCTURE; CLIMATE-CHANGE; ABIES-SPECTABILIS; VEGETATION; DIVERSITY; PATTERNS; FORESTS; SCALE; ZONE	With main purpose of developing a coherent baseline information of timberline forests of Sikkim, Eastern Himalaya, we investigated, (i) forest structure and composition, (ii) regeneration status of dominant timberline tree species between timberline and treeline, (iii) influence of environmental variables in species composition, and (iv) relationship between environmental variables and ecological attributes. The study was conducted along the timberline stretch of Dzongri landscape nested within the Khangchendzonga National Park (UNESCO's World Heritage Site, 2016), a core zone of Khangchendzonga Biosphere Reserve (in UNESCO WNBRs, 2018), Sikkim, India. We employed quadrat method to sample 9 contiguous sites to capture all possible variations in timberline composition. Transect method was used to study the regeneration of woody taxa between timberline to treeline. In total, 20 woody species belonging to 10 genera and 6 families were recorded. Among these, Abies densa, Rhododendron lanatum and Sorbus microphylla exhibited higher dominance, comprising of 50% of the total importance value index (IVI) weightage. Betula utilis the common treeline species in much of the western and central parts of Himalaya was absent here. Tree density in studied timberline was significantly higher than its western Himalayan counterparts of Indian Himalayan region. Environmental variables viz., elevation, slope, and humus were observed determinants of species composition across the study area. The species dominance correlated negatively (p<0.01; n = 9) with species diversity and richness. We observed an irregular spatial pattern of timberline across the 9 study sites, and the extent of timberline elements (seedling; sapling; live tree or dead tree) ranged between 5.3m to 187.7m higher than the current timberline at different sites. The present trends suggest that upslope advancement is unlikely to occur in near future, while treeline densification is anticipated. Further investigations are suggested to develop a holistic understating of these timberline patterns across the Indian Himalayan region.	[Pandey, Aseesh; Badola, Hemant K.; Rai, Sandhya] GB Pant Natl Inst Himalayan Environm & Sustainabl, Sikkim Unit, Gangtok, Sikkim, India; [Singh, Surendra P.] Cent Himalayan Environm Assoc, Waldorf Compound, Naini Tal, Uttarakhand, India; [Badola, Hemant K.] Govt Sikkim, Advisor Biodivers, Honble Chief Ministers Off, Gangtok, Sikkim, India	G.B. Pant National Institute of Himalayan Environment & Sustainable Development (GBPNIHESD)	Badola, HK (corresponding author), GB Pant Natl Inst Himalayan Environm & Sustainabl, Sikkim Unit, Gangtok, Sikkim, India.; Badola, HK (corresponding author), Govt Sikkim, Advisor Biodivers, Honble Chief Ministers Off, Gangtok, Sikkim, India.	hkbadola@gmail.com	Pandey, Aseesh/AFW-7196-2022; Pandey, Aseesh/AAI-7127-2020	Pandey, Aseesh/0000-0001-8063-2646; BADOLA, HEMANT/0000-0003-4570-4290	Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies through Central Himalayan Environment Association, Nainital, Uttarakhand	Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies through Central Himalayan Environment Association, Nainital, Uttarakhand	Funding support at the time of research studies from Ministry of Environment, Forest and Climate Change, Government of India under the National Mission on Himalayan Studies through Central Himalayan Environment Association, Nainital, Uttarakhand.	Acharya BK, 2011, ACTA OECOL, V37, P329, DOI 10.1016/j.actao.2011.03.005; Adhikari BS, 2011, ECOLOGICAL ASSESSMEN; Badola Hemant K., 2010, Biodiversity (Ottawa), V11, P8, DOI 10.1080/14888386.2010.9712659; Behera MD, 2007, BIODIVERS CONSERV, V16, P1851, DOI 10.1007/s10531-006-9083-0; Behera MD, 2016, CURR SCI INDIA, V111, P1220, DOI 10.18520/cs/v111/i7/1220-1225; Bindiu C., 1973, THESIS; Camarero JJ, 2007, ARCT ANTARCT ALP RES, V39, P210, DOI 10.1657/1523-0430(2007)39[210:ROPURT]2.0.CO;2; Champion S.H.G., 1968, REVISED SURVEY FORES; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Curtis J.T., 1956, PLANT ECOLOGY WORKBO, P193; Curtis JT, 1959, VEGETATION WISCONSIN; Danby RK, 2007, J ECOL, V95, P352, DOI 10.1111/j.1365-2745.2006.01200.x; Dutta P. K., 2014, Indian Forester, V140, P419; Edenhofer O., 2014, CONTRIBUTION WORKING; Gaire NP, 2015, FUUAST J BIOL, V5, P1, DOI DOI 10.5194/CP-10-1277-2014; Gamache I, 2005, J BIOGEOGR, V32, P849, DOI 10.1111/j.1365-2699.2004.01182.x; GOSZ JR, 1991, ECOTONES, P8; Greig-Smith P., 2010, QUANTITATIVE PLANT E; GRIGGS RF, 1946, ECOLOGY, V27, P275, DOI 10.2307/1933539; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holtmeier F.-K., 2009, ADV GLOBAL CHANGE RE, V36; Holtmeier FK, 2005, GLOBAL ECOL BIOGEOGR, V14, P395, DOI 10.1111/j.1466-822x.2005.00168.x; Jodlowski M., 2007, KRUMMHOLZ LINE TATRA; Karrenberg S, 2003, BASIC APPL ECOL, V4, P157, DOI 10.1078/1439-1791-00123; Kimmin JP, 1973, COMP BIOMASS DISTRIB, P315; Kroner C., 2012, ALPINE TREELINES FUN; Lachungpa, 1990, SIKKIM HIMALAYAN RHO; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lesica P, 2015, NAT AREA J, V35, P485, DOI 10.3375/043.035.0315; Li J, 2009, GLOBAL ECOL BIOGEOGR, V18, P264, DOI 10.1111/j.1466-8238.2008.00430.x; Lloyd AH, 1997, CAN J FOREST RES, V27, P936, DOI 10.1139/cjfr-27-6-936; Lv LX, 2012, J PLANT ECOL, V5, P147, DOI 10.1093/jpe/rtr016; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Maity D, 2007, WILD FLOWERS KANCHEN; Misra R., 1968, ECOLOGY WORKBOOK; Nath PC, 2005, BIODIVERS CONSERV, V14, P2109, DOI 10.1007/s10531-004-4361-1; NOBLE DL, 1977, FOREST SCI, V23, P420; O'Neill AR, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0148-9; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; ODUM E P, 1971, P574; Phillips E.A., 1959, METHODS VEGETATION S; Plesnik P., HORNAHRANICALESAVOVV; Qi W, 2013, J GEOGR SCI, V23, P595, DOI 10.1007/s11442-013-1031-9; Qian H, 1999, ANN BOT-LONDON, V83, P271, DOI 10.1006/anbo.1998.0816; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rai I. D., 2012, Notulae Scientia Biologicae, V4, P41; RAUNKIAER C., 1934; RAWAL RS, 1994, VEGETATIO, V112, P29, DOI 10.1007/BF00045097; Rawal RS, 1999, STUDIES SPECIES COMM; Rehm EM, 2013, FOREST ECOL MANAG, V305, P204, DOI 10.1016/j.foreco.2013.05.041; Richardson A. D., 2009, Journal of Sustainable Forestry, V28, P218, DOI 10.1080/10549810802626456; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; ROMME WH, 1991, CONSERV BIOL, V5, P373, DOI 10.1111/j.1523-1739.1991.tb00151.x; Schickhoff U, 2005, MOUNTAIN ECOSYSTEMS: STUDIES IN TREELINE ECOLOGY, P275; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Shaheen H, 2012, FOREST ECOL MANAG, V278, P138, DOI 10.1016/j.foreco.2012.05.009; Shaheen H, 2011, MT RES DEV, V31, P153, DOI 10.1659/MRD-JOURNAL-D-10-00091.1; Shank R.E., 1950, ECOLOGY, V11, P531; Shannon Claude E, 1963, MATH THEORY COMMUNIC; Sharma Pankaj, 2014, ScientificWorldJournal, V2014, P264878, DOI 10.1155/2014/264878; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Shugart HH, 2001, GLOBAL CHANGE BIOL, V7, P247, DOI 10.1046/j.1365-2486.2001.00379.x; Singh H., 2009, NATURE SCI, V7, P81; SINGH JS, 1987, BOT REV, V53, P80, DOI 10.1007/BF02858183; Singh SP, 2007, HIMALAYAN FOREST ECO, V9, P64; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P2335, DOI 10.1111/j.1365-2486.2012.02700.x; Tambe S, 2009, AMBIO, V38, P95, DOI 10.1579/0044-7447-38.2.95; Telwala Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057103; Timilsina N, 2007, FOREST ECOL MANAG, V241, P223, DOI 10.1016/j.foreco.2007.01.012; Tiwari A, 2017, DENDROCHRONOLOGIA, V41, P34, DOI 10.1016/j.dendro.2016.01.006; Tse-ring K., 2010, CLIMATE CHANGE VULNE; VAJDA J., 2008, OECOLOGIA MONTANA, V17, P30; Van Vechten G W., 1960, THESIS; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wardle P., ARCTIC ALPINE ENV, P371; Weiher E, 2003, J VEG SCI, V14, P917, DOI 10.1111/j.1654-1103.2003.tb02226.x; WHITFORD PB, 1949, ECOLOGY, V30, P199, DOI 10.2307/1931186; WHITTAKER R H, 1975, P385; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Yam Gyati, 2016, Journal of Asia-Pacific Biodiversity, V9, P160; Zhang D, 2013, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2013-1.RLTS.T42278A2969131.en, DOI 10.2305/IUCN.UK.2013-1.RLTS.T42278A2969131.EN]; Zheng D, 1981, GEOLOGICAL ECOLOGICA, P1851	83	14	16	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207762	10.1371/journal.pone.0207762	http://dx.doi.org/10.1371/journal.pone.0207762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485319	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800079
J	Shevchenko, A; Schuhmann, A; Thomas, H; Wetzel, G				Shevchenko, Anna; Schuhmann, Andrea; Thomas, Henrik; Wetzel, Guenter			Fine Endmesolithic fish caviar meal discovered by proteomics in foodcrusts from archaeological site Friesack 4 (Brandenburg, Germany)	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; BONE-COLLAGEN; PROTEIN; DEAMIDATION; IDENTIFICATION; PARVALBUMIN; TRIACYLGLYCEROLS; GLUTAMINE; CEMETERY; HUMANS	The role of aquatic resources in ancient economies and paleodiet is important for understanding the evolution of prehistorical societies. Charred food remains from ancient pottery are valuable molecular evidence of dietary habits in antiquity. However, conventional archaeometric approaches applied in their analysis lack organismal specificity, are affected by abundant environmental contaminants, do not elucidate food processing recipes and are limited in the inland regions where diverse dietary resources are available. We performed proteomics analysis of charred organic deposits adhered on early ceramics from Mesolithic-Neolithic inland site Friesack 4 (Brandenburg, Germany). One of pots-a small coarse bowl radiocarbon dated to the end of the 5th millennium BC-was attributed to Endmesolithic pottery. Proteomics of foodcrust from this vessel identified fine carp roe meal and revealed details of a prehistorical culinary recipe. Ancient proteins were unequivocally distinguished from contemporary contaminants by computing deamidation ratios of glutamine residues. These data paint a broader picture of the site-specific exploitation of aquatic resources and contribute to better understanding of the dietary context of Neolithic transition in European inland.	[Shevchenko, Anna; Schuhmann, Andrea; Thomas, Henrik] Max Planck Inst Mol Cell Biol & Genet MPI CBG, Dresden, Germany; [Wetzel, Guenter] Brandenburg Landesamt Denkmalpflege & Archaeol La, Aussenstelle Cottbus, Germany	Max Planck Society	Shevchenko, A (corresponding author), Max Planck Inst Mol Cell Biol & Genet MPI CBG, Dresden, Germany.	ashevche@mpi-cbg.de						Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Andersen SH, 1984, AARBOGER NORDISK OLD, P78; Araki N, 2011, RAPID COMMUN MASS SP, V25, P3396, DOI 10.1002/rcm.5237; Arif SH, 2009, BIOESSAYS, V31, P410, DOI 10.1002/bies.200800170; Bekmann JC, 1751, HIST BESCHREIBUNG CH, P612; Benecke N, 2016, ARBEITSBERICHTE BODE, P117; Bleicher N, 2015, J ARCHAEOL SCI, V63, P65, DOI 10.1016/j.jas.2015.08.012; Boethius A, 2016, J ARCHAEOL SCI, V66, P169, DOI 10.1016/j.jas.2016.01.008; Britton Kate, 2013, Am J Phys Anthropol, V151, P448, DOI 10.1002/ajpa.22284; Buckley M, 2014, J ARCHAEOL SCI, V41, P631, DOI 10.1016/j.jas.2013.08.021; Carrera M, 2012, J PROTEOMICS, V75, P3211, DOI 10.1016/j.jprot.2012.03.030; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craig OE, 2011, P NATL ACAD SCI USA, V108, P17910, DOI 10.1073/pnas.1107202108; Cramp LJE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2372; CRISAN EV, 1975, APPL MICROBIOL, V29, P106, DOI 10.1108/00483480010295844; Cziesla E., 2010, GERMANIA, V86, P405; Dallongeville S, 2016, CHEM REV, V116, P2, DOI 10.1021/acs.chemrev.5b00037; Daszkiewicz M, 2016, AUSGRABUNGEN NIEDERL; Doherty MK, 2013, J PROTEOME RES, V12, P5246, DOI 10.1021/pr4006475; Fischer A, 2007, J ARCHAEOL SCI, V34, P2125, DOI 10.1016/j.jas.2007.02.028; Friesack Gramsch B., 2000, JB ROMISCH GERMANISC, V47, P51; Fukui Y, 2012, J GEN APPL MICROBIOL, V58, P273; Gramsch B, 2014, MIK ANTHR M BRNO DOL; Gramsch B., 1987, VEROFFENTLICHUNGEN M, V21, P2; Gramsch B., 2013, VEROFFENTLICHUNGEN B, V47, P7; Halffman CM, 2015, P NATL ACAD SCI USA, V112, P12344, DOI 10.1073/pnas.1509747112; Hartz S, 2000, PRAEHIST Z, V75, P129; HARTZ S, 2007, P BRIT ACAD, V144, P567, DOI DOI 10.5871/BACAD/9780197264140.003.0027; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Hendy J, 2018, NAT ECOL EVOL, V2, P791, DOI 10.1038/s41559-018-0510-x; Heron C, 2015, RADIOCARBON, V57, P707, DOI 10.2458/azu_rc.57.18454; Heron C, 2015, J ARCHAEOL SCI, V63, P33, DOI 10.1016/j.jas.2015.08.002; Jahns S, 2016, SUBSISTENZ UMWELT FE, P25; Karim Nurul Farah Abdul, 2016, Trop Life Sci Res, V27, P1; Kim MS, 2014, J FOOD SCI, V79, pM927, DOI 10.1111/1750-3841.12431; KIRSCH R, 1990, AUSGRABUNGEN FUNDE, V35, P57; Klassen L., 2004, UNTERSUCHUNGEN ZUM N; KLOSS K., 1987, VEROFFENTLICHUNGEN M, V21, P101; Kolder ICRM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3038-y; Kotula A., 2015, FARCHAOLOGIE GESCH O, V8, P489; Kubiak-Martens L, 2015, VEG HIST ARCHAEOBOT, V24, P47, DOI 10.1007/s00334-014-0485-8; Kumar M, 2018, MOL CELL PROTEOMICS, V17, P384, DOI 10.1074/mcp.O117.067082; Kunz RI, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8175701; Laux F., 1986, HAMMABURG, V7, P9; Lee PW, 2012, FOOD CHEM, V135, P502, DOI 10.1016/j.foodchem.2012.05.030; Leo G, 2011, ANAL CHEM, V83, P2056, DOI 10.1021/ac1027275; LUA, 2010, NATURSCHUTZ LANDSCHA, V19; Mackie M, 2017, SCI TECHNOL ARCHAEOL, V3, P58, DOI 10.1080/20548923.2017.1361629; Mai HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18939; Menke M., 1999, RINGKLOSTER LODDESBO, P205; Muller T, 2017, MOL CELL PROTEOMICS, V16, P1173, DOI 10.1074/mcp.M116.064048; OLUKOSHI ER, 1994, MICROBIOL-SGM, V140, P931, DOI 10.1099/00221287-140-4-931; Pankratov T A, 2009, Mikrobiologiia, V78, P261; Philippsen Bente, 2014, INTERNET ARCHAEOL, DOI [10.11141/ia.37.9, DOI 10.11141/IA.37.9]; Raemaekers DCM, 2013, ARCHAOLOGISCHES KORR, V43; Ramminger B., 2012, GRENZEN GRENZRAUME F, P297; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reading BJ, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P635; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reitsema LJ, 2013, AM J HUM BIOL, V25, P445, DOI 10.1002/ajhb.22398; Robinson NE, 2014, MOL CLOCKS DEAMIDATI; Robson HK, 2016, SUBSISTENZ UMWELT FE, P160; Roffet-Salque M, 2017, J ARCHAEOL SCI-REP, V16, P627, DOI 10.1016/j.jasrep.2016.04.005; Schilling J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143225; Schindler R., 1953, HAMMABURG, V4, P1; Schindler R., 1961, ROSSENER ELEMENTE FR, P9; Schmidt J., 1894, MITTHEILUNGEN PROVIN, V1, P48; Schmolcke U., 2016, SUBSISTENZ UMWELT FE; Schneider M., 1932, ENTSTEHUNG MESOLITHI; Sheuchenko A, 2014, J PROTEOMICS, V105, P363, DOI 10.1016/j.jprot.2013.11.016; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shevchenko A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0158636; Solazzo C, 2014, ANAL CHEM, V86, P567, DOI 10.1021/ac4026362; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Tahvonen R, 1993, ACTA HORTIC, V342, P37, DOI DOI 10.17660/ACTAHORTIC.1993.342.4; Terberger T, 2012, MIND SET FLINT STUDI; van Doorn NL, 2012, RAPID COMMUN MASS SP, V26, P2319, DOI 10.1002/rcm.6351; VILLAR M, 1985, APPL ENVIRON MICROB, V49, P664, DOI 10.1128/AEM.49.3.664-666.1985; Voss A, 1901, Z ETHNOL, V33, P538; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Webb EC, 2016, SCI TECHNOL ARCHAEOL, V2, P54, DOI 10.1080/20548923.2015.1133121; Webb EC, 2015, J ARCHAEOL SCI, V63, P104, DOI 10.1016/j.jas.2015.08.001; Weiler SJ, 1807, AUGSBURGISCHES KOCHB, P6; Wetzel G., 2015, DABKI SITE POMERANIA, P511; Wetzel G, 2016, VEROFFENTLICHUNGEN B, V47, P79; Wilson J, 2012, ANAL CHEM, V84, P9041, DOI 10.1021/ac301333t; Xie MS, 2016, QUATERN INT, V426, P158, DOI 10.1016/j.quaint.2016.04.015; Yang YM, 2014, J ARCHAEOL SCI, V45, P178, DOI 10.1016/j.jas.2014.02.005	88	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206483	10.1371/journal.pone.0206483	http://dx.doi.org/10.1371/journal.pone.0206483			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485287	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800021
J	Villageliu, D; Lyte, M				Villageliu, Daniel; Lyte, Mark			Dopamine production in Enterococcus faecium: A microbial endocrinology-based mechanism for the selection of probiotics based on neurochemical-producing potential	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ABSORPTION; STRAIN	The mechanisms by which probiotics may influence host physiology are still incompletely understood. Microbial endocrinology, a field representing the union of microbiology, endocrinology and neurobiology, has theorized that microorganisms have the capacity to serve as neurochemical delivery vehicles [1]. According to microbial endocrinology, neurochemicals can serve as a common language between host and bacterium, enabling bidirectional communication. We report herein the first demonstration that Enterococcus sp. has the capacity to produce dopamine in a gastrointestinal-like environment when supplied with the dopamine precursor L-3,4 dihydroxyphenylalanine (L-dopa). The results presented herein provide a means to select probiotics based on neurochemical-producing potential and suggest the possibility that probiotics containing E. faecium may serve to influence the host through dopaminergic pathways.	[Villageliu, Daniel; Lyte, Mark] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Villageliu, Daniel] Iowa State Univ, Coll Vet Med, Iowa State Interdept Microbiol Program, Ames, IA USA	Iowa State University; Iowa State University	Lyte, M (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	mlyte@iastate.edu	Lyte, Mark/AAI-7602-2020	Lyte, Mark/0000-0001-8512-2581	United States Department of Defense, Office of Naval Research [N00014-15-1-2706]; W. Eugene Lloyd Chair in Toxicology	United States Department of Defense, Office of Naval Research; W. Eugene Lloyd Chair in Toxicology	This study was supported by the United States Department of Defense, Office of Naval Research award #N00014-15-1-2706 to ML and internal Iowa State University funds provided by the W. Eugene Lloyd Chair in Toxicology to ML.; The assistance of Meicen Liu (Iowa State University, USA) and Karrie Wright (Iowa State University, USA) in providing experimental support is acknowledged. This study was supported by the United States Department of Defense, Office of Naval Research award #N00014-15-1-2706 to ML. All authors declare that there are no conflicts of interests.	Araujo TF, 2013, BRAZ ARCH BIOL TECHN, V56, P457, DOI 10.1590/S1516-89132013000300014; Bargossi E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00259; BURBANO C, 1995, PLANT FOOD HUM NUTR, V47, P265, DOI 10.1007/BF01088335; Camargo SMR, 2014, J PHARMACOL EXP THER, V351, P114, DOI 10.1124/jpet.114.216317; DONOWITZ M, 1983, GASTROENTEROLOGY, V84, P516; Enck P, 2008, NEUROGASTROENT MOTIL, V20, P1103, DOI 10.1111/j.1365-2982.2008.01156.x; Fan Yu-jing, 2006, J Zhejiang Univ Sci B, V7, P987, DOI 10.1631/jzus.2006.B0987; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Gade J, 1989, Scand J Prim Health Care, V7, P23, DOI 10.3109/02813438909103666; Habermann W, 2001, ARZNEIMITTEL-FORSCH, V51, P931; Herak-Perkovic V, 2001, J VET PHARMACOL THER, V24, P267, DOI 10.1046/j.1365-2885.2001.00343.x; Hu YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116635; Jatkauskas J, 2014, EFFECTS ENCAPSULATED, P47; KHALKHALI S., 2017, INT J SCI BASIC MED, V2, P77; Kim Young Gyun, 2006, Korean J Gastroenterol, V47, P413; Kuritza, 2011, PROBIOTICS BASED ENT; KUROSAWA S, 1991, GASTROENTEROLOGY, V100, P1224; Leroy F, 2003, INT J FOOD MICROBIOL, V88, P235, DOI 10.1016/S0168-1605(03)00185-5; Lyte M, 2011, BIOESSAYS, V33, P574, DOI 10.1002/bies.201100024; Mackie A., 2015, IMPACT FOOD BIOACTIV, P13, DOI [10.1007/978-3-319-16104-4_2, DOI 10.1007/978-3-319-16104-4_2]; Magro F, 2006, DIGEST DIS SCI, V51, P2039, DOI 10.1007/s10620-006-9168-3; Magro F, 2002, DIGEST DIS SCI, V47, P216, DOI 10.1023/A:1013256629600; McFarland LV, 2008, WORLD J GASTROENTERO, V14, P2650, DOI 10.3748/wjg.14.2650; Mezey E, 1998, NEUROENDOCRINOLOGY, V67, P336, DOI 10.1159/000054332; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Oehlers SH, 2017, FEBS J, V284, P402, DOI 10.1111/febs.13976; Pollmann M, 2005, INFECT IMMUN, V73, P4346, DOI 10.1128/IAI.73.7.4346-4353.2005; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; STEPHENSON M, 1947, J GEN MICROBIOL, V1, P279, DOI 10.1099/00221287-1-3-279; Villageliu DN, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy096; Walker JKL, 2000, AM J PHYSIOL-GASTR L, V279, pG311, DOI 10.1152/ajpgi.2000.279.2.G311; Wu YY, 2019, POULTRY SCI, V98, P150, DOI 10.3382/ps/pey368; Zeyner A, 2006, J ANIM PHYSIOL AN N, V90, P25, DOI 10.1111/j.1439-0396.2005.00615.x; Zhang GH, 2007, EUR J PHARMACOL, V570, P188, DOI 10.1016/j.ejphar.2007.05.038; Zhou YZ, 2012, CHROMATOGRAPHIA, V75, P597, DOI 10.1007/s10337-012-2229-1	35	23	25	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207038	10.1371/journal.pone.0207038	http://dx.doi.org/10.1371/journal.pone.0207038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485295	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800039
J	Boland, MR				Boland, Mary Regina			A model investigating environmental factors that play a role in female fecundity or birth rate	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; REPRODUCTIVE-PERFORMANCE; SOCIOECONOMIC-STATUS; FERTILITY; IMPACT; WOMEN; FERTILIZATION; RESPONSES; MOTILITY; COUNT	Objective Over 12% of women in the United States have reduced fertility and/or fecundity. Environmental factors, such as temperature, and socioeconomic factors have been implicated in reducing female fecundity. The purpose of this study is to investigate the effect of environmental factors coupled with socioeconomic factors on birth rate at the country-level. We use birth rate as a proxy for female fecundity. This will enable us to identify the most important factors affecting female fecundity. Methods Using country-specific data from 182 countries, we constructed a regression model of the effects of environmental and socioeconomic factors on birth rate at the country-level. Our model assesses the role of temperature, Gross Domestic Product (GDP) per capita, fine air particulate matter (PM 2.5), and prevalence of male and female Body Mass Index (BMI) > = 25 (age-standardized) on birth rate per country. Because many of these factors are interdependent, we include all possible two-way interaction terms to assess the role of individual factors and interactions between multiple factors in the model. Results In the full regression model, we found that GDP per capita along with 5 interaction terms were significant after adjusting for multiple testing. Female BMI was only nominally significant. GDP per capita was independently associated with birth rate (adjusted p-value <0.001). Prevalence of BMI > = 25 age-standardized in males and females were also significant when interacting with air pollution or GDP on female fecundity (birth rate). Temperature did not affect birth rate either independently or as an interaction unless BMI was removed from the model. Conclusion A country's economic wealth was the most significant factor in predicting birth rate in a statistical model that includes environmental and socioeconomic variables. This is important for future studies investigating environmental factors involved in increasing or decreasing female fecundity.	[Boland, Mary Regina] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Boland, Mary Regina] Univ Penn, Inst Biomed Informat, Philadelphia, PA 19104 USA; [Boland, Mary Regina] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Boland, Mary Regina] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Boland, MR (corresponding author), Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA.; Boland, MR (corresponding author), Univ Penn, Inst Biomed Informat, Philadelphia, PA 19104 USA.; Boland, MR (corresponding author), Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA.; Boland, MR (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.	bolandm@upenn.edu		Boland, Mary Regina/0000-0001-8576-6408	Perelman School of Medicine, University of Pennsylvania; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Perelman School of Medicine, University of Pennsylvania; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was made possible by generous funding from the Perelman School of Medicine, University of Pennsylvania. The funder had no role in the study design, data collection, data analysis, decision to publish or preparation of the final manuscript.; This project was made possible by generous funding from the Perelman School of Medicine, University of Pennsylvania.	[Anonymous], 2018, LIST COUNTRIES WORLD; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Boland MR, 2015, J AM MED INFORM ASSN, V22, P1042, DOI 10.1093/jamia/ocv046; Bollen KA, 2007, POP STUD-J DEMOG, V61, P15, DOI 10.1080/00324720601103866; Cagnacci A, 2005, HUM REPROD, V20, P2190, DOI 10.1093/humrep/dei040; CDC, IS INF COMM PROBL; Centola GM, 1999, FERTIL STERIL, V72, P803, DOI 10.1016/S0015-0282(99)00395-7; Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1; CIERESZKO A, 1995, BIOL REPROD, V52, P982, DOI 10.1095/biolreprod52.5.982; Clark AM, 1998, HUM REPROD, V13, P1502, DOI 10.1093/humrep/13.6.1502; Dribe M, 2014, POP STUD-J DEMOG, V68, P135, DOI 10.1080/00324728.2014.889741; Edwards JL, 1997, MOL REPROD DEV, V46, P138, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;138::AID-MRD4&gt;3.0.CO;2-R; GROSSMAN GM, 1995, Q J ECON, V110, P353, DOI 10.2307/2118443; Gueresi P, 1997, ANN HUM BIOL, V24, P157, DOI 10.1080/03014469700004892; Hammoud A, 2010, FERTIL STERIL, V93, P1875, DOI 10.1016/j.fertnstert.2008.12.089; Hansen PJ, 2015, BOVINE REPRODUCTION, P580; HER E, 1988, J DAIRY SCI, V71, P1085, DOI 10.3168/jds.S0022-0302(88)79656-3; Huber S, 2008, HUM REPROD, V23, P1187, DOI 10.1093/humrep/den079; Huber S, 2004, HUM REPROD, V19, P1081, DOI 10.1093/humrep/deh247; Huber S, 2009, AM J HUM BIOL, V21, P25, DOI 10.1002/ajhb.20799; Huber S, 2011, AM J HUM BIOL, V23, P546, DOI 10.1002/ajhb.21184; HURTADO AM, 1990, J ANTHROPOL RES, V46, P293, DOI 10.1086/jar.46.3.3630428; Jensen MB, 2011, HUM REPROD, V26, P1307, DOI 10.1093/humrep/der059; Kemkes A, 2010, J BIOSOC SCI, V42, P177, DOI 10.1017/S002193200999054X; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lopez-Gatius F, 2003, THERIOGENOLOGY, V60, P89, DOI 10.1016/S0093-691X(02)01359-6; Nieuwenhuijsen MJ, 2014, ENVIRON INT, V70, P9, DOI 10.1016/j.envint.2014.05.005; Salah M S, 1990, Beitr Trop Landwirtsch Veterinarmed, V28, P85; Sartori R, 2002, J DAIRY SCI, V85, P2803, DOI 10.3168/jds.S0022-0302(02)74367-1; Thonneau P, 1998, HUM REPROD, V13, P2122, DOI 10.1093/humrep/13.8.2122; Wass P, 1997, HUM REPROD, V12, P2057, DOI 10.1093/humrep/12.9.2057; WHO, MOD GLOB AMB AIR POL; Wikipedia, 2017, LIST COUNTR AV YEARL; World Health Organization, GLOB HLTH OBS DAT RE; WorldBank. org, GDP PER CAP ALL COUN; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484	37	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207932	10.1371/journal.pone.0207932	http://dx.doi.org/10.1371/journal.pone.0207932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB9UV	30481214	Green Published, Green Submitted, gold			2022-12-26	WOS:000451440000029
J	Valadao, ALC; Pezzuto, P; Silva, VAO; Goncalves, BS; Rossi, AD; da Cunha, RD; Siani, AC; Tostes, JBD; Trovo, M; Damasco, P; Goncalves, G; Reis, RM; Aguiar, RS; Bento, CAD; Tanuri, A				Chaves Valadao, Ana Luiza; Pezzuto, Paula; Oliveira Silva, Viviane A.; Goncalves, Barbara Simonson; Rossi, Atila Duque; da Cunha, Rodrigo Delvecchio; Siani, Antonio Carlos; de Freitas Tostes, Joao Batista; Trovo, Marcelo; Damasco, Paulo; Goncalves, Gabriel; Reis, Rui Manuel; Aguiar, Renato Santana; de Melo Bento, Cleonice Alves; Tanuri, Amilcar			Reactivation of latent HIV-1 in vitro using an ethanolic extract from Euphorbia umbellata (Euphorbiaceae) latex	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHORBOL ESTERS; T-CELLS; INFECTION; GRANTII; TIRUCALLI; THERAPY; PHASE	Euphorbia umbellata (E. umbellata) belongs to Euphorbiaceae family, popularly known as Janauba, and its latex contains a combination of phorbol esters with biological activities described to different cellular protein kinase C (PKC) isoforms. Here, we identified deoxiphorbol esters present in E. umbellata latex alcoholic extract that are able to increase HIV transcription and reactivate virus from latency models. This activity is probably mediated by NF-kB activation followed by nuclear translocation and binding to the HIV LTR promoter. In addition, E. umbellata latex extract induced the production of pro inflammatory cytokines in vitro in human PBMC cultures. This latex extract also activates latent virus in human PBMCs isolated from HIV positive patients as well as latent SIV in non-human primate primary CD4(+) T lymphocytes. Together, these results indicate that the phorbol esters present in E. umbellata latex are promising candidate compounds for future clinical trials for shock and kill therapies to promote HIV cure and eradication.	[Chaves Valadao, Ana Luiza; Pezzuto, Paula; Rossi, Atila Duque; da Cunha, Rodrigo Delvecchio; Goncalves, Gabriel; Aguiar, Renato Santana; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil; [Oliveira Silva, Viviane A.] Hosp Canc Barretos, Ctr Pesquisa Oncol Mol, Barretos, Brazil; [Goncalves, Barbara Simonson; Damasco, Paulo; de Melo Bento, Cleonice Alves] Univ Fed Estado Rio de Janeiro, Dept Microbiol & Parasitol, Rio De Janeiro, Brazil; [Siani, Antonio Carlos; de Freitas Tostes, Joao Batista] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos, Dept Prod Nat, Rio De Janeiro, Brazil; [Trovo, Marcelo] Univ Fed Rio de Janeiro, Inst Biol, Dept Bot, Rio De Janeiro, Brazil; [Reis, Rui Manuel] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Reis, Rui Manuel] 3Bs PT Govt Associate Lab, ICVS, Braga, Portugal; [Chaves Valadao, Ana Luiza] Inst Human Genet, Dept Mol Basis Humans Dis, Mol Basis Inflammat Lab, Montpellier, France	Universidade Federal do Rio de Janeiro; Hospital de Cancer de Barretos; Universidade Federal do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade do Minho; Universite de Montpellier	Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.	atanuri1@gmail.com	Rossi, Atila Duque/AAV-6079-2020; Aguiar, Renato S/G-3542-2015; Reis, Rui Manuel/AAD-6470-2020; Tostes, João/ABH-1936-2020; Silva, Viviane A O/O-1772-2015; Tanuri, Amilcar/AAM-8601-2021; Reis, Rui Manuel/B-1744-2018; Tostes, João B.F./P-2514-2017; Siani, Antonio C/L-3868-2014; /AAD-2097-2020; Trovó, Marcelo/A-1763-2014	Rossi, Atila Duque/0000-0001-6235-8807; Aguiar, Renato S/0000-0001-5180-3717; Reis, Rui Manuel/0000-0002-9639-7940; Tostes, João/0000-0002-6085-365X; Reis, Rui Manuel/0000-0002-9639-7940; Tostes, João B.F./0000-0002-6085-365X; Trovó, Marcelo/0000-0002-0478-2332; Siani, Antonio Carlos/0000-0001-8108-2500; Silva, Viviane A O/0000-0001-5919-5242; Valadao, Ana Luiza/0000-0002-3839-3079	CNPq; CAPES; FAPERJ [E26/2015064289]; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Postdoc fellowships and PhD stipends were supported by CNPq and CAPES during this work. Research and experimental expenses were funded by the grant E26/2015064289 from FAPERJ.; We thank Dr. Thomas Friedrich from Virology Services Unit at the Wisconsin National Primate Research Center, Wisconsin, USA for QVOA assay using SIVmac239 in NHP CD4<SUP>+</SUP> Lymphocytes. We are also grateful to Mr. Wilson Camargo Barros Filho and Mr. Luis Antonio Nogueira for providing E. umbellata's latex used in this work. This work was sponsored by CNPq, CAPES and FAPERJ.	Bachu M, 2012, J BIOL CHEM, V287, P44714, DOI 10.1074/jbc.M112.397158; BAGAVATHI R, 1988, Planta Medica, V54, P506, DOI 10.1055/s-2006-962531; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Blackhall FH, 2001, BRIT J CANCER, V84, P465, DOI 10.1054/bjoc.2000.1624; Campos A, 2016, INT J TOXICOL, V35, P666, DOI 10.1177/1091581816659660; Coffin J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012526; Costa LLG, 2012, REV BRAS FARMACOGN, V22, P1070, DOI 10.1590/S0102-695X2012005000050; Cunha LC, 2009, BRAZILIAN J PHARMACO, V19, P403; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Dutra Rafael C, 2016, Pharmacol Res, V112, P4, DOI 10.1016/j.phrs.2016.01.021; El-Mekkawy S, 1998, PHYTOCHEMISTRY, V49, P1651, DOI 10.1016/S0031-9422(98)00254-4; Fatope MO, 1996, J MED CHEM, V39, P1005, DOI 10.1021/jm950509i; Franco-Salla GB, 2016, BMC COMPLEM ALTERN M, V16, P1, DOI [10.1186/s12906-015-0973-0, DOI 10.1186/S12906-015-0973-0]; Gallo RC, 1984, SCIENCE, V224, P3769; Hartmann D. B., 2011, Arquivos de Ciencias Veterinarias e Zoologia da UNIPAR, V14, P5; Hassan EM, 2012, REC NAT PROD, V6, P255; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Jiang G, 2017, AIDS RES HUM RETROV, P1; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jose DP, 2014, VIROLOGY, V462, P328, DOI 10.1016/j.virol.2014.05.033; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kashiwada Y, 1998, J NAT PROD, V61, P1090, DOI 10.1021/np9800710; Kim HJ, 2011, AM J TRANSL RES, V3, P166; KINGHORN AD, 1980, J PHARM SCI-US, V69, P1446, DOI 10.1002/jps.2600691228; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Levy J A, 2011, Adv Dent Res, V23, P13, DOI 10.1177/0022034511398874; Lin MW, 2012, FOOD CHEM TOXICOL, V50, P4333, DOI 10.1016/j.fct.2012.05.029; Loya S, 1999, BIOCHEM J, V344, P85, DOI 10.1042/0264-6021:3440085; Martiny-Baron G, 1999, J BIOL CHEM, V274, P15320, DOI [10.1074/jbc.274.22.15320, DOI 10.1074/JBC.274.22.15320]; McManamy Mary E. Manson, 2014, Antiviral Chemistry & Chemotherapy, V23, P145, DOI 10.3851/IMP2551; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Mochly-Rosen D, 1998, FASEB J, V12, P35; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Ohtake N, 2004, J CHROMATOGR B, V812, P135, DOI 10.1016/j.jchromb.2004.06.051; OLIVIER GWJ, 1992, J CHEM SOC PERK T 1, P1831, DOI 10.1039/p19920001831; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Porichis F, 2011, CURR OPIN HIV AIDS, V6, P174, DOI 10.1097/COH.0b013e3283454058; Prakash E., 2013, UNIVERS J PLANT SCI, V1, P113, DOI [10.13189/ujps.2013.010401, DOI 10.13189/UJPS.2013.010401]; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005; Siliciano RF, 2018, HIV LATENCY, P1, DOI [10.1101/cshperspect.a007096, DOI 10.1101/CSHPERSPECT.A007096]; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Tanaka M, 2001, BIOORG MED CHEM LETT, V11, P719, DOI 10.1016/S0960-894X(01)00045-2; Trushin SA, 2005, J VIROL, V79, P9821, DOI 10.1128/JVI.79.15.9821-9830.2005; UNAIDS, 2017, GLOB HIV AIDS DAT, P1; UZABAKILIHO B, 1987, PHYTOCHEMISTRY, V26, P3041, DOI 10.1016/S0031-9422(00)84589-6; Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09; Wang L, 2013, MOL MED REP, V8, P1279, DOI 10.3892/mmr.2013.1650; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207664	10.1371/journal.pone.0207664	http://dx.doi.org/10.1371/journal.pone.0207664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481211	Green Published, Green Submitted, gold			2022-12-26	WOS:000451440000018
J	Poulsen, ASR; de Jonge, N; Nielsen, JL; Hojberg, O; Lauridsen, C; Cutting, SM; Canibe, N				Poulsen, Ann-Sofie Riis; de Jonge, Nadieh; Nielsen, Jeppe Lund; Hojberg, Ole; Lauridsen, Charlotte; Cutting, Simon M.; Canibe, Nuria			Impact of Bacillus spp. spores and gentamicin on the gastrointestinal microbiota of suckling and newly weaned piglets	PLOS ONE			English	Article							CEREUS-VAR. TOYOI; GUT; SUBTILIS; PERFORMANCE; SOWS; LICHENIFORMIS; ECOLOGY; HEALTH; STRAIN; FEED	Administrating antibiotics to young piglets may have short-and long-term consequences on the gut microbiota. We hypothesised that these consequences may be alleviated by concurrent probiotic administration. The study objective was to investigate the effect of administrating gentamicin and a mixture of Bacillus (B.) licheniformis, B. subtilis and B. amyloliquefaeceans spores on the gut microbiota of piglets pre-and post-weaning. Twentyfour sows and their litters were randomly allocated to four treatment groups receiving; a) Bacillus spore mixture (six B. subtilis, two B. amyloliquefaeceans, and one B. licheniformis) fed to sows and piglets (PRO); b) gentamicin (5 mg per day) administered to piglets on day 4, 5, and 6 of age (AB); c) Bacillus spore mixture fed to sows and piglets, and gentamicin to piglets (PRO+AB); or d) no administration of probiotics or antibiotics (CTRL). Faecal and digesta samples were collected repeatedly during the study. Selected samples were subjected to 16S rRNA gene sequencing, culture counts, and organic acid, biogenic amine and tissue gene expression analysis. Treatment had a significant effect on the faecal microbial community composition on day 28 and 42, and colonic community on day 28. Faecal species richness (observed and estimated) and Shannon index, and colonic species richness, were higher in AB compared to PRO piglets on day 28, and were not significantly different from day 42. PRO piglets had the highest faecal concentration of iso-butyric acid on day 7 and a higher butyric acid concentration compared to CTRL piglets. We conclude that gentamicin and Bacillus spores influence the gut microbial diversity of piglets, although administration of gentamicin did not result in dysbiosis as hypothesised.	[Poulsen, Ann-Sofie Riis; Hojberg, Ole; Lauridsen, Charlotte; Canibe, Nuria] Aarhus Univ, Dept Anim Sci, Immunol & Microbiol, Tjele, Denmark; [de Jonge, Nadieh; Nielsen, Jeppe Lund] Aalborg Univ, Ctr Microbial Communities, Dept Chem & Biosci, Aalborg, Denmark; [Cutting, Simon M.] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England	Aarhus University; Aalborg University; University of London; Royal Holloway University London	Canibe, N (corresponding author), Aarhus Univ, Dept Anim Sci, Immunol & Microbiol, Tjele, Denmark.	nuria.canibe@anis.au.dk	Nielsen, Jeppe Lund/V-1762-2018	Nielsen, Jeppe Lund/0000-0002-8747-6938; Hojberg, Ole/0000-0002-4947-4536; Canibe, Nuria/0000-0002-5424-9974	Graduate School of Science and Technology, Aarhus University; Innovation Fund Denmark through the NEOMUNE consortium; GLUDS legat; SporeBiotic	Graduate School of Science and Technology, Aarhus University; Innovation Fund Denmark through the NEOMUNE consortium; GLUDS legat; SporeBiotic	GLUDS legat (N.C) and SporeBiotic (O.H, S.M.C) funded the experiment together with Graduate School of Science and Technology, Aarhus University (A-S. R.P) (http://phd.au.dk/gradschools/scienceandtechnology/), and Innovation Fund Denmark (https://innovationsfonden.dk/en) through the NEOMUNE consortium (C.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HR, 2001, VET PHARM THERAPEUTI; Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Alexopoulos C, 2004, J VET MED A, V51, P306, DOI 10.1111/j.1439-0442.2004.00637.x; Alm B, 2008, PEDIATRICS, V121, P697, DOI 10.1542/peds.2007-1232; ANAND A, 1994, AM J GASTROENTEROL, V89, P519; [Anonymous], 2017, SEQUENCE READ ARCHIV; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benis N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1733-8; Bian GR, 2016, ENVIRON MICROBIOL, V18, P1566, DOI 10.1111/1462-2920.13272; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breves G, 2000, DIGESTION, V61, P193, DOI 10.1159/000007757; Canibe N, 2007, J ANIM SCI, V85, P2959, DOI 10.2527/jas.2006-744; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chun J, 2000, ANTON LEEUW INT J G, V78, P123, DOI 10.1023/A:1026555830014; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Holdeman L. V, 1977, ANAEROBE LAB MANUAL, V4th; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jensen BB, 1988, P 4 INT SEM JABL POL; Kenward-Roger S. A, 2014, J STAT SOFTW, V59; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Kongsted H., 2013, SPAEDGRISEDIARRE DAN; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lalles JP, 2007, LIVEST SCI, V108, P82, DOI 10.1016/j.livsci.2007.01.091; Leser TD, 2008, J APPL MICROBIOL, V104, P1025, DOI 10.1111/j.1365-2672.2007.03633.x; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Nylund L, 2014, P NUTR SOC, V73, P457, DOI 10.1017/S0029665114000627; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Papatsiros VG, 2011, POL J VET SCI, V14, P117, DOI 10.2478/v10181-011-0017-8; Pirker A, 2013, FOOD AGR IMMUNOL, V24, P315, DOI 10.1080/09540105.2012.689816; Scharek L, 2007, VET IMMUNOL IMMUNOP, V120, P136, DOI 10.1016/j.vetimm.2007.07.015; Scharek L, 2005, VET IMMUNOL IMMUNOP, V105, P151, DOI 10.1016/j.vetimm.2004.12.022; Scharek L, 2007, ARCH ANIM NUTR, V61, P223, DOI 10.1080/17450390701431540; Schokker D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116523; Schokker D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100040; Slifierz MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0512-7; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tam NKM, 2006, J BACTERIOL, V188, P2692, DOI 10.1128/JB.188.7.2692-2700.2006; Taras D, 2005, ARCH ANIM NUTR, V59, P405, DOI 10.1080/17450390500353168; Vondruskova H, 2010, VET MED-CZECH, V55, P199, DOI 10.17221/2998-VETMED; Wang JQ, 2012, LIVEST SCI, V145, P79, DOI 10.1016/j.livsci.2011.12.024	45	25	27	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207382	10.1371/journal.pone.0207382	http://dx.doi.org/10.1371/journal.pone.0207382			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481191	Green Published, gold, Green Submitted			2022-12-26	WOS:000451440000012
J	Wang, YF; Wei, R; Ji, T; Chen, ZY; Guo, W				Wang, Yifei; Wei, Ran; Ji, Tao; Chen, Zhongyan; Guo, Wei			Surgical treatment of primary solitary fibrous tumors involving the pelvic ring	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-LOSS; HEMANGIOPERICYTOMA; CHONDROSARCOMA; RECURRENCE; SARCOMA; SPINE	The surgical treatment of primary solitary fibrous tumors (SFT) involving the pelvic ring has not been reported previously. In this study, we aimed to evaluate the efficacy of surgical treatment for this disease. From 2009 to 2015, 13 patients underwent tumor resection at our hospital, with an average age of 49.5 years (27-68 years). Four patients underwent en bloc resection, and 9 patients underwent piecemeal resections. A Chi-square test was used to compare the postoperative recurrence rates between the en bloc resection and the piecemeal resection groups (p = 0.68), and no significant difference was found between the benign and malignant solitary fibrous tumor groups (p = 0.44). The 5-year survival rate of the patients in this study was 83.3%, and the 5-year progression-free survival rate was 63.5%. The progression-free survival rate was not significantly different between the en bloc resection and piecemeal resection groups (p = 0.97). Piecemeal resection can also achieve acceptable local control, particularly for patients with sacral tumors, as they may achieve even better postoperative function with sacral nerve preservation. Recurrence and metastasis occur relatively late in the course of this disease. Therefore, long-term follow-up is required.	[Wang, Yifei; Wei, Ran; Ji, Tao; Chen, Zhongyan; Guo, Wei] Peking Univ, Dept Musculoskeletal Tumors, Peoples Hosp, Beijing, Peoples R China	Peking University	Guo, W (corresponding author), Peking Univ, Dept Musculoskeletal Tumors, Peoples Hosp, Beijing, Peoples R China.	bonetumor@163.com	wei, wei/HHR-8613-2022; Wei, ran/GXF-3452-2022					Albert GW, 2017, J NEUROSURG-PEDIATR, V19, P339, DOI 10.3171/2016.10.PEDS16279; Arantes M, 2009, NEUROCHIRURGIE, V55, P573, DOI 10.1016/j.neuchi.2008.10.013; Baldi GG, 2013, CLIN SARCOMA RES, V3, DOI 10.1186/2045-3329-3-4; Bouyer B, 2012, ORTHOP TRAUMATOL-SUR, V98, P850, DOI 10.1016/j.otsr.2012.05.015; Brigui M, 2013, J CLIN NEUROSCI, V20, P311, DOI 10.1016/j.jocn.2012.02.031; Chen H, 2012, ACTA NEUROCHIR, V154, P237, DOI 10.1007/s00701-011-1160-9; de Perrot M, 2002, ANN THORAC SURG, V74, P285, DOI 10.1016/S0003-4975(01)03374-4; Gao C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002433; Gold JS, 2002, CANCER, V94, P1057, DOI 10.1002/cncr.10328; Guo W, 2012, J SURG ONCOL, V106, P406, DOI 10.1002/jso.23076; Guo W, 2012, CLIN ORTHOP RELAT R, V470, P1213, DOI 10.1007/s11999-011-2190-6; Guo W, 2010, J SURG ONCOL, V101, P160, DOI 10.1002/jso.21442; Guo W, 2009, SPINE, V34, P2587, DOI 10.1097/BRS.0b013e3181bd4a2b; Hashimoto K, 2008, ARCH ORTHOP TRAUM SU, V128, P1111, DOI 10.1007/s00402-007-0529-y; Hwang US, 2014, J KOREAN NEUROSURG S, V56, P265, DOI 10.3340/jkns.2014.56.3.265; Insabato L, 2009, INT J SURG PATHOL, V17, P250, DOI 10.1177/1066896909333779; Ishii K, 2009, J ORTHOP SCI, V14, P450, DOI 10.1007/s00776-009-1339-6; Kawamura M, 2004, NEUROSURGERY, V55, P433, DOI 10.1227/01.NEU.0000130037.45768.84; Kawamura S, 2007, PATHOL INT, V57, P213, DOI 10.1111/j.1440-1827.2007.02083.x; Kayani B, 2016, AM J CLIN ONCOL; Khalifa J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1697-8; Kobayashi K, 2014, NAGOYA J MED SCI, V76, P217; Metellus P, 2007, NEUROSURGERY, V60, P715, DOI 10.1227/01.NEU.0000255418.93678.AD; Munoz E, 2008, SPINE, V33, pE397, DOI 10.1097/BRS.0b013e31817343dc; OKIKE N, 1978, J THORAC CARDIOV SUR, V75, P363; Park MS, 2011, CANCER-AM CANCER SOC, V117, P4939, DOI 10.1002/cncr.26098; Robert T, 2014, NEUROL NEUROCHIR POL, V48, P144, DOI 10.1016/j.pjnns.2013.09.006; Schuetze SM, 2017, CANCER-AM CANCER SOC, V123, P90, DOI 10.1002/cncr.30379; Son S, 2013, J KOREAN NEUROSURG S, V54, P246, DOI 10.3340/jkns.2013.54.3.246; Spitz FR, 1998, ANN SURG ONCOL, V5, P350, DOI 10.1007/BF02303499; Stacchiotti S, 2014, EUR J CANCER, V50, P3021, DOI 10.1016/j.ejca.2014.09.004; Stacchiotti S, 2012, ANN ONCOL, V23, P3171, DOI 10.1093/annonc/mds143; Takenouchi T, 2011, NEUROSURGERY, V68, pE1148, DOI 10.1227/NEU.0b013e31820a1573; Takizawa I, 2008, UROL ONCOL-SEMIN ORI, V26, P254, DOI 10.1016/j.urolonc.2007.03.024; Tang XD, 2011, ARCH ORTHOP TRAUM SU, V131, P1609, DOI 10.1007/s00402-011-1359-5; Tang XD, 2010, J BONE JOINT SURG AM, V92A, P1747, DOI 10.2106/JBJS.I.01333; Tang XD, 2009, CLIN ORTHOP RELAT R, V467, P1599, DOI 10.1007/s11999-008-0483-1; Valentin T, 2013, INVEST NEW DRUG, V31, P1626, DOI 10.1007/s10637-013-0023-z; Vogels RJC, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0224-6; Wilky BA, 2013, ANN SURG ONCOL, V20, P4080, DOI 10.1245/s10434-013-3241-x; Yi XP, 2017, WORLD NEUROSURG, V104, P318, DOI 10.1016/j.wneu.2017.05.016	41	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207581	10.1371/journal.pone.0207581	http://dx.doi.org/10.1371/journal.pone.0207581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481195	Green Submitted, gold, Green Published			2022-12-26	WOS:000451440000015
J	Dowling, L; Bonier, F				Dowling, Liam; Bonier, Frances			Should I stay, or should I go: Modeling optimal flight initiation distance in nesting birds	PLOS ONE			English	Article							RISK-TAKING; PREDATION RISK; TREE CAVITIES; LIFE-HISTORY; CONCEALMENT; BEHAVIOR; DEFENSE; RUN; DISTURBANCE; STRATEGIES	Flight initiation distance (FID)-the distance at which an individual leaves in response to the approach of a perceived threat-provides a measurement of risk-taking behavior. If individuals optimize their FID, this distance should reflect the point at which the fitness resulting from leaving exceeds the fitness resulting from all other possible decisions. Previous theory of FID has often been aimed at explaining this behavior in foraging individuals. Yet flight initiation in response to approaching threats occurs in a range of contexts that might influence optimal behavior. In breeding individuals, risk-taking decisions that are made at a location of offspring care (e.g., a nest or den) can have significant effects on fitness. Here, we develop a theoretical model of distances at which a parent bird flushes from a nest in response to an approaching threat. We estimate parent fitness with regards to characteristics of the parent (reproductive values, detection distance, and cost of lost parental care cost), the nest (concealment and accessibility), and the approaching predator (detection capability and predation success), developing a dichotomous scenario between staying at the nest or leaving at varying distances. Using a generalized comparison of the benefits of leaving versus staying, we find that increasing costs of lost parental care, probability of predation of the parent due to fleeing, or current reproductive value lead to more instances of staying at the nest. In a complementary approach with specified parameters based on biologically-informed factors that likely influence a predator-prey encounter, we find that increasing the current reproductive value, concealment of the nest, or costs of lost parental care decrease optimal FID and can lead to the parent staying at the nest. Other factors, such as increasing residual reproductive value, predation success, and predator capability of detecting the nest, increase optimal FID with some instances of costs of fleeing being so great that staying becomes an optimal strategy. Our theory provides a framework to explain variation in FID among nesting species and individuals and could provide a foundation for future empirical investigations of risk-taking behavior.	[Dowling, Liam; Bonier, Frances] Queens Univ, Dept Biol, Kingston, ON, Canada	Queens University - Canada	Dowling, L (corresponding author), Queens Univ, Dept Biol, Kingston, ON, Canada.	liam.dowling@queensu.ca			Natural Science and Resource Council of Canada (NSERC USRA) [468141]; Natural Science and Resource Council of Canada (NSERC) [05883-2014]	Natural Science and Resource Council of Canada (NSERC USRA); Natural Science and Resource Council of Canada (NSERC)	This research was supported by an Undergraduate Student Research Award from the Natural Science and Resource Council of Canada (NSERC USRA, grant number: 468141, URL: http://www.nserc-crsng.gc.ca/Students-Etudiants/UG-PC/USRA-BRPC_eng.asp) awarded to LD and a Discovery Grant from the Natural Science and Resource Council of Canada (NSERC, grant number: 05883-2014, URL: http://www.nserc-crsng. gc. ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng. asp) awarded to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2004, ETHOLOGY, V110, P603, DOI 10.1111/j.1439-0310.2004.00992.x; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; Burhans DE, 2001, AUK, V118, P237, DOI 10.1642/0004-8038(2001)118[0237:ROSNCT]2.0.CO;2; CALDER WA, 1983, J THEOR BIOL, V102, P135, DOI 10.1016/0022-5193(83)90266-7; Camp MJ, 2012, ETHOLOGY, V118, P1010, DOI 10.1111/eth.12000; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Dale S, 1996, BEHAV ECOL SOCIOBIOL, V39, P31, DOI 10.1007/s002650050264; Fisher RA, 1930, GENETICAL THEORY NAT; FORBES MRL, 1994, BEHAV ECOL SOCIOBIOL, V34, P79, DOI 10.1007/BF00164178; Ghalambor CK, 2000, ANIM BEHAV, V60, P263, DOI 10.1006/anbe.2000.1472; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Gotmark F, 1995, J AVIAN BIOL, V26, P305, DOI 10.2307/3677045; Kleindorfer S, 2005, ANIM BEHAV, V69, P307, DOI 10.1016/j.anbehav.2004.06.003; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Mallory ML, 1998, CONDOR, V100, P694, DOI 10.2307/1369751; Martin J, 2009, ANIM BEHAV, V78, P1011, DOI 10.1016/j.anbehav.2009.07.026; Martin TE, 2002, P ROY SOC B-BIOL SCI, V269, P309, DOI 10.1098/rspb.2001.1879; Maziarz M, 2014, J ORNITHOL, V155, P793, DOI 10.1007/s10336-014-1069-1; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; Osiejuk TS, 2007, WILDLIFE BIOL, V13, P11, DOI 10.2981/0909-6396(2007)13[11:FAFDII]2.0.CO;2; Ozel LD, 2011, J HERPETOL, V45, P395; Seltmann MW, 2012, ANIM BEHAV, V84, P889, DOI 10.1016/j.anbehav.2012.07.012; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Sutton NM, 2018, AM NAT, V192, P321, DOI 10.1086/698692; Wesolowski T, 2012, J AVIAN BIOL, V43, P454, DOI 10.1111/j.1600-048X.2012.05704.x; WESTMORELAND D, 1985, AUK, V102, P774; Wilson-Aggarwal JK, 2016, AM NAT, V188, P231, DOI 10.1086/687254; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	29	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0208210	10.1371/journal.pone.0208210	http://dx.doi.org/10.1371/journal.pone.0208210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475915	Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700108
J	Nguyen, NTQ; Cockwell, P; Maxwell, AP; Griffin, M; O'Brien, T; O'Neill, C				Nguyen, Nga T. Q.; Cockwell, Paul; Maxwell, Alexander P.; Griffin, Matthew; O'Brien, Timothy; O'Neill, Ciaran			Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England	PLOS ONE			English	Article							POSITION STATEMENT; GLOBAL BURDEN; RELIGIOSITY; UTILITY	Chronic kidney disease (CKD) affects up to 15% of the adult population and is strongly associated with other non-communicable chronic diseases including diabetes. However, there is limited information on a population basis of the relationship between CKD and health-related quality of life (HRQoL) and the consequent economic cost. We investigated this relationship in a representative sample in England using the 2010 Health Survey for England. Multivariable Tobit models were used to examine the relationship between HRQoL and CKD severity. HRQoL was converted to quality adjusted life year (QALY) measures by combining decrements in quality of life with reductions in life expectancy associated with increased disease severity. QALYs were adjusted for discounting and monetised using the UK threshold for reimbursement of 30,000 pound. The QALYs were then used in conjunction with forecasted prevalence to estimate the HRQoL burden associated with CKD among individuals with diabetes up to 2025. Individuals with more severe CKD had lower HRQoL compared to those with better kidney function. Compared to those with normal/low normal kidney function and stage 1 CKD, those with stage 2, stage 3 with albuminuria and stage 4/5 CKD experienced a decrement of 0.11, 0.18 and 0.28 in their utility index, respectively. Applying the UK reimbursement threshold for a QALY, the monetised lifetime burden of reduced HRQoL due to stage 2, stage 3 with albuminuria and stage 4/5 CKD were 103,734; pound 83,399; pound 125,335 pound in males and 143,582; pound 70,288; pound 203,804 pound in females, respectively. Utilizing the predicted prevalence of CKD among individuals with diabetes mellitus, the economic burden of CKD per million of individuals with diabetes is forecasted at approximately 11.4 pound billion in 2025. In conclusion, CKD has a strong adverse impact on HRQoL in multiple domains. The estimated economic burden of CKD among individuals with diabetes mellitus in the UK is projected to rise markedly over time.	[Nguyen, Nga T. Q.; Maxwell, Alexander P.; O'Neill, Ciaran] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Cockwell, Paul] Univ Hosp Birmingham, Birmingham, W Midlands, England; [Griffin, Matthew; O'Brien, Timothy] Natl Univ Ireland Galway, Galway, Ireland	Queens University Belfast; University of Birmingham; Ollscoil na Gaillimhe-University of Galway	Nguyen, NTQ (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	nnguyen05@qub.ac.uk		Nguyen, Nga/0000-0001-9843-4410; o'neill, ciaran/0000-0001-7668-3934; Griffin, Matthew/0000-0002-8701-8056; Maxwell, Alexander P./0000-0002-6110-7253; Cockwell, Paul/0000-0003-1975-266X	Health Research Board [RL/2013/16]; Vietnam International Education Development (VIED); European Union's Horizon 2020 research and innovation programme [634086]; MRC [MC_PC_15025] Funding Source: UKRI	Health Research Board; Vietnam International Education Development (VIED); European Union's Horizon 2020 research and innovation programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research is based upon work supported by the Health Research Board research grant RL/2013/16 and Vietnam International Education Development (VIED). This research has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 634086 ('NEPHSTROM'). The material presented and views expressed here are the responsibility of the author (s) only. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal HK, 2016, QJM-INT J MED, V109, P711, DOI 10.1093/qjmed/hcw054; Ara R, 2011, VALUE HEALTH, V14, P539, DOI 10.1016/j.jval.2010.10.029; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; Cruz JP, 2016, J RELIG HEALTH, V55, P895, DOI 10.1007/s10943-015-0103-9; Curry CW, 2006, AM J PREV MED, V30, P269, DOI 10.1016/j.amepre.2005.10.028; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Gibbons E, 2010, STRUCTURED REV PATIE, P1; Glassock RJ, 2017, NAT REV NEPHROL, V13, P104, DOI [10.1038/nmeph.2016.163, 10.1038/nrneph.2016.163]; Gorodetskaya I, 2005, KIDNEY INT, V68, P2801, DOI 10.1111/j.1523-1755.2005.00752.x; Greene William H, 1993, ECONOMETRIC ANAL; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Jesky MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165675; Kainz A, 2015, NEPHROL DIAL TRANSPL, V30, P113, DOI 10.1093/ndt/gfv073; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Lee H, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-19; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Mindell J, 2017, KEY FINDINGS HLTH SU, P1; Mujais SK, 2009, CLIN J AM SOC NEPHRO, V4, P1293, DOI 10.2215/CJN.05541008; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NatCen Social Research Royal Free and University College Medical School Department of Epidemiology and Public Health, 2015, HLTH SURV ENGL 2010, DOI [10.5255/UKDA-SN-6986-3, DOI 10.5255/UKDA-SN-6986-3]; NICE, METH DEV NICE PUBL H, VThird; Obrador GT, 2011, AM J KIDNEY DIS, V57, P361, DOI 10.1053/j.ajkd.2010.12.006; Okubo R, 2014, CLIN EXP NEPHROL, V18, P697, DOI 10.1007/s10157-013-0901-x; Pham PCT, 2009, CLIN KIDNEY J, V2, P111, DOI 10.1093/ndtplus/sfp001; Saffari M, 2013, NEPHROLOGY, V18, P269, DOI 10.1111/nep.12041; Sutton AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140063; Szende A, 2007, EUROQOL GROUP EQ 5D; Tajima R, 2010, CLIN EXP NEPHROL, V14, P340, DOI 10.1007/s10157-010-0304-1; Tong A, 2013, J PEDIATR-US, V163, P1179, DOI 10.1016/j.jpeds.2013.04.066; Turin Tanvir Chowdhury, 2014, Can J Kidney Health Dis, V1, P33, DOI 10.1186/s40697-014-0033-6; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Yang F, 2015, QUAL LIFE RES, V24, P2163, DOI 10.1007/s11136-015-0964-0	32	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207960	10.1371/journal.pone.0207960	http://dx.doi.org/10.1371/journal.pone.0207960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475893	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700097
J	Pfurtscheller, G; Schwerdtfeger, A; Fink, D; Brunner, C; Aigner, CS; Brito, J; Andrade, A				Pfurtscheller, Gert; Schwerdtfeger, Andreas; Fink, David; Brunner, Clemens; Aigner, Christoph Stefan; Brito, Joana; Andrade, Alexandre			MRI-related anxiety in healthy individuals, intrinsic BOLD oscillations at 0.1 Hz in precentral gyrus and insula, and heart rate variability in low frequency bands	PLOS ONE			English	Article							RESTING-STATE; FLOW VELOCITY; AMYGDALA; CONNECTIVITY; STRESS; FLUCTUATIONS; ACTIVATION	Participation in magnetic resonance imaging (MRI) scanning is associated with increased anxiety, thus possibly impacting baseline recording for functional MRI studies. The goal of the paper is to elucidate the significant hemispheric asymmetry between blood-oxygenation-level-dependent (BOLD) signals from precentral gyrus (PCG) and insula in 23 healthy individuals without any former MRI experience recently published in a PLOSONE paper. In addition to BOLD signals state anxiety and heart rate variability (HRV) were analyzed in two resting state sessions (R1, R2). Phase-locking and time delays from BOLD signals were computed in the frequency band 0.07-0.13 Hz. Positive (pTD) and negative time delays (nTD) were found. The pTD characterize descending neural BOLD oscillations spreading from PCG to insula and nTD characterize ascending vascular BOLD oscillations related to blood flow in the middle cerebral artery. HRV power in two low frequency bands 0.06-0.1 Hz and 0.1-0.14 Hz was computed. Based on the anxiety change from R1 to R2, two groups were separated: one with a strong anxiety decline (large change group) and one with a moderate decline or even anxiety increase (small change group). A significant correlation was found only between the left-hemispheric time delay (pTD, nTD) and anxiety change, with a dominance of nTD in the large change group. The analysis of within-scanner HRV revealed a pronounced increase of low frequency power between both resting states, dominant in the band 0.06-0.1 Hz in the large change group and in the band 0.1-0.14 Hz in the small change group. These results suggest different mechanisms related to anxiety processing in healthy individuals. One mechanism (large anxiety change) could embrace an increase of blood circulation in the territory of the left middle cerebral artery (vascular BOLD) and another (small anxiety change) translates to rhythmic central commands (neural BOLD) in the frequency band 0.1-0.14 Hz.	[Pfurtscheller, Gert] Graz Univ Technol, Inst Neural Engn, Graz, Austria; [Pfurtscheller, Gert; Schwerdtfeger, Andreas; Brunner, Clemens; Aigner, Christoph Stefan] BioTechMed, Graz, Austria; [Schwerdtfeger, Andreas; Fink, David; Brunner, Clemens] Karl Franzens Univ Graz, Dept Psychol, Graz, Austria; [Aigner, Christoph Stefan] Graz Univ Technol, Inst Med Engn, Graz, Austria; [Brito, Joana; Andrade, Alexandre] Univ Lisbon, Inst Biophys & Biomed Engn, Fac Sci, Lisbon, Portugal	Graz University of Technology; University of Graz; Graz University of Technology; Universidade de Lisboa	Schwerdtfeger, A (corresponding author), BioTechMed, Graz, Austria.; Schwerdtfeger, A (corresponding author), Karl Franzens Univ Graz, Dept Psychol, Graz, Austria.	andreas.schwerdtfeger@uni-graz.at	Aigner, Christoph Stefan/AAZ-9055-2020; Schwerdtfeger, Andreas Richard/U-5317-2019; Andrade, Alexandre/K-6236-2012	Aigner, Christoph Stefan/0000-0003-3618-9610; Andrade, Alexandre/0000-0002-8107-7338; Schwerdtfeger, Andreas/0000-0002-0371-3730				AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R., 1986, TRANSCRANEAL DOPPLER, P35; Appelhans BM, 2008, BIOL PSYCHOL, V77, P174, DOI 10.1016/j.biopsycho.2007.10.004; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Baur V, 2013, BIOL PSYCHIAT, V73, P85, DOI 10.1016/j.biopsych.2012.06.003; Chapman HA, 2010, PSYCHIAT RES-NEUROIM, V182, P160, DOI 10.1016/j.pscychresns.2010.01.005; Dennis EL, 2011, BRAIN CONNECT, V1, P245, DOI [10.1089/brain.2011.0064, 10.1089/brain.2011.0030]; Dewey M, 2007, J MAGN RESON IMAGING, V26, P1322, DOI 10.1002/jmri.21147; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Foster BL, 2012, NEUROIMAGE, V60, P384, DOI 10.1016/j.neuroimage.2011.12.019; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Garrison KA., 2013, ANN NY ACAD SCI, P1; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Harwood AE, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00021; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; KATZ RC, 1994, J BEHAV THER EXP PSY, V25, P131, DOI 10.1016/0005-7916(94)90005-1; Korhonen O, 2017, NETW NEUROSCI, V1, P254, DOI [10.1162/NETN_a_00013, 10.1162/netn_a_00013]; Kuusela T.A., 2003, BMC PHYSL, V13, P3; Lagos L., 2008, BIOFEEDBACK, V36, P109; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Laux L., 2013, STATE TRAIT ANGST DE; Mateo C, 2017, NEURON, V96, P936, DOI 10.1016/j.neuron.2017.10.012; Mather M, 2018, CURR OPIN BEHAV SCI, V19, P98, DOI 10.1016/j.cobeha.2017.12.017; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Pfurtscheller G, 2017, PLOS ONE; Pfurtscheller G, 2018, EUR J NEUROSCI, V47, P417, DOI 10.1111/ejn.13845; Pfurtscheller G, 2017, CLIN NEUROPHYSIOL, V128, P183, DOI 10.1016/j.clinph.2016.10.097; Pfurtscheller G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043640; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Snyder AZ, 2012, NEUROIMAGE, V62, P902, DOI 10.1016/j.neuroimage.2012.01.044; Spielberger C.D., 2009, MANUAL STATE TRAIT A; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thome J, 2017, HUM BRAIN MAPP, V38, P27, DOI 10.1002/hbm.23340; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Williams DP, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00520; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0206675	10.1371/journal.pone.0206675	http://dx.doi.org/10.1371/journal.pone.0206675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475859	Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700011
J	Sobierajewicz, J; Naskrecki, R; Jaskowski, W; Van der Lubbe, RHJ				Sobierajewicz, Jagna; Naskrecki, Ryszard; Jaskowski, Wojciech; Van der Lubbe, Rob H. J.			Do musicians learn a fine sequential hand motor skill differently than non-musicians?	PLOS ONE			English	Article							BRAIN; EEG; POTENTIALS; EXECUTION; EXPERTISE; MOVEMENTS; SEQUENCES; NETWORK; ERP	Do professional musicians learn a fine sequential hand motor skill more efficiently than non-musicians? Is this also the case when they perform motor imagery, which implies that they only mentally simulate these movements? Musicians and non-musicians performed a Go/NoGo discrete sequence production (DSP) task, which allows to separate sequence-specific from a-specific learning effects. In this task five stimuli, to be memorized during a preparation interval, signaled a response sequence. In a practice phase, different response sequences had to be either executed, imagined, or inhibited, which was indicated by different response cues. In a test phase, responses were required to familiar (previously executed, imagined, or inhibited) and unfamiliar sequences. In both phases, response times and response accuracy were measured while the electroencephalogram (EEG) was only registered during the practice phase to compare activity between motor imagery, motor execution, and motor inhibition for both groups. Results in the practice phase revealed that musicians learned the response sequences faster and more accurately than non-musicians although no difference in initiation time was found. EEG analyses revealed similar lateralized activity during learning a motor skill for both groups. Our results from the test phase showed better sequence-a-specific learning effects (i.e., faster response times and increased accuracy) for musicians than for non-musicians. Moreover, we revealed that non-musicians benefit more from physical execution while learning a required motor sequence, whereas sequence-specific learning effects due to learning with motor imagery were very similar for musicians and non-musicians.	[Sobierajewicz, Jagna; Naskrecki, Ryszard; Van der Lubbe, Rob H. J.] Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland; [Sobierajewicz, Jagna; Naskrecki, Ryszard; Van der Lubbe, Rob H. J.] Adam Mickiewicz Univ, Fac Phys, Lab Vis Sci & Optometry, Poznan, Poland; [Jaskowski, Wojciech] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland; [Van der Lubbe, Rob H. J.] Univ Twente, Cognit Psychol & Ergon, Enschede, Netherlands	Adam Mickiewicz University; Adam Mickiewicz University; Poznan University of Technology; University of Twente	Sobierajewicz, J (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland.; Sobierajewicz, J (corresponding author), Adam Mickiewicz Univ, Fac Phys, Lab Vis Sci & Optometry, Poznan, Poland.	jagna.s@amu.edu.pl	Jaśkowski, Wojciech/B-2237-2013; Naskrecki, Ryszard/AAB-1865-2020; van+der+Lubbe, Rob/AAJ-8120-2020	Jaśkowski, Wojciech/0000-0002-6059-0001; Naskrecki, Ryszard/0000-0002-7925-047X; van der Lubbe, Rob/0000-0003-3658-0345	National Science Centre in Poland [UMO-2012/05/B/HS6/03806]; Institute for Biomedical Technology and Technical Medicine (MIRA)	National Science Centre in Poland(National Science Centre, Poland); Institute for Biomedical Technology and Technical Medicine (MIRA)	This work was supported by a grant from the National Science Centre in Poland, UMO-2012/05/B/HS6/03806. Rob van der Lubbe was supported by the Institute for Biomedical Technology and Technical Medicine (MIRA).	Abrahamse EL, 2008, PSYCHOL RES-PSYCH FO, V72, P397, DOI 10.1007/s00426-007-0123-5; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Baumann S, 2007, BRAIN RES, V1161, P65, DOI 10.1016/j.brainres.2007.05.045; Berkowitz AL, 2008, NEUROIMAGE, V41, P535, DOI 10.1016/j.neuroimage.2008.02.028; Bernardi NF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00451; Bianco V, 2017, NEUROSCIENCE, V360, P39, DOI 10.1016/j.neuroscience.2017.07.059; Brochard R, 2004, BRAIN COGNITION, V54, P103, DOI 10.1016/S0278-2626(03)00264-1; Caldara R, 2004, EXP BRAIN RES, V159, P389, DOI 10.1007/s00221-004-2101-0; Crittenden BM, 2014, CEREB CORTEX, V24, P532, DOI 10.1093/cercor/bhs333; De Kleine E, 2011, BRAIN COGNITION, V75, P126, DOI 10.1016/j.bandc.2010.10.013; Debarnot U, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00280; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Galdo-Alvarez S, 2004, NEUROREPORT, V15, P2067, DOI 10.1097/00001756-200409150-00014; Gaser C, 2003, J NEUROSCI, V23, P9240; Groussard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013225; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Huang Z, 2010, NEUROSCIENCE, V168, P179, DOI 10.1016/j.neuroscience.2010.03.027; Jackson PL, 2003, NEUROIMAGE, V20, P1171, DOI 10.1016/S1053-8119(03)00369-0; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Keller PE, 2012, ANN NY ACAD SCI, V1252, P206, DOI 10.1111/j.1749-6632.2011.06439.x; Kranczioch C, 2009, HUM BRAIN MAPP, V30, P3275, DOI 10.1002/hbm.20748; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Lotze M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00280; Lu J, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00695; Miles SA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00278; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pinho AL, 2014, J NEUROSCI, V34, P6156, DOI 10.1523/JNEUROSCI.4769-13.2014; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Rodrigues AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00424; Ruitenberg MFL, 2012, PSYCHOL RES-PSYCH FO, V76, P812, DOI 10.1007/s00426-011-0388-6; Sobierajewicz J, 2017, EXPT BRAIN RES; Sobierajewicz J, 2017, EXP BRAIN RES, V235, P3757, DOI 10.1007/s00221-017-5096-z; Sobierajewicz J, 2016, ADV COGN PSYCHOL, V12, P178, DOI 10.5709/acp-0197-1; Talsma D, 2001, PSYCHOPHYSIOLOGY, V38, P425; Tian Y, 2013, PSYCHOPHYSIOLOGY, V50, P1282, DOI 10.1111/psyp.12130; Van der Lubbe RHJ, 2016, ADV COGN PSYCHOL, V12, P153, DOI 10.5709/acp-0195-3; Van der Lubbe RHJ, 2014, BRAIN RES, V1583, P179, DOI 10.1016/j.brainres.2014.08.007; Verwey WB, 2004, PSYCHOL RES-PSYCH FO, V68, P64, DOI 10.1007/s00426-003-0144-7; Verwey WB, 2001, ACTA PSYCHOL, V106, P69, DOI 10.1016/S0001-6918(00)00027-5; Verwey WB, 2016, EXP BRAIN RES, V234, P353, DOI 10.1007/s00221-015-4457-8; Verwey WB, 2015, PSYCHON B REV, V22, P54, DOI 10.3758/s13423-014-0773-4; Yao DZ, 2007, COMPUT BIOL MED, V37, P1529, DOI 10.1016/j.compbiomed.2007.02.002; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zhao TC, 2017, NEUROPSYCHOLOGIA, V106, P289, DOI 10.1016/j.neuropsychologia.2017.10.007	52	4	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207449	10.1371/journal.pone.0207449	http://dx.doi.org/10.1371/journal.pone.0207449			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB4VL	30462721	Green Submitted, Green Published, gold			2022-12-26	WOS:000451054800057
J	Takahashi, S; Ohmiya, M; Honda, S; Ni, K				Takahashi, Shinji; Ohmiya, Makoto; Honda, Sokichi; Ni, Keni			The KCNH3 inhibitor ASP2905 shows potential in the treatment of attention deficit/hyperactivity disorder	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RAT; DEFICIT HYPERACTIVITY DISORDER; ANIMAL-MODEL; CHOLINERGIC ENHANCEMENT; ACETYLCHOLINE-RELEASE; PRESCHOOL-CHILDREN; PREFRONTAL CORTEX; RECEPTOR; DOPAMINE; METHYLPHENIDATE	N-(4-fluorophenyl)-N'-phenyl-N ''-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine [ASP2905] is a potent and selective inhibitor of the potassium voltage-gated channel subfamily H member 3 (KCNH3) that was originally identified in our laboratory. KCNH3 is concentrated in the forebrain, and its overexpression in mice leads to cognitive deficits. In contrast, Kcnh3 knockout mice exhibit enhanced performance in cognitive tasks such as attention. These data suggest that KCNH3 plays important roles in cognition. Here we investigated the neurochemical and neurophysiological profiles of ASP2905 as well as its effects on cognitive function, focusing on attention. ASP2905 (0.0313 and 0.0625 mg/kg, po) improved the latent learning ability of mice, which reflects attention. Microdialysis assays in rats revealed that ASP2905 increased the efflux of dopamine and acetylcholine in the medial prefrontal cortex (0.03, 0.1 mg/kg, po; 0.1, 1 mg/kg, po, respectively). The activities of these neurotransmitters are closely associated with attention. We used a multiple-trial passive avoidance task to investigate the effects of ASP2905 on inattention and impulsivity in juvenile stroke-prone spontaneously hypertensive rats. ASP2905 (0.1 and 0.3 mg/kg, po) significantly prolonged cumulative latency as effectively as methylphenidate (0.1 and 0.3 mg/kg, sc), which is the gold standard for treating ADHD. Further, ASP2905, amphetamine, and methylphenidate significantly increased the alpha-band power of rats, suggesting that ASP2905 increases arousal, which is a pharmacologically important activity for treating ADHD. In contrast, atomoxetine and guanfacine did not significantly affect power. Together, these findings suggest that ASP2905, which acts through a novel mechanism, is as effective for treating ADHD as currently available drugs such as methylphenidate.	[Takahashi, Shinji; Ohmiya, Makoto; Honda, Sokichi; Ni, Keni] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki, Japan	Astellas Pharmaceuticals	Takahashi, S (corresponding author), Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki, Japan.	shinji-takahashi@astellas.com			Astellas Pharma Inc.	Astellas Pharma Inc.(Astellas Pharmaceuticals)	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. All Authors are employees of Astellas Pharma Inc.. Astellas Pharma Inc. provided support in the form of salaries for authors [ST, MO, SH, KN], but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Authors Contribution section.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; BARKLEY RA, 1990, J AM ACAD CHILD PSY, V29, P546, DOI 10.1097/00004583-199007000-00007; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Bentley P, 2004, NEURON, V41, P969, DOI 10.1016/S0896-6273(04)00145-X; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; BERCHOU R, 1986, CLIN ELECTROENCEPHAL, V17, P176; Chapotot F, 2003, PSYCHOPHARMACOLOGY, V166, P127, DOI 10.1007/s00213-002-1315-8; Connor DF, 2010, DRUG TODAY, V46, P299, DOI 10.1358/dot.2010.46.5.1450095; De Leonibus E, 2006, EUR J NEUROSCI, V23, P1332, DOI 10.1111/j.1460-9568.2006.04658.x; Elia J, 1999, NEW ENGL J MED, V340, P780, DOI 10.1056/NEJM199903113401007; ETTENBERG A, 1983, PHARMACOL BIOCHEM BE, V18, P645, DOI 10.1016/0091-3057(83)90294-0; Fox GB, 2002, BEHAV BRAIN RES, V131, P151, DOI 10.1016/S0166-4328(01)00379-5; Fox GB, 2004, CURR PROTOC PHARM; Ghuman JK, 2001, J AM ACAD CHILD PSY, V40, P516, DOI 10.1097/00004583-200105000-00010; Goldman-Rakic PS, 2004, PSYCHOPHARMACOLOGY, V174, P3, DOI 10.1007/s00213-004-1793-y; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Handen BL, 1999, J AM ACAD CHILD PSY, V38, P805, DOI 10.1097/00004583-199907000-00009; HAYES AG, 1986, NEUROPHARMACOLOGY, V25, P391, DOI 10.1016/0028-3908(86)90233-9; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hille B., 1992, IONIC CHANNELS EXCIT; ICHIHARA K, 1993, J PHARMACOL EXP THER, V264, P122; Izaki Y, 1998, NEUROSCI LETT, V258, P33, DOI 10.1016/S0304-3940(98)00841-6; KAYAMA Y, 1992, BRAIN RES, V569, P210, DOI 10.1016/0006-8993(92)90632-J; Kutcher S, 2004, EUR NEUROPSYCHOPHARM, V14, P11, DOI 10.1016/S0924-977X(03)00045-2; Levitan IB, 1991, NEURON CELL MOL BIOL; LEVY A, 1991, PHARMACOL BIOCHEM BE, V39, P781, DOI 10.1016/0091-3057(91)90164-W; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Mingote S, 2004, J NEUROSCI, V24, P2475, DOI 10.1523/JNEUROSCI.4547-03.2004; Miyake A, 1999, J BIOL CHEM, V274, P25018, DOI 10.1074/jbc.274.35.25018; Miyake A, 2009, J NEUROSCI, V29, P14637, DOI 10.1523/JNEUROSCI.0901-09.2009; Noda A, 2001, NEUROPSYCHOPHARMACOL, V24, P451, DOI 10.1016/S0893-133X(00)00192-5; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; Sagvolden T, 2000, NEUROSCI BIOBEHAV R, V24, P31, DOI 10.1016/S0149-7634(99)00058-5; SAGVOLDEN T, 1993, PHYSIOL BEHAV, V54, P1047, DOI 10.1016/0031-9384(93)90323-8; SAGVOLDEN T, 1992, BEHAV NEURAL BIOL, V58, P103, DOI 10.1016/0163-1047(92)90315-U; Sagvolden T, 2005, BIOL PSYCHIAT, V57, P1239, DOI 10.1016/j.biopsych.2005.02.002; SCALI C, 1994, NEUROSCI LETT, V170, P117, DOI 10.1016/0304-3940(94)90253-4; Smith RD, 1996, LIFE SCI, V59, P753, DOI 10.1016/0024-3205(96)00361-X; Takahashi S, 2001, EUR J PHARMACOL, V427, P211, DOI 10.1016/S0014-2999(01)01254-7; Takahashi S, 2004, 34 SOC NEUR PROGR; Takahashi S, 2017, EUR J PHARMACOL, V810, P26, DOI 10.1016/j.ejphar.2017.05.045; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; van Goethem NP, 2012, BEHAV BRAIN RES, V232, P323, DOI 10.1016/j.bbr.2012.03.023; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Weiss M, 2003, CAN MED ASSOC J, V168, P715; Wilens TE, 1999, AM J PSYCHIAT, V156, P1931; WULTZ B, 1990, BEHAV NEURAL BIOL, V53, P88, DOI 10.1016/0163-1047(90)90848-Z	48	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207750	10.1371/journal.pone.0207750	http://dx.doi.org/10.1371/journal.pone.0207750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB4VL	30462746	gold, Green Published, Green Submitted			2022-12-26	WOS:000451054800081
J	Kudo, K; Yoneda, A; Sakiyama, D; Kojima, K; Miyaji, T; Yamazaki, M; Yaita, S; Hyodo, T; Satow, R; Fukami, K				Kudo, Kohya; Yoneda, Atsuko; Sakiyama, Daiki; Kojima, Kai; Miyaji, Takeki; Yamazaki, Miku; Yaita, Saori; Hyodo, Takuya; Satow, Reiko; Fukami, Kiyoko			Cell surface CD63 increased by up-regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032	FASEB JOURNAL			English	Article						vemurafenib; 1; 3-N-acetylglucosaminyltransferase; drug resistance	CANCER CELLS; N-GLYCAN; RESISTANCE; IDENTIFICATION; BIOSYNTHESIS; BETA-3GNT2; PROTEIN; CLONING	The BRAF inhibitor PLX4032 is effective in treating BRAF-mutated melanoma; however, because drug resistance develops in most cases, it is critical to develop a new strategy for inhibiting drug-resistant melanoma growth. The melanoma-associated membrane glycoprotein CD63 is involved in cell proliferation and metastasis. Here, we found that cell surface CD63 suppresses the proliferation of human melanoma cells and PLX4032-resistant cells. Endogenous CD63 protein levels were negatively correlated with PLX4032 resistance of human melanoma cell lines. CD63 overexpression in these cells, in which endogenous CD63 levels are low, suppressed cell proliferation under PLX4032 treatment. The cell surface levels and average molecular mass of CD63 were increased with PLX4032 treatment because of the up-regulated polylactosamine modification caused by induced 1,3-N-acetylglucosaminyltransferase 2 expression, which is involved in polylactosamine synthesis. Forced cell surface localization of CD63 led to reduced melanoma cell proliferation without PLX4032 treatment. CD63 overexpression in PLX4032-resistant cells, in which CD63 levels were lower and cell surface polylactosamine levels were higher than those in parental cells, effectively suppressed proliferation. Our study shows the potential of CD63 to sensitize melanoma cells to PLX4032 and to reduce the proliferation of PLX4032-resistant cells.Kudo, K., Yoneda, A., Sakiyama, D., Kojima, K., Miyaji, T., Yamazaki, M., Yaita, S., Hyodo, T., Satow, R., Fukami, K. Cell surface CD63 increased by up-regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032.	[Kudo, Kohya; Yoneda, Atsuko; Sakiyama, Daiki; Kojima, Kai; Miyaji, Takeki; Yamazaki, Miku; Yaita, Saori; Hyodo, Takuya; Satow, Reiko; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan; [Yoneda, Atsuko; Satow, Reiko; Fukami, Kiyoko] Japan Agcy Med Res & Dev, Adv Res & Dev Programs Med Innovat AMED CREST, Tokyo, Japan; [Kudo, Kohya] Novartis Pharma KK, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Novartis	Yoneda, A (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	ayoneda@toyaku.ac.jp			Advanced Research and Development Programs for Medical Innovation (AMED-CREST), Japan Agency for Medical Research and Development	Advanced Research and Development Programs for Medical Innovation (AMED-CREST), Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The authors thank Dr. Y. Nakamura (Tokyo University of Pharmacy and Life Sciences) for helpful discussion, Dr. T. Kitamura (University of Tokyo, Tokyo, Japan) for Platinum A cell lines and pMXs-IP, and Dr. J. R. Couchman (University of Copenhagen, Copenhagen, Denmark) for the syndecan construct. This study was supported by a Grant-in-Aid for Scientific Research (B) and the Advanced Research and Development Programs for Medical Innovation (AMED-CREST), Japan Agency for Medical Research and Development to K.F., Grant-in-Aid for Young Scientists (A) to R.S., and a Grant-in-Aid for Scientific Research (C) to A.Y. The authors declare no conflicts of interest.	Ageberg M, 2003, CLIN LAB HAEMATOL, V25, P297, DOI 10.1046/j.1365-2257.2003.00541.x; ATKINSON B, 1984, CANCER RES, V44, P2577; Braeuer RR, 2012, PIGM CELL MELANOMA R, V25, P592, DOI 10.1111/j.1755-148X.2012.01026.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Henion TR, 2014, J CELL PHYSIOL, V229, P471, DOI 10.1002/jcp.24467; Hirata E, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026781; Ji ZY, 2015, J INVEST DERMATOL, V135, P1863, DOI 10.1038/jid.2015.105; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kinoshita M, 2014, J PROTEOME RES, V13, P1021, DOI 10.1021/pr401015b; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KOJIMA T, 1993, BIOCHEM BIOPH RES CO, V190, P814, DOI 10.1006/bbrc.1993.1122; Kudo Kohya, 2016, Advances in Biological Regulation, V61, P68, DOI 10.1016/j.jbior.2015.11.004; Li CW, 2018, CANCER CELL, V33, P187, DOI 10.1016/j.ccell.2018.01.009; Lupia A, 2014, J INVEST DERMATOL, V134, P2947, DOI 10.1038/jid.2014.258; Ma HY, 2013, IUBMB LIFE, V65, P409, DOI 10.1002/iub.1133; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Richard G, 2016, EMBO MOL MED, V8, P1143, DOI 10.15252/emmm.201505971; Satow R, 2017, CANCER RES, V77, P366, DOI 10.1158/0008-5472.CAN-16-0991; Shen L, 2014, INT J ONCOL, V45, P2560, DOI 10.3892/ijo.2014.2672; Termini CM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00034; Togayachi A, 2010, METHOD ENZYMOL, V479, P185, DOI 10.1016/S0076-6879(10)79011-X; Tominaga N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-134; Very N, 2018, ONCOTARGET, V9, P1380, DOI 10.18632/oncotarget.22377; Villanueva J, 2008, CURR ONCOL REP, V10, P439, DOI 10.1007/s11912-008-0067-y; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Xiao H, 2016, P NATL ACAD SCI USA, V113, P10304, DOI 10.1073/pnas.1608069113; Xiao JJ, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4583-3; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	35	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3851	3869		10.1096/fj.201800664RR	http://dx.doi.org/10.1096/fj.201800664RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30508500	Bronze			2022-12-26	WOS:000459794800061
J	Coelho, C; Brown, L; Maryam, M; Vij, R; Smith, DFQ; Burnet, MC; Kyle, JE; Heyman, HM; Ramirez, J; Prados-Rosales, R; Lauvau, G; Nakayasu, ES; Brady, NR; Hamacher-Brady, A; Coppens, I; Casadevall, A				Coelho, Carolina; Brown, Lisa; Maryam, Maria; Vij, Raghav; Smith, Daniel F. Q.; Burnet, Meagan C.; Kyle, Jennifer E.; Heyman, Heino M.; Ramirez, Jasmine; Prados-Rosales, Rafael; Lauvau, Gregoire; Nakayasu, Ernesto S.; Brady, Nathan R.; Hamacher-Brady, Anne; Coppens, Isabelle; Casadevall, Arturo			Listeria monocytogenes virulence factors, including listeriolysin O, are secreted in biologically active extracellular vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exosome (vesicle); extracellular vesicles; virulence factor; phospholipase C; Gram-positive bacteria; hemolysis; Listeria monocytogenes; listeriolysin O; MPLEx; multiomics	GRAM-POSITIVE BACTERIA; MEMBRANE-VESICLES; PHOSPHOLIPASE-C; CRYPTOCOCCUS-NEOFORMANS; INTRACELLULAR GROWTH; FATTY-ACIDS; LIPIDS; ROLES; STIMULATION; BIOGENESIS	Outer membrane vesicles produced by Gram-negative bacteria have been studied for half a century but the possibility that Gram-positive bacteria secrete extracellular vesicles (EVs) was not pursued until recently due to the assumption that the thick peptidoglycan cell wall would prevent their release to the environment. However, following their discovery in fungi, which also have cell walls, EVs have now been described for a variety of Gram-positive bacteria. EVs purified from Gram-positive bacteria are implicated in virulence, toxin release, and transference to host cells, eliciting immune responses, and spread of antibiotic resistance. Listeria monocytogenes is a Gram-positive bacterium that causes listeriosis. Here we report that L. monocytogenes produces EVs with diameters ranging from 20 to 200 nm, containing the pore-forming toxin listeriolysin O (LLO) and phosphatidylinositol-specific phospholipase C (PI-PLC). Cell-free EV preparations were toxic to mammalian cells, the murine macrophage cell line J774.16, in a LLO-dependent manner, evidencing EV biological activity. The deletion of plcA increased EV toxicity, suggesting PI-PLC reduced LLO activity. Using simultaneous metabolite, protein, and lipid extraction (MPLEx) multiomics we characterized protein, lipid, and metabolite composition of bacterial cells and secreted EVs and found that EVs carry the majority of listerial virulence proteins. Using immunogold EM we detected LLO at several organelles within infected human epithelial cells and with high-resolution fluorescence imaging we show that dynamic lipid structures are released from L. monocytogenes during infection. Our findings demonstrate that L. monocytogenes uses EVs for toxin release and implicate these structures in mammalian cytotoxicity.	[Coelho, Carolina; Maryam, Maria; Vij, Raghav; Smith, Daniel F. Q.; Ramirez, Jasmine; Brady, Nathan R.; Hamacher-Brady, Anne; Coppens, Isabelle; Casadevall, Arturo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Brown, Lisa; Lauvau, Gregoire; Casadevall, Arturo] Yeshiva Univ, Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Lauvau, Gregoire; Casadevall, Arturo] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA; [Burnet, Meagan C.; Kyle, Jennifer E.; Heyman, Heino M.; Nakayasu, Ernesto S.] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99352 USA; [Prados-Rosales, Rafael] CIC bioGUNE, Derio 48160, Bizkaia, Spain	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; CIC bioGUNE	Coelho, C (corresponding author), Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St, Baltimore, MD 21205 USA.; Casadevall, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St, Baltimore, MD 21205 USA.	carolina.coelho@abdn.ac.uk; acasade1@jhu.edu	Nakayasu, Ernesto S./AAJ-8374-2020; Heyman, Heino Martin/I-1670-2014; Vij, Raghav/GQY-8282-2022; Brown, Lisa/U-8366-2019; Hamacher-Brady, Anne/G-4268-2013; Prados-Rosales, Rafael/D-5840-2019	Nakayasu, Ernesto S./0000-0002-4056-2695; Heyman, Heino Martin/0000-0003-0941-2506; Vij, Raghav/0000-0001-5812-0484; Brown, Lisa/0000-0002-7719-6596; Prados-Rosales, Rafael/0000-0001-5964-0166; Coelho, Carolina/0000-0002-7523-3031; Brady, Nathan/0000-0002-1901-5996; Smith, Daniel/0000-0002-7674-9988; Hamacher-Brady, Anne/0000-0001-5042-1338	DOE [DE-AC05-76RLO01830]; MRC [MR/N006364/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103338] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Geoffrey Perumal, Benjamin Clark, and Leslie Gunther at the Analytical Imaging Facility, Albert Einstein College of Medicine, for assistance with the transmission EM. Negative staining was performed at the Johns Hopkins Microscopy Facility, and we particularly acknowledge Barbara McClintock. We also thank the technical competence of Kimberley Zichichi from the Electron Microscopy Facility at Yale University for the immuno-EM. We thank Howard Goldfine for the kind gift of PI-PLC antiserum. The MPLEx experiment was performed in the Environmental Molecular Science Laboratory, a United States Department of Energy (DOE) national scientific user facility at the Pacific Northwest National Laboratory (PNNL) in Richland, WA. Battelle operates PNNL for the DOE under contract DE-AC05-76RLO01830.	Alvarez-Jimenez VD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00272; Bannam T, 1999, INFECT IMMUN, V67, P182, DOI 10.1128/IAI.67.1.182-186.1999; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Bonnemain C, 2004, MOL MICROBIOL, V51, P1251, DOI 10.1111/j.1365-2958.2004.03916.x; Brown L, 2015, NAT REV MICROBIOL, V13, P620, DOI 10.1038/nrmicro3480; Brown L, 2014, MOL MICROBIOL, V93, P183, DOI 10.1111/mmi.12650; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; CAMILLI A, 1991, J EXP MED, V173, P751, DOI 10.1084/jem.173.3.751; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Carvalho F, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00048; Coconnier MH, 2000, CELL MICROBIOL, V2, P487, DOI 10.1046/j.1462-5822.2000.00073.x; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Elluri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106731; Fischer W, 1999, INT J SYST BACTERIOL, V49, P653, DOI 10.1099/00207713-49-2-653; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Frydrychowicz M, 2015, SCAND J IMMUNOL, V81, P2, DOI 10.1111/sji.12247; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; GEOFFROY C, 1987, INFECT IMMUN, V55, P1641, DOI 10.1128/IAI.55.7.1641-1646.1987; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Huang QY, 2016, BBA-PROTEINS PROTEOM, V1864, P697, DOI 10.1016/j.bbapap.2016.03.008; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jiang YL, 2014, INT J MED MICROBIOL, V304, P431, DOI 10.1016/j.ijmm.2014.02.006; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Jung AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06443-1; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kong MY, 2005, GEOL SOC AM BULL, V117, P244, DOI 10.1130/B25000.1; Koutero M., 2016, THESIS; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kyle JE, 2017, BIOINFORMATICS, V33, P1744, DOI 10.1093/bioinformatics/btx046; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073196; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Mastronlcolis SK, 2008, APPL ENVIRON MICROB, V74, P4543, DOI 10.1128/AEM.02041-07; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; Muraille E, 2007, CELL MICROBIOL, V9, P1445, DOI 10.1111/j.1462-5822.2007.00883.x; Olaya-Abril A, 2014, J PROTEOMICS, V106, P46, DOI 10.1016/j.jprot.2014.04.023; Piercey MJ, 2016, INT J FOOD MICROBIOL, V223, P63, DOI 10.1016/j.ijfoodmicro.2016.02.009; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Poussin MA, 2009, MICROB PATHOGENESIS, V46, P1, DOI 10.1016/j.micpath.2008.09.008; Resch U, 2016, MBIO, V7, DOI 10.1128/mBio.00207-16; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Sawyer RT, 1996, J LEUKOCYTE BIOL, V60, P603, DOI 10.1002/jlb.60.5.603; Schnupf P, 2007, INFECT IMMUN, V75, P5135, DOI 10.1128/IAI.00164-07; Schrempf H, 2015, MICROB BIOTECHNOL, V8, P644, DOI 10.1111/1751-7915.12274; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Sontag RL, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00032-15; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Sun Y, 2012, J BACTERIOL, V194, P5274, DOI 10.1128/JB.00045-12; Thay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054661; Thumser AE, 2007, MOL CELL BIOCHEM, V299, P67, DOI 10.1007/s11010-005-9041-2; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Toyofuku M, 2019, NAT REV MICROBIOL, V17, P13, DOI 10.1038/s41579-018-0112-2; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Vadia S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002356; van Bergenhenegouwen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089121; Vdovikova S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00154; VILLANUEVA MS, 1995, J IMMUNOL, V155, P5227; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	73	61	64	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1202	1217		10.1074/jbc.RA118.006472	http://dx.doi.org/10.1074/jbc.RA118.006472			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504226	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000457879500012
J	Cantero-Recasens, G; Butnaru, CM; Brouwers, N; Mitrovic, S; Valverde, MA; Malhotra, V				Cantero-Recasens, Gerard; Butnaru, Cristian M.; Brouwers, Nathalie; Mitrovic, Sandra; Valverde, Miguel A.; Malhotra, Vivek			Sodium channel TRPM4 and sodium/calcium exchangers (NCX) cooperate in the control of Ca2+-induced mucin secretion from goblet cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mucin; sodium-calcium exchange; transient receptor potential channels (TRP channels); secretion; cystic fibrosis; goblet cell; MUC2; MUC5AC; TRPM4; TRPM5	PROTEIN-KINASE-C; NA+/CA2+ EXCHANGE; INHIBITOR KB-R7943; MUCUS SECRETION; SENSITIVITY; ACTIVATION; EXOCYTOSIS; NEURONS; HEALTH; FAMILY	Regulated mucin secretion is essential for the formation of the mucus layer that protects the underlying epithelial cells from foreign particles. Alterations in the quantity or quality of secreted mucins are therefore detrimental to airway and colon physiology. Based on various biochemical assays in several human cell lines, we report here that Na+/Ca2+ exchanger 2 (NCX2) works in conjunction with transient receptor potential cation channel subfamily M member 4 (TRPM4), and perhaps TRPM5, Na+ channels to control Ca2+-mediated secretion of both mucin 2 (MUC2) and MUC5AC from HT29-18N2 colonic cancer cells. Differentiated normal bronchial epithelial (NHBE) cells and tracheal cells from patients with cystic fibrosis (CFT1-LC3) expressed only TRPM4 and all three isoforms of NCXs. Blocking the activity of TRPM4 or NCX proteins abrogated MUC5AC secretion from NHBE and CFT1-LC3 cells. Altogether, our findings reveal that NCX and TRPM4/TRPM5 are both required for mucin secretion. We therefore propose that these two proteins could be potential pharmacological targets to control mucus-related pathologies such as cystic fibrosis.	[Cantero-Recasens, Gerard; Butnaru, Cristian M.; Brouwers, Nathalie; Malhotra, Vivek] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain; [Malhotra, Vivek] UPF, Barcelona, Spain; [Mitrovic, Sandra] Univ Hosp Basel, Clin Chem, Petersgraben 4, CH-4031 Basel, Switzerland; [Valverde, Miguel A.] Univ Pompeu Fabra, Fac Hlth & Life Sci, Lab Mol Physiol, Barcelona 08003, Catalonia, Spain; [Malhotra, Vivek] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Basel; Pompeu Fabra University; ICREA	Malhotra, V (corresponding author), Ctr Genom Regulat CRG, Dept Cell & Dev Biol, Carrer Dr Aiguader 88, Barcelona 08003, Spain.	vivek.malhotra@crg.eu	Brouwers, Nathalie/L-2089-2014; Cantero-Recasens, Gerard/AAE-9003-2022; Cantero-Recasens, Gerard/AAH-1697-2019	Brouwers, Nathalie/0000-0002-9808-9394; Cantero-Recasens, Gerard/0000-0001-6452-782X; Valverde, Miguel A./0000-0002-6961-3361	Spanish Ministry of Economy and Competitiveness, through the Programmes Centro de Excelencia Severo Ochoa 2013-2017 [SEV-2012-0208]; Spanish Ministry of Economy and Competitiveness [SAF2015-69762R]; Maria de Maeztu Units of Excellence in RD [MDM-2015-0502, FPDI-2013-16916]	Spanish Ministry of Economy and Competitiveness, through the Programmes Centro de Excelencia Severo Ochoa 2013-2017; Spanish Ministry of Economy and Competitiveness(Spanish Government); Maria de Maeztu Units of Excellence in RD	This work was supported by the Spanish Ministry of Economy and Competitiveness, through the Programmes Centro de Excelencia Severo Ochoa 2013-2017 (SEV-2012-0208) and Maria de Maeztu Units of Excellence in R&D (MDM-2015-0502) and Grant FPDI-2013-16916 (to G.C.-R.). The research leading to these results was supported by Spanish Ministry of Economy and Competitiveness Grant SAF2015-69762R (to M. A. V.). The authors declare that they have no conflicts of interest with the contents of this article. This work reflects only the authors' views and the Community is not liable for any use that may be made of the information contained therein.	Abdullah LH, 1997, AM J PHYSIOL-LUNG C, V273, pL201, DOI 10.1152/ajplung.1997.273.1.L201; Adler Kenneth B, 2013, Front Endocrinol (Lausanne), V4, P129, DOI 10.3389/fendo.2013.00129; Arakawa N, 2000, BIOCHEM BIOPH RES CO, V279, P354, DOI 10.1006/bbrc.2000.3968; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Cantero-Recasens G, 2018, ELIFE, V7, DOI 10.7554/eLife.39729; Conway JD, 2003, AM J PHYSIOL-LUNG C, V284, pL945, DOI 10.1152/ajplung.00410.2002; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Dickinson JD, 2016, AUTOPHAGY, V12, P397, DOI 10.1080/15548627.2015.1056967; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Guinamard R, 2014, BRIT J PHARMACOL, V171, P1600, DOI 10.1111/bph.12582; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; Harper AGS, 2016, ADV EXP MED BIOL, V898, P67, DOI 10.1007/978-3-319-26974-0_4; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Iwamoto T, 2001, MOL PHARMACOL, V59, P524, DOI 10.1124/mol.59.3.524; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jones LC, 2012, J PHYSIOL-LONDON, V590, P545, DOI 10.1113/jphysiol.2011.222091; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kimura J, 1999, BRIT J PHARMACOL, V128, P969, DOI 10.1038/sj.bjp.0702869; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Lee H, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-13875; Li DY, 2012, INVEST OPHTH VIS SCI, V53, P6928, DOI 10.1167/iovs.12-10163; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lorenz Holger, 2008, V440, P227, DOI 10.1007/978-1-59745-178-9_17; Lu S, 2011, J PHARMACOL EXP THER, V336, P178, DOI 10.1124/jpet.110.171561; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Mitrovic S, 2013, ELIFE, V2, DOI 10.7554/eLife.00658; Niu CF, 2007, EUR J PHARMACOL, V573, P161, DOI 10.1016/j.ejphar.2007.06.033; OLSEN JC, 1992, HUM GENE THER, V3, P253, DOI 10.1089/hum.1992.3.3-253; Park JA, 2007, AM J PATHOL, V171, P1822, DOI 10.2353/ajpath.2007.070318; PHILLIPS TE, 1995, IN VITRO CELL DEV-AN, V31, P421, DOI 10.1007/BF02634251; Pintado AJ, 2000, BRIT J PHARMACOL, V130, P1893, DOI 10.1038/sj.bjp.0703519; Ren BH, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150004; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rossi AH, 2004, J PHYSIOL-LONDON, V559, P555, DOI 10.1113/jphysiol.2004.070433; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sobolevsky AI, 1999, NEUROPHARMACOLOGY, V38, P1235, DOI 10.1016/S0028-3908(99)00040-4; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tuvim MJ, 2009, J BIOL CHEM, V284, P9781, DOI 10.1074/jbc.M807849200; Van Kolen Kristof, 2006, Purinergic Signal, V2, P451, DOI 10.1007/s11302-006-9008-0; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	49	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					816	826		10.1074/jbc.RA117.000848	http://dx.doi.org/10.1074/jbc.RA117.000848			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482841	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000458670200008
J	Lo, TS; Chua, S; Tan, YL; Patrimonio, MC; Pue, LB				Lo, Tsia-Shu; Chua, Sandy; Tan, Yiap Loong; Patrimonio, Ma. Clarissa; Pue, Leng Boi			Ultrasonography and clinical outcomes following anti-incontinence procedures (Monarc vs MiniArc): A 3-year post-operative review	PLOS ONE			English	Review							URINARY-INCONTINENCE; IMPACT QUESTIONNAIRE; SHORT-FORM; TENSION; TAPE; WOMEN; ULTRASOUND; DISTRESS; QUALITY	Objective To compare the ultrasonographic positional changes of mid-urethral sling(MUS) tape in relation to symphysis pubis, and the different clinical outcomes among women who underwent MUS insertion with MiniArc TM or Monarc TM for the treatment of stress urinary incontinence 3 years after. Materials and methods A retrospective follow-up study on patients with clinically confirmed stress urodynamic incontinence and urodynamic stress incontinence who had undergone MiniArc or Monarc surgery. Data regarding preoperative evaluation, intraoperative complications and postoperative follow-ups were collated. Main outcome is to determine the change in position of the sling through measurement of the x- and y-axis at rest and during Valsalva maneuver using the 3D introital ultrasound. Results A total of 138 patients were evaluated, 82 belonged to Monarc and 56 to MiniArc. At 3years, objective and subjective cure rates for MiniArc and Monarc were comparable (88%, 91%; p>0.05; 83%, 89%, p>0.05 respectively). Ultrasonographic changes between MiniArc and Monarc from 6 months to 3 years, showed MiniArc to exhibit significant movement in both x[ 3.0 +/- 0.4 mm vs. 2.2 +/- 0.3 mm (p = 0.02) at rest; 2.6 +/- 0.3 mm vs. 1.6 +/- 0.3 mm (p<0.001) during valsalva] and y- axis [3.5 +/- 0.5 mm vs. 2.0 +/- 0.3 mm (p<0.001) at rest; 3.3 +/- 0.5 mm vs. 2.9 +/- 0.3 mm (p = 0.037) during Valsalva]. The mobility of MiniArc was significantly more than Monarc from rest to Valsalva (1.1 +/- 0.4 mm vs. 0.3 +/- 0.3 mm, p = 0.001). Tightness of the sling assessed from the major and minor axis of the urethral core had no significant difference in both groups at rest and during Valsalva. Urethral kinking percentage and the location of the sling did not yield statistical difference. Conclusion Maintenance of continence rates of mid- urethral slings depends on the compressive effect of the sling on the urethra, urethral kinking, and sling fixation. From 6months to 3 years, MiniArc changed its position in both x- and y- axis over time, which the authors attribute to loosening of the anchoring mechanism since no clinical relevance could be sought.	[Lo, Tsia-Shu] Chang Gung Mem Hosp, Med Ctr, Dept Obstet & Gynecol, Keelung, Taiwan; [Lo, Tsia-Shu; Chua, Sandy; Patrimonio, Ma. Clarissa] Chang Gung Mem Hosp, Linkou Med Ctr, Div Urogynecol, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Lo, Tsia-Shu] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Chua, Sandy] Cebu Velez Gen Hosp, Dept Obstet & Gynecol, Cebu Inst Med, Cebu, Philippines; [Tan, Yiap Loong] KPJ Healthcare, Dept Obstet & Gynecol, Kuching Specialist Hosp, Kuching, Sarawak, Malaysia; [Patrimonio, Ma. Clarissa] Dr Pablo O Torre Mem Hosp, Dept Obstet & Gynecol, Bacolod City, Philippines; [Pue, Leng Boi] Ramsay Sime Darby Hlth Care, Dept Obstet & Gynecol, Subang Jaya Med Ctr, Selangor, Malaysia	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lo, TS (corresponding author), Chang Gung Mem Hosp, Med Ctr, Dept Obstet & Gynecol, Keelung, Taiwan.; Lo, TS (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Div Urogynecol, Dept Obstet & Gynecol, Taoyuan, Taiwan.; Lo, TS (corresponding author), Chang Gung Univ, Sch Med, Taoyuan, Taiwan.	2378@cgmh.org.tw	Tan, Yiap Loong/AGY-8952-2022					Anding R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/401417; Chantarasorn V, 2011, INT UROGYNECOL J, V22, P493, DOI 10.1007/s00192-010-1306-y; Davila GW, 2006, INT UROGYNECOL J, V17, P460, DOI 10.1007/s00192-005-0039-9; Delorme E, 2001, PROG UROL, V11, P1306; Dietz HP, 2006, INT UROGYNECOL J, V17, P566, DOI 10.1007/s00192-006-0065-2; Dietz HP, 2011, INT UROGYNECOL J, V22, P1085, DOI 10.1007/s00192-011-1402-7; Haylen BT, 2008, OBSTET GYNECOL, V111, P1305, DOI 10.1097/AOG.0b013e31817615b2; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Kennelly MJ, 2010, J UROLOGY, V184, P604, DOI 10.1016/j.juro.2010.04.003; Lo TS, 2004, UROLOGY, V63, P671, DOI 10.1016/j.urology.2003.10.070; Lo TS, 2001, ACTA OBSTET GYN SCAN, V80, P65, DOI 10.1034/j.1600-0412.2001.800113.x; Lo TS, 2018, J MINIM INVAS GYN, V25, P116, DOI 10.1016/j.jmig.2017.08.647; Lo TS, 2016, INT UROGYNECOL J, V27, P1653, DOI 10.1007/s00192-016-3019-3; Lo TS, 2016, TAIWAN J OBSTET GYNE, V55, P519, DOI 10.1016/j.tjog.2015.12.019; Lo TS, 2014, EUR J OBSTET GYN R B, V182, P91, DOI 10.1016/j.ejogrb.2014.09.015; Mandaya A, 2015, NON TRADITIONAL REF; Petros P E, 1993, Scand J Urol Nephrol Suppl, V153, P1; Rogers RG, 2003, INT UROGYNECOL J PEL, V14, P164, DOI 10.1007/s00192-003-1063-2; Schauer I, 2017, NEUROUROL URODYNAM, V36, P614, DOI 10.1002/nau.22972; Shek KL, 2010, J UROLOGY, V183, P1450, DOI 10.1016/j.juro.2009.12.028; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Su TH, 2010, J SEX MED, V7, P3940, DOI 10.1111/j.1743-6109.2010.01891.x; UEBERSAX JS, 1995, NEUROUROL URODYNAM, V14, P131, DOI 10.1002/nau.1930140206; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; Ulmsten U, 1996, INT UROGYNECOL J PEL, V7, P81; Yang JM, 2012, ULTRASOUND OBST GYN, V39, P458, DOI 10.1002/uog.10086	27	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207375	10.1371/journal.pone.0207375	http://dx.doi.org/10.1371/journal.pone.0207375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513097	Green Submitted, Green Published, gold			2022-12-26	WOS:000452204800009
J	Arpad, T				Arpad, Todor			Willing to pay to save the planet? Evaluating support for increased spending on sustainable development and environmentally friendly policies in five countries	PLOS ONE			English	Article							CORPORATE SOCIAL-RESPONSIBILITY; KUZNETS CURVE; EMISSIONS; TRUST	While the 2016 Paris Agreement is in many ways an important attainment with the potential to represent a milestone in humanity's path towards sustainable development, and avoid thus a potential calamitous and destructive future, the achievement of the goals set in the agreement is a long way off. This paper investigates one of the most important worldwide hurdles frustrating the implementation of the policies required to limit environmental degradation and limit pollution, namely the still insufficient public support for the necessary environmental policies and their associated cost. Using a comparative database generated through an experimental study on tax compliance and policy preferences run in five countries (USA, UK, Italy, Sweden and Romania), I will evaluate five explanatory models of the degree to which people support environmentally friendly policies by accepting higher tax burdens and increased collective solidarity.	[Arpad, Todor] Natl Univ Polit Studies & Publ Adm, Polit Sci Dept, Bucharest, Romania	National University of Political Studies & Public Administration	Arpad, T (corresponding author), Natl Univ Polit Studies & Publ Adm, Polit Sci Dept, Bucharest, Romania.	todor.arpad@politice.ro			ERC [295675]	ERC(European Research Council (ERC)European Commission)	Research conducted within the "Willing to pay? Testing Institutionalist Theory with Experiments" ERC Grant agreement no. 295675, coordinated by Prof. Sven Steinmo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atici C, 2009, SUSTAIN DEV, V17, P155, DOI 10.1002/sd.372; Banfield E.C., 1967, MORAL BASIS BACKWARD; Bechtel MM, 2013, P NATL ACAD SCI USA, V110, P13763, DOI 10.1073/pnas.1306374110; Bernauer T, 2013, ANNU REV POLIT SCI, V16, P421, DOI 10.1146/annurev-polisci-062011-154926; Bruner DM, 2018, J BEHAV EC; Castiglione C, 2014, COGENT ECON FINANC, V2, DOI 10.1080/23322039.2014.967362; D'Attoma J, 2017, RES POLITICS, V4, DOI 10.1177/2053168017707151; Davidovic D, 2016, TRUST VALUES QUALITY; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Dunlap Riley E., 2001, ENVIRON POLIT, V10, P23, DOI DOI 10.1080/714000580; Edlund J, 2013, J PUBLIC POLICY, V33, P295, DOI 10.1017/S0143814X13000160; European Commission, 2016, TAX POL EUR UN 2016; Fairbrother M, 2019, BRIT J POLIT SCI, V49, P661, DOI 10.1017/S0007123416000727; Franzen A, 2013, GLOBAL ENVIRON CHANG, V23, P1001, DOI 10.1016/j.gloenvcha.2013.03.009; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Hakkinen K, 2014, PERS INDIV DIFFER, V70, P62, DOI 10.1016/j.paid.2014.06.030; Harring N, 2013, SUSTAINABILITY-BASEL, V5, P210, DOI 10.3390/su5010210; Jagers SC, 2018, J ENVIRON PLANN MAN, V61, P86, DOI 10.1080/09640568.2017.1289902; Kaika D, 2013, ENERG POLICY, V62, P1392, DOI 10.1016/j.enpol.2013.07.131; Kollmann A, 2015, CESIFO SEMINAR SER, P53; Kuznets S, 1955, AM ECON REV, V45, P1; Lee AR, 2000, INT J PUBLIC OPIN R, V12, P372, DOI 10.1093/ijpor/12.4.372; Levi M., 1989, RULE REVENUE; Lozza E., 2013, J SOC POLITICAL PSYC, V1, P51, DOI [10.5964/jspp.v1i1.108, DOI 10.5964/JSPP.V1I1.108]; Lyon TP, 2008, REV ENV ECON POLICY, V2, P240, DOI 10.1093/reep/ren004; Mazurkiewicz P., 2004, WORLD BANK, V2, P1; McCright AM, 2014, SOC SCI RES, V48, P251, DOI 10.1016/j.ssresearch.2014.06.008; Medarevic S, 2012, ENV CORPORATE SOCIAL; Muller NZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181407; Murphy RO, 2011, 1804189 SOC SCI RES; Neumayer E, 2003, ECOL ECON, V45, P203, DOI 10.1016/S0921-8009(03)00012-0; Pampel F, 2017, I ATTITUDES SHAPE TA; Pedersen LH, 2007, J EUR PUBLIC POLICY, V14, P59, DOI 10.1080/13501760601071653; Rahman N, 2012, J BUS ETHICS, V105, P307, DOI 10.1007/s10551-011-0967-x; Rashid NRNA, 2014, PROCD SOC BEHV, V130, P499, DOI 10.1016/j.sbspro.2014.04.058; Steinmo Sven., 1996, TAXATION DEMOCRACY S; Tabellini G, 2010, J EUR ECON ASSOC, V8, P677; Torgler B, 2002, J ECON SURV, V16, P657, DOI 10.1111/1467-6419.00185; Ward JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164733; Zhang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150277	40	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207862	10.1371/journal.pone.0207862	http://dx.doi.org/10.1371/journal.pone.0207862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496230	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800056
J	Bak, Y; Jun, S; Choi, JY; Lee, Y; Lee, SK; Han, S; Shin, NY				Bak, Yunjin; Jun, Sunyoung; Choi, Jun Yong; Lee, Youngjoon; Lee, Seung-Koo; Han, Sanghoon; Shin, Na-Young			Altered intrinsic local activity and cognitive dysfunction in HIV patients: A resting-state fMRI study	PLOS ONE			English	Article							INFECTED OLDER-ADULTS; NEUROCOGNITIVE DISORDER; FUNCTIONAL CONNECTIVITY; BRAIN ABNORMALITIES; CORTEX; DAMAGE; ERA	Purpose To characterize resting-state brain activation patterns and investigate altered areas for cognitive decline in HIV patients. Methods Twelve male HIV patients with intact cognition (HIV-IC), 10 with HIV-associated neurocognitive disorder (HAND), and 11 male healthy controls (HC) underwent resting-state functional MRI (rsfMRI). Three rsfMRI values, regional homogeneity (ReHo), amplitude of low-frequency fluctuation (ALFF), and fractional ALFF (fALFF) were calculated and compared between groups. Correlation analyses were performed between rsfMRI values and neuropsychological tests. Results rsfMRI analyses revealed decreased rsfMRI values in the frontal areas, and increases in the posterior brain regions for both HIV-IC and HAND compared to HC. When directly compared to HIV-IC, HAND showed lower fALFF in the orbitofrontal cortex and higher ReHo in the primary sensorimotor area. Additionally, decreased orbitofrontal fALFF, increased sensorimotor ReHo, and a larger difference between the two values were highly correlated with decreased verbal memory and executive function in HIV patients. Conclusions Regardless of cognitive status, altered local intrinsic activities were found in HIV patients. The orbitofrontal cortex and primary sensorimotor area were more disrupted in HAND relative to HIV-IC and correlated with behavioral performance, suggesting these areas are relevant to cognitive impairment in HIV patients.	[Bak, Yunjin; Shin, Na-Young] Catholic Univ Korea, Coll Med, Dept Radiol, Seoul, South Korea; [Jun, Sunyoung; Han, Sanghoon] Yonsei Univ, Dept Psychol, Seoul, South Korea; [Choi, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choi, Jun Yong] Yonsei Univ, Coll Med, AIDS Res Inst, Seoul, South Korea; [Lee, Youngjoon] Yonsei Univ, Coll Med, Dept Med Educ, Seoul, South Korea; [Lee, Seung-Koo] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, NY (corresponding author), Catholic Univ Korea, Coll Med, Dept Radiol, Seoul, South Korea.; Han, S (corresponding author), Yonsei Univ, Dept Psychol, Seoul, South Korea.	sanghoon.han@yonsei.ac.kr; nyshin@catholic.ac.kr		Shin, Na-Young/0000-0003-1157-6366; Lee, Seung-Koo/0000-0001-5646-4072; Lee, Youngjoon/0000-0002-9602-5186; Choi, Jun Yong/0000-0002-2775-3315; Jun, Suhnyoung/0000-0001-7849-0837	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF- 2013R1A1A2005412, NRF-2014R1A1A2055116]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported funding by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF- 2013R1A1A2005412 and NRF-2014R1A1A2055116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ann HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153493; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Becker KM, 2013, J NEUROVIROL, V19, P586, DOI 10.1007/s13365-013-0220-8; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Chaganti JR, 2017, AM J NEURORADIOL, V38, P1623, DOI 10.3174/ajnr.A5246; Dore GJ, 2003, AIDS, V17, P1539, DOI 10.1097/00002030-200307040-00015; Elman JA, 2013, NEUROIMAGE, V82, P44, DOI 10.1016/j.neuroimage.2013.05.113; EVERALL I, 1993, J NEUROPATH EXP NEUR, V52, P561, DOI 10.1097/00005072-199311000-00002; Goulden N, 2014, NEUROIMAGE, V99, P180, DOI 10.1016/j.neuroimage.2014.05.052; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton R.K., 1993, WISCONSIN CARD SORTI; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Herting MM, 2013, J COGNITIVE NEUROSCI, V25, P595, DOI 10.1162/jocn_a_00344; Kallianpur KJ, 2012, CEREB CORTEX, V22, P2065, DOI 10.1093/cercor/bhr285; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kim HK, 1999, HDB REY KIM MEMORY A; Kim HG, 2017, EUR RADIOL, V27, P2679, DOI 10.1007/s00330-016-4578-x; Kim M, 2004, KOREAN J CLIN PSYCHO, V23, P323; Ku NS, 2014, HIV MED, V15, P470, DOI 10.1111/hiv.12137; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; Rolls E. T., 2013, EMOTION DECISION MAK; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 2004, ANAT REC PART A, V281A, P1212, DOI 10.1002/ar.a.20126; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Shin NY, 2017, EUR RADIOL, V27, P4721, DOI 10.1007/s00330-017-4836-6; SNIDER WD, 1983, ANN NEUROL, V14, P403, DOI 10.1002/ana.410140404; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Thomas JB, 2013, NEUROLOGY, V80, P1186, DOI 10.1212/WNL.0b013e318288792b; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; Wang X, 2011, BRAIN CONNECT, V1, P207, DOI 10.1089/brain.2011.0016; WILEY CA, 1991, ANN NEUROL, V29, P651, DOI 10.1002/ana.410290613; Wilson TW, 2015, HUM BRAIN MAPP, V36, P897, DOI 10.1002/hbm.22674; Wilson TW, 2013, J NEUROIMMUNE PHARM, V8, P965, DOI 10.1007/s11481-013-9477-1; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yeom TH, 1992, KOREAN VERSION WECHS; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhou YW, 2017, NEURORADIOLOGY, V59, P1133, DOI 10.1007/s00234-017-1912-1; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; 이택영, 2001, [Physical Therapy Korea, 한국전문물리치료학회지], V8, P87	40	13	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207146	10.1371/journal.pone.0207146	http://dx.doi.org/10.1371/journal.pone.0207146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496203	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800024
J	Cassiolato, AP; Almeida, SCG; Andrade, AL; Minamisava, R; Brandileone, MCD				Cassiolato, Ana Paula; Grassi Almeida, Samanta Cristine; Andrade, Ana Lucia; Minamisava, Ruth; de Cunto Brandileone, Maria Cristina			Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae snerotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil	PLOS ONE			English	Article							SEROTYPE 19A; POPULATION SNAPSHOT; GENETIC-STRUCTURE; TEMPORAL TRENDS; UNITED-STATES; DISEASE; CHILDREN; INCREASE; ST320; INFECTIONS	Background In 2010, a ten-valent pneumococcal conjugate vaccine (PCV10) was introduced in the routine infant national immunization program in Brazil. Invasive pneumococcal disease (IPD) caused by serotype 19A (Spn19A) increased after the introduction of PCVs in several countries. We compared the frequency, antimicrobial resistance and molecular patterns of invasive Spn19A strains before and after PCV10 introduction in Brazil using data from the national laboratory-based surveillance. Methods We analyzed invasive Spn19A strains isolated from 2005-2009 (pre-PCV10 period), 2011-2015 and 2016-2017 (post-PCV10 periods). Antimicrobial susceptibility was performed for all Spn19A strains, and multilocus sequence typing (MLST) was performed for strains isolated in the age groups < 5 years and >= 50 years. Results Among the study period, a total of 9,852 invasive Spn strains were analyzed, and 673 (6.8%) belonged to serotype 19A. Overall, the proportion of Spn19A among the total number of IPD strains increased from 2.8% in 2005-2009 to 7.0% and 16.4% in 2011-2015 and 2016-2017, respectively. The relative increase in Spn19A was observed especially in children < 5 years old (2005-2009: 3.2%; 2011-2015: 15.5%; 2016-2017: 31.2%). The percentage of penicillin resistance (MIC 2.0-4.0 mu g/mL), erythromycin resistance and multidrug resistance (MDR) increased after PCV10 introduction due to the expansion of the MDR clonal complex CC320 (2005-2009: 8.6%; 2011-2015: 56.1%; 2016-2017: 66.5%). Conclusion We observed an expansion of MDR-CC320 among invasive Spn19A strains after PCV10 introduction in Brazil, probably related to a combination of factors, such as vaccination and antimicrobial pressure. Continued surveillance of Spn19A strains is necessary to monitor the sustainability of this clonal complex in the Brazilian population.	[Cassiolato, Ana Paula; Grassi Almeida, Samanta Cristine; de Cunto Brandileone, Maria Cristina] Adolfo Lutz Inst, Ctr Bacteriol, Natl Lab Meningitis & Pneumococcal Infect, Sao Paulo, SP, Brazil; [Andrade, Ana Lucia] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Minamisava, Ruth] Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil	Instituto Adolfo Lutz; Universidade Federal de Goias; Universidade Federal de Goias	Brandileone, MCD (corresponding author), Adolfo Lutz Inst, Ctr Bacteriol, Natl Lab Meningitis & Pneumococcal Infect, Sao Paulo, SP, Brazil.	maria.brandileone@ial.sp.gov.br	Almeida, Samanta C G/J-2798-2017; de Cunto Brandileone, Maria Cristina/J-2809-2017	Almeida, Samanta C G/0000-0002-0714-8142; de Cunto Brandileone, Maria Cristina/0000-0002-7254-9102; Minamisava, Ruth/0000-0001-9352-5567; Cassiolato, Ana Paula/0000-0001-5007-5383	Sao Paulo Research Foundation/FAPESP [13/03968-6]; Coordination for the Improvement of Higher Education Personnel/CAPES; National Council for Scientific and Technological Development/CNPq [304211/2014-1, 306096/2010-2]; Adolfo Lutz Institute	Sao Paulo Research Foundation/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Adolfo Lutz Institute	This study was financed by The Sao Paulo Research Foundation/FAPESP (grant to A.P. Cassiolato No. 13/03968-6), The Coordination for the Improvement of Higher Education Personnel/CAPES, The National Council for Scientific and Technological Development/CNPq [grants to M.C. C. Brandileone (Grant No. 304211/2014-1) and A. L. Andrade (Grant No. 306096/2010-2)] and Adolfo Lutz Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Azevedo J, 2016, J MED MICROBIOL, V65, P1164, DOI 10.1099/jmm.0.000346; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Brandileone MCC, 2018, VACCINE, V36, P2559, DOI 10.1016/j.vaccine.2018.04.010; Caierao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111129; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Christophe BL, 2018, J MED MICROBIOL; CLIS, 2016, PERFORMANCE STANDARD, V26th; Conklin L, 2014, PEDIATR INFECT DIS J, V33, pS109, DOI 10.1097/INF.0000000000000078; Dagan R, 2009, J INFECT DIS, V199, P776, DOI 10.1086/597044; Del Grosso M, 2013, J MED MICROBIOL, V62, P1220, DOI 10.1099/jmm.0.061242-0; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Hsieh YC, 2013, J INFECT DIS, V208, P203, DOI 10.1093/infdis/jit145; Hulten KG, 2013, J CLIN MICROBIOL, V51, P1294, DOI 10.1128/JCM.00058-13; Isturiz R, 2017, EXPERT REV VACCINES, V16, P1007, DOI 10.1080/14760584.2017.1362339; Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Mahjoub-Messai F, 2009, J CLIN MICROBIOL, V47, P837, DOI 10.1128/JCM.01547-08; Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, DOI [10.1016/j.cmi.2015.08.027, 10.1016/j.cmi.2016.08.001]; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Myint TTH, 2013, ADV THER, V30, P127, DOI 10.1007/s12325-013-0007-6; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Paulo AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176723; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pillai DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-642; Pneumococcal Molecular Epidemiology Network (PMEN), CRIT CLON NOM; Potin M, 2016, REV CHIL INFECTOL, V33, P304, DOI 10.4067/S0716-10182016000300009; Ramos V, 2014, VACCINE, V32, P755, DOI 10.1016/j.vaccine.2013.12.024; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Rinta-Kokko H, 2018, VACCINE, V36, P1934, DOI 10.1016/j.vaccine.2018.03.001; Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1; van der Linden M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-70; Vestrheim DF, 2012, CLIN VACCINE IMMUNOL, V19, P443, DOI 10.1128/CVI.05563-11; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; World Health Organization and Centers for Disease Control and Prevention, 2011, LAB METH DIAGN MEN C	48	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208211	10.1371/journal.pone.0208211	http://dx.doi.org/10.1371/journal.pone.0208211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496296	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800110
J	D'Avila, DA; Galvao, LMC; Sousa, GR; Britto, C; Moreira, OC; Chiari, E				D'Avila, Daniella Alchaar; Galvao, Lucia Maria C.; Sousa, Giovane R.; Britto, Constanca; Moreira, Otacilio C.; Chiari, Egler			Monitoring the parasite load in chronic Chagas disease patients: comparison between blood culture and quantitative real time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; TRYPANOSOMA-CRUZI INFECTION; LINKED-IMMUNOSORBENT-ASSAY; CHRONIC PHASE; DIAGNOSIS; DNA; SAMPLES; QUANTIFICATION; IDENTIFICATION; AMPLIFICATION	Background Despite the improvements in diagnostic tools for detection of Trypanosoma cruzi in human blood samples, the isolation of parasite from bloodstream in the chronic phase of Chagas disease is challenging. Thus, there is an increasing interest in the development of strategies that allow an accurate monitoring of the parasite load in bloodstream of Chagas disease patients. Given that, the comparison of a classical diagnostic method such as blood culture and multiplex quantitative real-time PCR (qPCR) was few explored so far. Therefore, this study aimed to compare the detection and quantification of T. cruzi load in the circulating blood of patients with chronic Chagas disease, using blood culture and qPCR techniques. Methods/Principal findings The multiplex real-time quantitative PCR assay (qPCR) based on TaqMan technology was evaluated in 135 blood samples from 91 patients with chronic Chagas disease presenting indeterminate (asymptomatic, n = 23) and cardiac (chronic cardiomyopathy, n = 68) forms, in comparison with the classical blood culture (BC) technique. The total positivity of qPCR and BC was 58.5% and 49.6%, respectively. The median parasite load of all positive patients was 1.18 [0.39-4.23] par. eq./mL, ranging from 0.01 to 116.10 par. eq./mL. We did not find significant differences between T. cruzi load with age and distinct clinical manifestations of patients. Conclusions/Significance Our data suggest that qPCR can be an auxiliary tool for studies that require T. cruzi isolation from the bloodstream of patients with chronic Chagas disease, after the establishment of a parasite load cut-off that guarantees a relative success rate of parasite isolation using BC technique.	[D'Avila, Daniella Alchaar; Galvao, Lucia Maria C.; Chiari, Egler] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Programa Posgrad Parasitol, Belo Horizonte, MG, Brazil; [Sousa, Giovane R.] Harvard Med Sch, Joslin Diabet Ctr, Sect Immunobiol, Boston, MA USA; [Britto, Constanca; Moreira, Otacilio C.] Fiocruz MS, Lab Biol Mol & Doencas Endem, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil	Universidade Federal de Minas Gerais; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Fundacao Oswaldo Cruz	Moreira, OC (corresponding author), Fiocruz MS, Lab Biol Mol & Doencas Endem, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.	otacilio@ico.fiocruz.br	da Cunha Galvão, Lúcia Maria/A-1512-2014; Moreira, Otacilio/AAS-5839-2020; Sousa, PhD, Giovane/H-6102-2016; Britto, Constanca/L-7658-2016	Moreira, Otacilio/0000-0002-5340-8697; Sousa, PhD, Giovane/0000-0003-0085-3882; Galvao, Lucia/0000-0002-6207-4502; Britto, Constanca/0000-0003-0788-7030	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) [23041]; FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); Fiocruz (Fundacao Oswaldo Cruz); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant MCTI/CNPq) [14/2013 (475572/2013-0)]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fiocruz (Fundacao Oswaldo Cruz); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant MCTI/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, grant no 23041), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro), Fiocruz (Fundacao Oswaldo Cruz) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant MCTI/CNPq No 14/2013 (475572/2013-0)) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. C Britto and OC Moreira are researcher fellows of FAPERJ (CNE - Cientista do nosso Estado, JCNE - Jovem Cientista do Nosso Estado) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade S.G., 1985, REV SOC BRASILEIRA M, V18, P39, DOI DOI 10.1590/S0037-86821985000100008; Antas PRZ, 2000, PARASITOL RES, V86, P813, DOI 10.1007/PL00008507; Apt W, 2016, ACTA TROP, V162, P155, DOI 10.1016/j.actatropica.2016.06.025; ARAUJO FG, 1986, INFECT IMMUN, V53, P179, DOI 10.1128/IAI.53.1.179-185.1986; AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N; Balouz V, 2017, ADV PARASIT, V97, P1, DOI 10.1016/bs.apar.2016.10.001; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; BRITTO C, 1993, MEM I OSWALDO CRUZ, V88, P171, DOI 10.1590/S0074-02761993000100030; Britto CC, 2009, MEM I OSWALDO CRUZ, V104, P122, DOI 10.1590/S0074-02762009000900018; Burgos JM, 2007, INT J PARASITOL, V37, P1319, DOI 10.1016/j.ijpara.2007.04.015; Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07; Cancado JR, 1999, MEM I OSWALDO CRUZ, V94, P331, DOI 10.1590/S0074-02761999000700064; Ramirez JC, 2015, J MOL DIAGN, V17, P605, DOI 10.1016/j.jmoldx.2015.04.010; Castro AM, 2002, PARASITOL RES, V88, P894, DOI 10.1007/s00436-002-0679-3; Castro C, 2000, Rev Soc Bras Med Trop, V33, P427; Chiari E, 1989, Rev Soc Bras Med Trop, V22, P19, DOI 10.1590/S0037-86821989000100004; CHIARI E., 1966, REV INST MED TROP SAO PAULO, V8, P134; Chiari E, 1975, REV SOC BRAS MED TRO, V9, P133; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; Cura CI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003765; D'Avila DA, 2009, J CLIN MICROBIOL, V47, P1718, DOI 10.1128/JCM.01658-08; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; Duffy T, 2009, PLOS NEGLECT TROP D, V3, P1; Duffy T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002000; Fleiss J.L., 2013, STAT METHODS RATES P; Flores-Chaves M, 2006, ENFERM INFEC MICR CL, V3, P29; Freitas JM, 2005, INT J PARASITOL, V35, P411, DOI 10.1016/j.ijpara.2004.10.023; GALVAO LMC, 1993, T ROY SOC TROP MED H, V87, P220, DOI 10.1016/0035-9203(93)90501-G; Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191; Gomes YM, 2009, MEM I OSWALDO CRUZ, V104, P115, DOI 10.1590/S0074-02762009000900017; Hernandez C, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0005112, 10.1371/journal.pntd.0004997]; Hernandez D., 2018, PARASITOLOGY, V145, P1; Hollander M, 2014, NONPARAMETRIC STAT M; Junqueira ACV, 1996, T ROY SOC TROP MED H, V90, P129, DOI 10.1016/S0035-9203(96)90111-X; Krettli A. U., 1984, Memorias do Instituto Oswaldo Cruz, V79, P157, DOI 10.1590/S0074-02761984000500027; Krettli AU, 2009, MEM I OSWALDO CRUZ, V104, P142, DOI 10.1590/S0074-02762009000900020; Lages-Silva E, 2001, AM J TROP MED HYG, V65, P435, DOI 10.4269/ajtmh.2001.65.435; Lages-Silva E, 2006, J CLIN MICROBIOL, V44, P2167, DOI 10.1128/JCM.02124-05; Landis J. R., 1977, BIOMETRICS; Le xenodiagnostic Brumpt E., 1914, B SOC PATHOL EXOT, V10, P706; Luquetti AO, 2005, REV SOC BRAS MED TRO, V38, P27; Meira WSF, 2002, J CLIN MICROBIOL, V40, P3735, DOI 10.1128/JCM.40.10.3735-3740.2002; Melo MF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0770-0; MELO RC, 1978, J PARASITOL, V64, P475, DOI 10.2307/3279787; Moreira OC, 2013, ACTA TROP, V125, P23, DOI 10.1016/j.actatropica.2012.08.020; Martin CMS, 2017, INFECT GENET EVOL, V49, P300, DOI 10.1016/j.meegid.2017.02.006; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Qvarnstrom Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001689; Ramirez JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188550; Rocha MOC, 2003, FRONT BIOSCI-LANDMRK, V8, pE44, DOI 10.2741/926; Saavedra M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1664-5; Schijman AG, 2000, J HEART LUNG TRANSPL, V19, P1114, DOI 10.1016/S1053-2498(00)00168-6; Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; SOUTO RP, 1993, MOL BIOCHEM PARASIT, V62, P45, DOI 10.1016/0166-6851(93)90176-X; Volpato FCZ, 2017, REV SOC BRAS MED TRO, V50, P506, DOI 10.1590/0037-8682-0046-2017; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	57	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208133	10.1371/journal.pone.0208133	http://dx.doi.org/10.1371/journal.pone.0208133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496249	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800098
J	Mahmud, N; Khanal, A; Taioli, S; Koca, E; Gaitonde, S; Petro, B; Sweiss, K; Halliday, L; Wang, XH; Patel, P; Rondelli, D				Mahmud, Nadim; Khanal, Amit; Taioli, Simone; Koca, Emre; Gaitonde, Sujata; Petro, Benjamin; Sweiss, Karen; Halliday, Lisa; Wang, Xinhe; Patel, Pritesh; Rondelli, Damiano			Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CONDITIONING REGIMEN; INTRAVENOUS BUSULFAN; LEUKEMIA; THERAPY; FLUDARABINE; SURVIVAL; DONORS; BLOOD	In this study we utilized a large animal model to identify a dose of intravenous busulfan that can cause reversible myelosuppression. Nine baboons (Papio anubis) were treated with IV busulfan at 6.4 (Group A), 8 (Group B), or 9.6 mg/kg (Group C). Peripheral blood counts were measured up to 90 days after treatment and serial bone marrow samples were obtained to analyze CD34+ cell content and colony forming units. Overall, the highest grade of peripheral blood cytopenia was observed 15 days after treatment in all three groups (n = 3/group). In particular, we observed a notable reduction of neutrophil and platelet counts in the blood and the number of marrow CD34+ cells and colony forming units. In contrast, the effect of busulfan on hemoglobin levels was mild. Baboons who received the highest dose of busulfan showed only a 25-35% recovery of marrow CD34+ cells and colony forming units after 90 days of busulfan administration. However, all three groups of animals showed a full recovery of peripheral blood counts and normal marrow cellularity and tri-lineage hematopoiesis after treatment. Notably, all three doses of busulfan were tolerated well without significant extra-medullary toxicity. These results validate the hierarchy of blood cells likely targeted by busulfan, and based on these findings, clinical trials using myelotoxic but not myeloablative doses of intravenous busulfan will be designed for patients with myeloid malignancies.	[Mahmud, Nadim; Khanal, Amit; Taioli, Simone; Koca, Emre; Petro, Benjamin; Patel, Pritesh; Rondelli, Damiano] Univ Illinois, Coll Med, Dept Med, Div Hematol Oncol, M-C 787,840 S Wood St, Chicago, IL 60612 USA; [Mahmud, Nadim; Patel, Pritesh; Rondelli, Damiano] Univ Illinois, Canc Ctr, Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL 60612 USA; [Gaitonde, Sujata] Univ Illinois Hosp & Hlth Sci Syst, Dept Pathol, Chicago, IL USA; [Sweiss, Karen] Univ Illinois Hosp & Hlth Sci Syst, Coll Pharm, Dept Pharm Practice, Chicago, IL USA; [Halliday, Lisa] Univ Illinois, Coll Med, Biol Resources Lab, Chicago, IL USA; [Wang, Xinhe] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mahmud, N; Rondelli, D (corresponding author), Univ Illinois, Coll Med, Dept Med, Div Hematol Oncol, M-C 787,840 S Wood St, Chicago, IL 60612 USA.; Mahmud, N; Rondelli, D (corresponding author), Univ Illinois, Canc Ctr, Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL 60612 USA.	nadim@uic.edu; drond@uic.edu	Taioli, Simone/ABA-2560-2021	Taioli, Simone/0000-0003-4010-8000; Mahmud, Nadim/0000-0003-3113-9155	Otsuka Pharmaceutical Co. Ltd; Michael Reese Foundation	Otsuka Pharmaceutical Co. Ltd(Otsuka Pharmaceutical); Michael Reese Foundation	This study was supported by a research grant to DR and NM from Otsuka Pharmaceutical Co. Ltd, and by the Michael Reese Foundation grant to DR. As mentioned in the Materials and Methods section of the manuscript, IV busulfan was provided by Otsuka Pharmaceutical Development and Commercialization, Inc. (Princeton, NJ) for the study. We hereby declare that the funders had no role in the study design, collection, analysis and interpretation of data; writing of the paper, and or decision to submit for publication.; The authors are indebted to Manuel Borce and Biologic Resources Laboratory (BRL) staff members for their dedicated services for animal care. Dr. Campbell-Lee is acknowledged for her assistance in typing baboon ABO blood groups. James Zacny, PhD is acknowledged for critical review of the manuscript. Li Liu, PhD from UIC School of Public Health is acknowledged for guidance related to statistical analysis. UIC Research Resource Center (RRC) Histology Services are acknowledged for their service in preparing bone marrow biopsy specimens for morphological studies. This study was supported by a research grant to DR and NM from Otsuka Pharmaceutical Co. Ltd, and by the Michael Reese Foundation grant to DR.	ABKOWITZ JL, 1993, BLOOD, V82, P2096; Andersson BS, 2002, BIOL BLOOD MARROW TR, V8, P145, DOI 10.1053/bbmt.2002.v8.pm11939604; Araki H, 2010, LEUKEMIA LYMPHOMA, V51, P1121, DOI 10.3109/10428191003786774; Beri R, 2010, BONE MARROW TRANSPL, V45, P249, DOI 10.1038/bmt.2009.133; BHALLA K, 1995, LEUKEMIA, V9, P1851; BLACKBURN EK, 1956, BRIT MED J, V1, P835, DOI 10.1136/bmj.1.4971.835; Bornhauser M, 2003, BLOOD, V102, P820, DOI 10.1182/blood-2002-11-3567; Bornhauser M, 2001, CLIN CANCER RES, V7, P2254; Cai SB, 2006, MOL THER, V13, P1016, DOI 10.1016/j.ymthe.2005.11.017; CARLOSTELLA C, 1993, STEM CELLS, V11, P170; Chunduri S, 2008, BONE MARROW TRANSPL, V41, P935, DOI 10.1038/bmt.2008.13; de Lima M, 2004, BLOOD, V104, P857, DOI 10.1182/blood-2004-02-0414; DUNN CDR, 1974, EXP HEMATOL, V2, P101; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Hassan M, 1999, MED ONCOL, V16, P166, DOI 10.1007/BF02906128; HAUT A, 1961, BLOOD, V17, P1; Kharfan-Dabaja MA, 2015, LEUKEMIA RES, V39, P933, DOI 10.1016/j.leukres.2015.04.009; Kuramoto K, 2004, BLOOD, V104, P1273, DOI 10.1182/blood-2003-08-2935; Lee KH, 2017, BIOL BLOOD MARROW TR, V23, P1555, DOI 10.1016/j.bbmt.2017.05.025; Mahmud N, 2005, EXP HEMATOL, V33, P1388, DOI 10.1016/j.exphem.2005.07.010; Mahmud N, 2004, BIOL BLOOD MARROW TR, V10, P681, DOI 10.1016/j.bbmt.2004.07.002; Mahmud N, 2001, BLOOD, V97, P3061, DOI 10.1182/blood.V97.10.3061; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; RANSON MR, 1991, BRIT J HAEMATOL, V79, P162, DOI 10.1111/j.1365-2141.1991.tb04517.x; SANTOS GW, 1983, NEW ENGL J MED, V309, P1347, DOI 10.1056/NEJM198312013092202; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; Schwartz GN, 1998, BONE MARROW TRANSPL, V22, P457, DOI 10.1038/sj.bmt.1701364; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763; Sorrentino BR, 2002, NAT REV CANCER, V2, P431, DOI 10.1038/nrc823; TUTSCHKA PJ, 1987, BLOOD, V70, P1382	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0206980	10.1371/journal.pone.0206980	http://dx.doi.org/10.1371/journal.pone.0206980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496309	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800020
J	Spilsbury, K; Rosenwax, L; Brameld, K; Kelly, B; Arendts, G				Spilsbury, Katrina; Rosenwax, Lorna; Brameld, Kate; Kelly, Brian; Arendts, Glenn			Morbidity burden and community-based palliative care are associated with rates of hospital use by people with schizophrenia in the last year of life: A population-based matched cohort study	PLOS ONE			English	Article							COST-EFFECTIVENESS; END; COMORBIDITIES; EXPECTANCY; MORTALITY; SERVICES; BARRIERS; MANITOBA; ILLNESS	Objective People with schizophrenia face an increased risk of premature death from chronic diseases and injury. This study describes the trajectory of acute care health service use in the last year of life for people with schizophrenia and how this varied with receipt of community-based specialist palliative care and morbidity burden. Method A population-based retrospective matched cohort study of people who died from 01/01/2009 to 31/12/2013 with and without schizophrenia in Western Australia. Hospital inpatient, emergency department, death and community-based care data collections were linked at the person level. Rates of emergency department presentations and hospital admissions over the last year of life were estimated. Results Of the 63508 decedents, 1196 (1.9%) had a lifetime history of schizophrenia. After adjusting for confounders and averaging over the last year of life there was no difference in the overall rate of ED presentation between decedents with schizophrenia and the matched cohort (HR 1.09; 95% CI 0.99-1.19). However, amongst the subset of decedents with cancer, choking or intentional self-harm recorded on their death certificate, those with schizophrenia presented to ED more often. Males with schizophrenia had the highest rates of emergency department use in the last year of life. Rates of hospital admission for decedents with schizophrenia were on average half (HR 0.53, 95% CI 0.44-0.65) that of the matched cohort although this varied by cause of death. Of all decedents with cancer, 27.5% of people with schizophrenia accessed community-based specialist palliative care compared to 40.4% of the matched cohort (p<0.001). Rates of hospital admissions for decedents with schizophrenia increased 50% (95% CI: 10%-110%) when enrolled in specialist palliative care. Conclusion In the last year of life, people with schizophrenia were less likely to be admitted to hospital and access community-based speciality palliative care, but more likely to attend emergency departments if male. Community-based specialist palliative care was associated with increased rates of hospital admissions.	[Spilsbury, Katrina; Brameld, Kate] Curtin Univ, Ctr Populat Hlth Res, Perth, WA, Australia; [Spilsbury, Katrina] Univ Notre Dame Australia, Inst Hlth Res, Perth, WA, Australia; [Rosenwax, Lorna] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia; [Kelly, Brian] Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW, Australia; [Kelly, Brian] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Arendts, Glenn] Univ Western Australia, Ctr Clin Res Emergency Med, Harry Perkins Inst Med Res, Perth, WA, Australia; [Arendts, Glenn] Fiona Stanley Hosp, Dept Emergency Med, Perth, WA, Australia	Curtin University; University of Notre Dame Australia; Curtin University; University of Newcastle; University of Newcastle; Harry Perkins Institute of Medical Research; University of Western Australia	Rosenwax, L (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia.	L.Rosenwax@curtin.edu.au	Kelly, Brian/G-7755-2013; Spilsbury, Katrina/B-5646-2016	Kelly, Brian/0000-0003-4460-1134; Spilsbury, Katrina/0000-0002-7434-2957; Arendts, Glenn/0000-0001-7830-7756	National Health and Medical Research Council of Australia [1084890]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia through a project grant #1084890 (https://www.nhmrc.gov.au/grants-funding) awarded to LR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2013, CAUS DEATH AUSTR 201; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Butler H, 2018, INT J MENT HEALTH NU, V27, P737, DOI 10.1111/inm.12360; Chapman M, 2018, BMJ SUPPORT PALLIAT, V8, P102, DOI 10.1136/bmjspcare-2015-001071; Chochinov HM, 2012, SCHIZOPHR RES, V141, P241, DOI 10.1016/j.schres.2012.07.028; Crump C, 2013, AM J PSYCHIAT, V170, P324, DOI 10.1176/appi.ajp.2012.12050599; Dickerson F, 2013, PSYCHIAT SERV, V64, P44, DOI [10.1176/appi.ps.201200143, 10.1176/appi.ps.001432012]; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Every-Palmer S, 2017, CNS DRUGS, V31, P699, DOI 10.1007/s40263-017-0448-6; Ferroni E, 2016, J PALLIAT MED, V19, P1260, DOI 10.1089/jpm.2016.0158; Ganzini L, 2010, PSYCHIAT SERV, V61, P725, DOI 10.1176/ps.2010.61.7.725; Glover J. D., 2003, WORKING PAPER SERIES, V9; Hetlevik O, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0719-1; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Holt RIG, 2010, J PSYCHOPHARMACOL, V24, P867, DOI 10.1177/0269881109102788; Hudson TJ, 2004, J CLIN PSYCHIAT, V65, P211; Irwin KE, 2014, CANCER-AM CANCER SOC, V120, P323, DOI 10.1002/cncr.28431; Kandratavicius L, 2014, EPILEPSY BEHAV, V38, P143, DOI 10.1016/j.yebeh.2014.01.005; Kulkarni DP, 2017, DYSPHAGIA, V32, P467, DOI 10.1007/s00455-017-9802-6; Lambert TJ, 2003, MED J AUSTRALIA, V178, pS67; Lan CC, 2011, GEN HOSP PSYCHIAT, V33, DOI 10.1016/j.genhosppsych.2011.02.006; Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008; Lavin K, 2017, J PAIN SYMPTOM MANAG, V54, P176, DOI 10.1016/j.jpainsymman.2017.04.003; Leng CH, 2016, SCHIZOPHR RES, V171, P97, DOI 10.1016/j.schres.2016.01.033; Martens PJ, 2013, J CLIN PSYCHIAT, V74, pE551, DOI 10.4088/JCP.12m08234; Miccinesi G, 2003, CANCER CAUSE CONTROL, V14, P971, DOI 10.1023/B:CACO.0000007964.16319.98; Muir-Cochrane E, 2006, J PSYCHIATR MENT HLT, V13, P447, DOI 10.1111/j.1365-2850.2006.01002.x; National Centre for Classification in Health, 2000, INT CLASS DIS AUSTR; National Coding Centre, 1995, INT CLASS DIS AUSTR; Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737; Pink B., 2008, INFORM PAPER INTRO S; Pink B (Australian Bureau of Statistics), 2008, INFORM PAPER CAUSE D; Pouliot K, 2017, AM J HOSP PALLIAT ME, V34, P166, DOI 10.1177/1049909115617139; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosenwax LK, 2005, PALLIATIVE MED, V19, P556, DOI 10.1191/0269216305pm1067oa; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sahlen KG, 2016, PALLIATIVE MED, V30, P296, DOI 10.1177/0269216315618544; Smith S, 2014, PALLIATIVE MED, V28, P130, DOI 10.1177/0269216313493466; Spilsbury K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185275; Spilsbury K, 2017, ANN EMERG MED, V69, P416, DOI 10.1016/j.annemergmed.2016.11.036; Sutradhar R, 2017, PALLIATIVE MED, V31, P448, DOI 10.1177/0269216316663508; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Xiong GL, 2008, PSYCHIAT SERV, V59, P929, DOI 10.1176/ps.2008.59.8.929	43	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208220	10.1371/journal.pone.0208220	http://dx.doi.org/10.1371/journal.pone.0208220			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496266	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800111
J	Goris, JM; Temple, VJ; Zomerdijk, N; Codling, K				Goris, Janny M.; Temple, Victor J.; Zomerdijk, Nienke; Codling, Karen			Iodine status of children and knowledge, attitude, practice of iodised salt use in a remote community in Kerema district, Gulf province, Papua New Guinea	PLOS ONE			English	Article							DEFICIENCY; STORAGE; KAMEA	Iodine deficiency is the single most common cause of preventable mental impairment in communities with suboptimal iodine intake. Objective of the present study was to assess in more detail the iodine status and knowledge, attitudes and practice (KAP) relating to use of iodised salt in a remote community in Kotidanga area, Kerema district, Gulf province, Papua New Guinea. This prospective school and community based cross-sectional study was carried out in 2017. Simple random sampling was used to select schools. Multistage sampling was used to randomly select 300 children aged 6 to 12 years, of which 289 consented to participate in the study. A single urine sample was collected from each of the consenting children, as well as a salt sample from their households. Discretionary salt intake was assessed in a sub-sample of the children's households. Salt iodine content and urinary iodine concentration (UIC) were analysed. A semi-structured modified Food and Agriculture Organisation questionnaire was used to assess KAP of three different community groups. Only 64% of households had salt on the day of data collection. Mean iodine content in household salt samples was 29.0 +/- 19.1 ppm. Iodine content was below 30.0 ppm in 54.8% and below 15.0 ppm in 31.2% of salt samples. Mean per capita discretionary intake of household salt was 2.9 +/- 1.8 g/day. Median UIC was 25.5 mu g/L and Interquartile Range was 15.0 to 47.5 mu g/L, indicating moderate status iodine nutrition. Median UIC was 34.3 mu g/L for children in households with salt, compared to 15.5 mu g/L for children in households without salt, indicating severe iodine deficiency in the latter group. The three community groups had limited knowledge about importance of using iodised salt and consequences of iodine deficiency on health outcomes. This remote community has limited access to adequately iodised household salt due to high cost, inappropriate packaging, storage and food preparation, resulting in iodine deficiency. Strategies to increase iodine intake are needed.	[Goris, Janny M.] PNG Fdn, North Tomborine, Qld, Australia; [Temple, Victor J.] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea; [Zomerdijk, Nienke] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Codling, Karen] Iodine Global Network, Southeast Asia & Pacific, Bangkok, Thailand	University of Papua New Guinea; University of Queensland	Temple, VJ (corresponding author), Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea.	templevj@upng.ac.pg	Zomerdijk, Nienke/AAV-5551-2021	Temple, Victor/0000-0003-4212-8232; Zomerdijk, Nienke/0000-0001-5008-6429				Aikat Aditi, 2011, J Indian Med Assoc, V109, P174; Ali Amjad, 1992, JPMA (Journal of the Pakistan Medical Association), V42, P138; Amoa B, 1998, Asia Pac J Clin Nutr, V7, P128; [Anonymous], 2007, ASS IOD DEF DIS MON; Ansari M, 2016, INT J COMMUNITY MED, V3, P1431, DOI [10.18203/2394-6040.ijcmph20161606, DOI 10.18203/2394-6040.IJCMPH20161606]; Barter P., 1995, PURE FOOD ACT AMENDM, pG 47; BLAKE NM, 1981, HUM HERED, V31, P191, DOI 10.1159/000153205; Bougma K, 2013, NUTRIENTS, V5, P1384, DOI 10.3390/nu5041384; Bourke R, 2011, FOOD AGR PAPUA NEW G; China National Salt Industry Corporation, 2012, WYD IOD CHECK INSTR; Dasgupta PK, 2008, ENVIRON SCI TECHNOL, V42, P1315, DOI 10.1021/es0719071; Department of Health of Papua New Guinea UNICEF Papua New Guinea University of Papua New Guinea US Centres of Disease Control and Prevention, 2011, PAC J MED SCI, V8, P54; Diosady L, STABILITY IODINE IOD; Goris JM, 2017, ASIA PAC J CLIN NUTR, V26, P665, DOI 10.6133/apjcn.052016.09; Hynes KL, 2013, J CLIN ENDOCR METAB, V98, P1954, DOI 10.1210/jc.2012-4249; Khoja Shariq, 2000, JPMA (Journal of the Pakistan Medical Association), V50, P296; Land M, 2013, COCHRANE DATABASE SY; Lomutopa S, 2013, PAC J MED SCI, V11, P70; Lowe N, 2015, NUTRIENTS, V7, P9672, DOI 10.3390/nu7115490; Macias YF., 2014, GUIDELINES ASSESSING; National Statistical Office of Papua New Guinea, 2014, 2011 NAT POP HOUS CE; Papua New Guinea National Department of Health, 2007, FOOD SAN REG STAT IN; PNG National Statistics, PAP REG GULD PROV; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Temple V, 2005, J PUBLIC HEALTH-UK, V27, P45, DOI 10.1093/pubmed/fdh199; Temple V., 2006, IDD NEWSLETTER, V22, P11; Temple V, 2018, PAC J MED SCI, V18, P3; Temple V. J., 2009, African Journal of Food, Agriculture, Nutrition and Development, V9, P1807; Temple VJ, 2006, ASIA PAC J CLIN NUTR, V15, P533; The Worldbank Group, 2015, CLIM CHANG KNOWL POR; United Nations Children's Emergency Fund, 2018, GUIDANCE MONITORING; Wang GY, 1999, BIOMED ENVIRON SCI, V12, P1; Waszkowiak K, 2008, INT J FOOD SCI TECH, V43, P895, DOI 10.1111/j.1365-2621.2007.01538.x; WHO UNICEF, 2007, REACH OPT IOD NUTR P; World Health Organization, 2014, GUID FORT FOODGR SAL; Zimmermann MB, 2015, LANCET DIABETES ENDO, V3, P286, DOI 10.1016/S2213-8587(14)70225-6	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0197647	10.1371/journal.pone.0197647	http://dx.doi.org/10.1371/journal.pone.0197647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485281	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800001
J	Kim, J; Joo, S; Eom, GH; Lee, SH; Lee, MA; Lee, M; Kim, KW; Kim, DH; Kook, H; Kwak, TH; Park, WJ				Kim, Jihwa; Joo, Sanghyun; Eom, Gwang Hyeon; Lee, Seung Hoon; Lee, Min-Ah; Lee, Miyoung; Kim, Ki Woo; Kim, Do Han; Kook, Hyun; Kwak, Tae Hwan; Park, Woo Jin			CCN5 knockout mice exhibit lipotoxic cardiomyopathy with mild obesity and diabetes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INSULIN-RESISTANCE; EXPRESSION; WISP2; HEART; RISK; ACCUMULATION; DYSFUNCTION; DISEASE; WHITE	Obesity is associated with various human disorders, such as type 2 diabetes, cardiovascular diseases, hypertension, and cancers. In this study, we observed that knockout ( KO) of CCN5, which encodes a matricellular protein, caused mild obesity in mice. The CCN5 KO mice also exhibited mild diabetes characterized by high fasting glucose levels and impaired insulin and glucose tolerances. Cardiac hypertrophy, ectopic lipid accumulation, and impaired lipid metabolism in hearts were observed in the CCN5 KO mice, as determined using histology, quantitative RT-PCR, and western blotting. Fibrosis was significantly greater in hearts from the CCN5 KO mice both in interstitial and perivascular regions, which was accompanied by higher expression of pro-fibrotic and pro-inflammatory genes. Both systolic and diastolic functions were significantly impaired in hearts from the CCN5 KO mice, as assessed using echocardiography. Taken together, these results indicate that CCN5 KO leads to lipotoxic cardiomyopathy with mild obesity and diabetes in mice.	[Kim, Jihwa; Joo, Sanghyun; Lee, Min-Ah; Lee, Miyoung; Kim, Do Han; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea; [Eom, Gwang Hyeon; Kook, Hyun] Chonnam Natl Univ, Med Sch, Dept Pharmacol, Hwasun Gun, Jeollanam Do, South Korea; [Eom, Gwang Hyeon; Kook, Hyun] Chonnam Natl Univ, Med Sch, Med Res Ctr Gene Regulat, Hwasun Gun, Jeollanam Do, South Korea; [Lee, Seung Hoon; Kwak, Tae Hwan] Wonkwang Univ, Wonkwang Start Up Assistance Ctr 201 1, NadianBio, Iksan, Jeollabuk Do, South Korea; [Kim, Ki Woo] Yonsei Univ, Dept Oral Biol, Coll Dent, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University; Wonkwang University; Yonsei University; Yonsei University Health System	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea.	woojinpark@icloud.com	Kook, Hyun/AAR-5405-2021; Kim, Ki Woo Woo/AAW-9645-2021	Kook, Hyun/0000-0002-0740-1806; Kim, Ki Woo Woo/0000-0002-7790-1515	National Research Foundation [2017R1A2B4007340, 2016R1A4A1009895, NRF-2015M3A9E6028951]; Institute for Basic Science Program grant - Korean government [IBS-R025-D1]	National Research Foundation; Institute for Basic Science Program grant - Korean government	This work was supported by a Basic Science Research Program grant (2017R1A2B4007340 to WJP), a Basic Research Laboratory Program grant (2016R1A4A1009895 to HK and WJP), and a Bio & Medical Technology Development Program grant (NRF-2015M3A9E6028951 to WJP) from the National Research Foundation, and the Institute for Basic Science Program grant (IBS-R025-D1 to KDH), funded by the Korean government, and The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NadianBio provided support in the form of salaries for SHL and THK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Boren J, 2013, J INTERN MED, V274, P25, DOI 10.1111/joim.12071; Burke GL, 2008, ARCH INTERN MED, V168, P928, DOI 10.1001/archinte.168.9.928; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Fuentes-Antras J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0173-8; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Grunberg JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep43515; Grunberg JR, 2014, J BIOL CHEM, V289, P6899, DOI 10.1074/jbc.M113.511964; Gustafson B, 2015, ATHEROSCLEROSIS, V241, P27, DOI 10.1016/j.atherosclerosis.2015.04.812; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Jeong D, 2016, J AM COLL CARDIOL, V67, P1556, DOI 10.1016/j.jacc.2016.01.030; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Khan RS, 2010, CURR OPIN CLIN NUTR, V13, P145, DOI 10.1097/MCO.0b013e3283357272; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Molavi B, 2006, CURR OPIN CARDIOL, V21, P479, DOI 10.1097/01.hco.0000240586.76344.f5; Pfeiffer A, 1996, DIABETES CARE, V19, P1113, DOI 10.2337/diacare.19.10.1113; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Tan CK, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.1; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Tsurutani Y, 2011, BIOCHEM BIOPH RES CO, V407, P68, DOI 10.1016/j.bbrc.2011.02.106; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	28	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207228	10.1371/journal.pone.0207228	http://dx.doi.org/10.1371/journal.pone.0207228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485307	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800050
J	Chat, V; Wu, F; Demmer, RT; Parvez, F; Ahmed, A; Eunus, M; Hasan, R; Nahar, J; Shaheen, I; Sarwar, G; Desvarieux, M; Ahsan, H; Chen, Y				Chat, Vylyny; Wu, Fen; Demmer, Ryan T.; Parvez, Faruque; Ahmed, Alauddin; Eunus, Mahbub; Hasan, Rabiul; Nahar, Jabun; Shaheen, Ishrat; Sarwar, Golam; Desvarieux, Moise; Ahsan, Habibul; Chen, Yu			Association between number of children and carotid intima-media thickness in Bangladesh	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; ARTERIAL-WALL THICKNESS; MAJOR DIETARY PATTERNS; REPRODUCTIVE HISTORY; OXIDATIVE STRESS; VASCULAR-DISEASE; ARSENIC EXPOSURE; DRINKING-WATER; WOMEN; ATHEROSCLEROSIS	Previous studies on the association between number of children and carotid intima-media thickness (cIMT) were limited to Western populations. Pregnancy in women is associated with physiologic changes that may influence the risk of cardiovascular disease. Comparing the association between number of children and cIMT in men and women can provide insights on whether the association may be due to pregnancy. We investigated the association between number of children and cIMT among 718 female (mean age 37.5 years) and 417 male participants (mean age 41.3 years), randomly selected from the Health Effect of Arsenic Longitudinal Study (HEALS), a population-based cohort study in Bangladesh. Multivariate linear regression was used to assess the association and to control for education attainment, history of diabetes, age, smoking, betel use, BMI, systolic blood pressure, and diastolic blood pressure. The average number of children was 4.43 for women and 3.74 for men. There were no nulliparous women. We observed a positive association between number of children and cIMT in women. Mean cIMT increased by 4.5 mu m (95% CI, 0.8-8.1) per increment of one birth (P = 0.02). Compared to women with two children, cIMT in women with 4 children and. 5 children was 23.6 mu m (95% CI, 2.6-44.7; P = 0.03) and 25.1 mu m (95% CI, 3.5-46.6; P = 0.02) greater, respectively. The association was not modified by BMI, SBP, betel use or age. Data in men showed no evidence of association (P = 0.4). The finding suggests a role of high parity in atherosclerosis in women of a low-income, high parity population.	[Chat, Vylyny; Wu, Fen; Chen, Yu] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA; [Chat, Vylyny; Wu, Fen; Chen, Yu] NYU, Sch Med, Dept Environm Med, New York, NY 10003 USA; [Demmer, Ryan T.; Desvarieux, Moise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Parvez, Faruque] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Ahmed, Alauddin; Eunus, Mahbub; Hasan, Rabiul; Nahar, Jabun; Shaheen, Ishrat; Sarwar, Golam] U Chicago Res Bangladesh Ltd, Dhaka, Bangladesh; [Desvarieux, Moise] INSERM UMR 1153, Ctr Rech Epidemiol & Stat Paris Sorbonne Cite CRE, METHODS Core, Paris, France; [Ahsan, Habibul] Univ Chicago, Ctr Canc Epidemiol & Prevent, Dept Hlth Studies, Chicago, IL 60637 USA	New York University; New York University; Columbia University; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Chicago	Chen, Y (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA.; Chen, Y (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10003 USA.	yu.chen@nyumc.org	Desvarieux, Moise/C-4991-2019	Demmer, Ryan/0000-0003-3429-0379; Chen, Yu/0000-0002-1519-4894	National Institutes of Health [R01 ES017541, P42 ES010349, P30 ES000260]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES027792, P42ES010349, R24ES028532, P30ES009089, P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Institutes of Health [R01 ES017541, P42 ES010349, and P30 ES000260]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Arnlov J, 2006, ANN INTERN MED, V145, P176, DOI 10.7326/0003-4819-145-3-200608010-00005; Blaudeau TE, 2006, INT J OBESITY, V30, P1119, DOI 10.1038/sj.ijo.0803252; Catov JM, 2008, ANN EPIDEMIOL, V18, P873, DOI 10.1016/j.annepidem.2008.09.009; Center for Global Health and Economic Development, 2004, RACE TIME CHALLENGE; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chen Y, 2013, AM J EPIDEMIOL; Chen Y, 2007, AM J EPIDEMIOL, V165, P541, DOI 10.1093/aje/kwk037; Chen Y, 2013, INT J CARDIOL, V167, P1495, DOI 10.1016/j.ijcard.2012.04.041; Chen Y, 2010, ENVIRON HEALTH PERSP, V118, P1299, DOI 10.1289/ehp.0901559; Crouse JR, 2002, CIRCULATION, V106, P2061, DOI 10.1161/01.CIR.0000033833.54884.34; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Doblhammer G, 2000, POP STUD-J DEMOG, V54, P169, DOI 10.1080/713779087; Gallagher LG, 2011, INT J EPIDEMIOL, V40, P1510, DOI 10.1093/ije/dyr134; Ge WZ, 2014, ATHEROSCLEROSIS, V232, P234, DOI 10.1016/j.atherosclerosis.2013.11.035; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; HANNAFORD PC, 1994, STROKE, V25, P935, DOI 10.1161/01.STR.25.5.935; Humphries KH, 2001, STROKE, V32, P2259, DOI 10.1161/hs1001.097224; Kharazmi E, 2007, ACTA OBSTET GYN SCAN, V86, P995, DOI 10.1080/00016340701464374; KVALE G, 1994, INT J EPIDEMIOL, V23, P691, DOI 10.1093/ije/23.4.691; LAYDE PM, 1989, J CLIN EPIDEMIOL, V42, P963, DOI 10.1016/0895-4356(89)90161-3; Lee CD, 2007, AM J CLIN NUTR, V86, P48, DOI 10.1093/ajcn/86.1.48; Mansour AA, 2009, EAT WEIGHT DISORD-ST, V14, pE50, DOI 10.1007/BF03327800; McClintock TR, 2016, PUBLIC HEALTH NUTR, V19, P218, DOI 10.1017/S136898001500124X; McClintock TR, 2014, INT J EPIDEMIOL, V43, P1174, DOI 10.1093/ije/dyu009; NESS RB, 1993, NEW ENGL J MED, V328, P1528, DOI 10.1056/NEJM199305273282104; Nicholson WK, 2006, DIABETES CARE, V29, P2349, DOI 10.2337/dc06-0825; Niemczyk NA, 2015, OBESITY, V23, P1085, DOI 10.1002/oby.21044; Parikh NI, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.017; Pierce BL, 2010, INT J EPIDEMIOL, V39, P1037, DOI 10.1093/ije/dyp364; Skilton MR, 2010, STROKE, V41, P1332, DOI 10.1161/STROKEAHA.110.579219; Skilton MR, 2009, STROKE, V40, P1152, DOI 10.1161/STROKEAHA.108.535807; STAMPFER MJ, 1990, ANN NY ACAD SCI, V592, P193; Steenland K, 1996, EPIDEMIOLOGY, V7, P641, DOI 10.1097/00001648-199611000-00014; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Sutton-Tyrrell K, 1998, STROKE, V29, P1116, DOI 10.1161/01.STR.29.6.1116; Toescu V, 2002, CLIN ENDOCRINOL, V57, P609, DOI 10.1046/j.1365-2265.2002.01638.x; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; WITTEMAN JCM, 1989, BRIT MED J, V298, P642, DOI 10.1136/bmj.298.6674.642; Wolff B, 2005, STROKE, V36, P938, DOI 10.1161/01.STR.0000162712.27799.20; World Health Organization, 2004, WORLD HLTH REP 2004; Wu F, 2016, J CLIN PERIODONTOL, V43, P909, DOI 10.1111/jcpe.12597; Wu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058516	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208148	10.1371/journal.pone.0208148	http://dx.doi.org/10.1371/journal.pone.0208148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481229	gold, Green Submitted, Green Published			2022-12-26	WOS:000451440000045
J	Balbuena, LD				Balbuena, Lloyd D.			The UK Research Excellence Framework and the Matthew effect: Insights from machine learning	PLOS ONE			English	Article							ASSESSMENT EXERCISE RATINGS; CITATION COUNTS; H-INDEX; SCIENCE; IMPACT; PRODUCTIVITY; UNIVERSITIES; KNOWLEDGE; SYSTEM; SCOPUS	With the high cost of the research assessment exercises in the UK, many have called for simpler and less time-consuming alternatives. In this work, we gathered publicly available REF data, combined them with library-subscribed data, and used machine learning to examine whether the overall result of the Research Excellence Framework 2014 could be replicated. A Bayesian additive regression tree model predicting university grade point average (GPA) from an initial set of 18 candidate explanatory variables was developed. One hundred and nine universities were randomly divided into a training set (n = 79) and test set (n = 30). The model "learned" associations between GPA and the other variables in the training set and was made to predict the GPA of universities in the test set. GPA could be predicted from just three variables: the number of Web of Science documents, entry tariff, and percentage of students coming from state schools (r-squared = .88). Implications of this finding are discussed and proposals are given.	[Balbuena, Lloyd D.] Univ Saskatchewan, Dept Psychiat, Saskatoon, SK, Canada	University of Saskatchewan	Balbuena, LD (corresponding author), Univ Saskatchewan, Dept Psychiat, Saskatoon, SK, Canada.	lloyd.balbuena@usask.ca	Balbuena, Lloyd/H-5658-2013	Balbuena, Lloyd/0000-0002-3745-5426				Adams J, 2005, SCIENTOMETRICS, V63, P567, DOI 10.1007/s11192-005-0228-9; Althouse BM, 2009, J AM SOC INF SCI TEC, V60, P27, DOI 10.1002/asi.20936; [Anonymous], 2016, TIMES HIGHER ED; Auranen O, 2010, RES POLICY, V39, P822, DOI 10.1016/j.respol.2010.03.003; Bar-Ilan J, 2008, SCIENTOMETRICS, V74, P257, DOI 10.1007/s11192-008-0216-y; BERRY C, 1981, BRIT J SOCIOL, V32, P381, DOI 10.2307/589284; Bishop D, DEP H INDEX IS MORE; Boliver V, 2015, OXFORD REV EDUC, V41, P608, DOI 10.1080/03054985.2015.1082905; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Burris V, 2004, AM SOCIOL REV, V69, P239, DOI 10.1177/000312240406900205; Castelvecchi D, 2016, NATURE, V537, P20, DOI 10.1038/538020a; Chang YC, 2009, RES POLICY, V38, P936, DOI 10.1016/j.respol.2009.03.005; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Choobbasti H.J., 2007, RES SOC STRAT MOBIL, V25, P233, DOI [10.1016/j.rssm.2007.04.001, DOI 10.1016/J.RSSM.2007.04.001]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dobbin KK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-31; Farla K., 2015, REF 2014 ACCOUNTABIL; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; Gannon F, 2004, EMBO REP, V5, P323, DOI 10.1038/sj.embor.7400138; Gibbons M, 1994, NEW PRODUCTION KNOWL, Vix; Gordon R, 2009, ACCOUNT RES, V16, P13, DOI 10.1080/08989620802689821; Gray R, 2015, J PSYCHIATR MENT HLT, V22, P155, DOI 10.1111/jpm.12217; Harnad S, 2009, SCIENTOMETRICS, V79, P147, DOI 10.1007/s11192-009-0409-z; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Higher Education Funding Council for England, 2015, REF 2014 KEY FACTS; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hoare T., 2011, IMPACT SUTTON TRUSTS; Jump P, WINNERS LOSERS HEFCE; Kapelner A, 2016, J STAT SOFTW, V70, P1; Lombardi JV, 2000, TOP AM RES U; LONG JS, 1981, AM SOCIOL REV, V46, P422, DOI 10.2307/2095262; LONG JS, 1978, AM SOCIOL REV, V43, P889, DOI 10.2307/2094628; Martin BR, 2011, RES EVALUAT, V20, P247, DOI 10.3152/095820211X13118583635693; McKnight A, DOWNWARD MOBILITY OP; Meho LI, 2007, J AM SOC INF SCI TEC, V58, P2105, DOI 10.1002/asi.20677; Merton RK., 1973, SOCIOLOGY SCI THEORE, Vxxxi; Mryglod O, 2015, SCIENTOMETRICS, V104, P1013, DOI 10.1007/s11192-015-1567-9; Mryglod O, 2015, SCIENTOMETRICS, V102, P2165, DOI 10.1007/s11192-014-1512-3; Norris M, 2003, J DOC, V59, P709, DOI 10.1108/00220410310698734; Nowotny H, 2003, MINERVA, V41, P179, DOI 10.1023/A:1025505528250; OPPENHEIM C, 1995, J DOC, V51, P18, DOI 10.1108/eb026940; Oppenheim C, 1997, J DOC, V53, P477, DOI 10.1108/EUM0000000007207; Owens B, 2013, NATURE, V502, P288, DOI 10.1038/502288a; R Core Team, 2013, R LANG ENV STAT COMP; Reay D, 2001, SOCIOLOGY, V35, P855, DOI 10.1177/0038038501035004004; Reeves R.V., 2013, GLASS FLOOR ED DOWNW; Reich ES, 2013, NATURE, V502, P291, DOI 10.1038/502291a; RESKIN BF, 1977, AM SOCIOL REV, V42, P491, DOI 10.2307/2094753; Russell Group, 2012, JEWELS CROWN IMPORTA; Sayer D., 5 REASONS WHY REF IS; Scott P, 2009, ISSUES HIGH EDUC-PAL, P58; Stephan PE, 2012, EC SHAPES SCI, Vxiv; Stern LN, ITS OUR DUTY ASSESS; Stern Review, 2016, BUILDING SUCCESS LEA; Sutton Trust, DEGR SUCC U CHANC IN; Universiteit Leiden, P SCI TECHN IND C 20; University and College Union, 2013, RES EXC FRAM REF UCU; Van Raan AFJ, 2005, SCIENTOMETRICS, V62, P133, DOI 10.1007/s11192-005-0008-6	58	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207919	10.1371/journal.pone.0207919	http://dx.doi.org/10.1371/journal.pone.0207919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475868	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700088
J	Cloete, R; Kapp, E; Joubert, J; Christoffels, A; Malan, SF				Cloete, Ruben; Kapp, Erika; Joubert, Jacques; Christoffels, Alan; Malan, Sarel F.			Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c	PLOS ONE			English	Article							INHIBITORS; PIPERINE; RECOGNITION; EFFICIENT; ISOLATE; TAP; WEB	Mycobacterial efflux pumps play a major role in the emergence of antimycobacterial drug resistance. Of particular interest is the proteinaceous multi-drug efflux pump protein Rv1258c that encodes a tetracycline/aminoglycoside resistance (TAP-2)-like efflux pump which is active in susceptible and drug resistant Mycobacterium tuberculosis. Rv1258c is implicated in drug resistance to numerous antimycobacterials including first line drugs rifampicin and isoniazid as well as fluoroquinolone and aminoglycoside antibiotic classes. To date, compounds like verapamil and piperine have been shown to inhibit Rv1258c but no direct evidence for binding or mode of action exist. Therefore in the present study we generated an accurate 3D model of Rv1258c using MODELLER and validated its structure using molecular dynamic simulation studies with GROMACS software. The 3D-structures of Rv1258c and the homologous template 1pw4 were simulated within a POPE/POPG lipid bilayer and found to behave similar. Another important finding was the identification of one local energy minima state of the apo protein, which speaks to the flexibility of the protein and will be investigated further. Extraction of one of the open channel conformations of Rv1258c and blind docking of various structurally diverse putative inhibitors and substrates, allowed for the identification of a probable binding site. Spectinamide was found to bind to a different location on the outside surface of the protein suggesting its ability to avoid the efflux channel. We further identified 246 putative compounds that showed higher binding affinity values to Rv1258c compared to piperine and verapamil. Interaction analysis of the top 20 purchasable compounds identified crucial hydrogen bond interactions with Ser26, Ser45 and Glu243 as well as a pi-pi stacking interaction with Trp32 that accounted for the strong affinity of these compounds for Rv1258c. Future studies will entail purchasing a number of compounds for in vitro activity testing against Mycobacterium tuberculosis.	[Cloete, Ruben; Christoffels, Alan] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Bellville, South Africa; [Kapp, Erika; Joubert, Jacques; Malan, Sarel F.] Univ Western Cape, Sch Pharm, Bellville, South Africa	South African Medical Research Council; University of the Western Cape; University of the Western Cape	Malan, SF (corresponding author), Univ Western Cape, Sch Pharm, Bellville, South Africa.	sfmalan@uwc.ac.za	Malan, Sarel/AAA-4189-2020; christoffels, alan/C-3269-2014	Malan, Sarel/0000-0002-1640-6457; christoffels, alan/0000-0002-0420-2916; cloete, ruben/0000-0003-1966-0212	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa [64751]; South African Medical Research Council [MRC-RFA-UFSP-01-2013/COMBAT-TB]; National Research Foundation of South Africa	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (64751 to A.C.) and the South African Medical Research Council (MRC-RFA-UFSP-01-2013/COMBAT-TB to A.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa.	Adams KN, 2014, J INFECT DIS, V210, P456, DOI 10.1093/infdis/jiu095; Ainsa JA, 1998, J BACTERIOL, V180, P5836; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; ATAL CK, 1985, J PHARMACOL EXP THER, V232, P258; Balganesh M, 2012, ANTIMICROB AGENTS CH, V56, P2643, DOI 10.1128/AAC.06003-11; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burger DM, 2017, ANN REV PHARM TOXICO; Chen C, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02107-17; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fornace ME, 2015, J CHEM THEORY COMPUT, V11, P568, DOI 10.1021/ct5011032; GUND P, 1977, PROGR MOL SUBCELLULA, V5, P117; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang X, 2008, MICROB DRUG RESIST, V14, P7, DOI 10.1089/mdr.2008.0772; Koes DR, 2011, J CHEM INF MODEL, V51, P1307, DOI 10.1021/ci200097m; Krivov SV, 2004, P NATL ACAD SCI USA, V101, P14766, DOI 10.1073/pnas.0406234101; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee RE, 2014, NAT MED, V20, P152, DOI 10.1038/nm.3458; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Malinga LA, 2017, CHARACTERIZATION EFF; Martins M, 2008, IN VIVO, V22, P69; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pule CM, 2016, J ANTIMICROB CHEMOTH, V71, P17, DOI 10.1093/jac/dkv316; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Stierand K., 2010, J CHEMINFORM, V2, P1, DOI [10.1186/1758-2946-2-s1-p50, DOI 10.1186/1758-2946-2-S1-P50]; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Williams T, 1998, ENVIRONMENT, V4, P5; World Health Organization, GLOB TUB REP 2016	40	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207605	10.1371/journal.pone.0207605	http://dx.doi.org/10.1371/journal.pone.0207605			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475855	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700044
J	Eveson, JP; Bravington, MV; Farley, JH				Eveson, J. Paige; Bravington, Mark V.; Farley, Jessica H.			Accounting for environmental and observer effects in estimating abundance of southern bluefin tuna from aerial survey data	PLOS ONE			English	Article							SPATIAL MODELS	Southern bluefin tuna (SBT) is a valuable species that has been subject to high exploitation rates since the 1950s. In 2011, the spawning stock biomass was estimated to be at a historically low level, at only 5% of pre-fished biomass. A key component for managing and rebuilding the stock is having reliable, fishery-independent estimates of juvenile abundance. This paper describes how such estimates have been constructed from aerial surveys of juvenile (age 2-4) SBT conducted annually in the Great Australian Bight from 1993-2000 and 2005-2009. During these surveys, observers flew along pre-set transect lines searching for surface schools of SBT. Data were collected on the location and biomass of SBT sightings, and on the environmental conditions present during the survey. Sea surface temperature (SST) was found to correlate with the size (biomass) of schools, and several environmental variables, SST and wind speed in particular, were found to correlate with the number of sightings (presumably by affecting the ability of observers to see surface schools as well as whether fish were present at the surface). In addition, observers changed over time and differed in their aptitude for spotting tuna. Thus, generalized linear mixed models (GLMMs) were used to standardize the sightings and biomass data to a common set of observers and environmental conditions in order to produce an annual time series of relative abundance estimates. These estimates, which form one of two key inputs to the management procedure used by the international Commission for the Conservation of Southern Bluefin Tuna to set the global catch quota, suggest juvenile abundance was highest in the first years of the survey (1993-1996), after which it declined and fluctuated around a level about four times lower.	[Eveson, J. Paige; Farley, Jessica H.] CSIRO, Oceans & Atmosphere, Hobart, Tas, Australia; [Bravington, Mark V.] CSIRO, Data 61, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Eveson, JP (corresponding author), CSIRO, Oceans & Atmosphere, Hobart, Tas, Australia.	paige.eveson@csiro.au	Farley, Jessica/E-4957-2014	Farley, Jessica/0000-0002-5047-746X	Australian Fisheries Management Agency (AFMA); Australian Government Department of Agriculture and Water Resources (DAWR); Australian Southern Bluefin Tuna Industry Association (ASBTIA); CSIRO	Australian Fisheries Management Agency (AFMA); Australian Government Department of Agriculture and Water Resources (DAWR); Australian Southern Bluefin Tuna Industry Association (ASBTIA); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Funding has been provided over the years by the Australian Fisheries Management Agency (AFMA), the Australian Government Department of Agriculture and Water Resources (DAWR), the Australian Southern Bluefin Tuna Industry Association (ASBTIA) and CSIRO.; The authors thank all of the spotters, pilots and data recorders involved in past surveys. The survey was initiated as part of a collaborative research program between the Japanese National Research Institute of Far Seas Fisheries (NRIFSF) and CSIRO Marine and Atmospheric Research (now CSIRO Oceans and Atmosphere). Funding has been provided over the years by the Australian Fisheries Management Agency (AFMA), the Australian Government Department of Agriculture and Water Resources (DAWR), the Australian Southern Bluefin Tuna Industry Association (ASBTIA) and CSIRO. Thanks also to two journal reviewers for providing useful comments that much improved the manuscript.	[Anonymous], 2011, 18 ANN M COMM COMM C; [Anonymous], 2013, 18 M SCI COMM COMM C; [Anonymous], 2017, 22 M SCI COMM COMM C; Basson M., 2012, SPATIAL INTERACTIONS; Basson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116245; Bestley S, 2010, ECOLOGY, V91, P2373, DOI 10.1890/08-2019.1; Buckland S.T., 2001, pi; Butterworth DS, 1999, ICES J MAR SCI, V56, P985, DOI 10.1006/jmsc.1999.0532; Canadas A., 2006, Journal of Cetacean Research and Management, V8, P13; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Eveson JP, 2018, DEEP-SEA RES PT II, V157, P179, DOI 10.1016/j.dsr2.2018.03.007; Eveson JP, 2015, FISH RES, V170, P39, DOI 10.1016/j.fishres.2015.05.008; Eveson JP, 2009, 14 M SCI COMM COMM C; Eveson JP, 2017, 22 M SCI COMM COMM C; Farley JH, 2007, FISH RES, V83, P151, DOI 10.1016/j.fishres.2006.09.006; Fonteneau A., 1999, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V49, P259; Griffin DA, 2005, 2003020 NOOC; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; HILBORN R, 1992; Hillary RM, 2016, FISH FISH, V17, P469, DOI 10.1111/faf.12121; Hobday A. J., 2015, BIOL ECOLOGY BLUEFIN, P189, DOI 10.1201/b18714-12; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; R Core Team, 2013, R LANG ENV STAT COMP; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	25	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207790	10.1371/journal.pone.0207790	http://dx.doi.org/10.1371/journal.pone.0207790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475864	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700068
J	Preis, H; Pardo, J; Peled, Y; Benyamini, Y				Preis, Heidi; Pardo, Joseph; Peled, Yoav; Benyamini, Yael			Changes in the basic birth beliefs following the first birth experience: Self-fulfilling prophecies?	PLOS ONE			English	Article							CHILDBIRTH; FEAR; MEDICALIZATION; PERCEPTIONS; ATTITUDES; DELIVERY; COHORT; WOMEN; LABOR; CARE	Women's basic beliefs about birth as a natural and as a medical process are associated with childbirth choices and experience. These beliefs have only recently been quantified and not much is known about their development. In the current study, we assessed the differential effects of the objective and the subjective birth experience on changes in these beliefs. Using self-report questionnaires, we evaluated prenatal to postpartum changes among 342 Israeli first-time mothers. Participants were recruited during pregnancy, between February 2016 and January 2017, mostly in clinical settings, and followed-up two months postpartum. On average, women's beliefs about birth being natural weakened following childbirth and their belief about birth being medical strengthened. In regression models, it was either the objective or the subjective experience that was related to change in the basic birth beliefs: A more medicalized birth was associated with strengthening of the medical belief while greater birth satisfaction was related to strengthening of the natural belief. A mediation effect was observed, which indicated that the beliefs are strengthened when the lived experience fulfilled women's expectation about birth being satisfying, natural or medical. This study adds to the growing body of knowledge regarding the development and evolution of the birth beliefs. It highlights the need to view the beliefs separately and to distinctively assess the objective and subjective birth experience. It supports the need to empower mothers, especially those who had more medicalized births or unsatisfactory ones, which would help conserve their belief in their body and in the normal physiological course of birth.	[Preis, Heidi; Benyamini, Yael] Tel Aviv Univ, Bob Shapell Sch Social Work, Tel Aviv, Israel; [Pardo, Joseph; Peled, Yoav] Rabin Med Ctr, Beilinson Hosp, Dept Obstet & Gynecol, Helen Schneider Hosp Women, Petah Tiqwa, Israel; [Pardo, Joseph; Peled, Yoav] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Preis, H (corresponding author), Tel Aviv Univ, Bob Shapell Sch Social Work, Tel Aviv, Israel.	heidibracp@mail.tau.ac.il	Benyamini, Yael/G-8367-2012; Preis, Heidi/HDL-9485-2022	Benyamini, Yael/0000-0001-5110-8212; Preis, Heidi/0000-0002-0459-290X	Israel Science Foundation [351/16]; Israel Pollak doctoral fellowship program for excellence, Tel Aviv University	Israel Science Foundation(Israel Science Foundation); Israel Pollak doctoral fellowship program for excellence, Tel Aviv University	Funding for the study was provided by the Israel Science Foundation (grant No. 351/16). The first author received a fellowship from the Israel Pollak doctoral fellowship program for excellence, Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WOR HEALT REP; [Anonymous], 2018, RECOMMENDATIONS INTR; Bell AF, 2016, MIDWIFERY, V39, P112, DOI 10.1016/j.midw.2016.04.014; Benyamini Y., 2011, OXFORD HDB HLTH PSYC, P281; Benyamini Y, 2017, WOMEN BIRTH, V30, P424, DOI 10.1016/j.wombi.2017.03.007; Brubaker SJ, 2009, SOCIOL COMPASS, V3, P31, DOI 10.1111/j.1751-9020.2008.00183.x; Chadwick RJ, 2014, HEALTH RISK SOC, V16, P68, DOI 10.1080/13698575.2013.863852; de Labrusse C, 2016, WOMEN HEALTH ISS, V26, P100, DOI 10.1016/j.whi.2015.09.003; Fenwick J, 2005, MIDWIFERY, V21, P23, DOI 10.1016/j.midw.2004.07.001; Fenwick J, 2009, J CLIN NURS, V18, P667, DOI 10.1111/j.1365-2702.2008.02568.x; Fisher C, 2006, SOC SCI MED, V63, P64, DOI 10.1016/j.socscimed.2005.11.065; FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839; Graham JE, 2002, PSYCHOL WOMEN QUART, V26, P222, DOI 10.1111/1471-6402.00061; Hadjigeorgiou E, 2012, MIDWIFERY, V28, P380, DOI 10.1016/j.midw.2011.05.006; Haines HM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-55; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; IBM, 2016, IBM SPSS STAT WINDOW; Kornelsen J, 2005, SOC SCI MED, V61, P1495, DOI 10.1016/j.socscimed.2005.03.007; Larkin P, 2009, MIDWIFERY, V25, pE49, DOI 10.1016/j.midw.2007.07.010; Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2; Logsdon K, 2017, MIDWIFERY, V55, P67, DOI 10.1016/j.midw.2017.09.004; Miller AC, 2012, SOC SCI MED, V75, P709, DOI 10.1016/j.socscimed.2012.03.051; Namey EE, 2010, SOC SCI MED, V71, P769, DOI 10.1016/j.socscimed.2010.05.024; Nilsson C, 2012, WOMEN BIRTH, V25, P114, DOI 10.1016/j.wombi.2011.06.001; Parry DC, 2008, HEALTH CARE WOMEN IN, V29, P784, DOI 10.1080/07399330802269451; Possamai-Inesedy A., 2006, HLTH SOCIOL REV, V15, P406, DOI DOI 10.5172/HESR.2006.15.4.406; Preis H, 2018, WOMEN BIRTH; Preis H, 2018, PSYCHOL WOMEN Q; Preis H, 2018, MIDWIFERY, V63, P46, DOI 10.1016/j.midw.2018.05.002; Preis H, 2017, J PSYCHOSOM OBST GYN, V38, P73, DOI 10.1080/0167482X.2016.1244180; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Stoll K, 2015, BIRTH-ISS PERINAT C, V42, P270, DOI 10.1111/birt.12178; van Haaren-ten Haken TM, 2018, J PSYCHOSOM OBST GYN, V39, P19, DOI 10.1080/0167482X.2017.1285900; Van Teijlingen E, 2005, SOCIORES ON, V10; Wilson KL, 2010, J REPROD INFANT PSYC, V28, P69, DOI 10.1080/02646830903190946; Zinsser LA, 2016, MIDWIFERY, V39, P98, DOI 10.1016/j.midw.2016.05.006	36	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0208090	10.1371/journal.pone.0208090	http://dx.doi.org/10.1371/journal.pone.0208090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475898	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700103
J	Vicente, CR; Falqueto, A				Vicente, Creuza Rachel; Falqueto, Aloisio			Differentiation of mucosal lesions in mucocutaneous leishmaniasis and paracoccidioidomycosis	PLOS ONE			English	Article							SERIES	Mucocutaneous leishmaniasis and paracoccidioidomycosis are infectious diseases with similar epidemiological and clinical aspects. Cases of both diseases may manifest similar lesions in the mucosa. Therefore, the determination of distinguishing characteristics for the purpose of differential diagnosis is critical for better management of the diseases. The present study evaluated factors that assist in the differentiation of mucosal lesions between these diseases. This cross-sectional study included data from medical records of 122 cases of mucocutaneous leishmaniasis and 83 cases of paracoccidioidomycosis attended at the university hospital Cassiano Antonio Moraes, located in Vitoria, Espirito Santo State, Brazil. Comparison between the diseases included the following variables: sex, age, time of disease evolution, location of the lesion and symptoms. Adults and males were affected by both diseases at higher rates. Lesions in the nasal region (95.1%; p-value = 0.000) and the pharynx (20.5%; p-value = 0.009) and nasal obstruction (34.4%; p-value = 0.000) were associated with leishmaniasis. Paracoccidioidomycosis was associated with lesions in the oral region (90.4%; p-value = 0.000), oral pain (16.9%; p-value = 0.000), and hoarseness (14.5%; p-value = 0.008). In leishmaniasis, lesions in oral regions were not associated with oral pain and were frequently located close to the nasal area. The manifestations cited above could improve the differential diagnosis of leishmaniasis and paracoccidioidomycosis, and thereby potentially aid in the choice of appropriate confirmatory diagnostic testing.	[Vicente, Creuza Rachel; Falqueto, Aloisio] Univ Fed Espirito Santo, Dept Social Med, Hlth Sci Ctr, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo	Vicente, CR (corresponding author), Univ Fed Espirito Santo, Dept Social Med, Hlth Sci Ctr, Vitoria, ES, Brazil.	vicentecrachel@gmail.com						Azenha Marcelo Rodrigues, 2012, Braz. Dent. J., V23, P753, DOI 10.1590/S0103-64402012000600021; Bellissimo-Rodrigues F, 2013, MED MYCOL, V51, P313, DOI 10.3109/13693786.2012.714529; Bernin H, 2014, J INFECT DIS, V209, pS107, DOI 10.1093/infdis/jit610; Brazao-Silva MT, 2011, MYCOSES, V54, pE189, DOI 10.1111/j.1439-0507.2010.01873.x; Campos MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194383; Carvalho T, 2006, ACTA ORL, V24, P77; Cincura C, 2017, AM J TROP MED HYG, V97, P761, DOI 10.4269/ajtmh.16-0349; Diniz JLCP, 2011, BRAZ J OTORHINOLAR, V77, P380, DOI 10.1590/S1808-86942011000300018; Colombo A L, 1992, Rev Soc Bras Med Trop, V25, P171, DOI 10.1590/S0037-86821992000300004; Dutra LM, 2018, J INFECT PUBLIC HEAL, V11, P530, DOI 10.1016/j.jiph.2017.10.009; Falqueto A, 2015, VERONESI TRATADO INF, P1841; Faria Marilia S., 2012, Journal of Parasitology Research, P930257, DOI 10.1155/2012/930257; Fornazieri MA, 2008, INT ARCH OTORHINOLAR, V12, P362; Franca DCC, 2011, REV ODONTOLOGICA ARA, V32, P9; Hrycyk MF, 2018, MED MYCOL, V56, P950, DOI 10.1093/mmy/myx142; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Sardinha JFJ, 2011, AN BRAS DERMATOL, V86, P708, DOI 10.1590/S0365-05962011000400013; Lopez-Martinez R, 2014, MYCOSES, V57, P525, DOI 10.1111/myc.12190; Marques Silvio Alencar, 2007, An. Bras. Dermatol., V82, P411, DOI 10.1590/S0365-05962007000500003; Ministerio da Saude. Brasil, 2010, DOENC INF PAR GUIA B; Lessa Marcus Miranda, 2007, Rev. Bras. Otorrinolaringol., V73, P843, DOI [10.1590/S0034-72992007000600016, 10.1016/S1808-8694(15)31181-2]; Mohammadpour I, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2178-7; Oyama Jully, 2018, Rev. Inst. Med. trop. S. Paulo, V60, pe3, DOI 10.1590/s1678-9946201860003; Pecanha PM, 2017, AM J TROP MED HYG, V97, P836, DOI 10.4269/ajtmh.16-0790; R Core Team, 2018, R LANG ENV STAT COMP; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; da Costa DCS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109790; Tirelli F, 2017, AN BRAS DERMATOL, V92, P641, DOI 10.1590/abd1806-4841.20175794; Trindade AH, 2017, MYCOSES, V60, P521, DOI 10.1111/myc.12622; Verli FD, 2005, REV SOC BRAS MED TRO, V38, P234, DOI 10.1590/S0037-86822005000300005; World Health Organization, 2017, 38 WHO	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0208208	10.1371/journal.pone.0208208	http://dx.doi.org/10.1371/journal.pone.0208208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475920	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700107
J	Zhou, PJ; Wang, X; An, N; Wei, LZ; Zhang, L; Huang, XX; Zhu, HH; Fang, YX; Gao, WQ				Zhou, Pei-Jie; Wang, Xiao; An, Na; Wei, Lianzi; Zhang, Long; Huang, Xingxu; Zhu, Helen He; Fang, Yu-Xiang; Gao, Wei-Qiang			Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; HIPPO PATHWAY; STEM-CELL; POLARITY PROTEIN; CANCER; CYCLE; COMPLEX; MURINE; BASAL; LINK	Although cell polarity plays an important role in epithelial tumorigenesis, the consequence of polarity protein loss in prostatic tumorigenesis and the underlying mechanisms remain unclear. Using conditional knockout mouse models, we found in the current study that loss of polarity protein Par3 increases prostatic epithelial cell growth, elevates symmetrical cell divisions in basal cells, and randomizes spindle orientation in luminal cells, causing the development of high-grade prostatic intraepithelial neoplasia (PIN). Mechanistically, loss of Par3 dissociates the Par3/merlin/Lats1 complex, consequently inhibiting phosphorylation of Lats1 to attenuate the Hippo pathway. Furthermore, attenuated Hippo pathway enhances nuclear translocation of Yes-associated protein (YAP), which promotes cell proliferation and symmetrical cell divisions through transcriptional activation of Ki-67 and Sox2. In addition, Lats1 dephosphorylation impairs its interaction with G protein signaling modulator 2 (GPSM2, which is also known as LGN) that causes randomization of spindle orientation in luminal cells. Interestingly, co-deletion of Par3 and Lats1 for complete blockade of the Hippo pathway in mice results in prostate tumor initiation, whereas co-deletion of Par3 and YAP for disrupting YAP nuclear translocation reverses the phenotypes to a relatively normal state. Therefore, our findings highlight combination of Par3 loss and blockade of the Hippo pathway as a novel mechanism for prostatic tumorigenesis.	[Zhou, Pei-Jie; Wang, Xiao; An, Na; Wei, Lianzi; Zhu, Helen He; Fang, Yu-Xiang; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Med X Clin Stern Cell Res Ctr, Ren Ji Hosp,Sch Med, Shanghai 200127, Peoples R China; [Zhang, Long] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Long] Zhejiang Univ, Innovat Ctr Cell Signalling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Huang, Xingxu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Zhejiang University; Zhejiang University; ShanghaiTech University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fang, YX; Gao, WQ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Med X Clin Stern Cell Res Ctr, Ren Ji Hosp,Sch Med, Shanghai 200127, Peoples R China.; Gao, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.; Gao, WQ (corresponding author), Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China.	fyx2003108@sina.com; gao.weiqiang@sjtu.edu.cn	Zhang, Long/AAT-6571-2021; Gao, Wei/GXH-0380-2022	Zhang, Long/0000-0001-8139-0474; huang, xingxu/0000-0001-8934-1247	Ministry of Science and Technology of the People's Republic of China [2017YFA0102900, 2016YFA0502500]; National Natural Science Foundation of China [81672543, 81630073, 81372189]; Science and Technology Commission of Shanghai Municipality [16JC1405700]; High Peak IV subject on stem cells and translational medicine from Education Commission of Shanghai Municipality; KC Wong foundation	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); High Peak IV subject on stem cells and translational medicine from Education Commission of Shanghai Municipality; KC Wong foundation	This study was supported by funds from the Ministry of Science and Technology of the People's Republic of China (2017YFA0102900 to W-QG, 2016YFA0502500 to LZ), National Natural Science Foundation of China (81672543 to Y-XF, 81630073 and 81372189 to W-QG), Science and Technology Commission of Shanghai Municipality (16JC1405700 to W-QG), High Peak IV subject on stem cells and translational medicine from Education Commission of Shanghai Municipality, and KC Wong foundation (to W-QG).	Abate-Shen C, 2003, CANCER RES, V63, P3886; Basu-Roy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7411; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Carminati M, 2016, NAT STRUCT MOL BIOL, V23, P155, DOI 10.1038/nsmb.3152; Chang YL, 2015, ONCOTARGET, V6, P24017, DOI 10.18632/oncotarget.4447; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Keder A, 2015, CURR BIOL, V25, P2739, DOI 10.1016/j.cub.2015.08.064; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Lv XB, 2015, EMBO REP, V16, P975, DOI 10.15252/embr.201439951; Lygerou Z, 2000, SCIENCE, V290, P2271; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Surzenko N, 2013, DEVELOPMENT, V140, P1445, DOI 10.1242/dev.071878; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4415; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; Xie YT, 2002, ONCOGENE, V21, P5791, DOI 10.1038/sj.onc.1205700; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhou PJ, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0609-y	35	16	16	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2019	38	12					2192	2205		10.1038/s41388-018-0580-x	http://dx.doi.org/10.1038/s41388-018-0580-x			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HP6UR	30467379				2022-12-26	WOS:000461822600014
J	Chen, WW; Zhang, J; Zhang, PJ; Hu, FY; Jiang, TT; Gu, JX; Chang, Q				Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing			Role of TLR4-MAP4K4 signaling pathway in models of oxygen-induced retinopathy	FASEB JOURNAL			English	Article						VEGF; angiogenesis; retina	RECEPTOR 4; ENDOTHELIAL-CELLS; PROTEIN-KINASE; C-JUN; ANGIOGENESIS; EXPRESSION; MAP4K4; INFLAMMATION; CANCER; VEGF	Retinopathy of prematurity is a vision-threatening condition, and therapies based on antagonizing VEGF may elicit serious side effects in premature infants. Mechanisms of retinal angiogenesis, particularly the signaling pathways independent of VEGF, remain elusive. The goals of our study were to explore TLR4-mediated signaling pathways in human retinal microvascular endothelial cells (HRMECs) and to examine the effects of TLR4 antagonists in models of oxygen-induced retinopathy (OIR). Our results show that intravitreal injection of the TLR4 antagonist TAK-242 reduced areas of nonperfusion, inhibited aberrant angiogenesis, and improved vascular density in the retina of OIR mice. The effects were further potentiated by the anti-VEGF antibody ranibizumab. In cultured HRMECs, the TLR4 agonist LPS up-regulated TLR4/MAPKK kinase kinase 4 (MAP4K4) signaling, and promoted cell proliferation and migration, and reduced barrier functions of the cells. Down-regulation of MAP4K4 in HRMECs abolished the proangiogenic effects by LPS. Our data suggest that the TLR4-MAP4K4 pathway can regulate retinal neovascularization via mechanisms independent of VEGF.Chen, W., Zhang, J., Zhang, P., Hu, F., Jiang, T., Gu, J., Chang, Q. Role of TLR4-MAP4K4 signaling pathway in models of oxygen-induced retinopathy.	[Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing] Fudan Univ, Eye & Ear Nose & Throat Hosp, Dept Ophthalmol & Vis Sci, Shanghai, Peoples R China; [Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing] Fudan Univ, Key Lab Myopia Natl Hlth Commiss, Shanghai, Peoples R China; [Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing] Chinese Acad Med Sci, Key Lab Myopia, Shanghai, Peoples R China; [Chen, Wenwen; Zhang, Juan; Zhang, Peijun; Hu, Fangyuan; Jiang, Tingting; Gu, Junxiang; Chang, Qing] Key Lab Visual Impairment & Restorat Shanghai, Shanghai, Peoples R China	Fudan University; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College	Chang, Q (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol & Vis Sci, 83 Fen Yang Rd, Shanghai 200031, Peoples R China.	qngchang@aliyun.com			National Natural Science Foundation of China [81870670, 81371041, 81500734]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81870670, 81371041, and 81500734). The funding organization had no role in the design or supervision of this study. The authors declare no conflicts of interest.	Axer-Siegel R, 2004, OPHTHALMOLOGY, V111, P1734, DOI 10.1016/j.ophtha.2004.03.024; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chan JJT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27082; Chan-Ling T, 2018, PROG RETIN EYE RES, V62, P77, DOI 10.1016/j.preteyeres.2017.09.002; Chuang HC, 2016, ADV IMMUNOL, V129, P277, DOI 10.1016/bs.ai.2015.09.006; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Feng YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139280; Flach RJR, 2016, MOL CELL BIOL, V36, P1740, DOI 10.1128/MCB.01121-15; Flach RJR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9995; Hartnett ME, 2016, EYE BRAIN, V8, P27, DOI 10.2147/EB.S105319; He C, 2013, ARTERIOSCL THROM VAS, V33, P330, DOI 10.1161/ATVBAHA.112.300679; Hu L, 2016, MOL ONCOL, V10, P1473, DOI 10.1016/j.molonc.2016.08.002; Jiang TT, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3528274; Lei CY, 2016, BRAIN RES, V1632, P1, DOI 10.1016/j.brainres.2015.11.045; Li N, 2012, CYTOKINE, V60, P806, DOI 10.1016/j.cyto.2012.08.003; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Liu AW, 2011, CLIN CANCER RES, V17, P710, DOI 10.1158/1078-0432.CCR-10-0331; Ma B, 2017, J TISSUE ENG REGEN M, V11, P1779, DOI 10.1002/term.2075; Ma M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004003; Martinez-Castellanos MA, 2013, RETINA-J RET VIT DIS, V33, P329, DOI 10.1097/IAE.0b013e318275394a; Monaghan-Benson E, 2011, METHODS MOL BIOL, V763, P281, DOI 10.1007/978-1-61779-191-8_19; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; Murad S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00313; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P4323, DOI 10.1167/iovs.11-9119; Ndubaku CO, 2015, ACS MED CHEM LETT, V6, P913, DOI 10.1021/acsmedchemlett.5b00174; Park SY, 2015, EUR J IMMUNOL, V45, P1216, DOI 10.1002/eji.201444908; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Sachdev U, 2013, J VASC SURG, V58, P460, DOI 10.1016/j.jvs.2012.11.071; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; Sinon SH, 2016, J ORAL PATHOL MED, V45, P28, DOI 10.1111/jop.12319; Sun YL, 2016, EXP CELL RES, V347, P274, DOI 10.1016/j.yexcr.2016.07.009; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Tremblay S, 2013, INVEST OPHTH VIS SCI, V54, P8125, DOI 10.1167/iovs.13-12496; Trigler L, 2005, J AAPOS, V9, P17, DOI 10.1016/j.jaapos.2004.10.007; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; VanderVeen DK, 2017, OPHTHALMOLOGY, V124, P619, DOI 10.1016/j.ophtha.2016.12.025; Vitorino P, 2015, NATURE, V519, P425, DOI 10.1038/nature14323; Wang HB, 2016, EYE BRAIN, V8, P81, DOI 10.2147/EB.S94449; Wang HB, 2014, INVEST OPHTH VIS SCI, V55, P737, DOI 10.1167/iovs.13-13429; Wang L, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0086-4; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Wu JH, 2014, AM J PATHOL, V184, P1900, DOI 10.1016/j.ajpath.2014.03.001; Xia S, 2018, J PHYSIOL-LONDON, V596, P1397, DOI 10.1113/JP275453; Xu WQ, 2016, INT J OPHTHALMOL-CHI, V9, P1343, DOI 10.18240/ijo.2016.09.19; Yang N, 2015, J HISTOCHEM CYTOCHEM, V63, P721, DOI 10.1369/0022155415590829; Yang S, 2014, J LEUKOCYTE BIOL, V95, P563, DOI 10.1189/jlb.0713412; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zabini D, 2015, J CELL MOL MED, V19, P1151, DOI 10.1111/jcmm.12519; Zhang X, 2015, PROTEOMICS, V15, P340, DOI 10.1002/pmic.201400315	50	5	5	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3451	3464		10.1096/fj.201801086RR	http://dx.doi.org/10.1096/fj.201801086RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30475644	Bronze			2022-12-26	WOS:000459794800030
J	Ihara, H; Kakihana, Y; Yamakage, A; Kai, K; Shibata, T; Nishida, M; Yamada, K; Uchida, K				Ihara, Hideshi; Kakihana, Yuki; Yamakage, Akane; Kai, Kenji; Shibata, Takahiro; Nishida, Motohiro; Yamada, Ken-ichi; Uchida, Koji			2-Oxo-histidine-containing dipeptides are functional oxidation products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; mass spectrometry (MS); oxidative stress; peptides; histidine; 2-oxo-histidine-containing dipeptides; imidazole; neuroprotection	AMINO-ACID-RESIDUES; CATALYZED OXIDATION; IMIDAZOLE RING; COPPER-BINDING; HISTIDINE; CARNOSINE; INHIBITION; IDENTIFICATION; PROTEIN; HOMOCARNOSINE	Imidazole-containing dipeptides (IDPs), such as carnosine and anserine, are found exclusively in various animal tissues, especially in the skeletal muscles and nerves. IDPs have antioxidant activity because of their metal-chelating and free radical-scavenging properties. However, the underlying mechanisms that would fully explain IDP antioxidant effects remain obscure. Here, using HPLC-electrospray ionization-tandem MS analyses, we comprehensively investigated carnosine and its related small peptides in the soluble fractions of mouse tissue homogenates and ubiquitously detected 2-oxo-histidine-containing dipeptides (2-oxo-IDPs) in all examined tissues. We noted enhanced production of the 2-oxo-IDPs in the brain of a mouse model of sepsis-associated encephalopathy. Moreover, in SH-SY5Y human neuroblastoma cells stably expressing carnosine synthase, H2O2 exposure resulted in the intracellular production of 2-oxo-carnosine, which was associated with significant inhibition of the H2O2 cytotoxicity. Notably, 2-oxo-carnosine showed a better antioxidant activity than endogenous antioxidants such as GSH and ascorbate. Mechanistic studies indicated that carnosine monooxygenation is mediated through the formation of a histidyl-imidazole radical, followed by the addition of molecular oxygen. Our findings reveal that 2-oxo-IDPs are metal-catalyzed oxidation products present in vivo and provide a revised paradigm for understanding the antioxidant effects of the IDPs.	[Ihara, Hideshi; Kakihana, Yuki; Yamakage, Akane] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998531, Japan; [Kai, Kenji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Biol Chem, Sakai, Osaka 5998531, Japan; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nishida, Motohiro] Natl Inst Physiol Sci, Div Cardiocirculatory Signaling, Okazaki, Aichi 4448787, Japan; [Yamada, Ken-ichi] Kyushu Univ, Fac Pharmaceut Sci, Phys Chem Life Sci Lab, Fukuoka, Fukuoka 8120054, Japan; [Yamada, Ken-ichi; Uchida, Koji] Japan Agcy Med Res & Dev, CREST, Tokyo 1020076, Japan; [Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kyushu University; Japan Science & Technology Agency (JST); University of Tokyo	Ihara, H (corresponding author), Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998531, Japan.; Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	ihara@b.s.osakafu-u.ac.jp; a-uchida@mail.ecc.u-tokyo.ac.jp	; Shibata, Takahiro/I-6872-2014	Kai, Kenji/0000-0002-4036-9959; Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X; Nishida, Motohiro/0000-0002-2587-5458	Japanese Ministry of Education, Sciences, Sports, Technology [17H06170, 16H04674, 16K13089, 26111011]; AMED-CREST from AMED; Smoking Research Foundation	Japanese Ministry of Education, Sciences, Sports, Technology; AMED-CREST from AMED; Smoking Research Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (S) 17H06170) (to K. U.), Grant-in-Aid for Scientific Research (B) 16H04674 (to H. I.), Grant-in-Aid for Challenging Exploratory Research 16K13089 (to H. I.), and Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" 26111011 (to K. U., H. I., and M. N.) from the Japanese Ministry of Education, Sciences, Sports, Technology. This work was also supported by AMED-CREST from AMED (to K. Y. and K. U.) and the Smoking Research Foundation (to H. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg RMG, 2011, J CEREBR BLOOD F MET, V31, P1532, DOI 10.1038/jcbfm.2011.48; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; DAVEY CL, 1960, ARCH BIOCHEM BIOPHYS, V89, P303, DOI 10.1016/0003-9861(60)90059-X; Drozak J, 2015, J BIOL CHEM, V290, P17190, DOI 10.1074/jbc.M115.640037; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; GONZALEZESTRADA MT, 1980, BRAIN RES, V202, P373, DOI 10.1016/0006-8993(80)90149-3; Ihara H, 2012, BIOSCI BIOTECH BIOCH, V76, P1843, DOI 10.1271/bbb.120215; IKEDA T, 1980, J BIOCHEM-TOKYO, V87, P179, DOI 10.1093/oxfordjournals.jbchem.a132723; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; LENNEY JF, 1990, BIOL CHEM H-S, V371, P433, DOI 10.1515/bchm3.1990.371.1.433; LI SH, 1995, BIOCHEMISTRY-US, V34, P5762, DOI 10.1021/bi00017a008; MASAKI N, 1989, ARCH BIOCHEM BIOPHYS, V269, P390, DOI 10.1016/0003-9861(89)90122-7; Matoba T, 2003, ARTERIOSCL THROM VAS, V23, P1224, DOI 10.1161/01.ATV.0000078601.79536.6C; Requena JR, 2001, P NATL ACAD SCI USA, V98, P7170, DOI 10.1073/pnas.121190898; Retsky KL, 1999, FREE RADICAL BIO MED, V26, P90, DOI 10.1016/S0891-5849(98)00151-8; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; STEWART LC, 1987, BIOCHEMISTRY-US, V26, P5302, DOI 10.1021/bi00391a013; Tabakman R, 2004, J NEUROSCI RES, V75, P499, DOI 10.1002/jnr.20008; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; UCHIDA K, 1990, BIOCHIM BIOPHYS ACTA, V1034, P347, DOI 10.1016/0304-4165(90)90063-3; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; Uchida K, 2003, AMINO ACIDS, V25, P249, DOI 10.1007/s00726-003-0015-y; UCHIDA K, 1993, FEBS LETT, V332, P208, DOI 10.1016/0014-5793(93)80632-5; UCHIDA K, 1986, BIOCHEM BIOPH RES CO, V138, P659, DOI 10.1016/S0006-291X(86)80547-2; UCHIDA K, 1989, BIOORG CHEM, V17, P330, DOI 10.1016/0045-2068(89)90035-7; Winter GEM, 1996, BIOCHEMISTRY-US, V35, P11805, DOI 10.1021/bi960381m; YOSHIDA T, 1989, CHEM PHARM BULL, V37, P1919; Zhao F, 1997, J BIOL CHEM, V272, P9019	32	22	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1279	1289		10.1074/jbc.RA118.006111	http://dx.doi.org/10.1074/jbc.RA118.006111			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504220	Green Published, hybrid			2022-12-26	WOS:000457879500019
J	Bogdanovic, X; Schneider, S; Levanova, N; Wirth, C; Trillhaase, C; Steinemann, M; Hunte, C; Aktories, K; Jank, T				Bogdanovic, Xenia; Schneider, Silvia; Levanova, Nadezhda; Wirth, Christophe; Trillhaase, Christoph; Steinemann, Marcus; Hunte, Carola; Aktories, Klaus; Jank, Thomas			A cysteine protease-like domain enhances the cytotoxic effects of the Photorhabdus asymbiotica toxin PaTox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; cysteine protease; protease; crystal structure; X-ray crystallography; AvrPphB; C58-like cysteine protease; papain-like protease; virulence-associated protein toxin; YopT	CATERPILLARS-FLOPPY MCF; ESCHERICHIA-COLI; SHUTTLE VECTORS; YEAST; APOPTOSIS; BEAMLINE; CLEAVAGE; INSECT; SYSTEM	The nematode mutualistic bacterium Photorhabdus asymbiotica produces a large virulence-associated multifunctional protein toxin named PaTox. A glycosyltransferase domain and a deamidase domain of this large toxin function as effectors that specifically target host Rho GTPases and heterotrimeric G proteins, respectively. Modification of these intracellular regulators results in toxicity toward insects and mammalian cells. In this study, we identified a cysteine protease-like domain spanning PaTox residues 1844-2114 (PaTox(P)), upstream of these two effector domains and characterized by three conserved amino acid residues (Cys-1865, His-1955, and Asp-1975). We determined the crystal structure of the PaTox(P) C1865A variant by native single-wavelength anomalous diffraction of sulfur atoms (sulfur-SAD). At 2.0 A resolution, this structure revealed a catalytic site typical for papain-like cysteine proteases, comprising a catalytic triad, oxyanion hole, and typical secondary structural elements. The PaTox(P) structure had highest similarity to that of the AvrPphB protease from Pseudomonas syringae classified as a C58-protease. Furthermore, we observed that PaTox(P) shares structural homology also with non-C58-cysteine proteases, deubiquitinases, and deamidases. Upon delivery into insect larvae, PaTox(P) alone without full-length PaTox had no toxic effects. Yet, PaTox(P) expression in mammalian cells was toxic and enhanced the apoptotic phenotype induced by PaTox in HeLa cells. We propose that PaTox(P) is a C58-like cysteine protease module that is essential for full PaTox activity.	[Bogdanovic, Xenia; Wirth, Christophe; Hunte, Carola] Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Schneider, Silvia; Levanova, Nadezhda; Trillhaase, Christoph; Steinemann, Marcus; Aktories, Klaus; Jank, Thomas] Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Hunte, Carola; Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Hunte, C (corresponding author), Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.; Aktories, K; Jank, T (corresponding author), Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany.; Hunte, C; Aktories, K (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany.	carola.hunte@biochemie.uni-freiburg.de; klaus.aktories@pharmakol.uni-freiburg.de; thomas.jank@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Hunte, Carola/E-4071-2015; Schneider, Silvia/C-5229-2015	Aktories, Klaus/0000-0002-5397-0436; Hunte, Carola/0000-0002-0826-3986; Schneider, Silvia/0000-0003-0698-8411; Wirth, Christophe/0000-0001-8864-6508	Deutsche Forschungsgemeinschaft Collaborative Research Center [746]; Deutsche Forschungsgemeinschaft [AK6/22-1]; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; Excellence Initiative of the German State Government [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by grants from the Deutsche Forschungsgemeinschaft Collaborative Research Center 746 (to T. J., K. A., and C. H.), Deutsche Forschungsgemeinschaft Grant AK6/22-1 (to K. A.), and the Excellence Initiative of the German Federal and State Governments EXC 294 BIOSS (to K. A. and C. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal S, 2015, INFECT IMMUN, V83, P4392, DOI 10.1128/IAI.00570-15; Agarwal S, 2015, CELL MICROBIOL, V17, P1494, DOI 10.1111/cmi.12451; Akey DL, 2016, ACTA CRYSTALLOGR D, V72, P296, DOI 10.1107/S2059798315021920; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; Brink T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007248; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Dowling AJ, 2004, CELL MICROBIOL, V6, P345, DOI 10.1046/j.1462-5822.2003.00357.x; Dowling AJ, 2007, CELL MICROBIOL, V9, P2470, DOI 10.1111/j.1462-5822.2007.00974.x; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Gerrard JG, 2017, CURR TOP MICROBIOL, V402, P179, DOI 10.1007/82_2016_56; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hapeshi A, 2017, CURR TOP MICROBIOL, V402, P159, DOI 10.1007/82_2016_29; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	35	4	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1035	1044		10.1074/jbc.RA118.005043	http://dx.doi.org/10.1074/jbc.RA118.005043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478175	Green Published, hybrid			2022-12-26	WOS:000458670200026
J	Kumar, S; Rubino, FA; Mendoza, AG; Ruiz, N				Kumar, Sujeet; Rubino, Frederick A.; Mendoza, Alicia G.; Ruiz, Natividad			The bacterial lipid II flippase MurJ functions by an alternating-access mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; cysteine-mediated cross-linking; lipid II; peptidoglycan; glycolipid; cell wall; antibacterial target; conformational dynamics; MOP exporter	CROSS-LINKING; PEPTIDOGLYCAN BIOGENESIS; LACTOSE PERMEASE; STRUCTURAL BASIS; MULTIDRUG; IDENTIFICATION; TRANSPORTERS; MVIN; BIOSYNTHESIS; PROXIMITY	The peptidoglycan (PG) cell wall is an essential extracytoplasmic glycopeptide polymer that safeguards bacteria against osmotic lysis and determines cellular morphology. Bacteria use multiprotein machineries for the synthesis of the PG cell wall during cell division and elongation that can be targeted by antibiotics such as the beta-lactams. Lipid II, the lipid-linked precursor for PG biogenesis, is synthesized in the inner leaflet of the cytoplasmic membrane and then translocated across the bilayer, where it is ultimately polymerized into PG. In Escherichia coli, MurJ, a member of the MOP exporter superfamily, has been recently shown to have lipid II flippase activity that depends on membrane potential. Because of its essentiality, MurJ could potentially be targeted by much needed novel antibiotics. Recent structural information suggests that a central cavity in MurJ alternates between inward- and outward-open conformations to flip lipid II, but how these conformational changes occur are unknown. Here, we utilized structure-guided cysteine cross-linking and proteolysis-coupled gel analysis to probe the conformational changes of MurJ in E. coli cells. We found that paired cysteine substitutions in transmembrane domains 2 and 8 and periplasmic loops of MurJ could be cross-linked with homobifunctional cysteine cross-linkers, indicating that MurJ can adopt both inward- and outward-facing conformations in vivo. Furthermore, we show that dissipating the membrane potential with an ionophore decreases the prevalence of the inward-facing, but not the outward-facing state. Our study provides in vivo evidence that MurJ uses an alternating-access mechanism during the lipid II transport cycle.	[Kumar, Sujeet; Mendoza, Alicia G.; Ruiz, Natividad] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Rubino, Frederick A.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	University System of Ohio; Ohio State University; Harvard University	Ruiz, N (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ruiz.82@osu.edu	kumar, sujeet/U-1351-2018	kumar, sujeet/0000-0002-8207-4358; Ruiz, Natividad/0000-0002-6369-2206; Mendoza, Alicia/0000-0001-5010-2951; Rubino, Frederick/0000-0002-7149-6088	NIGMS, National Institutes of Health [R01 GM1000951]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100051, R01GM100951, R01GM076710] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM1000951 (to N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bolla JR, 2018, NAT CHEM, V10, P363, DOI [10.1038/NCHEM.2919, 10.1038/nchem.2919]; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Butler EK, 2014, J BACTERIOL, V196, P4111, DOI 10.1128/JB.02172-14; Butler EK, 2013, J BACTERIOL, V195, P4639, DOI 10.1128/JB.00731-13; Chamakura KR, 2017, NAT MICROBIOL, V2, P1480, DOI 10.1038/s41564-017-0023-4; Dell A., 2010, INT J MICROBIOL, V2010, DOI [10.1074/jbc.RA117.001068, DOI 10.1155/2010/148178]; Egan AJF, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0031; Elhenawy W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161587; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hennon SW, 2014, BIOCHEMISTRY-US, V53, P3278, DOI 10.1021/bi500257u; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kuk ACY, 2017, NAT STRUCT MOL BIOL, V24, P171, DOI 10.1038/nsmb.3346; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Liu XL, 2018, MOL MICROBIOL, V109, DOI 10.1111/mmi.14104; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Lu M, 2016, CHANNELS, V10, P88, DOI 10.1080/19336950.2015.1106654; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; Mohamed YF, 2014, GLYCOBIOLOGY, V24, P564, DOI 10.1093/glycob/cwu025; Monteiro JM, 2018, NATURE, V554, P528, DOI 10.1038/nature25506; Mulligan C, 2017, METHOD ENZYMOL, V594, P165, DOI 10.1016/bs.mie.2017.05.012; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Paz A, 2018, P NATL ACAD SCI USA, V115, pE2742, DOI 10.1073/pnas.1718451115; Qiao Y, 2017, NAT CHEM BIOL, V13, P793, DOI 10.1038/nchembio.2388; Rubino FA, 2018, J AM CHEM SOC, V140, P4481, DOI 10.1021/jacs.8b00942; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Ruiz N, 2016, CURR OPIN MICROBIOL, V34, P1, DOI 10.1016/j.mib.2016.07.010; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Schmid J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00496; Sham LT, 2018, MOL MICROBIOL, V109, P633, DOI 10.1111/mmi.14002; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P11959, DOI 10.1021/bi971172k; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Wu JH, 1999, BIOCHEMISTRY-US, V38, P1715, DOI 10.1021/bi982342b; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zheng SD, 2018, P NATL ACAD SCI USA, V115, P6709, DOI 10.1073/pnas.1802192115	47	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					981	990		10.1074/jbc.RA118.006099	http://dx.doi.org/10.1074/jbc.RA118.006099			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482840	hybrid, Green Published			2022-12-26	WOS:000458670200022
J	Farder-Gomes, CF; da Silva, VP; Pereira, TPL; Serrao, JE; Pires, EM; Oliveira, MA				Farder-Gomes, Cliver Fernandes; da Silva, Veronica Priscila; Lavinscky Pereira, Thalles Platiny; Serrao, Jose Eduardo; Pires, Evaldo Martins; Oliveira, Marco Antonio			Parasitism, sexual dimorphism and effect of host size on Apocephalus attophilus offspring, a parasitoid of the leaf-cutting ant Atta bisphaerica	PLOS ONE			English	Article							VOLLENWEIDERI HYMENOPTERA-FORMICIDAE; PSEUDACTEON FLIES DIPTERA; BODY-SIZE; OVIPOSITION BEHAVIOR; CLUTCH SIZE; PHORIDAE; FLY; NEODOHRNIPHORA; BIOLOGY; RATES	Atta bisphaerica (Forel) is a leaf-cutting ant that specializes on grass and causes productivity losses in sugar cane fields and pastures. Three phorid species, Apocephalus attophilus (Borgmeier), Myrmosicarius grandicornis (Borgmeier) and Eibesfeldtphora bragancai (Brown), have been found parasitizing A. bisphaerica workers. These parasitoids can reduce plant material transported into the nests and ant traffic on the trails. Therefore, phorid flies have been considered potential biological control agents for leaf-cutting ants. Here, we evaluated which parasitoid species attack the leaf-cutting ant A. bisphaerica in pasture areas of a Brazilian Savannah-Atlantic Forest ecotone, parasitism rate, effect of host size, sexual dimorphism and sex ratio of the emerged parasitoids. Four nests of A. bisphaerica were selected in pasture areas from August 2016 to August 2017, with 400 workers collected from each colony monthly. A total of 23,714 A. bisphaerica workers were collected during the study, of which 236 (0.99%) were parasitized by phorid parasitoids. Apocephalus attophilus, E. bragancai and M. grandicornis parasitized 217, 17 and 2 ants, respectively. The higher parasitism rate was found in the hottest/rainy season of the year. Non-parasitized ants survived longer than those parasitized by A. attophilus. The larval and pupal periods of this parasitoid were 2.2 +/- 0.8 and 16 +/- 1.4 days, respectively, and the number of pupae per parasitized ant ranged from 1 to 7. The number of A. attophilus pupae per host increased with the host head size. Likewise, the size of the adult parasitoids also increased according to the host ant. Apocephalus attophilus females were larger than males and the sex ratio (male: female) did not differ from 1: 1. Our results showed that A. attophilus would be a potential biocontrol agent of leaf-cutting ants because it produces multiple larvae per host, allowing a great production of parasitoids with short developmental time and kills the host ant faster than other phorids.	[Farder-Gomes, Cliver Fernandes; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [da Silva, Veronica Priscila] Fed Univ Vicosa Campus Florestal, Inst Biol Sci, Florestal, MG, Brazil; [Lavinscky Pereira, Thalles Platiny] Univ Sao Paulo, Dept Zool, Sao Paulo, SP, Brazil; [Pires, Evaldo Martins] Fed Univ Mato Grosso Campus Sinop, Postgrad Program Environm Sci, Sinop, Mato Grosso, Brazil	Universidade Federal de Vicosa; Universidade de Sao Paulo	Farder-Gomes, CF (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	cliver.farder@gmail.com		Pereira, Thalles Platiny Lavinscky/0000-0003-2075-3643	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CAG - APQ-01842-14]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (EDITAL 01/2014-DEMANDA UNIVERSAL-FAPEMIG - PROCESSO N. : CAG - APQ-01842-14) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AgroSciences D, 1998, CONTR FORM CORT; Arakawa R, 2004, APPL ENTOMOL ZOOL, V39, P177, DOI 10.1303/aez.2004.177; Barzegar S, 2016, NEOTROP ENTOMOL, V45, P507, DOI 10.1007/s13744-016-0400-3; Bell HA, 2005, J EXP BIOL, V208, P3199, DOI 10.1242/jeb.01759; Braganca MAL, 2016, SOCIOBIOLOGY, V63, P1015, DOI 10.13102/sociobiology.v63i4.1077; Braganca MAL, 1998, ENTOMOL EXP APPL, V89, P305, DOI 10.1023/A:1003572130111; Braganca MAL, 2007, BIOLOGICO SAO PAULO, V69, P447; Braganca MAL, 2006, NEOTROP ENTOMOL, V35, P408, DOI 10.1590/S1519-566X2006000300018; BRAGANÇA MARCOS A.L., 2002, Neotrop. entomol., V31, P241, DOI 10.1590/S1519-566X2002000200010; Braganca MAL, 2009, REV BRAS ENTOMOL, V53, P600, DOI 10.1590/S0085-56262009000400009; Bragança Marcos A.L., 2003, Neotrop. entomol., V32, P169, DOI 10.1590/S1519-566X2003000100028; Brown Brian V., 1997, Contributions in Science (Los Angeles), V468, P1; Brown BV, 2001, INSECT SYST EVOL, V32, P393, DOI 10.1163/187631201X00272; Calcaterra LA, 2008, ANN ENTOMOL SOC AM, V101, P539, DOI 10.1603/0013-8746(2008)101[539:APAPRO]2.0.CO;2; Callcott AMA, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0119; CHARNOV EL, 1984, FLA ENTOMOL, V67, P5, DOI 10.2307/3494101; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; Chirino MG, 2012, J ECON ENTOMOL, V105, P386, DOI 10.1603/EC09170; Cloutier C, 2000, ENTOMOL EXP APPL, V97, P29, DOI 10.1023/A:1004056818645; Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402; Della Lucia TMC, 2014, PEST MANAG SCI, V70, P14, DOI 10.1002/ps.3660; Della Lucia TMC, 1999, NATURALIA, V24, P53; Disney RHL, 2008, ANNU REV ENTOMOL, V53, P39, DOI 10.1146/annurev.ento.53.103106.093415; Disney RHL, 2006, SOCIOBIOLOGY, V47, P771; Erthal M, 2000, ENTOMOL EXP APPL, V95, P71, DOI 10.1046/j.1570-7458.2000.00643.x; Farder-Gomes CF, 2017, B ENTOMOL RES, V107, P487, DOI 10.1017/S0007485316001073; FEENER DH, 1990, BEHAV ECOL SOCIOBIOL, V26, P17; Folgarait P. J., 2013, Psyche: A Journal of Entomology, V2013, P539780, DOI 10.1155/2013/539780; Folgarait PJ, 2003, BIOL CONTROL, V28, P368, DOI 10.1016/S1049-9644(03)00093-8; Foo FK, 2017, ANN ENTOMOL SOC AM, V110, P227, DOI 10.1093/aesa/saw078; FOWLER HG, 1989, ENVIRON MANAGE, V13, P671, DOI 10.1007/BF01868306; Gao SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156831; Graham LC, 2003, FLA ENTOMOL, V86, P334, DOI 10.1653/0015-4040(2003)086[0334:FROTDF]2.0.CO;2; Guillade AC, 2015, ENTOMOL EXP APPL, V154, P53, DOI 10.1111/eea.12255; Guillade AC, 2014, J ECON ENTOMOL, V107, P105, DOI 10.1603/EC12498; Guillade AC, 2011, J ECON ENTOMOL, V104, P32, DOI 10.1603/EC10173; Han WC, 2018, CHEMOSPHERE, V192, P59, DOI 10.1016/j.chemosphere.2017.10.149; HURLBUTT B, 1987, BIOL J LINN SOC, V30, P63, DOI 10.1111/j.1095-8312.1987.tb00290.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Liu ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023260; Martins H. C., 2015, THESIS; Morrison LW, 1999, BIOL J LINN SOC, V66, P257, DOI 10.1006/bijl.1998.0265; Morrison LW, 1998, ECOL ENTOMOL, V23, P409, DOI 10.1046/j.1365-2311.1998.00159.x; Morrison LW, 1997, ENVIRON ENTOMOL, V26, P716, DOI 10.1093/ee/26.3.716; ORR MR, 1992, BEHAV ECOL SOCIOBIOL, V30, P395; Porter SD, 2011, FLA ENTOMOL, V94, P208, DOI 10.1653/024.094.0213; Saeki Y, 2013, ENTOMOL EXP APPL, V149, P241, DOI 10.1111/eea.12130; Segoli M, 2015, ECOL ENTOMOL, V40, P483, DOI 10.1111/een.12194; Tonhasca A, 2001, INSECT SOC, V48, P154, DOI 10.1007/PL00001759; Tonhasca Athayde Jr, 1996, Ecotropica, V2, P157; Ueno T, 1999, RES POPUL ECOL, V41, P47, DOI 10.1007/PL00011982; Uribe S, 2014, ZOOTAXA, V3814, P443, DOI 10.11646/zootaxa.3814.3.11	52	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208253	10.1371/journal.pone.0208253	http://dx.doi.org/10.1371/journal.pone.0208253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507956	Green Published, Green Submitted, gold			2022-12-26	WOS:000451886500034
J	Li, YF; An, JJ; Dang, ZH; Lv, HY; Pan, WL; Gao, ZL				Li, Yaofa; An, Jingjie; Dang, Zhihong; Lv, Haiying; Pan, Wenliang; Gao, Zhanlin			Treating wheat seeds with neonicotinoid insecticides does not harm the rhizosphere microbial community	PLOS ONE			English	Article							SOYBEAN APHID; EFFICACY; COTTON; SOIL; HYMENOPTERA; POPULATIONS; LEAFHOPPER; COLEOPTERA; IMPACT; GRAIN	Wheat aphids damage wheat plants directly by feeding on them and indirectly by transmitting plant pathogenic viruses, both of which result in low yield and plant death. Due to their high root absorption and systemic characteristics, neonicotinoid insecticidal seed treatments are increasingly applied to control wheat aphids throughout the growing season in China. Ecological concerns are raised in some research, because neonicotinoids can persist and accumulate in soils. They are prone to leach into waterways, and are found in crop nectars and pollens, where they may be harmful to pollinators. Less information is available about the effect of neonicotinoid seed treatments on soil microorganisms. Here, we posed the hypothesis that neonicotinoids are not harmful to soil microbial communities. We tested our hypothesis by evaluating the effects of two neonicotinoids, imidacloprid and clothianidin, on soil microbiomes using high-throughput sequencing during three points in the wheat growth season. Except for the imidacloprid-treated soil in the seedling stage, the community richness and diversity were not affected according to Chaol , ACE and the Shannon indices, and species distribution histogram at the phylum level. However, Beta diversity indices showed that the species richness of the bacterial and fungal community was suppressed by neonicotinoids in seedling stage (high neonicotinoids concentrations), whereas by the reviving period, the changes reverted into stimulation of the soil microorganisms (low neonicotinoids concentrations). Overall, the general microbiome recovered at the end of the wheat planting season. Generally, wheat seed dressing with neonicotinoid insecticides control aphids during the entire growth period, and have no lasting adverse effects on the soil microbiome. This study provides an understanding of the influence of neonicotinoids on crop land ecology at the level of soil microbe communities.	[Li, Yaofa; An, Jingjie; Dang, Zhihong; Lv, Haiying; Pan, Wenliang; Gao, Zhanlin] Hebei Acad Agr & Forestry Sci, Plant Protect Inst, Baoding, Peoples R China; [Li, Yaofa; An, Jingjie; Dang, Zhihong; Lv, Haiying; Pan, Wenliang; Gao, Zhanlin] IPM Ctr Hebei Prov, Baoding, Peoples R China; [Li, Yaofa; An, Jingjie; Dang, Zhihong; Lv, Haiying; Pan, Wenliang; Gao, Zhanlin] Minist Agr & Rural Affairs, Key Lab Integrated Pest Management Crops Northern, Baoding, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Ministry of Agriculture & Rural Affairs	Gao, ZL (corresponding author), Hebei Acad Agr & Forestry Sci, Plant Protect Inst, Baoding, Peoples R China.; Gao, ZL (corresponding author), IPM Ctr Hebei Prov, Baoding, Peoples R China.; Gao, ZL (corresponding author), Minist Agr & Rural Affairs, Key Lab Integrated Pest Management Crops Northern, Baoding, Peoples R China.	gaozhanlin@sina.com			National key research and development program of China [2017YFD0201603, 2017YFD0201707, 2016YFD0300705]	National key research and development program of China	This work was supported by the National key research and development program of China (2017YFD0201603 to WP, 2017YFD0201707 to ZD and 2016YFD0300705 to ZG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albajes R, 2003, J ECON ENTOMOL, V96, P1805, DOI 10.1603/0022-0493-96.6.1805; [Anonymous], 2016, J PHYTOPATHOLOGY PES; Deng Fei, 2014, Chinese Journal of Applied Entomology, V51, P360, DOI 10.7679/j.issn.2095-1353.2014.042; DRINKWATER TW, 1994, CROP PROT, V13, P341, DOI 10.1016/0261-2194(94)90048-5; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Hamady SE, 2008, CHEMOSPHERE, V71, P2173, DOI 10.1016/j.chemosphere.2007.12.027; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gray SM, 1996, CROP PROT, V15, P687, DOI 10.1016/S0261-2194(96)00040-3; Hu XJ, 2017, AGR ECOSYST ENVIRON, V248, P113, DOI 10.1016/j.agee.2017.07.031; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Krischik VA, 2007, ENVIRON ENTOMOL, V36, P1238, DOI 10.1603/0046-225X(2007)36[1238:SIITTN]2.0.CO;2; Krupke CH, 2017, J APPL ECOL, V54, P1449, DOI 10.1111/1365-2664.12924; Li YF, 2018, J ASIA-PAC ENTOMOL, V21, P430, DOI 10.1016/j.aspen.2018.01.003; Liu A, 2005, HENAN AGR SCI, V11, P63; [刘爱芝 Liu Aizhi], 2009, [植物保护, Plant Protection], V35, P152; Loganathachetti DS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09281-3; Longley M, 1997, ENTOMOL EXP APPL, V83, P41, DOI 10.1023/A:1002986700021; Lu Y, 2013, CHINA PLANT PROT, V33, P21; Luo XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20326; Magalhaes LC, 2009, J ECON ENTOMOL, V102, P187, DOI 10.1603/029.102.0127; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mahmoud M. F., 2017, Pesticidi i Fitomedicina, V32, P41, DOI 10.2298/PIF1701041M; Nault BA, 2004, CROP PROT, V23, P147, DOI 10.1016/j.cropro.2003.08.002; Palmieri D., 2016, PLANT SOIL, P1; Quast C., 2013, NUCLEIC ACIDS RES, V41, P28; Rogers MA, 2007, BIOL CONTROL, V42, P172, DOI 10.1016/j.biocontrol.2007.05.006; Rogers ME, 2003, J ECON ENTOMOL, V96, P1412, DOI 10.1603/0022-0493-96.5.1412; Saeed R, 2016, PEST MANAG SCI, V72, P1260, DOI 10.1002/ps.4146; Sajid Iqbal, 2014, American-Eurasian Journal of Agricultural & Environmental Sciences, V14, P172; Sallam AA, 2009, J PLANT DIS PROTECT, V116, P283, DOI 10.1007/BF03356325; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Shi L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41234; Smith SF, 1999, ENVIRON ENTOMOL, V28, P1189, DOI 10.1093/ee/28.6.1189; [宋超 Song Chao], 2016, [农药学学报, Chinese Journal of Pesticide Science], V18, P738; [孙红炜 SUN Hongwei], 2007, [麦类作物学报, Journal of Triticeae Crops], V27, P543; Wang FH, 2009, FIELD CROP RES, V111, P181, DOI 10.1016/j.fcr.2008.12.004; Wang Ji-qiang, 2008, Nongyaoxue Xuebao, V10, P87; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xu ZZ, 2013, J SCI FOOD AGR, V93, P2339, DOI 10.1002/jsfa.6098; [张红 Zhang Hong], 2005, [生态学报, Acta Ecologica Sinica], V25, P937; Zhang HS, 2011, BIOL FERT SOILS, V47, P543, DOI 10.1007/s00374-011-0563-3; Zhang P, 2016, PEST MANAG SCI, V72, P1141, DOI 10.1002/ps.4090; Zhang XC, 1985, J PLANT PROTECT, V12, P9; Zhang ZQ, 2017, J AGR FOOD CHEM, V65, P8083, DOI 10.1021/acs.jafc.7b03120; Zhang ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09251-9; Zong Jian-ping, 2009, Chinese Journal of Pesticide Science, V11, P219	47	13	14	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0205200	10.1371/journal.pone.0205200	http://dx.doi.org/10.1371/journal.pone.0205200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507964	gold, Green Submitted, Green Published			2022-12-26	WOS:000451886500001
J	Dong, M; Huang, XH; Xu, B				Dong, Meng; Huang, Xuhui; Xu, Bo			Unsupervised speech recognition through spike-timing-dependent plasticity in a convolutional spiking neural network	PLOS ONE			English	Article							STIMULUS LOCATION; WORD RECOGNITION; INFORMATION; FEATURES; REPRESENTATIONS; NEURONS; TIME; CODE	Speech recognition (SR) has been improved significantly by artificial neural networks (ANNs), but ANNs have the drawbacks of biologically implausibility and excessive power consumption because of the nonlocal transfer of real-valued errors and weights. While spiking neural networks (SNNs) have the potential to solve these drawbacks of ANNs due to their efficient spike communication and their natural way to utilize kinds of synaptic plasticity rules found in brain for weight modification. However, existing SNN models for SR either had bad performance, or were trained in biologically implausible ways. In this paper, we present a biologically inspired convolutional SNN model for SR. The network adopts the time-to-first-spike coding scheme for fast and efficient information processing. A biological learning rule, spike-timing-dependent plasticity (STDP), is used to adjust the synaptic weights of convolutional neurons to form receptive fields in an unsupervised way. In the convolutional structure, the strategy of local weight sharing is introduced and could lead to better feature extraction of speech signals than global weight sharing. We first evaluated the SNN model with a linear support vector machine (SVM) on the TIDIGITS dataset and it got the performance of 97.5%, comparable to the best results of ANNs. Deep analysis on network outputs showed that, not only are the output data more linearly separable, but they also have fewer dimensions and become sparse. To further confirm the validity of our model, we trained it on a more difficult recognition task based on the TIMIT dataset, and it got a high performance of 93.8%. Moreover, a linear spike-based classifier-tempotron-can also achieve high accuracies very close to that of SVM on both the two tasks. These demonstrate that an STDP-based convolutional SNN model equipped with local weight sharing and temporal coding is capable of solving the SR task accurately and efficiently.	[Dong, Meng] Harbin Univ Sci & Technol, Sch Automat, Harbin, Heilongjiang, Peoples R China; [Dong, Meng; Huang, Xuhui; Xu, Bo] Chinese Acad Sci, Res Ctr Brain Inspired Intelligence, Inst Automat, Beijing, Peoples R China; [Xu, Bo] Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China; [Xu, Bo] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Beijing, Peoples R China	Harbin University of Science & Technology; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Huang, XH; Xu, B (corresponding author), Chinese Acad Sci, Res Ctr Brain Inspired Intelligence, Inst Automat, Beijing, Peoples R China.; Xu, B (corresponding author), Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China.; Xu, B (corresponding author), Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Beijing, Peoples R China.	xuhui.huang@ia.ac.cn; xubo@ia.ac.cn		huang, xu hui/0000-0003-1477-9572	Natural Science Foundation of China [11505283]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDBS01070000]; Independent Deployment Project of CAS Center for Excellence in Brain Science and Intelligent Technology [CEBSIT2017-02]; NVIDIA Corporation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Independent Deployment Project of CAS Center for Excellence in Brain Science and Intelligent Technology; NVIDIA Corporation	This work was supported by the Natural Science Foundation of China (Grant No. 11505283), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDBS01070000), and the Independent Deployment Project of CAS Center for Excellence in Brain Science and Intelligent Technology (Grant No. CEBSIT2017-02). We also gratefully acknowledge the support of NVIDIA Corporation with the donation of the Titan X Pascal GPU used for this research.	AERTSEN AMHJ, 1981, BIOL CYBERN, V42, P133, DOI 10.1007/BF00336731; Akopyan F, 2015, IEEE T COMPUT AID D, V34, P1537, DOI 10.1109/TCAD.2015.2474396; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Cao YQ, 2015, INT J COMPUT VISION, V113, P54, DOI 10.1007/s11263-014-0788-3; Coates Adam, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P561, DOI 10.1007/978-3-642-35289-8_30; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; DAVIS SB, 1980, IEEE T ACOUST SPEECH, V28, P357, DOI 10.1109/TASSP.1980.1163420; Dibazar AA, 2004, IEEE IJCNN, P3071, DOI 10.1109/IJCNN.2004.4620175; Diehl P. U., 2016, P IEEE INT C REB COM, P1, DOI DOI 10.1109/ICRC.2016.7738691; Diehl PU, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00099; Diehl Peter U, 2015, 2015 INT JOINT C NEU, P1, DOI DOI 10.1109/IJCNN.2015.7280696; Furukawa S, 2002, J NEUROPHYSIOL, V87, P1749, DOI 10.1152/jn.00491.2001; Garofolo JS, 1993, NON TRADITIONAL REF; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Ghani A, 2008, LECT NOTES COMPUT SC, V5163, P513, DOI 10.1007/978-3-540-87536-9_53; Gutig R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000141; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Jin YY, 2017, NEUROCOMPUTING, V226, P145, DOI 10.1016/j.neucom.2016.11.045; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Kheradpisheh SR, 2018, NEURAL NETWORKS, V99, P56, DOI 10.1016/j.neunet.2017.12.005; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee JH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00508; Leonard R, 1993, LINGUISTIC DATA CONS; Li XM, 2018, PHYSICA A, V491, P716, DOI 10.1016/j.physa.2017.08.053; Li XM, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0286; Li XM, 2017, NEUROCOMPUTING, V243, P155, DOI 10.1016/j.neucom.2017.03.022; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Maass W, 2004, J COMPUT SYST SCI, V69, P593, DOI 10.1016/j jcss.2004.04.001; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Mohamed AR, 2012, IEEE T AUDIO SPEECH, V20, P14, DOI 10.1109/TASL.2011.2109382; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Neftci EO, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00324; Neil D, 2017, PR MACH LEARN RES, V70; Neil D, 2016, IEEE INT SYMP CIRC S, P2282, DOI 10.1109/ISCAS.2016.7539039; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; O'Connor P, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00178; O'reilly R.C., 2000, COMPUTATIONAL EXPLOR; Pantev C, 2004, EUR J NEUROSCI, V19, P2337, DOI 10.1111/j.0953-816X.2004.03296.x; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Petersen RS, 2002, BIOSYSTEMS, V67, P187, DOI 10.1016/S0303-2647(02)00076-X; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; Qiao N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00141; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; Rolls ET, 2006, VISION RES, V46, P4193, DOI 10.1016/j.visres.2006.07.026; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Serrano-Gotarredona T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00002; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Srinivasan G, 2016, SCI REP-UK, V6, DOI 10.1038/srep29545; Tang J, 2008, P NATL ACAD SCI USA, V105, P7600, DOI 10.1073/pnas.0802961105; Tavanaei A, 2018, DEEP LEARNING SPIKIN; Tavanaei A, 2017, LECT NOTES COMPUT SC, V10639, P899, DOI 10.1007/978-3-319-70136-3_95; Tavanaei A, 2017, NEUROCOMPUTING, V240, P191, DOI 10.1016/j.neucom.2017.01.088; Theunissen FE, 2014, NAT REV NEUROSCI, V15, P355, DOI 10.1038/nrn3731; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Doremalen J, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2566; Verstraeten D, 2005, INFORM PROCESS LETT, V95, P521, DOI 10.1016/j.ipl.2005.05.019; Wade JJ, 2010, IEEE T NEURAL NETWOR, V21, P1817, DOI 10.1109/TNN.2010.2074212; Xie XR, 2017, IEEE T NEUR NET LEAR, V28, P1411, DOI 10.1109/TNNLS.2016.2541339; Zhang M, 2017, IEEE T COGNITIVE DEV; Zhang ML, 2017, NEUROCOMPUTING, V219, P333, DOI 10.1016/j.neucom.2016.09.044; Zhang Y, 2015, IEEE T NEUR NET LEAR, V26, P2635, DOI 10.1109/TNNLS.2015.2388544	67	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0204596	10.1371/journal.pone.0204596	http://dx.doi.org/10.1371/journal.pone.0204596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496179	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800010
J	Duclert-Savatier, N; Bouvier, G; Nilges, M; Malliavin, TE				Duclert-Savatier, Nathalie; Bouvier, Guillaume; Nilges, Michael; Malliavin, Therese E.			Conformational sampling of CpxA: Connecting HAMP motions to the histidine kinase function	PLOS ONE			English	Article							ACCELERATED MOLECULAR-DYNAMICS; FREE-ENERGY; SIGNAL-TRANSDUCTION; STRESS-RESPONSE; HELIX ROTATION; RARE EVENTS; MECHANISMS; SYSTEM; METADYNAMICS; RESISTANCE	In the histidine kinase family, the HAMP and DHp domains are considered to play an important role into the transmission of signal arising from environmental conditions to the autophosphorylation site and to the binding site of response regulator. Several conformational motions inside HAMP have been proposed to transmit this signal: (i) the gearbox model, (ii) a helices rotations, pistons and scissoring, (iii) transition between ordered and disordered states. In the present work, we explore by temperature-accelerated molecular dynamics (TAMD), an enhanced sampling technique, the conformational space of the cytoplasmic region of histidine kinase CpxA. Several HAMP motions, corresponding to a helices rotations, pistoning and scissoring have been detected and correlated to the segmental motions of HAMP and DHp domains of CpxA.	[Duclert-Savatier, Nathalie; Bouvier, Guillaume; Nilges, Michael; Malliavin, Therese E.] Inst Pasteur, Unite Bioinformat Struct, Paris, France; [Duclert-Savatier, Nathalie; Bouvier, Guillaume; Nilges, Michael; Malliavin, Therese E.] CNRS UMR3528, Paris, France; [Duclert-Savatier, Nathalie; Bouvier, Guillaume; Nilges, Michael; Malliavin, Therese E.] Inst Pasteur, Ctr Bioinformat Biostat & Biol Integrat, Paris, France; [Duclert-Savatier, Nathalie; Bouvier, Guillaume; Nilges, Michael; Malliavin, Therese E.] CNRS USR3756, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Malliavin, TE (corresponding author), Inst Pasteur, Unite Bioinformat Struct, Paris, France.; Malliavin, TE (corresponding author), CNRS UMR3528, Paris, France.; Malliavin, TE (corresponding author), Inst Pasteur, Ctr Bioinformat Biostat & Biol Integrat, Paris, France.; Malliavin, TE (corresponding author), CNRS USR3756, Paris, France.	therese.malliavin@pasteur.fr	Nilges, Michael/E-4803-2011	Nilges, Michael/0000-0002-1451-8092	Institut Pasteur CNRS [FP7-IDEAS-ERC 294809, ANR-16-CONV-0005, IA-16-CONV-0005]; project Investissement d'avenir [ANR-16-CONV-0005]	Institut Pasteur CNRS; project Investissement d'avenir	MN was supported by FP7-IDEAS-ERC 294809, erc.europa.eu Institut Pasteur CNRS. TM was supported by ANR-16-CONV-0005 /www.agence-nationale-recherche.fr/ProjetIA-16-CONV-0005 Institut Pasteur CNRS.; The authors acknowledge Prof Michael Airola for providing dimeric structures of the PDB entry 4i3m, and Dr Riccardo Pellarin for fruitful discussions. Dr. Dunin-Horkawicz is acknowledged for the generous gift of the SamCC python script. The project Investissement d'avenir ANR-16-CONV-0005 is acknowledged for computer ressources.	Abrams C, 2014, ENTROPY-SWITZ, V16, P163, DOI 10.3390/e16010163; Abrams CF, 2010, P NATL ACAD SCI USA, V107, P4961, DOI 10.1073/pnas.0914540107; Abrams JB, 2008, J PHYS CHEM B, V112, P15742, DOI 10.1021/jp805039u; Airola MV, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001479; Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Bernardi RC, 2015, BBA-GEN SUBJECTS, V1850, P872, DOI 10.1016/j.bbagen.2014.10.019; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Casino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4258; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cavalli A, 2015, ACCOUNTS CHEM RES, V48, P277, DOI 10.1021/ar500356n; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; Cortes-Ciriano I, 2015, J CHEM THEORY COMPUT, V11, P3446, DOI 10.1021/acs.jctc.5b00153; Cybulski LE, 2010, CURR BIOL, V20, P1539, DOI 10.1016/j.cub.2010.06.074; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Debnath I, 2013, INFECT IMMUN, V81, P1450, DOI 10.1128/IAI.01213-12; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Duclert-Savatier N, 2016, J CHEM INF MODEL, V56, P1762, DOI 10.1021/acs.jcim.6b00211; Dunin-Horkawicz S, 2010, J STRUCT BIOL, V170, P226, DOI 10.1016/j.jsb.2010.01.023; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Ferris HU, 2014, J STRUCT BIOL, V186, P349, DOI 10.1016/j.jsb.2014.03.015; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Ferris HU, 2012, STRUCTURE, V20, P56, DOI 10.1016/j.str.2011.11.014; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Fiorin G, 2013, MOL PHYS, V111, P3345, DOI 10.1080/00268976.2013.813594; Frenkel D., 2000, UNDERSTANDING MOL SI; Guest RL, 2016, TRENDS MICROBIOL, V24, P377, DOI 10.1016/j.tim.2016.03.001; Gushchin I, 2017, SCIENCE, V356, DOI 10.1126/science.aah6345; Gushchin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066917; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klose D, 2014, FEBS LETT, V588, P3970, DOI 10.1016/j.febslet.2014.09.012; Krell T, 2013, CURR OPIN BIOTECH, V24, P451, DOI 10.1016/j.copbio.2012.08.011; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kurabayashi K, 2014, J BACTERIOL, V196, P248, DOI 10.1128/JB.01151-13; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Maragliano L, 2006, CHEM PHYS LETT, V426, P168, DOI 10.1016/j.cplett.2006.05.062; Maragliano L, 2010, J AM CHEM SOC, V132, P1010, DOI 10.1021/ja905671x; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Markwick PRL, 2011, PHYS CHEM CHEM PHYS, V13, P20053, DOI 10.1039/c1cp22100k; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mechaly AE, 2017, STRUCTURE, V25, P939, DOI 10.1016/j.str.2017.04.011; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; Miao YL, 2016, MOL SIMULAT, V42, P1046, DOI 10.1080/08927022.2015.1121541; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; Mitsutake Ayori, 2013, Methods Mol Biol, V924, P153, DOI 10.1007/978-1-62703-017-5_7; Naveh ZMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088555; Ortega DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003337; Ortega DR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3881; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Podgornaia AI, 2013, STRUCTURE, V21, P1636, DOI 10.1016/j.str.2013.07.005; Raivio TL, 2014, BBA-MOL CELL RES, V1843, P1529, DOI 10.1016/j.bbamcr.2013.10.018; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schreiber M, 2009, CURR OPIN CELL BIOL, V21, P325, DOI 10.1016/j.ceb.2009.01.026; Schrodinger LLC., 2015, PYMOL MOL GRAPH SYST; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Selwa E, 2014, PROTEINS, V82, P2483, DOI 10.1002/prot.24612; Stewart RC, 2010, CURR OPIN MICROBIOL, V13, P133, DOI 10.1016/j.mib.2009.12.013; Stewart V, 2014, MOL MICROBIOL, V91, P853, DOI 10.1111/mmi.12516; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Valsson O, 2016, ANNU REV PHYS CHEM, V67, P159, DOI 10.1146/annurev-physchem-040215-112229; Vashisth H, 2013, J PHYS CHEM B, V117, P3738, DOI 10.1021/jp3126297; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wang XQ, 2012, J AM CHEM SOC, V134, P16107, DOI 10.1021/ja3056694; Zhu LZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002913	77	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207899	10.1371/journal.pone.0207899	http://dx.doi.org/10.1371/journal.pone.0207899			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496238	gold, Green Submitted, Green Published			2022-12-26	WOS:000451763800061
J	Lukas, I; Kohl-Schwartz, A; Geraedts, K; Rauchfuss, M; Wolfler, MM; Haberlin, F; von Orelli, S; Eberhardt, M; Imthurn, B; Imesch, P; Leeners, B				Lukas, Ilona; Kohl-Schwartz, Alexandra; Geraedts, Kirsten; Rauchfuss, Martina; Woelfler, Monika M.; Haeberlin, Felix; von Orelli, Stephanie; Eberhardt, Markus; Imthurn, Bruno; Imesch, Patrick; Leeners, Brigitte			Satisfaction with medical support in women with endometriosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; PATIENT SATISFACTION; PAIN SEVERITY; IMPACT; DYSPAREUNIA; DELAY; DEPRESSION; STRATEGIES; PREDICTORS; DIAGNOSIS	Endometriosis affects various aspects of women's lives. We searched for predictors for patient satisfaction with medical support (PSwMS) in women with endometriosis. The study was designed as a multi-centre retrospective cohort study. We approached women with histologically confirmed endometriosis from 2010 until 2016, comparing women satisfied to women dissatisfied with medical support. We analysed data on characteristics of endometriosis, PSwMS and the influence of disease characteristics on PSwMS. Information on satisfaction with medical support was collected through a standardized questionnaire. After exclusion of 73 women because of inchoately filled in questionnaires, data from 498 women was evaluated. Altogether, it was observed that 54.6% (n = 272) of the study participants were satisfied with medical support and 45.4% (n = 226) were not. Feeling adequately informed by the time of diagnosis (p < 0.001), taking women's mental troubles seriously (p < 0.001) and supporting women in handling their pain (p < 0.001) were significantly associated with satisfaction. We found adequate information to be the most distinctive indicator for PSwMS. Further, acknowledging psychological distress and supporting women in handling their symptoms rather than to alleviate them, positively affect PSwMS. To achieve PSwMS, healthcare providers have to give adequate information on endometriosis and its management.	[Lukas, Ilona; Kohl-Schwartz, Alexandra; Geraedts, Kirsten; Imthurn, Bruno; Leeners, Brigitte] Univ Hosp Zurich, Dept Reprod Endocrinol, Zurich, Switzerland; [Kohl-Schwartz, Alexandra] Univ Womens Hosp, Div Gynecol Endocrinol & Reprod Med, Bern, Switzerland; [Rauchfuss, Martina] Charite, Dept Psychosomat, Berlin, Germany; [Woelfler, Monika M.] Univ Hosp Graz, Dept Gynecol & Obstet, Graz, Austria; [Haeberlin, Felix] Canton Hosp St Gallen, Dept Gynecol & Obstet, St Gallen, Switzerland; [von Orelli, Stephanie] Triemli Hosp Zurich, Dept Gynecol & Obstet, Zurich, Switzerland; [Eberhardt, Markus] Canton Hosp Schaffhausen, Dept Gynecol & Obstet, Schaffhausen, Switzerland; [Imesch, Patrick] Univ Hosp Zurich, Dept Gynecol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Kantonsspital St. Gallen; Triemli Hospital; University of Zurich; University Zurich Hospital	Leeners, B (corresponding author), Univ Hosp Zurich, Dept Reprod Endocrinol, Zurich, Switzerland.	Brigitte.Leeners@usz.ch	Leeners, Brigitte/GRJ-4693-2022	Leeners, Brigitte/0000-0003-4027-6151; Kohl Schwartz, Alexandra/0000-0002-7558-1327				Bair MJ, 2007, J REHABIL RES DEV, V44, P143, DOI 10.1682/JRRD.2006.06.0061; Ballard K, 2006, FERTIL STERIL, V86, P1296, DOI 10.1016/j.fertnstert.2006.04.054; Ben Charif A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1542-0; Bertakis KD, 1998, MED CARE, V36, P879, DOI 10.1097/00005650-199806000-00011; Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1; Buser K, 2007, MEDIZINISCHE PSYCHOL, P328; Chow A, 2009, SURGERY, V146, P435, DOI 10.1016/j.surg.2009.03.019; Cox H, 2003, INT J CONSUM STUD, V27, P200, DOI DOI 10.1046/J.1470-6431.2003.00302.X; Culley L, 2013, HUM REPROD UPDATE, V19, P625, DOI 10.1093/humupd/dmt027; Denny E, 2008, EUR J OBSTET GYN R B, V139, P111, DOI 10.1016/j.ejogrb.2007.10.006; Denny E, 2007, J FAM PLAN REPROD H, V33, P189, DOI 10.1783/147118907781004831; Di Donato N, 2014, EUR J OBSTET GYN R B, V179, P69, DOI 10.1016/j.ejogrb.2014.05.022; Exacoustos C, 2014, BEST PRACT RES CL OB, V28, P655, DOI 10.1016/j.bpobgyn.2014.04.010; Friedl F, 2015, ARCH GYNECOL OBSTET, V292, P1393, DOI 10.1007/s00404-015-3789-8; Hadfield R, 1996, HUM REPROD, V11, P878; Hammerli S, 2018, J SEX MED, V15, P853, DOI 10.1016/j.jsxm.2018.03.087; Hirsh AT, 2004, THESIS; Hirsh K W, 2001, J Obstet Gynaecol, V21, P500; Hudelist G, 2012, HUM REPROD, V27, P3412, DOI 10.1093/humrep/des316; Jackson JL, 2001, SOC SCI MED, V52, P609, DOI 10.1016/S0277-9536(00)00164-7; Mira JJ, 2009, SURGERY, V145, P536, DOI 10.1016/j.surg.2009.01.012; Jones G, 2004, J PSYCHOSOM OBST GYN, V25, P123, DOI 10.1080/01674820400002279; Kodaman PH, 2015, OBSTET GYN CLIN N AM, V42, P87, DOI 10.1016/j.ogc.2014.10.005; Koga K, 2015, FERTIL STERIL, V104, P793, DOI 10.1016/j.fertnstert.2015.08.026; Kundu S, 2015, GEBURTSH FRAUENHEILK, V75, P462, DOI 10.1055/s-0035-1546052; Leeners B, 2018, HUM REPROD UPDATE, V24, P290, DOI 10.1093/humupd/dmy004; Liebermann C, 2018, HUM REPROD, V33, P1449, DOI 10.1093/humrep/dey111; Moradi M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-123; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Quintana JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-102; Ramin-Wright A, 2018, HUM REPROD, V33, P1459, DOI 10.1093/humrep/dey115; Schwartz ASK, 2017, FERTIL STERIL, V108, P806, DOI 10.1016/j.fertnstert.2017.08.025; Shakiba K, 2008, OBSTET GYNECOL, V111, P1285, DOI 10.1097/AOG.0b013e3181758ec6; Sperschneider ML, HUMAN REPROD; Stratton P, 2011, HUM REPROD UPDATE, V17, P327, DOI 10.1093/humupd/dmq050; van der Houwen LEE, 2014, GYNECOL ENDOCRINOL, V30, P798, DOI 10.3109/09513590.2014.932341; van der Zanden M, 2016, REPROD BIOMED ONLINE, V32, P527, DOI 10.1016/j.rbmo.2016.02.003; Vercellini P, 2013, HUM REPROD, V28, P1221, DOI 10.1093/humrep/det041; Vercellini P, 2012, HUM REPROD, V27, P3450, DOI 10.1093/humrep/des313; Vercellini P, 2009, HUM REPROD UPDATE, V15, P177, DOI 10.1093/humupd/dmn062; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Vyas S, 2015, OBSTET GYNAECOL REPR, V25, P133, DOI DOI 10.1016/J.OGRM.2015.02.001; Ward SE, 1996, J PAIN SYMPTOM MANAG, V11, P242, DOI 10.1016/0885-3924(95)00190-5	43	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208023	10.1371/journal.pone.0208023	http://dx.doi.org/10.1371/journal.pone.0208023			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496315	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000451763800082
J	Nieboer, MM; Dorssers, LCJ; Strayer, R; Looijenga, LHJ; de Ridder, J				Nieboer, Marleen M.; Dorssers, Lambert C. J.; Strayer, Roy; Looijenga, Leendert H. J.; de Ridder, Jeroen			TargetClone: A multi-sample approach for reconstructing subclonal evolution of tumors	PLOS ONE			English	Article							GERM-CELL TUMORS; COPY-NUMBER; COLORECTAL-CANCER; HETEROGENEITY; INFERENCE; DISCOVERY; MUTATION	Most tumors are composed of a heterogeneous population of subclones. A more detailed insight into the subclonal evolution of these tumors can be helpful to study progression and treatment response. Problematically, tumor samples are typically very heterogeneous, making deconvolving individual tumor subclones a major challenge. To overcome this limitation, reducing heterogeneity, such as by means of microdissections, coupled with targeted sequencing, is a viable approach. However, computational methods that enable reconstruction of the evolutionary relationships require unbiased read depth measurements, which are commonly challenging to obtain in this setting. We introduce TargetClone, a novel method to reconstruct the subclonal evolution tree of tumors from single-nucleotide polymorphism allele frequency and somatic single-nucleotide variant measurements. Furthermore, our method infers copy numbers, alleles and the fraction of the tumor component in each sample. TargetClone was specifically designed for targeted sequencing data obtained from microdissected samples. We demonstrate that our method obtains low error rates on simulated data. Additionally, we show that our method is able to reconstruct expected trees in a testicular germ cell cancer and ovarian cancer dataset. The TargetClone package including tree visualization is written in Python and is publicly available at https://github.com/UMCUGenetics/targetclone.	[Nieboer, Marleen M.; Strayer, Roy; de Ridder, Jeroen] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [Looijenga, Leendert H. J.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	de Ridder, J (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.	J.deRidder-4@umcutrecht.nl	Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911				Amarasinghe KC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-732; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Bokeh Development Team, 2014, BOK PYTH LIB INT VIS; Boublikova L, 2014, CRIT REV ONCOL HEMAT, V89, P366, DOI 10.1016/j.critrevonc.2013.10.001; Chen Y, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1566-3; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Dorssers LC, 2018, MOL HETEROGENEITY EA; El-Kebir M, 2015, BIOINFORMATICS, V31, P62, DOI 10.1093/bioinformatics/btv261; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Espina V, 2007, EXPERT REV MOL DIAGN, V7, P647, DOI 10.1586/14737159.7.5.647; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Hajirasouliha I, 2014, BIOINFORMATICS, V30, P78, DOI 10.1093/bioinformatics/btu284; Hoogstraat M, 2014, GENOME RES, V24, P200, DOI 10.1101/gr.161026.113; Jiao W, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-35; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kader T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0375-z; Killian JK, 2016, GENOME RES, V26, P1490, DOI 10.1101/gr.201293.115; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuipers J, 2016, STAT TEST SINGLE CEL; Lassmann S, 2009, J MOL MED, V87, P211, DOI 10.1007/s00109-008-0419-y; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Nam JY, 2016, BRIEF BIOINFORM, V17, P185, DOI 10.1093/bib/bbv055; Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115; Navin NE, 2010, MOL ONCOL, V4, P267, DOI 10.1016/j.molonc.2010.04.010; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oesper L, 2013, LNBI, V7821, P171; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Popic V, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0647-8; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Rijlaarsdam MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122146; Rosenthal R, 2017, ANNU REV CANC BIOL, V1, P223, DOI 10.1146/annurev-cancerbio-042516-011348; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Schwarz RF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003535; Spiller CM, 2017, INT J BIOCHEM CELL B, V86, P22, DOI 10.1016/j.biocel.2017.03.004; Strino F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt641; Xu WH, 2014, DISCOV MED, V17, P223; Yu ZH, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0255-4; Yu ZH, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1174-7; Zaccaria S, 2017, LECT N BIOINFORMAT, V10229, P318, DOI 10.1007/978-3-319-56970-3_20	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208002	10.1371/journal.pone.0208002	http://dx.doi.org/10.1371/journal.pone.0208002			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496231	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800074
J	Yang, SF; Zhao, ZC; Zhang, AY; Jia, FJ; Song, MX; Huang, ZL; Fu, J; Li, GM; Lin, SQ				Yang, Shifa; Zhao, Zengcheng; Zhang, Anyuan; Jia, Fengjuan; Song, Minxun; Huang, Zhongli; Fu, Jian; Li, Guiming; Lin, Shuqian			Proteomics analysis of chicken peripheral blood lymphocyte in Taishan Pinus massoniana pollen polysaccharide regulation	PLOS ONE			English	Article							ADJUVANT ACTIVITY; IMMUNE-RESPONSES; NOX ENZYMES; DISEASE; IDENTIFICATION; VIRUS	The natural polysaccharides extracted from the pollen of Pinus massoniana (TPPPS) have been shown to be a promising immune adjuvant against several viral chicken diseases. However, the exact mechanism through which TPPPS enhances the host immune response in chicken remains poorly understood. In the current study, chicken peripheral blood lymphocytes were treated with varying concentrations of TPPPS and pro-inflammatory cytokines such as IFN-gamma, iIL-2 and IL-6 were measured to determine the optimal dose of the polysaccharide. A comparative analysis was subsequently performed between the proteome of lymphocytes subjected to the best treatment conditions and that of untreated cells. Protein identification and quantitation revealed a panel of three up-regulated and seven down-regulated candidates in TPPPS-treated chicken peripheral blood lymphocytes. Further annotation and functional analysis suggested that a number of those protein candidates were involved in the regulation of host innate immune response, inflammation and other immune-related pathways. We believe that our results could serve as a stepping stone for further research on the immune-enhancing properties of TPPPS and other polysaccharide-based immune adjuvants.	[Yang, Shifa; Zhao, Zengcheng; Song, Minxun; Huang, Zhongli; Fu, Jian; Li, Guiming; Lin, Shuqian] Shandong Acad Agr Sci, Inst Poultry Sci, Jinan, Shandong, Peoples R China; [Yang, Shifa; Jia, Fengjuan; Li, Guiming] Shandong Prov Key Lab Poultry Dis Diag & Immunol, Jinan, Shandong, Peoples R China; [Zhang, Anyuan] Inst Vet Drug Qualily Inspect Shandong Prov, Jinan, Shandong, Peoples R China; [Jia, Fengjuan] Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Li, GM; Lin, SQ (corresponding author), Shandong Acad Agr Sci, Inst Poultry Sci, Jinan, Shandong, Peoples R China.; Li, GM (corresponding author), Shandong Prov Key Lab Poultry Dis Diag & Immunol, Jinan, Shandong, Peoples R China.	86632026@qq.com; shuqianlin@126.com			National Key Research and Development Program of China [2017YFC1702700]; Natural Science Foundation of Shandong Province [ZR2018LC018]; Shandong Modern Agricultural Technology and Industry System [SDAIT-11-01]	National Key Research and Development Program of China; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Modern Agricultural Technology and Industry System	Funding was provided by The National Key Research and Development Program of China (2017YFC1702700), Natural Science Foundation of Shandong Province (ZR2018LC018), and Shandong Modern Agricultural Technology and Industry System (No. SDAIT-11-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; COHEN IR, 1991, IMMUNOL TODAY, V12, P105, DOI 10.1016/0167-5699(91)90093-9; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Genini S, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-48; Guo FX, 2014, RES VET SCI, V96, P260, DOI 10.1016/j.rvsc.2013.11.010; Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409; Kumar S, 2016, J MAT CHEM B, P4; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li B, 2015, MICROB PATHOGENESIS, V78, P7, DOI 10.1016/j.micpath.2014.11.010; Li LJ, 2012, MAR DRUGS, V10, P2648, DOI 10.3390/md10122648; Liu J., 2015, BIOACT CARBOHYDR DIE, V5, P31, DOI [10.1016/j.bcdf.2014.12.001, DOI 10.1016/J.BCDF.2014.12.001]; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Massa C, 2005, CANCER RES, V65, P7942, DOI 10.1158/0008-5472.CAN-05-0377; Medeiros AI, 2008, J IMMUNOL, V181, P8544, DOI 10.4049/jimmunol.181.12.8544; Mizzen L, 1998, BIOTHERAPY, V10, P173, DOI 10.1007/BF02678295; Ogier-Denis E, 2008, SEMIN IMMUNOPATHOL, V30, P291, DOI 10.1007/s00281-008-0120-9; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Ren L, 2012, FOOD FUNCT, V3, P1118, DOI 10.1039/c2fo10279j; Ren X, 2017, AQUAC RES, DOI [10.1111/are.12988, DOI 10.1111/ARE.12988]; Schuster TB, 2011, J PROTEOME RES, V10, P4661, DOI 10.1021/pr200461p; Sharma RK, 2013, J IMMUNOL, V191, P3462, DOI 10.4049/jimmunol.1300967; SHINNICK TM, 1991, CURR TOP MICROBIOL, V167, P145; Snelgrove RJ, 2011, THORAX, V66, P550, DOI 10.1136/thoraxjnl-2011-200234; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; van Altena SEC, 2016, VET IMMUNOL IMMUNOP, V174, P11, DOI 10.1016/j.vetimm.2016.04.005; Wei K, 2011, VACCINE, V29, P2530, DOI 10.1016/j.vaccine.2011.01.068; Xu DN, 2014, BIOL TRACE ELEM RES, V160, P232, DOI 10.1007/s12011-014-0056-y; Xu XF, 2016, FOOD FUNCT, V7, P250, DOI 10.1039/c5fo00904a; Yang SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115638; Yang X, 2016, DATA BRIEF, V9, P741, DOI 10.1016/j.dib.2016.10.017; Zhang WJ, 2016, INT J BIOL MACROMOL, V87, P7, DOI 10.1016/j.ijbiomac.2016.02.023; Zhao X, 2013, INT IMMUNOPHARMACOL, V17, P793, DOI 10.1016/j.intimp.2013.09.008	34	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208314	10.1371/journal.pone.0208314	http://dx.doi.org/10.1371/journal.pone.0208314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496273	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800129
J	Aguilar, R; Calvino, A; Ashworth, L; Aguirre-Acosta, N; Carbone, LM; Albrieu-Llinas, G; Nolasco, M; Ghilardi, A; Cagnolo, L				Aguilar, Ramiro; Calvino, Ana; Ashworth, Lorena; Aguirre-Acosta, Natalia; Manuel Carbone, Lucas; Albrieu-Llinas, Guillermo; Nolasco, Miguel; Ghilardi, Adrian; Cagnolo, Luciano			Unprecedented plant species loss after a decade in fragmented subtropical Chaco Serrano forests	PLOS ONE			English	Article							EXTINCTION DEBT; CENTRAL ARGENTINA; GRAN-CHACO; BIODIVERSITY; COLONIZATION; GRASSLANDS; VEGETATION; RICHNESS; WOODLAND; CORDOBA	Current biodiversity loss is mostly caused by anthropogenic habitat loss and fragmentation, climate change, and resource exploitation. Measuring the balance of species loss and gain in remaining fragmented landscapes throughout time entails a central research challenge. We resurveyed in 2013 plant species richness in the same plots of a previous sampling conducted in 2003 across 18 forest fragments of different sizes of the Chaco Serrano forest in Argentina. While the area of these forest remnants was kept constant, their surrounding forest cover changed over this time period. We compared plant species richness of both sampling years and calculated the proportion of species loss and gain at forest edges and interiors. As in 2003, we found a positive relationship between fragment area and plant richness in 2013 and both years showed a similar slope. However, we detected a net decrease of 24% of species' richness across all forest fragments, implying an unprecedentedly high rate and magnitude of species loss driven mainly by non-woody, short-lived species. There was a higher proportion of lost and gained species at forest edges than in forest interiors. Importantly, fragment area interacted with percent change in surrounding forest cover to explain the proportion of species lost. Small forest fragments showed a relatively constant proportion of species loss regardless of any changes in surrounding forest cover, whereas in larger fragments the proportion of species lost increased when surrounding forest cover decreased. We show that despite preserving fragment area, habitat quality and availability in the surroundings is of fundamental importance in shaping extinction and immigration dynamics of plant species at any given forest remnant. Because the Chaco Serrano forest has already lost 94% of its original cover, we argue that plant extinctions will continue through the coming decades unless active management actions are taken to increase native forest areas.	[Aguilar, Ramiro; Calvino, Ana; Ashworth, Lorena; Aguirre-Acosta, Natalia; Manuel Carbone, Lucas; Cagnolo, Luciano] Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina; [Aguilar, Ramiro; Ashworth, Lorena; Ghilardi, Adrian] Univ Nacl Autonoma Mexico, Unidad Morelia, Escuela Nacl Estudios Super, Lab Nacl Anal & Sintesis Ecol, Antigua Carretera Patzcuaro, Morelia, Michoacan, Mexico; [Manuel Carbone, Lucas; Nolasco, Miguel] Univ Nacl Cordoba, Fac Ciencias Agr, Cordoba, Argentina; [Albrieu-Llinas, Guillermo] Univ Nacl Cordoba, CONICET, Fac Ciencias Med, Inst Virol Dr Vanella,Lab Arbovirus, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidad Nacional Autonoma de Mexico; National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Aguilar, R (corresponding author), Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina.; Aguilar, R (corresponding author), Univ Nacl Autonoma Mexico, Unidad Morelia, Escuela Nacl Estudios Super, Lab Nacl Anal & Sintesis Ecol, Antigua Carretera Patzcuaro, Morelia, Michoacan, Mexico.	rams.aguilar@gmail.com	Ghilardi, Adrian/P-9585-2017; Carbone, Lucas M./H-9380-2019	Ghilardi, Adrian/0000-0002-7286-0670; Carbone, Lucas M./0000-0002-2571-5905; Albrieu-Llinas, Guillermo/0000-0003-2481-9582; Aguirre-Acosta, Natalia/0000-0002-4767-6062; Aguilar, Ramiro/0000-0003-4741-2611; Calvino, Ana/0000-0002-4653-7917	Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) de la Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2016-0764]; Consejo Nacional de Investigaciones Cientificas y Tecnicas. Proyectos de Investigacion Plurianuales [PIP 2015-0371]; Mexican Council for Science and Technology: SENER CONACYT [2014 246911]	Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) de la Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas. Proyectos de Investigacion Plurianuales; Mexican Council for Science and Technology: SENER CONACYT	This work received support from the following: Funding to RA from Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) de la Agencia Nacional de Promocion Cientifica y Tecnologica: PICT 2016-0764; Funding to LA from Consejo Nacional de Investigaciones Cientificas y Tecnicas. Proyectos de Investigacion Plurianuales: PIP 2015-0371; Funding to AG from the Mexican Council for Science and Technology: SENER CONACYT 2014 246911.	Aguilar R, 2004, OECOLOGIA, V138, P513, DOI 10.1007/s00442-003-1451-9; Anton AM, 2015, FLORA ARGENTINA PLAN; Arganaraz JP, 2015, FIRE ECOL, V11, P55, DOI 10.4996/fireecology.1101055; Ashworth L, 2015, AUSTRAL ECOL, V40, P634, DOI 10.1111/aec.12230; Auffret AG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05991-y; Bagaria G, 2015, OECOLOGIA, V179, P823, DOI 10.1007/s00442-015-3377-4; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; CABIDO M, 1991, Phytocoenologia, V19, P547, DOI 10.1127/phyto/19/1991/547; Cagnolo L, 2006, BIOL CONSERV, V132, P510, DOI 10.1016/j.biocon.2006.05.012; Carbone LM, 2017, B SOC ARGENT BOT, V52, P753, DOI 10.31055/1851.2372.v52.n4.18861; Carranza ML, 2015, LANDSCAPE URBAN PLAN, V143, P238, DOI 10.1016/j.landurbplan.2015.08.006; Cingolani AM, 2013, RANGELAND J, V35, P285, DOI 10.1071/RJ12095; Cingolani Ana M, 2008, Ecol. austral, V18, P253; Congalton R.G., 2019, ASSESSING ACCURACY R, VThird, DOI 10.1201/9780429052729; Cousins SAO, 2009, J VEG SCI, V20, P3, DOI 10.1111/j.1654-1103.2009.05647.x; Drayton B, 1996, CONSERV BIOL, V10, P30, DOI 10.1046/j.1523-1739.1996.10010030.x; Ehrlen J, 2002, OIKOS, V98, P308, DOI 10.1034/j.1600-0706.2002.980212.x; Fahrig L, 2017, ANNU REV ECOL EVOL S, V48, P1, DOI 10.1146/annurev-ecolsys-110316-022612; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Frate L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142855; Gavier GI, 2004, REV ACAD NAC CS, V110, P1; Giorgis Melisa A, 2011, Kurtziana, V36, P9; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Halley JM, 2017, J VEG SCI, V28, P459, DOI 10.1111/jvs.12538; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jung M, 2016, ECOL INFORM, V31, P18, DOI 10.1016/j.ecoinf.2015.11.006; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuemmerle T, 2017, SCIENCE, V355, P465, DOI 10.1126/science.aal3020; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lindborg R, 2012, ECOGRAPHY, V35, P356, DOI 10.1111/j.1600-0587.2011.07286.x; Ludecke D., 2018, SJPLOT DATA VISUALIZ, DOI 10.5281/zenodo.1308158; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Otsu C, 2017, J VEG SCI, V28, P464, DOI 10.1111/jvs.12514; Piessens K, 2006, BIOL CONSERV, V132, P382, DOI 10.1016/j.biocon.2006.04.032; Piqueray J, 2013, J NAT CONSERV, V21, P189, DOI 10.1016/j.jnc.2012.12.005; Piqueray J, 2011, LANDSCAPE ECOL, V26, P823, DOI 10.1007/s10980-011-9611-5; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers DA, 2009, CONSERV BIOL, V23, P1497, DOI 10.1111/j.1523-1739.2009.01256.x; Saar L, 2012, DIVERS DISTRIB, V18, P808, DOI 10.1111/j.1472-4642.2012.00885.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; United States Geological Survey, LANDS PROGR; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Zak MR, 2008, ENVIRON MANAGE, V42, P181, DOI 10.1007/s00267-008-9101-y; Zak MR, 2004, BIOL CONSERV, V120, P589, DOI 10.1016/j.biocon.2004.03.034; Zak MR, 2002, APPL VEG SCI, V5, P213, DOI 10.1111/j.1654-109X.2002.tb00551.x	55	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206738	10.1371/journal.pone.0206738	http://dx.doi.org/10.1371/journal.pone.0206738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485340	gold, Green Submitted, Green Published			2022-12-26	WOS:000451755800029
J	Tan, BH; De Guzman, MRT; Donato, LKS; Kalimuddin, S; Lee, WHL; Tan, AL; Wong, GC				Tan, Ban Hock; De Guzman, Marvin Raden Torres; Donato, Lara Kristina Sioco; Kalimuddin, Shirin; Lee, Winnie Hui Ling; Tan, Ai Ling; Wong, Gee Chuan			Impact of an alternating first-line antibiotics strategy in febrile neutropenia	PLOS ONE			English	Article							RESISTANT; DIVERSITY; PROGRAM	Background Rising antibiotic resistance poses a challenge to the management of febrile neutropenia in patients with haematological malignancies receiving chemotherapy. Aim We studied an alternating first-line antibiotic strategy to determine its impact on all-cause mortality and bacteremia rates in patients with febrile neutropenia. Methods An alternating first-line antibiotic strategy was established in mid-2013. Data for 2012 (before strategy implementation) and 2014 (post-strategy implementation) were compared. Antibiotic Heterogeneity Index (AHI) for each of the two time-periods was also calculated. Findings There were 2012 admissions (26082 patient-days) in 2012 and 1843 admissions (24331 patient-days) in 2014. There was no significant difference in the baseline characteristics of patients in the two groups. The defined daily doses (DDD) of cefepime (CEF) fell while the DDD of piperacillin-tazobactam (PTZ) rose in 2014 compared with 2012. Vancomycin DDD fell in 2014. The AHI was 0.466 in 2012 and 0.582 in 2014. The difference in all-cause mortality was not statistically significant. There was no difference in rates of bacteremia with CEF-resistant, PTZ-resistant and carbapenem-resistant gram-negative organisms in the two groups. Rates of new cases of Methicillin-resistant Staphylococcus aureus (MRSA) were 2.38/1000 and 2.59/1000 patient-days in 2012 and 2014 respectively. Rates of new cases of Vancomycin-resistant Enterococcus (VRE) were 1.84/1000 and 1.81/1000 patient-days in 2012 and 2014 respectively. There was no Carbapenem-resistant Enterobacteriaceae (CRE) bacteremia in 2012 and 1 in 2014. Conclusion An alternating first-line antibiotic strategy resulted in an increase in antibiotic heterogeneity, without increasing mortality. There was also no significant increase in bacteremia rates.	[Tan, Ban Hock; Kalimuddin, Shirin] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore; [De Guzman, Marvin Raden Torres; Donato, Lara Kristina Sioco; Wong, Gee Chuan] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Lee, Winnie Hui Ling] Singapore Gen Hosp, Dept Pharm, Singapore, Singapore; [Tan, Ai Ling] Singapore Gen Hosp, Dept Microbiol, Singapore, Singapore	Singapore General Hospital; Singapore General Hospital; Singapore General Hospital; Singapore General Hospital	Tan, BH (corresponding author), Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.	tan.ban.hock@singhealth.com.sg						Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Cadena J, 2007, BONE MARROW TRANSPL, V40, P151, DOI 10.1038/sj.bmt.1705704; Cumpston A, 2013, TRANSPL INFECT DIS, V15, P142, DOI 10.1111/tid.12035; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Irfan S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-80; Kock R, 2014, EUROSURVEILLANCE, V19, P23, DOI 10.2807/1560-7917.ES2014.19.29.20860; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Martinez JA, 2006, CRIT CARE MED, V34, P329, DOI 10.1097/01.CCM.0000195010.63855.45; Moghnieh R, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00011; Munoz-Price LS, 2013, CURR OPIN INFECT DIS, V26, P378, DOI 10.1097/01.qco.0000431853.71500.77; Pang JX, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1024-7; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; Sandiumenge A, 2006, J ANTIMICROB CHEMOTH, V57, P1197, DOI 10.1093/jac/dkl097; Sandiumenge A, 2011, CHEST, V140, P643, DOI 10.1378/chest.11-0462; Satlin MJ, 2016, J INFECTION, V73, P336, DOI 10.1016/j.jinf.2016.07.002; Satlin MJ, 2013, LEUKEMIA LYMPHOMA, V54, P799, DOI 10.3109/10428194.2012.723210; Statistics NCfH, 2003, MED EX COR HDB DEATH; Takesue Y, 2010, J HOSP INFECT, V75, P28, DOI 10.1016/j.jhin.2009.11.022; Tan TT, 2014, PATHOLOGY, V46, P650, DOI 10.1097/PAT.0000000000000177; Wong GC, 2008, ANN ACAD MED SINGAP, V37, P21	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208039	10.1371/journal.pone.0208039	http://dx.doi.org/10.1371/journal.pone.0208039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485357	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800099
J	Wan, SS; Cheng, J; Dong, YL; Xie, LX				Wan, Shanshan; Cheng, Jun; Dong, Yanling; Xie, Lixin			Epithelial defects after penetrating keratoplasty in infectious keratitis: An analysis of characteristics and risk factors	PLOS ONE			English	Article							OCULAR SURFACE; CORNEAL EPITHELIUM; INFLAMMATION	To investigate the clinical characteristics, treatment, risk factors of occurrence and graft transparency of corneal epithelial defects after penetrating keratoplasty in patients with infectious keratitis. 594 patients (594 eyes) with infectious keratitis treated by penetrating keratoplasty at Shandong Eye Institute were reviewed retrospectively between January 2008 and January 2018. We investigated the demographic data, diameter and sources of graft, onset time, location, scope, time of healing and treatment of epithelial defects, as well as other postoperative complications and graft clarity. 114 of the 594 grafts (19.2%) that developed epithelial defects were included in the epithelial defects group, while the other 480 patients were classified in the non-defect group. The mean age of patients with epithelial defects was statistically greater than that of patients without epithelial defects (P = 0.006). The epithelial defects group accounted for a larger proportion of male patients (P<0.001). The proportion of patients with a graft diameter >9mm in the epithelial defect group (29.8%) was more than that in the non-defects group (16.3%) (P = 0.001). The incidence of epithelial defects significantly differed among the pathogenic causes of infectious keratitis (P = 0.002). The incidence of graft infection (21.1%, 9.2%, respectively, P<0.001) and graft dysfunction (7.9%, 2.5%, respectively, P = 0.012) in the epithelial defect group was higher than in the non-defects group. Multivariate logistic regression revealed that male sex (P = 0.001), age. 60 years (P = 0.024), graft diameter >9mm (P = 0.001), bacterial (P = 0.039) and herpes simplex keratitis (P = 0.008), rheumatism (P = 0.031) and cancer treated with chemo- or radiotherapy (P = 0.032) were independent risk factors for epithelial defects. Graft clarity after epithelial defects were significantly differed between fungal and viral infections (P<0.001). We found that being an elderly male patient, a graft diameter >9 mm, bacterial and viral keratitis and systemic diseases (including rheumatism and cancer treated with chemo- or radiotherapy) were independent risk factors for postoperative epithelial defects.	[Wan, Shanshan; Xie, Lixin] Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Wan, Shanshan; Cheng, Jun; Dong, Yanling; Xie, Lixin] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Shandong, Peoples R China	Wuhan University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Xie, LX (corresponding author), Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan, Hubei, Peoples R China.; Xie, LX (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Shandong, Peoples R China.	lixin_xie@hotmail.com	Xie, li/HGE-6052-2022; Cheng, Jun/AAV-9031-2021		Natural Science Foundation of Shandong Province [ZR2017BH026]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was funded by the Natural Science Foundation of Shandong Province (ZR2017BH026). The funder Dr Jun Cheng had role in methodology, decision to publish and preparation of the manuscript. No other external funding was received for this work.	BEYER CF, 1990, AM J OPHTHALMOL, V109, P95, DOI 10.1016/S0002-9394(14)75590-4; CHOU L, 1994, OPHTHALMIC SURG LAS, V25, P700; Cosar CB, 2001, CORNEA, V20, P787, DOI 10.1097/00003226-200111000-00002; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; Dan J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196741; Dong X, 2000, Zhonghua Yan Ke Za Zhi, V36, P21; Feiz V, 2001, Trans Am Ophthalmol Soc, V99, P159; Fu Y, 2012, CORNEA, V31, P723, DOI 10.1097/ICO.0b013e31821142ee; Halberstadt M, 2002, BRIT J OPHTHALMOL, V86, P646, DOI 10.1136/bjo.86.6.646; Kamble N, 2017, EYE CONTACT LENS, V43, P324, DOI 10.1097/ICL.0000000000000277; Kawamoto K, 2006, AM J OPHTHALMOL, V142, P173, DOI 10.1016/j.ajo.2006.01.077; Kimakura M, 2014, J OCUL PHARMACOL TH, V30, P810, DOI 10.1089/jop.2014.0044; Kitzmann AS, 2009, OPHTHALMOLOGY, V116, P864, DOI 10.1016/j.ophtha.2008.12.029; Machado RAM, 2002, CORNEA, V21, P574, DOI 10.1097/00003226-200208000-00008; Mannis MJ, 1997, CORNEA, V16, P7; Mashaghi A, 2017, BRIT J OPHTHALMOL, V101, P1, DOI 10.1136/bjophthalmol-2015-307848; Mizoguchi S, 2017, EXP EYE RES, V163, P78, DOI 10.1016/j.exer.2017.06.011; Moshirfar M, 2005, CORNEA, V24, P833, DOI 10.1097/01.ico.0000157420.11448.d4; Ramamurthy S, 2016, AM J OPHTHALMOL, V162, P83, DOI 10.1016/j.ajo.2015.11.004; Ricci F, 2010, NEW MICROBIOL, V33, P171; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Seitz B, 2011, CORNEA, V30, P269, DOI 10.1097/ICO.0b013e3181eae8ea; Shimazaki J, 1999, CORNEA, V18, P559, DOI 10.1097/00003226-199909000-00008; Song XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113843; Sugar A, 1984, Cornea, V3, P268; TSUBOTA K, 1995, BRIT J OPHTHALMOL, V79, P257, DOI 10.1136/bjo.79.3.257; Wagoner MD, 2009, CORNEA, V28, P385, DOI 10.1097/ICO.0b013e31818d3aef; Wang T, 2016, GRAEF ARCH CLIN EXP, V254, P1585, DOI 10.1007/s00417-016-3412-0	28	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208163	10.1371/journal.pone.0208163	http://dx.doi.org/10.1371/journal.pone.0208163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485371	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800115
J	Wilson, DA; Tomonaga, M				Wilson, Duncan A.; Tomonaga, Masaki			Exploring attentional bias towards threatening faces in chimpanzees using the dot probe task	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; PAN-TROGLODYTES; SELECTIVE ATTENTION; SOCIAL ANXIETY; ANGRY FACES; CAPTIVE CHIMPANZEES; STIMULI; DISCRIMINATION; DISENGAGEMENT; MANIPULATION	Primates have evolved to rapidly detect and respond to danger in their environment. However, the mechanisms involved in attending to threatening stimuli are not fully understood. The dot-probe task is one of the most widely used experimental paradigms to investigate these mechanisms in humans. However, to date, few studies have been conducted in non-human primates. The aim of this study was to investigate whether the dot-probe task can measure attentional biases towards threatening faces in chimpanzees. Eight adult chimpanzees participated in a series of touch screen dot-probe tasks. We predicted faster response times towards chimpanzee threatening faces relative to neutral faces and faster response times towards faces of high threat intensity (scream) than low threat intensity (bared teeth). Contrary to prediction, response times for chimpanzee threatening faces relative to neutral faces did not differ. In addition, we found no difference in response times for faces of high and low threat intensity. In conclusion, we found no evidence that the touch screen dot-probe task can measure attentional biases specifically towards threatening faces in our chimpanzees. Methodological limitations of using the task to measure emotional attention in human and non-human primates, including stimulus threat intensity, emotional state, stimulus presentation duration and manual responding are discussed.	[Wilson, Duncan A.; Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan	Kyoto University	Wilson, DA (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan.	dawilson100@hotmail.com		Wilson, Duncan/0000-0003-0096-454X	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [150528]; Japan Society for the Promotion of Science (JSPS)-MEXT KAKENHI [18H05811, 15H05709, 16H06283, 18H04194, 20002001, 23220006, 24000001]; JSPS-CCSN; JSPS Leading Graduate Program in Primatology and Wildlife Science [U04]; National Bio Resource Project-Great Ape Information Network (GAIN)	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)-MEXT KAKENHI; JSPS-CCSN; JSPS Leading Graduate Program in Primatology and Wildlife Science; National Bio Resource Project-Great Ape Information Network (GAIN)	This research was financially supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT: http://www.mext.go.jp/en/) (#150528) to DAW, and the Japan Society for the Promotion of Science (JSPS)-MEXT KAKENHI (https://www.jsps.go.jp/english/e-grants/) (#18H05811) to DAW and (#15H05709, #16H06283, #18H04194, #20002001, #23220006, #24000001 to MT and #18H05811 to DAW), JSPS-CCSN, National Bio Resource Project-Great Ape Information Network (GAIN, https://shigen.nig.ac.jp/gain/index.jsp) and JSPS Leading Graduate Program in Primatology and Wildlife Science (U04) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I., 2017, APA HDB COMP PSYCHOL, V2, P141, DOI [10.1037/0000012-007, DOI 10.1037/0000012-007]; Bar-Haim Y, 2010, J CHILD PSYCHOL PSYC, V51, P859, DOI 10.1111/j.1469-7610.2010.02251.x; Bethell EJ, 2016, BEHAV SCI, V6, DOI 10.3390/bs6010002; Bethell EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044387; Bourne VJ, 2006, LATERALITY, V11, P373, DOI 10.1080/13576500600633982; Bourne VJ, 2006, Q J EXP PSYCHOL, V59, P1117, DOI 10.1080/02724980543000150; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; Bradley BP, 1997, COGNITION EMOTION, V11, P25, DOI 10.1080/026999397380014; Chen YP, 2002, BEHAV RES THER, V40, P677, DOI 10.1016/S0005-7967(01)00086-9; Chevalier-Skolnikoff S., 1973, DARWIN FACIAL EXPRES, P11; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Coleman K, 2014, ILAR J, V55, P333, DOI 10.1093/ilar/ilu019; Cooper RM, 2006, BEHAV RES THER, V44, P1321, DOI 10.1016/j.brat.2005.10.004; Dahl CD, 2013, SCI REP-UK, V3, DOI 10.1038/srep01044; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; de Valk JM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01240; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ekman P., 2006, DARWIN FACIAL EXPRES, P169, DOI DOI 10.1371/J0URNAL.P0NE.0014679; Eldar S, 2008, BEHAV RES THER, V46, P450, DOI 10.1016/j.brat.2008.01.012; Fashler SR, 2016, J PAIN RES, V9, P551, DOI 10.2147/JPR.S104268; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; Grillon C, 2011, PSYCHOPHYSIOLOGY, V48, P1745, DOI 10.1111/j.1469-8986.2011.01268.x; Hirata S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01342; Holmes A, 2005, COGNITION EMOTION, V19, P899, DOI 10.1080/02699930441000454; King HM, 2012, PSYCHONEUROENDOCRINO, V37, P396, DOI 10.1016/j.psyneuen.2011.07.010; Klumpp H, 2009, ANXIETY STRESS COPIN, V22, P283, DOI 10.1080/10615800802449602; Koda H, 2013, BEHAV PROCESS, V98, P31, DOI 10.1016/j.beproc.2013.04.013; Koster EHW, 2005, COGNITION EMOTION, V19, P771, DOI 10.1080/02699930441000418; Koster EHW, 2006, BEHAV RES THER, V44, P1757, DOI 10.1016/j.brat.2005.12.011; Kret ME, 2018, J COMP PSYCHOL, V132, P395, DOI 10.1037/com0000108; Kret ME, 2016, P NATL ACAD SCI USA, V113, P3761, DOI 10.1073/pnas.1522060113; Kret ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104886; Kuniecki M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00212; Lacreuse A, 2013, ANIM COGN, V16, P861, DOI 10.1007/s10071-013-0618-y; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; Marzouki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102562; Matsuzawa T, 2006, COGNITIVE DEV CHIMPA, DOI [10.1167/12.10.1, DOI 10.1167/12.10.1]; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Mogg K, 2004, J ABNORM PSYCHOL, V113, P160, DOI 10.1037/0021-843X.113.1.160; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Palomares M, 2012, J VISION, V12, DOI [10.1167/12.10.15, 10.1167/12.10.18]; Parr LA, 2003, ANN NY ACAD SCI, V1000, P56, DOI 10.1196/annals.1280.005; Parr LA, 2007, EMOTION, V7, P172, DOI 10.1037/1528-3542.7.1.172; Parr LA, 2013, PSYCHONEUROENDOCRINO, V38, P1748, DOI 10.1016/j.psyneuen.2013.02.011; Pine DS, 2009, NEUROPSYCHOPHARMACOL, V34, P213, DOI 10.1038/npp.2008.113; Pineles SL, 2005, J ABNORM PSYCHOL, V114, P314, DOI 10.1037/0021-843X.114.2.314; Pishyar R, 2004, ANXIETY STRESS COPIN, V17, P23, DOI 10.1080/10615800310001601458; Schmukle SC, 2005, EUROPEAN J PERSONALI, V19, DOI [10.3389/fpsyg.2015.01240, DOI 10.3389/FPSYG.2015.01240]; Sposari JA, 2007, COGNITIVE THER RES, V31, P23, DOI 10.1007/s10608-006-9073-2; Staugaard SR, 2010, CLIN PSYCHOL REV, V30, P669, DOI 10.1016/j.cpr.2010.05.001; Staugaard SR., 2009, PSYCHOL SCI Q, V51, P339, DOI [DOI 10.1080/02699930903205698, 10.4081/mi.2011.e5, DOI 10.4081/MI.2011.E5]; Stevens S, 2009, BRIT J CLIN PSYCHOL, V48, P125, DOI 10.1348/014466508X368856; Tanaka M, 2007, PRIMATES, V48, P303, DOI 10.1007/s10329-007-0044-3; Team RC, 2015, LANG ENV STAT COMP; Tomonaga M, 1997, JPN PSYCHOL RES, V39, P200, DOI 10.1111/1468-5884.00055; Tomonaga M, 2007, J COMP PSYCHOL, V121, P156, DOI 10.1037/0735-7036.121.2.156; Tomonaga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11437; Tomonaga M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-14; Torrence RD, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13051; van Rooijen R, 2017, PSYCHON B REV, V24, P1686, DOI 10.3758/s13423-016-1224-1; Watanuki Koshiro, 2014, Primate Research, V30, P147; Weierich MR, 2008, COGNITION EMOTION, V22, P985, DOI 10.1080/02699930701597601; Wilson DA, 2018, PRIMATES, V59, P243, DOI 10.1007/s10329-018-0649-8; Wilson DA, 2016, PRIMATES, V57, P433, DOI 10.1007/s10329-016-0537-z; Wilson E, 2003, J ABNORM PSYCHOL, V112, P212, DOI 10.1037/0021-843X.112.2.212; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Yamanashi Y, 2011, AM J PRIMATOL, V73, P1231, DOI 10.1002/ajp.20995; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698; Young A. W., 1982, DIVIDED VISUAL FIELD, P11	76	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207378	10.1371/journal.pone.0207378	http://dx.doi.org/10.1371/journal.pone.0207378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485317	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800064
J	Cantu, H; Cote, JN; Nantel, J				Cantu, Hiram; Cote, Julie N.; Nantel, Julie			A new method based on quiet stance baseline is more effective in identifying freezing in Parkinson's disease	PLOS ONE			English	Article							BIMANUAL COORDINATION; GAIT QUESTIONNAIRE; DUAL-TASKING; MOVEMENT; DYNAMICS; DEFICITS; EPISODES	Freezing, an episodic movement breakdown that goes from disrupted gait patterns to complete arrest, is a disabling symptom in Parkinson's disease. Several efforts have been made to objectively identify freezing episodes (FEs), although a standardized methodology to discriminate freezing from normal movement is lacking. Novel mathematical approaches that provide information in the temporal and frequency domains, such as the continuous wavelet transform, have demonstrated promising results detecting freezing, although still with limited effectiveness. We aimed to determine whether a computerized algorithm using the continuous wavelet transform based on baseline (i.e. no movement) rather than on amplitude decrease is more effective detecting freezing. Twenty-six individuals with Parkinson's disease performed two trials of a repetitive stepping-in-place task while they were filmed by a video camera and tracked by a motion capture system. The number of FEs and their total duration were determined from a visual inspection of the videos and from three different computed algorithms. Differences in the number and total duration of the FEs between the video inspection and each of the three methods were obtained. The accuracy to identify the time of occurrence of a FE by each method was also calculated. A significant effect of Method was found for the number (p = 0.016) and total duration (p = 0.013) of the FEs, with the method based on baseline being the closest one to the values reported from the videos. Moreover, the same method was the most accurate in detecting the time of occurrence, and the one reaching the highest sensitivity (88.2%). Findings suggest that threshold detection methods based on baseline and movement amplitude decreases capture different characteristics of Parkinsonian gait, with the first one being more effective at detecting FEs. Moreover, robust approaches that consider both time and frequency characteristics are more sensitive in identifying freezing.	[Cantu, Hiram] Univ Monterrey, Dept Ingn Biomed, Vicerrectoria Ciencias Salud, San Pedro Garza Garcia, Nuevo Leon, Mexico; [Cantu, Hiram; Cote, Julie N.] Jewish Rehabil Hosp, Michael Feil & Ted Oberfeld CRIR Res Ctr, Occupat Biomech & Ergon Lab, Laval, PQ, Canada; [Cantu, Hiram; Cote, Julie N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Nantel, Julie] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada	Tecnologico de Monterrey; Universidad de Monterrey; McGill University; McGill University; University of Ottawa	Cantu, H (corresponding author), Univ Monterrey, Dept Ingn Biomed, Vicerrectoria Ciencias Salud, San Pedro Garza Garcia, Nuevo Leon, Mexico.; Cantu, H (corresponding author), Jewish Rehabil Hosp, Michael Feil & Ted Oberfeld CRIR Res Ctr, Occupat Biomech & Ergon Lab, Laval, PQ, Canada.; Cantu, H (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.	hiram.cantu@mail.mcgill.ca	Nantel, Julie/AAE-8114-2021	Cantu, Hiram/0000-0002-4881-3436	Canada Foundation for Innovation (CFI) [10131]; Natural Sciences and Engineering Research Council (NSERC) [05111]; Consejo Nacional de Ciencia y Tecnologia (National Council of Science and Technology, CONACYT); Bloomberg Manulife Fellowship	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Consejo Nacional de Ciencia y Tecnologia (National Council of Science and Technology, CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Bloomberg Manulife Fellowship	This work was supported by grants from the Canada Foundation for Innovation (CFI, #10131) (www.innovation.ca) and from the Natural Sciences and Engineering Research Council (NSERC, #05111) (www.nserc-crsng.gc.ca).HC was supported by a PhD scholarship from the Consejo Nacional de Ciencia y Tecnologia (National Council of Science and Technology, CONACYT) (www.conacyt.gob.mx) and by the Bloomberg Manulife Fellowship (www.mcgill.ca/manulife-prize/fellowships).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2003, BRAIN RES BULL, V61, P219, DOI 10.1016/S0361-9230(03)00119-9; Addison P.S., 2017, ILLUSTRATED WAVELET; Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Almeida QJ, 2003, NEUROPSYCHOLOGIA, V41, P442, DOI 10.1016/S0028-3932(02)00155-0; Almeida QJ, 2002, MOVEMENT DISORD, V17, P30, DOI 10.1002/mds.10030; Asai Y, 2003, BIOSYSTEMS, V71, P11, DOI 10.1016/S0303-2647(03)00105-9; Bachlin M, 2010, IEEE T INF TECHNOL B, V14, P436, DOI 10.1109/TITB.2009.2036165; Barbe MT, 2014, J NEUROL, V261, P330, DOI 10.1007/s00415-013-7199-1; Bergamini E, 2014, SENSORS-BASEL, V14, P18625, DOI 10.3390/s141018625; Brown MJN, 2015, J NEUROL, V262, P41, DOI 10.1007/s00415-014-7514-5; Cantiniaux S, 2010, J NEUROL NEUROSUR PS, V81, P177, DOI 10.1136/jnnp.2009.174375; Fietzek UM, 2013, PARKINSONISM RELAT D, V19, P894, DOI 10.1016/j.parkreldis.2013.04.004; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Gilat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066718; Jacobs JV, 2014, PARKINSONISM RELAT D, V20, P779, DOI 10.1016/j.parkreldis.2014.04.001; Kwon Y, 2014, CLIN INTERV AGING, V9, P1709, DOI 10.2147/CIA.S69773; Lebold CA, 2011, PARKINSONS DIS, P1, DOI [10.4061/2010/732508, DOI 10.4061/2010/732508PMID:20976094]; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; Martens KAE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062602; Matar E, 2013, PARKINSONISM RELAT D, V19, P937, DOI 10.1016/j.parkreldis.2013.06.002; Mensink SHG, 2014, J NEUROL, V261, P999, DOI 10.1007/s00415-014-7274-2; Mojtahedi K, 2015, IEEE T BIO-MED ENG, V62, P1363, DOI 10.1109/TBME.2015.2388592; Moreau C, 2007, MOVEMENT DISORD, V22, P1503, DOI 10.1002/mds.21549; Nantel J, 2012, NEUROSCIENCE, V221, P151, DOI 10.1016/j.neuroscience.2012.07.007; Nantel J, 2011, GAIT POSTURE, V34, P329, DOI 10.1016/j.gaitpost.2011.05.020; Nieuwboer A, 2013, MOVEMENT DISORD, V28, P1509, DOI 10.1002/mds.25683; Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x; Nonnekes J, 2014, J NEUROL, V261, P1763, DOI 10.1007/s00415-014-7422-8; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Park HK, 2014, NEUROL SCI, V35, P357, DOI 10.1007/s10072-013-1519-1; Rezvanian S, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16040475; Shine JM, 2013, BRAIN, V136, P3671, DOI 10.1093/brain/awt272; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Vercruysse S, 2014, CEREB CORTEX, V24, P3154, DOI 10.1093/cercor/bht170; Vercruysse S, 2014, NEUROSCI BIOBEHAV R, V43, P213, DOI 10.1016/j.neubiorev.2014.04.010; Vercruysse S, 2012, NEUROREHAB NEURAL RE, V26, P636, DOI 10.1177/1545968311431964; Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015; Williams AJ, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/595378	42	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207945	10.1371/journal.pone.0207945	http://dx.doi.org/10.1371/journal.pone.0207945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475908	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700093
J	Michelet, L; de Cruz, K; Karoui, C; Tambosco, J; Moyen, JL; Henault, S; Boschiroli, ML				Michelet, Lorraine; de Cruz, Krystel; Karoui, Claudine; Tambosco, Jennifer; Moyen, Jean-Louis; Henault, Sylvie; Boschiroli, Maria Laura			Second line molecular diagnosis for bovine tuberculosis to improve diagnostic schemes	PLOS ONE			English	Article							RHODOCOCCUS-EQUI; LYMPH-NODES; MYCOBACTERIUM-BOVIS; GENETIC DIVERSITY; CATTLE; IDENTIFICATION; SURVEILLANCE; ERADICATION; PHYLOGENY	Surveillance of bovine tuberculosis (bTB) is partly based on the sanitary inspection of carcasses at the abattoir to detect bTB-like lesions which, in compliance with EU recommendations, are analysed by bacteriology and histopathology to disclose Mycobacterium bovis (or M. caprae) infection. Moreover, since 2012, a PCR method with similar sensitivity and specificity values of histopathology and bacteriology respectively is additionally employed in France, partially compensating for the weaknesses of classical diagnostic methods. We analysed a collection of bTB-like lesions from cattle presenting positive histological results albeit with negative PCR results. We present here the results of these samples, recovered from 292 animals culled between 2013 and 2016, analysed with a second line molecular diagnosis approach that consists in a combination of PCRs targeting the M. tuberculosis-M. avium complexes as well as the Mycobacterium genus and sequencing of hsp65 gene. These molecular analyses disclosed to identify the presence of non-tuberculous bacteria which could be responsible for most of these non-specific TB lesions: non tuberculous mycobacteria (24%) or Actinomycetales (56%) such as Rhodococcus equi (53%); 24% of the samples were negative. M. bovis-or any other MTBC members-was neither detected by molecular methods nor isolated in any of them at the end of the 3 months of culture. In conclusion, these results highlight the lack of specificity of histopathology and the usefulness of a first line PCR with a second line molecular diagnostic test to circumvent it. This diagnostic strategy makes it possible to reduce the number of suspect bTB cases raised at the abattoir or shortening their lock-up periods. By simplifying diagnostic schemes, the use of this tool could improve bTB surveillance and make eradication programs more efficient in the future.	[Michelet, Lorraine; de Cruz, Krystel; Karoui, Claudine; Tambosco, Jennifer; Henault, Sylvie; Boschiroli, Maria Laura] Univ Paris Est, French Agcy Food Environm & Occupat Hlth & Safety, Lab Anim Hlth, Maisons Alfort, France; [Moyen, Jean-Louis] Lab Dept Anal & Rech Dordogne, Coulounieix Chamiers, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA)	Boschiroli, ML (corresponding author), Univ Paris Est, French Agcy Food Environm & Occupat Hlth & Safety, Lab Anim Hlth, Maisons Alfort, France.	maria-laura.boschiroli@anses.fr	Boschiroli, Maria Laura/AAR-3319-2021; Michelet, Lorraine/AAR-3577-2021	Michelet, Lorraine/0000-0003-2991-1660; Boschiroli, Maria Laura/0000-0002-6705-1684				Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; [Anonymous], [No title captured]; BARTON MD, 1984, VET MICROBIOL, V9, P65, DOI 10.1016/0378-1135(84)90079-8; Lara GHB, 2011, RES VET SCI, V90, P185, DOI 10.1016/j.rvsc.2010.06.009; Biet F, 2014, RES VET SCI, V97, pS69, DOI 10.1016/j.rvsc.2014.08.007; Courcoul A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090334; Domingo M, 2014, RES VET SCI, V97, pS20, DOI 10.1016/j.rvsc.2014.03.017; Dvorska L, 1999, VET MED-CZECH, V44, P321; Fediaevsky A, 2013, B EPID SANTE ANIM AL, V59, P4; Flynn O, 2001, VET MICROBIOL, V78, P221, DOI 10.1016/S0378-1135(00)00297-2; Galizzi N, 2013, J CLIN MICROBIOL, V51, P3467, DOI 10.1128/JCM.01028-13; Garcia-Jimenez WL, 2015, TRANSBOUND EMERG DIS, V62, P72, DOI 10.1111/tbed.12083; Ghielmetti G, 2018, TRANSBOUND EMERG DIS, V65, P711, DOI 10.1111/tbed.12793; Gormley E, 2014, RES VET SCI, V97, pS30, DOI 10.1016/j.rvsc.2014.04.010; Guerin-Faublee V, 2013, INT J SYST EVOL MICR, V63, P4669, DOI 10.1099/ijs.0.051979-0; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; Hughes MS, 2005, VET MICROBIOL, V108, P101, DOI 10.1016/j.vetmic.2005.03.001; Lambert S, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-016-1071-4; McCorry TP, 2004, VET MICROBIOL, V99, P281, DOI 10.1016/j.vetmic.2003.12.006; MCKENZIE RA, 1979, J COMP PATHOL, V89, P31, DOI 10.1016/0021-9975(79)90005-7; Menin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053884; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Nuru A, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1168-3; Pavlik I, 2009, ECOLOGY OF MYCOBACTERIA: IMPACT ON ANIMAL'S AND HUMAN'S HEALTH, 2ND EDITION, P199, DOI 10.1007/978-1-4020-9413-2_6; PITULLE C, 1992, INT J SYST BACTERIOL, V42, P337, DOI 10.1099/00207713-42-3-337; Radunz B, 2006, VET MICROBIOL, V112, P283, DOI 10.1016/j.vetmic.2005.11.017; Ramos DF, 2015, BRAZ J BIOL, V75, P830, DOI 10.1590/1519-6984.23613; Ronai Z, 2016, J APPL MICROBIOL, V121, P41, DOI 10.1111/jam.13152; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Simmon KE, 2009, INT J SYST EVOL MICR, V59, P1371, DOI 10.1099/ijs.0.007799-0; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Thoen CO, 1995, MYCOBACTERIUM BOVIS, P63; Tortoli E, 2017, INFECT GENET EVOL, V56, P19, DOI 10.1016/j.meegid.2017.10.013; Varello K, 2008, J VET DIAGN INVEST, V20, P164, DOI 10.1177/104063870802000204; Vazquez-Boland JA, 2013, VET MICROBIOL, V167, P9, DOI 10.1016/j.vetmic.2013.06.016; Watrelot-Virieux D, 2006, J VET MED B, V53, P321, DOI 10.1111/j.1439-0450.2006.00957.x; Witkowski L, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0445-1	37	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207614	10.1371/journal.pone.0207614	http://dx.doi.org/10.1371/journal.pone.0207614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475835	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700045
J	Han, JH; Jung, SK				Han, Jae-Hoon; Jung, Sang-Kyu			High-throughput toxicity study of lubricant emulsions and their common ingredients using zebrafish	PLOS ONE			English	Article							NANOPARTICLES; MODEL	Though lubricant emulsions have been widely used in many industrial processes, various human health hazards have been reported. Conducting a systematic toxicity study on emulsions is difficult since emulsions contain multiple chemical compounds, and hydrophobic compounds form complex emulsion particles via surfactants. For a quantitative toxicity study, we developed a high-throughput imaging system using zebrafish and conducted a large scale in vivo toxicity assay of lubricant emulsion and their common ingredients. By computing the locomotion activity of zebrafish from captured time-lapse images, we could quantify the degree of relative toxicity of 29 chemicals. The changes in the locomotion activity over time were observed to vary significantly depending on emulsions, indicating that the degree of toxicity of the commercial products was very diverse. We found that primary ethanolamines were more toxic than secondary or tertiary ethanolamines, and several factors, such as alkyl chain length, EO mole, test concentration, and emulsion particle size, affected toxicity.	[Han, Jae-Hoon; Jung, Sang-Kyu] Hongik Univ, Dept Bio & Chem Engn, Sejong, South Korea	Hongik University	Jung, SK (corresponding author), Hongik Univ, Dept Bio & Chem Engn, Sejong, South Korea.	skjung@hongik.ac.kr			National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, ICT & Future Planning) [NRF-2017R1C1B2004356]; Hongik University Research Fund	National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, ICT & Future Planning); Hongik University Research Fund	This work was supported by National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science, ICT & Future Planning; NRF-2017R1C1B2004356), and 2016 Hongik University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Rho-Shin Park and Sung-Hyun Park in Houghton Korea, Inc. for providing chemicals. Also, we would like to thank Professor Dae-Yu Kim of Inha University for providing the experimental space as a research collaborator. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science, ICT & Future Planning; NRF-2017R1C1B2004356) and the 2016 Hongik University Research Fund.	Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Bradley Derek, 2007, Journal of Graphics Tools, V12, P13; Brooks, 2008, PHAS 1 CO2 AM SCREEN, P5698; Churgin MA, 2017, ELIFE, V6, DOI [10.7554/elife.26652, 10.7554/eLife.26652]; Cohen H, 2006, J OCCUP ENVIRON HYG, V3, P501, DOI 10.1080/15459620600867872; Eisen EA, 2001, SCAND J WORK ENV HEA, V27, P240, DOI 10.5271/sjweh.611; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Grand View Research I, 2016, MET FLUIDS MARK AN P, V2022; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Jung SK, 2015, ENVIRON SCI TECHNOL, V49, P2477, DOI 10.1021/es5056462; Jung SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084830; Lin SJ, 2013, SMALL, V9, P1776, DOI 10.1002/smll.201202128; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Mirer FE, 2010, AM J IND MED, V53, P792, DOI 10.1002/ajim.20853; Pandeya S, 1997, INTRO DRUG DESIGN NE; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Sinks GD, 1998, SAR QSAR ENVIRON RES, V9, P217, DOI 10.1080/10629369808039157; Spomer W, 2012, JALA-J LAB AUTOM, V17, P435, DOI 10.1177/2211068212464223; Sullivan J.B., 2001, CLIN ENV HLTH TOXIC; Suuronen K., 2009, METALWORKING FLUIDS; Talmage S.S., 1994, ENV HUMAN SAFETY MAJ; Verma SK, 2017, ALTERED PHYSIOCHEMIC, V7, P13909; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Wong DCL, 1997, ENVIRON TOXICOL CHEM, V16, P1970, DOI 10.1002/etc.5620160929; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207946	10.1371/journal.pone.0207946	http://dx.doi.org/10.1371/journal.pone.0207946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462734	Green Submitted, Green Published, gold			2022-12-26	WOS:000451054800094
J	Christensen, A; Pike, CJ				Christensen, Amy; Pike, Christian J.			APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice	FASEB JOURNAL			English	Article						-amyloid; inflammation; metabolism; microglia; obesity	APOLIPOPROTEIN-E GENOTYPE; TRANSGENIC MOUSE MODEL; COGNITIVE FUNCTION; RISK-FACTORS; DISEASE; SEX; DEMENTIA; ALLELE; INFLAMMATION; ASSOCIATION	Development of Alzheimer's disease (AD) is regulated by interactive effects of genetic and environmental risk factors. The most significant genetic risk factor for AD is the epsilon 4 allele of apolipoprotein E (APOE4), which has been shown to exert greater AD risk in women. An important modifiable AD risk factor is obesity and its associated metabolic dysfunctions. Whether APOE genotype might interact with obesity in females to regulate AD pathogenesis is unclear. To investigate this issue, we studied the effects of Western diet (WD) on female EFAD mice, a transgenic mouse model of AD that includes human APOE alleles epsilon 3 (E3FAD) and epsilon 4 (E4FAD). EFAD mice were fed either control (10% fat, 7% sugar) or WD (45% fat, 17% sugar), and both metabolic and neuropathologic outcomes were determined. Although E4FAD mice generally exhibited poorer metabolic status at baseline, E3FAD mice showed greater diet-induced metabolic impairments. Similarly, E4FAD mice exhibited higher levels of AD-related pathology overall, but only E3FAD showed significant increases on select measures of -amyloid pathology after exposure to WD. These data demonstrate a gene-environment interaction between APOE and obesogenic diets in females. Understanding how AD-promoting effects of obesity are modulated by genetic factors will foster the identification of at-risk populations and development of preventive interventions.Christensen, A., Pike, C. J. APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice.	[Christensen, Amy; Pike, Christian J.] Univ Southern Calif, Leonard Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA	University of Southern California	Pike, CJ (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	cjpike@usc.edu		Christensen, Amy/0000-0002-3357-0523; Pike, Christian/0000-0003-4577-7668	U.S. National Institutes of Health (NIH) National Institute on Aging Grant [AG026572]; NIH National Institute on Aging [T32 AG052374]; NATIONAL INSTITUTE ON AGING [P01AG026572] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging Grant; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the U.S. National Institutes of Health (NIH) National Institute on Aging Grant AG026572 (to C.J.P.). A.C. was supported, in part, by the NIH National Institute on Aging Grant T32 AG052374. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Arbones-Mainar JM, 2016, INT J OBESITY, V40, P1574, DOI 10.1038/ijo.2016.93; Barron AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078554; Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; Beydoun MA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.017; Biessels G.J., 2010, DIABETES BRAIN; Buckley RF, 2018, ALZHEIMERS DEMENT, V14, P1193, DOI 10.1016/j.jalz.2018.04.010; Cacciottolo M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.280; Cacciottolo M, 2016, NEUROBIOL AGING, V37, P47, DOI 10.1016/j.neurobiolaging.2015.10.010; Christensen A, 2018, NEUROSCI LETT, V683, P7, DOI 10.1016/j.neulet.2018.06.029; Christensen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178490; Christensen A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00130; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craft S, 1999, NEUROENDOCRINOLOGY, V70, P146, DOI 10.1159/000054469; de la Monte SM, 2014, ENDOCRIN METAB CLIN, V43, P245, DOI 10.1016/j.ecl.2013.09.006; Oliveira BCD, 2018, NEUROSCIENCE, V376, P127, DOI 10.1016/j.neuroscience.2018.02.012; Dufouil C, 2014, J ALZHEIMERS DIS, V42, pS353, DOI 10.3233/JAD-141629; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Ghebranious N, 2011, CLIN MED RES, V9, P17, DOI 10.3121/cmr.2010.894; Hanson AJ, 2016, DEMENT GER COGN D EX, V6, P78, DOI 10.1159/000444079; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Holmes C, 2013, NEUROPATH APPL NEURO, V39, P51, DOI 10.1111/j.1365-2990.2012.01307.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Jayaraman A, 2014, ENDOCRINOLOGY, V155, P1398, DOI 10.1210/en.2013-1725; Johnson LA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43701; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Karim R., 2018, MENOPAUSE; Kohjima M, 2010, ENDOCRINOLOGY, V151, P1532, DOI 10.1210/en.2009-1196; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kuusisto J, 1997, BRIT MED J, V315, P1045, DOI 10.1136/bmj.315.7115.1045; Kypreos KE, 2018, J BIOMED RES, V32, P183, DOI 10.7555/JBR.32.20180007; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Liu YW, 2010, J ALZHEIMERS DIS, V21, P947, DOI 10.3233/JAD-2010-100201; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Morris JK, 2017, J ALZHEIMERS DIS, V58, P1129, DOI 10.3233/JAD-170148; Morris JK, 2016, NEUROBIOL AGING, V44, P138, DOI 10.1016/j.neurobiolaging.2016.04.017; Moser VA, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0077-17.2017; Moser VA, 2016, NEUROSCI BIOBEHAV R, V67, P102, DOI 10.1016/j.neubiorev.2015.08.021; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Nam KN, 2018, BBA-MOL BASIS DIS, V1864, P152, DOI 10.1016/j.bbadis.2017.10.018; Neu SC, 2017, JAMA NEUROL, V74, P1178, DOI 10.1001/jamaneurol.2017.2188; O'Brien PD, 2017, LANCET NEUROL, V16, P465, DOI 10.1016/S1474-4422(17)30084-4; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827; Profenno LA, 2008, AM J MED GENET B, V147B, P822, DOI 10.1002/ajmg.b.30694; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Ramsden M, 2003, NEUROSCIENCE, V122, P573, DOI 10.1016/j.neuroscience.2003.08.048; Rettberg JR, 2016, NEUROBIOL AGING, V40, P155, DOI 10.1016/j.neurobiolaging.2016.01.011; Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228; Tai LM, 2017, J LIPID RES, V58, P1733, DOI 10.1194/jlr.R076315; Tai LM, 2015, J NEUROCHEM, V133, P465, DOI 10.1111/jnc.13072; Trumble BC, 2017, FASEB J, V31, P1508, DOI 10.1096/fj.201601084R; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Wu L, 2018, J NEUROSCI, V38, P6665, DOI 10.1523/JNEUROSCI.2262-17.2018; Yang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125922; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300	70	7	7	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4054	4066		10.1096/fj.201801756R	http://dx.doi.org/10.1096/fj.201801756R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509127	Bronze, Green Published			2022-12-26	WOS:000459794800076
J	Peigneur, S; Cheneval, O; Maiti, M; Leipold, E; Heinemann, SH; Lescrinier, E; Herdewijn, P; De Lima, ME; Craik, DJ; Schroeder, CI; Tytgat, J				Peigneur, Steve; Cheneval, Olivier; Maiti, Mohitosh; Leipold, Enrico; Heinemann, Stefan H.; Lescrinier, Eveline; Herdewijn, Piet; De Lima, Maria Elena; Craik, David J.; Schroeder, Christina I.; Tytgat, Jan			Where cone snails and spiders meet: design of small cyclic sodium-channel inhibitors	FASEB JOURNAL			English	Article						voltage-gated sodium channel; peptide cyclization; toxin-based therapeutics; peptide toxin	MU-CONOTOXIN-KIIIA; BRAZILIAN ARMED SPIDER; LETHAL NEUROTOXIN TX1; DE-NOVO DESIGN; FUNCTIONAL EXPRESSION; SUBTYPE SPECIFICITY; PEPTIDES; VENOM; BLOCKER; TETRODOTOXIN	A 13 aa residue voltage-gated sodium (Na-V) channel inhibitor peptide, Pn, containing 2 disulfide bridges was designed by using a chimeric approach. This approach was based on a common pharmacophore deduced from sequence and secondary structural homology of 2 Na-V inhibitors: Conus kinoshitai toxin IIIA, a 14 residue cone snail peptide with 3 disulfide bonds, and Phoneutria nigriventer toxin 1, a 78 residue spider toxin with 7 disulfide bonds. As with the parent peptides, this novel Na-V channel inhibitor was active on Na(V)1.2. Through the generation of 3 series of peptide mutants, we investigated the role of key residues and cyclization and their influence on Na-V inhibition and subtype selectivity. Cyclic PnCS1, a 10 residue peptide cyclized via a disulfide bond, exhibited increased inhibitory activity toward therapeutically relevant Na-V channel subtypes, including Na(V)1.7 and Na(V)1.9, while displaying remarkable serum stability. These peptides represent the first and the smallest cyclic peptide Na-V modulators to date and are promising templates for the development of toxin-based therapeutic agents.Peigneur, S., Cheneval, O., Maiti, M., Leipold, E., Heinemann, S. H., Lescrinier, E., Herdewijn, P., De Lima, M. E., Craik, D. J., Schroeder, C. I., Tytgat, J. Where cone snails and spiders meet: design of small cyclic sodium-channel inhibitors.	[Peigneur, Steve; Tytgat, Jan] Katholieke Univ KU Leuven, Toxicol & Pharmacol, Campus Gasthuisberg, Leuven, Belgium; [Peigneur, Steve; De Lima, Maria Elena] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Venenos & Toxinas Anim, Belo Horizonte, MG, Brazil; [Cheneval, Olivier; Craik, David J.; Schroeder, Christina I.] Univ Queensland, Inst Mol Biolsci, Brisbane, Qld 4072, Australia; [Maiti, Mohitosh; Lescrinier, Eveline; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst Med Res, Lab Med Chem, Leuven, Belgium; [Leipold, Enrico; Heinemann, Stefan H.] Friedrich Schiller Univ Jena, Jena Univ Hosp, Ctr Mol Biomed, Dept Biophys, Jena, Germany; [De Lima, Maria Elena] Grp Santa Casa Belo Horizonte, Inst Ensino & Pesquisa Santa Casa Belo Horizonte, Programa Posgrad Ciencias Saude Biomed & Med, Belo Horizonte, MG, Brazil; [Leipold, Enrico] Univ Lubeck, CBBM, Lubeck, Germany; [Leipold, Enrico] Univ Lubeck, Clin Anesthesiol & Intens Care, Lubeck, Germany	KU Leuven; Universidade Federal de Minas Gerais; University of Queensland; KU Leuven; Friedrich Schiller University of Jena; Instituto de Ensino Superior e Pesquisa da Santa Casa; University of Lubeck; University of Lubeck	Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biolsci, Brisbane, Qld 4072, Australia.; Tytgat, J (corresponding author), Univ Leuven, Toxicol, Campus Gasthuisberg,POB 922, B-3000 Louvain, Belgium.	c.schroeder@imb.uq.edu.au; jan.tytgat@pharm.kuleuven.be	Lima, Maria E/P-1707-2017; Lescrinier, Eveline/G-9339-2016; de Lima, Maria Elena/GQH-4440-2022; Craik, David/B-1695-2010; Schroeder, Christina/K-2042-2014; Cheneval, Olivier/O-1384-2017	Lima, Maria E/0000-0001-6185-4032; Lescrinier, Eveline/0000-0001-7066-4329; Craik, David/0000-0003-0007-6796; Herdewijn, Piet/0000-0003-3589-8503; Peigneur, Steve/0000-0003-0504-5702; Schroeder, Christina/0000-0002-6737-6374; Cheneval, Olivier/0000-0003-0109-7767; Heinemann, Stefan H./0000-0002-4144-0251	CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Australian Research Council [FL150100146, FT160100055]; CAPES, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FundacAo de Pesquisa do Estado de Minas Gerais;  [CELSA/17/047-BOF/ISP]	CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Australian Research Council(Australian Research Council); CAPES, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FundacAo de Pesquisa do Estado de Minas Gerais; 	The authors thank John N. Wood (University College London, London, United Kingdom) for sharing rNa<INF>V</INF>1.8; A. L. Goldin (University of California, Irvine, Irvine, CA, USA) for sharing rNa<INF>V</INF>1.1, rNa<INF>V</INF>1.2, rNa<INF>V</INF>1.3, and mNa<INF>V</INF>1.6; G. Mandel (State University of New York, Stony Brook, NY, USA) for sharing rNa<INF>V</INF>1.4; R. G. Kallen (Roche Institute of Molecular Biology, Nutley, NJ, USA) for sharing hNa<INF>V</INF>1.5; K. Dong (Michigan State University, East Lansing, MI, USA) for sharing the BgNa<INF>V</INF>1.1 and VdNa<INF>V</INF>1 clones; S. C. Cannon (University of Texas Southwestern Medical Center, Dallas, TX, USA) for sharing the h1 subunit; and Martin S. Williamson (Rothhamsted Research, Harpenden, United Kingdom) for providing the Para and tipE clone. The Na<INF>V</INF>1.7 clone was kindly provided by F. Bosmans (Johns Hopkins University, Baltimore, MD, USA). J.T. was supported by Grant CELSA/17/047-BOF/ISP. S.P. is a Ph.D. fellow supported by CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). D.J.C. is an Australian Research Council Australian Laureate Fellow (FL150100146) and C.I.S. is an Institute for Molecular Bioscience Industry Fellow and Australian Research Council Future Fellow (FT160100055). M.E.D.L. was supported by grants from CAPES, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and FundacAo de Pesquisa do Estado de Minas Gerais. The authors declare no conflicts of interest.	Abdelsayed M, 2013, CHANNELS, V7, P146, DOI 10.4161/chan.24380; Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Almeida Flavia De Marco, 2015, Shengli Xuebao, V67, P261; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Brady RM, 2013, BIOORG MED CHEM LETT, V23, P4892, DOI 10.1016/j.bmcl.2013.06.086; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Lima M. E., 2015, SPIDER VENOMS, P1, DOI [10.1007/978-94-007-6646-4, DOI 10.1007/978-94-007-6646-4]; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; DINIZ CR, 1990, FEBS LETT, V263, P251, DOI 10.1016/0014-5793(90)81386-3; Diniz MRV, 2006, PROTEIN EXPRES PURIF, V50, P18, DOI 10.1016/j.pep.2006.06.012; DINIZ MRV, 1993, J BIOL CHEM, V268, P15340; French RJ, 2010, MAR DRUGS, V8, P2153, DOI 10.3390/md8072153; Goral RO, 2015, PFLUG ARCH EUR J PHY, V467, P2423, DOI 10.1007/s00424-015-1709-1; Green BR, 2014, FUTURE MED CHEM, V6, P1677, DOI [10.4155/fmc.14.107, 10.4155/FMC.14.107]; Han TS, 2009, CHEMMEDCHEM, V4, P406, DOI 10.1002/cmdc.200800292; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; Khoo KK, 2012, BIOCHEMISTRY-US, V51, P9826, DOI 10.1021/bi301256s; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leao RM, 2000, NEUROPHARMACOLOGY, V39, P1756, DOI 10.1016/S0028-3908(99)00267-1; Lebbe EKM, 2014, PEPTIDES, V53, P300, DOI 10.1016/j.peptides.2013.07.005; Leipold E, 2011, NEUROPHARMACOLOGY, V61, P105, DOI 10.1016/j.neuropharm.2011.03.008; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu M, 2011, PAIN MED, V12, pS93, DOI 10.1111/j.1526-4637.2011.01158.x; Markgraf R, 2012, BRIT J PHARMACOL, V167, P576, DOI 10.1111/j.1476-5381.2012.02004.x; Martin-Moutot N, 2006, MOL PHARMACOL, V69, P1931, DOI 10.1124/mol.105.021147; Moreau A, 2015, CHANNELS, V9, P139, DOI 10.1080/19336950.2015.1031937; Prashanth JR, 2017, MOL BIOSYST, V13, P2453, DOI 10.1039/c7mb00511c; Schroeder CI, 2012, BIOPOLYMERS, V98, P161, DOI 10.1002/bip.22032; Silva AO, 2012, BIOCHIMIE, V94, P2756, DOI 10.1016/j.biochi.2012.08.016; Spronk CAEM, 2002, J BIOMOL NMR, V22, P281, DOI 10.1023/A:1014971029663; Stevens M, 2012, J BIOL CHEM, V287, P31382, DOI 10.1074/jbc.M112.375733; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Torres FS, 2010, TOXICON, V56, P1172, DOI 10.1016/j.toxicon.2010.04.010; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; Walewska A, 2008, J AM CHEM SOC, V130, P14280, DOI 10.1021/ja804303p; Walewska A, 2013, EUR J MED CHEM, V65, P144, DOI 10.1016/j.ejmech.2013.04.041; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2010, J NEUROPHYSIOL, V104, P88, DOI 10.1152/jn.00145.2010; Zhang MM, 2009, CHANNELS, V3, P32, DOI 10.4161/chan.3.1.7500	47	20	20	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3693	3703		10.1096/fj.201801909R	http://dx.doi.org/10.1096/fj.201801909R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509130	Green Accepted, Bronze			2022-12-26	WOS:000459794800049
J	Liang, C; Zhang, ZL; Chen, QF; Yan, HY; Zhang, M; Xiang, XF; Yi, Q; Pan, X; Cheng, HK; Wang, FW				Liang, Cai; Zhang, Zhenlei; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Xiang, Xingfeng; Yi, Qi; Pan, Xuan; Cheng, Hankun; Wang, Fangwei			A positive feedback mechanism ensures proper assembly of the functional inner centromere during mitosis in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitosis; centromere; kinetochore; chromosomes; histone modification; chromosomal passenger complex; cohesin; Haspin; Sgo1; sister chromatid cohesion	SISTER-CHROMATID COHESION; PROTEIN PHOSPHATASE 2A; B KINASE-ACTIVITY; AURORA B; CENP-B; THR-3 PHOSPHORYLATION; MITOTIC CHROMOSOME; ERROR-CORRECTION; SHUGOSHIN; HASPIN	The inner centromere region of a mitotic chromosome critically regulates sister chromatid cohesion and kinetochore-microtubule attachments. However, the molecular mechanism underlying inner centromere assembly remains elusive. Here, using CRISPR/Cas9-based gene editing in HeLa cells, we disrupted the interaction of Shugoshin 1 (Sgo1) with histone H2A phosphorylated on Thr-120 (H2ApT120) to selectively release Sgo1 from mitotic centromeres. Interestingly, cells expressing the H2ApT120-binding defective mutant of Sgo1 have an elevated rate of chromosome missegregation accompanied by weakened centromeric cohesion and decreased centromere accumulation of the chromosomal passenger complex (CPC), an integral part of the inner centromere and a key player in the correction of erroneous kinetochore-microtubule attachments. When artificially tethered to centromeres, a Sgo1 mutant defective in binding protein phosphatase 2A (PP2A) is not able to support proper centromeric cohesion and CPC accumulation, indicating that the Sgo1-PP2A interaction is essential for the integrity of mitotic centromeres. We further provide evidence indicating that Sgo1 protects centromeric cohesin to create a binding site for the histone H3-associated protein kinase Haspin, which not only inhibits the cohesin release factor Wapl and thereby strengthens centromeric cohesion but also phosphorylates histone H3 at Thr-3 to position CPC at inner centromeres. Taken together, our findings reveal a positive feedback-based mechanism that ensures proper assembly of the functional inner centromere during mitosis. They further suggest a causal link between centromeric cohesion defects and chromosomal instability in cancer cells.	[Liang, Cai; Zhang, Zhenlei; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Xiang, Xingfeng; Yi, Qi; Pan, Xuan; Cheng, Hankun; Wang, Fangwei] Zhejiang Univ, Life Sci Inst, MOE Lab Biosyst Homeostasis & Protect & Innovat, Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Wang, FW (corresponding author), Zhejiang Univ, Life Sci Inst, MOE Lab Biosyst Homeostasis & Protect & Innovat, Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	fwwang@zju.edu.cn		Chen, Qinfu/0000-0003-4581-5329; Wang, Fangwei/0000-0001-5617-282X; Cai, Liang/0000-0002-1885-4237; zhang, zhenlei/0000-0001-9288-9908	National Key Research and Development Program of China [2017YFA0503600]; Natural Science Foundation of Zhejiang Province [LR13C070001, LY17C070003]; National Natural Science Foundation of China [31771499, 31571393, 31561130155, 31322032, 31371359]; Newton Advanced Fellowship [NA140075]; Fundamental Research Funds for the Central Universities	National Key Research and Development Program of China; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Newton Advanced Fellowship; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by National Key Research and Development Program of China Grant 2017YFA0503600 (to F. W.); Natural Science Foundation of Zhejiang Province Grant LZ19C070001 (to F. W.); National Natural Science Foundation of China Grants 31771499, 31571393, 31561130155, 31322032, and 31371359 (to F. W.); Newton Advanced Fellowship NA140075 (to F. W.); Natural Science Foundation of Zhejiang Province Grants LR13C070001 (to F. W.) and LY17C070003 (to H.Y); and Fundamental Research Funds for the Central Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2016, DEV CELL, V36, P487, DOI 10.1016/j.devcel.2016.02.008; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Baron AP, 2016, ELIFE, V5, DOI 10.7554/eLife.12187; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; De Koninck M, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026476; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Gorbsky GJ, 2013, CURR BIOL, V23, pR986, DOI 10.1016/j.cub.2013.08.017; Goto Y, 2017, CURR BIOL, V27, P1005, DOI 10.1016/j.cub.2017.02.066; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hara K, 2014, NAT STRUCT MOL BIOL, V21, P864, DOI 10.1038/nsmb.2880; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Higgins JMG, 2016, DEV CELL, V36, P477, DOI 10.1016/j.devcel.2016.02.019; Higgins JMG, 2013, CURR BIOL, V23, pR883, DOI 10.1016/j.cub.2013.08.026; Hindriksen S, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00112; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kleyman M, 2014, J CELL SCI, V127, P4225, DOI 10.1242/jcs.151613; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lara-Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049041; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Liang C, 2018, EMBO REP, V19, P43, DOI 10.15252/embr.201744737; Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Liu H, 2013, NAT CELL BIOL, V15, P40, DOI 10.1038/ncb2637; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Makrantoni V, 2018, CURR BIOL, V28, pR688, DOI 10.1016/j.cub.2018.05.019; Marston AL, 2015, MOL CELL BIOL, V35, P634, DOI 10.1128/MCB.01176-14; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Meppelink A, 2015, CELL REP, V11, P508, DOI 10.1016/j.celrep.2015.03.052; Morales C, 2018, CURR OPIN CELL BIOL, V52, P51, DOI 10.1016/j.ceb.2018.01.010; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nishiyama T, 2013, P NATL ACAD SCI USA, V110, P13404, DOI 10.1073/pnas.1305020110; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Ouyang ZQ, 2016, MOL CELL, V62, P248, DOI 10.1016/j.molcel.2016.02.033; Ouyang ZQ, 2013, P NATL ACAD SCI USA, V110, P11355, DOI 10.1073/pnas.1304594110; Perera D, 2007, DEV CELL, V13, P566, DOI 10.1016/j.devcel.2007.08.008; Perera D, 2010, J CELL SCI, V123, P653, DOI 10.1242/jcs.059501; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tanno Y, 2010, GENE DEV, V24, P2169, DOI 10.1101/gad.1945310; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Trivedi P, 2016, TRENDS BIOCHEM SCI, V41, P160, DOI 10.1016/j.tibs.2015.11.002; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; van der Lehr P, 2017, ELIFE, V6, DOI 10.7554/eLife.26980; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhou LL, 2017, CURR BIOL, V27, P992, DOI 10.1016/j.cub.2017.02.019	82	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1437	1450		10.1074/jbc.RA118.006046	http://dx.doi.org/10.1074/jbc.RA118.006046			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30498087	Green Published, hybrid			2022-12-26	WOS:000457879200001
J	Vo, TM; Burchett, R; Brun, M; Monckton, EA; Poon, HY; Godbout, R				The Minh Vo; Burchett, Rebecca; Brun, Miranda; Monckton, Elizabeth A.; Poon, Ho-Yin; Godbout, Roseline			Effects of nuclear factor I phosphorylation on calpastatin (CAST) gene variant expression and subcellular distribution in malignant glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; transcription factor; calpain; cancer biology; protein phosphorylation; chromatin immunoprecipitation (ChIP); gene regulation; cysteine protease; gel shifts; immunofluorescence; malignant glioma; nuclear factor I; calpastatin; calcineurin; brain tumor; cell signaling	CALPAIN-MEDIATED PROTEOLYSIS; ACID-BINDING PROTEIN; DNA-BINDING; B-FABP; BRAIN; TRANSCRIPTION; CALCINEURIN; LOCALIZATION; GLIOBLASTOMA; MEMBRANE	Malignant glioma (MG) is the most lethal primary brain tumor. In addition to having inherent resistance to radiation treatment and chemotherapy, MG cells are highly infiltrative, rendering focal therapies ineffective. Genes involved in MG cell migration and glial cell differentiation are up-regulated by hypophosphorylated nuclear factor I (NFI), which is dephosphorylated by the phosphatase calcineurin in MG cells. Calcineurin is cleaved and thereby activated by calpain proteases, which are, in turn, inhibited by calpastatin (CAST). Here, we show that the CAST gene is a target of NFI and has NFI-binding sites in its intron 3 region. We also found that NFI-mediated regulation of CAST depends on NFI's phosphorylation state. We noted that occupation of CAST intron 3 by hypophosphorylated NFI results in increased activation of an alternative promoter. This activation resulted in higher levels of CAST transcript variants, leading to increased levels of CAST protein that lacks the N-terminal XL domain. CAST was primarily present in the cytoplasm of NFI-hypophosphorylated MG cells, with a predominantly perinuclear immunostaining pattern. NFI knockdown in NFI-hypophosphorylated MG cells increased CAST levels at the plasma membrane. These results suggest that NFI plays an integral role in the regulation of CAST variants and CAST subcellular distribution. Along with the previous findings indicating that NFI activity is regulated by calcineurin, these results provide a foundation for further investigations into the possibility of regulatory cross-talk between NFI and the CAST/calpain/calcineurin signaling pathway in MG cells.	[The Minh Vo; Burchett, Rebecca; Brun, Miranda; Monckton, Elizabeth A.; Poon, Ho-Yin; Godbout, Roseline] Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada	University of Alberta	Godbout, R (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	rgodbout@ualberta.ca	; Godbout, Roseline/I-4639-2016	Burchett, Rebecca/0000-0002-0328-2336; Godbout, Roseline/0000-0002-4779-9265	Canadian Institutes of Health Research Grant [130314]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 130314. The authors declare that they have no conflicts of interest with the contents of this article.	ADACHI Y, 1988, BIOL CHEM H-S, V369, P223; Alevizopoulos A, 1997, J BIOL CHEM, V272, P23597, DOI 10.1074/jbc.272.38.23597; Averna M, 2003, CELL MOL LIFE SCI, V60, P2669, DOI 10.1007/s00018-003-3288-0; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Baek KH, 2016, ONCOTARGET, V7, P30831, DOI 10.18632/oncotarget.8791; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Becker-Santos DD, 2017, EBIOMEDICINE, V22, P2, DOI 10.1016/j.ebiom.2017.05.027; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Brun M, 2018, NEOPLASIA, V20, P1023, DOI 10.1016/j.neo.2018.08.007; Brun M, 2013, J BIOL CHEM, V288, P24104, DOI 10.1074/jbc.M113.455832; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Cong M, 1998, J BIOL CHEM, V273, P660, DOI 10.1074/jbc.273.1.660; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; De Tullio R, 2007, ARCH BIOCHEM BIOPHYS, V465, P148, DOI 10.1016/j.abb.2007.05.007; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Ding FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155504; EMORI Y, 1988, J BIOL CHEM, V263, P2364; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Gil-Parrado S, 2003, J BIOL CHEM, V278, P16336, DOI 10.1074/jbc.M208657200; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; GRONOSTAJSKI RM, 1987, NUCLEIC ACIDS RES, V15, P5545, DOI 10.1093/nar/15.14.5545; GRONOSTAJSKI RM, 1986, NUCLEIC ACIDS RES, V14, P9117, DOI 10.1093/nar/14.22.9117; Heng YHE, 2012, NEUROSIGNALS, V20, P159, DOI 10.1159/000330651; Kallenberg K, 2013, J NEURO-ONCOL, V112, P217, DOI 10.1007/s11060-013-1049-y; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KRUSE U, 1994, FEBS LETT, V348, P46, DOI 10.1016/0014-5793(94)00585-0; Lal S, 2012, J NEUROSCI RES, V90, P769, DOI 10.1002/jnr.22794; LANE RD, 1992, EXP CELL RES, V203, P5, DOI 10.1016/0014-4827(92)90033-5; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; LEE WJ, 1992, J BIOL CHEM, V267, P8437; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; NILSSON E, 1990, NEUROBIOL AGING, V11, P425, DOI 10.1016/0197-4580(90)90009-O; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; Ogura K, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-97; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Parr T, 2001, ARCH BIOCHEM BIOPHYS, V395, P1, DOI 10.1006/abbi.2001.2546; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Shankar A, 2014, CHIN J CANCER, V33, P148, DOI 10.5732/cjc.013.10095; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; Takano J, 2000, J BIOCHEM, V128, P83, DOI 10.1093/oxfordjournals.jbchem.a022733; Tangmansakulchai K, 2016, MITOCHONDRION, V30, P151, DOI 10.1016/j.mito.2016.07.009; Tremper-Wells B, 2005, J BIOL CHEM, V280, P2165, DOI 10.1074/jbc.M410591200; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200	68	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1173	1188		10.1074/jbc.RA118.004787	http://dx.doi.org/10.1074/jbc.RA118.004787			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504225	Green Published, hybrid			2022-12-26	WOS:000457879500010
J	Klyuyeva, A; Tuganova, A; Kedishvili, N; Popov, KM				Klyuyeva, Alla; Tuganova, Alina; Kedishvili, Natalia; Popov, Kirill M.			Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyruvate dehydrogenase complex (PDC); pyruvate dehydrogenase kinase (PDC kinase); mitochondria; carbohydrate metabolism; protein phosphorylation; carbohydrate metabolism; mitochondria; oxidative decarboxylation of pyruvate; protein kinase; protein phosphorylation; metabolic flux	GLUCOSE-HOMEOSTASIS; METABOLISM; INHIBITION; MECHANISMS; HEART; PHOSPHORYLATION; PROTEIN; PHOSPHATASE; ISOENZYME; ISOFORMS	The pyruvate dehydrogenase complex (PDC) is a multienzyme assembly that converts pyruvate to acetyl-CoA. As pyruvate and acetyl-CoA play central roles in cellular metabolism, understanding PDC regulation is pivotal to understanding the larger metabolic network. The activity of mammalian PDC is regulated through reversible phosphorylation governed by at least four isozymes of pyruvate dehydrogenase kinase (PDK). Deciphering which kinase regulates PDC in organisms at specific times or places has been challenging. In this study, we analyzed mouse strains carrying targeted mutations of individual isozymes to explore their role in regulating PDC activity. Analysis of protein content of PDK isozymes in major metabolic tissues revealed that PDK1 and PDK2 were ubiquitously expressed, whereas PDK3 and PDK4 displayed a rather limited tissue distribution. Measurement of kinase activity showed that PDK1 is the principal isozyme regulating hepatic PDC. PDK2 was largely responsible for inactivation of PDC in tissues of muscle origin and brown adipose tissue (BAT). PDK3 was the principal kinase regulating pyruvate dehydrogenase activity in kidney and brain. In a well-fed state, the tissue levels of PDK4 protein were fairly low. In most tissues tested, PDK4 ablation had little effect on the overall rates of inactivation of PDC in kinase reaction. Taken together, these data strongly suggest that the activity of PDC is regulated by different isozymes in different tissues. Furthermore, it appears that the overall flux through PDC in a given tissue largely reflects the properties of the PDK isozyme that is principally responsible for the regulation of PDC activity in that tissue.	[Tuganova, Alina; Kedishvili, Natalia; Popov, Kirill M.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, KAUL 440A,720 20th St S, Birmingham, AL 35294 USA; [Tuganova, Alina; Kedishvili, Natalia; Popov, Kirill M.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, KAUL 440A,720 20th St S, Birmingham, AL 35294 USA; [Klyuyeva, Alla] Avanti Polar Lipids Inc, 700 Ind Pk Dr, Alabaster, AL 35007 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Popov, KM (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, KAUL 440A,720 20th St S, Birmingham, AL 35294 USA.; Popov, KM (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, KAUL 440A,720 20th St S, Birmingham, AL 35294 USA.	kpopov@uab.edu			NIGMS, National Institutes of Health [GM51262]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant GM51262. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Desagher S, 1997, J NEUROSCI, V17, P9060; Dunford EC, 2011, AM J PHYSIOL-REG I, V300, pR1487, DOI 10.1152/ajpregu.00498.2010; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; Hollidge-Horvat MG, 1999, AM J PHYSIOL-ENDOC M, V277, pE647, DOI 10.1152/ajpendo.1999.277.4.E647; HOLNESS MJ, 1989, BIOCHEM J, V258, P529, DOI 10.1042/bj2580529; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jeoung NH, 2012, BIOCHEM J, V443, P829, DOI 10.1042/BJ20112197; Karpova T, 2003, BBA-PROTEINS PROTEOM, V1652, P126, DOI 10.1016/j.bbapap.2003.08.010; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YJ, 2003, MICROVASC RES, V66, P91, DOI 10.1016/S0026-2862(03)00052-9; LINN TC, 1969, P NATL ACAD SCI USA, V64, P227, DOI 10.1073/pnas.64.1.227; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Mohanty I, 2002, MOL CELL BIOCHEM, V238, P129, DOI 10.1023/A:1019961922260; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI DOI 10.1074/jbc.RA117.001068; Ohlrogge J, 2000, BIOCHEM SOC T, V28, P567, DOI 10.1042/BST0280567; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Perrin A, 2002, BIOCHIMIE, V84, P1003, DOI 10.1016/S0300-9084(02)00008-1; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pithukpakorn M, 2005, MOL GENET METAB, V85, P243, DOI 10.1016/j.ymgme.2005.06.006; Popov K M, 1991, Protein Expr Purif, V2, P278, DOI 10.1016/1046-5928(91)90084-V; POPOV KM, 1994, J BIOL CHEM, V269, P29720; PRIESTMAN DA, 1992, FEBS LETT, V308, P83, DOI 10.1016/0014-5793(92)81056-R; Rajendran P, 2011, CRIT REV BIOCHEM MOL, V46, P181, DOI 10.3109/10409238.2011.557713; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; SALE GJ, 1982, BIOCHEM J, V203, P99, DOI 10.1042/bj2030099; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Story J A, 1984, Lab Res Methods Biol Med, V10, P217; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2003, OBES RES, V11, P167, DOI 10.1038/oby.2003.26; SUGDEN PH, 1978, BIOCHEM J, V169, P433, DOI 10.1042/bj1690433; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; TONKS NK, 1982, EUR J BIOCHEM, V122, P549; Wagman AS, 2001, CURR PHARM DESIGN, V7, P417, DOI 10.2174/1381612013397915; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Woolbright BL, 2018, MOL CANCER THER, V17, P2004, DOI 10.1158/1535-7163.MCT-18-0063; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197	51	19	20	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					838	851		10.1074/jbc.RA118.006433	http://dx.doi.org/10.1074/jbc.RA118.006433			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482839	hybrid, Green Published			2022-12-26	WOS:000458670200010
J	Feng, CL; Li, J; Li, X; Li, KL; Luo, K; Liao, XS; Liu, T				Feng, Chong-ling; Li, Jin; Li, Xue; Li, Ke-lin; Luo, Kun; Liao, Xing-sheng; Liu, Tao			Characterization and mechanism of lead and zinc biosorption by growing Verticillium insectorum J3	PLOS ONE			English	Article							HEAVY-METALS; PHANEROCHAETE-CHRYSOSPORIUM; RISK-ASSESSMENT; REMOVAL; CHITOSAN; BIOACCUMULATION; NANOPARTICLES; RESISTANCE; REDUCTION; CADMIUM	Verticillium insectorum J3 was isolated from a local lead-zinc deposit tailing, and its biosorption characteristics and reaction to the toxicities of different Pb(II) and Zn(II) concentrations were investigated. SEM, FTIR, a pH test and a desorption experiment were carried out to identify a possible mechanism. The biosorption of J3 presented an inhibition trend at low concentrations (25-75 mg L-1) and promotion at high concentrations (100-300 mg L-1). J3 absorbed Pb(II) prior to Zn(II) and produced alkaline substances, while mycelial and pellet morphology modifications were important for the removal of Pb(II) and Zn(II) under different stressful conditions (SEM results). Both intracellular accumulation and extracellular absorption may contribute to the removal of Pb(II) at lower concentrations (25-50 mg L-1), although mainly extracellular biosorption occurred at higher concentrations (75-300 mg L-1). However, Zn(II) bioaccumulation occurred at all concentrations assayed. Verticillium insectorum J3 may have evolved active defenses to alleviate the toxicity of heavy metals and proved to be a highly efficient biosorbent, especially for Pb(II) at high concentrations. This study is a useful reference for the development of biotreatment technologies to mitigate heavy metal waste.	[Feng, Chong-ling; Li, Jin; Li, Ke-lin] Cent South Univ Forestry & Technol, Inst Environm Sci & Engn Res, Changsha, Hunan, Peoples R China; [Li, Xue; Luo, Kun; Liao, Xing-sheng] Changsha Univ, Dept Biol & Environm Engn, Changsha, Hunan, Peoples R China; [Liu, Tao] Hunan Guozhen Environm Technol Co Ltd, Changsha, Hunan, Peoples R China	Central South University of Forestry & Technology; Changsha University	Li, X; Luo, K (corresponding author), Changsha Univ, Dept Biol & Environm Engn, Changsha, Hunan, Peoples R China.	gina0131@163.com; luokun@ccsu.edu.cn			National Natural Science Foundation of China [51308076, 51709285]; Hunan Provincial Science and Technology Department grant [2017SK2243, 2018JJ3564]; Education Department of Hunan Province grant [15A018]; Hunan Guozhen Environmental Technology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Science and Technology Department grant; Education Department of Hunan Province grant; Hunan Guozhen Environmental Technology Co., Ltd	The funder (Hunan Guozhen Environmental Technology Co., Ltd) provided support in the form of salaries for author [TL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section. This work was supported by National Natural Science Foundation of China grant 51308076 to XL, National Natural Science Foundation of China grant 51709285 to CF, Hunan Provincial Science and Technology Department grant 2017SK2243 to XL, Hunan Provincial Science and Technology Department grant 2018JJ3564 to KL, and Education Department of Hunan Province grant 15A018 to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldrian P, 2003, ENZYME MICROB TECH, V32, P78, DOI 10.1016/S0141-0229(02)00245-4; Borremans B, 2001, J BACTERIOL, V183, P5651, DOI 10.1128/JB.183.19.5651-5658.2001; Cabuk A, 2006, J HAZARD MATER, V136, P317, DOI 10.1016/j.jhazmat.2005.12.019; Fan T, 2008, J HAZARD MATER, V160, P655, DOI 10.1016/j.jhazmat.2008.03.038; Fathi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173877; Fomina M, 2014, BIORESOURCE TECHNOL, V160, P3, DOI 10.1016/j.biortech.2013.12.102; Gao HM, 2005, CHIN J SCH HLTH, V26, P24; Govarthanan M, 2013, CHEMOSPHERE, V90, P2267, DOI 10.1016/j.chemosphere.2012.10.038; Guo HJ, 2010, BIORESOURCE TECHNOL, V101, P8599, DOI 10.1016/j.biortech.2010.06.085; Huang DL, 2013, ADV MATER RES-SWITZ, V779-780, P1674, DOI 10.4028/www.scientific.net/AMR.779-780.1674; Huang DL, 2008, ENVIRON SCI TECHNOL, V42, P4946, DOI 10.1021/es800072c; Huang F, 2014, CHEMOSPHERE, V109, P134, DOI 10.1016/j.chemosphere.2014.01.066; Jiang L, 2017, J MOL LIQ, V247, P230, DOI 10.1016/j.molliq.2017.09.117; Jiang MQ, 2010, DESALINATION, V252, P33, DOI 10.1016/j.desal.2009.11.005; Jiang Y, 2016, INT J BIOL MACROMOL, V82, P702, DOI 10.1016/j.ijbiomac.2015.11.021; Li DD, 2017, J ENVIRON MANAGE, V196, P8, DOI 10.1016/j.jenvman.2017.02.076; LI F, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/SU10010091; Li F, 2018, PROCESS SAF ENVIRON, V116, P169, DOI 10.1016/j.psep.2018.02.007; Li F, 2017, ENVIRON GEOCHEM HLTH, V39, P923, DOI 10.1007/s10653-016-9864-7; Li X, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010092; Li X, 2011, DESALINATION, V276, P136, DOI 10.1016/j.desal.2011.03.041; Luo SL, 2011, CHEMOSPHERE, V85, P1130, DOI 10.1016/j.chemosphere.2011.07.053; Mahmoud ME, 2015, INT J BIOL MACROMOL, V81, P672, DOI 10.1016/j.ijbiomac.2015.08.063; Munoz AJ, 2012, CHEM ENG J, V210, P325, DOI 10.1016/j.cej.2012.09.007; Naik MM, 2013, LETT APPL MICROBIOL, V56, P99, DOI 10.1111/lam.12026; Pagnanelli F, 2013, CHEM ENG J, V231, P94, DOI 10.1016/j.cej.2013.07.013; Cazon JP, 2013, J ENVIRON MANAGE, V129, P423, DOI 10.1016/j.jenvman.2013.07.011; Ren GM, 2015, ECOTOX ENVIRON SAFE, V117, P141, DOI 10.1016/j.ecoenv.2015.03.033; Roane TM, 1999, MICROB ECOL, V37, P218, DOI 10.1007/s002489900145; Sabyasachi Chatterjee, 2012, Advances in Bioscience and Biotechnology, V3, P290, DOI 10.4236/abb.2012.33041; Saharan V, 2015, INT J BIOL MACROMOL, V75, P346, DOI 10.1016/j.ijbiomac.2015.01.027; Sari A, 2009, J HAZARD MATER, V164, P1004, DOI 10.1016/j.jhazmat.2008.09.002; Tonietto AE, 2014, WATER RES, V49, P381, DOI 10.1016/j.watres.2013.10.025; Xu P, 2016, ECOL ENG, V87, P150, DOI 10.1016/j.ecoleng.2015.11.029; Zhang Y, 2007, BIOSENS BIOELECTRON, V22, P2121, DOI 10.1016/j.bios.2006.09.030; Zhou J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191139; Zhu YH, 2012, J HAZARD MATER, V221, P155, DOI 10.1016/j.jhazmat.2012.04.026	37	8	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0203859	10.1371/journal.pone.0203859	http://dx.doi.org/10.1371/journal.pone.0203859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513078	Green Submitted, Green Published, gold			2022-12-26	WOS:000452204800002
J	Guo, GF; Chen, XX; He, WZ; Wang, HH; Wang, YX; Hu, PL; Rong, YM; Fan, L; Xia, LP				Guo, Guifang; Chen, Xiuxing; He, Wenzhuo; Wang, Haohua; Wang, Yixing; Hu, Pili; Rong, Yuming; Fan, Lei; Xia, Liangping			Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; LYMPHOCYTE RATIO; SURVIVAL; CEA; STATISTICS; THERAPY; IMPACT	Purpose To establish three novel prognostic nomograms with inflammatory factors for advanced colorectal cancer (ACRC), right-sided colon cancer (RSCC) and left-sided colorectal cancer (LSCRC) according to real world data. Materials and methods ACRC patients receiving medicine therapy from January 1st, 2005 to September 31th, 2015 in Sun Yat-sen University Cancer Center were enrolled. Inflammatory indicators such as the neutrophil-to-lymphocyte ratio (NLR), the platelet-lymphocyte ratio (PLR), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), lactate dehydrogenase (LDH) and Creactive protein (CRP) were analyzed for establishing nomograms predicting overall survival (OS). Concordance index (C-index) determined predictive accuracy and discriminative ability. Results Our study selected 807 ACRC patients, 29.6% RSCC and 70.4% LSCRC. Median OS was 23.36 months. Patients at lower level of NLR, PLR, CEA, CA 19-9, LDH and CRP showed longer OS (P < 0.001). For all patients, pathological grade (P = 0.018), treatments (P = 0.042), sidedness (P = 0.003), NLR (P < 0.001), CA 19-9 (P < 0.001), LDH (P < 0.001) and CRP (P = 0.0012) contributed to OS independently. For RSCC, pathological grade (P = 0.022), CA 19-9 (P < 0.001), LDH (P < 0.001) and CRP (P = 0.001) were significantly related with OS. For LSCRC patients, treatments (cetuximab vs chemotherapy: P = 0.008; bevacizumab vs chemotherapy: P = 0.166), NLR (P < 0.001), CA 19-9 (P = 0.030) and LDH (P < 0.001) were independent factors for OS. Final models showed acceptable internal validity with C-indexes of 0.687, 0.697 and 0.667 in all, RSCC and LSCRC patients. Conclusions Inflammatory factors enrolled in the proposed nomograms showed accurately individualized prognostic prediction, and prognostic factors for RSCC and LSCRC were different.	[Guo, Guifang; Chen, Xiuxing; He, Wenzhuo; Wang, Haohua; Wang, Yixing; Hu, Pili; Rong, Yuming; Xia, Liangping] Sun Yat Sen Univ, Canc Ctr, VIP Reg, Guangzhou, Guangdong, Peoples R China; [Guo, Guifang; Chen, Xiuxing; He, Wenzhuo; Wang, Haohua; Wang, Yixing; Hu, Pili; Rong, Yuming; Xia, Liangping] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Guo, Guifang; Chen, Xiuxing; He, Wenzhuo; Wang, Haohua; Wang, Yixing; Hu, Pili; Rong, Yuming; Xia, Liangping] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Fan, Lei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Guo, GF; Xia, LP (corresponding author), Sun Yat Sen Univ, Canc Ctr, VIP Reg, Guangzhou, Guangdong, Peoples R China.; Guo, GF; Xia, LP (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Guo, GF; Xia, LP (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	gguifang@163.com; xialp@sysucc.org.cn	Wang, Yixing/HDN-4897-2022	guo, gui fang/0000-0002-6283-7266	Natural Science Foundation of Guangdong Province [2017A030313685]; Guangdong Provincial Traditional Chinese Medicine Bureau of scientific research projects [20171069]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Traditional Chinese Medicine Bureau of scientific research projects	This work was funded by Natural Science Foundation of Guangdong Province (grant number No. 2017A030313685, 2017), and Guangdong Provincial Traditional Chinese Medicine Bureau of scientific research projects (grant number No. 20171069, 2017).	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Battersby NJ, 2018, GUT, V67, P688, DOI 10.1136/gutjnl-2016-312695; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chen ZY, 2015, BRIT J CANCER, V112, P1088, DOI 10.1038/bjc.2015.61; Chiang SF, 2012, INT J COLORECTAL DIS, V27, P1347, DOI 10.1007/s00384-012-1459-x; COLLINS JJ, 1971, NEW ENGL J MED, V285, P175, DOI 10.1056/NEJM197107152850313; CORMAN M, 1994, JAMA-J AM MED ASSOC, V271, P346, DOI 10.1001/jama.1994.03510290027023; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dienstmann R, 2017, NAT REV CANCER, V17, P79, DOI 10.1038/nrc.2016.126; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Haas M, 2013, J CANCER RES CLIN, V139, P681, DOI 10.1007/s00432-012-1371-3; Han DS, 2012, J CLIN ONCOL, V30, P3834, DOI 10.1200/JCO.2012.41.8343; Hoang T, 2005, J CLIN ONCOL, V23, P175, DOI 10.1200/JCO.2005.04.177; Holch JW, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.3586; Huang YQ, 2016, J CLIN ONCOL, V34, P2157, DOI 10.1200/JCO.2015.65.9128; Kattan MW, 2003, J CLIN ONCOL, V21, P3647, DOI 10.1200/JCO.2003.01.240; Liang WH, 2015, J CLIN ONCOL, V33, P861, DOI 10.1200/JCO.2014.56.6661; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; LOKICH JJ, 1984, J CLIN ONCOL, V2, P181, DOI 10.1200/JCO.1984.2.3.181; NOVIS BH, 1986, J CLIN ONCOL, V4, P987, DOI 10.1200/JCO.1986.4.6.987; Passardi A, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0139468, 10.1371/journal.pone.0134732]; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Qin SK, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.4_suppl.683; Scartozzi M, 2012, BRIT J CANCER, V106, P799, DOI 10.1038/bjc.2012.17; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Silvestris N, 2015, EXPERT OPIN BIOL TH, V15, P155, DOI 10.1517/14712598.2015.986452; Tampellini M, 2015, TUMOR BIOL, V36, P1519, DOI 10.1007/s13277-014-2693-3; Tan DW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003837; Tas F, 2014, CANCER CHEMOTH PHARM, V73, P1163, DOI 10.1007/s00280-014-2450-8; Venook AP, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3504; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Yang HI, 2010, J CLIN ONCOL, V28, P2437, DOI 10.1200/JCO.2009.27.4456	35	11	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208547	10.1371/journal.pone.0208547	http://dx.doi.org/10.1371/journal.pone.0208547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513126	Green Published, Green Submitted, gold			2022-12-26	WOS:000452204800038
J	Cole, SL; Robinson, MJF; Berridge, KC				Cole, Shannon L.; Robinson, Mike J. F.; Berridge, Kent C.			Optogenetic self-stimulation in the nucleus accumbens: D1 reward versus D2 ambivalence	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; DOPAMINE D-3 RECEPTORS; BRAIN-STIMULATION; STRIATAL NEURONS; COCAINE; SHELL; EXPRESSION; MOTIVATION; BEHAVIOR; FOOD	The nucleus accumbens (NAc) contains multiple subpopulations of medium spiny neurons (MSNs). One subpopulation expresses D1-type dopamine receptors, another expresses D2-type receptors, and a third expresses both. The relative roles in NAc of D1 neurons versus D2 neurons in appetitive motivation were assessed here. Specifically, we asked whether D1-Cre mice would instrumentally seek optogenetic self-stimulation specifically targeted at D1 MSNs in NAc, and similarly if D2-Cre mice would self-stimulate D2 neurons in NAc. Mice were implanted with Cre-targeted channelrhodopsin (ChR2) virus and optic fibers in NAc. Subsequently, mice could earn brief NAc laser illuminations by actively touching a metal spout in one task, or by going to a particular location in a separate task. Results indicated that D1 neuronal excitation in NAc supported intense self-stimulation in both tasks. D1-Cre mice earned hundreds to thousands of spout-touches per half-hour session, and also sought out locations that delivered NAc laser to excite D1 MSNs. By comparison, D2 ChR2 mice showed lower but still positive levels of self-stimulation in the spout-touch task, earning dozens to hundreds of NAc laser illuminations. However, in the location task, D2 mice failed to show positive self-stimulation. If anything, a few D2 individuals gradually avoided the laser location. Brain-wide measures indicated that D1 and D2 stimulations in NAc recruited heavily overlapping patterns of Fos activation in distant limbic structures. These results confirm that excitation of D1 MSNs in NAc supports strong incentive motivation to self-stimulate. They also suggest that excitation of D2 neurons in NAc supports self-stimulation under some conditions, but fails under others and possibly may even shift to negative avoidance.	[Cole, Shannon L.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Robinson, Mike J. F.] Wesleyan Univ, Dept Psychol, Middletown, CT USA; [Berridge, Kent C.] Univ Michigan, Dept Psychol, Ann Abor, MI USA	University System of Maryland; University of Maryland Baltimore; Wesleyan University; University of Michigan System; University of Michigan	Cole, SL (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	shannoncole@som.umaryland.edu	Core, Vector/CAF-4832-2022; Berridge, Kent C/C-1525-2009	Berridge, Kent C/0000-0002-6031-2626	National Institutes of Health [MH63649, DA015188]; National Institute of Health [DA007267]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007267, R01DA015188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants MH63649 (https://www.nimh.nih.gov/index.shtml) and DA015188 (https://www.drugabuse.gov/) for Kent Berridge. Shannon Cole was supported by National Institute of Health grant DA007267 (https://www.drugabuse.gov/).	Bachtell RK, 2005, PSYCHOPHARMACOLOGY, V183, P41, DOI 10.1007/s00213-005-0133-1; Bari AA, 2005, NEUROSCIENCE, V135, P959, DOI 10.1016/j.neuroscience.2005.06.048; Bernal SY, 2008, BEHAV BRAIN RES, V190, P59, DOI 10.1016/j.bbr.2008.02.003; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; BRENE S, 1990, EXP BRAIN RES, V83, P96; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Castro DC, 2016, NEUROPSYCHOPHARMACOL, V41, P2101, DOI 10.1038/npp.2016.10; Castro DC, 2014, J NEUROSCI, V34, P4239, DOI 10.1523/JNEUROSCI.4458-13.2014; Collins AL, 2016, NEUROPSYCHOPHARMACOL, V41, P2830, DOI 10.1038/npp.2016.81; DeBundel D, 2016, MOL PSYCHIAT; Faure A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011223; Gallo EF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03272-2; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hamlin AS, 2006, NEUROSCIENCE, V143, P25, DOI 10.1016/j.neuroscience.2006.07.035; Heidbreder CA, 2005, BRAIN RES REV, V49, P77, DOI 10.1016/j.brainresrev.2004.12.033; Hernandez G, 2012, J NEUROSCI, V32, P11032, DOI 10.1523/JNEUROSCI.1051-12.2012; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Ikemoto S, 2014, NEUROPHARMACOLOGY, V76, P329, DOI 10.1016/j.neuropharm.2013.04.031; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Koo JW, 2014, NEUROPSYCHOPHARMACOL; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2011, CURR OPIN NEUROBIOL, V21, P433, DOI 10.1016/j.conb.2011.02.010; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kupchik YM, 2015, NAT NEUROSCI, V18, P1230, DOI 10.1038/nn.4068; Larson EB, 2015, J NEUROSCI, V35, P3537, DOI 10.1523/JNEUROSCI.1524-14.2015; LEMOINE C, 1990, NEUROSCI LETT, V117, P248, DOI 10.1016/0304-3940(90)90671-U; Lex A, 2008, LEARN MEMORY, V15, P483, DOI 10.1101/lm.978708; Liao RM, 2008, PHARMACOL BIOCHEM BE, V89, P367, DOI 10.1016/j.pbb.2008.01.009; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Meredith GE, 2008, BRAIN STRUCT FUNCT, V213, P17, DOI 10.1007/s00429-008-0175-3; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Mueller K, 2015, NEUROIMAGE, V116, P68, DOI 10.1016/j.neuroimage.2015.05.006; Natsubori A, 2017, J NEUROSCI; Nunes EJ, 2013, NEUROSCI BIOBEHAV R, V37, P2015, DOI 10.1016/j.neubiorev.2013.04.002; O'Connor EC, 2015, NEURON, V88, P553, DOI 10.1016/j.neuron.2015.09.038; O'Sullivan SS, 2009, CNS DRUGS, V23, P157, DOI 10.2165/00023210-200923020-00005; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Perreault ML, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00031; Perreault ML, 2011, CNS NEUROSCI THER, V17, P52, DOI 10.1111/j.1755-5949.2010.00228.x; Porter-Stransky KA, 2013, EUR J NEUROSCI, V38, P2572, DOI 10.1111/ejn.12253; Poyraz FC, 2016, J NEUROSCI, V36, P5988, DOI 10.1523/JNEUROSCI.0444-16.2016; Richard JM, 2011, J NEUROSCI, V31, P12866, DOI 10.1523/JNEUROSCI.1339-11.2011; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Rolls E T, 1975, Prog Neurobiol, V3, P73; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Saunders BT, 2013, J NEUROSCI, V33, P13989, DOI 10.1523/JNEUROSCI.0450-13.2013; Schmidt HD, 2006, EUR J NEUROSCI, V23, P219, DOI 10.1111/j.1460-9568.2005.04524.x; Soares-Cunha C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11829; Song R, 2013, NEUROPHARMACOLOGY, V72, P82, DOI 10.1016/j.neuropharm.2013.04.042; Steinberg EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094771; Trifilieff P, 2013, MOL PSYCHIATR, V18, P1025, DOI 10.1038/mp.2013.57; VALENSTEIN ES, 1963, AM PSYCHOL, V18, P436; Vicente AM, 2016, CURR BIOL, V26, pR267, DOI 10.1016/j.cub.2016.02.036; Volkow ND, 2016, NEW ENGL J MED, V374, P363, DOI 10.1056/NEJMra1511480; Vuust P, 2010, INTERDISCIPL SCI REV, V35, P166, DOI 10.1179/030801810X12723585301192; Wakabayashi KT, 2004, BEHAV BRAIN RES, V154, P19, DOI 10.1016/j.bbr.2004.01.013; Warlow SM, 2017, J NEUROSCI, V37, P8330, DOI 10.1523/JNEUROSCI.3141-16.2017; WISE RA, 1985, BEHAV BRAIN SCI, V8, P178, DOI 10.1017/S0140525X00020306; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Xi ZX, 2013, ADDICT BIOL, V18, P665, DOI 10.1111/j.1369-1600.2012.00486.x; Yoo JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13697; Zatorre RJ, 2015, ANN NY ACAD SCI, V1337, P202, DOI 10.1111/nyas.12677	63	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207694	10.1371/journal.pone.0207694	http://dx.doi.org/10.1371/journal.pone.0207694			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496206	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800043
J	Iovino, C; Fossarello, M; Giannaccare, G; Pellegrini, M; Braghiroli, M; Demarinis, G; Napoli, PE				Iovino, Claudio; Fossarello, Maurizio; Giannaccare, Giuseppe; Pellegrini, Marco; Braghiroli, Mirco; Demarinis, Giuseppe; Napoli, Pietro Emanuele			Corneal endothelium features in Fuchs' Endothelial Corneal Dystrophy: A preliminary 3D anterior segment optical coherence tomography study	PLOS ONE			English	Article							IN-VIVO; LOCUS; OCT	Purpose To evaluate the feasibility of 3D anterior segment optical coherence tomography (AS-OCT) for the detection of corneal endothelial features in patients with Fuchs' Endothelial Corneal Dystrophy (FECD). Methods Twenty patients with clinical diagnosis of FECD (group A), and 20 control subjects (group B) were enrolled. In all patients a complete ophthalmological examination was performed, including best corrected visual acuity (BCVA), slit lamp examination for subjective grading of FECD and corneal endothelial specular microscopy. A 512x128 AS-OCT cube centered on the corneal apex was performed, and then the inner surface of the cornea was visualized and analyzed individually. Results Overall, the study participants were adults (mean age was 57.35 +/- 8.45 years [mean +/- SD] 80% female) with a BCVA ranged from 1.3 to 0 LogMAR. The OCT analysis disclosed three different patterns of the corneal endothelium (1, 2, 3) according to the signal distribution and the level of reflectivity: a homogenous, hypo-reflective surface (pattern 1); the presence of hyper-reflective orange-yellowish points (pattern 2); and a mottled appearance with a variable number of hyper-reflective areas (pattern 3). The distributions of these morphological models in the two populations were as follows: patterns 1, 2 and 3 were observed respectively in 0%, 80%, and 20% of patients in group A, and in 80%, 20% and 0% of subjects in group B. Correlation analysis unveiled a positive relationship between OCT corneal endothelium reflectivity and the clinical severity score (assessed with biomicroscopy), as well as an inverse relationship between the OCT pattern and the integrity of corneal endothelium. Conclusion 3D AS-OCT is a useful tool in investigation of endothelial features and therefore may represent a valuable support in the setting of FECD diagnosis and staging.	[Iovino, Claudio; Fossarello, Maurizio; Braghiroli, Mirco; Demarinis, Giuseppe; Napoli, Pietro Emanuele] Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy; [Fossarello, Maurizio] Azienda Osped Univ Cagliari, San Giovanni di Dio Hosp, Clin Oculist, Cagliari, Italy; [Giannaccare, Giuseppe; Pellegrini, Marco] Univ Bologna, S Orsola Malpighi Univ Hosp, Ophthalmol Unit, Bologna, Italy	University of Cagliari; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Napoli, PE (corresponding author), Univ Cagliari, Dept Surg Sci, Eye Clin, Cagliari, Italy.	pietronapoli@ymail.com	Fossarello, Maurizio/AAD-8235-2021; Iovino, Claudio/O-7680-2019; Pellegrini, Marco/T-3694-2019; Braghiroli, Mirco/AAV-2965-2020; Napoli, Pietro/AAP-8423-2020; Fossarello, Maurizio/G-2032-2015	Iovino, Claudio/0000-0003-1984-0555; Pellegrini, Marco/0000-0002-6419-6941; Braghiroli, Mirco/0000-0003-1025-7822; Napoli, Pietro Emanuele/0000-0001-7020-0823; Demarinis, Giuseppe/0000-0002-9298-1963; Fossarello, Maurizio/0000-0003-1520-7760				ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; Chu HY, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/8747013; Elhalis H, 2010, OCUL SURF, V8, P173, DOI 10.1016/S1542-0124(12)70232-X; Fuchs E, 1910, GRAEFES ARCH CLIN EX, V76, P478, DOI DOI 10.1007/BF01986362; Ghouali W, 2015, J FR OPHTALMOL, V38, P388, DOI 10.1016/j.jfo.2014.10.015; Giasson CJ, 2007, OPHTHALMOLOGY, V114, P1469, DOI 10.1016/j.ophtha.2006.11.022; Kim TI, 2010, BRIT J OPHTHALMOL, V94, P341, DOI 10.1136/bjo.2009.164525; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Louttit MD, 2012, CORNEA, V31, P26, DOI 10.1097/ICO.0b013e31821c9b8f; Napoli PE, 2017, INT MED CASE REP J, V10, P247, DOI 10.2147/IMCRJ.S138786; Napoli PE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165558; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P3179, DOI 10.1167/iovs.13-13613; Nowinska AK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/805367; Pousen ET, 2014, J PROTEOME RES, V13, P4659, DOI 10.1021/pr500252r; Repp DJ, 2013, OPHTHALMOLOGY, V120, P687, DOI 10.1016/j.ophtha.2012.09.022; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; ROSENBLUM P, 1980, AM J OPHTHALMOL, V90, P455, DOI 10.1016/S0002-9394(14)75011-1; Shih CY, 2009, AM J OPHTHALMOL, V147, P796, DOI 10.1016/j.ajo.2008.12.015; Siebelmann S, 2018, SURV OPHTHALMOL, V63, P365, DOI 10.1016/j.survophthal.2017.08.001; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Vedana G, 2016, CLIN OPHTHALMOL, V10, P321, DOI 10.2147/OPTH.S83467; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; WILSON SE, 1988, CORNEA, V7, P2; Wright AF, 2010, NEW ENGL J MED, V363, P1072, DOI 10.1056/NEJMe1007495	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207891	10.1371/journal.pone.0207891	http://dx.doi.org/10.1371/journal.pone.0207891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496218	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800060
J	Yanala, UR; Johanning, JM; Pipinos, II; High, RR; Larsen, G; Velander, WH; Carlson, MA				Yanala, Ujwal R.; Johanning, Jason M.; Pipinos, Iraklis I.; High, Robin R.; Larsen, Gustavo; Velander, William H.; Carlson, Mark A.			Fluid administration rate for uncontrolled intraabdominal hemorrhage in swine	PLOS ONE			English	Article							HYPOTENSIVE RESUSCITATION; LACTATED RINGERS; TRAUMA PATIENTS; ANIMAL-MODEL; BLOOD-LOSS; COAGULOPATHIC SWINE; HYPERTONIC SALINE; IMPROVES SURVIVAL; CLOSED-ABDOMEN; SHOCK	Background We hypothesized that slow crystalloid resuscitation would result in less blood loss and a smaller hemoglobin decrease compared to a rapid resuscitation during uncontrolled hemorrhage. Methods Anesthetized, splenectomized domestic swine underwent hepatic lobar hemitransection. Lactated Ringers was given at 150 or 20 mL/min IV (rapid vs. slow, respectively, N = 12 per group; limit of 100 mL/kg). Primary endpoints were blood loss and serum hemoglobin; secondary endpoints included survival, vital signs, coagulation parameters, and blood gases. Results The slow group had a less blood loss (1.6 vs. 2.7 L, respectively) and a higher final hemoglobin concentration (6.0 vs. 3.4 g/dL). Conclusions Using a fixed volume of crystalloid resuscitation in this porcine model of uncontrolled intraabdominal hemorrhage, a slow IV infusion rate produced less blood loss and a smaller hemoglobin decrease compared to rapid infusion.	[Yanala, Ujwal R.; Johanning, Jason M.; Pipinos, Iraklis I.; Carlson, Mark A.] Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68588 USA; [Yanala, Ujwal R.; Johanning, Jason M.; Pipinos, Iraklis I.; Carlson, Mark A.] VA Nebraska Western Iowa Hlth Care Syst, Dept Surg, Omaha, NE 68105 USA; [High, Robin R.] Univ Nebraska, Med Ctr, Dept Biostat, Omaha, NE USA; [Larsen, Gustavo; Velander, William H.] Univ Nebraska, Coll Engn, Dept Chem & Biomol Engn, Lincoln, NE USA; [Carlson, Mark A.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68588 USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center	Carlson, MA (corresponding author), Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68588 USA.; Carlson, MA (corresponding author), VA Nebraska Western Iowa Hlth Care Syst, Dept Surg, Omaha, NE 68105 USA.; Carlson, MA (corresponding author), Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68588 USA.	macarlso@unmc.edu	yanala, ujwal/AGE-1225-2022	Pipinos, Iraklis/0000-0001-6873-6346; Carlson, Mark/0000-0002-8113-9199; Yanala, Ujwal/0000-0002-1344-9208	United States Army [W81XWH-11-1-0836]	United States Army(United States Department of DefenseUnited States Army)	This work was supported by a grant from the United States Army (W81XWH-11-1-0836).	Aksu U, 2012, RESUSCITATION, V83, P767, DOI 10.1016/j.resuscitation.2011.11.022; American Veterinary Medical Association, 2013, AVMA GUIDELINES EUTH; [Anonymous], 2011, GUIDE CARE USE LAB A; Bebarta VS, 2013, J TRAUMA ACUTE CARE, V75, P920, DOI 10.1097/TA.0b013e3182a539b8; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BICKELL WH, 1992, ANN EMERG MED, V21, P1077, DOI 10.1016/S0196-0644(05)80648-1; Blackbourne LH, 2010, J TRAUMA, V69, pS1, DOI 10.1097/TA.0b013e3181e4206f; Boysen SR, 2016, SHOCK, V46, P439, DOI 10.1097/SHK.0000000000000608; Butler FK, 2013, J SPEC OPER MED, V14, P13; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Cannon WB, 1918, J AMER MED ASSOC, V70, P618; Carlson MA, 2014, J SURG RES, V187, P334, DOI 10.1016/j.jss.2013.09.039; Cho SD, 2009, SHOCK, V31, P87, DOI 10.1097/SHK.0b013e3181777ffb; Committee on Tactical Combat Casualty Care, 2018, ICCC GUID MED PERS 1; Delgado AV, 2008, J TRAUMA, V64, P75, DOI 10.1097/TA.0b013e31815b843c; Duggan M, 2013, J TRAUMA ACUTE CARE, V74, P1462, DOI 10.1097/TA.0b013e31828da937; Duggan MJ, 2014, J SURG RES, V187, P536, DOI 10.1016/j.jss.2013.12.005; Duggan MJ, 2013, J SURG RES, V182, P101, DOI 10.1016/j.jss.2012.07.048; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Grottke O, 2011, J SURG RES, V171, P234, DOI 10.1016/j.jss.2010.02.002; Hildebrand F, 2013, SHOCK, V40, P247, DOI 10.1097/SHK.0b013e3182a3cd74; Holcomb JB, 1999, J TRAUMA, V46, P49, DOI 10.1097/00005373-199901000-00009; Kellum JA, 2006, CHEST, V130, P962, DOI 10.1378/chest.130.4.962; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; Langan NR, 2014, JAMA SURG, V149, P904, DOI 10.1001/jamasurg.2014.940; Moore HB, 2018, LANCET, V392, P283, DOI 10.1016/S0140-6736(18)31553-8; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Neter J, 1990, APPL LINEAR STAT MOD; Pusateri AE, 2003, J TRAUMA, V55, P518, DOI 10.1097/01.TA.0000075336.92129.27; Riha GM, 2011, J TRAUMA, V71, P1755, DOI 10.1097/TA.0b013e3182367b1c; Schreiber MA, 2002, J TRAUMA, V53, P252, DOI 10.1097/00005373-200208000-00011; Schreiber MA, 2015, J TRAUMA ACUTE CARE, V78, P687, DOI 10.1097/TA.0000000000000600; Sena MJ, 2013, J SURG RES, V183, P704, DOI 10.1016/j.jss.2013.02.039; Shrestha B, 2015, J TRAUMA ACUTE CARE, V78, P336, DOI 10.1097/TA.0000000000000514; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Soller B, 2015, SHOCK, V44, P90, DOI 10.1097/SHK.0000000000000307; Sondeen JL, 2003, J TRAUMA, V54, pS110, DOI 10.1097/01.TA.0000047220.81795.3D; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Swindle MM, 2016, SWINE LAB SURG ANEST; Via D, 2001, J TRAUMA, V50, P1076, DOI 10.1097/00005373-200106000-00016; Woolley T, 2018, J TRAUMA ACUTE CARE, V84, pS3, DOI 10.1097/TA.0000000000001856; Yanala UR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108293	44	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207708	10.1371/journal.pone.0207708	http://dx.doi.org/10.1371/journal.pone.0207708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496239	Green Published, gold			2022-12-26	WOS:000451763800044
J	Christensen, CD; Hofmeyr, JHS; Rohwer, JM				Christensen, Carl D.; Hofmeyr, Jan-Hendrik S.; Rohwer, Johann M.			Delving deeper: Relating the behaviour of a metabolic system to the properties of its components using symbolic metabolic control analysis	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; FLUX CONTROL; KINETICS; PATHWAY; MODEL; FERMENTATION; GLUCOSE	High-level behaviour of metabolic systems results from the properties of, and interactions between, numerous molecular components. Reaching a complete understanding of metabolic behaviour based on the system's components is therefore a difficult task. This problem can be tackled by constructing and subsequently analysing kinetic models of metabolic pathways since such models aim to capture all the relevant properties of the system components and their interactions. Symbolic control analysis is a framework for analysing pathway models in order to reach a mechanistic understanding of their behaviour. By providing algebraic expressions for the sensitivities of system properties, such as metabolic flux or steady-state concentrations, in terms of the properties of individual reactions it allows one to trace the high level behaviour back to these low level components. Here we apply this method to a model of pyruvate branch metabolism in Lactococcus lactis in order to explain a previously observed negative flux response towards an increase in substrate concentration. With this method we are able to show, first, that the sensitivity of flux towards changes in reaction rates (represented by flux control coefficients) is determined by the individual metabolic branches of the pathway, and second, how the sensitivities of individual reaction rates towards their substrates (represented by elasticity coefficients) contribute to this flux control. We also quantify the contributions of enzyme binding and mass-action to enzyme elasticity separately, which allows for an even finer-grained understanding of flux control. These analytical tools allow us to analyse the control properties of a metabolic model and to arrive at a mechanistic understanding of the quantitative contributions of each of the enzymes to this control. Our analysis provides an example of the descriptive power of the general principles of symbolic control analysis.	[Christensen, Carl D.; Hofmeyr, Jan-Hendrik S.; Rohwer, Johann M.] Stellenbosch Univ, Dept Biochem, Lab Mol Syst Biol, Stellenbosch, South Africa; [Hofmeyr, Jan-Hendrik S.] Stellenbosch Univ, Ctr Complex Syst Transit, Stellenbosch, South Africa	Stellenbosch University; Stellenbosch University	Rohwer, JM (corresponding author), Stellenbosch Univ, Dept Biochem, Lab Mol Syst Biol, Stellenbosch, South Africa.	jr@sun.ac.za	Hofmeyr, Jan-Hendrik S./F-3547-2010; Rohwer, Johann/A-2027-2008	Hofmeyr, Jan-Hendrik S./0000-0002-1542-459X; Rohwer, Johann/0000-0001-6288-8904; Christensen, Carl/0000-0002-5881-7799	National Research Foundation of South Africa [81129, 84611]	National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by the National Research Foundation of South Africa (http://www.nrf.ac.za) [grant #81129 to J.M.R., and #84611 to C.D.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst TJ, 2011, THESIS STELLENBOSCH; [Anonymous], 2016, PERSPECT SCI, DOI DOI 10.1016/J.PISC.2016.05.011; BOOGERD FC, 2007, SYSTEMS BIOL PHILOS, P3, DOI DOI 10.1016/B978-044452085-2/50003-6; CASCANTE M, 1989, MATH BIOSCI, V94, P271, DOI 10.1016/0025-5564(89)90067-9; Christensen CD, 2018, BIOINFORMATICS, V34, P124, DOI 10.1093/bioinformatics/btx567; Christensen CD, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0236-1; Costa RS, 2014, MOL BIOSYST, V10, P628, DOI 10.1039/c3mb70265k; de Felipe FL, 1997, FEMS MICROBIOL LETT, V156, P15, DOI 10.1111/j.1574-6968.1997.tb12699.x; Fell D, 1996, FRONTIERS METABOLISM; FELL DA, 1985, EUR J BIOCHEM, V148, P555, DOI 10.1111/j.1432-1033.1985.tb08876.x; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; GALAZZO JL, 1990, ENZYME MICROB TECH, V12, P162, DOI 10.1016/0141-0229(90)90033-M; Garrigues C, 1997, J BACTERIOL, V179, P5282, DOI 10.1128/jb.179.17.5282-5287.1997; GIERSCH C, 1988, EUR J BIOCHEM, V174, P509, DOI 10.1111/j.1432-1033.1988.tb14128.x; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Heinrich R., 1996, REGULATION CELLULAR; Heux S, 2006, METAB ENG, V8, P303, DOI 10.1016/j.ymben.2005.12.003; Hoefnagel MHN, 2002, MICROBIOL-SGM, V148, P1003, DOI 10.1099/00221287-148-4-1003; Hoefnagel MHN, 2002, MOL BIOL REP, V29, P157, DOI 10.1023/A:1020313409954; Hofmeyr JHS, 1995, J BIOENERG BIOMEMBR, V27, P479, DOI 10.1007/BF02110188; HOFMEYR JHS, 1989, EUR J BIOCHEM, V186, P343, DOI 10.1111/j.1432-1033.1989.tb15215.x; Hofmeyr JHS, 1997, COMPUT APPL BIOSCI, V13, P377; HOFMEYR JHS, 1993, EUR J BIOCHEM, V212, P833, DOI 10.1111/j.1432-1033.1993.tb17725.x; Hofmeyr JHS, 1986, THESIS STELLENBOSCH; Hofmeyr JHS, 2001, P ICSB 2001, P291; Hols P, 1999, J BACTERIOL, V181, P5521, DOI 10.1128/JB.181.17.5521-5526.1999; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Levering J, 2012, FEBS J, V279, P1274, DOI 10.1111/j.1742-4658.2012.08523.x; Maarleveld TR, 2013, BIOTECHNOL J, V8, P997, DOI 10.1002/biot.201200291; Morandini P, 2013, PLANT BIOTECHNOL J, V11, P253, DOI 10.1111/pbi.12035; Morandini P, 2009, PLANT SCI, V176, P441, DOI 10.1016/j.plantsci.2009.01.005; Moreno-Sanchez R, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/597913; Noor E, 2013, FEBS LETT, V587, P2772, DOI 10.1016/j.febslet.2013.07.028; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Olivier BG, 2004, BIOINFORMATICS, V20, P2143, DOI 10.1093/bioinformatics/bth200; Olivier BG, 2005, BIOINFORMATICS, V21, P560, DOI 10.1093/bioinformatics/bti046; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pfau T, 2011, BRIEF FUNCT GENOMICS, V10, P266, DOI 10.1093/bfgp/elr022; Ramli US, 2014, BIOCATAL AGRIC BIOTE, V3, P49, DOI 10.1016/j.bcab.2013.12.001; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; REICH JG, 1981, ENERGY METABOLISM CE; Rohwer JM, 2008, EXPT STANDARD CONDIT, P137; Rohwer JM, 2008, J THEOR BIOL, V252, P546, DOI 10.1016/j.jtbi.2007.10.032; Rohwer JM, 2012, J EXP BOT, V63, P2275, DOI 10.1093/jxb/ers080; Rohwer JM, 2010, J PHYS CHEM B, V114, P16280, DOI 10.1021/jp108412s; Sauro HM, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0848; SymPy Development Team, 2012, SYMPY PYTH LIB SYMB; Teusink B, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S11; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; Thomas S, 1997, BIOCHEM J, V322, P119, DOI 10.1038/387119a0; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; van Hoek MJA, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-22; VANDERGUGTEN AA, 1993, MODERN TRENDS IN BIOTHERMOKINETICS, P253; WESTERHOFF HV, 1987, BIOTECHNOL BIOENG, V30, P101, DOI 10.1002/bit.260300115	56	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207983	10.1371/journal.pone.0207983	http://dx.doi.org/10.1371/journal.pone.0207983			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485345	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800092
J	Guzman, LM; Vanschoenwinkel, B; Farjalla, VF; Poon, A; Srivastava, DS				Guzman, Laura Melissa; Vanschoenwinkel, Bram; Farjalla, Vinicius F.; Poon, Anita; Srivastava, Diane S.			A precipitation gradient drives change in macroinvertebrate composition and interactions within bromeliads	PLOS ONE			English	Article							TROPHIC INTERACTIONS; HABITAT SIZE; INTRAGUILD PREDATION; ECOSYSTEM FUNCTION; COMMUNITIES; NETWORKS; INSIGHTS; DROUGHT; IMPACT; TESTS	Ecological communities change across spatial and environmental gradients due to (i) changes in species composition, (ii) changes in the frequency or strength of interactions or (iii) changes in the presence of the interactions. Here we use the communities of aquatic invertebrates inhabiting clusters of bromeliad phytotelms along the Brazilian coast as a model system for examining variation in multi-trophic communities. We first document the variation in the species pools of sites across a geographical climate gradient. Using the same sites, we also explored the geographic variation in species interaction strength using a Markov network approach. We found that community composition differed along a gradient of water volume within bromeliads due to the spatial turnover of some species. From the Markov network analysis, we found that the interactions of certain predators differed due to differences in bromeliad water volume. Overall, this study illustrates how a multi-trophic community can change across an environmental gradient through changes in both species and their interactions.	[Guzman, Laura Melissa; Poon, Anita; Srivastava, Diane S.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Vanschoenwinkel, Bram] Vrije Univ Brussel, Community Ecol Lab, Ixelles, Belgium; [Farjalla, Vinicius F.] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil	University of British Columbia; Vrije Universiteit Brussel; Universidade Federal do Rio de Janeiro	Guzman, LM (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	guzman@zoology.ubc.ca	Farjalla, Vinicius F/V-4351-2019; Vanschoenwinkel, Bram/I-9021-2019; Guzman, Laura Melissa/GYD-5251-2022	Farjalla, Vinicius F/0000-0003-4084-5983; Vanschoenwinkel, Bram/0000-0002-8973-6297; 	CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through PVE grants [400454/2014-9]; Mitacs [F15-00162]; Natural Sciences and Engineering Research Council of Canada - NSERC [6564]; University of British Columbia [6569]; NSERC Discovery Grants	CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through PVE grants(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Mitacs; Natural Sciences and Engineering Research Council of Canada - NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of British Columbia; NSERC Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partially funded by CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br) through PVE grants (Process 400454/2014-9 to V.F.F.) and the Mitacs (http://www.mitacs.ca/en) Globalink scholarships (F15-00162). L.M.G. is supported by Natural Sciences and Engineering Research Council of Canada - NSERC (http://www.nserc-crsng.gc.ca) CGS-D (#6564) and University of British Columbia Four Year Fellowships (#6569), (https://www.grad.ubc.ca/awards/four-year-doctoral-fellowship-4yf).D.S.S is supported by NSERC Discovery Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albajes R, 2004, ENCY ENTOMOLOGY, P818; Amundrud SL, 2016, ECOLOGY, V97, P1475, DOI 10.1890/15-1638.1; Amundrud SL, 2015, ECOLOGY, V96, P1957, DOI 10.1890/14-1828.1; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brendonck L, 2015, OIKOS, V124, P741, DOI 10.1111/oik.01710; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Connolly J, 1996, OECOLOGIA, V108, P311, DOI 10.1007/BF00334656; Dezerald O, 2015, FRESHWATER BIOL, V60, P1917, DOI 10.1111/fwb.12621; Dezerald O, 2014, HYDROBIOLOGIA, V723, P77, DOI 10.1007/s10750-013-1464-2; Edgerly JS, 1999, J MED ENTOMOL, V36, P394, DOI 10.1093/jmedent/36.3.394; Englund G, 2009, ECOL LETT, V12, P663, DOI 10.1111/j.1461-0248.2009.01322.x; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; FINCKE OM, 1994, OECOLOGIA, V100, P118, DOI 10.1007/BF00317138; Fox J., 2018, R COMPANION APPL REG, VThird; Freilich MA, 2018, ECOLOGY, V99, P690, DOI 10.1002/ecy.2142; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; HAMMILL E, 2014, J FRESHWATER ECOL, V60, P125, DOI DOI 10.1111/FWB.12475); Hammill E, 2015, ECOSYSTEMS, V18, P857, DOI 10.1007/s10021-015-9866-9; Harris D, 2015, R PACKAGE, DOI [10.5281/zenodo.17808, DOI 10.5281/ZENODO.17808]; Harris DJ, 2016, ECOLOGY, V97, P3308, DOI 10.1002/ecy.1605; Jabiol J, 2009, FOREST ECOL MANAG, V257, P351, DOI 10.1016/j.foreco.2008.09.010; Kitching RL, 2000, FOOD WEBS CONTAINER; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Laliberte E, 2010, ECOLOGY, V91, P1740, DOI 10.1890/09-1328.1; Leibold M.A., 2017, METACOMMUNITY ECOLOG; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Maser GL, 2007, J THEOR BIOL, V247, P337, DOI 10.1016/j.jtbi.2007.03.003; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; Petermann JS, 2015, ECOLOGY, V96, P428, DOI 10.1890/14-0304.1; Pires APF, 2016, ECOLOGY, V97, P2750, DOI 10.1002/ecy.1501; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; R Core Team, 2021, R LANGUAGE ENV STAT; Rall BC, 2012, PHILOS T R SOC B, V367, P2923, DOI 10.1098/rstb.2012.0242; Romero GQ, 2016, ECOLOGY, V97, P2705, DOI 10.1002/ecy.1496; Scarano FR, 2002, ANN BOT-LONDON, V90, P517, DOI 10.1093/aob/mcf189; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Srivastava DS, 2008, AM NAT, V172, P761, DOI 10.1086/592868; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Tylianakis JM, 2017, ANNU REV ECOL EVOL S, V48, P25, DOI 10.1146/annurev-ecolsys-110316-022821; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2	51	1	1	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0200179	10.1371/journal.pone.0200179	http://dx.doi.org/10.1371/journal.pone.0200179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485263	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800003
J	Hermes, R; Saragusty, J; Moser, I; Barth, SA; Holtze, S; Lecu, A; Cracknell, J; Williams, D; Goritz, F; Hildebrandt, TB				Hermes, Robert; Saragusty, Joseph; Moser, Irmgard; Barth, Stefanie A.; Holtze, Susanne; Lecu, Alexis; Cracknell, Jonathan; Williams, Duncan; Goeritz, Frank; Hildebrandt, Thomas Bernd			Differential detection of tuberculous and non-tuberculous mycobacteria by qPCR in lavage fluids of tuberculosis-suspicious white rhinoceros	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; DICEROS-BICORNIS-MINOR; STAT-PAK ASSAY; BLACK RHINOCEROS; AFRICAN WILDLIFE; BOVIS INFECTION; SYNCERUS CAFFER; DIAGNOSIS; AVIUM; IDENTIFICATION	Tuberculosis (TB) occurs in a wide range of mammalian species and thus poses a health risk to humans living or working in close proximity with TB infected animals. Despite a high incidence of M. bovis infections in domestic or wildlife species tuberculosis infections in rhinoceros have so far been very limited. Over the past 53 years, tuberculosis of the respiratory tract has been confirmed in just 22 rhinoceros, most of those infected not by M. bovis but M. tuberculosis. However, because of the zoonotic risk TB testing is recommended or becomes even mandatory in endangered species. The dilemma in rhinoceros and many other wildlife species; non-validated tests are highly inconsistent in their ability to identify TB infection. Current lack of TB diagnostics may result in TB positive rhinoceros living with the infection, transmitting it to those around them or in euthanasia of animals found unconfirmed at necropsy. This is an unacceptable diagnostic status considering that some species are critically endangered and therefore should not be euthanized in order to confirm suspicion of disease. To overcome this shortcoming we used bronchoscopy to detect mycobacteria in respiratory fluids of TB suspicious rhinoceros. Fluids from seven, TB suspicious white rhinoceros were harvested during 21 bronchoscopies. Our new approach: In addition to bacterial culture a dual quantitative PCR system tested for the general presence of DNA from NTM and more specifically for DNA from MTC. Both, bacterial culture and qPCR were negative for MTC in respiratory fluids of all rhinoceros (7/7). At the same time, respiratory fluids from six rhinoceros tested positive for the presence of NTM or other closely related bacteria (6/7). M. tuberculosis was found only once in an oesophageal aspirate. The high incidence of mycobacterial DNA in the respiratory tract suggests that white rhinoceros, as strict grazers, are immensely exposed to environmental bacteria of this genus. Presence of NTM in the respiratory or intestinal system could possibly cause false positive results in intradermal tests. A wider use of bronchoalveolar lavage is warranted to further elucidate immunologic response to NTM and exposure to, incidence and prevalence of MTC infections in rhinoceros.	[Hermes, Robert; Holtze, Susanne; Goeritz, Frank; Hildebrandt, Thomas Bernd] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Saragusty, Joseph] Univ Teramo, Fac Vet Med, Lab Embryol, Teramo, Italy; [Moser, Irmgard; Barth, Stefanie A.] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany; [Lecu, Alexis] Paris Zoo, Paris, France; [Cracknell, Jonathan] Conservat Med Serv, Potters Bar, Herts, England; [Williams, Duncan] Garston Vet Grp, Frome, England	Leibniz Institut fur Zoo und Wildtierforschung; University of Teramo; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Hermes, R (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	hermes@izw-berlin.de	Saragusty, Joseph/M-5030-2016; Barth, Stefanie/K-7053-2019	Saragusty, Joseph/0000-0002-9274-7800; Barth, Stefanie/0000-0003-4921-5056	Conservation Medicine Services	Conservation Medicine Services	Conservation Medicine Services and the Garston Veterinary Group only provided financial support in the form of authors' salaries [JC and DW, respectively] and research materials and did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agren E, 2008, P EUROPE ASS ZOO WIL, P141; Ball RL, 2007, P AM ASS ZOO VET ANN, P88; Barbiers R., 1994, P AM ASS ZOO VET ANN, P149; Bryant B, 2012, J ZOO WILDLIFE MED, V43, P391, DOI 10.1638/2010-0161.1; DALOVISIO JR, 1992, CLIN INFECT DIS, V15, P598, DOI 10.1093/clind/15.4.598; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; Duncan AE, 2009, J ZOO WILDLIFE MED, V40, P781, DOI 10.1638/2009-0044.1; Espie IW, 2009, J WILDLIFE DIS, V45, P1187, DOI 10.7589/0090-3558-45.4.1187; Godfrey RW, 1990, P AM ASS ZOO VET, P353; GUERRERO C, 1995, J CLIN MICROBIOL, V33, P304, DOI 10.1128/JCM.33.2.304-307.1995; Karlastim E, 2015, J COMP PATHOL, V152, P54; KEEP M E, 1973, Journal of the South African Veterinary Association, V44, P285; Keet DF, 1996, ONDERSTEPOORT J VET, V63, P239; Kirschner P, 1998, METH MOL B, V101, P349, DOI 10.1385/0-89603-471-2:349; KUNZE ZM, 1992, J CLIN MICROBIOL, V30, P2366, DOI 10.1128/JCM.30.9.2366-2372.1992; Lecu A., 2011, International Zoo Yearbook, V45, P183, DOI 10.1111/j.1748-1090.2011.00141.x; LEPPER AWD, 1977, AUST VET J, V53, P214, DOI 10.1111/j.1751-0813.1977.tb00188.x; Lyashchenko KP, 2007, CLIN VACCINE IMMUNOL, V14, P1158, DOI 10.1128/CVI.00230-07; Lyashchenko KP, 2006, CLIN VACCINE IMMUNOL, V13, P722, DOI 10.1128/CVI.00133-06; MANN PC, 1981, J AM VET MED ASSOC, V179, P1123; Michel AL, 2009, VET MICROBIOL, V133, P335, DOI 10.1016/j.vetmic.2008.07.023; Michel AL, 2002, ANN NY ACAD SCI, V969, P251, DOI 10.1111/j.1749-6632.2002.tb04387.x; Michel AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179943; Miller M, 2017, TRANSBOUND EMERG DIS, V64, P1071, DOI 10.1111/tbed.12489; Miller M, 2015, J WILDLIFE DIS, V51, P493, DOI 10.7589/2014-07-170; Miller MA, 2017, EMERG INFECT DIS, V23, P557, DOI 10.3201/eid2303.161622; Miller MA, 2015, J ZOO WILDLIFE MED, V46, P100, DOI 10.1638/2014-0172R1.1; Morar D, 2013, TRANSBOUND EMERG DIS, V60, P60, DOI 10.1111/tbed.12132; Moser I, 2008, VET MICROBIOL, V127, P399, DOI 10.1016/j.vetmic.2007.08.028; Oh P, 2002, EMERG INFECT DIS, V8, P1290; Palmer MV, 2013, TRANSBOUND EMERG DIS, V60, P1, DOI 10.1111/tbed.12115; POWERS RD, 1967, J AM VET MED ASSOC, V151, P890; Ravenel MP, 1902, J COMP PATH THER, V15, P112; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; RODRIGUEZ JG, 1995, MICROBIOL-SGM, V141, P2131, DOI 10.1099/13500872-141-9-2131; Ruettger A, 2012, J CLIN MICROBIOL, V50, P2492, DOI 10.1128/JCM.00442-12; Stetter MD, 1995, J AM VET MED ASSOC, V207, P1618; Takagi S., 1964, Bulletin of University of Osaka, V15B, P125; Thapa J, 2016, EMERG INFECT DIS, V22, P570, DOI 10.3201/eid2203.151929; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Valandikar S.C., 1996, ZOOS PRINT, P16	42	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207365	10.1371/journal.pone.0207365	http://dx.doi.org/10.1371/journal.pone.0207365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485372	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800061
J	Pech, M; Weckmann, M; Konig, IR; Franke, A; Heinsen, FA; Oliver, B; Ricklefs, I; Fuchs, O; Rabe, K; Hansen, G; Mutius, EV; Kopp, MV				Pech, Martin; Weckmann, Markus; Koenig, Inke R.; Franke, Andre; Heinsen, Femke-Anouska; Oliver, Brian; Ricklefs, Isabel; Fuchs, Oliver; Rabe, Klaus; Hansen, Gesine; Mutius, Erika, V; Kopp, Matthias, V		ALLIANCE-Study Grp	Rhinovirus infections change DNA methylation and mRNA expression in children with asthma	PLOS ONE			English	Article							B-ASSOCIATED TRANSCRIPT-3; EPITHELIAL-CELLS; VIRAL-INFECTIONS; RECEPTORS; MOLECULES; ILLNESSES; NKG2D; RISK	Human rhinovirus infection (HRVI) plays an important role in asthma exacerbations and is thought to be involved in asthma development during early childhood. We hypothesized that HRVI causes differential DNA methylation and subsequently differential mRNA expression in epithelial cells of children with asthma. Primary nasal epithelial cells from children with (n = 10) and without (n = 10) asthma were cultivated up to passage two and infected with Rhinovirus-16 (RV-16). HRVI-induced genome-wide differences of DNA methylation in asthmatics (vs. controls) and resulting mRNA expression were analyzed by the Human-Methylation450 BeadChip Kit (Illumina) and RNA sequencing. These results were further verified by pyrosequencing and quantitative PCR, respectively. 471 CpGs belonging to 268 genes were identified to have HRVI-induced asthma-specifically modified DNA methylation and mRNA expression. A minimum-change criteria was applied to restrict assessment of genes with changes in DNA methylation and mRNA expression of at least 3% and least 0.1 reads/kb per million mapped reads, respectively. Using this approach we identified 16 CpGs, including HLA-B-associated transcript 3 (BAT3) and Neuraminidase 1 (NEU1), involved in host immune response against HRVI. HRVI in nasal epithelial cells leads to specific modifications of DNA methylation with altered mRNA expression in children with asthma. The HRVI-induced alterations in DNA methylation occurred in genes involved in the host immune response against viral infections and asthma pathogenesis. The findings of our pilot study may partially explain how HRVI contribute to the persistence and progression of asthma, and aid to identify possible new therapeutic targets. The promising findings of this pilot study would benefit from replication in a larger cohort.	[Pech, Martin; Weckmann, Markus; Ricklefs, Isabel; Fuchs, Oliver; Kopp, Matthias, V] Univ Med Ctr Schleswig Holstein, ARCN, Dept Pediat Pneumol & Allergol, Campus Lubeck, Lubeck, Germany; [Pech, Martin; Weckmann, Markus; Koenig, Inke R.; Ricklefs, Isabel; Fuchs, Oliver; Kopp, Matthias, V] German Ctr Lung Res DZL, Lubeck, Germany; [Koenig, Inke R.] Univ Lubeck, ARCN, Inst Med Biometry & Stat, Lubeck, Germany; [Franke, Andre; Heinsen, Femke-Anouska] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Oliver, Brian] Univ Technol Sydney, Sydney, NSW, Australia; [Oliver, Brian] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia; [Fuchs, Oliver] Univ Bern, Univ Childrens Hosp Bern, Dept Pediat Resp Med, Inselspital, Bern, Switzerland; [Rabe, Klaus] LungenClin Grosshansdorf, Dept Pneumol, Grosshansdorf, Germany; [Rabe, Klaus] ARCN, Grosshansdorf, Germany; [Rabe, Klaus] German Ctr Lung Res DZL, Grosshansdorf, Germany; [Hansen, Gesine] Hannover Med Sch, Dept Paediat Pneumol Allergol & Neonatol, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Hansen, Gesine] German Ctr Lung Res DZL, Hannover, Germany; [Mutius, Erika, V] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, CPC M, Munich, Germany; [Mutius, Erika, V] German Ctr Lung Res DZL, Munich, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel; University of Technology Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Bern; University Hospital of Bern; Grosshansdorf Hospital; Hannover Medical School; University of Munich	Kopp, MV (corresponding author), Univ Med Ctr Schleswig Holstein, ARCN, Dept Pediat Pneumol & Allergol, Campus Lubeck, Lubeck, Germany.; Kopp, MV (corresponding author), German Ctr Lung Res DZL, Lubeck, Germany.	matthias.kopp@uksh.de	Oliver, Brian/E-7939-2010; Rabe, Klaus F./AAW-6296-2021; Franke, Andre/B-2151-2010; Weckmann, Markus/GXG-3428-2022; Aydin, Malik/AAF-5085-2020; König, Inke R/A-4544-2009; Fuchs, Oliver/Q-1100-2016	Oliver, Brian/0000-0002-7122-9262; Rabe, Klaus F./0000-0002-7020-1401; Franke, Andre/0000-0003-1530-5811; Weckmann, Markus/0000-0001-5342-979X; König, Inke R/0000-0003-0504-6465; Heinsen, Femke-Anouska/0000-0003-3652-6402; Fuchs, Oliver/0000-0002-7127-5226	German Center of Lung Research (DZL) [82DZL00106]	German Center of Lung Research (DZL)	This research was supported by the German Center of Lung Research (DZL) grant number: 82DZL00106; https://www.dzl.de/index.php/en/research/disease-areas/asthma-and-allergy). Funders had no role in any of the experimental work or publication.	Abdulkhalek, 2010, J VIS EXP; Alt E, 2011, BIOL CELL, V103, P197, DOI 10.1042/BC20100117; Aoyagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018196; Bergougnoux A, 2015, EPIGENOMICS-UK, V7, P119, DOI [10.2217/EPI.14.65, 10.2217/epi.14.65]; Borrego F, 2002, MOL IMMUNOL, V38, P637, DOI 10.1016/S0161-5890(01)00107-9; Chen G. W., 2014, XINJIANG RECLAIM SCI, V1, P3, DOI DOI 10.7554/ELIFE.04066; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; ESTERRE P, 1992, CELL MOL BIOL, V38, P297; FORSTNER JF, 1978, DIGESTION, V17, P234, DOI 10.1159/000198115; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Iwasaki J, 2014, J ALLERGY CLIN IMMUN, V134, P25, DOI 10.1016/j.jaci.2014.03.014; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Katoh S, 2010, CLIN EXP IMMUNOL, V161, P233, DOI 10.1111/j.1365-2249.2010.04165.x; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; McErlean P, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-37; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Papi A, 1999, J BIOL CHEM, P274; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Sethi SK, 1997, CLIN EXP IMMUNOL, V110, P362, DOI 10.1046/j.1365-2249.1997.4221440.x; Sharma G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25006; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Telcian AG, 2014, CHEST, V146, P32, DOI 10.1378/chest.13-2247; The Global Asthma Network, 2014, THE GLOBAL ASTHMA RE; Triantafilou K, 2011, VIRULENCE, V2, P22, DOI 10.4161/viru.2.1.13807; van der Gugten AC, 2013, PEDIATR INFECT DIS J, V32, P827, DOI 10.1097/INF.0b013e318290620e; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Yang IV, 2017, J ALLERGY CLIN IMMUN, V139, P1478, DOI 10.1016/j.jaci.2016.07.036; YOKOYAMA A, 1995, AM J RESP CRIT CARE, V151, P1354, DOI 10.1164/ajrccm.151.5.7735584; Zardo G, 2005, CELL RES, V15, P679, DOI 10.1038/sj.cr.7290337	43	30	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0205275	10.1371/journal.pone.0205275	http://dx.doi.org/10.1371/journal.pone.0205275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485264	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800008
J	Neiva, DM; Araujo, S; Gominho, J; Carneiro, AD; Pereira, H				Neiva, Duarte M.; Araujo, Solange; Gominho, Jorge; Carneiro, Angelica de Cassia; Pereira, Helena			An integrated characterization of Picea abies industrial bark regarding chemical composition, thermal properties and polar extracts activity	PLOS ONE			English	Article							NORWAY SPRUCE; EUCALYPTUS-GLOBULUS; PINUS-SYLVESTRIS; BIOREFINERY; AUTOHYDROLYSIS; ANTIOXIDANTS; VALORIZATION; FEEDSTOCK; INNER	The present work determines the chemical and thermal characteristics as well as the phytochemical and antioxidant potential of the polar extractives of the Picea abies bark from an industrial mill, their wood and bark components and also different bark fractions obtained by mechanical fractionation (fine B-1, Phi<0.180 mm, medium B-3, 0.450<Phi<0.850 mm and coarse B-6, 2<Phi<10 mm). The aim is to increase the knowledge on the Picea abies bark to better determine possible uses other than burning for energy production and to test an initial size reduction process to achieve fractions with different characteristics. Compared to wood, bark presented similar lignin (27%), higher mineral (3.9% vs 0.4%) and extractives (20.3% vs 3.8%) and lower polysaccharides (48% vs 71%) contents. Regarding bark fractions the fines showed higher ash (6.3%), extractives (25%) and lignin (29%) than the coarse fraction (3.9%, 19% and 25% respectively). Polysaccharide contents increased with particle size of the bark fractions (38% vs 52% for B-1 and B-6) but showed the same relative composition. The phytochemical profile of ethanol and water extracts presented higher contents for bark than wood of total phenols (2x higher), flavonoids (3x higher) and tannins (4-10x higher) with an increasing tendency with particle size. Bark antioxidant activity was higher than that of wood for ferric-reducing antioxidant power (FRAP, 10 vs 6 mmolFe(2+)/g(Ext) for the ethanol extract) and free radical scavenging activity (DPPH, 6 vs 18 mg/L IC50 for the ethanol extract) methods. The different bark fractions antioxidant activity was very similar. Bark thermal properties showed a much lower volatiles to fixed carbon ratio (V/FC) than wood (3.1 vs 5.2) although the same higher heating value (20.3 MJ/kg). The fractions were quite similar. Bark presented chemical features that point to their possible upgrade, whether by taking advantage of the high extractives with bioactive compounds or the production potential for hemicellulose-derived oligomers with possible use in nutraceutical and pharmaceutical industries.	[Neiva, Duarte M.; Araujo, Solange; Gominho, Jorge; Pereira, Helena] Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal; [Carneiro, Angelica de Cassia] Univ Fed Vicosa, Vicosa, MG, Brazil	Universidade de Lisboa; Universidade Federal de Vicosa	Neiva, DM (corresponding author), Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal.	duarteneiva@isa.ulisboa.pt	Gominho, Jorge/B-4816-2009; Pereira, Helena/V-5236-2019; Neiva, Duarte Miranda/E-3135-2016	Gominho, Jorge/0000-0003-3419-6075; Pereira, Helena/0000-0002-5393-4443; Neiva, Duarte Miranda/0000-0002-5913-5976	Fundacao para a Ciencia e a Tecnologia (FCT) [UID/AGR/00239/2013]; FCT [PD/BD/52697/2014, SFRH/BPD/118743/2016]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The Forest Research Center (CEF) is a research unit funded by Fundacao para a Ciencia e a Tecnologia (FCT) under UID/AGR/00239/2013. The first author acknowledges a PhD scholarship (PD/BD/52697/2014) under the SUSFOR doctoral program, and the second author a Post Doc scholarship (SFRH/BPD/118743/2016) that are both financed by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsen G, 2008, EUR J FOREST RES, V127, P387, DOI 10.1007/s10342-008-0222-x; Bridgeman TG, 2007, FUEL, V86, P60, DOI 10.1016/j.fuel.2006.06.022; Co M, 2012, PHYTOCHEM ANALYSIS, V23, P1, DOI 10.1002/pca.1316; Corder S. E., 1976, PROPERTIES USES BARK; Feng SH, 2013, RENEW SUST ENERG REV, V26, P560, DOI 10.1016/j.rser.2013.06.024; Ferreira JPA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197135; Ferreira JPA, 2015, IND CROP PROD, V74, P998, DOI 10.1016/j.indcrop.2015.05.065; Francezon N, 2017, IND CROP PROD, V108, P348, DOI 10.1016/j.indcrop.2017.06.052; Garrote G, 2002, J FOOD ENG, V52, P211, DOI 10.1016/S0260-8774(01)00108-X; Harkin JM, 1971, BARK ITS POSSIBLE US; Kemppainen K, 2014, IND CROP PROD, V52, P158, DOI 10.1016/j.indcrop.2013.10.009; Krogell J, 2012, NORD PULP PAP RES J, V27, P6, DOI 10.3183/npprj-2012-27-01-p006-017; Lacoste C, 2015, IND CROP PROD, V73, P144, DOI 10.1016/j.indcrop.2015.03.089; Latva-Maenpaa H, 2013, TREES-STRUCT FUNCT, V27, P131, DOI 10.1007/s00468-012-0780-x; Le Normand M, 2014, CELLULOSE, V21, P4583, DOI 10.1007/s10570-014-0423-z; Le Normand M, 2014, CARBOHYD POLYM, V111, P979, DOI 10.1016/j.carbpol.2014.04.092; Le Normand M, 2014, CARBOHYD POLYM, V101, P699, DOI 10.1016/j.carbpol.2013.09.067; Le Normand M, 2012, NORD PULP PAP RES J, V27, P18, DOI 10.3183/npprj-2012-27-01-p018-023; Leite C, 2017, FRONT MATER, V3, DOI 10.3389/fmats.2016.00063; MANNILA E, 1992, PHYTOCHEMISTRY, V31, P3288, DOI 10.1016/0031-9422(92)83500-X; Matthews S, 1997, PHYTOCHEMISTRY, V45, P405, DOI 10.1016/S0031-9422(96)00873-4; Miranda I, 2017, MADERAS-CIENC TECNOL, V19, P185, DOI 10.4067/S0718-221X2017005000016; Miranda I, 2012, BIORESOURCES, V7, P4350; Miranda I, 2013, IND CROP PROD, V41, P299, DOI 10.1016/j.indcrop.2012.04.024; Miranda I, 2012, IND CROP PROD, V36, P395, DOI 10.1016/j.indcrop.2011.10.035; Moniz P, 2017, RICE RICE STRAW PROD, P55; Neiva DM, 2018, IND CROP PROD, V123, P262, DOI 10.1016/j.indcrop.2018.06.070; Neiva DM, 2016, J WOOD CHEM TECHNOL, V36, P383, DOI 10.1080/02773813.2016.1184280; Neiva DM, 2014, BIORESOURCES, V9, P2907; NORIN T, 1972, ACTA CHEM SCAND, V26, P2289, DOI 10.3891/acta.chem.scand.26-2289; Pan SB, 2013, BIOENERG RES, V6, P24, DOI 10.1007/s12155-012-9223-1; PELTONEN S, 1981, PAP PUU-PAP TIM, V63, P593; Pietarinen SP, 2006, J WOOD SCI, V52, P436, DOI 10.1007/s10086-005-0780-1; Pizzi A, 2006, J ADHES SCI TECHNOL, V20, P829, DOI 10.1163/156856106777638635; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rhen C, 2004, SCAND J FOREST RES, V19, P72, DOI 10.1080/02827580310019185; Sanchez-Moreno C, 1998, J SCI FOOD AGR, V76, P270, DOI 10.1002/(SICI)1097-0010(199802)76:2<270::AID-JSFA945>3.3.CO;2-0; Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026; Sen A, 2016, IND CROP PROD, V92, P42, DOI 10.1016/j.indcrop.2016.07.044; Tamaki Y, 2010, IND CROP PROD, V31, P534, DOI 10.1016/j.indcrop.2010.02.004; Vazquez MJ, 2005, BIORESOURCE TECHNOL, V96, P889, DOI 10.1016/j.biortech.2004.08.013; Voipio R, 1992, FOLIA FORESTALIA, V789; Xavier D, 2012, CELL CHEM TECHNOL, V46, P541; Yemele MCN, 2013, IND CROP PROD, V42, P50, DOI 10.1016/j.indcrop.2012.05.012; Zhang Lu, 2009, CHARACTERIZATION LIG, P1	45	28	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208270	10.1371/journal.pone.0208270	http://dx.doi.org/10.1371/journal.pone.0208270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481221	gold, Green Published, Green Submitted			2022-12-26	WOS:000451440000046
J	Zurita-Ortega, F; Chacon-Cuberos, R; Cofre-Bolados, C; Knoxid, E; Muros, JJ				Zurita-Ortega, Felix; Chacon-Cuberos, Ramon; Cofre-Bolados, Cristian; Knoxid, Emily; Joaquin Muros, Jose			Relationship of resilience, anxiety and injuries in footballers: Structural equations analysis	PLOS ONE			English	Article							SCALE CD-RISC; SPORT ACHIEVEMENT; SOCCER PLAYERS; MENTAL-HEALTH; PREVENTION; STRESS; MODEL; PREDICTION; HARDINESS; OPTIMISM	Resilience is a psychological characteristic which enhances personal assets and protects individuals from potential negative effects of various stressors. While this topic has been considered in the separate context of sports injuries and anxiety states, these issues have rarely been considered together. The objective of this study is to analyse the association between motivation to overcome injuries in football and the state of anxiety caused by those injuries. One hundred and eighty-five footballers from Spain were analysed by way of the Connor-Davidson Resilience Scale, the State-Trait Anxiety Inventory questionnaires, and an injury self-registration sheet. Statistical analyses were performed using structural equations. Results showed a direct and positive relationship between the capacity to face up to injuries or potential injuries and to adapt successfully to them for injured footballers, especially when anxiety was considered as a transitory emotional state. In addition, this relationship was stronger in non-injured sportspersons because their resilience capacity was not being impaired by the experience of an injury.	[Zurita-Ortega, Felix; Joaquin Muros, Jose] Univ Granada, Dept Didact Mus Plast & Corporal Express, Granada, Spain; [Chacon-Cuberos, Ramon] Univ Granada, Res Grp HUM 238, Granada, Spain; [Cofre-Bolados, Cristian] Univ Santiago, Sch Sci Phys Act Sport & Hlth ECIADES, Santiago Of Chile, Chile; [Cofre-Bolados, Cristian] Univ Santo Tomas, Sports Sci & Phys Act, Santiago Of Chile, Chile; [Knoxid, Emily] Univ Nottingham, Sch Hlth Sci, Nottingham, England	University of Granada; University of Granada; Universidad Santo Tomas; University of Nottingham	Chacon-Cuberos, R (corresponding author), Univ Granada, Res Grp HUM 238, Granada, Spain.	rchacon@ugr.es	Muros, José/Q-9540-2019; Chacón-Cuberos, Ramón/H-7507-2017; Knox, Emily/H-6310-2013	Muros, José/0000-0001-7573-0399; Chacón-Cuberos, Ramón/0000-0003-0937-1089; Knox, Emily/0000-0001-8155-9428				Cano LA, 2010, REV LAT AM PSICOL, V42, P265; ANDERSEN MB, 1988, J SPORT EXERCISE PSY, V10, P294, DOI 10.1123/jsep.10.3.294; Aroian KJ, 2000, WESTERN J NURS RES, V22, P54, DOI 10.1177/01939450022044269; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BESHARAT MA, 2011, PSYCHOLOGY, V2, P760, DOI DOI 10.4236/PSYCH.2011.27116; Clansey AC, 2012, MED SCI SPORT EXER, V44, P1917, DOI 10.1249/MSS.0b013e318259480d; Clausen MB, 2014, AM J SPORT MED, V42, P2487, DOI 10.1177/0363546514541224; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Connor KM, 2003, J TRAUMA STRESS, V16, P487, DOI 10.1023/A:1025762512279; de la Vega R, 2011, REV PSICOL DEPORTE, V20, P445; de Lira CAB, 2017, INT J SPORTS PHYS TH, V12, P1103, DOI 10.26603/ijspt20171103; Drew B, 2019, J CLIN SPORT PSYCHOL, V13, P421, DOI 10.1123/jcsp.2017-0043; Ensari I, 2015, DEPRESS ANXIETY, V32, P624, DOI 10.1002/da.22370; Ermolaeva YS, 2015, PEDAGOG PSYCHOL MED, V19, P22, DOI 10.15561/18189172.2015.0204; Fernández García Rubén, 2014, Univ. Psychol., V13, P433, DOI 10.11144/Javeriana.UPSY13-2.reae; Fletcher D, 2012, PSYCHOL SPORT EXERC, V13, P669, DOI 10.1016/j.psychsport.2012.04.007; Galli N, 2015, INT J SPORT EXERC PS, V13, P243, DOI 10.1080/1612197X.2014.946947; Gonzalez SP, 2016, PSYCHOL SPORT EXERC, V23, P31, DOI 10.1016/j.psychsport.2015.10.005; Gonzalez-Valero G, 2017, ESHPA, V1, P41; Gucciardi DF, 2011, PSYCHOL SPORT EXERC, V12, P423, DOI 10.1016/j.psychsport.2011.02.005; Hosseini SA, 2010, PROCD SOC BEHV, V5, P633, DOI 10.1016/j.sbspro.2010.07.156; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Johnson U, 2014, REV PSICOL DEPORTE, V23, P401; Jones NS, 2014, CURR SPORT MED REP, V13, P319, DOI 10.1249/JSR.0000000000000085; Joreskog Karl G., 1977, APPL STAT; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Lamond AJ, 2008, J PSYCHIATR RES, V43, P148, DOI 10.1016/j.jpsychires.2008.03.007; Leo FM, 2014, INT J MED SCI PHYS A, V53, P10; Liberal R, 2014, REV PSICOL DEPORTE, V23, P451; Liu DWY, 2015, J PSYCHOPATHOL BEHAV, V37, P340, DOI 10.1007/s10862-014-9452-z; Madzar T, 2017, KINESIOLOGY, V49, P84; MCDONALD RP, 1990, PSYCHOL BULL, V107, P247, DOI 10.1037/0033-2909.107.2.247; Michaelidis M, 2014, PHYS THER SPORT, V15, P200, DOI 10.1016/j.ptsp.2013.12.002; Fernandes HM, 2014, REV PSICOL DEPORTE, V23, P445; Monroy Cortés Brisa Gissel, 2011, Salud Ment, V34, P237; Morgan PBC, 2015, PSYCHOL SPORT EXERC, V16, P91, DOI 10.1016/j.psychsport.2014.08.007; Nezhad MAS, 2010, PROCD SOC BEHV, V5, P757, DOI 10.1016/j.sbspro.2010.07.180; Noh Young-Eun, 2007, Res Sports Med, V15, P13, DOI 10.1080/15438620600987064; Zafra AO, 2011, UNIV PSYCHOL, V10, P909; Padlipsky PS, 2014, PEDIATR EMERG CARE, V30, P725, DOI 10.1097/PEC.0000000000000236; Garcia CR, 2014, REV IBEROAM PSICOL E, V9, P271; Ruiz R, 2012, REV PSICOL DEPORTE, V21, P143; Saquero A, 2018, J SPORT HEALTH RES, V10, P79; Sarkar M, 2014, J SPORT SCI, V32, P1419, DOI 10.1080/02640414.2014.901551; Scott-Hamilton J, 2016, INT J SPORT PSYCHOL, V47, P103, DOI 10.7352/IJSP.2016.47.103; Sous SJO, 2013, REV INT MED CIENC AC, V13, P257; Spielberger C. D., 1970, SELF EVALUATION QUES; Wagnild Gail, 2003, J Gerontol Nurs, V29, P42; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; Yu XN, 2011, COMPR PSYCHIAT, V52, P218, DOI 10.1016/j.comppsych.2010.05.010; Zurita Ortega F., 2014, CPD, V14, P81; Zurita-Ortega F, 2016, ARCH BUDO, V12, P201	52	19	20	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207860	10.1371/journal.pone.0207860	http://dx.doi.org/10.1371/journal.pone.0207860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475896	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700083
J	Weng, CC; Ding, PY; Liu, YH; Hawse, JR; Subramaniam, M; Wu, CC; Lin, YC; Chen, CY; Hung, WC; Cheng, KH				Weng, Ching-Chieh; Ding, Pei-Ya; Liu, Yu-Hsuan; Hawse, John R.; Subramaniam, Malayannan; Wu, Chia-Chen; Lin, Yu-Chun; Chen, Chiao-Yun; Hung, Wen-Chun; Cheng, Kuang-Hung			Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis	ONCOGENE			English	Article							P-SELECTIN; POOR-PROGNOSIS; ADVANCED-STAGE; EXPRESSION; GROWTH; ACTIVATION; ANTIGEN; CELLS; RAF; ADENOCARCINOMA	Prostate cancer (PCA), one of the most common malignant tumors in men, is the second leading cause of cancer deaths in males worldwide. We report here that PCA models harboring conditional LSL/Kras(G12D) or BRAF(F-V600E) allele with prostate-specific abrogated p53 function recapitulate human PCA precursor lesions, histopathology, and clinical behaviors. We found that the development of reprogrammed EMT-like phenotypes and skeleton metastatic behavior requires concurrent activated Kras and p53 depletion in PCA. Microarray analyses of primary PCA cells derived from these models identified several cancer stemness genes including CD24, EpCAM, and CD133 upregulated by KRAS(G12D). Among these stemness markers, we identified CD24 as a key driver of tumorigenesis and metastasis in vivo. These data demonstrate that specific factors involved in cancer stemness are critical for metastatic conversion of PCA and may be ideal targets for therapeutic intervention.	[Weng, Ching-Chieh; Ding, Pei-Ya; Liu, Yu-Hsuan; Wu, Chia-Chen; Lin, Yu-Chun; Cheng, Kuang-Hung] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan; [Hawse, John R.; Subramaniam, Malayannan] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Chen, Chiao-Yun] Kaohsiung Med Univ Hosp, Dept Med Imaging, Kaohsiung, Taiwan; [Hung, Wen-Chun; Cheng, Kuang-Hung] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Cheng, Kuang-Hung] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	National Sun Yat Sen University; Mayo Clinic; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University	Cheng, KH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan.; Cheng, KH (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.; Cheng, KH (corresponding author), Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.	khcheng@faculty.nsysu.edu.tw			MOST from the Ministry of Science and Technology, Taiwan, ROC [105-2320-B-110-004, 105-2321-B-400-010]; Kaohsiung Medical University, Kaohsiung, Taiwan [KMU-TP105G00]	MOST from the Ministry of Science and Technology, Taiwan, ROC; Kaohsiung Medical University, Kaohsiung, Taiwan	Supported by MOST grants 105-2320-B-110-004 and 105-2321-B-400-010 (to K.H. Cheng) from the Ministry of Science and Technology, Taiwan, ROC, and grant KMU-TP105G00 (to K.H. Cheng) from Kaohsiung Medical University, Kaohsiung, Taiwan.	Aigner S, 1997, BLOOD, V89, P3385, DOI 10.1182/blood.V89.9.3385; ARGUELLO F, 1988, CANCER RES, V48, P6876; Bedard PW, 2008, J PHARMACOL EXP THER, V324, P497, DOI 10.1124/jpet.107.128124; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; D'Amico AV, 2002, INT J RADIAT ONCOL, V53, P581, DOI 10.1016/S0360-3016(02)02797-9; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Dosch JS, 2015, CANCER RES, V75, P4582, DOI 10.1158/0008-5472.CAN-14-2793; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102590; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; ISAACS WB, 1994, COLD SPRING HARB SYM, V59, P653, DOI 10.1101/SQB.1994.059.01.075; ISAACS WB, 1991, CANCER RES, V51, P4716; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; KANO J, 1994, J CELL PHYSIOL, V161, P358, DOI 10.1002/jcp.1041610221; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Kristiansen G, 2004, PROSTATE, V58, P183, DOI 10.1002/pros.10324; Lee JW, 2012, J NAT MED-TOKYO, V66, P8, DOI 10.1007/s11418-011-0537-7; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Overdevest JB, 2012, P NATL ACAD SCI USA, V109, pE3588, DOI 10.1073/pnas.1113960109; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Salmaninejad A, 2015, CLIN LAB, V61, P749, DOI 10.7754/Clin.Lab.2014.141210; Silan F, 2012, MOL BIOL REP, V39, P1595, DOI 10.1007/s11033-011-0898-8; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Thudi NK, 2011, PROSTATE, V71, P615, DOI 10.1002/pros.21277; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Weng CC, 2017, ONCOGENE, V36, P5532, DOI 10.1038/onc.2017.155; Weng CC, 2016, PANCREAS, V45, P443, DOI 10.1097/MPA.0000000000000460; Yang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099412; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151	50	26	28	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2019	38	12					2005	2019		10.1038/s41388-018-0575-7	http://dx.doi.org/10.1038/s41388-018-0575-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HP6UR	30467381	Green Published, hybrid			2022-12-26	WOS:000461822600002
J	Mayyas, F; Saadeh, N; Al-Muqbel, K; Van Wagoner, DR				Mayyas, Fadia; Saadeh, Nesreen; Al-Muqbel, Kusai; Van Wagoner, David R.			Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidism	PLOS ONE			English	Article							ARRHYTHMOGENIC ACTIVITY; THYROID-HORMONE; RISK-FACTOR; HYPOTHYROIDISM; PREDICTOR	Background Endothelin-1 (ET-1) is a potent vasoconstrictor, mitogen and inflammatory factor that may contribute to development of atrial fibrillation (AF). Plasma ET-1 levels are increased in hyperthyroid patients, but studies evaluating its relation to AF development in hyperthyroid patients are lacking. Objective The present study seeks to evaluate the relation of plasma ET-1 to AF development as a function of thyroid status. Methods Blood samples from euthyroid patients (n = 41), hypothyroid (n = 61), hyperthyroid (n = 41), AF with hyperthyroidism (n = 9), and euthyroid AF (n = 10) patients were collected. Plasma ET-1, CRP, and thyroid hormone levels were measured and compared between groups. Results Plasma ET-1 levels were higher in hyperthyroid and euthyroid AF patients> hyperthyroidnon-AF > hypo and euthyroid non-AF patients. Plasma ET-1 levels positively correlated with free T3 and T4 levels, and negatively with TSH levels. By multivariate analysis, plasma ET-1 was positively associated with AF, hyperthyroidism, and age. Plasma CRP did not vary by study group in either univariate or multivariate analyses. Conclusion Plasma ET-1 is associated with AF, elevated in hyperthyroid patients and positively correlated with thyroid hormone levels, suggesting that hyperthyroidism may increase ET-1 expression and release. This study may guide development of novel predictors of AF associated with hyperthyroidism, and may help to personalize therapy in hyperthyroid patients.	[Mayyas, Fadia] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan; [Saadeh, Nesreen] Jordan Univ Sci & Technol, Fac Med, Dept Internal Med, Irbid, Jordan; [Al-Muqbel, Kusai] Jordan Univ Sci & Technol, Fac Med, Dept Diagnost Radiol & Nucl Med, Irbid, Jordan; [Van Wagoner, David R.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA	Jordan University of Science & Technology; Jordan University of Science & Technology; Jordan University of Science & Technology; Cleveland Clinic Foundation	Mayyas, F (corresponding author), Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan.	famayyas@just.edu.jo	; Van Wagoner, David R./C-6783-2008	Mayyas, Fadia/0000-0002-2086-7205; Van Wagoner, David R./0000-0001-8250-9828	Jordan University of Science and Technology, Irbid, Jordan [176/2012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111314] Funding Source: NIH RePORTER	Jordan University of Science and Technology, Irbid, Jordan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the deanship of research (grant number 176/2012, FM) at Jordan University of Science and Technology, Irbid, Jordan, http://www.just.edu.jo/Deanships/DeanshipofResearch/Pages/Default.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer CR, 2017, CELL SIGNAL, V36, P240, DOI 10.1016/j.cellsig.2017.04.010; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; BaumgartnerParzer SM, 1997, J ENDOCRINOL, V154, P231, DOI 10.1677/joe.0.1540231; Cesareo R, 2000, Minerva Endocrinol, V25, P1; Chen YC, 2002, J AM COLL CARDIOL, V39, P366, DOI 10.1016/S0735-1097(01)01731-4; Chu CH, 2006, EXP BIOL MED, V231, P1040; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; Dezsi CA, 2006, EXP BIOL MED, V231, P852; Franklyn JA, 2012, LANCET, V379, P1155, DOI 10.1016/S0140-6736(11)60782-4; Gao XL, 2018, CARDIOVASC RES, V114, P737, DOI 10.1093/cvr/cvy011; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Iervasi G, 2013, INTERN EMERG MED, V8, pS71, DOI 10.1007/s11739-013-0911-4; Jabati S, 2018, CLIN APPL THROMB-HEM, V24, P718, DOI 10.1177/1076029618761006; Krishnan Sandeep Kumar, 2011, Mo Med, V108, P280; LAM HC, 1993, J CARDIOVASC PHARM, V22, pS299, DOI 10.1097/00005344-199322008-00078; Latini R, 2011, J INTERN MED, V269, P160, DOI 10.1111/j.1365-2796.2010.02287.x; Lee WY, 2004, ARCH MED RES, V35, P540, DOI 10.1016/j.arcmed.2004.08.003; Lu RX, 2018, INTERACT CARDIOV TH, V26, P66, DOI 10.1093/icvts/ivx250; Mayyas F, 2018, J CARDIOVASC PHARM T, V23, P216, DOI 10.1177/1074248417753677; Mayyas F, 2015, CARDIOVASC PATHOL, V24, P19, DOI 10.1016/j.carpath.2014.08.004; Mayyas F, 2011, CARDIOVASC RES, V89, P852, DOI 10.1093/cvr/cvq380; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; N Jayaprasad, 2005, Indian Pacing Electrophysiol J, V5, P305; Nakazawa Y, 2009, HEART RHYTHM, V6, P725, DOI 10.1016/j.hrthm.2009.02.027; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL1115, DOI 10.1152/ajplung.2001.281.5.L1115; Shin AN, 2017, CURR TOP MED CHEM, V17, P1788, DOI 10.2174/1568026617666161116142417; Shohet RV, 2004, P NATL ACAD SCI USA, V101, P2088, DOI 10.1073/pnas.0307159101; Tang XY, 2006, UROLOGY, V68, P455, DOI 10.1016/j.urology.2006.03.068; Tilly N, 2003, EXP CLIN ENDOCR DIAB, V111, P80, DOI 10.1055/s-2003-39234; Udyavar AR, 2008, J CARDIOVASC ELECTR, V19, P285, DOI 10.1111/j.1540-8167.2007.01033.x; VanWagoner DR, 1997, CIRC RES, V80, P772; Wu S, 2018, ATHEROSCLEROSIS, V272, P1, DOI 10.1016/j.atherosclerosis.2018.02.034; Yan JJ, 2018, CIRC RES, V122, P821, DOI 10.1161/CIRCRESAHA.117.312536; Yang R, 2018, EUR J PHARMACOL, V834, P274, DOI 10.1016/j.ejphar.2018.07.042; Zhang YH, 2013, CIRC-ARRHYTHMIA ELEC, V6, P952, DOI 10.1161/CIRCEP.113.000502	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208206	10.1371/journal.pone.0208206	http://dx.doi.org/10.1371/journal.pone.0208206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513109	Green Submitted, gold, Green Published			2022-12-26	WOS:000452204800026
J	Jiang, M; Yang, G; Fang, LY; Wan, J; Yang, YH; Wang, Y				Jiang, Man; Yang, Guang; Fang, Lvying; Wan, Jin; Yang, Yinghua; Wang, Ying			Factors associated with healthcare utilization among community-dwelling elderly in Shanghai, China	PLOS ONE			English	Article							HIV-INFECTED PERSONS; SELF-RATED HEALTH; SERVICE UTILIZATION; EMERGENCY-ROOM; OLDER-PEOPLE; MEDICAL-CARE; INSURANCE; MODEL; NEED; HOSPITALIZATIONS	Objective The objective of this study was to evaluate the factors associated with the health status of older Chinese people living in the community, in order to inform strategies to expand access to healthcare. Methods Two-phase stratified cluster sampling was applied; 2000 older people participated in this study. Face-to-face interviews were conducted in Shanghai between June and August, 2011. Descriptive analysis was used to examine the respondents' characteristics. Based on Andersen's healthcare utilization model, a chi-squared test and multiple logistic regression were performed to examine the influences of predisposing, enabling, need, and contextual factors on healthcare utilization. Results We found that 44.5% of the older people in the sample had good self-reported health status, while 12.8% were poor, 14.5% had visited hospitals or clinics as outpatients in the previous two weeks, and 16.5% had been hospitalized in the previous year. Logistic regression analysis revealed that outpatient health services were more likely to be used by women and those whose income was from friends or social relief, who had poor to good self-reported health status, who were experiencing declining health, who engaged in volunteer activities, and who had chronic diseases. Meanwhile, hospitalization was more likely among those in the older age groups, those with pension income, living in outer suburbs, with poor self-reported health status, experiencing difficulty with activities of daily living and outdoor activities, or having a chronic disease. Conclusions The results showed the impact of economic status, health status, demographic and social characteristics, and other factors on the health service utilization of elderly people living in the community in Shanghai. Need variables were the strongest predictors of health service use, although contextual factors also contributed.	[Jiang, Man; Fang, Lvying] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Yang, Guang] Fudan Univ, Eye & ENT Hosp, Shanghai, Peoples R China; [Wan, Jin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China; [Yang, Yinghua] Shanghai Municipal Ctr Dis Control & Prevent, Management Dept, Shanghai, Peoples R China; [Wang, Ying] Fudan Univ, Natl Hlth & Family Planning Commiss Peoples Repub, Key Lab Hlth Technol Assessment, Sch Publ Hlth, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention; Fudan University	Wang, Y (corresponding author), Fudan Univ, Natl Hlth & Family Planning Commiss Peoples Repub, Key Lab Hlth Technol Assessment, Sch Publ Hlth, Shanghai, Peoples R China.	wangying1013@fudan.edu.cn	Jiang, Man-Xi/A-1790-2016	Wang, Ying/0000-0003-4757-1364	National Natural Science Foundation of China [71673055]; Key Lab of Health Technology Assessment, National Health and Family Planning Commission of the People's Republic of China, Fudan University; Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China [15JZD029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Lab of Health Technology Assessment, National Health and Family Planning Commission of the People's Republic of China, Fudan University; Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China(Ministry of Education, China)	This work is partially supported by the National Natural Science Foundation of China (71673055) (http://www.nsfc.gov.cn), Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China (15JZD029), and Key Lab of Health Technology Assessment, National Health and Family Planning Commission of the People's Republic of China, Fudan University.	Adams PD, 2014, AM J SURG, V208, P656, DOI 10.1016/j.amjsurg.2014.03.006; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; ANDRULIS DP, 1995, J ACQ IMMUN DEF SYND, V9, P193; Aparasu RR, 2003, J AM GERIATR SOC, V51, P671, DOI 10.1034/j.1600-0579.2003.00212.x; Aroian KJ, 2001, J NURS SCHOLARSHIP, V33, P265, DOI 10.1111/j.1547-5069.2001.00265.x; BERKI SE, 1976, MED CARE, V14, P405, DOI 10.1097/00005650-197605000-00003; Borras J M, 1994, Gac Sanit, V8, P30; Brown C, 2009, J ALTERN COMPLEM MED, V15, P911, DOI 10.1089/acm.2008.0561; Chao JQ, 2013, ARCH GERONTOL GERIAT, V56, P199, DOI 10.1016/j.archger.2012.10.001; Chen FW, 2007, MOD PREV MED, V16, P3083; de Belvis AG, 2008, PUBLIC HEALTH, V122, P784, DOI 10.1016/j.puhe.2007.08.018; deBoer AGEM, 1997, HEALTH POLICY, V42, P101, DOI 10.1016/S0168-8510(97)00062-6; Dunlop DD, 2002, J GERONTOL B-PSYCHOL, V57, pS221, DOI 10.1093/geronb/57.4.S221; Fernandez-Olano C, 2006, HEALTH POLICY, V75, P131, DOI 10.1016/j.healthpol.2005.02.005; Fuller GF, 2000, AM FAM PHYSICIAN, V61, P2159; Gong CH, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1307-8; HENDEE WR, 1990, ARCH INTERN MED, V150, P2459; Hu HW, 2011, J GUANGXI EC MANAG C, V3, P20; HULKA BS, 1985, MED CARE, V23, P438, DOI 10.1097/00005650-198505000-00009; Jia P, 2014, INT C INF MAN INN MA; Jiang HR, 2013, THEOR RES, P122; Jung M, 2013, SOC SCI MED, V77, P60, DOI 10.1016/j.socscimed.2012.11.005; Kim ES, 2014, PREV MED, V69, P176, DOI 10.1016/j.ypmed.2014.09.008; Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106; Landi F, 2004, J CLIN EPIDEMIOL, V57, P832, DOI 10.1016/j.jclinepi.2004.01.013; Law M, 2005, HEALTH PLACE, V11, P367, DOI 10.1016/j.healthplace.2004.05.004; Li X, 2013, SOC SCI MED, V85, P59, DOI 10.1016/j.socscimed.2013.02.037; Li YN, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1825-4; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; Lin YT, 2011, J CLIN GERONTOL GERI, V2, P53, DOI 10.1016/j.jcgg.2011.03.002; Liu LF, 2012, HEALTH POLICY, V108, P246, DOI 10.1016/j.healthpol.2012.08.022; MAHONEY F I, 1965, Md State Med J, V14, P61; Markides KS, 1996, J AGING HEALTH, V8, P254, DOI [10.1177/089826439600800206, DOI 10.1177/089826439600800206]; Martinez-Selles M, 2002, EUR J HEART FAIL, V4, P779, DOI 10.1016/S1388-9842(02)00116-2; MCCOY JL, 1978, SOC SECUR BULL, V41, P14; McGrail MR, 2014, APPL GEOGR, V54, P182, DOI 10.1016/j.apgeog.2014.08.005; McKinney MM, 2002, J RURAL HEALTH, V18, P455, DOI 10.1111/j.1748-0361.2002.tb00910.x; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; MUTCHLER JE, 1991, J HEALTH SOC BEHAV, V32, P342, DOI 10.2307/2137102; Nie JX, 2008, J EVAL CLIN PRACT, V14, P1044, DOI 10.1111/j.1365-2753.2008.00952.x; PADGETT DK, 1992, SOC SCI MED, V35, P1189, DOI 10.1016/0277-9536(92)90231-E; PADGETT DK, 1995, SOC SCI MED, V41, P547, DOI 10.1016/0277-9536(94)00364-Y; RAJAN SI, 1994, ECON POLIT WEEKLY, V29, P2502; Saliba W, 2013, EUR J INTERN MED, V24, P536, DOI 10.1016/j.ejim.2013.06.002; Schellhorn M, 2000, HEALTH ECON, V9, P533, DOI 10.1002/1099-1050(200009)9:6<533::AID-HEC532>3.0.CO;2-V; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHAPIRO E, 1984, GERONTOLOGIST, V24, P270, DOI 10.1093/geront/24.3.270; United Nations, 1956, AG POP ITS EC SOC IM; Upchurch DM, 2008, WOMEN HEALTH ISS, V18, P62, DOI 10.1016/j.whi.2007.08.003; Wu Xian-guo, 2004, RES APPL BUILDING MA, V1, P21; Xu G, 2010, CHIN J GERONTOL, V10, P1417; Yang L, 2008, MOD PREV MED, V6, P1076; Zang JP, 2002, CHIN RURAL HLTH SERV, V22, P21; Zhang CL, 1996, POPUL RES, V2, P70; 王粤湘, 2008, [中国老年学杂志, Chinese Journal of Gerontology], V28, P2037; 潘传德, 2005, [中国老年学杂志, Chinese Journal of Gerontology], V25, P1325	57	16	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207646	10.1371/journal.pone.0207646	http://dx.doi.org/10.1371/journal.pone.0207646			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC6BO	30507929	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500008
J	Lawrence, YA; Dangott, LJ; Rodrigues-Hoffmann, A; Steiner, JM; Suchodolski, JS; Lidbury, JA				Lawrence, Yuri A.; Dangott, Lawrence J.; Rodrigues-Hoffmann, Aline; Steiner, Jorg M.; Suchodolski, Jan S.; Lidbury, Jonathan A.			Proteomic analysis of liver tissue from dogs with chronic hepatitis	PLOS ONE			English	Article							APOPTOSIS; PROTEIN	Chronic hepatitis is the most common hepatic disease in dogs. Copper accumulation is an important cause of chronic hepatitis in dogs; however, the etiology in most dogs cannot be determined. Clinical signs of chronic hepatitis are often non-specific; therefore, this disease is frequently diagnosed in an advanced stage that makes successful intervention less likely. Early diagnosis of chronic hepatitis in dogs would thus be beneficial. The identification of proteins that are differentially expressed in dogs with chronic hepatitis could contribute to the development of novel diagnostic markers for this disease and provide insight into its pathogenesis. The objective of this study was to identify novel proteins that are differentially expressed in the liver of dogs with chronic hepatitis. Hepatic tissue was collected from 8 healthy dogs during ovariohysterectomy and from 8 dogs with histologically confirmed chronic hepatitis. The proteome of the liver samples was extracted by mechanical disruption and detergent-based cell lysis and differentially labeled prior to analysis by 2-dimensional fluorescence difference gel electrophoresis. Spots with an absolute fold change value > 2.0 were selected for further analysis. Protein identification was achieved by nanoflow liquid chromatography tandem mass spectrometry. Differential expression of select proteins was validated by Western blot. Five protein spots were differentially expressed between patients with chronic hepatitis and healthy control dogs. From these 5 protein spots 11 proteins were identified. Differential expression of cytokeratin 18 and annexin 5 were confirmed by Western blot analysis. Differential protein expression was shown between dogs with chronic hepatitis and healthy control dogs. Upregulation of cytokeratin 18 in chronic hepatitis may suggest increased hepatocellular apoptosis and necrosis, whereas upregulation of annexin 5A suggests increased hepatocellular apoptosis. Further studies are needed to determine whether either protein has diagnostic utility.	[Lawrence, Yuri A.; Steiner, Jorg M.; Suchodolski, Jan S.; Lidbury, Jonathan A.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA; [Dangott, Lawrence J.] Texas A&M Univ, Dept Biochem & Biophys, Prot Chem Lab, College Stn, TX 77843 USA; [Rodrigues-Hoffmann, Aline] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Lawrence, YA (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA.	ylawrence@cvm.tamu.edu	Lawrence, Yuri A/I-3701-2019	Lawrence, Yuri A/0000-0001-9078-2293				Administration FAD, 2001, GUID IND BIOAN METH; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bexfield NH, 2011, VET REC, V169, P415, DOI 10.1136/vr.d4665; Center SA, 2007, VET CLIN N AM-SMALL, V37, P297, DOI 10.1016/j.cvsm.2006.11.009; Cullen J., 2006, WSAVA STANDARDS CLIN; Dirksen K, 2017, J VET INTERN MED, V31, P1017, DOI 10.1111/jvim.14716; Dirksen K, 2016, VET J, V211, P75, DOI 10.1016/j.tvjl.2016.01.010; Grider A, 2007, MOL GENET METAB, V92, P249, DOI 10.1016/j.ymgme.2007.07.003; Hawkins TE, 2002, P NATL ACAD SCI USA, V99, P8054, DOI 10.1073/pnas.132598099; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Kemp SD, 2015, J VET INTERN MED, V29, P51, DOI [10.1111/jvim.12508, 10.1111/jvim.12455]; Lawrence YA, 2017, VET CLIN N AM-SMALL, V47, P539, DOI 10.1016/j.cvsm.2016.11.005; Lebensztejn DM, 2011, ACTA BIOCH POLONICA, V58; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Linder S, 2004, CANCER LETT, V214, P1, DOI 10.1016/j.canlet.2004.06.032; Molleken C, 2009, HEPATOLOGY, V49, P1257, DOI 10.1002/hep.22764; Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; Raffan E, 2009, J VET INTERN MED, V23, P63, DOI 10.1111/j.1939-1676.2008.0230.x; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; SEVELIUS E, 1995, J SMALL ANIM PRACT, V36, P521, DOI 10.1111/j.1748-5827.1995.tb02801.x; Thornburg LP, 1998, VET PATHOL, V35, P380, DOI 10.1177/030098589803500507; Tsutsui M, 2010, J CLIN GASTROENTEROL, V44, P440, DOI 10.1097/MCG.0b013e3181bdefe2; VANDENINGH TSGAM, 1988, VET QUART, V10, P84, DOI 10.1080/01652176.1988.9694154; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yilmaz Y, 2009, ALIMENT PHARM THER, V30, P1103, DOI 10.1111/j.1365-2036.2009.04148.x	26	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208394	10.1371/journal.pone.0208394	http://dx.doi.org/10.1371/journal.pone.0208394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500850	Green Published, Green Submitted, gold			2022-12-26	WOS:000451883700035
J	Fossdal, TS; Kippe, K; Handegard, BH; Lagestad, P				Fossdal, Tom Stian; Kippe, Karin; Handegard, Bjorn Helge; Lagestad, Pal			"Oh oobe doo, I wanna be like you" associations between physical activity of preschool staff and preschool children	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; ACCELEROMETER; KINDERGARTEN; CALIBRATION; ENVIRONMENT; CHILDHOOD; ADULTHOOD; PROMOTION; ATTITUDES; OBESITY	Objective Physical activity contributes to prevent serious diseases and ailments, and previous research indicates that lifestyle habits are likely to track from early childhood to adulthood. 90% of Norwegian children aged 1-5 are enrolled in preschools, and preschool staff can play an important role in children's activity levels. This study's aim was to identify whether any associations exist between preschool staff's characteristics (initiative, participation, attitudes, and activity levels) and children's activity in preschool. Method 289 children aged 4-6 and 72 preschool staff from 13 randomly selected preschools in a region of Nord-Troendelag, Norway, were enrolled in the study. All participants wore an Actigraph accelerometer for seven consecutive days. Questionnaires were also utilized to identify correlates between preschool staff's attitudes and initiative in relation to children's physical activity, in addition to their participation in children's physical activity. A multilevel analysis, the linear mixed model (LMM), was used to elucidate associations between preschool staff and children's activity levels. Results A significant association was found between preschool staff's average activity levels during preschool hours and children's corresponding activity levels during preschool hours (t = 2.57; p = 0.021; f(2) = 0.013). There were, however, no significant associations identified between the attitudes (t = -0.44; p = 0.67), initiative (t = -0.14; p = 0.89), and participation (t = 0.66; p = 0.52) variables among preschool staff and children's activity levels during preschool hours. Conclusion The study demonstrated that a significant association exists between preschool staff's aggregated activity levels and 4-6-year-olds' individual activity levels. However, an observational study is requisite in order to determine whether the association is based on preschool staff's impact on children's physical activity or if it is the children that affect the preschool staff's activity levels, or a combination there of.	[Fossdal, Tom Stian; Kippe, Karin; Lagestad, Pal] Nord Univ, Fac Educ & Arts, Levanger, Norway; [Handegard, Bjorn Helge] UIT Arctic Univ Norway, Ctr Child & Adolescent Mental Hlth, Tromso, Norway	Nord University; UiT The Arctic University of Tromso	Fossdal, TS (corresponding author), Nord Univ, Fac Educ & Arts, Levanger, Norway.	tomstianfossdal@gmail.com		Fossdal, Tom Stian/0000-0002-2943-1504				Addy CL, 2014, PEDIATR EXERC SCI, V26, P103, DOI 10.1123/pes.2013-0021; Ainsworth B, 2015, PROG CARDIOVASC DIS, V57, P387, DOI 10.1016/j.pcad.2014.10.005; Anderssen S., 2009, FYSISK AKTIVITET BLA; Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; Biddle S, 1996, J SCHOOL HEALTH, V66, P75, DOI 10.1111/j.1746-1561.1996.tb07914.x; Boon RM, 2010, BRIT J SPORT MED, V44, P741, DOI 10.1136/bjsm.2008.052167; Bower JK, 2008, AM J PREV MED, V34, P23, DOI 10.1016/j.amepre.2007.09.022; Brage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137206; Brown WH, 2009, J EARLY INTERVENTION, V31, P126, DOI 10.1177/1053815109331858; Brown WH, 2009, CHILD DEV, V80, P45, DOI 10.1111/j.1467-8624.2008.01245.x; Bruin J, 2006, NEWTEST COMMAND COMP; Butte NF, 2014, MED SCI SPORT EXER, V46, P1216, DOI 10.1249/MSS.0000000000000209; Cashmore AW, 2008, J RES CHILD EDUC, V23, P179, DOI 10.1080/02568540809594654; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Copeland KA, 2012, HEALTH EDUC RES, V27, P81, DOI 10.1093/her/cyr038; De Marco AC, 2015, EARLY EDUC DEV, V26, P1, DOI 10.1080/10409289.2014.932237; Dencker M, 2006, EUR J APPL PHYSIOL, V96, P587, DOI 10.1007/s00421-005-0117-1; Dowda Marsha, 2009, Pediatrics, V123, pe261, DOI 10.1542/peds.2008-2498; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Eagly A. H., 1993, PSYCHOL ATTITUDES, DOI DOI 10.1002/MAR; Ekornrud T, 2012, SAMFUNNSSPEILET; Elhakeem A, 2015, INT J BEHAV NUTR PHY, V12, DOI [10.1186/s12966-015-0250-0, 10.1186/s12966-015-0274-5]; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Festinger L., 1962, THEORY COGNITIVE DIS; Finn K, 2002, J PEDIATR-US, V140, P81, DOI 10.1067/mpd.2002.120693; Goldfield GS, 2016, AM J PREV MED, V51, P225, DOI 10.1016/j.amepre.2016.03.024; Goldfield GS, 2012, INT J ENV RES PUB HE, V9, P1326, DOI 10.3390/ijerph9041326; Gubbels JS, 2011, HEALTH PSYCHOL, V30, P84, DOI 10.1037/a0021586; Hansen B, 2014, FYSISK BLANT VOKSNE; Hansen BH, 2014, INT J PUBLIC HEALTH, V59, P221, DOI 10.1007/s00038-013-0472-3; Hesketh Kathryn R, 2016, Prev Med Rep, V3, P53, DOI 10.1016/j.pmedr.2015.12.004; Hinkley T, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0444-0; Kim Y, 2013, J SCI MED SPORT, V16, P129, DOI 10.1016/j.jsams.2012.05.015; Kippe K, PHYS ACTIVITY LEVEL; Kolle E, 2012, IS2002 HELS; Lagestad P, 2016, SCI J PUBLIC HLTH, V4, P147, DOI DOI 10.11648/J.SJPH.20160403.12; LaPiere RT, 1934, SOC FORCES, V13, P230, DOI 10.2307/2570339; Madland A., 2013, BETYDNINGEN HELE MEG; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Mcclain JJ, 2007, MED SCI SPORT EXER, V39, P1509, DOI 10.1249/mss.0b013e3180dc9954; Metcalf BS, 2008, ARCH DIS CHILD, V93, P772, DOI 10.1136/adc.2007.135012; Mikkelsen BE, 2011, INT J PEDIATR OBES, V6, P12, DOI 10.3109/17477166.2011.613655; Nerhus KA, 2011, NORSK EPIDEMIOLOGI, V20; Nicaise V, 2011, PREV MED, V53, P309, DOI 10.1016/j.ypmed.2011.08.018; Nielsen G, BARRIERER BORNS BEVA, P183; Oliver M, 2007, SPORTS MED, V37, P1045, DOI 10.2165/00007256-200737120-00004; Pate RR, 2004, PEDIATRICS, V114, P1258, DOI 10.1542/peds.2003-1088-L; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; Pate RR, 2013, RES Q EXERCISE SPORT, V84, P448, DOI 10.1080/02701367.2013.844038; Penpraze V, 2006, PEDIATR EXERC SCI, V18, P483, DOI 10.1123/pes.18.4.483; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Raitakari OT, 2005, INT J OBESITY, V29, pS101, DOI 10.1038/sj.ijo.0803085; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sansolios S, 2011, INT J PEDIATR OBES, V6, P28, DOI 10.3109/17477166.2011.613659; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; SNIJDERS TAB, 2011, INT ENCY STAT SCI, P879, DOI DOI 10.1007/978-3-642-04898-2_387; Sorensen HV, 2012, THESIS; Statistics Norway, 2017, BARN 2016 END TALL; Taylor RW, 2009, MED SCI SPORT EXER, V41, P96, DOI 10.1249/MSS.0b013e3181849d81; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Thomas JR., 2015, RES METHODS PHYS ACT, V7; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Utdanningsdirektoratet, 2016, BARNS TRIVS VOKSN AN; Vaage OF, 2012, TIDENE SKIFTER; Vale S, 2009, PEDIATR EXERC SCI, V21, P413, DOI 10.1123/pes.21.4.413; Van Cauwenberghe E, 2010, ANN EXCH M CAMBR AMS; van Rossem L, 2012, PREV MED, V54, P55, DOI 10.1016/j.ypmed.2011.10.016; Vygotsky L.S., 1978, MIND SOC DEV HIGHER, P79, DOI DOI 10.2307/J.CTVJF9VZ4.11; World Health Organization, 2010, GLOB REC PHYS ACT HL; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079	77	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208001	10.1371/journal.pone.0208001	http://dx.doi.org/10.1371/journal.pone.0208001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496229	Green Submitted, gold, Green Published			2022-12-26	WOS:000451763800073
J	Kikuchi, H; Kanda, E; Mori, T; Sato, H; Iimori, S; Nomura, N; Naito, S; Sohara, E; Okado, T; Uchida, S; Fushimi, K; Rai, T				Kikuchi, Hiroaki; Kanda, Eiichiro; Mori, Takayasu; Sato, Hidehiko; Iimori, Soichiro; Nomura, Naohiro; Naito, Shotaro; Sohara, Eisei; Okado, Tomokazu; Uchida, Shinichi; Fushimi, Kiyohide; Rai, Tatemitsu			Short-term prognosis of emergently hospitalized dialysis-independent chronic kidney disease patients: A nationwide retrospective cohort study in Japan	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY PARADOX; WORKLOAD INDEX; TRANSFER SCORE; MORTALITY; OUTCOMES; ASSOCIATION; STABILITY; WEIGHT; CKD	In patients with chronic kidney disease (CKD), low body mass index (BMI) is associated with high mortality. This relationship in emergently hospitalized CKD patients is unknown. We investigated the association between obesity and short-term mortality in emergently admitted patients with dialysis-independent CKD (DI-CKD) with and without infection. This retrospective cohort study examined Diagnosis Procedure Combination data of 26103 emergently hospitalized DI-CKD patients. Patients were divided into 8 groups according to their BMI and the presence of infectious diseases. The primary outcome was in-hospital death within 100 days. Cox proportional hazards models adjusted for baseline characteristics showed that low BMI was associated with the outcome both in infected and in noninfected patients (reference group as non-infected and medium BMI [24-26 kg/m(2)] group): infected and the lowest BMI (<= 20 kg/m(2)) group, hazard ratio (HR) 1.82 (95% confidence interval 1.51, 2.19); non-infected and the lowest BMI group, 1.39 (1.16, 1.67). When patients were stratified according to presence of diabetes mellitus (DM), patients with DM showed that low BMI was associated with the outcome both in infected and in non-infected patients, whereas in non-DM patients, this relationship was attenuated in the non-infected group. For emergently hospitalized CKD patients with infection, high BMI was associated with lower mortality irrespective of the DM status. For non-infected patients, the effects of obesity for in-hospital mortality were modified by the DM status.	[Kikuchi, Hiroaki; Mori, Takayasu; Sato, Hidehiko; Iimori, Soichiro; Nomura, Naohiro; Naito, Shotaro; Sohara, Eisei; Okado, Tomokazu; Uchida, Shinichi; Rai, Tatemitsu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nephrol, Tokyo, Japan; [Kanda, Eiichiro] Kawasaki Med Sch, Med Sci, Okayama, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hlth Policy & Informat, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Kawasaki Medical School; Tokyo Medical & Dental University (TMDU)	Rai, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nephrol, Tokyo, Japan.	trai.kid@tmd.ac.jp			Ministry of Health, Labour, and Welfare, Japan [H27-Policy-Designated-009]; Japan Society for the Promotion of Science [16K09642]	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants for Research on Policy Planning and Evaluation from the Ministry of Health, Labour, and Welfare, Japan (grant numbers: H27-Policy-Designated-009) (http://www.mhlw.go.jp/english/), and Grants-in-Aid for Scientific Research (C) (16K09642) to TR from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants/index.html).There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190410; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bello A, 2013, NEPHROL DIAL TRANSPL, V28, P57, DOI 10.1093/ndt/gft284; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Costanzo P, 2015, ANN INTERN MED, V162, P610, DOI 10.7326/M14-1551; Dehlendorff C, 2014, JAMA NEUROL, V71, P978, DOI 10.1001/jamaneurol.2014.1017; Fleischmann E, 1999, KIDNEY INT, V55, P1560, DOI 10.1046/j.1523-1755.1999.00389.x; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gajic O, 2008, CRIT CARE MED, V36, P676, DOI 10.1097/CCM.0B013E318164E3B0; Hutagalung R, 2011, INTENS CARE MED, V37, P1793, DOI 10.1007/s00134-011-2321-2; Kalantar-Zadeh K, 2017, KIDNEY INT REP, V2, P271, DOI 10.1016/j.ekir.2017.01.009; Kastrup M, 2013, CRIT CARE MED, V41, P1608, DOI 10.1097/CCM.0b013e31828a217b; Kikuchi H, 2017, CLIN EXP NEPHROL, V21, P55, DOI 10.1007/s10157-016-1251-2; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Kwan BCH, 2007, CLIN J AM SOC NEPHRO, V2, P992, DOI 10.2215/CJN.04221206; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Malgorzewicz S, 2004, J RENAL NUTR, V14, P242, DOI 10.1053/j.jrn.2004.07.007; Ni YN, 2017, CRIT CARE, V21, P36, DOI [10.1016/j.jacc.2013.05.058, DOI 10.1016/J.JACC.2013.05.058]; Park J, 2014, PROG CARDIOVASC DIS, V56, P415, DOI 10.1016/j.pcad.2013.10.005; Payvar S, 2013, J AM COLL CARDIOL, V62, P692, DOI 10.1016/j.jacc.2013.05.058; Pupim LB, 2005, KIDNEY INT, V68, P2368, DOI 10.1111/j.1523-1755.2005.00699.x; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Rios-Diaz AJ, 2017, AM J SURG, V214, P385, DOI 10.1016/j.amjsurg.2016.05.006; Rosa RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143127; Stenvinkel P, 2016, J AM SOC NEPHROL, V27, P1479, DOI 10.1681/ASN.2015030252; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Wada T, 2016, STROKE, V47, P471, DOI 10.1161/STROKEAHA.115.011250	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208258	10.1371/journal.pone.0208258	http://dx.doi.org/10.1371/journal.pone.0208258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496295	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800119
J	Rehman, IU; Munib, S; Ramadas, A; Khan, TM				Rehman, Inayat Ur; Munib, Syed; Ramadas, Amutha; Khan, Tahir Mehmood			Prevalence of chronic kidney disease-associated pruritus, and association with sleep quality among hemodialysis patients in Pakistan	PLOS ONE			English	Article							OF-LIFE; UREMIC PRURITUS; DIALYSIS OUTCOMES; PRACTICE PATTERNS; IMPACT; HYPERTENSION; DURATION; ITCH	Background The prevalence of chronic kidney disease-associated pruritus (CKD-aP) varies from 22% to 84% among patients receiving hemodialysis. It occurs more frequently at night, and often affects patient's sleep quality. CKD-aP is often unreported by patients, and many do not receive effective treatment. There is, however, a paucity of available data on the prevalence and impact of CKD-aP on patients receiving hemodialysis in Pakistan. Methods A multicenter cross-sectional study was undertaken from July 2016 to April 2017 at a tertiary care hospitals in Pakistan. Results 354 patients undergoing hemodialysis were studied. 35.6% had CKD for 1-2 years, and 42.4% were receiving hemodialysis for 1-2 years. The prevalence of pruritus was 74%. The median [interquartile range] score for pruritus was 10.0 (out of possible 25) [8.0-12.0]; while the median [interquartile range] Pittsburgh Sleep Quality Index (PSQI) score was 8.0 (out of possible 21) [7.0-10.0]'. Pruritus was significantly correlated with the sleep score (r = 0.423, p< 0.001). The results of the multivariate linear regression revealed a positive association between pruritus and age of patients (beta = 0.031; 95% CI = 0.002-0.061; p = 0.038) and duration of CKD (beta = -0.013; 95% CI = -0.023-0.003; p = 0.014). Similarly there was a positive association between sleep score and duration of CKD (beta = 0.010; 95% CI = 0.002-0.019; p = 0.012) and pruritus (beta = 0.143; 95% CI = 0.056-0.230; p = 0.001). Conclusions Chronic kidney disease-associated pruritus is very common in patients receiving hemodialysis in Pakistan. Pruritus is significantly associated with poor sleep quality.	[Rehman, Inayat Ur; Khan, Tahir Mehmood] Monash Univ, Sch Pharm, Jalan Lagoon Selatan, Selangor Darul Ehsan, Malaysia; [Rehman, Inayat Ur] Abdul Wali Khan Univ, Dept Pharm, Mardan, Pakistan; [Munib, Syed] Inst Kidney Dis, Dept Nephrol, Peshawar, Pakistan; [Ramadas, Amutha] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Jalan Lagoon Selatan, Selangor Darul Ehsan, Malaysia; [Khan, Tahir Mehmood] UVAS, IPS, Lahore, Pakistan	Monash University; Monash University Sunway; Abdul Wali Khan University; Monash University; Monash University Sunway	Rehman, IU; Khan, TM (corresponding author), Monash Univ, Sch Pharm, Jalan Lagoon Selatan, Selangor Darul Ehsan, Malaysia.; Rehman, IU (corresponding author), Abdul Wali Khan Univ, Dept Pharm, Mardan, Pakistan.; Khan, TM (corresponding author), UVAS, IPS, Lahore, Pakistan.	inayat.rehman@monash.edu; tahir.mehmood@monash.edu	Ramadas, Amutha/G-7532-2014; Munib, Syed/AAW-7080-2021; Khan, Tahir/ABA-6714-2021; Khan, Yusra Habib/AFK-9024-2022; Rehman, Inayat Ur/GVT-4724-2022	Khan, Yusra Habib/0000-0002-9479-6147; Rehman, Inayat Ur/0000-0002-8657-9791; Ramadas, Amutha/0000-0002-8238-9659				Adejumo O, 2016, ETHIOP J HEALTH SCI, V26, P549, DOI 10.4314/ejhs.v26i6.7; Akca NK, 2013, ALTERN THER HEALTH M, V19, P12; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Boivin MJ, 2018, AIDS, V32, P189, DOI 10.1097/QAD.0000000000001683; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cengic B, 2012, INT UROL NEPHROL, V44, P557, DOI 10.1007/s11255-010-9881-x; Chauhan R, 2015, Indian J Nephrol, V25, P329, DOI 10.4103/0971-4065.151762; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; Einollahi B, 2015, NEPHROUROL MON, V7, P1; Elder SJ, 2008, NEPHROL DIAL TRANSPL, V23, P998, DOI 10.1093/ndt/gfm630; Elman S, 2010, BRIT J DERMATOL, V162, P587, DOI 10.1111/j.1365-2133.2009.09586.x; Erturk IE, 2012, ANN DERMATOL, V24, P406, DOI 10.5021/ad.2012.24.4.406; Guo XF, 2015, J SLEEP RES, V24, P351, DOI 10.1111/jsr.12274; HIROSHIGE K, 1995, AM J KIDNEY DIS, V25, P413, DOI 10.1016/0272-6386(95)90102-7; Hu XM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010633; Ibrahim MK, 2016, J CLIN DIAGN RES, V10, pWC1, DOI 10.7860/JCDR/2016/16273.7488; Karadag E, 2014, JPN J NURS SCI, V11, P180, DOI 10.1111/jjns.12019; Kavurmaci M, 2015, HEMODIAL INT, V19, P531, DOI 10.1111/hdi.12301; Khan Sla TI, 2010, PAKISTAN J MED HLTH, V4, P116; Khan TM, 2016, SCI REPORTS, V6; Kim KH, 2010, J PAIN SYMPTOM MANAG, V40, P117, DOI 10.1016/j.jpainsymman.2009.11.325; Kimata N, 2014, HEMODIAL INT, V18, P657, DOI 10.1111/hdi.12158; Ko MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071404; Luqman N., 2012, J PAK ASS DERMATOL, V22, P219; Mathur VS, 2010, CLIN J AM SOC NEPHRO, V5, P1410, DOI 10.2215/CJN.00100110; Meisinger C, 2005, DIABETOLOGIA, V48, P235, DOI 10.1007/s00125-004-1634-x; Melo NCV, 2009, HEMODIAL INT, V13, P38, DOI 10.1111/j.1542-4758.2009.00346.x; Mirza R, 2012, J LIAQUAT UNIV MED H, V11, P24; Mistik S, 2006, J EUR ACAD DERMATOL, V20, P672, DOI 10.1111/j.1468-3083.2006.01570.x; Narita I, 2006, KIDNEY INT, V69, P1626, DOI 10.1038/sj.ki.5000251; Narita I, 2008, J NEPHROL, V21, P161; Noh SH, 2018, ANN DERMATOL, V30, P473, DOI 10.5021/ad.2018.30.4.473; Novak M, 2004, J PSYCHOSOM RES, V56, P527, DOI 10.1016/j.jpsychores.2004.02.007; Ozen N, 2018, KIDNEY RES CLIN PRAC, V37, P138, DOI 10.23876/j.krcp.2018.37.2.138; Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461; Ramakrishnan K, 2014, INT J NEPHROL RENOV, V7, P1, DOI 10.2147/IJNRD.S52985; Rehman IU, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0717-0; Sheikh M., 2016, J PAK ASS DERMATOL, V24, P150; Shirazian S, 2017, INT J NEPHROL RENOV, V10, P11, DOI 10.2147/IJNRD.S108045; Takahashi N, 2016, RENAL REPLACEMENT TH, V2, P1; Tattersall J, 2018, NEPHROL DIAL TRANSPL, V33, P742, DOI 10.1093/ndt/gfy042; Tessari G, 2009, J NEPHROL, V22, P241; Van Cauter E, 2011, DIABETIC MED, V28, P1455, DOI 10.1111/j.1464-5491.2011.03459.x; Vozoris NT, 2013, J HYPERTENS, V31, P663, DOI 10.1097/HJH.0b013e32835ed5d0; Weiss M, 2015, ACTA DERM-VENEREOL, V95, P816, DOI 10.2340/00015555-2087; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032; Yosipovitch G, 2001, ACTA DERM-VENEREOL, V81, P108; Zucker I, 2003, J AM ACAD DERMATOL, V49, P842, DOI 10.1016/S0190-9622(03)02478-2	48	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207758	10.1371/journal.pone.0207758	http://dx.doi.org/10.1371/journal.pone.0207758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496235	gold, Green Submitted, Green Published			2022-12-26	WOS:000451763800046
J	Wang, WJ; Tang, MH; Jiao, PF				Wang, Wenjun; Tang, Minghu; Jiao, Pengfei			A unified framework for link prediction based on non-negative matrix factorization with coupling multivariate information	PLOS ONE			English	Article							MISSING LINKS	Many link prediction methods have been developed to infer unobserved links or predict missing links based on the observed network structure that is always incomplete and subject to interfering noise. Thus, the performance of existing methods is usually limited in that their computation depends only on input graph structures, and they do not consider external information. The effects of social influence and homophily suggest that both network structure and node attribute information should help to resolve the task of link prediction. This work proposes SASNMF, a link prediction unified framework based on non-negative matrix factorization that considers not only graph structure but also the internal and external auxiliary information, which refers to both the node attributes and the structural latent feature information extracted from the network. Furthermore, three different combinations of internal and external information are proposed and input into the framework to solve the link prediction problem. Extensive experimental results on thirteen real networks, five node attribute networks and eight non-attribute networks show that the proposed framework has competitive performance compared with benchmark methods and state-of-the-art methods, indicating the superiority of the presented algorithm.	[Wang, Wenjun; Tang, Minghu; Jiao, Pengfei] Tianjin Univ, Coll Intelligence & Comp, Sch Comp Sci & Technol, Tianjin, Peoples R China; [Tang, Minghu] Qinghai Nationalities Univ, Sch Comp Sci & Technol, Xining, Qinghai, Peoples R China	Tianjin University; Qinghai Nationalities University	Tang, MH (corresponding author), Tianjin Univ, Coll Intelligence & Comp, Sch Comp Sci & Technol, Tianjin, Peoples R China.; Tang, MH (corresponding author), Qinghai Nationalities Univ, Sch Comp Sci & Technol, Xining, Qinghai, Peoples R China.	mhtang@tju.edu.cn	Wang, Ji/A-3774-2009	Wang, Ji/0000-0002-0724-7538; Tang, MingHu/0000-0003-2236-959X	Major Project of National Social Science Fundation of China [14ZDB153]; major research plan of the National Natural Science Foundation of China [91746205, 91746107, 91224009, 51438009]; research project of applied basic of Qinghai Province [2018-ZJ-707]	Major Project of National Social Science Fundation of China; major research plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); research project of applied basic of Qinghai Province	This work was supported by the Major Project of National Social Science Fundation of China (14ZDB153), the major research plan of the National Natural Science Foundation of China (91746205,91746107,91224009,51438009), the research project of applied basic of Qinghai Province(2018-ZJ-707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Al Hasan M, 2006, SDM06 WORKSH LINK AN; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; Bao Y, 2014, AAAI CONF ARTIF INTE, P2; Batagelj V., PAJEK DATASETS; Benigni MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181405; Berlusconi G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154244; Bohannon J, 2009, SCIENCE, V325, P409, DOI 10.1126/science.325_409; Budur E, 2015, COMPUTER SCI, P641; Chen BL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182968; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Fan XH, 2017, IEEE T CYBERNETICS, V47, P589, DOI 10.1109/TCYB.2016.2521376; Feng SS, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P2069; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Gong NZ, 2014, ACM T INTEL SYST TEC, V5, DOI 10.1145/2594455; Grossetti M, 2006, SOCIOL TRAV, V48, P88, DOI 10.1016/j.soctra.2006.01.001; Guan Q, 2016, ENERGY, V102, P406, DOI 10.1016/j.energy.2016.02.099; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Hsu CC, 2017, WSDM'17: PROCEEDINGS OF THE TENTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P771, DOI 10.1145/3018661.3018668; Huang ZC, 2017, LECT NOTES ARTIF INT, V10234, P368, DOI 10.1007/978-3-319-57454-7_29; Jordan T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176094; Kim, 2011, ARXIV11065053; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kumar R, 2004, COMMUN ACM, V47, P35, DOI 10.1145/1035134.1035162; kumar R, 2006, KDD 06; La Ford T., 2010, P WWW 2010, P601, DOI [10.1145/1772690.1772752, DOI 10.1145/1772690.1772752]; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu FD, 2018, J ELECTR COMPUT ENG, V2018, DOI 10.1155/2018/6270816; Liu Z, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48007; Lu Q, 2003, P IJCAI WORKSH TEX M; Lu LY, 2015, P NATL ACAD SCI USA, V112, P2325, DOI 10.1073/pnas.1424644112; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Mallek S., 2017, LNCS LNAI, V10350, P595, DOI [10.1007/978-3-319-60042-0_65, DOI 10.1007/978-3-319-60042-0_65, 10.1007/978-3-319-60042, DOI 10.1007/978-3-319-60042]; Martinez V, 2017, ACM COMPUT SURV, V49, DOI 10.1145/3012704; McAuley J.J, 2012, ADV NEURAL INFORM PR, P548; Menon A. K., 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P364, DOI 10.1109/ICDM.2010.148; Menon AK, 2011, LECT NOTES ARTIF INT, V6912, P437, DOI 10.1007/978-3-642-23783-6_28; Miller KT, 2009, P NEUR INF PROC SYST; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Pan LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22955; Pech R, 2017, EPL-EUROPHYS LETT, V117, DOI 10.1209/0295-5075/117/38002; Shi SL, 2015, 2015 12TH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (FSKD), P1263, DOI 10.1109/FSKD.2015.7382124; Sui DZ, 2011, ICWSM, P81, DOI DOI 10.1109/WCSP.2011.6096843; Tayebi MA, 2016, LECT NOTES SOC NETW, P7, DOI 10.1007/978-3-319-41492-8_2; Tong, 2008, P 14 ACM SIGKDD INT, P686, DOI DOI 10.1145/1401890.1401973; Tsugawa S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170279; Vasiloglou N., 2009, P 2009 SIAM INT C DA, P673, DOI [10.1137/1.9781611972795.58, DOI 10.1137/1.9781611972795.58]; WANG P, 2015, SCI CHINA INFORM SCI, V58, P1, DOI DOI 10.1007/S11432-014-5237-Y; Wang WQ, 2016, SCI REP-UK, V6, DOI [10.1038/srep19637, 10.1038/srep38938]; Wang YX, 2013, IEEE T KNOWL DATA EN, V25, P1336, DOI 10.1109/TKDE.2012.51; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xu XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14847-2; Yang Q, 2014, P INT CONF NAT COMPU, P823, DOI 10.1109/ICNC.2014.6975944; Yin Z, 2010, P 19 INT C WORLD WID, P1211, DOI DOI 10.1145/1772690.1772879; Yuan GC, 2014, PROCEEDINGS OF THE 8TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS'14), P17, DOI 10.1145/2645710.2645734; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang XC, 2016, IEEE T NEUR NET LEAR, V27, P1514, DOI 10.1109/TNNLS.2015.2448653; Zhang Y, 2014, 2014 11TH WEB INFORMATION SYSTEM AND APPLICATION CONFERENCE (WISA), P144, DOI 10.1109/WISA.2014.34	62	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208185	10.1371/journal.pone.0208185	http://dx.doi.org/10.1371/journal.pone.0208185			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496261	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800104
J	Einbeck, J; Ainsbury, EA; Sales, R; Barnard, S; Kaestle, F; Higueras, M				Einbeck, Jochen; Ainsbury, Elizabeth A.; Sales, Rachel; Barnard, Stephen; Kaestle, Felix; Higueras, Manuel			A statistical framework for radiation dose estimation with uncertainty quantification from the gamma-H2AX assay	PLOS ONE			English	Article							DICENTRIC CHROMOSOMES; DNA-DAMAGE; FOCI; BIODOSIMETRY; IRRADIATION; REGRESSION; TOOL	Over the last decade, the gamma-H2AX focus assay, which exploits the phosphorylation of the H2AX histone following DNA double-strand-breaks, has made considerable progress towards acceptance as a reliable biomarker for exposure to ionizing radiation. While the existing literature has convincingly demonstrated a dose-response effect, and also presented approaches to dose estimation based on appropriately defined calibration curves, a more widespread practical use is still hampered by a certain lack of discussion and agreement on the specific dose-response modelling and uncertainty quantification strategies, as well as by the unavailability of implementations. This manuscript intends to fill these gaps, by stating explicitly the statistical models and techniques required for calibration curve estimation and subsequent dose estimation. Accompanying this article, a web applet has been produced which implements the discussed methods.	[Einbeck, Jochen; Sales, Rachel] Univ Durham, Dept Math Sci, Durham, England; [Ainsbury, Elizabeth A.; Barnard, Stephen] Publ Hlth England, Chem & Environm Hazards, Didcot, Oxon, England; [Kaestle, Felix] Fachbereich Strahlenschutz & Gesundheit, Bundesamt Strahlenschutz, Oberschleissheim, Germany; [Higueras, Manuel] Univ La Rioja, Dept Matemat & Comp, Logrono, La Rioja, Spain; [Higueras, Manuel] Basque Ctr Appl Math, Bilbao, Basque Country, Spain	Durham University; Public Health England; Universidad de La Rioja; Basque Center for Applied Mathematics (BCAM)	Einbeck, J (corresponding author), Univ Durham, Dept Math Sci, Durham, England.	jochen.einbeck@durham.ac.hk	Einbeck, Jochen/AAL-7261-2021; Higueras, Manuel/F-4966-2017	Einbeck, Jochen/0000-0002-9457-2020; Barnard, Stephen/0000-0002-1041-8908; Ainsbury, Elizabeth/0000-0001-8076-6978; Higueras, Manuel/0000-0001-5530-1714	European Cooperation in Science and Technology [IC1408]; Basque Government [BERC 360 2014-2017]; Spanish Ministry of Economy and Competitiveness [SEV-2013-0323]; European Union [EUMUC2017]; UK NIHR; Pilot Grant from the Opportunity Funds Management Core of the Centers for Medical Countermeasures against Radiation, National Institute of Allergy and Infectious Diseases [U19AI067773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Basque Government(Basque Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union(European Commission); UK NIHR(National Institute for Health Research (NIHR)); Pilot Grant from the Opportunity Funds Management Core of the Centers for Medical Countermeasures against Radiation, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant Number: Action IC1408, Funder: European Cooperation in Science and Technology URL https://www.cost.eu/actions/IC1408/, Recipient: Jochen Einbeck; Grant Number: BERC 360 2014-2017, Funder: Basque Government, URL http://www.euskadi.eus/gobierno-vasco/-/ayuda_subvencion/2014/berc/, Recipient: Manuel Higureas; Grant Number: SEV-2013-0323, Funder: Spanish Ministry of Economy and Competitiveness, URL https://rio.jrc.ec.europa.eu/en/organisations/ministry-economy-and-competitiveness-mineco, Recipient: Manuel Higueras; Grant Number: EUMUC2017, Funder: European Union, URL: https://www.erasmusplus.org.uk/, Recipient: Felix Kaestle; Grant Number: NIHR-HPRU-Chemical&RadiationThreats& Hazards, Funder: UK NIHR, URL: https://www.nihr.ac.uk/about-us/how-we-are-managed/our-structure/research/health-protection-research-units.htm, Recipient: Liz Ainsbury and Stephen Barnard; and Grant Number: U19AI067773, Funder: Pilot Grant from the Opportunity Funds Management Core of the Centers for Medical Countermeasures against Radiation, National Institute of Allergy and Infectious Diseases, URL: https://www.niaid.nih.gov/research/radiation-nuclear-countermeasures-program, Recipient: Liz Ainsbury and Stephen Barnard.	Ainsbury EA, 2017, INT J RADIAT BIOL, V93, P127, DOI 10.1080/09553002.2016.1227106; Ainsbury EA, 2010, HEALTH PHYS, V98, P290, DOI 10.1097/01.HP.0000346305.84577.b4; Barnard Stephen, 2013, Genome Integr, V4, P1, DOI 10.1186/2041-9414-4-1; Chua MLK, 2011, RADIOTHER ONCOL, V99, P225, DOI 10.1016/j.radonc.2011.04.009; Deperas J, 2007, RADIAT PROT DOSIM, V124, P115, DOI 10.1093/rpd/ncm137; Edwards AA, 1997, RADIAT RES, V148, pS39, DOI 10.2307/3579715; Einbeck J., 2017, TRENDS MATH, V7, P89; Higueras M, 2016, RADIAT PROT DOSIM, V168, P330, DOI 10.1093/rpd/ncv356; Higueras M, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2014.0588; HILALI A, 1991, RADIAT RES, V128, P108, DOI 10.2307/3578074; Hlatky L, 2002, BIOESSAYS, V24, P714, DOI 10.1002/bies.10126; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Horn S., 2011, PLOS ONE, V6; IAEA, 2011, CYT DOS APPL PREP RE; Lisowska H, 2013, INT J RADIAT BIOL, V89, P191, DOI 10.3109/09553002.2013.741284; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Ludwig Fahrmeir, 2011, MULTIVARIATE STAT MO; Manning G, 2013, INT J RADIAT BIOL, V89, P512, DOI 10.3109/09553002.2013.769694; Maznyk NA, 2012, RADIAT PROT DOSIM, V151, P611, DOI 10.1093/rpd/ncs156; Moquet J, 2017, INT J RADIAT BIOL, V93, P58, DOI 10.1080/09553002.2016.1207822; Moquet J, 2014, PEERJ, V2, DOI 10.7717/peerj.282; Oliveira M, 2016, BIOMETRICAL J, V58, P259, DOI 10.1002/bimj.201400233; Perumal V, 2015, WORLD J RADIOL, V7, P266, DOI 10.4329/wjr.v7.i9.266; Puig P, 2011, P ROY SOC A-MATH PHY, V467, P897, DOI 10.1098/rspa.2010.0384; R Core Team, 2018, R A LANGUAGE AND ENV; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romm H, 2013, MUTAT RES-GEN TOX EN, V756, P174, DOI 10.1016/j.mrgentox.2013.05.013; Rothkamm K, 2013, RADIAT RES, V180, P149, DOI 10.1667/RR3238.1; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Rothkamm K, 2013, MUTAT RES-GEN TOX EN, V756, P170, DOI 10.1016/j.mrgentox.2013.04.012; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Savani V, 2007, METRIKA, V65, P207, DOI 10.1007/s00184-006-0071-x; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Viau M, 2015, MUTAT RES-GEN TOX EN, V793, P123, DOI 10.1016/j.mrgentox.2015.05.009; Vinnikov VA, 2010, RADIAT RES, V174, P403, DOI 10.1667/RR2228.1; Wu J, 2013, CLIN CANCER RES, V19, P721, DOI 10.1158/1078-0432.CCR-12-2529	36	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207464	10.1371/journal.pone.0207464	http://dx.doi.org/10.1371/journal.pone.0207464			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485322	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000451755800071
J	Sangbaramou, R; Camara, I; Huang, XZ; Shen, J; Tan, SQ; Shi, WP				Sangbaramou, Rouguiatou; Camara, Ibrahima; Huang, Xin-zheng; Shen, Jie; Tan, Shu-qian; Shi, Wang-peng			Behavioral thermoregulation in Locusta migratoria manilensis (Orthoptera: Acrididae) in response to the entomopathogenic fungus, Beauveria bassiana	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; BIOLOGICAL-CONTROL; DESERT LOCUST; FEVER; TEMPERATURE; RESISTANCE; REPRODUCTION; GRASSHOPPER; INHIBITION; DROSOPHILA	Insects such as locusts and grasshoppers can reduce the effectiveness of pathogens and parasites by adopting different defense strategies. We investigated the behavioral thermopreference of Locusta migratoria manilensis (Meyen) (Orthoptera: Acrididae) induced by the fungus Beauveria bassiana, and the impact this behavior had on the fungal mycosis under laboratory conditions. By basking in higher temperature locations, infected nymphs elevated their thoracic temperature to 30-32.6 degrees C, which is higher than the optimum temperature (25 degrees C) for B. bassiana conidial germination and hyphal development. A minimum thermoregulation period of 3 h/day increased survival of infected locusts by 43.34%. The therapeutic effect decreased when thermoregulation was delayed after initial infection. The fungus grew and overcame the locusts as soon as the thermoregulation was interrupted, indicating that thermoregulation helped the insects to cope with infection but did not completely rid them of the fungus. A significant enhancement in the number of haemocytes was observed in infected thermoregulating locusts, reaching levels that were even higher than those observed in the controls. In contrast, haemocyte concentration was severely reduced in infected insects that did not thermoregulate. In infected non-thermoregulating locusts, the reduction in haemocyte number was accompanied by an increase in fungal blastospore concentration that was obvious in the haemolymph by day four. In contrast, no circulating blastospores were found in the haemolymph of infected thermoregulating locusts three days post-inoculation. We also examined the phagocytic activity of infected insects in vivo by using fluorescein isothiocyanate (FITC)-labelled silica beads. The proportion of beads that was engulfed by haemocytes in infected, thermoregulating insects was similar to that in the controls throughout the experiment, whereas the rate of phagocytosis in infected, non-thermoregulating insects progressively decreased after infection. These findings demonstrated that behavioural thermoregulation can adversely affect B. bassiana mycosis in infected L. migratoria manilensis, thereby limiting the development of lethal entomopathogenic fungi in locusts. This is apparently accomplished through an increase in the levels of haemocytes, leading to greater phagocytic activity under certain environmental conditions.	[Tan, Shu-qian] China Agr Univ, Coll Plant Protect, Dept Entomol, Beijing, Peoples R China; China Agr Univ, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Tan, SQ (corresponding author), China Agr Univ, Coll Plant Protect, Dept Entomol, Beijing, Peoples R China.	zhiweijianniyixiao@163.com	shen, jie/W-9807-2019; Shi, wp/AAF-9334-2020	shen, jie/0000-0002-6021-7151; Tan, Shuqian/0000-0001-9689-9249	National Key Program [2017YFD0201200]; National Natural Science Foundation of China [31772221]; China Postdoctoral Science Foundation [2017M611056]	National Key Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was funded by the National Key Program (2017YFD0201200 to WS), National Natural Science Foundation of China (31772221 to WS and ST), China Postdoctoral Science Foundation funded projects (2017M611056 to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2011, J EXP BIOL, V214, P1997, DOI 10.1242/jeb.056531; Anderson RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062269; Arala-Chaves M, 2000, AQUACULTURE, V191, P247, DOI 10.1016/S0044-8486(00)00430-0; Arthurs S, 2000, BIOCONTROL SCI TECHN, V10, P321, DOI 10.1080/09583150050044592; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blanford S, 2000, ENVIRON ENTOMOL, V29, P1060, DOI 10.1603/0046-225X-29.5.1060; Blanford S, 2001, J INVERTEBR PATHOL, V78, P1, DOI 10.1006/jipa.2001.5031; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Brader L., 2006, MULTILATERAL EVALUAT; Bundey S, 2003, ARCH INSECT BIOCHEM, V52, P183, DOI 10.1002/arch.10081; Campbell J, 2010, PARASITOLOGY, V137, P1487, DOI 10.1017/S0031182010000235; Catalan TP, 2012, J INSECT PHYSIOL, V58, P1450, DOI 10.1016/j.jinsphys.2012.08.011; Coggan N, 2011, P ROY SOC B-BIOL SCI, V278, P2745, DOI 10.1098/rspb.2010.2675; CORNELIS L, 2004, IMMUNOL REV, V198, P116; Dimbi S, 2004, BIOCONTROL, V49, P83, DOI 10.1023/B:BICO.0000009397.84153.79; Ding XY, 2009, J BEIJING U AGR, V1; Elliot SL, 2005, BIOL LETT-UK, V1, P181, DOI 10.1098/rsbl.2004.0279; Elliot SL, 2002, P ROY SOC B-BIOL SCI, V269, P1599, DOI 10.1098/rspb.2002.2067; Enserink M, 2004, SCIENCE, V306, P1880, DOI 10.1126/science.306.5703.1880; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Fu XJ, 2010, BIOCONTROL SCI TECHN, V20, P683, DOI 10.1080/09583151003710321; Fuller CA, 2011, ECOL ENTOMOL, V36, P459, DOI 10.1111/j.1365-2311.2011.01289.x; Gardner SN, 2002, EVOLUTIONARY ECOLOGY, V4, P133; Gul HT., 2014, APPL SCI BUS EC, V1, P10; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Hillyer JF, 2016, DEV COMP IMMUNOL, V58, P102, DOI 10.1016/j.dci.2015.12.006; Hunt VL, 2011, J INSECT PHYSIOL, V57, P1341, DOI 10.1016/j.jinsphys.2011.06.008; Hunter David M., 2010, Journal of Orthoptera Research, V19, P133, DOI 10.1665/034.019.0108; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Inglis GD, 1996, BIOL CONTROL, V7, P131, DOI 10.1006/bcon.1996.0076; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kalsbeek V, 2001, BIOL CONTROL, V21, P264, DOI 10.1006/bcon.2001.0943; Klass JI, 2007, AGR FOREST ENTOMOL, V9, P201, DOI 10.1111/j.1461-9563.2007.00336.x; Latchininsky AV, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.075099; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Millist N, BENEFIT COST ANAL AU; Noma T, 2000, ENVIRON ENTOMOL, V29, P394, DOI 10.1603/0046-225X(2000)029[0394:EOBBOL]2.0.CO;2; Ouedraogo RM, 2004, OECOLOGIA, V138, P312, DOI 10.1007/s00442-003-1431-0; Ouedraogo RM, 2003, J INVERTEBR PATHOL, V82, P103, DOI 10.1016/S0022-2011(02)00185-4; Ouedraogo RM, 2002, J INVERTEBR PATHOL, V81, P19, DOI 10.1016/S0022-2011(02)00117-9; Qazzaz F. O., 2015, ADV ENTOMOLOGY, V3, P44, DOI DOI 10.4236/AE.2015.32006; Rajitha K., 2013, International Journal of Agricultural Science and Research (IJASR), V3, P265; ROHLOFF LH, 1994, J INSECT PHYSIOL, V40, P1045, DOI 10.1016/0022-1910(94)90057-4; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; Shang YF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005037; Shi WP, 2009, BIOCONTROL, V54, P77, DOI 10.1007/s10526-008-9153-1; Shi WP, 2014, P NATL ACAD SCI USA, V111, P1343, DOI 10.1073/pnas.1314009111; Shi WP, 2004, J APPL ENTOMOL, V128, P414, DOI 10.1111/j.1439-0418.2004.00865.x; Springate S, 2005, ECOL ENTOMOL, V30, P724, DOI 10.1111/j.0307-6946.2005.00743.x; Starks PT, 2000, NATURWISSENSCHAFTEN, V87, P229, DOI 10.1007/s001140050709; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Thomas MB, 2003, ECOL LETT, V6, P183, DOI 10.1046/j.1461-0248.2003.00414.x; van Sambeek J, 1999, J INVERTEBR PATHOL, V73, P154, DOI 10.1006/jipa.1998.4823; Vega FE, 2012, INSECT PATHOLOGY, 2ND EDITION, P171, DOI 10.1016/B978-0-12-384984-7.00006-3; Wiesner Andreas, 1998, P11; Yanagawa A, 2007, BIOCONTROL, V52, P75, DOI 10.1007/s10526-006-9020-x; Zhang Long, 2001, Journal of China Agricultural University, V6, P90; Zhang Long, 2017, Journal of Orthoptera Research, V26, P155, DOI 10.3897/jor.26.20119; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	61	9	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206816	10.1371/journal.pone.0206816	http://dx.doi.org/10.1371/journal.pone.0206816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485309	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800030
J	Gine, GAF; Faria, D				Fernandez Gine, Gaston Andres; Faria, Deborah			Combining species distribution modeling and field surveys to reappraise the geographic distribution and conservation status of the threatened thin-spined porcupine (Chaetomys subspinosus)	PLOS ONE			English	Article							ATLANTIC FOREST; RODENTIA ERETHIZONTIDAE; PROTECTED AREAS; HOME-RANGE; NICHE; BIODIVERSITY; BRAZIL; UNCERTAINTY; PATTERNS; FOLIVORE	The threatened thin-spined porcupine (Chaetomys subspinosus), a forest-specialist endemic to the Brazilian Atlantic forest, was rarely detected in the wild during the 20 th century. Previous geographic distribution assessments were carried out nearly three decades ago and were based on interview data. We performed extensive field surveys (based on active search and interviews), a literature review, and species distribution modeling to predict and validate a more reliable picture of its geographic distribution and environmental suitability gradient. We identified the main predictors of species' incidence, its conservation status, and pinpointed key areas for species conservation. Our results indicated that C. subspinosus is distributed continuously in the Atlantic forest from southeastern Espirito Santo to central-eastern Sergipe state, totaling 104,326 km 2 of occurrence area, although only 3,299 km 2 (13.3%) is currently represented by native forests (species habitat). C. subspinosus was absent or at least so rare that it was not detected in more than half of the locations sampled by interviews (53.5%). Our results suggest that populations are sensitive to climatic conditions and habitat loss, becoming abruptly rarer when the remaining forest cover reaches less than 10% area within a region (similar to 5,000 km(2) scale). This result indicates that the high deforestation level of the Atlantic forest is already close to the limit of regional species resistance. Bahia state still harbors the bulk of the remaining forest with high climatic suitability, and generally under low levels of legal protection. Herein we highlight priority areas and research gaps that could guide decision makers to promote conservation strategies for this threatened species.	[Fernandez Gine, Gaston Andres; Faria, Deborah] Univ Estadual Santa Cruz, Dept Ciencias Biol, Lab Ecol & Conservacao Especies Ameacadas, Ilheus, BA, Brazil; [Fernandez Gine, Gaston Andres] Univ Fed Juiz de Fora, Dept Zool, Programa Posgrad Ciencias Biol Comportamento & Bi, Juiz De Fora, MG, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal de Juiz de Fora	Gine, GAF (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Lab Ecol & Conservacao Especies Ameacadas, Ilheus, BA, Brazil.	gastongine10@gmail.com	faria, deborah/ABC-2757-2021; Faria, Deborah/F-2879-2010	faria, deborah/0000-0002-0375-2887; Faria, Deborah/0000-0002-0375-2887; Gine, Gaston Andres Fernandez/0000-0003-1470-3674	Ministerio do Meio Ambiente do Brasil (MMA) [FNMA/PROBIO 01/2003]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [552198/2011-0]; CAPES [02566/09-5]; CNPq [3045371/2015]	Ministerio do Meio Ambiente do Brasil (MMA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Ministerio do Meio Ambiente do Brasil (MMA; http://www.mma.gov.br/; project FNMA/PROBIO 01/2003), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://cnpq.br/), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; http://www.capes.gov.br; project CASADINHO/PROCAD; 552198/2011-0). CAPES provided fellowships to G.A.F. Gine (02566/09-5) and CNPq for the research fellowships to D. Faria (3045371/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alves DMCC, 2013, TROP CONSERV SCI, V6, P558, DOI 10.1177/194008291300600408; [Anonymous], ATL REM FLOR MAT ATL; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Avila-Pires F.D., 1967, REV BRAS BIOL, V27, P177; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Bezerra RA, 2016, DETECCAO MOL MICROOR; Brito, 2000, ECOLOGIA ALIMENTAR O; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Cardoso P, 2011, BIOL CONSERV, V144, P2432, DOI 10.1016/j.biocon.2011.06.020; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Castilho LC, 2013, TROP CONSERV SCI, V6, P796, DOI 10.1177/194008291300600607; Catzeflis F, 2008, IUCN RED LIST THREAT; Chiarello AG, 1999, BIOL CONSERV, V89, P71, DOI 10.1016/S0006-3207(98)00130-X; Chiarello AG, 1997, MAMMALIA, V61, P29, DOI 10.1515/mamm.1997.61.1.29; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; DAVIES RB, 1987, BIOMETRIKA, V74, P33, DOI 10.1093/biomet/74.1.33; Pena JCD, 2014, BIOL CONSERV, V170, P130, DOI 10.1016/j.biocon.2013.12.015; Lima RBD, 2010, MAMM BIOL, V75, P538, DOI 10.1016/j.mambio.2009.09.002; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Environmental Systems Research Institute I, 2006, ARCGIS V 9 3; Estavillo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082369; Faria D, 2011, SERIE ESPECIES AMEAC, V17; Gine GAF, 2015, J MAMMAL, V96, P1095, DOI 10.1093/jmammal/gyv117; Gine GAF, 2012, J ZOOL, V286, P131, DOI 10.1111/j.1469-7998.2011.00855.x; Gine GAF, 2010, J MAMMAL, V91, P931, DOI 10.1644/09-MAMM-A-185.1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garla RC, 2001, BIOTROPICA, V33, P691, DOI 10.1111/j.1744-7429.2001.tb00226.x; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Hemery LG, 2016, DIVERS DISTRIB, V22, P1314, DOI 10.1111/ddi.12490; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2002, MAP VEG; Jimenez-Alfaro B, 2012, BIOL CONSERV, V147, P190, DOI 10.1016/j.biocon.2011.12.030; McGullagh P., 1989, GEN LINEAR MODELS; Ferraz KMPMD, 2012, ENVIRON CONSERV, V39, P316, DOI 10.1017/S0376892912000094; Montgomery GG., 1978, S HELD CONS RES CTR, P23; Moojen J., 1952, OS ROEDORES BRASIL, V1; Moreira DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110929; Novaes RLM, 2013, TROP CONSERV SCI, V6, P477, DOI 10.1177/194008291300600402; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Oliveira CG, 2011, GENET MOL RES, V10, P923, DOI 10.4238/vol10-2gmr1039; Oliveira PA, 2012, MAMM BIOL, V77, P97, DOI 10.1016/j.mambio.2011.09.005; Oliver WLR, 1991, JERSEY WILDLIFE PRES, V4; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Platts PJ, 2014, DIVERS DISTRIB, V20, P1307, DOI 10.1111/ddi.12244; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Silva DP, 2014, ECOL MODEL, V273, P200, DOI 10.1016/j.ecolmodel.2013.11.016; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; SOS MATA ATLANTICA INPE, 2016, ATL REM FLOR MAT ATL; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Thorn JS, 2009, DIVERS DISTRIB, V15, P289, DOI 10.1111/j.1472-4642.2008.00535.x; van Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI 10.1111/ecog.01509; Voss RS, 2013, AM MUSEUM NOVIT, V3769; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x	65	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207914	10.1371/journal.pone.0207914	http://dx.doi.org/10.1371/journal.pone.0207914			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481222	Green Published, Green Submitted, gold			2022-12-26	WOS:000451440000026
J	Song, GB; Han, MJ; Li, ZH; Gan, XD; Chen, XW; Yang, J; Dong, SF; Yan, M; Wan, J; Wang, YG; Huang, ZL; Yin, Z; Zheng, F				Song, Guibo; Han, Mingjun; Li, Zuhua; Gan, Xuedong; Chen, Xiaowen; Yang, Jie; Dong, Sufang; Yan, Ming; Wan, Jun; Wang, Yanggan; Huang, Zhuliang; Yin, Zhan; Zheng, Fang			Deletion of Pr72 causes cardiac developmental defects in Zebrafish	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; SERINE/THREONINE PHOSPHATASES; REGULATORY SUBUNIT; PHOSPHORYLATION; PP2A	The alpha regulator subunit B'' of protein phosphatase 2 (PPP2R3A), a regulatory subunit of protein phosphatase 2A (PP2A), was reported to present a special subcellular localization in cardiomyocytes and elevate in non-ischemia failing hearts. PPP2R3A has two transcriptions PR72 and PR130. PR72 acts as a negative regulator of the Wnt signaling cascade, while the Wnt signaling cascade plays a pivotal role in cardiac development. And PR130 was found to be involved in cardiac development of zebrafish in our previous study. Thus, to investigate the function of PR72 in heart, two stable pr72 knockout (KO) zebrafish lines were generated using Transcription Activator-Like Effector Nuclease (TALEN) technology. Homozygous pr72 KO fish struggled to survive to adulthood and exhibited cardiac developmental defects, including enlarged ventricular chambers, reduced cardiomyocytes and decreased cardiac function. And the defective sarcomere ultrastructure that affected mitochondria, I bands, Z lines, and intercalated disks was also observed. Furthermore, the abnormal heart looping was detected in mutants which could be rescued by injection with wild type pr72 mRNA. Additionally, it was found that Wnt effectors were elevated in mutants. Those indicated that deletion of pr72 in zebrafish interrupted cardiac development, probably through activation of the Wnt pathway.	[Song, Guibo; Han, Mingjun; Li, Zuhua; Yang, Jie; Dong, Sufang; Yan, Ming; Huang, Zhuliang; Zheng, Fang] Wuhan Univ, Ctr Gene Diag, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Gan, Xuedong; Wang, Yanggan] Wuhan Univ, Dept Cardiol, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Chen, Xiaowen; Yin, Zhan] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Wan, Jun] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Wuhan University	Zheng, F (corresponding author), Wuhan Univ, Ctr Gene Diag, Zhongnan Hosp, Wuhan, Hubei, Peoples R China.; Yin, Z (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Hubei, Peoples R China.	zyin@ihb.ac.cn; zhengfang@whu.edu.cn			National Natural Science Foundation of China [81472024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Grant of National Natural Science Foundation of China (Grant Numbers. 81472024). F.Z. recieived the funding.	Brewis N, 2000, AM J PHYSIOL-HEART C, V279, pH1307, DOI 10.1152/ajpheart.2000.279.3.H1307; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Chen XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029515; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; Durak O, 2015, MOL PSYCHIATR, V20, P388, DOI 10.1038/mp.2014.42; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Glaser D, 2017, CIRCULATION, V136; Heijman J, 2017, J MOL CELL CARDIOL, V103, P110, DOI 10.1016/j.yjmcc.2016.12.009; Hood AR, 2017, J MOL CELL CARDIOL, V107, P52, DOI 10.1016/j.yjmcc.2017.05.002; Jin YR, 2011, DEV BIOL, V352, P1, DOI 10.1016/j.ydbio.2011.01.004; Li L, 2016, AM J TRANSL RES, V8, P1769; Lin XY, 2009, DEVELOPMENT, V136, P207, DOI 10.1242/dev.029561; Lubbers ER, 2016, J MOL CELL CARDIOL, V101, P127, DOI 10.1016/j.yjmcc.2016.11.003; Martin J, 2010, J ANAT, V216, P92, DOI 10.1111/j.1469-7580.2009.01171.x; Novikov N, 2013, DEVELOPMENT, V140, P3787, DOI 10.1242/dev.093567; Palpant NJ, 2013, DEVELOPMENT, V140, P3799, DOI 10.1242/dev.094789; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Ranieri A, 2018, J MOL CELL CARDIOL, V115, P20, DOI 10.1016/j.yjmcc.2017.12.016; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Varadkar P, 2014, DEV DYNAM, V243, P778, DOI 10.1002/dvdy.24111; Yang J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111746; Yin XK, 2010, MOL CELL PROTEOMICS, V9, P497, DOI 10.1074/mcp.M900275-MCP200; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	27	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0206883	10.1371/journal.pone.0206883	http://dx.doi.org/10.1371/journal.pone.0206883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481179	gold, Green Submitted, Green Published			2022-12-26	WOS:000451440000007
J	Bernasconi, A; Crabbe, F; Raab, M; Rossi, R				Bernasconi, Andrea; Crabbe, Francois; Raab, Martin; Rossi, Rodolfo			Can the use of digital algorithms improve quality care? An example from Afghanistan	PLOS ONE			English	Article							INTEGRATED MANAGEMENT; CHILDHOOD ILLNESS; IMPLEMENTATION; GUIDELINES; SYSTEM	Background Quality of care is a difficult parameter to measure. With the introduction of digital algorithms based on the Integrated Management of Childhood Illness (IMCI), we are interested to understand if the adherence to the guidelines improved for a better quality of care for children under 5 years old. Methods More than one year after the introduction of digital algorithms, we carried out two cross sectional studies to assess the improvements in comparison with the situation prior to the implementation of the project, in two Basic Health Centres in Kabul province. One survey was carried out inside the consultation room and was based on the direct observation of 181 consultations of children aged 2 months to 5 years old, using a checklist completed by a senior physicians. The second survey queried 181 caretakers of children outside the health facility for their opinion about the consultation carried out through the tablet and prescriptions and medications given. Results We measured the quality of care as adherence to the IMCI's guidelines. The study evaluated the quality of the physical examination and the therapies prescribed with a special attention to antibiotic prescription. We noticed a dramatic improvement (p<0.05) of several indicators following the introduction of digital algorithms. The baseline physical examination was appropriate only for 23.8% [IC% 19.9-28.1] of the patients, 34.5% [IC% 30.0-39.2] received a correct treatment and 86.1% [IC% 82.4-89.2] received at least one antibiotic. With the introduction of digital algorithms, these indicators statistically improved respectively to 84.0% [IC% 77.9-88.6], >85% and less than 30%. Conclusions Our findings suggest that digital algorithms improve quality of care by applying the guidelines more effectively. Our experience should encourage to test this tool in different settings and to scale up its use at province/state level.	[Bernasconi, Andrea; Crabbe, Francois; Raab, Martin] Swiss TPH, Basel, Switzerland; [Bernasconi, Andrea; Crabbe, Francois; Raab, Martin] Univ Basel, Basel, Switzerland; [Rossi, Rodolfo] Int Comm Red Cross, PHC Programs, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Bernasconi, A (corresponding author), Swiss TPH, Basel, Switzerland.; Bernasconi, A (corresponding author), Univ Basel, Basel, Switzerland.	doigb@libero.it						Ahmed HM, 2010, HEALTH POLICY, V96, P128, DOI 10.1016/j.healthpol.2010.01.013; [Anonymous], 2000, ERR IS HUMAN BUILDIN; Bernasconi A, 2017, INT J MED INFORM; Berner ES, 1999, CLIN DECISION SUPPOR; Blank A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-44; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Bryan C, 2008, INFORM PRIM CARE, P16; Bryce J, 2004, AM J PUBLIC HLTH, V94; Cabana MD, 1999, JAMA, V282; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Costello A, 2016, GRAND CONVERGENCE CH; Darling G, 2002, SURG ONCOL, V11, P255, DOI 10.1016/S0960-7404(02)00046-4; Eberhardt J, 2012, J SURG ONCOL, V105, P502, DOI 10.1002/jso.23053; European Commission, 2000, PAT SAF QUAL HEALTHC; Fraser HS, 2005, INFORM PRIM CARE, V13; Garg A, 2005, JAMA, V293; Gera T, 2016, COCHRANE DATABASE SY, V6; Gould J, 1985, COMMUN ACM, V28; Graham ID, 2000, ONCOLOGY, V59; Hannan TJ, 2000, INT J MED INFORM, V60, P21, DOI 10.1016/S1386-5056(00)00068-X; Haynes RB, 2010, IMPLEMENT SCI, V5; Institute of Medicine (US), 2001, CROSSING QUALITY CHA; Kahigwa E, 2002, T R SOC TROP MED HYG, V96; Kawamoto K, 2005, BMJ, V765; Keitel K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002411; Lange S, 2014, SOC SCI MED, V104, P56, DOI 10.1016/j.socscimed.2013.12.020; Leonard KL, 2009, HEALTH ECON, V19; Levine R, 2012, INT J QUAL HLTH CARE, V24; Maestad P, 2008, CHR MICHELSEN I, V12; Mendez J, 2007, REV MED CHIL, V135; Mensah N, 2015, GLOB HLTH ACTION, V8; Mitchell M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-95; Nylenna M, 2005, P P, V5; OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4; Pandya H, 2018, HEALTH POLICY PLANN, V33, P171, DOI 10.1093/heapol/czx154; Rambaud-Althaus C, 2015, PLOS ONE, V10; Rotich JK, 2003, J AM MED INFORM ASSN, V10, P295, DOI 10.1197/jamia.M1301; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Shao AF, 2015, PLOS ONE, V10; Walter ND, 2009, B WORLD HEALTH ORGAN, V87; *WHO UNICEF, 1997, INT MAN CHILDH ILLN; Williams CJ, 1998, CLIN ONCOLOGY, V10; Woolf SH, 1999, BMJ, V318; World Bank, 2003, WORLD DEV REPORT 200, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X, 10.1596/0-8213-5468-X]; World Health Organization, 2014, INTEGRATED MANAGEMEN	46	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207233	10.1371/journal.pone.0207233	http://dx.doi.org/10.1371/journal.pone.0207233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475833	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700019
J	Lese, I; Graf, DA; Tsai, C; Taddeo, A; Matter, MT; Constantinescu, MA; Herrmann, IK; Olariu, R				Lese, Ioana; Graf, David Alexander; Tsai, Catherine; Taddeo, Adriano; Matter, Martin Tobias; Constantinescu, Mihai A.; Herrmann, Inge Katrin; Olariu, Radu			Bioactive nanoparticle-based formulations increase survival area of perforator flaps in a rat model	PLOS ONE			English	Article							OXIDE NANOPARTICLES; SKIN; ANGIOGENESIS; ZINC; MECHANISMS; STRONTIUM; NECROSIS; GLASSES; OXYGEN	Background Distal flap necrosis is a frequent complication of perforator flaps. Advances in nanotechnology offer exciting new therapeutic approaches. Anti-inflammatory and neo-angiogenic properties of certain metal oxides within the nanoparticles, including bioglass and ceria, may promote flap survival. Here, we explore the ability of various nanoparticle formulations to increase flap survival in a rat model. Materials and methods A 9 x 3 cm dorsal flap based on the posterior thigh perforator was raised in 32 Lewis rats. They were divided in 4 groups and treated with different nanoparticle suspensions: I-saline (control), II-Bioglass, III-Bioglass/ceria and IV-Zinc-doped strontium-substituted bioglass/ceria. On post-operative day 7, planimetry and laser Doppler analysis were performed to assess flap survival and various samples were collected to investigate angiogenesis, inflammation and toxicity. Results All nanoparticle-treated groups showed a larger flap survival area as compared to the control group (69.9%), with groups IV (77,3%) and II (76%) achieving statistical significance. Blood flow measurements by laser Doppler analysis showed higher perfusion in the nanoparticle- treated flaps. Tissue analysis revealed higher number of blood vessels and increased VEGF expression in groups II and III. The cytokines CD31 and MCP-1 were decreased in groups II and IV. Conclusions Bioglass-based nanoparticles exert local anti-inflammatory and neo-angiogenic effects on the distal part of a perforator flap, increasing therefore its survival. Substitutions in the bioglass matrix and trace metal doping allow for further tuning of regenerative activity. These results showcase the potential utility of these nanoparticles in the clinical setting.	[Lese, Ioana; Constantinescu, Mihai A.; Olariu, Radu] Bern Univ Hosp, Dept Plast & Hand Surg, Inselspital, Bern, Switzerland; [Lese, Ioana; Tsai, Catherine; Taddeo, Adriano; Constantinescu, Mihai A.; Olariu, Radu] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Graf, David Alexander] Univ Bern, Fac Med, Bern, Switzerland; [Matter, Martin Tobias; Herrmann, Inge Katrin] Empa, Dept Mat Meet Life, Particles Biol Interact, Swiss Fed Labs Mat Sci & Technol, St Gallen, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Geneva; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Lese, I (corresponding author), Bern Univ Hosp, Dept Plast & Hand Surg, Inselspital, Bern, Switzerland.; Lese, I (corresponding author), Univ Bern, Dept Biomed Res, Bern, Switzerland.	ioana.lese@gmail.com	Matter, Martin T./O-1771-2019; Taddeo, Adriano/AAW-3861-2021; Matter, Martin/H-7857-2017; Constantinescu, Mihai A./AAC-6061-2020; Herrmann, Inge/H-6318-2018	Matter, Martin T./0000-0003-0748-1508; Taddeo, Adriano/0000-0003-3281-1548; Matter, Martin/0000-0003-0748-1508; Tsai, Catherine/0000-0002-5675-1941; Olariu, Radu/0000-0002-0204-4432; Lese, Ioana/0000-0002-3007-097X; Graf, David/0000-0001-8867-3135; Herrmann, Inge/0000-0002-3018-6796	Gottfried und Julia Bangerter-Rhyner-Stiftung; Helmut Horten Foundation	Gottfried und Julia Bangerter-Rhyner-Stiftung; Helmut Horten Foundation	This work was supported by Gottfried und Julia Bangerter-Rhyner-Stiftung (Martin Tobias Matter) and Helmut Horten Foundation (Martin Tobias Matter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie John H., 1992, Nutrition Research Reviews, V5, P167, DOI 10.1079/NRR19920013; Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303; BRANDAONETO J, 1995, NUTR RES, V15, P335, DOI 10.1016/0271-5317(95)00003-8; Celardo I, 2011, NANOSCALE, V3, P1411, DOI 10.1039/c0nr00875c; Coskunfirat OK, 2002, ANN PLAS SURG, V48, P286; Das S, 2012, BIOMATERIALS, V33, P7746, DOI 10.1016/j.biomaterials.2012.07.019; Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768; Dhar SC, 1999, PLAST RECONSTR SURG, V104, P2079, DOI 10.1097/00006534-199912000-00021; Duisit J, 2017, ANN SURG, V266, P754, DOI 10.1097/SLA.0000000000002396; Fukunaga Y, 2017, WOUND REPAIR REGEN, V25, P217, DOI 10.1111/wrr.12510; Ghali S, 2007, PLAST RECONSTR SURG, V119, P1735, DOI 10.1097/01.prs.0000246384.14593.6e; Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]; Haws MJ, 2001, J RECONSTR MICROSURG, V17, P39, DOI 10.1055/s-2001-12687; Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Hoshyar N, 2016, NANOMEDICINE-UK, V11, P673, DOI 10.2217/nnm.16.5; Ince B, 2016, BALK MED J, V33, P645, DOI 10.5152/balkanmedj.2016.150981; Jafari SMS, 2017, PLAST RECONSTR SURG, V139, p1116E, DOI 10.1097/PRS.0000000000003259; Kononenko V, 2015, ARH HIG RADA TOKSIKO, V66, P97, DOI 10.1515/aiht-2015-66-2582; Lang C, 2007, AM J PHYSIOL-LUNG C, V292, pL577, DOI 10.1152/ajplung.00280.2006; Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055; Matter MT, 2017, NANOSCALE, V9, P8418, DOI 10.1039/c7nr01176h; Miguez-Pacheco V, 2015, ACTA BIOMATER, V13, P1, DOI 10.1016/j.actbio.2014.11.004; Muller S, 2013, J SURG RES, V181, P170, DOI 10.1016/j.jss.2012.05.088; Nall AV, 1996, ARCH OTOLARYNGOL, V122, P171; NIELSEN FH, 1990, BIOL TRACE ELEM RES, V26-7, P599, DOI 10.1007/BF02992716; Qing LM, 2017, EXP THER MED, V13, P2012, DOI 10.3892/etm.2017.4205; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Rose S, 2014, NATURE, V505, P382, DOI 10.1038/nature12806; Saint-Cyr M, 2009, PLAST RECONSTR SURG, V124, P1529, DOI 10.1097/PRS.0b013e3181b98a6c; Schlachter EK, 2011, INT J NANOMED, V6, P1793, DOI 10.2147/IJN.S23638; Shahnazari M, 2006, J BONE MINER RES, V21, P1696, DOI 10.1359/JBMR.060724; Sheng LL, 2011, TOHOKU J EXP MED, V224, P229, DOI 10.1620/tjem.224.229; STEWART RJ, 1994, ARCH SURG-CHICAGO, V129, P982; Stewart RJ, 1960, ARCH SURG-CHICAGO, V129, P7; Walkey C, 2015, ENVIRON SCI-NANO, V2, P33, DOI 10.1039/c4en00138a; Wang SP, 2014, ANN PLAS SURG, V72, P94, DOI 10.1097/SAP.0b013e318255a3eb; Williams BA, 2009, MICROCIRCULATION, V16, P235, DOI 10.1080/10739680802548814; Yamaguchi M, 1998, J TRACE ELEM EXP MED, V11, P119, DOI 10.1002/(SICI)1520-670X(1998)11:2/3&lt;119::AID-JTRA5&gt;3.0.CO;2-3; Yu HF, 2016, ACS APPL MATER INTER, V8, P703, DOI 10.1021/acsami.5b09853; Zhang F, 2003, BRIT J PLAST SURG, V56, P653, DOI 10.1016/s0007-1226(03)00214-5; Zhang S, 2018, J VASCULAR SURG; Zhou KL, 2016, SCI REP-UK, V6, DOI 10.1038/srep18945	43	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207802	10.1371/journal.pone.0207802	http://dx.doi.org/10.1371/journal.pone.0207802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475867	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700071
J	Pawlitzki, M; Sweeney-Reed, CM; Meuth, SG; Reinhold, D; Neumann, J				Pawlitzki, Marc; Sweeney-Reed, Catherine M.; Meuth, Sven G.; Reinhold, Dirk; Neumann, Jens			CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PLASMA-EXCHANGE; FACTOR MIF; CYTOKINE; SECRETION; DISABILITY; CELLS	Glucocorticoid (GC) refractory relapses in patients with multiple sclerosis (MS) or clinically isolated syndrome (CIS), who are in potential need of treatment escalation, are a key challenge in routine clinical practice. The pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) has been shown to be an endogenous counter-regulator of GC, and potentiates autoimmune-mediated neuroinflammation. In order to evaluate whether MIF levels are elevated in the cerebrospinal fluid (CSF) of MS patients (CSF-MIF), and whether they are higher still during a GC refractory relapse, we compared CSF-MIF concentrations of CIS/MS patients with acute optic neuritis as their first inflammatory episode (ON, n = 20), CIS/MS patients with a stable disease progression/without relapse (CIS/MS w/o, n = 18), and healthy controls (HC, n = 20) using ANOVA. Mean CSF-MIF concentrations in CIS/MS w/o patients were significantly higher than in ON patients and HCs, whereas ON patients and HCs did not differ. A subgroup analysis of the ON group revealed 10 patients to be responsive to GC-treatment (GC-ON) and 10 patients refractory under GC-treatment (rGCON). However, mean CSF-MIF concentrations did not differ between GC-ON and rGC-ON cases. We therefore conclude that MIF is not suitable for distinguishing GC responders from non-responders in a group of patients with acute optic neuritis, but it rather mirrors the ongoing inflammation in long-term MS disease progression.	[Pawlitzki, Marc; Sweeney-Reed, Catherine M.; Neumann, Jens] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Pawlitzki, Marc; Meuth, Sven G.] Univ Hosp Muenster, Dept Neurol, Inst Translat Neurol, Munster, Germany; [Reinhold, Dirk] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany	Otto von Guericke University; University of Munster; Otto von Guericke University	Pawlitzki, M (corresponding author), Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany.; Pawlitzki, M (corresponding author), Univ Hosp Muenster, Dept Neurol, Inst Translat Neurol, Munster, Germany.	Marc.pawlitzki@ukmuenster.de	Meuth, Sven G/HHM-8941-2022	Meuth, Sven G/0000-0003-2571-3501; Pawlitzki, Marc/0000-0003-3080-2277				Akoum A, 2005, J CLIN ENDOCR METAB, V90, P2904, DOI 10.1210/jc.2004-1900; Assis DN, 2016, DIGEST DIS SCI, V61, P3506, DOI 10.1007/s10620-016-4322-z; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bevan C, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0345-6; Bloom J, 2016, J BIOL CHEM, V291, P26502, DOI 10.1074/jbc.M116.743328; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Castro BA, 2017, ONCOGENE, V36, P3749, DOI 10.1038/onc.2017.1; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Ehler J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081749; Ehler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134583; Fagone P, 2018, J NEUROIMMUNOL, V322, P46, DOI 10.1016/j.jneuroim.2018.06.009; Fan HP, 2014, ARTHRITIS RHEUMATOL, V66, P2059, DOI 10.1002/art.38689; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Gupta Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146482; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; Huscher D, 2009, ANN RHEUM DIS, V68, P1119, DOI 10.1136/ard.2008.092163; Jarius S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0929-z; Jarius S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0718-0; Ji NN, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000139; Kawczyk-Krupka A, 2015, PHOTODIAGN PHOTODYN, V12, P27, DOI 10.1016/j.pdpdt.2014.12.013; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; Komori M, 2015, ANN NEUROL, V78, P3, DOI 10.1002/ana.24408; Koziolek MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-80; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lang TL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00577; Li Cai-feng, 2006, Zhonghua Er Ke Za Zhi, V44, P806; Lugrin J, 2009, BBA-MOL CELL RES, V1793, P1749, DOI 10.1016/j.bbamcr.2009.09.007; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Meyer-Siegler K, 2000, J INTERF CYTOK RES, V20, P769, DOI 10.1089/10799900050151030; Modvig S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077163; Mucke HAM, 2012, DRUG TODAY, V48, P577, DOI 10.1358/dot.2012.48.9.1855758; Niino M, 2000, J NEUROL SCI, V179, P127, DOI 10.1016/S0022-510X(00)00397-X; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Oliveira CS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-630; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; REIBER H, 1991, CLIN CHEM, V37, P1153; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Schneider-Gold C, 2016, THER ADV NEUROL DISO, V9, P297, DOI 10.1177/1756285616637046; Schwarz SC, 1998, EXP BRAIN RES, V120, P95, DOI 10.1007/s002210050381; Sellebjerg F, 2005, EUR J NEUROL, V12, P939, DOI 10.1111/j.1468-1331.2005.01352.x; Srisupa-Olan T, 2018, MULT SCLER RELAT DIS, V20, P115, DOI 10.1016/j.msard.2018.01.010; Wang FZ, 2011, NEUROSCI RES, V71, P210, DOI 10.1016/j.neures.2011.07.1821; Xu L, 2014, J MED CHEM, V57, P3737, DOI 10.1021/jm401908w	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207726	10.1371/journal.pone.0207726	http://dx.doi.org/10.1371/journal.pone.0207726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475854	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700059
J	Dakic, I; Arandjelovic, I; Savic, B; Jovanovic, S; Tosic, M; Kurucin, T; Vukovic, D				Dakic, Ivana; Arandjelovic, Irena; Savic, Branislava; Jovanovic, Snezana; Tosic, Mirjana; Kurucin, Tatjana; Vukovic, Dragana			Pulmonary isolation and clinical relevance of nontuberculous mycobacteria during nationwide survey in Serbia, 2010-2015	PLOS ONE			English	Article							DISEASE; EPIDEMIOLOGY; DIAGNOSIS; TUBERCULOSIS; INFECTIONS; PREVALENCE; ONTARIO; ASSAY	The rates of pulmonary colonization and disease due to nontuberculous mycobacteria (NTM) appear to be increasing globally, but diversity of species recovered as well as clinical relevance of NTM isolates differ considerably by geographic region. The first nationwide study of isolation frequency and clinical significance of NTM in Serbia included all patients with respiratory specimens yielding a positive NTM culture over the six-year period, 2010-2015. We analyzed trends in annual NTM isolation and NTM pulmonary disease (PD) incidence rates, with NTM PD cases defined in accordance with microbiological criteria established by the American Thoracic Society/Infectious Diseases Society of America (ATS/ IDSA). 777 pulmonary NTM isolates were collected from 565 patients, of whom 126 (22.3%) met the ATS/IDSA criteria. The annual NTM isolation and NTM PD incidence rates per 100,000 changed over 2010-2015 from 0.9 to 1.6 (p = 0.1746) and from 0.18 to 0.48 (p = f0.0040), respectively. Both isolation and disease rates increased considerably with age, while higher NTM PD rates were also associated with residence in urbanized areas. Diversity of NTM species isolated was shown to be region-specific, with M. xenopi as the most prevalent species (17.3%), and increasing isolation rates of rapid growing mycobacteria (RGM) (p = 0.0072). M. xenopi was also the most common cause of NTM PD (28.6%), followed by RGM (27.8%). With 73% clinically relevant isolates, M. abscessus was identified as the most clinically relevant NTM species. While NTM PD obviously remains a rare disease in Serbia, the overall results justify recognition of NTM as pathogens of rising importance, and require further characterization of their epidemiology in the country.	[Dakic, Ivana; Arandjelovic, Irena; Savic, Branislava; Vukovic, Dragana] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Jovanovic, Snezana] Clin Ctr Serbia, Dept Microbiol, Belgrade, Serbia; [Tosic, Mirjana] Municipal Inst Pulm Dis & TB, Dept Microbiol, Belgrade, Serbia; [Kurucin, Tatjana] Inst Pulm Dis Vojvodina, Ctr Microbiol Virol & Immunol, Sremska Kamenica, Serbia	University of Belgrade; Clinical Centre of Serbia	Vukovic, D (corresponding author), Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia.	dragana.vukovic@med.bg.ac.rs		Dakic, Ivana/0000-0002-0305-2143; Vukovic, Dragana/0000-0002-4028-308X; Arandjelovic, Irena/0000-0002-3753-8248	Ministry of Education, Science, and Technological Development, Republic of Serbia [MPNTR 175039]	Ministry of Education, Science, and Technological Development, Republic of Serbia	The study was supported by the Ministry of Education, Science, and Technological Development, Republic of Serbia; Award Number MPNTR 175039 (http://www.mpn.gov.rs/) to ID, IA, BS, DV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun E, 2013, INT J TUBERC LUNG D, V17, P96, DOI 10.5588/ijtld.12.0237; Brode SK, 2014, INT J TUBERC LUNG D, V18, P1370, DOI 10.5588/ijtld.14.0120; Falkinham JO, 2013, SEMIN RESP CRIT CARE, V34, P95, DOI 10.1055/s-0033-1333568; Gerogianni I, 2008, INT J TUBERC LUNG D, V12, P807; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Henkle E, 2015, ANN AM THORAC SOC, V12, P642, DOI 10.1513/AnnalsATS.201412-559OC; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Institute of Public Health of Serbia, 2016, HLTH STAT YB REP SER; Jankovic M, 2016, INT J TUBERC LUNG D, V20, P934, DOI 10.5588/ijtld.15.0633; Jankovic M, 2013, INT J TUBERC LUNG D, V17, P836, DOI 10.5588/ijtld.12.0843; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Marras TK, 2013, EMERG INFECT DIS, V19, P1889, DOI 10.3201/eid1911.130737; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Moore JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-612; Namkoong H, 2016, EMERG INFECT DIS, V22, P1116, DOI 10.3201/eid2206.151086; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Prevots DR, 2015, CLIN CHEST MED, V36, P13, DOI 10.1016/j.ccm.2014.10.002; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Richter E, 2003, J CLIN MICROBIOL, V41, P2672, DOI 10.1128/JCM.41.6.2672-2675.2003; Richter E, 2006, J CLIN MICROBIOL, V44, P1769, DOI 10.1128/JCM.44.5.1769-1775.2006; Rindi L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1380-y; Ringshausen FC, 2016, EMERG INFECT DIS, V22, P1102, DOI 10.3201/eid2206.151642; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Smith GS, 2016, J INFECTION, V72, P678, DOI 10.1016/j.jinf.2016.03.008; van der Werf MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-62; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; van Ingen J., 2009, THESIS; van Ingen J, 2015, CLIN CHEST MED, V36, P43, DOI 10.1016/j.ccm.2014.11.005; [WHO Regional Office for Europe European Centre for Disease Prevention and Control], 2017, TUB SURV MON EUR 201; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109736	30	3	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207751	10.1371/journal.pone.0207751	http://dx.doi.org/10.1371/journal.pone.0207751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462740	Green Published, Green Submitted, gold			2022-12-26	WOS:000451054800082
J	Chong, YC; Lim, TE; Fu, YY; Shin, EM; Tergaonkar, V; Han, WP				Chong, Yong Chun; Lim, Tau En; Fu, Yanyun; Shin, Eun Myoung; Tergaonkar, Vinay; Han, Weiping			Indian Hedgehog links obesity to development of hepatocellular carcinoma	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HEPATIC STELLATE CELLS; PATHWAY ACTIVATION; WNT/BETA-CATENIN; C-MYC; LIVER; CANCER; FIBROSIS; ROLES; SHH	Obesity increases the risk of hepatocellular carcinoma (HCC), but precise identification and characterization of druggable oncogenic pathways that contribute to the progression of NAFLD to HCC, and hence to the increased incidence and aggressiveness of HCC in obese individuals is lacking. In this regard, we demonstrate that the Indian Hedgehog (Ihh) signaling pathway is upregulated in the fatty livers of mice consuming a high fat diet, and furthermore sustained in HCC tumors specifically within the context of a NAFLD microenvironment. Using a diet-induced mouse model of HCC wherein only obese mice develop HCC, targeted ablation of hepatocyte-secreted Ihh results in a decreased tumor burden and lower grade tumors. Ihh activation regulates the transdifferentiation of ciliated stellate cells and proliferation of Epcam(+) ductal cells to promote fibrosis. Mechanistically, increased expression of hitherto uncharacterized effectors of Hh pathway, namely Myc and Tgf-beta 2 is critical to the observed physiology. This pro-tumorigenic response is driven by increased expression of Wnt5a to effect a poorly-differentiated and invasive tumor phenotype. Wnt5a secreted from activated stellate cells act on Ror2-expressing hepatocytes. We further demonstrate that Wnt5a expression is also elevated in poorly-differentiated HCC cells, suggesting that these ligands are also able to function in an autocrine positive feedback manner to sustain poorly-differentiated tumors. Taken together, our study provides a mechanistic understanding for how Ihh signaling promotes HCC tumorigenesis specifically in obese mice. We propose that therapeutic targeting of the Hh pathway offers benefit for patients with dietary / NAFLD-driven steatotic HCC.	[Chong, Yong Chun; Lim, Tau En; Fu, Yanyun; Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Shin, Eun Myoung] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Shin, Eun Myoung; Tergaonkar, Vinay; Han, Weiping] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Tergaonkar, Vinay; Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Tergaonkar, Vinay] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Tergaonkar, Vinay] SA Pathol, Adelaide, SA, Australia	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Centre for Cancer Biology; University of South Australia; SA Pathology	Han, WP (corresponding author), ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore.; Han, WP (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.; Han, WP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.	Weiping_Han@sbic.a-star.edu.sg		Chong, Yong Chun/0000-0001-9664-1715	A*STAR Biomedical Research Council [OFYIRG17may044]; National Medical Research Council, Singapore	A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	WH is supported by intramural funding from the A*STAR Biomedical Research Council. YCC is supported by a Young Individual Research Grant (OFYIRG17may044) from the National Medical Research Council, Singapore.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055; Axelson M, 2013, CLIN CANCER RES, V19, P2289, DOI 10.1158/1078-0432.CCR-12-1956; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bijlsma MF, 2008, EXP BIOL MED, V233, P989, DOI 10.3181/0711-RM-307; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Casey D, 2017, CLIN CANCER RES, V23, P2377, DOI 10.1158/1078-0432.CCR-16-2051; Choi SS, 2011, INT J BIOCHEM CELL B, V43, P238, DOI 10.1016/j.biocel.2010.10.015; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Debebe A, 2017, ONCOGENE, V36, P6020, DOI 10.1038/onc.2017.207; Dohi T, 2012, J LEUKOCYTE BIOL, V92, P265, DOI 10.1189/jlb.0112042; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Hassan MM, 2015, GASTROENTEROLOGY, V149, P119, DOI 10.1053/j.gastro.2015.03.044; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jung IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027941; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Lodato F, 2006, WORLD J GASTROENTERO, V12, P7239, DOI 10.3748/wjg.v12.i45.7239; Long FX, 2001, DEVELOPMENT, V128, P5099; Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Novoyatleva T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0325-x; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Peng T, 2015, NATURE, V526, P578, DOI 10.1038/nature14984; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Potter JJ, 1999, LIVER, V19, P135, DOI 10.1111/j.1478-3231.1999.tb00023.x; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Stewart GA, 2003, J PATHOL, V199, P488, DOI 10.1002/path.1295; Swiderska-Syn M, 2014, GUT, V63, P1333, DOI 10.1136/gutjnl-2013-305962; Szczepny A, 2017, ONCOGENE, V36, P5544, DOI 10.1038/onc.2017.173; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	60	17	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2019	38	12					2206	2222		10.1038/s41388-018-0585-5	http://dx.doi.org/10.1038/s41388-018-0585-5			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HP6UR	30470823				2022-12-26	WOS:000461822600015
J	Kakihana, A; Oto, Y; Saito, Y; Nakayama, Y				Kakihana, Ayana; Oto, Yui; Saito, Youhei; Nakayama, Yuji			Heat shock-induced mitotic arrest requires heat shock protein 105 for the activation of spindle assembly checkpoint	FASEB JOURNAL			English	Article						Hsp105; mitosis; misorientation; spindle assembly checkpoint; heat shock	ORIENTATION; CELLS; CENTROSOME; EXPRESSION; KINASE; HSP105; CANCER; HSP70; PHOSPHORYLATION; HYPERTHERMIA	Heat shock causes proteotoxic stress that induces various cellular responses, including delayed mitotic progression and the generation of an aberrant number of chromosomes. In this study, heat shock delayed the onset of anaphase by increasing the number of misoriented cells, accompanied by the kinetochore localization of budding uninhibited by benzimidazole-related (BubR)1 in a monopolar spindle (Mps)1-dependent manner. The mitotic delay was canceled by knockdown of mitotic arrest defect (Mad)2. Knockdown of heat shock protein (Hsp)105 partially abrogated the mitotic delay with the loss of the kinetochore localization of BubR1 under heat shock conditions and accelerated mitotic progression under nonstressed conditions. Consistent with this result, Hsp105 knockdown increased the number of anaphase cells with lagging chromosomes, through mitotic slippage, and decreased taxol sensitivity more than Mad2 knockdown. Hsp105 was coprecipitated with cell division cycle (Cdc)20 in an Mps1-dependent manner; however, its knockdown did not affect coprecipitation of Mad2 and BubR1 with Cdc20. We propose that heat shock delays the onset of anaphase via the activation of the spindle assembly checkpoint (SAC). Hsp105 prevents abnormal cell division by contributing to SAC activation under heat shock and nonstressed conditions by interacting with Cdc20 but not affecting formation of the mitotic checkpoint complex.Kakihana, A., Oto, Y., Saito, Y., Nakayama, Y. Heat shock-induced mitotic arrest requires heat shock protein 105 for the activation of spindle assembly checkpoint.	[Kakihana, Ayana; Oto, Yui; Saito, Youhei; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto, Japan	Kyoto Pharmaceutical University	Nakayama, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Yamashina Ku, 5 Misasagi Nakauchi Cho, Kyoto 6078414, Japan.	nakayama@mb.kyoto-phu.ac.jp		Saito, Youhei/0000-0002-8545-6925; Nakayama, Yuji/0000-0001-7882-0066	Japan Society for the Promotion of Science [16K08253, 25460076, 18K06672, 26870701]; Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1311035]; Nagai Memorial Research Scholarship from Pharmaceutical Society of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagai Memorial Research Scholarship from Pharmaceutical Society of Japan	The authors thank Dr. Takeshi Tomonaga (Chiba University, Chiba, Japan) for HCT116 cells and Dr. Hideyuki Saya (Kumamoto University, Kumamoto, Japan), Dr. Teru Kanda (Aichi Cancer Center Research Institute, Aichi, Japan), and Dr. Geoffrey M. Wahl (Salk Institute for Biological Studies, La Jolla, CA, USA) for HeLa cells expressing histone H2B-GFP. This work was supported, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science 16K08253 (to Y.N.), 25460076 (to Y.N.), 18K06672 (to Y.S.), and 26870701 (to Y.S.) and grants from the Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University and Chiba University) (to Y.N.); the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research (to Y.S.); the MEXT-Supported Program for the Strategic Research Foundation at Private Universities Grant S1311035 (to Y.S.); and Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan (to A.K.). The authors declare no conflicts of interest.	Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Chen YJ, 2014, ARCH TOXICOL, V88, P1711, DOI 10.1007/s00204-014-1222-x; COSS RA, 1982, CANCER RES, V42, P1059; Dai BB, 2013, J BIOL CHEM, V288, P1634, DOI 10.1074/jbc.M112.379362; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Erenpreisa JE, 2000, CELL BIOL INT, V24, P61, DOI 10.1006/cbir.1999.0466; Fuchs M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005582; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Furlong F, 2012, J PATHOL, V226, P746, DOI 10.1002/path.3035; Furusawa Y, 2012, APOPTOSIS, V17, P102, DOI 10.1007/s10495-011-0660-7; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Giovinazzi S, 2013, CELL CYCLE, V12, P2598, DOI 10.4161/cc.25591; Gupta RK, 2008, CANCER BIOL THER, V7, P1473, DOI 10.4161/cbt.7.9.6428; Hatayama T, 1997, CELL STRUCT FUNCT, V22, P517, DOI 10.1247/csf.22.517; Held T, 2011, REPRODUCTION, V142, P133, DOI 10.1530/REP-11-0023; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; HONDA K, 1989, BIOCHEM BIOPH RES CO, V160, P60, DOI 10.1016/0006-291X(89)91620-3; Hut HMJ, 2005, MOL BIOL CELL, V16, P3776, DOI 10.1091/mbc.E05-01-0038; IZUMI M, 1991, EXP CELL RES, V197, P229, DOI 10.1016/0014-4827(91)90427-V; Jia LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10818; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Katschinski DM, 2000, J BIOL CHEM, V275, P21094, DOI 10.1074/jbc.M001629200; Kimura A, 2016, ONCOTARGET, V7, P18415, DOI 10.18632/oncotarget.7821; Krenn V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00225; Lagos-Cabre R, 2008, REPRODUCTION, V135, P471, DOI 10.1530/REP-07-0389; LAMBOWITZ AM, 1983, NATURE, V303, P806, DOI 10.1038/303806a0; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Madlener S, 2009, HUM MOL GENET, V18, P1990, DOI 10.1093/hmg/ddp123; Maeshima K, 2018, CURR BIOL, V28, P444, DOI 10.1016/j.cub.2017.12.035; Makhnevych T, 2012, J CELL BIOL, V198, P623, DOI 10.1083/jcb.201111105; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mikami H, 2017, EXP CELL RES, V352, P225, DOI 10.1016/j.yexcr.2017.02.004; Miyazaki M, 2005, CANCER SCI, V96, P695, DOI 10.1111/j.1349-7006.2005.00093.x; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nakahata K, 2002, INT J HYPERTHER, V18, P332, DOI 10.1080/02656730210129736; Nitta M, 1997, ONCOGENE, V15, P561, DOI 10.1038/sj.onc.1201210; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; O'Regan L, 2015, J CELL BIOL, V209, P349, DOI 10.1083/jcb.201409151; Park YY, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0069-2; PATRIARCA EJ, 1990, EXP CELL RES, V190, P57, DOI 10.1016/0014-4827(90)90143-X; Pawlik A, 2013, ACTA HISTOCHEM, V115, P8, DOI 10.1016/j.acthis.2012.02.006; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rogon C, 2014, MOL BIOL CELL, V25, P2260, DOI 10.1091/mbc.E14-02-0742; Saito Y, 2003, EXP CELL RES, V286, P233, DOI 10.1016/S0014-4827(03)00054-5; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seldin L, 2013, MOL BIOL CELL, V24, P3651, DOI 10.1091/mbc.E13-05-0277; Senju M, 2006, J CANCER RES CLIN, V132, P150, DOI 10.1007/s00432-005-0047-7; Singh D, 2016, GENESIS, V54, P220, DOI 10.1002/dvg.22930; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Vertii A, 2015, MOL BIOL CELL, V26, P3451, DOI 10.1091/mbc.E15-03-0158; VIDAIR CA, 1993, J CELL PHYSIOL, V154, P443, DOI 10.1002/jcp.1041540302; Wang G, 2014, J CELL SCI, V127, P4111, DOI 10.1242/jcs.151753; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Woodford MR, 2016, CELL REP, V14, P872, DOI 10.1016/j.celrep.2015.12.084; Yamagishi N, 2000, BIOCHEM BIOPH RES CO, V272, P850, DOI 10.1006/bbrc.2000.2864; Yamagishi N, 2003, FEBS LETT, V555, P390, DOI 10.1016/S0014-5793(03)01292-4; Yamagishi N, 2006, EXP CELL RES, V312, P3215, DOI 10.1016/j.yexcr.2006.06.007; Yang YF, 2014, P NATL ACAD SCI USA, V111, P2158, DOI 10.1073/pnas.1319341111; YASUDA K, 1995, J BIOL CHEM, V270, P29718, DOI 10.1074/jbc.270.50.29718; Zhu DH, 1997, DEVELOPMENT, V124, P3007	71	8	8	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3936	3953		10.1096/fj.201801369R	http://dx.doi.org/10.1096/fj.201801369R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496702	Bronze			2022-12-26	WOS:000459794800067
J	Gayle, SS; Sahni, JM; Webb, BM; Weber-Bonk, KL; Shively, MS; Spina, R; Bar, EE; Summers, MK; Keri, RA				Gayle, Sylvia S.; Sahni, Jennifer M.; Webb, Bryan M.; Weber-Bonk, Kristen L.; Shively, Melyssa S.; Spina, Raffaella; Bar, Eli E.; Summers, Mathew K.; Keri, Ruth A.			Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; breast cancer; bromodomain-containing protein 4 (BRD4); senescence; B-cell lymphoma 2 (Bcl-2) family; B-cell lymphoma-extra large; BCL-xL; BET inhibitor; senolytic agent	CELLULAR SENESCENCE; EXPRESSION; OVEREXPRESSION; RESISTANCE; APOPTOSIS; BCL-X(L); BAX; PHOSPHORYLATION; CHEMOTHERAPY; DISRUPTION	Inhibitors of bromodomain and extra-terminal proteins (BETi) suppress oncogenic gene expression and have been shown to be efficacious in many in vitro and murine models of cancer, including triple-negative breast cancer (TNBC), a highly aggressive disease. However, in most cancer models, responses to BETi can be highly variable. We previously reported that TNBC cells either undergo senescence or apoptosis in response to BETi, but the specific mechanisms dictating these two cell fates remain unknown. Using six human TNBC cell lines, we show that the terminal response of TNBC cells to BETi is dictated by the intrinsic expression levels of the anti-apoptotic protein B-cell lymphoma-extra large (BCL-xL). BCL-xL levels were higher in cell lines that senesce in response to BETi compared with lines that primarily die in response to these drugs. Moreover, BCL-xL expression was further reduced in cells that undergo BETi-mediated apoptosis. Forced BCL-xL overexpression in cells that normally undergo apoptosis following BETi treatment shifted them to senescence without affecting the reported mechanism of action of BETi in TNBC, that is, mitotic catastrophe. Most importantly, pharmacological or genetic inhibition of BCL-xL induced apoptosis in response to BETi, and inhibiting BCL-xL, even after BETi-induced senescence had already occurred, still induced cell death. These results indicate that BCL-xL provides a senescent cell death-inducing or senolytic target that may be exploited to improve therapeutic outcomes of TNBC in response to BETi. They also suggest that the basal levels of BCL-xL should be predictive of tumor responses to BETi in current clinical trials.	[Gayle, Sylvia S.; Sahni, Jennifer M.; Webb, Bryan M.; Weber-Bonk, Kristen L.; Shively, Melyssa S.; Keri, Ruth A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Spina, Raffaella; Bar, Eli E.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Summers, Mathew K.] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Summers, Mathew K.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Sahni, Jennifer M.] NY Univ, Sch Med, Dept Pathol, New York, NY 10016 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Keri, RA (corresponding author), 2109 Adelbert Rd, Cleveland, OH 44106 USA.	keri@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088; Roberts, Melyssa/0000-0001-6864-779X; Sahni, Jennifer/0000-0002-2735-1789	National Institutes of Health [T32 CA059366, F32CA210426, F99CA212460, F31CA224809, RO1CA187780, R01GM112895, R01GM108743, R01CA206505]; NATIONAL CANCER INSTITUTE [F32CA210426, R01CA187780, F99CA212460, R01CA206505, F31CA224809, T32CA059366] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM112895, R01GM108743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants T32 CA059366 (to S.S.G. and J.M.S.), F32CA210426 (to S.S.G.), F99CA212460 (to J.M.S.), F31CA224809 (to B.M.W.), RO1CA187780 (to E.E.B.), R01GM112895 (to M.K.S.), R01GM108743 (to M.K.S.), and R01CA206505 (to R.A.K.).	Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Bai LC, 2017, CANCER RES, V77, P2476, DOI 10.1158/0008-5472.CAN-16-2622; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Conery AR, 2016, CANCER RES, V76, P1313, DOI 10.1158/0008-5472.CAN-15-1458; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; da Motta LL, 2017, ONCOGENE, V36, P122, DOI 10.1038/onc.2016.184; Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Fernandez Y, 2000, CELL DEATH DIFFER, V7, P350, DOI 10.1038/sj.cdd.4400662; Ghaneh Paula, 2002, J Hepatobiliary Pancreat Surg, V9, P1, DOI 10.1007/s005340200000; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Gobe G, 2002, CANCER INVEST, V20, P324, DOI 10.1081/CNV-120001177; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Khongkow P, 2016, ONCOGENE, V35, P990, DOI 10.1038/onc.2015.152; Korb E, 2015, NAT NEUROSCI, V18, P1464, DOI 10.1038/nn.4095; Krajewska M, 1996, AM J PATHOL, V148, P1567; Liu R, 1999, AM J PATHOL, V155, P1861, DOI 10.1016/S0002-9440(10)65505-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Ma F, 2014, CANCER LETT, V353, P153, DOI 10.1016/j.canlet.2014.06.022; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Park SS, 2007, BIOCHEM BIOPH RES CO, V363, P1044, DOI 10.1016/j.bbrc.2007.09.037; Reuben JM, 2011, EUR J CANCER, V47, P1527, DOI 10.1016/j.ejca.2011.01.011; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Sahni JM, 2017, CANCER RES, V77, P5395, DOI 10.1158/0008-5472.CAN-17-1571; Sahni JM, 2016, J BIOL CHEM, V291, P23756, DOI 10.1074/jbc.M116.738666; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang LQ, 2017, CELL REP, V21, P773, DOI 10.1016/j.celrep.2017.09.085; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wang Q, 2011, INT J CANCER, V128, P1546, DOI 10.1002/ijc.25482; Watanabe J, 2002, INT J ONCOL, V21, P515; Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190	44	32	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					875	886		10.1074/jbc.RA118.004712	http://dx.doi.org/10.1074/jbc.RA118.004712			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482844	Green Published, hybrid			2022-12-26	WOS:000458670200014
J	Ceccarelli, F; Sciandrone, M; Perricone, C; Galvan, G; Cipriano, E; Galligari, A; Levato, T; Colasanti, T; Massaro, L; Natalucci, F; Spinelli, FR; Alessandri, C; Valesini, G; Conti, F				Ceccarelli, Fulvia; Sciandrone, Marco; Perricone, Carlo; Galvan, Giulio; Cipriano, Enrica; Galligari, Alessandro; Levato, Tommaso; Colasanti, Tania; Massaro, Laura; Natalucci, Francesco; Spinelli, Francesca Romana; Alessandri, Cristiano; Valesini, Guido; Conti, Fabrizio			Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models	PLOS ONE			English	Article							MUSCULOSKELETAL ULTRASOUND; CARBAMYLATED PROTEINS; JOINT INVOLVEMENT; ANTIBODIES; CRITERIA; DISEASE; INDEX	Objective Limited evidences are available on biomarkers to recognize Systemic Lupus erythematosus (SLE) patients at risk to develop erosive arthritis. Anti-citrullinated peptide antibodies (ACPA) have been widely investigated and identified in up to 50% of X-ray detected erosive arthritis; conversely, few studies evaluated anti-carbamylated proteins antibodies (antiCarP). Here, we considered the application of machine learning models to identify relevant factors in the development of ultrasonography (US)-detected erosive damage in a large cohort of SLE patients with joint involvement. Methods We enrolled consecutive SLE patients with arthritis/arthralgia. All patients underwent joint (DAS28, STR) and laboratory assessment (detection of ACPA, anti-CarP, Rheumatoid Factor, SLE-related antibodies). The bone surfaces of metacarpophalangeal and proximal interphalangeal joints were assessed by US: the presence of erosions was registered with a dichotomous value (0/1), obtaining a total score (0-20). Concerning machine learning techniques, we applied and compared Logistic Regression and Decision Trees in conjunction with the feature selection Forward Wrapper method. Results We enrolled 120 SLE patients [M/F 8/112, median age 47.0 years (IQR 15.0); median disease duration 120.0 months (IQR 156.0)], 73.3% of them referring at least one episode of arthritis. Erosive damage was identified in 25.8% of patients (mean +/- SD 0.7 +/- 1.6), all of them with clinically evident arthritis. We applied Logistic Regression in conjunction with the Forward Wrapper method, obtaining an AUC value of 0.806 +/- 0.02. As a result of the learning procedure, we evaluated the relevance of the different factors: this value was higher than 35% for ACPA and anti-CarP. Conclusion The application of Machine Learning Models allowed to identify factors associated with US-detected erosive bone damage in a large SLE cohort and their relevance in determining this phenotype. Although the scope of this study is limited by the small sample size and its cross-sectional nature, the results suggest the relevance of ACPA and anti-CarP antibodies in the development of erosive damage as also pointed out in other studies.	[Ceccarelli, Fulvia; Perricone, Carlo; Cipriano, Enrica; Colasanti, Tania; Massaro, Laura; Natalucci, Francesco; Spinelli, Francesca Romana; Alessandri, Cristiano; Valesini, Guido; Conti, Fabrizio] Sapienza Univ Roma, Lupus Clin, Rheumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy; [Sciandrone, Marco; Galvan, Giulio; Galligari, Alessandro; Levato, Tommaso] Univ Firenze, Dipartimento Ingn Informaz, Florence, Italy	Sapienza University Rome; University of Florence	Ceccarelli, F (corresponding author), Sapienza Univ Roma, Lupus Clin, Rheumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy.	fulviaceccarelli@gmail.com	Spinelli, Francesca Romana/AAM-7061-2020; COLASANTI, Tania/AAF-4074-2022; COLASANTI, Tania/AFI-8434-2022	Spinelli, Francesca Romana/0000-0003-1969-2097; COLASANTI, Tania/0000-0002-4413-1817; COLASANTI, Tania/0000-0002-4413-1817; Valesini, Guido/0000-0002-7757-8092; Galvan, Giulio/0000-0002-0384-0334; Levato, Tommaso/0000-0002-4616-8277; Ceccarelli, Fulvia/0000-0001-5026-8783; Galligari, Alessandro/0000-0002-8599-642X; Perricone, Carlo/0000-0003-4771-6981				Amezcua-Guerra LM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2036; Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3; Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Blazadonakis ME, 2008, COMPUT BIOL MED, V38, P894, DOI 10.1016/j.compbiomed.2008.05.005; Brakenhoff LKPM, 2014, SCAND J RHEUMATOL, V43, P416, DOI 10.3109/03009742.2014.882407; Ceccarelli F, 2017, CLIN EXP RHEUMATOL, V35, P674; Ceccarelli F, 2014, SCI WORLD J, V2014; Ceccarelli F, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1622-z; Ceccarelli F, 2017, SEMIN ARTHRITIS RHEU, V47, P53, DOI 10.1016/j.semarthrit.2017.03.022; Ceccarelli F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174200; Cipriano E, 2015, REUMATISMO, V67, P62, DOI 10.4081/reumatismo.2015.828; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jin Y, 2016, EURASIP J BIOINFORM, DOI 10.1186/s13637-016-0046-9; Massaro L, 2018, LUPUS, V27, P105, DOI 10.1177/0961203317713141; Mastrangelo A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/712490; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Tang HY, 2011, ASAIO J, V57, P300, DOI 10.1097/MAT.0b013e318222db30; Taraborelli M, 2012, REUMATISMO, V64, P321, DOI 10.4081/reumatismo.2012.321; Tonidandel S, 2010, ORGAN RES METHODS, V13, P767, DOI 10.1177/1094428109341993; VERHEUL MK, 2018, ARTHRITIS RHEUMATOL; Wakefield RJ, 2005, J RHEUMATOL, V32, P2485; Wright S, 2006, LUPUS, V15, P501, DOI 10.1191/0961203306lu2340oa; Ziegelasch M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1192-x	27	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207926	10.1371/journal.pone.0207926	http://dx.doi.org/10.1371/journal.pone.0207926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513105	Green Submitted, gold, Green Published			2022-12-26	WOS:000452204800018
J	Jodoin, R; Perreault, JP				Jodoin, Rachel; Perreault, Jean-Pierre			G-quadruplexes formation in the 5'UTRs of mRNAs associated with colorectal cancer pathways	PLOS ONE			English	Article							UNTRANSLATED REGIONS; GENE ONTOLOGY; DNA; TRANSLATION; 5'-UTR; ACTIVATION; SEQUENCES; BINDS; COLON; MOTIF	RNA G-quadruplexes (rG4) are stable non-canonical secondary structures composed of G-rich sequences. Many rG4 structures located in the 5'UTRs of mRNAs act as translation repressors due to their high stability which is thought to impede ribosomal scanning. That said, it is not known if these are mRNA-specific examples, or if they are indicative of a global expression regulation mechanism of the mRNAs involved in a common pathway based on structure folding recognition. Gene-ontology analysis of mRNAs bearing a predicted rG4 motif in their 5'UTRs revealed an enrichment for mRNAs associated with the colorectal cancer pathway. Bioinformatic tools for rG4 prediction, and experimental in vitro validations were used to confirm and compare the folding of the predicted rG4s of the mRNAs associated with dysregulated pathways in colorectal cancer. The rG4 folding was confirmed for the first time for 9 mRNAs. A repressive effect of 3 rG4 candidates on the expression of a reporter gene was also measured in colorectal cancer cell lines. This work highlights the fact that rG4 prediction is not yet accurate, and that experimental characterization is still essential in order to identify the precise rG4 folding sequences and the possible common features shared between the rG4 overrepresented in important biological pathways.	[Jodoin, Rachel; Perreault, Jean-Pierre] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ, Canada	University of Sherbrooke	Perreault, JP (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ, Canada.	Jean-Pierre.Perreault@USherbrooke.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada [155219-12, 155219-17]; Fonds de Recherche Quebec Nature et Technologies (FRQNT); Canadian Institutes of Health Research (CIHR); Fonds de Recherche Quebec Sante (FRQS)	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Quebec Nature et Technologies (FRQNT); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Quebec Sante (FRQS)	This project was supported by grants 155219-12 and 155219-17 of the Natural Sciences and Engineering Research Council (NSERC) of Canada, www.nserc-crsng.gc.ca, and Fonds de Recherche Quebec Nature et Technologies (FRQNT), www.frqnt.gouv.qc.ca to JPP. RJ received student fellowships from the Canadian Institutes of Health Research (CIHR), www.cihr-irsc.gc.ca and Fonds de Recherche Quebec Sante (FRQS), www.frqs.gouv.qc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala P, 2013, BIOCHEMISTRY-US, V52, P1528, DOI 10.1021/bi301365g; Arachchilage GM, 2014, CHEM COMMUN, V50, P1250, DOI 10.1039/c3cc47381c; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beaudoin JD, 2014, NUCLEIC ACIDS RES, V42, P1209, DOI 10.1093/nar/gkt904; Beaudoin JD, 2013, METHODS, V64, P79, DOI 10.1016/j.ymeth.2013.02.017; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Bhattacharyya D, 2017, BIOCHIMIE, V137, P147, DOI 10.1016/j.biochi.2017.03.007; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Bolduc F, 2016, J BIOL CHEM, V291, P21751, DOI 10.1074/jbc.M116.744839; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Cammas A, 2017, NUCLEIC ACIDS RES, V45, P1584, DOI 10.1093/nar/gkw1280; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; de la Faverie AR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku111; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fay MM, 2017, J MOL BIOL, V429, P2127, DOI 10.1016/j.jmb.2017.05.017; Fleming AM, 2018, BIOCHEMISTRY-US, V57, P991, DOI 10.1021/acs.biochem.7b01172; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Garant JM, 2018, BIOCHIMIE, V151, P115, DOI 10.1016/j.biochi.2018.06.002; Garant JM, 2017, BIOINFORMATICS, V33, P3532, DOI 10.1093/bioinformatics/btx498; Garant JM, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav059; Guo JU, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5371; Halder K, 2012, METHODS, V57, P115, DOI 10.1016/j.ymeth.2012.02.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang H, 2014, NAT CHEM BIOL, V10, P686, DOI [10.1038/NCHEMBIO.1561, 10.1038/nchembio.1561]; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jodoin R, 2014, RNA, V20, P1129, DOI 10.1261/rna.044578.114; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kwok CK, 2016, NAT METHODS, V13, P841, DOI 10.1038/nmeth.3965; Laguerre A, 2015, J AM CHEM SOC, V137, P8521, DOI 10.1021/jacs.5b03413; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Liu H, 2002, J MOL BIOL, V322, P955, DOI 10.1016/S0022-2836(02)00876-8; Lorenz R, 2013, IEEE ACM T COMPUT BI, V10, P832, DOI 10.1109/TCBB.2013.7; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Martadinata H, 2014, BIOCHEMISTRY-US, V53, P1595, DOI 10.1021/bi4015727; Mcrae EKS, 2017, NUCLEIC ACIDS RES, V45, P6656, DOI 10.1093/nar/gkx380; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morris MJ, 2010, J AM CHEM SOC, V132, P17831, DOI 10.1021/ja106287x; Motulsky H., 2014, INTUITIVE BIOSTATIST; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nicoludis JM, 2012, NUCLEIC ACIDS RES, V40, P5432, DOI 10.1093/nar/gks152; Parrotta L, 2014, EXPERT OPIN DRUG DIS, V9, P1167, DOI 10.1517/17460441.2014.941353; Rouleau S, 2020, ADV BIOCHEM ENG BIOT, V170, P1, DOI 10.1007/10_2017_8; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Song JW, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2016.1244031; Tang CF, 2006, J AM CHEM SOC, V128, P5966, DOI 10.1021/ja0603958; Tang WL, 2016, HUM MOL GENET, V25, P2060, DOI 10.1093/hmg/ddw079; Trachman RJ, 2017, NAT CHEM BIOL, V13, P807, DOI 10.1038/nchembio.2392; Weldon C, 2016, BIOCHEM SOC T, V44, P1761, DOI 10.1042/BST20160109	56	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208363	10.1371/journal.pone.0208363	http://dx.doi.org/10.1371/journal.pone.0208363			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507959	Green Submitted, Green Published, gold			2022-12-26	WOS:000451886500035
J	Okubadejo, NU; Rizig, M; Ojo, OO; Jonvik, H; Oshinaike, O; Brown, E; Houlden, H				Okubadejo, Njideka U.; Rizig, Mie; Ojo, Oluwadamilola O.; Jonvik, Hallgeir; Oshinaike, Olajumoke; Brown, Emmeline; Houlden, Henry			Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease	PLOS ONE			English	Article							G2019S; FAMILIES; EVENTS; COMMON; GENE	To date the LRRK2 p.G2019S mutation remains the most common genetic cause of Parkinson disease (PD) worldwide. It accounts for up to 6% of familial and approximately 1.5% of sporadic cases. LRRK2 has a kinase enzymatic domain which provides an attractive potential target for drug therapies and LRRK2 kinase inhibitors are in development. Prevalence of the p.G2019S has a variable ethnic and geographic distribution, the highest reported among Ashkenazi Jews (30% in patients with familial PD, 14% in sporadic PD, 2.0% in controls) and North African Berbers (37% in patients with familial PD, 41% in sporadic PD, and 1% in controls). Little is known about the frequency of the LRRK2 p.G2019S among populations in sub-Saharan Africa. Our group and others previously reported that the p.G2019S is absent in a small cohort of Nigerian PD patients and controls. Here we used Kompetitive Allele Specific PCR (KASP) assay to screen for the p.G2019S in a larger cohort of Black African PD patients (n = 126) and healthy controls (n = 54) from Nigeria. Our analysis confirmed that all patients and controls are negative for the p.G2019S mutation. This report provides further evidence that the LRRK2 p.G2019S is not implicated in PD in black populations from Nigeria and support the notion that p.G2019S mutation originated after the early human dispersal from sub-Saharan Africa. Further studies using larger cohorts and advance sequencing technology are required to underpin the genetic causes of PD in this region.	[Okubadejo, Njideka U.; Ojo, Oluwadamilola O.] Univ Lagos, Coll Med, Fac Clin Sci, Dept Med,Neurol Unit, Idi Araba, Lagos State, Nigeria; [Okubadejo, Njideka U.; Ojo, Oluwadamilola O.] Lagos Univ, Teaching Hosp, Idi Araba, Lagos State, Nigeria; [Rizig, Mie; Jonvik, Hallgeir; Brown, Emmeline; Houlden, Henry] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Rizig, Mie; Jonvik, Hallgeir; Brown, Emmeline; Houlden, Henry] Natl Hosp Neurol & Neurosurg, Queen Sq, London, England; [Oshinaike, Olajumoke] Lagos State Univ, Teaching Hosp, Dept Med, Ikeja, Lagos State, Nigeria	University of Lagos; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Lagos State University	Okubadejo, NU (corresponding author), Univ Lagos, Coll Med, Fac Clin Sci, Dept Med,Neurol Unit, Idi Araba, Lagos State, Nigeria.; Okubadejo, NU (corresponding author), Lagos Univ, Teaching Hosp, Idi Araba, Lagos State, Nigeria.	nokubadejo@unilag.edu.ng	Rizig, Mie/GNP-2995-2022; Brown, Emmeline/GZL-2389-2022; Houlden, Henry J/C-1532-2008	Rizig, Mie/0000-0003-2420-4449; Houlden, Henry J/0000-0002-2866-7777; Okubadejo, Njideka/0000-0003-2975-8803; Ojo, Oluwadamilola/0000-0001-6461-2653	University of Lagos Central Research Committee Grant [CRC 11-004-5125]; MRC [G1001253] Funding Source: UKRI	University of Lagos Central Research Committee Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NUO received a University of Lagos Central Research Committee Grant to fund recruitment of study participants (clinical data collection). Funders website: www.unilag.edu.ng. Grant ID: CRC 11-004-5125 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardien S, 2010, J NEURAL TRANSM, V117, P847, DOI 10.1007/s00702-010-0423-6; Benamer HTS, 2010, EUR NEUROL, V63, P321, DOI 10.1159/000279653; Cilia R, 2012, J NEUROL, V259, P569, DOI 10.1007/s00415-011-6210-y; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Guedes LC, 2010, PARKINSONISM RELAT D, V16, P237, DOI 10.1016/j.parkreldis.2009.11.004; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Landoulsi Z, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0432-5; Lesage S, 2005, AM J HUM GENET, V77, P330, DOI 10.1086/432422; Lesage S, 2010, HUM MOL GENET, V19, P1998, DOI 10.1093/hmg/ddq081; Okubadejo N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003421; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2009, HUM MUTAT, V30, P1153, DOI 10.1002/humu.21038; Papapetropoulos S, 2008, J CLIN NEUROSCI, V15, P1027, DOI 10.1016/j.jocn.2007.08.013; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; West AB, 2017, EXP NEUROL, V298, P236, DOI 10.1016/j.expneurol.2017.07.019; Williams U, 2018, J MOV DISORD, V11, P53, DOI 10.14802/jmd.17028; Yonova-Doing E, 2012, PARKINSONISM RELAT D, V18, P567, DOI 10.1016/j.parkreldis.2012.02.018; Zabetian CP, 2006, AM J HUM GENET, V79, P752, DOI 10.1086/508025; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	19	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207984	10.1371/journal.pone.0207984	http://dx.doi.org/10.1371/journal.pone.0207984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507963	gold, Green Published, Green Submitted			2022-12-26	WOS:000451886500015
J	Seliger, C; Schaertl, J; Gerken, M; Luber, C; Proescholdt, M; Riemenschneider, MJ; Leitzmann, MF; Hau, P; Klinkhammer-Schalke, M				Seliger, Corinna; Schaertl, Julia; Gerken, Michael; Luber, Christian; Proescholdt, Martin; Riemenschneider, Markus J.; Leitzmann, Michael F.; Hau, Peter; Klinkhammer-Schalke, Monika			Use of statins or NSAIDs and survival of patients with high-grade glioma	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN GLIOBLASTOMA CELLS; LOW-DOSE ASPIRIN; NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-II; METRONOMIC CHEMOTHERAPY; VENOUS THROMBOEMBOLISM; ADJUVANT TEMOZOLOMIDE; CELECOXIB; PROLIFERATION	Background High-grade glioma (HGG) is associated with a limited prognosis. Drug repurposing has become of increasing interest to improve standard therapy. Statins and NSAIDs inhibit glioma cell growth in vitro and in vivo, but data on statin and NSAID treatment in relation to survival of patients with HGG are sparse. Methods We performed multivariable adjusted Cox-regression analyses among 1,093 patients with HGG from a regional cancer registry to obtain Hazard Ratios (HRs) with 95% Confidence Intervals (CIs) for overall survival (OS) and progression-free survival (PFS) according to treatment with statins or NSAIDs. Data on dose and duration of treatment was mostly lacking in our analysis, therefore we were not able to perform dose-response analyses. Results Use of statins was unrelated to OS or PFS of glioma patients. Use of aspirin was associated with prolonged OS and PFS in patients with WHO grade III, but not WHO grade IV glioma. Use of other NSAIDs (diclofenac, ibuprofen) or non-NSAID analgesics (paracetamol) was mostly unrelated to survival of glioma patients. Use of selective COX-2 inhibitors and metamizol was related to inferior patient survival in parts of the analyses. Conclusions Use of statins or NSAIDS, including aspirin, was not associated with prolonged OS or PFS of patients with WHO grade IV glioma in our selected cohort. There was an indication for improved survival in patients with WHO grade III glioma using aspirin, but further studies are needed to confirm our first observation.	[Seliger, Corinna; Schaertl, Julia; Luber, Christian; Hau, Peter] Regensburg Univ, Med Ctr, Dept Neurol, Regensburg, Germany; [Seliger, Corinna; Proescholdt, Martin; Riemenschneider, Markus J.; Hau, Peter] Regensburg Univ, Med Ctr, Wilhelm Sander Neurooncol Unit, Regensburg, Germany; [Gerken, Michael; Klinkhammer-Schalke, Monika] Univ Regensburg, Tumor Ctr, Inst Qual Assurance & Hlth Serv Res, Regensburg, Germany; [Proescholdt, Martin] Regensburg Univ, Dept Neurosurg, Med Ctr, Regensburg, Germany; [Riemenschneider, Markus J.] Regensburg Univ Hosp, Dept Neuropathol, Regensburg, Germany; [Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Seliger, C (corresponding author), Regensburg Univ, Med Ctr, Dept Neurol, Regensburg, Germany.; Seliger, C (corresponding author), Regensburg Univ, Med Ctr, Wilhelm Sander Neurooncol Unit, Regensburg, Germany.	corinna.seliger@klinik.uni-regensburg.de	Seliger, Corinna/GSE-3989-2022; Reifenberger, Guido/AAE-3599-2019	Hau, Peter/0000-0003-3894-5053	German Research Foundation (Deutsche Forschungsgemeinschaft); Wilhelm Sander-Stiftung, Munich and Ingolstadt, Germany	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Wilhelm Sander-Stiftung, Munich and Ingolstadt, Germany	This work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft to C.S. and M.F.L.) and it was partly supported by the Wilhelm Sander-Stiftung, Munich and Ingolstadt, Germany (to P.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all members of the Clinical Research Unit KFO 262, especially Marina Kreutz and Peter Oefner for critical discussions and valuable ideas and all patients, clinicians and practitioners who contributed data to the registry. This work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft to C.S. and M.F.L.) and it was partly supported by the Wilhelm Sander-Stiftung, Munich and Ingolstadt, Germany (to P.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshordel S, 2015, PHARMACOL RES, V91, P69, DOI 10.1016/j.phrs.2014.11.006; Akasaki Y, 2004, J IMMUNOL, V173, P4352, DOI 10.4049/jimmunol.173.7.4352; Back MF, 2007, ANN ACAD MED SINGAP, V36, P338; Bhaysar S, 2016, J CLIN NEUROSCI, V31, P176, DOI 10.1016/j.jocn.2016.03.010; Bouterfa HL, 2000, ANTICANCER RES, V20, P2761; Brockmann MA, 2007, NEURO-ONCOLOGY, V9, P335, DOI 10.1215/15228517-2007-013; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Chambless LB, 2012, J NEURO-ONCOL, V106, P383, DOI 10.1007/s11060-011-0676-4; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chan DYL, 2008, J NEURO-ONCOL, V86, P273, DOI 10.1007/s11060-007-9475-3; Chen JC, 2007, ANTICANCER RES, V27, P2547; Chirasani SR, 2013, INT J CANCER, V132, P843, DOI 10.1002/ijc.27712; Cote DJ, 2016, SEMIN THROMB HEMOST, V42, P877, DOI 10.1055/s-0036-1592334; Daugherty SE, 2011, CANCER PREV RES, V4, P2027, DOI 10.1158/1940-6207.CAPR-11-0274; Elaskalani O, 2017, CANCERS, V9, DOI 10.3390/cancers9070094; Ferris JS, 2012, INT J CANCER, V131, pE1031, DOI 10.1002/ijc.27536; Gaiser T, 2008, NEUROSCI LETT, V442, P109, DOI 10.1016/j.neulet.2008.07.014; Gaist D, 2013, BRIT J CANCER, V108, P1189, DOI 10.1038/bjc.2013.87; Gaist D, 2014, CANCER EPIDEMIOL, V38, P722, DOI 10.1016/j.canep.2014.09.010; Gliemroth J, 2003, NEUROSURG REV, V26, P117, DOI 10.1007/s10143-003-0258-9; Glynn RJ, 2007, ANN INTERN MED, V147, P525, DOI 10.7326/0003-4819-147-8-200710160-00004; Gottfried E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066987; Gupta SC, 2013, TRENDS PHARMACOL SCI, V34, P508, DOI 10.1016/j.tips.2013.06.005; Happold C, 2018, J NEURO-ONCOL, V138, P163, DOI 10.1007/s11060-018-2786-8; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Holmes MD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-391; Huded C, 2015, AM J CARDIOVASC DRUG, V15, P379, DOI 10.1007/s40256-015-0139-y; Ishikawa H, 2013, CANCER MED-US, V2, P50, DOI 10.1002/cam4.46; Jiang ZH, 2004, J NEUROCHEM, V89, P168, DOI 10.1111/j.1471-4159.2004.02319.x; JONES KD, 1994, BIOCHEM BIOPH RES CO, V205, P1681, DOI 10.1006/bbrc.1994.2861; Kang SG, 2006, ONCOL REP, V15, P7; Kardosh A, 2004, CANCER BIOL THER, V3, P55, DOI 10.4161/cbt.3.1.571; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kesari S, 2008, NEURO-ONCOLOGY, V10, P300, DOI 10.1215/15228517-2008-005; Kesari S, 2007, NEURO-ONCOLOGY, V9, P354, DOI 10.1215/15228517-2007-006; Koyuturk M, 2004, NEUROSCI LETT, V370, P212, DOI 10.1016/j.neulet.2004.08.020; Le Rhun E, 2018, EUR J CANCER, V101, P95, DOI 10.1016/j.ejca.2018.06.029; Leidgens V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140613; Louis, 2016, WHO CLASSIFICATION G; Ma HI, 2011, J NEUROSURG, V114, P651, DOI 10.3171/2009.11.JNS091396; Morgan ER, 2016, EXPERT REV NEUROTHER, V16, P803, DOI 10.1080/14737175.2016.1181542; Murray LJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3638; Nam DH, 2004, ONCOL REP, V11, P263; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Obara S, 2002, CANCER LETT, V185, P153, DOI 10.1016/S0304-3835(02)00278-1; Penas-Prado M, 2015, NEURO-ONCOLOGY, V17, P266, DOI 10.1093/neuonc/nou155; Pitter KL, 2016, BRAIN, V139, P1458, DOI 10.1093/brain/aww046; Porkholm M, 2014, PEDIATR BLOOD CANCER, V61, P1603, DOI 10.1002/pbc.25045; Prima V, 2017, P NATL ACAD SCI USA, V114, P1117, DOI 10.1073/pnas.1612920114; Rachidi S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0065-5; Reardon DA, 2005, CANCER-AM CANCER SOC, V103, P329, DOI 10.1002/cncr.20776; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sareddy GR, 2012, J NEURO-ONCOL, V106, P99, DOI 10.1007/s11060-011-0662-x; Scheurer ME, 2008, CANCER EPIDEM BIOMAR, V17, P1277, DOI 10.1158/1055-9965.EPI-07-2621; Schmidt F, 2001, ACTA NEUROPATHOL, V101, P217; Seliger C, 2016, CELL CYCLE, V15, P1755, DOI 10.1080/15384101.2016.1186316; Seliger C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149293; Sharma V, 2011, NEUROCHEM INT, V59, P567, DOI 10.1016/j.neuint.2011.06.018; Shono T, 2001, CANCER RES, V61, P4375; Sivak-Sears NR, 2004, AM J EPIDEMIOL, V159, P1131, DOI 10.1093/aje/kwh153; SOMA MR, 1994, BIOCHEM BIOPH RES CO, V200, P1143, DOI 10.1006/bbrc.1994.1570; Stockhammer F, 2010, J NEURO-ONCOL, V100, P407, DOI 10.1007/s11060-010-0192-y; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki K, 2013, NEURO-ONCOLOGY, V15, P1186, DOI 10.1093/neuonc/not062; Toth L, 2013, J MOL GRAPH MODEL, V40, P99, DOI 10.1016/j.jmgm.2012.12.013; Welzel G, 2015, J NEURO-ONCOL, V124, P265, DOI 10.1007/s11060-015-1834-x; Wong ET, 2015, BRIT J CANCER, V113, P1642, DOI 10.1038/bjc.2015.404; Wu H, 2009, NEUROSURGERY, V65, P96; Wu HT, 2009, NEUROSURGERY, V65, P1087, DOI 10.1227/01.NEU.0000360130.52812.1D; Yanae M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-74; Zhong SL, 2015, CANCER EPIDEM BIOMAR, V24, P1645, DOI 10.1158/1055-9965.EPI-15-0452	72	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207858	10.1371/journal.pone.0207858	http://dx.doi.org/10.1371/journal.pone.0207858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507932	Green Submitted, Green Published, gold			2022-12-26	WOS:000451886500012
J	Mohr-Sasson, A; Spira, M; Rahav, R; Manela, D; Schiff, E; Mazaki-Tovi, S; Orvieto, R; Sivan, E				Mohr-Sasson, Aya; Spira, Maya; Rahav, Rony; Manela, Dafna; Schiff, Eyal; Mazaki-Tovi, Shali; Orvieto, Raoul; Sivan, Eyal			Ovarian reserve after uterine artery embolization in women with morbidly adherent placenta: A cohort study	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; FIBROID EMBOLIZATION; ABNORMAL PLACENTATION; CONSERVATIVE MANAGEMENT; FERTILITY; ACCRETA; PREGNANCY; DIAGNOSIS; OUTCOMES; PREVIA	Objective To evaluate ovarian reserve in women after preservative cesarean delivery using uterine artery embolization due to morbidly adherent placenta. Study design A historical cohort study including all women admitted to a single tertiary care center, with morbidly adherent placenta that had preservative cesarean delivery with bilateral uterine artery embolization. Inclusion criteria included gestational age > 24 weeks, singleton pregnancy and placenta increta / percreta. Exclusion criteria included maternal age > 43 years old and cesarean hysterectomy. Control group included women attending the infertility clinic due to male factor or single women conceiving via sperm donation, matched by age. Blood samples were collected on day 2-5 of menstruations for hormonal profile and Anti Mullarian Hormone (AMH) levels. Primary outcome was ovarian reserve evaluated by the levels of AMH. Results 59 women underwent preservative cesarean delivery using uterine artery embolization during the study period. 21 women met inclusion criteria (33.9%) and were matched controls (n = 40). Circulating levels of E2 and FSH did not differ significantly between the two groups (p = 0.665, p = 0.396, respectively). AMH was lower in the study group ( median 0.8 IQR 0.44-1.80) compared to the controls (median 2.08 IQR 1.68-3.71) (p = 0.001). This finding was consistent in linear multivariate regression analysis where the group of cesarean delivery using bilateral artery embolization due to placenta accrete was significantly predictive for the levels of AMH (B = -1.308, p = 0.012). Conclusion Women post preservative cesarean delivery using uterine artery embolization due to placenta accrete have lower ovarian reserve compare to controls matched by age.	[Mohr-Sasson, Aya; Spira, Maya; Rahav, Rony; Manela, Dafna; Schiff, Eyal; Mazaki-Tovi, Shali; Orvieto, Raoul; Sivan, Eyal] Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel; [Mohr-Sasson, Aya; Spira, Maya; Rahav, Rony; Schiff, Eyal; Mazaki-Tovi, Shali; Orvieto, Raoul; Sivan, Eyal] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Mohr-Sasson, A (corresponding author), Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel.; Mohr-Sasson, A (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	mohraya@gmail.com						Bauer ST, 2009, SEMIN PERINATOL, V33, P88, DOI 10.1053/j.semperi.2008.12.003; Bonduki CE, 2011, CLINICS, V66, P807, DOI 10.1590/S1807-59322011000500016; Bouvier A, 2012, CLIN RADIOL, V67, P1089, DOI 10.1016/j.crad.2012.04.001; Carcopino X, 2009, BJOG-INT J OBSTET GY, V116, P1538, DOI 10.1111/j.1471-0528.2009.02249.x; Chrisman HB, 2000, J VASC INTERV RADIOL, V11, P699, DOI 10.1016/S1051-0443(07)61627-3; Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P77; David M, 2013, GEBURTSH FRAUENHEILK, V73, P247, DOI 10.1055/s-0032-1328318; de Marcillac FD, 2016, J GYNECOL OBST BIO R, V45, P849, DOI 10.1016/j.jgyn.2016.03.012; Eller AG, 2009, BJOG-INT J OBSTET GY, V116, P648, DOI 10.1111/j.1471-0528.2008.02037.x; Eshkoli T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.037; Fitzpatrick KE, 2014, BJOG-INT J OBSTET GY, V121, P62, DOI 10.1111/1471-0528.12405; Gruijters MJG, 2003, MOL CELL ENDOCRINOL, V211, P85, DOI 10.1016/j.mce.2003.09.024; Iwase Akira, 2016, Reproductive Medicine and Biology, V15, P127, DOI 10.1007/s12522-015-0227-3; Jung S, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.02.105; Khokhar RS, 2016, SAUDI J ANAESTH, V10, P332, DOI 10.4103/1658-354X.174913; Kim CW, 2016, EUR J OBSTET GYN R B, V206, P172, DOI 10.1016/j.ejogrb.2016.09.001; Kroncke T, 2010, ROFO-FORTSCHR RONTG, V182, P615, DOI 10.1055/s-0029-1245468; Kroon B, 2011, AUST NZ J OBSTET GYN, V51, P289, DOI 10.1111/j.1479-828X.2011.01300.x; McLucas B, 2001, J AM COLL SURGEONS, V192, P95, DOI 10.1016/S1072-7515(00)00738-9; McLucas B, 2018, MINIM INVASIV THER, V27, P186, DOI 10.1080/13645706.2017.1365728; Meczekalski B, 2016, J ENDOCRINOL INVEST, V39, P1259, DOI 10.1007/s40618-016-0497-6; Meng JL, 2017, INT J GYNAECOL OBSTE; Millischer AE, 2017, PLACENTA, V53, P40, DOI 10.1016/j.placenta.2017.03.006; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; Pan Y, 2017, INT J GYNECOL OBSTET, V137, P45, DOI 10.1002/ijgo.12090; Payne JF, 2002, OBSTET GYNECOL, V100, P883, DOI 10.1016/S0029-7844(02)02270-6; Pisco JM, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.08.032; Rao KP, 2012, OBSTET GYNECOL SURV, V67, P503, DOI 10.1097/OGX.0b013e3182685870; Sentilhes L, 2013, ACTA OBSTET GYN SCAN, V92, P1125, DOI 10.1111/aogs.12222; Sentilhes L, 2010, HUM REPROD, V25, P2803, DOI 10.1093/humrep/deq239; Shellhaas CS, 2009, OBSTET GYNECOL, V114, P224, DOI 10.1097/AOG.0b013e3181ad9442; Sivan E, 2010, AM J PERINAT, V27, P455, DOI 10.1055/s-0030-1247599; Stokes LS, 2010, J VASC INTERV RADIOL, V21, P1153, DOI 10.1016/j.jvir.2010.03.015; Su HW, 2017, TAIWAN J OBSTET GYNE, V56, P353, DOI 10.1016/j.tjog.2017.04.016; THALER I, 1990, AM J OBSTET GYNECOL, V162, P121, DOI 10.1016/0002-9378(90)90834-T; Tropeano G, 2011, FERTIL STERIL, V96, P980, DOI 10.1016/j.fertnstert.2011.07.007; Tropeano G, 2010, FERTIL STERIL, V94, P2296, DOI 10.1016/j.fertnstert.2009.12.007; Tse G, 2010, TECH VASC INTERV RAD, V13, P148, DOI 10.1053/j.tvir.2010.03.002; Tsikouras P, 2017, MINIM INVASIV THER, V26, P284, DOI 10.1080/13645706.2017.1292919; Tulandi T, 2010, OBSTET GYNECOL, V115, P857, DOI 10.1097/AOG.0b013e3181d4891e; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074; Yu PC, 2009, FERTIL STERIL, V91, P1951, DOI 10.1016/j.fertnstert.2008.02.170; Zec I, 2011, BIOCHEM MEDICA, V21, P219	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208139	10.1371/journal.pone.0208139	http://dx.doi.org/10.1371/journal.pone.0208139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496259	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800099
J	Jiang, ZJ; Cinti, C; Taranta, M; Mattioli, E; Schena, E; Singh, S; Khurana, R; Lattanzi, G; Tsinoremas, NF; Capobianco, E				Jiang, Zhijie; Cinti, Caterina; Taranta, Monia; Mattioli, Elisabetta; Schena, Elisa; Singh, Sakshi; Khurana, Rimpi; Lattanzi, Giovanna; Tsinoremas, Nicholas F.; Capobianco, Enrico			Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures	PLOS ONE			English	Article							DNA METHYLATION; GENE-EXPRESSION; CANCER; PACKAGE; EPIGENETICS; CLEAVAGE; TARGETS; VACCINE; MODULES; CELLS	Background In melanoma, like in other cancers, both genetic alterations and epigenetic underlie the metastatic process. These effects are usually measured by changes in both methylome and transcriptome profiles, whose cross-correlation remains uncertain. We aimed to assess at systems scale the significance of epigenetic treatment in melanoma cells with different metastatic potential. Methods and findings Treatment by DAC demethylation with 5-Aza-2'-deoxycytidine of two melanoma cell lines endowed with different metastatic potential, SKMEL-2 and HS294T, was performed and high-throughput coupled RNA-Seq and RRBS-Seq experiments delivered differential profiles (DiP) of both transcriptomes and methylomes. Methylation levels measured at both TSS and gene body were studied to inspect correlated patterns with wide-spectrum transcript abundance levels quantified in both protein coding and non-coding RNA (ncRNA) regions. The DiP were then mapped onto standard bio-annotation sources (pathways, biological processes) and network configurations were obtained. The prioritized associations for target identification purposes were expected to elucidate the reprogramming dynamics induced by the epigenetic therapy. The interactomic connectivity maps of each cell line were formed to support the analysis of epigenetically re-activated genes. i.e. those supposedly silenced by melanoma. In particular, modular protein interaction networks (PIN) were used, evidencing a limited number of shared annotations, with an example being MAPK13 (cascade of cellular responses evoked by extracellular stimuli). This gene is also a targetassociated to the PANDAR ncRNA, therapeutically relevant because of its aberrant expression observed in various cancers. Overall, the non-metastatic SKMEL-2 map reveals post-treatment re-activation of a richer pathway landscape, involving cadherins and integrins as signatures of cell adhesion and proliferation. Relatively more lncRNAs were also annotated, indicating more complex regulation patterns in view of target identification. Finally, the antigen maps matched to DiP display other differential signatures with respect to the metastatic potential of the cell lines. In particular, as demethylated melanomas show connected targets that grow with the increased metastatic potential, also the potential target actionability seems to depend to some degree on the metastatic state. However, caution is required when assessing the direct influence of re-activated genes over the identified targets. In light of the stronger treatment effects observed in non-metastatic conditions, some limitations likely refer to in silico data integration tools and resources available for the analysis of tumor antigens. Conclusion Demethylation treatment strongly affects early melanoma progression by re-activating many genes. This evidence suggests that the efficacy of this type of therapeutic intervention is potentially high at the pre-metastatic stages. The biomarkers that can be assessed through antigens seem informative depending on the metastatic conditions, and networks help to elucidate the assessment of possible targets actionability.	[Jiang, Zhijie; Khurana, Rimpi; Tsinoremas, Nicholas F.; Capobianco, Enrico] Univ Miami, Ctr Computat Sci, Miami, FL 33146 USA; [Cinti, Caterina; Taranta, Monia; Singh, Sakshi] CNR, Inst Clin Physiol, Siena, Italy; [Mattioli, Elisabetta; Schena, Elisa; Lattanzi, Giovanna] CNR, Inst Mol Genet, Bologna, Italy; [Mattioli, Elisabetta; Lattanzi, Giovanna] IRCCS Rizzoli Orthoped Inst, Bologna, Italy; [Schena, Elisa] Alma Mater Studiorum Univ Bologna, S Orsola Malpighi Hosp, Dept Med & Surg Sci, Endocrinol Unit, Bologna, Italy; [Tsinoremas, Nicholas F.] Univ Miami, Dept Med, Miami, FL USA	University of Miami; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Ortopedico Rizzoli; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Miami	Capobianco, E (corresponding author), Univ Miami, Ctr Computat Sci, Miami, FL 33146 USA.	ecapobianco@med.miami.edu	Khurana, Rimpi/J-5050-2019; Lattanzi, Giovanna/AAY-3186-2020	Lattanzi, Giovanna/0000-0002-7103-8722; Mattioli, Elisabetta/0000-0002-1395-1927; Khurana, Rimpi/0000-0002-0493-6266; Capobianco, Enrico/0000-0001-9360-4767; Cinti, Caterina/0000-0001-8049-0369; Schena, Elisa/0000-0001-5960-4157	Istituto Toscano Tumori, 2013 Oncology Competition; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002736] Funding Source: NIH RePORTER	Istituto Toscano Tumori, 2013 Oncology Competition; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Istituto Toscano Tumori, 2013 Oncology Competition, http://www.ittumori.it/IttSanitaSrty/jsp/start_ENG.jsp?lang=ENG.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Bartlett TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084573; Baylin SB, 2016, COLD SPRING HARB PER, V8; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Bhartiya D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat034; Bianconi D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122037; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Bonitsis N., 2006, Experimental Oncology, V28, P187; Broers JLV, 2002, EUR J CELL BIOL, V81, P677, DOI 10.1078/0171-9335-00282; Bruner HC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029330; Capobianco E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17337-7; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Celia-Terrassa T, 2016, GENE DEV, V30, P892, DOI 10.1101/gad.277681.116; Columbaro M, 2001, FEBS LETT, V509, P423, DOI 10.1016/S0014-5793(01)03203-3; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FALCIERI E, 1994, HISTOCHEMISTRY, V102, P221; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Hamidi H, 2016, BRIT J CANCER, V115, P1017, DOI 10.1038/bjc.2016.312; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Imai-Okano K, 2016, CADHERIN SUPERFAMILY, DOI [10.1007/978-4-431-56033-3_11, DOI 10.1007/978-4-431-56033-3_11]; Janji B, 1999, INT J CANCER, V83, P255, DOI 10.1002/(SICI)1097-0215(19991008)83:2<255::AID-IJC18>3.3.CO;2-O; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kissick HT, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033704; Knijnenburg TA, 2014, NAT METHODS, V11, P689, DOI [10.1038/NMETH.2924, 10.1038/nmeth.2924]; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Li JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02962; Liang YJ, 2012, J BIOL CHEM, V287, P33533, DOI 10.1074/jbc.M112.392332; Ma XK, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1490-6; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Melief CJM, 2017, NATURE, V547, P165, DOI 10.1038/nature23093; Micevic G, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0332-8; Nguyen M, 2017, EPIGENOMES, V1, DOI 10.3390/epigenomes1010003; Olsen LR, 2017, CANCER IMMUNOL IMMUN, V66, P731, DOI 10.1007/s00262-017-1978-y; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Pitcovski J, 2017, CRIT REV ONCOL HEMAT, V115, P36, DOI 10.1016/j.critrevonc.2017.05.001; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Sarkar D, 2015, EPIGENETICS-US, V10, P103, DOI 10.1080/15592294.2014.1003746; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shrager J, 2014, NAT REV CLIN ONCOL, V11, P109, DOI 10.1038/nrclinonc.2013.244; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sun Q, 2017, ONCOTARGET, V8, P42983, DOI 10.18632/oncotarget.17785; Tabaries S, 2017, ONCOGENE, V36, P1176, DOI 10.1038/onc.2016.289; Teschendorff AE, 2018, NAT REV GENET, V19, P129, DOI 10.1038/nrg.2017.86; Turinsky AL, 2011, NUCLEIC ACIDS RES, V39, pD889, DOI 10.1093/nar/gkq857; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Venza M, 2016, ONCOL REP, V35, P2451, DOI 10.3892/or.2016.4618; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Weisenberger DJ, 2018, ONCOGENE, V37, P566, DOI 10.1038/onc.2017.374; Wijetunga NA, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1477-3; Witte T, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0066-6; Wolf DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088309; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zhang J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3259-0; Zhang XY, 2016, ONCOL LETT, V12, P3041, DOI 10.3892/ol.2016.5093; Zhao H, 2014, GENE, V548, P234, DOI 10.1016/j.gene.2014.07.038	60	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206686	10.1371/journal.pone.0206686	http://dx.doi.org/10.1371/journal.pone.0206686			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485296	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800026
J	McGregor, JE; Yin, L; Yang, Q; Godat, T; Huynh, KT; Zhang, J; Williams, DR; Merigan, WH				McGregor, Juliette E.; Yin, Lu; Yang, Qiang; Godat, Tyler; Huynh, Khang T.; Zhang, Jie; Williams, David R.; Merigan, William H.			Functional architecture of the foveola revealed in the living primate	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; IMAGING LIGHT RESPONSES; GANGLION-CELLS; CONE PHOTORECEPTORS; RETINA; NEURONS; POPULATIONS; RESOLUTION; LUMINANCE; DENSITY	The primate foveola, with its high cone density and magnified cortical representation, is exquisitely specialized for high-resolution spatial vision. However, uncovering the wiring of retinal circuitry responsible for this performance has been challenging due to the difficulty in recording receptive fields of foveal retinal ganglion cells (RGCs) in vivo. In this study, we use adaptive optics scanning laser ophthalmoscopy (AOSLO) to image the calcium responses of RGCs in the living primate, with a stable, high precision visual stimulus that allowed us to localize the receptive fields of hundreds of foveal ganglion cells. This approach revealed a precisely radial organization of foveal RGCs, despite the many distortions possible during the extended developmental migration of foveal cells. By back projecting the line connecting RGC somas to their receptive fields, we have been able to define the 'physiological center' of the foveola, locating the vertical meridian separating left and right hemifields in vivo.	[McGregor, Juliette E.; Yin, Lu; Yang, Qiang; Godat, Tyler; Huynh, Khang T.; Zhang, Jie; Williams, David R.; Merigan, William H.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Godat, Tyler; Williams, David R.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Huynh, Khang T.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Merigan, William H.] Univ Rochester, Med Ctr, Flaum Eye Inst, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Merigan, WH (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.; Merigan, WH (corresponding author), Univ Rochester, Med Ctr, Flaum Eye Inst, Rochester, NY 14642 USA.	billm@cvs.rochester.edu		Huynh, Khang/0000-0002-2585-5756; Williams, David R/0000-0003-3227-8333; Godat, Tyler/0000-0002-9195-6475	National Eye Institute [NIH EY014375, NIH EY01319, NIH EY021166]; Arnold and Mabel Beckman Foundation through the BeckmanArgyros Award in Vision Science; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY021166, P30EY001319] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Arnold and Mabel Beckman Foundation through the BeckmanArgyros Award in Vision Science; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by The National Eye Institute https://nei.nih.gov/about through grants NIH EY014375 to DRW, NIH EY01319 to DRW, NIH EY021166 to WHM, the Arnold and Mabel Beckman Foundation through the BeckmanArgyros Award in Vision Science http://www.beckman-foundation.org/programs/beckmanargyros-vision-program-information to DRW, and through an unrestricted grant to the Flaum Eye Institute from Research to Prevent Blindness https://www.rpbusa.org/rpb/grants-and-research/grants/institutional-grants/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arathorn DW, 2007, OPT EXPRESS, V15, P13731, DOI 10.1364/OE.15.013731; BLAKEMORE C, 1986, J PHYSIOL-LONDON, V380, P453, DOI 10.1113/jphysiol.1986.sp016297; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cooper B, 2012, J OPT SOC AM A, V29, pA314, DOI 10.1364/JOSAA.29.00A314; CROOK JM, 1988, J PHYSIOL-LONDON, V396, P205, DOI 10.1113/jphysiol.1988.sp016959; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; Delori FC, 2007, J OPT SOC AM A, V24, P1250, DOI 10.1364/JOSAA.24.001250; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; Geng Y, 2012, BIOMED OPT EXPRESS, V3, P715, DOI 10.1364/BOE.3.000715; Gibbons J. D., 2010, NONPARAMETRIC STAT I, DOI DOI 10.5005/JP/BOOKS/10313_14; Gray DC, 2008, INVEST OPHTH VIS SCI, V49, P467, DOI 10.1167/iovs.07-0605; Harmening WM, 2014, J NEUROSCI, V34, P5667, DOI 10.1523/JNEUROSCI.5191-13.2014; HENDRICKSON A, 1976, INVEST OPHTH VISUAL, V15, P746; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Li XB, 2015, CEREB CORTEX, V25, P1920, DOI 10.1093/cercor/bhu002; Liu ZL, 2017, P NATL ACAD SCI USA, V114, P12803, DOI 10.1073/pnas.1711734114; MARTIN PR, 1992, J COMP NEUROL, V323, P269, DOI 10.1002/cne.903230210; PACKER O, 1990, J COMP NEUROL, V298, P472, DOI 10.1002/cne.902980408; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; Polyak S. L., 1941, RETINA-J RET VIT DIS; Provis JM, 2013, PROG RETIN EYE RES, V35, P63, DOI 10.1016/j.preteyeres.2013.01.005; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Sadakane O, 2015, CELL REP, V13, P1989, DOI 10.1016/j.celrep.2015.10.050; SCHEIN SJ, 1988, J COMP NEUROL, V269, P479, DOI 10.1002/cne.902690403; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAPLEY R, 1981, NATURE, V292, P543, DOI 10.1038/292543a0; Sincich LC, 2009, NAT NEUROSCI, V12, P967, DOI 10.1038/nn.2352; Sinha R, 2017, CELL, V168, P413, DOI 10.1016/j.cell.2017.01.005; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomek J, 2013, J NEUROPHYSIOL, V110, P243, DOI 10.1152/jn.00087.2013; Wilder HD, 1996, VISUAL NEUROSCI, V13, P335, DOI 10.1017/S0952523800007586; Wilk MA, 2017, VISION RES, V132, P53, DOI 10.1016/j.visres.2016.05.001; Yang Q, 2015, OPT LETT, V40, P85, DOI 10.1364/OL.40.000085; Yin L, 2014, J NEUROSCI, V34, P6596, DOI 10.1523/JNEUROSCI.4438-13.2014; Yin L, 2011, INVEST OPHTH VIS SCI, V52, P2775, DOI 10.1167/iovs.10-6250	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207102	10.1371/journal.pone.0207102	http://dx.doi.org/10.1371/journal.pone.0207102			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485298	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800044
J	Pickering, C; Kiely, J; Suraci, B; Collins, D				Pickering, C.; Kiely, J.; Suraci, B.; Collins, D.			The magnitude of Yo-Yo test improvements following an aerobic training intervention are associated with total genotype score	PLOS ONE			English	Article							INTERMITTENT RECOVERY TEST; C-REACTIVE PROTEIN; CARDIORESPIRATORY FITNESS; PHYSIOLOGICAL-RESPONSE; PHYSICAL PERFORMANCE; ENDURANCE; EXERCISE; POLYMORPHISM; GENE; INTENSITY	Recent research has demonstrated that there is considerable inter-individual variation in the response to aerobic training, and that this variation is partially mediated by genetic factors. As such, we aimed to investigate if a genetic based algorithm successfully predicted the magnitude of improvements following eight-weeks of aerobic training in youth soccer players. A genetic test was utilised to examine five single nucleotide polymorphisms (VEGF rs2010963, ADRB2 rs1042713 and rs1042714, CRP rs1205 & PPARGC1A rs8192678), whose occurrence is believed to impact aerobic training adaptations. 42 male soccer players (17.0 +/- 1y, 176 +/- 6 cm, 69 +/- 9 kg) were tested and stratified into three different Total Genotype Score groups; "low", "medium" and "high", based on the possession of favourable polymorphisms. Subjects underwent two Yo-Yo tests separated by eight-weeks of sports-specific aerobic training. Overall, there were no significant differences between the genotype groups in pre-training Yo-Yo performance, but evident between-group response differentials emerged in post-training Yo-Yo test performance. Subjects in the "high" group saw much larger improvements (58%) than those in the 'medium' (35%) and "low" (7%) groups. There were significant (p<0.05) differences between the groups in the magnitude of improvement, with athletes in the "high" and medium group having larger improvements than the "low" group (d = 2.59 "high" vs "low"; d = 1.32 "medium" vs "low"). In conclusion, the magnitude of improvements in aerobic fitness following a training intervention were associated with a genetic algorithm comprised of five single nucleotide polymorphisms. This information could lead to the development of more individualised aerobic training designs, targeting optimal fitness adaptations.	[Pickering, C.; Kiely, J.; Collins, D.] Univ Cent Lancashire, Inst Coaching & Performance, Sch Sport & Wellbeing, Preston, Lancs, England; [Pickering, C.; Suraci, B.] DNAFit Ltd, Exercise & Nutr Genom Res Ctr, London, England; [Suraci, B.] Suraci Consultancy, Portsmouth, Hants, England	University of Central Lancashire	Pickering, C (corresponding author), Univ Cent Lancashire, Inst Coaching & Performance, Sch Sport & Wellbeing, Preston, Lancs, England.; Pickering, C (corresponding author), DNAFit Ltd, Exercise & Nutr Genom Res Ctr, London, England.	craig@dnafit.com						Ahmetov I. I., 2008, Human Physiology, V34, P477, DOI 10.1134/S0362119708040129; Ahmetov II, 2016, MED SPORT SCI, V61, P41, DOI 10.1159/000445240; Atkinson G, 2015, EXP PHYSIOL, V100, P577, DOI 10.1113/EP085070; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Beattie K, 2014, SPORTS MED, V44, P845, DOI 10.1007/s40279-014-0157-y; Bonafiglia JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167790; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Buchheit M, 2017, INT J SPORT PHYSIOL, V12, P1111, DOI 10.1123/ijspp.2017-0422; Coelho DB, 2016, J SPORT MED PHYS FIT, V56, P241; Coelho DB, 2016, APPL PHYSIOL NUTR ME, V41, P692, DOI 10.1139/apnm-2015-0514; Cohen J.E., 1988, STAT POWER ANAL BEHA; Del Coso J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172965; Erskine RM, 2014, SCAND J MED SCI SPOR, V24, P642, DOI 10.1111/sms.12055; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Jones AM, 2011, STRENGTH COND, P291; Jones N, 2016, BIOL SPORT, V33, P117, DOI 10.5604/20831862.1198210; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Kuo HK, 2007, INT J CARDIOL, V114, P28, DOI 10.1016/j.ijcard.2005.11.110; Meckel Y, 2014, ACTA KINESIOLOGIAE U, V20, P25; Montero D, 2017, J PHYSIOL-LONDON, V595, P3377, DOI 10.1113/JP273480; Moore GE, 2001, METABOLISM, V50, P1391, DOI 10.1053/meta.2001.28140; Obisesan TO, 2004, ARTERIOSCL THROM VAS, V24, P1874, DOI 10.1161/01.ATV.0000140060.13203.22; Pickering C., 2017, DNAFIT BLOGS    1004; Pickering Craig, 2017, BMJ Open Sport Exerc Med, V3, pe000309, DOI 10.1136/bmjsem-2017-000309; Pimenta EM, 2013, J STRENGTH COND RES, V27, P3286, DOI 10.1519/JSC.0b013e3182915e66; Rankinen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147330; Ring-Dimitriou S., 2014, J EXERC PHYSL ONLINE, V17, P1; Ross R, 2015, MAYO CLIN PROC, V90, P1506, DOI 10.1016/j.mayocp.2015.07.024; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Santiago C, 2010, SCAND J MED SCI SPOR, V20, pE188, DOI 10.1111/j.1600-0838.2009.00943.x; Scharhag-Rosenberger F, 2012, SCAND J MED SCI SPOR, V22, P113, DOI 10.1111/j.1600-0838.2010.01139.x; Seiler S, 2013, SCAND J MED SCI SPOR, V23, P74, DOI 10.1111/j.1600-0838.2011.01351.x; Shephard RJ, 2001, SPORTS MED, V32, P169; Solomon SR, 2009, J MOD APPL STAT METH, V8, P448, DOI 10.22237/jmasm/1257034080; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Tonnessen E, 2013, INT J SPORT PHYSIOL, V8, P323, DOI 10.1123/ijspp.8.3.323; Webborn N, 2015, BRIT J SPORT MED, V49, P1398, DOI 10.1136/bjsports-2013-093273; Williamson PJ, 2017, SPORTS MED, V47, P1501, DOI 10.1007/s40279-017-0680-8; Wolfarth B, 2007, METABOLISM, V56, P1649, DOI 10.1016/j.metabol.2007.07.006; Yvert T, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13003	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207597	10.1371/journal.pone.0207597	http://dx.doi.org/10.1371/journal.pone.0207597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485313	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000451755800075
J	Sieber, P; Schafer, A; Lieberherr, R; Le Goff, F; Stritt, M; Welford, RWD; Gatfield, J; Peter, O; Nayler, O; Luthi, U				Sieber, Patrick; Schafer, Anny; Lieberherr, Raphael; Le Goff, Francois; Stritt, Manuel; Welford, Richard W. D.; Gatfield, John; Peter, Oliver; Nayler, Oliver; Luthi, Urs			Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors	PLOS ONE			English	Article							PROSTAGLANDIN E-2; CARDIAC-GLYCOSIDES; DIFFERENTIATION; FIBROBLAST; REVERSAL; INHIBITION; DISCOVERY; DEDIFFERENTIATION; HALOFUGINONE; PATHOGENESIS	Pathological features of pulmonary fibrosis include accumulation of myofibroblasts and increased extracellular matrix (ECM) deposition in lung tissue. Contractile alpha-smooth muscle actin (alpha-SMA)-expressing myofibroblasts that produce and secrete ECM are key effector cells of the disease and therefore represent a viable target for potential novel anti-fibrotic treatments. We used primary normal human lung fibroblasts (NHLF) in two novel high-throughput screening assays to discover molecules that inhibit or revert fibroblast-to-myofibroblast differentiation. A phenotypic high-content assay (HCA) quantified the degree of myofibroblast differentiation, whereas an impedance-based assay, multiplexed with MS / MS quantification of alpha-SMA and collagen 1 alpha 1 (COL1) protein, provided a measure of contractility and ECM formation. The synthetic prostaglandin E-1 (PGE(1)) alprostadil, which very effectively and potently attenuated and even reversed TGF-beta 1-induced myofibroblast differentiation, was identified by screening a library of approved drugs. In TGF-beta 1-induced myofibroblasts the effect of alprostadil was attributed to activation of prostanoid receptor 2 and 4 (EP2 and EP4, respectively). However, selective activation of the EP2 or the EP4 receptor was already sufficient to prevent or reverse TGF-beta 1-induced NHLF myofibroblast transition. Our high-throughput assays identified chemical structures with potent anti-fibrotic properties acting through potentially novel mechanisms.	[Sieber, Patrick; Schafer, Anny; Lieberherr, Raphael; Le Goff, Francois; Stritt, Manuel; Welford, Richard W. D.; Gatfield, John; Peter, Oliver; Nayler, Oliver; Luthi, Urs] Idorsia Pharmaceut Ltd, Allschwil, Switzerland	Idorsia Pharmaceuticals Ltd	Sieber, P (corresponding author), Idorsia Pharmaceut Ltd, Allschwil, Switzerland.	patrick.sieber@idorsia.com		Sieber, Patrick/0000-0003-4104-5312				af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x; Alberts B., 2002, MOLECULAR BIOLOGY OF, Vxxxiv; Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Blouin M, 2010, J MED CHEM, V53, P2227, DOI 10.1021/jm901771h; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Cameron KO, 2009, BIOORG MED CHEM LETT, V19, P2075, DOI 10.1016/j.bmcl.2009.01.059; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Driesen RB, 2014, CARDIOVASC RES, V101, P411, DOI 10.1093/cvr/cvt338; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Epa AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135266; Failla M, 2009, AM J RESP CELL MOL, V41, P50, DOI 10.1165/rcmb.2007-0438OC; Feng YH, 2016, METHODS MOL BIOL, V1394, P43, DOI 10.1007/978-1-4939-3341-9_4; Garrison G, 2013, AM J RESP CELL MOL, V48, P550, DOI 10.1165/rcmb.2012-0262OC; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Hecker L, 2011, EXP CELL RES, V317, P1914, DOI 10.1016/j.yexcr.2011.03.016; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Kosla J, 2013, EUR J CELL BIOL, V92, P363, DOI 10.1016/j.ejcb.2013.10.013; Kosla J, 2013, GENE, V513, P90, DOI 10.1016/j.gene.2012.10.069; La J, 2016, AM J PHYSIOL-LUNG C, V310, pL815, DOI 10.1152/ajplung.00322.2015; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; McGaha TL, 2002, J INVEST DERMATOL, V118, P461, DOI 10.1046/j.0022-202x.2001.01690.x; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Ogawa S, 2016, ACS MED CHEM LETT, V7, P306, DOI 10.1021/acsmedchemlett.5b00455; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Pines M, 2015, MOLECULES, V20, P573, DOI 10.3390/molecules20010573; Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Skold CM, 2017, J INTERN MED, V281, P149, DOI 10.1111/joim.12571; Sobel K, 2013, J BIOL CHEM, V288, P14839, DOI 10.1074/jbc.M112.426726; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Wang L, 2007, J PHARMACOL EXP THER, V320, P525, DOI 10.1124/jpet.106.113043; Wettlaufer SH, 2016, AM J RESP CELL MOL, V54, P114, DOI 10.1165/rcmb.2014-0468OC; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yang XH, 2014, EUR J PHARMACOL, V734, P83, DOI 10.1016/j.ejphar.2014.04.007; Yoon JH, 2013, EMBO MOL MED, V5, P1720, DOI 10.1002/emmm.201302524	51	14	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207872	10.1371/journal.pone.0207872	http://dx.doi.org/10.1371/journal.pone.0207872			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485339	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800083
J	Kim, SH; On, JW; Pyo, H; Ko, KS; Won, JC; Yang, J; Park, MJ				Kim, Shin-Hye; On, Ji-won; Pyo, Heesoo; Ko, Kyung Soo; Won, Jong Chul; Yang, Jiyeon; Park, Mi Jung			Percentage fractions of urinary di(2-ethylhexyl) phthalate metabolites: Association with obesity and insulin resistance in Korean girls	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; SPECIES-DIFFERENCES; BODY-MASS; DEHP; EXPRESSION; CHILDHOOD; EXPOSURE; ESTROGEN; PATTERN; GLUCOSE	Objective We assessed the associations of percentage fractions of urinary di(2-ethylhexyl) phthalate (DEHP) metabolites with obesity and insulin resistance in Korean girls. Methods In total, 137 girls, aged 6 to 13 years (65 overweight cases and 72 controls), were recruited. Anthropometric indices and the homeostatic model assessment of insulin resistance (HOMA-IR) index were determined. Four major urinary DEHP metabolites were analyzed in spot urine samples by gas chromatography-tandem mass spectrometry, including mono(2-ethylhexyl) phthalate, mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-ethyl-5-carboxypentyl) phthalate. Results There were no significant differences in the urinary concentrations of the DEHP metabolites between the overweight and control groups. The percentage fraction of MEHHP (MEHHP %) among all DEHP metabolites was significantly higher in the overweight prepubertal girls than in the controls (P = 0.035). MEHHP% was positively associated with the body mass index percentile, waist circumference, body fat percentage, and HOMA-IR index in the prepubertal girls. After adjusting for covariates, the prepubertal girls in a higher MEHHP% quartile were found to have a higher odds ratio for central obesity than those in a lower quartile (odds ratios: 5.05 for quartile 3; 7.30 for quartile 4). The relative rate of MEHHP oxidation to MEOHP was negatively associated with the body mass index percentile and waist circumference in the prepubertal girls. However, no such association was observed in the pubertal girls. Conclusions MEHHP% was positively associated with obesity and insulin resistance in prepubertal girls. Further studies are necessary to elucidate the causal links between altered phthalate metabolism and increased susceptibility to insulin resistance in children.	[Kim, Shin-Hye; Park, Mi Jung] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pediat, Seoul, South Korea; [On, Ji-won] Korea Inst Sci & Technol, Mol Recognit Res Ctr, Seoul, South Korea; [On, Ji-won; Pyo, Heesoo] Korea Univ, Dept Chem, Seoul, South Korea; [Ko, Kyung Soo; Won, Jong Chul] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Internal Med, Seoul, South Korea; [Yang, Jiyeon] Yonsei Univ, Coll Med, Inst Environm Res, Seoul, South Korea	Inje University; Korea Institute of Science & Technology (KIST); Korea University; Inje University; Yonsei University; Yonsei University Health System	Park, MJ (corresponding author), Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pediat, Seoul, South Korea.	PMJ@paik.ac.kr			Korean Diabetes Association	Korean Diabetes Association	This work was supported by a grant (to SHK, 2013) from the Korean Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379; ASTDR (Agency for Toxic Substances and Disease Registry), 2012, TOX PROF DI2ETHYLHAL; BANDIERA S, 1992, ARCH BIOCHEM BIOPHYS, V296, P286, DOI 10.1016/0003-9861(92)90574-G; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Buser MC, 2014, INT J HYG ENVIR HEAL, V217, P687, DOI 10.1016/j.ijheh.2014.02.005; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Choi K, 2013, TOXICOL IN VITRO, V27, P1451, DOI 10.1016/j.tiv.2013.03.012; Choi K, 2012, TOXICOL IN VITRO, V26, P315, DOI 10.1016/j.tiv.2011.12.002; Choi SY, 2013, DRUG METAB DISPOS, V41, P263, DOI 10.1124/dmd.112.046276; DANNAN GA, 1986, J BIOL CHEM, V261, P728; Dirinck E, 2015, ENVIRON RES, V137, P419, DOI 10.1016/j.envres.2015.01.010; Dirtu AC, 2013, ENVIRON INT, V59, P344, DOI 10.1016/j.envint.2013.06.023; ELCOMBE CR, 1986, ENVIRON HEALTH PERSP, V70, P211, DOI 10.2307/3430357; Enke U, 2013, INT J HYG ENVIR HEAL, V216, P735, DOI 10.1016/j.ijheh.2013.01.006; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; GOLLAMUDI R, 1983, J TOXICOL ENV HEALTH, V12, P623, DOI 10.1080/15287398309530454; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Huang TY, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-6; Jia Y., 2016, INT J ENV RES PUB HE, V13; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071392; Kim Shin Hye, 2014, Ann Pediatr Endocrinol Metab, V19, P69, DOI 10.6065/apem.2014.19.2.69; Koukouritaki SB, 2004, J PHARMACOL EXP THER, V308, P965, DOI 10.1124/jpet.103.060137; Kwack SJ, 2010, TOXICOL RES-GER, V26, P75, DOI 10.5487/TR.2010.26.1.075; Lv ZQ, 2016, OBESITY, V24, P368, DOI 10.1002/oby.21359; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Sargis RM, 2014, DIABETES METAB J, V38, P13, DOI 10.4093/dmj.2014.38.1.13; Smerieri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117831; Song NR, 2013, ENVIRON INT, V54, P65, DOI 10.1016/j.envint.2013.01.007; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006; Trasande L, 2013, PEDIATRICS, V132, pE646, DOI 10.1542/peds.2012-4022; Trasande L, 2013, ENVIRON HEALTH PERSP, V121, P501, DOI 10.1289/ehp.1205526; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056800; Wang HM, 1997, ARCH BIOCHEM BIOPHYS, V344, P365, DOI 10.1006/abbi.1997.0230; Yaghjyan L, 2015, INT J OBESITY, V39, P994, DOI 10.1038/ijo.2015.8; Yang ZF, 2010, GENET MOL RES, V9, P1844, DOI 10.4238/vol9-3gmr938; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104852; 문진수, 2008, Clinical and Experimental Pediatrics, V51, P1	39	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208081	10.1371/journal.pone.0208081	http://dx.doi.org/10.1371/journal.pone.0208081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481198	gold, Green Published, Green Submitted			2022-12-26	WOS:000451440000041
J	Chao, YS; Huang, YM				Chao, Yi-Shan; Huang, Yao-Moan			Spore morphology and its systematic implication in Pteris (Pteridaceae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; TAIWAN; DRYOPTERIDACEAE; GREVILLEANA; INFERENCE; MRBAYES	Pteris (Pteridaceae) spores are usually trilete and can be distinguished by the perine ornamentation. The systematic value of spore morphology in Pteris is unclear, especially based on the renewed infrageneric classification of Pteris. In the present study, we used scanning electron microscopy (SEM) to understand spore characters in 57 Pteris species, one Onychium species, and two Astrolepis species; 40 species are reported here for the first time. The observed spore characters combined with published spore data, totaling 100 species from 16 sections of Pteris, were mapped onto a reconstructed phylogenetic tree. Seven characters (five proposed in previous studies), including an equatorial flange, laesural ridges, proximal ridges, distal ridges, tubercula on distal faces, coarse reticula on distal faces, and a row of extervermiculi between the distal face and equatorial flange, were analyzed to investigate spore morphology evolution in Pteris. However, the results showed no synapomorphies with other genera in Pteridaceae. Most of the characters were found to have arisen independently several times in different lineages or were even frequently reversed. Equatorial flanges and tubercula on distal faces are plesiomorphies and present in most Pteris species. Overall, the application of spore morphology in section circumscription is limited. Thus, we suggest combining spore morphology with leaf characters for Pteris infrageneric classification.	[Chao, Yi-Shan] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Huang, Yao-Moan] Taiwan Forestry Res Inst, Div Silviculture, Taipei, Taiwan	Kaohsiung Medical University	Chao, YS (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	pteridaceae@gmail.com	huang, yao/GWR-5388-2022; Chao, Yi-Shan/T-1186-2019	Chao, Yi-Shan/0000-0001-7433-5987	Ministry of Science and Technology of Taiwan [MOST106-2311-B-037-005-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (MOST106-2311-B-037-005-MY3) to YSC.	Akaike H., 1973, P 2 INT S INF THEOR; Chao Y.S., 2012, J BOT, V2012, P1, DOI DOI 10.1155/2012/817920; Chao YS, 2017, SYST BOT, V42, DOI 10.1600/036364417X696609; Chao YS, 2014, ANN BOT-LONDON, V114, P109, DOI 10.1093/aob/mcu086; Chao Yi-Shan, 2012, Taiwania, V57, P278; Chao YS, 2010, BOT STUD, V51, P209; Dai Xi-Ling, 2005, Acta Botanica Yunnanica, V27, P489; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang T-C., 1980, SPORE FLORA TAIWAN; HUANG TC, 1978, BOT BULL ACAD SINICA, V19, P13; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Link-Perez MA, 2011, SYST BOT, V36, P565, DOI 10.1600/036364411X583556; Lugardon B., 1990, MICROSPORES EVOLUTIO, P95, DOI DOI 10.1016/C2009-0-03229-2; Martinez OG, 2009, GRANA, V48, P193, DOI 10.1080/00173130902969993; Moran RC, 2010, INT J PLANT SCI, V171, P872, DOI 10.1086/655856; Palacios-Rios M, 2017, GRANA, V56, P241, DOI 10.1080/00173134.2016.1217038; Posada D, 2006, MOL ECOL NOTES, V6, P590, DOI 10.1111/j.1471-8286.2006.01368.x; RANKER TA, 1989, AM J BOT, V76, P297, DOI 10.2307/2444672; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouhan G, 2007, BRITTONIA, V59, P115, DOI 10.1663/0007-196X(2007)59[115:PPAOTF]2.0.CO;2; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRYON AF, 1964, AM J BOT, V51, P939, DOI 10.2307/2440244; Tryon AF., 1990, SPORES PTERIDOPHYTA; Vasco A, 2009, TAXON, V58, P825, DOI 10.1002/tax.583011; Wang Q., 2010, SPORES POLYPODIALES; WU SK, 1991, FERN FAMILIES GENERA; Yang DongMei, 2013, Guangxi Zhiwu / Guihaia, V33, P1; Zhang L, 2018, MOL PHYLOGENET EVOL, V118, P265, DOI 10.1016/j.ympev.2017.09.011; Zhang L, 2015, CLADISTICS, V31, P406, DOI 10.1111/cla.12094	31	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207712	10.1371/journal.pone.0207712	http://dx.doi.org/10.1371/journal.pone.0207712			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475849	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700057
J	Kamus, LJ; Theoret, C; Costa, MC				Kamus, Louis J.; Theoret, Christine; Costa, Marcio C.			Use of next generation sequencing to investigate the microbiota of experimentally induced wounds and the effect of bandaging in horses	PLOS ONE			English	Article							THICKNESS SKIN WOUNDS; DIVERSITY; BACTERIA; INFLAMMATION; EXPRESSION; INFECTION; BIOFILM; INJURY; CELLS	Objectives To use next generation sequencing to characterize the microbiota of horses during healing of skin wounds in two anatomical locations (body and limb) known to present different healing patterns; and to investigate the impact of bandaging on bacterial communities of skin wounds located on the limbs of horses. Methods Full-thickness skin wounds were created on the distal extremity of both thoracic limbs and on one lateral mid-thoracic wall of four healthy horses. Limb wounds were randomly assigned to bandaging or not. A full-thickness sample was collected with a biopsy punch from intact thorax and limb skin (T0) and from the margin of one wound per site (thorax, unbandaged limb, bandaged limb) 1 week (T1) and 2 weeks (T2) postoperatively, and at full healing (T3). Thoracic skin samples obtained from three healthy horses were included in the analysis as controls. Results Anatomic location (thorax vs. limb) significantly influenced bacterial composition of equine skin and healing wounds. Fusobacterium and Actinobacillus were strongly associated with limb wounds during the initial phases of healing. Bandaging had a significant impact on the microbiota during the healing process. The skin microbiota after healing was more similar to samples from controls, demonstrating the resilience and stability of the environment. Conclusions Equine skin microbiota is a rich and stable environment that is disturbed by wounding, but returns to its previous stage after full healing. Anatomic location significantly influences bacterial composition of the equine skin during wound healing. Bandaging has a significant impact on the skin microbiota of horses during the healing process. Results of this study provide new insight for a better understanding of the contribution of bacteria to wound healing in horses and may facilitate the future development of therapeutic strategies using commensal bacteria.	[Kamus, Louis J.; Theoret, Christine; Costa, Marcio C.] Univ Montreal, Dept Vet Biomed Sci, St Hyacinthe, PQ, Canada	Universite de Montreal	Costa, MC (corresponding author), Univ Montreal, Dept Vet Biomed Sci, St Hyacinthe, PQ, Canada.	marcio.costa@umontreal.ca		Kamus, Louis/0000-0002-7192-3377; Costa, Marcio/0000-0001-5067-7501	Natural Sciences and Engineering Research Council of Canada (NSERC) [250231]; Association des Veterinaires Equins du Quebec	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Association des Veterinaires Equins du Quebec	This study was funded in part by the Natural Sciences and Engineering Research Council of Canada (NSERC grant #250231) and the Association des Veterinaires Equins du Quebec to CT.	Adams MK, 2010, J EQUINE VET SCI, V30, P687, DOI 10.1016/j.jevs.2010.11.002; Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Bessegatto JA, 2017, RES VET SCI, V114, P355, DOI 10.1016/j.rvsc.2017.06.011; BIGBIE RB, 1991, AM J VET RES, V52, P1376; Bodaan CJ, 2016, WOUND REPAIR REGEN, V24, P966, DOI 10.1111/wrr.12488; Christensen GJM, 2014, BENEF MICROBES, V5, P201, DOI 10.3920/BM2012.0062; Costa MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171642; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Freeman K, 2009, CAN J MICROBIOL, V55, P197, DOI [10.1139/w08-115, 10.1139/W08-115]; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hernandez-Chirlaque C, 2016, J CROHNS COLITIS, V10, P1324, DOI 10.1093/ecco-jcc/jjw096; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jorgensen E, 2017, VET MICROBIOL, V204, P90, DOI 10.1016/j.vetmic.2017.03.011; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lagier JC, 2015, CLIN MICROBIOL REV, V28, P237, DOI 10.1128/CMR.00014-14; Mertz PM, 2003, WOUNDS, V15, P129; NAHMS, 2006, BAS REF EQ HLTH MA 1; Owen KR, 2012, EQUINE VET J, V44, P143, DOI 10.1111/j.2042-3306.2011.00387.x; Ross AA, 2018, P NATL ACAD SCI USA, V115, pE5786, DOI 10.1073/pnas.1801302115; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055380; Siddiqui AR, 2010, CLIN DERMATOL, V28, P519, DOI 10.1016/j.clindermatol.2010.03.009; Sole A., 2015, AUSTR EQUINE VET, V34, P68; Theoret CL, 2016, NEW ZEAL VET J, V64, P90, DOI 10.1080/00480169.2015.1091396; Theoret CL, 2013, WOUND REPAIR REGEN, V21, P365, DOI 10.1111/wrr.12018; Theoret CL, 2002, VET SURG, V31, P266, DOI 10.1053/jvet.2002.32394; Theoret CL, 2001, VET SURG, V30, P269, DOI 10.1053/jvet.2001.23341; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291; Westgate SJ, 2011, VET MICROBIOL, V150, P152, DOI 10.1016/j.vetmic.2011.01.003; Weyrich LS, 2015, AUSTRALAS J DERMATOL, V56, P268, DOI 10.1111/ajd.12253; Wilmink JM, 2002, EQUINE VET J, V34, P270, DOI 10.2746/042516402776186047; Wolcott RD, 2010, J WOUND CARE, V19, P272; Wolcott RD, 2016, WOUND REPAIR REGEN, V24, P163, DOI 10.1111/wrr.12370; Wong VW, 2013, PLAST RECONSTR SURG, V132, p854E, DOI 10.1097/PRS.0b013e3182a3c11e	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0206989	10.1371/journal.pone.0206989	http://dx.doi.org/10.1371/journal.pone.0206989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475922	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700017
J	Pereiro, X; Ruzafa, N; Acera, A; Fonollosa, A; Rodriguez, FD; Vecino, E				Pereiro, Xandra; Ruzafa, Noelia; Acera, Arantxa; Fonollosa, Alex; David Rodriguez, F.; Vecino, Elena			Dexamethasone protects retinal ganglion cells but not Muller glia against hyperglycemia in vitro	PLOS ONE			English	Article							GLUCOSE-INDUCED APOPTOSIS; NECROSIS-FACTOR-ALPHA; INTRAVITREAL IMPLANT; TNF-ALPHA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GLUCOCORTICOID-RECEPTORS; OXIDATIVE STRESS; DYSFUNCTION; ACTIVATION; EXPRESSION	Diabetic retinopathy (DR) is a common complication of diabetes, for which hyperglycemia is a major etiological factor. It is known that retinal glia (Muller cells) and retinal ganglion cells (RGCs) are affected by diabetes, and there is evidence that DR is associated with neural degeneration. Dexamethasone is a glucocorticoid used to treat many inflammatory and autoimmune conditions, including several eye diseases like DR. Thus, our goal was to study the effect of dexamethasone on the survival of RGCs and Muller glial cells isolated from rat retinas and maintained in vitro under hyperglycemic conditions. The behavior of primary RGC cell cultures, and of mixed RGC and Muller cell co-cultures, was studied in hyperglycemic conditions (30 mM glucose), both in the presence and absence of Dexamethasone (1 mu M). RGC and Muller cell survival was evaluated, and the conditioned media of these cultures was collected to quantify the inflammatory cytokines secreted by these cells using a multiplex assay. The role of IL-1 beta, IL-6 and TNF alpha in RGC death was also evaluated by adding these cytokines to the co-cultures. RGC survival decreased significantly when these cells were grown in high glucose conditions, reaching 54% survival when they were grown alone and only 33% when co-cultured with Muller glia. The analysis of the cytokines in the conditioned media revealed an increase in IL-1 beta, IL-6 and TNF alpha under hyperglycemic conditions, which reverted to the basal concentration in co-cultures maintained in the presence of dexamethasone. Finally, when these cytokines were added to co-cultures they appeared to have a direct effect on RGC survival. Hence, these cytokines could be implicated in the death of RGCs when glucose concentrations increase and dexamethasone might protect RGCs from the cell death induced in these conditions.	[Pereiro, Xandra; Ruzafa, Noelia; Acera, Arantxa; Vecino, Elena] Univ Basque Country, Dept Cell Biol & Histol, UPV EHU, Leioa, Vizcaya, Spain; [Fonollosa, Alex] BioCruces, Serv Oftalmol, Hosp Cruces, Baracaldo, Vizcaya, Spain; [David Rodriguez, F.] Univ Salamanca, Dept Biochem & Mol Biol, Salamanca, Spain	University of Basque Country; Hospital Universitario Cruces; University of Salamanca	Pereiro, X (corresponding author), Univ Basque Country, Dept Cell Biol & Histol, UPV EHU, Leioa, Vizcaya, Spain.	xandra.pereiro@gmail.com	Fonollosa, Alex/Q-9545-2019; Vecino, Elena/AAO-3462-2021; Rodriguez, Francisco David/B-6409-2018; Pereiro, Xandra/AAD-6697-2022	Vecino, Elena/0000-0002-1672-5132; Rodriguez, Francisco David/0000-0002-8322-2711; Pereiro, Xandra/0000-0003-2973-0405; ACERA, ARANTXA/0000-0002-6942-6144; Ruzafa, Noelia/0000-0002-1853-0099	Retos-MINECO Fondos Feder [RTC-2016-48231]; Grupos Consolidados del Gobierno Vasco [IT437-10]	Retos-MINECO Fondos Feder; Grupos Consolidados del Gobierno Vasco	This work was funded by the support of Retos-MINECO Fondos Feder (RTC-2016-48231) and Grupos Consolidados del Gobierno Vasco (IT437-10) to E.V.	Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BLOODWORTH JMB, 1962, DIABETES, V11, P1; Boyer DS, 2014, OPHTHALMOLOGY, V121, P1904, DOI 10.1016/j.ophtha.2014.04.024; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Callanan DG, 2013, OPHTHALMOLOGY, V120, P1843, DOI 10.1016/j.ophtha.2013.02.018; Cao Y, 2014, PHARMACOLOGY, V94, P123, DOI 10.1159/000363062; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Coughlin BA, 2017, VISION RES, V139, P93, DOI 10.1016/j.visres.2017.03.013; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Eastlake K, 2016, GLIA, V64, P495, DOI 10.1002/glia.22942; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; FREIDIN M, 1992, P NATL ACAD SCI USA, V89, P10440, DOI 10.1073/pnas.89.21.10440; Gallina D, 2015, EXP NEUROL, V273, P114, DOI 10.1016/j.expneurol.2015.08.007; Gallina D, 2014, DEVELOPMENT, V141, P3340, DOI 10.1242/dev.109835; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Garcia M, 2002, INVEST OPHTH VIS SCI, V43, P3735; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gougeon PY, 2013, J NEUROSCI, V33, P3339, DOI 10.1523/JNEUROSCI.3564-12.2013; GRAHAM RO, 1974, ARCH OPHTHALMOL-CHIC, V92, P149, DOI 10.1001/archopht.1974.01010010155016; Hassan I, 2017, INVEST OPHTH VIS SCI, V58, P3473, DOI 10.1167/iovs.16-20712; Jayaguru Prathiba, 2011, J Ocul Biol Dis Infor, V4, P34, DOI 10.1007/s12177-012-9085-y; Khurana RN, 2015, OSLI RETINA, V46, P56, DOI 10.3928/23258160-20150101-09; Kusner LL, 2004, INVEST OPHTH VIS SCI, V45, P1553, DOI 10.1167/iovs.03-1294; Lei Xia, 2011, Front Biosci (Elite Ed), V3, P201, DOI 10.2741/e234; Li Q, 2002, INVEST OPHTH VIS SCI, V43, P3109; Lim JC, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00270; Lin XM, 2013, NEUROL SCI, V34, P1339, DOI 10.1007/s10072-012-1236-1; Liu C, 2016, BIOCHEM BIOPH RES CO, V479, P198, DOI 10.1016/j.bbrc.2016.09.032; Lorenzi M, 2001, DIABETOLOGIA, V44, P791, DOI 10.1007/s001250100544; Lozano Lopez V., 2015, ARCH SOC ESP OFTALMO, V90, P14, DOI [10.1016/j.oftal.2013.10.007, DOI 10.1016/J.OFTAL.2013.10.007]; Madeira MH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/673090; MALEFYT RD, 1991, J EXP MED, V174, P915; Matteucci A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/364924; Matteucci A, 2014, EXP EYE RES, V125, P20, DOI 10.1016/j.exer.2014.05.011; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Moynagh PN, 2003, J ENDOCRINOL, V179, P139, DOI 10.1677/joe.0.1790139; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Osborne NN, 2013, CURR OPIN PHARMACOL, V13, P16, DOI 10.1016/j.coph.2012.09.002; Puro Donald G, 2002, Trans Am Ophthalmol Soc, V100, P339; Qiu AW, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.117; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Ruzafa N, 2015, Arch Soc Esp Oftalmol, V90, P522, DOI 10.1016/j.oftal.2015.03.009; Shanab AY, 2012, NEUROBIOL DIS, V48, P556, DOI 10.1016/j.nbd.2012.07.025; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Silva KC, 2009, DIABETES, V58, P1382, DOI 10.2337/db09-0166; Tamura H, 2005, INVEST OPHTH VIS SCI, V46, P1440, DOI 10.1167/iovs.04-0905; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tezel G, 2000, J NEUROSCI, V20, P8693; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Walker RJ, 2012, MOL VIS, V18, P271; Wang K, 2008, BIOL PHARM BULL, V31, P1541, DOI 10.1248/bpb.31.1541; WOLTER JR, 1961, AM J OPHTHALMOL, V51, P1123; Wood JPM, 2005, J NEUROCHEM, V93, P686, DOI 10.1111/j.1471-4159.2005.03059.x; Xi X, 2005, BIOCHEM BIOPH RES CO, V326, P548, DOI 10.1016/j.bbrc.2004.11.064; Yamamoto T, 2011, NEUROSCI LETT, V487, P335, DOI 10.1016/j.neulet.2010.10.051; Yego ECK, 2009, INVEST OPHTH VIS SCI, V50, P1920, DOI 10.1167/iovs.08-2082; Yoshida S, 2001, CURR EYE RES, V22, P341, DOI 10.1076/ceyr.22.5.341.5498; Zhao M, 2016, GENET MOL RES, V15; Zhao Y, 2015, MED SCI MONITOR, V21, P3068, DOI [10.12659/MSM.894453, 10.12659/MSM.895433]; Zhou Jia, 2016, Med Sci Monit, V22, P1460; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	68	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207913	10.1371/journal.pone.0207913	http://dx.doi.org/10.1371/journal.pone.0207913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475883	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700087
J	You, JS; McNally, RM; Jacobs, BL; Privett, RE; Gundermann, DM; Lin, KH; Steinert, ND; Goodman, CA; Hornberger, TA				You, Jae-Sung; McNally, Rachel M.; Jacobs, Brittany L.; Privett, Rachel E.; Gundermann, David M.; Lin, Kuan-Hung; Steinert, Nate D.; Goodman, Craig A.; Hornberger, Troy A.			The role of raptor in the mechanical load-induced regulation of mTOR signaling, protein synthesis, and skeletal muscle hypertrophy	FASEB JOURNAL			English	Article						mTORC1; rapamycin; mechanotransduction; exercise; growth	MAMMALIAN TARGET; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDIC-ACID; MESSENGER-RNA; RODENT MODEL; RAPAMYCIN; ACTIVATION; EXERCISE; ABLATION; MASS	It is well known that an increase in mechanical loading can induce skeletal muscle hypertrophy, and a long standing model in the field indicates that mechanical loads induce hypertrophy via a mechanism that requires signaling through the mechanistic target of rapamycin complex 1 (mTORC1). Specifically, it has been widely proposed that mechanical loads activate signaling through mTORC1 and that this, in turn, promotes an increase in the rate of protein synthesis and the subsequent hypertrophic response. However, this model is based on a number of important assumptions that have not been rigorously tested. In this study, we created skeletal muscle specific and inducible raptor knockout mice to eliminate signaling by mTORC1, and with these mice we were able to directly demonstrate that mechanical stimuli can activate signaling by mTORC1, and that mTORC1 is necessary for mechanical load-induced hypertrophy. Surprisingly, however, we also obtained multiple lines of evidence that indicate that mTORC1 is not required for a mechanical load-induced increase in the rate of protein synthesis. This observation highlights an important shortcoming in our understanding of how mechanical loads induce hypertrophy and illustrates that additional mTORC1-independent mechanisms play a critical role in this process.You, J.-S., McNally, R. M., Jacobs, B. L., Privett, R. E., Gundermann, D. M., Lin, K.-H., Steinert, N. D., Goodman, C. A., Hornberger, T. A. The role of raptor in the mechanical load-induced regulation of mTOR signaling, protein synthesis, and skeletal muscle hypertrophy.	[You, Jae-Sung; McNally, Rachel M.; Jacobs, Brittany L.; Privett, Rachel E.; Gundermann, David M.; Lin, Kuan-Hung; Steinert, Nate D.; Goodman, Craig A.; Hornberger, Troy A.] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA; [You, Jae-Sung; McNally, Rachel M.; Jacobs, Brittany L.; Privett, Rachel E.; Gundermann, David M.; Lin, Kuan-Hung; Steinert, Nate D.; Goodman, Craig A.; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, 2015 Linden Dr, Madison, WI 53706 USA; [Goodman, Craig A.] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Goodman, Craig A.] Victoria Univ, Australian Inst Musculoskeletal Sci, St Albans, Vic, Australia	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Victoria University; Victoria University	Hornberger, TA (corresponding author), Univ Wisconsin, Sch Vet Med, 2015 Linden Dr, Madison, WI 53706 USA.	troy.hornberger@wisc.edu	You, Jae-Sung/ABF-6763-2020; lin, ke/GZM-8300-2022	You, Jae-Sung/0000-0001-7791-8563; Goodman, Craig/0000-0002-5874-7743	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057347]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR057347 (to T.A.H.). The authors declare no conflicts of interest.	Adams GR, 2012, COMPR PHYSIOL, V2, P2829, DOI 10.1002/cphy.c110066; Astratenkova I V, 2014, Ross Fiziol Zh Im I M Sechenova, V100, P649; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; COX RD, 1990, DIFFERENTIATION, V43, P183, DOI 10.1111/j.1432-0436.1990.tb00445.x; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Ge YJ, 2012, J BIOL CHEM, V287, P43928, DOI 10.1074/jbc.R112.406942; Goodman CA, 2014, REV PHYSIOL BIOCH P, V166, P43, DOI 10.1007/112_2013_17; Goodman CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037890; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Gordon BS, 2014, AM J PHYSIOL-ENDOC M, V307, pE703, DOI 10.1152/ajpendo.00250.2014; Gundermann DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1198, DOI 10.1152/ajpendo.00600.2013; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Jacobs BL, 2014, J MUSCLE RES CELL M, V35, P11, DOI 10.1007/s10974-013-9367-4; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kirby TJ, 2016, METHODS MOL BIOL, V1460, P43, DOI 10.1007/978-1-4939-3810-0_4; Kubica N, 2005, J BIOL CHEM, V280, P7570, DOI 10.1074/jbc.M413732200; Terena SMT, 2017, REV ASSOC MED BRAS, V63, P164, DOI 10.1590/1806-9282.63.02.164; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Marcotte GR, 2015, CALCIFIED TISSUE INT, V96, P196, DOI 10.1007/s00223-014-9925-9; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Murach KA, 2018, PHYSIOLOGY, V33, P26, DOI 10.1152/physiol.00019.2017; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Ogasawara R, 2018, FASEB J, V32, P5824, DOI 10.1096/fj.201701422R; Ogasawara R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31142; Pahor M, 1998, J Nutr Health Aging, V2, P97; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pasiakos SM, 2012, NUTRIENTS, V4, P740, DOI 10.3390/nu4070740; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Seguin R, 2003, AM J PREV MED, V25, P141, DOI 10.1016/S0749-3797(03)00177-6; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Spangenburg EE, 2009, APPL PHYSIOL NUTR ME, V34, P328, DOI 10.1139/H09-010; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Yamada AK, 2012, J RECEPT SIG TRANSD, V32, P42, DOI 10.3109/10799893.2011.641978; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yonezawa K, 2003, CURR TOP MICROBIOL, V279, P271; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; You JS, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6847; You JS, 2014, J BIOL CHEM, V289, P1551, DOI 10.1074/jbc.M113.531392; You J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048613; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	56	66	66	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4021	4034		10.1096/fj.201801653RR	http://dx.doi.org/10.1096/fj.201801653RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509128	Green Published			2022-12-26	WOS:000459794800073
J	Devequi-Nunes, D; Machado, BAS; Barreto, GD; Silva, JR; da Silva, DF; da Rocha, JLC; Brandao, HN; Borges, VM; Umsza-Guez, MA				Devequi-Nunes, Danielle; Souza Machado, Bruna Aparecida; Barreto, Gabriele de Abreu; Silva, Jessica Reboucas; da Silva, Danielle Figueredo; Luiz Carneiro da Rocha, Jose; Brandao, Hugo Neves; Borges, Valeria M.; Umsza-Guez, Marcelo Andres			Chemical characterization and biological activity of six different extracts of propolis through conventional methods and supercritical extraction	PLOS ONE			English	Article							BRAZILIAN PROPOLIS; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; PHENOLIC-COMPOUNDS; GREEN PROPOLIS; CARBON-DIOXIDE; RED PROPOLIS; LEISHMANICIDAL ACTIVITY; ANTIOXIDANT ACTIVITY; CYTOTOXIC ACTIVITIES	Propolis is a natural product with many demonstrated biological activities and propolis extract has been used in the food, pharmaceutical and cosmetics industries. Different works have showed the variations in the chemical composition, and consequently, on the biological activity of the propolis that are associated with its type and geographic origin. Due to this study evaluated propolis extracts obtained through supercritical extraction and ethanolic extraction (conventional) in three samples of different types of propolis (red, green and brown), collected from different regions in Brazil (state of Bahia). Analyses were performed to determine the humidity, water activity, the content of total ash, proteins, lipids and fiber in raw propolis samples. The content of phenolic compounds, flavonoids, in vitro antioxidant activity (DPPH), catechin, ferulic acid and luteolin and antimicrobial activity against two bacteria (Staphylococcus aureus and Escherichia coli) were determined for all extracts. For the green and red ethanolic extracts the anti-leishmanicidal potential was also evaluated. The physicochemical profiles showed agreement in relation to the literature. The results identified significant differences among the extracts (p > 0.05), which are in conformity with their extraction method, as well as with type and botanical origin of the samples. The extraction with supercritical fluid was not efficient to obtain extracts with the highest contents of antioxidants compounds, when compared with the ethanolic extracts. The best results were shown for the extracts obtained through the conventional extraction method (ethanolic) indicating a higher selectivity for the extraction of antioxidants compounds. The red variety showed the largest biological potential, which included the content of antioxidants compounds. The results found in this study confirm the influence of the type of the raw material on the composition and characteristics of the extracts. The parameters analysis were important to characterize and evaluate the quality of the different Brazilian propolis extracts based on the increased use of propolis by the natural products industry.	[Devequi-Nunes, Danielle; Souza Machado, Bruna Aparecida; Barreto, Gabriele de Abreu] Natl Serv Ind Learning SENAI, SENAI CIMATEC Univ Ctr, Hlth Inst Technol ITS CIMATEC, Salvador, BA, Brazil; [Devequi-Nunes, Danielle; Silva, Jessica Reboucas; Borges, Valeria M.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil; [Devequi-Nunes, Danielle; Silva, Jessica Reboucas; Borges, Valeria M.; Umsza-Guez, Marcelo Andres] Univ Fed Bahia, Salvador, BA, Brazil; [da Silva, Danielle Figueredo; Luiz Carneiro da Rocha, Jose; Brandao, Hugo Neves] Estadual Univ Feira de Santana, Feira De Santana, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia	Machado, BAS (corresponding author), Natl Serv Ind Learning SENAI, SENAI CIMATEC Univ Ctr, Hlth Inst Technol ITS CIMATEC, Salvador, BA, Brazil.	brunamachado17@hotmail.com	Borges, Valeria/G-2009-2014; Umsza-Guez, Marcelo Andrés/AAL-1315-2020; Machado, Bruna/AAP-6877-2021; Machado, Bruna Aparecida Souza/C-3130-2016; Umsza-Guez, Marcelo/AAV-8564-2020; Borges, Val/N-6647-2019	Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Borges, Val/0000-0002-2775-5409; Barreto, Gabriele/0000-0002-0180-281X; Silva, Jessica/0000-0003-0062-7316; Figueredo da Silva, Danielle/0000-0001-8037-4114				Abu-Mellal A, 2012, PHYTOCHEMISTRY, V77, P251, DOI 10.1016/j.phytochem.2012.01.012; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; AOAC, 1997, OFFICIAL METHODS ANA; Ayres DC, 2007, MEM I OSWALDO CRUZ, V102, P215, DOI 10.1590/S0074-02762007005000020; Ayres DC, 2011, REV INST MED TROP SP, V53, P329, DOI 10.1590/S0036-46652011000600006; Bankova V, 1999, FITOTERAPIA, V70, P190, DOI [10.1016/S0367-326X(98)00045-8, 10.1016/S0367-326X(98)00044-6]; Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; Bankova V, 1998, APIDOLOGIE, V29, P361, DOI 10.1051/apido:19980406; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Bashipour F, 2014, J SUPERCRIT FLUID, V95, P348, DOI 10.1016/j.supflu.2014.09.034; Biscaia D, 2009, J SUPERCRIT FLUID, V51, P17, DOI 10.1016/j.supflu.2009.07.011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonvehi JS, 2000, Z NATURFORSCH C, V55, P778; Brazil. Ministry of Health. National Health Surveillance Agency (ANVISA), 2001, TECHN REG ID QUAL BE; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Cao J, 2017, ANAL CHIM ACTA, V963, P24, DOI 10.1016/j.aca.2017.01.063; Cao YH, 2004, CHROMATOGRAPHIA, V59, P135, DOI 10.1365/s10337-003-0138-z; Catchpole OJ, 2004, J SUPERCRIT FLUID, V29, P97, DOI 10.1016/S0896-8446(03)00033-0; Chen CR, 2009, J SUPERCRIT FLUID, V50, P176, DOI 10.1016/j.supflu.2009.06.001; Cheung KW, 2011, J ETHNOPHARMACOL, V138, P463, DOI 10.1016/j.jep.2011.09.031; Christov R, 2005, NAT PROD RES, V19, P673, DOI 10.1080/14786410512331328159; Cottica SM, 2011, J BRAZIL CHEM SOC, V22, P929, DOI 10.1590/S0103-50532011000500016; Croci AN, 2009, FARMACIA, V57, P52; Frozza COD, 2013, FOOD CHEM TOXICOL, V52, P137, DOI 10.1016/j.fct.2012.11.013; Dantas AP, 2006, J ETHNOPHARMACOL, V103, P187, DOI 10.1016/j.jep.2005.07.018; Silva RPD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172585; Daugsch A., 2007, THESIS; Machado GMD, 2007, MEM I OSWALDO CRUZ, V102, P73, DOI 10.1590/S0074-02762007000100012; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; de Lima GG, 2016, J PHARM SCI-US, V105, P1248, DOI 10.1016/j.xphs.2015.12.027; De Zordi N, 2014, J SUPERCRIT FLUID, V95, P491, DOI 10.1016/j.supflu.2014.10.006; Doganli GA, 2016, REC NAT PROD, V10, P617; Duran N, 2011, PARASITOL RES, V108, P95, DOI 10.1007/s00436-010-2039-z; Escriche I, 2018, FOOD RES INT, V106, P834, DOI 10.1016/j.foodres.2018.01.055; Falcao SI, 2014, PHYTHER RES, V28, DOI [10.1111/lam.12543, DOI 10.1111/LAM.12543]; Fernandes-Silva CC, 2013, QUIM NOVA, V36, P237, DOI 10.1590/S0100-40422013000200006; Fischer G, 2007, VACCINE, V25, P1250, DOI 10.1016/j.vaccine.2006.10.005; Franchi GC, 2012, EVIDENCE BASED COMPL, V2012; de Mendonca ICG, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0888-9; Goncalves G. M. S., 2011, Revista de Ciencias Farmaceuticas Basica e Aplicada, V32, P349; Hatano A, 2012, FOOD SCI TECHNOL RES, V18, P577, DOI 10.3136/fstr.18.577; Hegazi AG, 2002, Z NATURFORSCH C, V57, P395; Jug M, 2014, LWT-FOOD SCI TECHNOL, V57, P530, DOI 10.1016/j.lwt.2014.02.006; Kalogeropoulos N, 2009, FOOD CHEM, V116, P452, DOI 10.1016/j.foodchem.2009.02.060; Kasiotis KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170077; Kim YH, 2011, NEW BIOTECHNOL, V28, P713, DOI 10.1016/j.nbt.2010.12.006; Koo H, 2000, CURR MICROBIOL, V41, P192, DOI 10.1007/s0028400101170; Koru O, 2007, ANAEROBE, V13, P140, DOI 10.1016/j.anaerobe.2007.02.001; Kubiliene L, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0677-5; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Lewicki PP, 2004, J FOOD ENG, V61, P483, DOI 10.1016/S0260-8774(03)00219-X; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Marcucci MC, 2001, J ETHNOPHARMACOL, V74, P105, DOI 10.1016/S0378-8741(00)00326-3; Marcucci MC, 1998, Z NATURFORSCH C, V53, P8; Melliou E, 2007, FOOD CHEM, V103, P375, DOI 10.1016/j.foodchem.2006.07.033; Miranda MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125101; Mohdaly AA, 2015, J FOOD BIOCHEM, DOI [10.1111/jfbc.12226, DOI 10.1111/JFBC.12226]; Monroy YM, 2018, J SUPERCRIT FLUID, V138, P167, DOI 10.1016/j.supflu.2018.04.016; Monzote L, 2012, MEM I OSWALDO CRUZ, V107, P978, DOI 10.1590/S0074-02762012000800003; National Committee for Clinical Laboratory Standards, 2000, METH DIL ANT SUSC TE; National Institute of Metrology Standardization and Industrial Quality (INMETRO), 2011, GUID CHEM TEST METH; Nedji N., 2014, Asian Pacific Journal of Tropical Disease, V4, P433, DOI 10.1016/S2222-1808(14)60601-0; Nina N, 2016, LETT APPL MICROBIOL, V62, P290, DOI 10.1111/lam.12543; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Paulino N, 2008, EUR J PHARMACOL, V587, P296, DOI 10.1016/j.ejphar.2008.02.067; Paviani LC, 2012, BRAZ J CHEM ENG, V29, P243, DOI 10.1590/S0104-66322012000200005; Pellati F, 2013, J PHARMACEUT BIOMED, V81-82, P126, DOI 10.1016/j.jpba.2013.04.003; Piccinelli AL, 2011, J AGR FOOD CHEM, V59, P6484, DOI 10.1021/jf201280z; Picoli T, 2016, CARACTERIZACAO QUIMI, V38, P365; Pietta PG, 2002, FITOTERAPIA, V73, pS7, DOI 10.1016/S0367-326X(02)00186-7; Popova M, 2017, MOLECULES, V22, DOI 10.3390/molecules22071159; Popova MP, 2007, APIDOLOGIE, V38, P306, DOI 10.1051/apido:2007013; Reboucas-Silva J, 2017, EVID-BASED COMPL ALT, V2017, P1; Regueira-Neto MD, 2018, FOOD CHEM TOXICOL, V119, P215, DOI 10.1016/j.fct.2018.04.029; REZENDE GP, 2006, BRAZILIAN J ORAL SCI, V0005, P00967, DOI DOI 10.20396/BJOS.V5I16.8641876; Righi AA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/267878; Rufatto LC, 2017, ASIAN PAC J TROP BIO, V7, P591, DOI 10.1016/j.apjtb.2017.06.009; Salatino A, 2005, EVID-BASED COMPL ALT, V2, P33, DOI 10.1093/ecam/neh060; Santana LCLR, 2014, NAT PROD RES, V28, P340, DOI 10.1080/14786419.2013.856904; Sawaya ACHF, 2004, BRAZ J MICROBIOL, V35, P104, DOI 10.1590/S1517-83822004000100017; Sena-Lopes A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191797; Sforcin JM, 2016, PHYTOTHER RES, V30, P894, DOI 10.1002/ptr.5605; Silici S, 2005, J ETHNOPHARMACOL, V99, P69, DOI 10.1016/j.jep.2005.01.046; Silva SS, 2015, SEM CIENCIAS BIOL SA, V36, P25; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Machado BAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145954; Machado BAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134489; Machado BAS, 2013, SEP SCI TECHNOL, V48, P2741, DOI 10.1080/01496395.2013.811422; Tagliacollo VA, 2011, CIENCIA TECNOL ALIME, V31, P752, DOI 10.1590/S0101-20612011000300031; Tei ANA, 2008, 16 C PAUL UN; Toreti VC, 2013, EVIDENCE BASED COMPL, V2013; Trusheva B, 2006, EVID-BASED COMPL ALT, V3, P249, DOI 10.1093/ecam/nel006; Trusheva B, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-13; Utispan Kusumawadee, 2017, Asian Pac J Cancer Prev, V18, P1051; VANSOEST PJ, 1967, J ASSOC OFF ANA CHEM, V50, P50; Weston RJ, 1999, FOOD CHEM, V64, P295, DOI 10.1016/S0308-8146(98)00100-9; Wilson MB, 2015, J INVERTEBR PATHOL, V124, P44, DOI 10.1016/j.jip.2014.10.005; Woisky RG, 1998, J APICULT RES, V37, P99, DOI 10.1080/00218839.1998.11100961; Wu JJ, 2009, SEP PURIF TECHNOL, V70, P190, DOI 10.1016/j.seppur.2009.09.015; Yang L, 2013, TROP J PHARM RES, V12, P771, DOI 10.4314/tjpr.v12i5.17; Yen GC, 1999, FOOD CHEM, V65, P375, DOI 10.1016/S0308-8146(98)00239-8; Zhang CP, 2014, J FOOD SCI, V79, pC1315, DOI 10.1111/1750-3841.12510	102	75	78	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207676	10.1371/journal.pone.0207676	http://dx.doi.org/10.1371/journal.pone.0207676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513100	Green Published, Green Submitted, gold			2022-12-26	WOS:000452204800013
J	Su, BW; Zhao, GX; Dong, C				Su, Baowei; Zhao, Gengxing; Dong, Chao			Spatiotemporal variability of soil nutrients and the responses of growth during growth stages of winter wheat in northern China	PLOS ONE			English	Article							SPATIAL VARIABILITY; TOTAL NITROGEN; BIOCHAR; MINERALIZATION; TERRAIN; CARBON	Studying soil nutrient variability and its effect on the growth and development of crops under a traditional tillage mode is the foundation for comprehensively implementing precision agriculture policies at the field scale and ensuring excellent crop management. In this paper, a 28.5 hm(2) winter wheat field under the traditional cultivation model in Tianzhuang town of Huantai County was selected as the research area. The mesh point method was utilized for sampling (60x60 m), and the characteristics of soil available nitrogen (AN), available phosphorus (AP) and available potassium (AK) variations in the before sowing, reviving, jointing, and filling stages of winter wheat were analyzed using geostatistical and GIS methods. Moreover, Pearson correlation analysis was used to study the response of wheat growth and development to soil nutrient variations. As the growth stages progressed, 1) each nutrient showed the characteristics of low-high-low and moderate variability. The highest AN and AK contents were found at the reviving stage, while AP reached a turning point at the jointing stage. The order of variability of each nutrient was AN>AP>AK.2) The nutrient variations first increased and then decreased and showed medium to strong spatial correlation. The three nutrients were strongly spatially correlated in the before sowing stage and moderately spatially correlated during the reviving stage. During the jointing and filling stages, AN had moderate spatial correlation, and AP and AK had strong spatial correlation. The spatial correlation of each nutrient was the weakest in the reviving stage, and the spatial correlation of AN was strongest in the before sowing stage, while the spatial correlations of AP and AK were strongest in the jointing stage. The spatial correlation of each soil nutrient decreased from the before sowing stage to the reviving stage and from the jointing stage to the filling stage, and the spatial correlation increased from the reviving stage to the jointing stage. 3) The soil nutrient content first increased and then decreased, and the grades of the nutrients gradually decreased. 4) The correlation between soil nutrients and wheat growth gradually increased. AN had the highest correlation with wheat growth, followed by AK and AP. The effect of soil nutrients on the growth of wheat at the reviving stage was greater than the effect of nutrients in the current stage. The growth of wheat at the jointing stage was mainly influenced by nutrients in the current stage, while the growth of wheat at the filling stage was influenced by the nutrient contents of both the previous and current stages. Thus, the date of fertilizer supplementation should be postponed properly. In this study, the soil nutrient dynamics and their influence on the growth of wheat during the winter wheat growth period under the traditional field model were well described, and these results could provide a theoretical basis for the precision management of soil nutrients in the northern winter wheat area where the planting environment and cultivation management are relatively uniform.	[Su, Baowei; Zhao, Gengxing] Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China; [Dong, Chao] Shandong Agr Univ, Coll Informat Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Zhao, GX (corresponding author), Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China.	zhaogx@sdau.edu.cn			twelfth Five-Year National Science and Technology Support Plan [2015BAD23B0202]; funds of Shandong "Double Tops" program [SYL2017XTTD02]	twelfth Five-Year National Science and Technology Support Plan; funds of Shandong "Double Tops" program	This study was supported jointly by the twelfth Five-Year National Science and Technology Support Plan (No. 2015BAD23B0202), and the funds of Shandong "Double Tops" program (SYL2017XTTD02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1954, 34 USDA; Bi LD, 2015, SOIL TILL RES, V152, P94, DOI 10.1016/j.still.2015.04.005; Blanchet G, 2017, GEODERMA, V290, P107, DOI 10.1016/j.geoderma.2016.12.002; Bogunovic I, 2014, SOIL TILL RES, V144, P174, DOI 10.1016/j.still.2014.07.020; Boussadia O, 2010, SCI HORTIC-AMSTERDAM, V123, P336, DOI 10.1016/j.scienta.2009.09.023; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; Fu WJ, 2010, SOIL TILL RES, V106, P185, DOI 10.1016/j.still.2009.12.001; Gallardo A, 2007, GEODERMA, V139, P199, DOI 10.1016/j.geoderma.2007.01.022; Garten CT, 2007, SOIL BIOL BIOCHEM, V39, P2621, DOI 10.1016/j.soilbio.2007.04.033; Haileslassie A, 2005, AGR ECOSYST ENVIRON, V108, P1, DOI 10.1016/j.agee.2004.12.010; He XB, 2018, SHANDONG AGR SCI, V50, P101; Hu KL, 2014, GEODERMA, V226, P54, DOI 10.1016/j.geoderma.2014.03.001; Jackson-Blake L, 2012, SCI TOTAL ENVIRON, V431, P100, DOI 10.1016/j.scitotenv.2012.05.019; [厉彦玲 Li Yanlinga], 2018, [自然资源学报, Journal of Natural Resources], V33, P489; Marchal G, 2013, ENVIRON POLLUT, V181, P200, DOI 10.1016/j.envpol.2013.06.026; Mathur M, 2014, J AGR SCI TECH-IRAN, V16, P1187; Maynard JJ, 2016, FOREST ECOL MANAG, V369, P89, DOI 10.1016/j.foreco.2016.03.018; Meynet P, 2014, SOIL BIOL BIOCHEM, V68, P20, DOI 10.1016/j.soilbio.2013.09.015; Miao YF, 1999, J NW A F U, V2, P46; Mohammadi J., 2002, Journal of Agricultural Science and Technology, V4, P83; Olmo M, 2016, SCI TOTAL ENVIRON, V562, P690, DOI 10.1016/j.scitotenv.2016.04.089; Paz A, 1996, COMMUN SOIL SCI PLAN, V27, P479, DOI 10.1080/00103629609369570; [乔江飞 Qiao Jiangfei], 2017, [新疆农业科学, Xinjiang Agricultural Sciences], V54, P667; Rosemary F, 2017, CATENA, V150, P53, DOI 10.1016/j.catena.2016.10.017; Sanscartier D, 2009, BIOREMEDIAT J, V13, P92, DOI 10.1080/10889860902902057; Santillano-Cazares J, 2012, J PLANT NUTR, V35, P2055, DOI 10.1080/01904167.2012.717159; SCHOLLENBERGER CJ, 1945, SOIL SCI, V59, P13, DOI 10.1097/00010694-194501000-00004; Shabani G, 2015, J AGR SCI TECH-IRAN, V17, P299; Umali BP, 2012, CATENA, V93, P38, DOI 10.1016/j.catena.2012.01.010; Vaezi AR, 2010, J AGR SCI TECH-IRAN, V12, P241; Vasu D, 2017, SOIL TILL RES, V169, P25, DOI 10.1016/j.still.2017.01.006; Wang CR, 2005, CHINESE AGR SCI B, V8, P238; Wang T, 2017, CATENA, V155, P41, DOI 10.1016/j.catena.2017.03.004; [徐英 XU Ying], 2009, [灌溉排水学报, Journal of Irrigation and Drainage], V28, P27; Xu Ying, 2009, Journal of Shenyang Agricultural University, V40, P296; Yang Qi-yong, 2011, Yingyong Shengtai Xuebao, V22, P431; Zhang ShiWen, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P159; Zingore S, 2007, AGR ECOSYST ENVIRON, V119, P112, DOI 10.1016/j.agee.2006.06.019	39	8	9	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0203509	10.1371/journal.pone.0203509	http://dx.doi.org/10.1371/journal.pone.0203509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513092	gold, Green Published, Green Submitted			2022-12-26	WOS:000452204800001
J	Monir, MM; Khatun, M; Mollah, MNH				Monir, Md. Mamun; Khatun, Mita; Mollah, Md. Nurul Haque			beta-composite Interval Mapping for robust QTL analysis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DIVERGENCE; SEPARATION	Interval mapping approaches have been playing significant role for quantitative trait locus (QTL) mapping to discover genetic architecture of diseases or traits with molecular markers. Composite interval mapping (CIM) is one of the superior approaches of the interval mapping for discovering both linked and unlinked putative QTL positions. However, estimators of this approach are not robust against phenotypic outliers. As a result, it fails to detect true QTL positions in presence of outliers. In this study, we investigated the performance of beta-Composite Interval Mapping (BetaCIM) for detecting both linked and unlinked important QTLs positions from the robustness points of views. Performance of this approach depends on the value of tuning parameter beta. It reduces to the classical CIM approach for beta -> 0. We described and formulated the cross-validation procedure for selecting trait specific optimum value of beta. It was observed that the optimum value of beta depends on both amount of contaminated observations and their scatteredness. BetaCIM approach discover similar QTL positions as classical IM/CIM in absence of phenotypic outliers, but gives better results in presence of phenotypic outliers in terms of detecting true QTLs and effects estimation. We formulated the generalized forms of robust QTL analysis and developed an R-package named "BetaCIM" by implementing this robust approach. Left and right kidney weight data sets of mouse intercross population (129 S1/SvlmJ x A/J) were analyzed by using BetaCIM, CIM, and IM approaches. For right kidney weight (RKW) CIM and BetaCIM provided similar LOD score profile, and both approaches identified 3 QTL positions. IM approach also identified 3 QTL positions. For left kidney weight (LKW), there was evidence of one outlying observation; and in this case the BetaCIM approach identified 2 QTL positions. However, none of the QTLs were significant by CIM and IM approaches at 5% level of significance. Gene expression ontology (GEO) search showed that the candidate genes (Otof and A330033J07Rik) of the identified QTLs for LKW were expressed in kidney. Both simulation and real data analysis results showed that BetaCIM approach improves the performance over the existing methods in presence of phenotypic outliers. Otherwise, it keeps almost equal performance.	[Monir, Md. Mamun; Mollah, Md. Nurul Haque] Univ Rajshahi, Dept Stat, Rajshahi, Bangladesh; [Monir, Md. Mamun; Khatun, Mita] Zhejiang Univ, Inst Bioinformat, Hangzhou, Zhejiang, Peoples R China	University of Rajshahi; Zhejiang University	Mollah, MNH (corresponding author), Univ Rajshahi, Dept Stat, Rajshahi, Bangladesh.	mollah.stat.bio@ru.ac.bd		Mollah, Md. Nurul Haque/0000-0002-3883-3396				Calderon CI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150276; CHURCHILL GA, 1994, GENETICS, V138, P963; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Elisabete Fernandes, 2007, Journal of Zhejiang University-Science B, V8, P792, DOI 10.1631/jzus.2007.B0792; Feng MJ, 2009, HYPERTENSION, V54, P802, DOI 10.1161/HYPERTENSIONAHA.109.134569; Foiada F, 2015, THEOR APPL GENET, V128, P875, DOI 10.1007/s00122-015-2477-1; Fujisawa H, 2006, J STAT PLAN INFER, V136, P3989, DOI 10.1016/j.jspi.2005.03.008; Hampel F. R., 2005, ROBUST STAT APPROACH; Hayat Y, 2008, J ZHEJIANG UNIV-SC B, V9, P931, DOI 10.1631/jzus.B0820045; Ishiyama S, 2014, J NEUROSCI, V34, P14687, DOI 10.1523/JNEUROSCI.2060-14.2014; JANSEN RC, 1994, GENETICS, V136, P1447; Kao CH, 1997, BIOMETRICS, V53, P653, DOI 10.2307/2533965; LANDER ES, 1989, GENETICS, V121, P185; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Mihoko M, 2002, NEURAL COMPUT, V14, P1859, DOI 10.1162/089976602760128045; Mollah MNH, 2010, INT J DATA MIN BIOIN, V4, P471, DOI 10.1504/IJDMB.2010.034199; Mollah MNH, 2010, NEURAL NETWORKS, V23, P226, DOI 10.1016/j.neunet.2009.11.011; Mollah MNH, 2010, INT J BIOMETRICBIO, V4, P13; Mollah NH, 2008, IEEE INT C BIOINFORM, P115, DOI 10.1109/BIBM.2008.43; Sax K, 1923, GENETICS, V8, P552; Shearer A.E., 1993, GENEREVIEWS R; THODAY JM, 1961, NATURE, V191, P368, DOI 10.1038/191368a0; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208234	10.1371/journal.pone.0208234	http://dx.doi.org/10.1371/journal.pone.0208234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507966	gold, Green Published, Green Submitted			2022-12-26	WOS:000451886500032
J	Daher, S; Cohen, NL; Massarwa, M; Mahamid, M; Nasser, M; Hazou, W; Oren, R; Safadi, R; Khoury, T				Daher, Saleh; Cohen, Namma Lev; Massarwa, Muhammad; Mahamid, Mahmud; Nasser, Mira; Hazou, Wadi; Oren, Rani; Safadi, Rifaat; Khoury, Tawfik			Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease	PLOS ONE			English	Article							NATURAL-HISTORY; FOLLOW-UP; AMERICAN ASSOCIATION; SCORING SYSTEM; CIRRHOSIS; NAFLD; RISK; POPULATION; PREVALENCE; VALIDATION	Background and aim The progression of non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH) is believed to be the driver for future development of fibrosis and cirrhosis. Nevertheless, there remains a clear deficit in non-invasive methods for the diagnosis of NASH. The aim of the present study was to evaluate the prevalence of portal lymphadenopathy (PL) in biopsy-proven NAFLD patients and to determine whether PL correlates with NAFLD stage and severity. Methods A retrospective study included biopsy-proven NAFLD patients with up to date (within one year) abdominal imaging by computed tomography (CT) and/or magnetic resonance imaging (MRI). Patients were clustered into three groups based on their NAFLD Activity Score (NAS): NAS1-2 (mild), NAS3-4 (moderate) and NAS >= 5 (advanced). We Assessed for association between PL and other clinical and laboratory findings with NAS, NAS components and fibrosis. Results Seventy-five patients with NAFLD and no other competing etiologies for liver diseases or PL were included. The mean age was 50.7 +/- 14.84 years with male predominance (N = 47, 62.7%). Twenty-five (33.3%), 37 (49.3%) and 13 (17.3%) patients had mild, moderate and advanced NAS, respectively. PL significantly correlated with advanced NAS >= 5 (Fisher's (F) 9.5, P = 0.009). Correlation was driven mainly by a link to hepatocytes ballooning (F of 5.9, P = 0.043). In addition, PL significantly correlated with portal inflammation (F 4.29, P = 0.038). As for hepatic fibrosis, the F test wasn't significant, though spearman's coefficient (SC) was significant (0.277, P = 0.012). On multivariate analysis, PL was identified as a sole predictor of advanced NAS score (Odds ratio of 2.68, P = 0.002). Incorporation of PL into noninvasive fibrosis scores improved their diagnostic yield. Conclusion PL predicts severity of NAFLD. Its presence may serve as a novel radiological marker for NAFLD/NASH differentiation and disease progression.	[Daher, Saleh; Massarwa, Muhammad; Nasser, Mira; Hazou, Wadi; Oren, Rani; Safadi, Rifaat; Khoury, Tawfik] Hadassah Univ Hosp, Inst Gastroenterol & Liver Dis, Dept Med, Liver Unit, Jerusalem, Israel; [Cohen, Namma Lev] Hadassah Univ Hosp, Dept Radiol, Jerusalem, Israel; [Mahamid, Mahmud] Nazareth Hosp, Gastroenterol & Endoscopy United, EMMS, Nazareth, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Daher, S (corresponding author), Hadassah Univ Hosp, Inst Gastroenterol & Liver Dis, Dept Med, Liver Unit, Jerusalem, Israel.	saleh@hadassah.org.il		Khoury, Tawfik/0000-0001-6699-8625				Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Bzowej NH, 2018, CURR OPIN ORGAN TRAN, V23, P169, DOI 10.1097/MOT.0000000000000502; Caldwell S, 2017, ANN HEPATOL, V16, P182, DOI 10.5604/16652681.1231550; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Clark JM, 2003, GASTROENTEROLOGY, V124, P248, DOI 10.1053/gast.2003.50032; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Erickson SK, 2009, J LIPID RES, V50, pS412, DOI 10.1194/jlr.R800089-JLR200; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kruger FC, 2011, SAMJ S AFR MED J, V101, P477; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Moschen AR, 2013, TRENDS ENDOCRIN MET, V24, P537, DOI 10.1016/j.tem.2013.05.009; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Pupulim LF, 2015, ABDOM IMAGING, V40, P1997, DOI 10.1007/s00261-015-0350-y; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Sanyal AJ, 2015, HEPATOLOGY, V61, P1392, DOI 10.1002/hep.27678; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sung KC, 2014, J HEPATOL, V60, P1040, DOI 10.1016/j.jhep.2014.01.009; Tanaka M, 2016, CELL MOL GASTROENTER, V2, P733, DOI 10.1016/j.jcmgh.2016.09.002; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1002/hep.1840220616; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Verhaegh P, 2018, CLIN GASTROENTEROL H, V16, P837, DOI 10.1016/j.cgh.2017.08.024; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207479	10.1371/journal.pone.0207479	http://dx.doi.org/10.1371/journal.pone.0207479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500848	Green Published, gold, Green Submitted			2022-12-26	WOS:000451883700009
J	Ananta, P; Kham-ngam, I; Chetchotisakd, P; Chaimanee, P; Reechaipichitkul, W; Namwat, W; Lulitanond, V; Faksri, K				Ananta, Pimjai; Kham-ngam, Irin; Chetchotisakd, Ploenchan; Chaimanee, Prajuab; Reechaipichitkul, Wipa; Namwat, Wises; Lulitanond, Viraphong; Faksri, Kiatichai			Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; MACROLIDE RESISTANCE; MUTATIONS; INFECTIONS; MECHANISMS; THERAPY; STRAINS; DISEASE; ERM(41)	Mycobacterium abscessus is an important infectious agent highly associated with drug resistance and treatment failure. We investigated the drug resistance situation of M. abscessus in Northeast Thailand and the possible genetic basis for this. Sixty-eight M. abscessus clinical isolates were obtained from 26 patients at Srinagarind Hospital during 2012-2016. Drug susceptibility tests and sequencing of erm(41), rrl and rrs genes were performed. Mycobacterium abscessus was resistant to 11/15 antibiotics (nearly 100% resistance in each case). Partial susceptibility to four antibiotics was found (amikacin, tigecycline, clarithromycin and linezolid). Non-massiliense subspecies were significantly associated with clarithromycin resistance (p<0.0001) whereas massiliense subspecies were associated with tigecycline resistance (p = 0.028). Inducible clarithromycin resistance was seen in 22/68 (32.35%) isolates: 21 of these isolates (95.45%) belonged to non-massiliense subspecies and resistance was explicable by the T28C mutation in erm(41). Inducible clarithromycin resistance was found in one isolate of the massiliense subspecies. Acquired clarithromycin resistance explicable by the A2271G/C mutation of rrl was seen in only 7/16 (43.75%) of strains. Inducible and acquired resistance mechanisms can be interchangeable during the course of infection. Rrs mutations were not associated with amikacin resistance in our study. Antibiotic resistance in subspecies of M. abscessus was reported from Northeast Thailand. Known resistance-associated mutations cannot explain all of the resistance patterns observed.	[Ananta, Pimjai; Kham-ngam, Irin; Namwat, Wises; Lulitanond, Viraphong; Faksri, Kiatichai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Ananta, Pimjai; Chaimanee, Prajuab] Khon Kaen Univ, Srinagarind Hosp, Fac Med, Clin Lab Unit, Khon Kaen, Thailand; [Kham-ngam, Irin; Namwat, Wises; Lulitanond, Viraphong; Faksri, Kiatichai] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Khon Kaen, Thailand; [Chetchotisakd, Ploenchan; Reechaipichitkul, Wipa] Khon Kaen Univ, Fac Med, Dept Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Faksri, K (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.; Faksri, K (corresponding author), Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Khon Kaen, Thailand.	kiatichai@kku.ac.th		Faksri, Kiatichai/0000-0001-5022-4182	Khon Kaen University, Thailand [6200039]	Khon Kaen University, Thailand	This study was financially supported by General Supportive Grant, Khon Kaen University, Thailand 2019 (Grant number: 6200039). This grant provided only research budget and no publication fee budget was provided. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by General Supportive Grant, Khon Kaen University, Thailand 2019 (Grant number: 6200039). We would like to acknowledge Prof. David Blair for editing the MS via Publication Clinic KKU, Thailand.	Alcaide F, 1997, ANTIMICROB AGENTS CH, V41, P2270, DOI 10.1128/AAC.41.10.2270; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Broda A, 2013, J CLIN MICROBIOL, V51, P217, DOI 10.1128/JCM.02260-12; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Carneiro MD, 2017, MEM I OSWALDO CRUZ, V112, P775, DOI 10.1590/0074-02760170080; Cowman S, 2016, J INFECTION, V72, P324, DOI 10.1016/j.jinf.2015.12.007; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Kehrmann J, 2016, J CLIN MICROBIOL, V54, P1653, DOI 10.1128/JCM.00147-16; Kendall BA, 2011, EMERG INFECT DIS, V17, P506, DOI 10.3201/eid1703.101164; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Lee SH, 2014, ANN LAB MED, V34, P31, DOI 10.3343/alm.2014.34.1.31; Lee SH, 2014, J CLIN LAB ANAL, V28, P409, DOI 10.1002/jcla.21702; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084065; Lipworth SIW, 2018, WHOLE GENOME SEQUENC, DOI [10.1101/251918, DOI 10.1101/251918]; Maurer FP, 2014, J ANTIMICROB CHEMOTH, V69, P1559, DOI 10.1093/jac/dku007; Maurer FP, 2012, J ANTIMICROB CHEMOTH, V67, P2606, DOI 10.1093/jac/dks279; Mougari F, 2016, J ANTIMICROB CHEMOTH, V71, P2208, DOI 10.1093/jac/dkw130; Nash KA, 2006, ANTIMICROB AGENTS CH, V50, P3476, DOI 10.1128/AAC.00402-06; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Nessar R, 2011, J ANTIMICROB CHEMOTH, V66, P1719, DOI 10.1093/jac/dkr209; Oh CT, 2014, J ANTIMICROB CHEMOTH, V69, P1599, DOI 10.1093/jac/dku024; Pang H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/419392; Park S, 2008, J KOREAN MED SCI, V23, P49, DOI 10.3346/jkms.2008.23.1.49; Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x; Pfister P, 2004, J MOL BIOL, V342, P1569, DOI 10.1016/j.jmb.2004.07.095; Phowthongkum Prasit, 2005, Journal of the Medical Association of Thailand, V88, P1153; Prammananan T, 1998, J INFECT DIS, V177, P1573, DOI 10.1086/515328; Ramirez A, 2015, J GLOB ANTIMICROB RE, V3, P205, DOI 10.1016/j.jgar.2015.05.007; Rominski A, 2017, J ANTIMICROB CHEMOTH, V72, P3070, DOI 10.1093/jac/dkx284; Rominski A, 2017, J ANTIMICROB CHEMOTH, V72, P2191, DOI 10.1093/jac/dkx125; Rominski A, 2017, J ANTIMICROB CHEMOTH, V72, P376, DOI 10.1093/jac/dkw466; Rubio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140166; Rudra P, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00119-18, 10.1128/aac.00119-18]; Sander P, 1997, MOL MICROBIOL, V26, P469, DOI 10.1046/j.1365-2958.1997.5811946.x; Sassi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-359; SRIYABHAYA N, 1981, REV INFECT DIS, V3, P1085; Sungkanuparph Somnuek, 2003, Journal of the Medical Association of Thailand, V86, P772; Yoshida S, 2018, INT J TUBERC LUNG D, V22, P413, DOI 10.5588/ijtld.17.0673; Yoshida S, 2018, J MED MICROBIOL, V67, P74, DOI 10.1099/jmm.0.000661	41	21	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208053	10.1371/journal.pone.0208053	http://dx.doi.org/10.1371/journal.pone.0208053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496270	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800087
J	Bernard, A; Barreneche, T; Lheureux, F; Dirlewanger, E				Bernard, Anthony; Barreneche, Teresa; Lheureux, Fabrice; Dirlewanger, Elisabeth			Analysis of genetic diversity and structure in a worldwide walnut (Juglans regia L.) germplasm using SSR markers	PLOS ONE			English	Article							MORPHOLOGICAL TRAITS; MOLECULAR CHARACTERIZATION; POPULATION-STRUCTURE; CORE COLLECTIONS; R-PACKAGE; GENOTYPES; CULTIVAR; IDENTIFICATION; VARIABILITY; SOFTWARE	Persian or English walnut (Juglans regia L.), the walnut species cultivated for nut production, is one of the oldest food sources known and is grown worldwide in temperate areas. France is the 7 th leading producer as of 2016 with 39 kt. Deciphering walnut genetic diversity and structure is important for efficient management and use of genetic resources. In this work, 253 worldwide accessions from the INRA walnut germplasm collection, containing English walnut and several related species, were genotyped using 13 SSR (Single Sequence Repeat) markers selected from the literature to assess diversity and structure. Genetic diversity parameters showed a deficiency of heterozygotes and, for several SSRs, allelespecificities among the accessions tested. Principal Coordinate Analysis (PCoA) showed the 253 accessions clustered in largely in agreement with the existing botanical classification of the genus. Among the 217 J. regia accessions, two main clusters, accessions from Eastern Europe and Asia, and accessions from Western Europe and America, were identified using STRUCTURE software. This was confirmed by Principal Coordinate Analysis and supported by Neighbor-Joining tree construction using DARwin software. Moreover, a substructure was found within the two clusters, mainly according to geographical origin. A core collection containing 50 accessions was selected using the maximum length sub-tree method and prior knowledge about their phenotype. The present study constitutes a preliminary population genetics overview of INRA walnut genetic resources collection using SSR markers. The resulting estimations of genetic diversity and structure are useful for germplasm management and for future walnut breeding programs.	[Bernard, Anthony; Barreneche, Teresa; Dirlewanger, Elisabeth] Univ Bordeaux, INRA, UMR BFP 1332, Villenave Dornon, France; [Bernard, Anthony; Lheureux, Fabrice] Ctifl, Ctr Operat Lanxade, Prigonrieux, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux	Dirlewanger, E (corresponding author), Univ Bordeaux, INRA, UMR BFP 1332, Villenave Dornon, France.	elisabeth.dirlewanger@inra.fr	Lheureux, Fabrice/ABH-6450-2020	Dirlewanger, Elisabeth/0000-0003-3244-5197; BARRENECHE, Teresa/0000-0002-7852-1418	Region Nouvelle-Aquitaine; 'ANRT' (Agence Nationale de la Recherche et de la Technologie) [2016/1558]	Region Nouvelle-Aquitaine(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); 'ANRT' (Agence Nationale de la Recherche et de la Technologie)	The Ctifl, holder of the project "INNOV'noyer", and in partnership with INRA, want to thank the 'Region Nouvelle-Aquitaine' for funding a part of this project. The Ctifl also thank the 'Cifre' convention by 'ANRT' (Agence Nationale de la Recherche et de la Technologie) for funding half the cost of the doctoral fellowship of Anthony Bernard (2016/1558). To finish, the project is labelled by the 'AgriSudOuest Innovation' competitiveness cluster.	Ali AM, 2016, J PURE APPL SCI, V28, P50; Aradhya M, 2010, ACTA HORTIC, V861, P127, DOI 10.17660/ActaHortic.2010.861.16; Aradhya MK, 2006, DARWINS HARVEST NEW; Bayazit S, 2007, SCI HORTIC-AMSTERDAM, V111, P394, DOI 10.1016/j.scienta.2006.11.006; Bernard A, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-017-1214-0; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Butterfield T, 2015, IDENTIFYING GENETIC; Campoy JA, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0712-9; Christopoulos MV, 2010, SCI HORTIC-AMSTERDAM, V125, P584, DOI 10.1016/j.scienta.2010.05.006; Cubry P, 2013, GENET RESOUR CROP EV, V60, P483, DOI 10.1007/s10722-012-9851-5; Dang M, 2016, FORESTS, V7, DOI 10.3390/f7100247; Dangl GS, 2005, J AM SOC HORTIC SCI, V130, P348, DOI 10.21273/JASHS.130.3.348; Dong WP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01148; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebrahimi A, 2017, SCI HORTIC-AMSTERDAM, V220, P36, DOI 10.1016/j.scienta.2017.03.030; Ebrahimi A, 2011, SCI HORTIC-AMSTERDAM, V130, P146, DOI 10.1016/j.scienta.2011.06.028; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fatahi R, 2010, HORTIC ENVIRON BIOTE, V51, P51; Fernandez-Cruz J, 2016, CONSERV GENET, V17, P949, DOI 10.1007/s10592-016-0835-4; FJELLSTROM RG, 1994, GENOME, V37, P690, DOI 10.1139/g94-097; Fornari B, 2001, ACTA HORTIC, P167, DOI 10.17660/ActaHortic.2001.544.23; Germain E, 1999, MONOGRAPHIE CTIFL; Han H, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1064-1; Hintum T. J. L. van, 2000, IPGRI Technical Bulletin; Hu J, 2011, BIOL PLANTARUM, V55, P577, DOI 10.1007/s10535-011-0129-0; Ince AG, 2017, J SCI ENG RES, V2017, P236; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karimi R, 2010, HORTSCIENCE, V45, P1403, DOI 10.21273/HORTSCI.45.9.1403; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Liang W, 2015, PLANT MOL BIOL REP, V33, P458, DOI 10.1007/s11105-014-0754-9; Mahmoodi R, 2013, SPAN J AGRIC RES, V11, P431, DOI 10.5424/sjar/2013112-3445; MALVOLTI ME, 1994, J HERED, V85, P389, DOI 10.1093/oxfordjournals.jhered.a111484; MANNING WE, 1978, ANN MO BOT GARD, V65, P1058, DOI 10.2307/2398782; Martinez-Garcia PJ, 2016, PLANT J, V87, P507, DOI 10.1111/tpj.13207; McGranahan G, 2004, HORTSCIENCE, V39, P1772, DOI 10.21273/HORTSCI.39.7.1772; Mohsenipoor S, 2010, ACTA HORTIC, V861, P133, DOI 10.17660/ActaHortic.2010.861.17; Nicese FP, 1998, EUPHYTICA, V101, P199, DOI 10.1023/A:1018390120142; Noor Shah U, 2016, J SAUDI SOC AGR SCI; Odong TL, 2013, THEOR APPL GENET, V126, P289, DOI 10.1007/s00122-012-1971-y; Odong TL, 2011, THEOR APPL GENET, V123, P195, DOI 10.1007/s00122-011-1576-x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira-Lorenzo S, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1197-x; Pereira-Lorenzo S, 2011, GENOME, V54, P301, DOI [10.1139/G10-122, 10.1139/g10-122]; Perrier X., 2006, DARWIN SOFTWARE; Pollegioni P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172541; Potter D, 2002, J AM SOC HORTIC SCI, V127, P75, DOI 10.21273/JASHS.127.1.75; Pritchard JK, 2000, GENETICS, V155, P945; Ruiz-Garcia L, 2011, SPAN J AGRIC RES, V9, P179; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Torres AR, 2015, SCI AGR, V72, P47, DOI 10.1590/0103-9016-2014-0039; Tulecke W, 13 U CAL GEN RES CON; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Vischi M, 2017, FORESTS, V8, DOI 10.3390/f8030081; Wang H, 2008, J AM SOC HORTIC SCI, V133, P197, DOI 10.21273/JASHS.133.2.197; Woeste K, 2002, J HERED, V93, P58, DOI 10.1093/jhered/93.1.58; Woodworth RH, 1930, AM J BOT, V17, P863, DOI 10.1002/j.1537-2197.1930.tb04927.x; Zeven A.C, 1975, DICT CULTIVATED PLAN	60	32	34	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208021	10.1371/journal.pone.0208021	http://dx.doi.org/10.1371/journal.pone.0208021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481202	Green Submitted, Green Published, gold			2022-12-26	WOS:000451440000036
J	Fujita, E; Yakushi, K; Takeda, M; Islam, MM; Nakagaichi, M; Taaffe, DR; Takeshima, N				Fujita, Eiji; Yakushi, Karen; Takeda, Masaki; Islam, Mohammod Monirul; Nakagaichi, Masaki; Taaffe, Dennis Robert; Takeshima, Nobuo			Proficiency in pole handling during Nordic walking influences exercise effectiveness in middle-aged and older adults	PLOS ONE			English	Article								Nordic walking (NW) is a total body version of walking increasingly used as a health-promoting activity by middle-aged and older adults. The present study examined the relationship between force exerted through the pole and physiological response during NW. In this nonrandomized exercise trial, 17 participants comprising 8 middle-aged and older recreationally trained Nordic walkers (NWrec: 63.7 +/- 8.1 years) and 9 experienced NW instructors (NWinstr: 57.5 +/- 7.8 years) underwent outdoor ordinary walking (OW) and NW bouts as fast as possible for 12 minutes. Walking distance, speed, heart rate (HR), energy expenditure (METs and J/kg/m) and upper and lower limb muscle activities using surface electromyogram (EMG) were assessed. A pole with a built-in load cell measured force applied to the pole with peak pole force, pole contact time, % of pole contact time with respect to the gait cycle, and pole impulse derived. We conducted two-way analysis of covariance adjusted for age and BMI. There was a significant group and walking type interaction for walking distance and speed (P = 0.04), METs (P < 0.01), and HR (P = 0.04) with higher values in the NWinstr group during NW than OW. As expected, upper limb EMG activities increased (P < 0.01) with NW in both groups. All pole force measures were significantly higher in NWinstr than NWrec (P. 0.01). Change in walking distance and speed were correlated with pole peak force (r = 0.67, P < 0.01) and pole impulse (r = 0.63, P = 0.01). Similarly, change in METs was associated with peak pole force (r = 0.66, P < 0.01) and pole impulse (r = 0.56, P = 0.02). These results indicate that planting the pole on the ground more forcefully and for longer periods to derive a driving force in NW enhances the effectiveness of the exercise and potentially the health-derived benefits.	[Fujita, Eiji; Islam, Mohammod Monirul; Nakagaichi, Masaki] Natl Inst Fitness & Sports Kanoya, Dept Sports & Life Sci, 1 Shiromizucho, Kanoya, Kagoshima, Japan; [Yakushi, Karen] Natl Inst Fitness & Sports Kanoya, Grad Sch Phys Educ, 1 Shiromizucho, Kanoya, Kagoshima, Japan; [Takeda, Masaki] Doshisha Univ, Fac Hlth & Sports Sci, 1-3 Tataramiyakodani, Kyotanabe, Kyoto, Japan; [Taaffe, Dennis Robert] Edith Cowan Univ, Sch Med & Hlth Sci, Exercise Med Res Inst, Joondalup, Australia; [Takeshima, Nobuo] Asahi Univ, Sch Hlth Sci, Dept Hlth & Sports Sci, 1851 Hozumi, Mizuho, Gifu, Japan	National Institute Fitness & Sports Kanoya; National Institute Fitness & Sports Kanoya; Doshisha University; Edith Cowan University; Asahi University	Fujita, E (corresponding author), Natl Inst Fitness & Sports Kanoya, Dept Sports & Life Sci, 1 Shiromizucho, Kanoya, Kagoshima, Japan.	fujita@nifs-k.ac.jp		Taaffe, Dennis/0000-0001-6381-1597; Takeda, Masaki/0000-0002-2438-5692	Japan Society for the Promotion of Science program for KAKENHI [JP16K0174]; Fostering Globally Talented Researchers [G2802]	Japan Society for the Promotion of Science program for KAKENHI; Fostering Globally Talented Researchers	This work was supported by Japan Society for the Promotion of Science program for KAKENHI (Grant-in-Aid for Scientific Research), grant number: JP16K0174 and Fostering Globally Talented Researchers, grant number: G2802 (https://www.jsps.go.jp/english/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Cabinet office of Japan, 2016, CURR STAT TRENDS ELD; Cabinet office of Japan, 2016, SIT ON AG; Figard-Fabre H, 2010, EUR J APPL PHYSIOL, V108, P1141, DOI 10.1007/s00421-009-1315-z; Fujita E, 2016, RES J SPORTS PERFORM, V8, P165; Fujita E, 2011, MED SCI SPORT EXER, V43, P2328, DOI 10.1249/MSS.0b013e3182207ed8; Hasegawa T, 2016, RES J SPORTS PERFORM, V8, P398; Hislop HJ, 2002, DANIELS WORTHINGHAMS, V7th; Je-Myng S, 2013, J PHYS THER SCI, V25, P1553, DOI [10.1589/jpts.25.1553, DOI 10.1589/JPTS.25.1553]; Knight CA, 2000, MED SCI SPORT EXER, V32, P2093, DOI 10.1097/00005768-200012000-00020; Ministry of health, 2013, EX PHYS ACT REF HLTH; Miura M, 2015, NORDIC WALKING EFFEC; Parkatti T, 2012, J AGING PHYS ACTIV, V20, P93, DOI 10.1123/japa.20.1.93; Pellegrini B, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.09195438, 10.1371/journal.pone.0195438]; Pellegrini B, 2017, GAIT POSTURE, V51, P234, DOI 10.1016/j.gaitpost.2016.10.010; Pellegrini B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138906; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Schiffer T, 2011, EUR J APPL PHYSIOL, V111, P1121, DOI 10.1007/s00421-010-1739-5; Schiffer T, 2009, MED SCI SPORT EXER, V41, P663, DOI 10.1249/MSS.0b013e31818b9321; Schubert Matthew M, 2018, Sports Med Int Open, V2, pE67, DOI 10.1055/a-0631-0920; Sengoku N, 2012, JPN J PHYS ED HLTH S, V57, P449, DOI [10.5432/jjpehss.11027, DOI 10.5432/JJPEHSS.11027]; Stahl Sarah E, 2016, BMJ Open Sport Exerc Med, V2, pe000106; Sugiyama K, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-2; Takai Y., 2008, INT J SPORT HLTH SCI, V6, P169, DOI [10.5432/ijshs.IJSHS20080329, DOI 10.5432/IJSHS.IJSHS20080329]; TAKESHIMA N, 1992, Japanese Journal of Physical Fitness and Sports Medicine, V41, P295; Takeshima N, 2013, J SPORT SCI MED, V12, P422; Tanaka H, 2012, JPN J PHYS ED HLTH S, V57, P21, DOI [10.5432/jjpehss.11029, DOI 10.5432/JJPEHSS.11029]; Tschentscher M, 2013, AM J PREV MED, V44, P76, DOI 10.1016/j.amepre.2012.09.043; WHO, AG AND HLTH; Yamamoto K., 2007, B ASAIGAKUEN U SCH L, V7, P108	30	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208070	10.1371/journal.pone.0208070	http://dx.doi.org/10.1371/journal.pone.0208070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481199	Green Published, Green Submitted, gold			2022-12-26	WOS:000451440000040
J	Zhao, YL; Ge, L; Zhou, YJ; Sun, ZF; Zheng, EL; Wang, XM; Huang, YC; Cheng, HP				Zhao, Youlin; Ge, Liang; Zhou, Yijun; Sun, Zhongfang; Zheng, Erlong; Wang, Xingmeng; Huang, Yongchun; Cheng, Huiping			A new Seasonal Difference Space-Time Autoregressive Integrated Moving Average (SD-STARIMA) model and spatiotemporal trend prediction analysis for Hemorrhagic Fever with Renal Syndrome (HFRS)	PLOS ONE			English	Article							PUUMALA HANTAVIRUS; CHINA; IDENTIFICATION; DYNAMICS; PROVINCE; STARMA	Hemorrhagic fever with renal syndrome (HFRS) is a naturally-occurring, fecally transmitted disease caused by a Hantavirus (HV). It is extremely damaging to human health and results in many deaths annually, especially in Hubei Province, China. One of the primary characteristics of HFRS is the spatiotemporal heterogeneity of its occurrence, with notable seasonal differences. In view of this heterogeneity, the present study suggests that there is a need to focus on trend simulation and the spatiotemporal prediction of HFRS outbreaks. To facilitate this, we constructed a new Seasonal Difference Space-Time Autoregressive Integrated Moving Average (SD-STARIMA) model. The SD-STARIMA model is based on the spatial and temporal characteristics of the Space-Time Autoregressive Integrated Moving Average (STARMA) model first developed by Cliff and Ord in 1974, which has proven useful in modelling the temporal aspects of spatially located data. This model can simulate the trends in HFRS epidemics, taking into consideration both spatial and temporal variations. The SD-STARIMA model is also able to make seasonal difference calculations to eliminate temporally non-stationary problems that are present in the HFRS data. Experiments have demonstrated that the proposed SD-STARIMA model offers notably better prediction accuracy, especially for spatiotemporal series data with seasonal distribution characteristics.	[Zhao, Youlin; Huang, Yongchun] Hohai Univ, Business Sch, Nanjing, Jiangsu, Peoples R China; [Ge, Liang; Zhou, Yijun; Sun, Zhongfang; Zheng, Erlong; Wang, Xingmeng] Tianjin Inst Surveying & Mapping, Tianjin, Peoples R China; [Cheng, Huiping] Hubei Univ Technol, Sch Econ & Management, Wuhan, Hubei, Peoples R China	Hohai University; Hubei University of Technology	Zhao, YL (corresponding author), Hohai Univ, Business Sch, Nanjing, Jiangsu, Peoples R China.; Ge, L (corresponding author), Tianjin Inst Surveying & Mapping, Tianjin, Peoples R China.	sobzyl@hhu.edu.cn; geliang0021@126.com		Ge, Liang/0000-0002-3365-353X	National Natural Science Foundation of China [71503068, 71603075]; National Philosophy and Social Science Fund Key Grant [16AGL005, 16ZDA046]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_17R35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Philosophy and Social Science Fund Key Grant; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China, no. 71503068 by Youlin Zhao no. 71603075 by Huiping Cheng; National Philosophy and Social Science Fund Key Grant, no. 16AGL005 by Yongchun Huang and no. 16ZDA046; Program for Changjiang Scholars and Innovative Research Team in University (no. IRT_17R35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, SPATIAL ECONOMETRICS; Box GEP, 2015, TIME SERIES ANAL; Busch M, 2004, TROP MED INT HEALTH, V9, P508, DOI 10.1111/j.1365-3156.2004.01218.x; Caputo B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004463; de Melo VW, 2015, EVOL APPL, V8, P545, DOI 10.1111/eva.12263; den Butter F A G, 1985, EMPIR ECON, V10, P209; Dobly A, 2012, J VECTOR ECOL, V37, P276, DOI 10.1111/j.1948-7134.2012.00228.x; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Garrido RA, 1998, TRANSPORT RES REC, P8; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; Ge L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167836; Ge L, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111062; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; Huang HQ, 2010, ADV MATER RES-SWITZ, V108-111, P893, DOI 10.4028/www.scientific.net/AMR.108-111.893; K CADO, 1975, SPAC TIM MOD APPL RE; K CDOJ, 1981, SPATIAL PROCESSES MO; Khashei M, 2012, SOFT COMPUT, V16, P1091, DOI 10.1007/s00500-012-0805-9; Kurt S, 2015, WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP, P2537, DOI 10.1016/j.sbspro.2015.06.441; Lee SD, 2007, KOREAN J APPL STAT, V20, P91; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li S, 2014, INT J ENV RES PUB HE; Li SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163771; Li SJ, 2014, INT J ENV RES PUB HE, V11, P12129, DOI 10.3390/ijerph111212129; Li ZH, 2016, ADV INTELL SYST, V367, P275, DOI 10.1007/978-3-319-19105-8_26; Lin HL, 2014, INT J BIOMETEOROL, V58, P1031, DOI 10.1007/s00484-013-0688-1; Lin HL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-207; Lin S L, 2009, MACH LEARN CYB 2009, P6; Liu L, 2016, EPIDEMIOL INFECT, V144, P144, DOI [10.1017/S0950268815001144, 10.1017/S0950268815001582]; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; MARTIN RL, 1975, T I BRIT GEOGR, P95, DOI 10.2307/621623; PFEIFER PE, 1981, GEOGR ANAL, V13, P117; PFEIFER PE, 1980, TECHNOMETRICS, V22, P397, DOI 10.2307/1268325; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Song X, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003929; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Wang Shang-bei, 2014, Application Research of Computers, V31, P2315, DOI 10.3969/j.issn.1001-3695.2014.08.017; Wang T, 2016, JPN J INFECT DIS, V69, P279, DOI 10.7883/yoken.JJID.2014.567; Wang T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1404-7; Wu W, 2009, EPIDEMIOL INFECT, V137, P1766, DOI 10.1017/S0950268809002659; Wu W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-229; Wu Xiaoxu, 2016, Environ Int, V86, P14, DOI 10.1016/j.envint.2015.09.007; XU ZY, 1985, J INFECT DIS, V152, P137, DOI 10.1093/infdis/152.1.137; Zhang WY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003344; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092700; [郑姗姗 Zheng Shanshan], 2014, [地理科学进展, Progress in Geography], V33, P949; Zheng Y., 2017, ADV BIOENERGY, P1; Zou Y, 2008, J MED VIROL, V80, P680, DOI 10.1002/jmv.21119; Zuo SQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000945	51	8	9	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207518	10.1371/journal.pone.0207518	http://dx.doi.org/10.1371/journal.pone.0207518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475830	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700034
J	Reinke, AA; Li, SH; Warnock, M; Shaydakov, ME; Guntaka, NS; Su, EJ; Diaz, JA; Emal, CD; Lawrence, DA				Reinke, Ashley A.; Li, Shih-Hon; Warnock, Mark; Shaydakov, Maxim E.; Guntaka, Naga Sandhya; Su, Enming J.; Diaz, Jose A.; Emal, Cory D.; Lawrence, Daniel A.			Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serpin; high-throughput screening (HTS); small molecule; thrombosis; plasminogen; pharmacokinetics; inhibitor; drug discovery; PAI-1; serpin E1; vitronectin	INSULIN-RESISTANCE; CRYSTAL-STRUCTURE; PAI-1 INHIBITOR; MECHANISM; MICE; HYPERLIPIDEMIA; POLYPHENOLS; OBESITY; ASSAYS; MODEL	Plasminogen activator inhibitor type-1 (PAI-1) is a serine protease inhibitor (serpin) implicated in numerous pathological processes, including coronary heart disease, arterial and venous thrombosis, and chronic fibrotic diseases. These associations have made PAI-1 an attractive pharmaceutical target. However, the complexity of the serpin inhibitory mechanism, the inherent metastability of serpins, and the high-affinity association of PAI-1 with vitronectin in vivo have made it difficult to identify pharmacologically effective small-molecule inhibitors. Moreover, the majority of current small-molecule PAI-1 inhibitors are poor pharmaceutical candidates. To this end and to find leads that can be efficiently applied to in vivo settings, we developed a dual-reporter high-throughput screen (HTS) that reduced the rate of nonspecific and promiscuous hits and identified leads that inhibit human PAI-1 in the high-protein environments present in vivo. Using this system, we screened >152,000 pure compounds and 27,000 natural product extracts (NPEs), reducing the apparent hit rate by almost 10-fold compared with previous screening approaches. Furthermore, screening in a high-protein environment permitted the identification of compounds that retained activity in both ex vivo plasma and in vivo. Following lead identification, subsequent medicinal chemistry and structure-activity relationship (SAR) studies identified a lead clinical candidate, MDI-2268, having excellent pharmacokinetics, potent activity against vitronectin-bound PAI-1 in vivo, and efficacy in a murine model of venous thrombosis. This rigorous HTS approach eliminates promiscuous candidate leads, significantly accelerates the process of identifying PAI-1 inhibitors that can be rapidly deployed in vivo, and has enabled identification of a potent lead compound.	[Reinke, Ashley A.; Warnock, Mark; Su, Enming J.; Lawrence, Daniel A.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Li, Shih-Hon] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Shaydakov, Maxim E.; Diaz, Jose A.] Univ Michigan, Dept Surg, Sect Vasc Surg, Ann Arbor, MI 48109 USA; [Guntaka, Naga Sandhya; Emal, Cory D.] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eastern Michigan University	Lawrence, DA (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	dlawrenc@med.umich.edu	Shaydakov, Maxim/X-4250-2019; Guntaka, Naga Sandhya/I-7671-2019	Guntaka, Naga Sandhya/0000-0002-3753-6277; Lawrence, Daniel/0000-0003-3126-1935; Shaydakov, Maxim/0000-0002-1186-8556; Diaz, MD, Jose Antonio/0000-0001-5205-2118	University of Michigan Cancer Center Grant [G011130]; NHLBI, National Institutes of Health [HL55374, HL089407, T32HL007853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853, R01HL055374] Funding Source: NIH RePORTER	University of Michigan Cancer Center Grant; NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by University of Michigan Cancer Center Grant G011130 and NHLBI, National Institutes of Health, Grants HL55374 and HL089407 (to D. A. L.) and T32HL007853 (to A. A. R.). D. A. L., C. D. E., and E. J. S. have an equity interest in MDI Therapeutics, which holds an option to license MDI-2268 from the University of Michigan. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baxi S, 2008, THROMB HAEMOSTASIS, V99, P749, DOI 10.1160/TH07-11-0669; BOOTH NA, 1988, BRIT J HAEMATOL, V70, P327, DOI 10.1111/j.1365-2141.1988.tb02490.x; Bothra A, 1998, J BIOMOL STRUCT DYN, V15, P959, DOI 10.1080/07391102.1998.10508216; Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192; Cale JM, 2010, J BIOL CHEM, V285, P7892, DOI 10.1074/jbc.M109.067967; Cheng XH, 2003, J BIOMOL SCREEN, V8, P292, DOI 10.1177/1087057103008003007; Diaz JA, 2012, J VASC SURG, V55, P815, DOI 10.1016/j.jvs.2011.08.038; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Eitzman DT, 2000, BLOOD, V95, P577, DOI 10.1182/blood.V95.2.577; Eren M, 2014, P NATL ACAD SCI USA, V111, P7090, DOI 10.1073/pnas.1321942111; Eschelbach JW, 2011, J BIOMOL SCREEN, V16, P1112, DOI 10.1177/1087057111416237; Flevaris P, 2017, SEMIN THROMB HEMOST, V43, P169, DOI 10.1055/s-0036-1586228; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Grant SK, 2002, J BIOMOL SCREEN, V7, P531, DOI 10.1177/1087057102238627; Henrich CJ, 2013, NAT PROD REP, V30, P1284, DOI 10.1039/c3np70052f; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Khan SS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1617; Latruffe N, 2014, MOLECULES, V19, P17066, DOI 10.3390/molecules191117066; Li SH, 2013, P NATL ACAD SCI USA, V110, pE4941, DOI 10.1073/pnas.1216499110; Li SH, 2011, METHOD ENZYMOL, V501, P177, DOI 10.1016/B978-0-12-385950-1.00009-2; Liang A, 2005, THROMB RES, V115, P341, DOI 10.1016/j.thromres.2004.09.021; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lucking AJ, 2010, J THROMB HAEMOST, V8, P1333, DOI 10.1111/j.1538-7836.2010.03872.x; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; Palmer OR, 2018, RES PRACT THROMB HAE, V2, P266, DOI 10.1002/rth2.12074; Pautus S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36462; Piao L, 2016, BRIT J PHARMACOL, V173, P2622, DOI 10.1111/bph.13541; Placencio VR, 2015, CANCER RES, V75, P2969, DOI 10.1158/0008-5472.CAN-15-0876; Rouch A, 2015, EUR J MED CHEM, V92, P619, DOI 10.1016/j.ejmech.2015.01.010; SAIFUKU K, 1978, CLIN CHIM ACTA, V84, P85; Schafer K, 2001, FASEB J, V15, P1840, DOI 10.1096/fj.00-0750fje; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Sobel BE, 2003, ARTERIOSCL THROM VAS, V23, P1979, DOI 10.1161/01.ATV.0000091250.53231.4D; Tamura Y, 2014, ENDOCRINOLOGY, V155, P1708, DOI 10.1210/en.2013-1888; Wu Qingyu, 2002, Current Drug Targets - Cardiovascular and Haematological Disorders, V2, P27, DOI 10.2174/1568006023337727; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Yamaoka N, 2018, BIOORG MED CHEM LETT, V28, P809, DOI 10.1016/j.bmcl.2017.11.016; Ye B, 2003, BIOORG MED CHEM LETT, V13, P3361, DOI 10.1016/S0960-894X(03)00686-3; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zuck P, 2005, ANAL BIOCHEM, V342, P254, DOI 10.1016/j.ab.2005.04.029	46	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1464	1477		10.1074/jbc.RA118.004885	http://dx.doi.org/10.1074/jbc.RA118.004885			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30510136	Green Published, hybrid			2022-12-26	WOS:000457879200003
J	Mizoi, J; Kanazawa, N; Kidokoro, S; Takahashi, F; Qin, F; Morimoto, K; Shinozaki, K; Yamaguchi-Shinozaki, K				Mizoi, Junya; Kanazawa, Natsumi; Kidokoro, Satoshi; Takahashi, Fuminori; Qin, Feng; Morimoto, Kyoko; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Heat-induced inhibition of phosphorylation of the stress-protective transcription factor DREB2A promotes thermotolerance of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant molecular biology; transcription factor; protein degradation; post-translational modification; protein phosphorylation; abiotic stress response; drought tolerance; thermotolerance	CASEIN KINASE-I; ABIOTIC STRESS; PROTEINS FUNCTION; BINDING DOMAIN; ABSCISIC-ACID; MAP KINASE; E3 LIGASE; GENE; DROUGHT; EXPRESSION	Plants have evolved complex systems to rapidly respond to severe stress conditions, such as heat, cold, and dehydration. Dehydration-responsive element-binding protein 2A (DREB2A) is a key transcriptional activator that induces many heat- and drought-responsive genes, increases tolerance to both heat and drought stress, and suppresses plant growth in Arabidopsis thaliana. DREB2A expression is induced by stress, but stabilization of the DREB2A protein in response to stress is essential for activating the expression of downstream stress-inducible genes. Under nonstress growth conditions, an integral negative regulatory domain (NRD) destabilizes DREB2A, but the mechanism by which DREB2A is stabilized in response to stress remains unclear. Here, based on bioinformatics, mutational, MS, and biochemical analyses, we report that Ser/Thr residues in the NRD are phosphorylated under nonstress growth conditions and that their phosphorylation decreases in response to heat. Furthermore, we found that this phosphorylation is likely mediated by casein kinase 1 and is essential for the NRD-dependent, proteasomal degradation of DREB2A under nonstress conditions. These observations suggest that inhibition of NRD phosphorylation stabilizes and activates DREB2A in response to heat stress to enhance plant thermotolerance. Our study reveals the molecular basis for the coordination of stress tolerance and plant growth through stress-dependent transcriptional regulation, which may allow the plants to rapidly respond to fluctuating environmental conditions.	[Mizoi, Junya; Kanazawa, Natsumi; Kidokoro, Satoshi; Morimoto, Kyoko; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Takahashi, Fuminori; Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Gene Discovery Res Grp, Yokohama, Kanagawa 2300045, Japan; [Qin, Feng] Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, Tsukuba, Ibaraki 3058686, Japan; [Qin, Feng] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China; [Morimoto, Kyoko] Univ Oxford, Dept Plant Sci, Plant Chemet Lab, South Parks Rd, Oxford OX1 3RB, England	University of Tokyo; RIKEN; Japan International Research Center for Agricultural Sciences; Chinese Academy of Sciences; Institute of Botany, CAS; University of Oxford	Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Shinozaki, Kazuo/AAB-4945-2019; Takahashi, Fuminori/D-6200-2017; Shinozaki, Kazuo/G-4202-2013; Mizoi, Junya/Y-6261-2019; Yamaguchi-Shinozaki, Kazuko/K-9004-2015	Shinozaki, Kazuo/0000-0002-6317-9867; Takahashi, Fuminori/0000-0001-8817-8652; Shinozaki, Kazuo/0000-0002-6317-9867; Mizoi, Junya/0000-0002-3383-8059; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Qin, Feng/0000-0001-9134-4711	JSPS KAKENHI [JP21780314, JP15K18652, JP15H05960]; Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan	This work was financially supported through JSPS KAKENHI Grant Numbers JP21780314, JP15K18652 (to J.M.) and JP15H05960 (to K.Y.-S) and the Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan (to K.S. and K.Y.-S.). The authors declare that they have no conflicts of interest with the contents of this article.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Ben-Nissan G, 2008, PLANT PHYSIOL, V148, P1897, DOI 10.1104/pp.108.129346; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen LY, 2015, MOL PLANT, V8, P242, DOI 10.1016/j.molp.2014.10.004; Chen LY, 2013, PLANT CELL, V25, P2253, DOI 10.1105/tpc.112.107292; Claeys H, 2013, PLANT PHYSIOL, V162, P1768, DOI 10.1104/pp.113.220921; Dai C, 2010, EMBO J, V29, P1916, DOI 10.1038/emboj.2010.75; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P3257, DOI 10.1093/nar/15.8.3257; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Hori K, 2013, PLANT J, V76, P36, DOI 10.1111/tpj.12268; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Kim JS, 2012, PLANT CELL, V24, P3393, DOI 10.1105/tpc.112.100933; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; KLIMCZAK LJ, 1995, PLANT PHYSIOL, V109, P687, DOI 10.1104/pp.109.2.687; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Kuromori T, 2015, MOL BIOL, V4, P1, DOI [10.1007/2F978-1-4939-0263-7_7-1, DOI 10.1007/2F978-1-4939-0263-7_7-1]; Kwon CT, 2014, PLANT CELL ENVIRON, V37, P101, DOI 10.1111/pce.12134; Lechner E, 2011, DEV CELL, V21, P1116, DOI 10.1016/j.devcel.2011.10.018; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; Li Z, 2012, NEW PHYTOL, V195, P85, DOI 10.1111/j.1469-8137.2012.04131.x; Link V, 2002, FEBS LETT, V531, P179, DOI 10.1016/S0014-5793(02)03498-1; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Mogami J, 2015, PLANT PHYSIOL, V167, P1039, DOI 10.1104/pp.114.249870; Morimoto K, 2017, P NATL ACAD SCI USA, V114, pE8528, DOI 10.1073/pnas.1704189114; Morimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080457; Ohama N, 2017, TRENDS PLANT SCI, V22, P53, DOI 10.1016/j.tplants.2016.08.015; Ohama N, 2016, PLANT CELL, V28, P181, DOI 10.1105/tpc.15.00435; Park HJ, 2008, J BIOL CHEM, V283, P23264, DOI 10.1074/jbc.M801720200; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sangwan V, 2002, PLANT J, V31, P629, DOI 10.1046/j.1365-313X.2002.01384.x; SCHARF KD, 1982, CELL, V30, P427, DOI 10.1016/0092-8674(82)90240-9; Tan ST, 2014, CELL REP, V9, P1692, DOI 10.1016/j.celrep.2014.10.047; Tan ST, 2013, PLANT CELL, V25, P2618, DOI 10.1105/tpc.113.114322; Tanaka H, 2012, PLANT J, V70, P599, DOI 10.1111/j.1365-313X.2012.04901.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Turck F, 1998, MOL CELL BIOL, V18, P2038, DOI 10.1128/MCB.18.4.2038; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Wang Z, 2015, P NATL ACAD SCI USA, V112, P8487, DOI 10.1073/pnas.1423325112; Weber H, 2009, FEBS J, V276, P6624, DOI 10.1111/j.1742-4658.2009.07373.x; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yoshida T, 2011, MOL GENET GENOMICS, V286, P321, DOI 10.1007/s00438-011-0647-7; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zhao SS, 2016, PLANT CELL, V28, P1422, DOI 10.1105/tpc.16.00078; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	61	36	41	4	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					902	917		10.1074/jbc.RA118.002662	http://dx.doi.org/10.1074/jbc.RA118.002662			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30487287	hybrid, Green Published			2022-12-26	WOS:000458670200016
J	Zhong, YD; Huang, W; Du, J; Wang, ZK; He, JB; Luo, LF				Zhong, Yadong; Huang, Wei; Du, Jiang; Wang, Zekun; He, Jianbo; Luo, Lingfei			Improved Tol2-mediated enhancer trap identifies weakly expressed genes during liver and beta cell development and regeneration in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zebrafish; liver; pancreas; development; regeneration; Cre/loxP; endoderm; enhancer trap; gene expression profiling; transposon; pancreatic beta cell	IN-VIVO; PANCREAS; CONVERSION; ORGANOGENESIS; ABLATION; DISEASE; GENOME; MODEL; RAB3D; TOOL	The liver and pancreas are two major digestive organs, and among the different cell types in them, hepatocytes and the insulin-producing beta cells have roles in both health and diseases. Accordingly, clinicians and researchers are very interested in the mechanisms underlying the development and regeneration of liver and pancreatic beta cells. Gene and enhancer traps such as the Tol2 transposon-based system are useful for identifying genes potentially involved in developmental processes in the zebrafish model. Here, we developed a strategy that combines a Tol2-mediated enhancer trap and the Cre/loxP system by using loxP-flanked reporters driven by beta cell- or hepatocyte-specific promoters and the upstream activating sequence (UAS)-driving Cre. Two double-transgenic reporter lines, Tg(ins:loxP-CFPNTR-loxP-DsRed; 10xUAS:Cre, cryaa:Venus) and Tg(fabp10:loxP-CFPNTR-loxP-DsRed; 10xUAS:Cre, cryaa:Venus), were established to label pancreatic beta cells and hepatocytes, respectively. These two double-transgenic lines were each crossed with the Tol2-enhancer trap founder lines to screen for and identify genes expressed in the beta cell and hepatocytes during development. This trap system coupled with application of nitroreductase (NTR)/metronidazole (Mtz)-mediated cell ablation could identify genes expressed during regeneration. Of note, pilot enhancer traps captured transiently and weakly expressed genes such as rab3da and ensab with higher efficiencies than traditional enhancer trap systems. In conclusion, through permanent genetic labeling by Cre/loxP, this improved Tol2-mediated enhancer trap system provides a promising method to identify transiently or weakly expressed, but potentially important, genes during development and regeneration.	[Zhong, Yadong; Huang, Wei; Du, Jiang; Wang, Zekun; He, Jianbo; Luo, Lingfei] Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China; [Zhong, Yadong; Huang, Wei; Du, Jiang; Wang, Zekun; He, Jianbo; Luo, Lingfei] Southwest Univ, Lab Mol Dev Biol, Sch Life Sci, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Luo, LF (corresponding author), Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China.; Luo, LF (corresponding author), Southwest Univ, Lab Mol Dev Biol, Sch Life Sci, Chongqing 400715, Peoples R China.	lluo@swu.edu.cn		Huang, Wei/0000-0003-4882-1409; Du, Jiang/0000-0001-8041-1405	National Key Basic Research Program of China [2015CB942800]; National Natural Science Foundation of China [31730060, 31801214, 91539201]; National Key Research and Development Program of China [2017YFA0106600]; 111 Program [B14037]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; 111 Program(Ministry of Education, China - 111 Project)	This work was supported by National Key Basic Research Program of China Grant 2015CB942800; National Natural Science Foundation of China Grants 31730060, 31801214, and 91539201; National Key Research and Development Program of China Grant 2017YFA0106600; and 111 Program Grant B14037. The authors declare that they have no conflicts of interest with the contents of this article.	Andreeva V, 2011, GENESIS, V49, P360, DOI 10.1002/dvg.20712; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Gale EAM, 2001, DIABETES, V50, P217, DOI 10.2337/diabetes.50.2.217; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Goessling W, 2015, GASTROENTEROLOGY, V149, P1361, DOI 10.1053/j.gastro.2015.08.034; Grise F, 2012, HEPATOLOGY, V55, P1766, DOI 10.1002/hep.25568; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kim HJ, 2006, MOL ENDOCRINOL, V20, P194, DOI 10.1210/me.2005-0189; Kimmel RA, 2016, METHOD CELL BIOL, V134, P431, DOI 10.1016/bs.mcb.2016.02.009; Kogel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057321; Li JJ, 2011, DEV CELL, V20, P409, DOI 10.1016/j.devcel.2011.04.001; Liu C, 2016, IMMUNITY, V44, P1162, DOI 10.1016/j.immuni.2016.03.008; Lu HQ, 2013, DEV CELL, V24, P543, DOI 10.1016/j.devcel.2013.01.021; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Okada T, 2015, NAT CELL BIOL, V17, P81, DOI 10.1038/ncb3082; Picardi A, 2006, DIABETES-METAB RES, V22, P274, DOI 10.1002/dmrr.636; Poon KL, 2010, DEV DYNAM, V239, P914, DOI 10.1002/dvdy.22203; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Shi WC, 2015, SCI CHINA LIFE SCI, V58, P343, DOI 10.1007/s11427-015-4838-z; Shih HP, 2013, ANNU REV CELL DEV BI, V29, P81, DOI 10.1146/annurev-cellbio-101512-122405; Tang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091551; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Tehrani Z, 2011, CELL CYCLE, V10, P3466, DOI 10.4161/cc.10.20.17764; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	45	5	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					932	940		10.1074/jbc.RA118.005568	http://dx.doi.org/10.1074/jbc.RA118.005568			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30504219	Green Published, hybrid			2022-12-26	WOS:000458670200018
J	Rudenko, L; Kiseleva, I; Krutikova, E; Stepanova, E; Rekstin, A; Donina, S; Pisareva, M; Grigorieva, E; Kryshen, K; Muzhikyan, A; Makarova, M; Sparrow, EG; Torelli, G; Kieny, MP				Rudenko, Larisa; Kiseleva, Irina; Krutikova, Elena; Stepanova, Ekaterina; Rekstin, Andrey; Donina, Svetlana; Pisareva, Maria; Grigorieva, Elena; Kryshen, Kirill; Muzhikyan, Arman; Makarova, Marina; Sparrow, Erin Grace; Torelli, Guido; Kieny, Marie-Paule			Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model	PLOS ONE			English	Article							ANN-ARBOR STRAIN; B VIRUS; ANIMAL-MODELS; RESPONSES; CHILDREN; LINEAGE; IMPACT; PATHOGENESIS; CIRCULATION; CHALLENGES	Background and aim The majority of seasonal influenza vaccines are trivalent, containing two A virus strains (H1N1 and H3N2) and one B virus strain. The co-circulation of two distinct lineages of B viruses can lead to mismatch between the influenza B virus strain recommended for the trivalent seasonal vaccine and the circulating B virus. This has led some manufacturers to produce quadrivalent influenza vaccines containing one strain from each B lineage in addition to H1N1 and H3N2 strains. However, it is also important to know whether vaccines containing a single influenza B strain can provide cross-protectivity against viruses of the antigenically distinct lineage. The aim of this study was to assess in naive ferrets the potential crossprotective activity of trivalent live attenuated influenza vaccine (T-LAIV) against challenge with a heterologous wild-type influenza B virus belonging to the genetically different lineage and to compare this activity with effectiveness of quadrivalent LAIV (Q-LAIV) in the ferret model. Methods and results Ferrets were vaccinated with either one dose of trivalent LAIV containing B/Victoria or B/Yamagata lineage virus, or quadrivalent LAIV (containing both B lineages), or placebo. They were then challenged with B/Victoria or B/Vamagata lineage wild-type virus 28 days after vaccination. The ferrets were monitored for clinical signs and morbidity. Nasal swabs and lung tissue samples were analyzed for the presence of challenge virus. Antibody response to vaccination was assessed by routine hemagglutination inhibition assay. All LAIVs tested were found to be safe and effective against wild-type influenza B viruses based on clinical signs, and virological and histological data. The absence of interference between vaccine strains in trivalent and quadrivalent vaccine formulations was confirmed. Trivalent LAIVs were shown to have the potential to be cross-protective against infection with genetically different influenza B/Victoria and B/Vamagata lineages. Conclusions In this ferret model, quadrivalent vaccine provided higher protection to challenge against both B/Victoria and B/Vamagata lineage viruses. However, T-LAIV provided some cross-protection in the case of a mismatch between circulating and vaccine type B strains. Notably, B/Victoria-based T-LAIV was more protective compared to B/Vamagata-based T-LAIV.	[Rudenko, Larisa; Kiseleva, Irina; Krutikova, Elena; Stepanova, Ekaterina; Rekstin, Andrey; Donina, Svetlana; Pisareva, Maria; Grigorieva, Elena] Inst Expt Med, Dept Virol, St Petersburg, Russia; [Kryshen, Kirill; Muzhikyan, Arman; Makarova, Marina] Inst Preclin Res Ltd, Dept Toxicol & Microbiol, St Petersburg, Russia; [Sparrow, Erin Grace; Torelli, Guido] WHO, Universal Hlth Coverage & Hlth Syst, Geneva, Switzerland; [Kieny, Marie-Paule] INSERM, Int Inst Cooperat, Paris, France	Institute of Experimental Medicine; World Health Organization; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kiseleva, I (corresponding author), Inst Expt Med, Dept Virol, St Petersburg, Russia.	irina.v.kiseleva@gmail.com	Pisareva, Maria/AAV-1692-2021; Grigorieva, Elena/AFR-6704-2022; Kieny, Marie-Paule/N-3914-2017; Stepanova, Ekaterina A./E-2286-2014; Krutikova, Elena/AAN-9827-2020; Muzhikyan, Arman/Z-1438-2018; Kiseleva, Irina/E-6555-2014; Rudenko, Larisa/AAN-9226-2020; Kieny, Marie-Paule/Q-1238-2019; Krutikova, Elena/P-2847-2017	Pisareva, Maria/0000-0002-1499-9957; Grigorieva, Elena/0000-0002-8439-6502; Kieny, Marie-Paule/0000-0002-5943-6488; Stepanova, Ekaterina A./0000-0002-8670-8645; Krutikova, Elena/0000-0002-0383-2625; Muzhikyan, Arman/0000-0002-7093-0014; Kiseleva, Irina/0000-0002-3892-9873; Rudenko, Larisa/0000-0002-0107-9959; Sparrow, Erin/0000-0003-3912-2550; Donina, Svetlana/0000-0002-6502-8341; Torelli, Guido/0000-0003-3342-5331; Kryshen, Kirill/0000-0003-1451-7716	WHO under the WHO Global Influenza Preparedness Plan [TTI-LOA17-IEM-1]	WHO under the WHO Global Influenza Preparedness Plan	This work was supported by a grant No TTI-LOA17-IEM-1 from WHO (http://www.who.int/) under the WHO Global Influenza Preparedness Plan. KK, AM and MM are employed by the commercial Institute of Preclinical Research Ltd, St Petersburg, Russia. They played a role in the study design, investigation, methodology, data collection and analysis. However, this company is not the funding organization; it did not provide financial support in the form of authors' salaries and/or research materials.	AAP Committee on Infectious Diseases, 2017, PEDIATRICS, V140, DOI DOI 10.1542/PEDS.2017-25501016/J.VACCINE.2017.01.062; Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Asahi-Ozaki Y, 2004, J MED VIROL, V74, P328, DOI 10.1002/jmv.20173; Bandell A, 2011, EXPERT REV VACCINES, V10, P1131, DOI [10.1586/erv.11.73, 10.1586/ERV.11.73]; Bandell AR, 2015, EXPERT REV VACCINES, V14, P963, DOI 10.1586/14760584.2015.1034695; Barr IG, 2006, COMMUN DIS INTELL, V30, P350; Barr IG, 2012, DRUGS, V72, P2177, DOI 10.2165/11641110-000000000-00000; Baxter R, 2017, VACCINE, V35, P1254, DOI 10.1016/j.vaccine.2017.01.062; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Belshe RB, 2010, VACCINE, V28, pD45, DOI 10.1016/j.vaccine.2010.08.028; Belshe RB, 2010, VACCINE, V28, P2149, DOI 10.1016/j.vaccine.2009.11.068; Block SL, 2011, VACCINE, V29, P9391, DOI 10.1016/j.vaccine.2011.09.109; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Caini S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3181-y; Camilloni B, 2009, VACCINE, V27, P4099, DOI 10.1016/j.vaccine.2009.04.078; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Cheng X, 2013, J INFECT DIS, V208, P594, DOI 10.1093/infdis/jit207; Chit A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133606; Cox NJ, 2014, REPORT 2 WHO INTEGRA; Dos Santos G, 2016, HUM VACC IMMUNOTHER, V12, P699, DOI 10.1080/21645515.2015.1086047; EVANS AS, 1975, YALE J BIOL MED, V48, P201; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Haber P, 2015, VACCINE, V33, P1987, DOI 10.1016/j.vaccine.2015.01.080; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Jang YH, 2013, YONSEI MED J, V54, P271, DOI 10.3349/ymj.2013.54.2.271; Jennings L, 2018, INFLUENZA OTHER RESP, V12, P383, DOI 10.1111/irv.12522; Kiseleva I, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9695628; Laurie KL, 2018, J INFECT DIS, V217, P548, DOI 10.1093/infdis/jix509; Lee VJ, 2018, INFLUENZA OTHER RESP, V12, P3, DOI 10.1111/irv.12533; LEVANDOWSKI RA, 1991, PEDIATRICS, V88, P1031; LEVANDOWSKI RA, 1991, J CLIN MICROBIOL, V29, P1530, DOI 10.1128/JCM.29.7.1530-1532.1991; Li WC, 2008, J CLIN VIROL, V42, P45, DOI 10.1016/j.jcv.2007.11.026; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; McNaughton R, 2016, DRUG SAFETY, V39, P323, DOI 10.1007/s40264-015-0384-7; Quinn E, 2014, EXPERT REV PHARM OUT, V14, P425, DOI 10.1586/14737167.2014.908713; Ray R, 2017, HUM VACC IMMUNOTHER, V13, P1640, DOI 10.1080/21645515.2017.1313375; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Rudenko L, 2016, VACCINE, V34, P5436, DOI 10.1016/j.vaccine.2016.08.018; Shaw MW, 2002, VIROLOGY, V303, P1, DOI 10.1006/viro.2002.1719; Sheldon EA, 2013, INFLUENZA OTHER RESP, V7, P1142, DOI 10.1111/irv.12027; Skowronski DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038929; Skowronski DM, 2011, PEDIATR INFECT DIS J, V30, P833, DOI 10.1097/INF.0b013e31822db4dc; Thangavel RR, 2014, J IMMUNOL METHODS, V410, P60, DOI 10.1016/j.jim.2014.03.023; Toback SL, 2012, EXPERT REV VACCINES, V11, P1293, DOI [10.1586/erv.12.108, 10.1586/ERV.12.108]; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; van de Sandt CE, 2015, J GEN VIROL, V96, P2061, DOI 10.1099/vir.0.000156; Widjojoatmodjo MN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-114; World Health Organization, 2002, WHO MAN AN INFL DIAG; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Zang Y, 2014, HUM VACC IMMUNOTHER, V10, P3642, DOI 10.4161/hv.34453	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208028	10.1371/journal.pone.0208028	http://dx.doi.org/10.1371/journal.pone.0208028			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507951	Green Published, Green Submitted, gold			2022-12-26	WOS:000451886500016
J	Autenrieth, CS; Beck, EJ; Stelzle, D; Mallouris, C; Mahy, M; Ghys, P				Autenrieth, Christine S.; Beck, Eduard J.; Stelzle, Dominik; Mallouris, Christoforos; Mahy, Mary; Ghys, Peter			Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020	PLOS ONE			English	Article							AGING POPULATION; OLDER-ADULTS; INFECTION; PREVALENCE; AIDS; INDIVIDUALS; PREVENTION; COUNTRIES; SUPPORT; RISK	Background The increasing numbers of people living with HIV (PLHIV) who are receiving antiretroviral therapy (ART) have near normal life-expectancy, resulting in more people living with HIV over the age of 50 years (PLHIV50+). Estimates of the number of PLHIV50+ are needed for the development of tailored therapeutic and prevention interventions at country, regional and global level. Methods The AIDS Impact Module of the Spectrum software was used to compute the numbers of PLHIV, new infections, and AIDS-related deaths for PLHIV50+ for the years 2000-2016. Projections until 2020 were calculated based on an assumed ART scale-up to 81% coverage by 2020, consistent with the UNAIDS 90-90-90 treatment targets. Results Globally, there were 5.7 million [4.7 million-6.6 million] PLHIV50+ in 2016. The proportion of PLHIV50+ increased substantially from 8% in 2000 to 16% in 2016 and is expected to increase to 21% by 2020. In 2016, 80% of PLHIV50+ lived in low-and middle-income countries (LMICs), with Eastern and Southern Africa containing the largest number of PLHIV50+. While the proportion of PLHIV50+ was greater in high income countries, LMICs have higher numbers of PLHIV50+ that are expected to continue to increase by 2020. Conclusions The number of PLHIV50+ has increased dramatically since 2000 and this is expected to continue by 2020, especially in LMICs. HIV prevention campaigns, testing and treatment programs should also focus on the specific needs of PLHIV50+. Integrated health and social services should be developed to cater for the changing physical, psychological and social needs of PLHIV50+, many of whom will need to use HIV and non-HIV services.	[Autenrieth, Christine S.; Beck, Eduard J.; Stelzle, Dominik; Mallouris, Christoforos; Mahy, Mary; Ghys, Peter] UNAIDS, Programme Branch, Geneva, Switzerland; [Beck, Eduard J.] UNAIDS, Latin Amer & Caribbean Reg Support Team, Georgetown, Guyana	UNAIDS	Beck, EJ (corresponding author), UNAIDS, Programme Branch, Geneva, Switzerland.; Beck, EJ (corresponding author), UNAIDS, Latin Amer & Caribbean Reg Support Team, Georgetown, Guyana.	eduard.beck@lshtm.ac.uk		Beck, Eduard/0000-0001-9675-8921				Alcaide ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063804; [Anonymous], 2016, INT EPIDEMIOLOGY DAT; [Anonymous], 2017, DEM HLTH SURV; Avenir Health, 2016, SPECTRUM; Beck EJ, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.32089; Beck EJ, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1440782; Beck EJ, 2017, AIDS CARE, V29, P1557, DOI 10.1080/09540121.2017.1316355; Bendavid Eran, 2012, AIDS, V26 Suppl 1, pS85; Bowen RL, 2004, GERONTOLOGY, V50, P265, DOI 10.1159/000079125; Brugnaro Pierluigi, 2015, World J Virol, V4, P209, DOI 10.5501/wjv.v4.i3.209; Chesney MA, 2003, JAIDS-J ACQ IMM DEF, V33, pS185, DOI 10.1097/00126334-200306012-00016; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dolan SE, 2004, AIDS, V18, P475, DOI 10.1097/00002030-200402200-00014; Dryden-Peterson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135602; Emlet CA, 2006, HEALTH SOC WORK, V31, P299, DOI 10.1093/hsw/31.4.299; Enel P, 2015, 6 HIV AG WORKSH WASH; Furlotte C, 2017, CAN J AGING, P1; Gross AM, 2016, MOL CELL, V62, P157, DOI 10.1016/j.molcel.2016.03.019; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hontelez JAC, 2011, AIDS, V25, P1665, DOI 10.1097/QAD.0b013e32834982ea; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Kearney F, 2010, AGE AGEING, V39, P536, DOI 10.1093/ageing/afq083; Kiefer EM, 2018, HIV MED, V19, P734, DOI 10.1111/hiv.12665; Kirk JB, 2009, J AM GERIATR SOC, V57, P2129, DOI 10.1111/j.1532-5415.2009.02494.x; Lazarus JV, 2010, HIV MED, V11, P479, DOI 10.1111/j.1468-1293.2009.00810.x; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; Mandalia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015677; Mathers BM, 2014, AIDS, V28, pS435, DOI 10.1097/QAD.0000000000000435; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Mussini C, 2008, AIDS, V22, P2461, DOI 10.1097/QAD.0b013e328314b5f1; Nasi M, 2017, CLIN EXP IMMUNOL, V187, P44, DOI 10.1111/cei.12814; Negin Joel, 2012, AIDS, V26 Suppl 1, pS1; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Ngum PA, 2017, NEUROL THER; Onen Nur F, 2011, Curr Aging Sci, V4, P33; Rasmussen LD, 2015, LANCET HIV, V2, pE288, DOI 10.1016/S2352-3018(15)00077-6; Rauf WN, 2010, S AFR FAM PRACT, V52, P573, DOI 10.1080/20786204.2010.10874049; Sabin CA, 2008, AIDS, V22, P1463; Santoro N, 2009, MATURITAS, V64, P160, DOI 10.1016/j.maturitas.2009.09.001; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Shippy RA, 2005, RES AGING, V27, P290, DOI 10.1177/0164027504273780; Shivakoti R, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1150-3; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Terrence Higgins Trust, 2017, UNCH TERR; Triant VA, 2014, REV CARDIOVASC MED, V15, pS1, DOI 10.3908.ricm15S1S002; UN Population Division, 2015, 2015 REV WORLD POP P; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2018, MIL GO GLOB AIDS UPD; UNAIDS, 2013, HIV AG SPEC SUPPL UN; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2015, SOC PROT ADV RESP HI; Vazquez E, 2017, AGING THRIVING HIV; World Health Organisation, 2016, ACT PLAN SUCC AG; Zhou YQ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-802	62	107	111	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207005	10.1371/journal.pone.0207005	http://dx.doi.org/10.1371/journal.pone.0207005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496302	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800021
J	Wang, Z; Taylor, SE; Sharma, P; Flury, M				Wang, Zhan; Taylor, Stephen E.; Sharma, Prabhakar; Flury, Markus			Poor extraction efficiencies of polystyrene nano- and microplastics from biosolids and soil	PLOS ONE			English	Article							MARINE-ENVIRONMENT; SEDIMENTS; IDENTIFICATION; PARTICLES	Extraction and quantification of nano- and microplastics from sediments and soils is challenging. Although no standard method has been established so far, flotation is commonly used to separate plastic from mineral material. The objective of this study was to test the efficiency of flotation for the extraction of nano- and microplastics from biosolids and soil. We spiked biosolids and soil samples with polystyrene nano- and microbeads (0.05, 1.0, 2.6, 4.8, and 100 mu m diameter). Different extraction methods (w/ and w/o H2O2 digestion) were tested, and plastic beads were separated from mineral particles by flotation in a ZnCl2 solution. Plastic particles were quantified by UV-Vis spectrometry and gravimetrically. While large beads (100 mu m) could be quantitatively extracted (similar to 100%) from both biosolids and soils, smaller beads had low extraction efficiencies (ranging from 5 to 80%, with an average of 20%). Except for the 100 mu m beads, oxidation with H2O2 negatively impacted the extraction efficiencies. For the soil, extraction with water only, followed by flotation in a ZnCl2 solution, resulted in relatively high extraction efficiencies (> 75%) for beads larger than 1 mu m, but low efficiencies (< 30%) for the 0.05 and 1.0 mu m beads. Our results indicate that while flotation generally works to separate plastic nano- and microbeads in a solution, the challenge is to quantitatively extract nano- and microbeads from a biosolids or soil matrix. Samples high in organic matter content require removal of the organic matter, but the common method of H2O2 oxidation leads to poor extraction efficiencies for nano- and microbeads.	[Wang, Zhan; Taylor, Stephen E.; Flury, Markus] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Wang, Zhan; Taylor, Stephen E.; Flury, Markus] Washington State Univ, Dept Crop & Soil Sci, Puyallup, WA 98371 USA; [Wang, Zhan] Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China; [Wang, Zhan] Minist Agr, Key Lab Arable Land Conservat Northeast China, Shenyang, Liaoning, Peoples R China; [Wang, Zhan] Natl Engn Lab Efficient Utilizat Soil & Fertilize, Shenyang, Liaoning, Peoples R China; [Sharma, Prabhakar] Nalanda Univ, Sch Ecol & Environm Studies, Nalanda, Bihar, India	Washington State University; Washington State University; Shenyang Agricultural University; Ministry of Agriculture & Rural Affairs	Flury, M (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.; Flury, M (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Puyallup, WA 98371 USA.	flury@wsu.edu	Flury, Markus/H-2983-2012; Sharma, Prabhakar/C-2133-2009	Flury, Markus/0000-0002-3344-3962; Sharma, Prabhakar/0000-0003-0894-0809; Taylor, Stephen/0000-0001-9019-5910	United States Department of Agriculture, Specialty Crops Research Initiative, Coordinated Agricultural Project [2014-51181-22382]; National Institute of Food and Agriculture Hatch Project [1014527]; National Natural Science Foundation of China [41601218]; China Scholarship Council	United States Department of Agriculture, Specialty Crops Research Initiative, Coordinated Agricultural Project; National Institute of Food and Agriculture Hatch Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	MF was supported by United States Department of Agriculture, Specialty Crops Research Initiative, Coordinated Agricultural Project (Award 2014-51181-22382) and National Institute of Food and Agriculture Hatch Project 1014527. ZW was supported by National Natural Science Foundation of China (No. 41601218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The China Scholarship Council provided support for Zhan Wang to visit Washington State University. We thank the WSU Franceschi Microscopy and Imaging Center for access to their facility and Valerie Lynch-Holm for help with the use of the electron microscope. Support was further provided by the National Institute of Food and Agriculture Hatch Project 1014527, and the National Natural Science Foundation of China (No. 41601218).	Bayo J., 2016, International Journal of Sustainable Development and Planning, V11, P812, DOI 10.2495/SDP-V11-N5-812-821; Blasing M, 2018, SCI TOTAL ENVIRON, V612, P422, DOI 10.1016/j.scitotenv.2017.08.086; Claessens M, 2013, MAR POLLUT BULL, V70, P227, DOI 10.1016/j.marpolbul.2013.03.009; Cole M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04528; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Crichton EM, 2017, ANAL METHODS-UK, V9, P1419, DOI [10.1039/C6AY02733D, 10.1039/c6ay02733d]; da Costa JP, 2016, SCI TOTAL ENVIRON, V566, P15, DOI 10.1016/j.scitotenv.2016.05.041; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; Enders K, 2017, ICES J MAR SCI, V74, P326, DOI 10.1093/icesjms/fsw173; Fuller S, 2016, ENVIRON SCI TECHNOL, V50, P5774, DOI 10.1021/acs.est.6b00816; Harrison JP, 2012, SCI TOTAL ENVIRON, V416, P455, DOI 10.1016/j.scitotenv.2011.11.078; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Horton AA, 2017, MAR POLLUT BULL, V114, P218, DOI 10.1016/j.marpolbul.2016.09.004; Hurley RR, 2018, ENVIRON SCI TECHNOL, V52, P7409, DOI 10.1021/acs.est.8b01517; Imhof HK, 2012, LIMNOL OCEANOGR-METH, V10, P524, DOI 10.4319/lom.2012.10.524; Leslie H.A., 2013, R1311 IVM I ENV STUD; Liebezeit G, 2012, B ENVIRON CONTAM TOX, V89, P213, DOI 10.1007/s00128-012-0642-7; Loder MGJ, 2015, MARINE ANTHROPOGENIC LITTER, P201, DOI 10.1007/978-3-319-16510-3_8; Loder MGJ, 2017, ENVIRON SCI TECHNOL, V51, P14283, DOI 10.1021/acs.est.7b03055; Machado AAD, 2018, GLOBAL CHANGE BIOL, V24, P1405, DOI 10.1111/gcb.14020; Magnusson K., 2014, SCREENING MICROPLAST; Mahon AM, 2017, ENVIRON SCI TECHNOL, V51, P810, DOI 10.1021/acs.est.6b04048; Ng KL, 2006, MAR POLLUT BULL, V52, P761, DOI 10.1016/j.marpolbul.2005.11.017; Nuelle MT, 2014, ENVIRON POLLUT, V184, P161, DOI 10.1016/j.envpol.2013.07.027; Qiu QX, 2015, MAR POLLUT BULL, V98, P274, DOI 10.1016/j.marpolbul.2015.07.028; Reisser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080466; Rocha-Santos T, 2015, TRAC-TREND ANAL CHEM, V65, P47, DOI 10.1016/j.trac.2014.10.011; Scheurer M, 2018, ENVIRON SCI TECHNOL, V52, P3591, DOI 10.1021/acs.est.7b06003; Van Cauwenberghe L, 2015, MAR ENVIRON RES, V111, P5, DOI 10.1016/j.marenvres.2015.06.007; Zhang SL, 2018, SCI TOTAL ENVIRON, V616, P1056, DOI 10.1016/j.scitotenv.2017.10.213; Zubris KAV, 2005, ENVIRON POLLUT, V138, P201, DOI 10.1016/j.envpol.2005.04.013	32	61	63	8	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208009	10.1371/journal.pone.0208009	http://dx.doi.org/10.1371/journal.pone.0208009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496263	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800078
J	Agongo, G; Nonterah, EA; Debpuur, C; Amenga-Etego, L; Ali, S; Oduro, A; Crowther, NJ; Ramsay, M				Agongo, Godfred; Nonterah, Engelbert Adamwaba; Debpuur, Cornelius; Amenga-Etego, Lucas; Ali, Stuart; Oduro, Abraham; Crowther, Nigel J.; Ramsay, Michele		AWI Gen H3Africa Consortium	The burden of dyslipidaemia and factors associated with lipid levels among adults in rural northern Ghana: An AWI-Gen sub-study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; SUBCUTANEOUS ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PHYSICAL-ACTIVITY; BLOOD-LIPIDS; POPULATION; FAT; APOLIPOPROTEINS; QUESTIONNAIRE	Dyslipidaemia is a primary risk factor for cardiometabolic disease, causing over 17 million deaths globally in 2015. However, the burden of dyslipidaemia and factors associated with lipid levels remain unknown in many rural African populations. Therefore, this study evaluated the association of socio-demographic, anthropometric and behavioural factors with lipid levels in rural Ghana. The prevalence of hypercholesterolaemia, hypertriglyceridaemia and elevated LDL-C in the total population of 1839 (846 men and 993 women) was 4.02%, 2.12%, and 5.55% respectively and did not differ between genders. The prevalence of low HDL-C levels was 60.30% and differed (p = 0.005) between men (56.86%) and women (63.24%). Subcutaneous abdominal fat was associated with TC (beta = 0.067, p = 0.015) and TG (beta = 0.137, p<0.001) among women and LDL-C (beta = 0.139, p = 0.006) and TC (beta = 0.071, p = 0.048) among men. Body mass index was associated with TC (beta = 0.010, p = 0.043) among men while waist circumference was associated with LDL-C (beta = 0.116, p<0.001) and TG (beta = 0.094, p<0.001) among women. Hip circumference was negatively associated (beta = -0.053, p = 0.043) while visceral fat was positively associated with TG (beta = 0.033, p = 0.022) among women. Socioeconomic status, education, being unmarried and employment were associated with HDL-C (beta = 0.081, p = 0.004), LDL-C (beta = 0.095, p = 0.004) and TG (beta = 0.095, p = 0.001) all among women, and TC (beta = 0.070, p = 0.010) among men, respectively. Nankana women had lower TC (beta = -0.069, p = 0.001), and men lower TG levels (beta = -0.084, p = 0.008) than the other ethnic groups. Tobacco smoking (beta = 0.066, p = 0.024) and alcohol intake (beta = 0.084, p = 0.001) were associated with HDL-C levels among men and women respectively. Further studies are required to investigate whether high prevalence of low HDL-C levels in this population presents with any adverse cardiovascular disease outcomes. Associations of education, employment and adiposity with lipid levels suggest that future societal advances and increases in the prevalence of obesity may lead to associated adverse health consequences. Monitoring and interventions are required to limit these effects.	[Agongo, Godfred; Nonterah, Engelbert Adamwaba; Debpuur, Cornelius; Amenga-Etego, Lucas; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Agongo, Godfred; Ali, Stuart; Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa; [Agongo, Godfred; Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Div Human Genet, Johannesburg, South Africa; [Agongo, Godfred; Crowther, Nigel J.; Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Nonterah, Engelbert Adamwaba] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Crowther, Nigel J.] Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa	Navrongo Health Research Center; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; Utrecht University; Utrecht University Medical Center; National Health Laboratory Service; University of Witwatersrand	Agongo, G (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Ghana.; Agongo, G (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa.; Agongo, G (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Div Human Genet, Johannesburg, South Africa.; Agongo, G (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa.	Godfred.Agongo@navrongo-hrc.org	Ali, Stuart/P-5514-2019; Nonterah, Engelbert A/L-6855-2018	Ali, Stuart/0000-0002-4124-2896; Nonterah, Engelbert A/0000-0001-8491-6478; ODURO, ABRAHAM/0000-0002-4191-7419; Ramsay, Michele/0000-0002-4156-4801; Crowther, Nigel/0000-0002-5766-1745; Debpuur, Cornelius/0000-0003-0968-5280; Agongo, Godfred/0000-0002-4218-5424	National Institutes of Health (NIH) through the H3Africa AWI-Gen project [U54HG006938]; Wits Non-Communicable Disease Research Leadership Program (NIH Forgarty International Centre) [D43TW008330]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006938] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the H3Africa AWI-Gen project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wits Non-Communicable Disease Research Leadership Program (NIH Forgarty International Centre); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the National Institutes of Health (NIH), URL www.https://grants.nih.gov/funding/index.htm, through the H3Africa AWI-Gen project (NIH grant number U54HG006938) and the Wits Non-Communicable Disease Research Leadership Program (NIH Forgarty International Centre grant number D43TW008330) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding was received by MR.	Abreu GD, 2015, ARQ BRAS CARDIOL, V105, P418, DOI 10.5935/abc.20150121; Adamu UG, 2013, VASC HEALTH RISK MAN, V9, P763, DOI 10.2147/VHRM.S50690; ADEBONOJO SA, 1989, J NATL MED ASSOC, V81, P547; Adediran O, 2012, J Cardiovasc Dis Res, V3, P191, DOI 10.4103/0975-3583.98890; Ahaneku GI, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.37.1926; Alsheikh-Ali AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102830; Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Arrebola Juan P, 2014, ENVIRON POLLUT, P195; Asare-Anane H, 2013, INT J SCI TECHNOL RE, V2, P168; Asiki G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126166; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P229; Bartlett J, 2016, CIRC-CARDIOVASC QUAL, V9, P206, DOI 10.1161/CIRCOUTCOMES.115.002436; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Bentley AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004190; Bentley AR, 2017, GLOB HEART, P1, DOI [10.1016/j.gheart.2017.04.002, DOI 10.1016/J.GHEART.2017.04.002]; Binka FN, 1999, J BIOSOC SCI, V31, P375, DOI 10.1017/S0021932099003752; Boshtam M, 2012, J RES MED SCI, V17, P519; Bovet P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-9; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Brown H, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0049-9; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Cheng ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125302; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; D'Agostino RB, 2013, GLOB HEART, V8, P11, DOI 10.1016/j.gheart.2013.01.001; Dai SF, 2009, AM J PREV MED, V37, pS56, DOI 10.1016/j.amepre.2009.04.012; Donin AS, 2010, AM J CLIN NUTR, P1; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, J AM MED ASS, V285, P2486; Goh VHH, 2007, ASIAN J ANDROL, V9, P787, DOI 10.1111/j.1745-7262.2007.00294.x; Gradidge PJL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162247; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Gupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044098; Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1210/jc.2011-3362, 10.1097/gme.0b013e31824d8f40]; Harman JL, 2011, J CLIN LIPIDOL, V5, P173, DOI 10.1016/j.jacl.2011.02.002; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kechagias S, 2011, ANN MED, V43, P545, DOI 10.3109/07853890.2011.588246; Khine A A, 2016, SAMJ, S. Afr. med. j., V106, P724, DOI [10.7196/SAMJ.2016.v106i7.10337, 10.7196/samj.2016.v106i7.10337]; Kodaman N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162753; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Li KL, 2016, INT J CLIN EXP PATHO, V9, P10688; Lokpo SY, 2017, OPEN ACCESS LIB J, V4; Longo-Mbenza B, 2011, DIABETES METAB SYND, V5, P17, DOI 10.1016/j.dsx.2010.05.009; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Mc Auley MT, 2015, COMPUT STRUCT BIOTEC, V13, P38, DOI 10.1016/j.csbj.2014.11.006; Micah F B, 2012, Ghana Med J, V46, P14; Ni WQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0073-7; Ntzani EE, 2013, PESTIC EPIDEMIOL, P1; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Ogunmola OJ, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-89; Okaka EI, 2013, AFRICAN J MED HLTH S, V12, P1; Okecka-Szymanska J, 2011, BIOMED HUM KINET, V3, P1, DOI 10.2478/v10101-011-0001-x; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Pardhe BD, 2017, BIOCHEM RES INT, V2017, DOI 10.1155/2017/3824903; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Qi L, 2015, INT J ENV RES PUB HE, V12, P13455, DOI 10.3390/ijerph121013455; Ramsay M, 2016, GLOB HLTH EPIDEM NOV, P1; Rashan MA, 2016, INT J COLLAB RES INT, V8, P491; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Reiger S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187347; Reinikainen J, 2015, INT J EPIDEMIOL, V44, P108, DOI 10.1093/ije/dyu235; Rodriguez CJ, 2014, AM J MED, V127, P1186, DOI 10.1016/j.amjmed.2014.07.026; Ruige JB, 2009, OBESITY, V17, P1621, DOI 10.1038/oby.2009.25; Shohaimi S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-782; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Sumner AE, 2011, CVD PREV CONTROL, V5, P75, DOI [10.18865/ed.26.4.553, DOI 10.18865/ED.26.4.553]; Tang LZ, 2016, CLIN ENDOCRINOL, V85, P46, DOI 10.1111/cen.13013; THUSA study, 2007, Cardiovasc J Afr, V18, P282; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Vuvor F., 2016, J HLTH RES REV, V3, P66, DOI [10.4103/2394-2010.184232, DOI 10.4103/2394-2010.184232]; Wahed WYA, 2016, EPIDEMIOL BIOSTAT PU, V13, DOI 10.2427/11769; Wakabayashi I, 2014, DIABETIC MED, V31, P868, DOI 10.1111/dme.12430; Wan MWA, 2013, INT J ENDOCRINOL, V2013, DOI [10.1155/2013/341506, DOI 10.1155/2013/341506]; WHO, 1997, WHO TECHN REP SER, P114; WHO, 2008, WAIST CIRCUMFERENCE; Woudberg NJ, 2016, ETHNIC DIS, V26, P553, DOI 10.18865/ed.26.4.553; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	79	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206326	10.1371/journal.pone.0206326	http://dx.doi.org/10.1371/journal.pone.0206326			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485283	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800018
J	Liu, JJ; Wang, YJ; Xie, K; Liu, YC				Liu, Jianjun; Wang, Yingjie; Xie, Kai; Liu, Yichen			Gas injection and brine discharge in rock salt gas storage studied via numerical simulation	PLOS ONE			English	Article								Underground gas storage in rock salt is of great importance for peak-shaving and emergency gas supply. This paper addressed an actual rock salt underground gas storage facility in Jiangsu province, China, as the research project and carried out the following research centered on a detailed geological model, a salt cavern model and the process of gas injection and brine discharge. First, based on the theory of gas-liquid two-phase flow, the authors established a relationship between brine flow and natural gas bubbles under high pressure in the process of brine discharge. Second, the effect of pipe depth on the gas injection and brine discharge was simulated. The objective was mainly to choose the best combination of pipe depth and rate of brine discharge flow based on analysis of the relationship between the brine discharge pipe depth and the flow rate of the residual brine, and the optimal rate was given according to different distances. Third, the effect of residual brine on the gas injection and brine discharge was analyzed. The relationship curves between the maximum velocity on the surface of brine and the distance from the lower end of the brine discharge pipe to the bottom of the gas storage were obtained, and reasonable rates were suggested under different actual working conditions.	[Liu, Jianjun; Wang, Yingjie; Liu, Yichen] Southwest Petr Univ, Sch Geosci & Technol, Chengdu, Sichuan, Peoples R China; [Liu, Jianjun] Chinese Acad Sci, Inst Rock & Soil Mech, State Key Lab Geomech & Geotech Engn, Wuhan, Hubei, Peoples R China; [Xie, Kai] Southwest Petr Univ, Sch Civil Engn & Architecture, Chengdu, Sichuan, Peoples R China	Southwest Petroleum University; Chinese Academy of Sciences; Wuhan Institute of Rock & Soil Mechanics, CAS; Southwest Petroleum University	Liu, JJ (corresponding author), Southwest Petr Univ, Sch Geosci & Technol, Chengdu, Sichuan, Peoples R China.; Liu, JJ (corresponding author), Chinese Acad Sci, Inst Rock & Soil Mech, State Key Lab Geomech & Geotech Engn, Wuhan, Hubei, Peoples R China.	liujj0906@163.com	liu, yang/HHY-8583-2022; liu, yichen/GVT-6262-2022; Liu, Jianjun/K-8732-2015	Liu, Jianjun/0000-0003-4935-219X	National Natural Science Foundation of China [51174170]; China National Science and Technology Major Project [2017ZX05037001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Science and Technology Major Project	The authors gratefully acknowledge the financial support given by the National Natural Science Foundation of China (Grant No. 51174170. Web: http://www.nsfc.gov.cn/) and the China National Science and Technology Major Project (Grant No. 2017ZX05037001. Web: http://www.nmp.gov.cn/).; The authors gratefully acknowledge the financial support given by the National Natural Science Foundation of China (Grant No. 51174170) and the China National Science and Technology Major Project (Grant No. 2017ZX05037001).	Alkan H, 2009, INT J ROCK MECH MIN, V46, P716, DOI 10.1016/j.ijrmms.2008.08.002; Berest P, 1999, INT J ROCK MECH MIN, V36, P1031, DOI 10.1016/S0148-9062(99)00062-5; Cao L., 2009, J HARBIN I TECHNOL, V16, P633; Chen F, 2009, ROCK SOIL MECH, V30, P3602; Ding G., 2007, OIL GAS STORAGE TRAN, V26, P23; Ding G., 2010, SALT CAVERN UNDERGRO; Hagoort J., 1993, SPE26654; Jessen R W., 1964, SPE13308; Li W, 2007, WELL TESTING, V16, P65; Li W., 2004, COMPUTATIONAL FLUID; Liang W., 2003, THEORY APPL CONTROLL; Liu Changling, 2018, ADV GEO ENERGY RES, V2, P43; [刘健 Liu Jian], 2013, [西南石油大学学报．自然科学版, Journal of Southwest Petroleum University. Science & Technology Edition], V35, P115; Liu JT, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/209028; Liu Z., 2010, STUDY TECHNOLOGY VIS; Ma H., 2010, STUDY FEASIBILITY RO; Oren P., 1993, SPE ADV TECHNOLOGY S, V1, P133; Reda D C, 1986, SPE13308; Shen X., 2015, BASIC RES STABILITY; Sidiq H., 2017, ADV GEO ENERG RES, V1, P64, DOI [10.26804/ager.2017.01.06, DOI 10.26804/AGER.2017.01.06]; Staudtmeister K., 1997, INT J ROCK MECH MIN, V34, P300, DOI [DOI 10.1016/S1365-1609(97)00199-8, 10.1016/S1365-1609(97)00199-8]; Tan Y., 2010, TECHNOLOGY NUMERICAL; Wang H., 2005, FUNDAMENTALS FLUID M; Wang Y, 2014, ELECT J GEOTECHNICAL, V9, P19; [完颜祺琪 Wanyan Qiqi], 2015, [西南石油大学学报．自然科学版, Journal of Southwest Petroleum University. Science & Technology Edition], V37, P57; Yang H., 2010, PETROCHEM IND APPL, V29, P61; Yu L., 2015, PETROLEUM, V1, P82, DOI [10.1016/j.petlm.2015.03.006, DOI 10.1016/J.PETLM.2015.03.006]; Yuan Jin-ping, 2009, Natural Gas Industry, V29, P76, DOI 10.3787/j.issn.1000-0976.2009.02.020; ZHAO Ke-lie, 2009, RES USABILITY UNDERG; Zhao Z., 2003, THEORY FLUID TRANSPO; Zhou Z., 2008, COMPUTATIONAL FLUID; Zhuang Q., 2010, OIL GASFIELD SURFACE, V29, P65	32	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207058	10.1371/journal.pone.0207058	http://dx.doi.org/10.1371/journal.pone.0207058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485293	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800041
J	Niczyporuk, JS				Niczyporuk, Jowita Samanta			Deep analysis of Loop L1 HVRs1-4 region of the hexon gene of adenovirus field strains isolated in Poland	PLOS ONE			English	Article							MAJOR COAT PROTEIN; PHYLOGENETIC ANALYSIS; FOWL ADENOVIRUSES; SEQUENCE; REVEALS; ORGANIZATION	Background To date, studies on loop L1 HVRs1-4 region of the hexon gene in fowl adenovirus genome (FAdVs) lack comprehensive molecular data. In this study detailed prospectively obtained sequences from field adenovirus strains, NVRI, Poland have been analyzed. Methods Overall hundred and thirty seven adenovirus strains were collected, evaluated, and examined of hyper variable loop L1 region HVRs1-4 of the hexon gene for the presence of similarity, mutations, tertiary structure, and spinal conformation. Results Sequences were characterized, and divided for five species and seven types, FAdV-A-E/FAdV-1/2/4/5/7/8a/8b/11. The presence of predicted tertiary structure depending on type/species were determined. Analysis of specific selected sequences: GQMTN 1/A, 7/E, and 8b/E, GQMTT 2/11/D, GQLSN 4/C, GQMTH 5/B, and GQMSN 8a/E in examined HVRs1-4 Loop L1 region of hexon gene compared to tertiary structure indicated that this visibly conservative region represents the antigenic binging activity. Conclusion This is the first molecular study on tertiary structure on HVRs1-4 region in adenovirus genome conducted in Poland. Analysis indicated specific sequence in Loop L1 HVR1-4 region which is strictly responsible for antibodies binding. This information could assist during the process connected with specific preventive strategies based on their molecular genome investigation and new facilitate studies. This study will help to better understand the mechanisms of pathogenicity of adenovirus strains provide a guide for disease control in birds.	[Niczyporuk, Jowita Samanta] Natl Vet Res Inst, Dept Poultry Viral Dis, Pulawy, Poland	National Veterinary Institute - National Research Institute	Niczyporuk, JS (corresponding author), Natl Vet Res Inst, Dept Poultry Viral Dis, Pulawy, Poland.	jowita.niczyporuk@piwet.pulawy.pl	Niczyporuk, Jowita Samanta/V-2697-2019	Niczyporuk, Jowita Samanta/0000-0003-3714-0552	National Science Centre, Poland [NN308571240]	National Science Centre, Poland(National Science Centre, Poland)	This study was funded by National Science Centre, Poland (grant number NN308571240. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHAPPILLY FK, 1994, J MOL BIOL, V242, P430, DOI 10.1006/jmbi.1994.1593; Behura SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043111; Benko M., 2005, VIRUS TAXONOMY 8 REP, P213; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; Corredor JC, 2008, VIRUS GENES, V36, P331, DOI 10.1007/s11262-007-0194-9; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; Epstein RJ, 2000, GENE, V245, P291, DOI 10.1016/S0378-1119(00)00042-1; Ganesh K, 2001, VET MICROBIOL, V78, P1, DOI 10.1016/S0378-1135(00)00288-1; GELDERBLOM H, 1982, ARCH VIROL, V72, P289, DOI 10.1007/BF01315225; Gunes A, 2013, AVIAN DIS, V57, P290, DOI 10.1637/10323-081012-ResNote.1; Harrach B., 2011, AVIADENOVIRIDAE, P13, DOI DOI 10.1007/978-0-387-95919-1_2; Kajan GL, 2011, ACTA VET HUNG, V59, P279, DOI 10.1556/AVet.2011.006; Kajan GL, 2013, VET MICROBIOL, V167, P357, DOI 10.1016/j.vetmic.2013.09.025; LAVER WG, 1971, VIROLOGY, V45, P598, DOI 10.1016/0042-6822(71)90175-9; Lenong L, 2016, J IMMUNOL, V197, P1399, DOI [/10.4049/jimmunol.1600541, DOI 10.4049/JIMMUNOL.1600541]; Meulemans G, 2004, AVIAN PATHOL, V33, P164, DOI 10.1080/03079450310001652086; Nasz I., 2006, Acta Microbiologica et Immunologica Hungarica, V53, P115, DOI 10.1556/AMicr.53.2006.2.1; Niczyporuk JS, 2016, ARCH VIROL, V161, P33, DOI 10.1007/s00705-015-2635-4; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; PRINGAKERBLOM P, 1995, VIROLOGY, V206, P564, DOI 10.1016/S0042-6822(95)80073-5; Raue R, 2005, ARCH VIROL, V150, P1933, DOI 10.1007/s00705-005-0578-x; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Singh AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139339; STEWART PL, 1991, CELL, V67, P145, DOI 10.1016/0092-8674(91)90578-M; Xu L, 2007, J STRUCT BIOL, V157, P424, DOI 10.1016/j.jsb.2006.08.017; Yu B, 2012, BIOCHEM BIOPH RES CO, V421, P170, DOI 10.1016/j.bbrc.2012.03.125; [No title captured]	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207668	10.1371/journal.pone.0207668	http://dx.doi.org/10.1371/journal.pone.0207668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481218	Green Published, gold, Green Submitted			2022-12-26	WOS:000451440000019
J	Jo, D; Park, R; Kim, H; Jang, M; Lee, EJ; Jang, IS; Park, J				Jo, Daum; Park, Rackhyun; Kim, Hyunju; Jang, Minsu; Lee, Eun-Ju; Jang, Ik-Soon; Park, Junsoo			AMP-activated protein kinase regulates the expression of human telomerase reverse transcriptase	PLOS ONE			English	Article							CELL-PROLIFERATION; PROMOTER; GENE; AUTOPHAGY; NUTRIENT; PATHWAY; CLONING; TARGET; GROWTH; AP-1	The expression of hTERT in tumor cells contributes to oncogenic transformation by promoting immortalization. For this reason, hTERT is one of the major targets for cancer therapy, and an efficient method to downregulate hTERT expression is required for treatment of hTERT-positive cancer. In this report, we demonstrated that inhibition of AMP-activated protein kinase (AMPK) downregulates the expression of hTERT. We screened cell signaling pathways in AMPK alpha 1 knockout cells and found that AMPK alpha 1 is required for activity of the hTERT promoter. AMPK alpha 1 knockout cells showed decreased expression of hTERT mRNA and protein. We also demonstrated that compound C, a reversible AMPK inhibitor, suppressed the expression of hTERT. However, AMPK activators, including AICAR and metformin, did not increase the level of hTERT protein. Finally, we showed that tumor cells stably expressing hTERT are resistant to compound C treatment. These results indicate that AMPK activity is required for tumor progression.	[Jo, Daum; Park, Rackhyun; Kim, Hyunju; Jang, Minsu; Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Lee, Eun-Ju] Chung Ang Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea; [Jang, Ik-Soon] Korea Basic Sci Inst, Div Bioconvergence Anal, Daejeon, South Korea	Yonsei University; Chung Ang University; Chung Ang University Hospital; Korea Basic Science Institute (KBSI)	Park, J (corresponding author), Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea.	junsoo@yonsei.ac.kr		MINSU, JANG/0000-0003-4988-5930; Park, Junsoo/0000-0002-2355-6760; LEE, EUN-JU/0000-0001-9446-1059	Leading Space Core Technology Development Program through the NRF - Ministry of Science and ICT [2013M1A3A3A02042433]; National Research Foundation of Korea (NRF) - Korean government [2016R1A2B4009665]	Leading Space Core Technology Development Program through the NRF - Ministry of Science and ICT; National Research Foundation of Korea (NRF) - Korean government	This study was supported by a grant from the Leading Space Core Technology Development Program through the NRF funded by the Ministry of Science and ICT (2013M1A3A3A02042433) and by a National Research Foundation of Korea (NRF) grant funded by the Korean government (2016R1A2B4009665).	Bermudez Y, 2006, CLIN INTERV AGING, V1, P155, DOI 10.2147/ciia.2006.1.2.155; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Guo YT, 2016, ARCH BIOCHEM BIOPHYS, V600, P56, DOI 10.1016/j.abb.2016.04.015; Han XJ, 2016, AGING CELL, V15, P416, DOI 10.1111/acel.12446; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Horikawa I, 1999, CANCER RES, V59, P826; Ido Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115341; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jang M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30977-7; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jhun BS, 2006, BIOCHEM BIOPH RES CO, V351, P986, DOI 10.1016/j.bbrc.2006.10.138; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu X, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-4; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Ouellette MM, 1999, BIOCHEM BIOPH RES CO, V254, P795, DOI 10.1006/bbrc.1998.0114; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Wright WE, 1996, DEV GENET, V18, P173; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560; Yamashita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101864; Yang WL, 2012, J SURG ONCOL, V106, P680, DOI 10.1002/jso.23184	42	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207864	10.1371/journal.pone.0207864	http://dx.doi.org/10.1371/journal.pone.0207864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475873	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700084
J	Gooding, AJ; Zhang, B; Gunawardane, L; Beard, A; Valadkhan, S; Schiemann, WP				Gooding, Alex J.; Zhang, Bing; Gunawardane, Lalith; Beard, Abigail; Valadkhan, Saba; Schiemann, William P.			The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers	ONCOGENE			English	Article							NF-KAPPA-B; LONG NONCODING RNAS; CELL-CYCLE; OXIDATIVE STRESS; PROTEIN; TUMOR; GENE; DOXORUBICIN; ACTIVATION; PATTERNS	Disseminated breast cancer cells employ adaptive molecular responses following cytotoxic therapeutic insult which promotes their survival and subsequent outgrowth. Here we demonstrate that expression of the pro-metastatic lncRNA BORG (BMP/OP-Responsive Gene) is greatly induced within triple-negative breast cancer (TNBC) cells subjected to environmental and chemotherapeutic stresses commonly faced by TNBC cells throughout the metastatic cascade. This stress-mediated induction of BORG expression fosters the survival of TNBC cells and renders them resistant to the cytotoxic effects of doxorubicin both in vitro and in vivo. The chemoresistant traits of BORG depend upon its robust activation of the NF-kappa B signaling axis via a novel BORG-mediated feed-forward signaling loop, and via its ability to bind and activate RPA1. Indeed, genetic and pharmacologic inhibition of NF-kappa B signaling or the DNA-binding activity of RPA1 abrogates the pro-survival features of BORG and renders BORG-expressing TNBCs sensitive to doxorubicin-induced cytotoxicity. These findings suggest that therapeutic targeting of BORG or its downstream molecular effectors may provide a novel means to alleviate TNBC recurrence.	[Gooding, Alex J.; Beard, Abigail; Schiemann, William P.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Zhang, Bing; Gunawardane, Lalith; Valadkhan, Saba] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Schiemann, WP (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Valadkhan, S (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	saba.valadkhan@case.edu; william.schiemann@case.edu	Valadkhan, Saba/G-7271-2012	Valadkhan, Saba/0000-0002-6859-4883	National Institutes of Health [CA129359, CA177069, CA194518, T32GM007250, F30CA203233]; METAvivor Foundation; Case Comprehensive Cancer Center's Research Innovation Fund - Case Council; Friends of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [F30CA203233] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); METAvivor Foundation; Case Comprehensive Cancer Center's Research Innovation Fund - Case Council; Friends of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Members of the Schiemann Laboratory are thanked for critical comments and reading of the manuscript. We thank Dr. Ricky Chan for assistance in our analyses of RNA-seq data. We also acknowledge the expertise provided by members of the Case Comprehensive Cancer Center's Core Facilities, including the Gene Expression & Genotyping Core, the Imaging Research Core, Tissue Resources Core, and the Genomics Core. Research support was provided in part by the National Institutes of Health to W.P.S. (CA129359, CA177069, and CA194518) and A.J.G (T32GM007250 and F30CA203233). Additional support was graciously provided by the METAvivor Foundation (W.P.S.), and by pilot funding from the Case Comprehensive Cancer Center's Research Innovation Fund, which is supported by the Case Council and Friends of the Case Comprehensive Cancer Center (W.P.S. and S.V.).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Ahmed KM, 2006, ANTICANCER RES, V26, P4235; Alluri P, 2014, SURG ONCOL CLIN N AM, V23, P567, DOI 10.1016/j.soc.2014.03.003; BARAL E, 1990, INT J RADIAT ONCOL, V19, P963, DOI 10.1016/0360-3016(90)90019-G; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Boutet-Robinet E, 2013, BIO PROTOC, V3, P12; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Courilleau C, 2012, J CELL BIOL, V199, P1067, DOI 10.1083/jcb.201205059; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Di Gesualdo F, 2014, ONCOTARGET, V5, P10976, DOI 10.18632/oncotarget.2770; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Furlow PW, 2015, NAT CELL BIOL, V17, P943, DOI 10.1038/ncb3194; Godwin P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00120; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gooding AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12716-6; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Huang Z, 2016, INT J CANCER, V139, P23, DOI 10.1002/ijc.29990; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jezierska-Drutel A, 2013, ADV CANCER RES, V119, P107, DOI 10.1016/B978-0-12-407190-2.00003-4; Khan S, 2013, CANCER LETT, V337, P90, DOI 10.1016/j.canlet.2013.05.020; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Kouroukis TC, 2014, CURR ONCOL, V21, pE573, DOI 10.3747/co.21.1798; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lakhotia SC, 2012, WIRES RNA, V3, P779, DOI 10.1002/wrna.1135; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Li SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098021; Ling YH, 1996, MOL PHARMACOL, V49, P832; Lopez JS, 2017, NAT REV CLIN ONCOL, V14, P57, DOI 10.1038/nrclinonc.2016.96; Lu SQ, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-13; Lupertz R, 2010, TOXICOLOGY, V271, P115, DOI 10.1016/j.tox.2010.03.012; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Mahadevan NR, 2011, J IMMUNOL, V187, P4403, DOI 10.4049/jimmunol.1101531; Malhotra A, 2017, ONCOTARGET, V8, P110671, DOI 10.18632/oncotarget.22577; Mao XH, 2017, IMMUNOLOGY, V150, P379, DOI 10.1111/imm.12698; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Montagut C, 2006, ENDOCR-RELAT CANCER, V13, P607, DOI 10.1677/erc.1.01171; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; Neil JR, 2009, J BIOL CHEM, V284, P21209, DOI 10.1074/jbc.M109.018374; Paramore A, 2003, NAT REV DRUG DISCOV, V2, P611, DOI 10.1038/nrd1159; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Senft D, 2016, TRENDS CANCER, V2, P429, DOI 10.1016/j.trecan.2016.06.004; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shuck SC, 2010, CANCER RES, V70, P3189, DOI 10.1158/0008-5472.CAN-09-3422; Somaiah C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145068; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda K, 1998, J BIOL CHEM, V273, P17079, DOI 10.1074/jbc.273.27.17079; Tiligada E, 2006, ENDOCR-RELAT CANCER, V13, pS115, DOI 10.1677/erc.1.01272; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Tornatore L, 2014, CANCER CELL, V26, P495, DOI 10.1016/j.ccr.2014.07.027; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; Valadkhan S, 2016, CURR TOP MICROBIOL, V394, P203, DOI 10.1007/82_2015_489; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Victorino VJ, 2014, CURR MED CHEM, V21, P3211, DOI 10.2174/0929867321666140601164647; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yap WT, 2013, TISSUE ENG PT A, V19, P2361, DOI [10.1089/ten.tea.2013.0033, 10.1089/ten.TEA.2013.0033]; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zanotto A, 2016, MOL CANCER THER, V15, P3000, DOI 10.1158/1535-7163.MCT-16-0271; Zhang B, 2014, MOL CELL BIOL, V34, P2318, DOI 10.1128/MCB.01673-13; Zhao MM, 2017, CELL REP, V20, P1997, DOI 10.1016/j.celrep.2017.08.015; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	83	55	56	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2019	38	12					2020	2041		10.1038/s41388-018-0586-4	http://dx.doi.org/10.1038/s41388-018-0586-4			22	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HP6UR	30467380	Green Accepted			2022-12-26	WOS:000461822600003
J	Poble, PB; Phan, C; Quatremare, T; Bordenave, J; Thuillet, R; Cumont, A; Huertas, A; Tu, L; Dorfmuller, P; Humbert, M; Ghigna, MR; Savale, L; Guignabert, C				Poble, Paul-Benoit; Phan, Carole; Quatremare, Timothee; Bordenave, Jennifer; Thuillet, Raphael; Cumont, Amelie; Huertas, Alice; Tu, Ly; Dorfmueller, Peter; Humbert, Marc; Ghigna, Maria-Rosa; Savale, Laurent; Guignabert, Christophe			Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension	FASEB JOURNAL			English	Article						pulmonary arterial hypertension; pulmonary vascular remodeling; extracellular matrix; FoxO1	SERINE ELASTASE INHIBITOR; TRANSCRIPTION FACTOR; FIBROSIS; TARGETS; PREVENTS	Heightened pulmonary artery smooth muscle cell (PA-SMC) proliferation and migration and dynamic remodeling of the extracellular matrix are hallmark pathogenic features of pulmonary arterial hypertension (PAH). Pirfenidone (PFD) is an orally bioavailable pyridone derivative with antifibrotic, antiinflammatory, and antioxidative properties currently used in the treatment of idiopathic pulmonary fibrosis. We therefore evaluated the efficacy of curative treatments with PFD in the sugen/hypoxia (SuHx) rat model of severe pulmonary hypertension. Treatment with PFD (30 mg/kg per day by mouth 3 times a day for 3 wk) started 5 wk after sugen injection partially reversed established pulmonary hypertension, reducing total pulmonary vascular resistance and remodeling. Consistent with these observations, we found that continued PFD treatment decreases PA-SMC proliferation and levels of extracellular matrix deposition in lungs and right ventricles in SuHx rats. Importantly, PFD attenuated the proproliferative and promigratory potentials of cultured PA-SMCs from patients with idiopathic PAH and their capacity to produce extracellular matrix components. Finally, we found that PFD dose dependently enhanced forkhead box O1 protein levels and its nuclear translocation in cultured idiopathic PAH PA-SMCs and in PFD-treated SuHx rats. PFD appears to be a potential therapy for PAH worthy of investigation and evaluation for clinical use in conjunction with current PAH treatments.Poble, P.-B., Phan, C., Quatremare, T., Bordenave, J., Thuillet, R., Cumont, A., Huertas, A., Tu, L., Dorfmuller, P., Humbert, M., Ghigna, M.-R., Savale, L., Guignabert, C. Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.	[Poble, Paul-Benoit; Phan, Carole; Quatremare, Timothee; Bordenave, Jennifer; Thuillet, Raphael; Cumont, Amelie; Huertas, Alice; Tu, Ly; Dorfmueller, Peter; Humbert, Marc; Ghigna, Maria-Rosa; Savale, Laurent; Guignabert, Christophe] INSERM, UMR S 999, Le Plessis Robinson, France; [Poble, Paul-Benoit; Phan, Carole; Quatremare, Timothee; Bordenave, Jennifer; Thuillet, Raphael; Cumont, Amelie; Huertas, Alice; Tu, Ly; Dorfmueller, Peter; Humbert, Marc; Ghigna, Maria-Rosa; Savale, Laurent; Guignabert, Christophe] Univ Paris Saclay, Univ Paris Sud, Le Kremlin Bicetre, France; [Huertas, Alice; Humbert, Marc; Savale, Laurent] Hop Bicetre, AP HP, DHU Thorax Innovat, Ctr Reference Hypertens Pulm Severe,Serv Pneumol, Le Kremlin Bicetre, France; [Dorfmueller, Peter; Ghigna, Maria-Rosa] Hop Marie Lannelongue, Pathol Dept, Le Plessis Robinson, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue	Guignabert, C (corresponding author), Hop Marie Lannelongue, INSERM, UMR S 999, 133 Ave Resistance, F-92350 Le Plessis Robinson, France.	christophe.guignabert@inserm.fr	GUIGNABERT, Christophe/G-3873-2013; Humbert, Marc/ABD-5112-2021; Savale, Laurent/AAJ-9781-2020; TU, Ly/G-4035-2013; GUIGNABERT, Christophe/AGI-2488-2022; Humbert, Marc/AAC-8459-2019; Huertas, Alice/E-8244-2017; TU, Ly/AAK-4996-2020	GUIGNABERT, Christophe/0000-0002-8545-4452; TU, Ly/0000-0003-2336-5099; GUIGNABERT, Christophe/0000-0002-8545-4452; Humbert, Marc/0000-0003-0703-2892; Huertas, Alice/0000-0001-8545-747X; TU, Ly/0000-0003-2336-5099; bordenave, jennifer/0000-0001-8866-3666; Dorfmuller, Peter/0000-0003-2499-6829	INSERM, the University of Paris-Sud; University Paris-Saclay, Marie Lannelongue Hospital; French National Agency for Research (ANR) [ANR-16-CE17-0014]; Fondation de la Recherche Medicale (FRM) [DEQ20150331712]; Departement Hospitalo-Universitaire Thorax Innovation; Assistance Publique-Hopitaux de Paris, Service de Pneumologie, Centre de Reference de l'Hypertension Pulmonaire Severe; LabEx LERMIT [ANR-10-LABX-0033]; French PAH patient association (HTAP France); French Fonds de Dotation "Recherche en Sante Respiratoire" (FRSR); Fondation du Souffle (FdS); FRSR-FdS; FRM	INSERM, the University of Paris-Sud; University Paris-Saclay, Marie Lannelongue Hospital; French National Agency for Research (ANR)(French National Research Agency (ANR)); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Departement Hospitalo-Universitaire Thorax Innovation; Assistance Publique-Hopitaux de Paris, Service de Pneumologie, Centre de Reference de l'Hypertension Pulmonaire Severe; LabEx LERMIT; French PAH patient association (HTAP France); French Fonds de Dotation "Recherche en Sante Respiratoire" (FRSR); Fondation du Souffle (FdS); FRSR-FdS; FRM(Fondation pour la Recherche Medicale)	This research was supported by grants from INSERM, the University of Paris-Sud, the University Paris-Saclay, Marie Lannelongue Hospital, the French National Agency for Research (ANR; Grant ANR-16-CE17-0014, TAMIRAH), the Fondation de la Recherche Medicale (FRM; Grant DEQ20150331712, Equipe FRM 2015), and in part by the Departement Hospitalo-Universitaire Thorax Innovation, the Assistance Publique-Hopitaux de Paris, Service de Pneumologie, Centre de Reference de l'Hypertension Pulmonaire Severe, the LabEx LERMIT (Grant ANR-10-LABX-0033), the French PAH patient association (HTAP France), and the French Fonds de Dotation "Recherche en Sante Respiratoire" (FRSR), Fondation du Souffle (FdS). P.-B.P. and C.P. are supported by the FRSR-FdS and J.B. is supported by the FRM. P.-B.P., C.P., T.Q., J.B., R.T., A.C., A.H., L.T., P.D., M.-R.G., and C.G. have no conflicts of interest to disclose. In the past 3 yr, M.H. and L.S. report grants, personal fees, and nonfinancial support from Actelion, Pfizer, Bayer, GlaxoSmithKline, and MSD outside of the submitted work.	Al-Tamari HM, 2018, EMBO MOL MED, V10, P276, DOI 10.15252/emmm.201606261; Avouac J, 2017, ARTHRITIS RHEUMATOL, V69, P2209, DOI 10.1002/art.40229; Bertero T, 2016, J CLIN INVEST, V126, P3313, DOI 10.1172/JCI86387; Bonniaud P, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02133-2017; Boucly A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00889-2017; Cowan KN, 2000, NAT MED, V6, P698, DOI 10.1038/76282; Egemnazarov B, 2018, MATRIX BIOL, V68-69, P507, DOI 10.1016/j.matbio.2018.01.010; Golob MJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12815; Guignabert C, 2016, J CLIN INVEST, V126, P3207, DOI 10.1172/JCI86249; Guignabert C, 2015, CHEST, V147, P529, DOI 10.1378/chest.14-0862; Huertas A, 2017, CURR OPIN PULM MED, V23, P377, DOI 10.1097/MCP.0000000000000404; Huertas A, 2015, EUR RESPIR J, V45, P1066, DOI 10.1183/09031936.00193014; ILKIW R, 1989, CIRC RES, V64, P814, DOI 10.1161/01.RES.64.4.814; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Lee KW, 2006, CIRCULATION, V114, P1703, DOI 10.1161/CIRCULATIONAHA.106.624320; Tu L, 2012, AM J RESP CRIT CARE, V186, P666, DOI 10.1164/rccm.201202-0309OC; Tu L, 2011, AM J RESP CELL MOL, V45, P311, DOI 10.1165/rcmb.2010-0317OC; MARUYAMA K, 1991, AM J PHYSIOL, V261, pH1716, DOI 10.1152/ajpheart.1991.261.6.H1716; Mirkovic S, 2002, BRIT J PHARMACOL, V135, P961, DOI 10.1038/sj.bjp.0704539; Nguyen DT, 2010, HEART RHYTHM, V7, P1438, DOI 10.1016/j.hrthm.2010.04.030; Noble PW, 2016, EUR RESPIR J, V47, P243, DOI 10.1183/13993003.00026-2015; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Richter MJ, 2018, AM J RESP CRIT CARE, V198, P808, DOI 10.1164/rccm.201801-0195LE; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tamura Y, 2018, J CLIN INVEST, V128, P1956, DOI 10.1172/JCI96462; Vieillard-Baron A, 2003, HUM GENE THER, V14, P861, DOI 10.1089/104303403765701150; Vivar R, 2016, BBA-MOL CELL RES, V1863, P128, DOI 10.1016/j.bbamcr.2015.10.019; Wang YL, 2013, CARDIOLOGY, V126, P1, DOI 10.1159/000351179; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yoshida M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7653; Zaidi SHE, 2002, CIRCULATION, V105, P516, DOI 10.1161/hc0402.102866	33	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3670	3679		10.1096/fj.201801659R	http://dx.doi.org/10.1096/fj.201801659R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481487	Green Submitted, Bronze			2022-12-26	WOS:000459794800047
J	Raychaudhury, P; Marians, KJ				Raychaudhury, Paromita; Marians, Kenneth J.			The recombination mediator proteins RecFOR maintain RecA* levels for maximal DNA polymerase V Mut activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA repair; DNA recombination; nucleic acid enzymology; lesion bypass; RecA; recombination mediator protein; translesion synthesis	SINGLE-STRANDED-DNA; EXCISION-DEFECTIVE STRAIN; ESCHERICHIA-COLI; BIOCHEMICAL BASIS; POL-V; III HOLOENZYME; SOS; MUTAGENESIS; BINDING; MUTATIONS	DNA template damage can potentially block DNA replication. Cells have therefore developed different strategies to repair template lesions. Activation of the bacterial lesion bypass DNA polymerase V (Pol V) requires both the cleavage of the UmuD subunit to UmuD ' and the acquisition of a monomer of activated RecA recombinase, forming Pol V Mut. Both of these events are mediated by the generation of RecA* via the formation of a RecA-ssDNA filament during the SOS response. Formation of RecA* is itself modulated by competition with the ssDNA-binding protein (SSB) for binding to ssDNA. Previous observations have demonstrated that RecA filament formation on SSB-coated DNA can be favored in the presence of the recombination mediator proteins RecF, RecO, and RecR. We show here using purified proteins that in the presence of SSB and RecA, a stable RecA-ssDNA filament is not formed, although sufficient RecA* is generated to support some activation of Pol V. The presence of RecFOR increased RecA* generation and allowed Pol V to synthesize longer DNA products and to elongate from an unpaired primer terminus opposite template damage, also without the generation of a stable RecA-ssDNA filament.	[Raychaudhury, Paromita; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Raychaudhury, Paromita/AAE-9186-2020	Raychaudhury, Paromita/0000-0003-1087-1240	National Institutes of Health [R01 GM34557, R35 GM126907]; Cancer Center Support Grant NCI [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034557, R35GM126907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants R01 GM34557 and R35 GM126907 (to K.J.M.) and Cancer Center Support Grant NCI P30CA008748 (to the Memorial Sloan Kettering Cancer Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arad G, 2008, J BIOL CHEM, V283, P8274, DOI 10.1074/jbc.M710290200; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; CASTELLAZZI M, 1972, MOL GEN GENET, V119, P139, DOI 10.1007/BF00269133; DUTREIX M, 1989, J BACTERIOL, V171, P2415, DOI 10.1128/jb.171.5.2415-2423.1989; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Erdem AL, 2014, ELIFE, V3, DOI 10.7554/eLife.02384; Fijalkowska IJ, 2012, FEMS MICROBIOL REV, V36, P1105, DOI 10.1111/j.1574-6976.2012.00338.x; Fuchs RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012682; Fujii S, 2006, EMBO J, V25, P5754, DOI 10.1038/sj.emboj.7601474; Fujii S, 2009, P NATL ACAD SCI USA, V106, P14825, DOI 10.1073/pnas.0905855106; Gabbai CB, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.613257; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; HEGDE S, 1995, MOL GEN GENET, V246, P254, DOI 10.1007/BF00294689; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Karata K, 2012, DNA REPAIR, V11, P431, DOI 10.1016/j.dnarep.2012.01.012; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; LAVERY PE, 1988, J MOL BIOL, V203, P861, DOI 10.1016/0022-2836(88)90112-X; LAVERY PE, 1990, J BIOL CHEM, V265, P4004; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LU C, 1987, J MOL BIOL, V196, P497, DOI 10.1016/0022-2836(87)90027-1; Maor-Shoshani A, 2002, BIOCHEMISTRY-US, V41, P14438, DOI 10.1021/bi0262909; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; MINDEN JS, 1986, J BIOL CHEM, V261, P1906; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; RECKMANN B, 1985, EUR J BIOCHEM, V152, P633, DOI 10.1111/j.1432-1033.1985.tb09242.x; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Rupp WD, 2005, DNA REPAIR, V4, P620; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680; WITKIN EM, 1982, MOL GEN GENET, V185, P43, DOI 10.1007/BF00333788; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; YU X, 1993, J MOL BIOL, V231, P29, DOI 10.1006/jmbi.1993.1254	51	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					852	860		10.1074/jbc.RA118.005726	http://dx.doi.org/10.1074/jbc.RA118.005726			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482842	Green Published, hybrid			2022-12-26	WOS:000458670200011
J	Melendez, DM; Marti, S; Pajor, EA; Sidhu, PK; Gellatly, D; Moya, D; Janzen, ED; Coetzee, JF; Schwartzkopf-Genswein, KS				Melendez, Daniela M.; Marti, Sonia; Pajor, Edmond A.; Sidhu, Pritam K.; Gellatly, Desiree; Moya, Diego; Janzen, Eugene D.; Coetzee, Johann F.; Schwartzkopf-Genswein, Karen S.			Effect of meloxicam and lidocaine administered alone or in combination on indicators of pain and distress during and after knife castration in weaned beef calves	PLOS ONE			English	Article							ACUTE CORTISOL RESPONSE; SURGICAL CASTRATION; LOCAL-ANESTHESIA; PLASMA-CORTISOL; EPIDURAL-ANESTHESIA; FLUNIXIN MEGLUMINE; ORAL MELOXICAM; BEHAVIOR; PERFORMANCE; STRESS	To assess the effect of meloxicam and lidocaine on indicators of pain associated with castration, forty-eight Angus crossbred beef calves (304 +/- 40.5 kg of BW, 7-8 months of age) were used in a 28 day experiment. The experiment consisted of a 2 x 2 factorial design where main factors included provision of analgesia and local anaesthesia. Analgesia consisted of: no-meloxicam (N; n = 24) single s.c. administration of lactated ringer's solution and meloxicam (M; n = 24) single dose of 0.5 mg/kg of s.c. meloxicam. Local anesthesia consisted of: no-lidocaine (R; n = 24) ring block administration of lactated ringer's solution or lidociane (L; n = 24) ring block administration of lidocaine. To yield the following treatments: no meloxicam + no lidocaine (N-R; n = 12), no meloxicam + lidocaine (N-L; n = 12), meloxicam + no lidocaine (M-R; n = 12) and meloxicam + lidocaine (M-L; n = 12). Salivary cortisol concentrations were lower (lidocaine x time effect; P < 0.01) in L calves than R calves 0.5 and 1 hours after castration, while concentrations were lower (meloxicam x time effect; P = 0.02) in M calves than N calves at 2, 4 and 48 hours. The serum amyloid-A concentrations were greater (lidocaine x time effect; P < 0.01) in R calves than L calves on days 1, 3, 21 and 28 after castration. Haptoglobin concentrations were greater (meloxicam x time effect; P = 0.01) in N calves than M calves 24 and 48 hours after castration. Lower (lidocaine effect; P < 0.01) visual analog scale (VAS) scores, leg movement frequencies and head movement distance were observed in L calves than R calves at the time of castration. Escape behaviour during castration was lower (lidocaine effect; P < 0.05) in L calves than R calves based on data captured with accelerometer and head gate devices. Scrotal circumference had a triple interaction (lidocaine x meloxicam x time; P = 0.03), where M-R calves had greater scrotal circumference than M-L calves 28 d after castration, but no differences were observed between both groups and N-R and N-L calves. No differences (P > 0.05) were observed for average daily gain (ADG), weights or feeding behaviour. Overall, both lidocaine and meloxicam reduced physiological and behavioural indicators of pain. Although there was only one meloxicam x lidocaine interaction, lidocaine and meloxicam reduced physiological and behavioural parameters at different time points, which could be more effective at mitigating pain than either drug on its own.	[Melendez, Daniela M.; Marti, Sonia; Pajor, Edmond A.; Gellatly, Desiree; Janzen, Eugene D.] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada; [Melendez, Daniela M.; Gellatly, Desiree; Schwartzkopf-Genswein, Karen S.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Marti, Sonia] IRTA, Dept Ruminant Prod, Barcelona, Spain; [Sidhu, Pritam K.; Coetzee, Johann F.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Moya, Diego] Univ Saskatchewan, Dept Large Anim Clin Sci, Saskatoon, SK, Canada	University of Calgary; Agriculture & Agri Food Canada; IRTA; Kansas State University; University of Saskatchewan	Schwartzkopf-Genswein, KS (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	Karen.genswein@agr.gc.ca	MartÍ, Sonia/P-9800-2016; Coetzee, Hans/GOK-3477-2022; Meléndez, Daniela/AAT-9279-2020; Marti, Sonia/S-1799-2019	MartÍ, Sonia/0000-0002-8115-0582; Coetzee, Hans/0000-0003-1802-3991; Meléndez, Daniela/0000-0002-0153-9708; Moya Fernandez, Diego/0000-0002-0969-6740	Agriculture and Agri-Food Canada; Beef Cattle Research Council; Canadian Beef Cattle Industry Science Cluster [ANH.21.13 AIP-CL01]; Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster; CERCA program from Generalitat de Catalunya	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Beef Cattle Research Council; Canadian Beef Cattle Industry Science Cluster; Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster; CERCA program from Generalitat de Catalunya	Funding is provided by Agriculture and Agri-Food Canada (http://www.agr.gc.ca/eng/home/? id= 1395690825741) and the Beef Cattle Research Council (http://www.beefresearch.ca/) through the Canadian Beef Cattle Industry Science Cluster (ANH.21.13 AIP-CL01). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; We are very thankful for the funding provided by Agriculture and Agri-Food Canada and the Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster. The authors appreciate the invaluable help of Agriculture and Agri-Food Canada research feedlot staff and beef welfare technicians Randy Wilde and Fiona Brown. We would also like to thank all the students that helped with data collection and behavioural scoring: Jonathan Low, Nicholas Wong and Oriol Solanes. The co-author Sonia Marti was partly supported by the CERCA program from Generalitat de Catalunya. This is Lethbridge Research Centre contribution #38718040.	ALSEMGEEST SPM, 1994, VET QUART, V16, P21, DOI 10.1080/01652176.1994.9694410; Ballou MA, 2013, VET IMMUNOL IMMUNOP, V151, P285, DOI 10.1016/j.vetimm.2012.11.018; BAUMANN H, 1989, ANN NY ACAD SCI, V557, P280; Bretschneider G, 2005, LIVEST PROD SCI, V97, P89, DOI 10.1016/j.livprodsci.2005.04.006; Brown AC, 2015, J ANIM SCI, V93, P2460, DOI 10.2527/jas.2014-8695; Cassuto J, 2006, ACTA ANAESTH SCAND, V50, P265, DOI 10.1111/j.1399-6576.2006.00936.x; CCAC, 2009, CCAC GUID AN US PROT; Coetzee JF, 2008, AM J VET RES, V69, P751, DOI 10.2460/ajvr.69.6.751; Coetzee JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-153; Coetzee JF, 2011, APPL ANIM BEHAV SCI, V135, P192, DOI 10.1016/j.applanim.2011.10.016; Currah JM, 2009, CAN VET J, V50, P375; DOWLING J, 1982, PAIN, V14, P387, DOI 10.1016/0304-3959(82)90146-4; Earley B, 2002, J ANIM SCI, V80, P1044; Egger CM, 2013, PAIN MANAGEMENT VETE, P85; FELL LR, 1986, AUST VET J, V63, P16, DOI 10.1111/j.1751-0813.1986.tb02864.x; Fisher AD, 1996, J ANIM SCI, V74, P2336; Ganheim C, 2003, J VET MED B, V50, P183, DOI 10.1046/j.1439-0450.2003.00658.x; Gonzalez LA, 2010, J ANIM SCI, V88, P802, DOI 10.2527/jas.2008-1752; HOCKE GM, 1992, MOL CELL BIOL, V12, P2282, DOI 10.1128/MCB.12.5.2282; HORADAGODA A, 1994, RES VET SCI, V57, P129, DOI 10.1016/0034-5288(94)90094-9; Lahav M, 2002, CLIN EXP IMMUNOL, V127, P226, DOI 10.1046/j.1365-2249.2002.01747.x; Lehmann HS, 2017, VET ANAESTH ANALG, V44, P1341, DOI 10.1016/j.vaa.2017.04.009; Lomax S, 2013, J ANIM SCI, V91, P4945, DOI 10.2527/jas.2012-5984; Marti S, 2017, CAN VET J, V58, P1081; Martin P., 2007, RECORDING METHODS ME, V3rd, P48; Melendez D, 2017, J ANIM SCI; Melendez D, 2017, ACUTE PAIN J ANIM SC; Melendez D, 2018, ACUTE PAIN; Mintline EM, 2014, J ANIM SCI, V92, P5659, DOI 10.2527/jas.2014-7885; Moggy MA, 2017, J ANIM SCI, V95, P958, DOI 10.2527/jas.2016.0949; Molony V, 1995, APPL ANIM BEHAV SCI, V46, P33, DOI 10.1016/0168-1591(95)00635-4; Moya D, 2014, J ANIM SCI, V92, P1684, DOI 10.2527/jas.2013-7298; Moya D, 2013, LIVEST SCI, V158, P138, DOI 10.1016/j.livsci.2013.10.007; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; National Academies of Science Engineering and Medicine, 2016, NUTR REQ BEEF CATTL; NFACC, 2013, COD PRACT CAR HANDL; Ochroch EA, 2003, DRUGS, V63, P2709, DOI 10.2165/00003495-200363240-00002; PERRIER D, 1982, J PHARM SCI, V71, P372, DOI 10.1002/jps.2600710332; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Roberts SL, 2015, J ANIM SCI, V93, P4123, DOI 10.2527/jas.2015-9160; ROBERTSON IS, 1994, RES VET SCI, V56, P8, DOI 10.1016/0034-5288(94)90189-9; Rollin BE, 2004, J ANIM SCI, V82, P955; Schwartzkopf-Genswein KS, 2005, CAN J ANIM SCI, V85, P131, DOI 10.4141/A04-051; Schwartzkopf-Genswein KS, 2003, CAN J ANIM SCI, V83, P29, DOI 10.4141/A02-027; Sowell BF, 1998, APPL ANIM BEHAV SCI, V59, P277, DOI 10.1016/S0168-1591(98)00110-5; Stafford KJ, 2002, RES VET SCI, V73, P61, DOI 10.1016/S0034-5288(02)00045-0; Stewart M, 2010, J DAIRY SCI, V93, P3602, DOI 10.3168/jds.2010-3114; Stock ML, 2015, VET CLIN N AM-FOOD A, V31, P113, DOI 10.1016/j.cvfa.2014.11.002; Ting STL, 2003, J ANIM SCI, V81, P1281; Toutain PL, 2004, AM J VET RES, V65, P1533, DOI 10.2460/ajvr.2004.65.1533; Toutain PL, 2002, AAPS PHARMSCI, V4; UBC AWP (University of British Columbia Animal Welfare Program), 2013, UBC AN WELF PROGR SO, P1; Vedung T, 2010, CLIN PHYSIOL FUNCT I, V30, P399, DOI 10.1111/j.1475-097X.2010.00955.x; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Weary DM, 2004, WELL BEING FARM ANIM, P325; Webster HB, 2013, J DAIRY SCI, V96, P6285, DOI 10.3168/jds.2012-6238; White BJ, 2008, AM J VET RES, V69, P1005, DOI 10.2460/ajvr.69.8.1005	57	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207289	10.1371/journal.pone.0207289	http://dx.doi.org/10.1371/journal.pone.0207289			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500846	Green Published, gold, Green Submitted			2022-12-26	WOS:000451883700008
J	Kelly, RA; Leedale, J; Harrell, A; Beard, DA; Randle, LE; Chadwick, AE; Webb, SD				Kelly, Ross A.; Leedale, Joseph; Harrell, Andy; Beard, Daniel A.; Randle, Laura E.; Chadwick, Amy E.; Webb, Steven D.			Modelling the impact of changes in the extracellular environment on the cytosolic free NAD(+)/NADH ratio during cell culture	PLOS ONE			English	Article							ENERGY-METABOLISM; LIVER CELLS; GLYCOLYSIS; RESPIRATION; TRANSPORTER; GLUCONEOGENESIS; MITOCHONDRIA; SUBSTRATE; PYRUVATE; PROTEIN	Cancer cells depend on glucose metabolism via glycolysis as a primary energy source, despite the presence of oxygen and fully functioning mitochondria, in order to promote growth, proliferation and longevity. Glycolysis relies upon NAD(+) to accept electrons in the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) reaction, linking the redox state of the cytosolic NAD(+) pool to glycolytic rate. The free cytosolic NAD(+)/NADH ratio is involved in over 700 oxidoreductive enzymatic reactions and as such, the NAD(+)/NADH ratio is regarded as a metabolic readout of overall cellular redox state. Many experimental techniques that monitor or measure total NAD(+) and NADH are unable to distinguish between protein-bound and unbound forms. Yet total NAD(+)/NADH measurements yield little information, since it is the free forms of NAD(+) and NADH that determine the kinetic and thermodynamic influence of redox potential on glycolytic rate. Indirect estimations of free NAD(+)/NADH are based on the lactate/pyruvate (L/P) ratio at chemical equilibrium, but these measurements are often undermined by high lability. To elucidate the sensitivity of the free NAD(+)/NADH ratio to changes in extracellular substrate, an in silico model of hepatocarcinoma glycolysis was constructed and validated against in vitro data. Model simulations reveal that over experimentally relevant concentrations, changes in extracellular glucose and lactate concentration during routine cancer cell culture can lead to significant deviations in the NAD(+)/NADH ratio. Based on the principles of chemical equilibrium, the model provides a platform from which experimentally challenging situations may be examined, suggesting that extracellular substrates play an important role in cellular redox and bioenergetic homeostasis.	[Kelly, Ross A.; Webb, Steven D.] Liverpool John Moores Univ, Dept Appl Math, Liverpool, Merseyside, England; [Leedale, Joseph; Webb, Steven D.] Univ Liverpool, EPSRC Liverpool Ctr Math Healthcare, Dept Math Sci, Liverpool, Merseyside, England; [Harrell, Andy] GlaxoSmithKline, David Jack Ctr Res, Ware, Herts, England; [Beard, Daniel A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Randle, Laura E.] Liverpool John Moores Univ, Dept Pharm & Biomol Sci, Liverpool, Merseyside, England; [Chadwick, Amy E.] Univ Liverpool, Dept Mol & Clin Pharmacol, MRC Ctr Drug Safety Sci, Liverpool, Merseyside, England	Liverpool John Moores University; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Liverpool; GlaxoSmithKline; University of Michigan System; University of Michigan; Liverpool John Moores University; University of Liverpool	Leedale, J (corresponding author), Univ Liverpool, EPSRC Liverpool Ctr Math Healthcare, Dept Math Sci, Liverpool, Merseyside, England.	j.leedale@liverpool.ac.uk	Chadwick, Amy E/D-8633-2015; Randle, Laura/AHA-7633-2022	Chadwick, Amy E/0000-0002-7399-8655; Kelly, Ross/0000-0002-5505-460X; Randle, Laura/0000-0002-7881-2979; Leedale, Joseph/0000-0001-9010-4126	EPSRC Liverpool Centre for Mathematics in Healthcare [EP/N014499/1]; BBSRC Industry Case Partnership; GSK [BB/L502273/2]; EPSRC [EP/N014499/1] Funding Source: UKRI; MRC [MR/L006758/1] Funding Source: UKRI	EPSRC Liverpool Centre for Mathematics in Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC Industry Case Partnership(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GSK(GlaxoSmithKline); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.L. acknowledges funding support from the EPSRC Liverpool Centre for Mathematics in Healthcare (EP/N014499/1), https://epsrc.ukri.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. R.A.K. acknowledges funding support from a BBSRC Industry Case Partnership with GSK (BB/L502273/2), https://bbsrc.ukri.org, https://www.gsk.com.GSK provided support in the form of salaries for author A.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrahams M, 1999, BRIT J ANAESTH, V83, P467, DOI 10.1093/bja/83.3.467; Beeson CC, 2010, ANAL BIOCHEM, V404, P75, DOI 10.1016/j.ab.2010.04.040; Bezawork-Geleta A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04603-z; Christensen CE, 2014, J BIOL CHEM, V289, P2344, DOI 10.1074/jbc.M113.498626; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Devin A, 1997, FEBS LETT, V410, P329, DOI 10.1016/S0014-5793(97)00612-1; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; Kamalian L, 2015, TOXICOL IN VITRO, V29, P732, DOI 10.1016/j.tiv.2015.02.011; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; KATZ A, 1987, ACTA PHYSIOL SCAND, V131, P119, DOI 10.1111/j.1748-1716.1987.tb08213.x; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086872; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Marcu R, 2014, MOL CELL BIOL, V34, P2890, DOI 10.1128/MCB.00068-14; Mookerjee SA, 2015, JOVE-J VIS EXP, DOI 10.3791/53464; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; SAUER LA, 1985, J BIOL CHEM, V260, P7496; SCHWARTZ JP, 1974, J BIOL CHEM, V249, P4138; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sun FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034525; Technologies A, 2017, PUBLICATIONS SEAHORS; Vanlier J, 2009, BIOINFORMATICS, V25, P836, DOI 10.1093/bioinformatics/btp069; Vinnakota K, 2006, BIOPHYS J, V91, P1264, DOI 10.1529/biophysj.105.073296; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yang Y, 2015, PHARM RES-DORDR, V32, P1975, DOI 10.1007/s11095-014-1591-0; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhao YZ, 2016, NAT PROTOC, V11, P1345, DOI 10.1038/nprot.2016.074	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207803	10.1371/journal.pone.0207803	http://dx.doi.org/10.1371/journal.pone.0207803			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496306	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000451763800051
J	Osei, FB; Stein, A; Nyadanu, SD				Osei, Frank Badu; Stein, Alfred; Nyadanu, Sylvester Dodzi			Spatial and temporal heterogeneities of district-level typhoid morbidities in Ghana: A requisite insight for informed public health response	PLOS ONE			English	Article							RISK-FACTORS; PARATYPHOID FEVER; LOCAL INDICATORS; MORANS I; ASSOCIATION; CHILDREN; DISEASE; AFRICA	Typhoid fever is estimated to cause between 9.9-24.2 million cases and 75,000-208,000 deaths per year globally. Low-income and middle-income countries report the majority of cases, especially those in sub-Saharan Africa. The epidemiology of typhoid fever is poorly understood, particularly in Ghana where there has been no study of the within-country variation. Our objective was to explore and analyze the spatial and temporal patterns of typhoid fever morbidities in Ghana. We used the global and local Moran's indices to uncover the existence of global and local spatial patterns, respectively. Generalized linear autoregressive moving average (glarma) models were developed to explore the overall and regional level temporal patterns of morbidities. The overall index of spatial association was 0.19 (p < 0.001). The global Moran's monthly indices of clustering ranged from approximate to 0 - 0.28, with few non-significant (p > 0.05) estimates. The yearly estimates were all significant (p < 0.001) and ranged from 0.1-0.19, suggesting spatial clustering of typhoid. The local Moran's maps indicated isolated high contributions of clustering within the Upper West and Western regions. The overall and regional level glarma models indicated significant first and second-order serial correlation as well as quarterly trends. These findings can provide relevant epidemiological insight into the spatial and temporal patterns of typhoid epidemiology and useful to complement the development of control strategies by public health managers.	[Osei, Frank Badu; Stein, Alfred] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands; [Nyadanu, Sylvester Dodzi] ECHO Res Grp Int, Aflao, Ghana	University of Twente	Osei, FB (corresponding author), Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands.	f.b.osei@utwente.nl	Nyadanu, Sylvester Dodzi/AAF-4432-2020	Nyadanu, Sylvester Dodzi/0000-0002-6233-0262	ECHO Research Group International	ECHO Research Group International	The ECHO Research Group International provided support in the form of salaries for SDN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Akullian A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004212; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Antillon M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005376; Assuncao RM, 1999, STAT MED, V18, P2147, DOI 10.1002/(SICI)1097-0258(19990830)18:16<2147::AID-SIM179>3.0.CO;2-I; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; Biritwum RB, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20096; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Corner RJ, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-13; Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998; Dougan G, 2017, LANCET GLOB HEALTH, V5, pE236, DOI 10.1016/S2214-109X(17)30045-1; Dunsmuir WTM, 2015, J STAT SOFTW, V67, P1; Espinoza LMC, 2016, CLIN INFECT DIS, V62, pS17, DOI 10.1093/cid/civ787; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Gasem MH, 2001, TROP MED INT HEALTH, V6, P484, DOI 10.1046/j.1365-3156.2001.00734.x; Gu HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00461-9; Guo L, 2013, INT J APPL EARTH OBS, V21, P384, DOI 10.1016/j.jag.2011.11.003; Hinman Sarah E, 2006, Int J Health Geogr, V5, P13, DOI 10.1186/1476-072X-5-13; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Lawson AB, 2013, STAT METHODS SPATIAL; Lee JS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2074-1; Marks F, 2017, LANCET GLOB HEALTH, V5, pE310, DOI 10.1016/S2214-109X(17)30022-0; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; MARSHALL RJ, 1991, J R STAT SOC C-APPL, V40, P283; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morand S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01774; Mweu E, 2008, TROP MED INT HEALTH, V13, P532, DOI 10.1111/j.1365-3156.2008.02031.x; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; Owusu K, 2013, THEOR APPL CLIMATOL, V112, P419, DOI 10.1007/s00704-012-0736-5; RCore Team, 2020, R LANG ENV STAT COMP; Schabenberger O., 2004, STAT METHODS SPATIAL; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Tiefelsdorf M, 2002, GEOGR ANAL, V34, P187, DOI 10.1111/j.1538-4632.2002.tb01084.x; Verma R, 2011, HUM VACCINES, V7, P883, DOI 10.4161/hv.7.8.16282; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; Wang LX, 2012, CHINESE MED J-PEKING, V125, P455, DOI 10.3760/cma.j.issn.0366-6999.2012.03.010; Wang YJ, 2015, INT J ENV RES PUB HE, V12, P767, DOI 10.3390/ijerph120100767	40	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208006	10.1371/journal.pone.0208006	http://dx.doi.org/10.1371/journal.pone.0208006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496258	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800077
J	Buxade, CPC; Sola-Perez, T; Castizo-Olier, J; Carrasco-Marginet, M; Roy, A; Marfell-Jones, M; Irurtia, A				Perez-Chirinos Buxade, Carla; Sola-Perez, Toni; Castizo-Olier, Jorge; Carrasco-Marginet, Marta; Roy, Alex; Marfell-Jones, Michael; Irurtia, Alfredo			Assessing subcutaneous adipose tissue by simple and portable field instruments: Skinfolds versus A-mode ultrasound measurements	PLOS ONE			English	Article							RESEARCH WORKING GROUP; BODY-COMPOSITION; POSITION STATEMENT; FAT THICKNESS; HEALTH; PERFORMANCE; CALIPERS; RELIABILITY; AUSPICES; BEHALF	Purpose This study compared subcutaneous adipose tissue (SAT) measurements using a skinfold caliper and Renco Lean-Meater Series 12 A-mode portable ultrasound scanner (A-US). It aimed to assess their inter-and intra-rater reliability and measure the agreement between both methods. Methods Eighty-four volunteers of different fitness levels were divided into three groups by Sigma 6 skinfolds: G1 <= 55 mm (n = 33 males); G2 > 55 mm (n = 32 males); G3 = 98.0 +/- 52.3 mm (n = 19 females). Triceps, subscapular, biceps, iliac crest, supraspinal, abdominal, front thigh and medial calf were assessed by ultrasound and skinfolds. Two technicians for both tools performed triplicate measures. Intraclass correlation (ICC), technical error of measurement (TEM) and coefficients of variation (CVs) were applied for test-retest and inter-rater reliability. Non-Parametric statistics were used in order to establish possible statistical differences and correlation between skinfolds thickness and uncompressed subcutaneous adipose tissue thickness from ultrasound. The amount of agreement between both methods was assessed with Lin's coefficient and a scatterplot of all site locations. A Bland-Altman plot was constructed to establish limits of agreement between groups and regression analysis was employed to assess the ability of skinfolds to explain the variance of ultrasound. Results Test-retest ICC for skinfolds and ultrasound were higher than 0.989 and 0.793, respectively. Inter-rater ICC for skinfolds was 0.999 with a 95% CI of 0.995 to 0.999 and for ultrasound was 0.755 with a much larger 95% CI of 0.622 to 0.841. TEMs (> 8.50%) and CVs (> 6.72%) compromised ultrasound reliability. Statistical differences were found in most of the analysed anatomical sites (p < 0.001) except in biceps G2 (Z = -1.150, p = 0.25) and G3 (Z = -1.309, p = 0.19). Good correlations (r > 0.7, p <= 0.05) were reported at almost all anatomical sites and groups except for biceps (G1: Rho = 0.26, p = 0.140) and abdominal (G2: Rho = -0.16, p = 0.38; G3: Rho = 0.43, p = 0.068). Lin's concordance correlation coefficient registered low values of agreement between skinfolds and A-mode ultrasound (ranged from-0.009-0.646). The scatterplot and the estimated regression line drawn through the midst of all anatomical sites of the whole sample had a slope of 0.51 and R-2 adjusted = 0.62 was obtained. The combined analysis between the Bland-Altman plot and the linear regression showed that specifically in the G2 and G3 groups, as the SAT increases the differences between skinfolds and ultrasounds measurements also increases. Conclusions The Renco Lean-Meater ultrasound is not interchangeable with skinfold measures. Its utility is questionable, particularly for assessing SAT in active adult populations. Its poor test-retest and inter-rater reliability as well as the lack of agreement when compared to the skinfolds would exclude the free use of the A-mode ultrasound scanner in its hypothetical replacing of the classical calipers.	[Perez-Chirinos Buxade, Carla; Castizo-Olier, Jorge; Carrasco-Marginet, Marta; Roy, Alex; Irurtia, Alfredo] Univ Barcelona, Inst Nacl Educ Fis Catalunya, Barcelona Sports Sci Res Grp, Barcelona, Spain; [Sola-Perez, Toni] Univ Vic, Dept Expt Sci & Technol, Vic, Spain; [Marfell-Jones, Michael] Univ Catolica San Antonio Murcia UCAM, Murcia, Spain	University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universidad Catolica de Murcia	Sola-Perez, T (corresponding author), Univ Vic, Dept Expt Sci & Technol, Vic, Spain.	tonisolaperez@gmail.com	IRURTIA, ALFREDO/R-3360-2019; Castizo-Olier, Jorge/AAU-4921-2021; Carrasco-Marginet, Marta/Z-3918-2019	Castizo-Olier, Jorge/0000-0003-0517-9110; Carrasco-Marginet, Marta/0000-0002-8531-0993; Irurtia, Alfredo/0000-0002-3463-6643; Sola Perez, Toni/0000-0002-2184-2720; Perez-Chirinos Buxade, Carla/0000-0001-8260-7276				Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; Akyer S.P., 2014, ANATOMY, V8, P2, DOI [10.2399/ana.14.037, DOI 10.2399/ANA.14.037]; BOOTH RAD, 1966, BRIT J NUTR, V20, P719, DOI 10.1079/BJN19660073; BORKAN GA, 1982, AM J PHYS ANTHROPOL, V58, P307, DOI 10.1002/ajpa.1330580309; FANELLI MT, 1984, AM J CLIN NUTR, V39, P703, DOI 10.1093/ajcn/39.5.703; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; GRAY DS, 1990, AM J CLIN NUTR, V51, P571, DOI 10.1093/ajcn/51.4.571; Harris-Love MO, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00172; HAYES PA, 1988, MED SCI SPORT EXER, V20, P303, DOI 10.1249/00005768-198806000-00015; Heyward V.H., 2004, APPL BODY COMPOSITIO, V2nd ed.; HIMES JH, 1979, AM J CLIN NUTR, V32, P1734, DOI 10.1093/ajcn/32.8.1734; Hyde P, 2015, UTILIZATION B MODE U; Jones MM, 2001, P SEOUL INT SPORT SC, P313; KISPERT CP, 1987, PHYS THER, V67, P917, DOI 10.1093/ptj/67.6.917; Kopinski S, 2015, INT J SPORTS MED, V36, P1134, DOI 10.1055/s-0035-1555857; Loenneke JP, 2014, CLIN PHYSIOL FUNCT I, V34, P159, DOI 10.1111/cpf.12077; Martin Moreno V, 2001, Rev Esp Salud Publica, V75, P221, DOI 10.1590/S1135-57272001000300006; McEvoy FJ, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-32; Muller W, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-095641; Muller W, 2013, BRIT J SPORT MED, V47, P1001, DOI 10.1136/bjsports-2013-092882; Muller W, 2013, BRIT J SPORT MED, V47, P1028, DOI 10.1136/bjsports-2013-092232; Muller W, 2009, SPORTS MED, V39, P85, DOI 10.2165/00007256-200939020-00001; Neves EB, 2013, REV BRAS MED ESPORTE, V19, P323, DOI 10.1590/S1517-86922013000500004; Novelo ND, 2012, N AM J AQUACULT, V74, P169, DOI 10.1080/15222055.2012.672370; O'Neill DC, 2016, INT J SPORTS MED, V37, P359, DOI 10.1055/s-0035-1565168; ORPHANIDOU C, 1994, J AM DIET ASSOC, V94, P855, DOI 10.1016/0002-8223(94)92363-9; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Renco Corporation, 2006, INSTR MAN SER; Ross WD M-JM, 1991, KINANTHROPOMETRY; Selkow NM, 2011, J ATHL TRAINING, V46, P50, DOI 10.4085/1062-6050-46.1.50; Semiz S, 2007, INT J OBESITY, V31, P53, DOI 10.1038/sj.ijo.0803414; Sloan A, 1967, J APPL PHYSIOL, V17, P967; Smith-Ryan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091750; Sundgot-Borgen J, 2010, SCAND J MED SCI SPOR, V20, P112, DOI 10.1111/j.1600-0838.2010.01190.x; Sundgot-Borgen J, 2013, BRIT J SPORT MED, V47, P1012, DOI 10.1136/bjsports-2013-092966; Toomey C, 2011, ULTRASOUND, V19, P91, DOI 10.1258/ult.2011.010057; Ulbricht L, 2012, IEEE ENG MED BIO, P1952, DOI 10.1109/EMBC.2012.6346337; Utter AC, 2008, MED SCI SPORT EXER, V40, P943, DOI 10.1249/MSS.0b013e318163f29e; Wagner DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153146; Wagner DR, 1999, RES Q EXERCISE SPORT, V70, P135, DOI 10.1080/02701367.1999.10608031; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; [No title captured], DOI DOI 10.1155/2013/280713	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0205226	10.1371/journal.pone.0205226	http://dx.doi.org/10.1371/journal.pone.0205226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496211	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800012
J	Whitfield, CA; Horsley, A; Jensen, OE				Whitfield, Carl A.; Horsley, Alex; Jensen, Oliver E.			Modelling structural determinants of ventilation heterogeneity: A perturbative approach	PLOS ONE			English	Article							INERT-GAS WASHOUT; LUNG CLEARANCE INDEX; PRESSURE; CHALLENGES; TRANSPORT; MULTIPLE; POSTURE; DISEASE	We have developed a computational model of gas mixing and ventilation in the human lung represented as a bifurcating network. We have simulated multiple-breath washout (MBW), a clinical test for measuring ventilation heterogeneity (VH) in patients with obstructive lung conditions. By applying airway constrictions inter-regionally, we have predicted the response of MBW indices to obstructions and found that they detect a narrow range of severe constrictions that reduce airway radius to 10%-30% of healthy values. These results help to explain the success of the MBW test to distinguish obstructive lung conditions from healthy controls. Further, we have used a perturbative approach to account for intra-regional airway heterogeneity that avoids modelling each airway individually. We have found, for random airway heterogeneity, that the variance in MBW indices is greater when indices are already elevated due to constrictions. By quantifying this effect, we have shown that variability in lung structure and mechanical properties alone can lead to clinically significant variability in MBW indices (specifically the Lung Clearance Index-LCI, and the gradient of phase-III slopes-S-cond), but only in cases simulating obstructive lung conditions. This method is a computationally efficient way to probe the lung's sensitivity to structural changes, and to quantify uncertainty in predictions due to random variations in lung mechanical and structural properties.	[Whitfield, Carl A.; Horsley, Alex] Univ Manchester, Div Infect Immun & Resp Med, Southmoor Rd, Manchester M23 9LT, Lancs, England; [Whitfield, Carl A.; Jensen, Oliver E.] Univ Manchester, Sch Math, Oxford Rd, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Whitfield, CA (corresponding author), Univ Manchester, Div Infect Immun & Resp Med, Southmoor Rd, Manchester M23 9LT, Lancs, England.; Whitfield, CA (corresponding author), Univ Manchester, Sch Math, Oxford Rd, Manchester M13 9PL, Lancs, England.	carl.whitfield@physics.org	Jensen, Oliver/B-5880-2008; Whitfield, Carl/J-5751-2019	Jensen, Oliver/0000-0003-0172-6578; Whitfield, Carl/0000-0001-5913-735X; Horsley, Alex/0000-0003-1828-0058	UK Medical Research Council (MRC) [MR/R024944/1]; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/K037145/1]; UK National Institute for Health Research (NIHR) [CS012-13]; NIHR; NIHR Manchester Biomedical Research Centre; EPSRC [EP/K037145/1] Funding Source: UKRI; MRC [MR/R024944/1] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CW was funded by the UK Medical Research Council (MRC) grant number MR/R024944/1. CW and OE acknowledge the UK Engineering and Physical Sciences Research Council (EPSRC) for funding through grant reference EP/K037145/1. AH was funded by a UK National Institute for Health Research (NIHR) Clinician Scientist (CS012-13). This report presents independent research funded by the NIHR. This research was also supported by the NIHR Manchester Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR or the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CAW was funded by the UK Medical Research Council (MRC) grant number MR/R024944/1. CAW and OEJ acknowledge the UK Engineering and Physical Sciences Research Council (EPSRC) for funding through grant reference EP/K037145/1. AH was funded by a UK National Institute for Health Research (NIHR) Clinician Scientist (CS012-13). This report presents independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR or the UK Department of Health.	BECKLAKE MR, 1952, THORAX, V7, P111, DOI 10.1136/thx.7.1.111; Cotes JE, 2006, LUNG FUNCTION, DOI [10.1002/9781444312829, DOI 10.1002/9781444312829]; CRAWFORD ABH, 1985, J APPL PHYSIOL, V59, P838, DOI 10.1152/jappl.1985.59.3.838; Deninger AJ, 2002, MAGN RESON MED, V48, P223, DOI 10.1002/mrm.10206; Dutrieue B, 2000, J APPL PHYSIOL, V89, P1859, DOI 10.1152/jappl.2000.89.5.1859; ENGEL LA, 1983, J APPL PHYSIOL, V54, P609, DOI 10.1152/jappl.1983.54.3.609; Florens M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178104; Foy BH, 2017, RESP PHYSIOL NEUROBI, V235, P8, DOI 10.1016/j.resp.2016.09.009; Galetke W, 2007, RESP MED, V101, P1783, DOI 10.1016/j.rmed.2007.02.015; Gronkvist M, 2002, J APPL PHYSIOL, V92, P634, DOI 10.1152/japplphysiol.00161.2001; Guennebaud G, 2010, OTHERS; Gustafsson PM, 2001, J APPL PHYSIOL, V91, P637, DOI 10.1152/jappl.2001.91.2.637; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; Henry FS, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006809; Horn FC, 2014, J APPL PHYSIOL, V116, P129, DOI 10.1152/japplphysiol.00378.2013; HORSFIEL.K, 1971, J APPL PHYSIOL, V31, P207, DOI 10.1152/jappl.1971.31.2.207; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Horsley A, 2015, PAEDIATR RESPIR REV, V16, P15, DOI 10.1016/j.prrv.2015.07.010; Horsley A, 2009, RESP MED, V103, P793, DOI 10.1016/j.rmed.2009.01.025; Horsley AR, 2008, RESP PHYSIOL NEUROBI, V162, P197, DOI 10.1016/j.resp.2008.06.014; Hsia CCW, 2016, COMPR PHYSIOL, V6, P827, DOI 10.1002/cphy.c150028; Kim M, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2730; KOBLINGER L, 1986, ACTA PHYS HUNG, V59, P31; Marshall H, 2017, THORAX, V72, P760, DOI 10.1136/thoraxjnl-2016-208948; Maury B., 2013, RESP SYSTEM EQUATION, DOI DOI 10.1007/978-88-470-5214-7; Mitchell JH, 2012, RESP PHYSIOL NEUROBI, V183, P224, DOI 10.1016/j.resp.2012.06.031; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; NEUFELD GR, 1992, RESP PHYSIOL, V88, P257, DOI 10.1016/0034-5687(92)90001-D; PAIVA M, 1973, J APPL PHYSIOL, V35, P401, DOI 10.1152/jappl.1973.35.3.401; PAIVA M, 1982, RESP PHYSIOL, V49, P325, DOI 10.1016/0034-5687(82)90120-7; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P387, DOI 10.1016/0034-5687(70)90094-0; Pozin N, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2873; Ramsey KA, 2017, J CYST FIBROS, V16, P713, DOI 10.1016/j.jcf.2017.01.013; Ritz T, 2002, PSYCHOPHYSIOLOGY, V39, P546, DOI 10.1017/S0048577202010715; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Roth CJ, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2787; Scherer PW, 1996, RESP PHYSIOL, V103, P99, DOI 10.1016/0034-5687(95)00080-1; SCHERER PW, 1975, J APPL PHYSIOL, V38, P719, DOI 10.1152/jappl.1975.38.4.719; Smith L, 2018, AM J RESP CRIT CARE, V197, P397, DOI 10.1164/rccm.201705-0894LE; Swan AJ, 2012, J THEOR BIOL, V300, P222, DOI 10.1016/j.jtbi.2012.01.042; Sznitman J, 2009, J BIOMECH, V42, P789, DOI 10.1016/j.jbiomech.2008.12.022; Tawhai MH, 2009, J APPL PHYSIOL, V107, P912, DOI 10.1152/japplphysiol.00324.2009; Tawhai MH, 2001, RESP PHYSIOL, V127, P249, DOI 10.1016/S0034-5687(01)00239-0; Teague WG, 2014, J ASTHMA, V51, P677, DOI 10.3109/02770903.2014.914535; Tippe A, 2000, J AEROSOL SCI, V31, P979, DOI 10.1016/S0021-8502(99)00572-8; Tsuda A, 2008, RESP PHYSIOL NEUROBI, V163, P139, DOI 10.1016/j.resp.2008.02.010; Verbanck S, 1997, J APPL PHYSIOL, V83, P1907, DOI 10.1152/jappl.1997.83.6.1907; VERBANCK S, 1990, J APPL PHYSIOL, V69, P2269, DOI 10.1152/jappl.1990.69.6.2269; WAGNER PD, 1979, J APPL PHYSIOL, V46, P579, DOI 10.1152/jappl.1979.46.3.579; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; Whitfield CA, 2018, PULMSIM V1 1; Yoshihara L, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2812; YU CP, 1975, RESP PHYSIOL, V23, P257, DOI 10.1016/0034-5687(75)90064-X	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208049	10.1371/journal.pone.0208049	http://dx.doi.org/10.1371/journal.pone.0208049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496317	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800086
J	Noblejas-Lopez, MD; Morcillo-Garcia, S; Nieto-Jimenez, C; Nuncia-Cantarero, M; Gyorffy, B; Galan-Moya, EM; Pandiella, A; Ocana, A				del Mar Noblejas-Lopez, Maria; Morcillo-Garcia, Sara; Nieto-Jimenez, Cristina; Nuncia-Cantarero, Miriam; Gyorffy, Balazs; Galan-Moya, Eva M.; Pandiella, Atanasio; Ocana, Alberto			Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene	PLOS ONE			English	Article							NUCLEAR COREPRESSOR 1; CHROMATIN-STRUCTURE	Regulation of transcription is a key process in cellular homeostasis. It depends on regulators that either repress or stimulate the transcription of genes, therefore controlling different biological functions. The Nuclear Receptor Corepressor 1 (NCOR1) is one of those co-repressors that regulate the transcription by facilitating the recruitment of HDAC1, 2, 3, 4, 5 and 7. In our article, by using an in silico approach, we evaluate the mutational status of NCOR1 in breast and lung tumors. We identified that NORC1 is mutated in more than 3% of breast tumors and lung adenocarcinomas and linked this fact with detrimental outcome in some subtypes, particularly in those that are hormone receptor negative. In addition to these findings, as mutations in this gene are deleterious, we confirmed that high levels of this gene were linked with good prognosis in the same tumor subtypes. Findings in the same direction were identified in lung adenocarcinomas, with mutations associated with detrimental prognosis and high expression with better outcome. In conclusion, hereby we describe the presence and prognostic role of mutations in the NCOR1 gene in hormone receptor negative breast and lung adenocarcinomas, and we also confirm that NCOR1 is a tumor suppressor gene. Further studies should be performed to explore therapeutic mechanisms to restore its function.	[del Mar Noblejas-Lopez, Maria; Morcillo-Garcia, Sara; Nieto-Jimenez, Cristina; Nuncia-Cantarero, Miriam; Galan-Moya, Eva M.; Ocana, Alberto] Albacete Univ Hosp, Translat Res Unit, Albacete, Spain; [del Mar Noblejas-Lopez, Maria; Morcillo-Garcia, Sara; Nieto-Jimenez, Cristina; Nuncia-Cantarero, Miriam; Galan-Moya, Eva M.; Ocana, Alberto] Albacete Univ Hosp, CIBERONC, Albacete, Spain; [del Mar Noblejas-Lopez, Maria; Morcillo-Garcia, Sara; Nieto-Jimenez, Cristina; Nuncia-Cantarero, Miriam; Galan-Moya, Eva M.; Ocana, Alberto] Univ Castilla La Mancha, Ctr Reg Invest Biorned, Albacete, Spain; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Gyorffy, Balazs] MTA TTK Lendulet Canc Biomarker Res Grp, Inst Enzymol, Budapest, Hungary; [Pandiella, Atanasio] CSIC, IBSAL, Canc Res Ctr, Salamanca, Spain; [Pandiella, Atanasio] CIBERONC, Salamanca, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Universidad de Castilla-La Mancha; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Galan-Moya, EM; Ocana, A (corresponding author), Albacete Univ Hosp, Translat Res Unit, Albacete, Spain.; Galan-Moya, EM; Ocana, A (corresponding author), Albacete Univ Hosp, CIBERONC, Albacete, Spain.; Galan-Moya, EM; Ocana, A (corresponding author), Univ Castilla La Mancha, Ctr Reg Invest Biorned, Albacete, Spain.	EvaMaria.Galan@uclm.es; albertoo@sescam.jccm.es	Galan-Moya, Eva M/I-2912-2015; del Mar Noblejas-López, María/AAC-5949-2020; Gyorffy, Balazs/AAA-9135-2021; Nieto, Cristina/AFV-2076-2022; Nuncia, Miriam/R-3178-2017; , Atanasio/O-5180-2014	Galan-Moya, Eva M/0000-0001-5758-7592; del Mar Noblejas-López, María/0000-0001-9250-9688; Gyorffy, Balazs/0000-0002-5772-3766; Nuncia, Miriam/0000-0002-7501-1631; Ocana, Alberto/0000-0002-1067-9630; Nieto Jimenez, Cristina/0000-0002-3463-1439; , Atanasio/0000-0002-4704-8971	Instituto de Salud Carlos III [PI16/01121]; Diputacion de Albacete and CIBERONC; CRIS Cancer Foundation; cancer association ACEPAIN; implementation research program of the UCLM (UCLM); European Commission/FSE funds	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Diputacion de Albacete and CIBERONC; CRIS Cancer Foundation; cancer association ACEPAIN; implementation research program of the UCLM (UCLM); European Commission/FSE funds	This work has been funded by Instituto de Salud Carlos III (PI16/01121 to AO), Diputacion de Albacete and CIBERONC (to AO); and CRIS Cancer Foundation (to AO and AP). We would like to also thank the cancer association ACEPAIN for supporting part of this work. EMGM is funded by the implementation research program of the UCLM (UCLM resolution date: 31/07/2014), with a contract for accessing the Spanish System of Science, Technology and Innovation-Secti (co-funded by the European Commission/FSE funds).	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Cutrupi S, 2012, ONCOGENE, V31, P4353, DOI 10.1038/onc.2011.627; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Lu RQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12044; Martinez-Iglesias O, 2016, ONCOTARGET, V7, P79871; Martinez-Iglesias O, 2016, PHARMACOL RES, V108, P75, DOI 10.1016/j.phrs.2016.04.027; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Menyhart O, 2017, ONCOTARGET, V8, P77207, DOI 10.18632/oncotarget.20430; Mihaly Z, 2013, BREAST CANCER RES TR, V140, P219, DOI 10.1007/s10549-013-2622-y; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Pongor L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0228-1	18	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207776	10.1371/journal.pone.0207776	http://dx.doi.org/10.1371/journal.pone.0207776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485330	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000451755800080
J	Heiderer, M; Westenberg, C; Li, DS; Zhang, HM; Preininger, D; Dungl, E				Heiderer, Martina; Westenberg, Carmen; Li, Desheng; Zhang, Hemin; Preininger, Doris; Dungl, Eveline			Giant panda twin rearing without assistance requires more interactions and less rest of the mother-A case study at Vienna Zoo	PLOS ONE			English	Article							AILUROPODA-MELANOLEUCA; MATERNAL-CARE; REPRODUCTIVE SUCCESS; POLAR BEARS; GROWTH; EXPERIENCE; BEHAVIOR; IMPACT; CUBS; FOOD	The giant pandas' (Ailuropoda melanoleuca) reproductive strategy is unique among mammals. Yet there are characteristics of giant panda behaviour we do not fully understand. Probably one of the least understood is the assumption that in captivity virtually all giant panda females rear only one cub when twins are born and abandon the other if given the chance. So far, only two females have raised twins simultaneously, but just with intensive human assistance. This case-study marks the first successful rearing of giant panda twins in captivity entirely by the mother. Using video data for detailed behavioural observations, we provide the first behavioural assessment of a giant panda female raising two cubs simultaneously without direct human assistance or disturbance. We compared the maternal behaviour during the denning period of twin cubs raised in 2016 with two singleton cubs born 2007 and 2010. YANG YANG, the dam, rested less and interacted more with the twins than with the singletons in the first month postpartum and invested a greater part of her daily time budget on rearing the twins. We discuss potential favourable factors for the autonomous twin-rearing of a female giant panda, which could serve as a model for similar efforts elsewhere.	[Heiderer, Martina; Westenberg, Carmen; Preininger, Doris; Dungl, Eveline] Tiergarten Schonbrunn GmbH, Vienna, Austria; [Li, Desheng; Zhang, Hemin] Wolong Nat Reserve Adm Bur, Dujangyan City, Peoples R China		Heiderer, M (corresponding author), Tiergarten Schonbrunn GmbH, Vienna, Austria.	m.heiderer@zoovienna.at		Preininger, Doris/0000-0001-6842-1133	Vienna Zoo	Vienna Zoo	This work was supported by the Vienna Zoo, employer of authors. The funder provided support in the form of salaries for authors [MH, CW, DP, EW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AMSTRUP SC, 1993, ARCTIC, V46, P246; BAKER A, 1994, ZOO BIOL, V13, P413, DOI 10.1002/zoo.1430130504; Baker AJ, 1996, WILD MAMMALS CAPTIVI; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; CRES GPCU, 2007, GIANT PAND ETH; CURIO E, 1987, IBIS, V129, P344, DOI 10.1111/j.1474-919X.1987.tb03178.x; Czekala N, 2003, ZOO BIOL, V22, P389, DOI 10.1002/zoo.10108; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; Edwards MS, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P315, DOI 10.1017/CBO9780511542244.014; Fletcher QE, 2012, FUNCT ECOL, V26, P677, DOI 10.1111/j.1365-2435.2012.01975.x; Garshelis DL, 2004, GIANT PANDAS BIOL CO; Hall SS, 2009, URSUS, V20, P143, DOI 10.2192/09SC001.1; Heiderer M., 2014, THESIS; Huang Xiangming, 2005, Acta Theriologica Sinica, V25, P390; Huang Xiangming, 2007, Acta Theriologica Sinica, V27, P267; Iibuchi R, 2009, JPN J VET RES, V57, P13; KLEIMAN DG, 1983, Z TIERPSYCHOL, V62, P1; Koskela E, 1998, P ROY SOC B-BIOL SCI, V265, P1129, DOI 10.1098/rspb.1998.0408; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Liu Weixin, 1988, International Zoo Yearbook, V27, P304; LU Z, 1994, ZOO BIOL, V13, P567, DOI 10.1002/zoo.1430130606; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McGeehan L, 2002, ZOO BIOL, V21, P449, DOI 10.1002/zoo.10047; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; OCONNOR RJ, 1978, ANIM BEHAV, V26, P79, DOI 10.1016/0003-3472(78)90008-8; Oftedal OT, 2000, P NUTR SOC, V59, P99, DOI 10.1017/S0029665100000124; Owen MA, 2004, ZOO BIOL, V23, P147, DOI 10.1002/zoo.10124; Peel R.R., 1979, International Zoo Yearbook, V19, P177, DOI 10.1111/j.1748-1090.1979.tb00558.x; Peng JJ, 2007, APPL ANIM BEHAV SCI, V104, P151, DOI 10.1016/j.applanim.2006.04.029; Peng JJ, 2001, J ZOOL, V254, P261, DOI 10.1017/S0952836901000772; Powell DM, 2002, 4 INT S PHYSL BEH WI; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Schai-Braun SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134278; Schaller G.B., 1989, P212; Schaller GB, 1985, THE GIANT PANDAS OF; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Singh P., 2016, IMPERIAL J INTERDISC, V3; Snyder RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27509; Swaisgood RR, 2000, ANIM BEHAV, V60, P227, DOI 10.1006/anbe.2000.1464; Swaisgood RR, 2003, ZOO BIOL, V22, P347, DOI 10.1002/zoo.10111; Swenson J, 1997, WINTER ABANDONMENT B, P35; Synder RJ, 2003, J COMP PSYCHOL, V117, P235, DOI 10.1037/0735-7036.117.3.235; TAIT DEN, 1980, AM NAT, V115, P800, DOI 10.1086/283601; THOMPSON SD, 1986, NATURE, V321, P690, DOI 10.1038/321690a0; van Gessel C, 2015, ZOO BIOL, V34, P453, DOI 10.1002/zoo.21232; Wei RP, 2009, ZOO BIOL, V28, P331, DOI 10.1002/zoo.20232; Zhang GQ, 2000, ZOO BIOL, V19, P53, DOI 10.1002/(SICI)1098-2361(2000)19:1&lt;53::AID-ZOO6&gt;3.0.CO;2-9; Zhang GQ, 2004, ZOO BIOL, V23, P15, DOI 10.1002/zoo.10118; Zhang GQ, 1996, ZOO BIOL, V15, P13, DOI 10.1002/(SICI)1098-2361(1996)15:1<13::AID-ZOO2>3.0.CO;2-F; Zhang Z, 2006, GIANT PANDAS BIOLOGY; Zhu XJ, 2001, J ZOOL, V253, P141, DOI 10.1017/S0952836901000139	54	5	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207433	10.1371/journal.pone.0207433	http://dx.doi.org/10.1371/journal.pone.0207433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485373	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800068
J	Hilsden, RJ; Heitman, SJ; Mizrahi, B; Narod, SA; Goshen, R				Hilsden, Robert J.; Heitman, Steven J.; Mizrahi, Barak; Narod, Steven A.; Goshen, Ran			Prediction of findings at screening colonoscopy using a machine learning algorithm based on complete blood counts (ColonFlag)	PLOS ONE			English	Article							SOCIETY TASK-FORCE; COLORECTAL-CANCER; RECOMMENDATIONS	Adenomatous polyps are a common precursor lesion for colorectal cancer. ColonFlag is a machine-learning-based algorithm that uses basic patient information and complete blood cell counts (CBC) to identify individuals at elevated risk of colorectal cancer for intensified screening. The purpose of this study was to determine whether ColonFlag is also able to predict the presence of high risk adenomatous polyps at colonoscopy. This study was conducted at a large colon cancer screening center in Calgary, Alberta. The study population included asymptomatic individuals between the ages of 50 and 75 who underwent a screening colonoscopy between January 2013 and June 2015. All subjects had at least one CBC result within the year prior to colonoscopy. Based on age, sex, red blood cell parameters, inflammatory cells and platelets, the ColonFlag algorithm generated a score from 0 to 100. We compared the ability of the ColonFlag test result to discriminate between individuals who were found to have a high risk polyp and those with a normal colonoscopy. Among the 17,676 individuals who underwent a screening colonoscopy there were 1,014 found to have a high risk precancerous lesion (5.7%) and 60 were found to have colorectal cancer (0.3%). At a specificity of 95%, the odds ratio for a positive ColonFlag was 2.0 for those with an advanced precancerous lesion compared with those with a normal colonoscopy. The odds ratio did not vary according to patient subgroup, colorectal cancer location or stage. ColonFlag is a passive test that can use routine blood test results to help identify individuals at elevated risk for high risk precancerous polyps as well as frank colorectal cancer. These individuals may be targeted in an effort to achieve greater compliance with conventional screening tests.	[Hilsden, Robert J.; Heitman, Steven J.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Hilsden, Robert J.; Heitman, Steven J.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Mizrahi, Barak] Medial Canc Res, Kfar Malal, Israel; [Narod, Steven A.] Womens Coll Hosp, Womens Coll Res Inst, Familial Breast Canc Res Unit, Toronto, ON, Canada; [Narod, Steven A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Goshen, Ran] Medial Early Sign, Kfar Malal, Israel	University of Calgary; University of Calgary; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto	Hilsden, RJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada.; Hilsden, RJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.	rhilsden@ucalgary.ca	Narod, Steven A/AAA-6112-2022	Hilsden, Robert/0000-0003-1545-1093	Medial Early Sign Inc., Kfar Malal, Israel	Medial Early Sign Inc., Kfar Malal, Israel	This research was funded by a contract to the University of Calgary from Medial Early Sign Inc., Kfar Malal, Israel. RG, EC, DW, BM and RY are employees of Medial EarlySign, Inc and were involved in the study concept, development of the research protocol, statistical analysis and writing of the manuscript.	Altobelli E, 2014, PREV MED, V62, P132, DOI 10.1016/j.ypmed.2014.02.010; [Anonymous], 2010, AJCC CANC STAGING HD; Atkinson TM, 2015, J BEHAV MED, V38, P837, DOI 10.1007/s10865-015-9668-8; Canadian Task Force Preventive Hlt, 2016, CAN MED ASSOC J, V188, P340, DOI 10.1503/cmaj.151125; Driman DK, 2012, CANADIAN J PATHOL, V4, P81; Goshen R, 2017, BRIT J CANCER, V116, P944, DOI 10.1038/bjc.2017.53; Hornbrook MC, 2017, DIGEST DIS SCI, V62, P2719, DOI 10.1007/s10620-017-4722-8; Kinar Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171759; Kinar Y, 2016, J AM MED INFORM ASSN, V23, P879, DOI 10.1093/jamia/ocv195; Klabunde C, 2015, J MED SCREEN, V22, P119, DOI 10.1177/0969141315584694; Ma GK, 2014, CLIN GASTROENTEROL H, V12, P1624, DOI 10.1016/j.cgh.2014.01.042; Rex DK, 2017, AM J GASTROENTEROL, V112, P1016, DOI 10.1038/ajg.2017.174; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Ritvo PG, 2015, CANCER EPIDEM BIOMAR, V24, P506, DOI 10.1158/1055-9965.EPI-14-0744; Robertson DJ, 2017, GASTROINTEST ENDOSC, V85, P2, DOI 10.1016/j.gie.2016.09.025; White A, 2017, MMWR-MORBID MORTAL W, V66, P1, DOI 10.15585/mmwr.mm6608a1	16	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207848	10.1371/journal.pone.0207848	http://dx.doi.org/10.1371/journal.pone.0207848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481208	gold, Green Submitted, Green Published			2022-12-26	WOS:000451440000025
J	Dooner, MS; Stewart, C; Deng, YH; Papa, E; Pereira, M; Del Tatto, M; Johnson, S; Wen, SC; Amaral, A; Aliotta, J; Quesenberry, PJ; Goldberg, LR				Dooner, Mark S.; Stewart, Connor; Deng, Yanhui; Papa, Elaine; Pereira, Mandy; Del Tatto, Michael; Johnson, Shannon; Wen, Sicheng; Amaral, Ashley; Aliotta, Jason; Quesenberry, Peter J.; Goldberg, Laura R.			Daily rhythms influence the ability of lung-derived extracellular vesicles to modulate bone marrow cell phenotype	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; PROGENITOR/STEM; MICROVESICLES; EXPRESSION; CLOCKS	Extracellular vesicles (EVs) are important mediators of intercellular communication and have been implicated in myriad physiologic and pathologic processes within the hematopoietic system. Numerous factors influence the ability of EVs to communicate with target marrow cells, but little is known about how circadian oscillations alter EV function. In order to explore the effects of daily rhythms on EV-mediated intercellular communication, we used a well-established model of lung-derived EV modulation of the marrow cell transcriptome. In this model, co-culture of whole bone marrow cells (WBM) with lung-derived EVs induces expression of pulmonary specific mRNAs in the target WBM. To determine if daily rhythms play a role in this phenotype modulation, C57BL/6 mice were entrained in 12-hour light/12-hour dark boxes. Lungs harvested at discrete time-points throughout the 24-hour cycle were co-cultured across a cell-impermeable membrane with murine WBM. Alternatively, WBM harvested at discrete time-points was co-cultured with lung-derived EVs. Target WBM was collected 24hrs after co-culture and analyzed for the presence of pulmonary specific mRNA levels by RT-PCR. In both cases, there were clear time-dependent variations in the patterns of pulmonary specific mRNA levels when either the daily time-point of the lung donor or the daily time-point of the recipient marrow cells was altered. In general, WBM had peak pulmonary-specific mRNA levels when exposed to lung harvested at Zeitgeber time (ZT) 4 and ZT 16 (ZT 0 defined as the time of lights on, ZT 12 defined as the time of lights off), and was most susceptible to lung-derived EV modulation when target marrow itself was harvested at ZT 8-ZT 12. We found increased uptake of EVs when the time-point of the receptor WBM was between ZT 20 -ZT 24, suggesting that the time of day-dependent changes in transcriptome modulation by the EVs were not due simply to differential EV uptake. Based on these data, we conclude that circadian rhythms can modulate EV-mediated intercellular communication.	[Dooner, Mark S.; Stewart, Connor; Deng, Yanhui; Papa, Elaine; Pereira, Mandy; Del Tatto, Michael; Johnson, Shannon; Wen, Sicheng; Amaral, Ashley; Aliotta, Jason; Quesenberry, Peter J.; Goldberg, Laura R.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med,Div Hematol Oncol, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Goldberg, LR (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med,Div Hematol Oncol, Providence, RI 02903 USA.	lgoldberg@lifespan.org		Johnson, Shannon/0000-0002-6758-224X; Dooner, Mark/0000-0003-0653-6562	Herbert W. Savit 1949 Research Fellowship; Rhode Island Foundation Medical Research Grant	Herbert W. Savit 1949 Research Fellowship; Rhode Island Foundation Medical Research Grant	This project was supported by the Herbert W. Savit 1949 Research Fellowship and the Rhode Island Foundation Medical Research Grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding institutions.	Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Aliotta JM, 2016, CARDIOVASC RES, V110, P319, DOI 10.1093/cvr/cvw054; Aliotta JM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26166; Aliotta JM, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18163; Aliotta JM, 2012, STEM CELLS DEV, V21, P1627, DOI 10.1089/scd.2011.0550; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Castagna A, 2015, PROTEOM CLIN APPL, V9, P623, DOI 10.1002/prca.201400198; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Collino F, 2015, J AM SOC NEPHROL, V26, P2349, DOI 10.1681/ASN.2014070710; D'Hondt L, 2004, J CELL PHYSIOL, V200, P63, DOI 10.1002/jcp.20032; Danielson KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144678; Duffy JF, 2015, SLEEP MED CLIN, V10, P423, DOI 10.1016/j.jsmc.2015.08.002; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Feillet C, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur2015.00096, 10.3389/fneur.2015.00096]; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Kim Chung Mi, 2003, Korean Journal of Internal Medicine, V18, P76; Madden LA, 2008, THROMB HAEMOSTASIS, V99, P909, DOI [10.1160TH008-01-0030, 10.1160/TH008-01-0030]; Masri S, 2015, CURR OPIN ONCOL, V27, P50, DOI 10.1097/CCO.0000000000000153; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; Mullier F, 2013, J THROMB HAEMOST, V11, P693, DOI 10.1111/jth.12171; Paiva B, 2013, BLOOD, V122, P3591, DOI 10.1182/blood-2013-06-510453; Quesenberry PJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27575; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Thery C, 2015, NATURE, V523, P161, DOI 10.1038/nature14626; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; van der Meel R, 2014, INT J LAB HEMATOL, V36, P244, DOI 10.1111/ijlh.12247; Videnovic A, 2014, NAT REV NEUROL, V10, P683, DOI 10.1038/nrneurol.2014.206; Wen S, 2016, LEUKEMIA, V30, P2221, DOI 10.1038/leu.2016.107; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Wood PA, 1998, EXP HEMATOL, V26, P523	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207444	10.1371/journal.pone.0207444	http://dx.doi.org/10.1371/journal.pone.0207444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475846	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700032
J	Gonzalez-Ramos, S; Paz-Garcia, M; Rius, C; del Monte-Monge, A; Rodriguez, C; Fernandez-Garcia, V; Andres, V; Martinez-Gonzalez, J; Lasuncion, MA; Martin-Sanz, P; Soehnlein, O; Bosca, L				Gonzalez-Ramos, Silvia; Paz-Garcia, Marta; Rius, Cristina; del Monte-Monge, Alberto; Rodriguez, Cristina; Fernandez-Garcia, Victoria; Andres, Vicente; Martinez-Gonzalez, Jose; Lasuncion, Miguel A.; Martin-Sanz, Paloma; Soehnlein, Oliver; Bosca, Lisardo			Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1	FASEB JOURNAL			English	Article						cardiovascular disease; innate immunity; leukocyte	NF-KAPPA-B; ADHESION MOLECULES; DYSFUNCTION; ACTIVATION; EXPRESSION; HYPERCHOLESTEROLEMIA; PROLIFERATION; PEPTIDOGLYCAN; INFLAMMATION; MECHANISMS	Atherosclerosis is a chronic disease characterized by vascular lipid retention and inflammation, and pattern recognition receptors (PRRs) are important contributors in early stages of the disease. Given the implication of the intracellular PRR nucleotide-binding oligomerization domain 1 (NOD1) in cardiovascular diseases, we investigated its contribution to early atherosclerosis. We evidenced NOD1 induction in atherosclerotic human and mouse tissues, predominantly in vascular endothelial cells. Accordingly, NOD1 genetic inactivation in Apoe(-/-) mice reduced not only atherosclerosis burden, but also monocyte and neutrophil accumulation in atheromata. Of note, in the presence of either peptidoglycan or oxidized LDLs, endothelial NOD1 triggered VCAM-1 up-regulation through the RIP2-NF-B axis in an autocrine manner, enhancing firm adhesion of both sets of myeloid cells to the inflamed micro- and macrovasculature in vivo. Our data define a major proatherogenic role for endothelial NOD1 in early leukocyte recruitment to the athero-prone vasculature, thus introducing NOD1 as an innovative therapeutic target and potential prognostic molecule.Gonzalez-Ramos, S., Paz-Garcia, M., Rius, C., del Monte-Monge, A., Rodriguez, C., Fernandez-Garcia, V., Andres, V., Martinez-Gonzalez, J., Lasuncion, M. A., Martin-Sanz, P., Soehnlein, O., Bosca, L. Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1.	[Gonzalez-Ramos, Silvia; Paz-Garcia, Marta; Fernandez-Garcia, Victoria; Martin-Sanz, Paloma; Bosca, Lisardo] UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain; [Gonzalez-Ramos, Silvia; Paz-Garcia, Marta; del Monte-Monge, Alberto; Rodriguez, Cristina; Fernandez-Garcia, Victoria; Andres, Vicente; Martinez-Gonzalez, Jose; Martin-Sanz, Paloma; Bosca, Lisardo] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Rius, Cristina; del Monte-Monge, Alberto; Andres, Vicente] CNIC, Madrid, Spain; [Rodriguez, Cristina] Hosp Santa Creu & Sant Pau, Inst Recerca, ICCC, Barcelona, Spain; [Martinez-Gonzalez, Jose] CSIC, IIBB, St Pau Biomed Res Inst IIB St Pau, Barcelona, Spain; [Lasuncion, Miguel A.] Hosp Univ Ramon & Cajal IRyCIS, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Soehnlein, Oliver] Ludwig Maximilians Univ LMU, Inst Cardiovasc Prevent, Munich, Germany; [Soehnlein, Oliver] Karolinska Inst, Stockholm, Sweden; [Soehnlein, Oliver] Partner Site Munich Heart Alliance MHA, German Ctr Cardiovasc Res DZHK, Berlin, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital Universitario Ramon y Cajal; University of Munich; Karolinska Institutet; German Centre for Cardiovascular Research; Munich Heart Alliance	Bosca, L (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.; Soehnlein, O (corresponding author), Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Pettenkoferstr 9, D-80336 Munich, Germany.	oliver.soehnlein@gmail.com; lbosca@iib.uam.es	Del Monte Monge, Alberto/AAB-6859-2021; Andres, Vicente/I-6440-2014; Lasunción, Miguel A./K-6167-2014; Rodriguez, Cristina/D-3099-2011	Del Monte Monge, Alberto/0000-0002-6382-9639; Andres, Vicente/0000-0002-0125-7209; Lasunción, Miguel A./0000-0003-0299-9391; Rodriguez, Cristina/0000-0002-6472-5647; Fernandez-Garcia, Victoria/0000-0003-2521-0146	Ministry of Science, Innovation and Universities [SAF2015-64767-R, SAF2016-79490-R, SAF2015-70747-R, SAF2016-75004-R, SAF2017-82436-R/RTC2017-6283-1]; Center for Biomedical Research Network Consortium in Cardiovascular Diseases [CB16/11/00257, CB16/11/00405, CB/11/00222]; Community of Madrid Grant [BMD/3686]; German Research Foundation [SFB914 TP A02/B08/B09/Z03, SFB1123 TP A06/B05/B08/Z01]; Netherlands Organization for Scientific Research [91712303]; European Regional Development Fund	Ministry of Science, Innovation and Universities; Center for Biomedical Research Network Consortium in Cardiovascular Diseases; Community of Madrid Grant; German Research Foundation(German Research Foundation (DFG)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Regional Development Fund(European Commission)	The authors thank Gabriel Nunez (Department of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA) for providing Nod1<SUP>-/-</SUP> mice and Javier Perez (Instituto de Investigaciones Biomedicas Alberto) for preparing scientific drawings. This work was supported by the the Ministry of Science, Innovation and Universities (Grants SAF2015-64767-R, SAF2016-79490-R, SAF2015-70747-R, SAF2016-75004-R, SAF2017-82436-R/RTC2017-6283-1), the Center for Biomedical Research Network Consortium in Cardiovascular Diseases (Grants CB16/11/00257, CB16/11/00405, CB/11/00222), Community of Madrid Grant BMD/3686, the German Research Foundation (Grants SFB914 TP A02/B08/B09/Z03, SFB1123 TP A06/B05/B08/Z01), and the Netherlands Organization for Scientific Research (VIDI project 91712303). This project was also financed, in part, by the European Regional Development Fund. O.S. and L.B. contributed equally as senior authors. The authors declare no conflicts of interest.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Brown RA, 2017, AM J MED, V130, P268, DOI 10.1016/j.amjmed.2016.10.022; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Cid MC, 2000, ARTHRITIS RHEUM-US, V43, P184, DOI 10.1002/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Fueger BJ, 2006, J NUCL MED, V47, P999; Fuster JJ, 2011, ARTERIOSCL THROM VAS, V31, P2455, DOI 10.1161/ATVBAHA.111.235580; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gopal K, 2010, J THROMB THROMBOLYS, V30, P154, DOI 10.1007/s11239-010-0446-8; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Kanno S, 2015, J IMMUNOL, V194, P773, DOI 10.4049/jimmunol.1302841; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lee ES, 2012, J SURG RES, V177, P373, DOI 10.1016/j.jss.2012.06.021; Lee IT, 2014, CLIN SCI, V127, P375, DOI 10.1042/CS20130816; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lichtenstein L, 2015, CARDIOVASC RES, V106, P314, DOI 10.1093/cvr/cvv109; Liu JR, 2014, INFLAMMATION, V37, P522, DOI 10.1007/s10753-013-9766-0; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Martin BJ, 2009, CAN J CARDIOL, V25, p15A, DOI 10.1016/S0828-282X(09)71049-9; Motomura Y, 2015, ARTERIOSCL THROM VAS, V35, P1423, DOI 10.1161/ATVBAHA.114.304846; Ogawa H, 2003, J IMMUNOL, V170, P5956, DOI 10.4049/jimmunol.170.12.5956; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ortega-Gomez A, 2016, CIRCULATION, V134, P1176, DOI 10.1161/CIRCULATIONAHA.116.024790; Pirillo A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152786; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Prieto P, 2014, CLIN SCI, V127, P665, DOI 10.1042/CS20140180; Rius C, 2015, METHODS MOL BIOL, V1339, P357, DOI 10.1007/978-1-4939-2929-0_26; Schmidt EP, 2016, COMPR PHYSIOL, V6, P945, DOI 10.1002/cphy.c150020; Swirski FK, 2013, CIRC RES, V112, P744, DOI 10.1161/CIRCRESAHA.113.300867; Val-Blasco A, 2017, J AM COLL CARDIOL, V69, P423, DOI 10.1016/j.jacc.2016.10.073; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Yang H, 2015, APOPTOSIS, V20, P512, DOI 10.1007/s10495-015-1089-1; Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zimmer S, 2015, CIRC RES, V116, P323, DOI 10.1161/CIRCRESAHA.116.301135	44	19	19	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3912	3921		10.1096/fj.201801231RR	http://dx.doi.org/10.1096/fj.201801231RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496704	Green Submitted, Bronze			2022-12-26	WOS:000459794800065
J	Yan, TT; Jiang, XP; Lin, GA; Tang, D; Zhang, JH; Guo, XW; Zhang, DX; Zhang, Q; Jia, JZ; Huang, YS				Yan, Tiantian; Jiang, Xupin; Lin, Guoan; Tang, Di; Zhang, Junhui; Guo, Xiaowei; Zhang, Dongxia; Zhang, Qiong; Jia, Jiezhi; Huang, Yuesheng			Autophagy is required for the directed motility of keratinocytes driven by electric fields	FASEB JOURNAL			English	Article						wound healing; reepithelialization; autophagosome; directional electrical signals	MESENCHYMAL TRANSITION; CELL-MIGRATION; ADHESION; STIMULATION; APOPTOSIS; TRANSPORT; PATHWAYS; REPAIR; CA2+; CUE	Endogenous wound electric fields (EFs), an important and fundamental occurrence of wound healing, profoundly influence the directed migration of keratinocytes. Although numerous studies have unveiled the signals responsible for EF-biased direction, the mechanisms by which EFs promote keratinocyte motility remains to be elucidated. In our study, EFs enhanced the directed migratory speed of keratinocytes by inducing autophagic activity, thereby facilitating skin barrier restoration. Initially, we found that electrical signals directed keratinocytes to the cathode with enhanced motility parameters [i.e., trajectory distance, trajectory speed, displacement distance, and displacement speed (T-d/t)] and more efficient migration (directionality and T-d/t along the x axis, among others). Meanwhile, EFs induced a time-dependent increase in autophagic activity in keratinocytes, with constant autophagic flux, accompanied by increased transcription of numerous autophagy-related genes. Deficiency in Atg5, a key protein necessary for autophagosome formation, led to significant reduction of autophagy, which was accompanied by a substantial reduction in EF-stimulated directed motility. These results demonstrated a causal relationship between autophagy and EF-directed migratory speed. In addition, both cell migration under normal conditions and EF-biased directionality were autophagy independent. Thus, our findings define autophagy as an important functional regulator of electrically enhanced directed motility, adding to a growing understanding of EFs.Yan, T., Jiang, X., Lin, G., Tang, D., Zhang, J., Guo, X., Zhang, D., Zhang, Q., Jia, J., Huang, Y. Autophagy is required for the directed motility of keratinocytes driven by electric fields.	[Yan, Tiantian; Jiang, Xupin; Tang, Di; Zhang, Junhui; Zhang, Dongxia; Zhang, Qiong; Jia, Jiezhi; Huang, Yuesheng] Third Mil Med Univ, Army Med Univ, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res,Southwest Hosp, Gaotanyan Main St 30, Chongqing 400038, Peoples R China; [Yan, Tiantian; Lin, Guoan] Peoples Liberat Army, Mil Burn Ctr, Hosp 990 159, Zhumadian, Peoples R China; [Guo, Xiaowei] Peoples Liberat Army, Hosp 205, Dept Burns & Plast Surg, Jinzhou, Peoples R China	Army Medical University	Huang, YS (corresponding author), Third Mil Med Univ, Army Med Univ, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res,Southwest Hosp, Gaotanyan Main St 30, Chongqing 400038, Peoples R China.	yshuangtmmu@163.com			National Key Research and Development Program [2017YFC1103302]; Key Program of the National Natural Science Foundation of China [81430042]; Science Foundation for the Excellent Youth Scholars of the Third Military Medical University [2017MPRC-05]; Innovation Program of Southwest Hospital [SWH2016JSYB-02]	National Key Research and Development Program; Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for the Excellent Youth Scholars of the Third Military Medical University; Innovation Program of Southwest Hospital	This work was supported by National Key Research and Development Program Grant 2017YFC1103302 (to Y.H.); Key Program of the National Natural Science Foundation of China Grant 81430042 (to Y.H.); Science Foundation for the Excellent Youth Scholars of the Third Military Medical University Grant 2017MPRC-05 (to X.J.); and Innovation Program of Southwest Hospital Grant SWH2016JSYB-02 (to X.J.). The authors declare no conflicts of interest.	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Allen GM, 2013, CURR BIOL, V23, P560, DOI 10.1016/j.cub.2013.02.047; Busschaert N, 2017, NAT CHEM, V9, P667, DOI [10.1038/nchem.2706, 10.1038/NCHEM.2706]; Cicchini M, 2015, CLIN CANCER RES, V21, P498, DOI 10.1158/1078-0432.CCR-13-2438; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; East DA, 2013, AUTOPHAGY, V9, P1710, DOI 10.4161/auto.25367; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Funk RHW, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00143; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Guo XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10289; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoare JI, 2016, J LEUKOCYTE BIOL, V99, P1141, DOI 10.1189/jlb.3A0815-390R; Huttenlocher A, 2007, NEW ENGL J MED, V356, P303, DOI 10.1056/NEJMcibr066496; Iglesia DDS, 1996, J EXP ZOOL, V274, P56, DOI 10.1002/(SICI)1097-010X(19960101)274:1<56::AID-JEZ6>3.0.CO;2-E; Kenific CM, 2016, J CELL SCI, V129, P3685, DOI 10.1242/jcs.188490; Kenific CM, 2016, J CELL BIOL, V212, P577, DOI 10.1083/jcb.201503075; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KLYCE SD, 1982, J MEMBRANE BIOL, V66, P133, DOI 10.1007/BF01868489; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kondratskyi A, 2018, AUTOPHAGY, V14, P3, DOI 10.1080/15548627.2017.1384887; La Rovere RML, 2016, CELL CALCIUM, V60, P74, DOI 10.1016/j.ceca.2016.04.005; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Li J, 2011, LAB CHIP, V11, P1298, DOI 10.1039/c0lc00371a; Liu H, 2017, AUTOPHAGY, V13, P900, DOI 10.1080/15548627.2017.1291479; Liu Q, 2014, INT J BIOCHEM CELL B, V55, P264, DOI 10.1016/j.biocel.2014.09.014; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Martin P, 2015, BRIT J DERMATOL, V173, P370, DOI 10.1111/bjd.13954; Martinet W, 2006, J HISTOCHEM CYTOCHEM, V54, P85, DOI 10.1369/jhc.5A6743.2005; MCGAHAN MC, 1982, BIOCHIM BIOPHYS ACTA, V689, P385, DOI 10.1016/0005-2736(82)90273-5; Messerli MA, 2011, BIOL BULL-US, V221, P79, DOI 10.1086/BBLv221n1p79; Nuccitelli R, 2008, WOUND REPAIR REGEN, V16, P432, DOI 10.1111/j.1524-475X.2008.00389.x; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; Reid B, 2007, NAT PROTOC, V2, P661, DOI 10.1038/nprot.2007.91; Rognoni E, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178174; Sharifi MN, 2016, CELL REP, V15, P1660, DOI 10.1016/j.celrep.2016.04.065; Simpson MJ, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0413-5; Singh SS, 2018, ONCOGENE, V37, P1142, DOI 10.1038/s41388-017-0046-6; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Sun YH, 2013, CURR BIOL, V23, P569, DOI 10.1016/j.cub.2013.02.026; Thulabandu V, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.307; Tuloup-Minguez V, 2013, CELL CYCLE, V12, P3317, DOI 10.4161/cc.26298; White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490; Willenborg S, 2014, J DTSCH DERMATOL GES, V12, P214, DOI 10.1111/ddg.12290; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Yan TT, 2017, J DERMATOL SCI, V85, P96, DOI 10.1016/j.jdermsci.2016.11.007; Yan TT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169155; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2010, ADV WOUND CARE-SER, V1, P567, DOI 10.1089/awc.2009.0021; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	55	7	9	2	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3922	3935		10.1096/fj.201801294R	http://dx.doi.org/10.1096/fj.201801294R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509146	Bronze			2022-12-26	WOS:000459794800066
J	Zheng, WW; Li, XL; Liu, DQ; Li, J; Yang, S; Gao, Z; Wang, ZN; Yokota, H; Zhang, P				Zheng, Weiwei; Li, Xinle; Liu, Daquan; Li, Jie; Yang, Shuang; Gao, Zhe; Wang, Zhaonan; Yokota, Hiroki; Zhang, Ping			Mechanical loading mitigates osteoarthritis symptoms by regulating endoplasmic reticulum stress and autophagy	FASEB JOURNAL			English	Article						OA; eIF2alpha; P62; knee load; non-invasive physical therapy	UNFOLDED PROTEIN RESPONSE; BONE-FORMATION; MURINE TIBIAE; ER STRESS; KNEE; CARTILAGE; HISTOPATHOLOGY; STIMULATION; ACTIVATION; FREQUENCY	Osteoarthritis (OA) is a disease characterized by cartilage damage and abnormal remodeling of subchondral bone. Our previous study showed that in the early stage of OA, knee loading exerts protective effects by suppressing osteoclastogenesis through Wnt signaling, but little is known about loading effects at the late OA stage. Endoplasmic reticulum (ER) stress and autophagy are known to be involved in the late OA stage. We determined the effects of mechanical loading on ER stress and autophagy in OA mice. One hundred seventy-four mice were used for a surgery-induced OA model. In the first set of experiments, 60 mice were devoted to evaluation of the role of ER stress and autophagy in the development of OA. In the second set, 114 mice were used to assess the effect of knee loading on OA. Histologic, cellular, microcomputed tomography, and electron microscopic analyses were performed to evaluate morphologic changes, ER stress, and autophagy. Mechanical loading increased phosphorylation of eukaryotic translation initiation factor 2 (eIF2) and regulated expressions of autophagy markers LC3II/I and p62. Osteoarthritic mice also exhibited an elevated ratio of calcified cartilage to total articular cartilage (CC/TAC), and synovial hyperplasia with increased lining cells was found. At the early disease stage, subchondral bone plate thinning and reduced subchondral bone volume fraction (B.Ar/T.Ar) were observed. At the late disease stages, subchondral bone plate thickened concomitant with increased B.Ar/T.Ar. Mice subjected to mechanical loading exhibited resilience to cartilage destruction and a correspondingly reduced Osteoarthritis Research Society International score at 4 and 8 wk, as well as a decrease in synovitis and CC/TAC. While chondrocyte numbers in the OA group was notably decreased, mechanical loading restored chondrogenic differentiation. These results demonstrate that mechanical loading can retard the pathologic progression of OA at its early and late stages. The observed effects of loading are associated with the regulations of ER stress and autophagy.Zheng, W., Li, X., Liu, D., Li, J., Yang, S., Gao, Z., Wang, Z., Yokota, H., Zhang, P. Mechanical loading mitigates osteoarthritis symptoms by regulating endoplasmic reticulum stress and autophagy.	[Zheng, Weiwei; Li, Xinle; Liu, Daquan; Li, Jie; Yang, Shuang; Gao, Zhe; Wang, Zhaonan; Zhang, Ping] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Metab Dis, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Li, Xinle; Liu, Daquan; Li, Jie; Yang, Shuang; Zhang, Ping] Chinese Acad Med Sci, Int Cardiovasc Hosp, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China; [Li, Xinle; Liu, Daquan; Li, Jie; Yang, Shuang; Zhang, Ping] Peking Union Med Coll, Tianjin, Peoples R China; [Yokota, Hiroki; Zhang, Ping] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA	Tianjin Medical University; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Indiana University System; Indiana University-Purdue University Indianapolis	Zhang, P (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	pizhang2008@163.com			National Natural Science Foundation of China [81772405, 81572100, 81601863]; China Postdoctoral Science Foundation [2016M601275]; Tianjin Binhai New Area Health and Family Planning Commission [2016BWKL002, 2016BWKZ005]; Science and Technology Development Fund of Tianjin Education Commission for Higher Education [2017KJ223]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR052144]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052144] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tianjin Binhai New Area Health and Family Planning Commission; Science and Technology Development Fund of Tianjin Education Commission for Higher Education; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Natural Science Foundation of China (81772405 and 81572100 to P.Z.; 81601863 to X.L.), China Postdoctoral Science Foundation (2016M601275 to X.L.), Tianjin Binhai New Area Health and Family Planning Commission (2016BWKL002 to P.Z.; 2016BWKZ005 to D.L.), the Science and Technology Development Fund of Tianjin Education Commission for Higher Education (2017KJ223 to D.L.), and the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR052144 to H.Y.). The authors declare no conflicts of interest.	Binet F, 2015, CELL METAB, V22, P560, DOI 10.1016/j.cmet.2015.07.010; Binet F, 2013, CELL METAB, V17, P353, DOI 10.1016/j.cmet.2013.02.003; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Denny P, 2018, AUTOPHAGY, V14, P419, DOI 10.1080/15548627.2017.1415189; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2015, CURR OPIN PHARMACOL, V22, P51, DOI 10.1016/j.coph.2015.03.004; Hamamura K, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-312; Hang DH, 2012, CELLS TISSUES ORGANS, V195, P495, DOI 10.1159/000329502; Hendrickx G, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007321; Hilz FM, 2014, BIOELECTROMAGNETICS, V35, P116, DOI 10.1002/bem.21822; Hirasawa H, 2010, FEBS LETT, V584, P745, DOI 10.1016/j.febslet.2009.12.028; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Hu XH, 2018, J BONE MINER RES, V33, P945, DOI 10.1002/jbmr.3380; Huang ZY, 2016, NAT REV RHEUMATOL, V12, P123, DOI 10.1038/nrrheum.2015.158; Jayasuriya CT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25395-8; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Kaneko H, 2013, MATRIX BIOL, V32, P178, DOI 10.1016/j.matbio.2013.01.004; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kishino A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02960-1; Lapane KL, 2015, ARTHRITIS RHEUMATOL, V67, P724, DOI 10.1002/art.38933; Li CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18541-1; Li J, 2017, BONE, V97, P2, DOI 10.1016/j.bone.2016.12.009; Li XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24668; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Liu DQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05488-6; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Oliveira LC, 2016, OSTEOPOROSIS INT, V27, P2913, DOI 10.1007/s00198-016-3618-3; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Rhodes SD, 2013, J BONE MINER RES, V28, P2476, DOI 10.1002/jbmr.1992; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Sun HB, 2012, CONNECT TISSUE RES, V53, P180, DOI 10.3109/03008207.2011.628765; Tan N, 2018, HEPATOL RES, V48, P839, DOI 10.1111/hepr.13076; Tower RJ, 2015, BONE, V74, P171, DOI 10.1016/j.bone.2015.01.009; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vega-Rubin-de-Celis S, 2018, P NATL ACAD SCI USA, V115, P4176, DOI 10.1073/pnas.1717800115; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CJ, 2012, J SURG RES, V178, P196, DOI 10.1016/j.jss.2012.01.010; Wang CJ, 2011, ARCH ORTHOP TRAUM SU, V131, P1153, DOI 10.1007/s00402-011-1289-2; Wang HL, 2014, SHOCK, V41, P324, DOI 10.1097/SHK.0000000000000122; Yamasaki Y, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0613-3; Yoboue ED, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0033-4; Zhang P, 2006, J APPL PHYSIOL, V100, P1452, DOI 10.1152/japplphysiol.00997.2005; Zhang P, 2007, J BONE MINER METAB, V25, P383, DOI 10.1007/s00774-007-0774-8; Zhang P, 2007, J BONE MINER RES, V22, P1979, DOI 10.1359/JBMR.070803; Zhang P, 2007, BONE, V40, P538, DOI 10.1016/j.bone.2006.09.018; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020; Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	54	30	31	1	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4077	4088		10.1096/fj.201801851R	http://dx.doi.org/10.1096/fj.201801851R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30485126	Green Published, Bronze			2022-12-26	WOS:000459794800078
J	Ramirez-Santos, E; Rendon, P; Bourtzis, K; Schetelig, MF; Caceres, C; Targovska, A; Rehling, T; Guillen-Navarro, GK; Ruiz-Montoya, L; Toledo, J; Liedo, P				Ramirez-Santos, Edwin; Rendon, Pedro; Bourtzis, Kostas; Schetelig, Marc F.; Caceres, Carlos; Targovska, Asya; Rehling, Tanja; Guillen-Navarro, Griselda K.; Ruiz-Montoya, Lorena; Toledo, Jorge; Liedo, Pablo			Evaluation of horizontal gene transfer risk between the Mediterranean fruit fly Ceratitis capitata (Tephritidae) and its parasitoid Fopius ceratitivorus (Braconidae)	PLOS ONE			English	Article							STERILE INSECT TECHNIQUE; TRANSPOSABLE ELEMENT; DIPTERA; MARKING; POLYMORPHISM; HYMENOPTERA; POPULATIONS; EVOLUTION; SELECTION; ORIGIN	The transgenic strain of the Mediterranean fruit fly (medfly), Ceratitis capitata (Wied.) VIENNA 8 1260, developed from the classical genetic sexing strain VIENNA 8, has two molecular markers that exhibit red fluorescence in the body and green fluorescence in testicles and sperm. These traits offer a precise tool to discriminate between mass-reared sterile males and wild fertile males, and they could potentially increase the effectiveness of control programs for this pest. To assess the risk of horizontal transfer of the fluorescence transgenes in natural ecosystems, we used the VIENNA 8 1260 strain and the medfly parasitoid Fopius ceratitivorus. The fluorescence signal and the inheritance of the fluorescence gene markers were monitored for over 16 generations (about two years) in both species using fluorescence microscopy and a PCR-based assay. The PCR analysis was performed in four independent laboratories. Both fluorescence microscopy and PCR analysis indicated that no horizontal gene transfer of the DsRed transgene occurred during 16 generations of medfly parasitoid rearing under experimental conditions.	[Ramirez-Santos, Edwin; Guillen-Navarro, Griselda K.; Toledo, Jorge; Liedo, Pablo] Colegio Frontera Sur ECOSUR, Carretera Antiguo Aeropuerto Km 2-5, Tapachula, Chiapas, Mexico; [Ramirez-Santos, Edwin] Lab El Pino, Programa MOSCAMED, Km 47-5 Carretera El Salvador, Santa Rosa, Guatemala; [Rendon, Pedro] IAEA TC LAC, Guatemala City, Guatemala; [Bourtzis, Kostas; Caceres, Carlos; Targovska, Asya] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Seibersdorf, Austria; [Schetelig, Marc F.; Rehling, Tanja] Justus Liebig Univ Giessen, Inst Insect Biotechnol, Giessen, Germany; [Ruiz-Montoya, Lorena] Colegio Frontera Sur ECOSUR, Carretera Panamer & Perifer Sur S-N, San Cristobal Las Casas, Chiapas, Mexico	El Colegio de la Frontera Sur (ECOSUR); Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Justus Liebig University Giessen; El Colegio de la Frontera Sur (ECOSUR)	Ramirez-Santos, E (corresponding author), Colegio Frontera Sur ECOSUR, Carretera Antiguo Aeropuerto Km 2-5, Tapachula, Chiapas, Mexico.; Ramirez-Santos, E (corresponding author), Lab El Pino, Programa MOSCAMED, Km 47-5 Carretera El Salvador, Santa Rosa, Guatemala.	esantos@ecosur.edu.mx	Ramirez-Santos, Edwin/AAH-4079-2019; Guillén-Navarro, Karina/M-3782-2015; Guillén-Navarro, Karina/K-2170-2019; Liedo, Pablo/E-9313-2010; Schetelig, Marc F./AAD-2332-2019	Guillén-Navarro, Karina/0000-0001-5199-1156; Guillén-Navarro, Karina/0000-0001-5199-1156; Liedo, Pablo/0000-0002-0004-1721; Schetelig, Marc F./0000-0002-9217-394X	National Council on Science and Technology (CONACYT) [CVU 509334]; Emmy Noether program of the German Research Foundation [SCHE 1833/1-1]; LOEWE Center for Insect Biotechnology & Bioresources of the HMWK; Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture [D4.20.16]; Colegio de la Frontera Sur (ECOSUR)	National Council on Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Emmy Noether program of the German Research Foundation(German Research Foundation (DFG)); LOEWE Center for Insect Biotechnology & Bioresources of the HMWK; Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture; Colegio de la Frontera Sur (ECOSUR)	Partial funding was provided by the following organizations: The Colegio de la Frontera Sur (ECOSUR) provided laboratory facilities and partial funding. The National Council on Science and Technology (CONACYT) granted a scholarship for ERS postgraduate studies (CVU 509334). The Emmy Noether program of the German Research Foundation SCHE 1833/1-1 (MFS) and the LOEWE Center for Insect Biotechnology & Bioresources of the HMWK (MFS) supported this work. The Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, through the Coordianted Research Project No. D4.20.16 on "Comparing Rearing Efficiency and Competitiveness of Sterile Male Strains Produced by Genetic, Transgenic or Symbiont-based Technologies" provided partial funding. There was no additional external funding received for this study.	Alaoui A, 2010, INT J AGRIC BIOL, V12, P291; Ashgar U, 2015, ADV ENT, V3, P132; BARUFFI L, 1995, HEREDITY, V74, P425, DOI 10.1038/hdy.1995.60; Basso A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004665; Beroiz B, 2012, SPAN J AGRIC RES, V10, P815, DOI 10.5424/sjar/2012103-694-11; Bokonon-Ganta AH, 2007, BIOL CONTROL, V41, P361, DOI 10.1016/j.biocontrol.2007.02.011; Bonizzoni M, 2000, INSECT MOL BIOL, V9, P251, DOI 10.1046/j.1365-2583.2000.00184.x; Braga R, 2006, PESQUI AGROPECU BRAS, V41, P705, DOI 10.1590/S0100-204X2006000400023; Brelsfoard C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002728; Cordaux R, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070186; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Davies N, 1999, GENETICS, V153, P351; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; EFSA, 2013, GUID ENV RISK ASS GE; Enkerlin W, 1997, J ECON ENTOMOL, V90, P1066, DOI 10.1093/jee/90.5.1066; Enkerlin W, 1996, J ECON ENTOMOL, V89, P946, DOI 10.1093/jee/89.4.946; Fisher K, 1998, J ECON ENTOMOL, V91, P1406, DOI 10.1093/jee/91.6.1406; Fisher K., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P543; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Franz G, 2011, GENETICA, V139, P1, DOI 10.1007/s10709-010-9543-z; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Handler AM, 2002, GENETICA, V116, P137, DOI 10.1023/A:1020924028450; Handler AM, 2001, BIOTECHNIQUES, V31, P820; Hartl DL, 2001, GENETICS, V157, P471; HENDRICHS J, 1995, J APPL ENTOMOL, V119, P371, DOI 10.1111/j.1439-0418.1995.tb01303.x; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; Hilbeck A, 2015, ENVIRON SCI EUR, V27, DOI 10.1186/s12302-014-0034-1; Hoshino YT, 2008, SOIL SCI PLANT NUTR, V54, P701, DOI 10.1111/j.1747-0765.2008.00289.x; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; KOURTI A, 1992, ENTOMOL EXP APPL, V63, P63, DOI 10.1007/BF00350347; Kourti A, 1997, BIOCHEM GENET, V35, P363, DOI 10.1023/A:1022229632731; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lei GC, 1998, J ANIM ECOL, V67, P422, DOI 10.1046/j.1365-2656.1998.00204.x; Liedo P, 2004, 4 RES COORD M FAO IA, P1; Lopez M, 2003, FLA ENTOMOL, V86, P53, DOI 10.1653/0015-4040(2003)086[0053:COFCAN]2.0.CO;2; Morrison N.I., 2010, ASPAC J MOL BIOL BIO, V18, P275; NAPPO, 2007, 27 NAPPO RSPM; Peccoud J, 2017, P NATL ACAD SCI USA, V114, P4721, DOI 10.1073/pnas.1621178114; Pellegrini Pablo A., 2007, Cienc. docencia tecnol., P51; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Ramirez-Santos E, 2017, J ECON ENTOMOL, V110, P1483, DOI 10.1093/jee/tox119; Ramirez-Santos EM, 2017, J ECON ENTOMOL, V110, P24, DOI 10.1093/jee/tow239; Rempoulakis P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157679; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Rendon P, 1998, AREA WIDE CONTROL FR, P517; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; San Andres V, 2007, J ECON ENTOMOL, V100, P1444, DOI 10.1603/0022-0493(2007)100[1444:ANMATA]2.0.CO;2; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; SCHROEDER WJ, 1981, P HAWAII ENTOMOL SOC, V23, P437; SCHROEDER WJ, 1972, J ECON ENTOMOL, V65, P1217, DOI 10.1093/jee/65.4.1217; Scolari F, 2008, J APPL ENTOMOL, V132, P820, DOI 10.1111/j.1439-0418.2008.01347.x; Scolari F, 2011, GENETICA, V139, P41, DOI 10.1007/s10709-010-9483-7; Scolari F, 2008, NEW BIOTECHNOL, V25, P76, DOI 10.1016/j.nbt.2008.02.001; Silva JC, 2000, MOL BIOL EVOL, V17, P1542, DOI 10.1093/oxfordjournals.molbev.a026253; Simberloff D, 2011, CONSERVATION BIOL AL; Sormacheva I, 2012, MOL BIOL EVOL, V29, P3685, DOI 10.1093/molbev/mss181; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Trumble JT, 2009, CALIF AGR, V63, P73, DOI 10.3733/ca.v063n02p73; Watanabe J, 2014, SCIENCE, V344, P380, DOI 10.1126/science.1249656; Wharton RA, 2000, B ENTOMOL RES, V90, P517, DOI 10.1017/S0007485300000638; Wimmer EA, 2005, NAT BIOTECHNOL, V23, P432, DOI 10.1038/nbt0405-432; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x	63	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207999	10.1371/journal.pone.0207999	http://dx.doi.org/10.1371/journal.pone.0207999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513101	Green Published, Green Submitted, gold			2022-12-26	WOS:000452204800019
J	Sweitzer, MM; Watson, KK; Erwin, SR; Winecoff, AA; Datta, N; Huettel, S; Platt, ML; Zucker, NL				Sweitzer, Maggie M.; Watson, Karli K.; Erwin, Savannah R.; Winecoff, Amy A.; Datta, Nandini; Huettel, Scott; Platt, Michael L.; Zucker, Nancy L.			Neurobiology of social reward valuation in adults with a history of anorexia nervosa	PLOS ONE			English	Article							DISORDER EXAMINATION-QUESTIONNAIRE; EMOTION REGULATION; BRAIN; CORTEX; MOTIVATION; RECOVERY; INSIGHTS; ANTERIOR; SIGNALS; ILLNESS	Objective Anorexia nervosa (AN) is a disorder characterized by atypical patterns of reward valuation (e. g. positive valuation of hunger). Atypical reward processing may extend into social domains. If so, such findings would be of prognostic significance as impaired social functioning predicts worse outcome. We explore neural circuits implicated in social reward processing in individuals with a history of AN who are weight-restored relative to controls and examine the effects of illness course on the experience of social value. Method 20 weight-restored individuals with a history of AN (AN-WR) and 24 healthy control (HC) participants were assessed using fMRI tasks that tapped social reward: smiling faces and full human figures that varied in attractiveness and weight. Results AN-WR differed from HC in attractiveness ratings by weight (negatively correlated in ANWR). While there were no significant differences when viewing smiling faces, viewing full figures resulted in decreased activation in regions implicated in reward valuation (the right caudate) for AN-WR and this region was negatively correlated with a sustained course of the disorder. Exploratory whole brain analyses revealed reduced activation in regions associated with social reward, self-referential processing, and cognitive reappraisal (e. g., medial prefrontal cortex, striatum, and nucleus accumbens) with sustained disorder course. Discussion The rewarding value of full body images decreases with a sustained disorder course. This may reflect an extension of atypical reward processing documented in AN-WR, perhaps as a function of starvation dampening visceral motivational signals; the deployment of cognitive strategies that lessen the experience of reward; and/or the nature of the stimuli themselves as provocative of eating disorder symptoms (e. g., thin bodies). These findings did not extend to smiling face stimuli. Advances in technology (e. g., virtual avatars, text messaging) may provide novel means to build relationships, including therapeutic relationships, to support improved social connections without threats to symptom provocation.	[Sweitzer, Maggie M.; Huettel, Scott; Zucker, Nancy L.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Watson, Karli K.; Huettel, Scott; Zucker, Nancy L.] Univ Colorado, Inst Cognit Neurosci, Boulder, CO 80309 USA; [Erwin, Savannah R.; Winecoff, Amy A.; Datta, Nandini] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Huettel, Scott] Duke Univ, Sch Med, Med Scientist Training Program, Durham, NC USA; [Platt, Michael L.] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Platt, Michael L.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Platt, Michael L.] Univ Penn, Wharton Sch, Mkt Dept, Philadelphia, PA 19104 USA	Duke University; University of Colorado System; University of Colorado Boulder; Duke University; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Zucker, NL (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA.; Zucker, NL (corresponding author), Univ Colorado, Inst Cognit Neurosci, Boulder, CO 80309 USA.	zucke001@mc.duke.edu	Sweitzer, Maggie/GPK-2525-2022	Sweitzer, Maggie/0000-0002-5085-3752	National Institute of Mental Health; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA039294] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was the result of two grants from the National Institute of Mental Health: one awarded to Dr. Nancy Zucker and another awarded to Drs. Scott Huettel and Michael Platt. The funding sponsor was not involved in the creation of this manuscript.	Abbate Daga G, 2006, Eat Weight Disord, V11, pe68; Adenzato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044414; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bischoff-Grethe A, 2013, PSYCHIAT RES-NEUROIM, V214, P331, DOI 10.1016/j.pscychresns.2013.07.004; Blakemore SJ, 2004, NEUROREPORT, V15, P119, DOI 10.1097/00001756-200401190-00024; Broft A, 2015, PSYCHIAT RES-NEUROIM, V233, P380, DOI 10.1016/j.pscychresns.2015.06.013; Castellini G, 2012, J SEX MED, V9, P2590, DOI 10.1111/j.1743-6109.2012.02888.x; Claes Laurence, 2006, Eat Behav, V7, P196, DOI 10.1016/j.eatbeh.2006.05.001; Connan F, 2007, INT J EAT DISORDER, V40, P733, DOI 10.1002/eat.20427; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Cruwys T, 2016, INT J EAT DISORDER, V49, P84, DOI 10.1002/eat.22446; Davey CG, 2010, HUM BRAIN MAPP, V31, P660, DOI 10.1002/hbm.20895; Davies H, 2012, EUR EAT DISORD REV, V20, P476, DOI 10.1002/erv.1157; DeGuzman M, 2017, AM J PSYCHIAT, V174, P557, DOI 10.1176/appi.ajp.2016.16060671; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; Ehrlich S, 2015, J PSYCHIATR NEUROSCI, V40, P307, DOI 10.1503/jpn.140249; El Ghoch M, 2014, AM J CLIN NUTR, V99, P771, DOI 10.3945/ajcn.113.078816; Ertl M, 2013, NEUROIMAGE, V81, P412, DOI 10.1016/j.neuroimage.2013.05.044; Fairburn CG, 2008, COGNITIVE BEHAV THER; FICHTER MM, 1991, INT J EAT DISORDER, V10, P571, DOI 10.1002/1098-108X(199109)10:5&lt;571::AID-EAT2260100510&gt;3.0.CO;2-J; Frank GKW, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.199; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Frank GKW, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0396-x; Geisler D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42066; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Halmi KA, 2009, J CHILD PSYCHOL PSYC, V50, P163, DOI 10.1111/j.1469-7610.2008.01983.x; Healey KL, 2014, BRAIN COGNITION, V89, P39, DOI 10.1016/j.bandc.2013.12.004; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Li D, DEV SCI; Li DW, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12438; Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;349::AID-EAT15&gt;3.0.CO;2-M; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; McAdams CJ, 2016, SOC COGN AFFECT NEUR, V11, P1823, DOI 10.1093/scan/nsw092; Merwin RM, 2013, COGNITION EMOTION, V27, P441, DOI 10.1080/02699931.2012.719003; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Monosov IE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00072-y; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nilsson EW, 1999, J AM ACAD CHILD PSY, V38, P1389, DOI 10.1097/00004583-199911000-00013; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; O'Hara CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145894; Oldershaw A, 2015, CLIN PSYCHOL REV, V39, P83, DOI 10.1016/j.cpr.2015.04.005; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Phillipou A, 2014, AUST NZ J PSYCHIAT, V48, P128, DOI 10.1177/0004867413509693; Pinheiro AP, 2010, INT J EAT DISORDER, V43, P123, DOI 10.1002/eat.20671; Rieger E, 2006, EUR EAT DISORD REV, V14, P269, DOI 10.1002/erv.684; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Robinson PH, 2015, EUR EAT DISORD REV, V23, P318, DOI 10.1002/erv.2367; Rodin J, 1984, Nebr Symp Motiv, V32, P267; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SIMON Y, 1993, BRIT J PSYCHIAT, V162, P244, DOI 10.1192/bjp.162.2.244; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soussignan R, 2011, BIOL PSYCHOL, V86, P265, DOI 10.1016/j.biopsycho.2010.12.007; Steward T, 2018, CURR NEUROPHARMACOL, V16, P1150, DOI 10.2174/1570159X15666171017111532; Stoner SA, 1996, INT J EAT DISORDER, V19, P13, DOI 10.1002/(SICI)1098-108X(199601)19:1&lt;13::AID-EAT3&gt;3.0.CO;2-Z; SUNDAY SR, 1990, PHYSIOL BEHAV, V48, P587, DOI 10.1016/0031-9384(90)90196-B; Sweitzer MM, 2014, BIOL PSYCHIAT, V76, P681, DOI 10.1016/j.biopsych.2013.11.013; Tantleff-Dunn Stacey, 2011, Eat Disord, V19, P392, DOI 10.1080/10640266.2011.609088; Tchanturia K, 2012, INT J EAT DISORDER, V45, P962, DOI 10.1002/eat.22032; Treasure J, 2015, EARLY INTERV PSYCHIA, V9, P173, DOI 10.1111/eip.12170; Tziortzi AC, 2011, NEUROIMAGE, V54, P264, DOI 10.1016/j.neuroimage.2010.06.044; Vandereycken W, 2011, EUR EAT DISORD REV, V19, P289, DOI 10.1002/erv.1087; Via E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133539; Vitousek K, 1998, CLIN PSYCHOL REV, V18, P391, DOI 10.1016/S0272-7358(98)00012-9; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Ward A, 2001, BRIT J MED PSYCHOL, V74, P497, DOI 10.1348/000711201161145; Watson KK, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00036; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Winecoff A, 2013, J NEUROSCI, V33, P11032, DOI 10.1523/JNEUROSCI.4317-12.2013; Winecoff AA, 2015, EUR EAT DISORD REV, V23, P327, DOI 10.1002/erv.2363; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; Zucker N, 2012, OXFORD HDB DEV PERSP, P67; Zucker NL, 2007, PSYCHOL BULL, V133, P976, DOI 10.1037/0033-2909.133.6.976; Zucker NL, 2013, BEHAV RES THER, V51, P256, DOI 10.1016/j.brat.2013.01.010; Zucker NL, 2011, EMOTION, V3, P1	81	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0205085	10.1371/journal.pone.0205085	http://dx.doi.org/10.1371/journal.pone.0205085			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0NQ	30513084	Green Published, Green Submitted, gold			2022-12-26	WOS:000452204800005
J	Kim, J; Perera, BPU; Ghimire, S				Kim, Joomyeong; Perera, Bambarendage P. U.; Ghimire, Subash			Enhancer-driven alternative promoters of imprinted genes	PLOS ONE			English	Article							DNA METHYLATION; TRANSCRIPTION; PEG3	In the current study, we characterized the expression and histone modification profiles of the alternative promoters found within imprinted Igf2r, Mest, Zac1, Peg3, Snrpn and non-imprinted Myc loci. In terms of expression pattern, the alternative promoters are highly tissue-specific, which is in a stark contrast to the ubiquitous expression of the corresponding main promoters. The alternative promoters are associated with the histone modification mark H3K4me1, but not with H3K4me3, which is frequently associated with the main promoters. Phylogenetic analyses also indicated that the majority of the alternative promoters are unique to the mammalian lineage, further suggesting the recent formation of these promoters during mammalian evolution. Overall, this study suggests that the alternative promoters of imprinted loci may have been derived from enhancers in recent evolutionary times and co-evolved with the genomic imprinting mechanism.	[Kim, Joomyeong; Perera, Bambarendage P. U.; Ghimire, Subash] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Kim, Joomyeong/0000-0001-6577-5526; Ghimire, Subash/0000-0001-9544-4410	NIH (National Institute of General Medical Sciences) [R01-GM066225, R01-GM097074]	NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH (National Institute of General Medical Sciences; R01-GM066225 and R01-GM097074 to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andergassen D, 2017, ELIFE, V6, DOI 10.7554/eLife.25125; Barlow DP, 2014, COLD SPRING HARB PER, V6; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bretz CL, 2017, EPIGENETICS-US, V12, P945, DOI 10.1080/15592294.2017.1377869; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Keverne EB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0327; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Lewis MW, 2015, P NATL ACAD SCI USA, V112, P6871, DOI 10.1073/pnas.1411261111; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Perera BPU, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203850; Perera BPU, 2016, SCI REP-UK, V6, DOI 10.1038/srep24438; Perera BPU, 2016, ANAL BIOCHEM, V494, P82, DOI 10.1016/j.ab.2015.11.006; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Renfree MB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0151; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Singh VB, 2017, DEVELOPMENT, V144, P1820, DOI 10.1242/dev.145136; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Stewart KR, 2015, GENE DEV, V29, P2449, DOI 10.1101/gad.271353.115; Veselovska L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0769-z	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208421	10.1371/journal.pone.0208421	http://dx.doi.org/10.1371/journal.pone.0208421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500864	Green Published, Green Submitted, gold			2022-12-26	WOS:000451883700036
J	Cacador, NC; Capizzani, CPD; Torres, LAGMM; Galetti, R; Ciofu, O; Darini, ALD; Flefiby, N				Cacador, Natalia Candido; da Costa Capizzani, Carolina Paulino; Monteiro Marin Torres, Lfdia Alice Gomes; Galetti, Renata; Ciofu, Oana; da Costa Darini, Ana Lticia; Flefiby, Niels			Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients	PLOS ONE			English	Article							CHRONIC LUNG INFECTION; RESPIRATORY-TRACT; ALGT; CONVERSION; EXPRESSION; ANTIBODIES; DIVERSITY; SIGMA(22); SEQUENCE; HOST	Chronic lung infection by Pseudomonas aeruginosa is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. This is associated with the conversion of the non-mucoid to the mucoid phenotype. However, there is little information about the occurrence of alginate-producing P. aeruginosa in CF patients outside Europe and North America. The aim of the present study was to investigate mutations in the algTmucABD operon in mucoid and non-mucoid isolates from Brazilian CF patients. Twenty-seven mucoid and 37 non-mucoid isolates from 40 CF patients chronically infected by P. aeruginosa attending a CF reference center in Brazil were evaluated by sequence analysis. Mutations in mucA were observed in 93% of the mucoid isolates and 54% of the non-mucoid isolates. Among these non-mucoid isolates, 55% were considered revertants, since they also had mutations in algT (algU). Most isolates associated with moderate alginate production presented point mutations in mucB and/or mucD. We identified 30 mutations not previously described in the operon. In conclusion, mutations in mucA were the main mechanism of conversion to mucoidy, and most of the non-mucoid isolates were revertants, but the mechanism of revertance is not fully explained by changes in algT.	[Cacador, Natalia Candido; da Costa Capizzani, Carolina Paulino; Galetti, Renata; da Costa Darini, Ana Lticia] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Monteiro Marin Torres, Lfdia Alice Gomes] Univ Sao Paulo, Dept Pediat, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil; [Ciofu, Oana; Flefiby, Niels] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Flefiby, Niels] Univ Hosp, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Copenhagen; Rigshospitalet; University of Copenhagen	Cacador, NC; Darini, ALD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, SP, Brazil.	naticacador@yahoo.com; aldarini@usp.br	Ciofu, Oana/AAE-2413-2020; da Costa Darini, Ana Lucia/C-8127-2012	da Costa Darini, Ana Lucia/0000-0001-5433-926X; /0000-0001-7356-1931; Hoiby, Niels/0000-0002-1347-725X; Ciofu, Oana/0000-0001-5648-4858; Candido Cacador, Natalia/0000-0003-4404-9968	Sao Paulo Research Foundation [FAPESP 2014/14494-8]; FAPESP [2013/13358-0, 2013/13455-6, 2015/11728-0]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP 2014/14494-8 to ALCD). NCC, CPCC, and RG were supported by PhD fellowships from FAPESP (Grants 2013/13358-0, 2013/13455-6, and 2015/11728-0, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony M, 2002, J CLIN MICROBIOL, V40, P2772, DOI 10.1128/JCM.40.8.2772-2778.2002; Bjarnsholt T, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001420; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Boucher JC, 1996, J BACTERIOL, V178, P511, DOI 10.1128/jb.178.2.511-523.1996; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Canton R, 2005, CLIN MICROBIOL INFEC, V11, P690, DOI 10.1111/j.1469-0691.2005.01217.x; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; DEVRIES CA, 1994, J BACTERIOL, V176, P6677, DOI 10.1128/JB.176.21.6677-6687.1994; Feliziani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012669; Fernandez-Olmos A, 2013, J CLIN MICROBIOL, V51, P2761, DOI 10.1128/JCM.00802-13; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Gautom RK, 1997, RAPID PULSED FIELD G; Gilligan PH, 2006, CYSTIC FIBROSIS MICR; HOIBY N, 1974, ACTA PATH MICRO IM B, VB 82, P541; Jorgensen KM, 2015, MICROBIOL-SGM, V161, P1447, DOI 10.1099/mic.0.000093; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; Pressler T, 2006, J CYST FIBROS, V5, P9, DOI 10.1016/j.jcf.2005.11.002; Pressler T, 2009, J CYST FIBROS, V8, P37, DOI 10.1016/j.jcf.2008.08.002; Sautter R, 2012, GENE, V498, P242, DOI 10.1016/j.gene.2011.11.005; SCHURR MJ, 1994, J BACTERIOL, V176, P3375, DOI 10.1128/jb.176.11.3375-3382.1994; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tran A, 2015, J CLIN MICROBIOL, V53, P2473, DOI 10.1128/JCM.00833-15; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Wood LF, 2015, MICROBIOL-SGM, V161, P30, DOI 10.1099/mic.0.081182-0; Wyckoff TJO, 2002, MICROBIOL-SGM, V148, P3423, DOI 10.1099/00221287-148-11-3423; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	30	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208013	10.1371/journal.pone.0208013	http://dx.doi.org/10.1371/journal.pone.0208013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496246	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800080
J	Nielsen, SD; Beverly, RL; Underwood, MA; Dallas, DC				Nielsen, Soren D.; Beverly, Robert L.; Underwood, Mark A.; Dallas, David C.			Release of functional peptides from mother's milk and fortifier proteins in the premature infant stomach	PLOS ONE			English	Article							IN-VITRO DIGESTION; BIOACTIVE PEPTIDES; NECROTIZING ENTEROCOLITIS; HEAT-TREATMENT; BREAST-MILK; PROTEASES; BIRTH; ENZYMES; PEPTIDOMICS; DEGRADATION	Digestion of milk proteins in the premature infant stomach releases functional peptides; however, which peptides are present has not been reported. Premature infants are often fed a combination of human milk and bovine milk fortifiers, but the variety of functional peptides released from both human and bovine milk proteins remains uncharacterized. This study applied peptidomics to investigate the peptides released in gastric digestion of mother's milk proteins and supplemental bovine milk proteins in premature infants. Peptides were assessed for homology against a database of known functional peptides-Milk Bioactive Peptide Database. The peptidomic data were analyzed to interpret which proteases most likely released them from the parent protein. We identified 5,264 unique peptides from bovine and human milk proteins within human milk, fortifier or infant gastric samples. Plasmin was predicted to be the most active protease in milk, while pepsin or cathepsin D were predicted to be most active in the stomach. Alignment of the peptide distribution showed a different digestion pattern between human and bovine proteins. The number of peptides with high homology to known functional peptides (antimicrobial, angiotensin-converting enzyme-inhibitory, antioxidant, immunomodulatory, etc.) increased from milk to the premature infant stomach and was greater from bovine milk proteins than human milk proteins. The differential release of bioactive peptides from human and bovine milk proteins may impact overall health outcomes in premature infants.	[Nielsen, Soren D.; Beverly, Robert L.; Dallas, David C.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Coll Publ Hlth & Human Sci, Nutr Program, Corvallis, OR 97331 USA; [Underwood, Mark A.] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA	Oregon State University; University of California System; University of California Davis	Dallas, DC (corresponding author), Oregon State Univ, Sch Biol & Populat Hlth Sci, Coll Publ Hlth & Human Sci, Nutr Program, Corvallis, OR 97331 USA.	dave.dallas@oregonstate.edu	Nielsen, Søren Drud-Heydary/K-7790-2017; Dallas, David/AAD-7806-2022	Nielsen, Søren Drud-Heydary/0000-0002-6990-2200; Dallas, David/0000-0002-9696-0967; Beverly, Robert/0000-0002-4838-4600	K99/R00 Pathway to Independence Career Award, Eunice Kennedy Shriver Institute of Child Health & Development of the National Institutes of Health [R00HD079561]; USDA National Institute of Food and Agriculture; Gerber Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD079561] Funding Source: NIH RePORTER	K99/R00 Pathway to Independence Career Award, Eunice Kennedy Shriver Institute of Child Health & Development of the National Institutes of Health; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Gerber Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the K99/R00 Pathway to Independence Career Award, Eunice Kennedy Shriver Institute of Child Health & Development of the National Institutes of Health (R00HD079561) (DCD), the USDA National Institute of Food and Agriculture and The Gerber Foundation. The funders had no rodesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkanhal H. A., 2006, Egyptian Journal of Dairy Science, V34, P159; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bertino E, 2017, J PEDIATR NEONATAL I, V6, DOI 10.7363/060124; BRIOZZO P, 1988, CANCER RES, V48, P3688; BRITTON JR, 1989, EARLY HUM DEV, V19, P127, DOI 10.1016/0378-3782(89)90123-0; Clare DA, 2000, J DAIRY SCI, V83, P1187, DOI 10.3168/jds.S0022-0302(00)74983-6; Dallas D, 2018, METHODS MOL BIOL, V1719, P223, DOI 10.1007/978-1-4939-7537-2_15; Dallas DC, 2017, NESTLE NUTR WORKS SE, V88, P129, DOI 10.1159/000455250; Dallas DC, 2015, J MAMMARY GLAND BIOL, V20, P133, DOI 10.1007/s10911-015-9334-3; Dallas DC, 2015, J NUTR, V145, P425, DOI 10.3945/jn.114.203646; Dallas DC, 2014, J NUTR, V144, P815, DOI 10.3945/jn.113.185793; DALLAS DC, 2012, J NUTR DISORD THER, V2, P112, DOI DOI 10.4172/2161-0509.1000112; Demers-Mathieu V, 2018, J PEDIATR GASTR NUTR, V66, P318, DOI [10.1097/MPG.0000000000001719, 10.1097/mpg.0000000000001719]; Demers-Mathieu V, 2017, J NUTR, V147, P1152, DOI 10.3945/jn.116.244798; FitzGerald RJ, 1998, INT DAIRY J, V8, P451, DOI 10.1016/S0958-6946(98)00068-5; Ganapathy V, 2012, BREASTFEED MED, V7, P29, DOI 10.1089/bfm.2011.0002; Guerrero A, 2014, MOL CELL PROTEOMICS, V13, P3343, DOI 10.1074/mcp.M113.036194; Hay WW, 2010, PEDIATR NEONATOL, V51, P198, DOI 10.1016/S1875-9572(10)60039-3; Hernandez-Ledesma B, 2007, INT DAIRY J, V17, P42, DOI 10.1016/j.idairyj.2005.12.012; Herrmann K, 2014, BREASTFEED MED, V9, P184, DOI 10.1089/bfm.2013.0121; Holton TA, 2014, J PROTEOME RES, V13, P5777, DOI 10.1021/pr5006907; Huston RK, 2014, INFANT CHILD ADOLESC; Keene MFL, 1929, LANCET, V1, P767; Khaldi N, 2014, J AGR FOOD CHEM, V62, P7225, DOI 10.1021/jf405601e; Klein J, 2013, PROTEOMICS, V13, P1077, DOI 10.1002/pmic.201200493; KUNZ C, 1990, AM J CLIN NUTR, V51, P37, DOI 10.1093/ajcn/51.1.37; Law AJR, 1996, J DAIRY RES, V63, P35, DOI 10.1017/S0022029900031526; Lindberg T, 1998, J PEDIATR GASTR NUTR, V27, P30, DOI 10.1097/00005176-199807000-00006; Lindberg T, 1997, J PEDIATR GASTR NUTR, V24, P537, DOI 10.1097/00005176-199705000-00009; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Mohanty D, 2016, INT J FOOD PROP, V19, P837, DOI 10.1080/10942912.2015.1048356; Nielsen SD, 2017, J MAMMARY GLAND BIOL, V22, P251, DOI 10.1007/s10911-018-9388-0; Nielsen SD, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00054; Nielsen SD, 2017, FOOD CHEM, V232, P673, DOI 10.1016/j.foodchem.2017.04.056; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; Patel AL, 2013, J PERINATOL, V33, P514, DOI 10.1038/jp.2013.2; Picariello G, 2015, MOL NUTR FOOD RES, V59, P948, DOI 10.1002/mnfr.201400856; Purup S, 2019, INT J PEPT RES THER, V25, P483, DOI 10.1007/s10989-018-9692-y; Reyes-Diaz A, 2016, INTERCIENCIA, V41, P84; Ricci I, 2010, CRIT REV FOOD SCI, V50, P390, DOI 10.1080/10408390802304198; Sanchez-Rivera L, 2015, FOOD RES INT, V77, P132, DOI 10.1016/j.foodres.2015.08.001; Schanler RJ, 1999, PEDIATRICS, V103, P1150, DOI 10.1542/peds.103.6.1150; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sisk PM, 2007, J PERINATOL, V27, P428, DOI 10.1038/sj.jp.7211758; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008; Wada Y, 2015, PEDIATR RES, V77, P546, DOI 10.1038/pr.2015.10; Wagner J, 2014, ADV NEONAT CARE, V14, P281, DOI 10.1097/ANC.0000000000000108; Wehbi Z, 2005, J AGR FOOD CHEM, V53, P9730, DOI 10.1021/jf050825y	49	26	26	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208204	10.1371/journal.pone.0208204	http://dx.doi.org/10.1371/journal.pone.0208204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496293	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800108
J	Wu, TSJ; Kagoli, M; Kaasboll, JJ; Bjune, GA				Wu, Tsung-Shu Joseph; Kagoli, Matthew; Kaasboll, Jens Johan; Bjune, Gunnar Aksel			Integrated Disease Surveillance and Response (IDSR) in Malawi: Implementation gaps and challenges for timely alert	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; EBOLA SURVEILLANCE; PUBLIC-HEALTH; WEST-AFRICA; LESSONS; OUTBREAKS	Objective The recent 2014 Ebola Virus Disease (EVD) outbreaks rang the bell to call upon global efforts to assist resource-constrained countries to strengthen public health surveillance system for early response. Malawi adopted the Integrated Disease Surveillance and Response (IDSR) strategy to develop its national surveillance system since 2002 and revised its guideline to fulfill the International Health Regulation (IHR) requirements in 2014. This study aimed to understand the state of IDSR implementation and differences between guideline and practice for future disease surveillance system strengthening. Methods This was a mixed-method research study. Quantitative data were to analyze completeness and timeliness of surveillance system performance from national District Health Information System 2 (DHIS2) during October 2014 to September 2016. Qualitative data were collected through interviews with 29 frontline health service providers from the selected district and 7 key informants of the IDSR system implementation and administration at district and national levels. Findings The current IDSR system showed relatively good completeness (73.1%) but poor timeliness (40.2%) of total expected monthly reports nationwide and zero weekly reports during the study period. Major implementation gaps were lack of weekly report and trainings. The challenges of IDSR implementation revealed through qualitative data included case identification, compiling reports for timely submission and inadequate resources. Conclusions The differences between IDSR technical guideline and actual practice were huge. The developing information technology infrastructure in Malawi and emerging mobile health mHealth) technology can be opportunities for the country to overcome these challenges and improve surveillance system to have better timeliness for the outbreaks and unusual events detection.	[Wu, Tsung-Shu Joseph; Kaasboll, Jens Johan] Univ Oslo, Dept Informat, Oslo, Norway; [Wu, Tsung-Shu Joseph] Luke Int, Res Dept, Mzuzu City, Malawi; [Wu, Tsung-Shu Joseph] Pingtung Christian Hosp, Overseas Mission Dept, Pingtung Cty, Taiwan; [Wu, Tsung-Shu Joseph] Natl Taiwan Univ, Dept Publ Hlth, Taipei, Taiwan; [Kagoli, Matthew] Minist Hlth, Dept Epidemiol, Lilongwe City, Malawi; [Kagoli, Matthew] Publ Hlth Inst Malawi, Lilongwe, Malawi; [Bjune, Gunnar Aksel] Univ Oslo, Inst Hlth & Soc, Oslo, Norway	University of Oslo; National Taiwan University; University of Oslo	Wu, TSJ (corresponding author), Univ Oslo, Dept Informat, Oslo, Norway.; Wu, TSJ (corresponding author), Luke Int, Res Dept, Mzuzu City, Malawi.; Wu, TSJ (corresponding author), Pingtung Christian Hosp, Overseas Mission Dept, Pingtung Cty, Taiwan.; Wu, TSJ (corresponding author), Natl Taiwan Univ, Dept Publ Hlth, Taipei, Taiwan.	wcsg@lukeinternational.no	Wu, Tsung-Shu Joseph/K-6138-2018	Wu, Tsung-Shu Joseph/0000-0001-6155-9340	Pingtung Christian Hospital, Taiwan through Luke International, Norway [PS-IR-104001, PS-IR-105001]	Pingtung Christian Hospital, Taiwan through Luke International, Norway	This study was supported by the Pingtung Christian Hospital, Taiwan through Luke International, Norway with grant number: PS-IR-104001 and PS-IR-105001. https://www.ptch.org.tw/sar/research/data/result/plan/2014_a.doc.	Adokiya MN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1397-y; Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109; Axelsson R, 2006, INT J HEALTH PLAN M, V21, P75, DOI 10.1002/hpm.826; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; Brinkel J, 2014, INT J ENV RES PUB HE, V11, P11559, DOI 10.3390/ijerph111111559; Brown C, 2015, CAN MED ASSOC J, V187, pE301, DOI 10.1503/cmaj.109-5081; CDC, INN EL MED REC SYST; Chisha Z, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0735-y; Chretien JP, 2008, PLOS MED, V5, P367, DOI 10.1371/journal.pmed.0050072; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; German R R, 2001, MMWR Recomm Rep, V50, P1; German RR, 2001, MMWR RECOMM REP, V50, pCE1; Haddock RL, 2009, HAWAII MED J, V69, P50; ICF NSONa, 2017, MAL DEM HLTH SURV 20; K4health, MAL HLTH SURV AG PRO; Kasolo F, 2013, BIOSECUR BIOTERROR, V11, P163, DOI 10.1089/bsp.2013.0032; Kazi DS, 2017, J PUBLIC HEALTH-UK, V39, P616, DOI 10.1093/pubmed/fdw091; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lukwago L, 2013, HEALTH POLICY PLANN, V28, P30, DOI 10.1093/heapol/czs022; Malawi NSOo, 2015, MAL STAT YB; McNamara LA, 2016, MMWR-MORBID MORTAL W, V65, P35, DOI 10.15585/mmwr.su6503a6; Ministry of Health M, 2015, MAL NAT HLTH INF SYS; Ministry of Health M, 2014, TECHN GUID INT DIS S, P377; Ministry of Health M, 2013, HLTH INF SYST STRAT; Ministry of Health M ICF International U, 2014, MAL SERV PROV ASS 20; Moyo C, 2015, 2015 IST-AFRICA CONFERENCE; Mtema Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002002; Mwabukusi M, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.737; Nsubuga P, 2010, GLOB PUBLIC HEALTH, V5, P364, DOI 10.1080/17441690903334943; PASCOE Luba, IST AFR 2012 CONFERE; Phalkey RK, 2015, HEALTH POLICY PLANN, V30, P131, DOI 10.1093/heapol/czt097; Rumisha S F, 2007, Tanzan Health Res Bull, V9, P1; Sacks JA, 2015, GLOB HEALTH-SCI PRAC, V3, P646, DOI 10.9745/GHSP-D-15-00207; Schoonenboom J, 2017, KOLNER Z SOZIOL SOZ, V69, P107, DOI 10.1007/s11577-017-0454-1; Shah KG, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-31; Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29; Tanzania H, TANZANIA INTEGRATED; Thomas LM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000639; van Dijk A, 2009, EMERG INFECT DIS, V15, P799, DOI 10.3201/eid1505.081174; WHO, 2016, INT HLTH REG 2005, V3rd. ed.; WHO, 2001, INT DIS SURV AFR REG; WHO, NEW EB OUTBR DECL DE; WHO Global Health Workforce Alliance, 2010, GLOBAL EXPERIENCE CO; WHO Implementation of the International Health Regulations, 2011, IMPL INT HLTH REG 20; World Health Organization, EB SIT REP 2016; World Health Organization, 2010, TECHN GUID INT DIS S; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18	51	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0200858	10.1371/journal.pone.0200858	http://dx.doi.org/10.1371/journal.pone.0200858			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496177	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800004
J	Lindeman, JH; Hulsbos, L; van den Bogaerdt, AJ; Geerts, M; van Gool, AJ; Hamming, JF; van Dijk, RA; Schaapherder, AF				Lindeman, Jan H.; Hulsbos, Luuk; van den Bogaerdt, Antoon J.; Geerts, Marlieke; van Gool, Alain J.; Hamming, Jaap F.; van Dijk, Rogier A.; Schaapherder, Alexander F.			Qualitative evaluation of coronary atherosclerosis in a large cohort of young and middle-aged Dutch tissue donors implies that coronary thrombo-embolic manifestations are stochastic	PLOS ONE			English	Article							VULNERABLE PLAQUE; VASCULAR-LESIONS; ARTERY-DISEASE; RISK-FACTORS; ARTERIOSCLEROSIS; DEFINITION; PREVALENCE; COMMITTEE; COUNCIL; BURDEN	Background and aims With the intention to gain support for the hypothesis that incident ischemic complications of atherosclerotic disease involve a stochastic aspect, we performed a histological, qualitative evaluation of the epidemiology of coronary atherosclerotic disease in a cohort of aortic valve donors. Patients and methods Donors (n = 695, median age 54, range 11-65 years) were dichotomized into a non-cardiovascular (non-CVD) and a cardiovascular disease death (CVD) group. Consecutive 5 mm proximal left coronary artery segments were Movat stained, and the atherosclerotic burden for each segment was graded (revised AHA-classification). Results Non-CVD and CVD groups showed steep increase of atherosclerosis severity beyond the age of 40, resulting in an endemic presence of advanced atherosclerosis in men over 40 and women over 50 years. In fact, only 19% of the non-CVD and 6% of the CVD donors over 40 years were classified with a normal LCA or a so called non-progressive lesion type. Fibrous calcified plaques (FCP), the consolidated remnants of earlier ruptured lesions, dominated in both non-CVD and CVD donors. Estimates of the atherosclerosis burden (i. e. average lesion grade, proportion of FCPs, and average number of FCPs per cross-section) were all higher in the CVD group (p<1.10-16, p<0.0001, and p<0.05, respectively). Conclusions Dominance of consolidated FCP lesions in males over 40 and females over 50 years, show that plaque ruptures in the left coronary artery are common. However, the majority of these ruptures remain asymptomatic. This implies that the atherosclerotic process is repetitive. A relative difference in disease burden between CVD and non-CVD donors supports the concept that complications of atherosclerotic disease involve a stochastic element.	[Lindeman, Jan H.; Hulsbos, Luuk; Geerts, Marlieke; Hamming, Jaap F.; van Dijk, Rogier A.; Schaapherder, Alexander F.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Lindeman, Jan H.; Geerts, Marlieke; Hamming, Jaap F.; van Dijk, Rogier A.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [van den Bogaerdt, Antoon J.] Euro Heart Valve Bank, Beverwijk, Netherlands; [van Gool, Alain J.] TNO Metab Hlth Res, Leiden, Netherlands; [van Gool, Alain J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Radboud University Nijmegen	Lindeman, JH (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.; Lindeman, JH (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	Lindeman@lumc.nl		Lindeman, Jan/0000-0002-5656-4345; van Gool, Alain/0000-0003-0010-5286	European Commission (Cartardis, FP7 HEALTH. 2013.2.4.2-1)	European Commission (Cartardis, FP7 HEALTH. 2013.2.4.2-1)	This study was funded by the European Commission (Cartardis, FP7 HEALTH. 2013.2.4.2-1). The funders had no role in the study design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. There was no additional external funding received for this study.	Ahmadi A, 2015, CIRC RES, V117, P99, DOI 10.1161/CIRCRESAHA.117.305637; Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041; Armstrong PW, 2009, CIRCULATION, V119, P1293, DOI 10.1161/CIRCULATIONAHA.108.796383; Barter PJ, 2018, J CLIN LIPIDOL; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Coggon DIW, 2005, LANCET, V365, P1434, DOI 10.1016/S0140-6736(05)66380-5; Corti R, 2002, AM J MED, V113, P668, DOI 10.1016/S0002-9343(02)01344-X; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Lindeman JH, 2017, INT J CARDIOL, V229, P35, DOI 10.1016/j.ijcard.2016.12.011; MASSMANN J, 1970, ATHEROSCLEROSIS, V11, P37, DOI 10.1016/0021-9150(70)90006-7; Meershoek A, 2016, INT J CARDIOL, V224, P328, DOI 10.1016/j.ijcard.2016.09.043; Mercado N, 2011, EUROINTERVENTION, V7, P347, DOI 10.4244/EIJV7I3A59; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ruwanpathirana T, 2015, CARDIOVASC THER, V33, P62, DOI 10.1111/1755-5922.12110; Sanchez OD, 2014, EXPERT REV CARDIOVAS, V12, P601, DOI 10.1586/14779072.2014.902749; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; STRONG JP, 1972, ATHEROSCLEROSIS, V16, P193, DOI 10.1016/0021-9150(72)90053-6; Tuzcu EM, 2001, CIRCULATION, V103, P2705; Webber BJ, 2012, JAMA-J AM MED ASSOC, V308, P2577, DOI 10.1001/jama.2012.70830; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; Wykrzykowska JJ, 2012, JACC-CARDIOVASC IMAG, V5, pS10, DOI 10.1016/j.jcmg.2012.01.006; Yahagi K, 2016, NAT REV CARDIOL, V13, P79, DOI 10.1038/nrcardio.2015.164; YASHIN AI, 1985, THEOR POPUL BIOL, V27, P154, DOI 10.1016/0040-5809(85)90008-5	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207943	10.1371/journal.pone.0207943	http://dx.doi.org/10.1371/journal.pone.0207943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481212	Green Submitted, Green Published, gold			2022-12-26	WOS:000451440000031
J	Bond, T; Partridge, JC; Taylor, MD; Cooper, TF; McLean, DL				Bond, Todd; Partridge, Julian C.; Taylor, Michael D.; Cooper, Tim F.; McLean, Dianne L.			The influence of depth and a subsea pipeline on fish assemblages and commercially fished species	PLOS ONE			English	Article							CORAL-REEF FISH; HABITAT ASSOCIATIONS; ARTIFICIAL REEFS; OIL; OFFSHORE; MORTALITY; SELECTION; ACCURACY; SYSTEM; GROWTH	Knowledge of marine ecosystems that grow and reside on and around subsea oil and gas infrastructure is required to understand impacts of this offshore industry on the marine environment and inform decommissioning decisions. This study used baited remote underwater stereo-video systems (stereo-BRUVs) to compare species richness, fish abundance and size along 42.3 km of subsea pipeline and in adjacent areas of varying habitats. The pipeline is laid in an onshore-offshore direction enabling surveys to encompass a range of depths from 9 m nearshore out to 140 m depth offshore. Surveys off the pipeline were performed across this depth range and in an array of natural habitats (sand, macroalgae, coral reef) between 1 km and 40 km distance from the pipeline. A total of 14,953 fish were observed comprising 240 species (131 on the pipeline and 225 off-pipeline) and 59 families (39 on the pipeline and 56 off-pipeline) and the length of 8,610 fish were measured. The fish assemblage on and off the pipeline was similar in depths of <80 m. In depths beyond 80 m, the predominant habitat off-pipeline was sand and differences between fish assemblages on and off-pipeline were more pronounced. The pipeline was characterised by higher biomass and abundances of larger-bodied, commercially important species such as: Pristipomoides multidens (goldband snapper), Lutjanus malabaricus (saddletail snapper) and Lutjanus russellii (Moses' snapper) among others, and possessed a catch value 2-3 times higher per stereo-BRUV deployment than that of fish observed off-pipeline. Adjacent natural seabed habitats possessed higher abundances of Atule mate (yellowtail scad), Nemipterus spp. (threadfin bream) and Terapon jarbua (crescent grunter), species of no or low commercial value. This is the first published study to use stereo-BRUVs to report on the importance of subsea infrastructure to commercially important fishes over a depth gradient and increases our knowledge of the fish assemblage associated with subsea infrastructure off north-west Australia. These results provide a greater understanding of ecological and fisheries implications of decommissioning subsea infrastructure on the north-west shelf, and will help better inform decision-making on the fate of infrastructure at different depths.	[Bond, Todd; Partridge, Julian C.; Taylor, Michael D.; Cooper, Tim F.; McLean, Dianne L.] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia; [Bond, Todd; Partridge, Julian C.; Taylor, Michael D.] Univ Western Australia, Sch Biol Sci, Crawley, WA, Australia; [Cooper, Tim F.] BHP, Perth, WA, Australia; [McLean, Dianne L.] Univ Western Australia, Oceans Grad Sch, Crawley, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Bond, T (corresponding author), Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia.; Bond, T (corresponding author), Univ Western Australia, Sch Biol Sci, Crawley, WA, Australia.	todd.bond@uwa.edu.au	Bond, Todd/V-9231-2019; Partridge, Julian C/F-2097-2014; Bond, Todd/AAO-9083-2020; McLean, Dianne/H-2449-2012	Partridge, Julian C/0000-0003-3788-2900; Bond, Todd/0000-0001-6064-7015; McLean, Dianne/0000-0002-0306-8348; Taylor, Michael/0000-0001-8136-5359	BHP	BHP	We would like to acknowledge BHP the operator of the pipeline surveyed in this study for funding the work. Employees of the funder had input into study design and preparation of the manuscript. The funder provided support in the form of salaries for authors [TC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to acknowledge BHP the operator of the pipeline surveyed in this study for funding the work. We would also like to thank Andrew Edwards the skipper of Keshi-Mer and Keshi-Mer II and all the crew for their hard work in the field. Thank you to Tannika Shalders for her assistance with video analysis.	Anderson M.J., 2005, PERMUTATIONAL MULTIV; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Arnould JPY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130581; Azzurro E, 2007, MAR BIOL, V151, P2245, DOI 10.1007/s00227-007-0661-9; Bell N, 1999, NATURE, V402, P601, DOI 10.1038/45127; Bivand R, 2017, RGEOS INTERFACE GEOM; Bond T, 2018, FISH RES, V206, P220, DOI 10.1016/j.fishres.2018.05.011; Bond T, 2018, MARINE ENV RES; Brunner EJ, 2009, INT J EPIDEMIOL, V38, P93, DOI 10.1093/ije/dyn157; Burnham K P, 2003, MODEL SELECT MULTIMO; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; Cappo Mike, 2011, Journal of the Royal Society of Western Australia, V94, P303; Cordes EE, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00058; Cure K, 2017, MAR BIOL, V165, DOI 10.1007/s00227-017-3259-x; Evans RD, 2014, MAR BIOL, V161, P599, DOI 10.1007/s00227-013-2362-x; Fisher R, 2018, ECOL EVOL, V8, P6104, DOI 10.1002/ece3.4134; Fitzpatrick C, 2013, FISH RES, V146, P41, DOI 10.1016/j.fishres.2013.03.016; Fletcher W.J., 2017, STATUS REPORTS FISHE; Froese R, FISHBASE; Gleiss AC, 2017, HYDROBIOLOGIA, V787, P181, DOI 10.1007/s10750-016-2957-6; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey E, 2001, FISH B-NOAA, V99, P63; Harvey ES, 2012, CORAL REEFS, V31, P939, DOI 10.1007/s00338-012-0955-3; Harvey ES, 2012, J EXP MAR BIOL ECOL, V426, P78, DOI 10.1016/j.jembe.2012.05.019; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Hastie T., 1986, STAT SCI, V1, P297; Hutchins J. Barry, 2004, Records of the Western Australian Museum Supplement, V66, P343; Kobayashi R, 2002, NIPPON SUISAN GAKK, V68, P646, DOI 10.2331/suisan.68.646; Lange E, 2014, WORLD OCEAN REV; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Love MS, 2005, B MAR SCI, V77, P101; Macreadie PI, 2012, FRONT ECOL ENVIRON, V10, P179, DOI 10.1890/12.WB.013; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; McLean DL, 2018, CONT SHELF RES, V164, P10, DOI 10.1016/j.csr.2018.05.007; McLean DL, 2017, CONT SHELF RES, V141, P76, DOI 10.1016/j.csr.2017.05.006; McLean DL, 2016, ESTUAR COAST SHELF S, V178, P36, DOI 10.1016/j.ecss.2016.05.026; Morgan DL, 2017, ENDANGER SPECIES RES, V34, P235, DOI 10.3354/esr00847; Newman S. J., 2015, N COAST DEMERSAL FIS; Newman SJ, 2003, FISH B-NOAA, V101, P116; Newman SJ, 2002, FISH RES, V58, P215, DOI 10.1016/S0165-7836(01)00367-8; Newman SJ, 2004, CHARACTERISATION INS; Page HM, 2006, MAR ECOL PROG SER, V325, P101, DOI 10.3354/meps325101; Parente V, 2006, ENERG POLICY, V34, P1992, DOI 10.1016/j.enpol.2005.02.008; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Peverell S. C., THESIS; Pradella N, 2014, J FISH BIOL, V84, P247, DOI 10.1111/jfb.12274; PRIEDE IG, 1994, J MAR BIOL ASSOC UK, V74, P481, DOI 10.1017/S0025315400047615; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Ramm DC., 1994, AUSTR NO TRAWL FISHE; Rouse S, 2018, ICES J MAR SCI, V75, P279, DOI 10.1093/icesjms/fsx121; Ryan KL, 2013, FISHERIES RES REPORT; Sainsbury KJ, 1997, AM FISH S S, V20, P107; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Speare P, 2007, PRELIMINARY FINDINGS; Streich MK, 2017, MAR COAST FISH, V9, P170, DOI 10.1080/19425120.2017.1282897; Todd VLG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153320; Tornero V, 2016, MAR POLLUT BULL, V112, P17, DOI 10.1016/j.marpolbul.2016.06.091; Watson D, 2008, CONFIDENTIAL FINAL R; Wen CKC, 2013, J EXP MAR BIOL ECOL, V443, P39, DOI 10.1016/j.jembe.2013.02.027	64	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207703	10.1371/journal.pone.0207703	http://dx.doi.org/10.1371/journal.pone.0207703			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475853	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700055
J	Fister, AS; Landherr, L; Perryman, M; Zhang, YF; Guiltinan, MJ; Maximova, SN				Fister, Andrew S.; Landherr, Lena; Perryman, Melanie; Zhang, Yufan; Guiltinan, Mark J.; Maximova, Siela N.			Glucocorticoid receptor-regulated TcLEC2 expression triggers somatic embryogenesis in Theobroma cacao leaf tissue	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; BABY-BOOM; PLANT-REGENERATION; EMBRYO MATURATION; DNA METHYLATION; ARABIDOPSIS; L.; INDUCTION; LOCALIZATION	Theobroma cacao, the source of cocoa, is a crop of particular importance in many developing countries. Availability of elite planting material is a limiting factor for increasing productivity of Theobroma cacao; therefore, the development of new strategies for clonal propagation is essential to improve farmers' incomes and to meet increasing global demand for cocoa. To develop a more efficient embryogenesis system for cacao, tissue was transformed with a transgene encoding a fusion of Leafy Cotyledon 2 (TcLEC2) to a glucocorticoid receptor domain (GR) to control nuclear localization of the protein. Upon application of the glucocorticoid dexamethasone (dex), downstream targets of LEC2 involved in seed-development were up-regulated and somatic embryos (SEs) were successfully regenerated from TcLEC2-GR transgenic flower and leaf tissue in large numbers. Immature SEs regenerated from TcLEC2-GR leaves were smaller in size than immature SEs from floral tissue, suggesting a different ontogenetic origin. Additionally, exposure of TcLEC2-GR floral explants to dex increased the number of SEs compared to floral explants from control, non-transgenic trees or from TcLEC2-GR floral explants not treated with dex. Testing different durations of exposure to dex indicated that a three-day treatment produced optimal embryo regeneration. Leaf derived SEs were successfully grown to maturity, converted into plants, and established in the greenhouse, demonstrating that these embryos are fully developmentally competent. In summary, we demonstrate that regulating TcLEC2 activity offers a powerful new strategy for optimizing somatic embryogenesis pipelines for cacao.	[Fister, Andrew S.] Pairwise Plants, Durham, NC USA; [Landherr, Lena; Perryman, Melanie; Guiltinan, Mark J.; Maximova, Siela N.] Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA; [Zhang, Yufan] Essenlix Corp, Monmouth Jct, NJ USA; [Guiltinan, Mark J.; Maximova, Siela N.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Maximova, SN (corresponding author), Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA.; Maximova, SN (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.	snm104@psu.edu			Pennsylvania State University College of Agricultural Sciences; Huck Institutes of the Life Sciences; Penn State Endowed Program in Molecular Biology of Cacao; NSF Plant Genome Research Award [1546863]; USDA National Institute of Food and Agriculture [PEN04569, 1003147]	Pennsylvania State University College of Agricultural Sciences; Huck Institutes of the Life Sciences; Penn State Endowed Program in Molecular Biology of Cacao; NSF Plant Genome Research Award; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by The Pennsylvania State University College of Agricultural Sciences, the Huck Institutes of the Life Sciences, the Penn State Endowed Program in Molecular Biology of Cacao, NSF Plant Genome Research Award 1546863 to MG, and by the USDA National Institute of Food and Agriculture, Federal Appropriations under Project PEN04569 and Accession number 1003147 to MG. Pairwise Plants and Essenlix Corporation provided support in the form of salaries for authors ASF and YZ respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bailey BA, 2016, CACAO DIS HIST OLD E; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Brockmann B, 2001, PLANT CELL PHYSIOL, V42, P942, DOI 10.1093/pcp/pce120; Corredoira E, 2017, J PLANT PHYSIOL, V213, P42, DOI 10.1016/j.jplph.2017.02.012; Florez SL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0479-4; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goenaga R, 2015, HORTSCIENCE, V50, P358, DOI 10.21273/HORTSCI.50.3.358; Guo FD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071714, 10.1371/journal.pone.0076185]; Helliwell EE, 2016, PLANT BIOTECHNOL J, V14, P875, DOI 10.1111/pbi.12436; Karim R, 2018, PHYSIOL MOL BIOL PLA, V24, P741, DOI 10.1007/s12298-018-0566-8; Kroj T, 2003, DEVELOPMENT, V130, P6065, DOI 10.1242/dev.00814; Li ZJ, 1998, IN VITRO CELL DEV-PL, V34, P293, DOI 10.1007/BF02822737; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Maximova S, 2003, PLANT CELL REP, V21, P872, DOI 10.1007/s00299-003-0596-7; Maximova S. N., 2005, V77, P209; Maximova SN, 2008, IN VITRO CELL DEV-PL, V44, P487, DOI 10.1007/s11627-008-9130-5; Maximova SN, 2002, IN VITRO CELL DEV-PL, V38, P252, DOI 10.1079/IVP2001257; Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Mozgova I, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006562; NAMBARA E, 1995, DEVELOPMENT, V121, P629; Nardmann J, 2006, MOL BIOL EVOL, V23, P2492, DOI 10.1093/molbev/msl125; Ouwerkerk PBF, 2001, PLANTA, V213, P370, DOI 10.1007/s004250100583; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Puentes-Páramo Yina Jazbleidi, 2014, Acta Agron., V63, P145, DOI 10.15446/acag.v63n2.40041; Quainoo AK, 2012, J PLANT STUD, V1, P72, DOI DOI 10.5539/JPS.V1N1P72; Quainoo KA, 2012, FRONT PLANT SCI, V2, P6, DOI DOI 10.5923/J.FS.20120202.02; da Silva TER, 2008, PESQUI AGROPECU BRAS, V43, P1433, DOI 10.1590/S0100-204X2008001000024; Rodriguez-Sanz H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0224-4; Sena R., 2015, SUPPLYING NEW COCOA; Shin B, 2002, PLANT J, V30, P23, DOI 10.1046/j.1365-313X.2002.01264.x; Shires ME, 2017, BIOTECHNOL LETT, V39, P1747, DOI 10.1007/s10529-017-2404-4; Srinivasan C, 2007, PLANTA, V225, P341, DOI 10.1007/s00425-006-0358-1; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Swanson JD, 2008, INT J PLANT SCI, V169, P1187, DOI 10.1086/591986; Traore A, 2000, SOMATIC EMBRYOGENESI; Valledor L, 2007, PLANT CELL TISS ORG, V91, P75, DOI 10.1007/s11240-007-9262-z; Wickramasuriya AM, 2018, PLANT BIOTECHNOL J, V16, P4, DOI 10.1111/pbi.12848; Wojcikowska B, 2015, PLANT CELL TISS ORG, V121, P255, DOI 10.1007/s11240-014-0689-8; Wojcikowska B, 2013, PLANTA, V238, P425, DOI 10.1007/s00425-013-1892-2; Wood G. A. R., 2008, COCOA LONGMAN SCI TE; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Zhang DaPeng, 2016, Cacao diseases: a history of old enemies and new encounters, P3; Zhang YF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-106	53	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207666	10.1371/journal.pone.0207666	http://dx.doi.org/10.1371/journal.pone.0207666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475838	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700052
J	Ribes-Moya, AM; Raigon, MD; Moreno-Peris, E; Fita, A; Rodriguez-Burruezo, A				Ribes-Moya, Ana M.; Raigon, Maria D.; Moreno-Peris, Estela; Fita, Ana; Rodriguez-Burruezo, Adrian			Response to organic cultivation of heirloom Capsicum peppers: Variation in the level of bioactive compounds and effect of ripening	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; AGRICULTURAL PRACTICES; FRUITS; CAROTENOIDS; FLAVONOIDS; CAPACITY; TOMATOES; FOODS; EXTRACTION; NUTRITION	Peppers (Capsicum spp.) are one of the most important vegetables and their double use (vegetable or spice) and two commercial stages (unripe and fully ripe) contributed to their use in many recipes and fast diffusion from America. Nowadays, Spain is a center of diversity for C. annuum, with many landraces, offering a great opportunity for adaptation to organic cultivation. Furthermore, Capsicum peppers contain many bioactive compounds, essential to provide high added-value to these cultivars, especially for organic markets, although knowledge about the effect of organic cultivation on Capsicum fruit quality is still scarce. Here, 37 accessions of Spanish landraces and foreign materials from C. annuum and other species were grown under organic and conventional conditions and evaluated for ascorbic acid (AAC), total phenolics (TP) and total red and yellow/orange carotenoids, considering both ripening stages. A large genotypic variation was found within each ripening stage and growing condition for the studied traits. Also, both stages showed high levels, although fully ripe fruits were the richest. Organic conditions enabled higher levels in fully ripe fruits of AAC and TP on average (135 vs 117 mg.100 g(-1) and 232 vs 206 mg.100 g(-1)) and in most accessions, although the genotype x growing conditions interaction also contributed, but at lower extent, to the observed variation. Significant genotype x ripening stage and growing conditionsxripening stage interactions were also found, suggesting that the magnitude of the increase with ripening depends on the accession and growing conditions. By contrast, there were no differences between growing conditions for carotenoids and differences were mainly due to the genotype factor. Finally, the large genotypic variation and favourable organic conditions allowed identifying several materials from different types and uses with very high levels of bioactive compounds for organic cultivation, in both ripening stages but particularly at fully ripe stage (>500 mg.100 g(-1)).	[Ribes-Moya, Ana M.; Raigon, Maria D.; Moreno-Peris, Estela; Fita, Ana; Rodriguez-Burruezo, Adrian] Acceso J Univ Politecn Valencia, Inst COMAV, Edificio 8E, Valencia, Spain		Rodriguez-Burruezo, A (corresponding author), Acceso J Univ Politecn Valencia, Inst COMAV, Edificio 8E, Valencia, Spain.	adrodbur@doctor.upv.es	Fita, ANA/K-4250-2017; Burruezo, Adrian Rodriguez/AAB-1498-2019	Rodriguez-Burruezo, Adrian/0000-0002-4530-8071	INIA [RTA2014-00041-C02-02, RTA2013-00022-C02]; FEDER funds; Universitat Politecnica de Valencia (UPV) within the 2017 Programa para la Formacion de Personal Investigador (FPI)-Subprograma 1, UPV-FPI 2017-Subprograma 1 [34]	INIA(Instituto de Investigacion Agropecuaria (INIA)); FEDER funds(European Commission); Universitat Politecnica de Valencia (UPV) within the 2017 Programa para la Formacion de Personal Investigador (FPI)-Subprograma 1, UPV-FPI 2017-Subprograma 1	This work has been partially funded by INIA projects RTA2014-00041-C02-02 to ARB and RTA2013-00022-C02 to AF, FEDER funds. AMRB is granted by the Universitat Politecnica de Valencia (UPV) through a scholarship within the 2017 Programa para la Formacion de Personal Investigador (FPI)-Subprograma 1, UPV-FPI 2017-Subprograma 1 -no 34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abushita AA, 2000, J AGR FOOD CHEM, V48, P2075, DOI 10.1021/jf990715p; Alexandratos N., 2012, WORLD AGR 2030 2050, DOI DOI 10.22004/AG.ECON.288998; Alloway BJ, 2009, ENVIRON GEOCHEM HLTH, V31, P537, DOI 10.1007/s10653-009-9255-4; Barrett DM, 2007, J FOOD SCI, V72, pC441, DOI 10.1111/j.1750-3841.2007.00500.x; Best H, 2010, SOC NATUR RESOUR, V23, P451, DOI 10.1080/08941920802178206; Borovsky Y, 2008, THEOR APPL GENET, V117, P235, DOI 10.1007/s00122-008-0768-5; Bosland PW, 2012, CROP PROD SCI HORTIC, V22, P1, DOI 10.1079/9781845938253.0000; Boulay A., 2010, REV GEOGR GEOGR, V5, P125; Chassy AW, 2006, J AGR FOOD CHEM, V54, P8244, DOI 10.1021/jf060950p; d'Amour CB, 2017, P NATL ACAD SCI USA, V114, P8939, DOI 10.1073/pnas.1606036114; Gomez-Garcia MD, 2013, INT J MOL SCI, V14, P19025, DOI 10.3390/ijms140919025; Dewitt D, 2009, COMPLETE CHILLI PEPP, P336; Espin de Gea JC, 2006, INVESTIG CIENC, V356, P34; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Herencia JF, 2011, SCI HORTIC-AMSTERDAM, V129, P882, DOI 10.1016/j.scienta.2011.04.008; Gallie DR, 2013, L ASCORBIC ACID MULT; Ghasemnezhad M, 2011, J FUNCT FOODS, V3, P44, DOI 10.1016/j.jff.2011.02.002; Gnayfeed MH, 2001, J SCI FOOD AGR, V81, P1580, DOI 10.1002/jsfa.982; Gonzalez-Perez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116276; Hallmann E, 2012, J SCI FOOD AGR, V92, P2409, DOI 10.1002/jsfa.5624; Hill TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056200; Hornero-Mendez D, 2001, J AGR FOOD CHEM, V49, P3584, DOI 10.1021/jf010400l; Howard LR, 2000, J AGR FOOD CHEM, V48, P1713, DOI 10.1021/jf990916t; JARRELL WM, 1981, ADV AGRON, V34, P197, DOI 10.1016/S0065-2113(08)60887-1; Kang MS, 1998, ADV AGRON, V62, P199; Kaur C, 2002, INT J FOOD SCI TECH, V37, P153, DOI 10.1046/j.1365-2621.2002.00552.x; KHACHIK F, 1992, J AGR FOOD CHEM, V40, P390, DOI 10.1021/jf00015a006; Kollmannsberger H, 2011, J SCI FOOD AGR, V91, P1598, DOI 10.1002/jsfa.4354; Kris-Etherton PM, 2004, ANNU REV NUTR, V24, P511, DOI 10.1146/annurev.nutr.23.011702.073237; Kumar S, 2006, HANDBOOK OF HERBS AND SPICES, VOL 3, P299, DOI 10.1533/9781845691717.3.299; LEE Y, 1995, J FOOD SCI, V60, P473, DOI 10.1111/j.1365-2621.1995.tb09806.x; Lehmann A, 2014, SOIL BIOL BIOCHEM, V69, P123, DOI 10.1016/j.soilbio.2013.11.001; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Morales-Soto A, 2014, FOOD RES INT, V58, P35, DOI 10.1016/j.foodres.2014.01.050; Moreiras O, 2005, TABLAS COMPOSICION A; Moreiras Tuni O, 2005, TABLAS COMPOSICION A; Navarro JM, 2006, FOOD CHEM, V96, P66, DOI 10.1016/j.foodchem.2005.01.057; Manzur JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144142; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Perez-Lopez AJ, 2007, J AGR FOOD CHEM, V55, P8158, DOI 10.1021/jf071534n; Perez-Lopez AJ, 2007, J SCI FOOD AGR, V87, P2075, DOI 10.1002/jsfa.2966; Plazas M, 2014, INT J MOL SCI, V15, P17221, DOI 10.3390/ijms151017221; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Rodriguez-Burruezo A, 2009, EUPHYTICA, V170, P169, DOI 10.1007/s10681-009-9916-5; Rodriguez-Burruezo A, 2016, VARIEDADES LOCALES M, P480; Rodriguez-Burruezo A, 2010, J FOOD SCI, V75, pS446, DOI 10.1111/j.1750-3841.2010.01795.x; Rossi F, 2008, EUR J NUTR, V47, P266, DOI 10.1007/s00394-008-0721-z; Saini RK, 2018, FOOD CHEM, V240, P90, DOI 10.1016/j.foodchem.2017.07.099; Saini RK, 2015, FOOD RES INT, V76, P735, DOI 10.1016/j.foodres.2015.07.047; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776; Steel A., 1996, BIOESTADISTICA PRINC, Vsecond; Stracke BA, 2009, BRIT J NUTR, V101, P1664, DOI 10.1017/S0007114508116269; Sulaiman SF, 2011, J FOOD COMPOS ANAL, V24, P1, DOI 10.1016/j.jfca.2010.04.005; Sun M, 2006, J SUPERCRIT FLUID, V37, P397, DOI 10.1016/j.supflu.2006.01.008; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; van den Berg H, 2000, J SCI FOOD AGR, V80, P880, DOI 10.1002/(SICI)1097-0010(20000515)80:7&lt;880::AID-JSFA646&gt;3.0.CO;2-1; Wall MM, 2001, HORTSCIENCE, V36, P746, DOI 10.21273/HORTSCI.36.4.746; Zapata Nicolas Manuel, 1992, PIMIENTO PIMENTON; Zimmer AR, 2012, J ETHNOPHARMACOL, V139, P228, DOI 10.1016/j.jep.2011.11.005	60	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207888	10.1371/journal.pone.0207888	http://dx.doi.org/10.1371/journal.pone.0207888			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462729	gold, Green Published, Green Submitted			2022-12-26	WOS:000451054800092
J	Mnatsakanyan, N; Li, YX; Weber, J				Mnatsakanyan, Nelli; Li, Yunxiang; Weber, Joachim			Identification of two segments of the gamma subunit of ATP synthase responsible for the different affinities of the catalytic nucleotide-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; enzyme mechanism; ATPase; bioenergetics; enzyme catalysis; ligand-binding protein; conformational change; oxidative phosphorylation; proton translocation	ESCHERICHIA-COLI; BETA-SUBUNIT; ROTATIONAL CATALYSIS; TORQUE TRANSMISSION; DELSEED LOOP; CATCH-LOOP; F-1-ATPASE; MECHANISM; F1-ATPASE; COMPLEX	ATP synthase uses a rotary mechanism to couple transmembrane proton translocation to ATP synthesis and hydrolysis, which occur at the catalytic sites in the beta subunits. In the presence of Mg2+, the three catalytic sites of ATP synthase have vastly different affinities for nucleotides, and the position of the central gamma subunit determines which site has high, medium, or low affinity. Affinity differences and their changes as rotation progresses underpin the ATP synthase catalytic mechanism. Here, we used a series of variants with up to 45- and 60-residue-long truncations of the N- and C-terminal helices of the gamma subunit, respectively, to identify the segment(s) responsible for the affinity differences of the catalytic sites. We found that each helix carries an affinity-determining segment of similar to 10 residues. Our findings suggest that the affinity regulation by these segments is transmitted to the catalytic sites by the DELSEED loop in the C-terminal domain of the beta subunits. For the N-terminal truncation variants, presence of the affinity-determining segment and therefore emergence of a high-affinity binding site resulted in WT-like catalytic activity. At the C terminus, additional residues outside of the affinity-determining segment were required for optimal enzymatic activity. Alanine substitutions revealed that the affinity changes of the catalytic sites required no specific interactions between amino acid side chains in the gamma and alpha(3)beta(3) subunits but were caused by the presence of the helices themselves. Our findings help unravel the molecular basis for the affinity changes of the catalytic sites during ATP synthase rotation.	[Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Mnatsakanyan, Nelli] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Li, Yunxiang] Texas Womans Univ, Dept Chem & Biochem, Denton, TX 76204 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Yale University; Texas Womans University	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttu.edu		Li, Yunxiang/0000-0001-8035-4690	National Institutes of Health [GM071462]; American Recovery and Reinvestment Act Administrative Supplement	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act Administrative Supplement	Part of this work was supported by National Institutes of Health Grant GM071462 (including American Recovery and Reinvestment Act Administrative Supplement) (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2003, METHOD ENZYMOL, V361, P211; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Boltz KW, 2006, BIOCHEMISTRY-US, V45, P11190, DOI 10.1021/bi052592+; Boltz KW, 2005, BIOCHEMISTRY-US, V44, P9497, DOI 10.1021/bi050070o; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Hossain MD, 2006, BIOPHYS J, V90, P4195, DOI 10.1529/biophysj.105.079087; IWAMOTO A, 1990, J BIOL CHEM, V265, P5043; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; Kohori A, 2011, BIOPHYS J, V101, P188, DOI 10.1016/j.bpj.2011.05.008; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; Mnatsakanyan N, 2011, J BIOL CHEM, V286, P29788, DOI 10.1074/jbc.M111.254730; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P26519, DOI 10.1074/jbc.M109.030528; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2016, BBA-BIOENERGETICS, V1857, P129, DOI 10.1016/j.bbabio.2015.11.005; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Ren HM, 2006, BIOCHEMISTRY-US, V45, P6222, DOI 10.1021/bi060232w; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; STEFFENS K, 1987, J BIOL CHEM, V262, P6334; Tanigawara M, 2012, BIOPHYS J, V103, P970, DOI 10.1016/j.bpj.2012.06.054; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Watanabe R, 2015, BIOPHYS J, V108, P1144, DOI 10.1016/j.bpj.2015.01.017; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Watanabe R, 2013, FEBS LETT, V587, P1030, DOI 10.1016/j.febslet.2013.01.063; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 2004, METHOD ENZYMOL, V380, P132; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	49	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1152	1160		10.1074/jbc.RA118.002504	http://dx.doi.org/10.1074/jbc.RA118.002504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30510135	Green Published, hybrid			2022-12-26	WOS:000457879500008
J	Mostafiz, MM; Jhan, PK; Shim, JK; Lee, KY				Mostafiz, Mohammad Munir; Jhan, Pijush Kanti; Shim, Jae-Kyoung; Lee, Kyeong-Yeoll			Methyl benzoate exhibits insecticidal and repellent activities against Bemisia tabaci (Gennadius) (Hemiptera: Aleyrodidae)	PLOS ONE			English	Article							ESSENTIAL OILS; ARGENTIFOLII HOMOPTERA; Q-BIOTYPES; CONSTITUENTS; RESISTANCE; IDENTIFICATION; OVIPOSITION; MANAGEMENT; L.	Methyl benzoate (MB) is a plant-derived volatile organic compound with insecticidal properties, but such activity has not been evaluated against the sweetpotato whitefly Bemisia tabaci (Gennadius) (Hemiptera: Aleyrodidae), a major crop pest. In this study, we tested methyl benzoate control efficacy on B. tabaci infecting tomato plants in a greenhouse, specifically measuring contact and fumigant toxicity, as well as repellent activity. For direct spray applications of 0% (control), 0.1%, 0.25%, 0.5%, 1%, 2% MB onto tomato leaves infested with adults of B. tabaci (<5-d-old), 2% MB showed the highest corrected mortality (100%) at 24 h post-treatment. For residual toxicity in which the same MB solutions were sprayed onto tomato leaves and allowed to dry for 2 h before <5-d-old adults were released, the 2% MB also showed the highest corrected mortality (100%) at 48 h post-treatment. The lethal median concentration (LC50) for eggs, fourth-instar nymphs, and adults were 0.3%, 0.2%, and 0.2%, respectively. In pot culture experiments, 1% MB concentration was found more effective at killing nymphs and preventing adult eclosion than all other concentrations, and gave 100 percent population reduction compared with the control. MB repelled adult whiteflies and caused 96.5% fumigant toxicity within 10 h post-treatment. Repellency and anti-oviposition rates against B. tabaci had median effective doses of 0.24% and 0.16%, respectively. Our results suggest that MB has strong potential as an environmentally friendly biopesticide for control of B. tabaci but field trials and further greenhouse studies are required to establish efficacy under more natural conditions.	[Mostafiz, Mohammad Munir; Jhan, Pijush Kanti; Shim, Jae-Kyoung; Lee, Kyeong-Yeoll] Kyungpook Natl Univ, Coll Agr & Life Sci, Div Appl Biosci, Daegu, South Korea; [Shim, Jae-Kyoung] Kyungpook Natl Univ, Inst Plant Med, Daegu, South Korea; [Shim, Jae-Kyoung; Lee, Kyeong-Yeoll] Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu, South Korea; [Lee, Kyeong-Yeoll] Kyungpook Natl Univ, Sustainable Agr Res Ctr, Gunwi, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University	Lee, KY (corresponding author), Kyungpook Natl Univ, Coll Agr & Life Sci, Div Appl Biosci, Daegu, South Korea.; Lee, KY (corresponding author), Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu, South Korea.; Lee, KY (corresponding author), Kyungpook Natl Univ, Sustainable Agr Res Ctr, Gunwi, South Korea.	leeky@knu.ac.kr	Mostafiz, Md. Munir/AAD-7664-2019	Mostafiz, Md. Munir/0000-0003-2026-6247	Research Program for the Agricultural Biotechnology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [314085]	Research Program for the Agricultural Biotechnology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This work was supported by the Research Program for the Agricultural Biotechnology Development Program, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (grant number 314085) awarded to KYL.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adorjan B, 2010, FLAVOUR FRAG J, V25, P407, DOI 10.1002/ffj.2024; Ahmad M, 2010, J PEST SCI, V83, P409, DOI 10.1007/s10340-010-0311-8; ALWORTH WL, 1965, ARCH BIOCHEM BIOPHYS, V112, P45, DOI 10.1016/0003-9861(65)90008-1; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brunherotto Rogerio, 2001, Neotropical Entomology, V30, P455, DOI 10.1590/S1519-566X2001000300019; Cahill M, 1996, B ENTOMOL RES, V86, P343, DOI 10.1017/S000748530003491X; Chae SH, 2014, J ECON ENTOMOL, V107, P286, DOI 10.1603/EC13287; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Choudhary MI, 2008, PHYTOCHEMISTRY, V69, P1018, DOI 10.1016/j.phytochem.2007.10.028; Chu D, 2008, INSECT SCI, V15, P115, DOI 10.1111/j.1744-7917.2008.00191.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Deletre E, 2016, PEST MANAG SCI, V72, P179, DOI 10.1002/ps.3987; Dev S, 1997, INSECTICIDES NATURAL; Effmert U, 2005, PHYTOCHEMISTRY, V66, P1211, DOI 10.1016/j.phytochem.2005.03.031; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Emilie D, 2015, J ECON ENTOMOL, V108, P1890, DOI 10.1093/jee/tov118; Feng Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26242-6; Feng YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11100-8; Fukami H, 1971, NATURALLY OCCURRING, P71; Gonzalez-Zamora JE, 2004, CROP PROT, V23, P611, DOI 10.1016/j.cropro.2003.11.011; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Isman M., 1999, Pesticide Outlook, V10, P68; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; James RR, 2003, J ECON ENTOMOL, V96, P25, DOI 10.1603/0022-0493-96.1.25; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Khasdan V, 2005, B ENTOMOL RES, V95, P605, DOI 10.1079/BER2005390; KNUDSEN JT, 1993, BOT J LINN SOC, V113, P263, DOI 10.1111/j.1095-8339.1993.tb00340.x; Kordali S, 2008, BIORESOURCE TECHNOL, V99, P8788, DOI 10.1016/j.biortech.2008.04.048; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Li M, 2010, INT J PEST MANAGE, V56, P275, DOI 10.1080/09670871003743428; Li YF, 2014, ARTHROPOD-PLANT INTE, V8, P183, DOI 10.1007/s11829-014-9302-7; Liu XC, 2013, MOLECULES, V18, P10733, DOI 10.3390/molecules180910733; Mossa A. T. H., 2016, Journal of Environmental Science and Technology, V9, P354; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Palumbo JC, 2001, CROP PROT, V20, P739, DOI 10.1016/S0261-2194(01)00117-X; Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050; SAS Institute, 1995, SAS WIND REL; Shalev AH, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070205; Silva MA, 2012, FLA ENTOMOL, V95, P333, DOI 10.1653/024.095.0214; Sivakumar D, 2014, CROP PROT, V64, P27, DOI 10.1016/j.cropro.2014.05.012; Stansly PA, 2010, BEMISIA BIONOMICS MA, P540, DOI [DOI 10.1007/978-90-481-2460-2, 10.1007/978-90-481-2460-2]; SYSTAT, SYSTAT; Tehri K., 2015, INT J MOSQ RES, V2, P18; Wagan TA, 2017, FLA ENTOMOL, V100, P594, DOI 10.1653/024.100.0317; Wang KY, 2003, J APPL ENTOMOL, V127, P527, DOI 10.1111/j.1439-0418.2003.00778.x; Zhang LP, 2011, PEST MANAG SCI, V67, P226, DOI 10.1002/ps.2056; Zhang W, 2004, J ECON ENTOMOL, V97, P1310, DOI 10.1603/0022-0493-97.4.1310; ZITO SW, 1983, PLANTA MED, V47, P205, DOI 10.1055/s-2007-969986; [No title captured]	51	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208552	10.1371/journal.pone.0208552	http://dx.doi.org/10.1371/journal.pone.0208552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513123	Green Published, gold, Green Submitted			2022-12-26	WOS:000452204800039
J	Tripathy, A; Thakurela, S; Sahu, MK; Uthanasingh, K; Behera, M; Ajay, AK; Kumari, R				Tripathy, Anindita; Thakurela, Sudhir; Sahu, Manoj Kumar; Uthanasingh, Kanishka; Behera, Manas; Ajay, Amrendra Kumar; Kumari, Ratna			The molecular connection of histopathological heterogeneity in hepatocellular carcinoma: A role of Wnt and Hedgehog signaling pathways	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; BETA-CATENIN EXPRESSION; POOR-PROGNOSIS; CANCER; GENE; HEPATOCARCINOGENESIS; SFRP1; PROLIFERATION; FRZA/SFRP-1; METASTASIS	Background Hepatocellular carcinoma (HCC) is leading cause of cancer-related mortality and is categorized among the most common malignancies around the world. It is a heterogeneous tumor, which shows significant degree of histopathological heterogeneity. Despite the apparent histopathological diversity there has been very little distinct correlation between histopathological features and molecular aberrations particularly when it comes to the expression level of Wnt and Hh pathway molecules. The role of Wnt and Hh pathways in relation to HCC behavior viz. histopathological heterogeneity and aggressiveness is not known. Determining the sequential molecular changes and associated histopathological characteristic during HCC initiation, promotion, and progression would probably lead to a better treatment and prognosis. Methods N-Nitrosodiethylamine (DEN) induced HCC model in male Wistar rats were established to study the expression level of Wnt and Hh pathway molecules during different stages of hepatocarcinogenesis. Their expression levels were checked at mRNA and protein levels at initiation, promotion, and progression stages of HCC. The expression levels of Wnt and Hh pathway molecules were correlated with biospecimens of HCC patients of different stages. Results In the present study we identified the comprehensive change in the expression pattern of Wnt and Hh pathway molecules in DEN induced rodent hepatocarcinogenesis model. Our results demonstrate that beta-catenin/CTNNB1 plays important role in tumor initiation and promotion by stimulating tumor cell proliferation. The activated Wnt signaling in early stage of HCC is associated with well-differentiated histological pattern. The Hh activity although activated during the initiation stage but is significantly increased during the early promotion stage of hepatocarcinogenesis. The increased activity of both Wnt & Hh pathways during promotion stage is associated with moderately-differentiated histological pattern and was simultaneously linked with an increased expression of MMP9. Furthermore, our data demonstrated that during the progression stage Wnt pathway is modestly down-regulated but the Hh pathway activity sustained which in turn is associated with aggressive and invasive phenotype and poorly-differentiated histopathology. Conclusion Our data uncovers the grade related expression of Wnt and Hh pathway molecules and the potential utility of these molecular signatures in daily clinical practice is to decide best therapy according to patients characteristic. Additionally, our data offer insight into the interaction between Wnt and Hh pathways which triggers HCC development and progression.	[Tripathy, Anindita; Kumari, Ratna] KIIT Univ, KIIT Sch Biotechnol, Dis Biol Lab, Bhubaneswar, India; [Thakurela, Sudhir] Broad Inst MIT & Harvard, Cambridge, MA USA; [Thakurela, Sudhir] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Sahu, Manoj Kumar; Uthanasingh, Kanishka; Behera, Manas] IMS, Dept Gastroenterol & Hepatobiliary Sci, Bhubaneswar, India; [Sahu, Manoj Kumar; Uthanasingh, Kanishka; Behera, Manas] SUM Hosp, Bhubaneswar, India; [Ajay, Amrendra Kumar] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA	Kalinga Institute of Industrial Technology (KIIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Siksha 'O' Anusandhan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kumari, R (corresponding author), KIIT Univ, KIIT Sch Biotechnol, Dis Biol Lab, Bhubaneswar, India.	ratnaintouch@gmail.com	Thakurela, Sudhir/AAU-6339-2021; Sahu, Manoj/AAC-1465-2019; Ajay, Amrendra K/D-7431-2016	Thakurela, Sudhir/0000-0003-1285-8680; Sahu, Manoj/0000-0002-2615-1726; Ajay, Amrendra K/0000-0003-2790-5726; Uthansingh, Kanishka/0000-0002-2465-0839; Kumari, Ratna/0000-0003-0317-2601	Department of Biotechnology, Government of India [BT/Bio-CARe/07/567/2011-12]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by the Department of Biotechnology, Government of India (http://www.dbtindia.nic.in/), grant number BT/Bio-CARe/07/567/2011-12 to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Mrutyunjay Suar, Director, KIIT School of Biotechnology for being very supportive and giving all the encouragement to carry out this work. We also thank Department of Biotechnology, Government of India for providing financial support to carry out this work.	Aaltonen LA, 2000, PATHOLOGY GENETICS T; Abdo W, 2015, ONCOL LETT, V10, P716, DOI 10.3892/ol.2015.3313; Anfuso B, 2015, CLIN RES HEPATOL GAS, V39, pS92, DOI 10.1016/j.clinre.2015.05.011; Arii S, 1996, HEPATOLOGY, V24, P316; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Ban KC, 2004, J SURG ONCOL, V86, P157, DOI 10.1002/jso.20051; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cheng WT, 2009, INT J ONCOL, V34, P829, DOI 10.3892/ijo_00000209; Davaadorj M, 2016, ANTICANCER RES, V36, P659; Derwinger K, 2010, ACTA ONCOL, V49, P57, DOI 10.3109/02841860903334411; Dufourcq P, 2002, CIRCULATION, V106, P3097, DOI 10.1161/01.CIR.0000039342.85015.5C; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Friemel J, 2015, CLIN CANCER RES, V21, P1951, DOI 10.1158/1078-0432.CCR-14-0122; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Hectors SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02706-z; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kaur P, 2012, TUMOR BIOL, V33, P325, DOI 10.1007/s13277-012-0331-5; Keles I, 2014, CLIN MED RES, V3, P36, DOI DOI 10.11648/J.CMR.20140302.16; Kim TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171771; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; Mansour MA, 2010, BIOFACTORS, V36, P483, DOI 10.1002/biof.122; Martins SN, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00193; Monga P S, 2011, INT J BIOCHEM CELL B, DOI [10.1016/j.biocel.2009.09.001, DOI 10.1016/J.BIOCEL.2009.09.001]; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Newell P, 2008, J HEPATOL, V48, P858, DOI 10.1016/j.jhep.2008.01.008; Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003; Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001; Qu Y, 2013, EUR J CANCER, V49, P3718, DOI 10.1016/j.ejca.2013.07.011; Quan H, 2014, ONCOGENE, V33, P2826, DOI 10.1038/onc.2013.225; Saini S, 2009, CANCER RES, V69, P6815, DOI 10.1158/0008-5472.CAN-09-1254; Shih YL, 2006, CANCER, V107, P579, DOI 10.1002/cncr.22023; Sicklick JK, 2006, CARCINOGENESIS, V27, P748, DOI 10.1093/carcin/bgi292; Sun XH, 2017, ONCOL LETT, V14, P4841, DOI 10.3892/ol.2017.6754; Suzuki H, 2008, ANTICANCER RES, V28, P1821; Suzuki T, 2002, J GASTROEN HEPATOL, V17, P994, DOI 10.1046/j.1440-1746.2002.02774.x; Tabibi Ali, 2007, Urol J, V4, P10	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208194	10.1371/journal.pone.0208194	http://dx.doi.org/10.1371/journal.pone.0208194			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513115	Green Published, gold, Green Submitted			2022-12-26	WOS:000452204800025
J	Ulrich, N; Nagler, K; Laue, M; Cockell, CS; Setlow, P; Moeller, R				Ulrich, Nikea; Nagler, Katja; Laue, Michael; Cockell, Charles S.; Setlow, Peter; Moeller, Ralf			Experimental studies addressing the longevity of Bacillus subtilis spores - The first data from a 500-year experiment	PLOS ONE			English	Article							BACTERIAL-SPORES; WATER-CONTENT; DNA-REPAIR; RESISTANCE; GERMINATION; SPACE; ENDOSPORES; SURVIVAL; UV; PROTECTION	The ability to form endospores allows certain Gram-positive bacteria (e.g. Bacillus subtilis) to challenge the limits of microbial resistance and survival. Thus, B. subtilis is able to tolerate many environmental extremes by transitioning into a dormant state as spores, allowing survival under otherwise unfavorable conditions. Despite thorough study of spore resistance to external stresses, precisely how long B. subtilis spores can lie dormant while remaining viable, a period that potentially far exceeds the human lifespan; is not known although convincing examples of long term spore survival have been recorded. In this study, we report the first data from a 500-year microbial experiment, which started in 2014 and will finish in 2514. A set of vials containing a defined concentration of desiccated B. subtilis spores is opened and tested for viability every two years for the first 24 years and then every 25 years until experiment completion. Desiccated baseline spore samples were also exposed to environmental stresses, including X-rays, 254 nm UV-C, 10% H2O2, dry heat (120 degrees C) and wet heat (100 degrees C) to investigate how desiccated spores respond to harsh environmental conditions after long periods of storage. Data from the first 2 years of storage show no significant decrease in spore viability. Additionally, spores of B. subtilis were subjected to various short-term storage experiments, revealing that space-like vacuum and high NaCl concentration negatively affected spore viability.	[Ulrich, Nikea; Nagler, Katja; Moeller, Ralf] German Aerosp Ctr DLR eV, Inst Aerosp Med, Radiat Biol Dept, Space Microbiol Res Grp, Cologne, Germany; [Nagler, Katja] Max Planck Inst Terr Microbiol, MPG Res Grp CATs Complex Adapt Traits, Heidelberg, Germany; [Laue, Michael] Robert Koch Inst, Adv Light & Electron Microscopy ZBS 4, Berlin, Germany; [Cockell, Charles S.] Univ Edinburgh, UK Ctr Astrobiol, Sch Phys & Astron, Edinburgh, Midlothian, Scotland; [Setlow, Peter] Univ Connecticut, Hlth Ctr, Dept Mol Biol & Biophys, Farmington, CT USA	Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society; Robert Koch Institute; University of Edinburgh; University of Connecticut	Moeller, R (corresponding author), German Aerosp Ctr DLR eV, Inst Aerosp Med, Radiat Biol Dept, Space Microbiol Res Grp, Cologne, Germany.	ralf.moeller@dlr.de			DLR grant DLR-FuE-Projekt ISS LIFE, Programm RF-FuW, Teilprogramm 475	DLR grant DLR-FuE-Projekt ISS LIFE, Programm RF-FuW, Teilprogramm 475	N.J.U. and R.M. were supported by DLR grant DLR-FuE-Projekt ISS LIFE, Programm RF-FuW, Teilprogramm 475.	[Anonymous], 2014, MICROBIOL TODAY, P95; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bremer E., 2002, BACILLUS SUBTILIS IT, P385, DOI DOI 10.1128/9781555817992.CH27; Brown GS, 2007, APPL ENVIRON MICROB, V73, P706, DOI 10.1128/AEM.01082-06; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; Cockell C, 2015, ASTRON GEOPHYS, V56; Edwards AN, 2016, FRONT MICROBIOL, V7, P1, DOI [10.3389/fmicb.2016.00001, DOI 10.3389/FMICB.2016.00001]; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Graham-Smith GS, 1930, J HYG-CAMBRIDGE, V30, P213, DOI 10.1017/S0022172400010391; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Horneck G, 2001, ORIGINS LIFE EVOL B, V31, P527, DOI 10.1023/A:1012746130771; HORNECK G, 1993, ORIGINS LIFE EVOL B, V23, P37, DOI 10.1007/BF01581989; Horneck G, 2012, ASTROBIOLOGY, V12, P445, DOI 10.1089/ast.2011.0737; KENNEDY MJ, 1994, MICROBIOL-SGM, V140, P2513, DOI 10.1099/00221287-140-10-2513; Klobutcher LA, 2006, P NATL ACAD SCI USA, V103, P165, DOI 10.1073/pnas.0507121102; Leishman ON, 2010, J FOOD PROTECT, V73, P1694, DOI 10.4315/0362-028X-73.9.1694; Masiello SN, 2017, J DAIRY SCI, V100, P8783, DOI 10.3168/jds.2017-13139; MICKE U, 1994, ADV SPACE RES, V14, P207, DOI 10.1016/0273-1177(94)90469-3; Moeller R, 2005, FEMS MICROBIOL ECOL, V51, P231, DOI 10.1016/j.femsec.2004.08.008; Moeller R, 2008, APPL ENVIRON MICROB, V74, P6682, DOI 10.1128/AEM.01091-08; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Moeller R, 2014, APPL ENVIRON MICROB, V80, P104, DOI 10.1128/AEM.03136-13; Moeller R, 2012, APPL ENVIRON MICROB, V78, P8849, DOI 10.1128/AEM.02527-12; Moeller R, 2012, ARCH MICROBIOL, V194, P759, DOI 10.1007/s00203-012-0811-4; Mojarro A, 2017, ASTROBIOLOGY, V17, P747, DOI 10.1089/ast.2016.1535; Munakata N, 1997, MUTAT RES-GEN TOX EN, V390, P189, DOI 10.1016/S0165-1218(97)00020-7; Nagler K, 2016, ASTROBIOLOGY, V16, P500, DOI 10.1089/ast.2015.1419; Nagler K, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv023; Nagler K, 2014, APPL ENVIRON MICROB, V80, P1314, DOI 10.1128/AEM.03293-13; Nerandzic MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012285; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL, 2002, ANTON LEEUW INT J G, V81, P27, DOI 10.1023/A:1020561122764; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Perron GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0069533; Poli A, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5020025; POPHAM DL, 1995, APPL ENVIRON MICROB, V61, P3633, DOI 10.1128/AEM.61.10.3633-3638.1995; Ragkousi K, 2003, J BACTERIOL, V185, P2315, DOI 10.1128/JB.185.7.2315-2329.2003; Raguse M, 2016, APPL ENVIRON MICROB, V82, P2031, DOI 10.1128/AEM.03934-15; Rampelotto Pabulo Henrique, 2013, Life-Basel, V3, P482, DOI 10.3390/life3030482; Roth S, 2010, J APPL MICROBIOL, V108, P521, DOI 10.1111/j.1365-2672.2009.04453.x; Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; SETLOW P, 1994, J APPL BACTERIOL, V76, pS49, DOI 10.1111/j.1365-2672.1994.tb04357.x; Setlow P, 2014, J BACTERIOL, V196, P1297, DOI 10.1128/JB.01455-13; Shapiro L, 1997, SCIENCE, V276, P712, DOI 10.1126/science.276.5313.712; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Tovar-Rojo F, 2003, J APPL MICROBIOL, V95, P167, DOI 10.1046/j.1365-2672.2003.01958.x; Vaishampayan PA, 2012, ASTROBIOLOGY, V12, P487, DOI 10.1089/ast.2011.0738; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Wassmann M, 2012, ASTROBIOLOGY, V12, P498, DOI 10.1089/ast.2011.0772; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010; Wood JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138083; Yan N, 2015, INT SOIL WATER CONSE, V3, P316, DOI 10.1016/j.iswer.2015.11.003; Zhang Z, 2012, INT J FOOD MICROBIOL, V160, P99, DOI 10.1016/j.ijfoodmicro.2012.10.009	59	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208425	10.1371/journal.pone.0208425	http://dx.doi.org/10.1371/journal.pone.0208425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513104	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000452204800031
J	Hossain, MZ; Selvaraj, JAL; Rahim, NA				Hossain, M. Zakir; Selvaraj, Jeyraj A. L.; Rahim, N. A.			High voltage-gain full-bridge cascaded dc-dc converter for photovoltaic application	PLOS ONE			English	Article							INTEGRATING COUPLED-INDUCTOR; UP DC/DC CONVERTERS; BOOST CONVERTER; WIND ENERGY; MULTIPLIER; CELL; DESIGN	Over the past few years, high step-up dc-dc converters have been drawn substantial attention because of their wide-ranging application not only in the renewable energy sector but also in many other applications. To acquire a high voltage gain in photovoltaic (PV) and other renewable energy applications, a high step-up dc-dc converter is proposed in this paper. The proposed converter structure consists of a full-bridge (FB) module along with an input boost inductor and a voltage multiplier based on the Cockcroft-Walton (CW) principle with a parallel inductor. The key features of the proposed converter are: 1) high voltage gain with lower voltage stress on the switches, diodes and other passive elements without affecting the number of cascaded stages, 2) a minimum size of boost inductance and cascaded stage capacitance that ensures its compactness and low cost, and 3) a minimal number of major components. Circuit operation, steady-state analysis and various design parameters of the proposed converter are explained in details. In order to prove the performance of the theoretical analysis, a laboratory prototype is also implemented. The peak voltage gain and the maximum efficiency obtained are 11.9 and 94.6% respectively with very low input current ripple and output voltage ripple generated.	[Hossain, M. Zakir; Selvaraj, Jeyraj A. L.; Rahim, N. A.] Univ Malaya, UMPEDAC, Kuala Lumpur, Malaysia; [Hossain, M. Zakir] Univ Malaya, Inst Grad Studies, Kuala Lumpur, Malaysia; [Rahim, N. A.] King Abdulaziz Univ, Renewable Energy Res Grp, Jeddah, Saudi Arabia	Universiti Malaya; Universiti Malaya; King Abdulaziz University	Hossain, MZ; Selvaraj, JAL (corresponding author), Univ Malaya, UMPEDAC, Kuala Lumpur, Malaysia.; Hossain, MZ (corresponding author), Univ Malaya, Inst Grad Studies, Kuala Lumpur, Malaysia.	mzakir@um.edu.my; jeyraj@um.edu.my	RAHIM, NASRUDIN ABD/B-9204-2010; SELVARAJ, JEYRAJ/B-8712-2010	RAHIM, NASRUDIN ABD/0000-0002-1834-1984; 	Higher Institution Centre of Excellence (HICoE); UM Power Energy Dedicated Advanced Centre (UMPEDAC), University of Malaya; Ministry of Higher Education, Malaysia (Project: UM) [UM. 0000067/HME. OM, UMPEDAC-2016, UM.0000343/HRU.OP. RU 002-2017]; Postgraduate Research Grant (PPP), University of Malaya [PG252-2016A]	Higher Institution Centre of Excellence (HICoE); UM Power Energy Dedicated Advanced Centre (UMPEDAC), University of Malaya; Ministry of Higher Education, Malaysia (Project: UM); Postgraduate Research Grant (PPP), University of Malaya	The work was technically and financially supported by Higher Institution Centre of Excellence (HICoE) and UM Power Energy Dedicated Advanced Centre (UMPEDAC), University of Malaya, research grant under Ministry of Higher Education, Malaysia (Project: UM. 0000067/HME. OM, UMPEDAC-2016) and (UM.0000343/HRU.OP. RU 002-2017 to N.A.R.). Additionally, this research was supported by Postgraduate Research Grant (PPP), University of Malaya (PG252-2016A to N.A.R.).	Ajami A, 2015, IEEE T POWER ELECTR, V30, P4255, DOI 10.1109/TPEL.2014.2360495; Al-Saffar MA, 2015, RENEW ENERG, V82, P35, DOI 10.1016/j.renene.2014.08.020; Amir A, 2018, SOL ENERGY, V171, P212, DOI 10.1016/j.solener.2018.06.078; Ardi H, 2018, IEEE T IND ELECTRON, V65, P1306, DOI 10.1109/TIE.2017.2733476; Axelrod B, 2008, IEEE T CIRCUITS-I, V55, P687, DOI 10.1109/TCSI.2008.916403; Berkovich Y, 2008, IEEE W CONTR MODEL, P11; Chung HSH, 2003, IEEE T CIRCUITS-I, V50, P743, DOI 10.1109/TCSI.2003.812615; El-Helw HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161856; Fathabadi H, 2018, ENERG CONVERS MANAGE, V156, P317, DOI 10.1016/j.enconman.2017.11.015; Fathabadi H, 2016, ENERG CONVERS MANAGE, V110, P200, DOI 10.1016/j.enconman.2015.12.025; Pires VF, 2016, SOL ENERGY, V136, P1, DOI 10.1016/j.solener.2016.06.063; Guilbert D, 2016, RENEW ENERG, V90, P14, DOI 10.1016/j.renene.2015.12.054; Gurunathan R, 2001, IEEE T AERO ELEC SYS, V37, P889, DOI 10.1109/7.953244; Hasan R, 2017, SOL ENERGY, V146, P511, DOI 10.1016/j.solener.2017.03.015; Hossain MZ, 2018, RENEW SUST ENERG REV, V81, P205, DOI 10.1016/j.rser.2017.07.017; Hu XF, 2014, IEEE T POWER ELECTR, V29, P789, DOI 10.1109/TPEL.2013.2257870; Hwang F, 2006, IEEE T IND APPL, V42, P1139, DOI 10.1109/TIA.2006.880845; Kobougias IC, 2010, IEEE T POWER ELECTR, V25, P2460, DOI 10.1109/TPEL.2010.2049380; Li Q, 2008, IEEE T POWER ELECTR, V23, P1320, DOI 10.1109/TPEL.2008.920883; Li WH, 2011, IEEE T IND ELECTRON, V58, P1239, DOI 10.1109/TIE.2010.2049715; Lin JL, 2003, IEEE T POWER ELECTR, V18, P2, DOI 10.1109/TPEL.2002.807176; Liu LL, 2017, INT T ELECTR ENERGY, V27, DOI 10.1002/etep.2335; Lizarraga A, 2017, SOL ENERGY, V157, P934, DOI 10.1016/j.solener.2017.09.019; Malesani L., 1993, IEEE Transactions on Power Electronics, V8, P147, DOI 10.1109/63.223966; Naderipour A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0164856; Parastar A, 2015, IEEE T POWER ELECTR, V30, P644, DOI 10.1109/TPEL.2014.2314110; Prudente M, 2008, IEEE T POWER ELECTR, V23, P871, DOI 10.1109/TPEL.2007.915762; Tomaszuk A, 2011, B POL ACAD SCI-TECH, V59, P475, DOI 10.2478/v10175-011-0059-1; Tsang KM, 2015, SOL ENERGY, V119, P203, DOI 10.1016/j.solener.2015.07.005; Wai RJ, 2007, IEEE T POWER ELECTR, V22, P1986, DOI 10.1109/TPEL.2007.904167; Wai RJ, 2007, IEEE T IND ELECTRON, V54, P354, DOI 10.1109/TIE.2006.888794; Wang JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196501; Williamson SS, 2015, IEEE T IND ELECTRON, V62, P3021, DOI 10.1109/TIE.2015.2409052; Yang ZL, 2017, ENERG CONVERS MANAGE, V132, P460, DOI 10.1016/j.enconman.2016.11.050; Young CM, 2013, IEEE T IND ELECTRON, V60, P523, DOI 10.1109/TIE.2012.2188255; Zhang Y, 2017, 2017 IEEE APPL POW E	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0206691	10.1371/journal.pone.0206691	http://dx.doi.org/10.1371/journal.pone.0206691			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500857	Green Submitted, gold, Green Published			2022-12-26	WOS:000451883700004
J	Adelowo, OO; Helbig, T; Knecht, C; Reincke, F; Mausezahl, I; Muller, JA				Adelowo, Olawale Olufemi; Helbig, Therese; Knecht, Camila; Reincke, Franziska; Maeusezahl, Ines; Mueller, Jochen A.			High abundances of class 1 integrase and sulfonamide resistance genes, and characterisation of class 1 integron gene cassettes in four urban wetlands in Nigeria	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; WASTE-WATER TREATMENT; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL-RESISTANCE; BETA-LACTAMASE; POLLUTED RIVER; BACTERIA; DIVERSITY; ELEMENTS; ENTEROBACTERIACEAE	There is little information about environmental contamination with antibiotic resistance genes (ARG) in Sub-Saharan Africa, home to about 1 billion people. In this study we measured the abundance of three genes (sul1, sul2, and intl1) used as indicators of environmental contamination with ARGs in the sediments of four urban wetlands in southwestern Nigeria by qPCR. In addition, we characterised the variable regions of class 1 integrons in sulfamethoxazole/trimethoprim (SMX/TRI)-resistant bacteria isolated from the wetlands by PCR and DNA sequencing. The indicator ARGs were present in all wetlands with mean absolute copy numbers/gram of sediment ranging between 4.7x10(6) and 1.2x10(8) for sul1, 1.1x10(7) and 1x10(8) for sul2, and 5.3x10(5) and 1.9x10(7) for intl1. The relative abundances (ARG/16S rRNA copy number) ranged from about 10(-3) to 10(-1). These levels of ARG contamination were similar to those previously reported for polluted environments in other parts of the world. The integrase genes intl1 and intl2 were detected in 72% and 11.4% SMX/TRI-resistant isolates, respectively. Five different cassette array types (dfrA7; aadA2; aadA1 vertical bar dfrA1; acc(6')lb-cr vertical bar arr3 vertical bar dfrA27; arr3 vertical bar acc(6')lb-cr vertical bar dfrA27) were detected among 34 (59.6%) intl1-positive isolates. No gene cassettes were found in the nine intl2-positive isolates. These results show that African urban ecosystems impacted by anthropogenic activities are reservoirs of bacteria harbouring transferable ARG.	[Adelowo, Olawale Olufemi; Helbig, Therese; Knecht, Camila; Reincke, Franziska; Maeusezahl, Ines; Mueller, Jochen A.] Helmholtz Ctr Environm Res GmbH UFZ, Dept Environm Biotechnol, Leipzig, Germany; [Adelowo, Olawale Olufemi] Univ Ibadan, Dept Microbiol, Environm Microbiol & Biotechnol Lab, Ibadan, Oyo State, Nigeria; [Helbig, Therese] Martin Luther Univ Halle Wittenberg, Inst Biol Microbiol, Halle, Germany; [Knecht, Camila] Otto von Guericke Univ, Inst Instrumental & Environm Technol, Magdeburg, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Ibadan; Martin Luther University Halle Wittenberg; Otto von Guericke University	Adelowo, OO (corresponding author), Helmholtz Ctr Environm Res GmbH UFZ, Dept Environm Biotechnol, Leipzig, Germany.; Adelowo, OO (corresponding author), Univ Ibadan, Dept Microbiol, Environm Microbiol & Biotechnol Lab, Ibadan, Oyo State, Nigeria.	onomewaleadelowo@yahoo.co.uk	ADELOWO, OLAWALE/ABC-5821-2020; Müller, Jochen A./T-7318-2019	Müller, Jochen A./0000-0002-0935-1523; Knecht, Camila A./0000-0002-2908-6157; ADELOWO, OLAWALE OLUFEMI/0000-0002-5235-8122	Georg Forster (HERMES) Postdoctoral Fellowship of the Alexander von Humboldt-Foundation	Georg Forster (HERMES) Postdoctoral Fellowship of the Alexander von Humboldt-Foundation	This work was supported by a Georg Forster (HERMES) Postdoctoral Fellowship of the Alexander von Humboldt-Foundation (https://www.humboldt-foundation.de/) to OOA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekola O, 2012, WETLANDS, V32, P665, DOI 10.1007/s13157-012-0299-3; Adelowo OO, 2009, LETT APPL MICROBIOL, V48, P167, DOI 10.1111/j.1472-765X.2008.02523.x; Adelowo OO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33535-3; Adelowo OO, 2018, ENVIRON SCI POLLUT R, V25, P2744, DOI 10.1007/s11356-017-0686-7; Adelowo OO, 2012, TURK J BIOL, V36, P37, DOI 10.3906/biy-1010-145; Antelo Veronica, 2015, Advances in Polar Science, V26, P30, DOI 10.13679/j.advps.2015.1.00030; Baggesen DL, 2000, J CLIN MICROBIOL, V38, P1581, DOI 10.1128/JCM.38.4.1581-1586.2000; Bass L, 1999, ANTIMICROB AGENTS CH, V43, P2925, DOI 10.1128/AAC.43.12.2925; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Berglund B, 2015, ENVIRON TOXICOL CHEM, V34, P192, DOI 10.1002/etc.2784; Canal N, 2016, BRAZ J MICROBIOL, V47, P337, DOI 10.1016/j.bjm.2016.01.015; Martini MC, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fix190; Chen BW, 2015, J HAZARD MATER, V282, P61, DOI 10.1016/j.jhazmat.2014.06.010; Chen B, 2011, APPL ENVIRON MICROB, V77, P148, DOI 10.1128/AEM.01676-10; Chen CQ, 2017, SCI TOTAL ENVIRON, V580, P1175, DOI 10.1016/j.scitotenv.2016.12.075; Czekalski N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00106; da Silva MF, 2007, FEMS MICROBIOL ECOL, V60, P166, DOI 10.1111/j.1574-6941.2006.00268.x; Devarajan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149211; Fang HS, 2017, CHEMOSPHERE, V173, P99, DOI 10.1016/j.chemosphere.2017.01.027; Flores Ribeiro Angela, 2014, Sci Total Environ, V490, P370, DOI 10.1016/j.scitotenv.2014.05.012; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; Gao PP, 2012, WATER RES, V46, P2355, DOI 10.1016/j.watres.2012.02.004; Garbisu C, 2018, SCI TOTAL ENVIRON, V621, P725, DOI 10.1016/j.scitotenv.2017.11.221; Gillings MR, 2018, CURR POLLUT REP, V4, P49, DOI 10.1007/s40726-018-0076-x; Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226; Gillings MR, 2014, MICROBIOL MOL BIOL R, V78, P257, DOI 10.1128/MMBR.00056-13; Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001; Grape M, 2007, CLIN MICROBIOL INFEC, V13, P1112, DOI 10.1111/j.1469-0691.2007.01807.x; Guo X, 2011, LETT APPL MICROBIOL, V52, P667, DOI 10.1111/j.1472-765X.2011.03059.x; HUGHES R.H., 1992, DIRECTORY AFRICAN WE; Ishida Y, 2010, J VET MED SCI, V72, P727, DOI 10.1292/jvms.09-0538; Jiang L, 2013, SCI TOTAL ENVIRON, V458, P267, DOI 10.1016/j.scitotenv.2013.04.038; Jove T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000793; Khan GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062712; Koczura R, 2016, MICROB ECOL, V72, P909, DOI 10.1007/s00248-016-0843-4; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; Laffite A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01128; Lamba M, 2017, ENVIRON SCI TECHNOL, V51, P13906, DOI 10.1021/acs.est.7b03380; Leverstein-van Hall MA, 2002, J CLIN MICROBIOL, V40, P3038, DOI 10.1128/JCM.40.8.3038-3040.2002; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Lin M, 2016, DIS AQUAT ORGAN, V120, P115, DOI 10.3354/dao03013; Liu LM, 2018, ENVIRON INT, V117, P292, DOI 10.1016/j.envint.2018.05.023; Lu ZH, 2015, SCI TOTAL ENVIRON, V527, P429, DOI 10.1016/j.scitotenv.2015.04.101; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Ma LP, 2017, ENVIRON SCI TECHNOL, V51, P5721, DOI 10.1021/acs.est.6b05887; Machado E, 2005, ANTIMICROB AGENTS CH, V49, P1823, DOI 10.1128/AAC.49.5.1823-1829.2005; Makowska N, 2016, CHEMOSPHERE, V144, P1665, DOI 10.1016/j.chemosphere.2015.10.044; Marathe NP, 2018, ENVIRON INT, V112, P279, DOI 10.1016/j.envint.2017.12.036; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; McLain JE, 2016, J ENVIRON QUAL, V45, P432, DOI 10.2134/jeq2015.06.0317; Michael CA, 2004, AM NAT, V164, P1, DOI 10.1086/421733; Moura A, 2012, APPL ENVIRON MICROB, V78, P5413, DOI 10.1128/AEM.00042-12; Muziasari WI, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02137; Nardelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039223; Nolvak H, 2016, SCI TOTAL ENVIRON, V562, P678, DOI 10.1016/j.scitotenv.2016.04.035; Obasi A, 2017, MICROB DRUG RESIST, V23, P1013, DOI 10.1089/mdr.2016.0269; Odetoyin BW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183383; Orsini M, 2001, LETT APPL MICROBIOL, V33, P17, DOI 10.1046/j.1472-765X.2001.00938.x; Ozgumus OB, 2009, J MICROBIOL, V47, P19, DOI 10.1007/s12275-008-0206-z; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Peng S, 2017, J HAZARD MATER, V340, P16, DOI 10.1016/j.jhazmat.2017.06.059; Peters EDJ, 2001, ANTIMICROB AGENTS CH, V45, P2961, DOI 10.1128/AAC.45.10.2961-2964.2001; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Stalder T, 2014, ISME J, V8, P768, DOI 10.1038/ismej.2013.189; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Su HC, 2012, ENVIRON POLLUT, V169, P42, DOI 10.1016/j.envpol.2012.05.007; Sukumaran D.P., 2012, INTERDISCIPLINARY PE, V7, DOI [10.1155/2012/124879, DOI 10.1155/2012/124879]; Taviani E, 2008, FEMS MICROBIOL ECOL, V64, P45, DOI 10.1111/j.1574-6941.2008.00455.x; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Uluocha N.O., 2004, GEOL J, V61, P151, DOI DOI 10.1007/S10708-004-2868-3; Vinue L, 2011, INT J ANTIMICROB AG, V38, P526, DOI 10.1016/j.ijantimicag.2011.07.007; Vinue L, 2010, INT J ANTIMICROB AG, V35, P492, DOI 10.1016/j.ijantimicag.2010.01.012; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112626; Wu D, 2017, ENVIRON SCI TECHNOL, V51, P12859, DOI 10.1021/acs.est.7b03797; Xiong WG, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00061; Xu Y, 2017, ENVIRON POLLUT, V220, P900, DOI 10.1016/j.envpol.2016.10.074; Yang YY, 2019, J HAZARD MATER, V361, P283, DOI 10.1016/j.jhazmat.2018.09.002; Yang YY, 2018, ENVIRON INT, V116, P60, DOI 10.1016/j.envint.2018.04.011; You XX, 2018, ENVIRON INT, V113, P162, DOI 10.1016/j.envint.2018.02.002; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zhu YG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.270	91	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208269	10.1371/journal.pone.0208269	http://dx.doi.org/10.1371/journal.pone.0208269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496274	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800124
J	Buti, M; Dominguez-Hernandez, R; Casado, MA; Sabater, E; Esteban, R				Buti, Maria; Dominguez-Hernandez, Raquel; Angel Casado, Miguel; Sabater, Eliazar; Esteban, Rafael			Healthcare value of implementing hepatitis C screening in the adult general population in Spain	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; VIRUS GENOTYPE 1; LIVER FIBROSIS; THERAPY; DISEASE; LEDIPASVIR/SOFOSBUVIR; MANIFESTATIONS; PRODUCTIVITY; SOFOSBUVIR; INFECTION	Background Elimination of hepatitis C virus (HCV) infection requires high diagnostic rates and universal access to treatment. Around 40% of infected individuals are unaware of their infection, which indicates that effective screening strategies are needed. We analyzed the efficiency (incremental cost-utility ratio, ICUR) of 3 HCV screening strategies: a) general population of adults, b) high-risk groups, and c) population with the highest anti-HCV prevalence plus high-risk groups. Methods An analytical decision model, projecting progression of the disease over a lifetime, was used to establish the candidate population for HCV screening. HCV data were obtained from the literature: anti-HCV prevalence (0.56%-1.54%), viremic patients (31.5%), and percentage of undiagnosed persons among those with viremia (35%). It was assumed that most patients would be treated and have HCV therapy response (98% SVR); transition probabilities, utilities, and disease management annual costs were obtained from the literature. Efficiency over the life of patients under the National Health System perspective was measured as quality-adjusted life years (QALY) and total cost (screening, diagnosis, pharmacological and disease management). A discount rate of 3% was applied to costs and outcomes. Results Screening of the adult population would identify a larger number of additional chronic hepatitis C cases (N = 52,694) than screening the highest anti-HCV prevalence population plus high-risk groups (N = 42,027) or screening high-risk groups (N = 26,128). ICUR for the general population vs. high-risk groups was (sic)8914/QALY gained per patient ((sic)18,157 incremental cost and 2.037 QALY). ICUR for the general population vs. population with highest anti-HCV prevalence plus high-risk groups was (sic)7,448/QALY gained per patient ((sic)7,733 incremental cost and 1.038 QALY). These ICUR values are below the accepted efficiency threshold ((sic)22,000-(sic)30,000). Conclusion HCV screening and treatment of the general adult population is cost-effective compared to screening of high-risk groups or the population with the highest anti-HCV prevalence plus high-risk groups.	[Buti, Maria; Esteban, Rafael] Hosp Gen Univ Vall dHebron, CIBERehd, Barcelona, Spain; [Dominguez-Hernandez, Raquel; Angel Casado, Miguel; Sabater, Eliazar] Pharmacoecon & Outcomes Res Iberia, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Dominguez-Hernandez, R (corresponding author), Pharmacoecon & Outcomes Res Iberia, Madrid, Spain.	rdominguez@porib.com		Buti Ferret, Maria/0000-0002-0732-3078	Gilead Sciences	Gilead Sciences(Gilead Sciences)	MB, RDH, MAC, ES and RE has received unconditional funding from Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Raquel Dominguez-Hernandez, Eliazar Sabater and Miguel Angel Casado are employees of Pharmacoeconomics & Outcomes Research Iberia. Pharmacoeconomics & Outcomes Research Iberia provided support in the form of salaries for authors RDH, MAC and ES but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguinaga A, 2017, ENFERM INFECC MICROB; American Association For the Study of Liver Diseases (AASLD), INF DIS SOC AM REC T; [Anonymous], 2015, DESCRIPTION CHARACTE; Berenguer J, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw059; Buti M, 2005, J HEPATOL, V42, P639, DOI 10.1016/j.jhep.2004.12.031; Buti M, 2017, J VIRAL HEPATITIS, V24, P750, DOI 10.1111/jvh.12704; Buti M, MED CLIN BARC, V148, P277; Buti Maria, 2014, Farm Hosp., V38, P418, DOI [10.7399/fh.2014.38.5.7640, 10.7399/FH.2014.38.5.7640]; Cacoub P, 2018, ALIMENT PHARM THER, V47, P123, DOI 10.1111/apt.14382; Chahal HS, 2016, JAMA INTERN MED, V176, P65, DOI 10.1001/jamainternmed.2015.6011; Chaillon A, 2017, HEPATOLOGY, V66, p410A; Cuadrado A., 2018, EUR ASS STUD LIV INT, P68; Daivozadeh G, 2016, 2 NAT C GROUP STUD V; de Castilla Junta, 2015, ADMISSIONS OUTPATIEN; Deuffic-Burban S, 2016, AM SOC HEP ANN M BOS; European Association for the Study of the Liver, 2015, REC TREATM HEP C; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Ferrante SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-190; Garcia-Jurado L, 2012, ENFERM INFEC MICR CL, V30, P294, DOI 10.1016/j.eimc.2011.11.004; General Secretary of Penitentiary Institutions, 2017, PROGR PREV CONTR HIV; Hepatitis C, 2017, LANCET GASTROENTEROL, V2, P325; Kim DY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167770; Linthicum MT, 2016, AM J MANAG CARE, V22, pSP227; Lopez-Bastida J, 2010, EUR J HEALTH ECON, V11, P513, DOI 10.1007/s10198-010-0244-4; lvarez A S, 2016, LIV M AASLD BOST MA; Mancebo M, 2016, 2 NAT C VIR HEP GEHE; Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6; Maylin S, 2008, GASTROENTEROLOGY, V135, P821, DOI 10.1053/j.gastro.2008.05.044; Mena A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113062; Miguel RS, 2015, GUT, V64, P1277, DOI 10.1136/gutjnl-2014-307772; Ministry of Finance and Public Administration, UPD STAB PROGR 2016; Ministry of Health Social Services and Equality, 2015, ALC TOB ILL DRUGS SP; Ministry of Interior, 2017, PEN STAD INCL PREV L; Oblikue consulting, 2018, ESALUD; Oliva-Moreno J, 2015, EUR J GASTROEN HEPAT, V27, P631, DOI 10.1097/MEG.0000000000000336; Rattay T, 2017, GASTROENTEROLOGY, V153, P1531, DOI 10.1053/j.gastro.2017.10.016; Rodriguez-Tajes S, 2017, SPAN ASS STUD LIV MA; Roncero C, 2017, EUR J GASTROEN HEPAT, V29, P629, DOI 10.1097/MEG.0000000000000855; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Sacristán J.A., 2002, Gac Sanit, V16, P334; Scott N, 2017, INT J DRUG POLICY, V47, P107, DOI 10.1016/j.drugpo.2017.07.006; Spanish Association for the Study of the Liver, 2017, AEEH SEIMC GUID HEP; Spanish Ministry of Health Social Policy and Equality, 2014, HEP MORT AG SPAIN; Spanish Ministry of Health Social Policy and Equality, STRAT PLAN TACKL HEP; Spanish Ministry of Health Social Policy and Equality, 2014, MORT AG GROUPS SPAIN; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Statistics National Institute, 2016, POP SPAN FOR AG YEAR; Stepanova M, 2017, CLIN LIVER DIS, V21, P579, DOI 10.1016/j.cld.2017.03.012; Turnes J, 2017, REV ESP ENFERM DIG, V109, P809, DOI 10.17235/reed.2017.5063/2017; Turnes J, 2017, GASTROENT HEPAT-BARC, V40, P433, DOI 10.1016/j.gastrohep.2017.05.004; Vallejo-Torres L, 2017, HLTH EC; van der Meer AJ, 2016, J HEPATOL, V65, pS95, DOI 10.1016/j.jhep.2016.07.039; Wong William W L, 2017, CMAJ Open, V5, pE662, DOI 10.9778/cmajo.20170048; World Health Organization, 2016, GLOB HLTH SECT STRAT; Younossi Z, 2016, J VIRAL HEPATITIS, V23, P217, DOI 10.1111/jvh.12483; Younossi ZM, 2015, ALIMENT PHARM THER, V41, P544, DOI 10.1111/apt.13081; Younossi Z, 2018, LIVER INT, V38, P258, DOI 10.1111/liv.13519	57	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208036	10.1371/journal.pone.0208036	http://dx.doi.org/10.1371/journal.pone.0208036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485377	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800098
J	Chen, RQ; Wen, C; Fu, R; Li, JN; Wu, J				Chen, Riqing; Wen, Cheng; Fu, Rao; Li, Jianning; Wu, Jian			The effect of complex intramural microstructure caused by structural remodeling on the stability of atrial fibrillation: Insights from a three-dimensional multi-layer modeling study	PLOS ONE			English	Article							EPICARDIAL ELECTRICAL DISSOCIATION; TRANSMURAL CONDUCTION; CARDIAC FIBROSIS; MECHANISMS; DYNAMICS	Background Recent researches have suggested that the complex three-dimensional structures caused by structural remodeling play a key role in atrial fibrillation (AF) substrates. Here we aimed to investigate this hypothesis using a multi-layer model representing intramural microstructural features. Methods The proposed multi-layer model was composed of the endocardium, connection wall, and epicardium. In the connection wall, intramural fibrosis was simulated using fibrotic patches randomly scattered in the myocardial tissue of fibrotic layers, while endo-epicardial dissociation was simulated using myocardial patches randomly scattered in the fibrotic tissue of isolation layers. Multiple simulation groups were generated to quantitatively analyze the effects of endo-epicardial dissociation and intramural fibrosis on AF stability, including a stochastic group, interrelated groups, fibrosis-degree-controlled groups, and dissociation-degree-controlled groups. Results 1. Stable intramural re-entries were observed to move along complete re-entrant circuits inside the transmural wall in four of 65 simulations in the stochastic group. 2. About 21 of 23 stable simulations in the stochastic group were distributed in the areas with high endo-epicardial dissociation and intramural fibrosis. 3. The difference between fibrosis-degree-controlled groups and dissociation-degree-controlled groups suggested that some distributions of connection areas may affect AF episodes despite low intramural fibrosis and endo-epicardial dissociation. 4. The overview of tracking phase singularities revealed that endo-epicardial dissociation played a visible role in AF substrates. Conclusion The complex intramural microstructure is positively correlated with critical components of AF maintenance mechanisms. The occurrence of intramural re-entry further indicates the complexity of AF wave-dynamics.	[Chen, Riqing; Wen, Cheng; Fu, Rao; Li, Jianning; Wu, Jian] Tsinghua Univ, Grad Sch Shenzhen, Inst Biomed Engn, Shenzhen, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Wu, J (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Inst Biomed Engn, Shenzhen, Peoples R China.	wuj@sz.tsinghua.edu.cn			Guangdong Science and Technology Plan Grant [2017B020210003]; Knowledge Innovation Program of Basic Research Projects of Shenzhen Grant [JCYJ20160428182053361]; National Natural Science Foundation of China (NSFC) Grant [81771940, 81427803]	Guangdong Science and Technology Plan Grant; Knowledge Innovation Program of Basic Research Projects of Shenzhen Grant; National Natural Science Foundation of China (NSFC) Grant(National Natural Science Foundation of China (NSFC))	Research was supported by Guangdong Science and Technology Plan Grant (2017B020210003), the Knowledge Innovation Program of Basic Research Projects of Shenzhen Grant (JCYJ20160428182053361), and the National Natural Science Foundation of China (NSFC) Grant (81771940, 81427803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166972; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Corradi D, 2014, CARDIOVASC PATHOL, V23, P71, DOI 10.1016/j.carpath.2013.12.001; de Jong S, 2011, J CARDIOVASC PHARM, V57, P630, DOI 10.1097/FJC.0b013e318207a35f; de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Eckstein J, 2013, CIRC-ARRHYTHMIA ELEC, V6, P334, DOI 10.1161/CIRCEP.113.000342; Eckstein J, 2011, CARDIOVASC RES, V89, P816, DOI 10.1093/cvr/cvq336; Gharaviri A, 2012, EUROPACE, V14, pV10, DOI 10.1093/europace/eus270; Gutbrod SR, 2015, CIRC-ARRHYTHMIA ELEC, V8, P456, DOI 10.1161/CIRCEP.114.002545; Hansen Brian J, 2017, JACC Clin Electrophysiol, V3, P531, DOI 10.1016/j.jacep.2017.05.002; Hansen BJ, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004398; Hansen BJ, 2015, EUR HEART J, V36, P2390, DOI 10.1093/eurheartj/ehv233; Iyer AN, 2001, ANN BIOMED ENG, V29, P47, DOI 10.1114/1.1335538; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Janus I, 2016, BMC VET RES, V12, DOI 10.1186/s12917-015-0626-z; Jin J. M., 2014, FINITE ELEMENT METHO; Kazbanov IV, 2016, SCI REP-UK, V6, DOI 10.1038/srep20835; Li N, 2016, CIRCULATION, V134, P486, DOI 10.1161/CIRCULATIONAHA.115.021165; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Nygren A, 1998, CIRC RES, V82, P63; Quintanilla JG, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.002481; SCHUESSLER RB, 1993, CIRCULATION, V88, P250, DOI 10.1161/01.CIR.88.1.250; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Tobon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050883; Ugarte JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114577; Verheule S, 2014, PROG BIOPHYS MOL BIO, V115, P173, DOI 10.1016/j.pbiomolbio.2014.07.007; Verheule S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P202, DOI 10.1161/CIRCEP.112.975144; Woods CE, 2014, CIRC RES, V114, P1532, DOI 10.1161/CIRCRESAHA.114.302362; Zhao JC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005922	31	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208029	10.1371/journal.pone.0208029	http://dx.doi.org/10.1371/journal.pone.0208029			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485346	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800096
J	Habel, JC; Teucher, M; Rodder, D				Habel, Jan C.; Teucher, Mike; Roedder, Dennis			Mark-release-recapture meets Species Distribution Models: Identifying micro-habitats of grassland butterflies in agricultural landscapes	PLOS ONE			English	Article							DIURNAL MOTHS; ROAD VERGES; DISPERSAL; FRAGMENTATION; DIVERSITY; BIODIVERSITY; RICHNESS; SCALE	Habitat demands and species mobility strongly determine the occurrence of species. Sedentary species with specific habitat requirements are assumed to occur more patchy than mobile habitat generalist species, and thus suffer stronger under habitat fragmentation and habitat deterioration. In this study we measured dispersal and habitat preference of three selected butterfly species using mark-release-recapture technique. We used data on species abundance to calculate Species Distribution Models based on high-resolution aerial photographs taken using RGB / NIR cameras mounted on a UAV. We found that microhabitats for species with specific habitat requirements occur spatially restricted. In contrast, suitable habitats are more interconnected and widespread for mobile habitat generalists. Our models indicate that even managed grassland sites have comparatively little habitat quality, while road verges provide high quality micro-habitats. In addition, dispersal was more restricted for specialist butterfly species, and higher for the two other butterfly species with less ecological specialisation. This study shows synergies arising when combining ecological data with high precision aerial pictures and Species Distribution Models, to identify micro-habitats for butterflies. This approach might be suitable to identify and conserve high quality habitats, and to improve nature conservation at the ground.	[Habel, Jan C.] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Teucher, Mike] Univ Halle, Inst Geosci & Geog, Dept Remote Sensing & Cartog, Halle, Germany; [Roedder, Dennis] Zool Forsch Museum Alexander Koenig, Bonn, Germany	Technical University of Munich; Martin Luther University Halle Wittenberg; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Habel, JC (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany.	Janchristianhabel@gmx.de	Rödder, Dennis/AAT-8644-2021; Habel, Jan Christian/H-2112-2019	Rödder, Dennis/0000-0002-6108-1639; Habel, Jan Christian/0000-0003-1378-9381				Asher J, 2001, MILLENNIUM ATLAS BUT; Autengruber H., 2007, KALKMAGERRASENRELIKT; Batary P, 2017, NAT ECOL EVOL, V1, P1279, DOI 10.1038/s41559-017-0272-x; Bink F.A., 1992, ECOLOGISCHE ATLAS DA; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Cousins SAO, 2006, BIOL CONSERV, V127, P500, DOI 10.1016/j.biocon.2005.09.009; Dennis RLH, 1997, J INSECT CONSERV, V1, P167, DOI 10.1023/A:1018455714879; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Ebert G, 1991, SCHMETTERLINGE BADEN, V1-10, P1991; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Filz KJ, 2013, BIODIVERS CONSERV, V22, P2223, DOI 10.1007/s10531-012-0413-0; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Habel JC, 2018, BIOL CONSERV, V218, P211, DOI 10.1016/j.biocon.2017.12.018; Habel JC, 2016, LANDSCAPE ECOL, V31, P2385, DOI 10.1007/s10980-016-0409-3; Habel JC, 2016, CONSERV BIOL, V30, P754, DOI 10.1111/cobi.12656; Habel JC, 2013, BIODIVERS CONSERV, V22, P2401, DOI 10.1007/s10531-012-0407-y; Habel JC, 2010, J INSECT CONSERV, V14, P467, DOI 10.1007/s10841-010-9275-5; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hughes JB, 2000, OECOLOGIA, V123, P375, DOI 10.1007/s004420051024; Konvicka M, 2008, J INSECT CONSERV, V12, P519, DOI 10.1007/s10841-007-9092-7; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Leon-Cortes JL, 2003, OIKOS, V102, P449, DOI 10.1034/j.1600-0706.2003.12129.x; Lethmate J, 2005, BIOL UNSERER Z, V35, P118; Louy D, 2007, CONSERV GENET, V8, P671, DOI 10.1007/s10592-006-9213-y; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Polus E, 2007, BIODIVERS CONSERV, V16, P3423, DOI 10.1007/s10531-006-9008-y; QGIS Development Team, 2018, QGIS GEOGR INF SYST; REINHARDT R, 2012, NATURSCHUTZ BIOL VIE, V70, P167; Saarinen K, 2005, BIOL CONSERV, V123, P403, DOI 10.1016/j.biocon.2004.12.012; Schmitt T, 2002, ACTA BIOL DEBR, V24, P113; Schmitt T, 2000, BASIC APPL ECOL, V1, P53, DOI 10.1078/1439-1791-00008; Schmitt Thomas, 1993, Atalanta (Marktleuthen), V24, P33; Schneider C, 2003, ECOL ENTOMOL, V28, P252, DOI 10.1046/j.1365-2311.2003.00495.x; Schneider C, 2003, ECOL ENTOMOL; Slamova I, 2013, INSECT CONSERV DIVER, V6, P243, DOI 10.1111/j.1752-4598.2012.00212.x; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevens VM, 2010, BIOL REV, V85, P625, DOI 10.1111/j.1469-185X.2009.00119.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Valtonen A., 2006, Animal Biodiversity and Conservation, V29, P133; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Weidemann HJ, 1995, TAGFALTER BEOBACHTEN	43	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207052	10.1371/journal.pone.0207052	http://dx.doi.org/10.1371/journal.pone.0207052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485301	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800040
J	Mallon, C; Gooberman-Hill, R; Blom, A; Whitehouse, M; Moore, A				Mallon, Charlotte; Gooberman-Hill, Rachael; Blom, Ashley; Whitehouse, Michael; Moore, Andrew			Surgeons are deeply affected when patients are diagnosed with prosthetic joint infection	PLOS ONE			English	Article							QUALITATIVE RESEARCH; MEDICAL ERROR; 2ND VICTIM; BURNOUT; EXPERIENCE; RESIDENTS; RESPONSES; STRESS; NEEDS	Knee replacement is a common preference sensitive quality-of-life procedure that can reduce pain and improve function for people with advanced knee arthritis. While most patients improve, knee replacement surgery has the potential for serious complications. Prosthetic knee infection is an uncommon but serious complication. This study explored the impact of cases of prosthetic knee infection on surgeons' personal and professional wellbeing. Qualitative telephone interviews were conducted with consultant orthopaedic surgeons who treated patients for prosthetic knee infection in one of six high-volume NHS orthopaedic departments. Data was audio-recorded, transcribed and analysed thematically. Eleven surgeons took part. Analysis identified three overarching themes: (i) At some point infection is inevitable but surgeons still feel accountable; (ii) A profound emotional impact and (iii) Supporting each other. The occurrence of prosthetic joint infection has a significant emotional impact on surgeons who report a collective sense of devastation and personal ownership, even though prosthetic joint infection cannot be fully controlled for. Surgeons stressed the importance of openly discussing the management of prosthetic joint infection with a supportive multidisciplinary team and this has implications for the ways in which orthopaedic surgeons may be best supported to manage this complication. This article also acknowledges that surgeons are not alone in experiencing personal impact when patients have infection.	[Mallon, Charlotte; Gooberman-Hill, Rachael; Blom, Ashley; Whitehouse, Michael; Moore, Andrew] Univ Bristol, Bristol Med Sch, Dept Translat Hlth Sci, Musculoskeletal Res Unit, Bristol, Avon, England; [Gooberman-Hill, Rachael; Blom, Ashley; Whitehouse, Michael] Univ Bristol, Natl Inst Hlth Res, Bristol Med Sch, Bristol Biomed Res Ctr, Bristol, Avon, England	University of Bristol; University of Bristol	Moore, A (corresponding author), Univ Bristol, Bristol Med Sch, Dept Translat Hlth Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	a.j.moore@bristol.ac.uk	Whitehouse, Michael/AAR-3898-2020; Moore, Andrew/ABA-8956-2021	Whitehouse, Michael/0000-0003-2436-9024; Moore, Andrew/0000-0003-3185-1599; Blom, Ashley/0000-0002-9940-1095; Gooberman-Hill, Rachael/0000-0003-3353-2882	National Institute for Health Research Programme Grants for Applied Research (NIHR PGfAR) programme [RP-PG-1210-12005]; NIHR Comprehensive Clinical Research Network (CRN); NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol	National Institute for Health Research Programme Grants for Applied Research (NIHR PGfAR) programme; NIHR Comprehensive Clinical Research Network (CRN); NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol	This paper presents independent research funded by the National Institute for Health Research Programme Grants for Applied Research (NIHR PGfAR) programme (grant number: RP-PG-1210-12005) and supported by the NIHR Comprehensive Clinical Research Network (CRN). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. This study was supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	[Anonymous], 2012, NVIVO QUAL DAT AN SO; Balch CM, 2009, ARCH SURG-CHICAGO, V144, P371, DOI 10.1001/archsurg.2008.575; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; Beaton DE, 2009, J BONE JOINT SURG AM, V91A, P107, DOI 10.2106/JBJS.H.01631; Blom AW, 2004, J BONE JOINT SURG BR, V86B, P688, DOI 10.1302/0301-620X.86B5.14887; Bohle A, 2001, J UROLOGY, V165, P1158, DOI 10.1016/S0022-5347(05)66454-3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cahill J L, 2008, J Orthop Surg (Hong Kong), V16, P58; Campbell DA, 2001, SURGERY, V130, P696, DOI 10.1067/msy.2001.116676; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Engel KG, 2006, ACAD MED, V81, P86, DOI 10.1097/00001888-200601000-00021; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Firth-Cozens J, 2003, BRIT MED J, V326, P670, DOI 10.1136/bmj.326.7391.670; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Gawande A., 2008, COMPLICATIONS SURG N; Gehrke T, 2015, BONE JOINT J, V97B, P20, DOI 10.1302/0301-620X.97B10.36475; Glaser B.G., 1968, DISCOV GROUNDED THEO; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; JOHNSON JT, 1993, HEAD NECK-J SCI SPEC, V15, P557, DOI 10.1002/hed.2880150614; Kunutsor SK, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150866, 10.1371/journal.pone.0151537]; Lander LI, 2006, LARYNGOSCOPE, V116, P1114, DOI 10.1097/01.mlg.0000224493.81115.57; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Luu S, 2012, MED EDUC, V46, P1179, DOI 10.1111/medu.12058; Mallon CM, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2264-7; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Moore AJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009495; Orri M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143763; Orri M, 2014, ANN SURG, V260, P721, DOI 10.1097/SLA.0000000000000962; Parvizi J, 2017, BONE JOINT J, V99B, P3, DOI [10.1302/0301-620X.99B4.BJJ-2016-1212.R1, 10.1302/0301-620X.99B4BJJ-2016-1212.R1]; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pinto A, 2013, BRIT J SURG, V100, P1748, DOI 10.1002/bjs.9308; Pope C, 2006, QUALITATIVE RES HLTH; Royal College of Surgeons, 2017, PROF SUPP SURG; Ruggieri Paul A., 2012, CONFESSIONS SURG GOO; Sadat-Ali M, 2005, SAUDI MED J, V26, P1180; Scott SD, 2009, QUAL SAF HEALTH CARE, V18, P325, DOI 10.1136/qshc.2009.032870; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Skevington SM, 2012, PSYCHOL HEALTH MED, V17, P1, DOI 10.1080/13548506.2011.592841; Stake R.E., 2005, SAGE HDB QUALITATIVE, V3rd, P119; The NJR Editorial Board, 2016, 13 ANN REP 2016; Ullstrom S, 2014, BMJ QUAL SAF, V23, P325, DOI 10.1136/bmjqs-2013-002035; Upton D, 2012, SURGERY, V151, P493, DOI 10.1016/j.surg.2011.09.035; Vincent C., 2010, PATIENT SAFETY, V2nd Ed.; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726; Yost WB, 2005, TRANSPL P, V37, P1399, DOI 10.1016/j.transproceed.2005.01.055; Zmistowski B, 2013, J BONE JOINT SURG AM, V95A, P2177, DOI 10.2106/JBJS.L.00789	47	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207260	10.1371/journal.pone.0207260	http://dx.doi.org/10.1371/journal.pone.0207260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485337	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800055
J	Lan, YX; Mohr, C; Hu, XM; Kuhn, G				Lan, Yuxuan; Mohr, Christine; Hu, Xiaomeng; Kuhn, Gustav			Fake science: The impact of pseudo-psychological demonstrations on people's beliefs in psychological principles	PLOS ONE			English	Article							MAGICAL THINKING; MISINFORMATION; COEXISTENCE; SUGGESTION; CHILDREN	Magicians use deception to create effects that allow us to experience the impossible. More recently, magicians have started to contextualize these tricks in psychological demonstrations. We investigated whether witnessing a magic demonstration alters people's beliefs in these pseudo-psychological principles. In the classroom, a magician claimed to use psychological skills to read a volunteer's thoughts. After this demonstration, participants reported higher beliefs that an individual can 1) read a person's mind by evaluating micro expressions, psychological profiles and muscle activities, and 2) effectively prime a person's behaviour through subtle suggestions. Whether he was presented as a magician or psychologist did not influence people's beliefs about how the demonstration was achieved, nor did it influence their beliefs in pseudo-psychological principles. Our results demonstrate that pseudo-psychological demonstrations can have a significant impact on perpetuating false beliefs in scientific principles and raise important questions about the wider impact of scientific misinformation.	[Lan, Yuxuan; Hu, Xiaomeng] Tsinghua Univ, Sch Social Sci, Dept Psychol, Beijing, Peoples R China; [Mohr, Christine] Lausanne Univ, Dept Psychol, Lausanne, Switzerland; [Kuhn, Gustav] Goldsmiths Univ London, Dept Psychol, London, England	Tsinghua University; University of Lausanne; University of London; Goldsmiths University London	Kuhn, G (corresponding author), Goldsmiths Univ London, Dept Psychol, London, England.	g.kuhn@gold.ac.uk		Kuhn, Gustav/0000-0003-2888-914X; Mohr, Christine/0000-0002-3720-7115	Swiss National Science Foundation - SNF [100014_162370]	Swiss National Science Foundation - SNF(Swiss National Science Foundation (SNSF))	Funding was provided by Swiss National Science Foundation - SNF (100014_162370) to CM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENASSI VA, 1980, J SCI STUD RELIG, V19, P337, DOI 10.2307/1386128; Braddock K, 2016, COMMUN MONOGR, V83, P446, DOI 10.1080/03637751.2015.1128555; Busselle R, 2008, COMMUN THEOR, V18, P255, DOI 10.1111/j.1468-2885.2008.00322.x; Chan MPS, 2017, PSYCHOL SCI, V28, P1531, DOI 10.1177/0956797617714579; Christopher Milbourne, 2006, ILLUSTRATED HIST MAG; CRAWFORD HJ, 1992, J ABNORM PSYCHOL, V101, P663, DOI 10.1037/0021-843X.101.4.663; GILBERT DT, 1991, AM PSYCHOL, V46, P107, DOI 10.1037/0003-066X.46.2.107; Kuhn G., EXPERIENCING IMPOSSI; Lamont P., 2018, SECRET HIST MAGIC TR; Lamont Peter, 2013, EXTRAORDINARY BELIEF; Leddington J, 2016, J AESTHET ART CRITIC, V74, P253, DOI 10.1111/jaac.12290; Legare CH, 2008, COGNITIVE SCI, V32, P607, DOI 10.1080/03640210802066766; Legare CH, 2012, CHILD DEV, V83, P779, DOI 10.1111/j.1467-8624.2012.01743.x; Lesaffre L, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02129; Lewandowsky S, 2017, J APPL RES MEM COGN, V6, P353, DOI 10.1016/j.jarmac.2017.07.008; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; LOFTUS EF, 1995, PSYCHIAT ANN, V25, P720, DOI 10.3928/0048-5713-19951201-07; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; Marks D.F., 2000, PSYCHOL PSYCHIC; Mohr C, 2017, SCI MAG ASS C LOND; Mohr C, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01542; Nash M.R., 2012, OXFORD HDB HYPNOSIS, DOI DOI 10.3389/fpsyg.2013.00387; Parris BA, 2009, NEUROIMAGE, V45, P1033, DOI 10.1016/j.neuroimage.2008.12.036; Rensink RA, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01508; Subbotsky E, 2004, BRIT J DEV PSYCHOL, V22, P123, DOI 10.1348/026151004772901140; Subbotsky E, 2007, BRIT J PSYCHOL, V98, P547, DOI 10.1348/000712606X166069; Thomas C, 2017, Q J EXPT PSYCHOL; Thomas C, 2016, COGNITION, V154, P169, DOI 10.1016/j.cognition.2016.06.002; Wicht C, 2018, EXPLAIN PARANORMAL E; Wiseman R, 2003, BRIT J PSYCHOL, V94, P285, DOI 10.1348/000712603767876235; Woolley JD, 1997, CHILD DEV, V68, P991, DOI 10.2307/1132282	31	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207629	10.1371/journal.pone.0207629	http://dx.doi.org/10.1371/journal.pone.0207629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB9UV	30481220	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000451440000016
J	Kambutse, I; Igiraneza, G; Ogbuagu, O				Kambutse, Immaculate; Igiraneza, Grace; Ogbuagu, Onyema			Perceptions of HIV transmission and preexposure prophylaxis among health care workers and community members in Rwanda	PLOS ONE			English	Article							PREVENTION; MEN; INFECTION; PREP; SEX	There are too many new HIV infections globally with 1.8 million persons infected in 2016 alone. Pre-exposure prophylaxis (PrEP) holds potential to decrease new infections and is synergistic with efforts currently in place to achieve an end to the AIDS epidemic in SubSaharan African, but uptake is limited. Given its novelty, assessing the beliefs and attitudes of healthcare professionals and members of the community towards HIV transmission and PrEP will be helpful to inform implementation efforts. Study was a random survey of 201 community members and 51 healthcare providers, carried out at multiple community sites in Huye district, Southern Province, Rwanda and at Kigali University Teaching Hospital (KUTH). The study findings are that there are still misconceptions about HIV in the community with some respondents believing that HIV is due to punishment from God (5.4%), poverty (3.0%), smoking cigarettes (1.0%), drinking alcohol (2.0%), punishment from ancestors (1.0%) and witchcraft (1.5%), and that its transmission is by mosquito bites (10.9%), sharing food or drinks with a HIV infected person (6.5%) or as a result of carelessness (47.8%). More than 50% of respondents from both groups had insufficient knowledge regarding PrEP, but expressed some interest in PrEP (82.6% of the respondents from the community and 86.5% of the health workers). However, some healthcare workers felt that promotion of safe sex practices (74.5%), HIV testing and treating HIV infected patients (60.8%) would work better than PrEP to decrease new HIV infections. Barriers to PrEP implementation included perceived stigma, delayed access to prevention services at the health facilities while personal-level concerns included lack of family support, reluctance to take a medication daily and fear of being perceived as having HIV. This study showed that health care workers and community members are willing to utilize PrEP in Rwanda, but many challenges exist including limited knowledge about PrEP, stigma, provider and system level service delivery barriers at health facilities among others. More studies are needed to assess ways of addressing and /or eliminating these barriers.	[Kambutse, Immaculate; Igiraneza, Grace; Ogbuagu, Onyema] Univ Teaching Hosp Kigali, Dept Med, Kigali, Rwanda; [Ogbuagu, Onyema] Yale Univ, Dept Med, Sect Infect Dis, Yale AIDS Program, New Haven, CT 06520 USA	Yale University	Kambutse, I (corresponding author), Univ Teaching Hosp Kigali, Dept Med, Kigali, Rwanda.	ikambutse@gmail.com						[Anonymous], 2016, NAT GUID PREV MAN HI; Atujuna M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191251; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cairns GP, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21120; Center for AIDS Prevention Studies (CAPS), 1995, VOLUNTARY COUNSELING; Corneli Amy L, 2014, J Int AIDS Soc, V17, P19152, DOI 10.7448/IAS.17.3.19152; Delaugerre C, 2018, AIDS; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Kelly JA, 1998, AIDS, V12, pF91, DOI 10.1097/00002030-199810000-00001; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Mack N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-231; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mugo PM, 2015, AIDS BEHAV, V19, P794, DOI 10.1007/s10461-014-0958-x; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; National Institute of Statistics of Rwanda (NISR) [Rwanda] M of H (MOH) [Rwanda], 2012, ICF INT RWAND DEM HL; Patel RC, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21134; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Republic of Rwanda Ministry of Health, 2014, GLOB AIDS RESP PROGR; Ross I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173057; Rwanda Ministry of Health, ANN REP 2015 2016; Sayinzoga F, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1351-4; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tun W, 2004, CLIN INFECT DIS, V38, P1167, DOI 10.1086/383033; UNAIDS, UNAIDS FACT SHEET JU; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25094; Venter WDF, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00188; Wheelock A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001234; Young LE, 2018, CLIN TRIALS, V15, P44, DOI 10.1177/1740774517730012	30	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207650	10.1371/journal.pone.0207650	http://dx.doi.org/10.1371/journal.pone.0207650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475841	gold, Green Submitted, Green Published			2022-12-26	WOS:000451325700048
J	Lu, M; Williamson, N; Mishra, A; Michel, CH; Kaminski, CF; Tunnacliffe, A; Schierle, GSK				Lu, Meng; Williamson, Neil; Mishra, Ajay; Michel, Claire H.; Kaminski, Clemens F.; Tunnacliffe, Alan; Schierle, Gabriele S. Kaminski			Structural progression of amyloid-beta Arctic mutant aggregation in cells revealed by multiparametric imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; amyloid-beta (A beta); molecular dynamics; microscopic imaging; structural model; 3D structure of amyloid aggregates; Alzheimer's disease; amyloid-beta; Arctic mutant; neurodegeneration; SIM	A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; ACCUMULATION; MORPHOLOGY; MUTATION; OLIGOMERIZATION; DEGRADATION; KINETICS; PICALM	The 42-amino-acid beta-amyloid (A beta 42) is a critical causative agent in the pathology of Alzheimer's disease. The hereditary Arctic mutation of A beta 42 (E22G) leads to increased intracellular accumulation of beta-amyloid in early-onset Alzheimer's disease. However, it remains largely unknown how the Arctic mutant variant leads to aggressive protein aggregation and increased intracellular toxicity. Here, we constructed stable cell lines expressing fluorescent-tagged wildtype (WT) and E22G A beta 42 to study the aggregation kinetics of the Arctic A beta 42 mutant peptide and its heterogeneous structural forms. Arctic-mutant peptides assemble and form fibrils at a much faster rate than WT peptides. We identified five categories of intracellular aggregate-oligomers, single fibrils, fibril bundles, clusters, and aggresomes-that underline the heterogeneity of these A beta 42 aggregates and represent the progression of A beta 42 aggregation within the cell. Fluorescence-lifetime imaging (FLIM) and 3D structural illumination microscopy (SIM) showed that all aggregate species displayed highly compact structures with strong affinity between individual fibrils. We also found that aggregates formed by Arctic mutant A beta 42 were more resistant to intracellular degradation than their WT counterparts. Our findings uncover the structural basis of the progression of Arctic mutant A beta 42 aggregation in the cell.	[Lu, Meng; Mishra, Ajay; Kaminski, Clemens F.; Tunnacliffe, Alan; Schierle, Gabriele S. Kaminski] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge Infinitus Res Ctr, Cambridge CB3 0AS, England; [Lu, Meng; Williamson, Neil; Mishra, Ajay; Michel, Claire H.; Kaminski, Clemens F.; Schierle, Gabriele S. Kaminski] Univ Cambridge, Dept Chem Engn & Biotechnol, West Cambridge Site,Philippa Fawcett Dr, Cambridge CB3 0AS, England; [Williamson, Neil] Bactevo Ltd, Merrifield Ctr, Rosemary Lane, Cambridge CB1 3LQ, England	University of Cambridge; University of Cambridge	Schierle, GSK (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.	gsk20@cam.ac.uk	; Kaminski, Clemens/G-7488-2016	mishra, ajay/0000-0001-8201-4067; Kaminski, Clemens/0000-0002-5194-0962	Infinitus (China) Company Ltd.; European Research Council Advanced Investigator Award [AdG233232]; Wellcome Trust; Alzheimer Research UK (ARUK); UK Medical Research Council (MRC); BBSRC [BB/H023917/1] Funding Source: UKRI; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K015850/1, MC_G1000734, MR/K02292X/1, MR/N012453/1, G0902243] Funding Source: UKRI	Infinitus (China) Company Ltd.; European Research Council Advanced Investigator Award(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer Research UK (ARUK)(Alzheimer's Research UK (ARUK)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Infinitus (China) Company Ltd. and European Research Council Advanced Investigator Award AdG233232 (to A. T.) and Wellcome Trust, UK Medical Research Council (MRC), and Alzheimer Research UK (ARUK) funding (to G. S. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Chen WY, 2017, NANO LETT, V17, P143, DOI 10.1021/acs.nanolett.6b03686; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kassler K, 2010, J MOL MODEL, V16, P1011, DOI 10.1007/s00894-009-0611-1; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Kruitwagen T, 2015, ELIFE, V4, DOI 10.7554/eLife.10396; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lin YS, 2012, BIOPHYS J, V103, pL47, DOI 10.1016/j.bpj.2012.11.009; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lu M, 2015, J BIOL CHEM, V290, P27986, DOI 10.1074/jbc.M115.676437; Lu M, 2015, BIOTECHNOL BIOENG, V112, P1883, DOI 10.1002/bit.25606; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; MIZUGUCHI M, 1992, BRAIN RES, V584, P219, DOI 10.1016/0006-8993(92)90898-J; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Norlin N, 2012, J STRUCT BIOL, V180, P174, DOI 10.1016/j.jsb.2012.06.010; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pensalfini A, 2014, NEUROBIOL DIS, V71, P53, DOI 10.1016/j.nbd.2014.07.011; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schaefer PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168157; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; Schreiner B, 2015, J ALZHEIMERS DIS, V43, P369, DOI 10.3233/JAD-132543; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; XU HX, 1995, J BIOL CHEM, V270, P23243, DOI 10.1074/jbc.270.40.23243; Young LJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53988; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025	44	17	17	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1478	1487		10.1074/jbc.RA118.004511	http://dx.doi.org/10.1074/jbc.RA118.004511			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30504224	Green Published, hybrid			2022-12-26	WOS:000457879200004
J	Wilson, C; Lee, MD; Heathcote, HR; Zhang, X; Buckley, C; Girkin, JM; Saunter, CD; McCarron, JG				Wilson, Calum; Lee, Matthew D.; Heathcote, Helen R.; Zhang, Xun; Buckley, Charlotte; Girkin, John M.; Saunter, Christopher D.; McCarron, John G.			Mitochondrial ATP production provides long-range control of endothelial inositol trisphosphate-evoked calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial cell; inositol 1,4,5-trisphosphate (IP3); calcium imaging; endoplasmic reticulum (ER); mitochondria; cell signaling; fluorescence imaging; inositol trisphosphate; mesenteric artery; reactive oxygen species (ROS); endothelium; ATP; Ca2+signaling; myoendothelial junction	MYOENDOTHELIAL GAP-JUNCTIONS; PROTEIN S-GLUTATHIONYLATION; SMOOTH-MUSCLE; ENDOPLASMIC-RETICULUM; 1,4,5-TRISPHOSPHATE RECEPTOR; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; MESENTERIC-ARTERIES; IP3 RECEPTORS; K-CA	Endothelial cells are reported to be glycolytic and to minimally rely on mitochondria for ATP generation. Rather than providing energy, mitochondria in endothelial cells may act as signaling organelles that control cytosolic Ca2+ signaling or modify reactive oxygen species (ROS). To control Ca2+ signaling, these organelles are often observed close to influx and release sites and may be tethered near Ca2+ transporters. In this study, we used high-resolution, wide-field fluorescence imaging to investigate the regulation of Ca2+ signaling by mitochondria in large numbers of endothelial cells (similar to 50 per field) in intact arteries from rats. We observed that mitochondria were mostly spherical or short-rod structures and were distributed widely throughout the cytoplasm. The density of these organelles did not increase near contact sites with smooth muscle cells. However, local inositol trisphosphate (IP3)-mediated Ca2+ signaling predominated near these contact sites and required polarized mitochondria. Of note, mitochondrial control of Ca2+ signals occurred even when mitochondria were far from Ca2+ release sites. Indeed, the endothelial mitochondria were mobile and moved throughout the cytoplasm. Mitochondrial control of Ca2+ signaling was mediated by ATP production, which, when reduced by mitochondrial depolarization or ATP synthase inhibition, eliminated local IP3-mediated Ca2+ release events. ROS buffering did not significantly alter local Ca2+ release events. These results highlight the importance of mitochondrial ATP production in providing long-range control of endothelial signaling via IP3-evoked local Ca2+ release in intact endothelium.	[Wilson, Calum; Lee, Matthew D.; Heathcote, Helen R.; Zhang, Xun; Buckley, Charlotte; McCarron, John G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, SIPBS Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland; [Girkin, John M.; Saunter, Christopher D.] Univ Durham, Dept Phys, Biophys Sci Inst, Ctr Adv Instrumentat, South Rd, Durham DH1 3LE, England	University of Strathclyde; Durham University	Wilson, C; McCarron, JG (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, SIPBS Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	c.wilson@strath.ac.uk; john.mccarron@strath.ac.uk	Wilson, Calum/AAI-1541-2019; Wilson, Calum/AAC-9114-2020	Wilson, Calum/0000-0003-2500-0632; ZHANG, XUN/0000-0003-0790-4291; Girkin, John/0000-0003-2568-3576; Lee, Matthew D/0000-0001-8265-382X; Buckley, Charlotte/0000-0002-7961-4544	Wellcome Trust [202924/Z/16/Z]; British Heart Foundation [PG/16/54/32230, PG16/82/32439]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by Wellcome Trust Grant 202924/Z/16/Z and British Heart Foundation Grants PG/16/54/32230 and PG16/82/32439. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Anzai K, 2000, ANTIOXID REDOX SIGN, V2, P35, DOI 10.1089/ars.2000.2.1-35; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; Barstow KL, 2004, NEUROSCIENCE, V124, P327, DOI 10.1016/j.neuroscience.2003.12.010; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BIRD GS, 1993, J BIOL CHEM, V268, P17917; Boerman EM, 2016, AM J PHYSIOL-HEART C, V310, pH1091, DOI 10.1152/ajpheart.00038.2016; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; Bruce JIE, 2004, J BIOL CHEM, V279, P12909, DOI 10.1074/jbc.M309070200; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Chalmers S, 2016, J PHYSIOL-LONDON, V594, P4283, DOI 10.1113/JP271942; Chalmers S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16875; Chalmers S, 2012, ARTERIOSCL THROM VAS, V32, P3000, DOI 10.1161/ATVBAHA.112.255174; Chalmers S, 2009, CELL CALCIUM, V46, P107, DOI 10.1016/j.ceca.2009.05.007; Cheranov SY, 2004, J PHYSIOL-LONDON, V556, P755, DOI 10.1113/jphysiol.2003.059568; Chidgey J, 2016, FREE RADICAL BIO MED, V97, P274, DOI 10.1016/j.freeradbiomed.2016.06.010; Collins TJ, 2000, BIOCHEM J, V347, P593, DOI 10.1042/0264-6021:3470593; Coutelle O, 2014, EMBO MOL MED, V6, P624, DOI 10.1002/emmm.201303016; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; Dai JZ, 2005, CELL CALCIUM, V37, P333, DOI 10.1016/j.ceca.2004.12.002; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; DOBRINA A, 1983, BIOCHIM BIOPHYS ACTA, V762, P295, DOI 10.1016/0167-4889(83)90084-8; Dora KA, 2003, J VASC RES, V40, P480, DOI 10.1159/000074549; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eelen G, 2018, PHYSIOL REV, V98, P3, DOI 10.1152/physrev.00001.2017; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; Fitzgerald G, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00100; Francis M, 2016, CIRC RES, V118, P1078, DOI 10.1161/CIRCRESAHA.115.308141; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; Groschner LN, 2012, PFLUG ARCH EUR J PHY, V464, P63, DOI 10.1007/s00424-012-1085-z; Guillery O, 2008, NEUROMUSCULAR DISORD, V18, P319, DOI 10.1016/j.nmd.2007.12.008; Haak LL, 2002, J NEUROCHEM, V80, P405, DOI 10.1046/j.0022-3042.2001.00727.x; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; Hajnoczky G, 2000, J PHYSIOL-LONDON, V529, P69, DOI 10.1111/j.1469-7793.2000.00069.x; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Kamishima T, 1998, BIOPHYS J, V75, P1767, DOI 10.1016/S0006-3495(98)77618-0; Katakam PVG, 2013, ARTERIOSCL THROM VAS, V33, P752, DOI 10.1161/ATVBAHA.112.300560; KAUFFMAN RF, 1980, J BIOL CHEM, V255, P2735; Khan SA, 2013, BIOCHEM J, V451, P177, DOI 10.1042/BJ20121600; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1; KRUTZFELDT A, 1990, J MOL CELL CARDIOL, V22, P1393, DOI 10.1016/0022-2828(90)90984-A; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Lapel M, 2017, AM J PHYSIOL-CELL PH, V312, pC56, DOI 10.1152/ajpcell.00250.2016; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; LEIGHTON B, 1987, FEBS LETT, V225, P93, DOI 10.1016/0014-5793(87)81137-7; Lock JT, 2012, J PHYSIOL-LONDON, V590, P3431, DOI [10.1113/jphysiol.2012.230656, 10.1113/jphysiol.2012.232645]; Lock JT, 2011, AM J PHYSIOL-HEART C, V300, pH493, DOI 10.1152/ajpheart.01073.2010; Maarouf N, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12330; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; MAEDA N, 1991, J BIOL CHEM, V266, P1109; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309; Marchant JS, 2002, AM J PHYSIOL-CELL PH, V282, pC1374, DOI 10.1152/ajpcell.00446.2001; MAYRLEITNER M, 1991, CELL CALCIUM, V12, P505, DOI 10.1016/0143-4160(91)90032-A; McCarron JG, 2004, J BIOL CHEM, V279, P8417, DOI 10.1074/jbc.M311797200; McCarron JG, 1999, J PHYSIOL-LONDON, V516, P149, DOI 10.1111/j.1469-7793.1999.149aa.x; McCarron JG, 2000, J PHYSIOL-LONDON, V525, P113, DOI 10.1111/j.1469-7793.2000.00113.x; McCarron JG, 2017, TRENDS PHARMACOL SCI, V38, P322, DOI 10.1016/j.tips.2017.01.008; McCarron JG, 2013, J VASC RES, V50, P357, DOI 10.1159/000353883; McCarron JG, 2010, J CELL PHYSIOL, V224, P334, DOI 10.1002/jcp.22103; McCarron JG, 2009, J GEN PHYSIOL, V133, P439, DOI 10.1085/jgp.200810189; MERTENS S, 1990, AM J PHYSIOL, V258, pH689, DOI 10.1152/ajpheart.1990.258.3.H689; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mumtaz S, 2011, CELL CALCIUM, V49, P66, DOI 10.1016/j.ceca.2010.11.010; NICHOLLS DG, 1980, FEBS LETT, V111, P261, DOI 10.1016/0014-5793(80)80806-4; NIXON GF, 1994, J MUSCLE RES CELL M, V15, P682, DOI 10.1007/BF00121075; Oancea E, 1996, J BIOL CHEM, V271, P17253, DOI 10.1074/jbc.271.29.17253; Olson ML, 2012, BIOCHEM SOC T, V40, P158, DOI 10.1042/BST20110705; Olson ML, 2010, J BIOL CHEM, V285, P2040, DOI 10.1074/jbc.M109.027094; Paltauf-Doburzynska J, 2004, J CARDIOVASC PHARM, V44, P423, DOI 10.1097/01.fjc.0000139449.64337.1b; Parker I, 1996, J PHYSIOL-LONDON, V491, P663, DOI 10.1113/jphysiol.1996.sp021247; Pathak T, 2018, PHARMACOL THERAPEUT, V192, P112, DOI 10.1016/j.pharmthera.2018.07.001; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Peters K, 2009, CELL PHYSIOL BIOCHEM, V24, P483, DOI 10.1159/000257490; Piquereau J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00102; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Scheitlin CG, 2016, AM J PHYSIOL-CELL PH, V310, pC479, DOI 10.1152/ajpcell.00171.2015; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Shuai JW, 2005, CELL CALCIUM, V37, P283, DOI 10.1016/j.ceca.2004.10.008; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simpson PB, 1996, J BIOL CHEM, V271, P33493, DOI 10.1074/jbc.271.52.33493; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654; SMITH JB, 1985, J BIOL CHEM, V260, P4413; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Sward K, 2002, CIRC RES, V90, P792, DOI 10.1161/01.RES.0000015214.40360.84; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Szado T, 2003, FASEB J, V17, P28, DOI 10.1096/fj.02-0334com; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Vaur S, 2000, GEN PHYSIOL BIOPHYS, V19, P265; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; Wang Q, 2005, FASEB J, V19, P837, DOI 10.1096/fj.04-2657fje; Wilson C, 2016, J VASC RES, V53, P358, DOI 10.1159/000454811; Wilson C, 2016, J PHYSIOL-LONDON, V594, P7267, DOI 10.1113/JP272927; Wilson C, 2016, FASEB J, V30, P2000, DOI 10.1096/fj.201500090; Wilson C, 2015, J PHYSIOL-LONDON, V593, P5231, DOI 10.1113/JP271157; Zhou LF, 2011, J MOL CELL CARDIOL, V51, P632, DOI 10.1016/j.yjmcc.2011.05.007; Zimmermann B, 2000, J PHYSIOL-LONDON, V525, P707, DOI 10.1111/j.1469-7793.2000.t01-1-00707.x	121	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					737	758		10.1074/jbc.RA118.005913	http://dx.doi.org/10.1074/jbc.RA118.005913			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30498088	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000458670200001
J	Ji, WX; Wang, LJ; He, SY; Yan, L; Li, TY; Wang, JX; Kong, ANT; Yu, SW; Zhang, Y				Ji, Weixiu; Wang, Linjia; He, Shiyi; Yan, Lu; Li, Tieying; Wang, Jianxiong; Ah-Ng Tony Kong; Yu, Siwang; Zhang, Ying			Effects of acute hypoxia exposure with different durations on activation of Nrf2-ARE pathway in mouse skeletal muscle	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; RESPONSE ELEMENT; UP-REGULATION; EXPRESSION; ERYTHROPOIETIN; INTERMITTENT; EXERCISE; PROTEIN; INDUCTION; ENZYMES	Background Hypoxia training enhances the endurance capacity of athletes. This response may in part be attributed to the hypoxia-induced increase in antioxidant capacity in skeletal muscles. Nuclear factor erythroid 2-related factor 2 (Nrf2), a key transcription factor which regulates the expression of genes via binding to the antioxidant-response element (ARE) of these genes, plays a crucial role in stimulating the body's defense system and potentially responds to hypoxia. Meanwhile, hypoxia-inducible factor-1 alpha (HIF-1 alpha) is an important player in protecting cells from hypoxic stress. The purpose of this study was to investigate the effects of acute hypoxia exposure with different durations on the activation of Nrf2-ARE pathway and a possible regulatory role of HIF-1 alpha in these responses. Methods C57BL/6J mice were allocated into the non-hypoxia 0-hour, 6-hour, 24-hour, and 48-hour hypoxic exposure (11.2% oxygen) groups. The quadriceps femoris was collected immediately after hypoxia. Further, to investigate the possible role of HIF-1 alpha, C2C12 myoblasts with HIF-1 alpha knockdown by small interfering RNA (siRNA) and the inducible HIF-1 alpha transgenic mice were employed. Results The results showed that 48-hour hypoxia exposure up-regulated protein expression of Nrf2, Nrf2/ARE binding activity and the transcription of antioxidative genes containing ARE (Sod1 and others) in mouse skeletal muscle. Moreover, HIF-1 alpha siRNA group of C2C12 myoblasts showed a remarkable inhibition of Nrf2 protein expression and nuclear accumulation in hypoxia exposure for 72 hours compared with that in siRNA-Control group of the cells. In addition, HIF-1 alpha transgenic mice gave higher Nrf2 protein expression, Nrf2/ARE binding activity and expressions of Nrf2-mediated antioxidative genes in their skeletal muscle, compared with those in the wild-type mice. Conclusions The findings suggested that the acute hypoxia exposure could trigger the activation of Nrf2-ARE pathway, with longer duration associated with higher responses, and HIF-1 alpha expression might be involved in promoting the Nrf2-mediated antioxidant responses in skeletal muscle.	[Ji, Weixiu; Wang, Linjia; He, Shiyi; Yan, Lu; Li, Tieying; Zhang, Ying] Beijing Sport Univ, Sch Sport Sci, Beijing, Peoples R China; [Ji, Weixiu] Tianjin Univ Sport, Tianjin, Peoples R China; [Wang, Jianxiong] Univ Southern Queensland, Fac Hlth Engn & Sci, Toowoomba, Qld, Australia; [Ah-Ng Tony Kong] Rutgers State Univ, Ernest Mario Sch Pharm, Camden, NJ USA; [Yu, Siwang] Peking Univ, Dept Biol Chem, Sch Pharmaceut Sci, Beijing, Peoples R China	Beijing Sport University; Tianjin University of Sport; University of Southern Queensland; Rutgers State University Camden; Rutgers State University New Brunswick; Peking University	Zhang, Y (corresponding author), Beijing Sport Univ, Sch Sport Sci, Beijing, Peoples R China.	zhyi9256@126.com	yu, Siwang/AAL-8059-2020; Kong, Ah-Ng Tony/AAX-2828-2020	Yu, Siwang/0000-0002-3336-202X	National Natural Science Foundation of China [31471134]; project of Beijing Sport University [2018GJ007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of Beijing Sport University	This study was supported by the National Natural Science Foundation of China (31471134) and the project of Beijing Sport University (2018GJ007).	Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Bailey DM, 2001, CLIN SCI, V101, P465, DOI 10.1042/CS20010065; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Genc K, 2010, CELL BIOCHEM FUNCT, V28, P197, DOI 10.1002/cbf.1639; Gonchar O, 2005, J SPORT SCI MED, V4, P160; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Huang XS, 2014, MOL CELL BIOCHEM, V385, P33, DOI 10.1007/s11010-013-1812-6; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Itoigawa Y, 2010, BIOCHEM BIOPH RES CO, V399, P721, DOI 10.1016/j.bbrc.2010.08.007; Jin W, 2014, J TRAUMA ACUTE CARE, V76, P1228, DOI 10.1097/TA.0000000000000211; Kang KW, 2002, NITRIC OXIDE-BIOL CH, V7, P244, DOI 10.1016/S1089-8603(02)00117-9; Li G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122593; Li T, 2015, FREE RADICAL RES, V49, P1269, DOI 10.3109/10715762.2015.1066784; Li W, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/326346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Polotsky VY, 2010, PHYSIOL GENOMICS, V41, P306, DOI 10.1152/physiolgenomics.00091.2009; Ponsot E, 2006, J APPL PHYSIOL, V100, P1249, DOI 10.1152/japplphysiol.00361.2005; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shu LF, 2016, NEUROSCI LETT, V611, P74, DOI 10.1016/j.neulet.2015.11.012; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09; Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014; Xie HC, 2014, PHYSIOL RES, V63, P801, DOI 10.33549/physiolres.932849; Yan YF, 2015, J CARDIOVASC PHARM, V66, P148, DOI 10.1097/FJC.0000000000000257; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Zhang Y, 2015, EDORIUM J BIOMEDICAL, V1, P4; Zhao RZ, 2016, FRONT BIOSCI-LANDMRK, V21, P385, DOI 10.2741/4395	33	17	20	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208474	10.1371/journal.pone.0208474	http://dx.doi.org/10.1371/journal.pone.0208474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513114	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000452204800035
J	Olusanya, HO; de Jong, MV				Olusanya, Hope O.; de Jong, M. van Zyll			Assessing the vulnerability of freshwater fishes to climate change in Newfoundland and Labrador	PLOS ONE			English	Article							POTENTIAL IMPACTS; SPECIES VULNERABILITY; TROUT STREAMS; TEMPERATURES; SYSTEMS; MARINE; RISK	Freshwater fish populations are rapidly declining globally due to the impacts of rapid climate change and existing non-climatic anthropogenic stressors. In response to these drivers, freshwater fishes are responding by shifting their distribution range, altering the timing of migration and spawning and through demographic processes. By 2050, the mean daily air temperature is predicted to increase by 2 to 3 degrees C in insular Newfoundland and by 3 to 4 degrees C in Labrador. Mean daily precipitation is also projected to increase in all locations, with increased intensity projected for several regions. To mitigate negative consequences of these changes, managers require analytical approaches that describe the vulnerability of fish to climate change. To address this need, the current study adopts the National Marine Fisheries Service vulnerability assessment framework to characterize the vulnerability of freshwater fishes in Newfoundland and Labrador. Twelve vulnerability indicators were developed from an extensive literature review and applied to the assessment. Experts were solicited using an online questionnaire survey and scores for exposure, sensitivity and adaptive capacity were collated and analyzed to derive a final vulnerability score and rank for each species. The analysis showed one species to be of high-very high vulnerability, two species were highly vulnerable while four species were moderately vulnerable to climate change. The result provides insight into the factors that drive vulnerability of freshwater fishes in the region, this information is significant to decision-makers and other stakeholders engaged in managing freshwater fish resources in Newfoundland and Labrador.	[Olusanya, Hope O.] Mem Univ Grenfell Campus, Environm Policy Inst, Corner Brook, NF, Canada; [de Jong, M. van Zyll] Univ New Brunswick, Dept Biol Sci, St John, NB, Canada	University of New Brunswick	Olusanya, HO (corresponding author), Mem Univ Grenfell Campus, Environm Policy Inst, Corner Brook, NF, Canada.	hoo070@grenfell.mun.ca						Abdel-Fattah S, 2016, CAN MANUSCR REP FISH, V3108; Abdel-Fattah S, 2016, CAN MANUSCRIPT REP F, V3108; [Anonymous], 2013, PROJECTED IMPACTS CL; [Anonymous], 2015, METHODOLOGY ASSESSIN; Bradbury C, 1999, LIFE HIST CHARACTERI; Brooks RT, 2009, CLIMATIC CHANGE, V95, P469, DOI 10.1007/s10584-008-9531-9; Chessman BC, 2013, BIOL CONSERV, V160, P40, DOI 10.1016/j.biocon.2012.12.032; Chu C, 2005, DIVERS DISTRIB, V11, P299, DOI 10.1111/j.1366-9516.2005.00153.x; Closs GP, 2016, CONSERV BIOL SER, P37; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; de Jong MCV, 2004, FISHERIES MANAG ECOL, V11, P183; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Foden W. B, 2015, THESIS; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Harrod C, 2016, FRESHWATER FISHERIES ECOLOGY, P641; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hoving C. L, 2013, CHANGING CLIMATE CHA, P3564; IPCC, 2007, CLIM CHANG 2007 AD V; Isaak DJ, 2012, CLIMATIC CHANGE, V113, P499, DOI 10.1007/s10584-011-0326-z; Johnson K. A., 2014, CLIMATE CHANGE VULNE; Karvonen A, 2010, INT J PARASITOL, V40, P1483, DOI 10.1016/j.ijpara.2010.04.015; Kuhnert PM, 2005, ENVIRONMETRICS, V16, P717, DOI 10.1002/env.732; Lawrence DJ, 2014, ECOL APPL, V24, P895, DOI 10.1890/13-0753.1; Lynch AJ, 2016, FISHERIES, V41, P346, DOI 10.1080/03632415.2016.1186016; Maurer EP., 2007, ADV EARTH SPACE SCI, DOI [10.1029/2007EO470006, DOI 10.1029/2007EO470006]; Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Murray JV, 2009, J APPL ECOL, V46, P842, DOI 10.1111/j.1365-2664.2009.01671.x; NRCan (Natural Resources Canada), 2010, THE ATL OF CAN; Nunn AD, 2007, FRESHWATER BIOL, V52, P1576, DOI 10.1111/j.1365-2427.2007.01789.x; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Poff N.L., 2002, AQUATIC ECOSYSTEMS G; Prowse TD, 2009, AMBIO, V38, P266, DOI 10.1579/0044-7447-38.5.266; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022906; Shoo LP, 2013, CLIMATIC CHANGE, V119, P239, DOI 10.1007/s10584-013-0699-2; Sievert N. A, THESIS; Stortini CH, 2015, ICES J MAR SCI, V72, P1731, DOI 10.1093/icesjms/fsv022; Thistle M. E, 2013, TRENDS AIR TEMPERATU; Trumbo BA, 2014, T AM FISH SOC, V143, P173, DOI 10.1080/00028487.2013.835282; Ward EJ, 2015, GLOBAL CHANGE BIOL, V21, P2500, DOI 10.1111/gcb.12847; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Webb BW, 2007, HYDROLOG SCI J, V52, P74, DOI 10.1623/hysj.52.1.74; Williams J. E, 2015, COLD WATER FISHES CL; Williams JE, 2015, FISHERIES, V40, P304, DOI 10.1080/03632415.2015.1049692	49	12	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208182	10.1371/journal.pone.0208182	http://dx.doi.org/10.1371/journal.pone.0208182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507972	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500029
J	Punzo, F; Tortora, C; Argenziano, M; Casale, M; Perrotta, S; Rossi, F				Punzo, Francesca; Tortora, Chiara; Argenziano, Maura; Casale, Maddalena; Perrotta, Silverio; Rossi, Francesca			Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis	PLOS ONE			English	Article							OVERLOAD; DEFERASIROX; THERAPY; METABOLISM; EFFICACY; DISEASE	Chronic blood transfusions are responsible to cause iron overload, which leads to several complications to end organs and osteoporosis. Iron chelation is needed to remove iron excess and to contain bone-mass loss. Deferasirox is the most recent oral iron chelator that prevents transfusion related iron overload complications. Recently Eltrombopag (ELT) iron chelating properties are emerging. ELT is an agonist at Thrombopoietin receptor, used in treatment of thrombocytopenia. We tested ELT and Deferasirox in iron overloaded osteoclasts from thalassemic patients and donors measuring intracellular iron, TRAP expression and osteoclast activity. We confirmed ELT iron chelation capacity also in bone tissue and a synergic effect when used with Deferasirox. Moreover, having demonstrated its effects on osteoclast activity, we suggest for the first time that ELT could ameliorate bone tissue's health reducing bone mass loss.	[Punzo, Francesca; Casale, Maddalena; Perrotta, Silverio; Rossi, Francesca] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Special Surg, Naples, Italy; [Punzo, Francesca; Tortora, Chiara; Argenziano, Maura] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Rossi, F (corresponding author), Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Special Surg, Naples, Italy.	francesca.rossi@unicampania.it		Perrotta, Silverio/0000-0001-6149-6845; casale, maddalena/0000-0003-4740-2421; Rossi, Francesca/0000-0003-2879-6277; Argenziano, Maura/0000-0003-4457-1318	PRIN (Progetti di Rilevante Interesse Nazionale) 2015 [20153NBRS3_002]; Department of Woman, Child and General and Special Surgery of the University of Campania "Luigi Vanvitelli"	PRIN (Progetti di Rilevante Interesse Nazionale) 2015(Ministry of Education, Universities and Research (MIUR)); Department of Woman, Child and General and Special Surgery of the University of Campania "Luigi Vanvitelli"	The study was supported by PRIN (Progetti di Rilevante Interesse Nazionale) 2015. 20153NBRS3_002 to FR, and the Department of Woman, Child and General and Special Surgery of the University of Campania "Luigi Vanvitelli". There was no additional external funding received for this study. Moreover, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydinok Y, 2015, BLOOD, V125, P3868, DOI 10.1182/blood-2014-07-586677; Burness CB, 2016, DRUGS, V76, P869, DOI 10.1007/s40265-016-0581-4; Casale M, 2014, AM J HEMATOL, V89, P1102, DOI 10.1002/ajh.23844; Dahal S, 2017, MEDITERR J HEMATOL I, V9, DOI 10.4084/MJHID.2017.019; Daher R, 2017, TRANSFUS CLIN BIOL, V24, P115, DOI 10.1016/j.tracli.2017.06.015; Dede AD, 2016, OSTEOPOROSIS INT, V27, P3409, DOI 10.1007/s00198-016-3719-z; Dev S, 2017, HEMODIAL INT, V21, pS6, DOI 10.1111/hdi.12542; Fibach E, 2017, PRESSE MED, V46, pE296, DOI 10.1016/j.lpm.2017.10.007; Goodnough LT, 2017, MED CLIN N AM, V101, P431, DOI 10.1016/j.mcna.2016.09.012; Kontoghiorghes GJ, 2017, EUR J HAEMATOL, V99, P465, DOI 10.1111/ejh.12939; Lambert MP, 2017, AM J HEMATOL, V92, pE88, DOI 10.1002/ajh.24705; Lu MY, 2017, THER DRUG MONIT, V39, P185, DOI 10.1097/FTD.0000000000000378; Musallam KM, 2011, NEW ENGL J MED, V364, P1476, DOI 10.1056/NEJMc1101838; Poggiali E, 2012, BLOOD TRANSFUS-ITALY, V10, P411, DOI 10.2450/2012.0008-12; Rossi F, 2014, HAEMATOLOGICA, V99, P1876, DOI 10.3324/haematol.2014.104463; Rumi MG, 2018, SEMIN LIVER DIS, V38, P112, DOI 10.1055/s-0038-1655774; Taher AT, 2017, HEMATOL-AM SOC HEMAT, P265, DOI 10.1182/asheducation-2017.1.265; Valenti L, 2009, OSTEOPOROSIS INT, V20, P549, DOI 10.1007/s00198-008-0701-4; Vlachodimitropoulou E, 2017, BLOOD, V130, P1923, DOI 10.1182/blood-2016-10-740241; Wong RSM, 2017, BLOOD, V130, P2527, DOI 10.1182/blood-2017-04-748707	20	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208102	10.1371/journal.pone.0208102	http://dx.doi.org/10.1371/journal.pone.0208102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507954	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500020
J	Shi, Y; Lv, X; Liu, YA; Li, BC; Liu, MM; Yan, M; Liu, YJ; Li, Q; Zhang, XJ; He, S; Zhu, MS; He, JL; Zhu, Y; Zhu, Y; Ai, D				Shi, Ying; Lv, Xue; Liu, Yanan; Li, Bochuan; Liu, Mingming; Yan, Meng; Liu, Yajin; Li, Qi; Zhang, Xuejiao; He, Shuang; Zhu, Mason; He, Jinlong; Zhu, Yan; Zhu, Yi; Ai, Ding			Elevating ATP-binding cassette transporter G1 improves re-endothelialization function of endothelial progenitor cells via Lyn/Akt/eNOS in diabetic mice	FASEB JOURNAL			English	Article						high glucose; cholesterol efflux; vasculogenesis; vascular repair	ACTIVATED PROTEIN-KINASE; ABCG1(-/-) BONE-MARROW; TYROSINE KINASE; CHOLESTEROL EFFLUX; ACCELERATES ATHEROSCLEROSIS; ANGIOGENESIS; DYSFUNCTION; DEFICIENCY; METABOLISM; MELLITUS	Endothelial progenitor cell (EPC) dysfunction contributes to diabetes-induced delay in endothelium repair after vessel injury, prominently associated with diabetic cardiovascular complications such as neointima formation. ATP-binding cassette transporter G1 (ABCG1) promotes cholesterol efflux to HDL, which may favorably affect EPC function. However, whether ABCG1 improves EPC function, especially in diabetes, remains unknown. Here we investigated the role of ABCG1 in EPCs by using Tie2-mediated ABCG1 transgenic (Tie2-ABCG1(Tg)) mice. Mice were injected with streptozotocin to induce diabetes mellitus. As compared with wild-type (WT) mice, in Tie2-ABCG1(Tg) mice, diabetes-impaired EPC migration and tube formation were reversed. In vitro gain-of-function and loss-of-function studies further revealed that ABCG1-overexpressing EPCs showed increased migration and tube formation and differentiation via the Lck/Yes-related novel protein tyrosine kinase /Akt/endothelial NO synthase pathway by enhancing cellular cholesterol efflux. Finally, type 1 and type 2 diabetic mouse models with arterial injury were intravenously injected with labeled EPCs from WT or Tie2-ABCG1(Tg) mice. Re-endothelialization in diabetic mice was improved to a greater extent by injection of ABCG1-overexpressing than WT EPCs. Our study demonstrated that ABCG1 in EPCs improved repair after vascular injury in diabetes by increasing EPC function such as migration, tube formation and differentiation, and subsequent re-endothelialization. ABCG1 might be a promising therapeutic target for diabetes-associated vascular diseases.Shi, Y., Lv, X., Liu, Y., Li, B., Liu, M., Yan, M., Liu, Y., Li, Q., Zhang, X., He, S., Zhu, M., He, J., Zhu, Y., Zhu, Y., Ai, D. Elevating ATP-binding cassette transporter G1 improves re-endothelialization function of endothelial progenitor cells via Lyn/Akt/eNOS in diabetic mice.	[Shi, Ying; Lv, Xue; Liu, Yanan; Li, Bochuan; Liu, Mingming; Yan, Meng; Liu, Yajin; Li, Qi; Zhang, Xuejiao; He, Jinlong; Zhu, Yi; Ai, Ding] Tianjin Med Univ, Dept Physiol & Pathophysiol, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Shi, Ying] Tianjin Chest Hosp, Tianjin Inst Cardiovasc Dis, Tianjin, Peoples R China; [He, Shuang; Zhu, Yan] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Zhu, Mason] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA	Tianjin Medical University; Tianjin University of Traditional Chinese Medicine; University of California System; University of California San Diego	Ai, D (corresponding author), Tianjin Med Univ, Dept Physiol, Qixiangtai Rd 22, Tianjin 300070, Peoples R China.	dingai@tmu.edu.cn	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936; Ai, Ding/0000-0001-5992-9904	National Key Research and Development Program of China [2017YFC1307402]; National Natural Science Foundation of China [81420108003, 81670388, 81400320]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China Grant 2017YFC1307402, and by National Natural Science Foundation of China Grants 81420108003 (to Yi Z.), 81670388 (to D.A.), and 81400320 (to J.H.). The authors declare no conflicts of interest.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Brown RJ, 2013, ANAL BIOCHEM, V433, P56, DOI 10.1016/j.ab.2012.10.007; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cochran BJ, 2016, DIABETES, V65, P3610, DOI 10.2337/db16-0668; Ding JZ, 2015, DIABETES, V64, P3464, DOI 10.2337/db14-1314; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Georgescu A, 2011, EUR J PHARMACOL, V669, P1, DOI 10.1016/j.ejphar.2011.07.035; Ii M, 2006, CIRC RES, V98, P697, DOI 10.1161/01.RES.0000209948.50943.ea; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Kessler T, 2015, CIRCULATION, V131, P1191, DOI 10.1161/CIRCULATIONAHA.114.014072; Li XX, 2012, MICROCIRCULATION, V19, P547, DOI 10.1111/j.1549-8719.2012.00186.x; Ma FX, 2006, J LIPID RES, V47, P1227, DOI 10.1194/jlr.M500507-JLR200; Mao RF, 2017, CIRC RES, V120, P1727, DOI 10.1161/CIRCRESAHA.116.309754; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Pagler TA, 2011, CIRC RES, V108, P194, DOI 10.1161/CIRCRESAHA.110.228619; Psaltis PJ, 2015, CIRC RES, V116, P1392, DOI 10.1161/CIRCRESAHA.116.305368; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Song YM, 2013, CARDIOVASC RES, V99, P514, DOI 10.1093/cvr/cvt113; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; van Oostrom O, 2007, ARTERIOSCL THROM VAS, V27, P1864, DOI 10.1161/ATVBAHA.107.143875; Wei SP, 2015, J MOL CELL CARDIOL, V87, P17, DOI 10.1016/j.yjmcc.2015.08.004; Westerterp M, 2016, CIRC RES, V119, P13, DOI 10.1161/CIRCRESAHA.116.309116; Westerterp M, 2016, ARTERIOSCL THROM VAS, V36, P1328, DOI 10.1161/ATVBAHA.115.306670; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Xue SS, 2016, BIOCHEM BIOPH RES CO, V477, P247, DOI 10.1016/j.bbrc.2016.06.050; Ye L, 2015, WORLD J STEM CELLS, V7, P894, DOI 10.4252/wjsc.v7.i6.894; Yiu KH, 2014, ARTERIOSCL THROM VAS, V34, P1136, DOI 10.1161/ATVBAHA.114.302192; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang QH, 2010, EXP BIOL MED, V235, P1082, DOI 10.1258/ebm.2010.010060	48	15	16	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2018	32	12					6525	6536		10.1096/fj.201800248RR	http://dx.doi.org/10.1096/fj.201800248RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GZ4JB	30495987				2022-12-26	WOS:000449359700014
J	de Miranda, LHM; Meli, M; Conceicao-Silva, F; Novacco, M; Menezes, RC; Pereira, SA; Sugiarto, S; dos Reis, EG; Gremiao, IDF; Hofmann-Lehmann, R				Monteiro de Miranda, Luisa Helena; Meli, Marina; Conceicao-Silva, Fatima; Novacco, Marilisa; Menezes, Rodrigo Caldas; Pereira, Sandro Antonio; Sugiarto, Sarah; dos Reis, Erica Guerino; Ferreira Gremiao, Isabella Dib; Hofmann-Lehmann, Regina			Co-infection with feline retrovirus is related to changes in immunological parameters of cats with sporotrichosis	PLOS ONE			English	Article							RIO-DE-JANEIRO; HIV-INFECTED PATIENTS; IMMUNODEFICIENCY VIRUS; SPOROTHRIX-SCHENCKII; POTASSIUM-IODIDE; CYTOKINE PRODUCTION; IMMUNE-RESPONSE; ABCD GUIDELINES; IL-10; PREVENTION	Feline sporotrichosis due to Sporothrix brasiliensis is frequently severe and often correlated to zoonotic transmission. Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV) cause immunodeficiency in cats; no association has been identified with critical cases of sporotrichosis. Moreover, the cytokine profile in Sporothrix-infected cats and a potential impact of retrovirus co-infections on their immunity is unknown. This study assessed immunological parameters in cats with sporotrichosis with and without FIV or FeLV co-infection. FeLV infection was detected by antigen ELISA and by provirus PCR. FIV infection was investigated through ELISA and Western blot. Cytokine transcription (IFN-gamma, IL-4, IL-5, IL-6, IL-10, IL-12, TNF-alpha) was quantified using RT-qPCR and lymphocyte subpopulations (CD4, CD8, CD5 and CD21) were assessed by flow cytometry. Thirty cats with sporotrichosis were recruited to the study, including three FIV-positive and five FeLV-positive (progressive infection) cats. One cat with regressive FeLV infection was excluded from statistics. In comparison to retrovirus-negative cats, FIV-positive cats and FeLV-positive cats had higher IL-10 levels, FeLV-positive cats had lower IL-4 levels and FIV-positive cats had lower IL-12 levels and a lower CD4+/CD8+ ratio. Remarkably, all cats with poor general condition were FeLV (progressive infection) or FIV-positive, but the retrovirus status was not associated with the sporotrichosis treatment length or outcome. The immunological changes and the more severe clinical presentation observed in cats with retrovirus co-infections encourage future prospective studies that address the impact of these changes on prognostic determinants of feline sporotrichosis and the development of new therapy strategies that control disease spread.	[Monteiro de Miranda, Luisa Helena; Menezes, Rodrigo Caldas; Pereira, Sandro Antonio; dos Reis, Erica Guerino; Ferreira Gremiao, Isabella Dib] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Res Dermatozoonoses Domest Anim, Rio De Janeiro, Brazil; [Monteiro de Miranda, Luisa Helena; Meli, Marina; Novacco, Marilisa; Sugiarto, Sarah; Hofmann-Lehmann, Regina] Univ Zurich, Vetsuisse Fac, Clin Lab, Zurich, Switzerland; [Monteiro de Miranda, Luisa Helena; Meli, Marina; Novacco, Marilisa; Sugiarto, Sarah; Hofmann-Lehmann, Regina] Univ Zurich, Vetsuisse Fac, Ctr Clin Studies, Zurich, Switzerland; [Conceicao-Silva, Fatima] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; University of Zurich; University of Zurich; Fundacao Oswaldo Cruz	de Miranda, LHM (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Res Dermatozoonoses Domest Anim, Rio De Janeiro, Brazil.; de Miranda, LHM (corresponding author), Univ Zurich, Vetsuisse Fac, Clin Lab, Zurich, Switzerland.; de Miranda, LHM (corresponding author), Univ Zurich, Vetsuisse Fac, Ctr Clin Studies, Zurich, Switzerland.	luisahmiranda@gmail.com	Novacco, Marilisa/B-7892-2018; Miranda, Luisa/ABB-7298-2020; Menezes, Rodrigo/O-8722-2019; Hofmann-Lehmann, Regina/C-6528-2009; Gremião, Isabella Dib Ferreira/AAH-4740-2019; Pereira, Sandro/C-5380-2013; Gremão, Isabela/AAY-9033-2021	Novacco, Marilisa/0000-0001-6290-1291; Menezes, Rodrigo/0000-0003-1853-3449; Hofmann-Lehmann, Regina/0000-0001-9750-4296; Gremião, Isabella Dib Ferreira/0000-0001-8428-7616; Pereira, Sandro/0000-0002-0614-4713	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [3229/13-0]; CAPES [88887.091508/2014-00]; collaborative project Switzerland-Brazil (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ/Swiss National Science Foundation - SNSF/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq] [400064/2017-0]; FAPERJ [JCNE E-26/203.303/2016]; Oswaldo Cruz Institute; Oswaldo Cruz Foundation [PAEF-IOC-008-FIO-15]; CNPq	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); collaborative project Switzerland-Brazil (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ/Swiss National Science Foundation - SNSF/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq]; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Oswaldo Cruz Institute; Oswaldo Cruz Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Part of the laboratory work was performed using logistics at the Center for Clinical Studies, Vetsuisse Faculty, University of Zurich. LHMM was a postdoctoral fellow with financial support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [Programa Estagio Pos-Doutoral/BEX, No 3229/13-0] and is currently a research fellow with financial support from CAPES [Programa Jovens Talentos, No 88887.091508/2014-00]. This study is part of a collaborative project Switzerland-Brazil (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ/Swiss National Science Foundation - SNSF/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq no 400064/2017-0) and was partially funded by FAPERJ [JCNE E-26/203.303/2016] and by Oswaldo Cruz Institute, Oswaldo Cruz Foundation [PAEF-IOC-008-FIO-15]. RCM and SAO are recipients of productivity fellowships from the CNPq	Achleitner A, 2011, VET IMMUNOL IMMUNOP, V143, P307, DOI 10.1016/j.vetimm.2011.06.009; Almeida-Paes R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003094; Barros MBL, 2008, EPIDEMIOL INFECT, V136, P1192, DOI 10.1017/S0950268807009727; CALZOLARI M, 1995, VET IMMUNOL IMMUNOP, V46, P83, DOI 10.1016/0165-2427(94)07008-U; Carvalho Miriam Tomoko Mitsuno, 2002, Rev. Soc. Bras. Med. Trop., V35, P655, DOI 10.1590/S0037-86822002000600018; Costa RO, 2013, AN BRAS DERMATOL, V88, P396, DOI 10.1590/abd1806-4841.20132377; Barros MBD, 2011, CLIN MICROBIOL REV, V24, P633, DOI 10.1128/CMR.00007-11; Barros MBD, 2010, REV PANAM SALUD PUBL, V27, P455; Dean GA, 1998, J VIROL, V72, P9436, DOI 10.1128/JVI.72.12.9436-9440.1998; Dean GA, 1998, VET IMMUNOL IMMUNOP, V65, P125, DOI 10.1016/S0165-2427(98)00148-2; Diller ML, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6309219; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Oliveira MME, 2014, REV IBEROAM MICOL, V31, P2, DOI 10.1016/j.riam.2013.09.008; Fernandes KSS, 2008, IMMUNOLOGY, V123, P469, DOI 10.1111/j.1365-2567.2007.02712.x; Gremiao IDF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006077; Ferreira LS, 2015, IMMUNOBIOLOGY, V220, P985, DOI 10.1016/j.imbio.2015.02.009; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fujio K, 2010, ADV IMMUNOL, V105, P99, DOI 10.1016/S0065-2776(10)05004-2; Gomes-Keller MA, 2006, VET MICROBIOL, V112, P11, DOI 10.1016/j.vetmic.2005.10.027; Gremiao IDF, 2015, MED MYCOL, V53, P15, DOI 10.1093/mmy/myu061; Helfer-Hungerbuehler AK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-14; Hofmann-Lehmann R, 2001, J GEN VIROL, V82, P1589, DOI 10.1099/0022-1317-82-7-1589; Hofmann-Lehmann R, 2008, VET IMMUNOL IMMUNOP, V123, P119, DOI 10.1016/j.vetimm.2008.01.017; HofmannLehmann R, 1997, CLIN DIAGN LAB IMMUN, V4, P33, DOI 10.1128/CDLI.4.1.33-42.1997; Hosie MJ, 2009, J FELINE MED SURG, V11, P575, DOI 10.1016/j.jfms.2009.05.006; Kessler Y, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-106; Kienzle N, 2005, J IMMUNOL, V174, P2021, DOI 10.4049/jimmunol.174.4.2021; Kipar A, 2001, VET IMMUNOL IMMUNOP, V78, P305, DOI 10.1016/S0165-2427(01)00240-9; Kipar A, 2006, VET IMMUNOL IMMUNOP, V112, P141, DOI 10.1016/j.vetimm.2006.02.004; LEHMANN R, 1992, VET IMMUNOL IMMUNOP, V35, P199, DOI 10.1016/0165-2427(92)90132-A; Leutenegger CM, 1999, VET IMMUNOL IMMUNOP, V71, P291, DOI 10.1016/S0165-2427(99)00100-2; Levy JK, 2004, VET IMMUNOL IMMUNOP, V98, P101, DOI 10.1016/j.vetimm.2003.11.002; Lopez-Romero E, 2011, FUTURE MICROBIOL, V6, P85, DOI 10.2217/FMB.10.157; LUTZ H, 1988, J VET MED B, V35, P773, DOI 10.1111/j.1439-0450.1988.tb00559.x; LUTZ H, 1983, J IMMUNOL METHODS, V56, P209, DOI 10.1016/0022-1759(83)90413-1; Lutz H, 2009, J FELINE MED SURG, V11, P565, DOI 10.1016/j.jfms.2009.05.005; Maiti PK, 2013, ANN MED HEALTH SCI R, V3, P397, DOI 10.4103/2141-9248.117956; Martinez-Alvarez JA, 2014, REV IBEROAM MICOL, V31, P62, DOI 10.1016/j.riam.2013.09.015; Miller MM, 2013, J VIROL, V87, P9373, DOI 10.1128/JVI.00996-13; Miranda LHM, 2016, MED MYCOL, V54, P29, DOI 10.1093/mmy/myv079; Miranda LHM, 2013, COMP IMMUNOL MICROB, V36, P425, DOI 10.1016/j.cimid.2013.03.005; Moreira JAS, 2015, INFECTION, V43, P267, DOI 10.1007/s15010-015-0746-1; Negrini TD, 2013, IMMUNOL INVEST, V42, P36, DOI 10.3109/08820139.2012.719982; Ng CT, 2014, CURR TOP MICROBIOL, V380, P129, DOI 10.1007/978-3-662-43492-5_6; Pereira SA, 2010, VET REC, V166, P290, DOI [10.1136/vr.b4752, 10.1136/vr.166.10.290]; Pereira SA, 2014, REV SOC BRAS MED TRO, V47, P392, DOI 10.1590/0037-8682-0092-2013; Reis EG, 2016, MED MYCOL, V54, P684, DOI 10.1093/mmy/myw027; Robert-Tissot C, 2011, VET IMMUNOL IMMUNOP, V143, P269, DOI 10.1016/j.vetimm.2011.06.005; Rodrigues AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005638; Rodrigues AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002281; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Freitas DFS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003110; Freitas DFS, 2012, MED MYCOL, V50, P170, DOI 10.3109/13693786.2011.596288; Freitas DFS, 2010, CLIN INFECT DIS, V50, DOI 10.1086/649891; Sassa MF, 2009, IMMUNOLOGY, V128, P301, DOI 10.1111/j.1365-2567.2009.03118.x; Sassa MF, 2012, MYCOPATHOLOGIA, V174, P21, DOI 10.1007/s11046-012-9523-1; Schubach TMP, 2004, JAVMA-J AM VET MED A, V224, P1623, DOI 10.2460/javma.2004.224.1623; SHER A, 1991, J IMMUNOL, V147, P2713; Silva-Vergara MLO, 2012, AM J TROP MED HYG, V86, P477, DOI 10.4269/ajtmh.2012.11-0441; Tandon R, 2005, J VIROL METHODS, V130, P124, DOI 10.1016/j.jviromet.2005.06.017; da Silva MBT, 2012, CAD SAUDE PUBLICA, V28, P1867, DOI 10.1590/S0102-311X2012001000006; Torres-Mendoza Blanca, 1997, Revista Iberoamericana de Micologia, V14, P98; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; YANGCO BG, 1984, ANTIMICROB AGENTS CH, V25, P413, DOI 10.1128/AAC.25.4.413; Zhang XN, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035700, 10.1371/journal.pone.0035991]	68	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207644	10.1371/journal.pone.0207644	http://dx.doi.org/10.1371/journal.pone.0207644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500849	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000451883700012
J	Adedoja, OA; Kehinde, T; Samways, MJ				Adedoja, Opeyemi A.; Kehinde, Temitope; Samways, Michael J.			Insect-flower interaction networks vary among endemic pollinator taxa over an elevation gradient	PLOS ONE			English	Article							FOREST ECOTONE RESPONSE; CLIMATE-CHANGE IMPACTS; REPRODUCTIVE SUCCESS; GEOGRAPHIC PATTERNS; SPECIES TURNOVER; SUCCULENT KAROO; RANGE SHIFTS; DIVERSITY; PLANTS; BEES	Interaction networks are sensitive to elevation gradients through changes in local distribution of interacting partners. Here, we use plant-pollinator interaction network metrics to assess the effect of elevation on flowers and flower-visiting insect assemblages on a sentinel mountain used for monitoring climate change in the flower-and insect-rich Cape Floristic Region. We also use these interaction metrics to explain the effect of environmental factors on the interaction networks. We did this over four vegetation zones <1640m asl, as determined by former botanical studies. Overall, bees were the dominant flower visitors, followed by monkey beetles, and far behind were wasps and flies. The middle elevation zone (650-744 m a.s.l), which is also an ecotone between two distinct botanical zones, had the highest species richness and abundance of interacting plants and insects. Interaction frequency and size of network were also greatest in the middle zone, as were network diversity, generality, and linkage density, while lowest in the peak zone. In sum, there was distinct elevation zoning of flower-visiting insects. The greatest zonal change was between species at the middle compared with peak zone. Large-sized monkey beetles, bees and flies characterized the unique assemblage in the peak zone (1576-1640 m a.s.l.). The insect zonation tracked that of plant assemblages, with air temperature (lapse rate) being the primary driver of bee distribution, with lowest levels in the peak zone. In contrast, beetle distribution was driven mostly by flower assemblages as well as air temperature. In turn, wasp and fly interaction networks were not affected by any of the measured environmental variables. We conclude that increased elevation stress from reduced temperatures, changing abiotic weather conditions (e.g. strong winds at high elevations), and decline in flowering plant composition causes breakdown of interaction networks involving bees and beetles but not that of flies and wasps.	[Adedoja, Opeyemi A.; Samways, Michael J.] Stellenbosch Univ, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa; [Adedoja, Opeyemi A.; Kehinde, Temitope] Obafemi Awolowo Univ, Dept Zool, Ife, Nigeria	Stellenbosch University; Obafemi Awolowo University	Adedoja, OA (corresponding author), Stellenbosch Univ, Dept Conservat Ecol & Entomol, Stellenbosch, South Africa.; Adedoja, OA (corresponding author), Obafemi Awolowo Univ, Dept Zool, Ife, Nigeria.	adedojaopeyemiadebayo@gmail.com		Adedoja, Opeyemi/0000-0001-6163-3424; Kehinde, Temitope/0000-0003-2993-2373	National Geographic Society [WW-100ER-17]; Rufford foundation [20642-1]; Mondi group; National Research Foundation (NRF)	National Geographic Society(National Geographic Society); Rufford foundation; Mondi group; National Research Foundation (NRF)	AOA received early career grant from the National Geographic Society, funding number WW-100ER-17, www.nationalgeographic.org/grants.AOA also received funding from Rufford foundation small grants number 20642-1. MJS received funding from Mondi group. The financial assistance of the National Research Foundation (NRF) towards this research is hereby acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Agenbag L, 2008, BOTHALIA, V38, P161, DOI 10.4102/abc.v38i2.287; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Beck J, 2010, BASIC APPL ECOL, V11, P714, DOI 10.1016/j.baae.2010.08.009; Benadi G, 2014, J ANIM ECOL, V83, P639, DOI 10.1111/1365-2656.12158; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bishop JA, 1999, FUNCT ECOL, V13, P711, DOI 10.1046/j.1365-2435.1999.00351.x; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Brown CD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1779; Camill P, 2000, ECOSYSTEMS, V3, P534, DOI 10.1007/s100210000047; Carnicer J, 2009, ECOLOGY, V90, P1958, DOI 10.1890/07-1939.1; Carstensen DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112903; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Colville J, 2002, BIODIVERS CONSERV, V11, P243, DOI 10.1023/A:1014520226989; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Devoto M, 2005, OIKOS, V109, P461, DOI 10.1111/j.0030-1299.2005.13712.x; Dicks LV, 2002, J ANIM ECOL, V71, P32, DOI 10.1046/j.0021-8790.2001.00572.x; Dormann C.F., 2008, R NEWS, V8, P8; Dunne JA, 2006, SFI S SCI C, P27; Evans P, 2017, ENVIRON REV, V25, P423, DOI 10.1139/er-2017-0009; Geib JC, 2012, ECOLOGY, V93, P1581, DOI 10.1890/11-1271.1; Gess S. K., 2006, Annals of the Eastern Cape Museums, V5, P1; Gibson RH, 2011, OIKOS, V120, P822, DOI 10.1111/j.1600-0706.2010.18927.x; Goldblatt Peter, 2002, Adansonia (Paris), V24, P243; Hass AL, 2018, AGR ECOSYST ENVIRON, V253, P140, DOI 10.1016/j.agee.2017.10.019; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Heink U, 2010, BIODIVERS CONSERV, V19, P3769, DOI 10.1007/s10531-010-9926-6; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Inouye DW, 2003, AM J BOT, V90, P905, DOI 10.3732/ajb.90.6.905; Kark S., 2013, ECOLOGICAL SYSTEMS, P147, DOI DOI 10.1007/978-1-4614-5755-8_9; Kaspari M, 2001, GLOBAL ECOL BIOGEOGR, V10, P229, DOI 10.1046/j.1466-822X.2001.00214.x; Kemp JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168033; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Kilkenny FF, 2008, OECOLOGIA, V155, P247, DOI 10.1007/s00442-007-0903-z; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Koti S, 2005, J EXP BOT, V56, P725, DOI 10.1093/jxb/eri044; Kovac H, 2011, ECOL ENTOMOL, V36, P686, DOI 10.1111/j.1365-2311.2011.01313.x; Kuhlmann M, 2005, HYMENOPTERA APOIDEA, P167; Kuhlmann M, 2012, DIVERS DISTRIB, V18, P885, DOI 10.1111/j.1472-4642.2011.00877.x; Lazaro A, 2008, OECOLOGIA, V157, P249, DOI 10.1007/s00442-008-1066-2; Lazaro A, 2016, ECOL ENTOMOL, V41, P400, DOI 10.1111/een.12310; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Loehle C, 2000, CAN J FOREST RES, V30, P1632, DOI 10.1139/cjfr-30-10-1632; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Gonzalez AMM, 2009, J TROP ECOL, V25, P493, DOI 10.1017/S0266467409990034; Mayer C, 2006, J INSECT CONSERV, V10, P323, DOI 10.1007/s10841-006-9006-0; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Miller-Struttmann NE, 2014, OECOLOGIA, V176, P1033, DOI 10.1007/s00442-014-3066-8; Montoya JM, 2007, CURR BIOL, V17, pR128, DOI 10.1016/j.cub.2007.01.028; Morris RJ, 2015, ECOGRAPHY, V38, P792, DOI 10.1111/ecog.01078; Mucina L., 2006, VEGETATION S AFRICA; Namgail T, 2012, J PLANT RES, V125, P93, DOI 10.1007/s10265-011-0430-1; Nicolson SW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1597; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Oyen KJ, 2016, J THERM BIOL, V59, P52, DOI 10.1016/j.jtherbio.2016.04.015; Pato J, 2012, ECOSCIENCE, V19, P59, DOI 10.2980/19-1-3407; PETANIDOU T, 1995, NEW PHYTOL, V129, P155, DOI 10.1111/j.1469-8137.1995.tb03019.x; Ploquin EF, 2013, OECOLOGIA, V173, P1649, DOI 10.1007/s00442-013-2731-7; Plowman NS, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2564; Purcell J, 2011, BIOL REV, V86, P475, DOI 10.1111/j.1469-185X.2010.00156.x; Pyke GH, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1267; Pyke GH, 2012, ENVIRON ENTOMOL, V41, P1332, DOI 10.1603/EN11284; R Core Team, 2021, R LANGUAGE ENV STAT; Radmacher S, 2011, APIDOLOGIE, V42, P711, DOI 10.1007/s13592-011-0078-9; Ramos-Jiliberto R, 2010, ECOL COMPLEX, V7, P86, DOI 10.1016/j.ecocom.2009.06.001; Rolland C, 2003, J CLIMATE, V16, P1032, DOI 10.1175/1520-0442(2003)016<1032:SASVOA>2.0.CO;2; Scaven VL, 2013, CURR ZOOL, V59, P418, DOI 10.1093/czoolo/59.3.418; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.1890/0012-9658(2002)083[1214:MBENZP]2.0.CO;2; Schleuning M, 2012, CURR BIOL, V22, P1925, DOI 10.1016/j.cub.2012.08.015; Soares RGS, 2017, ECOL INDIC, V78, P361, DOI 10.1016/j.ecolind.2017.03.037; Spiesman BJ, 2013, ECOLOGY, V94, P2688, DOI 10.1890/13-0977.1; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Trunschke J, 2017, ALPINE BOT, V127, P41, DOI 10.1007/s00035-016-0176-4; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vrdoljak SM, 2016, J INSECT CONSERV, V20, P711, DOI 10.1007/s10841-016-9904-8; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Widhiono I., 2017, Psyche: A Journal of Entomology, V2017, P2968414; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zhao DQ, 2012, PLANT PHYSIOL BIOCH, V61, P187, DOI 10.1016/j.plaphy.2012.10.005	85	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207453	10.1371/journal.pone.0207453	http://dx.doi.org/10.1371/journal.pone.0207453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496213	Green Submitted, gold, Green Published			2022-12-26	WOS:000451763800030
J	dos Santos, LM; Vieira, MRMD; Oliveira, JFG; Trindade, JQ; Brasiliense, DM; Ferrari, SF; Tsutsumi, MY; Fuzii, HT; Sousa, EC; Ishikawa, EAY; Ishak, R; de Sousa, MS				dos Santos, Leonardo Miranda; Mendonca dos Santos Vieira, Maria Renata; Galdino Oliveira, Jessica Fernanda; Trindade, Josinaide Quaresma; Brasiliense, Danielle Murici; Ferrari, Stephen Francis; Tsutsumi, Mihoko Yamamoto; Fuzii, Hellen Thais; Sousa Junior, Edivaldo Costa; Yassui Ishikawa, Edna Aoba; Ishak, Ricardo; de Sousa, Maisa Silva			High prevalence of sexual Chlamydia trachomatis infection in young women from Marajo Island, in the Brazilian Amazon	PLOS ONE			English	Review							HUMAN-PAPILLOMAVIRUS; RISK; STRAINS	Background Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection (STI) in the world. Approximately 80% of infected women are asymptomatic, although this infection can lead to serious complications in the female reproductive tract. Few data on Chlamydia infection are available in rural Amazonian communities. Objectives To evaluate the prevalence of sexual C. trachomatis infection in women from Marajo Archipelago communities in the Amazon region of Brazil and to identify associated factors and genotypes. Methods We utilized amplification of the ompA gene by nested PCR. Positive samples were geno-typed by sequencing. Study participants completed a questionnaire on social, epidemiological, and reproductive health variables. A Poisson regression was used to evaluate the degree of association of these variables with the infection. Results The sexual infection by C. trachomatis was observed in 4% (16/393) of the subjects, and was more often found in women aged. 25 (14.3%; 95% CI = 2.83-35.47; p < 0.001), and in women with a household income of less than one Brazilian monthly minimum wage (5.2%; 95% CI = 1.33-11.37; p = 0.014). The ompA gene was sequenced in 13 samples, revealing F genotypes (38.4%, n = 5), D (23%, n = 3), E (15.3%, n = 2), Ia (7.6%, N = 1), J (7.6%, n = 1) and B (7.6%, n = 1). Conclusions We recorded a high prevalence of sexual infection by C. trachomatis in young and poor women from the interior of the Brazilian Amazon. This high prevalence and the frequencies of the main genotypes were similar to those found in major Brazilian urban centers. Our results reinforce the importance of the screening of this neglected infection, and the prevention of later sequelae in young women from rural and urban areas of Brazil.	[dos Santos, Leonardo Miranda; Mendonca dos Santos Vieira, Maria Renata; Yassui Ishikawa, Edna Aoba; de Sousa, Maisa Silva] Univ Fed Para, Nucleo Med Trop, Lab Biol Mol & Celular, Belem, Para, Brazil; [dos Santos, Leonardo Miranda] Univ Fed Para, Programa Posgrad Doencas Trop, Belem, Para, Brazil; [Mendonca dos Santos Vieira, Maria Renata; Tsutsumi, Mihoko Yamamoto] Univ Fed Para, Programa Posgrad Anal Clin, Belem, Para, Brazil; [Galdino Oliveira, Jessica Fernanda; Trindade, Josinaide Quaresma; Tsutsumi, Mihoko Yamamoto] Univ Fed Para, Inst Ciencias Biol, Lab Citopatol, Belem, Para, Brazil; [Brasiliense, Danielle Murici] Inst Evandro Chagas, Secao Bacteriol & Micol, Ananindeua, Para, Brazil; [Ferrari, Stephen Francis] Univ Fed Sergipe, Dept Ecol, Sao Cristovao, Brazil; [Fuzii, Hellen Thais] Univ Fed Para, Nucleo Med Trop, Lab Imunopatol, Belem, Para, Brazil; [Sousa Junior, Edivaldo Costa] Inst Evandro Chagas, Secao Virol, Ananindeua, Para, Brazil; [Ishak, Ricardo] Univ Fed Para, Inst Ciencias Biol, Lab Virol, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal de Sergipe; Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Para	dos Santos, LM (corresponding author), Univ Fed Para, Nucleo Med Trop, Lab Biol Mol & Celular, Belem, Para, Brazil.; dos Santos, LM (corresponding author), Univ Fed Para, Programa Posgrad Doencas Trop, Belem, Para, Brazil.	leonn_bio20@yahoo.com.br	de Sousa, Maísa Silva/AAE-8074-2021; Fuzii, Hellen Thais/F-9997-2012; Ishikawa, Edna/AAD-9519-2021	de Sousa, Maísa Silva/0000-0001-9944-7838; Ferrari, Stephen/0000-0003-0566-0000	Fundacao Amazonia Paraense de Amparo a Pesquisa [FAPESPA - ICAAF 014/2012]; Ministerio da Saude do Brasil	Fundacao Amazonia Paraense de Amparo a Pesquisa(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Ministerio da Saude do Brasil	The present study was fully supported by grants from the Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA - ICAAF 014/2012) and Ministerio da Saude do Brasil (MS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdella RMA, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0202-5; Brasil. Ministerio da Saude. Secretaria de Atencao a Saude. Secretaria de Vigilancia em Saude, 2012, NON TRADITIONAL REF; Brasiliense DM, 2016, J INFECT DEV COUNTR, V10, P134, DOI 10.3855/jidc.6474; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; CDC, 2014, MMWR-MORBID MORTAL W, V63; Cunha CB, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2002-0; Machado MSC, 2012, BRAZ J INFECT DIS, V16, P188, DOI 10.1590/S1413-86702012000200015; da Silva L, 2015, BRAZ J INFECT DIS, V19, P557, DOI 10.1016/j.bjid.2015.07.001; de Abreu ALP, 2012, AM J TROP MED HYG, V87, P1149, DOI 10.4269/ajtmh.2012.12-0287; Eleuterio RMN, 2007, NON TRADITIONAL REF, V39, P287; European Centre for Disease Prevention and Control, 2009, NON TRADITIONAL REF; Favacho J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006282; Fernandez-Benitez C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-388; Fieser N, 2013, INFECTION, V41, P159, DOI 10.1007/s15010-012-0301-2; Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS333, DOI 10.1590/S0102-311X2007001500002; Magalhaes PAF, 2015, ARCH GYNECOL OBSTET, V291, P1095, DOI 10.1007/s00404-014-3514-z; Garces AX, 2013, REV BRAS GINECOL OBS, V35, P379, DOI 10.1590/S0100-72032013000800008; Gottlieb SL, 2010, J INFECT DIS, V201, pS156, DOI 10.1086/652396; Greer C E, 1991, PCR Methods Appl, V1, P46; Greydanus DE, 2015, CURR OPIN PEDIATR, V27, P92, DOI 10.1097/MOP.0000000000000183; Ishak MDG, 2015, REV SOC BRAS MED TRO, V48, P170, DOI 10.1590/0037-8682-0038-2015; Haro-Cruz MJ, 2011, ENFERMIDADES INFECCI, V29, P102; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15; Hocking JS, 2008, MED J AUSTRALIA, V188, P106, DOI 10.5694/j.1326-5377.2008.tb01533.x; Jalal H, 2007, J CLIN MICROBIOL, V45, P2649, DOI 10.1128/JCM.00451-07; KALTENBOECK B, 1993, J BACTERIOL, V175, P487, DOI 10.1128/JB.175.2.487-502.1993; Lanjouw E, 2010, INT J STD AIDS, V21, P729, DOI 10.1258/ijsa.2010.010302; Lima HE, 2007, SEX TRANSM DIS, V34, P709, DOI 10.1097/01.olq.0000258399.27873.d9; Lopez-Corbeto E, 2015, ENFERMIDADES INFECCI; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Machado ACS, 2011, J MED MICROBIOL, V60, P472, DOI 10.1099/jmm.0.026476-0; Manavi K, 2006, BEST PRACT RES CL OB, V20, P941, DOI 10.1016/j.bpobgyn.2006.06.003; Mania-Pramanik Jayanti, 2012, J Reprod Infertil, V13, P204; Tavares MCM, 2014, MOL BIOL REP, V41, P865, DOI 10.1007/s11033-013-2927-2; Millman K, 2004, J BACTERIOL, V186, P2457, DOI 10.1128/JB.186.8.2457-2465.2004; Nakashima K, 2014, BMC INFECT DIS, V27, P14; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Pineiro L, 2009, ENFERM INFEC MICR CL, V27, P462, DOI 10.1016/j.eimc.2008.12.012; Preventive Services US, 2007, ANN INTERN MED, V147, P128; de Lima YAR, 2014, INT J INFECT DIS, V25, P16, DOI 10.1016/j.ijid.2014.03.1389; Reilly LA, 2007, CAD SAUDE PUBLICA, V23, P1682, DOI 10.1590/S0102-311X2007000700020; Samoff E, 2005, AM J EPIDEMIOL, V162, P668, DOI 10.1093/aje/kwi262; Santos LM, 2016, REV PAN AMAZONICA SA, V7, P101, DOI [10.5123/s2176-62232016000400012, DOI 10.5123/S2176-62232016000400012]; Santos Ulian WL, 2017, REV PAN-AMAZ SAUDE, V8, P27, DOI [10.5123/s2176-62232017000300004, DOI 10.5123/S2176-62232017000300004]; Sheringham J, 2013, SEX TRANSM INFECT, V89, P175, DOI 10.1136/sextrans-2011-050223; Stamm WE, 1999, J INFECT DIS, V179, pS380, DOI 10.1086/513844; Woodhall SC, 2015, SEX TRANSM INFECT, V91, P412, DOI 10.1136/sextrans-2015-052067; World Health Organization, 2005, NON TRADITIONAL REF; Yamazaki T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-82	50	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207853	10.1371/journal.pone.0207853	http://dx.doi.org/10.1371/journal.pone.0207853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496244	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800055
J	Frie, KG; Kamate, B; Traore, CB; Ly, M; Malle, B; Coulibaly, B; Wienke, A; Kantelhardt, EJ				Frie, Kirstin Grosse; Kamate, Bakarou; Traore, Cheick Boudagari; Ly, Madani; Malle, Brahima; Coulibaly, Bourama; Wienke, Andreas; Kantelhardt, Eva Johanna			Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali	PLOS ONE			English	Article							DELAY; STAGE; EXPERIENCE; WOMEN	Objective To analyse patient and healthcare system related factors influencing the time to first healthcare visit, diagnosis and treatment of breast cancer patients in sub-Saharan Africa and the impact on survival in order to advise on early detection strategies. Methods A prospective hospital cohort study was conducted at the only pathology department in Mali, at the University Hospital in Bamako. All the female patients with a breast cancer diagnosis between January and April 2016 were interviewed with a structured questionnaire (N = 64) to gather information about breast symptom recognition and first healthcare visit. Information on beginning of treatment and survival were collected at 18-months follow-up. Simple Cox regression analyses were performed. Results The median time to first healthcare visit was 4.8 months, from first healthcare visit to diagnosis was 0.9 months and for the patients who started treatment (N = 46) the time from diagnosis to treatment was 1.3 months. Knowledge of breast-self-examination and correct symptom interpretation increased the chance of an earlier healthcare visit. Prolonged time to diagnosis was found with shorter duration to first healthcare visit, for working women compared to housewives and for those living within Bamako. Living outside Bamako and smaller tumour size (T1/T2) prolonged time to treatment. Visit of a traditional healer and larger tumour size (T3/T4) shortened survival time, whereas time to first healthcare visit and subsequent time to diagnosis had no influence on survival. Conclusions Down-staging strategies are only useful if the continuum of breast cancer care is warranted for the majority of patients.	[Frie, Kirstin Grosse; Wienke, Andreas; Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Seale, Germany; [Kamate, Bakarou; Traore, Cheick Boudagari; Malle, Brahima; Coulibaly, Bourama] Univ Hosp Point G, Inst Pathol, Bamako, Mali; [Ly, Madani] Hop Luxemburg, Oncol Dept, Bamako, Mali; [Kantelhardt, Eva Johanna] Univ Hosp Halle Seale, Dept Gynaecol, Halle, Germany	Martin Luther University Halle Wittenberg	Frie, KG (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Seale, Germany.	grossefrie@web.de	Wienke, Andreas/AAN-3707-2020		DAAD P.R.I.M.E fellowship; German Federal Ministry of Education and Research; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007/2013) under REA grant [605728]; German Research Foundation (DFG)	DAAD P.R.I.M.E fellowship; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007/2013) under REA grant; German Research Foundation (DFG)(German Research Foundation (DFG))	The work leading to this publication has been supported by a DAAD P.R.I.M.E fellowship received by KGF with funding from the German Federal Ministry of Education and Research and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007/2013) under REA grant agreement no 605728. We further acknowledge the financial support within the funding programme Open Access Publishing by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesunkanmi ARK, 2006, BREAST, V15, P399, DOI 10.1016/j.breast.2005.06.008; Akuoko CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171024; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Benbakhta B, DETERMINANTS DELAIS; Bove RM, 2012, SOC SCI MED, V75, P1392, DOI 10.1016/j.socscimed.2012.06.012; Clegg-Lamptey J, 2009, Ghana Med J, V43, P127; Dedey F, 2016, HEALTH EDUC BEHAV, V43, P420, DOI 10.1177/1090198115620417; Dickens C, 2014, INT J CANCER, V135, P2173, DOI 10.1002/ijc.28861; Dye TD, 2010, CANCER-AM CANCER SOC, V116, P577, DOI 10.1002/cncr.24776; Ellis AA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-946; Ermiah Eramah, 2012, BMC Res Notes, V5, P452, DOI 10.1186/1756-0500-5-452; Espina C, 2017, ANN EPIDEMIOL, V27, P659, DOI 10.1016/j.annepidem.2017.09.007; Ezawawy AM, 2008, BREAST CARE, V3, P37, DOI 10.1159/000113936; Ferlay J, 2013, GLOBOCAN V1 0 CANC I; Frie KG, 2018, BREAST CARE, V13, P39, DOI 10.1159/000481087; Ibrahim NA, 2012, BREAST, V21, P416, DOI 10.1016/j.breast.2012.02.006; Jedy-Agba E, 2016, LANCET GLOB HEALTH, V4, pE923, DOI 10.1016/s2214-109x(16)30259-5; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Martyn KK, 2002, NURS RES, V51, P270, DOI 10.1097/00006199-200207000-00008; Moodley J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4219-7; Moodley J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009905; Mousa SM, 2011, BREAST, V20, P555, DOI 10.1016/j.breast.2011.07.001; O'Brien KS, 2012, J CANCER EDUC, V27, P573, DOI 10.1007/s13187-012-0370-z; Odongo J, 2015, BMC Res Notes, V8, P467, DOI 10.1186/s13104-015-1438-8; Olajide TO, 2014, NIGER J CLIN PRACT, V17, P802, DOI 10.4103/1119-3077.144404; Pace LE, 2015, ONCOLOGIST, V20, P780, DOI 10.1634/theoncologist.2014-0493; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Scherber Samuel, 2014, Breast Dis, V34, P139, DOI 10.3233/BD-140372; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Shulman LN, 2010, J ONCOL, V2010, DOI 10.1155/2010/595167; Strobele L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5360-6; Subramanian S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190113; Ukwenya AY, 2008, S AFR J SURG, V46, P106; Unger-Saldana K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-626; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68	36	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207928	10.1371/journal.pone.0207928	http://dx.doi.org/10.1371/journal.pone.0207928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496219	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800064
J	Wu, Q; Fu, M; Zheng, KX; Bo, H; Yang, H; Zhong, X; Liang, GL; Xu, YJ; Hao, BB; Hu, Z; Zhang, ZW; Jin, XD; Kang, Y				Wu, Qin; Fu, Min; Zheng, Kexin; Bo, Hong; Yang, Hao; Zhong, Xi; Liang, Guanlin; Xu, Yujun; Hao, Bibo; Hu, Zhi; Zhang, Zhongwei; Jin, Xiaodong; Kang, Yan			Elevated triglycerides level in hospital stay as a risk factor of mortality in patients with severe acute pancreatitis	PLOS ONE			English	Article							HYPERTRIGLYCERIDEMIA; ASSOCIATION; MANAGEMENT; GUIDELINE; SERUM	Hypertriglyceridaemia is one of the most common causes of severe acute pancreatitis (SAP). However, the association between elevated triglycerides (TG) level in hospital stay and outcome in SAP patients with normal TG level at admission has not been clearly demonstrated. This retrospective study assessed the serum TG levels of patients with SAP admitted to the intensive care unit (ICU) in 2017. Variables with a statistically significant association with the incidence of in-hospital TG elevation, as determined by univariate analysis, were analysed using a logistic regression model to predictors. Of the 99 patients included in the study, TG levels were within the normal range in 59 (59.59%) patients at admission. Among patients with normal TG level when admitted to ICU, 28 (47.46%) experienced at least one episode of TG level elevation during their ICU stay. Elevated TG level in hospitalization is associated with an increased length of ICU stay, as well as increased mortality. In addition to other factors, propofol usage was independently associated with the occurrence of in-hospital-TG elevation. To conclude, we retrospectively investigated the incidence, outcome, and risk factors for in-hospital TG elevation events in SAP patients admitted to the ICU. We found a high incidence of both preexisting and in-hospital-acquired TG elevation in SAP patients admitted to the ICU. The TG elevation that occurred during the ICU stay was associated with worse outcomes and long-term hospitalization of the ICU. Propofol usage was independently associated with the TG elevation occurrence in the ICU.	[Wu, Qin; Fu, Min; Zheng, Kexin; Bo, Hong; Yang, Hao; Zhong, Xi; Liang, Guanlin; Xu, Yujun; Hu, Zhi; Zhang, Zhongwei; Jin, Xiaodong; Kang, Yan] Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China; [Hao, Bibo] IBM Res, Beijing, Peoples R China	Sichuan University	Kang, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China.	kangyan@scu.edu.cn	Hao, Bibo/X-8485-2019; Hao, Bibo/I-2476-2013; Wu, Qin/AAF-5707-2022; Wu, Qin/AFJ-8752-2022	Hao, Bibo/0000-0003-1138-8365; Hao, Bibo/0000-0003-1138-8365; Wu, Qin/0000-0002-7470-8429; Wu, Qin/0000-0002-7470-8429	National Natural Science Foundation of China [81801892]; Wu Jieping Medical Foundation's special funding fund for clinical research [320.6750.17570]; Sichuan University Postdoctoral Research Fund [2018SCU12036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wu Jieping Medical Foundation's special funding fund for clinical research; Sichuan University Postdoctoral Research Fund	The work was supported by grants from National Natural Science Foundation of China (81801892), Wu Jieping Medical Foundation's special funding fund for clinical research (No.320.6750.17570) and Sichuan University Postdoctoral Research Fund (No.2018SCU12036). The funder (IBM Research) provided support in the form of salary for author (BH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213; Brahm A, 2013, NUTRIENTS, V5, P981, DOI 10.3390/nu5030981; Brereton MF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13496; Carr RA, 2016, PANCREATOLOGY, V16, P469, DOI 10.1016/j.pan.2016.02.011; Carroll JK, 2007, AM FAM PHYSICIAN, V75, P1513; Deng LH, 2008, WORLD J GASTROENTERO, V14, P4558, DOI 10.3748/wjg.14.4558; Devaud JC, 2012, INTENS CARE MED, V38, P1990, DOI 10.1007/s00134-012-2688-8; Jacobson TA, 2015, J CLIN LIPIDOL, V9, P129, DOI 10.1016/j.jacl.2015.02.003; Kiss L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32337-x; Lankisch PG, 2015, LANCET, V386, P85, DOI 10.1016/S0140-6736(14)60649-8; Lu GT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6089430; Mao EQ, 2003, WORLD J GASTROENTERO, V9, P2622; Papachristou GI, 2017, ANN GASTROENTEROL, V30, P106, DOI 10.20524/aog.2016.0109; Rawla P, 2018, CLIN J GASTROENTEROL, V11, P441, DOI 10.1007/s12328-018-0881-1; Roberts SE, 2017, PANCREATOLOGY, V17, P155, DOI 10.1016/j.pan.2017.01.005; Santos MA, 2017, J GEN INTERN MED, V32, P1267, DOI 10.1007/s11606-017-4086-y; Shen X, 2016, J CRIT CARE, V36, P140, DOI 10.1016/j.jcrc.2016.06.035; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985; Siriwardena AK, 2017, BRIT J SURG, V104, P1591, DOI 10.1002/bjs.10585; Swaroop VS, 2004, JAMA-J AM MED ASSOC, V291, P2865, DOI 10.1001/jama.291.23.2865; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Wang Q, 2017, J CLIN GASTROENTEROL, V51, P586, DOI 10.1097/MCG.0000000000000846; Wu CY, 2017, PANCREATOLOGY, V17, P561, DOI 10.1016/j.pan.2017.06.006; Zerem E, 2014, WORLD J GASTROENTERO, V20, P13879, DOI 10.3748/wjg.v20.i38.13879	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207875	10.1371/journal.pone.0207875	http://dx.doi.org/10.1371/journal.pone.0207875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496237	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800059
J	Kucur, SS; Hollo, G; Sznitman, R				Kucur, Serife Seda; Hollo, Gabor; Sznitman, Raphael			A deep learning approach to automatic detection of early glaucoma from visual fields	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; DIAGNOSIS	Purpose To investigate the suitability of multi-scale spatial information in 30 degrees visual fields (VF), computed from a Convolutional Neural Network (CNN) classifier, for early-glaucoma vs. control discrimination. Method Two data sets of VFs acquired with the OCTOPUS 101 G1 program and the Humphrey Field Analyzer 24-2 pattern were subdivided into control and early-glaucomatous groups, and converted into a new image using a novel voronoi representation to train a custom-designed CNN so to discriminate between control and early-glaucomatous eyes. Saliency maps that highlight what regions of the VF are contributing maximally to the classification decision were computed to provide classification justification. Model fitting was cross-validated and average precision (AP) score performances were computed for our method, Mean Defect (MD), square-root of Loss Variance (sLV), their combination (MD+sLV), and a Neural Network (NN) that does not use convolutional features. Results CNN achieved the best AP score (0.874 +/- 0.095) across all test folds for one data set compared to others (MD = 0.869 +/- 0.064, sLV = 0.775 +/- 0.137, MD+sLV = 0.839 +/- 0.085, NN = 0.843 +/- 0.089) and the third best AP score (0.986 +/- 0.019) on the other one with slight difference from the other methods (MD = 0.986 +/- 0.023, sLV = 0.992 +/- 0.016, MD+sLV = 0.987 +/- 0.017, NN = 0.985 +/- 0.017). In general, CNN consistently led to high AP across different data sets. Qualitatively, computed saliency maps appeared to provide clinically relevant information on the CNN decision for individual VFs. Conclusion The proposed CNN offers high classification performance for the discrimination of control and early-glaucoma VFs when compared with standard clinical decision measures. The CNN classification, aided by saliency visualization, may support clinicians in the automatic discrimination of early-glaucomatous and normal VFs.	[Kucur, Serife Seda; Sznitman, Raphael] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland; [Hollo, Gabor] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary	University of Bern; Semmelweis University	Kucur, SS (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland.	serife.kucur@artorg.unibe.ch		Kucur, Serife Seda/0000-0001-7995-2458	Haag-Streit Foundation	Haag-Streit Foundation	This work was supported by the Haag-Streit Foundation to SSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2013, ACTA OPHTHALMOL, V91, P413, DOI 10.1111/j.1755-3768.2012.02435.x; Apostolopoulos S., 2017, MED IMAGE COMPUTING, P294; ASMAN P, 1992, ARCH OPHTHALMOL-CHIC, V110, P812, DOI 10.1001/archopht.1992.01080180084033; Aulhorn E., 1977, DOC OPHTHALMOL PROC, V14, P75; AURENHAMMER F, 1991, ACM COMPUT SURV, V23, P345, DOI DOI 10.1145/116873.116880; Bizios D, 2007, J GLAUCOMA, V16, P20, DOI 10.1097/IJG.0b013e31802b34e4; Bryan SR, 2013, INVEST OPHTH VIS SCI, V54, P6694, DOI 10.1167/iovs.12-11185; Ceccon S, 2014, IEEE J BIOMED HEALTH, V18, P1008, DOI 10.1109/JBHI.2013.2289367; Ciller C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173900; Erler NS, 2014, INVEST OPHTH VIS SCI, V55, P2350, DOI 10.1167/iovs.13-12492; FLAMMER J, 1986, GRAEF ARCH CLIN EXP, V224, P389, DOI 10.1007/BF02173350; GOLDBAUM MH, 1994, INVEST OPHTH VIS SCI, V35, P3362; Goodfellow I., DEEP LEARNING; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hatanaka Y, 2012, IEEE ENG MED BIO, P5963, DOI 10.1109/EMBC.2012.6347352; Heijl A, 2012, FIELD ANAL PRIMER EF; Kingma D. P., 2015, P INT C LEARN REPR, P1; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Sample PA, 2004, INVEST OPHTH VIS SCI, V45, P2596, DOI 10.1167/iovs.03-0343; Sharma P, 2008, SURV OPHTHALMOL, V53, pS17, DOI 10.1016/j.survophthal.2008.08.003; Simonyan Karen, 2014, DEEP INSIDE CONVOLUT; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; THYLEFORS B, 1994, B WORLD HEALTH ORGAN, V72, P323; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; Voronoi G, 1908, J REINE ANGEW MATH, V134, P198, DOI 10.1515/crll.1908.134.198; Wattenberg M., SMOOTHGRAD REMOVING	27	32	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206081	10.1371/journal.pone.0206081	http://dx.doi.org/10.1371/journal.pone.0206081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485270	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800013
J	Schiffer, TA; Christensen, M; Gustafsson, H; Palm, F				Schiffer, Tomas A.; Christensen, Michael; Gustafsson, Hakan; Palm, Fredrik			The effect of inactin on kidney mitochondrial function and production of reactive oxygen species	PLOS ONE			English	Article							PROTON; ISOFLURANE; ANESTHESIA; RATS; LIPOSOMES; MECHANISM; SYNTHASE	Inactin is a long lasting anesthetic agent commonly used in rat studies, but is also shown to exert physiological effects such as reducing renal blood flow, glomerular filtration rate and depressing tubular transport capacity. The effect of inactin on isolated kidney mitochondria is unknown and may be important when studying related topics in anaesthetized animals. The aim of this study was to determine whether inactin exerts effects on mitochondrial function and production of reactive oxygen species. Kidney mitochondrial function and production of reactive oxygen after acutely (5 min) or longer (1.5 hour) anesthetizing rats with inactin was evaluated using high-resolution respirometry. The results demonstrate that inactin significantly improves respiratory control ratio, inhibits complex I in the mitochondrial respiratory chain, reduce both unregulated proton leak and time dependently reduce the regulated proton leak via uncoupling protein-2 and adenine nucleotide translocase. Inactin also contributes to increased mitochondrial hydrogen peroxide production. In conclusion, inactin exerts persistent effects on mitochondrial function and these profound effects on mitochondrial function should to be considered when studying mitochondria isolated from animals anesthesized with inactin.	[Schiffer, Tomas A.; Palm, Fredrik] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Christensen, Michael] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Gustafsson, Hakan] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Uppsala University; Aarhus University; Linkoping University	Schiffer, TA (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	tomas.schiffer@mcb.uu.se	; Schiffer, Tomas/X-1343-2018	Gustafsson, Hakan/0000-0001-6148-1053; Christensen, Michael/0000-0003-1693-058X; Schiffer, Tomas/0000-0002-9077-2682	Swedish Research Council; Swedish Diabetes Foundation; Ake Wiberg Foundation; Family Ernfors Foundation; Swedish Society for Medical Research; Lundbeck Foundation; Danish Diabetes Academy - Novo Nordisk Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Ake Wiberg Foundation; Family Ernfors Foundation; Swedish Society for Medical Research; Lundbeck Foundation(Lundbeckfonden); Danish Diabetes Academy - Novo Nordisk Foundation	This work was funded by the Swedish Research Council, the Swedish Diabetes Foundation, Ake Wiberg Foundation, the Family Ernfors Foundation, the Swedish Society for Medical Research, the Lundbeck Foundation and the Danish Diabetes Academy supported by the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand MD, 2003, BIOCHEM J, V376, P741, DOI 10.1042/BJ20030984; Brand MD, 1999, INT J OBESITY, V23, pS4, DOI 10.1038/sj.ijo.0800936; Brookes PS, 1997, BBA-BIOMEMBRANES, V1330, P157, DOI 10.1016/S0005-2736(97)00160-0; BUELKESAM J, 1978, LAB ANIM SCI, V28, P157; Canfield SG, 2016, ANESTH ANALG, V122, P1269, DOI 10.1213/ANE.0000000000001254; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Grivennikova VG, 2013, BBA-BIOENERGETICS, V1827, P446, DOI 10.1016/j.bbabio.2013.01.002; Hoch FL, 1998, J BIOENERG BIOMEMBR, V30, P511, DOI 10.1023/A:1020576315771; Hu ZY, 2014, FUND CLIN PHARMACOL, V28, P190, DOI 10.1111/fcp.12030; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; LEYSSAC PP, 1975, ACTA PHYSIOL SCAND, V94, P472, DOI 10.1111/j.1748-1716.1975.tb05907.x; Lukasik VM, 2003, NMR BIOMED, V16, P459, DOI 10.1002/nbm.836; MULLER M, 1984, EUR J BIOCHEM, V140, P447, DOI 10.1111/j.1432-1033.1984.tb08123.x; Pravdic D, 2012, EUR J PHARMACOL, V690, P149, DOI 10.1016/j.ejphar.2012.07.003; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Sababi M, 2001, ACTA PHYSIOL SCAND, V172, P115, DOI 10.1046/j.1365-201X.2001.00849.x; Sababi M, 1996, ACTA PHYSIOL SCAND, V158, P45, DOI 10.1046/j.1365-201X.1996.530287000.x; Schiffer TA, 2018, AM J PHYSIOL-RENAL, V315, pF677, DOI 10.1152/ajprenal.00207.2018; Teixeira G, 2015, ANESTHESIOLOGY, V123, P1374, DOI 10.1097/ALN.0000000000000876; WALKER LA, 1983, AM J PHYSIOL, V245, pF67, DOI 10.1152/ajprenal.1983.245.1.F67	21	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207728	10.1371/journal.pone.0207728	http://dx.doi.org/10.1371/journal.pone.0207728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475856	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700060
J	Pacheco-Quinto, J; Clausen, D; Perez-Gonzalez, R; Peng, H; Meszaros, A; Eckman, CB; Levy, E; Eckman, EA				Pacheco-Quinto, Javier; Clausen, Dana; Perez-Gonzalez, Rocio; Peng, Hui; Meszaros, Austin; Eckman, Christopher B.; Levy, Efrat; Eckman, Elizabeth A.			Intracellular metalloprotease activity controls intraneuronal A aggregation and limits secretion of A via exosomes	FASEB JOURNAL			English	Article						Alzheimer's disease; oligomer; ECE; multivesicular body	AMYLOID PRECURSOR PROTEIN; ENDOTHELIN-CONVERTING ENZYME; A-BETA ACCUMULATION; ALZHEIMERS-DISEASE; LYSOSOMAL DYSFUNCTION; COGNITIVE DEFICITS; TERMINAL FRAGMENTS; GAMMA-SECRETASE; MOUSE MODEL; WILD-TYPE	Accumulating evidence suggests that the abnormal aggregation of amyloid- () peptide in Alzheimer's disease (AD) begins intraneuronally, within vesicles of the endosomal-lysosomal pathway where A is both generated and degraded. Metalloproteases, including endothelin-converting enzyme (ECE)-1 and -2, reside within these vesicles and normally limit the accumulation of intraneuronally produced A. In this study, we determined whether disruption of A catabolism could trigger A aggregation within neurons and increase the amount of A associated with exosomes, small extracellular vesicles derived from endosomal multivesicular bodies. Using cultured cell lines, primary neurons, and organotypic brain slices from an AD mouse model, we found that pharmacological inhibition of the ECE family of metalloproteases increased intracellular and extracellular A levels and promoted the intracellular formation of A oligomers, a process that did not require internalization of secreted A. In vivo, the accumulation of intraneuronal A aggregates was accompanied by increased levels of both extracellular and exosome-associated A, including oligomeric species. Neuronal exosomes were found to contain both ECE-1 and -2 activities, suggesting that multivesicular bodies are intracellular sites of A degradation by these enzymes. ECE dysfunction could lead to the accumulation of intraneuronal A aggregates and their subsequent release into the extracellular space via exosomes.Pacheco-Quinto, J., Clausen, D., Perez-Gonzalez, R., Peng, H., Meszaros, A., Eckman, C. B., Levy, E., Eckman, E. A. Intracellular metalloprotease activity controls intraneuronal A aggregation and limits secretion of A via exosomes.	[Pacheco-Quinto, Javier; Clausen, Dana; Peng, Hui; Meszaros, Austin; Eckman, Christopher B.; Eckman, Elizabeth A.] Biomed Res Inst New Jersey, 140 East Hanover Ave, Cedar Knolls, NJ 07927 USA; [Pacheco-Quinto, Javier; Eckman, Elizabeth A.] Atlantic Hlth Syst, Morristown, NJ USA; [Perez-Gonzalez, Rocio; Levy, Efrat] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Perez-Gonzalez, Rocio; Levy, Efrat] NYU, Dept Psychiat, Langone Med Ctr, 550 1st Ave, New York, NY 10016 USA; [Levy, Efrat] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY USA; [Levy, Efrat] NYU, Inst Neurosci, Langone Med Ctr, New York, NY USA	Atlantic Health System; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Pacheco-Quinto, J; Eckman, EA (corresponding author), Biomed Res Inst New Jersey, 140 East Hanover Ave, Cedar Knolls, NJ 07927 USA.	pacheco-quinto@brinj.org; lizeckman@brinj.org	Perez-Gonzalez, Rocio/GQH-7068-2022; Eckman, Elizabeth/AAL-7316-2021	Perez-Gonzalez, Rocio/0000-0002-0641-2001; Eckman, Elizabeth/0000-0002-5391-4960	Vanech Family Foundation; U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke [NS073512]; NIH National Institute on Aging [AG017617, AG056732, P30 AG19610]; NIH National Institute of Neurological Disorders and Stroke [U2418 NS072026]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056732, P30AG019610, P01AG017617] Funding Source: NIH RePORTER	Vanech Family Foundation; U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Luis Marcelino and Joaquim Vieira (Biomedical Research Institute of New Jersey) for assistance with the mice and the Banner Sun Health Research Institute Brain and Body Donation Program (Sun City, AZ, USA), for the provision of human brain tissue. Research reported in this publication was supported in part by a grant from the Vanech Family Foundation (to J.P.-Q.), by U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke Grant NS073512 (to E.A.E.) and NIH National Institute on Aging Grants AG017617 and AG056732 (to E.L.). The Brain and Body Donation Program was supported by the NIH National Institute of Neurological Disorders and Stroke Grant U2418 NS072026 (National Brain and Tissue Resource for Parkinson's Disease and Related Disorders); the NIH National Institute on Aging Grant P30 AG19610 (Arizona Alzheimer's Disease Core Center); the Arizona Department of Health Services Contract 211002 (Arizona Alzheimer's Research Center); the Arizona Biomedical Research Commission Contracts 4001, 0011, 05-901 and 1001 (Arizona Parkinson's Disease Consortium), and the Michael J. Fox Foundation for Parkinson's Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boland B, 2010, J BIOL CHEM, V285, P37415, DOI 10.1074/jbc.M110.186411; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bur D, 2001, PROTEIN ENG, V14, P337, DOI 10.1093/protein/14.5.337; BURDICK D, 1992, J BIOL CHEM, V267, P546; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cermak S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167428; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Colacurcio DJ, 2018, FREE RADICAL BIO MED, V114, P40, DOI 10.1016/j.freeradbiomed.2017.10.001; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Fahnoe DC, 2000, J CARDIOVASC PHARM, V36, pS22, DOI 10.1097/00005344-200036051-00009; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hafez D, 2011, AM J PATHOL, V178, P306, DOI 10.1016/j.ajpath.2010.11.012; Hanson LR, 2011, J MOL NEUROSCI, V43, P424, DOI 10.1007/s12031-010-9460-8; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Lai A. Y., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/548380; Lanz TA, 2006, J NEUROSCI METH, V157, P71, DOI 10.1016/j.jneumeth.2006.03.023; Levy E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00142; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Muller L, 2003, J BIOL CHEM, V278, P545, DOI 10.1074/jbc.M208949200; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; Novo M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19961-3; Pacheco-Quinto J, 2016, NEUROBIOL AGING, V48, P83, DOI 10.1016/j.neurobiolaging.2016.08.011; Pacheco-Quinto J, 2013, J BIOL CHEM, V288, P5606, DOI 10.1074/jbc.M112.422964; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Perez-Gonzalez R, 2017, METHODS MOL BIOL, V1545, P139, DOI 10.1007/978-1-4939-6728-5_10; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Puzzo D, 2015, NEUROSCIENCE, V307, P26, DOI 10.1016/j.neuroscience.2015.08.039; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shinohara M, 2010, J BIOL CHEM, V285, P22091, DOI 10.1074/jbc.M110.102277; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tien NT, 2016, J BIOL CHEM, V291, P10528, DOI 10.1074/jbc.M116.719286; Valdenaire O, 1999, EUR J BIOCHEM, V264, P341, DOI 10.1046/j.1432-1327.1999.00602.x; Valdenaire O, 1999, J CELL SCI, V112, P3115; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vingtdeux V, 2011, FASEB J, V25, P219, DOI 10.1096/fj.10-167361; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Youmans KL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-8	62	18	18	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3758	3771		10.1096/fj.201801319R	http://dx.doi.org/10.1096/fj.201801319R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30481490	Bronze, Green Published			2022-12-26	WOS:000459794800054
J	Garcia, DM; de Oliveira, FR; Modulo, CM; Faustino, J; Barbosa, AP; Alves, M; Rocha, EM				Garcia, Denny Marcos; de Oliveira, Fabiola Reis; Modulo, Carolina Maria; Faustino, Jacqueline; Barbosa, Amanda Pires; Alves, Monica; Rocha, Eduardo Melani			Is Sjogren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests	PLOS ONE			English	Article							OCULAR SURFACE; SYMPTOMS; CLASSIFICATION; EFFICACY; SIGNS; SUBCOMMITTEE; CYCLOSPORINE; INVOLVEMENT; DEFINITION; HORMONES	Purpose Dry Eye Disease (DED) is part of several conditions, including Sjogren's syndrome (SS) and no single test to diagnosis DED. The present study intends to evaluate whether a set of signs and symptoms of DED can distinguish: a) SS from other non-overlapping systemic diseases related to DED; b) primary and secondary SS. Methods 182 consecutive patients with DED were evaluated under five groups: SS, graft-versus-host disease (GVHD), Graves' orbitopathy (GO), diabetes mellitus (DM), glaucoma under treatment with benzalkonium chloride medications (BAK). Twenty-four healthy subjects were included as control group (CG). The evaluation consisted of Ocular Surface Disease Index (OSDI), Schirmer test (ST), corneal fluorescein staining (CFS) and tear film break up time (TFBUT). Indeed, a subset of DED patients (n = 130), classified as SS1, SS2 and nonSS (NSS) by the American-European Criteria were compared. Quadratic discriminant analysis (QDA) classified the individuals based on variables collected. The area under Receiver Operating Characteristics (ROC) curve evaluated the classification performance in both comparisons. Results Comparing SS with other diseases, QDA showed that the most important variable for classification was OSDI, followed by TFBUT and CFS. Combined, these variables were able to correctly classify 62.6% of subjects in their actual group. At the discretion of the area under the ROC curve, the group with better classification was the control (97.2%), followed by DM (95.5%) and SS (92.5%). DED tests were different among the NSS, SS1 and SS2 groups. The analysis revealed that the combined tests correctly classified 54.6% of the patients in their groups. The area under the ROC curve better classified NSS (79.5%), followed by SS2 (74.4%) and SS1 (69.4%). Conclusions Diseases that causes DED, and also SS1, SS2 and NSS are distinguishable conditions, however a single ocular tools was not able to detect the differences among the respective groups.	[Garcia, Denny Marcos; Modulo, Carolina Maria; Faustino, Jacqueline; Barbosa, Amanda Pires; Rocha, Eduardo Melani] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Ribeirao Preto, SP, Brazil; [Garcia, Denny Marcos] Univ Sao Paulo, Craniofacial Res Support Ctr, Ribeirao Preto, SP, Brazil; [de Oliveira, Fabiola Reis] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Clin Med, Div Rheumatol, Ribeirao Preto, SP, Brazil; [Alves, Monica] Univ Estadual Campinas, Fac Med Sci, Dept Ophthalmol & Otorhinolaryngol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Rocha, EM (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Ribeirao Preto, SP, Brazil.	emrocha@fmrp.usp.br	Alves, Monica/J-1499-2014; Rocha, Eduardo/D-6002-2011	Alves, Monica/0000-0001-7940-0194; Rocha, Eduardo/0000-0001-9888-7313	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/20580-7, 2014/22451-7 2014/23211-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [474450/2012-0]; Research Core of Ocular Physiopathology and Therapeutics from University of Sao Paulo (NAP-FTO) [12.1.25431.01.7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Core of Ocular Physiopathology and Therapeutics from University of Sao Paulo (NAP-FTO); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work received support from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, 2015/20580-7, 2014/22451-7 2014/23211-0; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, 474450/2012-0; Research Core of Ocular Physiopathology and Therapeutics from University of Sao Paulo (NAP-FTO) 12.1.25431.01.7; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, financial code 001.	Alves M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097921; Alves M, 2013, OCUL SURF, V11, P181, DOI 10.1016/j.jtos.2013.02.002; Baffa LD, 2008, ARQ BRAS OFTALMOL, V71, P18, DOI 10.1590/S0004-27492008000100004; Baiza-Duran L, 2010, BRIT J OPHTHALMOL, V94, P1312, DOI 10.1136/bjo.2008.150011; Barabino S, 2014, INVEST OPHTH VIS SCI, V55, P6499, DOI 10.1167/iovs.14-14548; Barabino S, 2014, EUR J OPHTHALMOL, V24, P173, DOI 10.5301/ejo.5000355; Bengtsson AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159384; Bron AJ, 2007, OCUL SURF, V5, P108; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; Delaleu N, 2015, ARTHRITIS RHEUMATOL, V67, P1084, DOI 10.1002/art.39015; Dogru M, 2001, OPHTHALMOLOGY, V108, P586, DOI 10.1016/S0161-6420(00)00599-6; Eckstein AK, 2004, ACTA OPHTHALMOL SCAN, V82, P291, DOI 10.1111/j.1395-3907.2004.00268.x; Essa L, 2018, CONTACT LENS ANTERIO, V41, P60, DOI 10.1016/j.clae.2017.07.007; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; He J, 2013, RHEUMATOLOGY, V52, P1084, DOI 10.1093/rheumatology/kes374; Jee D, 2014, INVEST OPHTH VIS SCI, V55, P5081, DOI 10.1167/iovs.14-14483; Kaido M, 2014, INVEST OPHTH VIS SCI, V55, P3275, DOI 10.1167/iovs.13-13000; Khalid T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143283; Khanal S, 2008, INVEST OPHTH VIS SCI, V49, P1407, DOI 10.1167/iovs.07-0635; Krenzer KL, 1999, INVEST OPHTH VIS SCI, V40, pS2864; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; Labbe A, 2013, INVEST OPHTH VIS SCI, V54, P5144, DOI 10.1167/iovs.13-12370; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Leite SC, 2006, BONE MARROW TRANSPL, V38, P223, DOI 10.1038/sj.bmt.1705426; Lemp Michael A., 1995, CLAO Journal, V21, P221; Lemp MA, 2007, OCUL SURF, V5, P75; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; Marques Davi Lazarini, 2015, Rev. bras.oftalmol., V74, P68, DOI 10.5935/0034-7280.20150016; Massof RW, 2012, INVEST OPHTH VIS SCI, V53, P1905, DOI 10.1167/iovs.11-7768; Mathers William D., 2000, CLAO Journal, V26, P159; McCarty CA, 1998, OPHTHALMOLOGY, V105, P1114, DOI 10.1016/S0161-6420(98)96016-X; Modulo CM, 2009, ENDOCRINE, V36, P161, DOI 10.1007/s12020-009-9208-9; Murube J, 2010, OCUL SURF, V8, P49, DOI 10.1016/S1542-0124(12)70068-X; Nakamura Y, 2000, Nippon Ganka Gakkai Zasshi, V104, P110; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Pan Q, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009327.pub3; Pflugfelder SC, 2011, AM J OPHTHALMOL, V152, P900, DOI 10.1016/j.ajo.2011.08.023; Prigol AM, 2012, ARQ BRAS OFTALMOL, V75, P24, DOI 10.1590/S0004-27492012000100005; RAMOSREMUS C, 1994, CLIN EXP RHEUMATOL, V12, P375; Rocha EM, 2013, CURR OPIN OPHTHALMOL, V24, P348, DOI 10.1097/ICU.0b013e32836227bf; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Stevenson D, 2000, OPHTHALMOLOGY, V107, P967, DOI 10.1016/S0161-6420(00)00035-X; Sullivan B, 2014, OCUL SURF, V12, P2, DOI 10.1016/j.jtos.2013.10.002; Sullivan BD, 2014, ACTA OPHTHALMOL, V92, P161, DOI 10.1111/aos.12012; Sullivan DA, 2017, OCUL SURF, V15, P284, DOI 10.1016/j.jtos.2017.04.001; Tsubota K, 2002, ADV EXP MED BIOL, V506, P3; Villani E, 2010, INVEST OPHTH VIS SCI, V51, P4574, DOI 10.1167/iovs.10-5380; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Zagon IS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1468, DOI 10.1001/archophthalmol.2009.270; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	52	16	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208420	10.1371/journal.pone.0208420	http://dx.doi.org/10.1371/journal.pone.0208420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507949	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500037
J	Mohamed, Y; Durrant, K; Huggett, C; Davis, J; MacIntyre, A; Menu, S; Wilson, JN; Ramosaea, M; Sami, M; Barrington, DJ; McSkimming, D; Natoli, L				Mohamed, Yasmin; Durrant, Kelly; Huggett, Chelsea; Davis, Jessica; MacIntyre, Alison; Menu, Seta; Wilson, Joyce Namba; Ramosaea, Mary; Sami, Michael; Barrington, Dani J.; McSkimming, Donna; Natoli, Lisa			A qualitative exploration of menstruation-related restrictive practices in Fiji, Solomon Islands and Papua New Guinea	PLOS ONE			English	Article								Attitudes and beliefs about menstruation can place restrictions on menstruating women and girls, limiting their ability to fully participate in community life, education and employment. This paper presents evidence on menstruation-related beliefs contributing to restrictive practices in Papua New Guinea (PNG), Solomon Islands (SI) and Fiji. Focus group discussions and interviews were undertaken with 307 adolescent girls, women and men in a rural and urban site in each country. Data were analysed using an inductive thematic approach. Participants described a range of attitudes and beliefs that restrict the behaviour of menstruating women and girls. Themes include the belief that menstrual blood is `dirty'; that when menstruating, girls and women can bring 'bad luck' to men; secrecy and shame associated with menstruation; and beliefs about the impact of certain behaviours on menstruation and health. Restrictive practices were more frequently reported in PNG and SI than Fiji, and more common in rural compared with urban sites. Some restrictions, such as avoidance of household chores, were perceived as desirable or driven by women themselves. However participants identified other restrictions, such as not being able to attend church or hygienically wash menstrual hygiene materials, as unwanted, in some cases impacting on participation in school, work and community life. Education initiatives guided by women and girls, implemented by local stakeholders and grounded in a sound understanding of specific contexts are needed to address discriminatory attitudes and beliefs that contribute to unwanted restrictions, and to support enabling attitudes and beliefs regarding menstruation.	[Mohamed, Yasmin; Durrant, Kelly; Davis, Jessica; Natoli, Lisa] Burnet Inst, Melbourne, Vic, Australia; [Mohamed, Yasmin; Durrant, Kelly; Davis, Jessica] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Huggett, Chelsea; MacIntyre, Alison; Ramosaea, Mary] WaterAid, Melbourne, Vic, Australia; [Menu, Seta] Plan Int, Buka, Autonomous Regi, Papua N Guinea; [Wilson, Joyce Namba] Susu Mamas, Goroka, Eastern Highlan, Papua N Guinea; [Sami, Michael] Sub Reg Off Pacific, Int Planned Parenthood Federat, Suva, Fiji; [Barrington, Dani J.] Univ Leeds, Sch Civil Engn, Leeds, W Yorkshire, England; [McSkimming, Donna] Int Womens Dev Agcy, Melbourne, Vic, Australia	Burnet Institute; Monash University; University of Leeds	Mohamed, Y (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Mohamed, Y (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	yasmin.mohamed@burnet.edu.au	Mohamed, Yasmin/AAH-3916-2020; Barrington, Dani/B-6182-2008	Mohamed, Yasmin/0000-0001-7406-8639; Ramosaea, Mary Elizabeth/0000-0001-9746-6509; Barrington, Dani/0000-0002-1486-9247	Australian Government's Department of Foreign Affairs and Trade through Pacific Women Shaping Pacific Development	Australian Government's Department of Foreign Affairs and Trade through Pacific Women Shaping Pacific Development	This project was funded by the Australian Government's Department of Foreign Affairs and Trade through Pacific Women Shaping Pacific Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R., 2008, MENSTRUAL HYGIENE BR; Anand E, 2015, SEX REPROD HEALTHC, V6, P249, DOI 10.1016/j.srhc.2015.06.001; Bhanderi S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015453; Burnet Institute, 2016, LIT REV LAST TAB RES; Burnet Institute SurveyMETER WaterAid Australia Aliansi Rem aja Independen, 2015, MENSTR HYG MAN IND U; Burrows A, 2005, J REPROD INFANT PSYC, V23, P235, DOI 10.1080/02646830500165846; Caruso B, 2013, WASH SCH FREETOWN; Colombia University Unicef., 2012, WASH SCH EMP GIRLS E; Connolly S, 2013, J WATER SANITATION H, V3; CS WASH Fund, 2016, MENSTR HYG MAN LEARN; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Dhungel S., 2006, KATHMANDU U MED J KU, V5, P382; Emory University Unicef., 2013, WASH SCH EMP GIRLS E; Fiji Bureau of Statistics, 2016, POP REL 2007 CENS PO; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Geertz A., 2016, MENSTRUAL HLTH INDIA; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015334; Hennegan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146985; Her+ Project, 2010, FEM FACT WORK HLTH N; Hoskins J, 2002, ETHNOLOGY, V41, P317, DOI 10.2307/4153011; House S, 2012, MENSTRUAL HYGIENE MA; Ibitoye M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178884; Jayakaran R., 2002, 10 SEED TECHNIQUE; Klasen S, 2009, FEM ECON, V15, P91, DOI 10.1080/13545700902893106; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Mahon T, 2015, MENSTRUAL HYGIENE MA; Mason L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079132; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; OECD, 2012, GEND EQ ED EMPL ENTR; Oster E, 2012, J EUR ECON ASSOC, V10, P1263, DOI 10.1111/j.1542-4774.2012.01090.x; Oster E, 2011, AM ECON J-APPL ECON, V3, P91, DOI 10.1257/app.3.1.91; Patton GC, 2016, LANCET; PNG National Statistics Office, 2011, PAP NEW GUIN 2011 NA; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Satterthwaite M., 2012, JMP WORKING GROUP EQ; Selamawit Tamiru, 2015, Waterlines, V34, P92, DOI 10.3362/1756-3488.2015.009; Solomon Islands Government, 2013, 2009 POP HOUS CENS N; Sommer Marni, 2013, Public Health Rep, V128, P399, DOI 10.1177/003335491312800511; Sommer M, 2010, J ADOLESCENCE, V33, P521, DOI 10.1016/j.adolescence.2009.03.008; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Tamiru S., 2014, SNV NETHERLANDS DEV; Ttofi MM, 2008, VICTIMS OFFENDERS, V3, P289, DOI 10.1080/15564880802143397; UN Women, 2015, EL VIOL WOM AS PAC I; UNDP, HUM DEV REP FIJ 2016; UNICEF, 2013, MENSTR HYG SCH 2 COU; Unicef, 2015, 4 MHM VIRT C 22 23 O; Vallely Andrew, 2012, BMC Res Notes, V5, P613, DOI 10.1186/1756-0500-5-613; Varina Tjon A T, 2007, MILL DEV GOALS, P1; Water Supply & Sanitation Collaborative Council, 2013, CEL WOM BETT MENSTR; WaterAid, 2009, EC GYNAECOL; WHO, 2017, PROGR DRINK WAT SAN; Winkler, TAKING BLOODY LINEN; Women UN, 2015, PROGR WORLD WOM 2015, V2, P71	53	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208224	10.1371/journal.pone.0208224	http://dx.doi.org/10.1371/journal.pone.0208224			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507969	Green Published, gold			2022-12-26	WOS:000451886500030
J	Rau, M; Schmitt, J; Berg, T; Kremer, AE; Stieger, B; Spanaus, K; Bengsch, B; Romero, MR; Marin, JJ; Keitel, V; Klinker, H; Tony, HP; Mullhaupt, B; Geier, A				Rau, Monika; Schmitt, Johannes; Berg, Thomas; Kremer, Andreas E.; Stieger, Bruno; Spanaus, Katharina; Bengsch, Bertram; Romero, Marta R.; Marin, Jose J.; Keitel, Verena; Klinker, Hartwig; Tony, Hans-Peter; Mullhaupt, Beat; Geier, Andreas			Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+T cells in cholestatic HCV patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; IFN-INDUCIBLE PROTEIN-10; BILE-ACID LEVELS; RIBAVIRIN THERAPY; LIVER-DISEASE; ASSOCIATION; CXCL10; PEPTIDASE-4; INHIBITION; EXPRESSION	Background & aims Serum interferon-gamma-inducible protein-10 (IP-10) is elevated in cholestatic liver diseases and predicts response to antiviral therapy in patients with chronic hepatitis C virus (HCV) infection. Dipeptidylpeptidase 4 (DPPIV) cleaves active IP-10 into an inactive form, which inhibits recruitment of CXCR3+ T cells to the liver. In this study the link between IP-10 levels, DPPIV activity in serum and CXCR3+ T cells is analysed in cholestatic and non-cholestatic liver patients. Methods In serum DPPIV activity (by enzymatic assay), IP-10 (by ELISA) and bile acids (BA) (by enzymatic assay) were analysed in 229 naive HCV genotype (GT) 1 patients and in 16 patients with cholestatic liver disease. In a prospective follow-up (FU) cohort of 27 HCV GT 1 patients peripheral CD3+CXCR3+, CD4+CXCR3+ and CD8+CXCR3+ cells were measured by FACS. Results In 229 HCV patients serum IP-10 levels correlated positively to DPP IV serum activity. Higher IP-10 levels and DPPIV activity were detected in cholestatic and in cirrhotic HCV patients. Increased IP-10 serum levels were associated with therapeutic non-response to antiviral treatment with pegylated-interferon and ribavirin. In the HCV FU cohort elevated IP10 serum levels and increased BA were associated with higher frequencies of peripheral CD3+CXCR3+, CD4+CXCR3+ and CD8+CXCR3+ T cells. Positive correlation between serum IP-10 levels and DPPIV activity was likewise validated in patients with cholestatic liver diseases. Conclusions A strong correlation between elevated serum levels of IP-10 and DPPIV activity was seen in different cholestatic patient groups. Furthermore, in cholestatic HCV patients a functional link to increased numbers of peripheral CXCR3+ immune cells could be observed. The source of DPPIV release in cholestatic patients remains open.	[Rau, Monika; Schmitt, Johannes; Geier, Andreas] Univ Hosp Wurzburg, Div Hepatol, Dept Med 2, Wurzburg, Germany; [Berg, Thomas] Univ Hosp Leipzig, Div Hepatol, Dept Gastroenterol & Rheumatol, Leipzig, Germany; [Kremer, Andreas E.] Friedrich Alexander Univ Erlangen Nuremberg, Dept Med 1, Erlangen, Germany; [Stieger, Bruno] Univ Hosp Zurich, Div Clin Pharmacol & Toxicol, Zurich, Switzerland; [Spanaus, Katharina] Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland; [Bengsch, Bertram] Univ Med Ctr Freiburg, Dept Med Gastroenterol Hepatol Endocrinol & Infec, Freiburg, Germany; [Bengsch, Bertram] BIOSS Ctr Biol Signaling Studies, Freiburg, Germany; [Romero, Marta R.; Marin, Jose J.] Univ Salamanca, Lab Expt Hepatol & Drug Targeting, CIBERehd, IBSAL, Salamanca, Spain; [Keitel, Verena] Heinrich Heine Univ, Med Fac, Univ Hosp Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Klinker, Hartwig] Univ Hosp Wurzburg, Div Infect Dis, Dept Med 2, Wurzburg, Germany; [Tony, Hans-Peter] Univ Hosp Wurzburg, Div Rheumatol, Dept Med 2, Wurzburg, Germany; [Mullhaupt, Beat] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland	University of Wurzburg; Leipzig University; University of Erlangen Nuremberg; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Freiburg; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Salamanca; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Wurzburg; University of Wurzburg; University of Zurich; University Zurich Hospital	Geier, A (corresponding author), Univ Hosp Wurzburg, Div Hepatol, Dept Med 2, Wurzburg, Germany.	geier_a2@ukw.de	Romero, Marta Rodriguez/B-1596-2017; Stieger, Bruno/U-6323-2017; Bengsch, Bertram/ABF-2142-2020; Klinker, Hartwig/AAC-1134-2021; Keitel, Verena/AAH-9016-2021; Keitel, Verena/AAF-3471-2019; Marin, Jose/D-5017-2011; Rau, Monika/O-3212-2015; Mullhaupt, Beat/O-3744-2016	Romero, Marta Rodriguez/0000-0001-6729-0215; Stieger, Bruno/0000-0002-7190-5785; Bengsch, Bertram/0000-0003-2552-740X; Keitel, Verena/0000-0003-1383-7662; Marin, Jose/0000-0003-1186-6849; Rau, Monika/0000-0003-1219-4044; Mullhaupt, Beat/0000-0002-9020-8192	Carlos III Institute of Health, Spain - European Regional Development Fund -ERDF- [FIS PI15/00179, PI16/00598]; Ministry of Science and Innovation, Spain [SAF2013-40620-R, SAF2016-75197-R, AGL2014-58883-R, BFU2014-57736-P]; "Junta de Castilla y Leon", Spain [SA015U13, SA063P17]; Asociacion Espanola Contra el Cancer, Spain; Fundacion Samuel Solorzano Barruso, Spain [FS/10-2014, FS/13-2017]; "Fundacion Mutua Madrilena", Spain; German Research Foundation (DFG); University of Wuerzburg	Carlos III Institute of Health, Spain - European Regional Development Fund -ERDF-; Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Junta de Castilla y Leon", Spain(Junta de Castilla y Leon); Asociacion Espanola Contra el Cancer, Spain; Fundacion Samuel Solorzano Barruso, Spain; "Fundacion Mutua Madrilena", Spain; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was supported in part by the Carlos III Institute of Health, Spain (Grants FIS PI15/00179 and PI16/00598 co-financed by European Regional Development Fund -ERDF-); Ministry of Science and Innovation, Spain (SAF2013-40620-R, SAF2016-75197-R, AGL2014-58883-R, BFU2014-57736-P); "Junta de Castilla y Leon", Spain (SA015U13 and SA063P17); "Asociacion Espanola Contra el Cancer (AECC-2017), Spain; "Fundacion Samuel Solorzano Barruso (FS/10-2014 and FS/13-2017), Spain; and "Fundacion Mutua Madrilena", Spain (Call 2015). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Andrieu T, 2003, J CLIN VIROL, V27, P59, DOI 10.1016/S1386-6532(02)00128-2; Azer SA, 1996, J GASTROEN HEPATOL, V11, P208, DOI 10.1111/j.1440-1746.1996.tb00064.x; Bengsch B, 2012, J IMMUNOL, V188, P5438, DOI 10.4049/jimmunol.1103801; Blauenfeldt T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01456; Carlin AF, 2015, HEPATOLOGY, V62, P1047, DOI 10.1002/hep.27971; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; Decalf J, 2016, EMBO MOL MED, V8, P679, DOI 10.15252/emmm.201506145; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Firneisz G, 2012, TRANSL RES, V160, P95, DOI 10.1016/j.trsl.2012.01.016; Itou M, 2013, WORLD J GASTROENTERO, V19, P2298, DOI 10.3748/wjg.v19.i15.2298; Iwata R, 2011, J VIRAL HEPATITIS, V18, P768, DOI 10.1111/j.1365-2893.2010.01363.x; Iwata R, 2011, CLIN SCI, V120, P287, DOI 10.1042/CS20100246; Jorquera F, 2005, J GASTROEN HEPATOL, V20, P547, DOI 10.1111/j.1440-1746.2005.03725.x; Kobayashi H, 1999, J PEDIATR SURG, V34, P308, DOI 10.1016/S0022-3468(99)90197-5; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; Lebovics E, 1997, DIGEST DIS SCI, V42, P1094, DOI 10.1023/A:1018865809556; Li M, 2017, MOL ASPECTS MED, V56, P45, DOI 10.1016/j.mam.2017.06.001; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Meissner EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133236; Narumi S, 1997, J IMMUNOL, V158, P5536; Nishioji K, 2001, CLIN EXP IMMUNOL, V123, P271, DOI 10.1046/j.1365-2249.2001.01391.x; Perner F, 1999, J LAB CLIN MED, V134, P56, DOI 10.1016/S0022-2143(99)90054-9; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Ragab D, 2013, CYTOKINE, V63, P105, DOI 10.1016/j.cyto.2013.04.016; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Shlomai A, 2013, J VIRAL HEPATITIS, V20, P95, DOI 10.1111/j.1365-2893.2012.01628.x; Stauber RE, 2017, WIEN KLIN WOCHENSCHR, V129, P848, DOI 10.1007/s00508-017-1268-x; Wang YD, 2014, ANTIVIR RES, V103, P51, DOI 10.1016/j.antiviral.2014.01.001; Wood AM, 2018, OBSTET GYNECOL SURV, V73, P103, DOI 10.1097/OGX.0000000000000524	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208225	10.1371/journal.pone.0208225	http://dx.doi.org/10.1371/journal.pone.0208225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507970	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000451886500031
J	Ibanez-Erquiaga, B; Pacheco, AS; Rivadeneira, MM; Tejada, CL				Ibanez-Erquiaga, Bruno; Pacheco, Aldo S.; Rivadeneira, Marcelo M.; Tejada, Claudia L.			Biogeographical zonation of rocky intertidal communities along the coast of Peru (3.5-13.5 degrees S Southeast Pacific)	PLOS ONE			English	Article							BETA DIVERSITY; CLIMATE-CHANGE; CURRENT SYSTEM; MARINE; PATTERNS; FISH; CLASSIFICATION; GRADIENTS; FAUNA; PRODUCTIVITY	The biogeography of the Peruvian Eastern Pacific coast has been described based on oceanographic parameters and qualitative species occurrence data. This has generated disagreement about the limits and existence of different biogeographic units. In this study, the distribution of rocky-shore macrobenthic communities were recorded over 41 sites along the Peruvian coastline (3.5 degrees S-13.5 degrees S) and analyzed together with historic abiotic data in order to quantitatively evaluate the biogeographic zonation of rocky intertidal communities throughout the region and its relationship with environmental variables to propose an update bioregionalization. Clusters and non-metric multidimensional scaling were performed using Bray-Curtis dissimilarity matrices from abundance data to evaluate biogeographic patterns of dissimilarities of rocky-shore communities. Significant turnover of taxa among defined biogeographical units was tested using permutational multivariate dispersion. Relationships between of the biogeographical community's structure and environmental factors were examined using Random Forest analysis on datasets available at Bio-Oracle and Jet Propulsion Laboratory-California Institute of Technology. Variation of community structure of 239 taxa depicted three biogeographical units along the region matching Panamic, transitional and Humboldt provinces. Beta diversity analysis indicated a significant turnover of taxa within the transitional unit. Random forest analysis showed a strong correlation between biogeographic units with phosphate, sea surface temperature, nitrate, dissolved oxygen, cloud fraction, and silicates. Our results set the putative limits of three biogeographic units for rocky-shore communities along the coast of Peru, providing base-line information for understanding further biogeographic changes on communities associated with the ongoing regional coastal cooling and impacts of El Nino events.	[Ibanez-Erquiaga, Bruno; Tejada, Claudia L.] Univ Peruana Cayetano Heredia, Lab Ciencias Mar, Lima, Peru; [Ibanez-Erquiaga, Bruno; Tejada, Claudia L.] Asociac CONSERVACC, Lima, Peru; [Pacheco, Aldo S.] Univ Antofagasta, CENSOR Lab, Inst Ciencias Nat Alexander von Humboldt, Antofagasta, Chile; [Rivadeneira, Marcelo M.] Ctr Estudios Avanzados Zonas Aridas, Lab Paleobiol, Coquimbo, Chile; [Rivadeneira, Marcelo M.] Univ Catolica Norte, Fac Ciencias Biol, Dept Biol Marina, Coquimbo, Chile; [Rivadeneira, Marcelo M.] Univ La Serena, Dept Biol, La Serena, Chile	Universidad Peruana Cayetano Heredia; Universidad de Antofagasta; Universidad Catolica del Norte; Universidad de La Serena	Ibanez-Erquiaga, B (corresponding author), Univ Peruana Cayetano Heredia, Lab Ciencias Mar, Lima, Peru.; Ibanez-Erquiaga, B (corresponding author), Asociac CONSERVACC, Lima, Peru.	bruno.ibanez@upch.pe	Pacheco, Aldo S/L-9939-2017	Pacheco, Aldo S/0000-0002-2767-6436; Rivadeneira, Marcelo/0000-0002-1681-416X; Ibanez-Erquiaga, Bruno/0000-0002-9954-5953	Concejo Nacional de Ciencias y Tecnologia (CONCYTEC)-Peru	Concejo Nacional de Ciencias y Tecnologia (CONCYTEC)-Peru	This work was funded by Concejo Nacional de Ciencias y Tecnologia (CONCYTEC)-Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057918; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson RJ, 2012, AFR J MAR SCI, V34, P1, DOI 10.2989/1814232X.2012.673267; Arntz W. E., 2006, ADV GEOSCI, V6, P243, DOI DOI 10.5194/ADGE0-6-243-2006; Ashton T, 2008, HELGOLAND MAR RES, V62, pS107, DOI 10.1007/s10152-007-0084-5; Baker MR, 2014, DEEP-SEA RES PT II, V109, P215, DOI 10.1016/j.dsr2.2014.03.001; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bakun A, 2008, PROG OCEANOGR, V79, P290, DOI 10.1016/j.pocean.2008.10.027; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bernard FR, 1991, DISTRIBUTION ZOOGEOG, V112; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Boschi EE, 2000, J CRUSTACEAN BIOL, V20, P337, DOI 10.1163/1937240X-90000036; Boschi Enrique E., 2000, Revista de Investigacion y Desarrollo Pesquero, V13, P7; BRATTSTROM H, 1983, SARSIA, V68, P289, DOI 10.1080/00364827.1983.10420583; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRIGGS J C, 1974, P475; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY, V14; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brochier T, 2013, GLOBAL CHANGE BIOL, V19, P1841, DOI 10.1111/gcb.12184; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Burdett H, 2011, PALAEOGEOGR PALAEOCL, V302, P65, DOI 10.1016/j.palaeo.2010.07.027; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Bustamante RH, 1996, J EXP MAR BIOL ECOL, V196, P1, DOI 10.1016/0022-0981(95)00093-3; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Chaigneau A, 2013, J GEOPHYS RES-OCEANS, V118, P5251, DOI 10.1002/jgrc.20328; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chhak K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030203; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Clarke K. R., 2015, PRIMER V7 USER MANUA, P296; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Costello MJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01121-2; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dall WH, 1909, AM NAT, V43, P532, DOI 10.1086/279084; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Day J. H., 1967, MONOGRAPH POLYCHAETA, V2; Espinosa-Perez MD, 2006, BELG J ZOOL, V136, P219; Dolbeth M, 2003, MAR BIOL, V143, P1229, DOI 10.1007/s00227-003-1133-5; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Arellano CE, 2010, FISH RES, V101, P133, DOI 10.1016/j.fishres.2009.08.007; Fahrbach E, 1991, PINNIPEDS EL NINO, P8; Fenberg PB, 2015, ECOGRAPHY, V38, P83, DOI 10.1111/ecog.00880; Fontana G, 2008, J EXP MAR BIOL ECOL, V366, P104, DOI 10.1016/j.jembe.2008.07.014; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; Graco Michelle I, 2007, Rev. peru biol., V14, P117; Gutierrez D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046324; Hale SS, 2010, ESTUAR COAST, V33, P1039, DOI 10.1007/s12237-010-9332-z; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hattab T, 2015, J BIOGEOGR, V42, P1336, DOI 10.1111/jbi.12505; HAYDEN BP, 1984, ENVIRON CONSERV, V11, P199, DOI 10.1017/S0376892900014211; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hooker Y, 2011, REV AREAS MAR PROT 1, P3; Hooker Yuri, 2013, P277; Humboldt A, 1805, ESSAI GEOGRAPHIE PLA, DOI DOI 10.5962/BHL.TITLE.9309; Madariaga DJ, 2014, BIOL INVASIONS, V16, P2507, DOI 10.1007/s10530-014-0680-7; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Lathlean JA, 2015, J BIOGEOGR, V42, P1538, DOI 10.1111/jbi.12511; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Martino EJ, 2003, ESTUAR COAST SHELF S, V56, P969, DOI 10.1016/S0272-7714(02)00305-0; Meneses I, 2000, REV CHIL HIST NAT, V73, P615; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Naimi B, 2013, R PACKAGE VERSION, V1, P1; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; O'Hara TD, 2000, J BIOGEOGR, V27, P1321, DOI 10.1046/j.1365-2699.2000.00499.x; Pacheco A, 2005, ECOL APL, V4, P149, DOI 10.21704/rea.v4i1-2.310; Paredes C., 1998, REV PERUANA BIOL, DOI [10.15381/rpb.v5i2.8330, DOI 10.15381/RPB.V5I2.8330]; Paredes Carlos, 2004, Rev. peru biol., V11, P213; Paredes Q. C., 1974, Revista peru Biol, V1, P168; PINCKNEY JL, 1993, J PHYCOL, V29, P396, DOI 10.1111/j.1529-8817.1993.tb00140.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez R, 2003, REV BIOL TROP, V51, P225; Rice J, 2011, OCEAN COAST MANAGE, V54, P110, DOI 10.1016/j.ocecoaman.2010.10.010; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Sanford E, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P131; Schiel DR, 2011, J EXP MAR BIOL ECOL, V400, P33, DOI 10.1016/j.jembe.2011.02.026; Schoch GC, 2006, LIMNOL OCEANOGR, V51, P2564, DOI 10.4319/lo.2006.51.6.2564; Schrodl M, 2014, SPIXIANA, V37, P45; Shears NT, 2008, CONSERV BIOL, V22, P467, DOI 10.1111/j.1523-1739.2008.00882.x; Sherman K, 2005, MAR ECOL PROG SER, V300, P275; Sielfeld W, 2010, REV BIOL MAR OCEANOG, V45, P705, DOI 10.4067/S0718-19572010000400014; Sink KJ, 2005, AFR J MAR SCI, V27, P81, DOI 10.2989/18142320509504070; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sullivan Sealey K., 1999, SETTING GEOGRAPHIC P; Tarazona Juan, 2003, Gayana (Concepc.), V67, P206; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Uribe RA, 2013, SPIXIANA, V36, P43; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Vegas-Velez M., 1980, Boletim do Instituto Oceanografico, V29, P371; Wikramanayake E, 2002, CONSERV BIOL, V16, P238, DOI 10.1046/j.1523-1739.2002.01403.x; Hooker M. Yuri, 2009, Rev. peru biol., V16, P33; Zacharias MA, 2001, J BIOGEOGR, V28, P471, DOI 10.1046/j.1365-2699.2001.00559.x	102	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208244	10.1371/journal.pone.0208244	http://dx.doi.org/10.1371/journal.pone.0208244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500855	Green Published, gold, Green Submitted			2022-12-26	WOS:000451883700030
J	Watanabe, K; Kato, J; Zhu, JF; Oda, H; Ishiwata-Endo, H; Moss, J				Watanabe, Kizuku; Kato, Jiro; Zhu, Jianfeng; Oda, Hirotake; Ishiwata-Endo, Hiroko; Moss, Joel			Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice	PLOS ONE			English	Article							ADENYLATE-CYCLASE; RISK-FACTORS; GENDER BIAS; RIBOSYLATION; ACTIVATION; PROTEIN; FAMILY; RIBOSYLTRANSFERASES; INFECTIONS; MECHANISMS	Cholera toxin, an 84-kDa multimeric protein and a major virulence factor of Vibrio cholerae, uses the ADP-ribosyltransferase activity of its A subunit to intoxicate host cells. ADP-ribosylation is a posttranslational modification of proteins, in which the ADP-ribose moiety of NAD(+) is transferred to an acceptor. In mammalian cells, ADP-ribosylation of acceptors appears to be reversible. ADP-ribosyltransferases (ARTs) catalyze the modification of acceptor proteins, and ADP-ribose-acceptor hydrolases (ARHs) cleave the ADP-ribose-acceptor bond. ARH1 specifically cleaves the ADP-ribose-arginine bond. We previously demonstrated a role for endogenous ARH1 in regulating the extent of cholera toxin-mediated fluid and electrolyte abnormalities in a mouse model of intoxication. Murine ARH1-knockout (KO) cells and ARH1-KO mice exhibited increased sensitivity to cholera toxin compared to their wildtype (WT) counterparts. In the current report, we examined the sensitivity to cholera toxin of male and female ARH1-KO and WT mice. Intestinal loops derived from female ARH1-KO mice when injected with cholera toxin showed increased fluid accumulation compared to male ARH1-KO mice. WT mice did not show gender differences in fluid accumulation, ADPribosylarginine content, and ADP-ribosyl Gas levels. Injection of 8-Bromo-cAMP into the intestinal loops also increased fluid accumulation, however, there was no significant difference between female and male mice or in WT and KO mice. Female ARH1-KO mice showed greater amounts of ADP-ribosylated Gas protein and increased ADP-ribosylarginine content both in whole intestine and in epithelial cells than did male ARH1-KO mice. These results demonstrate that female ARH1-KO mice are more sensitive to cholera toxin than male mice. Loss of ARH1 confers gender sensitivity to the effects of cholera toxin but not of cyclic AMP. These observations may in part explain the finding noted in some clinical reports of enhanced symptoms of cholera and/or diarrhea in women than men.	[Watanabe, Kizuku; Kato, Jiro; Zhu, Jianfeng; Oda, Hirotake; Ishiwata-Endo, Hiroko; Moss, Joel] NHLBI, Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Zhu, Jianfeng] Siemens Healthcare Diagnost Inc, Newark, DE USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Siemens AG	Moss, J (corresponding author), NHLBI, Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	mossj@nhlbi.nih.gov	Oda, Hirotake/AAW-4269-2021		Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute.; This study was supported by the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute.	Ali M, 2011, J INFECT DIS, V204, P912, DOI 10.1093/infdis/jir416; Balasuriya GK, 2016, J PHYSIOL-LONDON, V594, P4325, DOI 10.1113/JP272071; Barbara G, 2004, ALIMENT PHARM THER, V20, P1, DOI 10.1111/j.1365-2036.2004.02036.x; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Bwire G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005407; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; Clemens JD, 2017, LANCET, V390, P1539, DOI 10.1016/S0140-6736(17)30559-7; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Corda Daniela, 2002, Sci STKE, V2002, ppe53, DOI 10.1126/stke.2002.163.pe53; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Cummings MJ, 2012, EPIDEMIOL INFECT, V140, P1376, DOI 10.1017/S0950268811001956; Davenport ER, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0454-7; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Diebel ME, 2011, J TRAUMA, V71, P474, DOI 10.1097/TA.0b013e318228239d; Elderman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184274; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; FAUVEAU V, 1991, INT J EPIDEMIOL, V20, P729, DOI 10.1093/ije/20.3.729; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; FINKELSTEIN RA, 1973, CRC CRIT R MICROBIOL, V2, P553; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; FISHMAN PH, 1982, J CELL BIOL, V93, P860, DOI 10.1083/jcb.93.3.860; FISHMAN PH, 1990, ADP RIBOSYLATING TOX, P127; GIANNELLA RA, 1973, ANN INTERN MED, V78, P271, DOI 10.7326/0003-4819-78-2-271; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; GILL DM, 1976, BIOCHEMISTRY-US, V15, P1242, DOI 10.1021/bi00651a011; GLASS RI, 1983, J INFECT DIS, V148, P998, DOI 10.1093/infdis/148.6.998; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Goodman WA, 2014, MUCOSAL IMMUNOL, V7, P1255, DOI 10.1038/mi.2014.15; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; HOLMGREN J, 1981, NATURE, V292, P413, DOI 10.1038/292413a0; HONJO T, 1968, J BIOL CHEM, V243, P3553; JACOBSON MK, 1984, METHOD ENZYMOL, V106, P483; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kato J, 2007, MOL CELL BIOL, V27, P5534, DOI 10.1128/MCB.00302-07; Kim D, 2016, NAT MED, V22, P524, DOI 10.1038/nm.4075; Krishnan A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-555; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; Luscher B, 2018, CHEM REV, V118, P216, DOI 10.1021/acs.chemrev.7b00122; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mashimo M, 2014, DNA REPAIR, V23, P88, DOI 10.1016/j.dnarep.2014.03.005; Matias WR, 2017, AM J TROP MED HYG, V97, P436, DOI 10.4269/ajtmh.16-0407; Mitra AK, 2000, J HEALTH POPUL NUTR, V18, P151; MOSS J, 1986, BIOCHEMISTRY-US, V25, P5408, DOI 10.1021/bi00367a010; MOSS J, 1983, J BIOL CHEM, V258, P1879; Moss J, 1997, ADV EXP MED BIOL, V419, P25; MOSS J, 1992, J BIOL CHEM, V267, P10481; MOSS J, 1979, ANNU REV BIOCHEM, V48, P581, DOI 10.1146/annurev.bi.48.070179.003053; MOSS J, 1985, P NATL ACAD SCI USA, V82, P5603, DOI 10.1073/pnas.82.17.5603; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nelson EJ, 2007, P NATL ACAD SCI USA, V104, P19091, DOI 10.1073/pnas.0706352104; Okazaki IJ, 1999, ANNU REV NUTR, V19, P485, DOI 10.1146/annurev.nutr.19.1.485; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Okazaki IJ, 1996, REV PHYSIOL BIOCH P, V129, P51; PUNYASHTHITI K, 1971, INFECT IMMUN, V4, P473, DOI 10.1128/IAI.4.4.473-478.1971; Schaetti C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-206; Sevilimedu V, 2016, T ROY SOC TROP MED H, V110, P637, DOI 10.1093/trstmh/trw080; Tornheim JA, 2010, INT J INFECT DIS, V14, pE499, DOI 10.1016/j.ijid.2009.07.021; World Health Organization, 2007, ADDR SEX GEND EP INF; World Health Organization, 2016, WKLY EPIDEMIOL REC, V38, P433; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352	62	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207693	10.1371/journal.pone.0207693	http://dx.doi.org/10.1371/journal.pone.0207693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500844	Green Published, Green Submitted, gold			2022-12-26	WOS:000451883700013
J	Battenfield, SD; Sheridan, JL; Silva, LDCE; Miclaus, KJ; Dreisigacker, S; Wolfinger, RD; Pena, RJ; Singh, RP; Jackson, EW; Fritz, AK; Guzman, C; Poland, JA				Battenfield, Sarah D.; Sheridan, Jaime L.; Silva, Luciano D. C. E.; Miclaus, Kelci J.; Dreisigacker, Susanne; Wolfinger, Russell D.; Pena, Roberto J.; Singh, Ravi P.; Jackson, Eric W.; Fritz, Allan K.; Guzman, Carlos; Poland, Jesse A.			Breeding-assisted genomics: Applying meta-GWAS for milling and baking quality in CIMMYT wheat breeding program	PLOS ONE			English	Article							BREAD-MAKING QUALITY; ASSOCIATION ANALYSIS; CORE COLLECTION; GENE; DISCOVERY; GERMPLASM; PROTEIN	One of the biggest challenges for genetic studies on natural or unstructured populations is the unbalanced datasets where individuals are measured at different times and environments. This problem is also common in crop and animal breeding where many individuals are only evaluated for a single year and large but unbalanced datasets can be generated over multiple years. Many wheat breeding programs have focused on increasing bread wheat (Triticum aestivum L.) yield, but processing and end-use quality are critical components when considering its use in feeding the rising population of the next century. The challenges with end-use quality trait improvements are high cost and seed amounts for testing, the latter making selection in early breeding populations impossible. Here we describe a novel approach to identify marker-trait associations within a breeding program using a meta-genome wide association study (GWAS), which combines GWAS analysis from multi-year unbalanced breeding nurseries, in a manner reflecting meta-GWAS in humans. This method facilitated mapping of processing and end-use quality phenotypes from advanced breeding lines (n = 4,095) of the CIMMYT bread wheat breeding program from 2009 to 2014. Using the meta-GWAS we identified marker-trait associations, allele effects, candidate genes, and can select using markers generated in this process. Finally, the scope of this approach can be broadly applied in 'breeding-assisted genomics' across many crops to greatly increase our functional understanding of plant genomes.	[Battenfield, Sarah D.] Agri Pro Wheat, Syngenta, Junction City, KS USA; [Sheridan, Jaime L.] Gen Mills, Crop Biosci Div, Manhattan, KS USA; [Silva, Luciano D. C. E.; Miclaus, Kelci J.; Wolfinger, Russell D.] SAS Inst Inc, JMP Genom Div, Cary, NC USA; [Dreisigacker, Susanne; Pena, Roberto J.; Singh, Ravi P.; Guzman, Carlos] Int Maize & Wheat Improvement Ctr, Mexico City, DF, Mexico; [Jackson, Eric W.] 25 2 Solut, Rockford, MN USA; [Fritz, Allan K.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Poland, Jesse A.] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA	Syngenta; SAS Institute Inc; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Kansas State University; Kansas State University	Guzman, C (corresponding author), Int Maize & Wheat Improvement Ctr, Mexico City, DF, Mexico.; Poland, JA (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.	C.Guzman@CGIAR.org; jpoland@ksu.edu	Guzman, Carlos/J-9987-2014; Da Costa E Silva, Luciano/F-9217-2011	Guzman, Carlos/0000-0002-1797-9273; 	United States Agency for International Development (USAID) [AID-OAA-A-13-00051]; National Science Foundation [1339389]; Monsanto Beachell-Borlaug International Scholars program	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); National Science Foundation(National Science Foundation (NSF)); Monsanto Beachell-Borlaug International Scholars program	This work was supported by the United States Agency for International Development (USAID) through a specific cooperative agreement AID-OAA-A-13-00051 and the National Science Foundation under Grant No. (1339389). SB was supported through the Monsanto Beachell-Borlaug International Scholars program. General Mills Inc. and SAS Institute Inc. provided support in the form of salaries for authors JLS, EWJ, LDCES, KJM and RDW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the United States Agency for International Development (USAID) through a specific cooperative agreement AID-OAA-A-13-00051 and the National Science Foundation under Grant No. (1339389). SB was supported through the Monsanto Beachell-Borlaug International Scholars program. General Mills Inc. and SAS Institute Inc. provided support in the form of salaries for authors JLS, EWJ, LDCES, KJM and RDW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or the U.S. Agency for International Development.	Acuna-Galindo MA, 2015, CROP SCI, V55, P477, DOI 10.2135/cropsci2013.11.0793; Battenfield SD, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.01.0005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bordes J, 2011, J CEREAL SCI, V54, P137, DOI 10.1016/j.jcs.2011.03.004; BORGHI B, 1995, EUR J AGRON, V4, P37, DOI 10.1016/S1161-0301(14)80015-4; Braun HJ, 1996, EUPHYTICA, V92, P175, DOI 10.1007/BF00022843; Bushuk W., 1997, Wheat: prospects for global improvement. Proceedings of the 5th International Wheat Conference, Ankara, Turkey, 10-14 June 1996., P203; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chapman JA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0582-8; Committee AAoCCAM, 2000, APPR METH AM ASS CER; Cormier F, 2015, AGRONOMY-BASEL, V5, P143, DOI 10.3390/agronomy5020143; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Furtado A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10446; Garg M, 2006, J PLANT NUTR, V29, P1357, DOI 10.1080/01904160600830134; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Guzman C, 2016, EUPHYTICA, V209, P689, DOI 10.1007/s10681-016-1659-5; Guzman C, 2015, J CEREAL SCI, V66, P59, DOI 10.1016/j.jcs.2015.10.009; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lantican M, 2015, IMPACTS INT WHEAT IM; Loffler M, 2009, MOL BREEDING, V23, P473, DOI 10.1007/s11032-008-9250-y; Swamy BPM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-319; Martin JM, 2001, CROP SCI, V41, P228, DOI 10.2135/cropsci2001.411228x; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Pena R, 2002, WHEAT BREAD OTHER FO, P483; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Rutkoski JE, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.02.0006; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Simmonds J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0191-9; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; WRIGLEY CW, 1982, AUST J PLANT PHYSIOL, V9, P15, DOI 10.1071/PP9820015; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	40	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0204757	10.1371/journal.pone.0204757	http://dx.doi.org/10.1371/journal.pone.0204757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496187	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800011
J	Tateyama, Y; Techasrivichien, T; Musumari, PM; Suguimoto, SP; Zulu, R; Macwan'gi, M; Dube, C; Ono-Kihara, M; Kihara, M				Tateyama, Yukiko; Techasrivichien, Teeranee; Musumari, Patou Masika; Suguimoto, S. Pilar; Zulu, Richard; Macwan'gi, Mubiana; Dube, Christopher; Ono-Kihara, Masako; Kihara, Masahiro			Obesity matters but is not perceived: A cross-sectional study on cardiovascular disease risk factors among a population-based probability sample in rural Zambia	PLOS ONE			English	Article							BODY-WEIGHT; OVERWEIGHT; ADULTS; HEALTH; PREVALENCE; AFRICA; PERCEPTIONS; COUNTRIES; ATTITUDES; BEAUTIFUL	Background Sub-Saharan Africa, including Zambia, has experienced an increase in overweight and obesity due to rapid lifestyle changes associated with recent economic growth. We explored the prevalence and correlates of overweight and obesity in rural Zambia. We also investigated the role of self-perception of body weight in weight control given the local socio-cultural context. Methods In this cross-sectional study, we recruited 690 residents of the Mumbwa district aged 25-64 years through a multistage, clustered, household random sampling. We administered a questionnaire and collected anthropometric and bio-behavioral data from May to July 2016. Factors associated with body mass index (BMI). 25 kg/m(2) and underestimation of body weight were assessed using multiple logistic regression. Results Of the weighted sample of 689 participants (335 men and 354 women), 185 (26.8%) had BMI >= 25 kg/m(2). In multivariate analyses, female gender, age 45-64 years, tertiary education, higher fruit and vegetable intake, high blood pressure, abnormal blood lipid profile, and Hemoglobin A1c >= 5.7% were significantly associated with BMI >= 25 kg/m(2). Among participants with BMI >= 25 kg/m(2), 14.2% and 58.2% perceived themselves as being underweight and normal weight, respectively. Age 45-64 years was the only factor significantly associated with body weight underestimation. Preference for obesity was reported by 17.5% and 3.6% of respondents with BMI < 25 kg/m(2) and BMI >= 25 kg/m(2), respectively; "looks attractive" and "fear of being perceived as HIV-positive" were the main reasons. Conclusion In rural Zambia, overweight and obesity are prevalent and significantly associated with alterations in blood pressure, blood lipid profile, and glucose metabolism. However, most subjects with BMI >= 25 kg/m(2) underestimated their body weight; some preferred obesity, in part due to cultural factors and HIV-related stigma. A health promotion program that addresses such perceptions and body weight underestimation should be urgently introduced in Zambia.	[Tateyama, Yukiko; Techasrivichien, Teeranee; Musumari, Patou Masika; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Suguimoto, S. Pilar] Kyoto Univ, Med Educ Ctr, Grad Sch Med, Kyoto, Japan; [Zulu, Richard; Macwan'gi, Mubiana] Univ Zambia, Inst Econ & Social Res, Lusaka, Zambia; [Dube, Christopher] Ndola Dist Hlth Off, Ndola, Zambia	Kyoto University; Kyoto University; University of Zambia	Tateyama, Y (corresponding author), Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Global Hlth & Socioepidemiol, Kyoto, Japan.	tateyama.yukiko.57c@st.kyoto-u.ac.jp	TATEYAMA, Yukiko/HCH-1160-2022	TATEYAMA, Yukiko/0000-0002-4649-8428; Suguimoto, S. Pilar/0000-0002-8447-9172; Macwan'gi, Mubiana/0000-0001-7739-9863	United Nations University, Institute for the Advanced Study of Sustainability (Global Leadership Training Programme in Africa); Inter-Graduate School Program for Sustainable Development and Survivable Societies, Kyoto University; 2016 Kyoto University School of Public Health Super Global Course's travel scholarship	United Nations University, Institute for the Advanced Study of Sustainability (Global Leadership Training Programme in Africa); Inter-Graduate School Program for Sustainable Development and Survivable Societies, Kyoto University; 2016 Kyoto University School of Public Health Super Global Course's travel scholarship	This work received support from the following: United Nations University, Institute for the Advanced Study of Sustainability (Global Leadership Training Programme in Africa), Award Number: None vertical bar Recipient: Yukiko Tateyama; Inter-Graduate School Program for Sustainable Development and Survivable Societies, Kyoto University Award Number: None vertical bar Recipient: Yukiko Tateyama; 2016 Kyoto University School of Public Health Super Global Course's travel scholarship, Award Number: None vertical bar Recipient: Yukiko Tateyama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Adeboye B, 2012, CARDIOVASC J AFR, V23, P512, DOI 10.5830/CVJA-2012-040; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Akindele Mukadas Oyeniran, 2017, JMIR Public Health Surveill, V3, pe56, DOI 10.2196/publichealth.7047; Amugsi DA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017344; Appiah CA, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.239.7883; Awah PK, 2008, HEALTH EDUC RES, V23, P612, DOI 10.1093/her/cym037; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Besa C, 2013, J HYPERTENS, V2; Bhanji S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-363; Bove R, 2009, SOC SCI MED, V68, P21, DOI 10.1016/j.socscimed.2008.09.045; Caleyachetty R, 2016, OBES RES CLIN PRACT, V10, P216, DOI 10.1016/j.orcp.2016.02.006; Central Statistical Office (CSO) [Zambia] Ministry of Health (MOH) [Zambia] and ICF International, ZAMB DEM HLTH SURV 2; Central Statistical Office Zambia, 2012, 2010 CENS POP HOUS, V11; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Clair C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-23; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Demaio A. R., 2011, BMC Public Health, V11; Faber M, 2005, ETHNIC DIS, V15, P238; Fezeu L, 2010, INT J OBESITY, V34, P446, DOI 10.1038/ijo.2009.256; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; Jayawardena R, 2014, OBES RES CLIN PRACT, V8, pE192, DOI 10.1016/j.orcp.2013.05.003; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Kim TJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019862; Kivimaki M, 2017, LANCET PUBLIC HEALTH, V2, pE277, DOI 10.1016/S2468-2667(17)30074-9; Kruger HS, 2005, PUBLIC HEALTH NUTR, V8, P491, DOI 10.1079/PHN2005785; Letamo G, 2011, J BIOSOC SCI, V43, P75, DOI 10.1017/S0021932010000519; Lopez-Arana S, 2013, OBES REV, V14, P806, DOI 10.1111/obr.12051; Macia E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161544; Mbanya JC, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0501-5; Min JW, 2018, OBES REV, V19, P49, DOI 10.1111/obr.12605; Ministry of Health (Zambia) World Health Organization, ZAMB LUS STEPS NONC; Morton LW, 2008, AGR HUM VALUES, V25, P107, DOI 10.1007/s10460-007-9095-8; Mulenga D, 2013, RURAL REMOTE HEALTH, V13; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; Otang-Mbeng W, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0098-9; Pasquet P, 2003, ANN HUM BIOL, V30, P551, DOI 10.1080/0301446032000112652; PERKINS KA, 1992, J APPL PHYSIOL, V72, P401, DOI 10.1152/jappl.1992.72.2.401; Pisa PT, 2017, EUR J PUBLIC HEALTH, V27, P404, DOI 10.1093/eurpub/ckw119; Prentice AM, 2009, NESTLE NUTR WORKSHOP, V63; Prentice AM, 2009, NESTLE NUTR WORKSHOP, V63; Prentice AM, 2009, NESTLE NUTR WORKS SE, V63, P33, DOI 10.1159/000209971; Puoane T, 2005, S AFR J CLIN NUTR, V18, P6; Puoane T, 2005, SAMJ S AFR MED J, V95, P228; Renzaho AMN, 2004, HEALTH PLACE, V10, P105, DOI 10.1016/S1353-8292(03)00051-0; Roberts C, 2007, OBESITY, V15, P3045, DOI 10.1038/oby.2007.363; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Rudatsikira Emmanuel, 2012, Int Arch Med, V5, P14, DOI 10.1186/1755-7682-5-14; Sartorius B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130218; Scott A, 2013, HEALTH PROMOT INT, V28, P4, DOI 10.1093/heapro/das038; Thorpe RJ, 2004, RES AGING, V26, P108, DOI 10.1177/0164027503258738; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2017, WHO STEPS SURV MAN; WHO, 2000, WOM MENT HLTH EV BAS; World Health Organization, 2018, OBESITY OVERWEIGHT F; World Health Organization, ZAMB STEPS SURV 2017; Yu Y, 2012, OBESITY, V20, P904, DOI 10.1038/oby.2011.307; Zyaambo C, 2012, DETERMINANTS OVERWEI	61	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208176	10.1371/journal.pone.0208176	http://dx.doi.org/10.1371/journal.pone.0208176			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4HL	30496252	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800103
J	Bendel, EM; Kammerer, CF; Kardjilov, N; Fernandez, V; Frobisch, J				Bendel, Eva-Maria; Kammerer, Christian F.; Kardjilov, Nikolay; Fernandez, Vincent; Froebisch, Joerg			Cranial anatomy of the gorgonopsian Cynariops robustus based on CT-reconstruction	PLOS ONE			English	Article							TOOTH REPLACEMENT; PATTERNS; THERAPSIDA; REPTILES; SUTURES; FUSION	Gorgonopsia is one of the major clades of non-mammalian synapsids, and includes an array of large-bodied carnivores that were the top terrestrial predators of the late Permian. Most research on the clade has focused on these largest members; small-bodied gorgonopsians are relatively little-studied. Here, we redescribe a small gorgonopsian skull (MB.R.999) from the late Permian (Tropidostoma Assemblage Zone) of South Africa on the basis of neutron and synchrotron CT reconstructions, which yield new data on internal cranial morphology in Gorgonopsia. Because of the largely undistorted nature of MB.R.999, we were also able to reconstruct unossified areas such as the brain endocast and the otic labyrinth. MB.R.999 can be referred to the taxon Cynariops robustus based on its general skull proportions, postcanine tooth count, preparietal morphology, and vomerine morphology. We refer additional small gorgonopsian specimens from the Victoria West area to Cynariops robustus, and consider Cynarioides grimbeeki and Cynarioides laticeps to be synonymous with C. robustus. Inclusion of Cynariops in a phylogenetic analysis of Gorgonopsia recovers it within a large clade of African taxa, more closely related to Lycaenops and rubidgeines than Eriphostoma or Gorgonops.	[Bendel, Eva-Maria; Kammerer, Christian F.; Froebisch, Joerg] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat, Berlin, Germany; [Kammerer, Christian F.] North Carolina Museum Nat Sci, Raleigh, NC USA; [Kammerer, Christian F.; Froebisch, Joerg] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Kammerer, Christian F.; Froebisch, Joerg] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa; [Kardjilov, Nikolay] Helmholtz Zentrum Berlin, Inst Appl Mat, Berlin, Germany; [Fernandez, Vincent] Nat Hist Museum, Imaging & Anal Ctr, London, England; [Fernandez, Vincent] European Synchrotron Radiat Facil, Grenoble, France; [Froebisch, Joerg] Humboldt Univ, Inst Biol, Berlin, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Witwatersrand; University of Witwatersrand; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Natural History Museum London; European Synchrotron Radiation Facility (ESRF); Humboldt University of Berlin	Bendel, EM (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat, Berlin, Germany.	eva-maria.bendel@mfn.berlin	Kardjilov, Nikolay/AAX-9855-2021	Kardjilov, Nikolay/0000-0002-0980-1440; Fernandez, Vincent/0000-0002-8315-1458; Bendel, Eva-Maria/0000-0002-5150-6445	Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [KA4133/1-1]; Museum fur Naturkunde; SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 Integrating Activities Programme; Leibniz Association	Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Museum fur Naturkunde; SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 Integrating Activities Programme; Leibniz Association	Research by EMB, CFK, and JF was supported by a Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation to JF. CFK was further supported by a grant from the Deutsche Forschungsgemeinschaft (KA4133/1-1) and by the Museum fur Naturkunde. This research received support from the SYNTHESYS Project (http://www.synthesys.info/) which is financed by European Community Research Infrastructure Action under the FP7 Integrating Activities Programme. The publication of this article was funded by the Open Access Fund of the Leibniz Association.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ARAUJO R, 2017, PEERJ, V5, DOI DOI 10.7717/PEERJ.3119; Araujo R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189883; Bailleul AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147687; Balolia KL, 2015, AM J PHYS ANTHROPOL, V156, P135, DOI 10.1002/ajpa.22633; Bendel E-M, 2017, VERTEBRATE ANATOMY M, V4, P10; Benoit J, 2017, BONY LABYRINTH LATE, V52, P58; BOONSTRA LIEUWE D., 1934, ANN S AFRICAN MUS, V31, P175; BROOM R., 1935, ANN TRANSVAAL MUS, V18, P55; Broom R, 1910, B AM MUS NAT HIST, V28, P197; BROOM R., 1935, ANN TRANSVAAL MUS, V18, P1; Broom R, 1911, P ZOOL SOC LOND, V1911, P1073; Broom R., 1925, Records of the Albany Museum, V3, P309; Broom R., 1913, B AM MUS NAT HIST, V32, P557; Castanhinha R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080974; Colbert EH, 1948, B AMNH, V89; Crompton AW, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1269116; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; Day MO, 2018, 20 BIENN C PAL SOC S; Edmund AG., 1960, TOOTH REPLACEMENT PH, DOI [10.5962/bhl.title.52196, DOI 10.5962/BHL.TITLE.52196]; Gebauer EV., 2007, THESIS; Gebauer EVI, 2014, VERTEBR PALEOBIOL PA, P185, DOI 10.1007/978-94-007-6841-3_12; HILLENIUS WJ, 1994, EVOLUTION, V48, P207, DOI 10.1111/j.1558-5646.1994.tb01308.x; Hillenius WJ, 2000, J MORPHOL, V245, P29, DOI 10.1002/1097-4687(200007)245:1<29::AID-JMOR3>3.0.CO;2-B; Hopson J. A., 1986, ECOLOGY BIOL MAMMAL, P83; HOPSON JAMES A., 1964, PROC ZOOL SOC LONDON, V142, P625; Hoson Osamu, 2009, Aquatic Mammals, V35, P72, DOI 10.1578/AM.35.1.2009.72; Ivakhnenko M.F., 2005, Paleontological Journal, V39, pS393; Ivakhnenko MF, 2003, PALEONTOL J+, V37, pS339; Janensch W., 1952, Palaeontologische Zeitschrift, V26, P229; Kammerer CF, 2017, PAPERS PALAEONTOLOGY, P1; Kammerer CF, 2018, PEERJ, V6, DOI 10.7717/peerj.4954; Kammerer CF, 2016, PEERJ, V4, DOI 10.7717/peerj.1608; Kammerer CF, 2015, PAP PALAEONTOL, V1, P201, DOI 10.1002/spp2.1012; Kammerer CF, 2015, PAP PALAEONTOL, V1, P41, DOI 10.1002/spp2.1002; Kammerer CF, 2014, VERTEBR PALEOBIOL PA, P171, DOI 10.1007/978-94-007-6841-3_11; Kardjilov N, 2011, NUCL INSTRUM METH A, V651, P95, DOI 10.1016/j.nima.2011.02.084; KEMP TS, 1969, PHILOS T ROY SOC B, V256, P1, DOI 10.1098/rstb.1969.0036; KERMACK KA, 1956, PHILOS T ROY SOC B, V240, P95, DOI 10.1098/rstb.1956.0013; Kitching J.W., 1977, Memoirs Bernard Price Inst palaeont Res, VNo. 1, P1; Laass M, 2016, ACTA PALAEONTOL POL, V61, P267, DOI 10.4202/app.00140.2014; Laass M, 2015, J MORPHOL, V276, P1089, DOI 10.1002/jmor.20397; Laurin M, 1998, J VERTEBR PALEONTOL, V18, P765, DOI 10.1080/02724634.1998.10011105; Lyckegaard A, 2008, MAT SYSTEMS, V97; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Maisano JA, 2002, J VERTEBR PALEONTOL, V22, P268, DOI 10.1671/0272-4634(2002)022[0268:TFOSEA]2.0.CO;2; Mirone A, 2014, NUCL INSTRUM METH B, V324, P41, DOI 10.1016/j.nimb.2013.09.030; O'Leary MA, 2016, B AM MUS NAT HIST, P3; Olson EC, 1944, ORIGIN MAMMALS BASED; OSBORN JW, 1970, NATURE, V225, P343, DOI 10.1038/225343a0; Owen R., 1881, Q J GEOL SOC LOND, V37, P261; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; PARRINGTON F. R., 1955, PROC ZOOL SOC LONDON, V125, P1; Pravoslavlev PA, 1927, GORGONOPSIDAE N DVIN, P3; Romer A, 1956, OSTEOLOGY REPTILES; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; SIGOGNEAU D, 1974, Annals of the South African Museum, V64, P53; Sigogneau D., 1970, REVISION SYSTEMATIQU; Sigogneau-Russell D., 1989, PHTHINOSUCHIA BIARMO; Vlassenbroeck J, 2006, ADVANC XRAY TOMOGRAP, P167; von Huene FF, 1938, PALAEONTOL Z, V19, P297, DOI DOI 10.1007/BF03042247; Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P469, DOI 10.1002/ajpa.20481; WESTERGAARD B, 1987, J ZOOL, V212, P191, DOI 10.1111/j.1469-7998.1987.tb05984.x; Whitlock JA, 2013, INT J ORAL SCI, V5, P66, DOI 10.1038/ijos.2013.36	64	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207367	10.1371/journal.pone.0207367	http://dx.doi.org/10.1371/journal.pone.0207367			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485338	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800062
J	Galan, A; Horvatic, A; Kules, J; Bilic, P; Gotic, J; Mrljak, V				Galan, Asier; Horvatic, Anita; Kules, Josipa; Bilic, Petra; Gotic, Jelena; Mrljak, Vladimir			LC-MS/MS analysis of the dog serum phosphoproteome reveals novel and conserved phosphorylation sites: Phosphoprotein patterns in babesiosis caused by Babesia canis, a case study	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; ACUTE-PHASE PROTEINS; FETUIN-A; FIBRINOPEPTIDE; CHROMATOGRAPHY; PARAMETERS; BIOMARKERS; DIAGNOSIS; DISEASES	Phosphorylation is the most commonly studied protein post-translational modification (PTM) in biological systems due to its importance in controlling cell division, survival, growth, etc. Despite the thorough research in phosphoproteomics of cells and tissues there is little information on circulating phosphoproteins. We compared serum from 10 healthy dogs and 10 dogs affected by B. canis-caused babesiosis with no organ dysfunctions by employing gel-free LC-MS/MS analysis of individual samples and tandem mass tag (TMT) label-based quantitative analyses of pools, both supported by phosphopeptide enrichment. Results showed a moderate number of phosphorylated proteins (50-55), with 89 phosphorylation sites not previously published for dogs although a number of them matched phosphorylation sites found in mammalian orthologs. Three phosphopeptides showed significant variation in babesiosis-affected dog sera compared to controls: Serum amyloid A (SAA) phosphorylated at serine 101 (up-regulation), kininogen 1 phosphorylated at threonine 326, and fibrinogen a phosphorylated at both threonine 20 and serine 22 (down-regulation). 71.9% of the detected phosphorylated sites were phosphoserine, 16.8% phosphothreonine and only 11.2% phosphotyrosine residues. TMT label-based quantitative analysis showed alpha-2-HS-glycoprotein / Fetuin A to be the most abundant phosphoprotein (50-70% of all phosphoproteins) followed by kininogen-1 (10-20%). The alterations of phosphorylated proteins observed in canine babesiosis caused by Babesia canis suggest new insights into the largely neglected role of extracellular protein phosphorylation in health and disease, encouraging urgent further research on this area. To the best of our knowledge the present study represents the first attempt to characterize canine serum phosphoproteome.	[Galan, Asier; Horvatic, Anita; Kules, Josipa; Bilic, Petra; Mrljak, Vladimir] Univ Zagreb, Fac Vet Med, Clin Internal dis, ERA Chair VetMedZg, Heinzelova 55, Zagreb, Croatia; [Gotic, Jelena; Mrljak, Vladimir] Univ Zagreb, Fac Vet Med, Clin Internal Dis, Heinzelova 55, Zagreb, Croatia	University of Zagreb; University of Zagreb	Mrljak, V (corresponding author), Univ Zagreb, Fac Vet Med, Clin Internal dis, ERA Chair VetMedZg, Heinzelova 55, Zagreb, Croatia.; Mrljak, V (corresponding author), Univ Zagreb, Fac Vet Med, Clin Internal Dis, Heinzelova 55, Zagreb, Croatia.	vmrljak@vef.hr	Horvatic, Anita/M-8933-2019	Horvatic, Anita/0000-0001-9625-1450; Galan, Asier/0000-0002-1883-2476; Mrljak, Vladimir/0000-0002-0723-7815; Kules, Josipa/0000-0002-4945-4690	Cordis [621394]; Croatian Science Foundation [4135]; European Structural and Investment Funds [KK.01.1.1.06.0004]	Cordis; Croatian Science Foundation; European Structural and Investment Funds	This study was funded by Cordis grant number 621394, https://cordis.europa.eu/; Croatian Science Foundation grant number 4135, http://www.hrzz.hr/default.aspx?ID=47; and European Structural and Investment Funds grant number KK.01.1.1.06.0004, https://strukturnifondovi.hr/. All were granted to Vladimir Mrljak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; [Anonymous], [No title captured]; Araya JE, 2008, MICROBES INFECT, V10, P892, DOI 10.1016/j.micinf.2008.05.003; Bahl JMC, 2008, ANAL CHEM, V80, P6308, DOI 10.1021/ac800835y; Beck R, 2009, INT J PARASITOL, V39, P843, DOI 10.1016/j.ijpara.2008.12.005; BEG ZH, 1989, J BIOL CHEM, V264, P6913; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chahrour O, 2015, J PHARMACEUT BIOMED, V113, P2, DOI 10.1016/j.jpba.2015.04.013; Chavakis T, 2002, J BIOL CHEM, V277, P23157, DOI 10.1074/jbc.M202529200; Cheng LC, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-017-0138-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Della Corte A, 2008, PLATELETS, V19, P43, DOI 10.1080/09537100701609035; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Eichenberger RM, 2016, J VET INTERN MED, V30, P174, DOI 10.1111/jvim.13822; Ferries S, 2017, J PROTEOME RES, V16, P3448, DOI 10.1021/acs.jproteome.7b00337; Ficarro SB, 2009, ANAL CHEM, V81, P4566, DOI 10.1021/ac9004452; Fila J, 2012, AMINO ACIDS, V43, P1025, DOI 10.1007/s00726-011-1111-z; Finizio AL, 2011, VET PARASITOL, V176, P132, DOI 10.1016/j.vetpar.2010.11.005; Galan A, 2018, PLOS ONE, V13; Geberhiwot T, 1997, BIOCHEM MOL BIOL INT, V41, P269; Giorgianni F, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4040037; Goddard A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150113; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Hanamura K, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002457; Hansson K, 2005, J THROMB HAEMOST, V3, P2633, DOI 10.1111/j.1538-7836.2005.01478.x; Hathout Y, 2015, P NATL ACAD SCI USA, V112, P7153, DOI 10.1073/pnas.1507719112; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang GH, 2015, MINI-REV ORG CHEM, V12, P468, DOI 10.2174/1570193X13666151218191044; Humphrey SJ, 2015, TRENDS ENDOCRIN MET, V26, P676, DOI 10.1016/j.tem.2015.09.013; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Jaros JAJ, 2012, J PROTEOMICS, V76, P43, DOI 10.1016/j.jprot.2012.05.027; Ji L, 2012, METHODS MOL BIOL, V818, P199, DOI 10.1007/978-1-61779-418-6_14; Ju HX, 2017, ENDOCRINE, V58, P190, DOI 10.1007/s12020-017-1383-5; Kang UB, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600092; Kettner F, 2003, J S AFR VET ASSOC, V74, P63; Klement E, 2017, MOL CELL PROTEOMICS, V16, P1, DOI 10.1074/mcp.O116.064188; Kules J, 2017, BMC VET RES, V13; Kules J, 2014, BMC VET RES, V10, DOI [10.1186/1746-6148-10-10, DOI 10.1186/1746-6148-10-10]; Kules J, 2017, VECTOR-BORNE ZOONOT, V17, P285, DOI 10.1089/vbz.2016.2074; Kumar S, 2016, ACTA NEUROPATHOL, V131, P525, DOI 10.1007/s00401-016-1546-0; Lee HJ, 2009, PROTEOMICS, V9, P3395, DOI 10.1002/pmic.200800943; Liebenberg C, 2013, J VET INTERN MED, V27, P150, DOI 10.1111/jvim.12016; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Maejima H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101773; Martinez-Subiela S, 2003, AM J VET RES, V64, P1021, DOI 10.2460/ajvr.2003.64.1021; Matijatko V, 2007, VET PARASITOL, V144, P242, DOI 10.1016/j.vetpar.2006.10.004; Matjila PT, 2009, J CLIN MICROBIOL, V47, P3586, DOI 10.1128/JCM.01110-08; Maurer MC, 1998, BIOCHEMISTRY-US, V37, P5888, DOI 10.1021/bi972538w; Montoya A, 2011, METHODS, V54, P370, DOI 10.1016/j.ymeth.2011.02.004; Mylonakis ME, 2011, J VET INTERN MED, V25, P811, DOI 10.1111/j.1939-1676.2011.0728.x; NEL AE, 1988, BIOCHEM J, V255, P29, DOI 10.1042/bj2550029; Nel M, 2004, J VET INTERN MED, V18, P471, DOI 10.1892/0891-6640(2004)18&lt;471:PVOBLB&gt;2.0.CO;2; Pappa E, 2017, WORLD J ORTHOP, V8, P461, DOI 10.5312/wjo.v8.i6.461; Patel P, 2016, STRUCTURE, V24, P1380, DOI 10.1016/j.str.2016.06.009; PURVIS D, 1994, VET CLIN N AM-SMALL, V24, P1225, DOI 10.1016/S0195-5616(94)50136-0; RAND MD, 1994, BLOOD, V83, P2180; Ray S, 2014, PROTEOM CLIN APPL, V8, P53, DOI 10.1002/prca.201300074; Rothe H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172407; Sacerdoti-Sierra N, 1997, J BIOL CHEM, V272, P30760, DOI 10.1074/jbc.272.49.30760; Salih E, 2010, ANAL BIOCHEM, V407, P19, DOI 10.1016/j.ab.2010.07.012; Salvi M, 2010, J PROTEOME RES, V9, P3335, DOI 10.1021/pr100058r; SEYDEWITZ HH, 1985, THROMB RES, V40, P29, DOI 10.1016/0049-3848(85)90347-0; SMITH EB, 1995, EUR HEART J, V16, P11, DOI 10.1093/eurheartj/16.suppl_A.11; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1957, DOI 10.1093/ndt/gfr609; Sreelatha A, 2015, BBA-PROTEINS PROTEOM, V1854, P1687, DOI 10.1016/j.bbapap.2015.03.015; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Takano S, 2010, BRIT J CANCER, V103, P223, DOI 10.1038/sj.bjc.6605734; Tao WA, 2017, FASEB J, V31; Trost B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152809; Ullah S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23534; Wang H, 2012, CURR MOL MED, V12, P625, DOI 10.2174/156652412800620039; Welzl C, 2001, J S AFR VET ASSOC, V72, P158; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]; Yalak G, 2014, J TRANSL MED, V12, DOI [10.1186/1479-5876-12-12, DOI 10.1186/1479-5876-12-12]; Yalak G, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0482-4; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R; Zawadzka AM, 2014, MOL CELL PROTEOMICS, V13, P1034, DOI 10.1074/mcp.M113.035485; Zhao MD, 2015, PROTEIN PEPTIDE LETT, V22, P795, DOI 10.2174/0929866522666150625111319; Zhou WD, 2009, J PROTEOME RES, V8, P5523, DOI 10.1021/pr900603n	79	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207245	10.1371/journal.pone.0207245	http://dx.doi.org/10.1371/journal.pone.0207245			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485286	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800052
J	Salybekov, AA; Kawaguchi, AT; Masuda, H; Vorateera, K; Okada, C; Asahara, T				Salybekov, Amankeldi A.; Kawaguchi, Akira T.; Masuda, Haruchika; Vorateera, Kosit; Okada, Chisa; Asahara, Takayuki			Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PERIPHERAL-BLOOD; MONONUCLEAR-CELLS; STEM-CELLS; INTRACORONARY INFUSION; CARDIAC-FUNCTION; BONE-MARROW; G-CSF; HEART; TRANSPLANTATION	Background Considering the impaired function of regenerative cells in myocardial infarction (MI) patients with comorbidities and associated risk factors, cell therapy to enhance the regenerative microenvironment was designed using regeneration-associated cells (RACs), including endothelial progenitor cells (EPCs) and anti-inflammatory cells. Methods RACs were prepared by quality and quantity control culture of blood mononuclear cells (QQMNCs). Peripheral blood mononuclear cells (PBMNCs) were isolated from Lewis rats and conditioned for 5 days using a medium containing stem cell factors, thrombopoietin, Flt-3 ligand, vascular endothelial growth factor, and interleukin-6 to generate QQMNCs. Results A 5.3-fold increase in the definitive colony-forming EPCs and vasculogenic EPCs was observed, in comparison to naive PBMNCs. QQMNCs were enriched with EPCs (28.9-fold, P<0.0019) and M2 macrophages (160.3-fold, P<0.0002). Genes involved in angiogenesis (angpt1, angpt2, and vegfb), stem/progenitors (c-kit and sca-1), and anti-inflammation (arg1, erg-2, tgfb, and foxp3) were upregulated in QQMNCs. For in vivo experiments, cells were administered into syngeneic rat models of MI. QQMNC-transplanted group (QQ-Tx) preserved cardiac function and fraction shortening 28 days post-MI in comparison with PBMNCs-transplanted (PB-Tx) (P<0.0001) and Control (P<0.0008) groups. QQ-Tx showed enhanced angiogenesis and reduced interstitial left ventricular fibrosis, along with a decrease in neutrophils and an increase in M2 macrophages in the acute phase of MI. Cell tracing studies revealed that intravenously administered QQMNCs preferentially homed to ischemic tissues via blood circulation. QQ-Tx showed markedly upregulated early cardiac transcriptional cofactors (Nkx2-5, 29.8-fold, and Gata-4, 5.2-fold) as well as c-kit (4.5-fold) while these markers were downregulated in PB-Tx. In QQ-Tx animals, de novo blood vessels formed a "Biological Bypass", observed macroscopically and microscopically, while PB-Tx and Control-Tx groups showed severe fibrotic adhesion to the surrounding tissues, but no epicardial blood vessels. Conclusion QQMNCs conferred potent angiogenic and anti-inflammatory properties to the regenerative microenvironment, enhancing myocardiogenesis and functional recovery of rat MI hearts.	[Salybekov, Amankeldi A.; Kawaguchi, Akira T.; Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan; [Masuda, Haruchika] Tokai Univ, Dept Physiol, Sch Med, Isehara, Kanagawa, Japan; [Vorateera, Kosit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Surg, Bangkok Noi, Thailand; [Okada, Chisa] Tokai Univ, Teaching & Res Support Core Ctr, Sch Med, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Mahidol University; Tokai University	Asahara, T (corresponding author), Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan.	asa777@is.icc.u-tokai.ac.jp	Salybekov, Amankeldi A./M-1130-2013	Salybekov, Amankeldi A./0000-0001-5490-9365	International Scholarship of the First President of Kazakhstan for studying in abroad "BOLASHAK"; AMED Japan Regenerative Medicine Project [15BK0104012H003]; KAKENHI [16H0000]	International Scholarship of the First President of Kazakhstan for studying in abroad "BOLASHAK"; AMED Japan Regenerative Medicine Project; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the International Scholarship of the First President of Kazakhstan for studying in abroad "BOLASHAK" Amankeldi A. Salybekov, and AMED Japan Regenerative Medicine Project (15BK0104012H003) to Takayuki Asahara, and KAKENHI (16H0000) was granted to Akira T. Kawaguchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET, V390, P1083, DOI 10.1016/S0140-6736(17)32465-0; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Barile L, 2014, CARDIOVASC RES, V103, P530, DOI 10.1093/cvr/cvu167; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cousin C, 2015, EUR J IMMUNOL, V45, P1772, DOI 10.1002/eji.201445000; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Czarna A, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0032-1; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fadini GP, 2015, DIABETES, V64, P2969, DOI 10.2337/db15-0077; Feng QP, 2001, CIRCULATION, V104, P700, DOI 10.1161/hc3201.092284; Gu XA, 2011, CIRC J, V75, P955, DOI 10.1253/circj.CJ-10-0898; Haywood GA, 1996, CIRCULATION, V93, P1087, DOI 10.1161/01.CIR.93.6.1087; Hill JM, 2005, J AM COLL CARDIOL, V46, P1643, DOI 10.1016/j.jacc.2005.01.067; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Landers-Ramos RQ, 2015, AM J PHYSIOL-HEART C, V309, pH407, DOI 10.1152/ajpheart.00123.2015; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Li GH, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0847-3; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Masuda H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000743; Masuda H, 2012, STEM CELL TRANSL MED, V1, P160, DOI 10.5966/sctm.2011-0023; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Mathiyalagan P, 2017, CIRC RES, V120, P1466, DOI 10.1161/CIRCRESAHA.116.310557; Meng X, 2016, NAT REV CARDIOL, V13, P167, DOI 10.1038/nrcardio.2015.169; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ohtake T, 2018, CELL TRANSPLANT, V27, P520, DOI 10.1177/0963689717753186; Oliveras A, 2008, J HUM HYPERTENS, V22, P183, DOI 10.1038/sj.jhh.1002304; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Ren B, 2010, J CLIN INVEST, V120, P1217, DOI 10.1172/JCI39837; Renko O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19417-8; Serpi R, 2011, CARDIOVASC RES, V89, P204, DOI 10.1093/cvr/cvq267; Swirski FK, 2013, J AM COLL CARDIOL, V62, P1902, DOI 10.1016/j.jacc.2013.07.058; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tanaka R, 2018, STEM CELL TRANSL MED, V7, P428, DOI 10.1002/sctm.17-0043; Tatsumi T, 2007, CIRC J, V71, P1199, DOI 10.1253/circj.71.1199; Tembhre MK, 2013, CLIN CHIM ACTA, V424, P27, DOI 10.1016/j.cca.2013.05.005; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Tillmanns J, 2008, P NATL ACAD SCI USA, V105, P1668, DOI 10.1073/pnas.0706315105; Tobler K, 2010, INT J OBESITY, V34, P687, DOI 10.1038/ijo.2009.280; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Wu BJ, 2015, INT J CARDIOL, V199, P204, DOI 10.1016/j.ijcard.2015.07.014; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023	56	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0203244	10.1371/journal.pone.0203244	http://dx.doi.org/10.1371/journal.pone.0203244			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485279	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800006
J	Nguyen, T; Vissoci, JRN; Joelson, T; Pesambili, M; Haglund, M; Gerardo, CJ; Mvungl, M; Staton, CA				TuanDat Nguyen; Vissoci, Joao Ricardo Nickenig; Joelson, Treasure; Pesambili, Msafiri; Haglund, Michael; Gerardo, Charles J.; Mvungl, Mark; Staton, Catherine A.			Injury prevalence and safety habits of boda boda drivers in Moshi, Tanzania: A mixed methods study	PLOS ONE			English	Article							ROAD-TRAFFIC INJURIES; TAXI DRIVERS; EPIDEMIOLOGY; PERCEPTION; CRASHES; HAZARD	Background Traffic crashes are a major cause of global morbidity and mortality disproportionately affecting low-and middle-income countries (LMICs). Motorcycle taxi (boda boda) drivers are particularly vulnerable because they are exposed to traffic risks with limited safety equipment. This study aims to characterize injury prevalence and safety habits among boda boda drivers, as well as ways to improve road traffic safety in LMICs. Methods A cross-sectional mixed methods study was conducted with 300 boda boda drivers between 24 March and 3 April 2014 in urban Moshi, Tanzania. A convenience sample of participants was drawn from 25 of 58 registered boda boda stands and 2 of 31 unregistered stands. Data were analyzed using R, and content thematic analysis was performed and agreed upon by three investigators. Logistic regression models were used to evaluate the association between boda boda characteristics and injury risk. Results In total, 300 drivers participated, of whom 148 (49.3%) had experienced a crash during their lifetime, and 114 (77.0%) sustained at least one injury. Only 27 of those injured (23.4%) were hospitalized. Of all participants, 220 (73.3%) reported consistent helmet usage, despite 285 participants (95.0%) agreeing that helmet usage reduces injury severity. From the 280 helmets observed, 231 (82.5%) were either damaged or fit improperly. Having a cracked helmet was associated with higher risk of being involved in a traffic crash. Owning a helmet with a proper fit was associated with reduced risk for a traffic crash (OR = 0.06) and road traffic injuries (OR = 0.07). A thematic analysis of boda boda drivers' suggestions to increase road safety identified four intervention areas: 1) roadway infrastructure and traffic regulation, 2) road user attitudes and safe driving behaviors, 3) education and training, and 4) law enforcement. Conclusion Our study demonstrates boda boda drivers' safety behaviors and identifies four intervention areas that can be leveraged to increase overall road traffic safety. Unfortunately, while boda boda drivers are aware of ways to improve safety, adherence to safety habits remains low. Successful multi- sectoral interventions are needed to improve road safety for boda boda drivers in Tanzania.	[TuanDat Nguyen; Vissoci, Joao Ricardo Nickenig; Haglund, Michael; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Vissoci, Joao Ricardo Nickenig; Gerardo, Charles J.; Staton, Catherine A.] Duke Univ, Div Emergency Med, Dept Surg, Sch Med, Durham, NC 27708 USA; [Vissoci, Joao Ricardo Nickenig; Haglund, Michael; Staton, Catherine A.] Duke Univ, Div Global Neurosurg & Neurosci, Dept Neurosurg, Med Ctr, Durham, NC 27708 USA; [Joelson, Treasure; Pesambili, Msafiri; Mvungl, Mark] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre	Vissoci, JRN (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Vissoci, JRN (corresponding author), Duke Univ, Div Emergency Med, Dept Surg, Sch Med, Durham, NC 27708 USA.; Vissoci, JRN (corresponding author), Duke Univ, Div Global Neurosurg & Neurosci, Dept Neurosurg, Med Ctr, Durham, NC 27708 USA.	jnv4@duke.edu		Staton, Catherine/0000-0002-6468-2894	HRSA [T84HA21123-02]; Fogarty International Center (Staton) [K01 TW010000-01A1]; FOGARTY INTERNATIONAL CENTER [K01TW010000] Funding Source: NIH RePORTER	HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Fogarty International Center (Staton); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was made possible by the Mentored Research Training Program in collaboration with the HRSA-funded KCMC MEPI grant #T84HA21123-02; U.S. National Institutes of Health and the Duke Division of Emergency Medicine. Dr. Staton would like to acknowledge salary support funding from the Fogarty International Center (Staton, K01 TW010000-01A1).	Adejugbagbe AM, 2015, AFR HEALTH SCI, V15, P480, DOI 10.4314/ahs.v15i2.22; Aldhafeeri E, 2018, INJURY, V49, P939, DOI 10.1016/j.injury.2018.01.030; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; [Anonymous], 2003, INT Q COMMUN HLTH ED, DOI [DOI 10.2190/KQPM-RJ52-4UY6-9L1Y, DOI 10.2190/]; Bambach MR, 2013, TRAFFIC INJ PREV, V14, P756, DOI 10.1080/15389588.2012.752077; Bener Abdulbari, 2005, Int J Inj Contr Saf Promot, V12, P45, DOI 10.1080/1745730051233142225; Casey ER, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-28; Chalya Phillipo L, 2010, Tanzan J Health Res, V12, P214; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; De Craen S, 2011, ACCIDENT ANAL PREV, V43, P1660, DOI 10.1016/j.aap.2011.03.024; Deery HA, 1999, J SAFETY RES, V30, P225, DOI 10.1016/S0022-4375(99)00018-3; Dischinger Patricia C, 2006, Annu Proc Assoc Adv Automot Med, V50, P237; Du HJ, 2015, TRAFFIC INJ PREV, V16, P468, DOI 10.1080/15389588.2014.971155; Falco A, 2013, J SAFETY RES, V46, P47, DOI 10.1016/j.jsr.2013.03.002; Feury Karen Jean, 2003, Orthop Nurs, V22, P124, DOI 10.1097/00006416-200303000-00010; Foong R, 2017, IEEE ENG MED BIO, P2482, DOI 10.1109/EMBC.2017.8037360; Forman JL, 2012, ACCIDENT ANAL PREV, V49, P229, DOI 10.1016/j.aap.2011.02.020; Freeman P, 2015, ACCIDENT ANAL PREV, V82, P1, DOI 10.1016/j.aap.2015.05.008; Galukande M., 2009, E CENT AFR J SURG, V14; Goldenhar LM, 2003, WORK STRESS, V17, P218, DOI 10.1080/02678370310001616144; Hingson R, 2003, ALCOHOL RES HEALTH, V27, P63; Hosking SG, 2010, ACCIDENT ANAL PREV, V42, P196, DOI 10.1016/j.aap.2009.07.023; Kircher K, 2013, TRAFFIC INJ PREV, V14, P103, DOI 10.1080/15389588.2012.671982; Kiunsi RB., 2013, J SUSTAINABLE DEV, V6, P94, DOI [DOI 10.5539/JSD.V6N2P94, 10.5539/jsd.v6n2p94.]; Liu CC, 2009, TRANSPORT RES F-TRAF, V12, P325, DOI 10.1016/j.trf.2009.04.003; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; Mitra S, 2014, SAFETY SCI, V70, P246, DOI 10.1016/j.ssci.2014.06.005; Museru L. M., 2002, East and Central African Journal of Surgery, V7, P23; Naddumba EK, E CENTRAL AFRICAN J, V9, P44; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; National Highway Traffic Safety Administration D of T, 2014, TRAFF SAF FACTS 2012; Ngallaba S E, 2013, East Afr J Public Health, V10, P487; Nithershini P., 2012, INJURY PREV, V18, pA213, DOI [10.1136/injuryprev-2012-040590u.33, DOI 10.1136/INJURYPREV-2012-040590U.33]; Oliver DG, 2005, SOC FORCES, V84, P1273, DOI 10.1353/sof.2006.0023; Peden M., 2004, WORLD REPORT ROAD TR; Polus Abishai, 2005, Traffic Inj Prev, V6, P240, DOI 10.1080/15389580590969210; Potoglou D., 2018, INT J INJ CONTROL SA, P1; La QN, 2013, ACCIDENT ANAL PREV, V50, P451, DOI 10.1016/j.aap.2012.05.022; R Core Team, 2018, R LANG ENV STAT COMP; Razzak JA, 2005, EMERG MED CLIN N AM, V23, P85, DOI 10.1016/j.emc.2004.09.008; Reardon JM, 2017, INJURY, V48, P1363, DOI 10.1016/j.injury.2017.05.004; Respicious B, 2016, PAN AFRICAN MED J KA, V23; Solagberu BA, 2006, INJURY PREV, V12, P266, DOI 10.1136/ip.2005.011221; Staton CA, 2015, INT J INJ CONTROL SA, V24, P69, DOI [10.1016/j.injury.2017.05.004, DOI 10.1016/J.INJURY.2017.05.004]; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Sumner SA, 2014, INJURY, V45, P1681, DOI 10.1016/j.injury.2014.04.034; Sze NN, 2011, ACCIDENT ANAL PREV, V43, P265, DOI 10.1016/j.aap.2010.08.020; Vaa T, 1997, ACCIDENT ANAL PREV, V29, P373, DOI 10.1016/S0001-4575(97)00003-1; Wells S, 2004, BRIT MED J, V328, P857, DOI 10.1136/bmj.37984.574757.EE; World Health Organisation, 2018, NONC DIS COUNTR PROF; Zegeer C. V., 1995, TRANSPORT RES REC, V1512, P29; Zimmerman K, 2015, TRAFFIC INJ PREV, V16, P456, DOI 10.1080/15389588.2014.973491	54	9	9	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207570	10.1371/journal.pone.0207570	http://dx.doi.org/10.1371/journal.pone.0207570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB9UV	30481196	Green Published, Green Submitted, gold			2022-12-26	WOS:000451440000014
J	Turgeon, P; Ng, V; Murray, R; Nesbitt, A				Turgeon, Patricia; Ng, Victoria; Murray, Regan; Nesbitt, Andrea			Forecasting the incidence of salmonellosis in seniors in Canada: A trend analysis and the potential impact of the demographic shift	PLOS ONE			English	Article							30 SPECIFIED PATHOGENS; UNITED-STATES; FOODBORNE ILLNESS; RISK-FACTORS; INFECTIONS; HOSPITALIZATIONS; ENTERITIDIS; FOODNET; SURVEILLANCE; COMMUNITY	Salmonella infections remain an important public health issue in Canada and worldwide. Although the majority of Salmonella cases are self-limiting, some will lead to severe symptoms and occasionally severe invasive infections, especially in vulnerable populations such as seniors. This study was performed to assess temporal trends of Salmonella cases in seniors over 15 years (2014-2028) and assess possible impact of demographic shift on national incidence; taking into account of trends in other age groups. The numbers of reported Salmonella cases in seniors (60 years and over) in eight provinces and territories for a period of fifteen years were analysed (1998-2013) using a time-adjusted Poisson regression model. With the demographic changes predicted in the age-structure of the population and in the absence of any targeted interventions, our analysis showed the incidence of Salmonella cases in seniors could increase by 16% by 2028 and the multi-provincial incidence could increase by 5.3%. As a result, the age distribution amongst the Salmonella cases is expected to change with a higher proportion of cases in seniors and a smaller proportion in children (0-4 years old). Over the next decades, cases of infection, hospitalizations and deaths associated with Salmonella in seniors could represent a challenge to public health due to an aging population in Canada. As life expectancy increases in Canada, identification of unique risk factors and targeted prevention in seniors should be pursued to reduce the impact of the demographic shift on disease incidence.	[Turgeon, Patricia; Nesbitt, Andrea] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada; [Turgeon, Patricia] Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ, Canada; [Ng, Victoria] Publ Hlth Agcy Canada, Natl Microbiol Lab, Guelph, ON, Canada; [Murray, Regan] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada	Public Health Agency of Canada; Universite de Montreal; Public Health Agency of Canada; Public Health Agency of Canada	Turgeon, P (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada.; Turgeon, P (corresponding author), Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ, Canada.	patricia.turgeon@canada.ca		Turgeon, Patricia/0000-0002-2264-6377; Ng, Victoria/0000-0002-7619-541X				Altekruse SF, 1999, AM J PREV MED, V16, P216, DOI 10.1016/S0749-3797(98)00099-3; Astridge K, 2015, COMMUN DIS INTELL, V39, pE236; Canadian Institute for Health Information [CIHI], 2011, HLTH CAR CAN 2011 FO; Cummings PL, 2016, FOODBORNE PATHOG DIS, V13, P40, DOI 10.1089/fpd.2015.1969; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; Franklin K, 2015, EPIDEMIOL INFECT, V143, P1368, DOI 10.1017/S0950268814002027; Greig JD, 2009, EPIDEMIOL INFECT, V137, P145, DOI 10.1017/S0950268808000757; Health Canada, 2014, NAT STRAT CONTR POUL; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580; Kirk MD, 2012, EPIDEMIOL INFECT, V140, P2028, DOI 10.1017/S0950268811002834; Kirk MD, 2012, EMERG INFECT DIS, V18, P377, DOI 10.3201/eid1803.110311; Kosa Katherine M., 2011, Journal of Nutrition in Gerontology and Geriatrics, V30, P369, DOI 10.1080/21551197.2011.623943; Marcus R, 2007, EPIDEMIOL INFECT, V135, P84, DOI 10.1017/S0950268806006558; Nesbitt A, 2012, EPIDEMIOL INFECT, V140, P1757, DOI 10.1017/S0950268811002548; Nesbitt A, 2008, BMC PUBLIC HEALTH, V8, P1; Ontario Ministry of Health and Long-Term Care, 2014, INF DIS PROT APP A D; Ontario Ministry of Health and Long-Term Care, 2006, OUTBR SALM ENT PHAG; Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P; Public Health Agency of Canada, 2015, FOODNET CAN UNPUB; Public Health Agency of Canada, 2013, NAT ENT SURV P UNPUB; Public Health Agency of Canada, 2014, NOTIFIABLE DISEASE O; Scallan E, 2005, INT J EPIDEMIOL, V34, P454, DOI 10.1093/ije/dyh413; Scallan E, 2015, FOODBORNE PATHOG DIS, V12, P492, DOI 10.1089/fpd.2014.1915; Statistics Canada, 2014, PROJ POP PROJ SCEN A; TELZAK EE, 1991, J INFECT DIS, V164, P538, DOI 10.1093/infdis/164.3.538; Thomas MK, 2015, FOODBORNE PATHOG DIS, V12, P820, DOI 10.1089/fpd.2015.1966; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Turgeon P, 2017, EPIDEMIOL INFECT, V145, P1527, DOI 10.1017/S0950268817000292; Vugia DJ, 2004, CLIN INFECT DIS, V38, pS149, DOI 10.1086/381581	30	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208124	10.1371/journal.pone.0208124	http://dx.doi.org/10.1371/journal.pone.0208124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481213	Green Submitted, Green Published, gold			2022-12-26	WOS:000451440000044
J	Xiong, LL; He, J; Zeng, MJ; Wu, YL; Xie, DH; Wang, AH; Kong, FJ; Wang, H; Liu, ZY				Xiong Lili; He Jian; Zeng Mengjun; Wu Yinglan; Xie Donghua; Wang Aihua; Kong Fanjuan; Wang Hua; Liu Zhiyu			Epidemiological analysis of maternal deaths in Hunan province in China between 2009 and 2014	PLOS ONE			English	Article							MORTALITY; TRENDS; TIME; CARE	Background The control of maternal deaths continues to be a significant public health issue and commands an enormous amount of attention, especially under the future family planning policy. Here, we describe the epidemiology and trends of maternal deaths in Hunan province, and give several policy implications. Methods Maternal deaths in Hunan province between 2009 and 2014 were retrospectively reviewed and analyzed. Cochran-Armitage trend test was used to assess the time trends of maternal mortality rates. Binary logistic regression analyses were undertaken to identify the factors that were associated with unavoidable maternal deaths. Results In total, there were 987 maternal deaths, with the overall MMR declining by 45.24%. The most common causes of maternal death during this period were pregnancy complications (28.37%), obstetric hemorrhage (25.33%), and amniotic fluid embolism (15.70%). Obstetric hemorrhage (28.14%) was higher in rural areas, while pregnancy complications were higher (29.27%) in urban areas. In all, 627 (63.5%) deaths were avoidable. The risk factors associated with unavoidable maternal deaths was above 35 years (aOR = 1.80 95% CI: 1.27-2.55), without prenatal examination (aOR = 8.97 95% CI: 1.11-7.78), low household incomes (aOR = 1.15 95% CI: 1.02-1.29), without adopting the new way to deliver (aOR = 5.15 95% CI: 3.20-8.31), and death location (aOR = 1.09 95% CI: 1.02-1.18). The most frequent and important factors associated with avoidable deaths was improper knowledge and skills of the county medical institutions. Conclusions Moderate progress was made in reducing the MMR in Hunan province. The government should aim to improve the basic midwifery skills in rural areas and the obstetric emergency rescue service for critically ill pregnant women in urban areas, and strengthen training to improve knowledge and skills in medical institutions in counties.	[Xiong Lili; He Jian; Xie Donghua; Wang Aihua; Kong Fanjuan; Wang Hua; Liu Zhiyu] Hunan Prov Maternal & Children Hlth Care Hosp, Dept Informat Management, Changsha, Hunan, Peoples R China; [Zeng Mengjun; Wu Yinglan] Hunan Prov Maternal & Children Hlth Care Hosp, Dept Maternal Healthcare Dept, Changsha, Hunan, Peoples R China		Wang, H; Liu, ZY (corresponding author), Hunan Prov Maternal & Children Hlth Care Hosp, Dept Informat Management, Changsha, Hunan, Peoples R China.	wanghua213@aliyun.com; 315038356@qq.com			Natural Science Foundation funding project of Hunan Province [2017JJ3143]	Natural Science Foundation funding project of Hunan Province	This study was funded by the Natural Science Foundation funding project of Hunan Province [2017JJ3143]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzahr C., 2004, MATERNAL MORTALITY 2, V3, P298; [Anonymous], 2009, NAT MAT CHILD HLTH I; [Anonymous], 2014, NAT MAT CHILD HLTH I; [Anonymous], 2016, NAT MAT CHILD HLTH I; Ayoola AB, 2010, BIRTH-ISS PERINAT C, V37, P37, DOI 10.1111/j.1523-536X.2009.00376.x; Balasch J, 2012, CURR OPIN OBSTET GYN, V24, P187, DOI 10.1097/GCO.0b013e3283517908; Black RE, 2016, LANCET, V388, P2811, DOI 10.1016/S0140-6736(16)00738-8; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Creanga AA, 2015, OBSTET GYNECOL, V125, P5, DOI 10.1097/AOG.0000000000000564; Du L, 2012, REPROD HEALTH MATTER, V20, P73, DOI 10.1016/S0968-8080(12)39608-0; Feng XL, 2010, BJOG-INT J OBSTET GY, V117, P1527, DOI 10.1111/j.1471-0528.2010.02707.x; Gao YQ, 2009, B WORLD HEALTH ORGAN, V87, P913, DOI 10.2471/BLT.08.060426; Hu KJ, 2014, LANCET, V383, P954, DOI 10.1016/S0140-6736(14)60482-7; Lewis G, 2003, BRIT MED BULL, V67, P27, DOI 10.1093/bmb/ldg009; Liang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037458; Liang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-243; Liang JA, 2010, INT J GYNECOL OBSTET, V110, P93, DOI 10.1016/j.ijgo.2010.03.013; McDonnell NJ, 2013, INT J OBSTET ANESTH, V22, P329, DOI 10.1016/j.ijoa.2013.08.004; Mu Y, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1106-6; Muganyizi PS, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-30; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Shore R., 1969, B WORLD HEALTH ORGAN, P93; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; World Health Organization, 1992, INT STAT CLASS DIS R; Yang SZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096552; You FZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047153; Zeng Y, 2016, LANCET, V388, P1930, DOI 10.1016/S0140-6736(16)31405-2	27	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207920	10.1371/journal.pone.0207920	http://dx.doi.org/10.1371/journal.pone.0207920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475882	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700089
J	Yang, HY; Zheng, LX; Zhang, ZF; Zhang, Y; Wu, WJ				Yang, Han-Ying; Zheng, Li-Xia; Zhang, Zhen-Fei; Zhang, Yang; Wu, Wei-Jian			The structure and morphologic changes of antennae of Cyrtorhinus lividipennis (Hemiptera: Miridae: Orthotylinae) in different instars	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; SEX-PHEROMONE; BROWN PLANTHOPPER; SENSE-ORGANS; FINE-STRUCTURE; MEYER HETEROPTERA; HONEY-BEE; SENSILLA; HYMENOPTERA; BUG	Cyrtorhinus lividipennis Reuter (Hemiptera: Miridae: Orthotylinae), including nymphs and adults, are one of the dominant predators and have a significant role in the biological control of leafhoppers and planthoppers in irrigated rice. In this study, we investigated the antennal morphology, structure and sensilla distribution of C. lividipennis in different instars using scanning electron microscopy. The antennae of both five different nymphal stages and adults were filiform in shape, which consisted of the scape, pedicel and flagellum with two flagellomeres. There were significant differences found in the types of antennal sensilla between nymphs and adults. The multiporous placodea sensilla (MPLA), basiconica sensilla II (BAS II), and sensory pits (SP) only occurred on the antennae of adult C. lividipennis of both sexes. Moreover, there was chaetica sensilla III (CHA III) only observed in males. Sixteen types of antennal sensilla were recorded altogether. They were microtrichia sensilla (MIC), three types of trichoidea sensilla (TRI I-III), three types of chaetica sensilla (CHA I-III), three types of basiconica sensilla (BAS I-III), two types of coeloconica sensilla (COE I and COE II), placodea sensilla (PLA), campaniform sensilla (CAM), MPLA, and SP. In the five different nymphal stages of C. lividipennis, the length of their antennae was significantly increased with the increase of the instar, as well as the number of the TRI II and TRI III. Moreover, sexual dimorphism usually occurred not only in the distribution (CHA III and SP) and the number of antennal sensilla (MIC, BAS II, TRI II, TRI III and MPLA), but also in the length of flagellum (F1 and F2). The possible functions of antennal sensilla are discussed. Those observations could contribute to a better understanding of the development of the olfactory system, and facilitate future studies on the antennal functions in C. lividipennis.	[Yang, Han-Ying; Wu, Wei-Jian] South China Agr Univ, Lab Insect Ecol, Guangzhou, Guangdong, Peoples R China; [Zheng, Li-Xia] Jiangxi Agr Univ, Coll Agron, Nanchang, Jiangxi, Peoples R China; [Zhang, Zhen-Fei; Zhang, Yang] Guangdong Agr Sci Acad, Plant Protect Inst, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Jiangxi Agricultural University	Wu, WJ (corresponding author), South China Agr Univ, Lab Insect Ecol, Guangzhou, Guangdong, Peoples R China.	weijwu@scau.edu.cn		wu, weijian/0000-0003-4108-4485	Science and Technology Project of Guangdong Province, China [2016B020202002]	Science and Technology Project of Guangdong Province, China	This study was supported by the Science and Technology Project of Guangdong Province, China (2016B020202002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2016, ZOOL ANZ, V261, P48, DOI 10.1016/j.jcz.2016.03.007; Allen CE, 2011, ANNU REV ENTOMOL, V56, P445, DOI 10.1146/annurev-ento-120709-144828; Bashir MU, 2010, PAK J AGR SCI, V47, P361; BAY D E, 1976, International Journal of Insect Morphology and Embryology, V5, P1, DOI 10.1016/0020-7322(76)90017-9; BLAND RG, 1989, ANN ENTOMOL SOC AM, V82, P368, DOI 10.1093/aesa/82.3.368; Blaney WM, 1989, BIOL GRASSHOPPERS, P1; Brezot P, 1996, INT J INSECT MORPHOL, V25, P427, DOI 10.1016/S0020-7322(96)00012-8; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cheng J., 2009, PLANTHOPPERS NEW THR, P157; Cheng X.N., 2003, RES PREVENTION BROWN, P52; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DIETZ A, 1971, ANN ENTOMOL SOC AM, V64, P919, DOI 10.1093/aesa/64.4.919; Dweck HKM, 2008, BIOCONTROL, V53, P841, DOI 10.1007/s10526-007-9145-6; Dweck HKM, 2009, MICRON, V40, P769, DOI 10.1016/j.micron.2009.07.012; Fu BX, 2012, MICROSC RES TECHNIQ, V75, P1492, DOI 10.1002/jemt.22093; Gao Y, 2007, MICRON, V38, P684, DOI 10.1016/j.micron.2006.09.004; Gonzaga-Segura J, 2013, ANN ENTOMOL SOC AM, V106, P510, DOI 10.1603/AN12127; Gullan PJ, 2004, INSECTS OUTLINE ENTO, P86; Hazussermann CK, 2015, APIDOLOGIE, V46, P771, DOI 10.1007/s13592-015-0367-9; HASHIMOTO Y, 1990, APPL ENTOMOL ZOOL, V25, P491, DOI 10.1303/aez.25.491; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; HEONG KL, 1990, RES POPUL ECOL, V32, P255, DOI 10.1007/BF02512561; Kim J, 2016, MICROSC RES TECHNIQ, V79, P501, DOI 10.1002/jemt.22658; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Kristoffersen L, 2006, ARTHROPOD STRUCT DEV, V35, P85, DOI 10.1016/j.asd.2006.04.001; Lakshmi V. Jhansi, 2010, Journal of Biological Control, V24, P244; Lakshmi V. Jhansi, 2006, Journal of Biological Control, V20, P175; Liang AP, 2002, AUST J ENTOMOL, V41, P39, DOI 10.1046/j.1440-6055.2002.00266.x; Liquido N.J., 1983, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V31, P159; Lou YG, 2003, BIOCONTROL, V48, P73, DOI 10.1023/A:1021291427256; Lu WW, 2017, PEST MANAG SCI, V73, P1709, DOI 10.1002/ps.4518; MELLOR HE, 1995, INT J INSECT MORPHOL, V24, P133, DOI 10.1016/0020-7322(94)00021-H; Meng J, 2016, ANN ENTOMOL SOC AM, V109, P99, DOI 10.1093/aesa/sav084; Meng YF, 2017, ZOOL ANZ, V268, P64, DOI 10.1016/j.jcz.2017.04.002; Merivee E, 2000, ACTA ZOOL-STOCKHOLM, V81, P339, DOI 10.1046/j.1463-6395.2000.00068.x; Merivee E, 2002, MICRON, V33, P429, DOI 10.1016/S0968-4328(02)00003-3; Merivee E, 2001, MICROSC RES TECHNIQ, V55, P339, DOI 10.1002/jemt.1182; Millar JG, 1997, J CHEM ECOL, V23, P1743, DOI 10.1023/B:JOEC.0000006448.01174.07; Millar OG, 1998, J ECON ENTOMOL, V91, P132, DOI 10.1093/jee/91.1.132; Ngern-Klun R, 2007, PARASITOL RES, V100, P993, DOI 10.1007/s00436-006-0426-2; Ochieng SA, 2000, ARTHROPOD STRUCT DEV, V29, P231, DOI 10.1016/S1467-8039(01)00008-1; Onagbola EO, 2008, MICRON, V39, P526, DOI 10.1016/j.micron.2007.08.001; Poddighe S, 2010, NATURWISSENSCHAFTEN, V97, P827, DOI 10.1007/s00114-010-0700-0; Pophof B, 1997, PHYSIOL ENTOMOL, V22, P239, DOI 10.1111/j.1365-3032.1997.tb01164.x; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Qiao F, 2016, BIOCONTROL SCI TECHN, V26, P1267, DOI 10.1080/09583157.2016.1194370; Rani Pathipati Usha, 2005, International Journal of Tropical Insect Science, V25, P198, DOI 10.1079/IJT200577; RANI PU, 1995, INT J INSECT MORPHOL, V24, P119, DOI 10.1016/0020-7322(94)00020-Q; Rapusas HR, 1996, BIOL CONTROL, V6, P394, DOI 10.1006/bcon.1996.0050; Reynes T.M, 1975, Philippine Ent, V3, P79; Romani R, 2010, PROG BIOL CONTROL, V9, P57, DOI 10.1007/978-1-4020-9110-0_3; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; Ruchty M, 2009, ARTHROPOD STRUCT DEV, V38, P195, DOI 10.1016/j.asd.2008.11.001; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Savary S, 2012, CROP PROT, V32, P54, DOI 10.1016/j.cropro.2011.10.012; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Sigsgaard L, 2002, EUROPEAN ARACHNOLOGY 2000, P57; Silva CCA, 2010, MICRON, V41, P289, DOI 10.1016/j.micron.2009.11.009; SLIFER EH, 1961, J MORPHOL, V109, P351, DOI 10.1002/jmor.1051090308; Smallegange RC, 2008, MICROSC RES TECHNIQ, V71, P880, DOI 10.1002/jemt.20636; SMITH RF, 1991, J CHEM ECOL, V17, P1437, DOI 10.1007/BF00983775; SMITH RF, 1994, CAN ENTOMOL, V126, P445, DOI 10.4039/Ent126445-2; Song LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174643; Steinbrecht R.A., 1984, BIOL INTEGUMENT, V1, P523, DOI DOI 10.1007/978-3-642-51593-4_28; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; STORT AC, 1981, J KANSAS ENTOMOL SOC, V54, P352; Tian XL, 2018, ZOOL ANZ, V272, P65, DOI 10.1016/j.jcz.2017.12.004; TURLINGS TCJ, 1991, ENTOMOL EXP APPL, V58, P75, DOI 10.1007/BF00163316; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Wang RR, 2013, MICRON, V44, P261, DOI 10.1016/j.micron.2012.07.003; Wang X, 2018, ZOOL ANZ, V274, P103, DOI 10.1016/j.jcz.2018.01.009; Yee D.A., 2014, ECOLOGY SYSTEMATICS; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1991, ANNU REV ENTOMOL, V36, P331, DOI 10.1146/annurev.en.36.010191.001555; Zhang CN, 2016, ZOOL ANZ, V262, P20, DOI 10.1016/j.jcz.2016.03.011; Zhang D, 2013, PARASITOL RES, V112, P2177, DOI 10.1007/s00436-013-3377-4; Zhang DJ, 2014, PARASITOL RES, V113, P399, DOI 10.1007/s00436-013-3668-9; Zhang GN, 2011, FLA ENTOMOL, V94, P379, DOI 10.1653/024.094.0301; Zhang L, 2014, MICROSC RES TECHNIQ, V77, P401, DOI 10.1002/jemt.22358; Zhang QH, 2008, J CHEM ECOL, V34, P719, DOI 10.1007/s10886-008-9479-2; Zhang XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121820; Zheng LX, 2014, B ENTOMOL RES, V104, P622, DOI 10.1017/S000748531400039X; Zheng Li-Xia, 2010, Kunchong Zhishi, V47, P525; Zhou H, 2013, NEOTROP ENTOMOL, V42, P278, DOI 10.1007/s13744-013-0113-9	85	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207551	10.1371/journal.pone.0207551	http://dx.doi.org/10.1371/journal.pone.0207551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475842	Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700038
J	Eberhardt, K; Matthaus, C; Marthandan, S; Diekmann, S; Popp, J				Eberhardt, Katharina; Matthaeus, Christian; Marthandan, Shiva; Diekmann, Stephan; Popp, Juergen			Raman and infrared spectroscopy reveal that proliferating and quiescent human fibroblast cells age by biochemically similar but not identical processes	PLOS ONE			English	Article							CELLULAR SENESCENCE; PROTEIN OXIDATION; CIRCULAR-DICHROISM; DEGRADATION; EXPRESSION; DIFFERENTIATION; PATHWAY; CYCLE; APOPTOSIS; AUTOPHAGY	Dermal fibroblast cells can adopt different cell states such as proliferation, quiescence, apoptosis or senescence, in order to ensure tissue homeostasis. Proliferating (dividing) cells pass through the phases of the cell cycle, while quiescent and senescent cells exist in a non-proliferating cell cycle-arrested state. However, the reversible quiescence state is in contrast to the irreversible senescence state. Long-term quiescent cells transit into senescence indicating that cells age also when not passing through the cell cycle. Here, by label-free in vitro vibrational spectroscopy, we studied the biomolecular composition of quiescent dermal fibroblast cells and compared them with those of proliferating and senescent cells. Spectra were examined by multivariate statistical analysis using a PLS-LDA classification model, revealing differences in the biomolecular composition between the cell states mainly associated with protein alterations (variations in the side chain residues of amino acids and protein secondary structure), but also within nucleic acids and lipids. We observed spectral changes in quiescent compared to proliferating cells, which increased with quiescence cultivation time. Raman and infrared spectroscopy, which yield complementary biochemical information, clearly distinguished contact-inhibited from serum-starved quiescent cells. Furthermore, the spectra displayed spectral differences between quiescent cells and proliferating cells, which had recovered from quiescence. This became more distinct with increasing quiescence cultivation time. When comparing proliferating, (in particular long-term) quiescent and senescent cells, we found that Raman as well as infrared spectroscopy can separate these three cellular states from each other due to differences in their biomolecular composition. Our spectroscopic analysis shows that proliferating and quiescent fibroblast cells age by similar but biochemically not identical processes. Despite their aging induced changes, over long time periods quiescent cells can return into the cell cycle. Finally however, the cell cycle arrest becomes irreversible indicating senescence.	[Eberhardt, Katharina; Matthaeus, Christian; Popp, Juergen] Leibniz Inst Photon Technol, Spect & Imaging, Jena, Germany; [Matthaeus, Christian; Popp, Juergen] Friedrich Schiller Univ, Inst Phys Chem, Jena, Germany; [Matthaeus, Christian; Popp, Juergen] Friedrich Schiller Univ, Abbe Ctr Photon, Jena, Germany; [Marthandan, Shiva; Diekmann, Stephan] Fritz Lipmann Inst, Leibniz Inst Aging, Dept Mol Biol, Jena, Germany; [Marthandan, Shiva] PAREXEL Int GmbH, Berlin, Germany	Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Parexel International	Popp, J (corresponding author), Leibniz Inst Photon Technol, Spect & Imaging, Jena, Germany.; Popp, J (corresponding author), Friedrich Schiller Univ, Inst Phys Chem, Jena, Germany.; Popp, J (corresponding author), Friedrich Schiller Univ, Abbe Ctr Photon, Jena, Germany.	Juergen.Popp@uni-jena.de			Carl-Zeiss-Stiftung	Carl-Zeiss-Stiftung	This study was funded by Carl-Zeiss-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Asai T, 2011, J CELL PHYSIOL, V226, P2215, DOI 10.1002/jcp.22561; AUGENLICHT LH, 1974, EXP CELL RES, V89, P255, DOI 10.1016/0014-4827(74)90789-7; Banerjee S, 2015, ANAL BIOANAL CHEM, V407, P7935, DOI 10.1007/s00216-015-8960-3; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Beleites C, 2016, CBMODELS COLLECTION; Beleites C, 2015, HYPERSPEC PACKAGE HA; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bourgo RJ, 2011, MOL CELL, V43, P663, DOI 10.1016/j.molcel.2011.06.029; Brauchle E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04698; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cho S, 2012, MOL CELLS, V33, P597, DOI 10.1007/s10059-012-0042-1; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eberhardt K, 2017, ANALYST, V142, P4405, DOI 10.1039/c7an00592j; Eberhardt K, 2017, ANAL CHEM, V89, P2937, DOI 10.1021/acs.analchem.6b04264; EPAND RM, 1974, BIOPOLYMERS, V13, P359, DOI 10.1002/bip.1974.360130211; Evertts AG, 2013, MOL BIOL CELL, V24, P3025, DOI 10.1091/mbc.E12-07-0529; Gioacchini G, 2014, FERTIL STERIL, V101, P120, DOI 10.1016/j.fertnstert.2013.09.012; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Helbing CC, 1998, ONCOGENE, V17, P1491, DOI 10.1038/sj.onc.1202241; Kallingappa PK, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.115.137109; Konorov SO, 2015, ANAL CHEM, V87, P10762, DOI 10.1021/acs.analchem.5b03295; Kovatcheva M, 2015, ONCOTARGET, V6, P8226, DOI 10.18632/oncotarget.3364; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Lackner DH, 2014, AGING CELL, V13, P946, DOI 10.1111/acel.12234; Laporte D, 2013, J CELL BIOL, V203, P585, DOI 10.1083/jcb.201306075; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Liland K. H., 2015, PLS PARTIAL LEAST SQ; Linkus B, 2016, AGING-US, V8, P382, DOI 10.18632/aging.100904; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lorenzini A, 2009, MECH AGEING DEV, V130, P784, DOI 10.1016/j.mad.2009.10.004; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Marthandan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154531; Marthandan S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731938; Marthandan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115597; Morita S, 2014, BIOPHYS J, V107, P2221, DOI 10.1016/j.bpj.2014.10.002; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460; Naderi J, 2003, APOPTOSIS, V8, P91, DOI 10.1023/A:1021657220843; Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pevsner A, 2003, BIOPOLYMERS, V72, P282, DOI 10.1002/bip.10416; Pignolo RJ, 1998, EXP GERONTOL, V33, P67, DOI 10.1016/S0531-5565(97)00090-9; PUPPELS GJ, 1991, EXP CELL RES, V195, P361, DOI 10.1016/0014-4827(91)90385-8; Ryabchykov O, 2016, CHEMOMETR INTELL LAB, V155, P1, DOI 10.1016/j.chemolab.2016.03.024; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Schauble S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042150; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com; Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8; Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8; SOPRANO KJ, 1994, J CELL BIOCHEM, V54, P405, DOI 10.1002/jcb.240540407; Suram A, 2014, AGING CELL, V13, P780, DOI 10.1111/acel.12246; Team RC, 2015, LANG ENV STAT COMP; Tolstik T, 2014, ANALYST, V139, P6036, DOI 10.1039/c4an00211c; TOWNEND R, 1966, BIOCHEM BIOPH RES CO, V23, P163, DOI 10.1016/0006-291X(66)90522-5; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Valentin M, 2008, CELL CYCLE, V7, P2762, DOI 10.4161/cc.7.17.6595; Venables WN., 2002, MODERN APPL STAT S 4; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Widmer R, 2006, FREE RADICAL RES, V40, P1259, DOI 10.1080/10715760600911154; Xie ZW, 2015, CELL, V160, P928, DOI 10.1016/j.cell.2015.02.002	68	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207380	10.1371/journal.pone.0207380	http://dx.doi.org/10.1371/journal.pone.0207380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507927	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500007
J	Meng, HL; Zhang, W; Zhang, GH; Wang, JJ; Meng, ZG; Long, GQ; Yang, SC				Meng, Heng-Ling; Zhang, Wei; Zhang, Guang-Hui; Wang, Jian-Jun; Meng, Zhen-Gui; Long, Guang-Qiang; Yang, Sheng-Chao			Unigene-based RNA-seq provides insights on drought stress responses in Marsdenia tenacissima	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; HIGH-SALINITY STRESSES; ABSCISIC-ACID; TRANSCRIPTION FACTORS; ABC TRANSPORTER; TOLERANCE; RICE; COLD; PROFILES; NETWORKS	Marsdenia tenacissima is a well-known anti-cancer medicinal plant used in traditional Chinese medicine, which often grows on the karst landform and the water conservation capacity of land is very poorly and drought occurrences frequently. We found M. tenacissima has strong drought resistance because of continuousdrought 16 d, the leaves of M. tenacissima were fully curly and dying. But the leaves were fully almost recovering after re-watering 24h. The activity of SOD and POD were almost doubled under drought stress. The content of osmotic regulating substance proline and soluble sugar were three times than control group. But after re-watering, these indexes were declined rapidly. Three cDNA libraries of control, drought stress, and re-watering treatments were constructed. There were 43,129,228, 47,116,844, and 42,815,454 clean reads with Q20 values of 98.06, 98.04, and 97.88 respectively. SRA accession number of raw data was PRJNA498187 on NCBI. A total of 8672, 6043, and 6537 differentially expressed genes (DEGs) were identified in control vs drought stress, control vs re-watering, and drought stress vs re-watering, respectively. In addition, 1039, 1016, and 980 transcription factors (TFs) were identified, respectively. Among them, 363, 267, and 299 TFs were identified as DEGs in drought stress, re-watering, and drought stress and re-watering, respectively. These differentially expressed TFs mainly belonged to the bHLH, bZIP, C2H2, ERF, MYB, MYB-related, and NAC families. A comparative analysis found that 1174 genes were up-regulated and 2344 were down-regulated under drought stress and this pattern was the opposite to that found after re-watering. Among the up-regulated genes, 64 genes were homologous to known functional genes that directly protect plants against drought stress. Furthermore, 44 protein kinases and 38 TFs with opposite expression patterns under drought stress and re-watering were identified, which are possibly candidate regulators for drought stress resistance in M. tenacissima. Our study is the first to characterize the M. tenacissima transcriptome in response to drought stress, and will serve as a useful resource for future studies on the functions of candidate protein kinases and TFs involved in M. tenacissima drought stress resistance.	[Meng, Heng-Ling; Zhang, Wei] Honghe Univ, Mengzi, Yunnan, Peoples R China; [Zhang, Guang-Hui; Wang, Jian-Jun; Meng, Zhen-Gui; Long, Guang-Qiang; Yang, Sheng-Chao] Yunnan Agr Univ, Yunnan Res Ctr Good Agr Practice Dominant Chinese, Kunming, Yunnan, Peoples R China	Honghe University; Yunnan Agricultural University	Long, GQ; Yang, SC (corresponding author), Yunnan Agr Univ, Yunnan Res Ctr Good Agr Practice Dominant Chinese, Kunming, Yunnan, Peoples R China.	ynaulong2316@163.com; shengchaoyang@163.com		Long, Guangqiang/0000-0001-9147-4399	Project of Science and Technology in Yunnan [2016RA009]; Project of Young and Middleaged Talent of Yunnan Province [2016PY068]; National Natural Science Foundation of China [81660636, 81660635]; Project of Young and Middle-aged Talent of Yunnan Province [2016PY068]	Project of Science and Technology in Yunnan; Project of Young and Middleaged Talent of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Young and Middle-aged Talent of Yunnan Province	This work was supported by the Project of Science and Technology in Yunnan: model construction and demonstration of wildlife tending for anticancer material M. tenacissima (grant No. 2016RA009), the Project of Young and Middleaged Talent of Yunnan Province (grant No. 2016PY068), and the National Natural Science Foundation of China (grant No. 81660636 and 81660635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Project of Science and Technology in Yunnan: model construction and demonstration of wildlife tending for anticancer material M. tenacissima (grant No. 2016RA009), the Project of Young and Middle-aged Talent of Yunnan Province (grant No. 2016PY068), and the National Natural Science Foundation of China (grant No. 81660636 and 81660635).	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Aprile A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-279; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Bhardwaj AR, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0405-1; Borovskii Genadii B, 2002, BMC Plant Biol, V2, P5, DOI 10.1186/1471-2229-2-5; Delorge I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00147; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Fu Y, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0471-8; Gayacharan, 2013, PHYSIOL MOL BIOL PLA, V19, P379, DOI 10.1007/s12298-013-0176-4; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gong L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128041; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; Huang LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1026; Huang ZR, 2013, ONCOL LETT, V5, P917, DOI 10.3892/ol.2013.1105; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jiang YW, 2002, CROP SCI, V42, P202, DOI 10.2135/cropsci2002.0202; Klein M, 2004, PLANT J, V39, P219, DOI 10.1111/j.1365-313X.2004.02125.x; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Kuromori T, 2011, PLANT J, V67, P885, DOI 10.1111/j.1365-313X.2011.04641.x; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li HY, 2012, J AM SOC HORTIC SCI, V137, P80, DOI 10.21273/JASHS.137.2.80; Li L., 2009, EXPT GUIDANCE PLANT; Li S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2334-2; Li WS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/879512; Liu SW, 2010, PHYSIOL PLANTARUM, V139, P375, DOI 10.1111/j.1399-3054.2010.01374.x; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; Luo M, 2010, J INTEGR PLANT BIOL, V52, P1059, DOI 10.1111/j.1744-7909.2010.01000.x; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Meng HengLing, 2015, Journal of Anhui Agricultural University, V42, P579; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; Paul M, 2007, CURR OPIN PLANT BIOL, V10, P303, DOI 10.1016/j.pbi.2007.04.001; Porcel R, 2005, J EXP BOT, V56, P1933, DOI 10.1093/jxb/eri188; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Samajova O, 2013, BIOTECHNOL ADV, V31, P118, DOI 10.1016/j.biotechadv.2011.12.002; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Valdes A, 2013, TRAC-TREND ANAL CHEM, V52, P142, DOI 10.1016/j.trac.2013.06.014; Walter J, 2011, ENVIRON EXP BOT, V71, P34, DOI 10.1016/j.envexpbot.2010.10.020; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Wu YQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-671; Xiao XW, 2009, PHYSIOL PLANTARUM, V136, P150, DOI 10.1111/j.1399-3054.2009.01222.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Yu S.S., 2011, CHINA J EXP TRADIT M, V17, P279, DOI DOI 10.13422/J.CNKI.SYFJX.2011.21.077; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063; Zhang JC, 2017, NAT PROD RES, V2, P1, DOI DOI 10.1155/2017/8197085; Zhao PC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00954; Zheng KY, 2014, GENOMICS, V104, P186, DOI 10.1016/j.ygeno.2014.07.013; Zhou QY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-399	64	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0202848	10.1371/journal.pone.0202848	http://dx.doi.org/10.1371/journal.pone.0202848			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500823	Green Published, Green Submitted, gold			2022-12-26	WOS:000451883700002
J	Yousefelahiyeh, M; Xu, JY; Alvarado, E; Yu, Y; Salven, D; Nissen, RM				Yousefelahiyeh, Mina; Xu, Jingyi; Alvarado, Estibaliz; Yu, Yang; Salven, David; Nissen, Robert M.			DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B	PLOS ONE			English	Article							PROTEIN-KINASE DYRK1A; DOWN-SYNDROME; AURICULOCONDYLAR SYNDROME; SUBCELLULAR-LOCALIZATION; HUMAN PAPILLOMAVIRUSES; E6 PROTEINS; GENE; MINIBRAIN; E1A; ACTIVATION	Overexpression of the Dual-specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) gene contributes to the retardation, craniofacial anomalies, cognitive impairment, and learning and memory deficits associated with Down Syndrome (DS). DCAF7/HAN11/WDR68 (hereafter WDR68) binds DYRK1A and is required for craniofacial development. Accumulating evidence suggests DYRK1A-WDR68 complexes enable proper growth and patterning of multiple organ systems and suppress inappropriate cell growth/transformation by regulating the balance between proliferation and differentiation in multiple cellular contexts. Here we report, using engineered mouse C2C12 and human HeLa cell lines, that WDR68 is required for normal levels of DYRK1A. However, Wdr68 does not significantly regulate Dyrk1a mRNA expression levels and proteasome inhibition did not restore DYRK1A in cells lacking Wdr68 (Delta wdr68 cells). Overexpression of WDR68 increased DYRK1A levels while overexpression of DYRK1A had no effect on WDR68 levels. We further report that WDR68 is similarly required for normal levels of the closely related DYRK1B kinase and that both DYRK1A and DYRK1B are essential for the transition from proliferation to differentiation in C2C12 cells. These findings reveal an additional role of WDR68 in DYRK1A-WDR68 and DYRK1B-WDR68 complexes.	[Yousefelahiyeh, Mina; Xu, Jingyi; Alvarado, Estibaliz; Yu, Yang; Salven, David; Nissen, Robert M.] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	California State University System; California State University Los Angeles	Nissen, RM (corresponding author), Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA.	missen@calstatela.edu		Salven, David Sebastian/0000-0002-5618-3446; Nissen, Robert/0000-0002-0591-1167	National Institute of Dental and Craniofacial Research [R15DE022902-01A1]	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant R15DE022902-01A1 from the National Institute of Dental and Craniofacial Research to RMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Jhaisha S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06874-w; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Alvarado E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166984; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Becker W, 2014, CNS NEUROL DISORD-DR, V13, P26, DOI 10.2174/18715273113126660186; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Bellmaine SF, 2017, ELIFE, V6, DOI 10.7554/eLife.24502; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Cohen MJ, 2013, J VIROL, V87, P10348, DOI 10.1128/JVI.00786-13; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; deVetten N, 1997, GENE DEV, V11, P1422, DOI 10.1101/gad.11.11.1422; Di Vona C, 2015, MOL CELL, V57, P506, DOI 10.1016/j.molcel.2014.12.026; Fernandez-Martinez P, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970048; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; GEY GO, 1952, CANCER RES, V12, P264; Glenewinkel F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28241; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; Gordon CT, 2013, AM J HUM GENET, V93, P1118, DOI 10.1016/j.ajhg.2013.10.023; Guedj F, 2014, CURR OPIN OBSTET GYN, V26, P92, DOI 10.1097/GCO.0000000000000056; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin NN, 2015, J BIOL CHEM, V290, P15219, DOI 10.1074/jbc.M115.645507; Kay LJ, 2016, ADV PROTEIN CHEM STR, V105, P127, DOI 10.1016/bs.apcsb.2016.07.001; Komorek J, 2010, J VIROL, V84, P2719, DOI 10.1128/JVI.02119-09; Kuppuswamy M, 2013, J VIROL, V87, P7781, DOI 10.1128/JVI.00037-13; Leslie EJ, 2016, HUM MOL GENET, V25, P2862, DOI 10.1093/hmg/ddw104; Li S, 2018, NUCL ACIDS RES, DOI [10.1093./nar/gky754, DOI 10.1093./NAR/GKY754]; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Liu Q, 2016, J BIOL CHEM, V291, P26399, DOI 10.1074/jbc.M116.717553; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Luco SM, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0276-4; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; McElyea SD, 2016, HUM MOL GENET, V25, P4856, DOI 10.1093/hmg/ddw309; Miyata Y, 2014, J BIOL CHEM, V289, P33320, DOI 10.1074/jbc.M114.586115; Miyata Y, 2011, BBA-MOL CELL RES, V1813, P1728, DOI 10.1016/j.bbamcr.2011.06.023; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Morriss GR, 2013, GENETICS, V195, P927, DOI 10.1534/genetics.113.154211; Nissen RM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-28; Park Joongkyu, 2013, Exp Neurobiol, V22, P244, DOI 10.5607/en.2013.22.4.244; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Peng ZM, 2016, J BIOL CHEM, V291, P21893, DOI 10.1074/jbc.M116.746198; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rieder MJ, 2012, AM J HUM GENET, V90, P907, DOI 10.1016/j.ajhg.2012.04.002; Ritterhoff S, 2010, EMBO J, V29, P3750, DOI 10.1038/emboj.2010.251; Tavares VLR, 2015, EUR J HUM GENET, V23, P481, DOI 10.1038/ejhg.2014.132; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Sin N, 1999, BIOORG MED CHEM LETT, V9, P2283, DOI 10.1016/S0960-894X(99)00376-5; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104; Starbuck JM, 2017, AM J MED GENET A, V173, P2861, DOI 10.1002/ajmg.a.38464; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Subramanian T, 2013, VIROLOGY, V443, P313, DOI 10.1016/j.virol.2013.05.018; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; TSUBUKI S, 1993, BIOCHEM BIOPH RES CO, V196, P1195, DOI 10.1006/bbrc.1993.2378; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; VINITSKY A, 1992, BIOCHEMISTRY-US, V31, P9421, DOI 10.1021/bi00154a014; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Xiang JX, 2017, P NATL ACAD SCI USA, V114, pE1224, DOI 10.1073/pnas.1614893114; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang L, 2016, P NATL ACAD SCI USA, V113, P10583, DOI 10.1073/pnas.1609417113; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070627	77	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207779	10.1371/journal.pone.0207779	http://dx.doi.org/10.1371/journal.pone.0207779			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496304	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800050
J	Canty, L; Hariharan, S; Liu, Q; Haney, SA; Andrews, DW				Canty, Laura; Hariharan, Santosh; Liu, Qian; Haney, Steven A.; Andrews, David W.			Peak emission wavelength and fluorescence lifetime are coupled in far-red, GFP-like fluorescent proteins	PLOS ONE			English	Article							IMPROVED BRIGHTNESS; RATIONAL DESIGN; PHOTOSTABILITY; MICROSCOPY; GREEN; CELLS	The discovery and use of fluorescent proteins revolutionized cell biology by allowing the visualization of proteins in living cells. Advances in fluorescent proteins, primarily through genetic engineering, have enabled more advanced analyses, including Forster resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM) and the development of genetically encoded fluorescent biosensors. These fluorescence protein-based sensors are highly effective in cells grown in monolayer cultures. However, it is often desirable to use more complex models including tissue explants, organoids, xenografts, and whole animals. These types of samples have poor light penetration owing to high scattering and absorption of light by tissue. Far-red light with a wavelength between 650-900nm is less prone to scatter, and absorption by tissues and can thus penetrate more deeply. Unfortunately, there are few fluorescent proteins in this region of the spectrum, and they have suboptimal fluorescent properties including low brightness and short fluorescence lifetimes. Understanding the relationships between the amino-acid sequences of far-red fluorescence proteins and their photophysical properties including peak emission wavelengths and fluorescence lifetimes would be useful in the design of new fluorescence proteins for this region of the spectrum. We used both site-directed mutagenesis and gene-shuffling between mScarlet and mCardinal fluorescence proteins to create new variants and assess their properties systematically. We discovered that for far-red, GFP-like proteins the emission maxima and fluorescence lifetime have a strong inverse correlation.	[Canty, Laura; Hariharan, Santosh; Liu, Qian; Andrews, David W.] Sunnybrook Res Inst, Dept Biol Sci, Toronto, ON, Canada; [Hariharan, Santosh; Andrews, David W.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Haney, Steven A.] Eli Lilly & Co, Dept Oncol & Translat Res, Indianapolis, IN 46285 USA; [Andrews, David W.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Eli Lilly; University of Toronto	Andrews, DW (corresponding author), Sunnybrook Res Inst, Dept Biol Sci, Toronto, ON, Canada.; Andrews, DW (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Andrews, DW (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	david.andrews@sri.utoronto.ca		Hariharan, Santosh/0000-0002-0941-0044; Andrews, David/0000-0002-9266-7157	Eli Lilly and Company through the Lilly Research Award Program (LRAP)	Eli Lilly and Company through the Lilly Research Award Program (LRAP)	This research was funded by Eli Lilly and Company through the Lilly Research Award Program (LRAP) and disbursed by Lilly Canada. The funder also provided support in the form of salaries for author S.A.H., but the corporation did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bajar BT, 2016, NAT METHODS, V13, P993, DOI [10.1038/NMETH.4045, 10.1038/nmeth.4045]; Bajar BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20889; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bindels DS, 2017, NAT METHODS, P1, DOI 10. 1038/ nmeth. 4074; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Eason MG, 2017, CURR OPIN STRUC BIOL, V45, P91, DOI 10.1016/j.sbi.2016.12.001; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hense A, 2015, PHOTOCH PHOTOBIO SCI, V14, P200, DOI 10.1039/c4pp00212a; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Lin LT, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126013; Liu Q, 2012, CELL CYCLE, V11, P3536, DOI 10.4161/cc.21462; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Martin KJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0183585; Matela G, 2017, CHEM COMMUN, V53, P979, DOI 10.1039/c6cc09081h; Meyer Adam J, 2014, Curr Protoc Mol Biol, V105, DOI 10.1002/0471142727.mb1512s105; Miyawaki A, 2012, CURR OPIN STRUC BIOL, V22, P679, DOI 10.1016/j.sbi.2012.09.002; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Osterlund Elizabeth J, 2015, Methods Mol Biol, V1264, P395, DOI 10.1007/978-1-4939-2257-4_34; Pandelieva AT, 2016, ACS CHEM BIOL, V11, P508, DOI 10.1021/acschembio.5b00774; Piatkevich KD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3153; Rice WL, 2015, CANCER RES, V75, P1236, DOI 10.1158/0008-5472.CAN-14-3001; Rodriguez EA, 2017, TRENDS BIOCHEM SCI, V42, P111, DOI 10.1016/j.tibs.2016.09.010; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shcherbakova DM, 2015, CURR OPIN CHEM BIOL, V27, P52, DOI 10.1016/j.cbpa.2015.06.005; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zlobovskaya OA, 2016, BIOTECHNIQUES, V60, P62, DOI 10.2144/000114377	46	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208075	10.1371/journal.pone.0208075	http://dx.doi.org/10.1371/journal.pone.0208075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485364	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800104
J	Fredriksson, SV; Alley, SJ; Rebar, AL; Hayman, M; Vandelanotte, C; Schoeppe, S				Fredriksson, Sara Veronica; Alley, Stephanie J.; Rebar, Amanda L.; Hayman, Melanie; Vandelanotte, Corneel; Schoeppe, Stephanie			How are different levels of knowledge about physical activity associated with physical activity behaviour in Australian adults?	PLOS ONE			English	Article							AWARENESS	People with knowledge of the benefits of physical activity tend to be more active; however, such knowledge is typically operationalized as a basic understanding that physical activity is 'good' for health. Therefore, the aim of this study was to investigate whether there are differences in how detailed a person's knowledge is about the benefits of physical activity. Participants (N = 615) completed an online survey to measure their current physical activity behaviour, as well as their level of knowledge of the benefits and risks of physical (in)activity. The majority of participants (99.6%) strongly agreed that physical activity is good for health, however on average, participants only identified 13.8 out of 22 diseases associated with physical inactivity and over half of participants (55.6%) could not identify how much physical activity is recommended for health benefits. Furthermore, 45% of the participants overestimated, 9% underestimated and 27% did not know the increased risk of disease resulting from inactivity as indicated by the Australian Department of Health. Participants were significantly more active when they correctly identified more diseases associated with physical inactivity and when they overestimated the risks associated with inactivity. Therefore, health promotion initiatives should increase knowledge of the types of diseases associated with inactivity. Low knowledge of physical activity guidelines suggest they should be promoted more, as this knowledge provides guidance on frequency, types and duration of physical activity needed for health.	[Fredriksson, Sara Veronica; Alley, Stephanie J.; Rebar, Amanda L.; Hayman, Melanie; Vandelanotte, Corneel; Schoeppe, Stephanie] Cent Queensland Univ, Phys Act Res Grp, Appleton Inst, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia	Central Queensland University	Vandelanotte, C (corresponding author), Cent Queensland Univ, Phys Act Res Grp, Appleton Inst, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia.	c.vandelanotte@cqu.edu.au	Vandelanotte, Corneel/ABF-5580-2020	Rebar, Amanda/0000-0003-3164-993X				Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Australian Bureau of Statistics, 2015, AUSTR HLTH SURV 1 RE; Australian Burreau of Statistics, 2016 CENS QUICKSTATS; Australian Burreau of Statistics, 2016 CENS NAT CAP CI; Australian institute of health and welfare, 2003, ACT AUSTR SURV GUID; Bennett GG, 2009, MED SCI SPORT EXER, V41, P1849, DOI 10.1249/MSS.0b013e3181a52100; Brenner PS, 2014, SOC INDIC RES, V117, P489, DOI 10.1007/s11205-013-0359-y; Brown WJ, 2012, 10515 AUSTR GOV DEP; Chapman S, 2005, TOB CONTROL, V14, pII8, DOI 10.1136/tc.2005.012591; Chapman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001342; Department of Health, 2014, MOR HALF ALL AUSTR A; Hall PA., 2007, HLTH PSYCHOL REV, V1, P6, DOI [10.1080/17437190701492437, DOI 10.1080/17437190701492437]; Hui SSC, 2001, J AGING PHYS ACTIV, V9, P372, DOI 10.1123/japa.9.4.372; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Morrow JR, 2004, RES Q EXERCISE SPORT, V75, P231, DOI 10.1080/02701367.2004.10609156; Plotnikoff RC, 2011, AM J HEALTH PROMOT, V25, P294, DOI 10.4278/ajhp.090211-ARB-60; Rhodes RE, 2003, BRIT J SOC PSYCHOL, V42, P129, DOI 10.1348/014466603763276162; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; Vandelanotte C, 2011, J HEALTH PSYCHOL, V16, P760, DOI 10.1177/1359105310390543	22	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207003	10.1371/journal.pone.0207003	http://dx.doi.org/10.1371/journal.pone.0207003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485310	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800038
J	Goldberg, ME; Montesion, M; Young, L; Suh, J; Greenbowe, J; Kennedy, M; Giaccone, G; Akerley, WL; Dowlati, A; Creelan, BC; Hicks, JK; Hesketh, PJ; Kelly, KL; Riess, JW; Miller, VA; Stephens, PJ; Frampton, GM; Ali, S; Gregg, JP; Albacker, LA				Goldberg, Michael E.; Montesion, Meagan; Young, Lauren; Suh, James; Greenbowe, Joel; Kennedy, Mark; Giaccone, Giuseppe; Akerley, Wallace L.; Dowlati, Afshin; Creelan, Benjamin C.; Hicks, James K.; Hesketh, Paul J.; Kelly, Karen L.; Riess, Jonathan W.; Miller, Vincent A.; Stephens, Philip J.; Frampton, Garrett M.; Ali, Siraj; Gregg, Jeffrey P.; Albacker, Lee A.			Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; GEFITINIB; C797S; AZD9291; OSIMERTINIB; SENSITIVITY; INHIBITORS; EMERGENCE; T790M	After sequential treatment with first- and third-generation EGFR tyrosine kinase inhibitors (TKIs), EGFR-mutant non-small cell lung cancers frequently harbor multiple resistance mutations in exon 20 of EGFR including T790M, mediating resistance to first-generation TKIs, and at codons 792, 796, or 797 mediating resistance to third-generation TKIs. However, whether these resistance mutations are in cis or trans has therapeutic implications for patients. We analyzed a cohort of 29 patients with NSCLC harboring EGFR mutations at codons 792, 796, or 797 to establish the configuration of these mutations. We performed hybrid capture-based, next-generation sequencing on formalin-fixed paraffin-embedded biopsy tissue or liquid biopsy. 27 samples had both a T790M mutation and a mutation at codons 792, 796, or 797. In all of these cases, the mutations were found in the cis configuration; the trans configuration was not observed. Two patients' samples harbored a mutation at codon 797 but no T790M mutation. In these two cases, longitudinal analysis showed earlier biopsies harbored EGFR T790M, which was undetectable following osimertinib treatment. Treatment of one these patients with both first-and third-generation EGFR TKIs resulted in a mixed response. Here we describe multiple configurations of EGFR T790M and third-generation TKI resistance mutations at codons 792, 796, and 797. These mutations are most commonly found in cis, which confers resistance to all current EGFR TKIs. We also describe two patients that exhibited T790M loss with acquisition of a mutation at codon 797. In addition, one of these patients, with an EGFR C797S in a lung biopsy was subsequently found to have EGFR C797N in a later biopsy of pleural fluid, highlighting the dynamic multiclonal nature of advanced NSCLC.	[Goldberg, Michael E.; Montesion, Meagan; Young, Lauren; Suh, James; Greenbowe, Joel; Kennedy, Mark; Miller, Vincent A.; Stephens, Philip J.; Frampton, Garrett M.; Ali, Siraj; Albacker, Lee A.] Fdn Med Inc, Cambridge, MA 02141 USA; [Giaccone, Giuseppe] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Akerley, Wallace L.] Huntsman Canc Inst, Salt Lake City, UT USA; [Dowlati, Afshin] Univ Hosp Cleveland, Seidman Canc Ctr, Cleveland, OH 44106 USA; [Creelan, Benjamin C.; Hicks, James K.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Hesketh, Paul J.] Lahey Hosp & Med Ctr, Lahey Hlth Canc Inst, Burlington, MA USA; [Kelly, Karen L.; Riess, Jonathan W.] Univ Calif Davis, Canc Ctr, Sacramento, CA 95817 USA; [Gregg, Jeffrey P.] UC Davis Hlth, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Suh, James] NCI, Frederick Natl Lab Canc Res, Washington, DC USA	Foundation Medicine; Georgetown University; Huntsman Cancer Institute; University Hospitals of Cleveland; H Lee Moffitt Cancer Center & Research Institute; Lahey Hospital & Medical Center; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Albacker, LA (corresponding author), Fdn Med Inc, Cambridge, MA 02141 USA.; Gregg, JP (corresponding author), UC Davis Hlth, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	jpgregg@ucdavis.edu; lalbacker@foundationmedicine.com	Ali, Siraj/AAE-2958-2019	Montesion, Meagan/0000-0001-9155-556X; Kelly, Karen/0000-0002-2235-6636; Creelan, Ben/0000-0002-2728-8070; Goldberg, Michael/0000-0003-3310-6349; Frampton, Garrett/0000-0002-2361-2750	Foundation Medicine Inc.; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	Foundation Medicine Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Foundation Medicine Inc. provided support in the form of salaries for authors (MEG, MM, LY, JS, JG, MK, VAM, PJS, GMF, SA, LAA), but apart from the authors listed, had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Foundation Medicine Inc. authors are articulated in the 'author contributions' section.	Arulananda S, 2017, J THORAC ONCOL, V12, P1728, DOI 10.1016/j.jtho.2017.08.006; Clark TA, 2018, J MOL DIAGN, V20, P686, DOI 10.1016/j.jmoldx.2018.05.004; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Niederst MJ, 2015, CLIN CANCER RES, V21, P3924, DOI 10.1158/1078-0432.CCR-15-0560; Ou SHI, 2017, LUNG CANCER, V108, P228, DOI 10.1016/j.lungcan.2017.04.003; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Ramalingam SS, 2018, J CLIN ONCOL, V36, P841, DOI 10.1200/JCO.2017.74.7576; Soria JC, 2017, N ENGL J MED; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Wang Z, 2017, J THORAC ONCOL, V12, P1723, DOI 10.1016/j.jtho.2017.06.017; Yang Z, 2018, CLIN CANCER RES, V24, P3097, DOI 10.1158/1078-0432.CCR-17-2310	19	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208097	10.1371/journal.pone.0208097	http://dx.doi.org/10.1371/journal.pone.0208097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481207	Green Submitted, Green Published, gold			2022-12-26	WOS:000451440000043
J	Chihana, ML; Huerga, H; Van Cutsem, G; Ellman, T; Wanjala, S; Masiku, C; Szumilin, E; Etard, JF; Davies, MA; Maman, D				Chihana, Menard Laurent; Huerga, Helena; Van Cutsem, Gilles; Ellman, Tom; Wanjala, Stephen; Masiku, Charles; Szumilin, Elisabeth; Etard, Jean Francois; Davies, Mary-Ann; Maman, David			Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries	PLOS ONE			English	Article							VIRAL LOAD; SCALE-UP; THERAPY; CARE; INFECTION; INITIATION; COVERAGE; CASCADE; AFRICA; KENYA	Background Latest WHO guidelines recommend starting HIV-positive individuals on antiretroviral therapy treatment (ART) regardless of CD4 count. We assessed additional impact of adopting new WHO guidelines. Methods We used data of individuals aged 15-59 years from three HIV population surveys conducted in 2012 (Kenya) and 2013 (Malawi and South Africa). Individuals were interviewed at home followed by rapid HIV and CD4 testing if tested HIV-positive. HIV-positive individuals were classified as "eligible for ART" if (i) had ever been initiated on ART or (ii) were not yet on ART but met the criteria for starting ART based on country's guidelines at the time of the survey (Kenya-CD4<= 350 cells/mu l and WHO Stage 3 or 4 disease, Malawi as for Kenya plus lifelong ART for all pregnant and breastfeeding women, South Africa as for Kenya plus ART for pregnant and breastfeeding women until cessation of breastfeeding). Findings Of 18,991 individuals who tested, 4,113 (21.7%) were HIV-positive. Using country's ART eligibility guidelines at the time of the survey, the proportion of HIV-infected individuals eligible for ART was 60.0% (95% CI: 57.2-62.7) (Kenya), 73.4% (70.8-75.8) (South Africa) and 80.1% (77.3-82.6) (Malawi). Applying WHO 2013 guidelines (eligibility at CD4< = 500 and Option B+ for pregnant and breastfeeding women), the proportions eligible were 82.0% (79.8-84.1) (Kenya), 83.7% (81.5-85.6) (South Africa) and 87.6% (85.0-89.8) (Malawi). Adopting "test and treat" would mean a further 18.0% HIV-positive individuals (Kenya), 16.3% (South Africa) and 12.4% (Malawi) would become eligible. In all countries, about 20% of adolescents (aged 15-19 years), became eligible for ART moving from WHO 2013 to "test and treat" while no differences by sex were observed. Conclusion Countries that have already implemented 2013 WHO recommendations, the burden of implementing "test and treat" would be small. Youth friendly programmes to help adolescents access and adhere to treatment will be needed.	[Chihana, Menard Laurent; Van Cutsem, Gilles; Davies, Mary-Ann; Maman, David] Univ Cape Town, Ctr Infect Dis & Epidemiol, Cape Town, South Africa; [Chihana, Menard Laurent; Maman, David] Epicentre, Cape Town, South Africa; [Huerga, Helena; Etard, Jean Francois] Epicentre, Paris, France; [Van Cutsem, Gilles; Ellman, Tom] Medecins Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Wanjala, Stephen] Medecins Sans Frontieres, Nairobi, Kenya; [Masiku, Charles] Medecins Sans Frontieres, Lilongwe, Malawi; [Szumilin, Elisabeth] Medecins Sans Frontieres, Paris, France; [Etard, Jean Francois] Montpellier Univ, TransVIHMI, INSERM U1175, IRD UMI 233, Montpellier, France	University of Cape Town; Doctors Without Borders; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Chihana, ML (corresponding author), Univ Cape Town, Ctr Infect Dis & Epidemiol, Cape Town, South Africa.; Chihana, ML (corresponding author), Epicentre, Cape Town, South Africa.	menardchihana@yahoo.com	Van Cutsem, Gilles/ABB-1171-2021; Etard, Jean François/A-9630-2008; Etard, Jean-Francois/V-4865-2019	Van Cutsem, Gilles/0000-0002-8972-4480; Etard, Jean François/0000-0002-4873-0788; Etard, Jean-Francois/0000-0002-4873-0788; Wanjala, Stephen/0000-0002-7001-0605; Maman, David/0000-0002-9839-3011				Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Black V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168199; Cohen J., SWAZILAND MAKES MAJO; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Davies MA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001650; Dutta A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001907; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Granich R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131353; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Huerga H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2740-y; Huerga H, 2016, JAIDS-J ACQ IMM DEF, V73, P411, DOI 10.1097/QAI.0000000000001081; Hussen SA, 2014, FUTURE VIROL, V9, P921, DOI 10.2217/FVL.14.73; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Inzaule SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167492; Kranzer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001649; Lessells RJ, 2014, JAIDS-J ACQ IMM DEF, V65, pE17, DOI 10.1097/QAI.0b013e31829ceb14; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; Malawi Ministry of Health, 2011, MAL GUID CLIN MAN HI; Maman D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20673; Maman D, 2015, AIDS, V29, P1557, DOI 10.1097/QAD.0000000000000741; Maskew M, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/4161738; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V62, pE70, DOI 10.1097/QAI.0b013e318278bcb0; National AIDS/ STI Control Program (NASCOP), 2011, GUID ANT THER KEN LI; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Odhiambo JO, 2014, JAIDS-J ACQ IMM DEF, V66, pS116, DOI 10.1097/QAI.0000000000000122; Reif LK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20859; Slogrove AL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21520; South African National Department of Health, 2013, S AFR ANT TREATM GUI; Stover J, 2014, AIDS, V28, pS225, DOI 10.1097/QAD.0000000000000235; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2016, GLOB AIDS UPD; Ventelou B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034101; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; WHO (World Health Organization), 2017, TREAT ALL POL AD IMP; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; World Health Organization, 2015, GUID START ANT THER	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207656	10.1371/journal.pone.0207656	http://dx.doi.org/10.1371/journal.pone.0207656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475865	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700051
J	Gjerde, JL; Rortveit, G; Adefris, M; Mekonnen, H; Belayneh, T; Blystad, A				Gjerde, Janne Lillelid; Rortveit, Guri; Adefris, Mulat; Mekonnen, Hibste; Belayneh, Tadesse; Blystad, Astrid			The lucky ones get cured: Health care seeking among women with pelvic organ prolapse in Amhara Region, Ethiopia	PLOS ONE			English	Article							UTERINE PROLAPSE; RISK-FACTORS; INCONTINENCE; PREVALENCE	Background The majority of women suffering from maternal morbidities live in resource-constrained settings with diverse barriers preventing access to quality biomedical health care services. This study aims to highlight the dynamics between the public health system and alternative healing through an exploration of the experiences of health care seeking among women living with severe symptomatic pelvic organ prolapse in an impoverished setting. Methods The data were collected through ethnographic fieldwork at the hospital and community levels in the Amhara region of Ethiopia. The fieldwork included participant observation, 42 semi-structured interviews and two focus group discussions over a period of one year. A group of 24 women with severe symptomatic pelvic organ prolapse served as the study's main informants. Other central groups of informants included health care providers, local healers and actors from the health authorities and non-governmental organisations. Results Three case stories were chosen to illustrate the key findings related to health care seeking among the informants. The women strove to find remedies for their aggravating ailment, and many navigated between and combined various available healing options both within and beyond the health care sector. Their choices were strongly influenced by poverty, by lack of knowledge about the condition, by their religious and spiritual beliefs and by the shame and embarrassment related to the condition. An ongoing health campaign in the study area providing free surgical treatment for pelvic organ prolapse enabled a study of the experiences related to the introduction of free health services targeting maternal morbidity. Conclusions This study highlights how structural barriers prevent women living in a resource-constrained setting from receiving health care for a highly prevalent and readily treatable maternal morbidity such as pelvic organ prolapse. Our results illustrate that the provision of free quality services may dramatically alter both health-and illness-related perceptions and conduct in an extremely vulnerable population.	[Gjerde, Janne Lillelid; Blystad, Astrid] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Res Grp Global Hlth Anthropol, Bergen, Norway; [Gjerde, Janne Lillelid] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Rortveit, Guri] Univ Bergen, Dept Global Publ Hlth & Primary Care, Res Grp Gen Practice, Bergen, Norway; [Rortveit, Guri] Uni Res Hlth, Res Unit Gen Practice, Bergen, Norway; [Adefris, Mulat] Univ Gondar, Coll Med & Hlth Sci, Dept Obstet & Gynecol, Gondar, Ethiopia; [Mekonnen, Hibste] Wogen Children & Mothers Support Assoc, Gondar, Ethiopia; [Belayneh, Tadesse] Univ Gondar, Coll Med & Hlth Sci, Dept Anaesthesiol, Gondar, Ethiopia	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Gondar; University of Gondar	Gjerde, JL (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Res Grp Global Hlth Anthropol, Bergen, Norway.; Gjerde, JL (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway.	janne.gjerde@uib.no		Gjerde, Janne Lillelid/0000-0001-5441-2412	Western Norway Regional Health Authority [911847]	Western Norway Regional Health Authority	The study was funded by the Western Norway Regional Health Authority, Project number 911847: https://forskningsprosjekter.ihelse.net/prosjekt/911847.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adefris M, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0416-9; Alemu B., 2008, Exchange on HIV/AIDS, Sexuality and Gender, P4; BAER HA, 1986, SOC SCI MED, V23, P95, DOI 10.1016/0277-9536(86)90358-8; Berhanu Z, 2010, J HIV-AIDS SOC SERV, V9, P240, DOI 10.1080/15381501.2010.502802; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; BISHAW M, 1991, SOC SCI MED, V33, P193, DOI 10.1016/0277-9536(91)90180-K; Blystad A, 2018, INT UROGYNECOL J, V29, P679, DOI 10.1007/s00192-017-3515-0; Bodner-Adler B, 2007, INT UROGYNECOL J, V18, P1343, DOI 10.1007/s00192-007-0331-y; Bonetti TR, 2004, REPROD HEALTH MATTER, V12, P166, DOI 10.1016/S0968-8080(04)23110-X; Central Statistical Agency, 2007, 2007 POP HOUS CENS 1; Central Statistical Agency/Ethiopia and ICF International, 2017, ETH DEM HLTH SURV 20; Ethiopian Public Health Institute Federal Ministry of Health Ethiopia Averting Maternal Death and Dis-ability (AMDD) Colombia University, 2017, ETH EM OBST NEWB CAR; Getahun S.A., 2013, MANUAL ETHIOPIAN MED, P15; Giday M, 2007, J ETHNOPHARMACOL, V110, P516, DOI 10.1016/j.jep.2006.10.011; Gjerde JL, 2013, INT UROGYNECOL J, V24, P953, DOI 10.1007/s00192-012-1951-4; Gjerde JL, 2017, INT UROGYNECOL J, V28, P361, DOI 10.1007/s00192-016-3077-6; Good Byron, 2010, READER MED ANTHR THE; Hannig A., 2012, THESIS; Hardee K, 2012, GLOB PUBLIC HEALTH, V7, P603, DOI 10.1080/17441692.2012.668919; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Helman CG, 2007, CULTURE HLTH ILLNESS; Kebede Deribe Kassaye, 2006, Ethiopian Journal of Health Development, V20, P127; Kumari S, 2000, J MIDWIFERY WOM HEAL, V45, P343, DOI 10.1016/S1526-9523(00)00033-7; Lukacz ES, 2006, OBSTET GYNECOL, V107, P1253, DOI 10.1097/01.AOG.0000218096.54169.34; Manonai J, 2011, INT UROGYNECOL J, V22, P347, DOI 10.1007/s00192-010-1286-y; Megabiaw B, 2013, INT UROGYNECOL J, V24, P1135, DOI 10.1007/s00192-012-1981-y; MESSING SD, 1958, AM ANTHROPOL, V60, P1120, DOI 10.1525/aa.1958.60.6.02a00060; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Muleta M, 2008, J OBSTET GYNAECOL CA, V30, P44, DOI 10.1016/S1701-2163(16)32712-8; Nguyen VM, 2003, ANNU REV ANTHROPOL, V32, P447, DOI 10.1146/annurev.anthro.32.061002.093412; Ravindran TS, 1999, SAFE MOTHERHOOD INIT, P166; REMINICK RA, 1974, ETHNOLOGY, V13, P279, DOI 10.2307/3773168; Rizk DEE, 2009, INT UROGYNECOL J, V20, P615, DOI 10.1007/s00192-009-0891-0; Rortveit G, 2007, OBSTET GYNECOL, V109, P1396, DOI 10.1097/01.AOG.0000263469.68106.90; Shrestha B, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-20; Singer M., 2004, ENCYCLOPAEDIA MEDICA, V1, P23; Walker GJA, 2011, INT UROGYNECOL J, V22, P127, DOI 10.1007/s00192-010-1215-0; Woldemicael G, 2010, MATERN CHILD HLTH J, V14, P988, DOI 10.1007/s10995-009-0535-5	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207651	10.1371/journal.pone.0207651	http://dx.doi.org/10.1371/journal.pone.0207651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475923	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700049
J	Kutil, Z; Skultetyova, L; Rauh, D; Meleshin, M; Snajdr, I; Novakova, Z; Mikesova, J; Pavlicek, J; Hadzima, M; Baranova, P; Havlinova, B; Majer, P; Schutkowski, M; Barinka, C				Kutil, Zsofia; Skultetyova, Lubica; Rauh, David; Meleshin, Marat; Snajdr, Ivan; Novakova, Zora; Mikesova, Jana; Pavlicek, Jiri; Hadzima, Martin; Baranova, Petra; Havlinova, Barbora; Majer, Pavel; Schutkowski, Mike; Barinka, Cyril			The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries	FASEB JOURNAL			English	Article						human acetylome; deacylation; deformylation; logo	2 CATALYTIC DOMAINS; ACETYLATION SITE; STRESS GRANULES; HDAC6; LYSINE; MICROTUBULES; PROTEINS; TUBULIN; ARRAYS; FORMYLATION	Histone deacetylase 6 (HDAC6) is a multidomain cytosolic hydrolase acting mostly on nonhistone protein substrates. Investigations of the substrate specificity of HDAC6 are confounded by the presence of 2 catalytically active deacetylase domains (DD1 and DD2). In this study, acetylome peptide microarrays and peptide libraries were used to map the substrate specificity of DD1 and DD2 of human HDAC6. The results show that DD1 is solely responsible for the deacetylation of substrates harboring the acetyllysine at their C terminus, whereas DD2 exclusively deacetylates peptides with an internal acetyllysine residue. Also, statistical analysis of the deacetylation data revealed amino acid preferences at individual positions flanking the acetyllysine, where glycine and arginine residues are favored at positions N-terminal to the central acetyllysine; negatively charged glutamate is strongly disfavored throughout the sequence. Finally, the deacylation activity of HDAC6 was profiled by using a panel of acyl derivatives of the optimized peptide substrate and showed that HDAC6 acts as a proficient deformylase. Our data thus offer a detailed insight into the substrate preferences of the individual HDAC6 domains at the peptide level, and these findings can in turn help in elucidating the biologic roles of the enzyme and facilitate the development of new domain-specific inhibitors as research tools or therapeutic agents.Kutil, Z., Skultetyova, L., Rauh, D., Meleshin, M., Snajdr, I., Novakova, Z., Mikesova, J., Pavlicek, J., Hadzima, M., Baranova, P., Havlinova, B., Majer, P., Schutkowski, M., Barinka, C. The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries.	[Kutil, Zsofia; Skultetyova, Lubica; Novakova, Zora; Mikesova, Jana; Pavlicek, Jiri; Baranova, Petra; Havlinova, Barbora; Barinka, Cyril] Czech Acad Sci, BIOCEV, Inst Biotechnol, Vestec, Czech Republic; [Rauh, David; Meleshin, Marat; Schutkowski, Mike] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Charles Tanford Prot Ctr, Dept Enzymol, Kurt Mothes Str 3a, D-06120 Halle, Saale, Germany; [Snajdr, Ivan; Hadzima, Martin; Majer, Pavel] CAS, Inst Organ Chem & Biochem, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Martin Luther University Halle Wittenberg; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Schutkowski, M (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Charles Tanford Prot Ctr, Dept Enzymol, Kurt Mothes Str 3a, D-06120 Halle, Saale, Germany.; Barinka, C (corresponding author), CAS, Inst Biotechnol, Vvi, Struct Biol Lab, Prumyslova 595, Vestec 25250, Czech Republic.	mike.schutkowski@biochemtech.uni-halle.de; cyril.barinka@ibt.cas.cz	Kutil, Zsofia/O-1096-2013; Novakova, Zora/G-8665-2014; Škultétyová, Ľubica/H-3053-2014; Majer, Pavel/G-1141-2019	Novakova, Zora/0000-0001-9804-6346; Škultétyová, Ľubica/0000-0001-7627-5367; Snajdr, Ivan/0000-0002-0831-4034; Rauh, David/0000-0001-7499-1693; Hadzima, Martin/0000-0002-6479-3682; Barinka, Cyril/0000-0003-2751-3060	Czech Science Foundation [15-19640S]; Czech Academy of Sciences [RVO: 86652036]; Charles University from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Biotechnology and Biomedicine Center of the Academy of Sciences	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences); Charles University from the European Regional Development Fund; Biotechnology and Biomedicine Center of the Academy of Sciences	The authors thank I. Jelinkova (Institute of Biotechnology of the Czech Academy of Sciences) and J. Barinkova (Institute of Organic Chemistry and Biochemistry of the CAS) for their excellent technical assistance. This work was supported by the Czech Science Foundation (Grant 15-19640S), the Czech Academy of Sciences (RVO: 86652036), and the Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109) from the European Regional Development Fund. The authors declare no conflicts of interest.	AbouElfetouh A, 2015, MICROBIOLOGYOPEN, V4, P66, DOI 10.1002/mbo3.223; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Castaneda CA, 2017, J BIOL CHEM, V292, P21568, DOI 10.1074/jbc.M117.811026; Castaneda CA, 2017, BIOCHEMISTRY-US, V56, P5663, DOI 10.1021/acs.biochem.7b00851; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Di Fulvio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028563; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Gurard-Levin ZA, 2009, CHEMBIOCHEM, V10, P2159, DOI 10.1002/cbic.200900417; Hai Y, 2016, NAT CHEM BIOL, V12, P741, DOI 10.1038/nchembio.2134; Han Y, 2009, BIOCHEM BIOPH RES CO, V383, P88, DOI 10.1016/j.bbrc.2009.03.147; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Jung HY, 2013, CANCER RES TREAT, V45, P134, DOI 10.4143/crt.2013.45.2.134; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kuo HY, 2013, ANAL CHEM, V85, P10635, DOI 10.1021/ac402614x; Kutil Z, 2018, ACS CHEM BIOL, V13, P685, DOI 10.1021/acschembio.7b00942; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Legros S, 2011, ONCOGENE, V30, P4050, DOI 10.1038/onc.2011.120; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Marino G, 2015, ACS CHEM BIOL, V10, P1754, DOI 10.1021/acschembio.5b00189; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McClure JJ, 2017, ACS CHEM BIOL, V12, P1644, DOI 10.1021/acschembio.7b00321; Miyake Y, 2016, NAT CHEM BIOL, V12, P748, DOI 10.1038/nchembio.2140; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Patel K, 2015, J BIOMOL SCREEN, V20, P842, DOI 10.1177/1087057115588512; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Reineke U., 2006, BIOMEMS BIOMEDICAL N, V2, P161; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Salemi LM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3430-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Thiele A, 2011, MOL BIOTECHNOL, V49, P283, DOI 10.1007/s12033-011-9402-x; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Wisniewski JR, 2008, NUCLEIC ACIDS RES, V36, P570, DOI 10.1093/nar/gkm1057; Wu JY, 2018, J BIOL CHEM, V293, P1976, DOI 10.1074/jbc.M117.795955; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Yu XD, 2002, J NATL CANCER I, V94, P504; Zhang LL, 2015, PROTEIN CELL, V6, P42, DOI 10.1007/s13238-014-0102-8; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	53	19	19	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4035	4045		10.1096/fj.201801680R	http://dx.doi.org/10.1096/fj.201801680R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496698	Bronze			2022-12-26	WOS:000459794800074
J	Lana, D; Ugolini, F; Wenk, GL; Giovannini, MG; Zecchi-Orlandini, S; Nosi, D				Lana, Daniele; Ugolini, Filippo; Wenk, Gary L.; Giovannini, Maria Grazia; Zecchi-Orlandini, Sandra; Nosi, Daniele			Microglial distribution, branching, and clearance activity in aged rat hippocampus are affected by astrocyte meshwork integrity: evidence of a novel cell-cell interglial interaction	FASEB JOURNAL			English	Article						neuroinflammation; aging; microglia dysregulation; neuronophagia; integrin-1	CHRONIC CEREBRAL HYPOPERFUSION; ALZHEIMERS-DISEASE; PROCESS EXTENSION; ACTIVATION; PHAGOCYTOSIS; FIBRONECTIN; INVOLVEMENT; CHEMOTAXIS; EXPRESSION; FORCES	Aging and neurodegenerative diseases share a condition of neuroinflammation entailing the production of endogenous cell debris in the CNS that must be removed by microglia (i.e., resident macrophages), to restore tissue homeostasis. In this context, extension of microglial cell branches toward cell debris underlies the mechanisms of microglial migration and phagocytosis. Amoeboid morphology and the consequent loss of microglial branch functionality characterizes dysregulated microglia. Microglial migration is assisted by another glial population, the astroglia, which forms a dense meshwork of cytoplasmic projections. Amoeboid microglia and disrupted astrocyte meshwork are consistent traits in aged CNS. In this study, we assessed a possible correlation between microglia and astroglia morphology in rat models of chronic neuroinflammation and aging, by 3-dimensional confocal analysis implemented with particle analysis. Our findings suggest that a microglia-astroglia interaction occurs in rat hippocampus via cell-cell contacts, mediating microglial cell branching in the presence of inflammation. In aged rats, the impairment of such an interaction correlates with altered distribution, morphology, and inefficient clearance by microglia. These data support the idea that generally accepted functional boundaries between microglia and astrocytes should be re-evaluated to better understand how their functions overlap and interact.Lana, D., Ugolini, F., Wenk, G. L., Giovannini, M. G., Zecchi-Orlandini, S., Nosi, D. Microglial distribution, branching, and clearance activity in aged rat hippocampus are affected by astrocyte meshwork integrity: evidence of a novel cell-cell interglial interaction.	[Lana, Daniele; Ugolini, Filippo; Giovannini, Maria Grazia] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [Zecchi-Orlandini, Sandra; Nosi, Daniele] Univ Florence, Dept Expt & Clin Med, Largo Brambilla 3, I-50134 Florence, Italy; [Wenk, Gary L.] Ohio State Univ, Dept Psychol, Columbus, OH USA	University of Florence; University of Florence; University System of Ohio; Ohio State University	Nosi, D (corresponding author), Univ Florence, Dept Expt & Clin Med, Largo Brambilla 3, I-50134 Florence, Italy.	daniele.nosi@unifi.it		Ugolini, Filippo/0000-0003-3603-2111	University of Florence	University of Florence	The authors thank Prof. Giovanni Delfino, University of Florence, and Prof. Diego Minciacchi, University of Florence, for their assistance in the preparation of the manuscript. This work was partially funded by grants to D. N. and S. Z.-O. by the University of Florence. The authors declare no conflicts of interest.	Barcia C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00809; Bollmann L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00363; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Chen YF, 2017, MOL BIOL CELL, V28, P3134, DOI 10.1091/mbc.E17-04-0228; Chitnis T, 2017, J CLIN INVEST, V127, P3577, DOI 10.1172/JCI90609; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Daria A, 2017, EMBO J, V36, P583, DOI 10.15252/embj.201694591; Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172; Elali A, 2016, BRAIN BEHAV IMMUN, V55, P138, DOI 10.1016/j.bbi.2015.07.021; Fan Y, 2017, MOL CELLS, V40, P163, DOI 10.14348/molcells.2017.0011; Fonseca RS, 2016, STEM CELLS DEV, V25, P542, DOI 10.1089/scd.2015.0319; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Giovannini MG, 2002, METHOD ENZYMOL, V345, P426; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Kanazawa H, 2002, J BIOL CHEM, V277, P20026, DOI 10.1074/jbc.M109218200; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kwon YH, 2017, FEBS LETT, V591, P1742, DOI 10.1002/1873-3468.12691; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lana D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00296; Lana D, 2017, EXP GERONTOL, V96, P46, DOI 10.1016/j.exger.2017.06.006; Lana D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00322; Lefort CT, 2011, J BIOL CHEM, V286, P3149, DOI 10.1074/jbc.M110.115733; Liu W, 2011, LIFE SCI, V89, P141, DOI 10.1016/j.lfs.2011.05.011; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Maldonado H, 2017, BBA-MOL CELL RES, V1864, P243, DOI 10.1016/j.bbamcr.2016.11.006; Mercatelli R, 2016, FASEB J, V30, P1480, DOI 10.1096/fj.15-275503; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ohsawa K, 2010, GLIA, V58, P790, DOI 10.1002/glia.20963; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Peng H, 2008, DEV NEUROBIOL, V68, P559, DOI 10.1002/dneu.20593; Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00566; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Tian L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-155; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; VanGuilder HD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-138; Vilalta A, 2018, FEBS J, V285, P3566, DOI 10.1111/febs.14323; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wes PD, 2016, GLIA, V64, P1710, DOI 10.1002/glia.22988; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Yamaguchi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep07656	62	16	17	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4007	4020		10.1096/fj.201801539R	http://dx.doi.org/10.1096/fj.201801539R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30496700				2022-12-26	WOS:000459794800072
J	Wang, YS; Wang, C; Liu, N; Hou, J; Xiao, WJ; Wang, H				Wang, Yongsheng; Wang, Cong; Liu, Na; Hou, Jun; Xiao, Wenjing; Wang, Hui			HOXC6 promotes cervical cancer progression via regulation of Bcl-2	FASEB JOURNAL			English	Article						BCL2 apoptosis; HPV; invasion; cell cycle	GENE-EXPRESSION; IN-VITRO; APOPTOSIS; FAMILY	Homeobox C6 (HOXC6) is a transcription factor that plays an important role in the development of several cancers. However, it is unknown whether HOXC6 regulates cervical cancer progression. In this study, we used quantitative PCR and Western blots to demonstrate that HOXC6 overexpression is associated with cervical cancer progression. These results are also supported by the public RNA-seq data showing that HOXC6 overexpression is correlated with poor patient survival. In vitro and in vivo experiments revealed that enhanced HOXC6 expression results in cervical cancer cell proliferation, cell cycle progression, anchorage colony formation, and xenograft tumor growth. Mechanistically, we show that HOXC6 up-regulates BCL2 expression through transcription regulation. Together, these results led us to conclude that overexpression of HOXC6 expression can enhance BCL2-mediated antiapoptotic effects to promote cervical cancer cell cycle progression and proliferation.Wang, Y., Wang, C., Liu, N., Hou, J., Xiao, W., Wang, H. HOXC6 promotes cervical cancer progression via regulation of Bcl-2.	[Wang, Yongsheng; Wang, Cong; Liu, Na; Wang, Hui] Peoples Hosp Linyi City, Dept Obstet & Gynecol, 27 Jiefang Rd, Linyi 276000, Shandong, Peoples R China; [Hou, Jun; Xiao, Wenjing] Chengdu Mil Gen Hosp, Dept Pharm, Chengdu, Sichuan, Peoples R China		Wang, H (corresponding author), Peoples Hosp Linyi City, Dept Obstet & Gynecol, 27 Jiefang Rd, Linyi 276000, Shandong, Peoples R China.	591768560@qq.com			National Natural Science Foundation of China [81402507]; China Postdoctoral Science Foundation Grant [2014M552600]; Innovation Project of Medical Science and Research of Sichuan Province [Q14006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Grant(China Postdoctoral Science Foundation); Innovation Project of Medical Science and Research of Sichuan Province	This work was supported by National Natural Science Foundation of China Grant 81402507 (to W.X.), China Postdoctoral Science Foundation Grant 2014M552600 (to J.H.), and Innovation Project of Medical Science and Research of Sichuan Province Grant Q14006 (to J.H.). The authors declare no conflicts of interest.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Abe M, 2006, ONCOL REP, V15, P797; ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Ansari KI, 2011, J MOL BIOL, V411, P334, DOI 10.1016/j.jmb.2011.05.050; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Bhatlekar S, 2014, J MOL MED, V92, P811, DOI 10.1007/s00109-014-1181-y; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Jin Y, 2014, INT J CLIN EXP PATHO, V7, P8724; Moon SM, 2012, J BIOL CHEM, V287, P35678, DOI 10.1074/jbc.M112.361675; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151427; Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shrestha B, 2012, FEBS J, V279, P3715, DOI 10.1111/j.1742-4658.2012.08733.x; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stein S, 1996, MECH DEVELOP, V55, P91, DOI 10.1016/0925-4773(95)00494-7; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Yim Eun-Kyoung, 2005, Cancer Res Treat, V37, P319, DOI 10.4143/crt.2005.37.6.319; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	32	19	20	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3901	3911		10.1096/fj.201801099RR	http://dx.doi.org/10.1096/fj.201801099RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509141				2022-12-26	WOS:000459794800064
J	Johnson, SR; Bhat, WW; Bibik, J; Turmo, A; Hamberger, B; Hamberger, B				Johnson, Sean R.; Bhat, Wajid Waheed; Bibik, Jacob; Turmo, Aiko; Hamberger, Britta; Hamberger, Bjoern		Evolutionary Mint Genomics	A database-driven approach identifies additional diterpene synthase activities in the mint family (Lamiaceae)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						secondary metabolism; terpenoid; plant biochemistry; transcriptomics; biosynthesis; chemotaxonomy; diterpene synthase; enzymes; Lamiaceae; phytochemistry	INSECT ANTIFEEDANT ACTIVITY; SINGLE RESIDUE SWITCH; MEDICINAL-PLANT; CLERODANE DITERPENES; DIPHOSPHATE SYNTHASE; BIOSYNTHESIS; LABDANE; CATALYZES; METABOLISM; EXPRESSION	Members of the mint family (Lamiaceae) accumulate a wide variety of industrially and medicinally relevant diterpenes. We recently sequenced leaf transcriptomes from 48 phylogenetically diverse Lamiaceae species. Here, we summarize the available chemotaxonomic and enzyme activity data for diterpene synthases (diTPSs) in the Lamiaceae and leverage the new transcriptomes to explore the diTPS sequence and functional space. Candidate genes were selected with an intent to evenly sample the sequence homology space and to focus on species in which diTPS transcripts were found, yet from which no diterpene structures have been previously reported. We functionally characterized nine class II diTPSs and 10 class I diTPSs from 11 distinct plant species and found five class II activities, including two novel activities, as well as a spectrum of class I activities. Among the class II diTPSs, we identified a neo-cleroda-4(18),13E-dienyl diphosphate synthase from Ajuga reptans, catalyzing the likely first step in the biosynthesis of a variety of insect-antifeedant compounds. Among the class I diTPSs was a palustradiene synthase from Origanum majorana, leading to the discovery of specialized diterpenes in that species. Our results provide insights into the diversification of diterpene biosynthesis in the mint family and establish a comprehensive foundation for continued investigation of diterpene biosynthesis in the Lamiaceae.	[Johnson, Sean R.; Bhat, Wajid Waheed; Bibik, Jacob; Turmo, Aiko; Hamberger, Britta; Hamberger, Bjoern] Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 212, E Lansing, MI 48824 USA; [Bhat, Wajid Waheed] Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Evolutionary Mint Genomics] Michigan State Univ, E Lansing, MI 48824 USA	Michigan State University	Hamberger, B (corresponding author), Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 212, E Lansing, MI 48824 USA.; Hamberger, B (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 212, E Lansing, MI 48824 USA.	hamberge@msu.edu	Bhat, Wajid Waheed/E-6645-2012; Hamberger, Bjoern/I-2122-2012	Bhat, Wajid Waheed/0000-0002-7049-8671; Hamberger, Bjoern/0000-0003-1249-1807; Johnson, Sean/0000-0001-8261-9015; Henry, Laura/0000-0003-0037-2114	Michigan State University Strategic Partnership Grant program; Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India; Indo-US Science and Technology Forum (IUSSTF) Indo-US postdoctoral fellowship; United States Department of Energy-Great Lakes Bioenergy Research Center [DE-FC02-07ER64494, DE-SC0018409]; Michigan State University Strategic Partnership Grant program "Plant-inspired Chemical Diversity"; Department of Molecular Biology and Biochemistry, Michigan State University; Michigan State University AgBioResearch Grant [MICL02454]; National Science Foundation [1737898]	Michigan State University Strategic Partnership Grant program; Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); Indo-US Science and Technology Forum (IUSSTF) Indo-US postdoctoral fellowship; United States Department of Energy-Great Lakes Bioenergy Research Center; Michigan State University Strategic Partnership Grant program "Plant-inspired Chemical Diversity"; Department of Molecular Biology and Biochemistry, Michigan State University; Michigan State University AgBioResearch Grant; National Science Foundation(National Science Foundation (NSF))	This work was primarily supported by the Michigan State University Strategic Partnership Grant program ("Evolutionary-Driven Genome Mining of Plant Biosynthetic Pathways"). Bjorn Hamberger, W. W. B., and S. R. J. report a potential conflict of interest: they have filed a patent application (United States Patent Application Serial No. 62/714,216) covering the genes reported in this study. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.; Supported by the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India and the Indo-US Science and Technology Forum (IUSSTF) Indo-US postdoctoral fellowship.; Supported by United States Department of Energy-Great Lakes Bioenergy Research Center Cooperative Agreements DE-FC02-07ER64494 and DE-SC0018409; the Michigan State University Strategic Partnership Grant program "Plant-inspired Chemical Diversity"; startup funding from the Department of Molecular Biology and Biochemistry, Michigan State University; and Michigan State University AgBioResearch Grant MICL02454 and supported in part by National Science Foundation Grant 1737898. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Michigan State University, 603 Wilson Rd., Rm. 212, East Lansing, MI 48824. E-mail: hamberge@msu.edu.	Alvarenga SAV, 2001, PHYTOCHEMISTRY, V56, P583, DOI 10.1016/S0031-9422(00)00424-6; Andersen-Ranberg J, 2016, ANGEW CHEM INT EDIT, V55, P2142, DOI 10.1002/anie.201510650; ANDERSON JC, 1989, TETRAHEDRON LETT, V30, P4737, DOI 10.1016/S0040-4039(01)80789-9; [Anonymous], 2018, DICTIONARY OF NATURA; Arima Y, 2007, TETRAHEDRON-ASYMMETR, V18, P1701, DOI 10.1016/j.tetasy.2007.07.010; Banerjee A, 2018, PHYTOCHEM REV, V17, P81, DOI 10.1007/s11101-017-9530-4; BARTON DH, 1961, J CHEM SOC, P5061, DOI 10.1039/jr9610005061; BELLES X, 1985, J CHEM ECOL, V11, P1439, DOI 10.1007/BF01012143; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boachon B, 2018, MOL PLANT, V11, P1084, DOI 10.1016/j.molp.2018.06.002; Boalino DM, 2004, J NAT PROD, V67, P714, DOI 10.1021/np030480i; BOHLMANN F, 1979, PHYTOCHEMISTRY, V18, P115, DOI 10.1016/S0031-9422(00)90926-9; Busta L, 2018, PHYTOCHEM REV, V17, P1275, DOI 10.1007/s11101-017-9542-0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caniard A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-119; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Chau MD, 2004, ARCH BIOCHEM BIOPHYS, V430, P237, DOI 10.1016/j.abb.2004.07.013; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chen XY, 2017, J EXP BOT, V68, P1109, DOI 10.1093/jxb/erw493; Chen YL, 2008, J NAT PROD, V71, P1207, DOI 10.1021/np800147z; Coll Josep, 2008, Phytochemistry Reviews, V7, P25, DOI 10.1007/s11101-006-9023-3; Cui GH, 2015, PLANT PHYSIOL, V169, P1607, DOI 10.1104/pp.15.00695; Dairi T, 2001, J BACTERIOL, V183, P6085, DOI 10.1128/JB.183.20.6085-6094.2001; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ennajdaoui H, 2010, PLANT MOL BIOL, V73, P673, DOI 10.1007/s11103-010-9648-x; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Fischedick JT, 2015, PHYTOCHEMISTRY, V113, P87, DOI 10.1016/j.phytochem.2014.11.020; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Gebbinck EAK, 2002, PHYTOCHEMISTRY, V61, P737, DOI 10.1016/S0031-9422(02)00174-7; GEUSKENS RBM, 1983, EXPERIENTIA, V39, P403, DOI 10.1007/BF01963148; GONZALEZ AG, 1991, PHYTOCHEMISTRY, V30, P4067, DOI 10.1016/0031-9422(91)83468-Z; Gray CA, 2003, PHYTOCHEMISTRY, V63, P409, DOI 10.1016/S0031-9422(03)00156-0; Gunnewich N, 2013, PHYTOCHEMISTRY, V91, P93, DOI 10.1016/j.phytochem.2012.07.019; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamano Y, 2002, J BIOL CHEM, V277, P37098, DOI 10.1074/jbc.M206382200; Hamberger B, 2011, PLANT PHYSIOL, V157, P1677, DOI 10.1104/pp.111.185843; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Han QB, 2006, ORG LETT, V8, P4727, DOI 10.1021/ol061757j; Hansen NL, 2017, PHYTOCHEMISTRY, V138, P52, DOI [10.1016/j.phytochem.2017.02.022, 10.1016/j.p]; Harris LJ, 2005, PLANT MOL BIOL, V59, P881, DOI 10.1007/s11103-005-1674-8; Heller SR, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0068-4; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Heskes AM, 2018, PLANT J, V93, P943, DOI 10.1111/tpj.13822; Hillwig ML, 2011, PLANT J, V68, P1051, DOI 10.1111/j.1365-313X.2011.04756.x; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Ikeda H, 2016, J IND MICROBIOL BIOT, V43, P325, DOI 10.1007/s10295-015-1694-6; Jia MR, 2018, ACS CATAL, V8, P3133, DOI 10.1021/acscatal.8b00121; Jia M, 2017, ACS CHEM BIOL, V12, P862, DOI 10.1021/acschembio.6b01075; Jia MR, 2016, METAB ENG, V37, P24, DOI 10.1016/j.ymben.2016.04.001; Jin BL, 2017, PLANT PHYSIOL, V174, P943, DOI 10.1104/pp.17.00202; Keeling CI, 2011, J BIOL CHEM, V286, P21145, DOI 10.1074/jbc.M111.245951; Kirby J, 2010, PHYTOCHEMISTRY, V71, P1466, DOI 10.1016/j.phytochem.2010.06.001; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kuhn S., 2012, J CHEMINFORMATICS, V4, P52, DOI [10.1186/1758-2946-4-S1-P52, DOI 10.1186/1758-2946-4-S1-P52]; Li B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34343; Li JL, 2012, PHYTOCHEMISTRY, V76, P32, DOI 10.1016/j.phytochem.2011.12.021; Li LM, 2009, J NAT PROD, V72, P1851, DOI 10.1021/np900406c; Li RT, 2016, NAT PROD REP, V33, P1166, DOI 10.1039/c5np00137d; Li XN, 2010, J NAT PROD, V73, P1803, DOI 10.1021/np1004328; Lopez-Perez JL, 2007, BIOINFORMATICS, V23, P3256, DOI 10.1093/bioinformatics/btm516; LOUB WD, 1985, J CHEM INF COMP SCI, V25, P99, DOI 10.1021/ci00046a009; Mafu S, 2015, CHEM COMMUN, V51, P13485, DOI 10.1039/c5cc05754j; Mann FM, 2010, J BIOL CHEM, V285, P20558, DOI 10.1074/jbc.M110.123307; Monaco P., 1982, REND ACCAD SCI FIS, V48, P465; Nutzmann HW, 2016, NEW PHYTOL, V211, P771, DOI 10.1111/nph.13981; OHSAKI A, 1994, BIOORG MED CHEM LETT, V4, P2889, DOI 10.1016/S0960-894X(01)80834-9; Ondari ME, 2008, J AM CHEM SOC, V130, P17187, DOI 10.1021/ja8067534; Pateraki I, 2017, ELIFE, V6, DOI 10.7554/eLife.23001; Pateraki I, 2014, PLANT PHYSIOL, V164, P1222, DOI 10.1104/pp.113.228429; Pelot KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176507; Pelot KA, 2017, PLANT J, V89, P885, DOI 10.1111/tpj.13427; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Potter K, 2014, ANGEW CHEM INT EDIT, V53, P7198, DOI 10.1002/anie.201402911; Potter KC, 2016, ANGEW CHEM INT EDIT, V55, P634, DOI 10.1002/anie.201509060; Roengsumran S, 1999, PHYTOCHEMISTRY, V50, P449, DOI 10.1016/S0031-9422(98)00604-9; RUDI A, 1992, J NAT PROD, V55, P1408, DOI 10.1021/np50088a004; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Schalk M, 2012, J AM CHEM SOC, V134, P18900, DOI 10.1021/ja307404u; Schulte S, 2018, BIOCHEMISTRY-US, V57, P3473, DOI 10.1021/acs.biochem.8b00193; Scotti MT, 2018, MOLECULES, V23, DOI 10.3390/molecules23010103; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174804; SUZUKI H, 1983, PHYTOCHEMISTRY, V22, P1294, DOI 10.1016/0031-9422(83)80249-0; URONES JG, 1994, PHYTOCHEMISTRY, V35, P713, DOI 10.1016/S0031-9422(00)90593-4; Wu CL, 1997, PHYTOCHEMISTRY, V44, P101; Xiang W, 2004, HELV CHIM ACTA, V87, P2860, DOI 10.1002/hlca.200490257; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; Yamada Y, 2016, J ANTIBIOT, V69, P515, DOI 10.1038/ja.2015.147; Zerbe P, 2015, PLANT J, V83, P783, DOI 10.1111/tpj.12925; Zerbe P, 2015, TRENDS BIOTECHNOL, V33, P419, DOI 10.1016/j.tibtech.2015.04.006; Zerbe P, 2014, PLANT J, V79, P914, DOI 10.1111/tpj.12589; Zhan X, 2015, PLANT PHYSIOL BIOCH, V96, P110, DOI 10.1016/j.plaphy.2015.07.011; Zi JC, 2014, ANNU REV PLANT BIOL, V65, P259, DOI 10.1146/annurev-arplant-050213-035705	97	31	31	10	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1349	1362		10.1074/jbc.RA118.006025	http://dx.doi.org/10.1074/jbc.RA118.006025			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30498089	Green Published, hybrid			2022-12-26	WOS:000457879500025
J	Marcelo, F; Supekar, N; Corzana, F; van der Horst, JC; Vuist, IM; Live, D; Boons, GJPH; Smith, DF; van Vliet, SJ				Marcelo, Filipa; Supekar, Nitin; Corzana, Francisco; van der Horst, Joost C.; Vuist, Ilona M.; Live, David; Boons, Geert-Jan P. H.; Smith, David F.; van Vliet, Sandra J.			Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular modeling; microarray; peptide array; alternative splicing; mutant; C-type lectin; carbohydrate specificity; MGL; Tn antigen; splice variant; glycopeptide; glycan; carbohydrate recognition domain	C-TYPE LECTIN; DENDRITIC CELLS; THREONINE GLYCOSYLATION; STRUCTURAL ELEMENTS; EXPRESSION; RECEPTOR; MGL; ANTIGEN; GLYCOPEPTIDES; ANTIBODY	The human macrophage galactose-type lectin (MGL) is a C-type lectin characterized by a unique specificity for terminal GalNAc residues present in the tumor-associated Tn antigen (alpha GalNAc-Ser/Thr) and its sialylated form, the sialyl-Tn antigen. However, human MGL has multiple splice variants, and whether these variants have distinct ligand-binding properties is unknown. Here, using glycan microarrays, we compared the binding properties of the short MGL 6C (MGL(short)) and the long MGL 6B (MGL(long)) splice variants, as well as of a histidine-to-threonine mutant (MGL(short) H259T). Although the MGL(short) and MGL(long) variants displayed similar binding properties on the glycan array, the MGL(short) H259T mutant failed to interact with the sialyl-Tn epitope. As the MGL(short) H259T variant could still bind a single GalNAc monosaccharide on this array, we next investigated its binding characteristics to Tn-containing glycopeptides derived from the MGL ligands mucin 1 (MUC1), MUC2, and CD45. Strikingly, in the glycopeptide microarray, the MGL(short) H259T variant lost high-affinity binding toward Tn-containing glycopeptides, especially at low probing concentrations. Moreover, MGL(short) H259T was unable to recognize cancer-associated Tn epitopes on tumor cell lines. Molecular dynamics simulations indicated that in WT MGL(short), His(259) mediates H bonds directly or engages the Tn-glycopeptide backbone through water molecules. These bonds were lost in MGL(short) H259T, thus explaining its lower binding affinity. Together, our results suggest that MGL not only connects to the Tn carbohydrate epitope, but also engages the underlying peptide via a secondary binding pocket within the MGL carbohydrate recognition domain containing the His(259) residue.	[Marcelo, Filipa] REQUIMTE, UCIBIO, Fac Ciencias & Tecnol, Dept Quim, P-2829516 Caparica, Portugal; [Supekar, Nitin; Live, David; Boons, Geert-Jan P. H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Corzana, Francisco] Univ La Rioja, Ctr Invest Sintesis Quim, Dept Quim, E-26006 Logrono, Spain; [van der Horst, Joost C.; Vuist, Ilona M.; van Vliet, Sandra J.] Vrije Univ Amsterdam, Amsterdam Infect & Immun Inst, Dept Mol Cell Biol & Immunol, Canc Ctr Amsterdam,Amsterdam UMC, NL-1081 HZ Amsterdam, Netherlands; [Smith, David F.] Emory Univ, Sch Med, Emory Comprehens Glyc Ctr, Dept Biochem, Atlanta, GA 30322 USA; [Vuist, Ilona M.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [Boons, Geert-Jan P. H.] Univ Utrecht, Dept Pharmaceut Sci & Chem, NL-3584 CG Utrecht, Netherlands	University System of Georgia; University of Georgia; Universidad de La Rioja; University of Amsterdam; Vrije Universiteit Amsterdam; Emory University; University of Amsterdam; Utrecht University	van Vliet, SJ (corresponding author), Locat VU Univ, Med Ctr, Amsterdam UMC, Dept Mol Cell Biol & Immunol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	s.vanvliet@vumc.nl	Boons, Geert-Jan P H/J-3211-2016; Van Vliet, Sandra/AAO-9534-2020; Marcelo, Filipa/C-9588-2013; Supekar, Nitin/K-5737-2019; Smith, David/GQQ-8257-2022; Corzana, Francisco/B-1310-2015	Boons, Geert-Jan P H/0000-0003-3111-5954; Marcelo, Filipa/0000-0001-5049-8511; Supekar, Nitin/0000-0002-7006-7177; van Vliet, Sandra/0000-0003-1811-2687; Corzana, Francisco/0000-0001-5597-8127	National Institutes of Health [U54GM62116, P41GM103390]; FCT-Portugal IF project [IF/00780/2015]; UCIBIO funding [UID/Multi/04378/2013]; FEDER [POCI-01-0145-FEDER-007728]; Ministerio de Economia y Competitividad Projects [CTQ2015-67727-R, UNLR13-4E-1931]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT-Portugal IF project; UCIBIO funding; FEDER(European Commission); Ministerio de Economia y Competitividad Projects; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a bridging grant under National Institutes of Health Grant U54GM62116 (to the Consortium for Functional Glycomics) and P41GM103390 (to the Research Resource for Integrated Glycotechnology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the FCT-Portugal IF project (IF/00780/2015) and the UCIBIO funding UID/Multi/04378/2013, co-financed by the FEDER (POCI-01-0145-FEDER-007728).; Supported by Ministerio de Economia y Competitividad Projects CTQ2015-67727-R and UNLR13-4E-1931.	Agravat SB, 2014, BIOINFORMATICS, V30, P3417, DOI 10.1093/bioinformatics/btu559; ANDREA TA, 1983, J CHEM PHYS, V79, P4576, DOI 10.1063/1.446373; Artigas G, 2017, J MED CHEM, V60, P9012, DOI 10.1021/acs.jmedchem.7b01242; Beatson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125994; Bermejo IA, 2018, J AM CHEM SOC, V140, P9952, DOI 10.1021/jacs.8b04801; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Brooks CL, 2010, P NATL ACAD SCI USA, V107, P10056, DOI 10.1073/pnas.0915176107; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; Corzana F, 2007, J AM CHEM SOC, V129, P9458, DOI 10.1021/ja072181b; Corzana F, 2006, J AM CHEM SOC, V128, P14640, DOI 10.1021/ja064539u; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; Feinberg H, 2009, J MOL BIOL, V394, P613, DOI 10.1016/j.jmb.2009.10.006; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Freire T, 2010, BLOOD, V116, P3526, DOI 10.1182/blood-2010-04-279133; Gibadullin R, 2017, ACS CHEM BIOL, V12, P2172, DOI 10.1021/acschembio.7b00471; HAKOMORI S, 1977, P NATL ACAD SCI USA, V74, P3023, DOI 10.1073/pnas.74.7.3023; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; Hirano K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981627; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697; Jegouzo SAF, 2013, GLYCOBIOLOGY, V23, P853, DOI 10.1093/glycob/cwt022; Joo EJ, 2014, OMICS, V18, P231, DOI 10.1089/omi.2013.0128; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; Lenos K, 2015, ONCOTARGET, V6, P26278, DOI 10.18632/oncotarget.4495; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Liao JH, 2016, J AM CHEM SOC, V138, P4787, DOI 10.1021/jacs.6b00111; Liu M, 2005, CARBOHYD RES, V340, P2111, DOI 10.1016/j.carres.2005.05.023; Madariaga D, 2015, ACS CHEM BIOL, V10, P747, DOI 10.1021/cb500855x; Madariaga D, 2014, CHEM-EUR J, V20, P12616, DOI 10.1002/chem.201403700; Marcelo F, 2014, CHEM-EUR J, V20, P16147, DOI 10.1002/chem.201404566; Marionneau S, 2002, GLYCOBIOLOGY, V12, P851, DOI 10.1093/glycob/cwf103; Martinez-Saez N, 2017, CHEM SOC REV, V46, P7154, DOI 10.1039/c6cs00858e; Mortezai N, 2013, GLYCOBIOLOGY, V23, P844, DOI 10.1093/glycob/cwt021; Movahedin M, 2017, GLYCOBIOLOGY, V27, P677, DOI 10.1093/glycob/cww131; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Rodriguez E, 2018, NAT REV IMMUNOL, V18, P204, DOI 10.1038/nri.2018.3; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Sakakura M, 2008, J BIOL CHEM, V283, P33665, DOI 10.1074/jbc.M804067200; Singh SK, 2009, MOL IMMUNOL, V46, P1240, DOI 10.1016/j.molimm.2008.11.021; Suzuki N, 1996, J IMMUNOL, V156, P128; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; van Vliet SJ, 2006, IMMUNOBIOLOGY, V211, P577, DOI 10.1016/j.imbio.2006.05.022; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; van Vliet SJ, 2013, J BIOL CHEM, V288, P27519, DOI 10.1074/jbc.M113.471045; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Ward SE, 2018, BLOOD, V131, P911, DOI 10.1182/blood-2017-06-787853; York WS, 2014, GLYCOBIOLOGY, V24, P402, DOI 10.1093/glycob/cwu018; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	55	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1300	1311		10.1074/jbc.RA118.004957	http://dx.doi.org/10.1074/jbc.RA118.004957			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504228	hybrid, Green Published			2022-12-26	WOS:000457879500021
J	Nevalainen, T; Autio, A; Mishra, BH; Marttila, S; Jylha, M; Hurme, M				Nevalainen, Tapio; Autio, Arttu; Mishra, Binisha Hamal; Marttila, Saara; Jylha, Marja; Hurme, Mikko			Aging-associated patterns in the expression of human endogenous retroviruses	PLOS ONE			English	Article							DNA METHYLATION; RETROELEMENTS; RESPONSES; TOPHAT; GENE	Human endogenous retroviruses (HERV) are relics of ancient retroviral infections in our genome. Most of them have lost their coding capacity, but proviral RNA or protein have been observed in several disease states (e. g. in inflammatory and autoimmune diseases and malignancies). However, their clinical significance as well as their mechanisms of action have still remained elusive. As human aging is associated with several biological characteristics of these diseases, we now analyzed the aging-associated expression of the individual proviruses of two HERV families, HERV-K (91 proviruses) and HERV-W (213 proviruses) using genome-wide RNA-sequencing (RNA-seq). RNA was purified from blood cells derived from healthy young individuals (n = 7) and from nonagenarians (n = 7). The data indicated that in the case of HERV-K (HML-2) 33 proviruses had a detectable expression but in only 3 of those the expression levels were significantly different between the young and old individuals. In the HERV-W family expression was observed in 45 loci and only in one case the young/old difference was significant. However, applying hierarchical clustering on the HERV expression data resulted in the formation of two distinct clusters, one containing the young individuals and another the nonagenarians. This suggests, that even though the aging-associated differences in the expression levels of individual proviruses are minor, there seems to be some underlying aging-related pattern. These data indicate that aging does not have a strong effect on the expression of individual HERV proviruses, but instead several proviruses are affected moderately, leading to age-dependent expression profiles.	[Nevalainen, Tapio; Autio, Arttu; Mishra, Binisha Hamal; Marttila, Saara; Hurme, Mikko] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Nevalainen, Tapio; Marttila, Saara; Jylha, Marja; Hurme, Mikko] Univ Tampere, Gerontol Res Ctr GEREC, Tampere, Finland; [Jylha, Marja] Univ Tampere, Fac Social Sci, Tampere, Finland; [Marttila, Saara] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England	Tampere University; Tampere University; Tampere University; University of Liverpool	Nevalainen, T (corresponding author), Univ Tampere, Fac Med & Life Sci, Tampere, Finland.; Nevalainen, T (corresponding author), Univ Tampere, Gerontol Res Ctr GEREC, Tampere, Finland.	tapio.l.nevalainen@uta.fi		Hamal Mishra, Binisha/0000-0002-5605-5196; Hurme, Mikko/0000-0002-8614-1044; Nevalainen, Tapio/0000-0003-1141-9854; Autio, Arttu/0000-0003-1601-6528; Marttila, Saara/0000-0003-3071-3784	Competitive Research Fund of Pirkanmaa Hospital District; Tampere Tuberculosis Foundation	Competitive Research Fund of Pirkanmaa Hospital District; Tampere Tuberculosis Foundation	MH received Competitive Research Fund of Pirkanmaa Hospital District (https://www.tays.fi/en-US/Research_and_training/Research). MH received grant from Tampere Tuberculosis Foundation (http://www.tuberkuloosisaatio.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga D, 2008, BIOSTATISTICS, V9, P128, DOI 10.1093/biostatistics/kxm017; Balestrieri E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/164529; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6; Canadas I, 2018, NAT MED, V24, P1143, DOI 10.1038/s41591-018-0116-5; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Goebeler S, 2003, AGING CLIN EXP RES, V15, P154; Gonzalez-Hernandez MJ, 2014, J VIROL, V88, P8924, DOI 10.1128/JVI.00556-14; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Grandi N, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0301-x; Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hurst TP, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060130; Kassiotis G, 2016, NAT REV IMMUNOL, V16, P207, DOI 10.1038/nri.2016.27; Kassiotis G, 2014, J IMMUNOL, V192, P1343, DOI 10.4049/jimmunol.1302972; Kotlyar M, 2002, NEUROCHEM RES, V27, P1133, DOI 10.1023/A:1020969208033; Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magiorkinis G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0504; Pawelec G, 2018, EXP GERONTOL, V105, P4, DOI 10.1016/j.exger.2017.10.024; Sheng WQ, 2018, CELL, V174, P549, DOI 10.1016/j.cell.2018.05.052; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zampieri M, 2015, MECH AGEING DEV, V151, P60, DOI 10.1016/j.mad.2015.02.002	33	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207407	10.1371/journal.pone.0207407	http://dx.doi.org/10.1371/journal.pone.0207407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513106	Green Published, gold			2022-12-26	WOS:000452204800010
J	Brennan, GP; Vitsios, DM; Casey, S; Looney, AM; Hallberg, B; Henshall, DC; Boylan, GB; Murray, DM; Mooney, C				Brennan, Gary P.; Vitsios, Dimitrios M.; Casey, Sophie; Looney, Ann-Marie; Hallberg, Boubou; Henshall, David C.; Boylan, Geraldine B.; Murray, Deirdre M.; Mooney, Catherine			RNA-sequencing analysis of umbilical cord plasma microRNAs from healthy newborns	PLOS ONE			English	Article							STROMAL CELL DECIDUALIZATION; GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; EARLY-PREGNANCY; CIRCULATING MICRORNA; MIRNA EXPRESSION; MESSENGER-RNA; UP-REGULATION; DIFFERENTIAL EXPRESSION; TRANSCRIPTION-3 STAT3	MicroRNAs are a class of small non-coding RNA that regulate gene expression at a post-transcriptional level. MicroRNAs have been identified in various body fluids under normal conditions and their stability as well as their dysregulation in disease has led to ongoing interest in their diagnostic and prognostic potential. Circulating microRNAs may be valuable predictors of early-life complications such as birth asphyxia or neonatal seizures but there are relatively few data on microRNA content in plasma from healthy babies. Here we performed small RNA-sequencing analysis of plasma processed from umbilical cord blood in a set of healthy newborns. MicroRNA levels in umbilical cord plasma of four male and four female healthy babies, from two different centres were profiled. A total of 1,004 individual microRNAs were identified, which ranged from 426 to 659 per sample, of which 269 microRNAs were common to all eight samples. Many of these microRNAs are highly expressed and consistent with previous studies using other high throughput platforms. While overall microRNA expression did not differ between male and female cord blood plasma, we did detect differentially edited microRNAs in female plasma compared to male. Of note, and consistent with other studies of this type, adenylation and uridylation were the two most prominent forms of editing. Six microRNAs, miR-128-3p, miR-29a-3p, miR-9-5p, miR-218-5p, 204-5p and miR-132-3p were consistently both uridylated and adenylated in female cord blood plasma. These results provide a benchmark for microRNA profiling and biomarker discovery using umbilical cord plasma and can be used as comparative data for future biomarker profiles from complicated births or those with earlylife developmental disorders.	[Brennan, Gary P.; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland; [Brennan, Gary P.; Henshall, David C.; Mooney, Catherine] Royal Coll Surgeons Ireland, FutureNeuro Res Ctr, Dublin, Ireland; [Vitsios, Dimitrios M.] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Casey, Sophie; Looney, Ann-Marie; Boylan, Geraldine B.; Murray, Deirdre M.; Mooney, Catherine] Univ Coll Cork, INFANT Res Ctr, Cork, Ireland; [Casey, Sophie; Boylan, Geraldine B.; Murray, Deirdre M.] Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Hallberg, Boubou] Karolinska Univ Hosp, Neonatol, Stockholm, Sweden; [Mooney, Catherine] Univ Coll Dublin, Sch Comp Sci, Dublin 4, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University College Cork; University College Cork; Karolinska Institutet; Karolinska University Hospital; University College Dublin	Mooney, C (corresponding author), Royal Coll Surgeons Ireland, FutureNeuro Res Ctr, Dublin, Ireland.; Mooney, C (corresponding author), Univ Coll Cork, INFANT Res Ctr, Cork, Ireland.; Mooney, C (corresponding author), Univ Coll Dublin, Sch Comp Sci, Dublin 4, Ireland.	catherine.mooney@ucd.ie	Casey, Sophie/AAW-1739-2021; Vitsios, Dimitrios/J-4281-2019	Casey, Sophie/0000-0001-7704-3568; Vitsios, Dimitrios/0000-0002-8939-5445; Hallberg, Boubou/0000-0002-2928-3126; Henshall, David/0000-0001-6237-9632; Boylan, Geraldine/0000-0003-0920-5291; Mooney, Catherine/0000-0002-7696-1364; Brennan, Gary/0000-0002-4262-0481	Science Foundation Ireland (SFI) [SFI/12/RC/2272, SFI/16/RC/3948, SFI/13/IA/1891, SFI/12/COEN/18, SFI/14/ADV/RC2721]; European Regional Development Fund; FutureNeuro; INFANT; Royal College of Surgeons in Ireland seed fund ("PLASMIR-Dx"); Irish Research Council Epilepsy Ireland/Medical Research Charities Group; CURE taking flight; H2020 Marie Sklowdowksa-Curie Actions Individual Fellowship [707530]; EMBL core funding; HRB Clinician Scientist Award [CSA 2012/40]	Science Foundation Ireland (SFI)(Science Foundation Ireland); European Regional Development Fund(European Commission); FutureNeuro; INFANT; Royal College of Surgeons in Ireland seed fund ("PLASMIR-Dx"); Irish Research Council Epilepsy Ireland/Medical Research Charities Group(Irish Research Council for Science, Engineering and Technology); CURE taking flight; H2020 Marie Sklowdowksa-Curie Actions Individual Fellowship; EMBL core funding; HRB Clinician Scientist Award	This publication has emanated from research supported in part by research grants from Science Foundation Ireland (SFI) under Grant Numbers SFI/12/RC/2272 (to D.M.M. and G.B.B.), SFI/16/RC/3948, SFI/13/IA/1891, SFI/12/COEN/18, SFI/14/ADV/RC2721 (to D.C.H. and C.M.) and co-funded under the European Regional Development Fund and by FutureNeuro and INFANT industry partners, the Royal College of Surgeons in Ireland seed fund ("PLASMIR-Dx"), the Irish Research Council Epilepsy Ireland/Medical Research Charities Group (to D.C.H.), CURE taking flight, a H2020 Marie Sklowdowksa-Curie Actions Individual Fellowship (Project no. 707530) (to G.P.B.) and EMBL core funding (to D.M.V). The BiHiVE 2 study was funded by the HRB Clinician Scientist Award CSA 2012/40 (to D.M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2021, LANG ENV STAT COMP; Anteby EY, 2005, EUR J OBSTET GYN R B, V118, P174, DOI 10.1016/j.ejogrb.2004.04.029; Argyropoulos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054662; Aryani Arian, 2015, BMC Res Notes, V8, P164, DOI 10.1186/s13104-015-1114-z; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Bayraktar R, 2017, MOL ONCOL, V11, P1673, DOI 10.1002/1878-0261.12144; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bethin KE, 2003, MOL ENDOCRINOL, V17, P1454, DOI 10.1210/me.2003-0007; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Boele J, 2014, P NATL ACAD SCI USA, V111, P11467, DOI 10.1073/pnas.1317751111; Bounds KR, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00060; Boxer RB, 2006, CELL METAB, V4, P475, DOI 10.1016/j.cmet.2006.10.011; Boyle KE, 2013, J CLIN ENDOCR METAB, V98, pE1601, DOI 10.1210/jc.2013-1943; Breuiller-Fouche M, 2006, REPRODUCTION, V131, P837, DOI 10.1530/rep.1.00725; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cario-Toumaniantz C, 2003, J PHYSIOL-LONDON, V552, P403, DOI 10.1113/jphysiol.2003.047738; Cesarini V, 2018, NUCLEIC ACIDS RES, V46, P2045, DOI 10.1093/nar/gkx1257; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chawla G, 2014, NUCLEIC ACIDS RES, V42, P5245, DOI 10.1093/nar/gku145; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chiofalo B, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6073167; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Contro E, 2017, MOL DIAGN THER, V21, P653, DOI 10.1007/s40291-017-0295-7; Conway JM, 2018, EARLY HUM DEV, V120, P80, DOI 10.1016/j.earlhumdev.2018.02.007; Darmochwal-Kolarz D, 2003, CLIN EXP IMMUNOL, V132, P339, DOI 10.1046/j.1365-2249.2003.02136.x; Denney JM, 2011, CYTOKINE, V53, P170, DOI 10.1016/j.cyto.2010.11.005; Doria S, 2010, EPIGENETICS-US, V5, P444, DOI 10.4161/epi.5.5.12118; Driscoll DJO, 2018, BRAIN BEHAV IMMUN, V69, P418, DOI 10.1016/j.bbi.2018.01.001; Du MR, 2008, BIOL REPROD, V78, P1102, DOI 10.1095/biolreprod.107.063503; Enquobahrie DA, 2011, INT J MOL EPIDEMIOL, V2, P78; Farrokhnia F, 2014, J BIOL CHEM, V289, P30404, DOI 10.1074/jbc.M114.587295; Forde N, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.129296; Fotovati A, 2011, J ANAT, V218, P668, DOI 10.1111/j.1469-7580.2011.01370.x; Fraga LR, 2014, EUR J OBSTET GYN R B, V182, P7, DOI 10.1016/j.ejogrb.2014.07.044; Freres P, 2016, ONCOTARGET, V7, P5416, DOI 10.18632/oncotarget.6786; Fulop V, 1998, J REPROD MED, V43, P119; Gallo A, 2017, HUM GENET, V136, P1265, DOI 10.1007/s00439-017-1837-0; Gray CA, 2006, BIOL REPROD, V74, P383, DOI 10.1095/biolreprod.105.046656; Gunel T, 2011, GENET MOL RES, V10, P4034, DOI 10.4238/2011.November.8.5; Guo Junhong, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P738, DOI 10.1007/s11596-006-0631-3; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Han L, 2017, BRATISL MED J, V118, P523, DOI 10.4149/BLL_2017_101; Haye D, 2014, AM J MED GENET A, V164, P2926, DOI 10.1002/ajmg.a.36726; Heale BSE, 2010, ADV EXP MED BIOL, V700, P76; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Huang L, 2013, PLACENTA, V34, P624, DOI 10.1016/j.placenta.2013.04.009; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ji LQ, 2017, PLACENTA, V50, P102, DOI 10.1016/j.placenta.2017.01.102; Jimeno-Yepes AJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-171; Kang YJ, 2015, J CELL SCI, V128, P804, DOI 10.1242/jcs.164004; Kent LN, 2012, INT J DEV BIOL, V56, P255, DOI 10.1387/ijdb.113407lk; Kiewisz J, 2011, THERIOGENOLOGY, V76, P687, DOI 10.1016/j.theriogenology.2011.03.022; Kim B, 2015, EMBO J, V34, P1801, DOI 10.15252/embj.201590931; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Ladyman SR, 2004, ENDOCRINOLOGY, V145, P3704, DOI 10.1210/en.2004-0338; Lagana AS, 2018, J MATERN-FETAL NEO M, V31, P817, DOI 10.1080/14767058.2017.1296426; Lamadrid-Romero M, 2018, NEUROSCI RES, V130, P8, DOI 10.1016/j.neures.2017.08.003; Lappas M, 2010, PLACENTA, V31, P1043, DOI 10.1016/j.placenta.2010.09.009; Lartey J, 2007, BIOL REPROD, V76, P971, DOI 10.1095/biolreprod.106.058982; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; LEVY C, 1980, AM J OBSTET GYNECOL, V136, P646, DOI 10.1016/0002-9378(80)91018-2; Li DD, 2016, MED SCI MONITOR, V22, P922, DOI 10.12659/MSM.895459; Li FX, 2008, BIOL REPROD, V78, P127, DOI 10.1095/biolreprod.107.063313; Li H, 2013, BIOMED RES INT, V2013; Li S, 2017, ONCOTARGET, V8, P89451, DOI 10.18632/oncotarget.20702; Li SH, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0091-3; Li YL, 2016, PLACENTA, V48, P133, DOI 10.1016/j.placenta.2016.10.017; Li YongWang, 2013, Journal of Northeast Agricultural University (English Edition), V20, P39; Lim AL, 2010, SEMIN CELL DEV BIOL, V21, P201, DOI 10.1016/j.semcdb.2009.10.008; Lim R, 2012, PLACENTA, V33, P52, DOI 10.1016/j.placenta.2011.10.004; Liu G, 2004, PLACENTA, V25, P530, DOI 10.1016/j.placenta.2003.11.006; Lizarraga D, 2016, EPIGENOMICS-UK, V8, P1619, DOI 10.2217/epi-2016-0031; Long X, 2015, REPROD BIOMED ONLINE, V31, P51, DOI 10.1016/j.rbmo.2015.04.005; Looney A, 2018, MOL NEUROBIOL, P1; Looney AM, 2017, MOL NEUROBIOL, V54, P8420, DOI 10.1007/s12035-016-0330-4; Looney AM, 2015, J PEDIATR-US, V167, P269, DOI 10.1016/j.jpeds.2015.04.060; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozoya T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087698; Luarte A, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1719050; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Lv XM, 2016, EXP THER MED, V12, P2865, DOI 10.3892/etm.2016.3692; Lycoudi A, 2015, EXPERT REV MOL DIAGN, V15, P999, DOI 10.1586/14737159.2015.1053468; Lynch SA, 2003, ARCH DIS CHILD-FETAL, V88, P250; Maccani MA, 2013, PEDIATR RES, V74, P272, DOI 10.1038/pr.2013.102; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; MARUO T, 1987, AM J OBSTET GYNECOL, V156, P721, DOI 10.1016/0002-9378(87)90086-X; McKinlay CJD, 2015, PEDIATRICS, V135, pE405, DOI 10.1542/peds.2014-2408; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Mong EF, 2018, ARTERIOSCL THROM VAS, V38, P1321, DOI 10.1161/ATVBAHA.118.310908; Mooney C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145316; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mouillet JF, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110049; Musavi SAA, 2018, ANIM SCI J, V89, P1609, DOI 10.1111/asj.13091; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Nigita G, 2016, NUCLEIC ACIDS RES, V44, P6298, DOI 10.1093/nar/gkw532; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; O'Brien M, 2008, REPROD SCI, V15, P382, DOI 10.1177/1933719108316179; Ospina-Prieto S, 2016, TRANSL RES, V172, P61, DOI 10.1016/j.trsl.2016.02.012; Paul D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02397-6; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Pinto Y, 2018, NUCLEIC ACIDS RES, V46, P71, DOI 10.1093/nar/gkx1176; Poehlmann TG, 2005, PLACENTA, V26, pS37, DOI 10.1016/j.placenta.2005.01.007; Ponnusamy V, 2016, PEDIATR RES, V79, P799, DOI 10.1038/pr.2015.276; Pringle KG, 2007, PLACENTA, V28, P286, DOI 10.1016/j.placenta.2006.04.006; Prossler J, 2014, CYTOKINE, V68, P9, DOI 10.1016/j.cyto.2014.03.001; Raoof R, 2018, EBIOMEDICINE, V38, P127, DOI 10.1016/j.ebiom.2018.10.068; Raoof R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02969-6; Rehman KS, 2003, MOL HUM REPROD, V9, P681, DOI 10.1093/molehr/gag078; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Riancho J, 2017, J ALZHEIMERS DIS, V57, P483, DOI 10.3233/JAD-161179; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romanelli V, 2009, PLACENTA, V30, P551, DOI 10.1016/j.placenta.2009.03.013; Salbaum JM, 2010, BIRTH DEFECTS RES A, V88, P601, DOI 10.1002/bdra.20680; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Sati L, 2016, EUROPEAN J OBSTET GY, V206, pe104, DOI [10.1016/j.ejogrb.2016.07.274, DOI 10.1016/J.EJOGRB.2016.07.274]; Savaris RF, 2008, REPROD SCI, V15, P797, DOI 10.1177/1933719108317585; Shan N, 2016, J MATERN-FETAL NEO M, V29, P393, DOI 10.3109/14767058.2014.1001974; Shang W, 2013, EUR REV MED PHARMACO, V17, P3376; Shanmugasundaram N, 2011, RUNX1 FUNCTIONS DOWN; Shimodaira M, 2012, ENDOCRINE, V42, P700, DOI 10.1007/s12020-012-9699-7; Shynlova O, 2010, BIOL REPROD, V82, P1248, DOI 10.1095/biolreprod.109.081158; Simeoli R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01841-5; Su MT, 2014, J ASSIST REPROD GEN, V31, P699, DOI 10.1007/s10815-014-0223-2; Takahashi H, 2014, MED J OBSTET GYNECOL, V2, P1032; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Tang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058737; Telonis AG, 2017, NUCLEIC ACIDS RES, V45, P2973, DOI 10.1093/nar/gkx082; Teng CB, 2004, REPRODUCTION, V128, P197, DOI 10.1530/rep.1.00053; Thornton JE, 2014, NUCLEIC ACIDS RES, V42, P11777, DOI 10.1093/nar/gku805; Tokyol C, 2008, UPSALA J MED SCI, V113, P235, DOI 10.3109/2000-1967-231; Tomaselli S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0575-z; Tong D, 2009, BIOL REPROD, V80, P1099, DOI 10.1095/biolreprod.108.071969; Tran ND, 2016, STEM CELLS, V34, P1985, DOI 10.1002/stem.2378; Uuskula L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049248; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Velazquez-Torres G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02851-7; Vitsios DM, 2017, NUCLEIC ACIDS RES, V45, P1079, DOI 10.1093/nar/gkw1031; Vitsios DM, 2015, BIOINFORMATICS, V31, P3365, DOI 10.1093/bioinformatics/btv380; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang QL, 2016, STEM CELLS DEV, V25, P415, DOI 10.1089/scd.2015.0267; Wang YB, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127308; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wu L, 2011, REPRODUCTION; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Xu T, 2014, EXPERT OPIN THER TAR, V18, P153, DOI 10.1517/14728222.2014.855201; Xu Y, 2013, INT J MOL MED, V32, P1115, DOI 10.3892/ijmm.2013.1499; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yang Q, 2011, CLIN CHIM ACTA, V412, P2167, DOI 10.1016/j.cca.2011.07.029; Yuan TZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19413; Zhang Q, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0019-y; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhao KQ, 2012, J CELL BIOCHEM, V113, P3266, DOI 10.1002/jcb.24204; Zhao Z, 2012, CLIN CHEM; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045; Zhu YN, 2015, INT J GYNECOL OBSTET, V130, P49, DOI 10.1016/j.ijgo.2015.01.010; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	179	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207952	10.1371/journal.pone.0207952	http://dx.doi.org/10.1371/journal.pone.0207952			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507953	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500014
J	McSherry, M; Masih, KE; Elcioglu, NH; Celik, P; Balci, O; Cengiz, FB; Nunez, D; Sineni, CJ; Seyhan, S; Kocaoglu, D; Guo, SR; Duman, D; Bademci, G; Tekin, M				McSherry, Megan; Masih, Katherine E.; Elcioglu, Nursel H.; Celik, Pelin; Balci, Ozge; Cengiz, Filiz Basak; Nunez, Daniella; Sineni, Claire J.; Seyhan, Serhat; Kocaoglu, Defne; Guo, Shengru; Duman, Duygu; Bademci, Guney; Tekin, Mustafa			Identification of candidate gene FAM183A and novel pathogenic variants in known genes: High genetic heterogeneity for autosomal recessive intellectual disability	PLOS ONE			English	Article							COPY-NUMBER VARIATION; MENTAL-RETARDATION; MUTATIONS; WDR62; ASPM; FAMILIES; PROTEIN; SLC9A6; ASSOCIATION; DISCOVERY	The etiology of intellectual disability (ID) is heterogeneous including a variety of genetic and environmental causes. Historically, most research has not focused on autosomal recessive ID (ARID), which is a significant cause of ID, particularly in areas where parental consanguinity is common. Identification of genetic causes allows for precision diagnosis and improved genetic counseling. We performed whole exome sequencing to 21 Turkish families, seven multiplex and 14 simplex, with nonsyndromic ID. Based on the presence of multiple affected siblings born to unaffected parents and/or shared ancestry, we consider all families as ARID. We revealed the underlying causative variants in seven families in MCPH1 (c.427dupA, p.T143Nfs*5), WDR62 (c.3406C>T, p.R1136*), ASPM (c.5219_5225delGAG-GATA, p.R1740Tfs*7), RARS (c.1588A>G, p.T530A), CC2D1A (c.811delG, p.A271Pfs*30), TUSC3 (c.793C>T, p.Q265*) and ZNF335 (c.808C>T, p.R270C and c.3715C>A, p.Q1239K) previously linked with ARID. Besides ARID genes, in one family, affected male siblings were hemizygous for PQBP1 (c.459_462delAGAG, p.R153Sfs*41) and in one family the proband was female and heterozygous for X-chromosomal SLC9A6 (c.1631+1G>A) variant. Each of these variants, except for those in MCPH1 and PQBP1, have not been previously published. Additionally in one family, two affected children were homozygous for the c.377G>A (p.W126*) variant in the FAM183A, a gene not previously associated with ARID. No causative variants were found in the remaining 11 families. A wide variety of variants explain half of families with ARID. FAM183A is a promising novel candidate gene for ARID.	[McSherry, Megan; Masih, Katherine E.; Cengiz, Filiz Basak; Nunez, Daniella; Sineni, Claire J.; Seyhan, Serhat; Guo, Shengru; Bademci, Guney; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussmann Inst Human Genom, Miami, FL 33136 USA; [Elcioglu, Nursel H.; Kocaoglu, Defne] Marmara Univ, Sch Med, Dept Pediat Genet, Istanbul, Turkey; [Elcioglu, Nursel H.] Eastern Mediterranean Univ, Sch Med, Mersin 10, Famagusta, North Cyprus, Turkey; [Celik, Pelin; Balci, Ozge] Ankara Univ, Sch Med, Dept Pediat, Div Dev Pediat, Ankara, Turkey; [Duman, Duygu] Ankara Univ, Sch Med, Dept Pediat, Div Genet, Ankara, Turkey; [Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33136 USA	University of Miami; Marmara University; Eastern Mediterranean University; Ankara University; Ankara University; University of Miami	Tekin, M (corresponding author), Univ Miami, Miller Sch Med, John P Hussmann Inst Human Genom, Miami, FL 33136 USA.; Tekin, M (corresponding author), Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33136 USA.	mtekin@med.miami.edu	duman, duygu/AAF-8093-2020; Tekin, Mustafa/ABG-7627-2020; Duman, Duygu/AAG-7765-2019	duman, duygu/0000-0001-7583-0349; Masih, Katherine/0000-0002-0809-668X; Sineni, Claire/0000-0003-4719-2815; Bademci, Guney/0000-0002-4052-8833; Seyhan, Serhat/0000-0002-7785-2995	John T. and Winifred M. Hayward Foundation	John T. and Winifred M. Hayward Foundation	This study is partially supported by the John T. and Winifred M. Hayward Foundation to M. T.	Abugessaisa I, 2016, DATABASE, V2016, P105; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Bademci G, 2016, GENET MED, V18, P364, DOI 10.1038/gim.2015.89; Bademci G, 2014, GENET TEST MOL BIOMA, V18, P658, DOI 10.1089/gtmb.2014.0121; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Bhat V, 2011, CLIN GENET, V80, P532, DOI 10.1111/j.1399-0004.2011.01686.x; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Darvish H, 2010, J MED GENET, V47, P823, DOI 10.1136/jmg.2009.076398; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dhandha MM, 2012, AUTOIMMUNITY, V45, P516, DOI 10.3109/08916934.2012.702811; Fichou Y, 2009, EUR J HUM GENET, V17, P1378, DOI 10.1038/ejhg.2009.82; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Garshasbi M, 2011, AM J MED GENET A, V155A, P1976, DOI 10.1002/ajmg.a.34077; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Hu H, 2019, MOL PSYCHIATR, V24, P1027, DOI 10.1038/s41380-017-0012-2; Hunter AGW, 2000, AM J MED GENET, V90, P60, DOI 10.1002/(SICI)1096-8628(20000103)90:1<60::AID-AJMG11>3.0.CO;2-P; Iqbal Z, 2014, HUM HERED, V77, P150, DOI 10.1159/000360539; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kochinke K, 2016, AM J HUM GENET, V98, P149, DOI 10.1016/j.ajhg.2015.11.024; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Moeschler JB, 2006, PEDIATRICS, V117, P2304, DOI 10.1542/peds.2006-1006; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Musante L, 2014, TRENDS GENET, V30, P32, DOI 10.1016/j.tig.2013.09.008; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nicholas AK, 2009, J MED GENET, V46, P249, DOI 10.1136/jmg.2008.062380; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Numata M, 1998, J BIOL CHEM, V273, P6951, DOI 10.1074/jbc.273.12.6951; Passemard S, 2016, CORTEX, V74, P158, DOI 10.1016/j.cortex.2015.10.010; Pescosolido MF, 2014, ANN NEUROL, V76, P581, DOI 10.1002/ana.24225; Reuter MS, 2017, JAMA PSYCHIAT, V74, P293, DOI 10.1001/jamapsychiatry.2016.3798; Riazuddin S, 2017, MOL PSYCHIATR, V22, P1604, DOI 10.1038/mp.2016.109; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Wolf NI, 2014, ANN NEUROL, V76, P134, DOI 10.1002/ana.24167; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zhang XY, 2017, HUM MOL GENET, V26, P955, DOI 10.1093/hmg/ddx010	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208324	10.1371/journal.pone.0208324	http://dx.doi.org/10.1371/journal.pone.0208324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500859	Green Submitted, Green Published, gold			2022-12-26	WOS:000451883700033
J	Orlova-Bienkowskaja, MJ; Spiridonov, SE; Butorina, NN; Bienkowski, AO				Orlova-Bienkowskaja, Marina J.; Spiridonov, Sergei E.; Butorina, Natalia N.; Bienkowski, Andrzej O.			Coinvasion by the ladybird Harmonia axyridis (Coleoptera: Coccinellidae) and its parasites, Hesperomyces virescens (Ascomycota: Laboulbeniales) and Parasitylenchus bifurcatus (Nematoda: Tylenchida, Allantonematidae), in the Caucasus	PLOS ONE			English	Article							HARLEQUIN LADYBIRD; PHYLOGENETIC-RELATIONSHIPS; PALLAS; FUNGUS; INVASION; ENEMY; HOST	The study of parasites in recently established populations of invasive species can shed light on the sources of invasion and possible indirect interactions between the alien species and native ones. We studied parasites of the global invader Harmonia axyridis (Coleoptera: Coccinellidae) in the Caucasus. In 2012, the first established population of Ha. axyridis was recorded in the Caucasus in Sochi (south of European Russia, Black Sea coast). By 2018, the ladybird had spread to a vast area: Armenia, Georgia and south Russia (Adygea, the Krasnodar territory, the Stavropol territory, Dagestan, Kabardino-Balkaria and North Ossetia). The examination of 213 adults collected in Sochi in 2018 showed that 53% were infested with Hesperomyces virescens fungi (Ascomycota: Laboulbeniales) and that 8% were infested with Parasitylenchus bifurcatus nematodes (Nematoda: Tylenchida, Allantonematidae). The examined Ha. axyridis specimens were free of the parasitic mite Coccipolipus hippodamiae. An analysis of the phylogenetic relationships of P. bifurcatus based on 18S rDNA confirmed the morphological identification of this species. Hesperomyces virescens and P. bifurcatus were first recorded in the Caucasus and Russia, although they are rather widespread in Europe. This likely indicates that they appeared as a result of coinvasion with their host because the populations of Ha. axyridis, He. virescens and P. bifurcatus in the Caucasus are isolated from the main parts of the ranges of these species in Europe. The nearest localities of Ha. axyridis is on another shore of the Black Sea, and the nearest localities of He. virescens and P. bifurcatus are more than 1000 km from the Caucasus. It is impossible to determine whether the first founders of the Caucasian population were infested with the parasites or whether the parasites were introduced by specimens of Ha. axyridis that arrived later from Europe. Harmonia axyridis was released in the region for pest control, but laboratory cultures are always free of He. virescens and P. bifurcatus. Therefore, the detection of He. virescens and P. bifurcatus indicates that the population of Ha. axyridis in the Caucasus could not have derived exclusively from released specimens. We did not find He. virescens on 400 specimens of 29 other ladybird species collected from the same localities as Ha. axyridis in the Caucasus. No reliable correlation between infestation by He. virescens and that by P. bifurcatus has been found. In addition to these two parasites, an unidentified species of the order Mermithida was recorded. This is the first documented case of Ha. axyridis infestation by a parasitic nematode of this order in nature.	[Orlova-Bienkowskaja, Marina J.; Spiridonov, Sergei E.; Butorina, Natalia N.; Bienkowski, Andrzej O.] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Moscow, Russia	Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Orlova-Bienkowskaja, MJ (corresponding author), Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Moscow, Russia.	marinaorlben@yandex.ru	Spiridonov, Sergei E./A-5383-2016; Orlova-Bienkowskaja, Marina J./R-5143-2016	Spiridonov, Sergei E./0000-0001-6657-0418; Bienkowski, Andrzej/0000-0003-0655-3119; Marina, Orlova-Bienkowskaja/0000-0002-1502-0763	Russian Science Foundation [16-14-10031]	Russian Science Foundation(Russian Science Foundation (RSF))	This research was funded by the Russian Science Foundation (Project No 16-14-10031 to AOB and MJOB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev SK, 2016, ACTUAL PROBLEMS CHEM, P71; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Belyakova NA, 2013, EUR J ENTOMOL, V110, P699, DOI 10.14411/eje.2013.093; Bugaeva LN, 2011, NEWSLETTER E PALAEAR, V42, P32; Ceryngier P, 2018, BIOL INVASIONS, V20, P1009, DOI 10.1007/s10530-017-1608-9; Ceryngier P, 2017, BIOINVASIONS REC, V6, P307, DOI 10.3391/bir.2017.6.4.02; Ceryngier P, 2013, EUR J ENTOMOL, V110, P549, DOI 10.14411/eje.2013.075; Cottrell Ted E., 2012, Psyche (Cambridge), V2012, DOI 10.1155/2012/814378; Danny H, 2014, CHINESE SCI BULL, V59, P528, DOI 10.1007/s11434-013-0060-1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Kesel A., 2011, STERBEECKIA, V30, P32; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Garnas JR, 2016, BIOL INVASIONS, V18, P935, DOI 10.1007/s10530-016-1082-9; Goryacheva I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198190; Haelewaters Danny, 2017, Entomologische Berichten (Amsterdam), V77, P106; Haelewaters D, 2017, BIOCONTROL, V62, P355, DOI 10.1007/s10526-016-9766-8; Hijmans R.J., 2001, PI GENET RESOURCES N, P15; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; IPERTI G., 1964, Entomophaga, V9, P153, DOI 10.1007/BF02376737; Kaiser H, 1985, MITTEILUNGEN NATURWI, V115, P115; Kalashian MY, 2017, RUSS J BIOL INVASION, V8, P313, DOI 10.1134/S207511171704004X; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuznetsov V. N., 1988, ZASHCHITA RASTENIY, V5, P19; Lombaert E, 2014, MOL ECOL, V23, P5979, DOI 10.1111/mec.12989; Lopez-Arroyo I, 2018, ENTOMOLOGIA MEXICANA, V5, P141; Mogilevich T. A., 2012, BEETLES COLEOPTEROLO; Nadler SA, 2006, SYST PARASITOL, V63, P161, DOI 10.1007/s11230-005-9009-3; NICHOLAS K.B., 1997, MULTIPLE SEQUENCE AL; Orlova-Bienkowskaja M. Ja., 2016, Kavkazskii Entomologicheskii Byulleten, V12, P93; Orlova-bienkowskaja M. Ja., 2014, Russian Journal of Biological Invasions, V5, P275, DOI 10.1134/S2075111714040055; Orlova-Bienkowskaja MJ, 2015, BIOL INVASIONS, V17, P1941, DOI 10.1007/s10530-015-0848-9; Pfliegler WP, 2018, MYCOLOGIA, V110, P39, DOI 10.1080/00275514.2017.1418567; Poinar G. O., 1979, NEMATODES BIOL CONTR; Poinar GO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-24; Raak-van den Berg CL, 2014, BIOCONTROL, V59, P229, DOI 10.1007/s10526-014-9561-3; Reshetnikov AN, 2017, HYDROBIOLOGIA, V788, P65, DOI 10.1007/s10750-016-2987-0; Riddick EW, 2010, B INSECTOL, V63, P13; Roy HE, 2016, BIOL INVASIONS, V18, P997, DOI 10.1007/s10530-016-1077-6; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Roy HE, 2011, BIOCONTROL, V56, P663, DOI 10.1007/s10526-011-9387-1; Seinhorst J. W., 1959, Nematologica, V4, P67; Stare Barbara Geric, 2017, Acta Agriculturae Slovenica, V109, P457, DOI 10.14720/aas.2017.109.2.28; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ukrainsky AS, 2014, BIOL INVASIONS, V16, P1003, DOI 10.1007/s10530-013-0571-3; v. Linstow O., 1898, Archiv fuer Mikroskopische Anatomie, Vliii, P149; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0202841	10.1371/journal.pone.0202841	http://dx.doi.org/10.1371/journal.pone.0202841			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496181	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800006
J	Barbosa, FB; Simioni, M; Wiezel, CEV; Torres, FR; Molck, MC; Bonilla, MM; de Araujo, TK; Donadi, EA; Gil-da-Silva-Lopes, VL; Lemos, B; Simoes, AL				Barbosa, Fernanda Bueno; Simioni, Milena; Vieira Wiezel, Claudia Emilia; Torres, Fabio Rossi; Molck, Miriam Coelho; Bonilla, Melvin M.; de Araujo, Tabia Kawasaki; Donadi, Eduardo Antonio; Gil-da-Silva-Lopes, Vera Lucia; Lemos, Bernardo; Simoes, Aguinaldo Luiz			Copy number variation in the susceptibility to systemic lupus erythematosus	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; ASSOCIATION; RISK; SLE; VARIANTS; DELETION; ONSET; LOCI; C4	Systemic lupus erythematosus (SLE) is an autoimmune disease with a strong genetic component and etiology characterized by chronic inflammation and autoantibody production. The purpose of this study was to ascertain copy number variation (CNV) in SLE using a case-control design in an admixed Brazilian population. The whole-genome detection of CNV was performed using Cytoscan HD array in SLE patients and healthy controls. The best CNV candidates were then evaluated by quantitative real-time PCR in a larger cohort or validated using droplet digital PCR. Logistic regression models adjusted for sex and ancestry covariates was applied to evaluate the association between CNV with SLE susceptibility. The data showed a synergistic effect between the FCGR3B and ADAM3A loci with the presence of deletions in both loci significantly increasing the risk to SLE (5.9-fold) compared to the deletion in the single FCGR3B locus (3.6-fold). In addition, duplications in these genes were indeed more frequent in healthy subjects, suggesting that high FCGR3B/ADAM3A gene copy numbers are protective factors against to disease development. Overall, 21 rare CNVs were identified in SLE patients using a four-step pipeline created for identification of rare variants. Furthermore, heterozygous deletions overlapping the CFHR4, CFHR5 and HLA-DPB2 genes were described for the first time in SLE patients. Here we present the first genome-wide CNV study of SLE patients in a tri-hybrid population. The results show that novel susceptibility loci to SLE can be found once the distribution of structural variants is analyzed throughout the whole genome.	[Barbosa, Fernanda Bueno; Vieira Wiezel, Claudia Emilia; Simoes, Aguinaldo Luiz] Univ Sao Paulo, Dept Genet, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil; [Simioni, Milena; Torres, Fabio Rossi; Molck, Miriam Coelho; de Araujo, Tabia Kawasaki; Gil-da-Silva-Lopes, Vera Lucia] Univ Estadual Campinas, Dept Med Genet, Fac Med Sci, Campinas, SP, Brazil; [Bonilla, Melvin M.; Lemos, Bernardo] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Donadi, Eduardo Antonio] Univ Sao Paulo, Dept Med, Div Clin Immunol, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Harvard University; Harvard T.H. Chan School of Public Health; Universidade de Sao Paulo	Simoes, AL (corresponding author), Univ Sao Paulo, Dept Genet, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil.	alsimoes@fmrp.usp.br	Gil-da-Silva-Lopes, Vera Lúcia L/G-2453-2012; Molck, Miriam C/D-1195-2017; Lemos, Bernardo/AAL-2429-2020; Simoes, Aguinaldo L/E-7508-2011; de Araujo, Tânia Kawasaki/D-1889-2015; Wiezel, Claudia/P-7748-2017; donadi, eduardo/H-7080-2013	Gil-da-Silva-Lopes, Vera Lúcia L/0000-0003-1288-0554; Molck, Miriam C/0000-0003-4080-3003; Lemos, Bernardo/0000-0001-6996-9483; de Araujo, Tânia Kawasaki/0000-0003-3056-3894; Simoes, Aguinaldo Luiz/0000-0001-5950-894X; Wiezel, Claudia/0000-0002-4381-0834; donadi, eduardo/0000-0002-9457-9601	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/23794-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do HCFMRP-USP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP [2013/17062-9, 2016/10306-8]; CNPq/Brazil [312547/2009-9, 304931/2014-4, 304455/2012-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do HCFMRP-USP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant number 2011/23794-7; http://www.fapesp.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/), Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do HCFMRP-USP (http://www.faepa.br/), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://cnpq.br/).FBB (grant numbers 2013/17062-9, 2016/10306-8) is currently supported by a research fellowship from FAPESP, while ALS (grant number 312547/2009-9), EAD (grant number 304931/2014-4) and VLGSL (grant number 304455/2012-1) are supported by CNPq/Brazil.	Alarcon-Riquelme ME, 2016, ARTHRITIS RHEUMATOL, V68, P932, DOI 10.1002/art.39504; Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Amur S, 2012, J AUTOIMMUNITY; Armstrong D, 2014, GENES IMMUNITY; Barbosa FB, 2017, ANN HUM GENET, V81, P225, DOI 10.1111/ahg.12208; Cantsilieris S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035255; Chen JY, 2016, ARTHRITIS RHEUMATOL, V68, P1442, DOI 10.1002/art.39589; Costenbader KH, 2012, AUTOIMMUN REV, V11, P604, DOI 10.1016/j.autrev.2011.10.022; Cui Y, 2013, J AUTOIMMUN, V41, P25, DOI 10.1016/j.jaut.2013.01.008; Gale DP, 2011, DIS MODEL MECH, V4, P721, DOI 10.1242/dmm.008052; Garcia-Ortiz H, 2010, ANN RHEUM DIS, V69, P1861, DOI 10.1136/ard.2009.124313; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim JH, 2013, ARTHRITIS RHEUM-US, V65, P1055, DOI 10.1002/art.37854; Lee YH, 2015, INFLAMM RES, V64, P983, DOI 10.1007/s00011-015-0882-1; Li N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42628; Liu JH, 2013, AM J EPIDEMIOL, V177, P351, DOI 10.1093/aje/kws234; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margery-Muir AA, 2017, AUTOIMMUN REV, V16, P258, DOI 10.1016/j.autrev.2017.01.007; Martin LS, 2016092106 BIORXIV; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33; Pereira KMC, 2016, RHEUMATOLOGY, V55, P869, DOI 10.1093/rheumatology/kev436; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahbari R, 2017, HUM MUTAT, V38, P390, DOI 10.1002/humu.23159; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Singh N, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4681; Sun C, 2016, NAT GENET, V48, P323, DOI 10.1038/ng.3496; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wu LJ, 2014, ACTA BIOCH BIOPH SIN, V46, P155, DOI 10.1093/abbs/gmt137; Yuan J, 2015, INT J RHEUMATIC DIS; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079; Zhou XJ, 2012, RHEUMATOLOGY, V51, P992, DOI 10.1093/rheumatology/ker419	36	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206683	10.1371/journal.pone.0206683	http://dx.doi.org/10.1371/journal.pone.0206683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485348	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800025
J	Moharrami, NN; Tande, EB; Ryan, L; Espevik, T; Boyartchuk, V				Moharrami, Neda Nejati; Tande, Erlend Bjorkoy; Ryan, Liv; Espevik, Terje; Boyartchuk, Victor			ROR alpha controls inflammatory state of human macrophages	PLOS ONE			English	Article							DNA-BINDING PROPERTIES; ORPHAN RECEPTOR; RETINOIC ACID; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MICE; IDENTIFICATION; SECRETION; COMPLEX; FAMILY	ROR family of nuclear receptor transcription factors forms nodes connecting metabolic and inflammatory signaling pathways. The ROR alpha members of the family have intrinsic transcriptional activity and they are involved in both activation and repression of a wide range of genes. The role of ROR alpha in control of inflammation has been extensively studied using animal models but its function in human cells is not as well understood. To address this shortcoming, we analyzed how ROR alpha is shaping the inflammatory state of human macrophages. Using CRISPR-Cas9 system, we deleted RORA in THP-1 human monocytic cell line. In mutant cells we observed a dramatic increase in basal expression of a subset of NF-kappa B regulated genes, including TNF, IL-1 beta and IL-6, at both transcriptional and translational levels. Furthermore, RORA-deletion cells produced notable amounts of pro-IL-1 beta even in the absence of LPS stimulation. Subsequent LPS stimulation induced cleavage of pro-IL-1 beta to mature form. Our RNAseq analysis further confirmed the key role of RORA in setting the inflammatory state of macrophages and defined the set of differentially regulated genes. Overall, our data provides evidence supporting the anti-inflammatory function of ROR alpha in human macrophages.	[Moharrami, Neda Nejati; Tande, Erlend Bjorkoy; Ryan, Liv; Espevik, Terje; Boyartchuk, Victor] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci MH, Dept Clin Res & Mol Med IKOM, Ctr Mol Inflammat Res CEMIR, Trondheim, Norway; [Boyartchuk, Victor] Trondheim Reg & Univ Hosp, St Olavs Hosp HF, Clin Cardiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Boyartchuk, V (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci MH, Dept Clin Res & Mol Med IKOM, Ctr Mol Inflammat Res CEMIR, Trondheim, Norway.; Boyartchuk, V (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp HF, Clin Cardiol, Trondheim, Norway.	victor.boyartchuk@ntnu.no		Tande, Erlend/0000-0003-2148-9960; Nejati Moharrami, Neda/0000-0001-9355-0383	Research Council of Norway through its Centre of Excellence funding scheme [223255/F50]; Norwegian University of Science and Technology (NTNU) [2014/23166]; Central Norway Regional Health Authority (RHA) [2014/23166]	Research Council of Norway through its Centre of Excellence funding scheme; Norwegian University of Science and Technology (NTNU); Central Norway Regional Health Authority (RHA)	This work was supported by the Research Council of Norway through its Centre of Excellence funding scheme, project number 223255/F50 and a grant to VB from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (2014/23166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Bosshart H, ANN TRANSL MED, P438; CARLBERG C, 1994, MOL ENDOCRINOL, V8, P757, DOI 10.1210/me.8.6.757; Coban N, 2017, ANATOL J CARDIOL, V17, P362, DOI 10.14744/AnatolJCardiol.2016.7411; Coban N, 2017, CELL BIOL INT, V41, P163, DOI 10.1002/cbin.10712; Dai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070392; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Dzhagalov I, 2004, J IMMUNOL, V173, P2952, DOI 10.4049/jimmunol.173.5.2952; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fink SL, INFECT IMMUN, P1907; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gardella S, 2000, BLOOD, V95, P3809; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gonzalez-Dominguez E, 2015, J LEUKOCYTE BIOL, V98, P453, DOI 10.1189/jlb.3HI1114-531R; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gulec C, 2017, EXP CELL RES, V353, P6, DOI 10.1016/j.yexcr.2017.02.028; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Han YC, 2017, 2017 13TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P20, DOI 10.1109/CIS.2017.00013; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Jetten Anton M., 2018, Current Opinion in Toxicology, V8, P66, DOI 10.1016/j.cotox.2018.01.005; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; KOPMELS B, 1992, J NEUROCHEM, V58, P192, DOI 10.1111/j.1471-4159.1992.tb09295.x; Liu Y, 2017, J BIOL CHEM, V292, P13959, DOI [10.1074/jbc.M117.782391, 10.1074/jbc.m117.782391]; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; MatysiakScholze U, 1997, GENOMICS, V43, P78, DOI 10.1006/geno.1997.4757; Meyer T, 2000, P NATL ACAD SCI USA, V97, P9197, DOI 10.1073/pnas.150246097; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pozo D, 2004, J PINEAL RES, V37, P48, DOI 10.1111/j.1600-079X.2004.00135.x; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Slominski AT, 2017, J STEROID BIOCHEM, V173, P42, DOI 10.1016/j.jsbmb.2016.09.024; Slominski AT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10202-7; Slominski AT, 2014, FASEB J, V28, P2775, DOI 10.1096/fj.13-242040; Stapleton CM, 2005, AM J PHYSIOL-LUNG C, V289, pL144, DOI 10.1152/ajplung.00348.2004; Stehlin-Gaon C, 2003, NAT STRUCT BIOL, V10, P820, DOI 10.1038/nsb979; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Sun Y, 2015, P NATL ACAD SCI USA, V112, P10401, DOI 10.1073/pnas.1504387112; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; Williams KC, 2015, J LEUKOCYTE BIOL, V98, P449, DOI 10.1189/jlb.1CE0615-233RR; Xiao Qianxun, 1998, Frontiers in Bioscience, V3, pA52; Yan ZH, 1997, J BIOL CHEM, V272, P10565; Zhu Y, 2006, ONCOGENE, V25, P2901, DOI 10.1038/sj.onc.1209314	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207374	10.1371/journal.pone.0207374	http://dx.doi.org/10.1371/journal.pone.0207374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485323	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800063
J	Yang, SSD; Jang, MY; Lee, KH; Hsu, WT; Chen, YC; Chen, WS; Chang, SJ				Yang, Stephen She-Dei; Jang, Mei-Yu; Lee, Kau-Han; Hsu, Wen-Tsang; Chen, Yi-Chu; Chen, Wan-San; Chang, Shang-Jen			Sexual and bladder dysfunction in male ketamine abusers: A large-scale questionnaire study	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; INDEX; PREVALENCE; SYMPTOMS; CYSTITIS; VERSION	Purpose To evaluate the prevalence of lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) in the illicit male ketamine abusers (KA). Materials and methods The male street KAs caught by policemen and patients visiting urologic clinics were invited to answer a structured questionnaire including demographic data, illicit drug use related details (duration, frequency, dosage and abstinence status), international prostate symptoms score (IPSS), interstitial cystitis symptoms and problem index (ICSI and ICPI) and International index of erectile function (IIEF-5). Erectile dysfunction was defined as IIEF-5 <= 21. Results Finally, we included 1056 participants (993 street, 63 hospital KAs) with a mean age of 27.4 +/- 6.2 years. ED presented in 30.8% of all KAs. and Hospital KAs were more subject to having ED than street KAs (69.6% vs. 28.0%, p<0.01). Multi-variate analysis revealed that risk factor for male ED were age >= 30 years (OR = 1.765). Subgroup analysis on male street KAs disclosed that abstinence >= 3 months is a protective factor for ED. Lower urinary tract symptoms (ICSI+ICPI >= 12) was prevalent in KAs and multivariate analysis disclosed that significant risk factors for LUTS (ICSI+ICPI >= 12) were age >= 30 years, duration >= 24 months and co-use of other illicit drugs. Conclusions Male ED and LUTS were frequently observed in the ketamine abusers. We suggested that street ketamine abuse should be considered in young men presented with ED and LUTS in the clinics.	[Yang, Stephen She-Dei; Chen, Yi-Chu; Chen, Wan-San; Chang, Shang-Jen] Taipei Tzu Chi Hosp, Dept Urol, New Taipei, Taiwan; [Yang, Stephen She-Dei; Chang, Shang-Jen] Buddhist Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Jang, Mei-Yu] Kaohsiung Municipal Hsia Kang Hosp, Dept Urol, Kaohsiung, Taiwan; [Lee, Kau-Han] Chi Mei Med Ctr, Dept Surg, Div Urol, Tainan, Taiwan; [Hsu, Wen-Tsang] Keelung Hosp, Dept Urol, Minist Hlth & Wealthfare, Keelung, Taiwan	Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University; Chi Mei Hospital	Chang, SJ (corresponding author), Taipei Tzu Chi Hosp, Dept Urol, New Taipei, Taiwan.; Chang, SJ (corresponding author), Buddhist Tzu Chi Univ, Sch Med, Hualien, Taiwan.	krissygnet@gmail.com		chang, shang-jen/0000-0003-1409-3853; Yang, Stephen Shei-Dei/0000-0002-1044-3281	Food and Drug Administration, Ministry of Health and Welfare, Taiwan [MOHW106-FDA-D-114-000634]	Food and Drug Administration, Ministry of Health and Welfare, Taiwan	This study received financial support from the Food and Drug Administration, Ministry of Health and Welfare, Taiwan(grant number MOHW106-FDA-D-114-000634).	Allen CA, 2018, J INFUS MURS, V41, P284, DOI 10.1097/NAN.0000000000000284; Chan WL, 2015, SUBST USE MISUSE, V50, P1390, DOI 10.3109/10826084.2015.1013135; Chang SR, 2009, J SEX MED, V6, P1609, DOI 10.1111/j.1743-6109.2009.01247.x; Chang T, 2012, LUTS, V4, P19, DOI 10.1111/j.1757-5672.2011.00101.x; Chao JK, 2011, J SEX MED, V8, P1156, DOI 10.1111/j.1743-6109.2010.02181.x; Chen IC, 2017, LOWER URINARY TRACT; Chen WJ, 2013, J FOOD DRUG ANAL, V21, pS102, DOI 10.1016/j.jfda.2013.09.044; Chou NH, 2015, J SEX MED, V12, P1694, DOI 10.1111/jsm.12926; Chu PSK, 2008, BJU INT, V102, P1616, DOI 10.1111/j.1464-410X.2008.07920.x; DUMAN R, 2018, F1000RESEARCH, V7; Jhang JF, 2017, NEUROUROL URODYNAM, V36, P687, DOI 10.1002/nau.22996; OLeary MP, 1997, UROLOGY, V49, P58, DOI 10.1016/S0090-4295(99)80333-1; Ren L, 2018, J PSYCHIATR RES, V104, P144, DOI 10.1016/j.jpsychires.2018.07.003; Robles-Martinez M, 2018, J PSYCHOACTIVE DRUGS, V50, P129, DOI 10.1080/02791072.2017.1371364; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Shahani R, 2007, UROLOGY, V69, P810, DOI 10.1016/j.urology.2007.01.038; Shang HS, 2017, ONCOTARGET, V8, P73670, DOI 10.18632/oncotarget.10727; Suppiah B, 2016, J PSYCHOACTIVE DRUGS, V48, P86, DOI 10.1080/02791072.2016.1156790; Tam YH, 2016, HONG KONG MED J, V22, P454, DOI 10.12809/hkmj154806; Yang SS, 2015, UROLOGICAL SCI, V26, P3	20	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207927	10.1371/journal.pone.0207927	http://dx.doi.org/10.1371/journal.pone.0207927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485367	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800086
J	Lu, J; Chen, SM; Guo, MJ; Ye, CY; Qiu, BL; Yang, CX; Pan, HP				Lu, Jing; Chen, Shimin; Guo, Mujuan; Ye, Cuiyi; Qiu, Baoli; Yang, Chunxiao; Pan, Huipeng			Selection of appropriate reference genes for RT-qPCR analysis in Propylea japonica (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							REAL-TIME PCR; NORMALIZATION; EXPRESSION	Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) is a reliable technique commonly used in molecular biology to analyze RNA expression. The selection of suitable reference genes for data normalization is a precondition for credible measurements of gene expression levels using RT-qPCR. Propylea japonica is one of the most common pests of many crop systems throughout East Asia, and has often been used in the testing of non-target impacts during environmental risk assessments of genetically engineered plants. The present study assessed the suitability of nine frequently used reference genes for comparisons of P. japonica gene expression. Expression stability was compared across developmental stages, sex, a range of tissues, and following exposure to different temperatures. Data were analyzed using RefFinder, which integrated the results obtained using NormFinder, geNorm, BestKeeper, and the Delta Ct method. This led to the identification of unique sets of reference genes for each experimental condition: ribosomal protein S18 (RPS18) and elongation factor 1 a (EF1A) for developmental stage comparisons, RPS18 and EF1A for sex comparisons, EF1A and ribosomal protein L4 for tissue comparisons, and RPS18 and EF1A for analyses of temperature-mediated effects. These reference genes will help to enhance the accuracy of RT-qPCR analyses of P. japonica gene expression. This work represents an initial move towards building a standardized system for RT-qPCR analysis of P. japonica, providing a basis for the ecological risk assessment of RNAi-based insect control products.	[Lu, Jing; Chen, Shimin; Guo, Mujuan; Ye, Cuiyi; Qiu, Baoli; Pan, Huipeng] South China Agr Univ, Key Lab Biopesticide Innovat & Applicat Guangdong, Engn Technol Res Ctr Agr Pest Biocontrol Guangdon, Guangzhou, Guangdong, Peoples R China; [Yang, Chunxiao] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Pan, HP (corresponding author), South China Agr Univ, Key Lab Biopesticide Innovat & Applicat Guangdong, Engn Technol Res Ctr Agr Pest Biocontrol Guangdon, Guangzhou, Guangdong, Peoples R China.; Yang, CX (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	yangchunxiao@scau.edu.cn; panhuipeng@scau.edu.cn			National Key R&D Program of China [2017YFD0200900]; GDUPS; South China Agricultural University	National Key R&D Program of China; GDUPS; South China Agricultural University	This research was supported by the National Key R&D Program of China (2017YFD0200900 to HP), project supported by GDUPS (2017 to HP), and a start-up fund from the South China Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Collins C, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.63; Dai TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173821; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Li RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061619; Li Y, 2017, SCI COLD ARID REGION, V9, P1, DOI DOI 10.1016/j.coldregions.2017.09.001; Li Y, 2017, TOXINS, V9, DOI 10.3390/toxins9030108; Li YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep07679; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Liu YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23507; Lu J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01560; Lv ZH, 2018, J ASIA-PAC ENTOMOL, V21, P19, DOI 10.1016/j.aspen.2017.10.001; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129482; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Su YL, 2013, J ECON ENTOMOL, V106, P1446, DOI 10.1603/EC12459; Tang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100946; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang CX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01672; Yang CX, 2015, SCI REP-UK, V5, DOI 10.1038/srep18201; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130593; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120833; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Yang XG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19426-7; Zhang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085395; Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20368	33	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208027	10.1371/journal.pone.0208027	http://dx.doi.org/10.1371/journal.pone.0208027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481225	Green Published, Green Submitted, gold			2022-12-26	WOS:000451440000037
J	Wang, H; Kleffner, K; Carolan, PL; Liotti, M				Wang, Huan; Kleffner, Killian; Carolan, Patrick L.; Liotti, Mario			Spatiotemporal dynamics of reward and punishment effects induced by associative learning	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; ORBITOFRONTAL CORTEX; AUTOMATIC ATTENTION; ANTERIOR CINGULATE; TEMPORAL DYNAMICS; EMOTIONAL STIMULI; LOSS ANTICIPATION; DECISION-MAKING; RESPONSES; ERROR	While reward associative learning has been studied extensively across different species, punishment avoidance learning has received far less attention. Of particular interest is how the two types of learning change perceptual processing of the learned stimuli. We designed a task that required participants to learn the association of emotionally neutral images with reward, punishment, and no incentive value outcomes through trial-and-error. During learning, participants received monetary reward, neutral outcomes or avoided punishment by correctly identifying corresponding images. Results showed an early bias in favor of learning reward associations, in the form of higher accuracy and fewer trials needed to reach learning criterion. We subsequently assessed electrophysiological learning effects with a task in which participants viewed the stimuli with no feedback or reinforcement. Critically, we found modulation of two early event-related potential components for reward images: the fronto-central P2 (170-230 ms) and the anterior N2/Early Anterior Positivity ( N2/EAP; 210-310 ms). We suggest that reward associations may change stimuli detection and incentive salience as indexed by P2 and N2/EAP. We also reported, on an exploratory basis, a late negativity with frontopolar distribution enhanced by punishment images.	[Wang, Huan; Kleffner, Killian; Carolan, Patrick L.; Liotti, Mario] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Liotti, Mario] Univ Padua, Dept Dev & Social Psychol, Padua, Italy; [Liotti, Mario] Univ Padua, Padua Neurosci Ctr, Padua, Italy	Simon Fraser University; University of Padua; University of Padua	Liotti, M (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.; Liotti, M (corresponding author), Univ Padua, Dept Dev & Social Psychol, Padua, Italy.; Liotti, M (corresponding author), Univ Padua, Padua Neurosci Ctr, Padua, Italy.	mliotti@sfu.ca		Kleffner, Killian/0000-0002-0442-7568; LIOTTI, MARIO/0000-0003-3375-5488	Natural Sciences and Engineering Research Council of Canada (NSERC) [297581]; Canada Foundation for Innovation (CFI) [10058]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by grants from Natural Sciences and Engineering Research Council of Canada (NSERC; #297581) to ML and Canada Foundation for Innovation (CFI; 10058) to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Megan Liau and research assistants in our lab for the help with data collection. We are particularly grateful to John McDonald and Anne Smith for valuable advice on the project. This research was supported by grants from Natural Sciences and Engineering Research Council of Canada (NSERC) and Canada Foundation for Innovation (CFI) to ML.	Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Asmaro D, 2014, ADDICT BEHAV, V39, P114, DOI 10.1016/j.addbeh.2013.09.012; Asmaro D, 2012, APPETITE, V58, P790, DOI 10.1016/j.appet.2012.01.030; Baker TE, 2011, BIOL PSYCHOL, V87, P25, DOI 10.1016/j.biopsycho.2011.01.010; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bergstrom ZM, 2016, J COGNITIVE NEUROSCI, V28, P1838, DOI 10.1162/jocn_a_01010; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Broyd SJ, 2012, J NEUROSCI METH, V209, P40, DOI 10.1016/j.jneumeth.2012.05.015; Carolan PL, 2014, PSYCHOPHYSIOLOGY, V51, P36, DOI 10.1111/psyp.12145; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2014, COGN AFFECT BEHAV NE, V14, P1228, DOI 10.3758/s13415-014-0270-2; Carretie L, 2013, NEUROPSYCHOLOGIA, V51, P1838, DOI 10.1016/j.neuropsychologia.2013.06.021; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Delgado MR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.033.2009; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Franken IHA, 2011, BIOL PSYCHOL, V86, P273, DOI 10.1016/j.biopsycho.2010.12.008; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Hauser TU, 2014, NEUROIMAGE, V84, P159, DOI 10.1016/j.neuroimage.2013.08.028; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hintze P, 2014, BIOL PSYCHOL, V99, P125, DOI 10.1016/j.biopsycho.2014.03.010; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2011, NEUROREPORT, V22, P249, DOI 10.1097/WNR.0b013e328345441d; Kahnt T, 2014, P NATL ACAD SCI USA, V111, P5000, DOI 10.1073/pnas.1320189111; Kahnt T, 2011, J NEUROSCI, V31, P14624, DOI 10.1523/JNEUROSCI.3412-11.2011; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Krebs RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053894; Lang P.J., 1997, INT AFFECTIVE PICTUR, V1, P3, DOI DOI 10.1027/0269-8803/A000147; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 2017, PSYCHOPHYSIOLOGY, V54, P146, DOI 10.1111/psyp.12639; Metereau E, 2015, CORTEX, V63, P42, DOI 10.1016/j.cortex.2014.08.012; Morel S, 2012, NEUROIMAGE, V61, P1461, DOI 10.1016/j.neuroimage.2012.04.016; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palminteri S, 2012, NEURON, V76, P998, DOI 10.1016/j.neuron.2012.10.017; Pfabigan DM, 2014, NEUROIMAGE, V96, P12, DOI 10.1016/j.neuroimage.2014.03.077; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Potts GF, 1996, BRAIN TOPOGR, V9, P3, DOI 10.1007/BF01191637; Proudfit GH, 2015, PSYCHOPHYSIOLOGY, V52, P449, DOI 10.1111/psyp.12370; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Samanez-Larkin GR, 2008, PSYCHOL SCI, V19, P320, DOI 10.1111/j.1467-9280.2008.02087.x; Santesso DL, 2012, SOC COGN AFFECT NEUR, V7, P794, DOI 10.1093/scan/nsr054; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Schacht A, 2012, BIOL PSYCHOL, V89, P130, DOI 10.1016/j.biopsycho.2011.10.001; Schaefer A, 2011, NEUROIMAGE, V54, P714, DOI 10.1016/j.neuroimage.2010.07.030; Schevernels H, 2014, NEUROIMAGE, V84, P639, DOI 10.1016/j.neuroimage.2013.09.039; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Smith AC, 2007, J NEUROPHYSIOL, V97, P2516, DOI 10.1152/jn.00946.2006; Solomon M, 2011, AUTISM RES, V4, P109, DOI 10.1002/aur.177; Steinberg C, 2013, BIOL PSYCHOL, V92, P526, DOI 10.1016/j.biopsycho.2012.02.009; Taake I, 2009, BIOL PSYCHOL, V81, P48, DOI 10.1016/j.biopsycho.2009.01.006; Tucker DM., 1994, HUM BRAIN MAPP, V1, DOI DOI 10.1002/HBM.460010206; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004; van den Berg B, 2014, COGN AFFECT BEHAV NE, V14, P561, DOI 10.3758/s13415-014-0281-z; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; West R, 2008, CEREB CORTEX, V18, P1112, DOI 10.1093/cercor/bhm142; West R, 2012, NEUROPSYCHOLOGIA, V50, P3450, DOI 10.1016/j.neuropsychologia.2012.10.011; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153	68	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0199847	10.1371/journal.pone.0199847	http://dx.doi.org/10.1371/journal.pone.0199847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475805	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700001
J	Untereiner, A; Abdo, S; Bhattacharjee, A; Gohil, H; Pourasgari, F; Ibeh, N; Lai, M; Batchuluun, B; Wong, A; Khuu, N; Liu, Y; Al Rijjal, D; Winegarden, N; Virtanen, C; Orser, BA; Cabrera, O; Varga, G; Rocheleau, J; Dai, FF; Wheeler, MB				Untereiner, Ashley; Abdo, Shaaban; Bhattacharjee, Alpana; Gohil, Himaben; Pourasgari, Farzaneh; Ibeh, Neke; Lai, Mi; Batchuluun, Battsetseg; Wong, Anthony; Khuu, Nicholas; Liu, Ying; Al Rijjal, Dana; Winegarden, Neil; Virtanen, Carl; Orser, Beverley A.; Cabrera, Over; Varga, Gabor; Rocheleau, Jonathan; Dai, Feihan F.; Wheeler, Michael B.			GABA promotes -cell proliferation, but does not overcome impaired glucose homeostasis associated with diet-induced obesity	FASEB JOURNAL			English	Article						insulin secretion; glucose tolerance; diet-induced obesity; single cell RNA-seq; GABAA receptor	GAMMA-AMINOBUTYRIC-ACID; PANCREATIC BETA-CELLS; INSULIN-SECRETION; EXPRESSION; MOUSE; REVEALS; RELEASE; ISLETS; ADULT; RESISTANCE	-Aminobutyric acid (GABA) administration has been shown to increase -cell mass, leading to a reversal of type 1 diabetes in mice. Whether GABA has any effect on cells of healthy and prediabetic/glucose-intolerant obese mice remains unknown. In the present study, we show that oral GABA administration (ad libitum) to mice indeed increased pancreatic -cell mass, which led to a modest enhancement in insulin secretion and glucose tolerance. However, GABA treatment did not further increase insulin-positive islet area in high fat diet-fed mice and was unable to prevent or reverse glucose intolerance and insulin resistance. Mechanistically, whether in vivo or in vitro, GABA treatment increased -cell proliferation. In vitro, the effect was shown to be mediated via the GABA(A) receptor. Single-cell RNA sequencing analysis revealed that GABA preferentially up-regulated pathways linked to -cell proliferation and simultaneously down-regulated those networks required for other processes, including insulin biosynthesis and metabolism. Interestingly, single-cell differential expression analysis revealed GABA treatment gave rise to a distinct subpopulation of cells with a unique transcriptional signature, including urocortin 3 (ucn3), wnt4, and hepacam2. Taken together, this study provides new mechanistic insight into the proliferative nature of GABA but suggests that -cell compensation associated with prediabetes overlaps with, and negates, its proliferative effects.Untereiner, A., Abdo, S., Bhattacharjee, A., Gohil, H., Pourasgari, F., Ibeh, N., Lai, M., Batchuluun, B., Wong, A., Khuu, N., Liu, Y., Al Rijjal, D., Winegarden, N., Virtanen, C., Orser, B. A., Cabrera, O., Varga, G., Rocheleau, J., Dai, F. F., Wheeler, M. B. GABA promotes -cell proliferation, but does not overcome impaired glucose homeostasis associated with diet-induced obesity.	[Untereiner, Ashley; Abdo, Shaaban; Gohil, Himaben; Pourasgari, Farzaneh; Batchuluun, Battsetseg; Wong, Anthony; Al Rijjal, Dana; Rocheleau, Jonathan; Dai, Feihan F.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Orser, Beverley A.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Bhattacharjee, Alpana; Lai, Mi; Liu, Ying; Rocheleau, Jonathan; Dai, Feihan F.; Wheeler, Michael B.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Ibeh, Neke; Virtanen, Carl] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Khuu, Nicholas; Winegarden, Neil] Univ Hlth Network, Princess Margaret Genom Ctr, Toronto, ON, Canada; [Cabrera, Over; Varga, Gabor] Eli Lilly & Co, Lilly Corp Ctr, Diabet & Complicat Res, Indianapolis, IN 46285 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Eli Lilly	Dai, FF; Wheeler, MB (corresponding author), Dept Physiol, 1 Kings Coll Circle Room 3352, Toronto, ON M5S 1A8, Canada.	f.dai@utoronto.ca; michael.wheeler@utoronto.ca		Untereiner, Ashley/0000-0002-1994-6651; Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Institutes of Health Research [FDN-143219]; New Ideas Grant from Ontario Institutes for Regenerative Medicine [OMNI-2017]; Faculty of Medicine at the University of Toronto; Banting and Best Diabetes Center; Banting and Best Diabetes Center Summer-Student Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); New Ideas Grant from Ontario Institutes for Regenerative Medicine; Faculty of Medicine at the University of Toronto(University of Toronto); Banting and Best Diabetes Center; Banting and Best Diabetes Center Summer-Student Award	The authors thank Islet Core and Clinical Islet Laboratory (Alberta Islet Distribution Program, University of Alberta, Edmonton, AB, Canada) and UHN Islet Isolation Program (UHN, Toronto, ON, Canada) for providing us with human islets from review board-approved donors. This study was supported by the Canadian Institutes of Health Research (Grant FDN-143219) and a New Ideas Grant (OMNI-2017) from the Ontario Institutes for Regenerative Medicine and the Faculty of Medicine at the University of Toronto (to M.B.W.). A.U. and S.A. were supported by Banting and Best Diabetes Center postdoctoral fellowships. A.W. was supported by Banting and Best Diabetes Center Summer-Student Award. The authors declare no conflicts of interest.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Ackermann AM, 2018, CELL METAB, V28, P787, DOI 10.1016/j.cmet.2018.07.002; Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981; Asghar Z, 2006, DIABETOLOGIA, V49, P90, DOI 10.1007/s00125-005-0045-y; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Ben-Othman N, 2017, CELL, V168, P73, DOI 10.1016/j.cell.2016.11.002; Ben-Yaakov G, 2003, INT J DEV NEUROSCI, V21, P153, DOI 10.1016/S0736-5748(03)00027-3; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Biju Mangatt P, 2002, J Biochem Mol Biol Biophys, V6, P209, DOI 10.1080/10258140290018667; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Braun M, 2004, J GEN PHYSIOL, V123, P191, DOI 10.1085/jgp.200308966; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Collombat P, 2009, CELL CYCLE, V8, P3450, DOI 10.4161/cc.8.21.9791; Dai FF, 2015, J BIOL CHEM, V290, P25045, DOI 10.1074/jbc.M115.648592; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Geigerseder Christof, 2004, Reprod Biol Endocrinol, V2, P13, DOI 10.1186/1477-7827-2-13; GILON P, 1991, ENDOCRINOLOGY, V129, P2521, DOI 10.1210/endo-129-5-2521; GU XH, 1993, LIFE SCI, V52, P687, DOI 10.1016/0024-3205(93)90229-V; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Korol SV, 2018, EBIOMEDICINE, V30, P273, DOI 10.1016/j.ebiom.2018.03.014; Li J, 2017, CELL, V168, P86, DOI 10.1016/j.cell.2016.11.010; Li JF, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00260; LIU QR, 1993, J BIOL CHEM, V268, P2106; Liu WJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00362; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Massumi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164457; Mendu SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042959; MESSERSMITH EK, 1993, NEUROCHEM RES, V18, P463, DOI 10.1007/BF00967250; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PETTY F, 1984, J AFFECT DISORDERS, V6, P131, DOI 10.1016/0165-0327(84)90018-1; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Prud'homme GJ, 2014, BIOCHEM BIOPH RES CO, V452, P649, DOI 10.1016/j.bbrc.2014.08.135; Prud'homme GJ, 2013, TRANSPLANTATION, V96, P616, DOI 10.1097/TP.0b013e31829c24be; Purwana I, 2014, DIABETES, V63, P4197, DOI 10.2337/db14-0153; ROBBINS MS, 1981, DIABETES, V30, P168, DOI 10.2337/diabetes.30.2.168; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; SENER A, 1984, EXPERIENTIA, V40, P1026, DOI 10.1007/BF01971448; Shang WT, 2018, FOOD FUNCT, V9, P2820, DOI 10.1039/c8fo00331a; Si X, 2018, J AGR FOOD CHEM, V66, P881, DOI 10.1021/acs.jafc.7b04994; Sohrabipour S, 2018, EUR J PHARMACOL, V826, P75, DOI 10.1016/j.ejphar.2018.01.047; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Tamura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126003; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tian JD, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/6403539; Tian J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00515-y; Tian JD, 2013, DIABETES, V62, P3760, DOI 10.2337/db13-0931; Tian J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025338; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	68	27	30	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3968	3984		10.1096/fj.201801397R	http://dx.doi.org/10.1096/fj.201801397R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509117	Bronze			2022-12-26	WOS:000459794800069
J	Godlewska, U; Bilska, B; Zegar, A; Brzoza, P; Borek, A; Murzyn, K; Bochenska, O; Morytko, A; Kuleta, P; Kozik, A; Pyza, E; Osyczka, A; Zabel, BA; Cichy, J				Godlewska, Urszula; Bilska, Bernadetta; Zegar, Aneta; Brzoza, Piotr; Borek, Arkadiusz; Murzyn, Krzysztof; Bochenska, Oliwia; Morytko, Agnieszka; Kuleta, Patryk; Kozik, Andrzej; Pyza, Elzbieta; Osyczka, Artur; Zabel, Brian A.; Cichy, Joanna			The antimicrobial activity of chemerin-derived peptide p4 requires oxidative conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermis; antimicrobial peptide (AMP); bacteria; host defense; host-pathogen interaction; chemotaxis; adipokine; Staphylococcus aureus (S. aureus); skin; chemerin; MRSA	DENDRITIC CELLS; RECEPTOR	Chemerin is a leukocyte attractant, adipokine, and antimicrobial protein abundantly produced in the skin epidermis. Despite the fact that most of the bactericidal activity present in human skin exudates is chemerin-dependent, just how chemerin shapes skin defenses remains obscure. Here we demonstrate that p4, a potent antimicrobial human chemerin peptide derivative, displays killing activity against pathogenic methicillin-resistant Staphylococcus aureus strains and suppresses microbial growth in a topical skin infection model. Mechanistically, we show that p4 homodimerization is required for maximal bactericidal activity and that an oxidative environment, such as at the skin surface, facilitates p4 disulfide bridge formation, required for the dimerization. p4 led to rapid damage of the bacterial internal membrane and inhibited the interaction between the membranous cytochrome bc(1) complex and its redox partner, cytochrome c. These results suggest that a chemerin p4-based defense strategy combats bacterial challenges at the skin surface.	[Godlewska, Urszula; Zegar, Aneta; Brzoza, Piotr; Morytko, Agnieszka; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Borek, Arkadiusz; Kuleta, Patryk; Osyczka, Artur] Jagiellonian Univ, Dept Mol Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Murzyn, Krzysztof] Jagiellonian Univ, Dept Computat Biophys & Bioinformat, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Bochenska, Oliwia; Kozik, Andrzej] Jagiellonian Univ, Dept Analyt Biochem, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Bilska, Bernadetta; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Cell Biol & Imaging, PL-30387 Krakow, Poland; [Zabel, Brian A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA	Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Cichy, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland.	Joanna.Cichy@uj.edu.pl	Brzoza, Piotr/AAM-4252-2021	Brzoza, Piotr/0000-0003-0516-3266; Cichy, Joanna/0000-0002-0552-8344; Bilska, Bernadetta/0000-0001-6142-7575; Osyczka, Artur/0000-0002-1637-2365; Borek, Arkadiusz/0000-0003-3195-3579	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The Faculty of Biochemistry, Biophysics, and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Polish Ministry of Science and Higher Education.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Banas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117830; Banas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058709; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bozaoglu K, 2010, J CLIN ENDOCR METAB, V95, P2476, DOI 10.1210/jc.2010-0042; Godlewska U, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00353; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Kracke F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00575; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; OLIVA B, 1992, ANTIMICROB AGENTS CH, V36, P913, DOI 10.1128/AAC.36.5.913; Sarewicz M, 2015, PHYSIOL REV, V95, P219, DOI 10.1152/physrev.00006.2014; Sarewicz M, 2010, BBA-BIOENERGETICS, V1797, P1820, DOI 10.1016/j.bbabio.2010.07.005; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Watts SW, 2013, ARTERIOSCL THROM VAS, V33, P1320, DOI 10.1161/ATVBAHA.113.301476; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2014, AM J CLIN EXP IMMUNO, V3, P1	29	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1267	1278		10.1074/jbc.RA118.005495	http://dx.doi.org/10.1074/jbc.RA118.005495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504221	Green Published, hybrid			2022-12-26	WOS:000457879500018
J	Shavit, R; Batyrshina, ZS; Dotan, N; Tzin, V				Shavit, Reut; Batyrshina, Zhaniya S.; Dotan, Nitsan; Tzin, Vered			Cereal aphids differently affect benzoxazinoid levels in durum wheat	PLOS ONE			English	Article							HYDROXAMIC ACIDS; HOMOPTERA-APHIDIDAE; RHOPALOSIPHUM-PADI; SPECTROMETRY DATA; DETOXIFICATION; BIOSYNTHESIS; RESISTANCE; METABOLISM; DAMAGE; DIMBOA	Aphids are major pests in cereal crops that cause direct and indirect damage leading to yield reduction. Despite the fact that wheat provides 20% of the world's caloric and protein diet, its metabolic responses to aphid attack, in general, and specifically its production of benzoxazinoid defense compounds are poorly understood. The objective of this study was to compare the metabolic diversity of durum wheat seedlings (Triticum turgidum ssp. durum) under attack by three different cereal aphids: i) the English grain aphid (Sitobion avenae Fabricius), ii) the bird cherry-oat aphid (Rhopalosiphum padi L.), and iii) the greenbug aphid (Schizaphis graminum Rondani), which are some of the most destructive aphid species to wheat. Insect progeny bioassays and metabolic analyses using chromatography/Q-Exactive/mass spectrometry non-targeted metabolomics and a targeted benzoxazinoid profile were performed on infested leaves. The insect bioassays revealed that the plants were susceptible to S. graminum, resistant to S. avenae, and mildly resistant to R. padi. The metabolic analyses of benzoxazinoids suggested that the predominant metabolites DIMBOA (2,4-dihydroxy-7-methoxy-1,4-benzoxazin- 3-one) and its glycosylated form DIMBOA-glucoside (GIc) were significantly induced upon both S. avenae, and R. padiaphid feeding. However, the levels of the benzoxazinoid metabolite HDMBOA-Glc (2-hydroxy-4,7-dimethoxy-1,4-benzoxazin-3-one glucoside) were enhanced due to the feeding of S. avenae and S. graminum aphids, to which Svevo was the most resistant and the most susceptible, respectively. The results showed a partial correlation between the induction of benzoxazinoids and aphid reproduction. Overall, our observations revealed diverse metabolic responses of wheat seedlings to cereal aphid feeding.	[Shavit, Reut; Batyrshina, Zhaniya S.; Dotan, Nitsan; Tzin, Vered] Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Drylands, Jacob Blaustein Inst Desert Res, Sede Boqer Campus, Beer Sheva, Israel; [Tzin, Vered] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel	Ben Gurion University	Tzin, V (corresponding author), Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Drylands, Jacob Blaustein Inst Desert Res, Sede Boqer Campus, Beer Sheva, Israel.; Tzin, V (corresponding author), Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel.	vtzin@bgu.ac.il	Tzin, Vered/AAH-8785-2019	Tzin, Vered/0000-0002-5912-779X; Batyrshina, Zhaniya/0000-0002-6747-8944; Shavit, Reut/0000-0003-0740-2187	Bona Terra Foundation Fund for Promoting Sustainable Agriculture in Drylands; Ministry of Science and Technology in Israel, Women in Science Scholarship	Bona Terra Foundation Fund for Promoting Sustainable Agriculture in Drylands; Ministry of Science and Technology in Israel, Women in Science Scholarship	This research was funded by Bona Terra Foundation Fund for Promoting Sustainable Agriculture in Drylands for RS and ZB, and by The Ministry of Science and Technology in Israel, Women in Science Scholarship for RS.	Adhikari KB, 2015, MOL NUTR FOOD RES, V59, P1324, DOI 10.1002/mnfr.201400717; Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; ALMOUSAWI AH, 1983, ANN ENTOMOL SOC AM, V76, P964, DOI 10.1093/aesa/76.6.964; Ben-abu Y, 2018, MOUNT CARMEL ISRAEL, P1; Betsiashvili M, 2015, J EXP BOT, V66, P571, DOI 10.1093/jxb/eru379; BING JW, 1991, ANN ENTOMOL SOC AM, V84, P549, DOI 10.1093/aesa/84.5.549; Blackman R. L., 2000, Aphids on the world's crops: an identification and information guide.; BOHIDAR K, 1986, ANN APPL BIOL, V109, P193, DOI 10.1111/j.1744-7348.1986.tb03199.x; Bui H, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01222; Castaneda LE, 2009, J EXP BIOL, V212, P1185, DOI 10.1242/jeb.020990; Chandrasekhar K, 2018, PLANT SIGNAL BEHAV, V13, DOI 10.1080/15592324.2018.1486148; Charmet G, 2011, CR BIOL, V334, P212, DOI 10.1016/j.crvi.2010.12.013; Cilia M, 2011, PROTEOMICS, V11, P2440, DOI 10.1002/pmic.201000519; Deutsch CA, 2018, SCIENCE, V361, P916, DOI 10.1126/science.aat3466; Elek H, 2013, ANN APPL BIOL, V162, P100, DOI 10.1111/aab.12005; FAOSTAT, 2014, FAO STAT DAT FOOD AG; FENG R, 1992, PESTIC BIOCHEM PHYS, V44, P147, DOI 10.1016/0048-3575(92)90112-D; FERERES A, 1989, ENVIRON ENTOMOL, V18, P388, DOI 10.1093/ee/18.3.388; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Gianoli E, 2000, ACTA AGR SCAND B-S P, V50, P35, DOI 10.1080/090647100750014394; Gilabert A, 2009, MOL ECOL, V18, P3050, DOI 10.1111/j.1365-294X.2009.04250.x; Glauser G, 2011, PLANT J, V68, P901, DOI 10.1111/j.1365-313X.2011.04740.x; Grun S, 2005, PHYTOCHEMISTRY, V66, P1264, DOI 10.1016/j.phytochem.2005.01.024; Guerrieri E, 2008, J PLANT INTERACT, V3, P223, DOI 10.1080/17429140802567173; Handrick V, 2016, PLANT CELL, V28, P1682, DOI 10.1105/tpc.16.00065; Hanhineva K, 2011, J AGR FOOD CHEM, V59, P921, DOI 10.1021/jf103612u; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Huffaker A, 2013, P NATL ACAD SCI USA, V110, P5707, DOI 10.1073/pnas.1214668110; IRWIN ME, 1988, PHILOS T R SOC B, V321, P421, DOI 10.1098/rstb.1988.0101; KIECKHEFER RW, 1988, CROP SCI, V28, P688, DOI 10.2135/cropsci1988.0011183X002800040027x; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; LACCM Smith, 2013, RESISTANCE MULTIPLE, P535; Loayza-Muro R, 2000, J CHEM ECOL, V26, P2725, DOI 10.1023/A:1026481524896; Maag D, 2016, PLANT J, V88, P976, DOI 10.1111/tpj.13308; Makowska B, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1927-3; Maxmen A, 2013, NATURE, V501, pS15, DOI 10.1038/501S15a; Meihls L N, 2012, Cold Spring Harb Symp Quant Biol, V77, P269, DOI 10.1101/sqb.2012.77.014662; Meihls LN, 2013, PLANT CELL, V25, P2341, DOI 10.1105/tpc.113.112409; Mukanganyama S, 2003, J INSECT PHYSIOL, V49, P223, DOI 10.1016/S0022-1910(02)00269-X; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Niculaes C, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8080143; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oikawa A, 2004, PHYTOCHEMISTRY, V65, P2995, DOI 10.1016/j.phytochem.2004.09.006; Parizoto G, 2013, TROP PLANT PATHOL, V38, P11, DOI 10.1590/S1982-56762013000100002; Parry HR, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-14; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Pereira JF, 2017, THEOR EXP PLANT PHYS, V29, P61, DOI 10.1007/s40626-017-0084-z; RABBINGE R, 1981, NETH J PLANT PATHOL, V87, P217, DOI 10.1007/BF02084437; Rebijith KB, 2017, BIOL J LINN SOC, V121, P796, DOI 10.1093/biolinnean/blx020; ROBINSON A. G., 1963, CANADIAN ENTOMOL, V95, P134; ROSSING WAH, 1990, NETH J PLANT PATHOL, V96, P343, DOI 10.1007/BF01998784; Shakoor A., 2018, BENZOXAZINOIDS PROTE, V55, P49; Sicker D, 2000, INT REV CYTOL, V198, P319; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sue M, 2011, PLANT PHYSIOL, V157, P985, DOI 10.1104/pp.111.182378; Tanwir F, 2017, PHYTOCHEMISTRY, V140, P95, DOI 10.1016/j.phytochem.2017.04.020; Trezbicki P, 2015, GLOBAL CHANGE BIOL, V21, P3511, DOI 10.1111/gcb.12941; Tzin V, 2015, MOL ECOL, V24, P5739, DOI 10.1111/mec.13418; Tzin V, 2015, PLANT PHYSIOL, V169, P1727, DOI 10.1104/pp.15.01039; Tzin V, 2009, PLANT J, V60, P156, DOI 10.1111/j.1365-313X.2009.03945.x; Voss TS, 1997, J ECON ENTOMOL, V90, P1346, DOI 10.1093/jee/90.5.1346; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhou SQ, 2018, PLANT CELL PHYSIOL, V59, P1528, DOI 10.1093/pcp/pcy064; Zhou SQ, 2015, PLANT PHYSIOL, V169, P1488, DOI 10.1104/pp.15.01405	65	20	22	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208103	10.1371/journal.pone.0208103	http://dx.doi.org/10.1371/journal.pone.0208103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507950	Green Published, Green Submitted, gold			2022-12-26	WOS:000451886500021
J	Sors, F; Lath, F; Bader, A; Santoro, I; Galmonte, A; Agostini, T; Murgia, M				Sors, Fabrizio; Lath, Franziska; Bader, Alexandra; Santoro, Ilaria; Galmonte, Alessandra; Agostini, Tiziano; Murgia, Mauro			Predicting the length of volleyball serves: The role of early auditory and visual information	PLOS ONE			English	Article							PERCEPTUAL-COGNITIVE EXPERTISE; ANTICIPATION; INTENTIONS; PLAYERS; SEARCH; SKILLS; THROW	In light of the growing body of research that is revealing the significant role of the auditory domain in sport, the present study aims to investigate the contribution of early auditory and visual information to the prediction of volleyball serves' length. To this purpose, three within-subjects experiments were run, which differed among them in terms of stimuli (audiovisual congruent vs audiovisual incongruent; audio only vs video only) and/or in terms of number of possible answers. In particular, expert volleyball players were asked to predict the length of temporally occluded overhand serves, choosing among either two or three possible landing sectors. Response accuracy and response times were measured. For the incongruent stimuli, the results revealed that the percentage of predictions in line with early auditory information was significantly higher than the respective percentage of predictions in line with early visual information. For unimodal stimuli, prediction accuracy was significantly higher on the basis of auditory information than on the basis of visual information, without any difference on response times. Taken together, the results highlighted the relevance of early auditory information for the prediction of volleyball serves' length.	[Sors, Fabrizio; Lath, Franziska; Bader, Alexandra; Santoro, Ilaria; Agostini, Tiziano; Murgia, Mauro] Univ Trieste, Dept Life Sci, Trieste, Italy; [Galmonte, Alessandra] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Lath, Franziska] Univ Erfurt, Dept Psychol, Erfurt, Germany; [Bader, Alexandra] Univ Innsbruck, Dept Psychol, Innsbruck, Austria	University of Trieste; University of Trieste; University of Erfurt; University of Innsbruck	Sors, F (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	fabrizio.sors@libero.it	MURGIA, MAURO/AEX-0770-2022; Galmonte, Alessandra CG/D-6402-2015	MURGIA, MAURO/0000-0002-8450-1157; Galmonte, Alessandra CG/0000-0003-2927-8965; Sors, Fabrizio/0000-0002-3803-1772; Lath, Franziska/0000-0001-5289-7815				Abernethy B, 2001, PERCEPTION, V30, P233, DOI 10.1068/p2872; Abernethy B, 2012, J EXP PSYCHOL-APPL, V18, P143, DOI 10.1037/a0028452; Agostini T, 2004, CISM COUR L, P67; Al-Abood SA, 2002, J SPORT SCI, V20, P271, DOI 10.1080/026404102317284817; Allerdissen M, 2017, PSYCHOL SPORT EXERC, V31, P123, DOI 10.1016/j.psychsport.2017.04.009; Brown AM, 2008, MED SCI SPORT EXER, V40, P1142, DOI 10.1249/MSS.0b013e31816770e1; Button C, 2011, COGN PROCESS, V12, P235, DOI 10.1007/s10339-010-0384-6; Camponogara I, 2017, J EXP PSYCHOL HUMAN, V43, P348, DOI 10.1037/xhp0000316; Canal-Bruland R, 2018, PSYCHOL SPORT EXERC, V36, P100, DOI 10.1016/j.psychsport.2018.02.001; Casanova R, 2015, J SPORT SCI, V33, P1822, DOI 10.1080/02640414.2015.1013052; Cesari P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090156; Craig C., 2013, SPORTS TECHNOLOGY, V6, P161, DOI DOI 10.1080/19346182.2013.855224; Davids K., 2002, INTERCEPTIVE ACTIONS, P1; Diaz GJ, 2012, J EXP PSYCHOL HUMAN, V38, P848, DOI 10.1037/a0026962; Farrow D, 2002, J SPORT SCI, V20, P471, DOI 10.1080/02640410252925143; Jackson RC, 2003, J SPORT SCI, V21, P503, DOI 10.1080/0264041031000101818; Kennel C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00069; Kennel C, 2014, PERCEPTION, V43, P796, DOI 10.1068/p7643; Loffing F, 2015, HUM MOVEMENT SCI, V40, P410, DOI 10.1016/j.humov.2015.01.018; Loffing F, 2014, PSYCHOL SPORT EXERC, V15, P260, DOI 10.1016/j.psychsport.2014.01.006; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Murgia M, 2015, OPEN PSYCHOL J, V8, P171, DOI [10.2174/1874350101508010171, DOI 10.2174/1874350101508010171]; Murgia M., 2015, OPEN PSYCHOL J, V8, P220; Murgia M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01340; Murgia M, 2014, PSYCHOL SPORT EXERC, V15, P642, DOI 10.1016/j.psychsport.2014.07.009; Murgia M, 2012, PERCEPTION, V41, P976, DOI 10.1068/p7227; Murphy CP, 2016, J EXP PSYCHOL-APPL, V22, P455, DOI 10.1037/xap0000094; Navia JA, 2017, J EXP PSYCHOL HUMAN, V43, P783, DOI 10.1037/xhp0000347; Oudejans RRD, 1997, J SPORT SCI, V15, P587, DOI 10.1080/026404197367029; Panchuk D, 2013, ACTA PSYCHOL, V142, P394, DOI 10.1016/j.actpsy.2013.01.014; Paulo A, 2018, J SPORT SCI, V36, P2621, DOI 10.1080/02640414.2018.1473098; Paulo A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01694; Pizzera A., 2015, OPEN PSYCHOL J, V8, P183; Rymal A., 2015, OPEN PSYCHOL J, V8, P203, DOI [10.2174/1874350101508010203, DOI 10.2174/1874350101508010203]; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; Schaffert N, 2011, J HUM SPORT EXERC, V6, P392, DOI 10.4100/jhse.2011.62.20; Sors F., 2015, OPEN PSYCHOL J, V8, P212, DOI DOI 10.2174/1874350101508010212; Sors F, 2017, PSYCHOL SPORT EXERC, V31, P44, DOI 10.1016/j.psychsport.2017.04.005; Steenson C., 2015, OPEN PSYCHOL J, V8, P174, DOI [10.2174/1874350101508010174, DOI 10.2174/1874350101508010174]; Stone JA, 2015, EXP BRAIN RES, V233, P449, DOI 10.1007/s00221-014-4126-3; Stone JA, 2014, PROCEDIA ENGINEER, V72, P156, DOI 10.1016/j.proeng.2014.06.027; TAKEUCHI T, 1993, PERCEPT MOTOR SKILL, V76, P1323, DOI 10.2466/pms.1993.76.3c.1323; Vickers JN., 1997, INT J SPORTS VIS, V4, P18; Woods EA, 2014, BRAIN COGNITION, V87, P122, DOI 10.1016/j.bandc.2014.03.007; Wuerger SM, 2012, SEEING PERCEIVING, V25, P15, DOI 10.1163/187847611X620892	45	12	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208174	10.1371/journal.pone.0208174	http://dx.doi.org/10.1371/journal.pone.0208174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC6BO	30507975	gold, Green Published, Green Submitted			2022-12-26	WOS:000451886500028
J	Trevino, SR; Klimko, CP; Reed, MC; Aponte-Cuadrado, MJ; Hunter, M; Shoe, JL; Meyer, JR; Dankmeyer, JL; Biryukov, SS; Quirk, AV; Fritts, KA; Kern, SJ; Fetterer, DP; Kohler, LJ; Toothman, RG; Bozue, JA; Schellhase, CW; Kreiselmeier, N; Daye, SP; Welkos, SL; Soffler, C; Worsham, PL; Waag, DM; Amemiya, K; Cote, CK				Trevino, Sylvia R.; Klimko, Christopher P.; Reed, Matthew C.; Aponte-Cuadrado, Michael J.; Hunter, Melissa; Shoe, Jennifer L.; Meyer, Joshua R.; Dankmeyer, Jennifer L.; Biryukov, Sergei S.; Quirk, Avery V.; Fritts, Kristen A.; Kern, Steven J.; Fetterer, David P.; Kohler, Lara J.; Toothman, Ronald G.; Bozue, Joel A.; Schellhase, Christopher W.; Kreiselmeier, Norman; Daye, Sharon P.; Welkos, Susan L.; Soffler, Carl; Worsham, Patricia L.; Waag, David M.; Amemiya, Kei; Cote, Christopher K.			Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei	PLOS ONE			English	Article							T-CELLS; CYTOKINE RESPONSES; IMMUNE-RESPONSE; CXC CHEMOKINES; C57BL/6 MICE; BALB/C MICE; MOUSE MODEL; IN-VIVO; MELIOIDOSIS; INFECTION	Mouse models have been essential to generate supporting data for the research of infectious diseases. Burkholderia pseudomallei, the etiological agent of melioidosis, has been studied using mouse models to investigate pathogenesis and efficacy of novel medical countermeasures to include both vaccines and therapeutics. Previous characterization of mouse models of melioidosis have demonstrated that BALB/c mice present with an acute infection, whereas C57BL/6 mice have shown a tendency to be more resistant to infection and may model chronic disease. In this study, either BALB/c or C57BL/6 mice were exposed to aerosolized human clinical isolates of B. pseudomallei. The bacterial strains included HBPUB10134a (virulent isolate from Thailand), MSHR5855 (virulent isolate from Australia), and 1106a (relatively attenuated isolate from Thailand). The LD50 values were calculated and serial sample collections were performed in order to examine the bacterial burdens in tissues, histopathological features of disease, and the immune response mounted by the mice after exposure to aerosolized B. pseudomallei. These data will be important when utilizing these models for testing novel medical countermeasures. Additionally, by comparing highly virulent strains with attenuated isolates, we hope to better understand the complex disease pathogenesis associated with this bacterium.	[Trevino, Sylvia R.; Klimko, Christopher P.; Aponte-Cuadrado, Michael J.; Hunter, Melissa; Shoe, Jennifer L.; Meyer, Joshua R.; Dankmeyer, Jennifer L.; Biryukov, Sergei S.; Quirk, Avery V.; Fritts, Kristen A.; Kohler, Lara J.; Toothman, Ronald G.; Bozue, Joel A.; Welkos, Susan L.; Soffler, Carl; Worsham, Patricia L.; Waag, David M.; Amemiya, Kei; Cote, Christopher K.] USAMRIID, Bacteriol Div, Frederick, MD 21702 USA; [Reed, Matthew C.; Schellhase, Christopher W.; Kreiselmeier, Norman; Daye, Sharon P.] USAMRIID, Div Pathol, Frederick, MD USA; [Kern, Steven J.; Fetterer, David P.] USAMRIID, Div Biostat, Frederick, MD USA	United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases; United States Army Medical Research Institute of Infectious Diseases	Cote, CK (corresponding author), USAMRIID, Bacteriol Div, Frederick, MD 21702 USA.	Christopher.k.cote.civ@mail.mil	Bozue, Joel/AAE-4363-2022; Bozue, Joel/AAE-4357-2022	Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176; Biryukov, Sergei/0000-0002-1297-2363	Defense Threat Reduction Agency	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	Funding was provided by the Defense Threat Reduction Agency to PLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Amemiya K, 2006, VACCINE, V24, P1413, DOI 10.1016/j.vaccine.2005.09.021; Amemiya K, 2015, MICROB PATHOGENESIS, V86, P53, DOI 10.1016/j.micpath.2015.07.004; Barnes JL, 2001, IMMUNOL CELL BIOL, V79, P490, DOI 10.1046/j.1440-1711.2001.01038.x; Bearss JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172627; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Brett P.J., 2018, TXB MILITARY MED MED, P223; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P865; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; GUYTON AC, 1947, AM J PHYSIOL, V150, P70, DOI 10.1152/ajplegacy.1947.150.1.70; Harris DP, 2005, J IMMUNOL, V175, P7103, DOI 10.4049/jimmunol.175.11.7103; Hartings Justin M., 2004, Journal of Pharmacological and Toxicological Methods, V49, P39, DOI 10.1016/j.vascn.2003.07.001; Hassan MRA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-302; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Inglis TJJ, 2006, APPL ENVIRON MICROB, V72, P6865, DOI 10.1128/AEM.01036-06; Janke M, 2010, EUR J IMMUNOL, V40, P1089, DOI 10.1002/eji.200939487; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kotimaa J, 2016, MOL IMMUNOL, V76, P13, DOI 10.1016/j.molimm.2016.06.004; Kwan WH, 2012, IMMUNOL RES, V54, P247, DOI 10.1007/s12026-012-8327-1; Laws TR, 2011, MICROB PATHOGENESIS, V51, P471, DOI 10.1016/j.micpath.2011.07.002; Li ZG, 2017, J IMMUNOL, V198, P1865, DOI 10.4049/jimmunol.1601336; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Liu MT, 2001, J IMMUNOL, V166, P1790, DOI 10.4049/jimmunol.166.3.1790; Liu X, 2015, EMERG INFECT DIS, V21, P159, DOI 10.3201/eid2101.140042; Lo TJ, 2009, EMERG INFECT DIS, V15, P1645, DOI 10.3201/eid1510.090246; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Massey S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04305; MAYS EE, 1975, CHEST, V68, P261, DOI 10.1378/chest.68.2.261; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; OGUNREMI O, 1993, EXP CLIN IMMUNOGENET, V10, P31; OKADA M, 1988, J IMMUNOL, V141, P1543; OSWALD IP, 1994, J IMMUNOL, V153, P1707; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Papotto PH, 2017, NAT IMMUNOL, V18, P604, DOI 10.1038/ni.3726; Rabolli V, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0069-x; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Sauty A, 1999, J IMMUNOL, V162, P3549; SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821; Settem RP, 2013, MUCOSAL IMMUNOL, V6, P415, DOI 10.1038/mi.2012.85; Sorman A, 2014, MOL IMMUNOL, V61, P79, DOI 10.1016/j.molimm.2014.06.010; Souto JT, 2003, AM J PATHOL, V163, P583, DOI 10.1016/S0002-9440(10)63686-3; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Takatsu K, 1998, CYTOKINE GROWTH F R, V9, P25, DOI 10.1016/S1359-6101(97)00034-8; Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013; Tamrakar SB, 2008, J APPL MICROBIOL, V105, P1361, DOI 10.1111/j.1365-2672.2008.03880.x; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; Ulett GC, 2002, INFECT IMMUN, V70, P3953, DOI 10.1128/IAI.70.7.3953-3958.2002; Ulett GC, 2000, ACTA TROP, V74, P229, DOI 10.1016/S0001-706X(99)00075-3; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; Urashima M, 1996, LEUKEMIA RES, V20, P507, DOI 10.1016/0145-2126(95)00098-4; Van Zandt KE, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00120; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Welkos SL, 2015, PLOS ONE, DOI [10.1016/j.micpath.2015.07.004, DOI 10.1016/J.MICPATH.2015.07.004]; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3074, DOI 10.1128/IAI.01733-06; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; YABUUCHI E, 1993, MICROBIOL IMMUNOL, V37, P823, DOI 10.1111/j.1348-0421.1993.tb01712.x; Zumbrun EE, 2012, VIRUSES-BASEL, V4, P3468, DOI 10.3390/v4123468	85	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208277	10.1371/journal.pone.0208277	http://dx.doi.org/10.1371/journal.pone.0208277			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500862	Green Published, gold, Green Submitted			2022-12-26	WOS:000451883700031
J	Bonanno, AM; Graham, TL; Wilson, LN; Madtson, BM; Ross, JD				Bonanno, Alicia M.; Graham, Todd L.; Wilson, Lauren N.; Madtson, Brianne M.; Ross, James D.			Efficacy of the perfluorocarbon dodecafluoropentane as an adjunct to pre-hospital resuscitation	PLOS ONE			English	Article							ACTIVATION-RELATED PSEUDOALLERGY; COMPLEMENT; LIPOSOMES; TRAUMA; PLASMA; VOLUME; MODEL	Background Hemorrhage is the most common cause of preventable death in the pre-hospital phase in trauma, with a critical capability gap optimizing pre-hospital resuscitation in austere environments. One promising avenue is the concept of a multi-functional resuscitation fluid (MRF) that contains a blood product backbone with agents that promote clotting and enhance oxygen delivery. Oxygen therapeutics, such as hemoglobin based oxygen carriers(HBOCs) and perfluorocarbons(PFCs), may be a critical MRF component. Our purpose was to assess the efficacy of resuscitation with a PFC, dodecafluoropentane(DDFPe), compared to fresh whole blood(FWB). Methods and findings Forty-five swine(78 +/- 5kg) underwent splenectomy and controlled hemorrhage via femoral arterial catheter until shock physiology(lactate = 7.0) was achieved prior to randomization into the following groups: 1) Control-no intervention, 2) Hextend-500mL, 3) FFP-500mL, 4) FFP+DDFPe-500mL, 5) FWB-500mL. Animals were observed for an additional 180 minutes following randomization. Results Baseline physiologic values did not statistically differ. At T = 60min, FWB had significantly decreased lactate(p = 0.001) and DDFPe was not statistically different from control. There was no statistical significance in tissue oxygenation(StO2) between groups at T = 60min. Survival was highest in the FWB and Hextend groups(30% at 180min). Kaplan-Meier analysis showed decreased survival of DDFPe+FFP in comparison to FWB(p<0.05) and was not significantly different from control or FFP. Four animals who received DDFPe died within 10 minutes of administration. This study was limited by a group receiving DDFPe alone, however this would not be feasible in this lethal swine model as DDFPe given its small volume. Conclusion DDFPe administration with FFP does not improve survival or enhance tissue oxygenation. However, given similar survival rates of Hextend and FWB, there is evidence that an ideal MRF should contain an element of volume expansion to enhance oxygen delivery.	[Bonanno, Alicia M.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Graham, Todd L.; Wilson, Lauren N.; Madtson, Brianne M.; Ross, James D.] Oregon Hlth & Sci Univ, Div Trauma & Acute Care Surg, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Ross, JD (corresponding author), Oregon Hlth & Sci Univ, Div Trauma & Acute Care Surg, Portland, OR 97201 USA.	rosja@ohsu.edu		Graham, Todd/0000-0002-2255-6603	Military Health and Research Foundation [SC-15-03 PO 0019]	Military Health and Research Foundation	This work was supported by Military Health and Research Foundation, Grant #SC-15-03 PO 0019, JDR, http://www.militaryhealthresearch.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur C, 2015, STROKE, V46; Arthur MC, 2017, MOL NEUROBIOL, V54, P4764, DOI 10.1007/s12035-016-0019-8; Cho SD, 2009, SHOCK, V31, P87, DOI 10.1097/SHK.0b013e3181777ffb; Correas JM, 2001, ULTRASOUND MED BIOL, V27, P565, DOI 10.1016/S0301-5629(00)00363-X; Culp WC, 2015, MOL NEUROBIOL, V52, P979, DOI 10.1007/s12035-015-9243-x; Culp WC, 2012, J VASC INTERV RADIOL, V23, P116, DOI 10.1016/j.jvir.2011.10.001; Fabian TC, 2011, J TRAUMA, V70, pS42, DOI 10.1097/TA.0b013e31821a5a3f; Fergusson DA, 2008, JAMA-J AM MED ASSOC, V299, P2324, DOI 10.1001/jama.299.19.jed80027; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Johnson JLH, 2009, ARTIF CELL BLOOD SUB, V37, P156, DOI 10.1080/10731190903043192; Lee TH, 2013, J TRAUMA ACUTE CARE, V75, P369, DOI 10.1097/TA.0b013e31829bb67c; Lewis CJ, 2006, BLOOD SUBSTITUTES, V77, P325; Sailliol A, 2013, TRANSFUSION S1, V53; Schreiber MA, 2005, CURR OPIN CRIT CARE, V11, P590, DOI 10.1097/01.ccx.0000186374.49320.ab; Sheppard FR, 2017, J TRAUMA ACUTE CARE, V1; Spinella PC, 2008, WORLD J SURG, V32, P2, DOI 10.1007/s00268-007-9201-5; Strom J, 2014, CARDIOVASC DRUG THER, V28, P541, DOI 10.1007/s10557-014-6557-2; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 2001, CRIT REV THER DRUG, V18, P567; Szebeni J, 2012, ADV DRUG DELIVER REV, V64, P1706, DOI 10.1016/j.addr.2012.07.005; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207197	10.1371/journal.pone.0207197	http://dx.doi.org/10.1371/journal.pone.0207197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496190	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800026
J	Hartmann, S; Vogt, R; Kunze, J; Rauschert, A; Kuhnert, KD; Wanzenbock, J; Lamatsch, DK; Witte, K				Hartmann, Sarah; Vogt, Roland; Kunze, Jan; Rauschert, Anna; Kuhnert, Klaus-Dieter; Wanzenboeck, Josef; Lamatsch, Dunja K.; Witte, Klaudia			Zebrafish larvae show negative phototaxis to near-infrared light	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; BEHAVIOR; TILAPIA; RESPONSES; SEQUENCE; HABITAT; EMBRYOS; BRAIN	Zebrafish larvae (Danio rerio) are among the most used model species to test biological effects of different substances in biomedical research, neuroscience and ecotoxicology. Most tests are based on changes in swimming activity of zebrafish larvae by using commercially available high-throughput screening systems. These systems record and analyse behaviour patterns using visible (VIS) and near-infrared (NIR) light sources, to simulate day (VIS) and night (NIR) phases, which allow continuous recording of the behaviour using a NIR sensitive camera. So far, however, the sensitivity of zebrafish larvae to NIR has never been tested experimentally, although being a critical piece of information for interpreting their behaviour under experimental conditions. Here, we investigated the swimming activity of 96 hpf (hours post fertilization) and 120 hpf zebrafish larvae under light sources of NIR at 860 nm and at 960 nm wavelength and under VIS light. A thermal source was simultaneously presented opposite to one of the light sources as control. We found that zebrafish larvae of both larval stages showed a clear negative phototactic response towards 860 nm NIR light and to VIS light, but not to 960 nm NIR light. Our results demonstrated that zebrafish larvae are able to perceive NIR at 860 nm, which is almost identical to the most commonly used light source in commercial screening systems (NIR at 850 nm) to create a dark environment. These tests, however, are not performed in the dark from the zebrafish's point of view. We recommend testing sensitivity of the used test organism before assuming no interaction with the applied light source of commonly used biosensor test systems. Previous studies on biological effects of substances to zebrafish larvae should be interpreted with caution.	[Hartmann, Sarah; Rauschert, Anna; Witte, Klaudia] Univ Siegen, Inst Biol, Dept Chem Biol, Res Grp Ecol & Behav Biol, Siegen, Germany; [Vogt, Roland; Wanzenboeck, Josef; Lamatsch, Dunja K.] Mondsee Univ Innsbruck, Res Dept Limnol, Mondsee, Austria; [Kunze, Jan; Kuhnert, Klaus-Dieter] Univ Siegen, Inst Real Time Learning Syst, Dept Elect Engn & Comp Sci, Siegen, Germany	Universitat Siegen; University of Innsbruck; Universitat Siegen	Hartmann, S (corresponding author), Univ Siegen, Inst Biol, Dept Chem Biol, Res Grp Ecol & Behav Biol, Siegen, Germany.	hartmann@chemie-bio.uni-siegen.de	Wanzenböck, Josef/AFR-9001-2022	Wanzenböck, Josef/0000-0002-9186-5565; Hartmann, Sarah/0000-0002-5714-342X	FP7 ERA-NET on Nanosafety: Safe Implementation of Innovative Nanoscience and Nanotechnology (SIINN); Federal Ministry of Education and Research (BMBF) [03XP0005A]; University of Siegen; Austrian Research Promotion Agency (FFG)	FP7 ERA-NET on Nanosafety: Safe Implementation of Innovative Nanoscience and Nanotechnology (SIINN); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); University of Siegen; Austrian Research Promotion Agency (FFG)	The authors gratefully acknowledged financial support from the FP7 ERA-NET on Nanosafety: Safe Implementation of Innovative Nanoscience and Nanotechnology (SIINN), the Federal Ministry of Education and Research (BMBF; 03XP0005A), the University of Siegen and from the Austrian Research Promotion Agency (FFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2012, BEHAVIOUR, V149, P1241, DOI 10.1163/1568539X-00003020; Ali S, 2012, BEHAV BRAIN RES, V228, P272, DOI 10.1016/j.bbr.2011.11.020; [Anonymous], 2021, LANG ENV STAT COMP; Bae MJ, 2014, SCI TOTAL ENVIRON, V466, P635, DOI 10.1016/j.scitotenv.2013.07.075; Brockerhoff SE, 1997, J NEUROSCI, V17, P4236; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Chen QQ, 2017, SCI TOTAL ENVIRON, V584, P1022, DOI 10.1016/j.scitotenv.2017.01.156; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; Colwill RM, 2011, BEHAV PROCESS, V86, P222, DOI 10.1016/j.beproc.2010.12.003; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P545, DOI 10.1016/j.ntt.2012.08.006; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Dowling JE, 2002, P AM PHILOS SOC, V146, P337; Ellis LD, 2012, BRAIN RES, V1449, P46, DOI 10.1016/j.brainres.2012.02.022; Emran Farida, 2008, J Vis Exp, DOI 10.3791/923; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; Gerhardt A, 2007, HUM ECOL RISK ASSESS, V13, P481, DOI 10.1080/10807030701340839; Gruber D., 1994, Journal of Aquatic Ecosystem Health, V3, P87, DOI 10.1007/BF00042938; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Guo S, 2009, EXPERT OPIN DRUG DIS, V4, P715, DOI 10.1517/17460440902988464; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ingebretson JJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00109; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; ISO, 1996, ISO73461 ISO; Jekely G, 2009, PHILOS T R SOC B, V364, P2795, DOI 10.1098/rstb.2009.0072; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kobayashi R, 2002, NIPPON SUISAN GAKK, V68, P646, DOI 10.2331/suisan.68.646; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Legradi J, 2015, ENVIRON SCI POLLUT R, V22, P16277, DOI 10.1007/s11356-014-3805-8; LYTHGOE JN, 1984, VISION RES, V24, P1539, DOI 10.1016/S0042-6989(84)80003-6; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Matsumoto T, 2005, FISHERIES SCI, V71, P350, DOI 10.1111/j.1444-2906.2005.00971.x; McClure MM, 2006, J FISH BIOL, V69, P553, DOI 10.1111/j.1095-8649.2006.01125.x; Meuthen D, 2012, NATURWISSENSCHAFTEN, V99, P1063, DOI 10.1007/s00114-012-0980-7; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Nusser LK, 2016, ECOTOX ENVIRON SAFE, V133, P271, DOI 10.1016/j.ecoenv.2016.07.033; OECD, 1995, GUID TEST CHEM, DOI [10.1787/9789264069787-en, DOI 10.1787/9789264203709-EN]; Padilla S, 2011, NEUROTOXICOL TERATOL, V33, P624, DOI 10.1016/j.ntt.2011.08.005; Pewsey A, 2013, CIRCULAR STAT R; Powers CM, 2011, NEUROTOXICOL TERATOL, V33, P708, DOI 10.1016/j.ntt.2011.02.002; ROBINSON J, 1993, P NATL ACAD SCI USA, V90, P6009, DOI 10.1073/pnas.90.13.6009; Robinson PD, 2009, CAN J FISH AQUAT SCI, V66, P1179, DOI 10.1139/F09-069; Schwoerbel J, 2010, EINFU HRUNG LIMNOLOG; Shcherbakov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064429; Shcherbakov D, 2012, ZOOLOGY, V115, P233, DOI 10.1016/j.zool.2012.01.005; Spence R, 2006, J FISH BIOL, V69, P1435, DOI 10.1111/j.1095-8649.2006.01206.x; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Vignet C, 2013, ZEBRAFISH, V10, P365, DOI 10.1089/zeb.2013.0871; Wootton R.J., 2012, ECOLOGY TELEOST FISH; Zhou YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116095	52	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207264	10.1371/journal.pone.0207264	http://dx.doi.org/10.1371/journal.pone.0207264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485324	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800056
J	Tada, H; Kawashiri, MA; Yasuda, K; Yamagishi, M				Tada, Hayato; Kawashiri, Masa-aki; Yasuda, Kenji; Yamagishi, Masakazu			Associations between questionnaires on lifestyle and atherosclerotic cardiovascular disease in a Japanese general population: A cross-sectional study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTH; RISK; BREAKFAST; COMMUNITY; STROKE; IMPACT; MEN	Objective We aimed to investigate the association between questionnaires related to lifestyle habits and atherosclerotic cardiovascular diseases (ASCVD). Design Cross-sectional observational study. Settings Community-based medical checkups, called specific health checkups started in Japan since 2008. This checkup includes standard medical examinations as well as a specific questionnaire related to lifestyle habits. Participants Overall, 47,842 subjects (males = 16,913, 35.4%) aged. 40 years who underwent a Japanese specific health checkup in 2014 in Kanazawa city were included. Main outcome measures Association between 12 lifestyle habits-related questionnaires and the presence of ASCVD, including coronary artery disease and stroke. The questionnaire included the following 12 questions on lifestyle habits: 1) weight gain (>10 kg/20 years), 2) exercise (>30 min, twice a week, >1 year), 3) daily walking or equivalent (>1 h), 4) walking faster (than others in the same generation), 5) body weight changes (>3 kg/year), 6) eating faster (than others in the same generation), 7) eating within 2 h before going to bed (more than three times a week), 8) having a snack after dinner (more than three times a week), 9) skipping breakfast (more than three times a week), 10) daily drinking (alcohol), 11) heavy drinking (more than 60 g ethanol/day), and 12) good sleeping. Results Multivariable logistic regression analyses revealed that walking faster (odds ratio [OR] = 0.74, 95% confidence interval [CI] = 0.69-0.79, p < 0.0003), body weight changes (>3 kg/year, OR = 1.26, 95% CI = 1.16-1.37, p < 0.0003), eating faster (OR = 1.09, 95% CI = 1.03-1.15, p = 0.003), daily drinking (OR = 0.83, 95% CI = 0.76-0.89, p < 0.0003), and good sleeping (OR = 0.86, 95% CI = 0.79-0.93, p < 0.0003) were independently associated with ASCVD. Subjects with a high lifestyle habits risk score (number of bad habits: 7-12) had significantly higher odds for ASCVD than those with a low risk score (number of bad habits: 0-3, OR = 1.78, 95% CI = 1.62-1.95, p < 0.0003). Conclusion Simple questionnaires related to lifestyle habits were associated with self-reported ASCVD.	[Tada, Hayato; Kawashiri, Masa-aki; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Dept Cardiovasc & Internal Med, Kanazawa, Ishikawa, Japan; [Yasuda, Kenji] Kanazawa Med Assoc, Kanazawa, Ishikawa, Japan	Kanazawa University	Tada, H (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Cardiovasc & Internal Med, Kanazawa, Ishikawa, Japan.	ht240z@sa3.so-net.ne.jp	KAWASHIRI, Masaaki/ABA-7159-2020	KAWASHIRI, Masaaki/0000-0002-5759-1353				Brown DL, 2015, STROKE, V46, P2861, DOI 10.1161/STROKEAHA.115.010678; Chun S, 2016, AM HEART J, V177, P17, DOI 10.1016/j.ahj.2016.03.018; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Gordon-Larsen P, 2009, ARCH INTERN MED, V169, P1216, DOI 10.1001/archinternmed.2009.163; Kubota Y, 2017, CIRCULATION, V135, P1471, DOI 10.1161/CIRCULATIONAHA.116.026557; Kubota Y, 2016, STROKE, V47, P477, DOI 10.1161/STROKEAHA.115.011350; Lv J, 2017, J AM COLL CARDIOL, V69, P1116, DOI 10.1016/j.jacc.2016.11.076; Martino F, 2016, INT J CARDIOL, V225, P284, DOI 10.1016/j.ijcard.2016.10.008; Menotti A, 2016, INT J CARDIOL, V210, P173, DOI 10.1016/j.ijcard.2016.02.115; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Tada H, 2017, EUR HEART J, V38, P1573, DOI 10.1093/eurheartj/ehx004; Tada H, 2017, ATHEROSCLEROSIS, V261, P111, DOI 10.1016/j.atherosclerosis.2017.02.015; Tada H, 2017, J ATHEROSCLER THROMB, V24, P338, DOI 10.5551/jat.36004; Tsuruya K, 2014, ATHEROSCLEROSIS, V233, P260, DOI 10.1016/j.atherosclerosis.2013.12.037; Uzhova I, 2017, J AM COLL CARDIOL, V70, P1833, DOI 10.1016/j.jacc.2017.08.027	15	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208135	10.1371/journal.pone.0208135	http://dx.doi.org/10.1371/journal.pone.0208135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485359	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800112
J	Huibregtse, JM				Huibregtse, Jon M.			A proteasomal partner goes missing in Angelman syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							UBIQUITIN-PROTEIN LIGASE; UBE3A; MUTATIONS; BINDING; AUTISM; E6	Loss-of-function mutations in the UBE3A ubiquitin ligase are associated with Angelman syndrome (AS), a severe neurologic disorder. A new study defines the role of mutations in an N-terminal AZUL domain as mediating direct binding to a proteasomal subunit and shows that this interaction is correlated with the ability of UBE3A to promote Wnt/-catenin signaling. These results provide new insights into a central biomolecule in AS and suggest that defects in Wnt/-catenin signaling may underlie some AS phenotypes.	[Huibregtse, Jon M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Huibregtse, Jon M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Huibregtse, JM (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Huibregtse, JM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	huibregtse@austin.utexas.edu		Huibregtse, Jon/0000-0002-9210-3343	National Institutes of Health [RO1 GM103619, RO1 AI096090]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 GM103619 and RO1 AI096090. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kuhnle S, 2018, J BIOL CHEM, V293, P18387, DOI 10.1074/jbc.RA118.004653; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Lemak A, 2011, J BIOMOL NMR, V51, P185, DOI 10.1007/s10858-011-9552-y; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Yi JJ, 2017, J BIOL CHEM, V292, P12503, DOI 10.1074/jbc.M117.788448	10	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18400	18401		10.1074/jbc.H118.006328	http://dx.doi.org/10.1074/jbc.H118.006328			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30470726	hybrid, Green Published			2022-12-26	WOS:000451375200030
J	Jeong, J; Choi, J; Kim, W; Dann, P; Takyar, F; Gefter, JV; Friedman, PA; Wysolmerski, JJ				Jeong, Jaekwang; Choi, Jungmin; Kim, Wonnam; Dann, Pamela; Takyar, Farzin; Gefter, Julia V.; Friedman, Peter A.; Wysolmerski, John J.			Inhibition of ezrin causes PKC alpha-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ezrin; scaffold protein; breast cancer; heat shock protein 90 (Hsp90); PDZ domain; protein kinase C (PKC); ErbB2/HER2; NHERF1; PMCA2	PROTEIN; ASSOCIATION; RECEPTORS; LOCALIZATION; NHERF1/EBP50; ACTIVATION; INTERACTS; REVEALS; PRODUCT; COMPLEX	Unlike other ErbB family members, HER2 levels are maintained on the cell surface when the receptor is activated, allowing prolonged signaling and contributing to its transforming ability. Interactions between HER2, HSP90, PMCA2, and NHERF1 within specialized plasma membrane domains contribute to the membrane retention of HER2. We hypothesized that the scaffolding protein ezrin, which has been shown to interact with NHERF1, might also help stabilize the HER2-PMCA2-NHERF1 complex at the plasma membrane. Therefore, we examined ezrin expression and its relationship with HER2, NHERF1, and PMCA2 levels in murine and human breast cancers. We also used genetic knockdown and/or pharmacologic inhibition of ezrin, HSP90, NHERF1, PMCA2, and HER2 to examine the functional relationships between these factors and membrane retention of HER2. We found ezrin to be expressed at low levels at the apical surface of normal mammary epithelial cells, but its expression is up-regulated and correlates with HER2 expression in hyperplasia and tumors in murine mammary tumor virus-Neu mice, in human HER2-positive breast cancer cell lines, and in ductal carcinoma in situ and invasive breast cancers from human patients. In breast cancer cells, ezrin co-localizes and interacts with HER2, NHERF1, PMCA2, and HSP90 in specialized membrane domains, and inhibiting ezrin disrupts interactions between HER2, PMCA2, NHERF1, and HSP90, inhibiting HER2 signaling and causing PKC alpha-mediated internalization and degradation of HER2. Inhibition of ezrin synergizes with lapatinib in a PKC alpha-dependent fashion to inhibit proliferation and promote apoptosis in HER2-positive breast cancer cells. We conclude that ezrin stabilizes a multiprotein complex that maintains active HER2 at the cell surface.	[Jeong, Jaekwang; Kim, Wonnam; Dann, Pamela; Takyar, Farzin; Wysolmerski, John J.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06510 USA; [Choi, Jungmin] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Kim, Wonnam] Semyung Univ, Coll Korean Med, Div Pharmacol, Jecheon 27136, South Korea; [Gefter, Julia V.; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Yale University; Yale University; Semyung University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wysolmerski, JJ (corresponding author), Yale Sch Med, TAC S123a,Box 208020, New Haven, CT 06520 USA.	john.wysolmerski@yale.edu		Choi, Jungmin/0000-0002-8614-0973; JEONG, JAEKWANG/0000-0001-8865-2545	National Institutes of Health [CA153702, HD076248]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants CA153702 and HD076248 (to J.J.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antelmi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075113; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Asp N, 2016, ONCOTARGET, V7, P25443, DOI 10.18632/oncotarget.8327; Bailey TA, 2014, J BIOL CHEM, V289, P30443, DOI 10.1074/jbc.M114.608992; Bellizzi A, 2010, BREAST CARE, V5, P86, DOI 10.1159/000298962; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; CAO HN, 1991, ONCOGENE, V6, P705; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; CARRAWAY CAC, 1993, J BIOL CHEM, V268, P5582; Castagnola P, 2016, ONCOTARGET, V7, P85411, DOI 10.18632/oncotarget.13392; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clucas J, 2015, J CELL SCI, V128, P1253, DOI 10.1242/jcs.170027; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DOBASHI K, 1989, DNA-J MOLEC CELL BIO, V8, P723, DOI 10.1089/dna.1989.8.723; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Georgescu MM, 2008, CURR MOL MED, V8, P459, DOI 10.2174/156652408785748031; Georgescu MM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1992; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Hansen MC, 2014, BIOTECHNIQUES, V56, P217, DOI 10.2144/000114164; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Ivanova JL, 2012, BIOCHIMIE, V94, P1833, DOI 10.1016/j.biochi.2012.04.011; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; Jeong J, 2017, J BIOL CHEM, V292, P6555, DOI 10.1074/jbc.M116.770883; Jeong J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174849; Jeong J, 2016, P NATL ACAD SCI USA, V113, pE282, DOI 10.1073/pnas.1516138113; Karn T, 2011, BREAST CANCER RES TR, V130, P409, DOI 10.1007/s10549-010-1333-x; Kawaguchi K, 2017, BIOL PHARM BULL, V40, P381, DOI 10.1248/bpb.b16-01011; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Lei CT, 2017, CELL PHYSIOL BIOCHEM, V42, P281, DOI 10.1159/000477329; Li JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17903; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080721; Ma LF, 2013, ONCOL REP, V30, P1899, DOI 10.3892/or.2013.2641; Magnifico A, 2007, CANCER RES, V67, P5308, DOI 10.1158/0008-5472.CAN-06-3936; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; MORI S, 1987, VIRCHOWS ARCH B, V54, P8, DOI 10.1007/BF02899192; Newton AC, 2018, SEMIN CANCER BIOL, V48, P18, DOI 10.1016/j.semcancer.2017.04.017; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Pan Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1846; Ponuwei GA, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0246-3; Sarrio D, 2006, BREAST CANCER RES TR, V98, P71, DOI 10.1007/s10549-005-9133-4; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; United States Cancer Statistics Working Group, 2017, US CANC STAT 1999 20; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Vaquero J, 2017, ONCOGENE, V36, P3067, DOI 10.1038/onc.2016.462; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Zagouri F, 2013, BREAST, V22, P569, DOI 10.1016/j.breast.2013.06.003	57	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					887	901		10.1074/jbc.RA118.004143	http://dx.doi.org/10.1074/jbc.RA118.004143			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30463939	hybrid, Green Published			2022-12-26	WOS:000458670200015
J	Kodzhahinchev, V; Biancolin, A; Bucking, C				Kodzhahinchev, Vladimir; Biancolin, Andrew; Bucking, Carol			Quantification of Mg2+, Ca2+ and H+ transport by the gastrointestinal tract of the goldfish, Carassius auratus, using the Scanning Ion-selective Electrode Technique (SIET)	PLOS ONE			English	Article							BASOLATERAL PLASMA-MEMBRANE; BRUSH-BORDER MEMBRANE; MARINE TELEOST FISH; RAINBOW-TROUT; MAGNESIUM TRANSPORT; FRESH-WATER; IN-VITRO; DROSOPHILA-MELANOGASTER; MALPIGHIAN TUBULES; CALCIUM-UPTAKE	An in vitro gut-sac technique and the scanning ion-selective electrode technique (SIET) were used to characterize Mg2+, Ca2+, and H+ transport at both the mucosal and serosal surfaces of non-everted and everted gastrointestinal tissues obtained from Carassius auratus. As part of the study, two magnesium ionophores were compared (II vs. VI). Unfed animals displayed uniform transport of all ions along the intestine. Feeding resulted in elevated Mg2+ and Ca2+ transport when the gut lumen contained chyme however, under symmetrical conditions this increased transport rate was absent. Furthermore, zonation of divalent cation transport was present for both Ca2+ and Mg2+ under non-symmetrical conditions while the zonation remained for Ca2+ alone under symmetrical conditions. High dietary Mg2+ vitro decreased absorption and induced secretion of Mg2+ in the posterior intestine. Uptake kinetics in the esophagus suggest large diffusive and/or convective components based on a linear relationship between Mg2+ transport and concentration and lack of inhibition by ouabain, an inhibitor of Na+-K+-ATPase. In contrast, kinetics in the rectum were suggestive of a low affinity, saturable carrier-mediated pathway. A decrease in Mg2+ and Ca2+ transport was observed in the posterior intestine (both at the mucosal and serosal surfaces) in response to ouabain. This impact was greatest for Ca2+ transport and when applied to the mucosal fluid and measured in everted preparations. In contrast a putative Mg2+ transport inhibitor, cobalt(III) hexamine-chloride, did not affect Mg2+ transport. This is the first study to use SIET approaches to study ion transport in the gut of teleost fish. This is also the first study to provide characterization of Mg2+ transport in the gut of C. auratus. Due to the limited selectivity of Magnesium ionophore II, subsequent studies of tissues bathed in physiological saline should be made using Magnesium Ionophore VI.	[Kodzhahinchev, Vladimir; Biancolin, Andrew; Bucking, Carol] York Univ, Dept Biol, Toronto, ON, Canada	York University - Canada	Bucking, C (corresponding author), York Univ, Dept Biol, Toronto, ON, Canada.	cbucking@yorku.ca		Bucking, Carol/0000-0003-3655-426X	Natural Sciences and Engineering Research Council of Canada [504132]; Canadian Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant (504132) to CB and the Canadian Foundation for Innovation to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajka BH, 2003, SCAND J GASTROENTERO, V38, P732, DOI 10.1080/00365520310003101; BEHAR J, 1974, AM J PHYSIOL, V227, P334, DOI 10.1152/ajplegacy.1974.227.2.334; Beyenbach KW, 2000, FRONT BIOSCI, V5, pD712, DOI 10.2741/Beyenbach; Bijvelds MJC, 1996, J MEMBRANE BIOL, V154, P217; Bijvelds MJC, 1998, J EXP BIOL, V201, P1981; Bijvelds MJC, 2001, EUR J BIOCHEM, V268, P2867, DOI 10.1046/j.1432-1327.2001.02170.x; Bucking C, 2009, AQUACULT NUTR, V15, P282, DOI 10.1111/j.1365-2095.2008.00593.x; Bucking C, 2007, J COMP PHYSIOL B, V177, P349, DOI 10.1007/s00360-006-0134-3; Bury NR, 2001, J EXP BIOL, V204, P3779; Chasiotis H, 2012, GEN COMP ENDOCR, V175, P277, DOI 10.1016/j.ygcen.2011.11.024; Cooper CA, 2006, COMP BIOCHEM PHYS A, V143, P292, DOI 10.1016/j.cbpa.2005.11.024; DABROWSKA H, 1991, FISH PHYSIOL BIOCHEM, V9, P165, DOI 10.1007/BF02265132; Del Duca O, 2011, J EXP BIOL, V214, P3992, DOI 10.1242/jeb.063719; Donini A, 2005, J EXP BIOL, V208, P603, DOI 10.1242/jeb.01422; Faggio C, 2011, J COMP PHYSIOL B, V181, P517, DOI 10.1007/s00360-010-0538-y; GATLIN DM, 1982, J NUTR, V112, P1182, DOI 10.1093/jn/112.6.1182; Genz J, 2013, COMP BIOCHEM PHYS A, V166, P293, DOI 10.1016/j.cbpa.2013.06.033; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Grosell M, 2006, AM J PHYSIOL-REG I, V291, pR1145, DOI 10.1152/ajpregu.00818.2005; Gunzel D, 2002, BIOMETALS, V15, P237, DOI 10.1023/A:1016074714951; Han D, 2012, AQUACULT NUTR, V18, P512, DOI 10.1111/j.1365-2095.2011.00910.x; Handy RD, 2000, J EXP BIOL, V203, P2365; Islam Z, 2013, AM J PHYSIOL-REG I, V305, pR385, DOI 10.1152/ajpregu.00507.2012; Kieft JS, 1997, STRUCTURE, V5, P713, DOI 10.1016/S0969-2126(97)00225-6; KNOX D, 1981, BRIT J NUTR, V45, P137, DOI 10.1079/BJN19810086; Kodzhahinchev V, 2017, COMP BIOCHEM PHYS A, V206, P69, DOI 10.1016/j.cbpa.2017.01.016; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Kolisek M, 2012, AM J PHYSIOL-CELL PH, V302, pC318, DOI 10.1152/ajpcell.00289.2011; Kolosov D, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25391; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lameris AL, 2015, AM J PHYSIOL-GASTR L, V308, pG206, DOI 10.1152/ajpgi.00093.2014; Messerli M.A., 2006, PLANT ELECTROPHYSIOL, P73; Monteiro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092594; Nadella SR, 2006, J COMP PHYSIOL B, V176, P793, DOI 10.1007/s00360-006-0101-z; Nguyen H, 2010, AM J PHYSIOL-REG I, V299, pR762, DOI 10.1152/ajpregu.00745.2009; OGINO C, 1978, B JPN SOC SCI FISH, V44, P1105; Ojo AA, 2008, AQUAT TOXICOL, V89, P55, DOI 10.1016/j.aquatox.2008.06.004; Ojo AA, 2007, AQUAT TOXICOL, V83, P10, DOI 10.1016/j.aquatox.2007.03.006; PERRY SF, 1985, J EXP BIOL, V116, P411; Rheault MR, 2004, J EXP BIOL, V207, P2173, DOI 10.1242/jeb.01003; Rheault MR, 2001, J EXP BIOL, V204, P2289; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; SCHOENMAKERS TJM, 1992, J MEMBRANE BIOL, V127, P161; Schweigel M, 2000, FRONT BIOSCI-LANDMRK, V5, pD666, DOI 10.2741/Schweigel; SHEARER KD, 1989, AQUACULTURE, V77, P201, DOI 10.1016/0044-8486(89)90202-0; SHEARER KD, 1992, FISH PHYSIOL BIOCHEM, V9, P387, DOI 10.1007/BF02274219; Shen WP, 2011, AM J PHYSIOL-REG I, V300, pR858, DOI 10.1152/ajpregu.00705.2010; Shih TH, 2008, AM J PHYSIOL-CELL PH, V295, pC1625, DOI 10.1152/ajpcell.00255.2008; SHIM KF, 1988, AQUACULTURE, V73, P131, DOI 10.1016/0044-8486(88)90048-8; Suzuki H, 2000, AM J PHYSIOL-GASTR L, V279, pG107, DOI 10.1152/ajpgi.2000.279.1.G107; VANDERVELDEN JA, 1990, J EXP BIOL, V152, P587; Venkatraman A, 1999, SCAND J GASTROENTERO, V34, P1087, DOI 10.1080/003655299750024878; Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1; Wood CM, 2010, J EXP BIOL, V213, P2681, DOI 10.1242/jeb.039164; Wood CM, 2010, WATER INTAKE HYDRATA, V30, P165, DOI DOI 10.1016/S1546-5098(10)03005-0; Zhang W, 2000, ANAL SCI, V16, P11, DOI 10.2116/analsci.16.11	57	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0207782	10.1371/journal.pone.0207782	http://dx.doi.org/10.1371/journal.pone.0207782			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0NQ	30513099	Green Submitted, Green Published, gold			2022-12-26	WOS:000452204800015
J	Assis, RIF; Wiench, M; Silverio, KG; da Silva, RA; Feltran, GD; Sallum, EA; Casati, MZ; Nociti, FH; Andia, DC				Assis, Rahyza I. F.; Wiench, Malgorzata; Silverio, Karina G.; da Silva, Rodrigo A.; Feltran, Georgia da Silva; Sallum, Enilson A.; Casati, Marcio Z.; Nociti, Francisco H., Jr.; Andia, Denise C.			RG108 increases NANOG and OCT4 in bone marrow-derived mesenchymal cells through global changes in DNA modifications and epigenetic activation	PLOS ONE			English	Article							INHIBITOR RG108; MAMMALIAN DNA; STROMAL CELLS; METHYLATION; GENES; TET1	Human bone marrow-derived mesenchymal stem cells (hBMSCs) are important for tissue regeneration but their epigenetic regulation is not well understood. Here we investigate the ability of a non-nucleoside DNA methylation inhibitor, RG108 to induce epigenetic changes at both global and gene-specific levels in order to enhance mesenchymal cell markers, in hBMSCs. hBMSCs were treated with complete culture medium, 50 mu M RG108 and DMSO for three days and subjected to viability and apoptosis assays, global and gene-specific methylation/hydroxymethylation, transcript levels' analysis of epigenetic machinery enzymes and multipotency markers, protein activities of DNMTs and TETs, immunofluorescence staining and western blot analysis for NANOG and OCT4 and flow cytometry for CD105. The RG108, when used at 50 mu M, did not affect the viability, apoptosis and proliferation rates of hBMSCs or hydroxymethylation global levels while leading to 75% decrease in DNMTs activity and 42% loss of global DNA methylation levels. In addition, DNMT1 was significantly downregulated while TET1 was upregulated, potentially contributing to the substantial loss of methylation observed. Most importantly, the mesenchymal cell markers CD105, NANOG and OCT4 were upregulated being NANOG and OCT4 epigenetically modulated by RG108, at their gene promoters. We propose that RG108 could be used for epigenetic modulation, promoting epigenetic activation of NANOG and OCT4, without affecting the viability of hBMSCs. DMSO can be considered a modulator of epigenetic machinery enzymes, although with milder effect compared to RG108.	[Assis, Rahyza I. F.; Silverio, Karina G.; Sallum, Enilson A.; Casati, Marcio Z.; Nociti, Francisco H., Jr.; Andia, Denise C.] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Prosthodont & Periodont, Piracicaba, SP, Brazil; [Wiench, Malgorzata] Univ Birmingham, Sch Canc Sci, Sch Dent, Birmingham, W Midlands, England; [da Silva, Rodrigo A.; Feltran, Georgia da Silva] Sao Paulo State Univ, Biosci Inst, Dept Chem & Biochem, Botucatu, SP, Brazil; [Andia, Denise C.] Univ Paulista, Sch Dent, Div Epigenet, Hlth Sci Inst, Sao Paulo, Brazil	Universidade Estadual de Campinas; University of Birmingham; Universidade Estadual Paulista; Universidade Paulista	Andia, DC (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Prosthodont & Periodont, Piracicaba, SP, Brazil.; Andia, DC (corresponding author), Univ Paulista, Sch Dent, Div Epigenet, Hlth Sci Inst, Sao Paulo, Brazil.	denise.andia@docente.unip.br	casati, marcio zaffalon/ABA-2670-2020; Silvério, Karina Gonzales/E-9424-2013; da Silva, Rodrigo Augusto/G-1222-2012; Inacio Freire de Assis, Rahyza/GLN-3653-2022; Andia, Denise Carleto/F-1080-2012; Silva, Rodrigo/GXM-7197-2022	casati, marcio zaffalon/0000-0001-9234-0536; da Silva, Rodrigo Augusto/0000-0002-7754-1855; Inacio Freire de Assis, Rahyza/0000-0003-3068-5728; Andia, Denise Carleto/0000-0002-0049-0201; Feltran, Georgia/0000-0002-5743-5182; Wiench, Malgorzata/0000-0002-0202-9881	Sao Paulo Research Foundation - FAPESP [2013/09650-8, 2015/02160-0]; FP7 Framework Marie Curie Actions Career Integration Grant (methDRE)	Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FP7 Framework Marie Curie Actions Career Integration Grant (methDRE)	This research was supported by grants from Sao Paulo Research Foundation - FAPESP (2013/09650-8 Andia D C and 2015/02160-0 Assis R I F) and from the FP7 Framework Marie Curie Actions Career Integration Grant (methDRE) to Wiench M.	Borges S, 2014, BREAST CANCER RES TR, V144, P79, DOI 10.1007/s10549-014-2857-2; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Chia-Wen Tsai, 2012, International Journal of Open Source Software and Processes, V4, P1, DOI 10.4018/jossp.2013040101; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Gilat N, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0368-9; Graca I, 2014, CURR PHARM DESIGN, V20, P1803, DOI 10.2174/13816128113199990516; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Iwatani M, 2006, STEM CELLS, V24, P2549, DOI 10.1634/stemcells.2005-0427; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118; Kashiwagi K, 2011, NUCLEIC ACIDS RES, V39, P874, DOI 10.1093/nar/gkq870; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Meadows JP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0715; Oh YS, 2016, CELL MOL NEUROBIOL, V36, P613, DOI 10.1007/s10571-015-0242-2; Oh YS, 2015, BIOTECHNOL APPL BIOC, V62, P583, DOI 10.1002/bab.1393; Olariu V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25438; Sales AJ, 2016, ACTA NEUROPSYCHIATR, V28, P11, DOI 10.1017/neu.2015.40; Shahid M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22771-2; Stenzig J, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-015-0528-z; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang MQ, 2009, CURR GENOMICS, V10, P336, DOI 10.2174/138920209788920994; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; Wang HC, 2013, OR SURG OR MED OR PA, V115, P376, DOI 10.1016/j.oooo.2012.12.011; Wei X, 2011, STEM CELLS DEV, V20, P441, DOI 10.1089/scd.2010.0069; Wongtrakoongate P, 2014, EXP CELL RES, V321, P231, DOI 10.1016/j.yexcr.2013.11.024; Xu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064705; Yokochi T, 2003, BIOORG CHEM, V32, P234, DOI [10.1634/stemcells.2005-0427, DOI 10.1634/STEMCELLS.2005-0427]	36	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207873	10.1371/journal.pone.0207873	http://dx.doi.org/10.1371/journal.pone.0207873			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507955	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500013
J	Capoor, MN; Ruzicka, F; Sandhu, G; Rollason, J; Mavrommatis, K; Ahmed, FS; Schmitz, JE; Raz, A; Bruggemann, H; Lambert, PA; Fischetti, VA; Slaby, O				Capoor, Manu N.; Ruzicka, Filip; Sandhu, Gurpreet; Rollason, Jess; Mavrommatis, Konstantinos; Ahmed, Fahad S.; Schmitz, Jonathan E.; Raz, Assaf; Bruggemann, Holger; Lambert, Peter A.; Fischetti, Vincent A.; Slaby, Ondrej			Importance of Propionibacterium acnes hemolytic activity in human intervertebral discs: A microbiological study	PLOS ONE			English	Article							LOW-BACK-PAIN; STAPHYLOCOCCUS; NERVE; ASSOCIATION; INNERVATION; POPULATION; PREVALENCE; INFECTION	Most patients with chronic lower back pain (CLBP) exhibit degenerative disc disease. Disc specimens obtained during initial therapeutic discectomies are often infected/colonized with Propionibacterium acnes, a Gram-positive commensal of the human skin. Although pain associated with infection is typically ascribed to the body's inflammatory response, the Gram-positive bacterium Staphylococcus aureus was recently observed to directly activate nociceptors by secreting pore-forming alpha-hemolysins that disrupt neuronal cell membranes. The hemolytic activity of P. acnes in cultured disc specimens obtained during routine therapeutic discectomies was assessed through incubation on sheep-blood agar. The beta-hemolysis pattern displayed by P. acnes on sheep-blood agar was variable and phylogroup-dependent. Their molecular phylogroups were correlated with their hemolytic patterns. Our findings raise the possibility that pore-forming proteins contribute to the pathogenesis and/or symptomology of chronic P. acnes disc infections and CLBP, at least in a subset of cases.	[Capoor, Manu N.; Raz, Assaf; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA; [Capoor, Manu N.; Ahmed, Fahad S.; Slaby, Ondrej] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Ruzicka, Filip] Masaryk Univ, St Annes Univ Hosp, Fac Med, Dept Microbiol, Brno, Czech Republic; [Sandhu, Gurpreet; Rollason, Jess] Coventry Univ, Fac Hlth & Life Sci, Sch Life Sci, Coventry, W Midlands, England; [Mavrommatis, Konstantinos] Celgene Corp, Informat Knowledge & Utilizat, San Francisco, CA USA; [Schmitz, Jonathan E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Bruggemann, Holger] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Lambert, Peter A.] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England	Rockefeller University; Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Coventry University; Bristol-Myers Squibb; Celgene Corporation; Vanderbilt University; Aarhus University; Aston University	Capoor, MN (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.; Capoor, MN; Slaby, O (corresponding author), Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic.	mcapoor@mail.rockefeller.edu; ondrej.slaby@ceitec.muni.cz	capoor, manu/AAI-2709-2021; Capoor, Manu/AAV-7927-2021; Růžička, Filip/K-6360-2015	Bruggemann, Holger/0000-0001-7433-0190; Ruzicka, Filip/0000-0001-5679-0513; Lambert, Peter/0000-0002-8243-2741; Mavrommatis, Konstantinos/0000-0003-4549-385X; Capoor, Manu/0000-0002-0861-4993	DiscitisDx, Inc.; Coventry University Centre for Sport, Exercise and Life Sciences	DiscitisDx, Inc.; Coventry University Centre for Sport, Exercise and Life Sciences	DiscitisDx, Inc. provided support in the form of a research grant which was used to pay for culturing, microscopy, and materials. Neither DiscitisDX, Inc. nor any other commercial organization provided any support in the form of salaries for authors and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KM's commercial affiliation with Celgene did not play a role in the study. GS's research is funded by Coventry University Centre for Sport, Exercise and Life Sciences. The funder provided no support in the form of salaries for authors, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh J, 2017, EUR SPINE J, V26, P3129, DOI 10.1007/s00586-016-4887-4; Albert HB, 2013, EUR SPINE J, V22, P690, DOI 10.1007/s00586-013-2674-z; Antonacci MD, 1998, J SPINAL DISORD, V11, P526; Bailey JF, 2011, J ANAT, V218, P263, DOI 10.1111/j.1469-7580.2010.01332.x; Barnard E, 2015, J CLIN MICROBIOL, V53, P1149, DOI 10.1128/JCM.02460-14; Becker S, 2017, SPINE J, V17, P218, DOI 10.1016/j.spinee.2016.08.032; Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Boyle KK, 2017, J SHOULDER ELB SURG, V26, pe161, DOI [10.1016/j.jse.2016.12.036, DOI 10.1016/J.JSE.2016.12.036]; Capoor MN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174518; Capoor MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161676; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Coscia MF, 2016, SPINE, V41, P1860, DOI 10.1097/BRS.0000000000001909; Dudli S, 2018, SPINE J, V18, P831, DOI 10.1016/j.spinee.2017.12.004; Fras Christian, 2003, Spine J, V3, P63, DOI 10.1016/S1529-9430(02)00455-2; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Ganko R, 2015, SPINE, V40, pE587, DOI 10.1097/BRS.0000000000000832; Garcia JBS, 2014, PAIN PHYSICIAN, V17, P379; Javanshir N, 2017, EUR SPINE J, V26, P3135, DOI 10.1007/s00586-017-5219-z; Mahylis JM, 2018, J SHOULDER ELB SURG, V27, P1097, DOI 10.1016/j.jse.2017.12.025; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Neuhauser H, 2005, GESUNDHEITSWESEN, V67, P685, DOI 10.1055/s-2005-858701; Nodzo Scott R, 2014, Am J Orthop (Belle Mead NJ), V43, pE93; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Rigal J, 2016, EUR SPINE J, V25, P1000, DOI 10.1007/s00586-016-4396-5; Rollason J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/530382; Sandhu GK, 2017, ASS LUMB DISC HEM MI; Sorensen M, 2010, J MICROBIOL METH, V83, P211, DOI 10.1016/j.mimet.2010.09.008; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Urquhart DM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0267-x; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wright Travis E, 2016, Infect Dis (Auckl), V9, P39	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208144	10.1371/journal.pone.0208144	http://dx.doi.org/10.1371/journal.pone.0208144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496247	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000451763800100
J	Fukuda, M; Shibata, S; Shibata, N; Fujita, N; Miyashita, H; Tanimura, N; Ishida, H; Kubo, E; Sasaki, H				Fukuda, Masamichi; Shibata, Shinsuke; Shibata, Naoko; Fujita, Nobuyuki; Miyashita, Hisanori; Tanimura, Naoki; Ishida, Hidetoshi; Kubo, Eri; Sasaki, Hiroshi			Polyvinyl alcohol-iodine induced corneal epithelial injury in vivo and its protection by topical rebamipide treatment	PLOS ONE			English	Article							POVIDONE-IODINE; POSTOPERATIVE ENDOPHTHALMITIS; EYE; PROPHYLAXIS; SURGERY	Periocular povidone-iodine (PI) and polyvinyl alcohol-iodine (PAI) have had a major role in the prevention of endophthalmitis. The purpose of this study was to investigate the corneal epithelial toxicity of PAI in a rabbit eye model using corneal resistance (CR) measurement, which is a good indicator of cell barrier function. Rabbit eyes were administered PAI solution at 4-, 6-, 8-, or 16-fold dilution with physiological saline solution (saline) or saline alone (control), to the conjunctival sac with/without wash-out with saline. Corneal epithelial injury assessed by fluorescein staining and the CR ratio was measured at 10 minutes (min) to 96 hours (h) after the initial administration. Histological observation was performed in the eyes following the PAI or control administrations. At 120 min after administration of PAI solution, the CR ratio was decreased and superficial punctate keratopathy (SPK) was significantly increased in each of the PAI-administered groups compared to the control. Recovery of CR and SPK after administration of 6- or 8-fold dilution of PAI was significantly delayed in eyes that were not subsequently washed with saline compared with eyes that were. Pre- or post-instillation of 2% rebamipide ophthalmic suspension significantly reduced PAI induced-SPK and -decrease of CR ratio. The CR method was able to accurately and quantitatively evaluate fine corneal epithelial injury. It is suggested that eyes should be washed with saline solution after administration of PAI solution or the instillation of rebamipide to prevent or reduce corneal epithelial injury.	[Fukuda, Masamichi; Shibata, Shinsuke; Shibata, Naoko; Fujita, Nobuyuki; Miyashita, Hisanori; Tanimura, Naoki; Ishida, Hidetoshi; Kubo, Eri; Sasaki, Hiroshi] Kanazawa Med Univ, Dept Ophthalmol, Kahoku, Ishikawa, Japan	Kanazawa Medical University	Fukuda, M (corresponding author), Kanazawa Med Univ, Dept Ophthalmol, Kahoku, Ishikawa, Japan.	fukuda@kanazawa-med.ac.jp						Alp BN, 2000, CORNEA, V19, P546, DOI 10.1097/00003226-200007000-00028; APT L, 1984, ARCH OPHTHALMOL-CHIC, V102, P728, DOI 10.1001/archopht.1984.01040030584025; APT L, 1989, OPHTHALMOLOGY, V96, P289, DOI 10.1016/S0161-6420(89)32897-1; Arimoto A, 2014, CORNEA, V33, P806, DOI 10.1097/ICO.0000000000000155; Chou SF, 2011, BRIT J OPHTHALMOL, V95, P277, DOI 10.1136/bjo.2010.189407; Fukuda M, 2007, J EYE ATARASHII GANK, V24, P521; Fukuda M, 2016, CORNEA, V35, P1305, DOI 10.1097/ICO.0000000000000894; Fukuda M, 2016, EUR J PHARMACOL, V787, P43, DOI 10.1016/j.ejphar.2016.05.012; Fukuda M, 2015, J OCUL PHARMACOL TH, V31, P536, DOI 10.1089/jop.2014.0118; Fukuda M, 2013, CLIN OPHTHALMOL, V7, P515, DOI 10.2147/OPTH.S40147; Fukuda M, 2012, CLIN OPHTHALMOL, V6, P585, DOI 10.2147/OPTH.S30935; Haripriya A, 2017, ASIA-PAC J OPHTHALMO, V6, P324, DOI 10.22608/APO.2017200; Hatano Hiroshi, 2015, Nippon Ganka Gakkai Zasshi, V119, P503; Higuchi K, 1998, DIGEST DIS SCI, V43, p99S; Inoue Y, 2008, JPN J OPHTHALMOL, V52, P151, DOI 10.1007/s10384-008-0517-y; Jiang J, 2009, CUTAN OCUL TOXICOL, V28, P119, DOI 10.1080/15569520903080511; KLEINE A, 1993, DIGEST DIS SCI, V38, P1441, DOI 10.1007/BF01308601; Matsuura K, 2014, JAPANESE J OPHTHALMI, V27, P451; Matsuura K, 2014, CLIN OPHTHALMOL, V8, P2013, DOI 10.2147/OPTH.S64756; Miyata K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1537, DOI 10.1001/archopht.121.11.1537; Rios JD, 2008, EXP EYE RES, V86, P629, DOI 10.1016/j.exer.2008.01.007; Sandvig KU, 2003, J CATARACT REFR SURG, V29, P1273, DOI 10.1016/S0886-3350(02)02048-5; Shibata Y, 2014, JPN J OPHTHALMOL, V58, P522, DOI 10.1007/s10384-014-0348-y; Shimada H, 2017, ACTA OPHTHALMOL, V95, pE373, DOI 10.1111/aos.13390; Shimada H, 2017, CURR PHARM DESIGN, V23, P574, DOI 10.2174/1381612822666161205105404; SPEAKER MG, 1991, OPHTHALMOLOGY, V98, P1769; Taban M, 2005, ARCH OPHTHALMOL-CHIC, V123, P613, DOI 10.1001/archopht.123.5.613; YOKOI N, 1995, CORNEA, V14, P485	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208198	10.1371/journal.pone.0208198	http://dx.doi.org/10.1371/journal.pone.0208198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496255	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800106
J	Kim, HM; Yang, HK; Hwang, JM				Kim, Hyeong Min; Yang, Hee Kyung; Hwang, Jeong-Min			Quantitative analysis of pupillometry in isolated third nerve palsy	PLOS ONE			English	Article							TOLOSA-HUNT-SYNDROME; MAGNETIC-RESONANCE; RISK-FACTORS; PUPIL; OPHTHALMOPLEGIA; RELIABILITY; PARALYSIS; IV; VI	Objectives To objectively assess pupillary involvement according to various etiologies of acquired isolated third nerve palsy using automated pupillometry, and evaluate the efficacy of digital pupillometry in discriminating compressive lesions from microvascular ischemic third nerve palsy. Design Retrospective, observational case series Methods A total of 171 subjects were included in this study, consisting of 60 subjects with presumed microvascular ischemic third nerve palsy, 51 with non-ischemic third nerve palsy, and 60 controls whose pupillary light responses were measured using a dynamic automated pupillometer. Subjects with non-ischemic third nerve palsy were divided into subgroups according to their etiology; inflammatory and compressive groups including tumor and aneurysm. Pupillometry parameters including minimum and maximum pupil diameters, constriction latency and ratio, maximum and average constriction velocities and dilation velocity were noted. The diagnostic ability of pupillometry parameters for discriminating compressive vs microvascular ischemic third nerve palsy was evaluated. The inter-eye difference of the involved eye and the uninvolved fellow eye was calculated to adjust for individual variability. Results Among all parameters, reduced pupillary constriction ratio was the most specific parameter for detecting non-ischemic third nerve palsy, as a large inter-eye difference beyond the normative range of controls was found in 0% of ischemic, 20% of inflammatory and 60% of compressive third nerve palsy. With the diagnostic criteria using inter-eye differences of 1) minimum pupil diameter > 0.45 mm, or 2) pupillary constriction ratio < -7.5% compared to the fellow eye, the sensitivity and specificity for diagnosing compressive third nerve palsy were 95% and 88%, respectively. In the compressive group, positive correlations were found between the degree of external ophthalmoplegia and constriction ratio (r = 0.615, p<0.001), average constriction velocity (r = 0.591, p = 0.001) and maximum constriction velocity (r = 0.582, p = 0.001). Conclusions Abnormal pupillary constriction ratio was highly specific for detecting compressive third nerve palsy, although the sensitivity was not high. Digital pupillometry demonstrated relatively good performance for discriminating compressive lesions from microvascular ischemic third nerve palsy.	[Kim, Hyeong Min; Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Coll Med, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Coll Med, Seongnam, South Korea.	hjm@snu.ac.kr			National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1A2B4011450]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2017R1A2B4011450). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLIT P, 1991, J NEUROL SCI, V103, P10, DOI 10.1016/0022-510X(91)90276-D; Bremner FD, 2004, EYE, V18, P1175, DOI 10.1038/sj.eye.6701560; Cahill M, 2001, BRIT J OPHTHALMOL, V85, P1225, DOI 10.1136/bjo.85.10.1225; Chang DS, 2013, INVEST OPHTH VIS SCI, V54, P5596, DOI 10.1167/iovs.13-12142; Du R, 2005, NEUROSURGERY, V57, P198, DOI 10.1227/01.NEU.0000163425.79170.CB; Fang CB, 2017, JAMA OPHTHALMOL, V135, P23, DOI 10.1001/jamaophthalmol.2016.4456; FOWLER TJ, 1975, BRIT J OPHTHALMOL, V59, P149, DOI 10.1136/bjo.59.3.149; GOLDSTEIN JE, 1960, ARCH OPHTHALMOL-CHIC, V64, P592; GREEN WR, 1964, ARCH OPHTHALMOL-CHIC, V72, P154; Hung CH, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-7; HUNT WE, 1976, J NEUROSURG, V44, P544, DOI 10.3171/jns.1976.44.5.0544; JACOBSON DM, 1994, ARCH OPHTHALMOL-CHIC, V112, P961, DOI 10.1001/archopht.1994.01090190109029; Jacobson DM, 1998, ARCH OPHTHALMOL-CHIC, V116, P723, DOI 10.1001/archopht.116.6.723; Jacobson DM, 1999, AM J OPHTHALMOL, V128, P94, DOI 10.1016/S0002-9394(99)00107-5; Keane JR, 2010, CAN J NEUROL SCI, V37, P662, DOI 10.1017/S0317167100010866; Keane JR, 1996, NEUROLOGY, V46, P1176, DOI 10.1212/WNL.46.4.1176; KISSEL JT, 1983, ANN NEUROL, V13, P149, DOI 10.1002/ana.410130207; KLINE LB, 1982, SURV OPHTHALMOL, V27, P79, DOI 10.1016/0039-6257(82)90190-4; La Mantia L, 2006, CEPHALALGIA, V26, P772, DOI 10.1111/j.1468-2982.2006.01115.x; Lee AG, 2002, SURV OPHTHALMOL, V47, P137, DOI 10.1016/S0039-6257(01)00303-4; Lee SH, 2002, CLIN NEUROL NEUROSUR, V104, P136, DOI 10.1016/S0303-8467(02)00008-2; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; LUSTBADER JM, 1988, ARCH OPHTHALMOL-CHIC, V106, P583; NADEAU SE, 1983, ANN NEUROL, V13, P143, DOI 10.1002/ana.410130206; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; RUCKER CW, 1966, AM J OPHTHALMOL, V61, P1293, DOI 10.1016/0002-9394(66)90258-3; RUSH JA, 1981, ARCH OPHTHALMOL-CHIC, V99, P76, DOI 10.1001/archopht.1981.03930010078006; Shwe-Tin A, 2012, J NEURO-OPHTHALMOL, V32, P111, DOI 10.1097/WNO.0b013e31823f45e5; SPECTOR RH, 1986, NEUROLOGY, V36, P198, DOI 10.1212/WNL.36.2.198; TEUSCHER AU, 1985, J NEUROL, V232, P144, DOI 10.1007/BF00313889; TROBE JD, 1985, OPHTHALMOLOGY, V92, P58; TROBE JD, 1988, ARCH OPHTHALMOL-CHIC, V106, P601, DOI 10.1001/archopht.1988.01060130655019; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Yoo YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186741; Yoo YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178361; Zhao WD, 2016, J CLIN NEUROSCI, V33, P79, DOI 10.1016/j.jocn.2016.01.039	36	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208259	10.1371/journal.pone.0208259	http://dx.doi.org/10.1371/journal.pone.0208259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496292	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800120
J	Kornej, J; Buttner, P; Hammer, E; Engelmann, B; Dinov, B; Sommer, P; Husser, D; Hindricks, G; Volker, U; Bollmann, A				Kornej, Jelena; Buettner, Petra; Hammer, Elke; Engelmann, Beatrice; Dinov, Borislav; Sommer, Philipp; Husser, Daniela; Hindricks, Gerhard; Voelker, Uwe; Bollmann, Andreas			Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade	PLOS ONE			English	Article							FIBRILLATION; GENE; INFLAMMATION; STROKE; SYSTEM; IMPACT; RISK	Background Left atrial (LA) electro-anatomical remodeling and diameter increase in atrial fibrillation (AF) indicates disease progression and is associated with poor therapeutic success. Furthermore, AF leads to a hypercoagulable state, which in turn promotes the development of a substrate for AF and disease progression in the experimental setting. The aim of this study was to identify pathways associated with LA remodeling in AF patients using untargeted proteomics approach. Methods Peripheral blood samples of 48 patients (62 +/- 10 years, 63% males, 59% persistent AF) undergoing AF catheter ablation were collected before ablation. 23 patients with left atrial low voltage areas (LVA), defined as <0.5 mV, and 25 patients without LVA were matched for age, gender and CHA(2)DS(2)-VASc score. Untargeted proteome analysis was performed using LC-ESI-Tandem mass spectrometry in a label free intensity based workflow. Significantly different abundant proteins were identified and used for pathway analysis and protein-protein interaction analysis. Results Analysis covered 280 non-redundant circulating plasma proteins. The presence of LVA correlated with 30 differentially abundant proteins of coagulation and complement cascade (q<0.05). Conclusions This pilot proteomic study identified plasma protein candidates associated with electro-anatomical remodeling in AF and pointed towards an imbalance in coagulation and complement pathway, tissue remodeling and inflammation.	[Kornej, Jelena; Buettner, Petra; Dinov, Borislav; Sommer, Philipp; Husser, Daniela; Hindricks, Gerhard; Bollmann, Andreas] Univ Leipzig, Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Germany; [Hammer, Elke; Engelmann, Beatrice; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Hammer, Elke; Voelker, Uwe] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany	Heart Center Leipzig GMBH; Leipzig University; Greifswald Medical School; German Centre for Cardiovascular Research	Kornej, J (corresponding author), Univ Leipzig, Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Germany.	jelena.kornej@gmx.de	Büttner, Petra/ADR-1721-2022; Sommer, Philipp/AAV-3133-2020	Hammer, Elke/0000-0002-1507-0402; Buttner, Petra/0000-0003-0799-4725	Peter-Osypka Grant 2015 (German Society of Cardiology); Volkswagen Foundation Germany through the Lichtenberg professorship program [84901]	Peter-Osypka Grant 2015 (German Society of Cardiology); Volkswagen Foundation Germany through the Lichtenberg professorship program	This project was supported by Peter-Osypka Grant 2015 (German Society of Cardiology) for JK and Volkswagen Foundation Germany through the Lichtenberg professorship program for PB and DH (#84901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006274; Beveridge AJ, 2012, PROTEINS, V80, P1987, DOI 10.1002/prot.24087; Buttner P, 2018, HEART RHYTHM, V15, P1132, DOI 10.1016/j.hrthm.2018.03.021; Christiansen CB, 2016, EUROPACE, V18, P1689, DOI 10.1093/europace/euv401; D'Ascenzo F, 2013, INT J CARDIOL, V167, P1984, DOI 10.1016/j.ijcard.2012.05.008; Dinov B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P483, DOI 10.1161/CIRCEP.113.001185; Friedrichs K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00214; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hazell GGJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39553; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kirchhof P., 2017, LANCET; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Knecht S, 2016, EUROPACE EUROPEAN PA; Kryczka J, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2570154; Malhotra R, 1999, BIOCHEM J, V341, P61, DOI 10.1042/0264-6021:3410061; Morikis VA, 2015, BIORHEOLOGY, V52, P447, DOI 10.3233/BIR-15067; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rutledge H, 2014, GENETICS, V198, P735, DOI 10.1534/genetics.114.168138; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Spragg DD, 2012, HEART RHYTHM, V9, P2003, DOI 10.1016/j.hrthm.2012.08.039; Spronk HMH, 2017, EUR HEART J, V38, P38, DOI 10.1093/eurheartj/ehw119; Teumer A, 2016, AGING CELL, V15, P811, DOI 10.1111/acel.12490; Wang AHJ, 2013, EMBO J, V32, P1075, DOI 10.1038/emboj.2013.54; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Xue L, 2017, ARTERIOSCL THROM VAS, V37, P983, DOI 10.1161/ATVBAHA.117.308995; Yang SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025131; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0198461	10.1371/journal.pone.0198461	http://dx.doi.org/10.1371/journal.pone.0198461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496173	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800002
J	Gaurivaud, P; Ganter, S; Villard, A; Manso-Silvan, L; Chevret, D; Boule, C; Monnet, V; Tardy, F				Gaurivaud, Patrice; Ganter, Sarah; Villard, Alexandre; Manso-Silvan, Lucia; Chevret, Didier; Boule, Christelle; Monnet, Veronique; Tardy, Florence			Mycoplasmas are no exception to extracellular vesicles release: Revisiting old concepts	PLOS ONE			English	Article							MEMBRANE-DERIVED VESICLES; PROTEOMICS; BACTERIA; INVASION; STRAINS; PROTEIN	Release of extracellular vesicles (EV) by Gram-negative and positive bacteria is being frequently reported. EV are nano-sized, membrane-derived, non-self-replicating, spherical structures shed into the extracellular environment that could play a role in bacteria-host interactions. Evidence of EV production in bacteria belonging to the class Mollicutes, which are wall-less, is mainly restricted to the genus Acholeplasma and is scanty for the Mycoplasma genus that comprises major human and animal pathogens. Here EV release by six Mycoplasma (sub)species of clinical importance was investigated. EV were obtained under nutritional stress conditions, purified by ultracentrifugation and observed by electron micros-copy. The membrane proteins of EV from three different species were further identified by mass spectrometry as a preliminary approach to determining their potential role in host-pathogen interactions. EV were shown to be released by all six (sub)species although their quantities and sizes (30-220 nm) were very variable. EV purification was complicated by the minute size of viable mycoplasmal cells. The proteins of EV-membranes from three (sub)species included major components of host-pathogen interactions, suggesting that EV could contribute to make the host-pathogen interplay more complex. The process behind EV release has yet to be deciphered, although several observations demonstrated their active release from the plasma membrane of living cells. This work shed new light on old concepts of "elementary bodies" and "not-cell bound antigens".	[Gaurivaud, Patrice; Ganter, Sarah; Villard, Alexandre; Tardy, Florence] Univ Lyon, Anses, Lab Lyon, UMR Mycoplasmoses Ruminants, Lyon, France; [Gaurivaud, Patrice; Ganter, Sarah; Villard, Alexandre; Tardy, Florence] Univ Lyon, VetAgro Sup, UMR Mycoplasmoses Ruminants, Marcy Letoile, France; [Manso-Silvan, Lucia] CIRAD, UMRASTRE, Montpellier, France; [Manso-Silvan, Lucia] INRA, UMR ASTRE, Montpellier, France; [Chevret, Didier; Monnet, Veronique] Univ Paris Saclay, AgroParisTech, INRA, PAPPSO,Micalis Inst, Jouy En Josas, France; [Boule, Christelle] Univ Claude Bernard Lyon 1, Ctr Technol Microstruct, Serv Etud Facon EZUS Lyon, Villeurbanne, France; [Villard, Alexandre] Univ Bretagne Loire, Stress Oxydant & Pathol Metabol, INSERM UMR 1063, Angers, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Lyon; VetAgro Sup; VetAgro Sup; CIRAD; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gaurivaud, P (corresponding author), Univ Lyon, Anses, Lab Lyon, UMR Mycoplasmoses Ruminants, Lyon, France.; Gaurivaud, P (corresponding author), Univ Lyon, VetAgro Sup, UMR Mycoplasmoses Ruminants, Marcy Letoile, France.	patrice.gaurivaud@anses.fr		Manso-Silvan, Lucia/0000-0002-5539-3804; TARDY, Florence/0000-0003-3968-4801; Gaurivaud, patrice/0000-0002-8390-8123	French Agency for Food, Environmental and Occupational Health and Safety (Anses); French Agricultural Research Centre for International Development (CIRAD)	French Agency for Food, Environmental and Occupational Health and Safety (Anses)(French National Research Agency (ANR)); French Agricultural Research Centre for International Development (CIRAD)	Sarah Ganter's PhD research is jointly funded by the French Agency for Food, Environmental and Occupational Health and Safety (Anses) and the French Agricultural Research Centre for International Development (CIRAD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lucie Geay (UCBL, Lyon, France) for preparation of samples for TEM and Sandrine Magnard (IBCP, Lyon, France) for access to ultracentrifugation facilities. The authors declare no conflict of interest. S.G.'s PhD research is jointly funded by the French Agency for Food, Environmental and Occupational Health and Safety (Anses) and the French Agricultural Research Centre for International Development (CIRAD).	Ayling RD, 2005, ANTIMICROB AGENTS CH, V49, P5162, DOI 10.1128/AAC.49.12.5162-5165.2005; Bertin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068373; BLADEN HA, 1963, J BACTERIOL, V86, P1339, DOI 10.1128/JB.86.6.1339-1344.1963; Browning GF, 2014, MOLLICUTES MOL BIOL, P77; Cacciotto C, 2016, CELL MICROBIOL, V18, P1751, DOI 10.1111/cmi.12613; Chernov VM, 2014, J PROTEOMICS, V110, P117, DOI 10.1016/j.jprot.2014.07.020; Chernov VM, 2011, THESCIENTIFICWORLDJO, V11, P1120, DOI 10.1100/tsw.2011.109; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; DOMERMUTH CH, 1964, J BACTERIOL, V88, P727, DOI 10.1128/JB.88.3.727-744.1964; DORWARD DW, 1990, APPL ENVIRON MICROB, V56, P1960, DOI 10.1128/AEM.56.6.1960-1962.1990; ENG J, 1971, ACTA PATH MICRO IM A, VB 79, P759; Folmsbee Martha, 2010, PDA J Pharm Sci Technol, V64, P581; Gaurivaud P, 2004, MICROBIOL-SGM, V150, P4009, DOI 10.1099/mic.0.27247-0; Grundel A, 2016, INT J MED MICROBIOL, V306, P675, DOI 10.1016/j.ijmm.2016.09.001; Haurat MF, 2015, BIOL CHEM, V396, P95, DOI 10.1515/hsz-2014-0183; Hegde S, 2018, INT J MED MICROBIOL, V308, P263, DOI 10.1016/j.ijmm.2017.11.010; Hopfe M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-55; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jan AT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01053; Jiang F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161170; Jiang YL, 2014, INT J MED MICROBIOL, V304, P431, DOI 10.1016/j.ijmm.2014.02.006; Kim JH, 2015, SEMIN CELL DEV BIOL, V40, P97, DOI 10.1016/j.semcdb.2015.02.006; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Langella O, 2017, J PROTEOME RES, V16, P494, DOI 10.1021/acs.jproteome.6b00632; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073196; Liu DY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184578; MANILOFF J, 1972, BACTERIOL REV, V36, P263, DOI 10.1128/MMBR.36.3.263-290.1972; Miltiadou DR, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-215; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mwirigi M, 2016, VET IMMUNOL IMMUNOP, V169, P63, DOI 10.1016/j.vetimm.2015.12.006; Olaya-Abril A, 2014, J PROTEOMICS, V106, P46, DOI 10.1016/j.jprot.2014.04.023; Paes JA, 2017, J PROTEOMICS, V154, P69, DOI 10.1016/j.jprot.2016.12.002; Rechnitzer H, 2006, CURR MICROBIOL, V53, P293, DOI 10.1007/s00284-006-0007-8; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; ROBERTSON J, 1975, J BACTERIOL, V124, P1007, DOI 10.1128/JB.124.2.1007-1018.1975; Schrempf H, 2011, MICROB BIOTECHNOL, V4, P286, DOI 10.1111/j.1751-7915.2011.00251.x; Singorenko PD, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1324731; Taguchi Yuzuru, 2014, Bio Protoc, V4, DOI 10.21769/BioProtoc.1139; Totte P, 2010, CLIN VACCINE IMMUNOL, V17, P1211, DOI 10.1128/CVI.00132-10; Widjaja M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10644-z; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000	45	20	20	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208160	10.1371/journal.pone.0208160	http://dx.doi.org/10.1371/journal.pone.0208160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485365	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800114
J	Jian, ZJ; Ma, FQ; Guo, QS; Qin, AL; Xiao, WF				Jian, Zunji; Ma, Fanqiang; Guo, Quanshui; Qin, Aili; Xiao, Wenfa			Long-term responses of riparian plants' composition to water level fluctuation in China's Three Gorges Reservoir	PLOS ONE			English	Article							ZONE; VEGETATION; AREA; LAKE; SUBMERGENCE; TOLERANCE; SURVIVAL; TRAITS; BELT	The water level fluctuation zone (WLFZ) has experienced a novel hydrological regime due to the anti-seasonal operation of China's Three Gorges Reservoir. Overall, hydrological change can significantly influence the riparian environment and shift the riparian vegetation. Although numerous studies have investigated the short-term responses of riparian plants to water level fluctuation in this zone, few have addressed long-term effects. In this study, four permanent plots in the WLFZ of the canyon landform area were chosen to evaluate the long-term responses of riparian plants to water level fluctuation from 2008 to 2015 and to screen candidate plants for ecological restoration. We recorded 146 species in 2008, 110 species in 2009, 68 species in 2012 and 69 species in 2015, indicating a conspicuous loss in riparian plants. Most of the remnant plants were annual and perennial herbs. Of the native species present in 2008, 82, 22 and 8 had disappeared in 2009, 2012 and 2015, respectively. Simultaneously, 45, 15 and 11 non-native species were first found, respectively. Additionally, over half of the native and the non-native species were not found after being subjected to a water level fluctuation. From 2008 to 2015, only 27 native species always presented; however, not all of them were chosen as candidates for ecological restoration because of their decreased importance values. In contrast, the importance value of Cynodon dactylon increased over time, suggesting its high tolerance to long-term winter flooding. We concluded that riparian plants' composition of the canyon landform area dramatically declined after long-term water level fluctuation and their presence was determined by the novel hydrological condition. Our results also suggested that Cynodon dactylon or its combination with other species (i.e. Digitaria chrysoblephara, Setaria glauca, Setaria viridis) is a better candidate for ecological restoration in the WLFZ.	[Jian, Zunji; Ma, Fanqiang; Guo, Quanshui; Qin, Aili; Xiao, Wenfa] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, State Forestry Adm, Key Lab Forest Ecol & Environm, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Jian, ZJ; Guo, QS (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, State Forestry Adm, Key Lab Forest Ecol & Environm, Beijing, Peoples R China.	jianzunji2014@163.com; guoqs@caf.ac.cn	Ma, Fanqiang/J-3050-2016		National "Thirteenth Five-Year", "Twelfth Five-Year" and "Eleventh Five-Year" Plan for Science & Technology Project of China [2015BAD07B040301, 2011BAD38B04, 2006BAD03A313]	National "Thirteenth Five-Year", "Twelfth Five-Year" and "Eleventh Five-Year" Plan for Science & Technology Project of China	This work was supported by National "Thirteenth Five-Year", "Twelfth Five-Year" and "Eleventh Five-Year" Plan for Science & Technology Project of China (No. 2015BAD07B040301 to AQ, 2011BAD38B04 to QG, 2006BAD03A313 to QG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Serres J, 2014, PLANT CELL ENVIRON, V37, P2211, DOI 10.1111/pce.12420; Bao YH, 2015, EARTH-SCI REV, V150, P14, DOI 10.1016/j.earscirev.2015.07.005; Chapin DM, 2013, WETLANDS, V33, P431, DOI 10.1007/s13157-013-0401-5; Deng QL, 2017, ENG GEOL, V221, P170, DOI 10.1016/j.enggeo.2017.02.017; Fan Da-Yong, 2015, Chinese Journal of Plant Ecology, V39, P416, DOI 10.17521/cjpe.2015.0041; Fu BJ, 2010, PROG PHYS GEOG, V34, P741, DOI 10.1177/0309133310370286; Garssen AG, 2015, GLOBAL CHANGE BIOL, V21, P2881, DOI 10.1111/gcb.12921; Guo Quan-shui, 2012, Xibei Zhiwu Xuebao, V32, P2328; Guo QuanShui, 2013, Scientia Silvae Sinicae, V49, P1; Hong Ming, 2011, Yingyong Shengtai Xuebao, V22, P2829; [洪明 HONG Ming], 2011, [河北农业大学学报, Journal of Agricultural University of Hebei], V34, P77; Jian Zun-ji, 2017, Shengtaixue Zazhi, V36, P328, DOI 10.13292/j.1000-4890.201702.018; Leira M, 2008, HYDROBIOLOGIA, V613, P171, DOI 10.1007/s10750-008-9465-2; Li B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146664; [李波 Li Bo], 2015, [环境科学研究, Research of Environmental Sciences], V28, P1578; Li X, 2011, ACTA ECOLOGICA SINIC, V31, P31, DOI DOI 10.1002/SIM.4341; Liu G, 2016, ADV SPACE RES, V57, P2487, DOI 10.1016/j.asr.2016.03.043; Liu X, 2008, RESOURCES ENV YANGTZ, V17, P60; Liu Y, 2013, ENVIRON SCI POLLUT R, V20, P7142, DOI 10.1007/s11356-013-1896-2; [吕明权 Lu Mingquan], 2015, [生态学报, Acta Ecologica Sinica], V35, P3504; Lu ZJ, 2010, PLANT ECOL, V209, P153, DOI 10.1007/s11258-010-9732-y; Molles Jr MC, 2011, ECOLOGY CONCEPTS APP; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Peng CR, 2014, ECOL ENG, V71, P574, DOI 10.1016/j.ecoleng.2014.07.078; Raulings EJ, 2010, FRESHWATER BIOL, V55, P701, DOI 10.1111/j.1365-2427.2009.02311.x; Sarneel JM, 2014, J APPL ECOL, V51, P1006, DOI 10.1111/1365-2664.12288; Strayer DL, 2010, AQUAT SCI, V72, P127, DOI 10.1007/s00027-010-0128-9; Su XL, 2017, SCI TOTAL ENVIRON, V599, P1485, DOI 10.1016/j.scitotenv.2017.05.001; Su XL, 2016, ECOL ENG, V87, P218, DOI 10.1016/j.ecoleng.2015.11.028; Su XL, 2013, ECOL ENG, V61, P456, DOI 10.1016/j.ecoleng.2013.10.009; Tan QX, 2013, ENV SCI, V24, P3043; Tan SD, 2010, ACTA PHYSIOL PLANT, V32, P133, DOI 10.1007/s11738-009-0388-y; Voesenek LACJ, 2013, CURR OPIN PLANT BIOL, V16, P647, DOI 10.1016/j.pbi.2013.06.008; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wang Hai-Feng, 2008, Zhiwu Shengtai Xuebao, V32, P977, DOI 10.3773/j.issn.1005-264x.2008.05.001; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100889; [王晓荣 Wang Xiaorong], 2010, [生态学报, Acta Ecologica Sinica], V30, P5821; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Wilcox DA, 2008, WETLANDS, V28, P487, DOI 10.1672/07-129.1; Wilcox DA, 2012, J GREAT LAKES RES, V38, P270, DOI 10.1016/j.jglr.2012.02.007; Yang F., 2012, ACTA ECOLOGICA SINIC, V32, P89, DOI [10.1016/j.chnaes.2012.02.004, DOI 10.1016/J.CHNAES.2012.02.004]; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108725; [姚洁 Yao Jie], 2015, [生态学报, Acta Ecologica Sinica], V35, P7347; Ye XiaoQi, 2013, Acta Hydrobiologica Sinica, V37, P450; Yuan Qing-ye, 2014, Yingyong Shengtai Xuebao, V25, P2229; [朱妮妮 Zhu Nini], 2015, [生态学报, Acta Ecologica Sinica], V35, P7852	46	9	10	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207689	10.1371/journal.pone.0207689	http://dx.doi.org/10.1371/journal.pone.0207689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485328	gold, Green Submitted, Green Published			2022-12-26	WOS:000451755800078
J	Chin, CY; Hsieh, SY; Tseng, VS				Chin, Chu-Yu; Hsieh, Sun-Yuan; Tseng, Vincent S.			eDRAM: Effective early disease risk assessment with matrix factorization on a large-scale medical database: A case study on rheumatoid arthritis	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; EARLY-DIAGNOSIS; PREDICTION; PATIENT; MODEL	Recently, a number of analytical approaches for probing medical databases have been developed to assist in disease risk assessment and to determine the association of a clinical condition with others, so that better and intelligent healthcare can be provided. The early assessment of disease risk is an emerging topic in medical informatics. If diseases are detected at an early stage, prognosis can be improved and medical resources can be used more efficiently. For example, if rheumatoid arthritis (RA) is detected at an early stage, appropriate medications can be used to prevent bone deterioration. In early disease risk assessment, finding important risk factors from large-scale medical databases and performing individual disease risk assessment have been challenging tasks. A number of recent studies have considered risk factor analysis approaches, such as association rule mining, sequential rule mining, regression, and expert advice. In this study, to improve disease risk assessment, machine learning and matrix factorization techniques were integrated to discover important and implicit risk factors. A novel framework is proposed that can effectively assess early disease risks, and RA is used as a case study. This framework comprises three main stages: data preprocessing, risk factor optimization, and early disease risk assessment. This is the first study integrating matrix factorization and machine learning for disease risk assessment that is applied to a nation-wide and longitudinal medical diagnostic database. In the experimental evaluations, a cohort established from a large-scale medical database was used that included 1007 RA-diagnosed patients and 921,192 control patients examined over a nine-year follow-up period (2000-2008). The evaluation results demonstrate that the proposed approach is more efficient and stable for disease risk assessment than state-of-the-art methods.	[Chin, Chu-Yu; Hsieh, Sun-Yuan] Natl Cheng Kung Univ, Comp Sci & Informat Engn, Tainan, Taiwan; [Tseng, Vincent S.] Natl Chiao Tung Univ, Comp Sci & Informat Engn, Hsinchu, Taiwan	National Cheng Kung University; National Yang Ming Chiao Tung University	Tseng, VS (corresponding author), Natl Chiao Tung Univ, Comp Sci & Informat Engn, Hsinchu, Taiwan.	vtseng@cs.nctu.edu.tw	Hsieh, Sun-Yuan/AAE-1087-2022	Tseng, Vincent/0000-0002-4853-1594	Ministry of Science and Technology, Taiwan [105-2218-E-009-031]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Telecommunication Laboratories, Chunghwa Telecom Co., Ltd provided support in the form of salaries for the author CY Chin, but it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Ministry of Science and Technology, Taiwan grant 105-2218-E-009-031 to VST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom M, 2017, SCAND J OCCUP THER, V24, P468, DOI 10.1080/11038128.2016.1272632; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Cader MZ, 2011, ANN RHEUM DIS, V70, P949, DOI 10.1136/ard.2010.143560; Cai D, 2011, IEEE T PATTERN ANAL, V33, P1548, DOI 10.1109/TPAMI.2010.231; Cao B, 2007, DETECT TRACK LATENT; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Carroll Robert J, 2011, AMIA Annu Symp Proc, V2011, P189; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chao TF, 2017, SCI REP-UK, V7, DOI 10.1038/srep46445; Cheng YT, 2017, IEEE J BIOMED HEALTH, V21, P303, DOI 10.1109/JBHI.2017.2657802; Chin CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122508; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Erichson NB, 2018, PATTERN RECOGN LETT, V104, P1, DOI 10.1016/j.patrec.2018.01.007; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Greco M, 2014, NEW LAB MARKERS MANA, P1729; Ho JC, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P115, DOI 10.1145/2623330.2623658; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Jansen H, 2017, J RHEUMATOL, V44, DOI 10.3899/jrheum.151444; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kuo CC, 2013, 2013 IEEE INT C BIOI; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lam C, 2014, COMPUT METH PROG BIO, V115, P103, DOI 10.1016/j.cmpb.2014.04.002; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Lesh N, 2000, IEEE INTELL SYST APP, V15, P48, DOI 10.1109/5254.850827; Liao JN, 2015, INT J CARDIOL, V199, P25, DOI 10.1016/j.ijcard.2015.06.170; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Liao Ruiqi, 2014, Genomics Proteomics & Bioinformatics, V12, P48, DOI 10.1016/j.gpb.2013.06.001; Liu B, 1998, KNOWLEDGE DISCOVERY, P80, DOI DOI 10.5555/3000292.3000305; Mejia-Roa E, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0485-4; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Mora C, 2009, BIOMEDICA, V29, P43; Ozaki Y, 2016, 2016 38 ANN INT C IE, P16; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Padilla P, 2012, IEEE T MED IMAGING, V31, P207, DOI 10.1109/TMI.2011.2167628; Paine MRL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154837; Rau HH, 2016, COMPUT METH PROG BIO, V125, P58, DOI 10.1016/j.cmpb.2015.11.009; Schneider M, 2013, DTSCH ARZTEBL INT, V110, P477, DOI 10.3238/arztebl.2013.0477; Scott DL, 2007, BRIT MED BULL, V81-82, P97, DOI 10.1093/bmb/ldm011; Shivade C, 2014, J AM MED INFORM ASSN, V21, P221, DOI 10.1136/amiajnl-2013-001935; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Tseng VS, 2009, EXPERT SYST APPL, V36, P9524, DOI 10.1016/j.eswa.2008.10.077; Turk SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193377; Wang BCM., 2016, DRUGS-REAL WOR OUTC, V3, P107, DOI [10.1007/s40801-016-0063-8, DOI 10.1007/S40801-016-0063-8]; Wei Wei-Qi, 2010, AMIA Annu Symp Proc, V2010, P857; Wenmin L, 2001, P 2001 IEEE INT C DA; Yang HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164880; Yang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154627	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207579	10.1371/journal.pone.0207579	http://dx.doi.org/10.1371/journal.pone.0207579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475847	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700040
J	Hepp, CM; Cocking, JH; Valentine, M; Young, SJ; Damian, D; Samuels-Crow, KE; Sheridan, K; Fofanov, VY; Furstenau, TN; Busch, JD; Erickson, DE; Lancione, RC; Smith, K; Will, J; Townsend, J; Keim, PS; Engelthaler, DM				Hepp, Crystal M.; Cocking, Jill Hager; Valentine, Michael; Young, Steven J.; Damian, Dan; Samuels-Crow, Kimberly E.; Sheridan, Krystal; Fofanov, Viacheslav Y.; Furstenau, Tara N.; Busch, Joseph D.; Erickson, Daryn E.; Lancione, Ryan C.; Smith, Kirk; Will, James; Townsend, John; Keim, Paul S.; Engelthaler, David M.			Phylogenetic analysis of West Nile Virus in Maricopa County, Arizona: Evidence for dynamic behavior of strains in two major lineages in the American Southwest	PLOS ONE			English	Article							NOTIFIABLE ARBOVIRAL DISEASES; UNITED-STATES; READ ALIGNMENT; INFERENCE; EVOLUTION; GENOTYPE; MODEL	West Nile Virus (WNV) has been detected annually in Maricopa County, Arizona, since 2003. With this in mind, we sought to determine if contemporary strains are endemic to the county or are annually imported. As part of this effort, we developed a new protocol for tiled amplicon sequencing of WNV to efficiently attain greater than 99% coverage of 14 WNV genomes collected directly from positive mosquito pools distributed throughout Maricopa County between 2014 and 2017. Bayesian phylogenetic analyses revealed that contemporary genomes fall within two major lineages; NA/WN02 and SW/WN03. We found that all of the Arizona strains possessed an amino acid substitution known to be under positive selection, which has arisen independently at least four times in Arizona. The SW/WN03 strains exhibited transient behavior, with at least 10 separate introductions into Arizona when considering both historical and contemporary strains. However, NA/WN02 strains are geographically differentiated and appear to be endemic in Arizona, with two clades that have been circulating for four and seven years. This establishment in Maricopa County provides the first evidence of local overwintering by a WNV strain over the course of several years in Arizona. Within a national context, the placement of eleven contemporary Arizona strains in the NA/WN02 lineage indicates while WNV first entered the northeastern United States in 1999, the most ancestral extant strains of WNV are now circulating in the American southwest.	[Hepp, Crystal M.; Cocking, Jill Hager; Samuels-Crow, Kimberly E.; Fofanov, Viacheslav Y.; Furstenau, Tara N.; Erickson, Daryn E.; Lancione, Ryan C.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA; [Hepp, Crystal M.; Cocking, Jill Hager; Sheridan, Krystal; Fofanov, Viacheslav Y.; Busch, Joseph D.; Erickson, Daryn E.; Lancione, Ryan C.; Keim, Paul S.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA; [Valentine, Michael; Sheridan, Krystal; Keim, Paul S.; Engelthaler, David M.] Translat Genom Res Inst, Flagstaff, AZ USA; [Young, Steven J.; Smith, Kirk; Will, James; Townsend, John] Maricopa Cty Environm Serv Dept Vector Control Di, Phoenix, AZ USA; [Damian, Dan] Maricopa Cty Environm Serv Dept Off Enterprise Te, Phoenix, AZ USA	Northern Arizona University; Northern Arizona University; Translational Genomics Research Institute	Hepp, CM (corresponding author), No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA.; Hepp, CM (corresponding author), No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA.	crystal.hepp@nau.edu	Furstenau, Tara/AAZ-1373-2020	Hepp, Crystal/0000-0002-0612-3648; Furstenau, Tara/0000-0001-5233-7383	Arizona Technology Research and Initiative Fund (TRIF); Arizona Biomedical Research Centre [ADHS18-198866]	Arizona Technology Research and Initiative Fund (TRIF); Arizona Biomedical Research Centre	Funding for this work was provided to C. M.H. by the Arizona Technology Research and Initiative Fund (TRIF) and the Arizona Biomedical Research Centre (ADHS18-198866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZDHS, 2017, ARIZONA 2017 W NIL V; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Burakoff A, 2018, MMWR-MORBID MORTAL W, V67, P13, DOI 10.15585/mmwr.mm6701a3; CDC, 2017, FIN CUM MAPS DAT 199; Colman RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126626; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; Di Giallonardo F, 2016, J VIROL, V90, P862, DOI 10.1128/JVI.02305-15; Drummond A, TRACER V1 6 2014; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duggal NK, 2015, VIROLOGY, V485, P79, DOI 10.1016/j.virol.2015.07.004; Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493; Ehrbar DJ, 2017, INFECT GENET EVOL, V51, P219, DOI 10.1016/j.meegid.2017.04.010; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Komar N, 2013, AM J TROP MED HYG, V89, P474, DOI 10.4269/ajtmh.13-0061; Krow-Lucal E, 2017, MMWR-MORBID MORTAL W, V66, P51, DOI 10.15585/mmwr.mm6602a3; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanciotti RS, 2001, J CLIN MICROBIOL, V39, P4506, DOI 10.1128/JCM.39.12.4506-4513.2001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MCDPH, 2007, 2003 2004 WNV REP MA; McMullen AR, 2011, EMERG INFECT DIS, V17, P785, DOI 10.3201/eid1705.101707; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Plante JA, 2014, EMERG INFECT DIS, V20, P272, DOI 10.3201/eid2002.131008; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0205801	10.1371/journal.pone.0205801	http://dx.doi.org/10.1371/journal.pone.0205801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475820	gold, Green Submitted, Green Published			2022-12-26	WOS:000451325700008
J	Saraceni, V; Benzaken, AS; Pereira, GFM; Andrade, KB; Oliveira, PB; Arakaki-Sanchez, D; Caruso, A; de Souza, FMA				Saraceni, Valeria; Benzaken, Adele Schwartz; Mendes Pereira, Gerson Fernando; Andrade, Kleydson Bonfim; Oliveira, Patricia Bartholomay; Arakaki-Sanchez, Denise; Caruso, Alessandro; Alves de Souza, Flavia Moreno			Tuberculosis burden on AIDS in Brazil: A study using linked databases	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; RIO-DE-JANEIRO; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; INITIATION; OUTCOMES; ADULTS; TB/HIV; IMPACT; DEATH	Objectives To estimate the burden of tuberculosis (TB) in reported AIDS cases, to compare the characteristics of TB/HIV subjects with those without TB and to evaluate survival with or without TB in Brazil. Methods The data source was the linked database between AIDS (2011-2014) and TB (2011-2014) databases from the Notifiable Diseases Information System (SINAN). The sociodemographic, clinical, laboratory results and use of antiretroviral therapy (ART) data were compared by TB occurrence or not. Survival probability was estimated using the Kaplan-Meier method and associated factors were sought using Cox regression. Results The proportion of TB diagnosed from 2011 to 2014 among AIDS cases reported between 2006 and 2014 was 6.3%. Subjects coinfected with TB were predominantly male, older, with lower schooling, with lower CD4 count, higher viral load, and higher proportion of ART initiation than those without TB. 57.5% were diagnosed with HIV before TB, 38.2% as concurrent TB/HIV and 4.3% with TB before HIV. 16,466 reported TB cases were not found in the AIDS database, although registered as HIV-infected in the SINAN TB database between 2011 and 2014. Median survival for PLHIV was 581 days, with 582 for those without TB, significantly higher than 547 for those with TB (log-rank teste, p = 0,001). In the Cox multivariate analysis, male gender [aHR = 1.27 (CI 95% 1.22-1.33)], older age [aHR = 1.020 (CI 95% 1.019-1.022)] and TB coinfection [aHR = 1.97 (CI 95% 1.88-2.07)] were positively associated with adjusted hazard of death, whereas CD4 count 200-499 cells [aHR = 0.21 (CI 95% 0.20-0.22)] and receiving ART [aHR = 0.22(CI 95% 0.21-0.23)] reduced the risk of death. Conclusions HIV-infected subjects should be screened for TB at care entry, to minimize diagnosis and treatment delays when active TB is present or to increase the odds of being offered latent TB infection therapy to prevent TB. On the other hand, TB cases should be promptly tested for HIV. All those will contribute to reduce mortality among people living with AIDS.	[Saraceni, Valeria] Rio de Janeiro City Hlth Secretariat, Hlth Situat Anal Branch, Rio De Janeiro, Brazil; [Benzaken, Adele Schwartz; Mendes Pereira, Gerson Fernando; Caruso, Alessandro; Alves de Souza, Flavia Moreno] Minist Hlth, Dept STIs Aids & Viral Hepatites, Brasilia, DF, Brazil; [Andrade, Kleydson Bonfim; Oliveira, Patricia Bartholomay; Arakaki-Sanchez, Denise] Minist Hlth, Natl TB Control Program, Brasilia, DF, Brazil		Saraceni, V (corresponding author), Rio de Janeiro City Hlth Secretariat, Hlth Situat Anal Branch, Rio De Janeiro, Brazil.	valsaraceni@gmail.com	da Cunha, Alessandro Ricardo Caruso/AAG-6448-2019; Arakaki-Sanchez, Denise/M-4766-2013; Saraceni, Valeria/I-3172-2012	da Cunha, Alessandro Ricardo Caruso/0000-0001-5441-1006; Saraceni, Valeria/0000-0001-7360-6490				Badje A, 2017, LANCET GLOB HEALTH, V5, pE1080, DOI 10.1016/S2214-109X(17)30372-8; Brasil. Ministerio da Saude, 2016, SECR VIG SAUD; Camargo K R Jr, 2000, Cad Saude Publica, V16, P439; Escada ROD, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2473-y; do Prado TN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-415; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2015, CLIN INFECT DIS, V60, P639, DOI 10.1093/cid/ciu849; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Batista JDL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063916; Magno ED, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00019315, 10.1590/0102-311x00019315]; Ministerio da Saude, 2017, SECR VIG SAUD COINF; Ministerio da Saude, 2015, SECR VIG SAUD PROT C; Naing C, 2013, LUNG, V191, P27, DOI 10.1007/s00408-012-9440-6; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Pinheiro RS, 2012, CAD SAUDE PUBLICA, V28, P1559, DOI 10.1590/S0102-311X2012000800014; Saraceni V, 2014, JAIDS-J ACQ IMM DEF, V67, P98, DOI 10.1097/QAI.0000000000000247; Schmaltz CAS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045704; Torrens A, 2016, REV PANAM SALUD PUBL, V39, P26; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2016, PREV HIV TEST TREAT; Young PW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181837	26	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207859	10.1371/journal.pone.0207859	http://dx.doi.org/10.1371/journal.pone.0207859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462733	Green Published, Green Submitted, gold			2022-12-26	WOS:000451054800090
J	Kim, TH; Ly, C; Christodoulides, A; Nowell, CJ; Gunning, PW; Sloan, EK; Rowat, AC				Kim, Tae-Hyung; Ly, Chau; Christodoulides, Alexei; Nowell, Cameron J.; Gunning, Peter W.; Sloan, Erica K.; Rowat, Amy C.			Stress hormone signaling through -adrenergic receptors regulates macrophage mechanotype and function	FASEB JOURNAL			English	Article						deformability; phagocytosis; chemotaxis; actin	FILOPODIA FORMATION; ARP2/3 COMPLEX; T-CELLS; PHAGOCYTOSIS; ACTIVATION; MIGRATION; SYSTEM; DIFFERENTIATION; DEFORMABILITY; LOCALIZATION	Critical functions of immune cells require them to rapidly change their shape and generate forces in response to cues from their surrounding environment. However, little is known about how soluble factors that may be present in the microenvironment modulate key aspects of cellular mechanobiologysuch as immune cell deformability and force generationto impact functions such as phagocytosis and migration. Here we show that signaling by soluble stress hormones through -adrenoceptors (-AR) reduces the deformability of macrophages; this is dependent on changes in the organization of the actin cytoskeleton and is associated with functional changes in phagocytosis and migration. Pharmacologic interventions reveal that the impact of -AR signaling on macrophage deformability is dependent on actin-related proteins 2/3, indicating that stress hormone signaling through -AR shifts actin organization to favor branched structures rather than linear unbranched actin filaments. These findings show that through remodeling of the actin cytoskeleton, -AR-mediated stress hormone signaling modulates macrophage mechanotype to impact functions that play a critical role in immune response.Kim, T.-H., Ly, C., Christodoulides, A., Nowell, C. J., Gunning, P. W., Sloan, E. K., Rowat, A. C. Stress hormone signaling through -adrenergic receptors regulates macrophage mechanotype and function.	[Kim, Tae-Hyung; Ly, Chau; Christodoulides, Alexei; Rowat, Amy C.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Kim, Tae-Hyung; Sloan, Erica K.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA 90024 USA; [Ly, Chau; Rowat, Amy C.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Sloan, Erica K.; Rowat, Amy C.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Sloan, Erica K.] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA; [Nowell, Cameron J.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic, Australia; [Gunning, Peter W.] Univ New South Wales Sydney, Sch Med Sci, Kensington, NSW, Australia; [Sloan, Erica K.] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Monash University; University of New South Wales Sydney; Peter Maccallum Cancer Center	Sloan, EK (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.; Rowat, AC (corresponding author), Univ Calif Los Angeles, Terasaki Life Sci Bldg 1125, Los Angeles, CA 90095 USA.	erica.sloan@monash.edu; rowat@ucla.edu	Kim, Tae-Hyung/B-1523-2009; Gunning, Peter W/E-9058-2010	Gunning, Peter/0000-0003-0833-3128; Christodoulides, Alexei/0000-0003-0685-3154; Ly, Chau/0000-0003-4010-8836	U.S. National Institutes of Health (NIH) [CA-16042, AI-28697]; Jonsson Comprehensive Cancer Center; David Geffen School of Medicine at UCLA; NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute [UL1TR000124]; University of California Cancer Research Coordinating Committe [CRR-18-52690]; National Science Foundation [CAREER DBI-1254185]; Australian National Health and Medical Research Council (NHMRC) [APP1147498]; Center for AIDS Research	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Comprehensive Cancer Center; David Geffen School of Medicine at UCLA(University of California System); NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute; University of California Cancer Research Coordinating Committe; National Science Foundation(National Science Foundation (NSF)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Center for AIDS Research	The authors thank Dr. Sherie L. Morrison [University of California, Los Angeles (UCLA)] for providing U937 cell line, and the UCLA Statistical Consulting Group for advice on data analysis. Flow cytometry ImageStream, and IncuCyte analyses were performed in the UCLA Flow Cytometry Core Facility, which is supported by U.S. National Institutes of Health (NIH) Awards CA-16042 (National Cancer Institute) and AI-28697 (National Institute of Allergy and Infectious Diseases) and by the Jonsson Comprehensive Cancer Center, the Center for AIDS Research, and the David Geffen School of Medicine at UCLA. This work was supported by NIH/National Center for Advancing Translational Science (NCATS) UCLA Clinical and Translational Science Institute Grant UL1TR000124, the University of California Cancer Research Coordinating Committe (CRR-18-52690), the National Science Foundation (CAREER DBI-1254185 to A.C.R.), and the Australian National Health and Medical Research Council (NHMRC) APP1147498. The authors declare no conflicts of interest.	Bendell AC, 2017, INTEGR BIOL-UK, V9, P695, DOI 10.1039/c7ib00070g; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Bufi N, 2015, BIOPHYS J, V108, P2181, DOI 10.1016/j.bpj.2015.03.047; Cao XO, 2016, CURR BIOL, V26, P2398, DOI 10.1016/j.cub.2016.08.046; Chen Y, 2017, EXP HEMATOL ONCOL, V6, DOI 10.1186/s40164-017-0083-4; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chiarella SE, 2014, J CLIN INVEST, V124, P2935, DOI 10.1172/JCI75157; Chitu V, 2005, MOL BIOL CELL, V16, P2947, DOI 10.1091/mbc.e04-10-0914; Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072; Creed SJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0655-3; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; Di Cerbo A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19563-z; Dimchev G, 2017, MOL BIOL CELL, V28, P1311, DOI 10.1091/mbc.E16-05-0334; Efimova N, 2018, J CELL BIOL, V217, P1827, DOI 10.1083/jcb.201708103; Ekpenyong AE, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602536; Ekpenyong AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045237; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fritzsche M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501337; Gabriele S, 2009, BIOPHYS J, V96, P4308, DOI 10.1016/j.bpj.2009.02.037; Gill N. K., 2017, PROTOC EXCH, DOI [10.1038/protex.2017.101, DOI 10.1038/PR0TEX.2017.101]; Groot-Kormelink PJ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-57; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; Hida A, 2000, IMMUNOLOGY, V99, P553, DOI 10.1046/j.1365-2567.2000.00985.x; Hoelzle DJ, 2014, JOVE-J VIS EXP, DOI 10.3791/51474; Hoffmann AK, 2014, FASEB J, V28, P3075, DOI 10.1096/fj.13-247049; Honold L, 2018, CIRC RES, V122, P113, DOI 10.1161/CIRCRESAHA.117.311071; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; Izeboud CA, 1999, J RECEPT SIGNAL TR R, V19, P191, DOI 10.3109/10799899909036645; Jevnikar Z, 2012, EUR J IMMUNOL, V42, P3429, DOI 10.1002/eji.201242610; Kage F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14832; Kapellos TS, 2016, BIOCHEM PHARMACOL, V116, P107, DOI 10.1016/j.bcp.2016.07.011; Kim TH, 2016, J CELL SCI, V129, P4563, DOI 10.1242/jcs.194803; Labernadie A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6343; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; LIU MY, 1992, EXP HEMATOL, V20, P974; MacQueen LA, 2012, J BIOMECH, V45, P2797, DOI 10.1016/j.jbiomech.2012.08.040; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; May RC, 2001, J CELL SCI, V114, P1061; MAZUR MT, 1977, J CELL BIOL, V75, P185, DOI 10.1083/jcb.75.1.185; McWhorter FY, 2015, CELL MOL LIFE SCI, V72, P1303, DOI 10.1007/s00018-014-1796-8; Mennens SFB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17787-z; Miller MR, 2017, J CELL SCI, V130, P1730, DOI 10.1242/jcs.195099; Muthu K, 2010, J LEUKOCYTE BIOL, V88, P715, DOI 10.1189/jlb.0410186; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nicholls AJ, 2018, J LEUKOCYTE BIOL, V103, P295, DOI 10.1002/JLB.3MA0517-194RR; Nyberg KD, 2017, BIOPHYS J, V113, P1574, DOI 10.1016/j.bpj.2017.06.073; Nyberg KD, 2016, LAB CHIP, V16, P3330, DOI 10.1039/c6lc00169f; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024; Pizarro-Cerda J, 2017, TRENDS CELL BIOL, V27, P93, DOI 10.1016/j.tcb.2016.08.001; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pon CK, 2016, FASEB J, V30, P1144, DOI 10.1096/fj.15-277798; PRENTKI M, 1979, J CELL BIOL, V81, P592, DOI 10.1083/jcb.81.3.592; Previtera ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145813; Qi DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17595; Qin JF, 2015, BMB REP, V48, P295, DOI 10.5483/BMBRep.2015.48.5.008; Revach OY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09466; Rottner K, 2017, J CELL SCI, V130, P3427, DOI 10.1242/jcs.206433; Rougerie P, 2013, IMMUNOL REV, V256, P222, DOI 10.1111/imr.12118; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Serio M, 1996, IMMUNOPHARM IMMUNOT, V18, P247, DOI 10.3109/08923979609052735; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Thauland TJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah3737; Thiam HR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10997; TSAI MA, 1994, BIOPHYS J, V66, P2166, DOI 10.1016/S0006-3495(94)81012-4; van den Dries K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2402; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Verhoeckx KCM, 2004, PROTEOMICS, V4, P1014, DOI 10.1002/pmic.200300669; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wirth T, 2014, BRAIN BEHAV IMMUN, V38, P100, DOI 10.1016/j.bbi.2014.01.007; Yang LF, 2017, J TOXICOL SCI, V42, P763, DOI 10.2131/jts.42.763; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08357-4	81	18	20	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3997	4006		10.1096/fj.201801429RR	http://dx.doi.org/10.1096/fj.201801429RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509116	Green Published, Bronze			2022-12-26	WOS:000459794800071
J	Kaye, Y; Huang, WC; Clowez, S; Saroussi, S; Idoine, A; Sanz-Luque, E; Grossman, AR				Kaye, Yuval; Huang, Weichao; Clowez, Sophie; Saroussi, Shai; Idoine, Adam; Sanz-Luque, Emanuel; Grossman, Arthur R.			The mitochondrial alternative oxidase from Chlamydomonas reinhardtii enables survival in high light	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; photosynthesis; electron transport system (ETS); chloroplast; mitochondrial respiratory chain complex; molecular imaging; respiration; reactive oxygen species (ROS); AOX; chloroplast-mitochondria; electron transport; high light; redox; oxidative stress	GREEN-ALGA CHLAMYDOMONAS; CYCLIC ELECTRON FLOW; CHLOROPHYLL FLUORESCENCE; STATE TRANSITIONS; OXIDATIVE STRESS; PHOTOSYNTHETIC PERFORMANCE; PLANT-MITOCHONDRIA; NICOTIANA-TABACUM; RESPIRATORY-CHAIN; OXYGEN PRODUCTION	Photosynthetic organisms often experience extreme light conditions that can cause hyper-reduction of the chloroplast electron transport chain, resulting in oxidative damage. Accumulating evidence suggests that mitochondrial respiration and chloroplast photosynthesis are coupled when cells are absorbing high levels of excitation energy. This coupling helps protect the cells from hyper-reduction of photosynthetic electron carriers and diminishes the production of reactive oxygen species (ROS). To examine this cooperative protection, here we characterized Chlamydomonas reinhardtii mutants lacking the mitochondrial alternative terminal respiratory oxidases, CrAOX1 and CrAOX2. Using fluorescent fusion proteins, we experimentally demonstrated that both enzymes localize to mitochondria. We also observed that the mutant strains were more sensitive than WT cells to high light under mixotrophic and photoautotrophic conditions, with the aox1 strain being more sensitive than aox2. Additionally, the lack of CrAOX1 increased ROS accumulation, especially in very high light, and damaged the photosynthetic machinery, ultimately resulting in cell death. These findings indicate that the Chlamydomonas AOX proteins can participate in acclimation of C. reinhardtii cells to excess absorbed light energy. They suggest that when photosynthetic electron carriers are highly reduced, a chloroplast-mitochondria coupling allows safe dissipation of photosynthetically derived electrons via the reduction of O-2 through AOX (especially AOX1)-dependent mitochondrial respiration.	[Kaye, Yuval; Huang, Weichao; Clowez, Sophie; Saroussi, Shai; Idoine, Adam; Sanz-Luque, Emanuel; Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA	Carnegie Institution for Science	Kaye, Y (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	ykaye@carnegiescience.edu	Saroussi, Shai/Y-2163-2019; Sanz-Luque, Emanuel/Z-2166-2019	Saroussi, Shai/0000-0003-0422-6165; Sanz-Luque, Emanuel/0000-0002-7300-9730	Carnegie Institution for Science; United States Department of Energy [0000229381, 0000235290]	Carnegie Institution for Science; United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Carnegie Institution for Science and by United States Department of Energy Grants 0000229381 and 0000235290. The authors declare that they have no conflicts of interest with the contents of this article.	Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Aksoy M, 2014, PLANT CELL, V26, P4214, DOI 10.1105/tpc.114.129270; Albury MS, 2009, PHYSIOL PLANTARUM, V137, P316, DOI 10.1111/j.1399-3054.2009.01270.x; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baurain D, 2003, PLANT PHYSIOL, V131, P1418, DOI 10.1104/pp.013409; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; Blaby IK, 2014, TRENDS PLANT SCI, V19, P672, DOI 10.1016/j.tplants.2014.05.008; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Cardol P, 2003, PLANT PHYSIOL, V133, P2010, DOI 10.1104/pp.103.028076; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; Clowez S, 2015, J BIOL CHEM, V290, P8666, DOI 10.1074/jbc.M114.632588; Dahal K, 2015, NEW PHYTOL, V208, P382, DOI 10.1111/nph.13479; Dahal K, 2014, PLANT PHYSIOL, V166, P1560, DOI 10.1104/pp.114.247866; Dang KV, 2014, PLANT CELL, V26, P3036, DOI 10.1105/tpc.114.126375; Dietzel L, 2008, FEBS J, V275, P1080, DOI 10.1111/j.1742-4658.2008.06264.x; Dinant M, 2001, CURR GENET, V39, P101, DOI 10.1007/s002940000183; Djajanegara I, 1999, FEBS LETT, V454, P220, DOI 10.1016/S0014-5793(99)00808-X; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Erickson E, 2015, PLANT J, V82, P449, DOI 10.1111/tpj.12825; Finnegan PM, 2004, ADV PHOTO RESPIRAT, V17, P163; Florez-Sarasa I, 2016, PLANT PHYSIOL, V172, P2176, DOI 10.1104/pp.16.01025; Florez-Sarasa I, 2011, PLANT CELL ENVIRON, V34, P1373, DOI 10.1111/j.1365-3040.2011.02337.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giraud E, 2008, PLANT PHYSIOL, V147, P595, DOI 10.1104/pp.107.115121; Grant N, 2009, PLANT PHYSIOL, V150, P987, DOI 10.1104/pp.109.139394; Haferkamp I, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00002; Haferkamp I, 2011, TRENDS PLANT SCI, V16, P507, DOI 10.1016/j.tplants.2011.04.001; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; Heinnickel M, 2016, P NATL ACAD SCI USA, V113, P2774, DOI 10.1073/pnas.1524040113; Hilal M, 1998, PLANT PHYSIOL, V117, P695, DOI 10.1104/pp.117.2.695; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Holtzapffel RC, 2003, BBA-BIOENERGETICS, V1606, P153, DOI 10.1016/S0005-2728(03)00112-9; Johnson X, 2013, EUKARYOT CELL, V12, P776, DOI 10.1128/EC.00318-12; Kleine T, 2015, BBA-BIOENERGETICS, V1847, P786, DOI 10.1016/j.bbabio.2014.12.009; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; KROMER S, 1995, ANNU REV PLANT PHYS, V46, P45, DOI 10.1146/annurev.pp.46.060195.000401; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; LEMAIRE C, 1988, P NATL ACAD SCI USA, V85, P1344, DOI 10.1073/pnas.85.5.1344; Mackinder LCM, 2016, P NATL ACAD SCI USA, V113, P5958, DOI 10.1073/pnas.1522866113; Massoz S, 2015, J BIOTECHNOL, V215, P27, DOI 10.1016/j.jbiotec.2015.05.009; Mathy G, 2010, J PROTEOME RES, V9, P2825, DOI 10.1021/pr900866e; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mettler T, 2014, PLANT CELL, V26, P2310, DOI 10.1105/tpc.114.124537; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Molen TA, 2006, PHYSIOL PLANTARUM, V127, P74, DOI 10.1111/j.1399-3054.2006.00643.x; MOORE AL, 1995, J BIOENERG BIOMEMBR, V27, P367, DOI 10.1007/BF02109999; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Murakami Y, 2008, PLANT BIOTECHNOL-NAR, V25, P361, DOI 10.5511/plantbiotechnology.25.361; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Ostroukhova M, 2017, EUR J PROTISTOL, V58, P1, DOI 10.1016/j.ejop.2016.11.005; Padua M, 1999, PLANT PHYSIOL BIOCH, V37, P131, DOI 10.1016/S0981-9428(99)80074-6; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Peltier G, 2016, ANNU REV PLANT BIOL, V67, P55, DOI 10.1146/annurev-arplant-043014-114752; Peltier G, 2010, PHOTOSYNTH RES, V106, P19, DOI 10.1007/s11120-010-9575-3; Polukhina I, 2016, PLANT PHYSIOL, V172, P1494, DOI 10.1104/pp.16.01310; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rachmilevitch S, 2007, PHYSIOL PLANTARUM, V129, P163, DOI 10.1111/j.1399-3054.2006.00784.x; Rasala BA, 2013, PLANT J, V74, P545, DOI 10.1111/tpj.12165; Rasmusson AG, 2009, PHYSIOL PLANTARUM, V137, P371, DOI 10.1111/j.1399-3054.2009.01252.x; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Salinas T, 2014, BIOCHIMIE, V100, P207, DOI 10.1016/j.biochi.2013.10.006; Saroussi S, 2017, CURR OPIN PLANT BIOL, V39, P114, DOI 10.1016/j.pbi.2017.06.002; Saroussi SI, 2016, PLANT PHYSIOL, V170, P1975, DOI 10.1104/pp.15.02014; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Selinski J, 2019, PLANT BIOLOGY, V21, P21, DOI 10.1111/plb.12869; Selinski J, 2017, PLANT PHYSIOL, V174, P2113, DOI 10.1104/pp.17.00681; Selinski J, 2018, PLANT PHYSIOL, V176, P1423, DOI 10.1104/pp.17.01331; Selinski J, 2016, PHYSIOL PLANTARUM, V157, P264, DOI 10.1111/ppl.12418; SIEDOW JN, 1995, FEBS LETT, V362, P10, DOI 10.1016/0014-5793(95)00196-G; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Takahashi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2954; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Uhmeyer A, 2017, PLANT PHYSIOL, V174, P1399, DOI 10.1104/pp.16.00946; Vanlerberghe GC, 1997, PLANT PHYSIOL, V113, P657, DOI 10.1104/pp.113.2.657; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Vishwakarma A, 2015, ANN BOT-LONDON, V116, P555, DOI 10.1093/aob/mcv122; Vishwakarma A, 2014, PLANT PHYSIOL BIOCH, V81, P44, DOI 10.1016/j.plaphy.2014.01.019; Wang J, 2011, PHYSIOL PLANTARUM, V142, P339, DOI 10.1111/j.1399-3054.2011.01471.x; Wang QJ, 2016, PLANT BIOTECHNOL J, V14, P1986, DOI 10.1111/pbi.12556; Whelan J, 1997, PLANT MOL BIOL, V33, P771, DOI 10.1023/A:1005755505738; Wobbe L, 2013, NUCLEIC ACIDS RES, V41, P6553, DOI 10.1093/nar/gkt313; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang WQ, 2014, PLANT CELL, V26, P4499, DOI 10.1105/tpc.114.129965; Yoshida K, 2007, PLANT CELL PHYSIOL, V48, P606, DOI 10.1093/pcp/pcm033; Yoshida K, 2011, PLANT CELL ENVIRON, V34, P618, DOI 10.1111/j.1365-3040.2010.02267.x; Zalutskaya Z, 2017, J PLANT PHYSIOL, V219, P123, DOI 10.1016/j.jplph.2017.10.004; Zalutskaya Z, 2016, ENVIRON EXP BOT, V130, P133, DOI 10.1016/j.envexpbot.2016.05.015; Zalutskaya Z, 2015, PLANT PHYSIOL BIOCH, V97, P229, DOI 10.1016/j.plaphy.2015.10.014; Zhang LT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-40	109	15	15	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1380	1395		10.1074/jbc.RA118.004667	http://dx.doi.org/10.1074/jbc.RA118.004667			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30510139	Green Published, hybrid			2022-12-26	WOS:000457879500027
J	Karimov, K; Kachel, SM; Hacklander, K				Karimov, Khalil; Kachel, Shannon M.; Hacklaender, Klaus			Responses of snow leopards, wolves and wild ungulates to livestock grazing in the Zorkul Strictly Protected Area, Tajikistan	PLOS ONE			English	Article							TRADITIONAL PASTORALISM; PANTHERA-UNCIA; CONSERVATION; SHEEP; BIODIVERSITY; COEXISTENCE; COMPETITION; CARNIVORES; LANDSCAPE; RESERVE	Long recognized as a threat to wildlife, livestock grazing in protected areas has the potential to undermine conservation goals, via competition, habitat degradation, human-carnivore conflict and disruption of predator-prey relationships. In the Strictly Protected Area Zorkul in Tajikistan ( Zorkul Reserve), grazing is commonplace despite official prohibition, with potentially detrimental effects on local fauna, in particular, snow leopard Panthera uncia, wolf Canis lupus, brown bear Ursus arctos, argali sheep Ovis ammon, Asiatic ibex Capra sibirica, and long-tailed marmot Marmota caudata. To understand the impacts of grazing and associated human pastoralism on the large mammal community in Zorkul Reserve we used data from camera traps to build models of ungulate and carnivore site use intensity, and we investigated carnivore summer diets using microscopic scat analysis. While sample sizes limited our inference for several species, we found that site use of the most common ungulate, argali, decreased with proximity to herder's camps, indicating possible displacement into sub-optimal habitats. However, no such pattern was present in carnivore site use. For wolf and snow leopard, the most frequently encountered prey items were argali and marmot, while bear depended almost exclusively on marmot. While current pastoralist practices in the reserve may not be incompatible with wildlife presence, our findings suggest that pastoralism may negatively impact ungulates by displacing them from otherwise suitable habitats, with unknown fitness consequences for ungulates or the predators that depend upon them. Managing Zorkul Reserve and other actively grazed protected areas to meet potentially competing demands of local pastoralist communities and conservation will require careful consideration of such interactions to minimize the risk of cascading negative impacts on wildlife.	[Karimov, Khalil; Hacklaender, Klaus] Univ Nat Resources & Life Sci BOKU, Inst Wildlife Biol & Game Management, Vienna, Austria; [Karimov, Khalil] Acad Sci Tajikistan, Inst Zool & Parasitol, Dushanbe, Tajikistan; [Kachel, Shannon M.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Kachel, Shannon M.] Panthera, New York, NY USA	University of Natural Resources & Life Sciences, Vienna; Academy of Sciences of Republic of Tajikistan; E.N. Pavlovsky Institute of Zoology & Parasitology; University of Washington; University of Washington Seattle	Karimov, K (corresponding author), Univ Nat Resources & Life Sci BOKU, Inst Wildlife Biol & Game Management, Vienna, Austria.; Karimov, K (corresponding author), Acad Sci Tajikistan, Inst Zool & Parasitol, Dushanbe, Tajikistan.	khalil.karimov@gmail.com		Kachel, Shannon/0000-0003-3694-6634	Kaplan Graduate Awards Program; University of Washington College of the Environment Hall Conservation Genetics Grant; Natural History Museum Vienna; Academy of Sciences of Tajikistan, Institute of Wildlife Biology and Game Management BOKU; IUCN SSC Caprinae Specialist Group, Panthera; Wildlife Conservation Society of Afghanistan	Kaplan Graduate Awards Program; University of Washington College of the Environment Hall Conservation Genetics Grant; Natural History Museum Vienna; Academy of Sciences of Tajikistan, Institute of Wildlife Biology and Game Management BOKU; IUCN SSC Caprinae Specialist Group, Panthera; Wildlife Conservation Society of Afghanistan	This work was made possible by support from the Kaplan Graduate Awards Program, the University of Washington College of the Environment Hall Conservation Genetics Grant, the Natural History Museum Vienna, Zorkul Strictly Protected Area, Academy of Sciences of Tajikistan, Institute of Wildlife Biology and Game Management BOKU, IUCN SSC Caprinae Specialist Group, Panthera and Wildlife Conservation Society of Afghanistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was made possible by support from the Kaplan Graduate Awards Program, the University of Washington College of the Environment Hall Conservation Genetics Grant, the Natural History Museum Vienna, Zorkul Strictly Protected Area, Academy of Sciences of Tajikistan, Institute of Wildlife Biology and Game Management BOKU, IUCN SSC Caprinae Specialist Group, Panthera and Wildlife Conservation Society of Afghanistan. We thank Stefan Michel, Dr. Marco Festa-Bianchet, and two anonymous reviewers for their helpful comments and feedback on earlier versions of this manuscript.	[Anonymous], ORYX; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Berger J, 2013, CONSERV BIOL, V27, P679, DOI 10.1111/cobi.12100; Berkes F., 2006, BIENN M INT ASS STUD; Bocci A, 2017, EUROPEAN J WILDLIFE, V63, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chaves PB, 2012, MOL ECOL RESOUR, V12, P18, DOI 10.1111/j.1755-0998.2011.03056.x; Chetri M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170549; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Diment A, 2012, ORYX, V46, P13; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ekernas LS, 2017, CONSERV BIOL, V31, P269, DOI 10.1111/cobi.12881; Fedosenko Alexander K., 2005, Mammalian Species, P1; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Harris Richard B., 2010, Galemys, V22, P55; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Jumabay-Uulu K, 2014, ORYX, V48, P529, DOI 10.1017/S0030605313000306; Kachel SM, 2017, ORYX, V51, P597, DOI 10.1017/S0030605316000193; Kumar A, 2016, CURR SCI INDIA, V111, P985; Liu S, 2017, SCI REPORTS, V7; Lyngdoh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088349; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mallon D, 2013, ZORKUL NATURE RESERV; Manly BFJ, 1992, DESIGN ANAL RES STUD; Marucco F, 2008, J MAMMAL, V89, P665, DOI 10.1644/07-MAMM-A-005R3.1; Mishra C, 2004, J APPL ECOL, V41, P344, DOI 10.1111/j.0021-8901.2004.00885.x; Namgail T, 2007, ECOL RES, V22, P25, DOI 10.1007/s11284-006-0015-y; NASA LP DAAC, 2016, MODIS TERR VEG IND 1; NASA/METI/AIST/Japan Spacesystems and U.S./Japan ASTER Science Team, 2009, ASTER GLOB DIG EL MO; PRINS HHT, 1992, ENVIRON CONSERV, V19, P117, DOI 10.1017/S0376892900030587; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schaller GB, 2008, ORYX, V42, P100, DOI 10.1017/S0030605308000811; Schuette P, 2013, BIOL CONSERV, V157, P148, DOI 10.1016/j.biocon.2012.09.011; Sharma RK, 2015, BIOL CONSERV, V190, P8, DOI 10.1016/j.biocon.2015.04.026; Shrestha R, 2008, ENVIRON CONSERV, V35, P125, DOI 10.1017/S0376892908004724; Singh NJ, 2008, THESIS; Wang J, 2014, CHINESE SCI BULL, V59, P3162, DOI 10.1007/s11434-014-0370-y; Weiskopf SR, 2016, WILDLIFE SOC B, V40, P233, DOI 10.1002/wsb.640; Witt KE, 2015, J HUM EVOL, V79, P105, DOI 10.1016/j.jhevol.2014.10.012; Yashchenko RV, 2006, ZAPOVEDNIKI SREDNEL; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7	42	13	14	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208329	10.1371/journal.pone.0208329	http://dx.doi.org/10.1371/journal.pone.0208329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500847	gold, Green Published, Green Submitted			2022-12-26	WOS:000451883700034
J	Strahan, RT; Laughlin, DC; Moore, MM				Strahan, Robert T.; Laughlin, Daniel C.; Moore, Margaret M.			An experimental test of the Community Assembly by Trait Selection (CATS) model	PLOS ONE			English	Article							PONDEROSA FOREST STRUCTURE; PLANT TRAITS; RELATIVE ABUNDANCE; SHADE TOLERANCE; LEAF; GERMINATION; PREDICTION; RESPONSES; PATTERNS; ECOLOGY	The Community Assembly by Trait Selection (CATS) model of community assembly predicts species abundances along environmental gradients in relatively undisturbed vegetation. Here we ask whether this model, when calibrated with data from natural plant communities, can predict the abundances of five dominant grass species (Bouteloua gracilis, Elymus elymoides, Festuca arizonica, Muhlenbergia montana, and Poa fendleriana) in a greenhouse experiment that manipulated light and soil properties. To address this question, we used generalized additive models (GAMs) to model community-weighted mean (CWM) seed mass, mean Julian flowering date, and specific root length (SRL) as non-linear functions of two environmental variables (soil pH and pine basal area) in natural vegetation. The model-fitted CWM traits were then used as constraints in the CATS model to predict the relative abundance of the five grass species that were seeded in a mixture at equal densities into a 2x2 factorial experiment with soil parent material and light level as crossed factors. Light was the most important factor influencing seedling community composition, especially the abundances of Bouteloua gracilis and Poa fendleriana. The model-predicted relative abundances were significantly correlated with the observed relative abundances, and the model accurately predicted the dominant species in every treatment. P. fendleriana was correctly predicted to be the most abundant species in both shade treatments and the sun-basalt treatment, and B. gracilis was correctly predicted to be the most abundant species in the sun-limestone treatment. Our results provide experimental evidence that environmental filtering of the species pool occurs in the early stages of community assembly (including germination, emergence, and early growth), and that trait-based models calibrated with data from natural plant communities can be used to predict the outcome of the early stages of community assembly under experimental conditions.	[Strahan, Robert T.] Southern Oregon Univ, Dept Biol, Ashland, OR 97520 USA; [Strahan, Robert T.] Southern Oregon Univ, Environm Sci & Policy Dept, Ashland, OR 97520 USA; [Laughlin, Daniel C.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Moore, Margaret M.] No Arizona Univ, Sch Forestry, Flagstaff, AZ USA	University of Wyoming; Northern Arizona University	Strahan, RT (corresponding author), Southern Oregon Univ, Dept Biol, Ashland, OR 97520 USA.; Strahan, RT (corresponding author), Southern Oregon Univ, Environm Sci & Policy Dept, Ashland, OR 97520 USA.	strahanr@sou.edu			USDA McIntire-Stennis appropriations to NAU School of Forestry; NAU Ecological Restoration Institute; Arizona Phoenix Chapter of the Achievement Rewards for College Scientists Foundation (ARCS) Foundation; USDA McIntire-Stennis	USDA McIntire-Stennis appropriations to NAU School of Forestry; NAU Ecological Restoration Institute; Arizona Phoenix Chapter of the Achievement Rewards for College Scientists Foundation (ARCS) Foundation; USDA McIntire-Stennis	This research was supported by USDA McIntire-Stennis appropriations to NAU School of Forestry, and by NAU Ecological Restoration Institute, and by the Arizona Phoenix Chapter of the Achievement Rewards for College Scientists Foundation (ARCS) Foundation.; We would like to thank Philip Patterson, Manager, at the Northern Arizona University (NAU) Greenhouse Research Complex for providing space and support to conduct this research. We thank Eddy Novice for his help identifying and tracking individual grass seedlings. This research was supported by USDA McIntire-Stennis appropriations to NAU School of Forestry, and by NAU Ecological Restoration Institute, and by the Arizona Phoenix Chapter of the Achievement Rewards for College Scientists Foundation (ARCS) Foundation.	Abella SR, 2008, RMRSRN35 USDA FOR SE; Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Burgess KS, 2007, HEREDITY, V99, P641, DOI 10.1038/sj.hdy.6801043; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; COVINGTON WW, 1994, J FOREST, V92, P39; Daws MI, 2002, FUNCT ECOL, V16, P258, DOI 10.1046/j.1365-2435.2002.00615.x; Dobarro I, 2010, ACTA OECOL, V36, P74, DOI 10.1016/j.actao.2009.10.005; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fenner M., 2005, ECOLOGY SEEDS; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fule PZ, 1997, ECOL APPL, V7, P895, DOI 10.1890/1051-0761(1997)007[0895:DRCFEM]2.0.CO;2; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Jankowska-Blaszczuk M, 2007, FUNCT ECOL, V21, P1055, DOI 10.1111/j.1365-2435.2007.01328.x; KEDDY PA, 1992, FUNCT ECOL, V6, P621, DOI 10.2307/2389954; Laliberte E, 2012, J ECOL, V100, P662, DOI 10.1111/j.1365-2745.2011.01947.x; Laughlin DC, 2007, ECOL MODEL, V205, P231, DOI 10.1016/j.ecolmodel.2007.02.018; Laughlin DC, 2014, J ECOL, V102, P186, DOI 10.1111/1365-2745.12187; Laughlin DC, 2013, TRENDS PLANT SCI, V18, P584, DOI 10.1016/j.tplants.2013.04.012; Laughlin DC, 2011, J ECOL, V99, P1489, DOI 10.1111/j.1365-2745.2011.01885.x; Laughlin DC, 2011, J ECOL, V99, P1091, DOI 10.1111/j.1365-2745.2011.01856.x; Laughlin DC, 2011, ECOLOGY, V92, P556, DOI 10.1890/09-2103.1; Laughlin DC, 2010, FUNCT ECOL, V24, P493, DOI 10.1111/j.1365-2435.2009.01672.x; Leishman MR, 2016, ECOL REGEN PLANT COM, V2000, P31; MacAdam JW, 2009, STRUCTURE FUNCTION P; Mayer AM., 1989, GERMINATION SEEDS; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Merow C, 2011, ECOLOGY, V92, P1523, DOI 10.1890/10-1174.1; Milberg P, 2000, SEED SCI RES, V10, P99, DOI 10.1017/S0960258500000118; Moore MM, 2006, RANGELAND ECOL MANAG, V59, P135, DOI 10.2111/05-051R2.1; Naumburg E, 1999, FOREST ECOL MANAG, V124, P205, DOI 10.1016/S0378-1127(99)00067-5; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; PETERS RH, 1991, CRITIQUE ECOLOGY; POORTER H, 1999, HDB FUNCTIONAL PLANT, P81; R Development Core Team, 2012, R LANG ENV STAT COMP; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Rendig VV, 1989, PRINCIPLES SOIL PLAN; RIEGEL GM, 1995, FOREST SCI, V41, P864; Roxburgh SH, 2010, OIKOS, V119, P583, DOI 10.1111/j.1600-0706.2009.17772.x; Saverimuttu T, 1996, J ECOL, V84, P681, DOI 10.2307/2261331; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Shipley B, 2011, ECOLOGY, V92, P507, DOI 10.1890/10-0394.1; Shipley B, 2010, OIKOS, V119, P604, DOI 10.1111/j.1600-0706.2009.17770.x; Sonnier G, 2012, OIKOS, V121, P1103, DOI 10.1111/j.1600-0706.2011.19871.x; Sonnier G, 2010, J VEG SCI, V21, P318, DOI 10.1111/j.1654-1103.2009.01145.x; Stohlgren TJ, 1998, J RANGE MANAGE, V51, P164, DOI 10.2307/4003202; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wood S., 2014, PACKAGE MGCV; Wright SJ, 1995, J ECOL, V83, P937, DOI 10.2307/2261176	55	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0206787	10.1371/journal.pone.0206787	http://dx.doi.org/10.1371/journal.pone.0206787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500826	gold, Green Published, Green Submitted			2022-12-26	WOS:000451883700005
J	Giordano, A; Liethmann, K; Kopke, S; Poettgen, J; Rahn, AC; Drulovic, J; Beckmann, Y; Sastre-Garriga, J; Galea, I; Heerings, M; Jongen, PJ; Vettorazzi, E; Solari, A; Heesen, C				Giordano, Andrea; Liethmann, Katrin; Koepke, Sascha; Poettgen, Jana; Rahn, Anne Christin; Drulovic, Jelena; Beckmann, Yesim; Sastre-Garriga, Jaume; Galea, Ian; Heerings, Marco; Jongen, Peter Joseph; Vettorazzi, Eik; Solari, Alessandra; Heesen, Christoph		AutoMS Grp	Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey	PLOS ONE			English	Article							DECISION-MAKING; QUESTIONNAIRE; PREFERENCES; PROGRAM	Background Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (pwMS) is a prerequisite for informed choices in medical encounters. Previous work showed that MS risk knowledge is low among pwMS and role preferences are different in Italy and Germany. Objective We investigated the level of risk knowledge and role preferences in 8 countries and assessed putative variables associated with risk knowledge. Methods An online-survey was performed based on the Risk knowledge questionnaire for people with relapsing-remitting MS (RIKNO 2.0), the electronic Control Preference Scale (eCPS), and other patient questionnaires. Inclusion criteria of participants were: (1) age >= 18 years, (2) a diagnosis of relapsing-remitting MS (RRMS), (3) being in a decision making process for a disease modifying drug. Results Of 1939 participants from Germany, Italy, the Netherlands, Serbia, Spain and Turkey, 986 (51%) (mean age 38.6 years [range 18-67], 77% women, 7.8 years of disease duration) completed the RIKNO 2.0, with a mean of 41% correct answers. There were less than 50 participants in the UK and Estonia and data were not analysed. Risk knowledge differed across countries (p < 0.001). Variables significantly associated with higher risk knowledge were higher education (p < 0.001), previous experience with disease modifying drugs (p = 0.001), correct answer to a medical data interpretation question (p < 0.001), while higher fear for wheelchair dependency was negatively associated to risk knowledge (p = 0.001). Conclusion MS risk knowledge was overall low and differed across participating countries. These data indicate that information is an unmet need of most pwMS.	[Giordano, Andrea; Solari, Alessandra] Fdn IRCCS Ist Neurol Carlo Besta, Serv Neuroepidemiol, Milan, Italy; [Giordano, Andrea] Univ Turin, Dept Psychol, Turin, Italy; [Liethmann, Katrin; Poettgen, Jana; Rahn, Anne Christin; Heesen, Christoph] Univ Klinikum Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sklerose, Hamburg, Germany; [Liethmann, Katrin; Rahn, Anne Christin] Univ Hamburg, Fac Math Informat & Nat Sci, Unit Hlth Sci & Educ, Hamburg, Germany; [Liethmann, Katrin] Univ Med Ctr Schleswig Holstein, Pediat & Med Psychol, Campus Kiel, Kiel, Germany; [Koepke, Sascha] Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany; [Poettgen, Jana] Univ Med Ctr Eppendorf, Dept Neurol, Hamburg, Germany; [Drulovic, Jelena] Univ Belgrade, Clin Ctr Serbia, Inst Neurol, Belgrade, Serbia; [Beckmann, Yesim] Ataturk Training & Res Hosp, Fac Med, Dept Neurol, Izmir, Turkey; [Sastre-Garriga, Jaume] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Multiple Sclerosis Ctr Catalonia Cemcat, Neurol Neuroimmunol Dept, Barcelona, Spain; [Galea, Ian] Univ Southampton, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton, Hants, England; [Heerings, Marco] Natl MS Fdn Netherlands, Rotterdam, Netherlands; [Jongen, Peter Joseph] Univ Med Ctr Groningen, Dept Community & Occupat Med, Groningen, Netherlands; [Jongen, Peter Joseph] MS4 Res Inst, Nijmegen, Netherlands; [Vettorazzi, Eik] Univ Klinikum Hamburg Eppendorf, Inst Med Biometrie & Epidemiol, Hamburg, Germany	IRCCS Istituto Neurologico Besta; University of Turin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; Clinical Centre of Serbia; University of Belgrade; Izmir Ataturk Training & Research Hospital; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Southampton; University of Groningen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heesen, C (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sklerose, Hamburg, Germany.	heesen@uke.de	Vettorazzi, Eik/B-8130-2019; Galea, Ian/B-7997-2011; Giordano, Andrea/AAN-3738-2021; Solari, Alessandra/AAO-1741-2021; Sastre Garriga, Jaume/E-8605-2018	Vettorazzi, Eik/0000-0002-3737-6402; Galea, Ian/0000-0002-1268-5102; Giordano, Andrea/0000-0003-4466-9788; Solari, Alessandra/0000-0001-9930-7579; Sastre Garriga, Jaume/0000-0002-1589-2254	Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/37]; German Hertie Foundation as part of the AutoMS project [12-03-2010]	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); German Hertie Foundation as part of the AutoMS project	This study was supported by grants from the Fondazione Italiana Sclerosi Multipla (FISM, www.aism.it) (grant No. 2010/R/37 to AS) and by the German Hertie Foundation (www.ghst.de/en) (grant number 12-03-2010 to CH) as part of the AutoMS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Boeije HR, 2004, SOC SCI MED, V59, P861, DOI 10.1016/j.socscimed.2003.11.040; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Charles C, 2014, J COMP EFFECT RES, V3, P197, DOI [10.2217/CER.13.91, 10.2217/cer.13.91]; Cokely ET, 2012, JUDGM DECIS MAK, V7, P25; Costello Kathleen, 2008, Medscape J Med, V10, P225; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Giordano A, 2010, MULT SCLER J, V16, P100, DOI 10.1177/1352458509352865; Haynes RB, 2002, BMJ-BRIT MED J, V324, P1350, DOI 10.1136/bmj.324.7350.1350; Heesen C, 2017, MULT SCLER RELAT DIS, V18, P186, DOI 10.1016/j.msard.2017.09.020; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Heesen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138364; Heesen C, 2013, J NEUROL SCI, V331, P2, DOI 10.1016/j.jns.2013.02.018; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Kasper J, 2012, HEALTH EXPECT, V15, P3, DOI 10.1111/j.1369-7625.2011.00657.x; Kopke S, 2017, CLIN REHABIL, V31, P250, DOI 10.1177/0269215516639734; Kopke S, 2014, J NEUROL NEUROSUR PS, V85, P411, DOI 10.1136/jnnp-2013-306441; Learmonth YC, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-37; Marrie RA, 2007, MULT SCLER J, V13, P1176, DOI 10.1177/1352458507078388; Marteau T M, 2001, Health Expect, V4, P99, DOI 10.1046/j.1369-6513.2001.00140.x; Rummer A, 2016, DTSCH ARZTEBLATT, V113, P322; Solari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066127	22	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208004	10.1371/journal.pone.0208004	http://dx.doi.org/10.1371/journal.pone.0208004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496233	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000451763800075
J	Frantz, MW; Wood, PB; Merovich, GT				Frantz, Mack W.; Wood, Petra B.; Merovich, George T., Jr.			Demographic characteristics of an avian predator, Louisiana Waterthrush (Parkesia motacilla), in response to its aquatic prey in a Central Appalachian USA watershed impacted by shale gas development	PLOS ONE			English	Article							HEADWATER STREAMS; MODEL SELECTION; SONGBIRD; HABITAT; PENNSYLVANIA; LANDSCAPE; INTEGRITY; MARCELLUS; ECOLOGY; INDEX	We related Louisiana Waterthrush (Parkesia motacilla) demographic response and nest survival to benthic macroinvertebrate aquatic prey and to shale gas development parameters using models that accounted for both spatial and non-spatial sources of variability in a Central Appalachian USA watershed. In 2013, aquatic prey density and pollution intolerant genera (i.e., pollution tolerance value < 4) decreased statistically with increased waterthrush territory length but not in 2014 when territory densities were lower. In general, most demographic responses to aquatic prey were variable and negatively related to aquatic prey in 2013 but positively related in 2014. Competing aquatic prey covariate models to explain nest survival were not statistically significant but differed annually and in general reversed from negative to positive influence on daily survival rate. Potential hydraulic fracturing runoff decreased nest survival both years and was statistically significant in 2014. The EPA Rapid Bioassessment protocol (EPA) and Habitat Suitability Index (HSI) designed for assessing suitability requirements for waterthrush were positively linked to aquatic prey where higher scores increased aquatic prey metrics, but EPA was more strongly linked than HSI and varied annually. While potential hydraulic fracturing runoff in 2013 may have increased Ephemeroptera, Plecoptera, and Trichoptera (EPT) richness, in 2014 shale gas territory disturbance decreased EPT richness. In 2014, intolerant genera decreased at the territory and nest level with increased shale gas disturbance suggesting the potential for localized negative effects on waterthrush. Loss of food resources does not seem directly or solely responsible for demographic declines where waterthrush likely were able to meet their foraging needs. However collective evidence suggests there may be a shale gas disturbance threshold at which waterthrush respond negatively to aquatic prey community changes. Density-dependent regulation of their ability to adapt to environmental change through acquisition of additional resources may also alter demographic response.	[Frantz, Mack W.] West Virginia Univ, West Virginia Cooperat Fish & Wildlife Res Unit, Davis Coll, Sch Nat Resources, Morgantown, WV 26506 USA; [Wood, Petra B.] West Virginia Univ, US Geol Survey, West Virginia Cooperat Fish & Wildlife Res Unit, Morgantown, WV USA; [Merovich, George T., Jr.] Juniata Coll, Fisheries & Aquat Sci Program, Dept Environm Sci, Huntingdon, PA 16652 USA	West Virginia University; United States Department of the Interior; United States Geological Survey; West Virginia University	Frantz, MW (corresponding author), West Virginia Univ, West Virginia Cooperat Fish & Wildlife Res Unit, Davis Coll, Sch Nat Resources, Morgantown, WV 26506 USA.	mwfrantz@mix.wvu.edu	Merovich, George/ABG-5668-2020	Merovich, George/0000-0003-1212-4636	West Virginia Division of Natural Resources (WVDNR); West Virginia University (WVU); National Aviary; Appalachian Stewardship Foundation (ASF); West Virginia University IACUC [04-0302, 07-0303]	West Virginia Division of Natural Resources (WVDNR); West Virginia University (WVU); National Aviary; Appalachian Stewardship Foundation (ASF); West Virginia University IACUC	Our research was funded by the West Virginia Division of Natural Resources (WVDNR) to PBW, West Virginia University (WVU) to MWF, National Aviary to PBW, and Appalachian Stewardship Foundation (ASF) to MWF. None of our funders had any influence on the content of the submitted or published manuscript and only the U.S. Geological Survey (USGS) required approval of the final manuscript prior to publication as required by their Fundamental Sciences Practices protocols (https://pubs.usgs.gov/circ/1367/).; West Virginia Division of Natural Resources (WVDNR) provided access to the study area and Wheeling Jesuit University provided access to field housing. We thank Jack Toriello, Robert (Blake) Hepner, Darin Blood, Jerry Kreiser, Steve Daniels, Jess Cosentino, and Ashley Akers who collected data in 2013-2014 for the project. We additionally thank Jim Sheehan for project assistance, and Stuart Welsh for manuscript review. This study was completed under the auspices of West Virginia University IACUC protocol #04-0302, 07-0303. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Arthur DJ, 2008, OVERVIEW MODERN SHAL; Askins R.A., 1990, Current Ornithology, V7, P1; Austin BJ, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5904-8; Barbour M.T., 1999, EPA 841 B 99 002; Becker DA, 2015, LANDSCAPE ECOL, V30, P339, DOI 10.1007/s10980-014-0134-8; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Brittingham MC, 2014, ENVIRON SCI TECHNOL, V48, P11034, DOI 10.1021/es5020482; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Conway R. W., 1962, J IND ENG, V12, P132, DOI DOI 10.1198/JCGS.2010.08080; Cook NA, 2015, ECOL ENG, V84, P180, DOI 10.1016/j.ecoleng.2015.09.006; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Drohan PJ, 2012, ENVIRON MANAGE, V49, P1061, DOI 10.1007/s00267-012-9841-6; Dunscomb JK, 2014, 201202 NAT CONS APP; Energy Information Administration (EIA), 2017, MARC SHAL PLAY GEOL; Energy Information Administration (EIA), 2017, UT SHAL PLAY GEOL RE; Entrekin S, 2011, FRONT ECOL ENVIRON, V9, P503, DOI 10.1890/110053; Evans JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089210; Farwell LS, 2016, BIOL CONSERV, V201, P78, DOI 10.1016/j.biocon.2016.06.019; Frantz MW, 2018, CONDOR, V120, P265, DOI 10.1650/CONDOR-17-130.1; Freeman MC, 2007, J AM WATER RESOUR AS, V43, P5, DOI 10.1111/j.1752-1688.2007.00002.x; Gerritsen J., 2000, STREAM CONDITION IND; Gomi T, 2002, BIOSCIENCE, V52, P905, DOI 10.1641/0006-3568(2002)052[0905:UPADLO]2.0.CO;2; Grant CJ, 2015, J ENVIRON SCI HEAL A, V50, P482, DOI 10.1080/10934529.2015.992670; Grant CJ, 2016, ECOTOXICOLOGY, V25, P1739, DOI 10.1007/s10646-016-1717-8; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Johnson E, 2015, SCI TOTAL ENVIRON, V530, P323, DOI 10.1016/j.scitotenv.2015.05.027; Keller DH, 2017, HYDROBIOLOGIA, V795, P49, DOI 10.1007/s10750-017-3112-8; Lack D., 1954, P343; Latta SC, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00406.1; Leonard PB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15304-w; Lowe WH, 2005, BIOSCIENCE, V55, P196, DOI 10.1641/0006-3568(2005)055[0196:MHSTTH]2.0.CO;2; Lutz AK, 2016, J FRESHWATER ECOL, V31, P211, DOI 10.1080/02705060.2015.1082157; MacDonald LH, 2007, FOREST SCI, V53, P148; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; Mattsson BJ, 2006, FRESHWATER BIOL, V51, P1941, DOI 10.1111/j.1365-2427.2006.01617.x; Mattsson BJ, 2009, BIRDS N AM; Mattsson BJ, 2009, AUK, V126, P64, DOI 10.1525/auk.2009.08001; Mauter MS, 2014, ENVIRON SCI TECHNOL, V48, P8298, DOI 10.1021/es405432k; Merriam ER, 2016, SCI TOTAL ENVIRON, V560, P170, DOI 10.1016/j.scitotenv.2016.04.053; Merriam ER, 2011, J N AM BENTHOL SOC, V30, P399, DOI 10.1899/10-079.1; Meyer JL, 2007, J AM WATER RESOUR AS, V43, P86, DOI 10.1111/j.1752-1688.2007.00008.x; Moran MD, 2017, FRONT ECOL ENVIRON, V15, P237, DOI 10.1002/fee.1492; Mulvihill RS, 2008, FRESHWATER BIOL, V53, P2158, DOI 10.1111/j.1365-2427.2008.02032.x; Nakano S, 1999, ECOLOGY, V80, P2435; O'Connell TR, 2003, 200301 US EPA STAR P; Pond GJ, 2013, ENVIRON MONIT ASSESS, V185, P1515, DOI 10.1007/s10661-012-2648-3; Prosser DJ, 1998, J FIELD ORNITHOL, V69, P288; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson JS, 2007, FOREST SCI, V53, P131; Ridout MS, 2004, STAT MODEL, V4, P77, DOI 10.1191/1471082X04st064oa; Robbins C. S., 1970, Audubon Fld Notes, V24, P723; Rousset F, 2014, ECOGRAPHY, V37, P781, DOI 10.1111/ecog.00566; Sauer J., 2015, N AM BREEDING BIRD S; Shmueli G, 2005, J ROY STAT SOC C-APP, V54, P127, DOI 10.1111/j.1467-9876.2005.00474.x; Sperry JH, 2008, J AVIAN BIOL, V39, P379, DOI 10.1111/j.0908-8857.2008.04451.x; Strager MP, 2009, J ENVIRON MANAGE, V90, P1854, DOI 10.1016/j.jenvman.2008.12.006; Swanson FJ, 1998, BIOSCIENCE, V48, P681, DOI 10.2307/1313331; USFWS (U.S. Fish and Wildlife Service), 2008, BIRDS CONS 2008; West Virginia Geological and Economic Survey (WVGES), 2015, WV MARC SHAL WELL CO; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wood PB, 2016, J FISH WILDL MANAG, V7, P423, DOI 10.3996/092015-JFWM-084; WVDEP (West Virginia Department of Environmental Protection), 2015, OIL GAS PROD DAT; Zuur Alain F., 2009, P1	66	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206077	10.1371/journal.pone.0206077	http://dx.doi.org/10.1371/journal.pone.0206077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485266	gold, Green Published, Green Submitted			2022-12-26	WOS:000451755800012
J	de Sanjose, S; Rodriguez-Sales, V; Bosch, XF; Ibanez, R; Bruni, L				de Sanjose, Silvia; Rodriguez-Sales, Vanesa; Bosch, Xavier F.; Ibanez, Raquel; Bruni, Laia			Population-based e-records to evaluate HPV triage of screen-detected atypical squamous cervical lesions in Catalonia, Spain, 2010-15	PLOS ONE			English	Article							CANCER; WOMEN; CYTOLOGY; RISK; PREVENTION; GUIDELINES	Equivocal lesions (ASC-US) are common abnormalities in cervical cancer screening exams. HPV testing helps to stratify the risk of progression to high-grade squamous intraepithelial lesions or more (HSIL+). Population-based medical electronic data can be used to evaluate screening recommendations. The study uses routine electronic data from primary health centers to estimate the impact of HPV testing in a 3-and a 5-year risk of HSIL+ after an ASC-US. The study includes data derived from medical electronic information from 85,775 women who first attended a cervical cancer screening visit at the National Health System facilities of Catalonia, Spain, during 2010-11 and followed up to 2015. Included women were aged between 25-65 years old, having at least one follow-up visit, and a cervical cytology of ASC-US (N = 1,647). Women with a first result of low-grade squamous intraepithelial lesions (LSIL) (N = 945) or those with negative cytology (N = 83,183) were included for comparison. Those with a baseline HSIL+ were excluded. Incident HSIL+ was evaluated by means of Kaplan-Meier curves and multivariate regression models. HPV test results were available for 63.4% of women with a baseline ASC-US. Among all ASC-US, 70 incident HSIL+ were identified at 5 years. ASC-US HPV positive women had a high risk of HSIL+ compared to women with negative cytology (adjusted HR = 32.7; 95% CI: 23.6-45.2) and a similar risk to women with baseline LSIL (HR = 29.3; 95% CI: 22.4-38.2), whereas ASC-US HPV negative women had no differential risk to that observed in baseline negative cytology. Women with ASC-US and no HPV test had an average HSIL+ risk (HR = 14.8; 95% CI: 9.7-22.5). Population-based e-medical records derived from primary health care centers allowed monitoring of screening recommendations, providing robust estimates for the study outcomes. This analysis confirms that HPV testing improved risk stratification of ASC-US lesions. The information can be used to improve diagnosis and management of screen detected lesions.	[de Sanjose, Silvia; Rodriguez-Sales, Vanesa; Bosch, Xavier F.; Ibanez, Raquel; Bruni, Laia] Catalan Inst Oncol, Canc Epidemiol Res Programme, IDIBELL, Barcelona, Spain; [de Sanjose, Silvia; Rodriguez-Sales, Vanesa] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [de Sanjose, Silvia] PATH, Reprod Hlth Global Program, Seattle, WA 98121 USA; [Bosch, Xavier F.; Ibanez, Raquel; Bruni, Laia] CIBERONC, Madrid, Spain	Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	de Sanjose, S (corresponding author), Catalan Inst Oncol, Canc Epidemiol Res Programme, IDIBELL, Barcelona, Spain.; de Sanjose, S (corresponding author), Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain.; de Sanjose, S (corresponding author), PATH, Reprod Hlth Global Program, Seattle, WA 98121 USA.	sdesanjose@path.org	Bruni, Laia/N-5816-2014; Vanesa, Rodriguez-Sales/G-5080-2015	Vanesa, Rodriguez-Sales/0000-0001-7336-8058; Ibanez, Raquel/0000-0003-3324-8312	Instituto de Salud Carlos III-ISCII (Spanish Government) - FEDER funds/European Regional Development Fund (ERDF)-A WAY TO BUILD Europe [PI16/01254]; Redes tematicas de investigacion cooperativa en salud (RETICS) [RD12/0036/0056]; Centro de Investigacion medica en Red: CIBERESP [CB06/02/0073]; Centro de Investigacion medica en Red: CIBERONC [CB16/12/00401]; Agencia de Gestion de Ayudas Universitarias y de Investigacion (AGAUR) de la Generalitat de Catalunya [20014SGR756]; Recercaixa [MD088652]; Bellvitge Biomedical Research Institute (IDIBELL) [2013-2116]	Instituto de Salud Carlos III-ISCII (Spanish Government) - FEDER funds/European Regional Development Fund (ERDF)-A WAY TO BUILD Europe; Redes tematicas de investigacion cooperativa en salud (RETICS); Centro de Investigacion medica en Red: CIBERESP; Centro de Investigacion medica en Red: CIBERONC; Agencia de Gestion de Ayudas Universitarias y de Investigacion (AGAUR) de la Generalitat de Catalunya; Recercaixa(La Caixa Foundation); Bellvitge Biomedical Research Institute (IDIBELL)	This work was partially supported by grants from the Instituto de Salud Carlos III-ISCII (Spanish Government) co-funded by FEDER funds/European Regional Development Fund (ERDF)-A WAY TO BUILD Europe [PI16/01254]; Redes tematicas de investigacion cooperativa en salud (RETICS) [RD12/0036/0056], Centro de Investigacion medica en Red: CIBERESP [CB06/02/0073] and CIBERONC [CB16/12/00401], Agencia de Gestion de Ayudas Universitarias y de Investigacion (AGAUR) de la Generalitat de Catalunya [20014SGR756] and Recercaixa 2015 [MD088652]. VR was under a doctoral fellowship (2013-2116) from the Bellvitge Biomedical Research Institute (IDIBELL). None of the funders were involved in the data analysis or in the preparation of this manuscript.	[Anonymous], 2014, RED CRIBADO CERVIX R; [Anonymous], 2016, ICD 10 VERSION; Arbyn M, 2015, EUROPEAN GUIDELINES, DOI [10.2875/93363, DOI 10.2875/93363]; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Blade A.T., 2014, REV ESP PATOL, V57, P1, DOI [10.1016/S0304-5013(14)73068-7, DOI 10.1016/S0304-5013(14)73068-7]; Bolibar B, 2012, MED CLIN-BARCELONA, V138, P617, DOI 10.1016/j.medcli.2012.01.020; Bulten J, 2011, ACTA ONCOL, V50, P611, DOI 10.3109/0284186X.2011.555779; Chris A, 2016, PACKAGE SURVMISC TIT; Cuzick J, 2017, JAMA ONCOL, V3, P1327, DOI 10.1001/jamaoncol.2017.1040; Demarco M, 2017, J LOW GENIT TRACT DI, V21, P261, DOI 10.1097/LGT.0000000000000343; Departament de Salut de la Generalitat de Catalunya, 2006, PROT ACT CRIBR CANC; Gage JC, 2016, CANCER EPIDEM BIOMAR, V25, P36, DOI 10.1158/1055-9965.EPI-15-0669; Gage JC, 2013, CANCER EPIDEM BIOMAR, V22, P1095, DOI 10.1158/1055-9965.EPI-12-1455; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS36, DOI 10.1097/LGT.0b013e3182854253; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Landy R, 2017, PREV MED BALTIM, V111, P429, DOI [10.1016/j.ypmed.2017.12, DOI 10.1016/J.YPMED.2017.12]; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Rodriguez-Sales V, 2014, GAC SANIT, V28, P7, DOI 10.1016/j.gaceta.2013.05.009; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Rutter CM, 2018, CANCER EPIDEM BIOMAR, V27, P158, DOI 10.1158/1055-9965.EPI-17-0378; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2016, INT J CANCER, V139, P2606, DOI 10.1002/ijc.30375; Solomon D, 2002, OBSTET GYNECOL SURV, V57, P505; Yu K, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djy044	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207812	10.1371/journal.pone.0207812	http://dx.doi.org/10.1371/journal.pone.0207812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475876	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700074
J	Ulsund, AH; Dahl, M; Frimurer, TM; Manfra, O; Schwartz, TW; Levy, FO; Andressen, KW				Ulsund, Andrea Hembre; Dahl, Marie; Frimurer, Thomas M.; Manfra, Ornella; Schwartz, Thue W.; Levy, Finn Olav; Andressen, Kjetil Wessel			Preassociation between the 5-HT7 serotonin receptor and G protein G(s): molecular determinants and association with low potency activation of adenylyl cyclase	FASEB JOURNAL			English	Article						FRAP; preassembly; precoupling; collision coupling; FRET	CRYO-EM STRUCTURE; ATYPICAL ANTIPSYCHOTICS CLOZAPINE; CRYSTAL-STRUCTURE; SPLICE VARIANTS; DOWN-REGULATION; GLP-1 RECEPTOR; AGONIST; PHARMACOLOGY; STIMULATION; COMPLEX	According to early models of GPCR signaling, G proteins only interact with activated receptors. However, some GPCRs were shown to assemble with G proteins before receptor activation, in accordance with more recent models. Previously, we found that the 5-HT7 receptor, as opposed to the 5-HT4 receptor, was preassociated with G(s), but the molecular determinants for this interaction are still elusive. In a series of chimeric 5-HT7 receptors with intracellular segments from 5-HT4, we determined the receptor-G protein interaction by performing antibody-immobilized fluorescence recovery after photobleaching and fluorescence resonance energy transfer. We identified the intracellular loop 3 and C-tail of the 5-HT7 receptor to be responsible for the preassociation with G(s), and we further delineated the TM5 extension in the intracellular loop 3 and helix 8 in the C-tail as the molecular determinants. These chimeric exchanges converted the 5-HT7 receptor into a collision-coupled receptor that recruited G proteins only upon agonist activation, whereas reciprocal exchanges converted 5-HT4 to a preassociated receptor. The 5-HT7 receptor displayed 2-component agonist-induced G(s) signaling with high and low potency. In addition, the same segments were involved in low-potency signaling and preassociation. The correspondence between G(s) preassociation and low-potency G(s) signaling is a novel aspect of GPCR pharmacology.Ulsund, A. H., Dahl, M., Frimurer, T. M., Manfra, O., Schwartz, T. W., Levy, F. O., Andressen, K. W. Preassociation between the 5-HT7 serotonin receptor and G protein G(s): molecular determinants and association with low potency activation of adenylyl cyclase.	[Ulsund, Andrea Hembre; Dahl, Marie; Manfra, Ornella; Levy, Finn Olav; Andressen, Kjetil Wessel] Univ Oslo, Fac Med, Inst Clin Med, Dept Pharmacol, Oslo, Norway; [Ulsund, Andrea Hembre; Dahl, Marie; Manfra, Ornella; Levy, Finn Olav; Andressen, Kjetil Wessel] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway; Oslo Univ Hosp, Oslo, Norway; [Frimurer, Thomas M.; Schwartz, Thue W.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Schwartz, Thue W.] Univ Copenhagen, Fac Hlth Sci, Mol Pharmacol Lab, Dept Biomed Res, Copenhagen, Denmark	University of Oslo; University of Oslo; University of Oslo; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Levy, FO (corresponding author), Univ Oslo, Fac Med, Dept Pharmacol, Sognsvannsveien 20,POB 1057 Blindern, N-0316 Oslo, Norway.	f.o.levy@medisin.uio.no		Andressen, Kjetil Wessel/0000-0003-1094-1501; Frimruer, Thomas/0000-0002-9682-8245	Norwegian Council on Cardiovascular Diseases; Research Council of Norway; Stiftelsen Kristian Gerhard Jebsen; Novo Nordisk Foundation; Anders Jahre Foundation for the Promotion of Science; Family Blix Foundation; Helgesen Foundation; University of Oslo	Norwegian Council on Cardiovascular Diseases; Research Council of Norway(Research Council of Norway); Stiftelsen Kristian Gerhard Jebsen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Anders Jahre Foundation for the Promotion of Science; Family Blix Foundation; Helgesen Foundation; University of Oslo	The authors thank Kristin Nordskogen Smeby (University of Oslo) for technical assistance, N. A. Lambert (Augusta University, Augusta, GA, USA) for the G beta gamma Venus plasmid, and G. Schulte (Karolinska Institutet, Stockholm, Sweden) for the G gamma Venus plasmid. This research was supported by the Norwegian Council on Cardiovascular Diseases, the Research Council of Norway, Stiftelsen Kristian Gerhard Jebsen, the Novo Nordisk Foundation, the Anders Jahre Foundation for the Promotion of Science, the Family Blix Foundation, the Helgesen Foundation, and grants from the University of Oslo. The authors declare no conflicts of interest.	Andressen KW, 2015, BRIT J PHARMACOL, V172, P3846, DOI 10.1111/bph.13169; Andressen KW, 2018, FASEB J, V32, P1059, DOI 10.1096/fj.201700486R; Andressen KW, 2006, MOL PHARMACOL, V69, P207, DOI 10.1124/mol.105.015396; Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Ayoub Mohammed Akli, 2013, Front Endocrinol (Lausanne), V4, P196, DOI 10.3389/fendo.2013.00196; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Bach T, 2001, N-S ARCH PHARMACOL, V363, P146, DOI 10.1007/s002100000299; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bruheim S, 2003, RECEPTOR CHANNEL, V9, P107, DOI 10.1080/10606820308245; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; HOYER D, 1994, PHARMACOL REV, V46, P157; Kaiser A, 2018, MOL PHARMACOL, V93, P387, DOI 10.1124/mol.117.110544; Keuerleber S, 2012, J BIOL CHEM, V287, P42104, DOI 10.1074/jbc.M112.393579; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Krobert KA, 2006, EUR J PHARMACOL, V532, P1, DOI 10.1016/j.ejphar.2005.11.039; Krobert KA, 2001, N-S ARCH PHARMACOL, V363, P620, DOI 10.1007/s002100000369; Krobert KA, 2002, BRIT J PHARMACOL, V135, P1563, DOI 10.1038/sj.bjp.0704588; Kvachnina E, 2009, BBA-MOL CELL RES, V1793, P1646, DOI 10.1016/j.bbamcr.2009.08.008; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Manfra O, 2015, ACS CHEM NEUROSCI, V6, P1206, DOI 10.1021/cn500339p; Matthys A, 2011, MOL NEUROBIOL, V43, P228, DOI 10.1007/s12035-011-8175-3; Newman-Tancredi A, 2002, MOL PHARMACOL, V62, P590, DOI 10.1124/mol.62.3.590; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2011, NATURE, V477, P540, DOI 10.1038/477540a; Thomas DR, 1999, BRIT J PHARMACOL, V128, P158, DOI 10.1038/sj.bjp.0702759; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	41	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3870	3886		10.1096/fj.201800805RR	http://dx.doi.org/10.1096/fj.201800805RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30508496	Bronze, Green Submitted			2022-12-26	WOS:000459794800062
J	Kosciuczuk, EM; Mehrotra, S; Saleiro, D; Kroczynska, B; Majchrzak-Kita, B; Lisowski, P; Driehaus, C; Rogalska, A; Turner, A; Lienhoop, T; Gius, D; Fish, EN; Vassilopoulos, A; Platanias, LC				Kosciuczuk, Ewa M.; Mehrotra, Swarna; Saleiro, Diana; Kroczynska, Barbara; Majchrzak-Kita, Beata; Lisowski, Pawel; Driehaus, Caroline; Rogalska, Anna; Turner, Acara; Lienhoop, Thomas; Gius, David; Fish, Eleanor N.; Vassilopoulos, Athanassios; Platanias, Leonidas C.			Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; post-translational modification (PTM); sirtuin; interferon; signal transducers and activators of transcription 1 (STAT1); innate immunity; histone deacetylase (HDAC); cytokine; deacetylation; immune regulation; SIRT2; STAT1; type I IFN	GENE-EXPRESSION; TRANSCRIPTION; ACETYLATION; PHOSPHORYLATION; TUMORIGENESIS; GLYCOLYSIS; INHIBITOR; PATHWAY; DIRECTS; ROLES	Type I interferons (IFNs) induce expression of multiple genes that control innate immune responses to invoke both antiviral and antineoplastic activities. Transcription of these interferon-stimulated genes (ISGs) occurs upon activation of the canonical Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathways. Phosphorylation and acetylation are both events crucial to tightly regulate expression of ISGs. Here, using mouse embryonic fibroblasts and an array of biochemical methods including immunoblotting and kinase assays, we show that sirtuin 2 (SIRT2), a member of the NAD-dependent protein deacetylase family, is involved in type I IFN signaling. We found that SIRT2 deacetylates cyclin-dependent kinase 9 (CDK9) in a type I IFN-dependent manner and that the CDK9 deacetylation is essential for STAT1 phosphorylation at Ser-727. We also found that SIRT2 is subsequently required for the transcription of ISGs and for IFN-driven antiproliferative responses in both normal and malignant cells. These findings establish the existence of a previously unreported signaling pathway whose function is essential for the control of JAK-STAT signaling and the regulation of IFN responses. Our findings suggest that targeting sirtuin activities may offer an avenue in the development of therapies for managing immune-related diseases and cancer.	[Kosciuczuk, Ewa M.; Mehrotra, Swarna; Saleiro, Diana; Kroczynska, Barbara; Driehaus, Caroline; Rogalska, Anna; Turner, Acara; Lienhoop, Thomas; Gius, David; Vassilopoulos, Athanassios; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kosciuczuk, Ewa M.; Mehrotra, Swarna; Saleiro, Diana; Platanias, Leonidas C.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Kosciuczuk, Ewa M.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2MI, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2MI, Canada; [Lisowski, Pawel] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, PL-05552 Jastrzebiec, Magdalenka, Poland; [Lisowski, Pawel] Warsaw Med Univ, Ctr Preclin Res & Technol CePT, Dept Med Genet, PL-02097 Warsaw, Poland; [Lisowski, Pawel] Max Delbruck Ctr Mol Med MDC, Helmholtz Assoc, iPS Cell Based Dis Modeling Grp, D-13092 Berlin, Germany; [Kroczynska, Barbara; Gius, David; Vassilopoulos, Athanassios] Northwestern Univ, Feinberg Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Medical University of Warsaw; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Northwestern University; Feinberg School of Medicine	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 East Super St,Lurie 3-125, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Kosciuczuk, Ewa Maria/AAD-2815-2022	Turner, Acara/0000-0001-7464-6494	National Institutes of Health [CA77816, CA155566]; Department of Veterans Affairs [I01CX000916]; NATIONAL CANCER INSTITUTE [R01CA214025, R01CA182506, T32CA080621, R01CA077816] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants CA77816 and CA155566 and Grant I01CX000916 from the Department of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Fish EN, 2014, MOL CANCER RES, V12, P1691, DOI 10.1158/1541-7786.MCR-14-0450; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Ginter T, 2012, CELL SIGNAL, V24, P1453, DOI 10.1016/j.cellsig.2012.02.018; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hoffmann G, 2014, J BIOL CHEM, V289, P5208, DOI 10.1074/jbc.M113.487736; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jing H, 2016, CANCER CELL, V29, P297, DOI 10.1016/j.ccell.2016.02.007; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kiladjian JJ, 2011, BLOOD, V117, P4706, DOI 10.1182/blood-2010-08-258772; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kosciuczuk EM, 2016, BLOOD, V128, P410, DOI 10.1182/blood-2016-02-698704; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; O'Callaghan C, 2017, AGING CELL, V16, P1208, DOI 10.1111/acel.12685; Park SH, 2016, CANCER RES, V76, P3802, DOI 10.1158/0008-5472.CAN-15-2498; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Saleiro D, 2015, CELL REP, V11, P605, DOI 10.1016/j.celrep.2015.03.056; Serrano L, 2013, GENE DEV, V27, P639, DOI 10.1101/gad.211342.112; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Song HY, 2016, ONCOTARGET, V7, P80336, DOI 10.18632/oncotarget.12015; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yanagisawa K, 1998, BLOOD, V91, P641, DOI 10.1182/blood.V91.2.641.641_641_648; Zhang H, 2013, P NATL ACAD SCI USA, V110, P13546, DOI 10.1073/pnas.1301463110	48	21	21	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					827	837		10.1074/jbc.RA118.005956	http://dx.doi.org/10.1074/jbc.RA118.005956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30487288	Green Published, hybrid			2022-12-26	WOS:000458670200009
J	Abraham, A; Brasov, I; Thekkiniath, J; Kilian, N; Lawres, L; Gao, RY; DeBus, K; He, L; Yu, X; Zhu, G; Graham, MM; Liu, XR; Molestina, R; Ben Mamoun, C				Abraham, Amanah; Brasov, Ioana; Thekkiniath, Jose; Kilian, Nicole; Lawres, Lauren; Gao, Ruiyi; DeBus, Kai; He, Lan; Yu, Xue; Zhu, Guan; Graham, Morven M.; Liu, Xinran; Molestina, Robert; Ben Mamoun, Choukri			Establishment of a continuous in vitro culture of Babesia duncani in human erythrocytes reveals unusually high tolerance to recommended therapies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parasitology; cell culture; infectious disease; inhibitor; erythrocyte; apicomplexa; Babesia duncani; human babesiosis; in vitro culture; red blood cells; tick-borne disease	WASHINGTON-STATE; INFECTION; MICROTI; WA1; APICOMPLEXA; PATHOLOGY	Human babesiosis is an emerging tick-borne disease caused by apicomplexan parasites of the genus Babesia. Clinical cases caused by Babesia duncani have been associated with high parasite burden, severe pathology, and death. In both mice and hamsters, the parasite causes uncontrolled fulminant infections, which ultimately lead to death. Resolving these infections requires knowledge of B. duncani biology, virulence, and susceptibility to anti-infectives, but little is known and further research is hindered by a lack of relevant model systems. Here, we report the first continuous in vitro culture of B. duncani in human red blood cells. We show that during its asexual cycle within human erythrocytes, B. duncani develops and divides to form four daughter parasites with parasitemia doubling every approximate to 22 h. Using this in vitro culture assay, we found that B. duncani has low susceptibility to the four drugs recommended for treatment of human babesiosis, atovaquone, azithromycin, clindamycin, and quinine, with IC50 values ranging between 500 nm and 20 m. These data suggest that current practices are of limited effect in treating the disease. We anticipate this new disease model will set the stage for a better understanding of the biology of this parasite and will help guide better therapeutic strategies to treat B. duncani-associated babesiosis.	[Abraham, Amanah; Thekkiniath, Jose; Kilian, Nicole; Lawres, Lauren; Gao, Ruiyi; DeBus, Kai; Ben Mamoun, Choukri] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT 06520 USA; [Graham, Morven M.; Liu, Xinran] Yale Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Graham, Morven M.; Liu, Xinran] Yale Sch Med, CCMI Electron Microscopy Core Facil, New Haven, CT 06520 USA; [Brasov, Ioana; Molestina, Robert] Amer Type Culture Collect, BEI Resources, Manassas, VA 20110 USA; [He, Lan] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430079, Hubei, Peoples R China; [Yu, Xue; Zhu, Guan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77845 USA	Yale University; Yale University; Yale University; Huazhong Agricultural University; Texas A&M University System; Texas A&M University College Station	Ben Mamoun, C (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, TAC S210,300 Cedar St, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu	Zhu, Guan/AFJ-2945-2022; ZHU, GUAN/GQB-0299-2022; He, Lan/AFU-5817-2022	Zhu, Guan/0000-0003-3888-0659; ZHU, GUAN/0000-0003-3888-0659; Kilian, Nicole/0000-0001-7489-9782	BEI Resources Program of NIAID, National Institutes of Health [HHSN 272201600013C]; National Institutes of Health [AI097218, GM110506, AI123321, R43AI136118]; Bill and Melinda Gates Foundation [OPP1021571]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI136118] Funding Source: NIH RePORTER	BEI Resources Program of NIAID, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the BEI Resources Program of NIAID, National Institutes of Health, Contract HHSN 272201600013C.; Supported by National Institutes of Health Grants AI097218, GM110506, AI123321, and R43AI136118 and Bill and Melinda Gates Foundation Grant OPP1021571.	Bloch EM, 2012, TRANSFUSION, V52, P1517, DOI 10.1111/j.1537-2995.2011.03467.x; Braga W, 2006, J PARASITOL, V92, P1104, DOI 10.1645/GE-712R.1; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; CULLEN JM, 1987, LAB ANIM SCI, V37, P640; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dao AH, 1996, LAB INVEST, V74, P853; Fang DC, 2016, TRANSFUS MED REV, V30, P132, DOI 10.1016/j.tmrv.2016.04.002; Gelfand Jeffrey A., 2003, Curr Infect Dis Rep, V5, P53, DOI 10.1007/s11908-003-0065-z; Glanternik JR, 2018, PEDIATR INFECT DIS J, V37, P269, DOI [10.1097/INF.0000000000001803, 10.1097/inf.0000000000001803]; Herwaldt BL, 1997, J INFECT DIS, V175, P1259, DOI 10.1086/593812; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1323, DOI 10.1016/S0020-7519(00)00137-5; Kjemtrup AM, 2002, TRANSFUSION, V42, P1482, DOI 10.1046/j.1537-2995.2002.00245.x; Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lawres LA, 2016, J EXP MED, V213, P1307, DOI 10.1084/jem.20151519; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; Moro MH, 1998, INFECT IMMUN, V66, P492, DOI 10.1128/IAI.66.2.492-498.1998; Paul AS, 2016, ANTIMICROB AGENTS CH, V60, P5059, DOI 10.1128/AAC.00928-16; PERSING DH, 1995, NEW ENGL J MED, V332, P298, DOI 10.1056/NEJM199502023320504; QUICK RE, 1993, ANN INTERN MED, V119, P284, DOI 10.7326/0003-4819-119-4-199308150-00006; Rossouw I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003711; SCHOLTENS RG, 1968, AM J TROP MED HYG, V17, P810, DOI 10.4269/ajtmh.1968.17.810; Scott JD, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020049; Swei A, 2019, INT J PARASITOL, V49, P95, DOI 10.1016/j.ijpara.2018.07.002; THOMFORD JW, 1994, J INFECT DIS, V169, P1050, DOI 10.1093/infdis/169.5.1050; Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008; Wilson DW, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0162-0; Wozniak EJ, 1996, LAB ANIM SCI, V46, P507; Zamoto-Niikura A, 2014, EMERG INFECT DIS, V20, P1398, DOI 10.3201/eid2008.130061	29	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19974	19981		10.1074/jbc.AC118.005771	http://dx.doi.org/10.1074/jbc.AC118.005771			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30463941	hybrid, Green Published			2022-12-26	WOS:000454685900003
J	Juric, V; O'Sullivan, C; Stefanutti, E; Kovalenko, M; Greenstein, A; Barry-Hamilton, V; Mikaelian, I; Degenhardt, J; Yue, P; Smith, V; Mikels-Vigdal, A				Juric, Vladi; O'Sullivan, Chris; Stefanutti, Erin; Kovalenko, Maria; Greenstein, Andrew; Barry-Hamilton, Vivian; Mikaelian, Igor; Degenhardt, Jeremiah; Yue, Peng; Smith, Victoria; Mikels-Vigdal, Amanda			MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GELATINASE-B; TGF-BETA; MATRIX-METALLOPROTEINASE-9; EXPRESSION; CANCER; GROWTH; CXCR3; ANTIBODY; RECRUITMENT	Matrix metalloproteinase-9 (MMP-9), whose expression is frequently dysregulated in cancer, promotes tumor growth, invasion, and metastasis by multiple mechanisms, including extracellular matrix remodeling and growth-factor and cytokine activation. We developed a monoclonal antibody against murine MMP-9, which we found decreased growth of established primary tumors in an orthotopic model of HER2-driven breast cancer (HC11-NeuT) in immunocompetent mice. RNA sequencing (RNAseq) profiling of NeuT tumors and additional mouse model tumors revealed that anti-MMP-9 treatment resulted in upregulation of immune signature pathways associated with cytotoxic T-cell response. As there is a need to boost the low response rates observed with anti-PDL1 antibody treatment in the clinical setting, we assessed the potential of anti-MMP-9 to improve T-cell response to immune checkpoint inhibitor anti-PDL1 in NeuT tumors. Anti-MMP-9 and anti-PDL1 cotreatment reduced T-cell receptor (TCR) clonality and increased TCR diversity, as detected by TCR sequencing of NeuT tumors. Flow cytometry analyses of tumors showed that the combination treatment increased the frequency of CD3+ T cells, including memory/effector CD4 and CD8 T cells, but not regulatory T cells, among tumor-infiltrating leukocytes. Moreover, in vitro enzymatic assays corroborated that MMP-9 cleaves key T-cell chemoattractant CXC receptor 3 ligands (CXC ligand [CXCL] 9, CXCL10, and CXCL11) and renders them inactive in T-cell migration assays. Consistent with our in vitro experiments, analysis of NeuT tumor protein lysates showed that anti-MMP-9 treatment increases expression of CXCL10 and other T cell-stimulating factors, such as interleukin (IL)-12p70 and IL-18. We show that inhibition of MMP-9, a key component of the tumor-promoting and immune-suppressive myeloid inflammatory milieu, increases T-helper cell 1 type cytokines, trafficking of effector/memory T cells into tumors, and intratumoral T-cell diversity.	[Juric, Vladi; O'Sullivan, Chris; Stefanutti, Erin; Kovalenko, Maria; Greenstein, Andrew; Barry-Hamilton, Vivian; Mikaelian, Igor; Degenhardt, Jeremiah; Yue, Peng; Smith, Victoria; Mikels-Vigdal, Amanda] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences	Mikels-Vigdal, A (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	Amanda.Mikels-Vigdal@gilead.com		Greenstein, Andrew/0000-0002-1470-1970	Gilead Sciences, Inc. - Gilead Sciences, Inc.	Gilead Sciences, Inc. - Gilead Sciences, Inc.	Gilead Sciences, Inc. funded this study and provided support in the form of salaries to all of the current authors. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Editorial assistance for this manuscript was provided by Impact Communication Partners, Inc., and funded by Gilead Sciences, Inc.	Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Al-Batran SE, 2012, ANN ONCOL, V23, P1699, DOI 10.1093/annonc/mdr552; Aoudjit F, 1999, INT J CANCER, V82, P743, DOI 10.1002/(SICI)1097-0215(19990827)82:5<743::AID-IJC19>3.0.CO;2-6; Appleby TC, 2017, J BIOL CHEM, V292, P6810, DOI 10.1074/jbc.M116.760579; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Bouchard F, 2010, BLOOD, V116, P759, DOI 10.1182/blood-2009-12-257030; Brahmer JR, 2015, FUTURE ONCOL, V11, P1307, DOI 10.2217/fon.15.52; Brandt R, 2001, ONCOGENE, V20, P5459, DOI 10.1038/sj.onc.1204709; Buhmeida Abdelbaset, 2009, J Gastrointest Cancer, V40, P91, DOI 10.1007/s12029-009-9091-x; Campregher PV, 2010, EXP HEMATOL, V38, P202, DOI 10.1016/j.exphem.2009.12.004; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chheda ZS, 2016, J IMMUNOL, V197, P2016, DOI 10.4049/jimmunol.1502376; Chu DK, 2011, INT J CANCER, V129, P887, DOI 10.1002/ijc.25734; Chu JW, 2011, INT J CARDIOL, V147, P336, DOI 10.1016/j.ijcard.2010.12.093; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Deng Chao, 2015, Quant Biol, V3, P135; Denney H, 2009, BIOCHEM BIOPH RES CO, V382, P341, DOI 10.1016/j.bbrc.2009.02.164; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Fuchs CS, 2017, EFFICACY SAFETY PEMB; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gingis-Velitski S, 2011, CANCER RES, V71, P6986, DOI 10.1158/0008-5472.CAN-11-0629; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Iniesta P, 2007, ONCOL REP, V17, P217; Janjigian YY, 2017, NIVOLUMAB IPILIMUMAB; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Lukaszewicz-Zajac M, 2011, CLIN CHIM ACTA, V412, P1725, DOI 10.1016/j.cca.2011.06.003; Marshall DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127063; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; Mikucki ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8458; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Ogata Y, 2006, CANCER CHEMOTH PHARM, V57, P577, DOI 10.1007/s00280-005-0081-9; Perng DW, 2011, LIFE SCI, V89, P204, DOI 10.1016/j.lfs.2011.06.008; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Shah MA, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.4_suppl.108; Shao LJ, 2017, BIOCHEM BIOPH RES CO, V493, P1478, DOI 10.1016/j.bbrc.2017.10.009; Shao WL, 2011, J SURG ONCOL, V104, P841, DOI 10.1002/jso.22001; Sun WX, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041159; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Yousef EM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-609; Yu Q, 2000, GENE DEV, V14, P163; Zhao S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0335-4	60	43	44	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207255	10.1371/journal.pone.0207255	http://dx.doi.org/10.1371/journal.pone.0207255			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500835	Green Submitted, Green Published, gold			2022-12-26	WOS:000451883700007
J	Abdelfattah, A; Ruano-Rosa, D; Cacciola, SO; Nicosia, MGL; Schena, L				Abdelfattah, Ahmed; Ruano-Rosa, David; Cacciola, Santa Olga; Nicosia, Maria G. Li Destri; Schena, Leonardo			Impact of Bactrocera oleae on the fungal microbiota of ripe olive drupes	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; POSTHARVEST ROTS; SWEET CHERRIES; APPLE FRUIT; FLY; COMMUNITIES	The olive fruit fly (OFF), Bactrocera oleae is the most devastating pest affecting olive fruit worldwide. Previous investigations have addressed the fungal microbiome associated with olive drupes or B. oleae, but the impact of the insect on fungal communities of olive fruit remains undescribed. In the present work, the fungal microbiome of olive drupes, infested and non-infested by the OFF, was investigated in four different localities and cultivars. Olive fruit fly infestations caused a general reduction of the fungal diversity, a higher quantity of the total DNA and an increase in taxa that remained unidentified or had unknown roles. The infestations led to imbalanced fungal communities with the growth of taxa that are usually outcompeted. While it was difficult to establish a cause-effect link between fly infestation and specific fungi, it is clear that the fly alters the natural microbial balance, especially the low abundant taxa. On the other hand, the most abundant ones, were not significantly influenced by the insect. In fact, despite the slight variation between the sampling locations, Aureobasidium, Cladosporium, and Alternaria, were the dominant genera, suggesting the existence of a typical olive fungal microbiome.	[Abdelfattah, Ahmed; Nicosia, Maria G. Li Destri; Schena, Leonardo] Univ Mediterranea Reggio Calabria, Dipartimento Agr, Reggio Di Calabria, Italy; [Abdelfattah, Ahmed] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Ruano-Rosa, David] Junta Castilla & Leon, Inst Tecnol Agr, Consejeria Agr & Ganaderia, Valladolid, Spain; [Cacciola, Santa Olga] Univ Catania, Dipartimento Agr Alimentaz & Ambiente, Catania, Italy	Universita Mediterranea di Reggio Calabria; Stockholm University; University of Catania	Schena, L (corresponding author), Univ Mediterranea Reggio Calabria, Dipartimento Agr, Reggio Di Calabria, Italy.	lschena@unirc.it	Ruano-Rosa, David/V-5080-2017; Schena, Leonardo/A-7492-2018; Li Destri Nicosia, Maria Giulia/AGG-0569-2022; Abdelfattah, Ahmed/P-1943-2015; RUANO-ROSA, DAVID/AFT-9954-2022	Ruano-Rosa, David/0000-0002-3539-0163; Schena, Leonardo/0000-0002-9737-2593; Abdelfattah, Ahmed/0000-0001-6090-7200; RUANO-ROSA, DAVID/0000-0002-3539-0163; Li Destri Nicosia, Maria Giulia/0000-0001-5201-0057	Italian Ministry of Education, University and Research [PON03PE_00090_02]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This research was funded by The Italian Ministry of Education, University and Research with grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle olive e dell'olio extravergine di oliva prodotto in Calabria" -PON Ricerca e competitivita 2007-2013 (PON03PE_00090_02).	Abdelfattah A, 2018, BIOL CONTROL, V120, P1, DOI 10.1016/j.biocontrol.2017.07.009; Abdelfattah A, 2017, MICROB ECOL, V73, P739, DOI 10.1007/s00248-016-0874-x; Abdelfattah A, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.47; Abdelfattah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131069; Alagna F, 2016, J INTEGR PLANT BIOL, V58, P413, DOI 10.1111/jipb.12343; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cacciola S. O., 2011, OLIVE DIS DISORDERS, P223; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P793, DOI 10.1007/s00253-009-1882-2; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Finkel OM, 2011, APPL ENVIRON MICROB, V77, P7647, DOI 10.1128/AEM.05565-11; Gutierrez AP, 2009, CLIMATIC CHANGE, V95, P195, DOI 10.1007/s10584-008-9528-4; Ippolito A, 2000, POSTHARVEST BIOL TEC, V19, P265, DOI 10.1016/S0925-5214(00)00104-6; Ippolito A, 2005, POSTHARVEST BIOL TEC, V36, P245, DOI 10.1016/j.postharvbio.2005.02.007; Lopez-Escudero FJ, 2011, PLANT SOIL, V344, P1, DOI 10.1007/s11104-010-0629-2; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Loumou A, 2003, AGRIC HUMAN VALUES, V20, P87, DOI 10.1023/A:1022444005336; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Malacrino A, 2017, MICROB ECOL, V73, P677, DOI 10.1007/s00248-016-0864-z; Malheiro R, 2015, TRENDS FOOD SCI TECH, V44, P226, DOI 10.1016/j.tifs.2015.04.009; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mosca S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114031; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pavlidi N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42633; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Pesce VM, 2018, BIOL CONTROL, V120, P43, DOI 10.1016/j.biocontrol.2017.03.005; Ras E, 2017, ENTOMOL EXP APPL, V164, P237, DOI 10.1111/eea.12609; Rognes T, 2016, PEERJ PREPRINTS, V4; Sacchetti P, 2008, J APPL ENTOMOL, V132, P682, DOI 10.1111/j.1439-0418.2008.01334.x; Sanzani SM, 2012, J PLANT PATHOL, V94, P469; Schena L, 2003, POSTHARVEST BIOL TEC, V30, P209, DOI 10.1016/S0925-5214(03)00111-X; Schena L, 2006, J MICROBIOL METH, V67, P70, DOI 10.1016/j.mimet.2006.03.003; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Torbati Mohsen, 2014, Archives of Phytopathology and Plant Protection, V47, P292, DOI 10.1080/03235408.2013.809183; Wang FW, 2007, WORLD J MICROB BIOT, V23, P79, DOI 10.1007/s11274-006-9195-4; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0199403	10.1371/journal.pone.0199403	http://dx.doi.org/10.1371/journal.pone.0199403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496186	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800003
J	Calderoli, PA; Espinola, FJ; Dionisi, HM; Gil, MN; Jansson, JK; Lozada, M				Calderoli, Priscila A.; Espinola, Fernando J.; Dionisi, Hebe M.; Gil, Monica N.; Jansson, Janet K.; Lozada, Mariana			Predominance and high diversity of genes associated to denitrification in metagenomes of subantarctic coastal sediments exposed to urban pollution	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; NITROUS-OXIDE REDUCTASE; MICROBIAL COMMUNITY; NITRITE REDUCTASE; PARACOCCUS-DENITRIFICANS; NITRATE REDUCTION; WEB SERVER; BACTERIA; ABUNDANCE; REVEALS	The aim of this work was to characterize the microbial nitrogen cycling potential in sediments from Ushuaia Bay, a subantarctic environment that has suffered a recent explosive demographic growth. Subtidal sediment samples were retrieved in triplicate from two urban points in the Bay, and analyzed through metagenomic shotgun sequencing. Sequences assigned to genes related to nitrification, nitrate reduction and denitrification were predominant in this environment with respect to metagenomes from other environments, including other marine sediments. The nosZ gene, responsible for nitrous oxide transformation into di-nitrogen, presented a high diversity. The majority of NosZ sequences were classified as Clade II (atypical) variants affiliated to different bacterial lineages such as Bacteroidetes, Chloroflexi, Firmicutes, Proteobacteria, Verrucomicrobia, as well as to Archaea. The analysis of a fos-mid metagenomic library from the same site showed that the genomic context of atypical variants was variable, and was accompanied by distinct regulatory elements, suggesting the evolution of differential ecophysiological roles. This work increases our understanding of the microbial ecology of nitrogen transformations in cold coastal environments and provides evidence of an enhanced denitrification potential in impacted sediment microbial communities. In addition, it highlights the role of yet overlooked populations in the mitigation of environmentally harmful forms of nitrogen.	[Calderoli, Priscila A.; Espinola, Fernando J.; Dionisi, Hebe M.; Lozada, Mariana] Consejo Nacl Invest Cient & Tecn, Lab Microbiol Ambiental, Ctr Estudio Sistemas Marinos, Puerto Madryn, Chubut Province, Argentina; [Gil, Monica N.] Consejo Nacl Invest Cient & Tecn, Ctr Estudio Sistemas Marinos, Lab Oceanog Quim & Contaminac Aguas, Puerto Madryn, Chubut Province, Argentina; [Gil, Monica N.] CCT CONICET CENPAT, Lab Quim Gen & Anal Elementos, Puerto Madryn, Chubut Province, Argentina; [Jansson, Janet K.] Pacific Northwest Natl Lab, Biol Sci Div, Earth & Biol Sci Directorate, Richland, WA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centro Nacional Patagonico (CENPAT); United States Department of Energy (DOE); Pacific Northwest National Laboratory	Lozada, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Lab Microbiol Ambiental, Ctr Estudio Sistemas Marinos, Puerto Madryn, Chubut Province, Argentina.	lozada@cenpat-conicet.gob.ar		LOZADA, MARIANA/0000-0003-4037-9169; Jansson, Janet/0000-0002-5487-4315	Pacific Northwest National Laboratory [DE-AC05-76RLO1830]; CONICET [112-201301-00174-CO]; CONICET Fund for Promotion, Development and Technology Management; US Department of Energy Joint Genome Institute (JGI), a DOE Office of Science User Facility [DE-AC02-05CH11231, CSP 328]	Pacific Northwest National Laboratory(United States Department of Energy (DOE)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET Fund for Promotion, Development and Technology Management; US Department of Energy Joint Genome Institute (JGI), a DOE Office of Science User Facility(United States Department of Energy (DOE))	ML and HMD are staff members, PC is a postdoctoral fellow and FJE is a doctoral fellow from The Argentinean National Research Council (CONICET). JKJ is supported by Pacific Northwest National Laboratory under Contract DE-AC05-76RLO1830. ML and HMD were supported by grant 112-201301-00174-CO from CONICET and CONICET Fund for Promotion, Development and Technology Management. Shotgun sequencing and annotation were conducted through the Community Sequencing Program (CSP 328) of the US Department of Energy Joint Genome Institute (JGI), a DOE Office of Science User Facility under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ML and HMD are staff members, PC is a postdoctoral fellow and FJE is a doctoral fellow from The Argentinean National Research Council (CONICET). JKJ is supported by Pacific Northwest National Laboratory under Contract DE-AC05-76RLO1830. ML and HMD are supported by grant PIP2014112-201301-00174-CO from CONICET and CONICET Fund for Promotion, Development and Technology Management. Shotgun sequencing and annotation were conducted through the Community Sequencing Program (CSP 328) of the US Department of Energy Joint Genome Institute (JGI), a DOE Office of Science User Facility under Contract No. DE-AC02-05CH11231.	Algar CK, 2014, AQUAT MICROB ECOL, V71, P223, DOI 10.3354/ame01678; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Baker BJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0077-6; BELL AI, 1990, MOL MICROBIOL, V4, P1753, DOI 10.1111/j.1365-2958.1990.tb00553.x; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Braker G, 2000, APPL ENVIRON MICROB, V66, P2096, DOI 10.1128/AEM.66.5.2096-2104.2000; Brown SM, 2014, ENVIRON MICROBIOL, V16, P3128, DOI 10.1111/1462-2920.12403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choi A, 2016, DEEP-SEA RES PT II, V123, P113, DOI 10.1016/j.dsr2.2015.07.016; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Crowe SA, 2012, BIOGEOSCIENCES, V9, P4309, DOI 10.5194/bg-9-4309-2012; CUYPERS H, 1992, J BACTERIOL, V174, P5332, DOI 10.1128/JB.174.16.5332-5339.1992; Davies BJ, 2012, J GLACIOL, V58, P1063, DOI 10.3189/2012JoG12J026; Decleyre H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2465-0; Decleyre H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01124; Domeignoz-Horta LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00971; Dong LF, 2009, APPL ENVIRON MICROB, V75, P3171, DOI 10.1128/AEM.02511-08; Eddy S., 2001, HMMER PROFILE HIDDEN; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Engstrom P, 2009, LIMNOL OCEANOGR, V54, P1643, DOI 10.4319/lo.2009.54.5.1643; Espinola F, 2017, MICROB ECOL, V75, P1; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gaimster H, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fnx277; Gao H, 2012, LIMNOL OCEANOGR, V57, P185, DOI 10.4319/lo.2012.57.1.0185; Giblin AE, 2013, OCEANOGRAPHY, V26, P124, DOI 10.5670/oceanog.2013.54; Gil MN, 2011, MAR POLLUT BULL, V62, P201, DOI 10.1016/j.marpolbul.2010.10.004; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Guibert LM, 2016, MICROB ECOL, V71, P100, DOI 10.1007/s00248-015-0698-0; Guibert LM, 2012, MICROB ECOL, V64, P605, DOI 10.1007/s00248-012-0051-9; Hallin S, 2018, TRENDS MICROBIOL, V26, P43, DOI 10.1016/j.tim.2017.07.003; HARBORNE NR, 1992, MOL MICROBIOL, V6, P2805, DOI 10.1111/j.1365-2958.1992.tb01460.x; Herbert RA, 1999, FEMS MICROBIOL REV, V23, P563, DOI 10.1016/S0168-6445(99)00022-4; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hutchings MI, 2002, J BACTERIOL, V184, P503, DOI 10.1128/JB.184.2.503-508.2002; Isabella VM, 2009, MOL MICROBIOL, V71, P227, DOI 10.1111/j.1365-2958.2008.06522.x; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Koike I., 1988, NITROGEN CYCLING COA, P251; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laverock B, 2011, BIOCHEM SOC T, V39, P315, DOI 10.1042/BST0390315; Loviso CL, 2015, J APPL MICROBIOL, V119, P411, DOI 10.1111/jam.12843; Lozada M, 2016, BIOL BIOTECHNOLOGY P, P15; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Marcos MS, 2012, APPL ENVIRON MICROB, V78, P1589, DOI 10.1128/AEM.06929-11; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Mason OU, 2014, ISME J, V8, P1464, DOI 10.1038/ismej.2013.254; Matos MN, 2016, ENVIRON MICROBIOL, V18, P4471, DOI 10.1111/1462-2920.13433; Matsen FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031009; Orellana LH, 2014, MBIO, V5, DOI 10.1128/mBio.01193-14; Palmer K, 2012, APPL ENVIRON MICROB, V78, P5584, DOI 10.1128/AEM.00810-12; Palmer K, 2009, APPL ENVIRON MICROB, V75, P5170, DOI 10.1128/AEM.00254-09; Park D, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00502-17, 10.1128/aem.00502-17]; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Rao AMF, 2007, CONT SHELF RES, V27, P1801, DOI 10.1016/j.csr.2007.03.001; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Reyes C, 2017, MAR BIOTECHNOL, V19, P175, DOI 10.1007/s10126-017-9741-0; Richardson D, 2009, TRENDS BIOTECHNOL, V27, P388, DOI 10.1016/j.tibtech.2009.03.009; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Saunders NFW, 1999, MOL MICROBIOL, V34, P24, DOI 10.1046/j.1365-2958.1999.01563.x; Scott NM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00108; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Shapleigh J.P., 2013, PROKARYOTES, VFourth, P405, DOI [10.1007/978-3-642-30141-4_71, DOI 10.1007/978-3-642-30141-4_71]; Spiro S, 2016, METALLOENZYMES DENIT, P312, DOI [10.1039/9781782623762-00312, DOI 10.1039/9781782623762-00312]; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Spiro S, 2017, RSC METALLOBIO SER, V9, P312; Strickland J.D.H., 1972, BULLETIN, V167; Sullivan MJ, 2013, P NATL ACAD SCI USA, V110, P19926, DOI 10.1073/pnas.1314529110; Thomson AJ, 2012, PHILOS T R SOC B, V367, P1157, DOI 10.1098/rstb.2011.0415; Torres AI, 2009, WATER AIR SOIL POLL, V204, P259, DOI 10.1007/s11270-009-0042-8; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Yoon S, 2016, APPL ENVIRON MICROB, V82, P3793, DOI 10.1128/AEM.00409-16; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	84	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207606	10.1371/journal.pone.0207606	http://dx.doi.org/10.1371/journal.pone.0207606			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496195	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800036
J	Shao, YT; Chuang, SY; Chang, HY; Tseng, YC; Shao, KT				Shao, Yi Ta; Chuang, Shang-Ying; Chang, Hao-Yi; Tseng, Yung-Che; Shao, Kwang-Tsao			Largescale mullet (Planiliza macrolepis) can recover from thermal pollution-induced malformations	PLOS ONE			English	Article							WATER TEMPERATURE; HOXD-4 EXPRESSION; RETINOIC ACID; HEAVY-METALS; FISH LARVAE; WILD-CAUGHT; VITAMIN-C; GROWTH; DEFORMITIES; STRESS	It is well known in aquaculture that hyperthermic perturbations may cause skeleton malformations in fish, but this phenomenon has rarely been documented in wild species. One rare location where thermal pollution has increased the proportion of malformed fish in wild population is in the waters near the Kuosheng Nuclear Power Plant in Taiwan. At this site, the threshold temperature and critical exposure time for inducing deformations have not been previously determined. In addition, it was unclear whether juvenile fish with thermal-induced malformations are able to recover when the temperature returns below the threshold. In the present study, juvenile largescale mullet (Planiliza macrolepis) were kept at temperatures ranging from 26 degrees C and 36 degrees C for 1-4 weeks, after which malformed fish were maintained at a preferred temperature of 26 degrees C for another 8 weeks. The vertebrae bending index (VBI) of fish was increased after 2 weeks at 36 degrees C, and deformed vertebral columns were detected by radiography after 4 weeks. However, malformations were not observed in groups kept at or below 34 degrees C. Moreover, at the end of the recovery period, both the VBI and the vertebrae malformations had returned to normal. The results of this study may help to more precisely determine potential environmental impacts of thermal pollution and raise the possibility that the capacity for fish vertebrae to recover from the impacts of chronic thermal exposures may be an important consideration in marine fish conservation.	[Shao, Yi Ta; Chuang, Shang-Ying; Chang, Hao-Yi; Shao, Kwang-Tsao] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Shao, Yi Ta] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Tseng, Yung-Che] Acad Sinica, Marine Res Stn, Inst Cellular & Organism Biol, Taipei, Taiwan; [Shao, Kwang-Tsao] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Shao, KT (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.; Shao, KT (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	zoskt@gate.sinica.edu.tw	Tseng, Yung-Che/AAE-7509-2022	Tseng, Yung-Che/0000-0001-7489-0403	Ministry of Science and Technology, Taiwan [NSC-105-2621-B019-006-MY2]; Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within the Ministry of Education (MOE) in Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within the Ministry of Education (MOE) in Taiwan	This study was supported by grants from the Ministry of Science and Technology, Taiwan (NSC-105-2621-B019-006-MY2) (https://www.most.gov.tw/?l=en) to YTS.; Historical data were provided from a long-term monitoring project by Taipower Company. Space and equipment for experiments were provided by the Marine Research Station, ICOB, Academia Sinica and the National Museum of Marine Biology and Aquarium. We would like thank Dr. Hsuan-Chin Ho for operating the X-ray and the technicians in the Marine Research Station for aquaculture technical assistance. In addition, we would like thank the supports from the Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan.	Al-Mamry Juma M., 2010, Anales de Biologia, V32, P73; Bevelhimer M., 2000, ENVIRON SCI POLICY, V3, P211, DOI DOI 10.1016/S1462-9011(00)00056-3; Boglione C, 2001, AQUACULTURE, V192, P1, DOI 10.1016/S0044-8486(00)00446-4; Bogutskaya NG, 2011, J FISH BIOL, V79, P991, DOI 10.1111/j.1095-8649.2011.03078.x; Brown CL, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P166, DOI 10.1079/9781845935535.0166; Cahu C, 2003, AQUACULTURE, V227, P245, DOI 10.1016/S0044-8486(03)00507-6; Cardona L, 2000, ESTUAR COAST SHELF S, V50, P727, DOI 10.1006/ecss.1999.0594; Chien LT, 1999, FISHERIES SCI, V65, P731, DOI 10.2331/fishsci.65.731; CLARK JR, 1969, SCI AM, V220, P19; Cooke SJ, 2003, WATER AIR SOIL POLL, V142, P113, DOI 10.1023/A:1022082003932; Dadras H, 2017, AQUAC RES, V48, P729, DOI 10.1111/are.13049; Darias MJ, 2011, AQUACULTURE, V315, P49, DOI 10.1016/j.aquaculture.2010.12.030; ENDO M, 1994, JPN J ICHTHYOL, V41, P76; ENGLARD S, 1986, ANNU REV NUTR, V6, P365, DOI 10.1146/annurev.nu.06.070186.002053; Fiaz AW, 2010, J APPL ICHTHYOL, V26, P289, DOI 10.1111/j.1439-0426.2010.01423.x; FOLKVORD A, 1991, AQUACULTURE, V97, P41, DOI 10.1016/0044-8486(91)90278-F; FRANCESCON A, 1988, AQUACULTURE, V72, P273, DOI 10.1016/0044-8486(88)90216-5; Gabillard JC, 2005, CYBIUM, V29, P107; Gil-Martens L, 2010, J APPL ICHTHYOL, V26, P350, DOI 10.1111/j.1439-0426.2010.01433.x; Gomez-Requeni P, 2012, J COMP PHYSIOL B, V182, P517, DOI 10.1007/s00360-011-0640-9; Hou JL, 2011, J APPL ICHTHYOL, V27, P514, DOI 10.1111/j.1439-0426.2011.01703.x; HOUDE ED, 1989, FISH B-NOAA, V87, P471; HUBBS C, 1959, ECOLOGY, V40, P154, DOI 10.2307/1929941; Hwang DF, 1998, FISHERIES SCI, V64, P291, DOI 10.2331/fishsci.64.291; Kelly DW, 2010, J ANIM ECOL, V79, P445, DOI 10.1111/j.1365-2656.2009.01636.x; Kingsolver JG, 2016, AM NAT, V187, P283, DOI 10.1086/684786; Kranenbarg S, 2005, J EXP BIOL, V208, P3493, DOI 10.1242/jeb.01808; KROGER R L, 1971, Chesapeake Science, V12, P276, DOI 10.2307/1350917; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Le Morvan C, 1998, J EXP BIOL, V201, P165; Lewis LM, 2004, AQUACULTURE, V241, P47, DOI 10.1016/j.aquaculture.2004.08.018; Ma ZH, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3142-0; Madeira D, 2013, COMP BIOCHEM PHYS A, V166, P237, DOI 10.1016/j.cbpa.2013.06.008; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Sfakianakis DG, 2015, ENVIRON RES, V137, P246, DOI 10.1016/j.envres.2014.12.014; Suzuki T, 1998, ZOOL SCI, V15, P57, DOI 10.2108/zsj.15.57; Suzuki T, 1999, DEV GROWTH DIFFER, V41, P143; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Wetang'ula GN, 2004, THESIS; Yershov P.N., 2008, [Труды Зоологического института РАН, Proceedings of the Zoological Institute RAS, Trudy Zoologicheskogo instituta RAN], V312, P74	40	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208005	10.1371/journal.pone.0208005	http://dx.doi.org/10.1371/journal.pone.0208005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496264	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800076
J	Aggarwal, P; Gupta, A				Aggarwal, Priya; Gupta, Anubha			Low rank and sparsity constrained method for identifying overlapping functional brain networks	PLOS ONE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; CONNECTIVITY; MRI; COMMUNITIES; ARCHITECTURE; PATTERNS; FMRI; HUBS	Analysis of functional magnetic resonance imaging (fMRI) data has revealed that brain regions can be grouped into functional brain networks (fBNs) or communities. A community in fMRI analysis signifies a group of brain regions coupled functionally with one another. In neuroimaging, functional connectivity (FC) measure can be utilized to quantify such functionally connected regions for disease diagnosis and hence, signifies the need of devising novel FC estimation methods. In this paper, we propose a novel method of learning FC by constraining its rank and the sum of non-zero coefficients. The underlying idea is that fBNs are sparse and can be embedded in a relatively lower dimension space. In addition, we propose to extract overlapping networks. In many instances, communities are characterized as combinations of disjoint brain regions, although recent studies indicate that brain regions may participate in more than one community. In this paper, large-scale overlapping fBNs are identified on resting state fMRI data by employing non-negative matrix factorization. Our findings support the existence of overlapping brain networks.	[Aggarwal, Priya; Gupta, Anubha] IIIT D, Signal Proc & Biomed Imaging Lab SBILab, New Delhi, India	Indraprastha Institute of Information Technology Delhi	Aggarwal, P (corresponding author), IIIT D, Signal Proc & Biomed Imaging Lab SBILab, New Delhi, India.	priyaa@iiitd.ac.in		Gupta, Anubha/0000-0002-7752-1926; Aggarwal, Priya/0000-0002-2993-4021	Visvesvaraya research fellowship, Department of Electronics and Information Tech., Ministry of Comm. and IT, Govt. of India	Visvesvaraya research fellowship, Department of Electronics and Information Tech., Ministry of Comm. and IT, Govt. of India	The first author would like to thank Visvesvaraya research fellowship, Department of Electronics and Information Tech., Ministry of Comm. and IT, Govt. of India, for providing financial support for this work (URL: https://phd.medialabasia.in/).	Aggarwal P, 2017, MED IMAGE ANAL, V42, P228, DOI 10.1016/j.media.2017.08.007; Aggarwal P, 2016, NEUROCOMPUTING, V216, P319, DOI 10.1016/j.neucom.2016.08.016; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Anderson A, 2014, NEUROIMAGE, V102, P207, DOI 10.1016/j.neuroimage.2013.12.015; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boyd S., 2010, FDN TRENDS MACH LEAR, V3, P1, DOI [10.1561/2200000016, DOI 10.1561/2200000016]; Buckner RL, 2013, TRENDS COGN SCI, V17, P648, DOI 10.1016/j.tics.2013.09.017; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Eavani H, 2015, NEUROIMAGE, V105, P286, DOI 10.1016/j.neuroimage.2014.09.058; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hirayama J, 2016, MACH LEARN, V105, P335, DOI 10.1007/s10994-016-5568-6; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li HJ, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30015-5; Li X, 2018, NEUROIMAGE, V166, P259, DOI 10.1016/j.neuroimage.2017.11.003; Li X, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00383; Marrelec G, 2007, MAGN RESON IMAGING, V25, P1181, DOI 10.1016/j.mri.2007.02.012; Najafi M, 2016, NEUROIMAGE, V135, P92, DOI 10.1016/j.neuroimage.2016.04.054; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nicolini C, 2017, NEUROIMAGE, V146, P28, DOI 10.1016/j.neuroimage.2016.11.026; Pessoa L, 2014, PHYS LIFE REV, V11, P400, DOI 10.1016/j.plrev.2014.03.005; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Precup D, 2012, PROCEEDINGS OF THE 2, P1459; Psorakis I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066114; Qiao LS, 2016, NEUROIMAGE, V141, P399, DOI 10.1016/j.neuroimage.2016.07.058; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sauwen N, 2015, NMR BIOMED, V28, P1599, DOI 10.1002/nbm.3413; Schmidt MN, 2009, LECT NOTES COMPUT SC, V5441, P540, DOI 10.1007/978-3-642-00599-2_68; Selesnick IW, 2010, SPARSE SIGNAL RESTOR; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XN, 2017, AAAI CONF ARTIF INTE, P2562; Sotiras A, 2015, NEUROIMAGE, V108, P1, DOI 10.1016/j.neuroimage.2014.11.045; Sporns O., 2010, NETWORKS BRAIN; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Sra S., 2006, NONNEGATIVE MATRIX A; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; YANG JAEWON, 2013, P 6 ACM INT C WEB SE, V13, P587, DOI DOI 10.1145/2433396.2433471; Yeo BTT, 2015, CEREB CORTEX, V25, P3654, DOI 10.1093/cercor/bhu217; Yu RP, 2017, HUM BRAIN MAPP, V38, P2370, DOI 10.1002/hbm.23524; Zhang ZY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062803; Zheng ZL, 2007, ENG APPL ARTIF INTEL, V20, P101, DOI 10.1016/j.engappai.2006.03.001; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	54	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208068	10.1371/journal.pone.0208068	http://dx.doi.org/10.1371/journal.pone.0208068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485369	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800102
J	De-Ugarte, L; Balcells, S; Nogues, X; Grinberg, D; Diez-Perez, A; Garcia-Giralt, N				De-Ugarte, Laura; Balcells, Susana; Nogues, Xavier; Grinberg, Daniel; Diez-Perez, Adolfo; Garcia-Giralt, Natalia			Pro-osteoporotic miR-320a impairs osteoblast function and induces oxidative stress	PLOS ONE			English	Article							CANCER CELL-PROLIFERATION; MICRORNA-320A	MicroRNAs (miRNAs) are important regulators of many cellular processes, including the differentiation and activity of osteoblasts, and therefore, of bone turnover. MiR-320a is overexpressed in osteoporotic bone tissue but its role in osteoblast function is unknown. In the present study, functional assays were performed with the aim to elucidate the mechanism of miR-320a action in osteoblastic cells. MiR-320a was either overexpressed or inhibited in human primary osteoblasts (hOB) and gene expression changes were evaluated through microarray analysis. In addition, the effect of miR-320a on cell proliferation, viability, and oxidative stress in hOB was evaluated. Finally, matrix mineralization and alkaline phosphatase activity were assessed in order to evaluate osteoblast functionality. Microarray results showed miR-320a regulation of a number of key osteoblast genes and of genes involved in oxidative stress. Regulation of osteoblast differentiation and ossification appeared as the best significant biological processes (PANTHER P value = 3.74E-05; and P value = 3.06E-04, respectively). The other enriched pathway was that of the cellular response to cadmium and zinc ions, mostly by the overexpression of metallothioneins. In hOBs, overexpression of miR-320a increased cell proliferation and oxidative stress levels whereas mineralization capacity was reduced. In conclusion, overexpression of miR-320a increased stress oxidation levels and was associated with reduced osteoblast differentiation and functionality, which could trigger an osteoporotic phenotype.	[De-Ugarte, Laura] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [De-Ugarte, Laura] Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN USA; [Balcells, Susana; Grinberg, Daniel] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, CIBERER,ISCIII,IBUB,RSJD, Barcelona, Catalonia, Spain; [Nogues, Xavier; Diez-Perez, Adolfo; Garcia-Giralt, Natalia] Hosp del Mar, Med Res Inst, Musculoskeletal Res Grp, CIBERFES,ISCIII,IMIM, Barcelona, Catalonia, Spain	Indiana University System; Indiana University Bloomington; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Instituto de Salud Carlos III	Garcia-Giralt, N (corresponding author), Hosp del Mar, Med Res Inst, Musculoskeletal Res Grp, CIBERFES,ISCIII,IMIM, Barcelona, Catalonia, Spain.	ngarcia@imim.es	Garcia-Giralt, Natalia/AAA-7588-2021; Grinberg, Daniel/F-3641-2010; Balcells, Susana/C-5222-2017	Garcia-Giralt, Natalia/0000-0001-6507-0147; Grinberg, Daniel/0000-0001-9859-2590; Balcells, Susana/0000-0003-1211-1907; Nogues, Xavier/0000-0002-5537-1859	Centro de Investigacion Biomedica en Red (CIBER) en Fragilidad y Envejecimiento Saludable (CIBERFES) [CB16/10/00245]; CIBER de Enfermedades Raras (CIBERER) [U720]; FEDER funds; ISCIII (Science and Innovation Ministry)	Centro de Investigacion Biomedica en Red (CIBER) en Fragilidad y Envejecimiento Saludable (CIBERFES); CIBER de Enfermedades Raras (CIBERER); FEDER funds(European Commission); ISCIII (Science and Innovation Ministry)	This work was supported by the Centro de Investigacion Biomedica en Red (CIBER) en Fragilidad y Envejecimiento Saludable (CIBERFES; CB16/10/00245 to ADP and NGG) and CIBER de Enfermedades Raras (CIBERER; U720 to SB), and FEDER funds. NGG was employee of CIBERFES. LDU was recipient of a PFIS predoctoral fellowship from the ISCIII (Science and Innovation Ministry). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Chiaverini N, 2010, FREE RADICAL RES, V44, P605, DOI 10.3109/10715761003692511; De-Ugarte L, 2018, HUM CELL, V31, P33, DOI 10.1007/s13577-017-0181-y; De-Ugarte L, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0149-2; Domazetovic V, 2017, CLIN CASES MINER BON, V14, P209, DOI 10.11138/ccmbm/2017.14.1.209; Flowers E, 2015, METABOLISM, V64, P1051, DOI 10.1016/j.metabol.2015.05.013; Forrest CM, 2006, CLIN EXP PHARMACOL P, V33, P1078, DOI 10.1111/j.1440-1681.2006.04490.x; Garcia-Giralt N D-UL, 2015, REV OSTEOPOR METAB M, V8, P5; Hamam D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.462; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JH, 2016, CELL PHYSIOL BIOCHEM, V38, P40, DOI 10.1159/000438607; Jin Y, 2017, BONE JOINT RES, V6, P196, DOI 10.1302/2046-3758.64.BJR-2016-0224.R1; Jing D, 2015, INT J ORAL SCI, V7, P131, DOI 10.1038/ijos.2015.22; Lian F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121499; Lu CC, 2017, ONCOL LETT, V13, P573, DOI 10.3892/ol.2016.5479; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Myatt SS, 2011, ANTIOXID REDOX SIGN, V14, P675, DOI 10.1089/ars.2010.3383; Robertson S, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/2021903; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Solomons NW, 2013, ANN NUTR METAB, V62, P8, DOI 10.1159/000348547; Sommariva E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05001-z; Sun JY, 2012, BIOCHEM BIOPH RES CO, V420, P787, DOI 10.1016/j.bbrc.2012.03.075; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; van Boven N, 2018, EUR J HEART FAIL, V20, P89, DOI 10.1002/ejhf.950; Villard Audrey, 2015, J Mol Biomark Diagn, V6; Wang JG, 2017, ONCOL LETT, V13, P3247, DOI 10.3892/ol.2017.5863; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yu FC, 2011, BIOSCI TRENDS, V5, P46, DOI 10.5582/bst.2011.v5.2.46; Zhang YX, 2018, BIOCHEM BIOPH RES CO, V503, P1401, DOI 10.1016/j.bbrc.2018.07.055	29	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208131	10.1371/journal.pone.0208131	http://dx.doi.org/10.1371/journal.pone.0208131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485349	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800111
J	Gill, NS; Yelenik, S; Banko, P; Dixon, CB; Jaenecke, K; Peck, R				Gill, Nathan S.; Yelenik, Stephanie; Banko, Paul; Dixon, Christopher B.; Jaenecke, Kelly; Peck, Robert			Invasive rat control is an efficient, yet insufficient, method for recovery of the critically endangered Hawaiian plant hau kuahiwi (Hibiscadelphus giffardianus)	PLOS ONE			English	Article							PSEUDOREPLICATION; ISLANDS	Biological invasions of rodents and other species have been especially problematic on tropical islands. Invasive Rattus rattus consumption of Hibiscadelphus giffardianus (Malvaceae; common Hawaiian name hau kuahiwi) fruit and seeds has been hypothesized to be the most-limiting factor inhibiting the critically endangered tree, but this has not been experimentally tested, and little is known about other factors affecting seed dispersal, germination, and seedling establishment. Thus, we do not know if rat removal is sufficient to increase hau kuahiwi recruitment. This study aims to evaluate the effect of rat population control on the ability of hau kuahiwi to retain fruit and establish seedlings. We compared hau kuahiwi fruiting and seedling recruitment in a stand treated to reduce rat abundance and a neighbouring control stand. Fruit retention increased following treatment but seedling establishment did not. Although rat control improves the ability of hau kuahiwi to retain fruit, other, presently unknown inhibitors to seed dispersal, germination, and/or seedling development remain. Seed and seedling predation by other species, competition from numerous invasive plant species, unsuitable climate, and/or other factors may be primary inhibitors in the absence of rats, but we emphasize that progressive isolation of these factors at individual hau kuahiwi life stages may be necessary to identify the remaining threats to the conservation of this critically endangered plant.	[Gill, Nathan S.; Yelenik, Stephanie; Banko, Paul] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Volcanoes Natl Pk, Volcano, HI 96785 USA; [Gill, Nathan S.] Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA; [Dixon, Christopher B.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Jaenecke, Kelly; Peck, Robert] Univ Hawaii Hilo, Hawaii Cooperat Studies Unit, Hawaii Volcanoes Natl Pk, Hilo, HI USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; Brigham Young University; University of Hawaii System; University Hawaii Hilo	Gill, NS (corresponding author), US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Volcanoes Natl Pk, Volcano, HI 96785 USA.; Gill, NS (corresponding author), Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA.	nsgill@wisc.edu	Yelenik, Stephanie/ABC-8265-2020	Yelenik, Stephanie/0000-0002-9011-0769; Peck, Robert/0000-0002-8739-9493; Gill, Nathan/0000-0003-1496-8197	National Science Foundation (NSF) [2015187717]; NSF Graduate Research Internship Program; U.S. Geological Survey through the Natural Resources Preservation Program (NRPP, with National Park Service); Science Support Program (SSP, with U.S. Fish and Wildlife Service); Ecosystems Mission Area	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Graduate Research Internship Program; U.S. Geological Survey through the Natural Resources Preservation Program (NRPP, with National Park Service); Science Support Program (SSP, with U.S. Fish and Wildlife Service); Ecosystems Mission Area	This work was supported by National Science Foundation (NSF; https://nsf.gov/) Graduate Research Fellowship No. 2015187717 (Nathan S Gill), an internship provided through the NSF Graduate Research Internship Program (Nathan S Gill and Stephanie Yelenik), and through the U.S. Geological Survey through the Natural Resources Preservation Program (NRPP, with National Park Service), Science Support Program (SSP, with U.S. Fish and Wildlife Service), and Ecosystems Mission Area. Any findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Coordination of GRIP at USGS is through the Youth and Education in Science programs within the Office of Science Quality and Integrity. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JK, 1977, PAC SCI, V31, P285; Baker JK, 1978, ROOF RAT DEPREDATION; Beauvais GP, 1999, WILDLIFE SOC B, V27, P39; Campbell DJ, 2002, BIOL CONSERV, V107, P19, DOI 10.1016/S0006-3207(02)00039-3; Davies GM, 2015, ECOL EVOL, V5, P5295, DOI 10.1002/ece3.1782; Drake DR, 2009, BIOL INVASIONS, V11, P1483, DOI 10.1007/s10530-008-9392-1; Duron Q, 2017, CONSERV BIOL, V31, P761, DOI 10.1111/cobi.12885; Erwin TL, 2010, PAC SCI, V64, P33, DOI 10.2984/64.1.033; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Giambelluca TW, 2014, EVAPOTRANSPIRA HAWAI; Grant-Hoffman MN, 2010, OECOLOGIA, V162, P1005, DOI 10.1007/s00442-009-1500-0; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Joe SM, 2008, BIOL INVASIONS, V10, P245, DOI 10.1007/s10530-007-9126-9; Junker RR, 2011, ECOL MONOGR, V81, P295, DOI 10.1890/10-1367.1; LOCKWOOD JP, 1988, MISCELLANEOUS INVEST; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Newton KM, 2016, J FISH WILDL MANAG, V7, P72, DOI 10.3996/082015-JFWM-073; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; Pender RJ, 2013, BIOL INVASIONS, V15, P213, DOI 10.1007/s10530-012-0280-3; Pratt LW, 2010, HCSU015 PAC AQ COAST; Rock J. F., 1913, INDIGENOUS TREES HAW; Shiels AB, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv057; Shiels AB, 2014, PAC SCI, V68, P145, DOI 10.2984/68.2.1; Shiels AB, 2010, THESIS; Shiels AB, 2014, REV INVASIVE RODENT; Spatz DR, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603080; Spurr EB, 2013, HCSU043 U HAW HIL HA; Thomson D, 2005, BIOL INVASIONS, V7, P615, DOI 10.1007/s10530-004-5853-3; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Wagner WL., 1990, MANUAL FLOWERING PLA, V1; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Wolf CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200743	32	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0208106	10.1371/journal.pone.0208106	http://dx.doi.org/10.1371/journal.pone.0208106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485341	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800107
J	Hagenaars, TJ; Boender, GJ; Bergevoet, RHM; van Roermund, HJW				Hagenaars, T. J.; Boender, G. J.; Bergevoet, R. H. M.; van Roermund, H. J. W.			Risk of poultry compartments for transmission of Highly Pathogenic Avian Influenza	PLOS ONE			English	Article							MODEL	When outbreaks of Highly Pathogenic Avian Influenza (HPAI) occur in OIE member countries with until then disease-free status, member countries can use 'compartmentalisation'. A compartment may be defined as a subset of farms under a common management system, complying with certain stringent surveillance, control and biosecurity measures, and based on that may receive a disease-free status. Based on this disease-free status the compartment is exempted from certain transport restrictions coming into force in case of outbreaks occurring in the country. For deciding whether a candidate compartment is granted official compartment status, it is relevant to assess the additional HPAI transmission risks that would arise due to the exemptions granted. These risks consist of both additional local transmission risks as well as the additional risk of a 'jump' of HPAI infection from one poultry area, via the compartment, to another area. Here such risk assessment is carried out using a spatial mathematical model for between-farm transmission in the Netherlands, yielding insight in the roles of compartment composition and contact structure and identify relevant evaluation criteria for granting HPAI compartment status. At the core of this model are transmission probabilities associated with indirect between-farm contacts, e.g. through feed delivery, egg collection and professional visitors. These probabilities were estimated from Dutch epidemic outbreak data in earlier work. The additional risk of a jump of HPAI from one area, via the compartment, to another area is calculated relative to the direct jump risk. The results show that additional transmission risks caused by a compartment to other farms are mainly dependent on the distance of densely populated poultry areas (DPPAs) to the nearest compartment farm. Apart from conditions on these distances, we also recommend specific routing requirements for transport and other movements within the compartment.	[Hagenaars, T. J.; Boender, G. J.; van Roermund, H. J. W.] Wageningen Biovet Res WBVR, Lelystad, Netherlands; [Bergevoet, R. H. M.] Wageningen Econ Res, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van Roermund, HJW (corresponding author), Wageningen Biovet Res WBVR, Lelystad, Netherlands.	herman.vanroermund@wur.nl		van Roermund, H J W/0000-0001-6917-6221	Dutch Ministry of Agriculture, Nature and Food Quality (LNV) [BO-08-010-011]	Dutch Ministry of Agriculture, Nature and Food Quality (LNV)	This work was supported by the Dutch Ministry of Agriculture, Nature and Food Quality (LNV, https://www.government.nl/ministries/ministry-of-agriculture-nature-and-food-quality), research project code BO-08-010-011, project title "Maatschappelijk aanvaardbare dierziekten bestrijding (MAD)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Annemarie Bouma and Jeroen Bonet (Dutch Ministry of Agriculture, Nature and Food Quality), Martine Laurijssens and Harry Rozendaal (Netherlands Food and Consumer Product Safety Authority, NVWA) and Marcel Berendsen (VPI) for discussions during the project. The work was supported by the Dutch Ministry of Agriculture, Nature and Food Quality (LNV, https://www.government.nl/ministries/ministry-of-agriculture-nature-and-food-quality), research project code BO-08-010-011, project title "Maatschappelijk aanvaardbare dierziekten bestrijding (MAD)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PUBLICATIE RLG, V03/ 8; [Anonymous], 2007, BELEIDSDRAAIBOEK AVI, V1.0; Backer JA, 2015, PREV VET MED, V121, P142, DOI 10.1016/j.prevetmed.2015.06.006; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Bruschke C, 2008, REV SCI TECH OIE, V27, P627, DOI 10.20506/rst.27.3.1824; Gemmeke EAAC, 2008, REV SCI TECH OIE, V27, P679, DOI 10.20506/rst.27.3.1830; Kandun IN, 2010, ZOONOSES PUBLIC HLTH, V57, P285, DOI 10.1111/j.1863-2378.2009.01246.x; Nickbakhsh S, 2014, EPIDEMIOL INFECT, V142, P1813, DOI 10.1017/S0950268813002963; OIE, TERR AN HLTH COD APP; OIE, TERR AN HLTH COD ZON; Ratananakorn L, 2011, REV SCI TECH OIE, V30, P297; Scott A, 2006, REV SCI TECH OIE, V25, P873, DOI 10.20506/rst.25.3.1702; Ssematimba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040929; Zepeda C, 2006, DEV BIOLOGICALS, V124, P163	14	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207076	10.1371/journal.pone.0207076	http://dx.doi.org/10.1371/journal.pone.0207076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485292	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800042
J	Mbuthia, GW; Olungah, CO; Ondicho, TG				Mbuthia, Grace Wambura; Olungah, Charles Owour; Ondicho, Tom Gesora			Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: A grounded theory study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SERVICE DELAY; CARE-SEEKING; PATIENT; TB; SUSPECTS; DISTRICT; ETHIOPIA	Background Patients' health-seeking behaviour can lead to delays in tuberculosis ( TB) diagnosis, however little is known about the experiences and treatment pathways of patients diagnosed with TB in Kenya. The aim of this study is to explore the health seeking practices and factors contributing to delay in TB diagnosis. Methods This study was based on explorative qualitative research using a constructivist grounded theory approach. A total of 61 TB patients in the intensive phase of treatment were recruited as informants in the study. Six focus group discussions and 15 in-depth interviews were used to collect data. Data were analysed through three step coding using the grounded theory approach. Results Participants adopted different treatment pathways as they sought care from a pluralistic health care system involving traditional healers, herbalists, private clinic, drug shops and the public health sector. The study revealed an explanatory model of factors leading to delay illustrated by the participant's expression "I suffered for a long time." The model is comprised of three categories that lead to delays, namely individual, social-cultural and structural factors. Conclusion There is a need to improve timely diagnosis of TB through innovative approaches such as intensive case finding. Similarly, the health-care system should decentralize TB services as much as possible and offer free diagnostic services to increase accessibility.	[Mbuthia, Grace Wambura] Moi Univ, Coll Hlth Sci, Eldoret, Kenya; [Olungah, Charles Owour; Ondicho, Tom Gesora] Univ Nairobi, Inst Anthropol Gender & African Studies, Nairobi, Kenya	Moi University; University of Nairobi	Mbuthia, GW (corresponding author), Moi Univ, Coll Hlth Sci, Eldoret, Kenya.	gmbuthia2002@yahoo.co.uk		Mbuthia, Grace/0000-0003-0994-5249	Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK) [087547/Z/08/Z]; Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York [B 8606]; Ford Foundation [1100-0399]; Google. Org [191994]; Sida [54100029]; MacArthur Foundation [10-95915-000-INP"1]	Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK)(Wellcome Trust); Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York; Ford Foundation; Google. Org; Sida; MacArthur Foundation	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Wellcome Trust (UK) (Grant No: 087547/Z/08/Z), the Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE), the Carnegie Corporation of New York (Grant No: B 8606), the Ford Foundation (Grant No: 1100-0399), Google. Org (Grant No: 191994), Sida (Grant No: 54100029) and MacArthur Foundation Grant No: 10-95915-000-INP"1.	[Anonymous], 2006, INTRO QUALITATIVE ME; [Anonymous], INTRO QUALITATIVE RE; Asefa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102884; Ayisi JG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-515; AYLES H, 2009, PLOS ONE, V4; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Barbour R., 1998, DEV FOCUS GROUP RES; Belay M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-369; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Bonadonna LV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185018; Buregyeya E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-586; Carter SM, 2007, QUAL HEALTH RES, V17, P1316, DOI 10.1177/1049732307306927; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Chikovore J, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26292; CHRISMAN N J, 1977, Culture Medicine and Psychiatry, V1, P351; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Cox HS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001760; Creswell JW., 2012, CONDUCT EVAL, V260, P375; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Derseh D, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2211-5; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Emslie C, 2006, SOC SCI MED, V62, P2246, DOI 10.1016/j.socscimed.2005.10.017; Finnie RKC, 2011, TROP MED INT HEALTH, V16, P394, DOI 10.1111/j.1365-3156.2010.02718.x; Gele AA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-5; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hanson C, 2017, J INFECT DIS, V216, pS686, DOI 10.1093/infdis/jix388; Hussen Awol, 2012, BMC Res Notes, V5, P320, DOI 10.1186/1756-0500-5-320; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Kleinman A., 1980, PATIENTS HEALERS CON, V3; Kumwenda M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154103; Lawn SD, 1998, INT J TUBERC LUNG D, V2, P635; Liefooghe R, 1997, TROP MED INT HEALTH, V2, P809, DOI 10.1046/j.1365-3156.1997.d01-380.x; Lonnroth K, 1999, INT J TUBERC LUNG D, V3, P992; Mason PH, 2015, INT J TUBERC LUNG D, V19, P1135, DOI 10.5588/ijtld.15.0066; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P7; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Ministry of Health (MOH), 2016, KEN TUB PREV SURV RE; Ministry of Health (MOH), 2013, NAT DLTLD GUID MAN T; Montavon A, 2013, TROP MED INT HEALTH, V18, P1044, DOI 10.1111/tmi.12147; Moynihan C, 1998, BRIT MED J, V317, P1072; National Tuberculosis Leprosy and Lung Disease(NTLD), 2013, ANN REPORT; Nyasulu P, 2016, QUAL HEALTH RES, V26, P1275, DOI 10.1177/1049732315588083; Olenja J, 2003, East Afr Med J, V80, P61; Otwombe KN, 2013, INT J TUBERC LUNG D, V17, P1199, DOI 10.5588/ijtld.12.0891; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; RUBEL AJ, 1992, PUBLIC HEALTH REP, V107, P626; Sagbakken M, 2010, TUBERCULOSIS GLOBAL; Satyanarayana S, 2016, LANCET INFECT DIS, V16, P1261, DOI 10.1016/S1473-3099(16)30215-8; Saunders MJ, 2016, LANCET INFECT DIS, V16, P395, DOI 10.1016/S1473-3099(15)00434-X; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Strauss A., 1998, BASICS QUALITATIVE R; TADESSE T, 2013, BMC PUBLIC HEALTH, V13, P75167; Tufford L, 2012, QUAL SOC WORK, V11, P80, DOI 10.1177/1473325010368316; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Verhagen LM, 2010, INFECTION, V38, P433, DOI 10.1007/s15010-010-0051-y; Ward H, 1997, HEALTH POLICY PLANN, V12, P19, DOI 10.1093/heapol/12.1.19; White A., 2003, REPORT STATE MENS HL; World Health Organization, 2016, WHOHTMTB2016; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112	65	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207995	10.1371/journal.pone.0207995	http://dx.doi.org/10.1371/journal.pone.0207995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485379	Green Submitted, gold, Green Published			2022-12-26	WOS:000451755800093
J	Woodall, LC; Jungblut, AD; Hopkins, K; Hall, A; Robinson, LF; Gwinnett, C; Paterson, GLJ				Woodall, Lucy C.; Jungblut, Anna D.; Hopkins, Kevin; Hall, Andie; Robinson, Laura F.; Gwinnett, Claire; Paterson, Gordon L. J.			Deep-sea anthropogenic macrodebris harbours rich and diverse communities of bacteria and archaea	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; MARINE; PLASTICS; BIOGEOGRAPHY; OCEAN	The deep sea is the largest biome on earth, and microbes dominate in biomass and abundance. Anthropogenic litter is now almost ubiquitous in this biome, and its deposition creates new habitats and environments, including for microbial assemblages. With the ever increasing accumulation of this debris, it is timely to identify and describe the bacterial and archaeal communities that are able to form biofilms on macrodebris in the deep sea. Using 16S rRNA gene high throughput sequencing, we show for the first time the composition of bacteria and archaea on macrodebris collected from the deep sea. Our data suggest differences in the microbial assemblage composition across litter of different materials including metal, rubber, glass, fabric and plastic. These results imply that anthropogenic macrodebris provide diverse habitats for bacterial and archaeal biofilms and each may harbour distinct microbial communities.	[Woodall, Lucy C.; Jungblut, Anna D.; Hopkins, Kevin; Hall, Andie; Paterson, Gordon L. J.] Nat Hist Museum, Dept Life Sci, London, England; [Woodall, Lucy C.] Nekton Fdn, Begbroke Sci Pk, Oxford, England; [Woodall, Lucy C.] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England; [Robinson, Laura F.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Gwinnett, Claire] Staffordshire Univ, Dept Criminal Justice & Forens Sci, Stoke On Trent, Staffs, England	Natural History Museum London; University of Oxford; University of Bristol; Staffordshire University	Woodall, LC (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.; Woodall, LC (corresponding author), Nekton Fdn, Begbroke Sci Pk, Oxford, England.; Woodall, LC (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.	lucy.woodall@zoo.ox.ac.uk		Hall, Andie/0000-0001-5546-7255; Hopkins, Kevin/0000-0002-3251-7093	ERC [278705]; Philip Leverhulme Prize [PLP-2012-088]; Natural History Museum DIF [14007]	ERC(European Research Council (ERC)European Commission); Philip Leverhulme Prize; Natural History Museum DIF	Field work was support by ERC grant 278705 and Philip Leverhulme Prize (PLP-2012-088) to LFR, and all other aspects were funded by Natural History Museum DIF grant 14007 (LCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the ship's crew, scientists and ROV team from JC94. In addition, we wish to thank J. Walsh who worked alongside LW to identify deep-sea sediment microplastic, and G. Rowlands for preparing Fig 1. Field work was support by ERC grant 278705 and Philip Leverhulme Prize (PLP-2012-088) to LFR, and all other aspects were funded by Natural History Museum DIF grant 14007.	Amaral-Zettler LA, 2015, FRONT ECOL ENVIRON, V13, P541, DOI 10.1890/150017; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bryant JA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00024-16; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Corinaldesi C, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00017; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; De Tender CA, 2015, ENVIRON SCI TECHNOL, V49, P9629, DOI 10.1021/acs.est.5b01093; Debroas D, 2017, SCI TOTAL ENVIRON, V599, P1222, DOI 10.1016/j.scitotenv.2017.05.059; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dussud C, 2018, ENVIRON POLLUT, V236, P807, DOI 10.1016/j.envpol.2017.12.027; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137201; Galgani F, 2015, MARINE ANTHROPOGENIC LITTER, P29, DOI 10.1007/978-3-319-16510-3_2; Gorley RN, 2006, PRIMER V6; Harrison JP, 2012, SCI TOTAL ENVIRON, V416, P455, DOI 10.1016/j.scitotenv.2011.11.078; Jiang PL, 2018, SCI TOTAL ENVIRON, V624, P48, DOI 10.1016/j.scitotenv.2017.12.105; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Kuhn S, 2015, MARINE ANTHROPOGENIC LITTER, P75, DOI 10.1007/978-3-319-16510-3_4; Lee JW, 2008, J MICROBIOL, V46, P174, DOI 10.1007/s12275-008-0032-3; Little BJ, 2007, MICROBIOLOGICALLY IN, DOI [10.1038/ismej.2012.37, DOI 10.1038/ISMEJ.2012.37]; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Oberbeckmann S, 2014, FEMS MICROBIOL ECOL, V90, P478, DOI 10.1111/1574-6941.12409; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Reisser J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100289; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Tully BJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00161; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Woodall LC, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00003; Woodall LC, 2015, MAR POLLUT BULL, V95, P40, DOI 10.1016/j.marpolbul.2015.04.044; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	35	20	20	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206220	10.1371/journal.pone.0206220	http://dx.doi.org/10.1371/journal.pone.0206220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485275	Green Published, Green Submitted, gold			2022-12-26	WOS:000451755800016
J	Santini, T; Zhao, YJ; Wood, S; Krishnamurthy, N; Kim, J; Farhat, N; Alkhateeb, S; Martins, T; Koo, M; Zhao, TJ; Aizenstein, HJ; Ibrahim, TS				Santini, Tales; Zhao, Yujuan; Wood, Sossena; Krishnamurthy, Narayanan; Kim, Junghwan; Farhat, Nadim; Alkhateeb, Salem; Martins, Tiago; Koo, Minseok; Zhao, Tiejun; Aizenstein, Howard J.; Ibrahim, Tamer S.			In-vivo and numerical analysis of the eigenmodes produced by a multi-level Tic-Tac-Toe head transmit array for 7 Tesla MRI	PLOS ONE			English	Article							TIME-INTERLEAVED ACQUISITION; ABSORPTION RATE; RF POWER; FIELD HOMOGENEITY; COIL; SAR; INHOMOGENEITY; EXCITATION; MODES; BODY	Radio-frequency (RF) field inhomogeneities and higher levels of specific absorption rate (SAR) still present great challenges in ultrahigh-field (UHF) MRI. In this study, an in-depth analysis of the eigenmodes of a 20-channel transmit Tic-Tac-Toe (TTT) RF array for 7T neuro MRI is presented. The eigenmodes were calculated for five different Z levels (along the static magnetic field direction) of the coil. Four eigenmodes were obtained for each Z level (composed of 4 excitation ports), and they were named based on the characteristics of their field distributions: quadrature, opposite-phase, anti-quadrature, and zero-phase. Corresponding finite-difference time-domain (FDTD) simulations were performed and experimental B-1(+) field maps were acquired using a homogeneous spherical phantom and human head (in-vivo). The quadrature mode is the most efficient and it excites the central brain regions; the opposite-phase mode excites the brain peripheral regions; anti-quadrature mode excites the head periphery; and the zero-phase mode excites cerebellum and temporal lobes. Using this RF array, up to five eigenmodes (from five different Z levels) can be simultaneously excited. The superposition of these modes has the potential to produce homogeneous excitation with full brain coverage and low levels of SAR at 7T MRI.	[Santini, Tales; Zhao, Yujuan; Wood, Sossena; Krishnamurthy, Narayanan; Kim, Junghwan; Farhat, Nadim; Alkhateeb, Salem; Martins, Tiago; Koo, Minseok; Aizenstein, Howard J.; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Zhao, Tiejun] Siemens Med Solut, Pittsburgh, PA USA; [Aizenstein, Howard J.; Ibrahim, Tamer S.] Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Siemens AG; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Ibrahim, TS (corresponding author), Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15260 USA.	tibrahim@pitt.edu		Santini, Tales/0000-0003-4533-9190; Koo, Minseok/0000-0002-4144-6696	National Institutes of Health [R01MH111265, R01EB009848]; CAPES Foundation, Ministry of Education of Brazil [13385/13-5]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work reported in this publication is supported by the National Institutes of Health under award numbers: R01MH111265 (https://projectreporter.nih.gov/project_info_description.cfm?aid=9483825&icde=0) R01EB009848. (https://projectreporter.nih.gov/project_info_description.cfm?aid=8100222&map=y).This work is also supported by the CAPES Foundation, Ministry of Education of Brazil, under the award number 13385/13-5. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Siemens Medical Solutions provided support in the form of salaries for author Tiejun Zhao, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alagappan V, 2008, P INT SOC MAG RESON, V16; Alsop DC, 1998, MAGN RESON MED, V40, P49, DOI 10.1002/mrm.1910400107; Aussenhofer SA, 2014, J MAGN RESON, V243, P122, DOI 10.1016/j.jmr.2014.04.001; Avdievich NI, 2018, MAGN RESON MED, V79, P1200, DOI 10.1002/mrm.26754; Avdievich NI, 2011, APPL MAGN RESON, V41, P483, DOI 10.1007/s00723-011-0280-y; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Collins CM, 1998, MAGNET RESON MED, V40, P847, DOI 10.1002/mrm.1910400610; Eichfelder G, 2011, MAGN RESON MED, V66, P1468, DOI 10.1002/mrm.22927; Fiedler TM, 2018, NEUROIMAGE, V168, P33, DOI 10.1016/j.neuroimage.2017.03.035; Gilbert KM, 2011, NMR BIOMED, V24, P815, DOI 10.1002/nbm.1627; Hoult DI, 2000, J MAGN RESON IMAGING, V12, P46, DOI 10.1002/1522-2586(200007)12:1<46::AID-JMRI6>3.0.CO;2-D; Hue Y- K., 2008, COMPLETE MODELING SY, P1193; Ibrahim T., 2013, 20 TO 8 CHANNEL TX A; Ibrahim T ST, 2017, HOMOGENOUS 7T NEURO; Ibrahim TS, 2007, J MAGN RESON IMAGING, V25, P1235, DOI 10.1002/jmri.20919; Ibrahim TS, 2007, NMR BIOMED, V20, P58, DOI 10.1002/nbm.1094; Ibrahim TS, 2009, NMR BIOMED, V22, P927, DOI 10.1002/nbm.1406; Ibrahim TS, 2001, MAGN RESON IMAGING, V19, P1339, DOI 10.1016/S0730-725X(01)00404-0; Ibrahim TS, 2008, INT SOC MAG RESON ME; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Kim J, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3664; Kim J, 2016, J MAGN RESON, V269, P55, DOI 10.1016/j.jmr.2016.04.012; King SB, 2006, CONCEPT MAGN RESON B, V29B, P42, DOI 10.1002/cmr.b.20054; King SB, 2010, MAGN RESON MED, V63, P1346, DOI 10.1002/mrm.22295; Kozlov M., 2015, ANT PROP USNC URSI N; Kozlov M, 2011, IEEE ENG MED BIO, P547, DOI 10.1109/IEMBS.2011.6090101; Kraff O, 2017, J MAGN RESON IMAGING, V46, P1573, DOI 10.1002/jmri.25723; Lattanzi R, 2012, MAGN RESON MED, V68, P286, DOI 10.1002/mrm.23198; Orzada S, 2012, MAGN RESON MED, V67, P1033, DOI 10.1002/mrm.23081; Orzada S, 2010, MAGN RESON MED, V64, P327, DOI 10.1002/mrm.22527; Pauly John, 2011, J Magn Reson, V213, P544, DOI 10.1016/j.jmr.2011.09.023; Raval S, 2017, IN VIVO 8S4 32 CH TX; Raval S, 2017, IN VIVO 8X4 32 CH TX; Raval SB, 2016, NMR BIOMED, V29, P1768, DOI 10.1002/nbm.3582; ROSCHMANN P, 1987, MED PHYS, V14, P922, DOI 10.1118/1.595995; Santini T, 2017, NEW RF COIL FOOT ANK; Santini T, 2018, MAGN RESON IMAGING, V45, P1, DOI 10.1016/j.mri.2017.09.005; Setsompop K, 2008, MAGN RESON MED, V60, P1422, DOI 10.1002/mrm.21739; Shajan G, 2014, MAGN RESON MED, V71, P870, DOI 10.1002/mrm.24726; Tang L, 2011, CONCEPT MAGN RESON B, V39B, P11, DOI 10.1002/cmr.b.20185; Taracila V, 2006, CONCEPT MAGN RESON B, V29B, P153, DOI 10.1002/cmr.b.20067; Trakic A, 2012, IEEE T BIO-MED ENG, V59, P1068, DOI 10.1109/TBME.2012.2182993; Trakic A, 2009, CONCEPT MAGN RESON B, V35B, P59, DOI 10.1002/cmr.b.20136; Tropp J, 2004, J MAGN RESON, V167, P12, DOI 10.1016/j.jmr.2003.11.003; Van den Berg CAT, 2007, MAGN RESON MED, V57, P577, DOI 10.1002/mrm.21149; van den Bergen B, 2007, PHYS MED BIOL, V52, P5429, DOI 10.1088/0031-9155/52/17/022; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Vester M, 2006, USING MODE CONCEPT R; Wang CS, 2006, J MAGN RESON, V182, P160, DOI 10.1016/j.jmr.2006.06.015; Wiggins OK G. C., 2006, 7 TESLA GRADIENT MOD; Yazdanbakhsh P, 2009, VARIABLE POWER COMBI, P397; Zhao Y, 2014, E FIELD CONSTRUCTION; Zhao YJ, 2015, MAGN RESON MED, V74, P1461, DOI 10.1002/mrm.25424; Zhao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103945; Zhao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077759	56	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0206127	10.1371/journal.pone.0206127	http://dx.doi.org/10.1371/journal.pone.0206127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481187	Green Published, gold, Green Submitted			2022-12-26	WOS:000451440000005
J	Yan, XD; Liu, XB; Song, YL				Yan, Xuedong; Liu, Xiaobing; Song, Yulei			Optimizing evacuation efficiency under emergency with consideration of social fairness based on a cell transmission model	PLOS ONE			English	Article							TRAFFIC ASSIGNMENT; KINEMATIC WAVES; SYSTEM; OPTIMIZATION; FLOW; NETWORKS; LOCATION	Traffic assignment and management objectives are considered as two significant parts in developing the emergency evacuation plan, which can directly influence the evacuation performance and efficiency. From the perspective of disaster response operators, the evacuation objective frequently is to minimize the total evacuation time to reduce losses, which may lead to an unreasonable and unfair phenomenon where people in highest risk areas may be forced to sacrifice their priorities of evacuation to improve the system evacuation efficiency. In this paper, considering both efficiency and social fairness in emergency evacuation, a weight function consisting of risk evaluation index as variable and the emphasis degree of managers on social fairness principle as coefficient was initially proposed and embedded in system optimal (SO) objective function. Combining the weight function and other constraints based on an extended cell transmission model (CTM), the linear program (LP) model was established to realize the simulation of dynamic traffic assignment in emergency evacuation. Employing this model, the impact of the management strategy of balancing both efficiency and social fairness on evacuation results was studied in the "Tianjin Explosions" case. In the end, the conclusion of "balancing social fairness is valuable during evacuation" was obtained.	[Yan, Xuedong; Liu, Xiaobing; Song, Yulei] Beijing Jiaotong Univ, Sch Traff & Transportat, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China	Beijing Jiaotong University	Yan, XD (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China.	xdyan@bjtu.edu.cn	Yan, Xuedong/A-5126-2009; Yan, Xuedong/L-6957-2019; Yan, Xuedong/S-3681-2019	Yan, Xuedong/0000-0003-0120-9183; Yan, Xuedong/0000-0003-0120-9183; Liu, Xiaobing/0000-0003-1142-5816	National Natural Science Foundation [91746201, 71621001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work is financially supported by National Natural Science Foundation (91746201, 71621001) to XY.; This work is financially supported by National Natural Science Foundation (91746201, 71621001). The authors declares that there is no conflict of interest regarding the publication of this paper.	Alcada-Almeida L, 2009, GEOGR ANAL, V41, P9, DOI 10.1111/j.1538-4632.2009.00745.x; [Anonymous], 2008, P COMM ROL PUBL TRAN; Athanasios K., 2000, T SCI, V34, P37; Bayram V, 2015, TRANSPORT RES B-METH, V72, P146, DOI 10.1016/j.trb.2014.11.010; Bish DR, 2013, EUR J OPER RES, V224, P79, DOI 10.1016/j.ejor.2012.07.036; Chakraborty J., 2005, NAT HAZARDS REV, V6, P23, DOI [10.1061/(ASCE)1527-6988(2005)6:1(23), DOI 10.1061/(ASCE)1527-6988(2005)6:1(23)]; Chen HK, 1998, TRANSPORT RES B-METH, V32, P219, DOI 10.1016/S0191-2615(97)00026-X; CNN. com, 2001, CNN LIV DAYBR ESC HU; Coutinho-Rodrigues J, 2012, J TRANSP GEOGR, V22, P206, DOI 10.1016/j.jtrangeo.2012.01.006; Cova TJ, 2003, TRANSPORT RES A-POL, V37, P579, DOI 10.1016/S0965-8564(03)00007-7; Cutter SL, 2000, ANN ASSOC AM GEOGR, V90, P713, DOI 10.1111/0004-5608.00219; Daganzo CF, 2011, TRANSPORT RES B-METH, V45, P1424, DOI 10.1016/j.trb.2011.05.015; DAGANZO CF, 1994, TRANSPORT RES B-METH, V28, P269, DOI 10.1016/0191-2615(94)90002-7; DAGANZO CF, 1995, TRANSPORT RES B-METH, V29, P79, DOI 10.1016/0191-2615(94)00022-R; Gai WM, 2018, SAFETY SCI, V106, P203, DOI 10.1016/j.ssci.2018.03.021; Hamacher HW, 2013, ANN OPER RES, V207, P161, DOI 10.1007/s10479-011-0953-9; Hsu YT, 2014, TRANSPORT RES C-EMER, V41, P73, DOI 10.1016/j.trc.2014.01.013; Jahn O, 2005, OPER RES, V53, P600, DOI 10.1287/opre.1040.0197; Kalafatas G, 2009, J INFRASTRUCT SYST, V15, P21, DOI 10.1061/(ASCE)1076-0342(2009)15:1(21); Kimms A, 2012, NETWORKS, V60, P179, DOI 10.1002/net.21457; Kimms A, 2018, EUR J OPER RES, DOI [10.1016/j.ejor.2016.10.019, DOI 10.1016/J.EJOR.2016.10.019]; Li J, 2015, NETW SPAT ECON, V15, P677, DOI 10.1007/s11067-014-9241-y; LIGHTHILL MJ, 1955, PROC R SOC LON SER-A, V229, P281, DOI 10.1098/rspa.1955.0088; LIGHTHILL MJ, 1955, PROC R SOC LON SER-A, V229, P317, DOI 10.1098/rspa.1955.0089; Ma JQ, 2016, TRANSPORT RES C-EMER, V64, P164, DOI 10.1016/j.trc.2015.03.004; Ma R, 2014, TRANSPORT RES B-METH, V68, P98, DOI 10.1016/j.trb.2014.06.003; Montz BE, 1998, APPL GEOGRAPHY C, V21, P315; Munoz L, 2003, P AMER CONTR CONF, P3750; Neumann C. J., 1987, 38 NOAA NWS NHC; Odeh D.J., 2002, NAT HAZARD REV, V3, P177, DOI [10.1061/(ASCE)1527-6988(2002)3:4(177), DOI 10.1061/(ASCE)1527-6988(2002)3:4(177)]; Peeta S, 1995, ANN OPER RES, V60, P81, DOI 10.1007/BF02031941; Pel AJ, 2012, TRANSPORTATION, V39, P97, DOI 10.1007/s11116-011-9320-6; RICHARDS PI, 1956, OPER RES, V4, P42, DOI 10.1287/opre.4.1.42; Shen W, 2014, TRANSPORT RES B-METH, V65, P1, DOI 10.1016/j.trb.2014.02.002; Sheu JB, 2014, TRANSPORT RES B-METH, V67, P284, DOI 10.1016/j.trb.2014.05.011; So SK, 2010, TRANSPORT RES B-METH, V44, P514, DOI 10.1016/j.trb.2009.11.002; Southworth F., 1991, ORNLTM11740; Sumalee A, 2011, TRANSPORT RES B-METH, V45, P507, DOI 10.1016/j.trb.2010.09.006; Szeto WY, 2006, TRANSPORTMETRICA, V2, P31, DOI 10.1080/18128600608685654; Tiaprasert K, 2017, TRANSPORT RES C-EMER, V85, P86, DOI 10.1016/j.trc.2017.09.008; Xie C, 2010, TRANSPORT RES E-LOG, V46, P295, DOI 10.1016/j.tre.2009.11.004; Yi WQ, 2017, TRANSPORT RES B-METH, V95, P285, DOI 10.1016/j.trb.2016.10.008; Zhao X, 2016, J ADV TRANSPORT, V50, P589, DOI 10.1002/atr.1362; Zheng H., 2014, J MATH MODEL ALGORIT, V13, P169; Ziliaskopoulos AK, 2000, TRANSPORT RES C-EMER, V8, P427, DOI 10.1016/S0968-090X(00)00027-9	45	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207916	10.1371/journal.pone.0207916	http://dx.doi.org/10.1371/journal.pone.0207916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB9UV	30481206	Green Published, gold, Green Submitted			2022-12-26	WOS:000451440000028
J	Abrosimova, LA; Migur, AY; Kubareva, EA; Zatsepin, TS; Gavshina, AV; Yunusova, AK; Perevyazova, TA; Pingoud, A; Oretskaya, TS				Abrosimova, Liudmila A.; Migur, Anzhela Yu.; Kubareva, Elena A.; Zatsepin, Timofei S.; Gavshina, Aleksandra V.; Yunusova, Alfiya K.; Perevyazova, Tatiana A.; Pingoud, Alfred; Oretskaya, Tatiana S.			A study on endonuclease BspD6I and its stimulus-responsive switching by modified oligonucleotides	PLOS ONE			English	Article							SITE-SPECIFIC NICKASE; PHOTOCHEMICAL REGULATION; RESTRICTION ENDONUCLEASES; ELECTROCHEMICAL DETECTION; DNA; NICKING; HYBRIDIZATION; AZOBENZENE; SEQUENCE; CLEAVAGE	Nicking endonucleases (NEases) selectively cleave single DNA strands in double-stranded DNAs at a specific site. They are widely used in bioanalytical applications and in genome editing; however, the peculiarities of DNA-protein interactions for most of them are still poorly studied. Previously, it has been shown that the large subunit of heterodimeric restriction endonuclease BspD6I (Nt.BstD6I) acts as a NEase. Here we present a study of interaction of restriction endonuclease BspD6I with modified DNA containing single non-nucleotide insertion with an azobenzene moiety in the enzyme cleavage sites or in positions of sugar-phosphate backbone nearby. According to these data, we designed a number of effective stimulus-responsive oligonucleotide inhibitors bearing azobenzene or triethylene glycol residues. These modified oligonucleotides modulated the functional activity of Nt. BspD6I after cooling or heating. We were able to block the cleavage of T7 phage DNA by this enzyme in the presence of such inhibitors at 20-25 degrees C, whereas the Nt. BspD6I ability to hydrolyze DNA was completely restored after heating to 45 degrees C. The observed effects can serve as a basis for the development of a platform for regulation of NEase activity in vitro or in vivo by external signals.	[Abrosimova, Liudmila A.; Migur, Anzhela Yu.; Kubareva, Elena A.; Zatsepin, Timofei S.; Gavshina, Aleksandra V.; Oretskaya, Tatiana S.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Abrosimova, Liudmila A.; Migur, Anzhela Yu.; Kubareva, Elena A.; Zatsepin, Timofei S.; Gavshina, Aleksandra V.; Oretskaya, Tatiana S.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Zatsepin, Timofei S.] Skolkovo Inst Sci & Technol, Skolkovo, Moscow Region, Russia; [Yunusova, Alfiya K.; Perevyazova, Tatiana A.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia; [Pingoud, Alfred] Justus Liebig Univ, Inst Biochem, Giessen, Germany; [Migur, Anzhela Yu.] Albert Ludwigs Univ, Biol 2 3, Freiburg, Germany; [Gavshina, Aleksandra V.] Russian Acad Sci, AN Bach Inst Biochem, Biotechnol Res Ctr, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Skolkovo Institute of Science & Technology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; Justus Liebig University Giessen; University of Freiburg; Research Center of Biotechnology RAS; Russian Academy of Sciences	Abrosimova, LA (corresponding author), Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia.; Abrosimova, LA (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	abrludmila@gmail.com	Abrosimova, Liudmila/I-3212-2012; Perevyazova, Tatiana A./B-1092-2014; Yunusova, Alfiya Kyashafovna/AAZ-4224-2021; Zatsepin, Timofei S/I-2821-2012; Kubareva, Elena A/I-3184-2012	Yunusova, Alfiya Kyashafovna/0000-0001-9734-7593; Zatsepin, Timofei S/0000-0003-0030-9174; Abrosimova, Liudmila/0000-0002-8975-8285; Perevazova, Tat'ana/0000-0001-7448-1386; Migur, Anzhela/0000-0002-2065-6088	Russian Foundation for Basic Research [N 17-54-45126]; Russian Science Foundation [N 14-24-00061]; RFBR [N. 17-54-45126]; RSF [N. 14-24-00061]; Russian Science Foundation [17-24-00003] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR)); RSF(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng). Grant N 17-54-45126 (to EAK); and Russian Science Foundation (http://rscf.ru/en). Grant N 14-24-00061 (to TSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their gratitude to Prof. L.A. Zheleznaya and Dr. W. Wende for helpful discussions of the experimental data. This work has been supported by the RFBR (N. 17-54-45126) and RSF (N. 14-24-00061) grants.	Abrosimova LA, 2015, IZV VUZOV-PRIKL KHIM, P48; Abrosimova LA, 2016, BBA-PROTEINS PROTEOM, V1864, P1072, DOI 10.1016/j.bbapap.2016.05.008; Abrosimova LA, 2013, IUBMB LIFE, V65, P1012, DOI 10.1002/iub.1222; Asanuma H, 2001, ANGEW CHEM INT EDIT, V40, P2671, DOI 10.1002/1521-3773(20010716)40:14<2671::AID-ANIE2671>3.0.CO;2-Z; Asanuma H, 2007, NAT PROTOC, V2, P203, DOI 10.1038/nprot.2006.465; Asanuma Hiroyuki, 2003, Nucleic Acids Res Suppl, P117; Azhibek D, 2014, NUCLEIC ACIDS RES, V42, P9531, DOI 10.1093/nar/gku688; Banerjee JK, 2014, MOL CELL BIOL, V34, P2566, DOI 10.1128/MCB.00411-14; CAI H, 1993, J BIOL CHEM, V268, P23567; Christensen J, 2001, J VIROL, V75, P7009, DOI 10.1128/JVI.75.15.7009-7017.2001; Dagdas YS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao0027; DiCarlo JE, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.3.13; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Farzan VM, 2017, BIOCONJUGATE CHEM, V28, P2599, DOI 10.1021/acs.bioconjchem.7b00462; Farzan VM, 2017, ANALYST, V142, P945, DOI 10.1039/c6an02441f; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Gabsalilow L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt080; Govan JM, 2011, BIOCONJUGATE CHEM, V22, P2136, DOI 10.1021/bc200411n; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Harrington LB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01408-4; Havlicek S, 2017, MOL THER, V25, P342, DOI 10.1016/j.ymthe.2016.11.007; Heider MR, 2017, J BIOL CHEM, V292, P8835, DOI 10.1074/jbc.M117.783472; Horiuchi K, 1997, GENES CELLS, V2, P425, DOI 10.1046/j.1365-2443.1997.1360334.x; Hu TX, 2016, ANALYST, V141, P1506, DOI 10.1039/c5an02484f; Hu YJ, 2007, ANAL BIOCHEM, V369, P54, DOI 10.1016/j.ab.2007.04.042; Ji YH, 2017, BIOSENS BIOELECTRON, V96, P201, DOI 10.1016/j.bios.2017.05.008; Kachalova GS, 2008, J MOL BIOL, V384, P489, DOI 10.1016/j.jmb.2008.09.033; Kashida H, 2009, CURR ORG CHEM, V13, P1065, DOI 10.2174/138527209788680736; Klein M, 2018, CELL REP, V22, P1413, DOI 10.1016/j.celrep.2018.01.045; Koo T, 2015, MOL CELLS, V38, P475, DOI 10.14348/molcells.2015.0103; KUBAREVA EA, 1992, NUCLEIC ACIDS RES, V20, P4533, DOI 10.1093/nar/20.17.4533; Hien LT, 2011, BIOCONJUGATE CHEM, V22, P1366, DOI 10.1021/bc200063m; Li J, 2014, CHEM-ASIAN J, V9, P3344, DOI 10.1002/asia.201402758; Li XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06594-1; Liang XG, 2003, J AM CHEM SOC, V125, P16408, DOI 10.1021/ja037248j; Lu W, 2017, BIOSENS BIOELECTRON, V90, P258, DOI 10.1016/j.bios.2016.10.024; Luan DD, 1996, MOL CELL BIOL, V16, P4726; Lukyanchikova NV, 2016, BIOCHEMISTRY-MOSCOW+, V81, P263, DOI 10.1134/S0006297916030093; Mougiakos I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01591-4; Nakayama K, 2004, CHEM COMMUN, P2386, DOI 10.1039/b409844g; Nunez JK, 2016, ACS CHEM BIOL, V11, P681, DOI 10.1021/acschembio.5b01019; Pennadam SS, 2004, J AM CHEM SOC, V126, P13208, DOI 10.1021/ja045275j; Perevyazova T. A., 2017, MEDLINERU, V18, P200; PETRAUSKENE OV, 1995, GENE, V157, P173, DOI 10.1016/0378-1119(94)00737-D; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Pyshnaya IA, 2004, NUCLEOS NUCLEOT NUCL, V23, P1065, DOI 10.1081/NCN-200026073; Roy D, 2010, MOL CELL BIOL, V30, P146, DOI 10.1128/MCB.00897-09; Schierling B, 2012, BIOCONJUGATE CHEM, V23, P1105, DOI 10.1021/bc3001326; Schierling B, 2012, NUCLEIC ACIDS RES, V40, P2623, DOI 10.1093/nar/gkr1112; Schierling B, 2010, P NATL ACAD SCI USA, V107, P1361, DOI 10.1073/pnas.0909444107; Sekerina SA, 2012, RUSS J BIOORG CHEM+, V38, P376, DOI 10.1134/S1068162012040127; Silanskas A, 2012, BIOCONJUGATE CHEM, V23, P203, DOI 10.1021/bc200480m; Silanskas A, 2011, BIOCHEMISTRY-US, V50, P2800, DOI 10.1021/bi2000609; Tang X, 2008, NUCLEIC ACIDS RES, V36, P559, DOI 10.1093/nar/gkm1029; Vinogradova OA, 2009, RUSS J BIOORG CHEM+, V35, P349, DOI 10.1134/S1068162009030108; WATERS VL, 1993, MOL MICROBIOL, V9, P1123, DOI 10.1111/j.1365-2958.1993.tb01242.x; WILK A, 1990, NUCLEIC ACIDS RES, V18, P2065, DOI 10.1093/nar/18.8.2065; Wrenbeck EE, 2016, NAT METHODS, V13, P928, DOI 10.1038/nmeth.4029; Xu XJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00180-1; Yang HL, 2005, BIOCHEM BIOPH RES CO, V328, P265, DOI 10.1016/j.bbrc.2004.12.159; Yang W, 2000, MUTAT RES-DNA REPAIR, V460, P245, DOI 10.1016/S0921-8777(00)00030-6; Yanik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082539; Young DD, 2009, CHEMBIOCHEM, V10, P1612, DOI 10.1002/cbic.200900090; Yunusova AK, 2006, BIOCHEMISTRY-MOSCOW+, V71, P815, DOI 10.1134/S0006297906070157; Zhang LK, 2017, SCI REP-UK, V7, DOI 10.1038/srep42542; Zheleznaya LA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P498, DOI 10.1023/A:1015250426726; Zhou WJ, 2014, BIOSENS BIOELECTRON, V53, P494, DOI 10.1016/j.bios.2013.10.020; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	68	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207302	10.1371/journal.pone.0207302	http://dx.doi.org/10.1371/journal.pone.0207302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475809	Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700022
J	Huang, FF; Zhang, MQ; Li, Y; Li, Z; Fang, JY; Guo, KY				Huang, Feifei; Zhang, Minqiang; Li, Yan; Li, Zhe; Fang, Junyan; Guo, Kaiyin			The longitudinal trajectory of body mass index in the Chinese population: A latent growth curve analysis	PLOS ONE			English	Article							RISK-FACTORS; DEFINE OVERWEIGHT; FOLLOW-UP; OBESITY; HYPERTENSION; HEALTH; NUTRITION; TRENDS; PREVALENCE; ADULTS	Aims The objective of this study was to investigate the longitudinal trajectory of BMI in the Chinese population, and to assess whether the gender or other personal characteristics were related to BMI, and whether there was a change in trajectory over time. Methods Data were obtained from 3,574 Chinese (5 to 89 years of age) who participated in the 20002011 of the China Health and Nutrition Survey. Latent growth curve models were used to investigate the longitudinal trajectory of BMI, and to examine the effect of some personal characteristics on BMI trajectory. Results The linear model resulted in a mean initial BMI value of 22.90 and a significant mean slope (Ms = 0.19, t = 10.73, p<0.001), suggesting a steady increase in BMI over time for the whole sample. For covariates, the educational level, alcohol and physical activity had differences on initial scores for BMI (beta = 0.05, p<0.001; beta =-0.12, p<0.05; beta =-0.08, p<0.05; respectively.), and the age had differences on both the initial scores and slope for BMI (beta = 0.01, p = <0.05; beta =-0.03, p<0.01; respectively.). Baseline measures revealed gender-associated differences on initial scores for BMI, and the slope for male was significantly steeper than that for female (beta =-0.11, p<0.05). The initial BMI status of Chinese living in the rural areas was significantly higher than that of Chinese living in the urban areas, and the slope for rural status was significantly steeper than that for urban status (beta = 0.21, p<0.001). Conclusions Results indicated a linear trajectory of BMI in the Chinese population over a 12-year period. The longitudinal trajectories differed by age, gender and urban-rural status, suggesting different interventions should be adopted for different groups.	[Huang, Feifei; Zhang, Minqiang; Li, Yan; Li, Zhe; Fang, Junyan] South China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Zhang, Minqiang; Guo, Kaiyin] South China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Zhang, MQ (corresponding author), South China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China.; Zhang, MQ (corresponding author), South China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China.	zhangmq1117@qq.com		Huang, Feifei/0000-0002-4088-2904				Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bell AC, 2002, AM J EPIDEMIOL, V155, P346, DOI 10.1093/aje/155.4.346; Chambers JA, 2010, BRIT J NUTR, V104, P298, DOI 10.1017/S0007114510000607; Chan D, 1998, ORGAN RES METHODS, V1, P421, DOI 10.1177/109442819814004; Chen PC, 2009, J HYPERTENS, V27, P1370, DOI 10.1097/HJH.0b013e32832af6d4; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Du S, 2001, Wei Sheng Yan Jiu, V30, P221; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Duncan T, 2006, INTRO LATENT VARIABL; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058453; He J, 1996, AM J HYPERTENS, V9, p74A, DOI DOI 10.1016/0895-7061(96)81695-5; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jaacks LM, 2013, INT J EPIDEMIOL, V42, P828, DOI 10.1093/ije/dyt052; Jebb S. A., 2007, Obesity Reviews, V8, pvi, DOI 10.1111/j.1467-789X.2007.00344.x; Levine JA, 2008, CHINESE MED J-PEKING, V121, P1043, DOI 10.1097/00029330-200806010-00015; Lewington S, 2016, JAMA INTERN MED, V176, P524, DOI 10.1001/jamainternmed.2016.0190; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; MEREDITH W, 1990, PSYCHOMETRIKA, V55, P107, DOI 10.1007/BF02294746; Misra A, 2003, INT J OBESITY, V27, P1294, DOI 10.1038/sj.ijo.0802412; Muthen L. K., 2004, MPLUS USERS GUIDE; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Ouyang YF, 2015, ASIA PAC J CLIN NUTR, V24, P692, DOI 10.6133/apjcn.2015.24.4.06; Reinehr T, 2006, AM J CLIN NUTR, V84, P490, DOI 10.1093/ajcn/84.3.490; Ren Q, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030257; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Ng SW, 2012, EMPIR ECON, V42, P413, DOI 10.1007/s00181-012-0547-7; Stevens J, 2003, INT J OBESITY, V27, P1297, DOI 10.1038/sj.ijo.0802417; Stevens J, 2003, INT J OBESITY, V27, P287, DOI 10.1038/sj.ijo.0802255; STEVENS J, 2003, PROGR OBESITY RES, P554; Walls TA, 2007, PSYCHOMETRIKA, V72, P643, DOI 10.1007/s11336-007-9011-6; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Wang YF, 2000, AM J CLIN NUTR, V72, P1018; Wang ZH, 2012, ASIA PAC J CLIN NUTR, V21, P253; Willett J. B., 1996, ADV STRUCTURAL EQUAT; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yu HM, 2017, INT J GERIATR PSYCH, V32, P940, DOI 10.1002/gps.4551; Zhang YX, 2011, ANN HUM BIOL, V38, P630, DOI 10.3109/03014460.2011.594453	41	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207845	10.1371/journal.pone.0207845	http://dx.doi.org/10.1371/journal.pone.0207845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475874	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700080
J	Jacobs, L; Berrens, Z; Stenson, EK; Zackoff, M; Danziger-Isakov, L; Lahni, P; Wong, HR				Jacobs, Lauren; Berrens, Zachary; Stenson, Erin K.; Zackoff, Matthew; Danziger-Isakov, Lara; Lahni, Patrick; Wong, Hector R.			Interleukin-27 as a candidate diagnostic biomarker for bacterial infection in immunocompromised pediatric patients	PLOS ONE			English	Article							SEPSIS; PROCALCITONIN; IL-27; ACCURACY	Background Immunocompromised pediatric patients constitute a growing population that is particularly vulnerable to bacterial infection, necessitating prompt recognition and treatment. This study assessed the utility of interleukin-27 (IL-27) and procalcitonin (PCT) as biomarkers of bacterial infection among immunocompromised pediatric subjects. Methods This is a single-center prospective cohort study conducted from July 2016 through September 2017, drawing subjects from the inpatient units at Cincinnati Children's Hospital Medical Center (CCHMC), a large, tertiary care children's hospital. Patients were included if they fit the definition of immunocompromised and were under clinical suspicion for infection, defined by the acquisition of a blood culture at any point during the admission. The primary analysis assessed the accuracy of IL-27 to diagnose bacterial infection in immunocompromised pediatric patients, using PCT as a comparator. Results 293 patients were recruited, representing 400 episodes of suspected bacterial infection. The median age was 7.8 years (IQR 3.1-13.8 years). Fifty-three percent (n = 213) of the population had a primary oncologic diagnosis, 24% (n = 95) had received a bone marrow transplant, and 21% (n = 85) had received a solid organ transplant. The overall infection rate was 37%, with 70% of those patients having some form of culture positivity. Twenty-eightday mortality was 5%, 60-day mortality was 9%, with 87% of patients surviving to hospital discharge. The AUC's of the ROC curve to diagnose bacterial infection were 0.62 (0.5-0.68) for IL-27 and 0.65 (0.6-0.73) for PCT. Using the previously determined cutoff of 5.0 ng/mL, the specificity of IL-27 to diagnose bacterial infection reached 94%, with a negative predictive value of 64%. Conclusions Despite prior work demonstrating IL-27 and PCT as possible biomarkers of bacterial infection in immunocompromised pediatric patients, we were unable to validate these findings. This illustrates the challenges associated with developing reliable biomarkers of bacterial infection in this vulnerable population.	[Jacobs, Lauren] Texas Childrens Hosp, Dept Pediat, Div Pediat Crit Care, Houston, TX 77030 USA; [Berrens, Zachary] Univ Indiana Hlth, Riley Hosp Children, Dept Pediat, Div Pediat Crit Care, Indianapolis, IN USA; [Stenson, Erin K.] Childrens Hosp Colorado, Dept Pediat, Div Pediat Crit Care, Aurora, CO USA; [Zackoff, Matthew; Lahni, Patrick; Wong, Hector R.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pediat Crit Care, Cincinnati, OH 45229 USA; [Danziger-Isakov, Lara] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pediat Infect Dis, Cincinnati, OH 45229 USA	Baylor College of Medicine; James Whitcomb Riley Hospital Children; Children's Hospital Colorado; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Jacobs, L (corresponding author), Texas Childrens Hosp, Dept Pediat, Div Pediat Crit Care, Houston, TX 77030 USA.	ljacobs@bcm.edu	Stenson, Erin/CAF-1429-2022; Berrens, Zachary/AAM-4508-2020	Berrens, Zachary/0000-0001-9756-9751	National Institutes of Health [R01GM108025]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a National Institutes of Health grant, R01GM108025, awarded to Hector R Wong. There were no sponsors, and the funder had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Hanna WJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1095-2; Hoeboer SH, 2015, CLIN MICROBIOL INFEC, V21, P474, DOI 10.1016/j.cmi.2014.12.026; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kraft JD, 2013, IMMUNOLOGY, V139, P484, DOI 10.1111/imm.12095; Krumbiegel D, 2008, PEDIAT ALLERG IMM-UK, V19, P513, DOI 10.1111/j.1399-3038.2007.00685.x; Liu X, 2015, LEUKEMIA LYMPHOMA, V56, P85, DOI 10.3109/10428194.2014.911864; Meyer Claudius U, 2015, BMC Res Notes, V8, P232, DOI 10.1186/s13104-015-1182-0; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Wong HR, 2014, J CRIT CARE, V29, P718, DOI 10.1016/j.jcrc.2014.04.004; Wong HR, 2013, SHOCK, V40, P382, DOI 10.1097/SHK.0b013e3182a67632; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11847; Zinter MS, 2015, CRIT CARE MED, V43, P1986, DOI 10.1097/CCM.0000000000001085	17	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207620	10.1371/journal.pone.0207620	http://dx.doi.org/10.1371/journal.pone.0207620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475852	gold, Green Published, Green Submitted			2022-12-26	WOS:000451325700046
J	Lim, DH; Han, JS; Chung, TY; Kang, S; Yim, HW				Lim, Dong Hui; Han, Jisang; Chung, Tae-Young; Kang, Sewoong; Yim, Hyeon Woo		Korean Ophthalmologic Soc	The high prevalence of myopia in Korean children with influence of parental refractive errors: The 2008-2012 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							VISUAL IMPAIRMENT; SCHOOL-CHILDREN; UNITED-STATES; EYE SIZE; ASSOCIATION; PROGRESSION; HISTORY; POPULATION; SEVERITY; IMPACT	The present study was conducted to investigate the effect of parental refractive errors on myopic children in Korean families using a nationally representative survey. We used the ophthalmologic examination dataset of the Korean National Health and Nutrition Examination Surveys IV and V, a nationwide population-based cross-sectional study using a complex, stratified, multistage, probability cluster survey, which were performed from 2008-2012. We included 3,862 children from 5-18 years of age from 2,344 families without any ocular trauma, surgical history, or cataract affecting refractive errors. The generalized estimating equation was conducted to assess the association of refractive errors among children and their parents. Among 3,862 children, 2,495 had myopia, which was 64.6% prevalence. There were 208 children with high myopia (5.4%). The prevalence rate ratio (PRR) for pediatric myopia and high myopia with myopic parents was 1.34 (95% confidence intervals [ CI] 1.24-1.45) and 3.11 (95% CI 1.93-5.01), respectively. The PRR of myopia and high myopia in children significantly increased to 1.37 (95% CI 1.04-1.81) and 11.41 (95% CI 6.24-20.88), as the degree of parental myopia increased (P<0.001, respectively). Children with two myopic parents were more myopic than those with only one myopic parent (P<0.001, respectively). In addition to parental myopia, the age of the child and household income were also significant risk factors for all degrees of pediatric myopia in a family (P. 0.005, respectively). In conclusion, Korean children showed high prevalence of myopia. Children with myopic parents showed a significantly greater risk for myopia and high myopia.	[Lim, Dong Hui; Chung, Tae-Young; Kang, Sewoong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Lim, Dong Hui; Yim, Hyeon Woo] Catholic Univ Korea, Grad Sch, Seoul, South Korea; [Han, Jisang] Seonam Univ, Sch Med, Myongji Hosp, Dept Ophthalmol, Goyang, South Korea; [Yim, Hyeon Woo] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Myongji Hospital; Seonam University; Catholic University of Korea	Yim, HW (corresponding author), Catholic Univ Korea, Grad Sch, Seoul, South Korea.; Yim, HW (corresponding author), Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea.				National Research Foundation of Korea - Korea government Ministry of Education (Seoul, Korea) [NRF-2018R1D1A1A02045884]	National Research Foundation of Korea - Korea government Ministry of Education (Seoul, Korea)	This work was supported by the National Research Foundation of Korea grant (https://nrf.re.kr/index, accessed in Nov 8, 2018) funded by the Korea government Ministry of Education (NRF-2018R1D1A1A02045884; Seoul, Korea), which was received by DHL. The funder had a role in data analysis and preparation of the manuscript.	Arevalo JF, 2012, GRAEF ARCH CLIN EXP, V250, P963, DOI 10.1007/s00417-011-1907-2; AVILA MP, 1984, OPHTHALMOLOGY, V91, P1573; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Buch H, 2001, OPHTHALMOLOGY, V108, P2347, DOI 10.1016/S0161-6420(01)00823-5; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Edwards MH, 1998, OPHTHAL PHYSL OPT, V18, P477, DOI 10.1016/S0275-5408(98)00019-2; Fan DSP, 2005, ACTA OPHTHALMOL SCAN, V83, P492, DOI 10.1111/j.1600-0420.2005.00481.x; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Fan DSP, 2004, ANN ACAD MED SINGAP, V33, P39; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Huang HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140419; HUI J, 1995, VISION RES, V35, P1353, DOI 10.1016/0042-6989(94)00224-A; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; Kim MH, 2013, INVEST OPHTH VIS SCI, V54, P3644, DOI 10.1167/iovs.12-11254; Kurtz D, 2007, INVEST OPHTH VIS SCI, V48, P562, DOI 10.1167/iovs.06-0408; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Kwon JW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005012; Lam DSC, 2008, INVEST OPHTH VIS SCI, V49, P873, DOI 10.1167/iovs.06-1097; Liang CL, 2004, INVEST OPHTH VIS SCI, V45, P3446, DOI 10.1167/iovs.03-1058; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; Lyu IJ, 2015, INVEST OPHTH VIS SCI, V56, P4712, DOI 10.1167/iovs.14-16262; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Pacella R, 1999, OPTOMETRY VISION SCI, V76, P381, DOI 10.1097/00006324-199906000-00017; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw S M, 2001, Ophthalmic Epidemiol, V8, P227, DOI 10.1076/opep.8.4.227.1609; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Steidl SM, 1997, AM J OPHTHALMOL, V123, P181, DOI 10.1016/S0002-9394(14)71034-7; TEIKARI J, 1989, OPTOMETRY VISION SCI, V66, P594, DOI 10.1097/00006324-198909000-00005; Tsai DC, 2016, INVEST OPHTH VIS SCI, V57, P6852, DOI 10.1167/iovs.16-20288; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Williams KM, 2017, JAMA OPHTHALMOL, V135, P47, DOI 10.1001/jamaophthalmol.2016.4752; Williams KM, 2015, OPHTHALMOLOGY, V122, P1489, DOI 10.1016/j.ophtha.2015.03.018; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Wu MMM, 1999, OPTOMETRY VISION SCI, V76, P387, DOI 10.1097/00006324-199906000-00018; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346; Yoon Kyung Chul, 2015, Korean J Ophthalmol, V29, P359, DOI 10.3341/kjo.2015.29.6.359; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Zhang DD, 2017, OPHTHALMIC GENET, V38, P434, DOI 10.1080/13816810.2016.1253105; Zheng YF, 2013, INVEST OPHTH VIS SCI, V54, P7532, DOI 10.1167/iovs.13-12795	48	31	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207690	10.1371/journal.pone.0207690	http://dx.doi.org/10.1371/journal.pone.0207690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475837	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700054
J	Moda, MD; Fagundes, TC; Briso, ALF; dos Santos, PH				Moda, Mariana Dias; Fagundes, Ticiane Cestari; Fraga Briso, Andre Luiz; dos Santos, Paulo Henrique			Analysis of the bond interface between self-adhesive resin cement to eroded dentin in vitro	PLOS ONE			English	Article							HYBRID LAYER; STRENGTH; EROSION; PRETREATMENT; DEGRADATION; FLUORIDE; ENAMEL; MATRIX; PH	The purpose of this study was to evaluate the bonding interface between a self-adhesive resin cement to in vitro eroded dentin. Seventy-two third molars were used and divided into two groups: sound dentin and in vitro eroded dentin. The in vitro erosion was performed following a demineralization protocol, in which the specimens were immersed in a demineralizing solution for 2 minutes per cycle and remineralizing solution for 10 minutes per cycle for 9 days. Both groups were submitted to four dentin surface treatments: control group (without any treatment), 2% chlorhexidine, 20% polyacrylic acid, and 0.1 M EDTA (n = 9). Blocks of resin-based composite were bonded with RelyX U200 self-adhesive resin cement applied on the pretreated dentin surfaces. The teeth were sectioned into beams (1mm(2)) and submitted to microtensile bond strength testing to evaluate the bond strength of self-adhesive resin cement to dentin after 24 hours and 8 months of immersion in artificial saliva. Three specimens of each group were longitudinally cut and evaluated using confocal laser scanning microscopy to analyze the dentin/cement interface. Eroded dentin showed higher bond strength values when compared to sound dentin for the 2% chlorhexidine group (p = 0.03), 24 hours after adhesion. When considering eroded dentin, the 0.1M EDTA group showed higher bond strength values with a statistically significant difference only for the control group (p = 0.002). After 8 months of storage, the present results showed that there was no statistically significant difference between the two substrates for all experimental groups (p>0.05). Analysis of the microscopy confocal showed different types of treatments performed on dentin generally increased tags formation when compared to the control group. The eroded dentin showed a significant increase in density and depth of resinous tags when compared to sound dentin. The storage of samples for 8 months seems to have not caused significant degradation of the adhesive interface.	[Moda, Mariana Dias; Fagundes, Ticiane Cestari; Fraga Briso, Andre Luiz] UNESP Sao Paulo State Univ, Aracatuba Dent Sch, Dept Restorat Dent, Aracatuba, SP, Brazil; [dos Santos, Paulo Henrique] UNESP Sao Paulo State Univ, Aracatuba Dent Sch, Dept Dent Mat & Prosthodont, Aracatuba, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	dos Santos, PH (corresponding author), UNESP Sao Paulo State Univ, Aracatuba Dent Sch, Dept Dent Mat & Prosthodont, Aracatuba, SP, Brazil.	paulosantos@foa.unesp.br	Santos, Paulo Henrique dos/C-8537-2012; Fagundes, Ticiane/AAC-6793-2020; Briso, André/AAQ-9746-2021; Briso, Andre/C-2792-2012; Briso, Andre/AID-8946-2022	Santos, Paulo Henrique dos/0000-0002-4100-5153; Fagundes, Ticiane/0000-0002-3418-0498; Briso, Andre/0000-0002-6126-1760; Moda, Mariana/0000-0001-5779-8410	Sao Paulo Research Foundation (FAPESP) - Brazil [2014/11734-8]	Sao Paulo Research Foundation (FAPESP) - Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The student was supported by research grants form Sao Paulo Research Foundation (FAPESP) - Brazil (#2014/11734-8 to MDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar TR, 2014, J PROSTHET DENT, V111, P404, DOI 10.1016/j.prosdent.2013.07.016; Al-Harbi F, 2015, OPER DENT, V40, P622, DOI 10.2341/14-152-L; Andre CB, 2013, BRAZ ORAL RES, V27, P389, DOI 10.1590/S1806-83242013000500002; Armstrong S, 2017, DENT MATER, V33, P133, DOI 10.1016/j.dental.2016.11.015; Barbosa CS, 2011, AUST DENT J, V56, P317, DOI 10.1111/j.1834-7819.2011.01338.x; Bartlett DW, 1996, BRIT DENT J, V181, P125, DOI 10.1038/sj.bdj.4809187; Bitter K, 2009, EUR J ORAL SCI, V117, P326, DOI 10.1111/j.1600-0722.2009.00623.x; Blumer L, 2015, DENT MATER, V31, P855, DOI 10.1016/j.dental.2015.04.015; Broyles AC, 2013, J PROSTHODONT, V22, P59, DOI 10.1111/j.1532-849X.2012.00890.x; Caneppele Taciana Marco Ferraz, 2012, Braz. Dent. J., V23, P373, DOI 10.1590/S0103-64402012000400011; D'Alpino PHP, 2006, J ADHES DENT, V8, P279; de Almeida CM, 2018, BRAZ ORAL RES, V32, DOI 10.1590/1807-3107bor-2018.vol32.0015; Di Hipolito V, 2012, DENT MATER, V28, P495, DOI 10.1016/j.dental.2011.11.027; Eliguzeloglu E, 2008, OPER DENT, V33, P338, DOI 10.2341/07-96; Fagundes TC, 2014, BRAZ DENT SCI, V17, P10; Fagundes TC, 2009, J DENT, V37, P342, DOI 10.1016/j.jdent.2009.01.002; Farrokh Asefzadeh, 2012, Indian J Dent Res, V23, P221, DOI 10.4103/0970-9290.100430; Ferracane JL, 2011, J ORAL REHABIL, V38, P295, DOI 10.1111/j.1365-2842.2010.02148.x; Francisconi-dos-Rios LF, 2015, J ADHES DENT, V17, P133, DOI 10.3290/j.jad.a34059; Francisconi-Dos-Rios LF, 2015, AM J DENT, V28, P28; Frassetto A, 2016, DENT MATER, V32, pE41, DOI 10.1016/j.dental.2015.11.007; Ganss C, 2014, CARIES RES, V48, P163, DOI 10.1159/000354679; Ganss C, 2014, MONOGR ORAL SCI, V25, P99, DOI 10.1159/000359939; Ganss C, 2009, EUR J ORAL SCI, V117, P255, DOI 10.1111/j.1600-0722.2009.00617.x; Hara AT, 2016, J DENT RES, V95, P537, DOI 10.1177/0022034516629941; Ivancik J, 2012, ACTA BIOMATER, V8, P2737, DOI 10.1016/j.actbio.2012.03.046; Kambara K, 2012, DENT MATER J, V31, P980, DOI 10.4012/dmj.2012-031; Leme AA, 2015, J BIOMECH, V48, P2067, DOI 10.1016/j.jbiomech.2015.03.016; Makishi P, 2016, OPER DENT, V41, P305, DOI 10.2341/15-163-L; Marigo L, 2012, DENT MATER J, V31, P988, DOI 10.4012/dmj.2012-022; Mazzitelli C, 2010, EUR J ORAL SCI, V118, P80, DOI 10.1111/j.1600-0722.2009.00703.x; Montagner AF, 2014, J DENT RES, V93, P733, DOI 10.1177/0022034514538046; Moretto MJ, 2010, CARIES RES, V44, P135, DOI 10.1159/000302902; Mulic A, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-8; Passos VF, 2013, MICROSC RES TECHNIQ, V76, P178, DOI 10.1002/jemt.22150; Pavan S, 2010, J PROSTHET DENT, V104, P258, DOI 10.1016/S0022-3913(10)60134-5; Pinto Shelon C S, 2013, BMC Res Notes, V6, P67, DOI 10.1186/1756-0500-6-67; Buzalaf MAR, 2012, J APPL ORAL SCI, V20, P493, DOI 10.1590/S1678-77572012000500001; Radovic I, 2008, J ADHES DENT, V10, P251; Ren LY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9189354; Ryou H, 2016, DENT MATER, V32, P161, DOI 10.1016/j.dental.2015.11.029; Santos MJMC, 2011, OPER DENT, V36, P512, DOI 10.2341/10-392-L; Sauro S, 2009, DENT MATER, V25, P1392, DOI 10.1016/j.dental.2009.06.010; Scaramucci Tais, 2011, Braz. Dent. J., V22, P473, DOI 10.1590/S0103-64402011000600006; Schlueter N, 2012, ARCH ORAL BIOL, V57, P1176, DOI 10.1016/j.archoralbio.2012.04.001; Schlueter N, 2010, ARCH ORAL BIOL, V55, P294, DOI 10.1016/j.archoralbio.2010.02.003; Shellis RP, 2010, EUR J ORAL SCI, V118, P475, DOI 10.1111/j.1600-0722.2010.00763.x; Simoes TC, 2016, OPER DENT, V41, pE64, DOI 10.2341/14-266-LR; Stape THS, 2012, OPER DENT, V37, P386, DOI 10.2341/11-256-L; Suzuki TYU, 2013, J PROSTHET DENT, V110, P47, DOI 10.1016/S0022-3913(13)60339-X; Tjaderhane L, 2013, DENT MATER, V29, P999, DOI 10.1016/j.dental.2013.07.016; Toledano M, 2013, J MECH BEHAV BIOMED, V27, P10, DOI 10.1016/j.jmbbm.2013.06.002; Wiegand A, 2009, J DENT, V37, P591, DOI 10.1016/j.jdent.2009.03.020; Youm SH, 2015, J ADV PROSTHODONT, V7, P317, DOI 10.4047/jap.2015.7.4.317	54	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0208024	10.1371/journal.pone.0208024	http://dx.doi.org/10.1371/journal.pone.0208024			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475892	Green Published, gold, Green Submitted			2022-12-26	WOS:000451325700100
J	Pietto, ML; Gatti, M; Raimondo, F; Lipina, SJ; Kamienkowski, JE				Pietto, Marcos L.; Gatti, Mathias; Raimondo, Federico; Lipina, Sebastian J.; Kamienkowski, Juan E.			Electrophysiological approaches in the study of cognitive development outside the lab	PLOS ONE			English	Article							SINGLE-TRIAL; EEG; ALPHA; OSCILLATIONS; POTENTIALS; ATTENTION; COMPONENT; ERP	The use of human neuroimaging technology provides knowledge about several emotional and cognitive processes at the neural level of organization. In particular, electroencephalographic (EEG) techniques allow researchers to explore high-temporal resolution of the neural activity that underlie the dynamics of cognitive processes. Although EEG research has been mostly applied in laboratory settings, recently a low-cost, portable EEG apparatus was released, which allows exploration of different emotional and cognitive processes during every-day activities. We compared a wide range of EEG measures using both a low-cost portable and a high-quality laboratory system. EEG recordings were done with both systems while participants performed an active task (Go/NoGo) and during their resting-state. Results showed similar waveforms in terms of morphology and amplitude of the ERPs, and comparable effects between conditions of the applied Go/NoGo paradigm. In addition, the contribution of each frequency to the entire EEG was not significantly different during resting-state, and fluctuations in amplitude of oscillations showed long-range temporal correlations. These results showed that low-cost, portable EEG technology can provide an alternative of enough quality for measuring brain activity outside a laboratory setting, which could contribute to the study of different populations in more ecological contexts.	[Pietto, Marcos L.; Lipina, Sebastian J.] Consejo Nacl Invest Cient & Tecn, UNA, CEMIC, Buenos Aires, DF, Argentina; [Pietto, Marcos L.; Gatti, Mathias; Raimondo, Federico; Kamienkowski, Juan E.] UBA, Lab Inteligencia Artificial Aplicada, Inst Ciencias Comp, FCEyN,CONICET, Buenos Aires, DF, Argentina; [Gatti, Mathias; Raimondo, Federico] UBA, Dept Comp, FCEyN, CONICET, Buenos Aires, DF, Argentina; [Raimondo, Federico] Inst Cerveau & Moelle Epiniere, Paris, France; [Raimondo, Federico] UPMC Univ Paris 06, Sorbonne Univ, Fac Med Pitie Salpetriere, Paris, France; [Raimondo, Federico] Univ Liege, Coma Sci Grp, Liege, Belgium; [Raimondo, Federico] Univ Hosp Liege, Liege, Belgium; [Kamienkowski, Juan E.] UBA, Dept Fis, FCEyN, CONICET, Buenos Aires, DF, Argentina	Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Liege; University of Liege; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pietto, ML (corresponding author), Consejo Nacl Invest Cient & Tecn, UNA, CEMIC, Buenos Aires, DF, Argentina.; Pietto, ML; Kamienkowski, JE (corresponding author), UBA, Lab Inteligencia Artificial Aplicada, Inst Ciencias Comp, FCEyN,CONICET, Buenos Aires, DF, Argentina.; Kamienkowski, JE (corresponding author), UBA, Dept Fis, FCEyN, CONICET, Buenos Aires, DF, Argentina.	marcos.pietto@gmail.com; juank@dc.uba.ar	Raimondo, Federico/O-5814-2017	Raimondo, Federico/0000-0003-4087-8259; Lipina, Sebastian Javier/0000-0001-5939-4073; Pietto, Marcos Luis/0000-0003-4130-7992	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [0794]; Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT) [1256, 0500]; Secretaria de Ciencia y Tecnica (UBACyT) [20020150200119BA]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT)(ANPCyTFONCyT); Secretaria de Ciencia y Tecnica (UBACyT)	This work was supported by (1) Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET): PIP 2015 #0794, www.conicet.gov.ar (SL); (2) Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT): PICT 2014 #0500, http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt (SL); (3) Secretaria de Ciencia y Tecnica (UBACyT): #20020150200119BA, cyt.rec.uba.ar (JK); (4) Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT): PICT 2014 #1256, http://www.agencia.mincyt.gob (JK).	Ahmadi M, 2013, NEUROIMAGE, V66, P672, DOI 10.1016/j.neuroimage.2012.10.062; ASPINALL P, 2015, BRIT J SPORT MED, V49, P272, DOI [DOI 10.1136/bjsports-2012-091877, DOI 10.1136/BJSPORTS-2012-091877]; Badcock NA, 2015, PEERJ, V3, DOI 10.7717/peerj.907; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Boutani H, 2013, IEEE ENG MED BIO, P1346, DOI 10.1109/EMBC.2013.6609758; Bowers EP, 2011, J ADOLESCENCE, V34, P1151, DOI 10.1016/j.adolescence.2011.07.007; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Debener S, 2012, PSYCHOPHYSIOLOGY, V49, P1617, DOI 10.1111/j.1469-8986.2012.01471.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Drake FL, 2010, PYTHON LIB REFERENCE, P1; Ekanayake H, 2010, P300 EMOTIV EPOC DOE; Foster JJ, 2016, J NEUROPHYSIOL, V115, P168, DOI 10.1152/jn.00860.2015; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Johnstone SJ, 2005, J PSYCHOPHYSIOL, V19, P11, DOI 10.1027/0269-8803.19.1.11; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kuziek JWP, 2017, J NEUROSCI METH, V277, P75, DOI 10.1016/j.jneumeth.2016.11.013; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Mavros P, 2016, APPL SPAT ANAL POLIC, V9, P191, DOI 10.1007/s12061-015-9181-z; Mayaud L, 2013, NEUROPHYSIOL CLIN, V43, P217, DOI 10.1016/j.neucli.2013.06.002; Mayer A, 2016, CEREB CORTEX, V26, P3146, DOI 10.1093/cercor/bhv146; Mota NB, 2016, MIND BRAIN EDUC, V10, P184, DOI 10.1111/mbe.12122; Munro P, 2011, ENCY MACHINE LEARNIN, P74; Napflin M, 2007, CLIN NEUROPHYSIOL, V118, P2519, DOI 10.1016/j.clinph.2007.07.022; Navajas J, 2013, J NEUROSCI, V33, P1337, DOI 10.1523/JNEUROSCI.1226-12.2013; Okahashi S, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-59; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pietto M. L., 2017, NEUROSCIENCE SOCIAL, P349, DOI [10.1007/978-3-319-68421-5_15, DOI 10.1007/978-3-319-68421-5_15]; Pietto M, 2016, J ALZHEIMERS DIS, V53, P1325, DOI 10.3233/JAD-160056; Price RB, 2016, DEV COGN NEUROS-NETH, V19, P128, DOI 10.1016/j.dcn.2016.03.001; Quiroga RQ, 2000, PHYSICA D, V145, P278, DOI 10.1016/S0167-2789(00)00116-0; Ries AJ, 2014, J NEUROSCI NEUROENG, V3, P10, DOI [10.1166/jnsne.2014.1092, DOI 10.1166/JNSNE.2014.1092]; Robertson K, 2017, CLIN NEUROPSYCHOL, V31, P16, DOI 10.1080/13854046.2016.1208847; St John AM, 2017, DEV PSYCHOBIOL, V59, P787, DOI 10.1002/dev.21540; Stopczynski A, 2014, INT J PSYCHOPHYSIOL, V91, P54, DOI 10.1016/j.ijpsycho.2013.08.007; Toppi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154236; Wilson BA., 1993, APPL PREV PSYCHOL, V2, P209, DOI [10.1016/S0962-1849(05)80091-5, DOI 10.1016/S0962-1849(05)80091-5]	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0206983	10.1371/journal.pone.0206983	http://dx.doi.org/10.1371/journal.pone.0206983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475814	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700016
J	Soremekun, S; Kasteng, F; Lingam, R; Vassall, A; Kertho, E; Settumba, S; Etou, PL; Nanyonjo, A; ten Asbroek, G; Kallander, K; Kirkwood, B				Soremekun, Seyi; Kasteng, Frida; Lingam, Raghu; Vassall, Anna; Kertho, Edmound; Settumba, Stella; Etou, Patrick L.; Nanyonjo, Agnes; ten Asbroek, Guus; Kallander, Karin; Kirkwood, Betty		inSCALE Study Grp	Variation in the quality and out-of-pocket cost of treatment for childhood malaria, diarrhoea, and pneumonia: Community and facility based care in rural Uganda	PLOS ONE			English	Article							CASE-MANAGEMENT; HEALTH WORKERS; COVERAGE; CHILDREN; MORBIDITY; MORTALITY; MOTIVATION; RETENTION; ILLNESS; AFRICA	Background A key barrier to appropriate treatment for malaria, diarrhoea, and pneumonia (MDP) in children under 5 years of age in low income rural settings is the lack of access to quality health care. The WHO and UNICEF have therefore called for the scale-up of integrated community case management (iCCM) using community health workers (CHWs). The current study assessed access to treatment, out-of-pocket expenditure and the quality of treatment provided in the public and private sectors compared to national guidelines, using data collected in a large representative survey of caregivers of children in 205 villages with iCCM-trained CHWs in mid-Western Uganda. Results The prevalence of suspected malaria, diarrhoea and suspected pneumonia in the preceding two weeks in 6501 children in the study sample were 45%, 11% and 24% respectively. Twenty percent of children were first taken to a CHW, 56% to a health facility, 14% to other providers and no care was sought for 11%. The CHW was more likely to provide appropriate treatment compared to any other provider or to those not seeking care for children with MDP (RR 1.51, 95% CI 1.42-1.61, p<0.001). Seeking care from a CHW had the lowest cost outlay (median $0.00, IQR $0.00-$1.80), whilst seeking care to a private doctor or clinic the highest (median $2.80, IQR $1.20-$6.00). We modelled the expected increase in overall treatment coverage if children currently treated in the private sector or not seeking care were taken to the CHW instead. In this scenario, coverage of appropriate treatment for MDP could increase in total from the current rate of 47% up to 64%. Conclusion Scale-up of iCCM-trained CHW programmes is key to the provision of affordable, high quality treatment for sick children, and can thus significantly contribute to closing the gap in coverage of appropriate treatment.	[Soremekun, Seyi; Lingam, Raghu; ten Asbroek, Guus; Kirkwood, Betty] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Kasteng, Frida; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Kasteng, Frida; Kallander, Karin] Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden; [Lingam, Raghu] Newcastle Univ, Inst Hlth & Soc, Newcastle, NSW, Australia; [Kertho, Edmound; Settumba, Stella; Nanyonjo, Agnes] Malaria Consortium, Kampala, Uganda; [Settumba, Stella] Univ New South Wales, Natl Perinatal Epidemiol & Stat Unit, Sydney, BC, Australia; [Nanyonjo, Agnes] African Populat Hlth Res Ctr, Nairobi, Kenya; [ten Asbroek, Guus] Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Kallander, Karin] Malaria Consortium, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Karolinska Institutet; University of Newcastle; University of New South Wales Sydney; African Population & Health Research Centre; University of Amsterdam; Academic Medical Center Amsterdam	Soremekun, S (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London, England.		Settumba, Stella/AAS-2570-2020; Soremekun, Seyi/AAH-4018-2021	Settumba, Stella/0000-0001-8514-7770; Vassall, Anna/0000-0002-2911-1375; Nanyonjo, Agnes/0000-0002-2036-9548; Kirkwood, Betty/0000-0001-5274-6072; Kallander, Karin/0000-0002-5778-5780; Soremekun, Seyi/0000-0002-5531-0220	Bill and Melinda Gates Foundation [OPP1002407]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by a Bill and Melinda Gates Foundation grant to the Malaria Consortium - number OPP1002407. Webpage: https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2009/10/OPP1002407.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzou A, 2016, AM J TROP MED HYG, V94, P596, DOI 10.4269/ajtmh.15-0586; Amuasi JH, 2017, LANCET GLOB HEALTH, V5, pE375, DOI 10.1016/S2214-109X(17)30087-6; [Anonymous], 2011, OAND CURR CONV; [Anonymous], 2014, COUNTDOWN 2015 MATER; [Anonymous], 2012, WHO UNICEF JOINT STA; Ansah EK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1351-1; Awor P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115440; Bennett A, 2017, LANCET GLOB HEALTH, V5, pE418, DOI 10.1016/s2214-109x(17)30076-1; Biemba G, 2016, TROP MED INT HEALTH, V21, P985, DOI 10.1111/tmi.12730; Brewster D., 2016, ANN TROP PAEDIATR, V13, P133; Buregyeya E, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1842-8; Campbell H, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001422, 10.1371/journal.pmed.1001421]; Chinbuah MA, 2012, AM J TROP MED HYG, V87, P11, DOI 10.4269/ajtmh.2012.12-0078; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S29; Dellicour S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1261-2; Diaz T, 2014, J GLOB HEALTH, V4, P150, DOI [10.7189/jogh.04.020409, 10.7189/jogh.04.020101]; Ezeonwu BU, 2014, ANN MED HEALTH SCI R, V4, P239, DOI 10.4103/2141-9248.141966; Ferdous F, 2013, SCI J PUBLIC HLTH, V1, P69, DOI DOI 10.11648/J.SJPH.20130102.14; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Health U. M. o, 2011, UG NAT MAL CONTR POL, P19; Health U. M. o, 2010, UG CLIN GUID, P658; Holy Innocents Children's Hospital Uganda, 2018, CHILDH DIS UG; Isaacs-Long Y, 2017, SAMJ S AFR MED J, V107, P219, DOI [10.7196/SAMJ.2017.v107i3.11364, 10.7196/samj.2017.v107i3.11364]; Kallander K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0657-6; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Kalyango JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-340; Kalyango JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060481; Kish L, 1995, SURVEY SAMPLING, P664; Knox Stephanie A, 2004, BMC Med Res Methodol, V4, P30, DOI 10.1186/1471-2288-4-30; Konde-Lule J, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-29; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Lofgren J, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-19; Lukacik M, 2008, PEDIATRICS, V121, P326, DOI 10.1542/peds.2007-0921; Matovu F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-222; Mbonye AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129545; Ministry of Health Uganda, 2015, NAT VILL HLTH TEAMS; Mugoyela V, 2011, RISK MANAG HEALTHC P, V4, P89, DOI 10.2147/RMHP.S23054; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Musaka N, 2012, J SUSTAINABLE REGION, V1, P2; Nsabagasani X, 2015, J PHARM POLICY PRACT, V8, P1; Oliphant N.P, 2017, COCHRANE DB SYST REV; Oliphant NP, 2014, J GLOB HEALTH, V4, P140, DOI 10.7189/jogh.04.020408; Oliver K, 2012, REV SYSTEMATIC CHALL; Onoka CA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-317; Organisation/ UNICEF W. H, 2004, WHO UNICEF JOINT STA, P8; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Rao VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069654; Ratnayake R., 2017, AM J TROP MED HYG; Rowe AK, 2002, INT J QUAL HEALTH C, V14, P521, DOI 10.1093/intqhc/14.6.521; Statistics U. B. o, 2018, HOUS SURV; Strachan DL, 2012, AM J TROP MED HYG, V87, P111, DOI 10.4269/ajtmh.2012.12-0030; Talisuna AO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-356; Tangcharoensathien V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0342-3; Tulenko K, 2013, B WORLD HEALTH ORGAN, V91, P847, DOI 10.2471/BLT.13.118745; Uganda Bureau of Statistics, 2010, UG NAT HOUS SURV 200, P1; Uganda Bureau of Statistics and ICF, 2017, UG DEM HLTH SURV 201; Uganda Ministry of Health, 2010, HLTH SECTOR STRATEGI; Uganda Ministry of Health WHO and UNICEF, 2010, INT COMM CAS MAN CHI; Unger CC, 2014, ARCH DIS CHILD, V99, P273, DOI 10.1136/archdischild-2013-304765; UNICEF, 2004, HLTH DEF IND; UNICEF, 2017, MULT IND CLUST SURV; UNICEF World Bank World Food Program USAID ENGINE, 2016, EV CHILD END AIDS 7, P1; United Nations, 2017, SDGS SUST DEV GOAL 3; USAID, 2017, DEM HLTH SURV PROGR; Walker CLF, 2015, J GLOB HEALTH, V5, P119, DOI 10.7189/jogh.05.020408; Walker CLF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001385; Walker CLF, 2009, B WORLD HEALTH ORGAN, V87, P780, DOI 10.2471/BLT.08.058990; Walker D, 2001, HEALTH POLICY PLANN, V16, P35, DOI 10.1093/heapol/16.1.35; WHO, 2016, WHO TECH REP SER, V997, P1; *WHO UNICEF, 2004, WHO UNICEF JOINT STA; Wogi Ajema, 2014, Ethiop Med J, V52 Suppl 3, P99; World Bank, 1993, WORLD DEV REP INV HL; World Health Organisation, 2014, REV WHO CLASS TREATM, P34; World Health Organisation, 2016, NUMB DEATHS CAUS WHO; World Health Organization, 2015, GUID TREATM MAL, P317; World Health Organization, 2005, HDB IMCI INT MAN CHI, P173; World Health Organization UNICEF, 2011, INT MAN CHILDH ILLN; Wyss K, 1996, E AFR MED J, V73, P357; Xu K, 2006, SOC SCI MED, V62, P866, DOI 10.1016/j.socscimed.2005.07.004; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Yukich J, 2013, PLOS MED, V10	83	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0200543	10.1371/journal.pone.0200543	http://dx.doi.org/10.1371/journal.pone.0200543			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475808	Green Published, gold			2022-12-26	WOS:000451325700003
J	Rufino, MM; Bez, N; Brind'Amour, A				Rufino, Marta Mega; Bez, Nicolas; Brind'Amour, Anik			Integrating spatial indicators in the surveillance of exploited marine ecosystems	PLOS ONE			English	Article							NORTH-SEA; FISHERIES MANAGEMENT; YELLOWTAIL FLOUNDER; TRAWL SURVEYS; GRAND BANK; ABUNDANCE; PATTERNS; DISTRIBUTIONS; AGGREGATION; OCCUPANCY	Spatial indicators are used to quantify the state of species and ecosystem status, that is the impacts of climate and anthropogenic changes, as well as to comprehend species ecology. These metrics are thus, determinant to the stakeholder's decisions on the conservation measures to be implemented. A detailed review of the literature (55 papers) showed that 18 spatial indicators were commonly used in marine ecology. Those indicators were than characterized and studied in detail, based on its application to empirical data (a time series of 35 marine species spatial distributions, sampled either with a random stratified survey or a regular transects surveys). The results suggest that the indicators can be grouped into three classes, that summarize the way the individuals occupy space: occupancy (the area occupied by a species), aggregation (spreading or concentration of species biomass) and quantity dependent (indicators correlated with biomass), whether these are spatially explicit (include the geographic coordinates, e.g. center of gravity) or not. Indicator's temporal variability was lower than between species variability and no clear effect was observed in relation to sampling design. Species were then classified accordingly to their indicators. One indicator was selected from each of the three categories of indicators, to represent the main axes of species spatial behavior and to interpret them in terms of occupancy-aggregationquantity relationships. All species considered were then classified according to their relationships among those three axes, into species that under increasing abundancy, primarily increase occupancy or aggregation or both. We suggest to use these relationships along the three-axes as surveillance diagrams to follow the yearly evolution of species distributional patterns in the future.	[Rufino, Marta Mega; Brind'Amour, Anik] IFREMER, French Res Inst Exploitat Sea, Ctr Atlantique, Dept Ecol & Modeles Halieut EMH, Issy Les Moulineaux, France; [Rufino, Marta Mega] Univ Algarve, Ctr Ciencias Mar CCMAR, Campus Gambelas, Faro, Portugal; [Bez, Nicolas] Univ Montpellier, MARBEC, IRD, CNRS,Ifremer, Sete, France	Ifremer; Universidade do Algarve; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Rufino, MM (corresponding author), IFREMER, French Res Inst Exploitat Sea, Ctr Atlantique, Dept Ecol & Modeles Halieut EMH, Issy Les Moulineaux, France.; Rufino, MM (corresponding author), Univ Algarve, Ctr Ciencias Mar CCMAR, Campus Gambelas, Faro, Portugal.	marta.m.rufino@gmail.com	Rufino, Marta M/A-9616-2013	Rufino, Marta M/0000-0002-0734-7491	MSFD from France	MSFD from France	The first author was financed through the MSFD from France.	Adams CF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196583; Adams CF, 2017, ICES J MAR SCI, V74, P170, DOI 10.1093/icesjms/fsw128; Babcock EA, 2005, ICES J MAR SCI, V62, P469, DOI 10.1016/j.icesjms.2005.01.010; Barange M, 2005, ICES J MAR SCI, V62, P645, DOI 10.1016/j.icesjms.2004.12.019; Barra M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135808; Bez N, 2000, FISH OCEANOGR, V9, P372, DOI 10.1046/j.1365-2419.2000.00148.x; Bez N, 2001, FISH RES, V50, P41, DOI 10.1016/S0165-7836(00)00241-1; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; Blome D, 1999, MAR BIOL, V133, P717, DOI 10.1007/s002270050513; Bock M, 2005, ECOL INDIC, V5, P322, DOI 10.1016/j.ecolind.2005.03.018; Brodie WB, 1998, J SEA RES, V39, P139, DOI 10.1016/S1385-1101(97)00056-7; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Caddy JF, 2005, FISH RES, V76, P123, DOI 10.1016/j.fishres.2005.06.003; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Cotter J, 2009, AQUAT LIVING RESOUR, V22, P243, DOI 10.1051/alr/2009025; Cotter J, 2009, AQUAT LIVING RESOUR, V22, P135, DOI 10.1051/alr/2009016; Cotter J, 2009, AQUAT LIVING RESOUR, V22, P127, DOI 10.1051/alr/2009015; CRECCO V, 1990, CAN J FISH AQUAT SCI, V47, P385, DOI 10.1139/f90-040; Cury PA, 2005, ICES J MAR SCI, V62, P307, DOI 10.1016/j.icesjms.2005.02.003; Dale MRT, 2002, ECOGRAPHY, V25, P558, DOI 10.1034/j.1600-0587.2002.250506.x; Doray M., 2014, MANUEL PROTOCOLES CA, DOI [10.13155/30259, DOI 10.13155/30259]; Doray M, 2018, PROG OCEANOGR, V166, P168, DOI 10.1016/j.pocean.2017.12.004; Evaluation Halieutique de l'Ouest Europeen, EVHOE CRUIS, DOI [10.18142/8, DOI 10.18142/8]; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; Frost MT, 2004, ECOGRAPHY, V27, P643; Gaertner JC, 1999, MAR BIOL, V135, P199, DOI 10.1007/s002270050617; Gastauer S, 2016, FISH RES, V183, P32, DOI 10.1016/j.fishres.2016.05.012; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gokhale, 1975, STAT DISTRIBUTIONS S, P343; Greenstreet SPR, 2012, ICES J MAR SCI, V69, P1789, DOI 10.1093/icesjms/fss148; Hoel PG, 1943, ANN MATH STAT, V14, P155, DOI 10.1214/aoms/1177731457; Hui C, 2012, BASIC APPL ECOL, V13, P169, DOI 10.1016/j.baae.2012.02.003; Hummel H, 2015, J MAR BIOL ASSOC UK, V95, P1519, DOI 10.1017/S0025315415000235; Huret M, 2010, PROG OCEANOGR, V87, P6, DOI 10.1016/j.pocean.2010.09.023; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Kassambara A., 2017, PRACTICAL GUIDE PRIN, V1; MacCall AD, 1990, DYMANIC GEOGRAPHY MA; MATSUURA Y, 1995, FISH B-NOAA, V93, P172; Modica L, 2016, ECOL INDIC, V67, P21, DOI 10.1016/j.ecolind.2016.02.010; Morfin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037907; MURAWSKI SA, 1988, CAN J FISH AQUAT SCI, V45, P1720, DOI 10.1139/f88-204; MYERS RA, 1995, CAN J FISH AQUAT SCI, V52, P1274, DOI 10.1139/f95-124; Myers RA, 1995, CHANGES CONCENTRATIO; Naeem S, 2009, NATURE, V458, P579, DOI 10.1038/458579a; Patricio J, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00177; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; Persohn C, 2009, FISH OCEANOGR, V18, P268, DOI 10.1111/j.1365-2419.2009.00515.x; Petitgas P, 1997, ICES J MAR SCI, V54, P213, DOI 10.1006/jmsc.1996.0184; Petitgas P, 1996, ICES J MAR SCI, V53, P147, DOI 10.1006/jmsc.1996.0015; Petitgas P, 1998, ICES J MAR SCI, V55, P443, DOI 10.1006/jmsc.1997.0345; Petitgas P, 2014, ICES J MAR SCI, V71, P2379, DOI 10.1093/icesjms/fsu111; Petitgas P, 2009, AQUAT LIVING RESOUR, V22, P165, DOI 10.1051/alr/2009018; Petitgas P, 2009, AQUAT LIVING RESOUR, V22, P119, DOI 10.1051/alr/2009014; Reuchlin-Hugenholtz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120500; Rindorf A, 2012, CAN J FISH AQUAT SCI, V69, P382, DOI 10.1139/F2011-153; Russo T, 2013, ECOL INDIC, V26, P141, DOI 10.1016/j.ecolind.2012.11.002; Saraux C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111211; Shephard S, 2015, ICES J MAR SCI, V72, P2269, DOI 10.1093/icesjms/fsv131; Simpson MR, 2004, J SEA RES, V51, P199, DOI 10.1016/j.seares.2003.08.007; Stelzenmuller V, 2004, INT REV HYDROBIOL, V89, P337, DOI 10.1002/iroh.200310718; Stoffels RJ, 2003, OIKOS, V103, P81, DOI 10.1034/j.1600-0706.2003.12453.x; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Szmyt J, 2014, SILVA FENN, V48, DOI 10.14214/sf.1008; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Teixeira H, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00207; Thorson JT, 2016, METHODS ECOL EVOL, V7, P990, DOI 10.1111/2041-210X.12567; Trenkel VM, 2011, MAR ECOL PROG SER, V442, P285, DOI 10.3354/meps09425; Wei T., 2017, PACKAGE CORRPLOT; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woillez M, 2006, RELATIONSHIPS POPULA; Woillez M, 2007, ICES J MAR SCI, V64, P537, DOI 10.1093/icesjms/fsm025; Woillez M, 2009, AQUAT LIVING RESOUR, V22, P193, DOI 10.1051/alr/2009020; Woillez M, 2009, AQUAT LIVING RESOUR, V22, P155, DOI 10.1051/alr/2009017; Yalcin S, 2017, GLOBAL ECOL BIOGEOGR, V26, P609, DOI 10.1111/geb.12579; Zwanenburg KC, 2002, INDICES FISH DISTRIB	75	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207538	10.1371/journal.pone.0207538	http://dx.doi.org/10.1371/journal.pone.0207538			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462744	Green Published, gold, Green Submitted			2022-12-26	WOS:000451054800065
J	Xie, SS; Jin, J; Xu, ZQ; Huang, YL; Zhang, W; Zhao, L; Lo, LJ; Peng, JR; Liu, W; Wang, FD; Shu, Q; Zhou, TH				Xie, Shanshan; Jin, Juan; Xu, Zhangqi; Huang, Yuliang; Zhang, Wen; Zhao, Lu; Lo, Li Jan; Peng, Jinrong; Liu, Wei; Wang, Fudi; Shu, Qiang; Zhou, Tianhua			Centrosomal protein FOR20 is essential for cilia-dependent development in zebrafish embryos	FASEB JOURNAL			English	Article						ciliogenesis; morphants; ciliopathies; Kupffer's vesicle	KUPFFERS VESICLE; SIZE CONTROL; CILIOGENESIS; TRANSITION; MECHANISMS; PRONEPHROS; DEFECTS; FLOW	Centrosomal proteins play critical roles in ciliogenesis. Mutations in many centrosomal proteins have been documented to contribute to developmental defects and cilium-related diseases. Centrosomal protein fibroblast growth factor receptor 1 oncogene partner-related protein of 20 kDa (FOR20) is crucial for ciliogenesis in mammalian cells and the unicellular eukaryote Paramecium; however, the biologic significance of FOR20 in vertebrate development remains unclear. We cloned the zebrafish homolog of the for20 gene and found that for20 mRNA is enriched in ciliated tissues during early zebrafish development. Knockdown of for20 by morpholino oligonucleotides in zebrafish results in multiple ciliary phenotypes, including curved body, hydrocephaly, pericardial edema, kidney cysts, and left-right asymmetry defects. for20 morphants show reduced number and length of cilia in Kupffer's vesicle and pronephric ducts. High-speed video microscopy reveals that cilia in most for20 morphants are consistently paralyzed or beat arrhythmically. To confirm the ciliary phenotypes of for20 morphants, we used the CRISPR/Cas9 system to disrupt for20 gene in zebrafish. for20 mutants exhibit multiple ciliary phenotypes resembling the defects in for20 morphants. All of these phenotypes in for20 morphants and mutants are significantly reversed by exogenous expression of for20 mRNA. Taken together, these data suggest that FOR20 is required for cilium-mediated processes during zebrafish embryogenesis.Xie, S., Jin, J., Xu, Z., Huang, Y., Zhang, W., Zhao, L., Lo, L. J., Peng, J., Liu, W., Wang, F., Shu, Q., Zhou, T. Centrosomal protein FOR20 is essential for cilia-dependent development in zebrafish embryos.	[Xie, Shanshan; Shu, Qiang] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310052, Zhejiang, Peoples R China; [Xie, Shanshan; Jin, Juan; Xu, Zhangqi; Huang, Yuliang; Zhang, Wen; Zhao, Lu; Liu, Wei; Wang, Fudi; Zhou, Tianhua] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Lo, Li Jan; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Minist Educ MOE, Key Lab Mol Anim Nutr, Hangzhou, Zhejiang, Peoples R China; [Zhou, Tianhua] Joint Inst Genet & Genom Med Zhejiang Univ & Univ, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Shu, Q (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310052, Zhejiang, Peoples R China.; Zhou, TH (corresponding author), Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China.	shuqiang@zju.edu.cn; tzhou@zju.edu.cn	Wang, Fudi/L-7888-2018; xie, shanshan/GSM-8999-2022; zhou, tianhua/K-4908-2013; Zhao, Lu/CAG-9052-2022	Wang, Fudi/0000-0001-8730-0003; zhou, tianhua/0000-0002-1791-2124; XIE, SHANSHAN/0000-0003-4294-8169	Chinese National Natural Scientific Foundation [31801132, 31620103911, 91740205, 31571446]	Chinese National Natural Scientific Foundation	The authors thank Dr. Xubo Niu (Boston Children's Hospital, Harvard University, Boston, MA, USA) for providing pCS2+ and pCS2+-foxa3 vector and Jun Chen (School of Life Science, Zhejiang University) for valuable suggestions and technology assistance; this work was supported by Chinese National Natural Scientific Foundation Grants 31801132, 31620103911, 91740205, and 31571446. The authors declare no conflicts of interest.	Aubusson-Fleury A, 2012, J CELL SCI, V125, P4395, DOI 10.1242/jcs.108639; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Chandrasekar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063123; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chavali PL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0468; Feng SJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.32; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gokey JJ, 2016, DEV DYNAM, V245, P22, DOI [10.1002/dvdy.24355, 10.1002/DVDY.24355]; Hamada H, 2012, DEV CELL, V22, P911, DOI 10.1016/j.devcel.2012.05.003; Hilgendorf KI, 2016, CURR OPIN CELL BIOL, V39, P84, DOI 10.1016/j.ceb.2016.02.008; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Juan H, 2001, GENES CELLS, V6, P923, DOI 10.1046/j.1365-2443.2001.00481.x; Kim S, 2013, CURR OPIN CELL BIOL, V25, P506, DOI 10.1016/j.ceb.2013.04.011; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058589; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pickett J, 2007, NAT REV MOL CELL BIO, V8, P676, DOI 10.1038/nrm2243; Sedjai F, 2010, J CELL SCI, V123, P2391, DOI 10.1242/jcs.065045; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Shen MH, 2013, CELL RES, V23, P1284, DOI 10.1038/cr.2013.127; Sorrells S, 2013, JOVE-J VIS EXP, DOI 10.3791/51060; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tumaneng K, 2012, CURR BIOL, V22, pR368, DOI 10.1016/j.cub.2012.03.003; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yang XL, 2011, CELL RES, V21, P715, DOI 10.1038/cr.2011.63; Zhang C, 2016, CELL RES, V26, P239, DOI 10.1038/cr.2015.152; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004	40	6	6	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3613	3622		10.1096/fj.201801235RR	http://dx.doi.org/10.1096/fj.201801235RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30475641	Bronze			2022-12-26	WOS:000459794800042
J	Yamasaki, TR; Holmes, BB; Furman, JL; Dhavale, DD; Su, BW; Song, ES; Cairns, NJ; Kotzbauer, PT; Diamond, MI				Yamasaki, Tritia R.; Holmes, Brandon B.; Furman, Jennifer L.; Dhavale, Dhruva D.; Su, Bryant W.; Song, Eun-Suk; Cairns, Nigel J.; Kotzbauer, Paul T.; Diamond, Marc I.			Parkinson's disease and multiple system atrophy have distinct alpha-synuclein seed characteristics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (alpha-synuclein); Parkinson disease; protein aggregation; biosensor; fluorescence resonance energy transfer (FRET); neurodegeneration; fibril; multiple system atrophy; prion strain	TO-NEURON TRANSMISSION; PRION STRAINS; NEUROPATHOLOGIC ASSESSMENT; ALZHEIMERS-DISEASE; TAU; PROPAGATION; INCLUSIONS; SCRAPIE; MECHANISMS; PATHOLOGY	Parkinson's disease (PD) and multiple system atrophy (MSA) are distinct clinical syndromes characterized by the pathological accumulation of alpha-synuclein (alpha-syn) protein fibrils in neurons and glial cells. These disorders and other neurodegenerative diseases may progress via prion-like mechanisms. The prion model of propagation predicts the existence of "strains" that link pathological aggregate structure and neuropathology. Prion strains are aggregated conformers that stably propagate in vivo and cause disease with defined incubation times and patterns of neuropathology. Indeed, tau prions have been well defined, and research suggests that both alpha-syn and beta-amyloid may also form strains. However, there is a lack of studies characterizing PD- versus MSA-derived alpha-syn strains or demonstrating stable propagation of these unique conformers between cells or animals. To fill this gap, we used an assay based on FRET that exploits a HEK293T "biosensor" cell line stably expressing alpha-syn (A53T)-CFP/YFP fusion proteins to detect alpha-syn seeds in brain extracts from PD and MSA patients. Both soluble and insoluble fractions of MSA extracts had robust seeding activity, whereas only the insoluble fractions of PD extracts displayed seeding activity. The morphology of MSA-seeded inclusions differed from PD-seeded inclusions. These differences persisted upon propagation of aggregation to second-generation biosensor cells. We conclude that PD and MSA feature alpha-syn conformers with very distinct biochemical properties that can be transmitted to alpha-syn monomers in a cell system. These findings are consistent with the idea that distinct alpha-syn strains underlie PD and MSA and offer possible directions for synucleinopathy diagnosis.	[Yamasaki, Tritia R.; Su, Bryant W.; Song, Eun-Suk] Univ Kentucky, Dept Neurol, Ste J401,740 S Limestone St, Lexington, KY 40536 USA; [Holmes, Brandon B.; Furman, Jennifer L.; Dhavale, Dhruva D.; Cairns, Nigel J.; Kotzbauer, Paul T.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Cairns, Nigel J.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Furman, Jennifer L.; Diamond, Marc I.] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Brain Inst, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Holmes, Brandon B.] Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave, San Francisco, CA 94143 USA	University of Kentucky; Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Yamasaki, TR (corresponding author), Univ Kentucky, Dept Neurol, Ste J401,740 S Limestone St, Lexington, KY 40536 USA.	tyamasaki@uky.edu	Cairns, Nigel/AAB-9713-2020; Dhavale, Dhruva/AAI-3934-2021; Yamasaki, Tritia/AAN-8831-2020	Cairns, Nigel/0000-0001-9858-3344; Dhavale, Dhruva/0000-0002-0096-1085; Yamasaki, Tritia/0000-0002-4046-274X; Holmes, Brandon/0000-0002-1153-840X	National Center for Advancing Translational Sciences [KL2 TR000116, 3857-77222B]; Mary E. Groff Charitable Trust; National Institute of Health NINDS [NS097799, NS075321, NS110436]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097799, R01NS075321, U01NS110436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mary E. Groff Charitable Trust; National Institute of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Center for Advancing Translational Sciences Grant KL2 TR000116 at the University of Kentucky, T32 Training Grant 3857-77222B at the Washington University School of Medicine, a Mary E. Groff Charitable Trust Grant, and National Institute of Health NINDS Grants NS097799, NS075321, and NS110436. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Angot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039465; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bagchi DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055031; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cairns NJ, 2015, NEUROPATHOLOGY, V35, P390, DOI 10.1111/neup.12205; Chu WH, 2015, J MED CHEM, V58, P6002, DOI 10.1021/acs.jmedchem.5b00571; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; DICKINSON AG, 1969, GENET RES, V13, P213, DOI 10.1017/S0016672300002895; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Furman JL, 2015, JOVE-J VIS EXP, DOI 10.3791/53205; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2011, NEUROBIOL DIS, V43, P552, DOI 10.1016/j.nbd.2011.05.001; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Levine DJ, 2015, ACS CHEM BIOL, V10, P1269, DOI 10.1021/cb5006239; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Solforosi L, 2013, PRION, V7, P99, DOI 10.4161/pri.23490; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanova N, 2009, LANCET NEUROL, V8, P1172, DOI 10.1016/S1474-4422(09)70288-1; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Woerman AL, 2015, P NATL ACAD SCI USA, V112, pE4949, DOI 10.1073/pnas.1513426112; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	59	95	95	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1045	1058		10.1074/jbc.RA118.004471	http://dx.doi.org/10.1074/jbc.RA118.004471			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478174	Green Published, hybrid			2022-12-26	WOS:000458670200027
J	Leitner, J; Pelster, S; Schopf, V; Berghoff, AS; Woitek, R; Asenbaum, U; Nenning, KH; Widhalm, G; Kiesel, B; Gatterbauer, B; Dieckmann, K; Birner, P; Prayer, D; Preusser, M; Furtner, J				Leitner, Johannes; Pelster, Sebastian; Schoepf, Veronika; Berghoff, Anna S.; Woitek, Ramona; Asenbaum, Ulrike; Nenning, Karl-Heinz; Widhalm, Georg; Kiesel, Barbara; Gatterbauer, Brigitte; Dieckmann, Karin; Birner, Peter; Prayer, Daniela; Preusser, Matthias; Furtner, Julia			High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases	PLOS ONE			English	Article							BODY-COMPOSITION; MASS; SARCOPENIA; EPIDEMIOLOGY; OBESITY; IMAGES	Objectives This study aimed to assess the correlation of temporal muscle thickness (TMT), measured on routine cranial magnetic resonance (MR) images, with lumbar skeletal muscles obtained on computed tomography (CT) images in brain metastasis patients to establish a new parameter estimating skeletal muscle mass on brain MR images. Methods We retrospectively analyzed the cross-sectional area (CSA) of skeletal muscles at the level of the third lumbar vertebra on computed tomography scans and correlated these values with TMT on MR images of the brain in two independent cohorts of 93 lung cancer and 61 melanoma patients (overall: 154 patients) with brain metastases. Results Pearson correlation revealed a strong association between mean TMT and CSA in lung cancer and melanoma patients with brain metastases (0.733; p<0.001). The two study cohorts did not differ significantly in patient characteristics, including age (p = 0.661), weight (p = 0.787), and height (p = 0.123). However, TMT and CSA measures differed significantly between male and female patients in both lung cancer and melanoma patients with brain metastases (p<0.001). Conclusion Our data indicate that TMT, measured on routine cranial MR images, is a useful surrogate parameter for the estimation of skeletal muscle mass in patients with brain metastases. Thus, TMT may be useful for prognostic assessment, treatment considerations, and stratification or a selection factor for clinical trials in patients with brain metastases. Further studies are needed to assess the association between TMT and clinical frailty parameters, and the usefulness of TMT in patients with primary brain tumors.	[Leitner, Johannes; Pelster, Sebastian; Woitek, Ramona; Asenbaum, Ulrike; Prayer, Daniela; Furtner, Julia] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Schoepf, Veronika] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Schoepf, Veronika] BioTechMed, Graz, Austria; [Berghoff, Anna S.; Preusser, Matthias] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Berghoff, Anna S.; Widhalm, Georg; Kiesel, Barbara; Gatterbauer, Brigitte; Dieckmann, Karin; Birner, Peter; Prayer, Daniela; Preusser, Matthias; Furtner, Julia] Med Univ Vienna, Comprehens Canc Ctr, Vienna, Austria; [Nenning, Karl-Heinz] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Computat Imaging Res Lab, Vienna, Austria; [Widhalm, Georg; Kiesel, Barbara; Gatterbauer, Brigitte] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Dieckmann, Karin] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria; [Birner, Peter] Med Univ Vienna, Dept Pathol, Vienna, Austria	Medical University of Vienna; University of Graz; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Furtner, J (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.; Furtner, J (corresponding author), Med Univ Vienna, Comprehens Canc Ctr, Vienna, Austria.	julia.furtner@meduniwien.ac.at	Preusser, Matthias/C-8530-2011; Widhalm, Georg/AFK-1669-2022	Preusser, Matthias/0000-0003-3541-2315; Widhalm, Georg/0000-0001-6014-0273; Schopf, Veronika/0000-0003-1937-4216; Berghoff, Anna Sophie/0000-0001-9379-6797; Furtner, Julia/0000-0001-8258-3681; Kiesel, Barbara/0000-0003-0939-9831; Nenning, Karl-Heinz/0000-0002-1073-9891	Medical University of Vienna	Medical University of Vienna	The costs for this project were covered by the research budget of the Medical University of Vienna.	Albanese CV, 2003, J CLIN DENSITOM, V6, P75, DOI 10.1385/JCD:6:2:75; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Berghoff AS, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2015-000024; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Souza VA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176230; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Furtner J, 2017, EUR RADIOL, V27, P3167, DOI 10.1007/s00330-016-4707-6; Gomez-Perez SL, 2016, JPEN-PARENTER ENTER, V40, P308, DOI 10.1177/0148607115604149; Grunheid T, 2009, EUR J ORTHODONT, V31, P596, DOI 10.1093/ejo/cjp093; Han DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19457; Kilgour AHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034444; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Nayak L, 2012, CURR ONCOL REP, V14, P48, DOI 10.1007/s11912-011-0203-y; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Qazi SL, 2017, J MUSCULOSKEL NEURON, V17, P192; Ranganathan K, 2014, J SURG RES, V186, P246, DOI 10.1016/j.jss.2013.07.059; Simon C., 2018, ANNSURG, P1, DOI [DOI 10.1097/SLA.0000000000002679, 10.1097/SLA.0000000000002679]; Swartz JE, 2016, ORAL ONCOL, V62, P28, DOI 10.1016/j.oraloncology.2016.09.006; Tamandl D, 2016, EUR RADIOL, V26, P1359, DOI 10.1007/s00330-015-3963-1; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823	22	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207849	10.1371/journal.pone.0207849	http://dx.doi.org/10.1371/journal.pone.0207849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496307	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800054
J	Olney, NT; Bischof, A; Rosen, H; Caverzasi, E; Stern, WA; Lomen-Hoerth, C; Miller, BL; Henry, RG; Papinutto, N				Olney, Nicholas T.; Bischof, Antje; Rosen, Howard; Caverzasi, Eduardo; Stern, William A.; Lomen-Hoerth, Catherine; Miller, Bruce L.; Henry, Roland G.; Papinutto, Nico			Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSCRANIAL MAGNETIC STIMULATION; GRAY-MATTER ATROPHY; MULTIPLE-SCLEROSIS; CLINICAL-FEATURES; ALS; CRITERIA; MRI; NEUROPATHOLOGY; SEGMENTATION	Background The spectrum of motor neuron disease (MND) includes numerous phenotypes with various life expectancies. The degree of upper and lower motor neuron involvement can impact prognosis. Phase sensitive inversion recovery (PSIR) imaging has been shown to detect in vivo gray matter (GM) and white matter (WM) atrophy in the spinal cord of other patient populations but has not been explored in MND. Methods In this study, total cord, WM and GM areas of ten patients with a diagnosis within the MND spectrum were compared to those of ten healthy controls (HC). Patients' diagnosis included amyotrophic lateral sclerosis (ALS), primary lateral sclerosis, primary muscular atrophy, facial onset sensory and motor neuronopathy and ALS-Frontotemporal dementia. Axial 2D PSIR images were acquired at four cervical disc levels (C2-C3, C3-C4, C5-C6 and C7-T1) with a short acquisition time (2 minutes) protocol. Total cross-sectional areas (TCA), GM and WM areas were measured using a combination of highly reliable manual and semi-automated methods. Cord areas in MND patients were compared with HC using linear regression analyses adjusted for age and sex. Correlation of WM and GM areas in MND patients was explored to gain insights into underlying atrophy patterns. Results MND patients as a group had significantly smaller cervical cord GM area compared to HC at all four levels (C2-C3: p = .009; C3-C4: p = .001; C5-C6: p = .006; C7-T1: p = .002). WM area at C5-C6 level was significantly smaller (p = .001). TCA was significantly smaller at C3-C4 (p = .018) and C5-C6 (p = .002). No significant GM and WM atrophy was detected in the two patients with predominantly bulbar phenotype. Concomitant GM and WM atrophy was detected in solely upper or lower motor neuron level phenotypes. There was a significant correlation between GM and WM areas at all four levels in this diverse population of MND. Conclusion Spinal cord GM and WM atrophy can be detected in vivo in patients within the MND spectrum using a short acquisition time 2D PSIR imaging protocol. PSIR imaging shows promise as a method for quantifying spinal cord involvement and thus may be useful for diagnosis, prognosis and for monitoring disease progression.	[Olney, Nicholas T.; Rosen, Howard; Miller, Bruce L.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Olney, Nicholas T.; Lomen-Hoerth, Catherine] Univ Calif San Francisco, Amyotroph Lateral Sclerosis Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Bischof, Antje; Caverzasi, Eduardo; Stern, William A.; Henry, Roland G.; Papinutto, Nico] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bischof, Antje] Univ Hosp Basel, Dept Neurol, Dept Med, Basel, Switzerland; [Bischof, Antje] Univ Hosp Basel, Dept Neurol, Dept Biomed & Clin Res, Basel, Switzerland; [Bischof, Antje] Univ Hosp Basel, Immunol Clin, Dept Med, Basel, Switzerland; [Bischof, Antje] Univ Hosp Basel, Immunol Clin, Dept Biomed & Clin Res, Basel, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Basel; University of Basel; University of Basel; University of Basel	Olney, NT (corresponding author), Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA.; Olney, NT (corresponding author), Univ Calif San Francisco, Amyotroph Lateral Sclerosis Ctr, Dept Neurol, San Francisco, CA 94143 USA.	nicholas.olney@ucaf.edu	Bischof, Antje/Z-3548-2019; Caverzasi, Eduardo/P-1707-2019	Bischof, Antje/0000-0003-3862-5738; Caverzasi, Eduardo/0000-0002-0350-0460; Miller, Bruce/0000-0002-2152-4220; Stern, William/0000-0003-1236-7654	American Academy of Neurology [P0519279]; Amyotrophic Lateral Sclerosis Association; Gottfried and Julia Bangerter-Rhyner Foundation, Basel, Switzerland; Freiwillige Akademische Gesellschaft, Basel, Switzerland;  [U01 AG045390];  [P01 AG019724-09]; NATIONAL INSTITUTE ON AGING [U01AG045390, P01AG019724] Funding Source: NIH RePORTER	American Academy of Neurology; Amyotrophic Lateral Sclerosis Association; Gottfried and Julia Bangerter-Rhyner Foundation, Basel, Switzerland; Freiwillige Akademische Gesellschaft, Basel, Switzerland; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Olney is supported by grant P0519279 from the American Academy of Neurology and Amyotrophic Lateral Sclerosis Association. Dr. Bischof is supported by grants from the Gottfried and Julia Bangerter-Rhyner Foundation, Basel, Switzerland and the Freiwillige Akademische Gesellschaft, Basel, Switzerland. Dr. Rosen is supported by grant U01 AG045390. Dr. Miller is supported by grant P01 AG019724-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2014, HUM BRAIN MAPP, V35, P1710, DOI 10.1002/hbm.22286; Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x; Benatar M, 2016, MUSCLE NERVE, V53, P169, DOI 10.1002/mus.24979; Berry James D, 2011, Clin Investig (Lond), V1, P1375; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2014, LANCET NEUROL, V13, P1228, DOI 10.1016/S1474-4422(14)70167-X; Cohen Y, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3592; Datta E, 2017, NEUROIMAGE, V147, P788, DOI 10.1016/j.neuroimage.2016.07.062; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; De Carvalho M, 2009, AMYOTROPH LATERAL SC, V10, P53, DOI 10.1080/17482960802521126; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Ferraro PM, 2017, NEUROIMAGE-CLIN, V16, P240, DOI 10.1016/j.nicl.2017.08.002; Floyd AG, 2009, NEUROLOGY, V72, P498, DOI 10.1212/01.wnl.0000341933.97883.a4; Gordon PH, 2009, NEUROLOGY, V72, P1948, DOI 10.1212/WNL.0b013e3181a8269b; Grolez G, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0672-6; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Iwata NK, 2011, BRAIN, V134, P2642, DOI 10.1093/brain/awr178; Kassubek J, 2018, J NEUROL NEUROSUR PS, V89, P374, DOI 10.1136/jnnp-2017-316365; Kaufmann P, 2004, NEUROLOGY, V62, P1753, DOI 10.1212/01.WNL.0000125182.17874.59; Kearney H, 2014, MULT SCLER J, V20, P72, DOI 10.1177/1352458513492245; Kellman P, 2002, MAGNET RESON MED, V47, P372, DOI 10.1002/mrm.10051; Kumar DR, 2011, CLIN MED RES, V9, P46, DOI 10.3121/cmr.2009.883; Muller HP, 2016, J NEUROL NEUROSUR PS, V87, P570, DOI 10.1136/jnnp-2015-311952; Papinutto N, 2015, J MAGN RESON IMAGING, V42, P698, DOI 10.1002/jmri.24819; Papinutto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118576; Paquin ME, 2018, AM J NEURORADIOL, V39, P184, DOI 10.3174/ajnr.A5427; Prados F, 2017, NEUROIMAGE, V152, P312, DOI 10.1016/j.neuroimage.2017.03.010; PRINGLE CE, 1992, BRAIN, V115, P495, DOI 10.1093/brain/115.2.495; Proudfoot M, 2016, AMYOTROPH LAT SCL FR, V17, P414, DOI 10.3109/21678421.2016.1140786; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rasoanandrianina H, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3801; Ravits J, 2013, AMYOTROPH LAT SCL FR, V14, P5, DOI 10.3109/21678421.2013.778548; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Saberi S, 2015, NEUROL CLIN, V33, P855, DOI 10.1016/j.ncl.2015.07.012; Schlaeger R, 2015, JAMA NEUROL, V72, P897, DOI 10.1001/jamaneurol.2015.0993; Schlaeger R, 2014, ANN NEUROL, V76, P568, DOI 10.1002/ana.24241; Schuster C, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0854-x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer MA, 2007, MUSCLE NERVE, V35, P291, DOI 10.1002/mus.20728; Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768; Van den Berg-Vos RM, 2009, ARCH NEUROL-CHICAGO, V66, P751, DOI 10.1001/archneurol.2009.91; Verstraete E, 2015, AMYOTROPH LAT SCL FR, V16, P524, DOI 10.3109/21678421.2015.1051989; Vucic S, 2017, NEUROTHERAPEUTICS, V14, P91, DOI 10.1007/s13311-016-0487-6; Vucic S, 2012, NEUROLOGY, V79, P73, DOI 10.1212/WNL.0b013e31825dce13; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Ziso B, 2015, CASE REP NEUROL, V7, P95, DOI 10.1159/000381944	47	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208255	10.1371/journal.pone.0208255	http://dx.doi.org/10.1371/journal.pone.0208255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496320	Green Published, gold, Green Submitted			2022-12-26	WOS:000451763800117
J	Sebela, M; Jahodarova, E; Raus, M; Lenobel, R; Hasler, P				Sebela, Marek; Jahodarova, Eva; Raus, Martin; Lenobel, Rene; Hasler, Petr			Intact cell MALDI-TOF mass spectrometric analysis of Chroococcidiopsis cyanobacteria for classification purposes and identification of possible marker proteins	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; GEN.; OSCILLATORIALES; MICROORGANISMS; MICROCOLEUS; POPULATION; 16S-23S; NOV.; TOOL; MS	Cyanobacteria represent a bacterial phyllum characteristic by the ability to photosynthesize. They are potentially applicable for the production of useful compounds but may also cause poisoning or at least health problems as they can produce cyanotoxins. The introduction of a fast methodology is important not only for fundamental taxonomic purposes, but also for reliable identifications in biological studies. In this work, we have used matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of intact cells to study Chroococcidiopsis strains. A library of the obtained reference mass spectra containing characteristic peptide/protein profiles was examined by software tools to characterize similarities and differences applicable for diagnostics and taxonomy. Both a similarity tree and heat map constructed from the mass spectrometric data proved consistent with 16S rRNA sequencing results. We show as novelty that a binary matrix combining ferulic and sinapinic acids performs well in acquiring reproducible mass spectra of cyanobacteria. Using the matrix solvent, a protein extraction from cells was done. After polyacrylamide gel electrophoresis, the separated protein fractions were in-gel digested and the resulting peptides analyzed by liquid chromatography coupled with tandem mass spectrometry. For the first time, photosystem protein components, phycobilisome proteins, electron transport proteins, nitrogen-metabolism and nucleic acids binding-proteins, cytochromes plus other enzymes and various uncharacterized proteins could be assigned to characteristic peaks in the mass spectrometric profiles and some of them suggested as markers in addition to 30S and 50S ribosomal proteins known from previous studies employing intact cell mass spectrometry of microorganisms.	[Sebela, Marek; Raus, Martin; Lenobel, Rene] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Prot Biochem & Prote, Olomouc, Czech Republic; [Jahodarova, Eva; Hasler, Petr] Palacky Univ, Fac Sci, Dept Bot, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc	Sebela, M (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Prot Biochem & Prote, Olomouc, Czech Republic.; Hasler, P (corresponding author), Palacky Univ, Fac Sci, Dept Bot, Olomouc, Czech Republic.	marek.sebela@upol.cz; petr.hasler@upol.cz	Sebela, Marek/AAL-2747-2020; LENOBEL, René/AAD-5606-2020; Hasler, Petr/ABD-9747-2020	Sebela, Marek/0000-0001-9835-1375; Hasler, Petr/0000-0003-4658-1114; Lenobel, Rene/0000-0001-7387-0056; Jahodarova, Eva/0000-0003-2855-4286	Ministry of Education, Youth and Sports, Czech Republic (the National Program of Sustainability I) [LO1204]; Ministry of Education, Youth and Sports, Czech Republic	Ministry of Education, Youth and Sports, Czech Republic (the National Program of Sustainability I); Ministry of Education, Youth and Sports, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government)	This work was supported by grant no. LO1204 from the Ministry of Education, Youth and Sports, Czech Republic (the National Program of Sustainability I) provided to MS., MR and RL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MS, MR, and RL are obligated to the Ministry of Education, Youth and Sports, Czech Republic, for financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Eliasi BJ, 2001, ANAL CHEM, V73, P5228, DOI 10.1021/ac010651t; ANAGNOSTIDIS K., 1985, ARCH HYDROBIOL S, V38/39, P291; Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P432, DOI 10.1002/rcm.1290031207; Beinhauer J, 2016, BBA-PROTEINS PROTEOM, V1864, P1093, DOI 10.1016/j.bbapap.2016.06.002; Boyer SL, 2002, J PHYCOL, V38, P1222, DOI 10.1046/j.1529-8817.2002.01168.x; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Chalupova J, 2014, BIOTECHNOL ADV, V32, P230, DOI 10.1016/j.biotechadv.2013.11.002; Chalupova J, 2012, J MASS SPECTROM, V47, P978, DOI 10.1002/jms.3046; de los Rios A, 2007, FEMS MICROBIOL ECOL, V59, P386, DOI 10.1111/j.1574-6941.2006.00256.x; DeRuyter Yanina Sarah, 2008, P217; Donner A., 2013, THESIS; Dvorak P, 2014, PHYTOTAXA, V170, P24; Dvorak P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040153; Erhard M, 1997, NAT BIOTECHNOL, V15, P906, DOI 10.1038/nbt0997-906; Fastner J, 2001, APPL ENVIRON MICROB, V67, P5069, DOI 10.1128/AEM.67.11.5069-5076.2001; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Fewer D, 2002, MOL PHYLOGENET EVOL, V23, P82, DOI 10.1006/mpev.2001.1075; Fiore MF, 2007, J PHYCOL, V43, P789, DOI 10.1111/j.1529-8817.2007.00376.x; Geitler L, 1932, RABENHORST KRYPTOGAM, V14, P1; GEITLER LOTHAR, 1933, ARCH HYDROBIOL SUPPL BD TROPISCHE BINNENGEWASSER, V12, P622; Hasler P, 2017, PHYCOLOGIA, V56, P284, DOI 10.2216/16.62.1; Hasler P, 2012, FOTTEA, V12, P341, DOI 10.5507/fot.2012.024; Havlicek V, 2013, ANAL CHEM, V85, P790, DOI 10.1021/ac3031866; Hillenkamp F., 2007, MALDI MS PRACTICAL G, V1st ed., P1, DOI [DOI 10.1002/9783527610464.CH1, 10.1002/9783527610464.ch1]; Imanishi SY, 2017, RAPID COMMUN MASS SP, V31, P325, DOI 10.1002/rcm.7793; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kemptner J, 2009, J MASS SPECTROM, V44, P1622, DOI 10.1002/jms.1669; Knoll Andrew H., 2008, P1; Komarek J, 2014, PRESLIA, V86, P295; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZY, 2005, J AM SOC MASS SPECTR, V16, P482, DOI 10.1016/j.jasms.2004.12.018; Liyanage R, 2006, CHEM ANAL SERIES MON, V169, P39; Nagy E, 2012, J MED MICROBIOL, V61, P1393, DOI 10.1099/jmm.0.043927-0; Nilsson CL, 1999, RAPID COMMUN MASS SP, V13, P1067, DOI 10.1002/(SICI)1097-0231(19990615)13:11<1067::AID-RCM612>3.0.CO;2-N; Petrovska B, 2014, CYTOGENET GENOME RES, V143, P78, DOI 10.1159/000365311; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raus M, 2013, J PROTEOM BIOINFORM, V6, P283, DOI DOI 10.4172/JPB.1000292; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Sauget M, 2017, TRENDS MICROBIOL, V25, P447, DOI 10.1016/j.tim.2016.12.006; Sebela M, 2006, PROTEOMICS, V6, P2959, DOI 10.1002/pmic.200500576; Sedo O, 2011, MASS SPECTROM REV, V30, P417, DOI 10.1002/mas.20287; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singhal N, 2016, PARASITOLOGY, V143, P1491, DOI 10.1017/S0031182016001189; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STANIER RY, 1978, INT J SYST BACTERIOL, V28, P335, DOI 10.1099/00207713-28-2-335; STAUB ROBERT, 1961, SCHWEIZ ZEIT HYDROL, V23, P82, DOI 10.1007/BF02505618; Sun LX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158483; Tsai CS, 2007, BIOMACROMOLECULES IN, P594; Ziegler D, 2015, APPL MICROBIOL BIOT, V99, P5547, DOI 10.1007/s00253-015-6515-3	51	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208275	10.1371/journal.pone.0208275	http://dx.doi.org/10.1371/journal.pone.0208275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496311	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800125
J	Ezeoke, I; Galac, MR; Lin, Y; Liem, AT; Roth, PA; Kilianski, A; Gibbons, HS; Bloch, D; Kornblum, J; Del Rosso, P; Janies, DA; Weiss, D				Ezeoke, Ifeoma; Galac, Madeline R.; Lin, Ying; Liem, Alvin T.; Roth, Pierce A.; Kilianski, Andrew; Gibbons, Henry S.; Bloch, Danielle; Kornblum, John; Del Rosso, Paula; Janies, Daniel A.; Weiss, Don			Tracking a serial killer: Integrating phylogenetic relationships, epidemiology, and geography for two invasive meningococcal disease outbreaks	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; SEROGROUP-C; NEW-YORK; SEX; MEN; TOOL; ANNOTATION; EMERGENCE; EVOLUTION; COMMUNITY	Background While overall rates of meningococcal disease have been declining in the United States for the past several decades, New York City (NYC) has experienced two serogroup C meningococcal disease outbreaks in 2005-2006 and in 2010-2013. The outbreaks were centered within drug use and sexual networks, were difficult to control, and required vaccine campaigns. Methods Whole Genome Sequencing (WGS) was used to analyze preserved meningococcal isolates collected before and during the two outbreaks. We integrated and analyzed epidemiologic, geographic, and genomic data to better understand transmission networks among patients. Betweenness centrality was used as a metric to understand the most important geographic nodes in the transmission networks. Comparative genomics was used to identify genes associated with the outbreaks. Results Neisseria meningitidis serogroup C (ST11/ET-37) was responsible for both outbreaks with each outbreak having distinct phylogenetic clusters. WGS did identify some misclassifications of isolates that were more distant from the outbreak strains, as well as those that should have been included based on high genomic similarity. Genomes for the second outbreak were more similar than the first and no polymorphism was found to either be unique or specific to either outbreak lineage. Betweenness centrality as applied to transmission networks based on phylogenetic analysis demonstrated that the outbreaks were transmitted within focal communities in NYC with few transmission events to other locations. Conclusions Neisseria meningitidis is an ever changing pathogen and comparative genomic analyses can help elucidate how it spreads geographically to facilitate targeted interventions to interrupt transmission.	[Ezeoke, Ifeoma; Bloch, Danielle; Del Rosso, Paula; Weiss, Don] Dept Hlth & Mental Hyg, Bur Communicable Dis, New York, NY 10025 USA; [Galac, Madeline R.; Kilianski, Andrew; Janies, Daniel A.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC USA; [Lin, Ying; Kornblum, John] Dept Hlth & Mental Hyg, Bur Publ Hlth Lab, New York, NY USA; [Liem, Alvin T.; Roth, Pierce A.; Gibbons, Henry S.] US Army Edgewood Chem & Biol Ctr, Dept Microbiol, Aberdeen Proving Ground, MD USA; [Liem, Alvin T.; Roth, Pierce A.] DCS Corp, Alexandria, VA USA	University of North Carolina; University of North Carolina Charlotte; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM)	Weiss, D (corresponding author), Dept Hlth & Mental Hyg, Bur Communicable Dis, New York, NY 10025 USA.	DWeiss@health.nyc.gov		Kilianski, Andy/0000-0002-2350-0142; Bloch, Danielle/0000-0001-9182-490X	New York City tax levy funding; Centers for Disease Control and Prevention Epidemiology and Laboratory Capacity Grant [3U50CK000407-01, NU50CK000407-03]; Centers for Disease Control and Prevention Public Health Emergency Preparedness Cooperative Agreement [NU90TP921922-01-00]; US National Academy of Science; US Defense Threat Reduction Agency (DTRA project) [CB2047]; United States Army via DCS Corporation	New York City tax levy funding; Centers for Disease Control and Prevention Epidemiology and Laboratory Capacity Grant; Centers for Disease Control and Prevention Public Health Emergency Preparedness Cooperative Agreement; US National Academy of Science; US Defense Threat Reduction Agency (DTRA project); United States Army via DCS Corporation	D.W., Y.L. and J.S.K. were supported by New York City tax levy funding, I.E. [grant number 3U50CK000407-01] and D.B. [grant number NU50CK000407-03] were supported by the Centers for Disease Control and Prevention Epidemiology and Laboratory Capacity Grant. P.D.R. was supported by the Centers for Disease Control and Prevention Public Health Emergency Preparedness Cooperative Agreement [grant number NU90TP921922-01-00]. A.K. was supported by the US National Academy of Science and the US Defense Threat Reduction Agency (DTRA project CB2047) as a National Research Council (NRC) fellow. A.T.L. and P.A.R. were supported by the United States Army via a contract with DCS Corporation. The salaries of A.T.L and P.A.R. were paid by the US Army. DCS Corporation, nor any other funder, did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the PLOS online author contributions section.	Aubert L, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.3.21016; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bazan JA, 2017, CLIN INFECT DIS, V65, P92, DOI 10.1093/cid/cix215; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Centers for Disease Control and Prevention, 2015, MMWR-MORBID MORTAL W, V64, P116; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Council of State and Territorial Epidemiologists, 2014, REV NAT SURV CAS DEF, DOI [10.1186/1471-2164-9-75, DOI 10.1186/1471-2164-9-75]; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Didelot X, 2016, NAT REV MICROBIOL, V14, P150, DOI 10.1038/nrmicro.2015.13; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Folaranmi TA, 2017, CLIN INFECT DIS, V65, P756, DOI 10.1093/cid/cix438; Guarner J, 2004, AM J CLIN PATHOL, V122, P754, DOI 10.1309/3489075U03LMK9AE; Gutierrez-Fernandez J, 2017, EMERG INFECT DIS, V23, P542, DOI 10.3201/eid2303.161039; Heckenberg Sebastiaan G B, 2014, Handb Clin Neurol, V121, P1361, DOI 10.1016/B978-0-7020-4088-7.00093-6; Janies DA, 2015, CLADISTICS, P1; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kleta S, 2017, EMERG INFECT DIS, V23, P1680, DOI 10.3201/eid2310.161623; Kratz MM, 2015, EMERG INFECT DIS, V21, P1379, DOI 10.3201/eid2108.141837; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Lapierre P, 2017, EMERG INFECT DIS, V23, P1784, DOI 10.3201/eid2311.170308; Lavezzo E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-554; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lucidarme J, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.45.30395; Marcus U, 2013, EUROSURVEILLANCE, V18, P6; Mustapha MM, 2016, VACCINE, V34, P1515, DOI 10.1016/j.vaccine.2016.02.014; Nanduri S, 2016, MMWR-MORBID MORTAL W, V65, P939, DOI 10.15585/mmwr.mm6535e1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quan G, 2007, CAN J INFECT DIS MED, V18, P363, DOI 10.1155/2007/295973; Read RC, 2014, CLIN MICROBIOL INFEC, V20, P391, DOI 10.1111/1469-0691.12647; Schmink S, 2007, J CLIN MICROBIOL, V45, P3768, DOI 10.1128/JCM.01190-07; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Schoen C, 2009, VACCINE, V27, pB103, DOI 10.1016/j.vaccine.2009.04.064; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Tsang RSW, 2003, J CLIN MICROBIOL, V41, P4411, DOI 10.1128/JCM.41.9.4411-4414.2003; Tzeng YL, 2017, P NATL ACAD SCI USA, V114, P4237, DOI 10.1073/pnas.1620971114; Veyrier FJ, 2013, GENOME ANNOUNC, V1, P20522; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weiss D, 2009, CLIN INFECT DIS, V48, P894, DOI 10.1086/597257; Yezli S., 2015, POL J MICROBIO, V64, P313, DOI [10.1016/j.tmaid.2018.05.003, DOI 10.1016/J.TMAID.2018.05.003]; Yezli S, 2018, TRAVEL MED INFECT DI, V24, P51, DOI 10.1016/j.tmaid.2018.05.003; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0202615	10.1371/journal.pone.0202615	http://dx.doi.org/10.1371/journal.pone.0202615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485280	Green Published, gold, Green Submitted			2022-12-26	WOS:000451755800005
J	Windes, P; Fan, XZ; Bender, M; Tafti, DK; Muller, R				Windes, Peter; Fan, Xiaozhou; Bender, Matt; Tafti, Danesh K.; Mueller, Rolf			A computational investigation of lift generation and power expenditure of Pratt's roundleaf bat (Hipposideros pratti) in forward flight	PLOS ONE			English	Article							GREATER HORSESHOE BAT; FLAPPING FLIGHT; TURNING FLIGHT; KINEMATICS; AERODYNAMICS; WAKE; ENERGETICS; PERFORMANCE; RECONSTRUCTION; DYNAMICS	The aerodynamic mechanisms of bat flight have been studied using a numerical approach. Kinematic data acquired using a high resolution motion capture system was employed to simulate the unsteady air flow around a bat's wings. A flapping bat wing contains many degrees of freedom, which make 3D motion tracking challenging. In order to overcome this challenge, an optical motion capture system of 21 cameras was used to reduce wing self-occlusion. Over the course of a meter-long flight, 108 discrete marker points on the bat's wings (Pratt's roundleaf bat, Hipposideros pratti) were tracked. The time evolution of the surface of each wing was computationally reconstructed in 3D space. The resulting kinematic model was interfaced with an unsteady incompressible flow solver using the immersed boundary method (IBM) and large eddy simulation (LES). Verification and validation of the flow simulation were conducted to establish accuracy. The aerodynamic forces calculated from the simulation compared well to the forces theoretically needed to sustain the observed flight trajectory. The transient flow field generated by the simulation allowed for the direct calculation of lift, drag, and power output of the bat during flight. The mean lift coefficient was found to be 3.21, and the flap cycle averaged aerodynamic power output was 1.05 W. Throughout the flap cycle, the planform area of the wings varied up to 46% between the largest and smallest values. During the upstroke, wing rotation was found to mitigate negative lift thereby improving overall flight efficiency. The high resolution motion capture and flow simulation framework presented here has the potential to facilitate the understanding of complex bat flight aerodynamics for both straight and maneuvering flight modes.	[Windes, Peter; Fan, Xiaozhou; Bender, Matt; Tafti, Danesh K.; Mueller, Rolf] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA; [Mueller, Rolf] Shandong Univ, Virginia Tech Int Lab, Jinan, Shandong, Peoples R China	Virginia Polytechnic Institute & State University; Shandong University	Tafti, DK (corresponding author), Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA.	dtafti@exchange.vt.edu			NSF CBET [1510797]; NSF IRES [1658620]; National Natural Science Foundation of China [11374192, 11574183]; Chinese Ministry of Education Tese Grant; VT ICTAS/BIST Center	NSF CBET(National Science Foundation (NSF)); NSF IRES(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education Tese Grant; VT ICTAS/BIST Center	The financial support of the NSF CBET Grant No. 1510797, NSF IRES Grant No. 1658620, support from VT ICTAS/BIST Center, National Natural Science Foundation of China (Grant Nos. 11374192 & 11574183), Chinese Ministry of Education Tese Grant for international faculty exchange is gratefully acknowledged.	ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; ALDRIDGE HDJN, 1987, J EXP BIOL, V130, P275; ALDRIDGE HDJN, 1988, J ZOOL, V216, P507, DOI 10.1111/j.1469-7998.1988.tb02447.x; ALDRIDGE HDJN, 1987, J EXP BIOL, V128, P419; ALDRIDGE HDJN, 1991, J EXP BIOL, V157, P183; Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Bender M. J., 2016, AIAA MOD SIM TECHN C, P1; Bender Matt J., 2015, MODEL SIMUL TECHNOL, P1; Bozkurttas M, 2009, J FLUID MECH, V631, P311, DOI 10.1017/S0022112009007046; Bullen R, 2001, AUST J ZOOL, V49, P235, DOI 10.1071/ZO00037; Chin DD, 2016, J EXP BIOL, V219, P920, DOI 10.1242/jeb.042317; Dabiri JO, 2005, J EXP BIOL, V208, P3519, DOI 10.1242/jeb.01813; Deetjen ME, 2017, J EXP BIOL, V220, P1956, DOI 10.1242/jeb.149708; Dong HL, 2010, ANESTHESIOLOGY, V112, P881, DOI 10.1097/ALN.0b013e3181d0486d; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; GERMANO M, 1991, PHYS FLUIDS A-FLUID, V3, P1760, DOI 10.1063/1.857955; Gutierrez E, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/12/1/016004; HARTMAN FRANK A., 1963, OHIO JOUR SCI, V63, P59; Hedenstrom A, 2010, ANIMAL LOCOMOTION, P361, DOI 10.1007/978-3-642-11633-9_28; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Hedenstrom A, 2015, J EXP BIOL, V218, P653, DOI 10.1242/jeb.031203; Hedenstrom A, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015001; Ho S, 2003, PROG AEROSP SCI, V39, P635, DOI 10.1016/j.paerosci.2003.04.001; Hubel TY, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0385; Hubel TY, 2012, J R SOC INTERFACE, V9, P1120, DOI 10.1098/rsif.2011.0838; Hubel TY, 2010, ANIMAL LOCOMOTION, P371, DOI 10.1007/978-3-642-11633-9_29; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; Johansson LC, 2008, J EXP BIOL, V211, P2909, DOI 10.1242/jeb.018192; Johansson LC, 2010, J R SOC INTERFACE, V7, P61, DOI 10.1098/rsif.2008.0541; Kunz TH, 2003, BAT ECOLOGY, P3; Lentink D, 2009, FLYING INSECTS AND ROBOTS, P185, DOI 10.1007/978-3-540-89393-6_14; Li CY, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/aa5761; Liu G, 2016, J FLUID MECH, V795, P634, DOI 10.1017/jfm.2016.175; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Muijres FT, 2011, J R SOC INTERFACE, V8, P1418, DOI 10.1098/rsif.2011.0015; Nagendra K, 2014, J COMPUT PHYS, V267, P225, DOI 10.1016/j.jcp.2014.02.045; Najjar FM, 1996, PHYS FLUIDS, V8, P1076, DOI 10.1063/1.868887; NORBERG UM, 1976, J EXP BIOL, V65, P179; NORBERG UM, 1993, J EXP BIOL, V182, P207; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Pennycuick C., 1989, BIRD FLIGHT PERFOMAN; RAYNER JMV, 1979, J EXP BIOL, V80, P17; Rayner JMV, 1999, AM ZOOL, V39, p4A; RAYNER JMV, 1985, J EXP BIOL, V118, P247; Ren Y, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.050511; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Shyy W, 2010, PROG AEROSP SCI, V46, P284, DOI 10.1016/j.paerosci.2010.01.001; Shyy W, 1999, PROG AEROSP SCI, V35, P455, DOI 10.1016/S0376-0421(98)00016-5; Song JL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0541; Spedding GR, 2010, ANIMAL LOCOMOTION, P187, DOI 10.1007/978-3-642-11633-9_16; Svoboda T, 2005, PRESENCE-VIRTUAL AUG, V14, P407, DOI 10.1162/105474605774785325; Swartz SM, 2015, CAN J ZOOL, V93, P977, DOI 10.1139/cjz-2015-0117; Tafti D.K., 2001, P ASME FLUIDS ENG DI, V256, P347; Tafti DK, 2011, INT SER DEV HEAT TRA, P217; THOMAS SP, 1972, J EXP BIOL, V57, P317; Tian XD, 2006, BIOINSPIR BIOMIM, V1, pS10, DOI 10.1088/1748-3182/1/4/S02; Tobalske BW, 2007, J EXP BIOL, V210, P2368, DOI 10.1242/jeb.005686; Viswanath K, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4864297; von Busse R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0147; Wan KY, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1160; Wang F., 2018, 2018 IEEE INT C MULT, P1, DOI DOI 10.1109/INTMAG.2018.8508038; WITHERS PC, 1977, J EXP BIOL, V70, P13; Wolf M, 2010, J EXP BIOL, V213, P2142, DOI 10.1242/jeb.029777	64	11	12	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207613	10.1371/journal.pone.0207613	http://dx.doi.org/10.1371/journal.pone.0207613			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485321	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800077
J	Xu, H; Li, PH; Barrow, TM; Colicino, E; Li, CP; Song, RX; Liu, HB; Tang, NJ; Liu, SY; Guo, LQ; Byun, HM				Xu, Hui; Li, Peng-hui; Barrow, Timothy M.; Colicino, Elena; Li, Changping; Song, Ruixue; Liu, Hongbin; Tang, Nai-jun; Liu, Songyan; Guo, Liqiong; Byun, Hyang-Min			Obesity as an effect modifier of the association between menstrual abnormalities and hypertension in young adult women: Results from Project ELEFANT	PLOS ONE			English	Article							CYCLE CHARACTERISTICS; REPRODUCTIVE HORMONES; PRIMARY DYSMENORRHEA; POLYCYSTIC OVARIES; SEX-HORMONES; ANOVULATION; LENGTH; RISK; AGE	Background The menstrual cycle is regulated by reproductive hormones such as estrogen which has been implicated in the pathogenesis of hypertension and is associated with obesity. However, to date there has scant study of hypertension in relation to menstrual characteristics and abnormalities. We hypothesize that adverse menstrual characteristics are associated with an increase the prevalence of hypertension and that this relationship is exacerbated by obesity. Methods Our study leverages 178,205 healthy female participants (mean age = 29) in a population-based cross-sectional study in Tianjin, China. Menstrual characteristics including menstrual cycle length and regularity, menstrual bleeding length, menstrual blood loss and dysmenorrhea were assessed by self-reported questionnaires, and hypertension was diagnosed by physician. Multiple logistic regression models were used to assess the relationships between menstrual characteristics and hypertension. Results Normal length menstrual cycle (OR = 1.21, 95% CI: 1.03-1.41), oligomenorrhea (OR = 1.54, 95% CI: 1.12-2.07), irregular cycle (OR = 1.54, 95% CI: 1.22-1.93), and light menstrual blood loss (OR = 1.36, 95% CI: 1.06-1.72) were associated with hypertension among women who are overweight or obese, but not among women who are normal weight. Longer menstrual bleeding duration (OR = 1.44, 95% CI: 1.24-1.67) and dysmenorrhea were associated with increased prevalence of hypertension (OR = 1.20, 95% CI: 1.14-1.41) in all young women. Conclusions The prevalence of hypertension is higher among women with menstrual abnormalities, and this association is modified by overweight and obesity.	[Xu, Hui; Song, Ruixue; Tang, Nai-jun; Guo, Liqiong] Tianjin Med Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, Tianjin, Peoples R China; [Xu, Hui; Li, Changping; Song, Ruixue] Tianjin Med Univ, Dept Epidemiol & Stat, Sch Publ Hlth, Tianjin, Peoples R China; [Li, Peng-hui] Tianjin Univ Technol, Sch Environm Sci & Safety Engn, Tianjin, Peoples R China; [Barrow, Timothy M.] Univ Sunderland, Fac Hlth Sci & Wellbeing, Sunderland, England; [Colicino, Elena] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Liu, Hongbin] Tianjin Res Inst Family Planning, Tianjin, Peoples R China; [Liu, Songyan] Changan Univ, Sch Mat Sci & Engn, Xian, Shanxi, Peoples R China; [Byun, Hyang-Min] Newcastle Univ, Human Nutr Res Ctr, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Tianjin Medical University; Tianjin Medical University; Tianjin University of Technology; University of Sunderland; Icahn School of Medicine at Mount Sinai; Chang'an University; Newcastle University - UK	Guo, LQ (corresponding author), Tianjin Med Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, Tianjin, Peoples R China.	yingqidao@163.com	Byun, Hyang-Min/X-2843-2018; Colicino, Elena/Q-4973-2016	Byun, Hyang-Min/0000-0002-6278-3165; Colicino, Elena/0000-0002-1875-8448; guo, liqiong/0000-0002-1141-9646; Barrow, Timothy/0000-0003-4551-3857	National Natural Science Foundation of China [81602827, 41601548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Natural Science Foundation of China (Grant numbers 81602827 to LG and 41601548 to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355; Apgar BS, 2007, AM FAM PHYSICIAN, V75, P1813; Azevedo George D., 2006, Arq Bras Endocrinol Metab, V50, P876, DOI 10.1590/S0004-27302006000500008; Charkoudian N, 2017, CLIN AUTON RES, V27, P149, DOI 10.1007/s10286-017-0420-z; Chen CM, 2004, BIOMED ENVIRON SCI, V17; Dasharathy SS, 2012, AM J EPIDEMIOL, V175, P536, DOI 10.1093/aje/kwr356; DESANCTIS V, 2017, ACTA BIOMED, V87, P233; Engin A, 2017, ADV EXP MED BIOL, V960, P345, DOI 10.1007/978-3-319-48382-5_15; Fruscalzo A, 2010, GYNECOL ENDOCRINOL, V26, P445, DOI 10.3109/09513591003632092; Gast GCM, 2010, FERTIL STERIL, V94, P2379, DOI 10.1016/j.fertnstert.2010.03.044; Gordon CM, 2010, NEW ENGL J MED, V363, P365, DOI 10.1056/NEJMcp0912024; Hambridge HL, 2013, HUM REPROD, V28, P1687, DOI 10.1093/humrep/det090; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Iacovides S, 2015, HUM REPROD UPDATE, V21, P762, DOI 10.1093/humupd/dmv039; Jukic AMZ, 2008, AM J EPIDEMIOL, V167, P25, DOI 10.1093/aje/kwm265; Jurca SJ, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0682-1; Kische H, 2016, METABOLISM, V65, P1286, DOI 10.1016/j.metabol.2016.05.011; LANDGREN BM, 1980, ACTA ENDOCRINOL-COP, V94, P89, DOI 10.1530/acta.0.0940089; Lyngso J, 2014, HUM REPROD, V29, P359, DOI 10.1093/humrep/det390; Master-Hunter T, 2006, AM FAM PHYSICIAN, V73, P1374; Matthews KA, 2006, J CLIN ENDOCR METAB, V91, P1789, DOI 10.1210/jc.2005-1057; Maybin JA, 2015, HUM REPROD UPDATE, V21, P748, DOI 10.1093/humupd/dmv038; Maybin JA, 2012, REV ENDOCR METAB DIS, V13, P253, DOI 10.1007/s11154-012-9228-2; Moretti C, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0740-3; Mumford SL, 2012, J CLIN ENDOCR METAB, V97, pE1871, DOI 10.1210/jc.2012-1350; POLSON DW, 1988, LANCET, V1, P870; PORETSKY L, 1987, ENDOCR REV, V8, P132, DOI 10.1210/edrv-8-2-132; Quinn SD, 2016, WOMENS HEALTH, V12, P21, DOI 10.2217/whe.15.85; Reed BG, 2000, THE NORMAL MENSTRUAL; Rosenman Robert, 2011, Int J Behav Healthc Res, V2, P320; Schisterman EF, 2010, AM J EPIDEMIOL, V172, P430, DOI 10.1093/aje/kwq131; Whelton PK, 2017, HYPERTENSION, V71, pe13, DOI [10.1161/HYPERTENSIONAHA.115.0710827001299, DOI 10.1161/HYP.0000000000000065]; Windham GC, 2002, EPIDEMIOLOGY, V13, P675, DOI 10.1097/00001648-200211000-00012; Wyatt KM, 2001, FERTIL STERIL, V76, P125, DOI 10.1016/S0015-0282(01)01847-7; Xu BY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42803; Yencilek F, 2010, FERTIL STERIL, V94, P1840, DOI 10.1016/j.fertnstert.2009.10.060; Yeung EH, 2013, INT J OBESITY, V37, P237, DOI 10.1038/ijo.2012.9; Zarei S, 2017, PAIN MED, V18, P3, DOI 10.1093/pm/pnw121; Zhang Q, 2017, BJOG-INT J OBSTET GY, V124, P1654, DOI 10.1111/1471-0528.14469	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207929	10.1371/journal.pone.0207929	http://dx.doi.org/10.1371/journal.pone.0207929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485368	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000451755800087
J	Ahn, JM; Kim, S; Ahn, KS; Cho, SH; Lee, KB; Kim, US				Ahn, Jin Mo; Kim, Sangsoo; Ahn, Kwang-Sung; Cho, Sung-Hoon; Lee, Kwan Bok; Kim, Ungsoo Samuel			A deep learning model for the detection of both advanced and early glaucoma using fundus photography	PLOS ONE			English	Article							CLASSIFIERS; CLASSIFICATION	Purpose To build a deep learning model to diagnose glaucoma using fundus photography. Design Cross sectional case study Subjects, Participants and Controls: A total of 1,542 photos (786 normal controls, 467 advanced glaucoma and 289 early glaucoma patients) were obtained by fundus photography. Method The whole dataset of 1,542 images were split into 754 training, 324 validation and 464 test datasets. These datasets were used to construct simple logistic classification and convolutional neural network using Tensorflow. The same datasets were used to fine tune pretrained GoogleNet Inception v3 model. Results The simple logistic classification model showed a training accuracy of 82.9%, validation accuracy of 79.9% and test accuracy of 77.2%. Convolutional neural network achieved accuracy and area under the receiver operating characteristic curve (AUROC) of 92.2% and 0.98 on the training data, 88.6% and 0.95 on the validation data, and 87.9% and 0.94 on the test data. Transfer-learned GoogleNet Inception v3 model achieved accuracy and AUROC of 99.7% and 0.99 on training data, 87.7% and 0.95 on validation data, and 84.5% and 0.93 on test data. Conclusion Both advanced and early glaucoma could be correctly detected via machine learning, using only fundus photographs. Our new model that is trained using convolutional neural network is more efficient for the diagnosis of early glaucoma than previously published models.	[Ahn, Jin Mo; Kim, Sangsoo] Soongsil Univ, Dept Bioinformat & Life Sci, Seoul, South Korea; [Ahn, Kwang-Sung; Cho, Sung-Hoon] PDXen Biosyst Inc, Funct Genome Inst, Seoul, South Korea; [Lee, Kwan Bok; Kim, Ungsoo Samuel] Kims Eye Hosp, Seoul, South Korea; [Kim, Ungsoo Samuel] Konyang Univ, Dept Ophthalmol, Coll Med, Daejeon, South Korea	Soongsil University; Konyang University; Konyang University Hospital	Kim, US (corresponding author), Kims Eye Hosp, Seoul, South Korea.; Kim, US (corresponding author), Konyang Univ, Dept Ophthalmol, Coll Med, Daejeon, South Korea.	ungsookim@kimeye.com	Kim, Ungsoo/AID-3701-2022	Kim, Ungsoo/0000-0003-2373-6240	PDXen	PDXen	PDXen partially funded and sponsored the study. There was no additional external funding received for this study. SHC and KSA: Employees - PDXen. PDXen provided support in the form of salary for authors SHC and KSA, and participated in data analysis, and interpretation of the results, and in the preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2016, ARXIV PREPRINT ARXIV; Barella KA, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/789129; Bizios D, 2010, ACTA OPHTHALMOL, V88, P44, DOI 10.1111/j.1755-3768.2009.01784.x; Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012; Chua J, 2015, JAMA OPHTHALMOL, V133, P938, DOI 10.1001/jamaophthalmol.2015.1478; Clifton L, 2013, IEEE T BIO-MED ENG, V60, P193, DOI 10.1109/TBME.2012.2208459; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; George D., 2017, ARXIV170607446; Glorot X., 2010, P 13 INT C ARTIFICIA, V9, P249, DOI DOI 10.1.1/207.2059; Goldbaum MH, 2002, INVEST OPHTH VIS SCI, V43, P162; Grassmann F, 2018, OPHTHALMOLOGY, V125, P1410, DOI 10.1016/j.ophtha.2018.02.037; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Holland O, 2016, 2016 23RD INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS (ICT), DOI 10.1109/ICT.2016.7500442; Kim SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177726; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Simonyan Karen, ICLR 2015; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wu ST, 2018, MULTIMED TOOLS APPL, V77, P10437, DOI 10.1007/s11042-017-4440-4; York N, 2018, DEEP CONVOLUTIONAL N, P1525; Zhang D, 2017, 2017 IEEE 5TH INTERNATIONAL SYMPOSIUM ON ROBOTICS AND INTELLIGENT SENSORS (IRIS), P1	22	85	86	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207982	10.1371/journal.pone.0207982	http://dx.doi.org/10.1371/journal.pone.0207982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481205	Green Published, gold, Green Submitted			2022-12-26	WOS:000451440000034
J	Cary, DC; Peterlin, BM				Cary, Daniele C.; Peterlin, B. Matija			Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HISTONE DEACETYLASE INHIBITORS; NF-KAPPA-B; P-TEFB; POSITIVE TRANSCRIPTION; MOLECULAR-MECHANISMS; ELONGATION; REPLICATION; ACTIVATION; RELEASE	Although anti-retroviral therapies have greatly extended the lives of HIV infected individuals, current treatments are unable to completely eliminate virally infected cells. A number of latency reversing agents have been proposed for use in a "shock and kill" strategy to reactivate latent HIV, thus making it vulnerable to killing mechanisms. Procyanidin trimer C1 (PC1) is a flavonoid found in multiple plant sources including grape, apple, and cacao, which has antioxidant and anti-inflammatory properties. We determined that PC1 reactivates latent HIV in cell line and primary cell models of HIV, through activation of the MAPK pathway. Notably, PC1 reactivates latent HIV without increasing surface markers of T cell activation. Combining several therapeutics, which activate HIV transcription through different mechanisms, is the most efficient approach to clinically reactivate latent reservoirs. We utilized PC1 (MAPK agonist), kansui (PKC agonist), and JQ1 (BET bromodomain inhibitor) in a triple combination approach to reactivate latent HIV in cell line and primary cell models of HIV latency. When used in combination, low concentrations which fail to reactivate HIV as single treatments, are effective. Thus, several mechanisms, using distinct activation pathways, act together to reactivate latent HIV.	[Cary, Daniele C.; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cary, DC (corresponding author), Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA.	Daniele.Cary@ucsf.edu		Cary, Daniele/0000-0003-4750-2035	National Institutes of Health [R01 AI049104, P50 GM082250]; National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30-AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI125104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USAUniversity of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants (https://www.nih.gov/): R01 AI049104 (Peterlin, PI) and P50 GM082250 (HARC grant). DCC was supported by a grant from the National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30-AI027763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097257; Anderson L, 2009, J AM ACAD DERMATOL, V60, P934, DOI 10.1016/j.jaad.2009.01.008; Andujar I, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/906252; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bensky D, 2004, CHINESE HERBAL MED M, V3rd; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Byun EB, 2013, INT IMMUNOPHARMACOL, V15, P450, DOI 10.1016/j.intimp.2012.11.021; Cary DC, 2018, AIDS RES HUM RETROV, V34, P31, DOI [10.1089/AID.2017.0232, 10.1089/aid.2017.0232]; Cary DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168027; Cary DC, 2016, J CLIN INVEST, V126, P448, DOI 10.1172/JCI80565; Cary DC, 2016, F1000RESEARCH, P5; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; De Rosso M, 2015, MOLECULES, V20, P18095, DOI 10.3390/molecules201018095; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Gu XD, 2007, CHIN J INTEGR MED, V13, P235, DOI 10.1007/s11655-007-0235-1; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hon T, 2015, BIOCHEM BIOPH RES CO, V459, P288, DOI 10.1016/j.bbrc.2015.02.102; Hou JJ, 2014, J PHARMACEUT BIOMED, V88, P321, DOI 10.1016/j.jpba.2013.08.049; Iyidogan P, 2014, VIRUSES-BASEL, V6, P4095, DOI 10.3390/v6104095; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jose DP, 2014, VIROLOGY, V462, P328, DOI 10.1016/j.virol.2014.05.033; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Khan N, 2014, NUTRIENTS, V6, P844, DOI 10.3390/nu6020844; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; KUPCHAN SM, 1976, SCIENCE, V191, P571, DOI 10.1126/science.1251193; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Liu PY, 2014, J BIOL CHEM, V289, P9918, DOI 10.1074/jbc.M113.539015; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Marsden MD, 2018, VIROLOGY, V520, P83, DOI 10.1016/j.virol.2018.05.006; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Perez M, 2010, CURR HIV RES, V8, P418, DOI 10.2174/157016210793499312; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P993, DOI 10.4161/hv.23800; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; SCHAUFELBERGER DE, 1991, J NAT PROD, V54, P1265, DOI 10.1021/np50077a004; Schiralli Lester Gillian M, 2012, Mol Biol Int, V2012, P614120, DOI 10.1155/2012/614120; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Shi QW, 2008, CHEM REV, V108, P4295, DOI 10.1021/cr078350s; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Sun MK, 2014, PROG MOL BIOL TRANSL, V122, P31, DOI 10.1016/B978-0-12-420170-5.00002-7; Sung NY, 2013, EUR J PHARMACOL, V714, P218, DOI 10.1016/j.ejphar.2013.02.059; Taube R, 2013, VIRUSES-BASEL, V5, P902, DOI 10.3390/v5030902; Wang LY, 2002, J NAT PROD, V65, P1246, DOI 10.1021/np0200921; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing F, 2012, J ETHNOPHARMACOL, V139, P343, DOI 10.1016/j.jep.2011.10.040; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; Yu WD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003146	60	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0208055	10.1371/journal.pone.0208055	http://dx.doi.org/10.1371/journal.pone.0208055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475902	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700102
J	Kunugi, Y; Arimura, TH; Iwata, K; Komatsu, E; Hirayama, Y				Kunugi, Yushi; Arimura, Toshi H.; Iwata, Kazuyuki; Komatsu, Eiji; Hirayama, Yoshie			Cost-efficient strategy for reducing PM 2.5 levels in the Tokyo metropolitan area: An integrated approach with air quality and economic models	PLOS ONE			English	Article							STREET-LEVEL; PM2.5; REDUCTIONS; MITIGATION; IMPACTS; JAPAN	To attain cleaner air, it is important that authorities make informed decisions when selecting a strategy. Concentrations of particulate matter with an aerodynamic diameter of less than or equal to 2.5 mu m (PM 2.5) are high in the Tokyo metropolitan area, even though concentrations of particulate matter with an aerodynamic diameter of less than or equal to 10 mu m (PM10) have dropped dramatically since the implementation of the NOx-PM Act. Currently, monitored concentration levels continue to exceed the designated ambient air quality standard set by the Japanese Ministry of the Environment. To our knowledge, no study has investigated a cost-efficient strategy for reducing PM 2.5 concentration levels in the Tokyo metropolitan area. This is the first study to examine a proper control strategy for Japan by developing an integrated model that includes both aerosol and economic models. The simulation results show that prefectures in the Tokyo metropolitan area cannot achieve the standards by relying on their own efforts to reduce PM 2.5. That is, prefectural governments in the Tokyo metropolitan areas need to cooperate with prefectures outside of the area to improve their PM 2.5 concentration levels. Thus, we simulated policies under the assumption that emissions from other sources are reduced to levels such that the PM 2.5 concentration declines by approximately 18 mu g/m(3). We first simulated an efficient policy, i. e., the implementation of a pollution tax. We found that the total abatement cost to meet the air quality standard using the cost-efficient strategy is approximately 142.7 billion yen.	[Kunugi, Yushi; Arimura, Toshi H.] Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan; [Kunugi, Yushi; Arimura, Toshi H.] Waseda Univ, Res Inst Environm Econ & Management, Tokyo, Japan; [Iwata, Kazuyuki] Matsuyama Univ, Fac Econ, Matsuyama, Ehime, Japan; [Komatsu, Eiji] Meiji Univ, Ctr Environm Law & Policy, Tokyo, Japan; [Komatsu, Eiji; Hirayama, Yoshie] Lab Ecol Reconstruct Sci, Tokyo, Japan	Waseda University; Waseda University; Meiji University	Kunugi, Y (corresponding author), Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan.; Kunugi, Y (corresponding author), Waseda Univ, Res Inst Environm Econ & Management, Tokyo, Japan.	kunugi.yu@gmail.com	Iwata, Kazuyuki/T-3879-2019; Iwata, Kazuyuki/M-6836-2015	Iwata, Kazuyuki/0000-0002-2712-9133; Iwata, Kazuyuki/0000-0002-2712-9133; Kunugi, Yushi/0000-0003-4146-535X	ERCA; Sonpo Japan Nipponkoa Environmental Foundation; Japan Society for the Promotion of Science [JP18H03433]	ERCA; Sonpo Japan Nipponkoa Environmental Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This paper is financially supported by ERCA, Sonpo Japan Nipponkoa Environmental Foundation funding given to YK, and the Japan Society for the Promotion of Science (JP18H03433 to KI) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo Joseph, 1990, RAINS MODEL ACIDIFIC; Amann M., 2004, RAINS MODEL DOCUMENT; Amann M., 2008, METHODOLOGY; Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; [Anonymous], 2014, ERCA RES EMISSION CO; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Chen F, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2316-7; Ciucci A, 2016, ATMOS ENVIRON, V140, P84, DOI 10.1016/j.atmosenv.2016.05.049; D'Elia I, 2009, ATMOS ENVIRON, V43, P6182, DOI 10.1016/j.atmosenv.2009.09.003; EPA, 2009, EPA600R08139F; Farrell A, 2001, GLOBAL ENVIRON CHANG, V11, P311, DOI 10.1016/S0959-3780(01)00009-7; Gery MW, 1989, J GEOPHYS RES, V94, pD10, DOI DOI 10.1029/JD094ID10P12925; Higashino H., 2003, J JPN SOC ATMOS ENV, V38, P100; Hordijk L, 2007, ENVIRON POLICY LAW, V37, P336; Inomata Y, 2016, SCI TOTAL ENVIRON, V553, P617, DOI 10.1016/j.scitotenv.2016.02.139; Inoue K., 2015, J JPN SOC ATMOS ENV, V50, P278, DOI [10.11298/taiki.50.278, DOI 10.11298/TAIKI.50.278]; Iwata K, 2014, E77 TCER; Iwata K, 2009, TRANSPORT RES D-TR E, V14, P157, DOI 10.1016/j.trd.2008.11.009; Japan Association of Aerosol Science and Technology, 2004, GLOSS AER SCI; JPEC, 2012, JPEC2011AQ0207; JPEC, 2012, JPEC2011AQ0208; JPEC (Japan Petroleum Energy Center), 2012, JPEC2011AQ0206; Kiesewetter G, 2015, ATMOS CHEM PHYS, V15, P1539, DOI 10.5194/acp-15-1539-2015; Kiesewetter G, 2014, ATMOS CHEM PHYS, V14, P813, DOI 10.5194/acp-14-813-2014; Kolstad C., 2010, ENV EC; Lu MQ, 2018, FRONT ENV SCI ENG, V12, DOI 10.1007/s11783-018-1005-3; Okun A.M., 2015, EQUALITY EFFICIENCY; Oxley T, 2013, ENVIRON INT, V61, P17, DOI 10.1016/j.envint.2013.09.009; PIELKE RA, 1992, METEOROL ATMOS PHYS, V49, P69, DOI 10.1007/BF01025401; Rao S, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/124013; Schoepp W., 2013, GAINS OPTIMIZATION M; Schopp W, 1999, ENVIRON MODELL SOFTW, V14, P1, DOI 10.1016/S1364-8152(98)00034-6; Siderius PJS, 2013, ENERG EFFIC, V6, P1, DOI 10.1007/s12053-012-9166-6; Sigman H, 2002, AM ECON REV, V92, P1152, DOI 10.1257/00028280260344687; Takemura T, 2003, J GEOPHYS RES ATMOSP, V108; Tani M, 2010, RIETI POLICY UPDATE; Tuinstra W, 1999, ENVIRONMENT, V41, P33, DOI 10.1080/00139159909605536; Vieno M, 2016, ATMOS CHEM PHYS, V16, P265, DOI 10.5194/acp-16-265-2016; Wagner F, 2013, J ENVIRON MANAGE, V129, P25, DOI 10.1016/j.jenvman.2013.05.054; Watanabe T, 2016, ATMOS ENVIRON, V129, P176, DOI 10.1016/j.atmosenv.2016.01.016; World Health Organization, AIR QUAL GUID GLOB U; Wu R, 2017, ENVIRON SCI TECHNOL, V51, P5035, DOI 10.1021/acs.est.7b00026; Yamagami M., 2008, J JPN SOC ATMOS ENV, V43, P273; Yamamoto K, 2018, RISK ASSESSMENT	44	5	6	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207623	10.1371/journal.pone.0207623	http://dx.doi.org/10.1371/journal.pone.0207623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB8GM	30475829	Green Submitted, gold, Green Published			2022-12-26	WOS:000451325700047
J	Valenzuela, C; Legarraga, P; Pena, A; Arenas, A; Berkowitz, L; Ramirez, G; Wozniak, A; Garcia, P; Alvarez-Lobos, M				Valenzuela, Carlos; Legarraga, Paulette; Pena, Arturo; Arenas, Alex; Berkowitz, Loni; Ramirez, Gigliola; Wozniak, Aniela; Garcia, Patricia; Alvarez-Lobos, Manuel			Etiologic and clinical characterization of community acquired gastroenteritis in adult patients in a Chilean emergency room by the FilmArray GI panel	PLOS ONE			English	Article							ENTERIC PATHOGENS; UNITED-STATES; STOOL; PCR; MULTICENTER; DIAGNOSIS; SAMPLES	Infectious diarrhea can be caused by a large number of microorganisms including bacteria virus and parasites. The clinical syndromic approach has been traditionally used to guide therapy. The aim of this study was to characterize the etiology of acute diarrhea by the FilmArray GI panel and to correlate it with its clinical presentation in an adult population presenting to the emergency room in a developing country. Material and Methods: Adult patients attending the ER due to acute diarrhea were selected. All patients included had a FilmArray GI panel performed and the clinical characteristics were recorded. Results: One hundred and ninety-nine patients were included. One hundred and eighteen (59.3%) were females. The mean age was 43 years old. Thirty three percent of the patients presented dysentery, 36.7% fever, 54.8% referred nauseas and 35.7% vomiting. Sixty three percent of the patients presented some degree of dehydration. In total, 221 microorganisms were detected of which 71.5% corresponded to bacteria (158/221), 19.9% to virus (44/221) and 8.6% to parasites (19/221). In 133 (67.0%) of 199 patients at least one microorganism was identified. Infections with more than one microorganism were detected in 27.1% of the patients. Polimicrobial infections were associated with a higher frequency of nausea (50.0% vs 32.0%, p 0.046), abdominal pain (87.0% vs 44.0%, p<0.0001) and travel history (20.0% vs 5.0%, p 0.0102). Bacterial infections occurred without a seasonal distribution with the exception of Salmonella sp whereas viral infections predominated during the autumn-winter months. Diarreicogenic E. coli were present in the context of a co-infection in more than 80.0% of the cases. Discussion: The use of multiplex panels has given us invaluable information regarding the epidemiology of acute diarrhea in adult. It highlighted the importance of polimicrobial infections and the frequency of diarreicogenic E. coli infections. Nevertheless, the lack of severity compared to monomicrobial infections and the usual association with other microorganisms in the latter make their clinical importance debatable.	[Valenzuela, Carlos; Arenas, Alex; Berkowitz, Loni; Ramirez, Gigliola; Alvarez-Lobos, Manuel] Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago, Chile; [Valenzuela, Carlos] Univ Catolica Santisima Concepcion, Fac Med, Concepcion, Chile; [Legarraga, Paulette; Wozniak, Aniela; Garcia, Patricia] Pontificia Univ Catolica Chile, Escuela Med, Dept Clin Labs, Santiago, Chile; [Pena, Arturo] Pontificia Univ Catolica Chile, Escuela Med, Emergency Room, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad Catolica de la Santisima Concepcion; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Alvarez-Lobos, M (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago, Chile.; Garcia, P (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Clin Labs, Santiago, Chile.	pgarcia@med.puc.cl; alvarezl@med.puc.cl		Valenzuela, Carlos/0000-0001-7673-3620				Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Bruijnesteijn van Coppenraet L E S, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.02.007; Buchan BW, 2013, J CLIN MICROBIOL, V51, P4001, DOI 10.1128/JCM.02056-13; Buss SN, 2015, J CLIN MICROBIOL, V53, P915, DOI 10.1128/JCM.02674-14; Comite de microbiologia clinica, 2002, REV CHIL INFECTOL, V19; De Wit MAS, 2001, EPIDEMIOL INFECT, V127, P389, DOI 10.1017/S0950268801006082; de Wit MAS, 2001, CLIN INFECT DIS, V33, P280, DOI 10.1086/321875; Farfan M, 2016, REV CHIL INFECTOL, V33, P89, DOI 10.4067/S0716-10182016000100016; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Guerrant RL, 2002, TRENDS PARASITOL, V18, P191, DOI 10.1016/S1471-4922(02)02253-5; Huhulescu S, 2009, INFECTION, V37, P103, DOI 10.1007/s15010-008-8106-z; Jones TF, 2012, J INFECT DIS, V205, P1334, DOI 10.1093/infdis/jis215; Khare R, 2014, J CLIN MICROBIOL, V52, P3667, DOI 10.1128/JCM.01637-14; KOTLOFF KL, 1988, PEDIATR INFECT DIS J, V7, P753, DOI 10.1097/00006454-198811000-00002; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McAuliffe GN, 2013, J INFECTION, V67, P122, DOI 10.1016/j.jinf.2013.04.009; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Riddle MS, 2016, AM J GASTROENTEROL, V111, P602, DOI 10.1038/ajg.2016.126; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Spina A, 2015, CLIN MICROBIOL INFEC, V21, P719, DOI 10.1016/j.cmi.2015.04.007; Stockmann C, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.07.011; Svraka-Latifovic S, 2014, CLIN MICROBIOL INFEC, V20, pO969, DOI 10.1111/1469-0691.12623; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Wikswo Mary E., 2012, Morbidity and Mortality Weekly Report, V61, P1	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207850	10.1371/journal.pone.0207850	http://dx.doi.org/10.1371/journal.pone.0207850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475924	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700081
J	Jardon-Valadez, E; Castillo-Guajardo, D; Martinez-Luis, I; Gutierrez-Sagai, R; Zarinan, T; Ulloa-Aguirre, A				Jardon-Valadez, Eduardo; Castillo-Guajardo, Derik; Martinez-Luis, Ivan; Gutierrez-Sagai, Ruben; Zarinan, Teresa; Ulloa-Aguirre, Alfredo			Molecular dynamics simulation of the follicle-stimulating hormone receptor. Understanding the conformational dynamics of receptor variants at positions N680 and D408 from in silico analysis	PLOS ONE			English	Article							INTERNAL WATER-MOLECULES; CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEIN; RHODOPSIN; POLYMORPHISMS; ARRESTIN; AGONIST; COMPLEX; SURFACE	Follicle-stimulating hormone receptor (FSHR) is a G-protein coupled receptor (GPCR) and a prototype of the glycoprotein hormone receptors subfamily of GPCRs. Structural data of the FSHR ectodomain in complex with follicle-stimulating hormone suggests a "pull and lift" activation mechanism that triggers a conformational change on the seven alpha-helix transmembrane domain (TMD). To analyze the conformational changes of the FSHR TMD resulting from sequence variants associated with reproductive impairment in humans, we set up a computational approach combining helix modeling and molecular simulation methods to generate conformational ensembles of the receptor at room (300 K) and physiological (310 K) temperatures. We examined the receptor dynamics in an explicit membrane environment of polyunsaturated phospholipids and solvent water molecules. The analysis of the conformational dynamics of the functional (N680 and S680) and dysfunctional (mutations at D408) variants of the FSHR allowed us to validate the FSHR-TMD model. Functional variants display a concerted motion of flexible intracellular regions at TMD helices 5 and 6. Disruption of side chain interactions and conformational dynamics were detected upon mutation at D408 when replaced with alanine, arginine, or tyrosine. Dynamical network analysis confirmed that TMD helices 2 and 5 may share communication pathways in the functional FSHR variants, whereas no connectivity was detected in the dysfunctional mutants, indicating that the global dynamics of the FSHR was sensitive to mutations at amino acid residue 408, a key position apparently linked to misfolding and variable cell surface plasma membrane expression of FSHRs with distinct mutations at this position.	[Jardon-Valadez, Eduardo] Univ Autonoma Metropolitana, Unidad Lerma, Dept Recursos Tierra, Lerma De Villada, Estado De Mexic, Mexico; [Castillo-Guajardo, Derik] Univ Autonoma Metropolitana, Unidad Lerma, Dept Ciencias Ambientales, Lerma De Villada, Estado De Mexic, Mexico; [Martinez-Luis, Ivan; Gutierrez-Sagai, Ruben; Zarinan, Teresa; Ulloa-Aguirre, Alfredo] Natl Univ Mexico UNAM, Red Apoyo Invest, Mexico City, DF, Mexico; [Martinez-Luis, Ivan; Gutierrez-Sagai, Ruben; Zarinan, Teresa; Ulloa-Aguirre, Alfredo] Inst Nacl Ciencias Med & Nutr SZ, Mexico City, DF, Mexico	Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Jardon-Valadez, E (corresponding author), Univ Autonoma Metropolitana, Unidad Lerma, Dept Recursos Tierra, Lerma De Villada, Estado De Mexic, Mexico.	h.jardon@correo.ler.uam.mx		Jardon-Valadez, Eduardo/0000-0003-3701-429X; Martinez-Luis, Ivan/0000-0001-8613-0129; Zarinan, Teresa/0000-0003-0855-2312	Consejo Mexiquense de Ciencia y Tecnologia [203G11000/103/2017]; Consejo Nacional de Ciencia y Tecnologia [240619]	Consejo Mexiquense de Ciencia y Tecnologia; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Mexiquense de Ciencia y Tecnologia (http://comecyt.edomex.gob.mx/) grant 203G11000/103/2017 to E.J.-V. Consejo Nacional de Ciencia y Tecnologia (http://www.conacyt.gob.mx) grant 240619 to A.U.-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Almeida JG, 2017, BBA-BIOMEMBRANES, V1859, P2021, DOI 10.1016/j.bbamem.2017.07.008; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bondar AN, 2012, BBA-BIOMEMBRANES, V1818, P942, DOI 10.1016/j.bbamem.2011.11.035; Bramble MS, 2016, HUM REPROD, V31, P905, DOI 10.1093/humrep/dew025; Casarini L, 2015, REPRODUCTION, V150, pR175, DOI 10.1530/REP-15-0251; Casarini L, 2014, MOL CELL ENDOCRINOL, V393, P83, DOI 10.1016/j.mce.2014.06.013; Cossio-Perez R, 2017, J CHEM INF MODEL, V57, P826, DOI 10.1021/acs.jcim.6b00646; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Feller SE, 1999, J CHEM PHYS, V111, P1281, DOI 10.1063/1.479313; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Garcia-Jimenez G, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0420-4; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Greb RR, 2005, J CLIN ENDOCR METAB, V90, P4866, DOI 10.1210/jc.2004-2268; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jardon-Valadez E, 2008, J PHYS CHEM B, V112, P10704, DOI 10.1021/jp800544x; Jardon-Valadez E, 2010, BIOPHYS J, V99, P2200, DOI 10.1016/j.bpj.2010.06.067; Jardon-Valadez E, 2009, J ENDOCRINOL, V201, P297, DOI 10.1677/JOE-08-0527; Jardon-Valadez E, 2009, BIOPHYS J, V96, P2572, DOI 10.1016/j.bpj.2008.12.3927; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; KELTON CA, 1992, MOL CELL ENDOCRINOL, V89, P141, DOI 10.1016/0303-7207(92)90220-Z; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kukol A., 2008, MOL MODELING PROTEIN; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lindau-Shepard B, 2001, J REPROD IMMUNOL, V49, P1, DOI 10.1016/S0165-0378(00)00079-6; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Melo-Nava B, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00076; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murakami M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126970; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Ota T, 2006, BIOCHEMISTRY-US, V45, P2845, DOI 10.1021/bi051937l; Pastor RW, 2011, J PHYS CHEM LETT, V2, P1526, DOI 10.1021/jz200167q; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Simoni M, 2014, EUR J ENDOCRINOL, V170, pR91, DOI 10.1530/EJE-13-0624; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Tranchant T, 2012, HUM REPROD S1, V27, pi45; Tranchant T, 2011, MOL CELL ENDOCRINOL, V331, P109, DOI 10.1016/j.mce.2010.08.016; Tuckerman M. E., 2010, STAT MECH THEORY MOL; Ulloa-Aguirre A, 2017, TARGETING TRAFFICKIN, P1; Ulloa-Aguirre A, 2018, ENDOCRINOLOGY, V159, P3020, DOI 10.1210/en.2018-00452; Ulloa-Aguirre A, 2016, MOL PHARMACOL, V90, P596, DOI 10.1124/mol.116.104398; Ulloa-Aguirre A, 2013, METHOD ENZYMOL, V521, P17, DOI 10.1016/B978-0-12-391862-8.00002-8; Uribe A, 2008, BIOL REPROD, V78, P869, DOI 10.1095/biolreprod.107.063925; van Koppen CJ, 2013, BIOCHEM PHARMACOL, V85, P1162, DOI 10.1016/j.bcp.2013.02.001; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Zambrano E, 1996, MOL HUM REPROD, V2, P563, DOI 10.1093/molehr/2.8.563; Zhang J, 2015, STRUCTURE, V23, P1538, DOI 10.1016/j.str.2015.06.007; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563	63	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207526	10.1371/journal.pone.0207526	http://dx.doi.org/10.1371/journal.pone.0207526			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462715	Green Submitted, gold, Green Published			2022-12-26	WOS:000451054800063
J	Urtishak, KA; Wang, LS; Culjkovic-Kraljacic, B; Davenport, JW; Porazzi, P; Vincent, TL; Teachey, DT; Tasian, SK; Moore, JS; Seif, AE; Jin, SH; Barrett, JS; Robinson, BW; Chen, IML; Harvey, RC; Carroll, MP; Carroll, AJ; Heerema, NA; Devidas, M; Dreyer, ZE; Hilden, JM; Hunger, SP; Willman, CL; Borden, KLB; Felix, CA				Urtishak, Karen A.; Wang, Li-San; Culjkovic-Kraljacic, Biljana; Davenport, James W.; Porazzi, Patrizia; Vincent, Tiffaney L.; Teachey, David T.; Tasian, Sarah K.; Moore, Jonni S.; Seif, Alix E.; Jin, Shenghao; Barrett, Jeffrey S.; Robinson, Blaine W.; Chen, I-Ming L.; Harvey, Richard C.; Carroll, Martin P.; Carroll, Andrew J.; Heerema, Nyla A.; Devidas, Meenakshi; Dreyer, ZoAnn E.; Hilden, Joanne M.; Hunger, Stephen P.; Willman, Cheryl L.; Borden, Katherine L. B.; Felix, Carolyn A.			Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; INITIATION-FACTOR EIF4E; GENE-EXPRESSION; PROGNOSTIC-FACTORS; IMPROVED SURVIVAL; DRUG-RESISTANCE; ANTIVIRAL DRUG; RNA REGULON; CELL-CYCLE; FACTOR 4E	The poor outcomes in infant acute lymphoblastic leukemia (ALL) necessitate new treatments. Here we discover that EIF4E protein is elevated in most cases of infant ALL and test EIF4E targeting by the repurposed antiviral agent ribavirin, which has anticancer properties through EIF4E inhibition, as a potential treatment. We find that ribavirin treatment of actively dividing infant ALL cells on bone marrow stromal cells (BMSCs) at clinically achievable concentrations causes robust proliferation inhibition in proportion with EIF4E expression. Further, we find that ribavirin treatment of KMT2A-rearranged (KMT2A-R) infant ALL cells and the KMT2A-AFF1 cell line RS4:11 inhibits EIF4E, leading to decreases in oncogenic EIF4E-regulated cell growth and survival proteins. In ribavirin-sensitive KMT2A-R infant ALL cells and RS4:11 cells, EIF4E-regulated proteins with reduced levels of expression following ribavirin treatment include MYC, MCL1, NBN, BCL2 and BIRC5. Ribavirin-treated RS4:11 cells exhibit impaired EIF4E-dependent nuclear to cytoplasmic export and/or translation of the corresponding mRNAs, as well as reduced phosphorylation of the p-AKT1, p-EIF4EBP1, p-RPS6 and p-EIF4E signaling proteins. This leads to an S-phase cell cycle arrest in RS4:11 cells corresponding to the decreased proliferation. Ribavirin causes nuclear EIF4E to re-localize to the cytoplasm in KMT2A-AFF1 infant ALL and RS4:11 cells, providing further evidence for EIF4E inhibition. Ribavirin slows increases in peripheral blasts in KMT2A-R infant ALL xenograft-bearing mice. Ribavirin cooperates with chemotherapy, particularly L-asparaginase, in reducing live KMT2A-AFF1 infant ALL cells in BMSC co-cultures. This work establishes that EIF4E is broadly elevated across infant ALL and that clinically relevant ribavirin exposures have preclinical activity and effectively inhibit EIF4E in KMT2A-R cases, suggesting promise in EIF4E targeting using ribavirin as a means of treatment.	[Urtishak, Karen A.; Davenport, James W.; Porazzi, Patrizia; Vincent, Tiffaney L.; Teachey, David T.; Tasian, Sarah K.; Seif, Alix E.; Robinson, Blaine W.; Hunger, Stephen P.; Felix, Carolyn A.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Wang, Li-San; Moore, Jonni S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Culjkovic-Kraljacic, Biljana; Borden, Katherine L. B.] Univ Montreal, IRIC, Dept Pathol & Cell Biol, Montreal, PQ, Canada; [Teachey, David T.; Tasian, Sarah K.; Seif, Alix E.; Barrett, Jeffrey S.; Hunger, Stephen P.; Felix, Carolyn A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jin, Shenghao; Carroll, Martin P.] Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA USA; [Barrett, Jeffrey S.] Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA; [Chen, I-Ming L.; Harvey, Richard C.; Willman, Cheryl L.] Univ New Mexico Hlth Serv, Dept Pathol, Albuquerque, NM USA; [Chen, I-Ming L.; Harvey, Richard C.; Willman, Cheryl L.] Univ New Mexico Hlth Serv, UNM Canc Ctr, Albuquerque, NM USA; [Carroll, Andrew J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Heerema, Nyla A.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Devidas, Meenakshi] Dept Biostat, Childrens Oncol Grp, Gainesville, FL USA; [Dreyer, ZoAnn E.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Hilden, Joanne M.] Childrens Hosp Colorado, Aurora, CO USA; [Hilden, Joanne M.] Univ Colorado, Sch Med, Aurora, CO USA; [Urtishak, Karen A.] NewAgeSys Inc, Princeton Jct, NJ USA; [Porazzi, Patrizia] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Barrett, Jeffrey S.] Bill & Melinda Gates Med Res Inst, Cambridge, MA USA; [Robinson, Blaine W.] Leukemia & Lymphoma Soc, Therapy Accelerat Program, Rye Brook, NY USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Universite de Montreal; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of New Mexico; University of New Mexico; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; Children's Oncology Group (COG); Baylor College of Medicine; Texas Children's Cancer Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Jefferson University	Felix, CA (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA.; Felix, CA (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	felix@email.chop.edu	Porazzi, Patrizia/AAA-3151-2020; Devidas, Meenakshi/H-1170-2019; Seif, Alix/B-9918-2013	Devidas, Meenakshi/0000-0002-1099-3478; Teachey, David/0000-0001-7373-8987; Porazzi, Patrizia/0000-0002-1372-7482; Tasian, Sarah/0000-0003-1327-1662; Seif, Alix/0000-0002-1799-2582	Leukemia & Lymphoma Society [SCOR 7372-07]; ASH Bridge Funding Program; CHOP Bridge Funding Program; Eagles Fly for Leukemia; CHOP Hematologic Malignancies Research Fund; SU2C St. Baldrick's Pediatric Dream Team Translational Research [SU2C-AACR-DT1113]; Cookies for Kids' Cancer Foundation; Rally Foundation [K08CA184418]; Hyundai Hope on Wheels Scholar Award [ACS MRSG-12-215-01-LIB]; Canada Research Chair [R01CA098571, R01CA080728]; COG Statistical Center [U10CA98413]; COG Specimen Banking [U24CA114766];  [R01CA198089]; NATIONAL CANCER INSTITUTE [U10CA098413, R01CA080728, R01CA098571, K08CA184418, U10CA180886, R01CA198089, P30CA016520, U10CA180899] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); ASH Bridge Funding Program; CHOP Bridge Funding Program; Eagles Fly for Leukemia; CHOP Hematologic Malignancies Research Fund; SU2C St. Baldrick's Pediatric Dream Team Translational Research; Cookies for Kids' Cancer Foundation; Rally Foundation; Hyundai Hope on Wheels Scholar Award; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); COG Statistical Center; COG Specimen Banking; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CAF, LSW, J.S.B., CLW, MD, and SPH supported by Leukemia & Lymphoma Society SCOR 7372-07. CAF supported by ASH Bridge Funding Program, CHOP Bridge Funding Program, Eagles Fly for Leukemia, and CHOP Hematologic Malignancies Research Fund. C.A.F. and S.K.T. supported by SU2C St. Baldrick's Pediatric Dream Team Translational Research Grant SU2C-AACR-DT1113 (SU2C is a program of Entertainment Industry Foundation administered by AACR). CAF and DTT supported by Cookies for Kids' Cancer Foundation. SKT supported by K08CA184418 and Rally Foundation for Childhood Cancer Research and was ALSF Scholar in Developmental Therapeutics. AES supported by ACS MRSG-12-215-01-LIB and Hyundai Hope on Wheels Scholar Award. MPC supported by R01CA198089. KLBB funded by R01CA098571 and R01CA080728 and holds a Canada Research Chair. Other support provided by U10CA98413 (COG Statistical Center), U24CA114766 (COG Specimen Banking).	Aebi C, 1997, J PEDIATR-US, V130, P612, DOI 10.1016/S0022-3476(97)70246-4; Asano K, 2001, COLD SPRING HARB SYM, V66, P403, DOI 10.1101/sqb.2001.66.403; ASSELIN BL, 1993, J CLIN ONCOL, V11, P1780, DOI 10.1200/JCO.1993.11.9.1780; Assouline S, 2015, HAEMATOLOGICA, V100, pE7, DOI 10.3324/haematol.2014.111245; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Barrett D, 2012, PEDIATR DRUGS, V14, P299, DOI 10.2165/11594740-000000000-00000; Barrington-Trimis JL, 2017, INT J CANCER, V140, P1000, DOI 10.1002/ijc.30487; Biondi A, 2006, HAEMATOLOGICA, V91, P534; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Borden KLB, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2016.1220899; Borden KLB, 2010, LEUKEMIA LYMPHOMA, V51, P1805, DOI 10.3109/10428194.2010.496506; Bunpo P, 2010, J NUTR, V140, P2020, DOI 10.3945/jn.110.129197; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170; Cheok MH, 2006, NAT REV CANCER, V6, P117, DOI 10.1038/nrc1800; Culjkovic B, 2008, J CELL BIOL, V181, P51, DOI 10.1083/jcb.200707018; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Culjkovic B, 2007, CELL CYCLE, V6, P65, DOI 10.4161/cc.6.1.3688; Culjkovic B, 2009, J ONCOL, V2009, DOI 10.1155/2009/981679; Culjkovic-Kraljacic B, 2016, BLOOD, V127, P858, DOI 10.1182/blood-2015-05-645069; Dai DH, 2017, BIOCHEM BIOPH RES CO, V482, P1259, DOI 10.1016/j.bbrc.2016.12.025; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Dreyer ZE, 2015, PEDIATR BLOOD CANCER, V62, P419, DOI 10.1002/pbc.25322; Dunn LA, 2018, HEAD NECK-J SCI SPEC, V40, P233, DOI 10.1002/hed.24938; Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016; Endres CJ, 2009, J PHARMACOL EXP THER, V331, P287, DOI 10.1124/jpet.109.153130; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; FERSTER A, 1994, BRIT J HAEMATOL, V86, P284, DOI 10.1111/j.1365-2141.1994.tb04727.x; Frost BM, 2002, MED PEDIATR ONCOL, V38, P329, DOI 10.1002/mpo.10052; Glue P, 1999, SEMIN LIVER DIS, V19, P17; Groninger E, 2004, CRIT REV ONCOL HEMAT, V52, P173, DOI 10.1016/j.critrevonc.2004.08.007; HALL CB, 1983, NEW ENGL J MED, V308, P1443, DOI 10.1056/NEJM198306163082403; Hijiya N, 2009, CANCER-AM CANCER SOC, V115, P23, DOI 10.1002/cncr.23988; Hilden JM, 2006, BLOOD, V108, P441, DOI 10.1182/blood-2005-07-3011; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Isakovic AM, 2017, EXP CELL RES, V350, P32, DOI 10.1016/j.yexcr.2016.11.001; Jarvis SM, 1998, BRIT J PHARMACOL, V123, P1587, DOI 10.1038/sj.bjp.0701775; Jedema I, 2004, EXP HEMATOL, V32, P188, DOI 10.1016/j.exphem.2003.11.005; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Kang HN, 2012, BLOOD, V119, P1872, DOI 10.1182/blood-2011-10-382861; Kentsis A, 2005, RNA, V11, P1762, DOI 10.1261/rna.2238705; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; KHARE GP, 1973, ANTIMICROB AGENTS CH, V3, P517, DOI 10.1128/AAC.3.4.517; Koren G, 2003, CAN MED ASSOC J, V168, P1289; Kosaka T, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.6_suppl.329; Kosaka T, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.e14010; Kraljacic BC, 2011, LEUKEMIA, V25, P1197, DOI 10.1038/leu.2011.57; Krilov LR, 2002, PEDIATR INFECT DIS J, V21, P479, DOI 10.1097/00006454-200205000-00037; KRISHAN A, 1976, CANCER RES, V36, P143; Landon AL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6413; LASKIN OL, 1987, CLIN PHARMACOL THER, V41, P546, DOI 10.1038/clpt.1987.70; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; LOWIS SP, 1993, CANCER RES, V53, P4881; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Manara MC, 2013, CURR PHARM DESIGN, V19, P5344, DOI 10.2174/1381612811319300004; Matsuo Y, 1998, LEUKEMIA RES, V22, P567, DOI 10.1016/S0145-2126(98)00050-2; MCLEOD HL, 1992, BRIT J CANCER, V66, pS23; MCLEOD HL, 1993, CANCER SURV, V17, P253; Mihara K, 2003, BRIT J HAEMATOL, V120, P846, DOI 10.1046/j.1365-2141.2003.04217.x; Moore AS, 2011, J PAEDIATR CHILD H, V47, P875, DOI 10.1111/j.1440-1754.2011.02103.x; Munson ME, 2010, CYTOM PART A, V77A, P909, DOI 10.1002/cyto.a.20935; Ogino A, 2014, ONCOL LETT, V8, P2469, DOI 10.3892/ol.2014.2569; Pessetto ZY, 2013, MOL CANCER THER, V12, P1299, DOI 10.1158/1535-7163.MCT-12-0968; Pettersson F, 2015, CANCER RES, V75, P1102, DOI 10.1158/0008-5472.CAN-14-1996; Pettersson F, 2011, CLIN CANCER RES, V17, P2874, DOI 10.1158/1078-0432.CCR-10-2334; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pozarowski Piotr, 2004, Curr Protoc Cell Biol, VChapter 18, DOI [10.1002/0471142956.cy0719s25, 10.1002/0471143030.cb1808s21]; Ramakers-van Woerden NL, 2004, LEUKEMIA, V18, P521, DOI 10.1038/sj.leu.2403253; Reaman GH, 1999, J CLIN ONCOL, V17, P445, DOI 10.1200/JCO.1999.17.2.445; Riner A, 2009, POSTGRAD MED, V121, P139, DOI 10.3810/pgm.2009.05.2014; Rixe O, 2007, CLIN CANCER RES, V13, P7280, DOI 10.1158/1078-0432.CCR-07-2141; Robinson BW, 2008, BRIT J HAEMATOL, V141, P827, DOI 10.1111/j.1365-2141.2008.07100.x; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schotte D, 2011, HAEMATOL-HEMATOL J, V96, P703, DOI 10.3324/haematol.2010.026138; Scully RE, 2007, CARDIOVASC TOXICOL, V7, P122, DOI 10.1007/s12012-007-0006-4; Shi FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136746; Sidwell RW, 2005, ANTIVIR RES, V68, P10, DOI 10.1016/j.antiviral.2005.06.003; Smee Donald F., 2004, Antiviral Chemistry & Chemotherapy, V15, P261; Stam RW, 2010, BLOOD, V115, P2835, DOI 10.1182/blood-2009-07-233049; Tan J, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22007; Tan K, 2008, BIOCHEM BIOPH RES CO, V375, P341, DOI 10.1016/j.bbrc.2008.07.163; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Teng LC, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-63; Topisirovic I, 2005, MOL CELL BIOL, V25, P1100, DOI 10.1128/MCB.25.3.1100-1112.2005; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08; Trentin L, 2009, EUR J HAEMATOL, V83, P406, DOI 10.1111/j.1600-0609.2009.01305.x; Urtishak KA, 2013, BLOOD, V121, P2689, DOI 10.1182/blood-2012-04-425033; Vallee S, 2000, EUR J PHARMACOL, V404, P49, DOI 10.1016/S0014-2999(00)00596-3; van Leeuwen IMM, 2012, CELL CYCLE, V11, P1851, DOI 10.4161/cc.20254; Volpin F, 2017, ONCOGENE, V36, P3037, DOI 10.1038/onc.2016.457; Volpon L, 2016, P NATL ACAD SCI USA, V113, P5263, DOI 10.1073/pnas.1524291113; Volpon L, 2013, BIOCHEM BIOPH RES CO, V434, P614, DOI 10.1016/j.bbrc.2013.03.125; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; WILLIS RC, 1978, P NATL ACAD SCI USA, V75, P3042, DOI 10.1073/pnas.75.7.3042; Xi CL, 2018, BIOCHEM BIOPH RES CO, V503, P2286, DOI 10.1016/j.bbrc.2018.06.150; Xu K, 2011, BRIEF BIOINFORM, V12, P341, DOI 10.1093/bib/bbr006; Yang CHT, 2017, J CLIN TRANSL HEPATO, V5, P59, DOI 10.14218/JCTH.2016.00053; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; Zahreddine HA, 2014, NATURE, V511, P90, DOI 10.1038/nature13283	108	21	21	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2241	2262		10.1038/s41388-018-0567-7	http://dx.doi.org/10.1038/s41388-018-0567-7			22	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30478448	Green Accepted			2022-12-26	WOS:000462588000002
J	Xin, LB; Zhao, R; Lei, J; Song, JC; Yu, L; Gao, R; Ha, CB; Ren, YY; Liu, X; Liu, YX; Yao, Z; Yang, J				Xin, Lingbiao; Zhao, Ran; Lei, Jing; Song, Jianchan; Yu, Lin; Gao, Ru; Ha, Chuanbo; Ren, Yuanyuan; Liu, Xin; Liu, Yixin; Yao, Zhi; Yang, Jie			SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells	FASEB JOURNAL			English	Article						metastasis; transcription coactivator; histone acetylation	STAPHYLOCOCCAL NUCLEASE; TUDOR-SN; COACTIVATOR; MECHANISMS; PROTEIN; TRANSCRIPTION; METASTASIS; TGF-BETA-1; PATHWAY; COMPLEX	Staphylococcal nuclease domain-containing protein 1 (SND1) has been reported as an oncoprotein in a variety of cancers involving multiple processes, including proliferation, angiogenesis, and metastasis. However, the mechanisms underlying metastasis remain largely unknown. Herein, by using the ovarian cancer cell line SKOV3, which has high metastasis ability, we showed that loss-of-function of SND1 dramatically suppressed the invasion and migration of SKOV3 cells. We then performed gene expression profiles and further verified (by use of quantitative PCR and Western blot analysis) that loss-of-function of SND1 resulted in up-regulation of epithelial markers, such as epithelial cadherin and claudin 1, and down-regulation of mesenchymal markers, including neural cadherin and vimentin. Moreover, we illustrated that SLUG, a key transcription factor implicated in epithelial-mesenchymal transition and metastasis, acts as an essential effector of the SND1-promoted epithelial-mesenchymal transition process via regulating N-CAD and VIM expression (or E-CAD and CLDN1). The underlying molecular mechanisms illustrated that SND1 regulates the gene transcriptional activation of SLUG by increasing chromatin accessibility through the recruitment of the acetyltransferases GCN5 and CBP/p300 to the SLUG promoter proximal region. Overall, SND1 was identified as a novel upstream regulator of SLUG, which plays important roles in regulating the E-CAD/N-CAD expression switch.Xin, L., Zhao, R., Lei, J., Song, J., Yu, L., Gao, R., Ha, C., Ren, Y., Liu, X., Liu, Y., Yao, Z., Yang, J. SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.	[Xin, Lingbiao; Zhao, Ran; Lei, Jing; Yu, Lin; Gao, Ru; Ha, Chuanbo; Ren, Yuanyuan; Liu, Xin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Minist Educ, Key Lab Immune Microenvironm & Dis, Tianjin, Peoples R China; [Xin, Lingbiao; Zhao, Ran; Lei, Jing; Yu, Lin; Gao, Ru; Ha, Chuanbo; Ren, Yuanyuan; Liu, Xin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Key Lab Cellular & Mol Immunol Tianjin, Tianjin, Peoples R China; [Xin, Lingbiao; Lei, Jing; Yu, Lin; Gao, Ru; Ren, Yuanyuan; Liu, Xin; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Qixiangtai Rd 22, Tianjin 300070, Peoples R China; [Zhao, Ran; Ha, Chuanbo; Yao, Zhi] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin 300070, Peoples R China; [Song, Jianchan; Liu, Yixin] Tianjin Cent Hosp Gynecol Obstet, Dept Pathol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yang, J (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Qixiangtai Rd 22, Tianjin 300070, Peoples R China.; Yao, Z (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin 300070, Peoples R China.	yaozhi@tmu.edu.cn; yangj@tmu.edu.cn	Yu, Lin/AAH-1131-2019	Yu, Lin/0000-0002-9972-3799	National Science Foundation for Distinguished Young Scholars of China [31125012]; Innovation Team Development Plan of the Ministry of Education [IRT13085]; National Science Foundation of China [31870747, 31370749, 31670759, 81572882, 81572867, 81802588]; Natural Science Foundation of Tianjin [17JCQNJC12600]; Science and Technology Development Fund of Tianjin Education Commission for Higher Education [2016YD18]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovation Team Development Plan of the Ministry of Education; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Science and Technology Development Fund of Tianjin Education Commission for Higher Education	The authors thank Prof. Lei Shi for kindly providing the lentivirus plasmids and the cell lines, Prof. Li Zhao for providing the GLuc reporter plasmid, and Xin Song for help with optical imaging (all from Tianjin Medical University). This work was supported by Grants from the National Science Foundation for Distinguished Young Scholars of China (31125012), the Innovation Team Development Plan of the Ministry of Education (IRT13085), the National Science Foundation of China (31870747, 31370749, and 31670759 to J.Y.; 81572882 to Z.Y.; 81572867 to X.L.; and 81802588 to L.X.), the Natural Science Foundation of Tianjin (17JCQNJC12600 to L.X.), and the Science and Technology Development Fund of Tianjin Education Commission for Higher Education (2016YD18 to L.X.). The authors declare no conflicts of interest.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Arretxe E, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv858; Cappellari M, 2014, ONCOGENE, V33, P3794, DOI 10.1038/onc.2013.360; Cardenas H, 2014, EPIGENETICS-US, V9, P1461, DOI 10.4161/15592294.2014.971608; Chen K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.138; Chen Y, 2017, BRIT J CANCER, V117, P1192, DOI 10.1038/bjc.2017.265; Elbarbary RA, 2017, SCIENCE, V356, P859, DOI 10.1126/science.aai9372; Grassi ML, 2017, J PROTEOMICS, V151, P2, DOI 10.1016/j.jprot.2016.06.009; Idoux-Gillet Y, 2018, ONCOGENE, V37, P578, DOI 10.1038/onc.2017.355; Jaaback K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005340.pub4; Josefowicz SZ, 2016, MOL CELL, V64, P347, DOI 10.1016/j.molcel.2016.09.026; Ju JY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00988-5; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Liu X, 2011, CELL MOL IMMUNOL, V8, P88, DOI 10.1038/cmi.2010.47; Mitra T, 2017, CELL PHYSIOL BIOCHEM, V41, P1336, DOI 10.1159/000464436; Rajasekaran D, 2016, J BIOL CHEM, V291, P10736, DOI 10.1074/jbc.M116.715359; Saarikettu J, 2010, HYBRIDOMA, V29, P231, DOI 10.1089/hyb.2009.0114; Santhekadur PK, 2014, FEBS OPEN BIO, V4, P353, DOI 10.1016/j.fob.2014.03.012; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Singh M, 2018, PHARMACOL THERAPEUT, V182, P80, DOI 10.1016/j.pharmthera.2017.08.009; Su C, 2015, J BIOL CHEM, V290, P7208, DOI 10.1074/jbc.M114.625046; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yu L, 2017, ONCOGENE, V36, P3903, DOI 10.1038/onc.2017.30; Yu L, 2015, CANCER RES, V75, P1275, DOI 10.1158/0008-5472.CAN-14-2387; Zhang XH, 2012, PROG BIOCHEM BIOPHYS, V39, P307, DOI 10.3724/SP.J.1206.2011.00284	33	18	19	4	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3795	3806		10.1096/fj.201801728R	http://dx.doi.org/10.1096/fj.201801728R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30509125	Bronze			2022-12-26	WOS:000459794800057
J	Scholz-Starke, J; Primo, C; Yang, J; Kandel, R; Gaxiola, RA; Hirschi, KD				Scholz-Starke, Joachim; Primo, Cecilia; Yang, Jian; Kandel, Raju; Gaxiola, Roberto A.; Hirschi, Kendal D.			The flip side of the Arabidopsis type I proton-pumping pyrophosphatase (AVP1): Using a transmembrane H+ gradient to synthesize pyrophosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; proton pump; Saccharomyces cerevisiae; vacuole; patch clamp; H+ pumping pyrophosphatase; pH gradient; PPi synthase; pyrophosphate (PPi); tonoplast	TRANSLOCATING PYROPHOSPHATASE; INORGANIC PYROPHOSPHATASE; FUNCTIONAL EXPRESSION; GENETIC MANIPULATION; MOLECULAR-CLONING; PPASE AVP1; V-ATPASE; TRANSPORT; ENERGY; PHLOEM	Energy partitioning and plant growth are mediated in part by a type I H+-pumping pyrophosphatase (H+-PPase). A canonical role for this transporter has been demonstrated at the tonoplast where it serves a job-sharing role with V-ATPase in vacuolar acidification. Here, we investigated whether the plant H+-PPase from Arabidopsis also functions in "reverse mode" to synthesize PPi using the transmembrane H+ gradient. Using patch-clamp recordings on Arabidopsis vacuoles, we observed inward currents upon P-i application on the cytosolic side. These currents were strongly reduced in vacuoles from two independent H+-PPase mutant lines (vhp1-1 and fugu5-1) lacking the classical PPi-induced outward currents related to H+ pumping, whereas they were significantly larger in vacuoles with engineered heightened expression of the H+-PPase. Current amplitudes related to reverse-mode H+ transport depended on the membrane potential, cytosolic P-i concentration, and magnitude of the pH gradient across the tonoplast. Of note, experiments on vacuolar membrane-enriched vesicles isolated from yeast expressing the Arabidopsis H+-PPase (AVP1) demonstrated P-i-dependent PPi synthase activity in the presence of a pH gradient. Our work establishes that a plant H+-PPase can operate as a PPi synthase beyond its canonical role in vacuolar acidification and cytosolic PPi scavenging. We propose that the PPi synthase activity of H+-PPase contributes to a cascade of events that energize plant growth.	[Scholz-Starke, Joachim] CNR, Inst Biophys, Via De Marini 6, I-16149 Genoa, Italy; [Primo, Cecilia; Yang, Jian; Hirschi, Kendal D.] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Kandel, Raju; Gaxiola, Roberto A.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Baylor College of Medicine; Arizona State University; Arizona State University-Tempe	Scholz-Starke, J (corresponding author), CNR, Inst Biophys, Via De Marini 6, I-16149 Genoa, Italy.; Hirschi, KD (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA.	joachim.scholzstarke@ge.ibf.cnr.it; kendalh@bcm.edu	hirschi, kendal/GNP-0351-2022; Primo Planta, Cecilia/AAU-1204-2021; Primo, Cecilia/AAT-8561-2021; Scholz-Starke, Joachim/A-2944-2014	Primo Planta, Cecilia/0000-0002-3305-5150; Gaxiola, Roberto/0000-0001-9348-9850; Scholz-Starke, Joachim/0000-0002-7376-6635	National Science Foundation [IOS 1557890]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS 1557890 (to R. K., C. P., K. D. H., and R. A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; Atwell BJ, 2015, NEW PHYTOL, V206, P36, DOI 10.1111/nph.13173; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpaneto A, 2017, EMBO REP, V18, P1100, DOI 10.15252/embr.201643814; Costa A, 2012, J PHYSIOL-LONDON, V590, P3421, DOI 10.1113/jphysiol.2012.230227; DAVIES JM, 1992, P NATL ACAD SCI USA, V89, P11701, DOI 10.1073/pnas.89.24.11701; Davies JM, 1997, TRENDS PLANT SCI, V2, P9, DOI 10.1016/S1360-1385(97)82732-X; Drake R, 2010, BIOCHEM J, V426, P147, DOI 10.1042/BJ20091491; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Facanha AR, 1998, PLANT PHYSIOL, V116, P1487, DOI 10.1104/pp.116.4.1487; FALCO SC, 1983, GENETICS, V105, P843; Ferjani A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01265; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; Fukuda M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00819; Gaxiola RA, 2002, PLANT PHYSIOL, V129, P967, DOI 10.1104/pp.020009; Gaxiola RA, 2016, TRENDS BIOTECHNOL, V34, P347, DOI 10.1016/j.tibtech.2015.12.016; Gaxiola RA, 2016, MOL PLANT, V9, P317, DOI 10.1016/j.molp.2015.09.008; Gaxiola RA, 2012, PLANT PHYSIOL, V159, P3, DOI 10.1104/pp.112.195701; GIAQUINTA R, 1977, PLANT PHYSIOL, V59, P750, DOI 10.1104/pp.59.4.750; Graus D, 2018, NEW PHYTOL, V219, P1421, DOI 10.1111/nph.15280; HEDRICH R, 1989, EMBO J, V8, P2835, DOI 10.1002/j.1460-2075.1989.tb08430.x; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Huang SB, 2008, TRENDS PLANT SCI, V13, P221, DOI 10.1016/j.tplants.2008.02.007; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Khadilkar AS, 2016, PLANT PHYSIOL, V170, P401, DOI 10.1104/pp.15.01409; KIM EJ, 1995, J BIOL CHEM, V270, P2630, DOI 10.1074/jbc.270.6.2630; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; Kriegel A, 2015, PLANT CELL, V27, P3383, DOI 10.1105/tpc.15.00733; Labbe S, 1999, METHOD ENZYMOL, V306, P145; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Li KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13596; Liu JL, 2015, P NATL ACAD SCI USA, V112, pE6571, DOI 10.1073/pnas.1514598112; Liu QX, 2010, PLANT MOL BIOL, V72, P47, DOI 10.1007/s11103-009-9549-z; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Marsh K, 2000, J AM SOC HORTIC SCI, V125, P420, DOI 10.21273/JASHS.125.4.420; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; MERTENS E, 1993, PARASITOL TODAY, V9, P122, DOI 10.1016/0169-4758(93)90169-G; Nakanishi Y, 1998, PLANT PHYSIOL, V116, P589, DOI 10.1104/pp.116.2.589; Obermeyer G, 1996, BBA-BIOMEMBRANES, V1284, P203, DOI 10.1016/S0005-2736(96)00130-7; Paez-Valencia J, 2013, PLANT PHYSIOL, V161, P1557, DOI 10.1104/pp.112.212852; Paez-Valencia J, 2011, PLANT SCI, V181, P23, DOI 10.1016/j.plantsci.2011.03.008; Perez-Castineira JR, 2011, BIOCHEM J, V437, P269, DOI 10.1042/BJ20110447; Pittman JK, 2005, FEBS LETT, V579, P2648, DOI 10.1016/j.febslet.2005.03.085; Pizzio GA, 2015, PLANT PHYSIOL, V167, P1541, DOI 10.1104/pp.114.254342; Rea P.A., 1990, METHODS PLANT BIOCH, V3, P385, DOI DOI 10.1016/B978-0-12-461013-2.50035-6; Regmi KC, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1231294; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Schilling RK, 2017, TRENDS PLANT SCI, V22, P154, DOI 10.1016/j.tplants.2016.11.012; Segami S, 2018, PLANT CELL, V30, P1040, DOI 10.1105/tpc.17.00911; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Stitt M, 1998, BOT ACTA, V111, P167, DOI 10.1111/j.1438-8677.1998.tb00692.x; Versaw WK, 2017, CURR OPIN PLANT BIOL, V39, P25, DOI 10.1016/j.pbi.2017.04.015; Viotti C, 2013, PLANT CELL, V25, P3434, DOI 10.1105/tpc.113.114827; Yang H, 2007, PLANT BIOTECHNOL J, V5, P735, DOI 10.1111/j.1467-7652.2007.00281.x	59	14	14	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1290	1299		10.1074/jbc.RA118.006315	http://dx.doi.org/10.1074/jbc.RA118.006315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30510138	Green Published, hybrid			2022-12-26	WOS:000457879500020
J	Banerjee, A; Mahata, B; Dhir, A; Mandal, TK; Biswas, K				Banerjee, Avisek; Mahata, Barun; Dhir, Arjun; Mandal, Tapan Kumar; Biswas, Kaushik			Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						specificity protein 1 (Sp1); histone deacetylase 1 (HDAC1); epigenetics; acetylation; ganglioside; gene regulation; B4Galnt1; GM2-synthase; renal cell carcinoma; transcriptional repression	DNA METHYLATION; HUMAN-MELANOMA; MESSENGER-RNA; MOUSE-BRAIN; T-CELLS; EXPRESSION; SP1; TRANSCRIPTION; GANGLIOSIDES; GM2	GM2-synthase produces sialic acid-containing glycosphingolipids called gangliosides, and its mRNA overexpression and the gangliosides it generates are linked to tumor progression, migration, and suppression of tumor-specific host immune responses. However, the mechanism underlying GM2-synthase de-repression in renal cell carcinoma (RCC) is poorly understood. Here, we demonstrate that higher GM2-synthase mRNA expression levels in various cancer cells and in human RCC tumors correlate with higher histone acetylation levels (H3K9, H3K14, or both) at region +38/+187 relative to the transcription start site (TSS) of the GM2-synthase gene than in normal kidney epithelial (NKE) cells or healthy adjacent tissues. An increase in GM2-synthase mRNA expression in cells treated with a histone deacetylase (HDAC) inhibitor was accompanied by increased histone acetylation levels at this promoter region. DNA methylation around the TSS was absent in both RCC cell lines and NKE cells. Of note, both the transcription factor Sp1 and corepressor HDAC1 associated with the +38/+187 region when the GM2-synthase gene was repressed in NKE and tumor-adjacent tissues, indicating plausible site-specific repressive roles of HDAC1 and Sp1 in GM2-synthase mRNA expression. Site-directed mutagenesis of the Sp1-binding site within the +38/+187 region relieved repressed luciferase activity of this region by limiting HDAC1 recruitment. Moreover, Sp1 or HDAC1 knock down increased GM2-synthase transcription, and butyrate-mediated activation of GM2-synthase mRNA expression in SK-RC-45 cells was accompanied by Sp1 and HDAC1 loss from the +38/+187 region. Taken together, we have identified an epigenetic mechanism for the de-repression of the GM2-synthase gene in RCC.	[Banerjee, Avisek; Mahata, Barun; Dhir, Arjun; Biswas, Kaushik] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India; [Mandal, Tapan Kumar] Nil Ratan Sircar Med Coll & Hosp, Dept Urol, Kolkata 700014, W Bengal, India	Department of Science & Technology (India); Bose Institute	Biswas, K (corresponding author), Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India.	kbiswas_1@yahoo.com	Biswas, Kaushik/AAR-1446-2020	Biswas, Kaushik/0000-0003-2502-9515; Mahata, Barun/0000-0002-1614-0791	Bose Institute, Kolkata, India; Department of Biotechnology, India [BT/PR5338/MED/30/989/2013, BT/469/NE/TBP/2013]; University Grants Commission; Council of Scientific and Industrial Research, India	Bose Institute, Kolkata, India(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Bose Institute, Kolkata, India, and the Department of Biotechnology, India Grants BT/PR5338/MED/30/989/2013 and BT/469/NE/TBP/2013. This work was also supported by Senior Research Fellowships from the University Grants Commission (to A. B.) and the Council of Scientific and Industrial Research, India (to B. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Aoki H, 2004, FEBS LETT, V567, P203, DOI 10.1016/j.febslet.2004.04.060; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Biswas K, 2006, CANCER RES, V66, P6816, DOI 10.1158/0008-5472.CAN-06-0250; Biswas S, 2009, J IMMUNOL, V183, P5050, DOI 10.4049/jimmunol.0900259; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Cai BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041742; Chahlavi A, 2005, CANCER RES, V65, P5428, DOI 10.1158/0008-5472.CAN-04-4395; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Furukawa K, 1996, J BIOL CHEM, V271, P20836, DOI 10.1074/jbc.271.34.20836; Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HOON DSB, 1993, J UROLOGY, V150, P2013, DOI 10.1016/S0022-5347(17)35956-6; HOON DSB, 1988, CELL IMMUNOL, V111, P410, DOI 10.1016/0008-8749(88)90104-9; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kou XX, 2013, CARCINOGENESIS, V34, P58, DOI 10.1093/carcin/bgs336; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kundu M, 2016, BBA-MOL CELL RES, V1863, P1472, DOI 10.1016/j.bbamcr.2016.04.004; Li CJ, 2005, J ANIM SCI, V83, P89; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li RG, 1996, J BIOL CHEM, V271, P18925, DOI 10.1074/jbc.271.31.18925; Mahata B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09048; Manfredi MG, 1999, CANCER RES, V59, P5392; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; Prinetti A, 2010, GLYCOBIOLOGY, V20, P62, DOI 10.1093/glycob/cwp143; Shou YP, 1998, J BIOL CHEM, V273, P5716, DOI 10.1074/jbc.273.10.5716; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; TAKI T, 1979, J BIOCHEM-TOKYO, V86, P1395, DOI 10.1093/oxfordjournals.jbchem.a132656; Tsai YT, 2014, J NEUROCHEM, V128, P101, DOI 10.1111/jnc.12456; TSUCHIDA T, 1987, J NATL CANCER I, V78, P55, DOI 10.1093/jnci/78.1.55; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; YUYAMA Y, 1995, CANCER, V75, P1273; Zaid A, 2001, EUR J BIOCHEM, V268, P5497, DOI 10.1046/j.0014-2956.2001.02453.x	43	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1005	1018		10.1074/jbc.RA118.004485	http://dx.doi.org/10.1074/jbc.RA118.004485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30463940	Green Published, hybrid			2022-12-26	WOS:000458670200024
J	Acar, F; Seurinck, R; Eickhoff, SB; Moerkerke, B				Acar, Freya; Seurinck, Ruth; Eickhoff, Simon B.; Moerkerke, Beatrijs			Assessing robustness against potential publication bias in Activation Likelihood Estimation (ALE) meta-analyses for fMRI	PLOS ONE			English	Article							FUNCTIONAL NEUROIMAGING DATA; SENSITIVITY; POWER	The importance of integrating research findings is incontrovertible and procedures for coordinate-based meta-analysis (CBMA) such as Activation Likelihood Estimation (ALE) have become a popular approach to combine results of fMRI studies when only peaks of activation are reported. As meta-analytical findings help building cumulative knowledge and guide future research, not only the quality of such analyses but also the way conclusions are drawn is extremely important. Like classical meta-analyses, coordinate-based meta-analyses can be subject to different forms of publication bias which may impact results and invalidate findings. The file drawer problem refers to the problem where studies fail to get published because they do not obtain anticipated results (e.g. due to lack of statistical significance). To enable assessing the stability of meta-analytical results and determine their robustness against the potential presence of the file drawer problem, we present an algorithm to determine the number of noise studies that can be added to an existing ALE fMRI meta-analysis before spatial convergence of reported activation peaks over studies in specific regions is no longer statistically significant. While methods to gain insight into the validity and limitations of results exist for other coordinate-based meta-analysis toolboxes, such as Galbraith plots for Multilevel Kernel Density Analysis (MKDA) and funnel plots and egger tests for seed-based d mapping, this procedure is the first to assess robustness against potential publication bias for the ALE algorithm. The method assists in interpreting meta-analytical results with the appropriate caution by looking how stable results remain in the presence of unreported information that may differ systematically from the information that is included. At the same time, the procedure provides further insight into the number of studies that drive the meta-analytical results. We illustrate the procedure through an example and test the effect of several parameters through extensive simulations. Code to generate noise studies is made freely available which enables users to easily use the algorithm when interpreting their results.	[Acar, Freya; Seurinck, Ruth; Moerkerke, Beatrijs] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, Ghent, Belgium; [Eickhoff, Simon B.] Heinrich Heine Univ Dusseldorf, Inst Syst Neurosci, Fac Med, Dusseldorf, Germany; [Eickhoff, Simon B.] Res Ctr Julich, Inst Neurosci & Med Brain & Behav INM 7, Julich, Germany	Ghent University; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Acar, F (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, Ghent, Belgium.	freya.acar@ugent.be	Eickhoff, Simon B./K-2061-2013	Eickhoff, Simon B./0000-0001-6363-2759	Research Foundation Flanders (FWO) [G.0149.14N]; National Institute of Mental Health [R01-MH074457]; Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain"; European Union [7202070]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER	Research Foundation Flanders (FWO)(FWO); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain"; European Union(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	FA, RS and BM would like to acknowledge the Research Foundation Flanders (FWO) for financial support (Grant G.0149.14). SBE was supported by the National Institute of Mental Health (R01-MH074457), the Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" and the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 7202070 (HBP SGA1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FA, RS and BM would like to acknowledge the Research Foundation Flanders (FWO) for financial support (Grant G.0149.14N).; SBE was supported by the National Institute of Mental Health (R01-MH074457), the Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" and the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 7202070 (HBP SGA1).	Carp J, 2012, NEUROIMAGE, V63, P289, DOI 10.1016/j.neuroimage.2012.07.004; CARSON KP, 1990, EDUC PSYCHOL MEAS, V50, P233, DOI 10.1177/0013164490502001; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Costafreda SG, 2012, J NEUROSCI METH, V210, P291, DOI 10.1016/j.jneumeth.2012.07.016; David SP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23976-1; David SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070104; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Durnez J, 2014, NEUROIMAGE, V84, P45, DOI 10.1016/j.neuroimage.2013.07.072; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eickhoff SB, 2016, NEUROIMAGE, V137, P70, DOI 10.1016/j.neuroimage.2016.04.072; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Hsu L. M., 2002, Understanding Statistics, V1, P85, DOI 10.1207/S15328031US0102_02; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Jennings RG, 2012, NEUROINFORMATICS, V10, P67, DOI 10.1007/s12021-011-9125-y; Kang J, 2014, ANN APPL STAT, V8, P1561; Kang J, 2011, J AM STAT ASSOC, V106, P124, DOI 10.1198/jasa.2011.ap09735; Kicinski M, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-004831, DOI 10.1136/BMJOPEN-2014-004831]; Laird A, 2008, NEUROINFORMATICS, P65; Laird AR, 2008, NEUROIMAGE, V41, P424, DOI 10.1016/j.neuroimage.2008.01.065; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Maumet C, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.102; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Radua J, 2014, NEUROPSYCHOPHARMACOL, V39, P1547, DOI 10.1038/npp.2014.5; Radua J, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-6; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; RAUDENBUSH SW, 1984, J EDUC PSYCHOL, V76, P85, DOI 10.1037/0022-0663.76.1.85; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Samartsidis P, 2017, BIORXIV, DOI [10.1101/225425, DOI 10.1101/225425]; Scargle J. D., 2000, J SCI EXPLORATION, V14, P91; Schonemann P. H., 2008, CHINESE J PSYCHOL, V50, P21; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stouffer S. A., 1949, AM SOLDIER, V1; Sutton AJAK, 2000, METHODS METAANALYSIS; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; Vevea JL, 2005, PSYCHOL METHODS, V10, P428, DOI 10.1037/1082-989X.10.4.428; Wager TD, 2007, SOC COGN AFFECT NEUR, V2, P150, DOI 10.1093/scan/nsm015; Wager TD, 2009, NEUROIMAGE, V45, pS210, DOI 10.1016/j.neuroimage.2008.10.061; Yue YR, 2012, ANN APPL STAT, V6, P697, DOI 10.1214/11-AOAS523	44	54	54	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0208177	10.1371/journal.pone.0208177	http://dx.doi.org/10.1371/journal.pone.0208177			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500854	gold, Green Published			2022-12-26	WOS:000451883700027
J	Madden, A; Hopwood, M; Neale, J; Treloar, C				Madden, Annie; Hopwood, Max; Neale, Joanne; Treloar, Carla			Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?	PLOS ONE			English	Article							VIRUS-INFECTION; STIGMA; HEALTH; CARE; ALCOHOL	Recent advances in the efficacy and tolerability of hepatitis C treatments and the introduction of a universal access scheme for the new Direct Acting Antiviral (DAA) therapies in March 2016, has resulted in a rapid increase in the uptake of hepatitis C treatment in Australia. Despite these positive developments, recent data suggest a plateauing of treatment numbers, indicating that more work may need to be done to identify and address ongoing barriers to hepatitis C treatment access and uptake. This paper aims to contribute to our understanding of the ongoing barriers to DAA therapies, with a focus on people who inject drugs. The paper draws on participant interview data from a qualitative research study based on a participatory research design that included a peer researcher with direct experience of both hepatitis C DAA treatment and injecting drug use at all stages of the research process. The study's findings show that residual barriers to DAA treatment exist at personal, provider and system levels and include poor venous access, DAA treatments not considered 'core-business' by opioid substitution treatment (OST) providers, and patients having to manage multiple health and social priorities that interfere with keeping medical appointments such as childcare and poor access to transport services. Further, efforts to increase access to and uptake of DAA hepatitis C treatment over time will require a focus on reducing stigma and discrimination towards people who inject drugs as this remains as a major barrier to care for many people.	[Madden, Annie; Hopwood, Max; Neale, Joanne; Treloar, Carla] UNSW Sydney, Ctr Social Res Hlth, Sydney, NSW, Australia; [Neale, Joanne] Kings Coll London, Natl Addict Ctr, London, England	University of New South Wales Sydney; University of London; King's College London	Treloar, C (corresponding author), UNSW Sydney, Ctr Social Res Hlth, Sydney, NSW, Australia.	c.treloar@unsw.edu.au		Treloar, Carla/0000-0002-8230-0386; Neale, Joanne/0000-0003-1502-5983	National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust; King's College London; Australian Government Research Training Program Scholarship; Australian Government Department of Health; PLuS Alliance	National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); PLuS Alliance	Joanne Neale is part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Annie Madden is currently a PhD candidate at the Centre for Social Research in Health and is supported through an Australian Government Research Training Program Scholarship. The Centre for Social Research in Health is supported by a grant from the Australian Government Department of Health. This project was supported by a seed grant from the PLuS Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2007, DRUG ALCOHOL DEPEN, V88, P188, DOI 10.1016/j.drugalcdep.2006.10.014; Bergold J, 2012, FORUM QUALITATIVE SO, V31; Biddle ML, 2014, INTERN MED J, V44, P581, DOI 10.1111/imj.12400; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bruggmann P, 2013, CLIN INFECT DIS, V57, pS56, DOI 10.1093/cid/cit271; Butler K, 2017, INT J DRUG POLICY, V47, P102, DOI 10.1016/j.drugpo.2017.07.008; Dore GJ, 2003, J CLIN VIROL, V26, P171, DOI 10.1016/S1386-6532(02)00116-6; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/m16-2575, 10.7326/M16-2575]; Feld JJ, 2016, J HEPATOL, V65, pS130, DOI 10.1016/j.jhep.2016.07.007; Gartrell A., 2015, TURNBALL GOVT SPEND; Grebely J, 2017, EXPERT REV MOL DIAGN, V17, P1109, DOI 10.1080/14737159.2017.1400385; Grebely J, 2013, J INFECT DIS, V207, pS19, DOI 10.1093/infdis/jis928; Harris M, 2012, ADDICTION, V107, P1090, DOI 10.1111/j.1360-0443.2011.03749.x; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Heard S., 2019, AUSTR NEEDLE SYRINGE; Hirsch AA, 2014, JT COMM J QUAL PATIE, V40, P351, DOI 10.1016/S1553-7250(14)40046-1; Marshall AD, 2015, INT J DRUG POLICY, V26, P984, DOI 10.1016/j.drugpo.2015.07.002; Patterson S, 2015, OPEN FORUM INFECT S1, V2, P1033, DOI [10.1093/ofid/ofv133.747, DOI 10.1093/OFID/OFV133.747]; Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P587, DOI 10.1053/j.gastro.2016.08.043; Petraglia J, 2009, HEALTH COMMUN, V24, P176, DOI 10.1080/10410230802676771; Read P, 2017, INT J DRUG POLICY, V47, P209, DOI 10.1016/j.drugpo.2017.05.032; Rhodes T, 2013, SOCIOL HEALTH ILL, V35, P1023, DOI 10.1111/1467-9566.12018; Room R, 2005, DRUG ALCOHOL REV, V24, P143, DOI 10.1080/09595230500102434; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; The Kirby Institute, 2018, MON HEP C TREATM UPT; The Kirby Institute; UNSW Sydney, 2021, MON HEP C TREATM UPT; Wicks PG, 2009, ACTION RES-LONDON, V7, P243, DOI 10.1177/1476750309336715; World Health Organization, 2016, COMB HEP B C REACH E	28	53	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207226	10.1371/journal.pone.0207226	http://dx.doi.org/10.1371/journal.pone.0207226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC6AO	30500863	Green Published, Green Submitted, gold			2022-12-26	WOS:000451883700006
J	Bencatel, J; Ferreira, CC; Barbosa, AM; Rosalino, LM; Alvares, F				Bencatel, Joana; Ferreira, Catarina C.; Marcia Barbosa, A.; Rosalino, Luis Miguel; Alvares, Francisco			Research trends and geographical distribution of mammalian carnivores in Portugal (SW Europe)	PLOS ONE			English	Article							RACCOON PROCYON-LOTOR; LYNX LYNX-PARDINUS; IBERIAN LYNX; CONSERVATION BIOGEOGRAPHY; BIODIVERSITY; PREDICTION; PRIORITIES; HOTSPOTS; HABITAT; SCALES	Information regarding species' status at a regional scale is instrumental for effective conservation planning. Some regions of southwestern Europe, such as Portugal, albeit included in the Mediterranean biodiversity hotspot, lack a detailed assessment of the distribution patterns of several taxonomic groups, such as carnivores. Moreover, information is scattered, often unreliable and biased towards some species or regions. This study aimed at reviewing the existing knowledge on mammalian terrestrial carnivores in Portugal, to analyse research trends, update the species checklist and assess their historical and current distribution patterns. We conducted a comprehensive review of 755 scientific studies to analyse several publication metrics and compiled 20,189 presence records of all mammalian terrestrial carnivores occurring in Portugal since historical times to evaluate their distribution patterns. Carnivore research in Portugal began in the 18th century, with a recent boost in the mid-1990s, and has been biased towards certain research topics and regionally threatened species. There are 15 extant species in Portugal, with nine occurring across the country, six showing a more limited range, as well as one additional species currently locally extinct (Ursus arctos). Over the last decades, the distribution ranges of seven species apparently remained stable, two expanded, two contracted, and three showed unclear trends. The presence of a new invasive carnivore, the raccoon (Procyon lotor), is also documented here. This study illustrates the relevance of a comprehensive analysis of non-systematic data to assess the historic and current status of mammalian terrestrial carnivores at a national level, and to identify knowledge gaps and research priorities.	[Bencatel, Joana; Alvares, Francisco] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBio, Vairao, Portugal; [Ferreira, Catarina C.] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Ferreira, Catarina C.] Trent Univ, Dept Biol, Peterborough, ON, Canada; [Marcia Barbosa, A.] Univ Evora, CIBIO InBIO, Evora, Portugal; [Rosalino, Luis Miguel] Ctr Environm & Marine Studies CESAM, Aveiro, Portugal; [Rosalino, Luis Miguel] Univ Aveiro, Dept Biol, Aveiro, Portugal	Universidade do Porto; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Trent University; University of Evora; Universidade de Aveiro; Universidade de Aveiro	Bencatel, J (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBio, Vairao, Portugal.	bencateljoana@gmail.com	Ferreira, Catarina Campos/A-3898-2011; Barbosa, A. Márcia/B-3992-2008; Rosalino, Luís Miguel/B-9406-2009; Alvares, Francisco/K-6353-2013	Ferreira, Catarina Campos/0000-0002-5093-0789; Barbosa, A. Márcia/0000-0001-8972-7713; Rosalino, Luís Miguel/0000-0003-4186-7332; Alvares, Francisco/0000-0002-4033-6989	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [IF/00266/2013, CP1168/CT0001, POCI-01-0145-FEDER-006821, UID/BIA/50027]; Marie Curie Outgoing International Fellowship for Career Development within the 7th Framework Programme of the European Union [PIOF-GA-2013-621571]; University of Aveiro (Department of Biology), Center for Environmental and Marine Studies - CESAM [UID/AMB/50017]; FCT/MEC; Fundo Europeu de Desenvolvimento Regional - FEDER; Fundo Europeu de Desenvolvimento Regional - FEDER within Compete 2020	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Marie Curie Outgoing International Fellowship for Career Development within the 7th Framework Programme of the European Union; University of Aveiro (Department of Biology), Center for Environmental and Marine Studies - CESAM; FCT/MEC; Fundo Europeu de Desenvolvimento Regional - FEDER(European Commission); Fundo Europeu de Desenvolvimento Regional - FEDER within Compete 2020	AMB is supported by Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through contract IF/00266/2013, exploratory project CP1168/CT0001, and funds POCI-01-0145-FEDER-006821 to research unit UID/BIA/50027. CCF is supported by a Marie Curie Outgoing International Fellowship for Career Development (PIOF-GA-2013-621571) within the 7th Framework Programme of the European Union. LMR was financially supported by the University of Aveiro (Department of Biology), Center for Environmental and Marine Studies - CESAM (UID/AMB/50017), FCT/MEC through national funds, and the co-funding by Fundo Europeu de Desenvolvimento Regional - FEDER, within the PT2020 Partnership Agreement and Compete 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar C., 2009, MONTANHA; Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; Almaca C, 1991, BEGINNING PORTUGUESE; Alvares F, 2010, ACAFA ON LINE, V3, P1; [Anonymous], 2013, ROOT CAUSES BIODIVER; Arnold J, 2012, MAMMAL REV, V42, P1, DOI 10.1111/j.1365-2907.2011.00185.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Baptista MD, 1789, FAUNAE CONIMBRICENCI; Baquero RA, 2001, BIODIVERS CONSERV, V10, P29, DOI 10.1023/A:1016698921404; Barbosa AM, 2003, BIOL CONSERV, V114, P377, DOI 10.1016/S0006-3207(03)00066-1; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Barros T, 2016, MAMM BIOL, V81, P176, DOI 10.1016/j.mambio.2015.09.003; Barros T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133768; Blanco JC, 1998, MAMIFEROS ESPANAL IN; Blondel J, 2010, MEDITERRANEAN REGION; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Brito JC, 2004, 4 INT MART S MART CA, P42; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Blanco JC, 2012, HYSTRIX, V23, P35; Cavallini P, 2008, IUCN RED LIST THREAT; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Clavero M, 2013, BIODIVERS CONSERV, V22, P1691, DOI 10.1007/s10531-013-0506-4; Clavero M, 2010, TRENDS ECOL EVOL, V25, P552, DOI 10.1016/j.tree.2010.07.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Ferreira C, 2012, EUR J WILDLIFE RES, V58, P885, DOI 10.1007/s10344-012-0664-9; Garcia JT, 2012, BIOL INVASIONS, V14, P1305, DOI 10.1007/s10530-011-0157-x; GASTON KJ, 1991, OIKOS, V61, P434, DOI 10.2307/3545251; Gaubert P., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T41698A45218636.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T41698A45218636.EN]; Gaubert P, 2011, J BIOGEOGR, V38, P341, DOI 10.1111/j.1365-2699.2010.02406.x; Huntley B, 1991, FUTURE RAPID ENV CHA, P487, DOI [10.1007/978-3-642-60599-4_37, DOI 10.1007/978-3-642-60599-4_37]; IUCN (International Union for Conservation of Nature), 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; IUCN Standards and Petitions Subcommittee, 2014, GUID US IUCN RED LIS; Linnell JDC, 2012, HYSTRIX, V23, P80, DOI 10.4404/hystrix-23.1-4676; Marucco F, 2012, HYSTRIX, V23, P5, DOI 10.4404/hystrix-23.1-4584; Mathias M da L, 1998, MAMIFEROS PORTUGAL; Mathias M. L., 1999, GUIA MAMIFEROS TERRE; Matos H, 2006, MARTES CARNIVORE COM, P45; Michener WK, 2015, ECOL INFORM, V29, P33, DOI 10.1016/j.ecoinf.2015.06.010; Miller Brian, 2001, Endangered Species Update, V18, P202; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Munoz P, 2007, ESTRATEGIA CONSERVAC, P44; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson Fred, 2009, Human Dimensions of Wildlife, V14, P381, DOI 10.1080/10871200903045228; Palma L, 1999, J APPL ECOL, V36, P812, DOI 10.1046/j.1365-2664.1999.00436.x; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Pérez-Irineo Gabriela, 2013, Mastozool. neotrop., V20, P113; Petrucci-Fonseca F, 1990, LOBO CANIS LUPUS SIG; Pimm SL, 2008, CURR BIOL, V18, pR117, DOI 10.1016/j.cub.2007.11.055; Pita R, 2009, AGR ECOSYST ENVIRON, V132, P57, DOI 10.1016/j.agee.2009.02.008; Prieto R, 2012, MAMMAL REV, V42, P235, DOI 10.1111/j.1365-2907.2011.00195.x; Projeto Life+ IBERLINCE, 2017, REC DISTR HIST LINC; QGIS Development Team, 2016, QGIS GEOGR INF SYST; Quaglietta L, 2015, MAMMAL RES, V60, P127, DOI 10.1007/s13364-015-0216-2; Real R, 2009, DIVERS DISTRIB, V15, P390, DOI 10.1111/j.1472-4642.2008.00546.x; Robertson PA, 2015, MAMMAL REV, V45, P128, DOI 10.1111/mam.12038; Rodrigues DC, 2015, BIOL INVASIONS, V17, P13, DOI 10.1007/s10530-014-0706-1; Rodriguez-Varela R, 2016, J ZOOL, V298, P94, DOI 10.1111/jzo.12289; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Salgado I, 2018, BIODIVERS CONSERV, V27, P2243, DOI 10.1007/s10531-018-1535-9; Santos Reis M., 1983, Acta Zoologica Fennica, P213; Santos-Reis Margarida, 1996, Hystrix, V8, P75; Sarmento P, 2009, EUR J WILDLIFE RES, V55, P247, DOI 10.1007/s10344-008-0240-5; Superina M, 2014, MAMMAL REV, V44, P69, DOI 10.1111/mam.12010; Temple H.J., 2009, STATUS DISTRIBUTION; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trindade A., 1998, DISTRIBUICAO LONTRA; Valenzuela-Galvan D, 2008, BIODIVERS CONSERV, V17, P539, DOI 10.1007/s10531-007-9269-0; Varela S, 2010, QUATERNARY SCI REV, V29, P2027, DOI 10.1016/j.quascirev.2010.04.017; Vargas A., 2008, International Zoo Yearbook, V42, P190, DOI 10.1111/j.1748-1090.2007.00036.x; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; Vidal Figueroa T., 1987, Ecologia (Madrid), V1, P145; Visconti P, 2011, PHILOS T R SOC B, V366, P2693, DOI 10.1098/rstb.2011.0105; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x	78	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207866	10.1371/journal.pone.0207866	http://dx.doi.org/10.1371/journal.pone.0207866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496223	gold, Green Published, Green Submitted			2022-12-26	WOS:000451763800057
J	Hung, JJ; Yeh, HY; Peng, SH; Chang, YP; Hwang, JS				Hung, Jia-Jang; Yeh, Hsiang-Yi; Peng, Shao-Hung; Chang, Yuan-Pin; Hwang, Jiang-Shiou			External-forcing modulation on temporal variations of hydrothermalism-evidence from sediment cores in a submarine venting field off northeastern Taiwan	PLOS ONE			English	Article							METAL ACCUMULATION; OFFSHORE TAIWAN; AMBITLE ISLAND; TUTUM BAY; DEEP-SEA; SYSTEM; KUEISHANTAO; GEOCHEMISTRY; ENVIRONMENTS; COMMUNITIES	The temporal variation of sulfur and metals in core sediments off Kueishantao Islet, a hydrothermal vent site at northeastern Taiwan, was explored to elucidate the changes in submarine hydrothermal emanation over a centennial time scale. The discharge of acidic fluids containing abundant sulfides and dissolved metals results in different concentrations of sulfur and metal accumulating in deposited sediments. In addition to particle size and organic carbon affecting metal contents, the content of total sulfur (TS), which is regarded as an indicator of hydrothermalism, correlates positively and strongly with Fe and other metals; however, it correlates negatively with another index of hydrothermalism, the Al/(Al+Fe+Mn) ratio. The TS content in Core Ks2, the core closest to the vents, increased during 1950-1956, 1968-1970, 1982-1987, 1990-1992, and 2004-2005, but decreased during 1967-1968, 1988-1990, and 1994-1995. The chronological changes in the TS concentration of Cores Ks3 and S2 were very similar to those of Core Ks2 within the aforementioned time spans. The numerous large earthquakes (M-L > 5) and typhoons that affect northeastern Taiwan appear to influence hydrothermal emanation and determine the temporal variation of sulfur and metals in sediment cores.	[Hung, Jia-Jang; Yeh, Hsiang-Yi; Peng, Shao-Hung; Chang, Yuan-Pin] Natl Sun Yat Sen Univ, Dept Oceanog, Asian Pacific Ocean Res Ctr, Kaohsiung, Taiwan; [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan	National Sun Yat Sen University; National Taiwan Ocean University	Hung, JJ (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Asian Pacific Ocean Res Ctr, Kaohsiung, Taiwan.	hungjj@mail.nsysu.edu.tw	Chang, Yuan-Pin/C-1656-2009	Chang, Yuan-Pin/0000-0001-8147-7860; Hung, Jia-Jang/0000-0003-3432-2107	National Sun Yat-sen Univesity; National Science Council, Republic of China [NSC 103-2611-M-110-003]	National Sun Yat-sen Univesity; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by National Sun Yat-sen Univesity and the National Science Council, Republic of China [contract numbers NSC 103-2611-M-110-003 to JJH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonini M, 2016, TECTONOPHYSICS, V672, P190, DOI 10.1016/j.tecto.2016.01.037; BOSTROM K, 1966, ECON GEOL, V61, P1258, DOI 10.2113/gsecongeo.61.7.1258; Bruland KW, 2014, TREATISE GEOCHEMISTR, V8; Cardigos F, 2005, CHEM GEOL, V224, P153, DOI 10.1016/j.chemgeo.2005.07.019; Chan I, 2014, MAR POLLUT BULL, V85, P648, DOI 10.1016/j.marpolbul.2013.11.015; Chang NN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204753; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Chen XG, 2016, J MARINE SYST, DOI [10.1016/j.marsys.2016.11.018, DOI 10.1016/J.MARSYS.2016.11.018]; Chen YJ, 2015, BIOGEOSCIENCES, V12, P2631, DOI 10.5194/bg-12-2631-2015; Chen YG, 2001, QUATERNARY SCI REV, V20, P869, DOI 10.1016/S0277-3791(00)00047-0; Chiang HT, 2010, TERR ATMOS OCEAN SCI, V21, P563, DOI 10.3319/TAO.2009.11.02.01(TH); Chiu CL, 2010, TERR ATMOS OCEAN SCI, V21, P575, DOI 10.3319/TAO.2010.02.22.02(TH); Dahma HU, 2018, HYDROBIOLOGIA, DOI [10.1007/s10750-017-3295-z, DOI 10.1007/S10750-017-3295-Z]; Du YS, 2007, SCI CHINA SER D, V50, P1628, DOI 10.1007/s11430-007-0111-z; Fonselius SH, 1983, METHODS SEAWATER ANA, P73; Gamo T, 2007, P JPN ACAD B-PHYS, V83, P199, DOI 10.2183/pjab/83.199; Glasby GP, 2001, EARTH-SCI REV, V52, P261, DOI 10.1016/S0012-8252(00)00031-3; Han CH, 2014, ACTA OCEANOL SIN, V33, P37, DOI 10.1007/s13131-014-0405-x; Ho TY, 2010, TALANTA, V82, P1478, DOI 10.1016/j.talanta.2010.07.022; Huh CA, 2006, MAR GEOL, V231, P129, DOI 10.1016/j.margeo.2006.05.009; Hung JJ, 2018, MAR CHEM, V198, P88, DOI 10.1016/j.marchem.2017.12.004; Hung JJ, 2009, J MARINE SYST, V76, P479, DOI 10.1016/j.jmarsys.2008.03.022; Hung JJ, 2004, MAR POLLUT BULL, V49, P986, DOI 10.1016/j.marpolbul.2004.06.028; Johnson HP, 2000, NATURE, V407, P174, DOI 10.1038/35025040; LAVELLE JW, 1992, J GEOPHYS RES-OCEANS, V97, P7413, DOI 10.1029/92JC00406; Little SA, 1998, GEOPHYS RES LETT, V15, P1491; Liu JT, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007630; Mascarenhas Peereira MBL, 2010, MAR CHEM, V121, P49; Mason RP, 2013, TRACE METALS IN AQUATIC SYSTEMS, P219; McCarthy KT, 2005, CHEM GEOL, V224, P55, DOI 10.1016/j.chemgeo.2005.07.014; Nakayama E, 2002, MARINE ENV PRESENT F, P345; Nozaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22163; Pichler T, 1999, MAR CHEM, V64, P229, DOI 10.1016/S0304-4203(98)00076-0; Price RE, 2005, CHEM GEOL, V224, P122, DOI 10.1016/j.chemgeo.2005.07.017; Price RE, 2013, CHEM GEOL, V348, P15, DOI 10.1016/j.chemgeo.2012.06.007; Sander SG, 2011, NAT GEOSCI, V4, P145, DOI [10.1038/ngeo1088, 10.1038/NGEO1088]; Sedwick P, 1996, MAR CHEM, V53, P147, DOI 10.1016/0304-4203(96)00020-5; SILVER PG, 1987, NATURE, V326, P589, DOI 10.1038/326589a0; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; van Dover CL, 2017, NAT GEOSCI, V10, P464, DOI 10.1038/ngeo2983; Van Dover CL, 2014, MAR ENVIRON RES, V102, P59, DOI 10.1016/j.marenvres.2014.03.008; Varnavas SP, 2005, CHEM GEOL, V224, P40, DOI 10.1016/j.chemgeo.2005.07.013; Von Dann KL, 2005, GEOCHIM COSMOCHIM AC, V49, P2197; YAMAMOTO K, 1987, SEDIMENT GEOL, V52, P65, DOI 10.1016/0037-0738(87)90017-0; Yang TF, 2005, GEOCHEM J, V39, P469, DOI 10.2343/geochemj.39.469	45	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0207774	10.1371/journal.pone.0207774	http://dx.doi.org/10.1371/journal.pone.0207774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496305	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800049
J	Phetcharat, T; Dawkrajai, P; Chitov, T; Wongpornchai, P; Saenton, S; Mhuantong, W; Kanokratana, P; Champreda, V; Bovonsombut, S				Phetcharat, Thanachai; Dawkrajai, Pinan; Chitov, Thararat; Wongpornchai, Pisanu; Saenton, Schradh; Mhuantong, Wuttichai; Kanokratana, Pattanop; Champreda, Verawat; Bovonsombut, Sakunnee			Effect of inorganic nutrients on bacterial community composition in oil-bearing sandstones from the subsurface strata of an onshore oil reservoir and its potential use in Microbial Enhanced Oil Recovery	PLOS ONE			English	Article							PETROLEUM RESERVOIRS; WATER; THERMUS	Microbial Enhanced Oil Recovery (MEOR) is a promising strategy to improve recovery of residual oil in reservoirs, which can be performed by promoting specific indigenous microorganisms. In this study, we performed preliminary evaluation of the possibility of conducting MEOR at Mae Soon reservoir, an onshore reservoir in Northern Thailand. The reservoir's physicochemical characteristics, including the characteristics of the wells, the oil-bearing sandstone cores, and the reservoir's produced water, were determined. The microbiological characteristics of the oil wells in the reservoir were also investigated by submerging the reservoir's sandstone core samples, obtained from 6 oil wells, in the reservoir's produced water and in the produced water added with inorganic nutrients (KNO3 and NaH2PO4). The uncultured bacteria in both treatments were determined, using tagged 16S rRNA gene amplicon with Ion Torrent Sequencing Analysis. The effects of inorganic nutrients and the reservoir's parameters on the bacterial communities were analysed. A total number of 16,828 OTUs were taxonomically classified into 89 classes and 584 genera. In the controls (sandstone cores submerged in the produced water), the dominant bacterial populations were related to Deinococcus-Thermus, and Betaproteobacteria; while in the nutrient treated samples, there was a marked increase in the relative abundance of Gammaproteobacteria in three samples. Thermus, Acinetobacter, and Pseudomonas were the most abundant genera, and these are potential microorganisms for MEOR. Analysis of correlations between physio-chemical properties of the reservoir and bacterial genera, using spearman's correlation analysis, suggested that some of the reservoir's properties, especially of the well and the rock, could influence some bacterial genera. To our knowledge, this is the first demonstration of the effect of inorganic nutrients on alteration of bacterial communities attached to reservoir's rock, and how the bacterial, physical, and chemical properties of a reservoir were co-analysed to serve as a basis for designing a MEOR process.	[Phetcharat, Thanachai] Chiang Mai Univ, Grad Sch, Interdisciplinary Program Biotechnol, Chiang Mai, Thailand; [Phetcharat, Thanachai; Chitov, Thararat; Bovonsombut, Sakunnee] Chiang Mai Univ, Fac Sci, ESRC, Chiang Mai, Thailand; [Dawkrajai, Pinan] NPDC, Def Energy Dept, Chiang Mai, Thailand; [Wongpornchai, Pisanu; Saenton, Schradh] Chiang Mai Univ, Fac Sci, Dept Geol Sci, Chiang Mai, Thailand; [Mhuantong, Wuttichai; Kanokratana, Pattanop; Champreda, Verawat] Natl Ctr Genet Engn & Biotechnol BIOTEC, Enzyme Technol Lab, Thailand Sci Pk, Pathum Thani, Thailand; [Chitov, Thararat; Bovonsombut, Sakunnee] Chiang Mai Univ, Fac Sci, Dept Biol, Div Microbiol, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chiang Mai University	Bovonsombut, S (corresponding author), Chiang Mai Univ, Fac Sci, ESRC, Chiang Mai, Thailand.; Bovonsombut, S (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Div Microbiol, Chiang Mai, Thailand.	sakunnee.b@cmu.ac.th	Saenton, Schradh/AAB-2720-2021; Saenton, Schradh/AAO-6512-2021; Bovonsombut, Sakunnee/D-2434-2018	Saenton, Schradh/0000-0001-9132-9896; Bovonsombut, Sakunnee/0000-0002-8436-9715	National Research Council of Thailand (NRCT); Environmental Science Research Center (ESRC); Graduate School of Chiang Mai University; Chiang Mai University	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Environmental Science Research Center (ESRC); Graduate School of Chiang Mai University; Chiang Mai University	This work was financially supported by the National Research Council of Thailand (NRCT), and Environmental Science Research Center (ESRC) and Graduate School of Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research work was partially supported by Chiang Mai University. The authors would like to express our gratitude to Dr. Robert Kieckhefer (guest lecturer, Department of Geological Sciences, Chiang Mai University) for his invaluable advice to improve the manuscript and Dr. Denis Sweatman (Chiang Mai University) for his kind assistance in proofreading the manuscript. We also would like to thank the staff members of the Northern Petroleum Development Centre, Defence Energy Department, Thailand, for providing the samples used in this study and the accompanying data.	Agrawal A, 2010, ANAEROBE, V16, P12, DOI 10.1016/j.anaerobe.2009.04.005; Al-Sulaimani H., 2011, BIOTECHNOL BIOINFORM, V1, P147; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; [Anonymous], 1991, SPE RESERV ENG, DOI DOI 10.2118/16737-PA; Aurepatipan N, 2018, J PETROL SCI ENG, V163, P295, DOI 10.1016/j.petrol.2017.12.077; Banat IM, 2010, APPL MICROBIOL BIOT, V87, P427, DOI 10.1007/s00253-010-2589-0; Bass C., 1997, OILFIELD REV     SPR, P17; Biria D, 2010, WORLD J MICROB BIOT, V26, P871, DOI 10.1007/s11274-009-0246-5; Bonch-Osmolovskaya EA, 2003, APPL ENVIRON MICROB, V69, P6143, DOI 10.1128/AEM.69.10.6143-6151.2003; Brakstad OG, 2008, INT J OIL GAS COAL T, V1, P211, DOI 10.1504/IJOGCT.2008.019843; Brown L, 2000, SPE J, DOI [10.2523/59306-MS, DOI 10.2523/59306-MS]; Brown LR, 2010, CURR OPIN MICROBIOL, V13, P316, DOI 10.1016/j.mib.2010.01.011; Bryant RS., 1989, SPE RESERV ENG, V4, P151, DOI [10.2118/16646-PA, DOI 10.2118/16646-PA]; Canganella Francesco, 2014, Life-Basel, V4, P77, DOI 10.3390/life4010077; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Donaldson EC, 1989, MICROBIAL ENHANCED O; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Sheshtawy H. S., 2015, Egyptian Journal of Petroleum, V24, P155, DOI 10.1016/j.ejpe.2015.05.005; Feitkenhauer H, 2003, BIODEGRADATION, V14, P367, DOI 10.1023/A:1027357615649; Ghojavand H, 2008, APPL MICROBIOL BIOT, V80, P1073, DOI 10.1007/s00253-008-1570-7; Guo HG, 2012, INT J COAL GEOL, V93, P56, DOI 10.1016/j.coal.2012.01.014; Hao RX, 2004, CAN J MICROBIOL, V50, P175, DOI [10.1139/w03-116, 10.1139/W03-116]; Hauke J, 2011, QUAEST GEOGR, V30, P87, DOI 10.2478/v10117-011-0021-1; Iglauer S, 2010, J PETROL SCI ENG, V71, P23, DOI 10.1016/j.petrol.2009.12.009; JEANTHON C, 1995, ARCH MICROBIOL, V164, P91, DOI 10.1007/BF02525313; KALISH PJ, 1964, J PETROL TECHNOL, V16, P805, DOI 10.2118/579-PA; Kaster KM, 2012, TRANSPORT POROUS MED, V91, P59, DOI 10.1007/s11242-011-9833-7; Kerschen EJ, 2001, J BACTERIOL, V183, P2125, DOI 10.1128/JB.183.6.2125-2131.2001; Kotlar HK, 2011, ENV MICROBIOL REP, V3, P674, DOI 10.1111/j.1758-2229.2011.00279.x; Lazar I, 2007, PETROL SCI TECHNOL, V25, P1353, DOI 10.1080/10916460701287714; Lewin A, 2013, CURR OPIN BIOTECH, V24, P516, DOI 10.1016/j.copbio.2012.10.012; Li H, 2012, PETROL SCI, V9, P469, DOI 10.1007/s12182-012-0232-7; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Nishanthi R, 2010, J ECOBIOTECHNOL, V2, P47; Olsson-Francis K., 2016, ADV MICROBIOL-NY, V6, P233, DOI [DOI 10.4236/AIM.2016.63023, 10.4236/aim.2016.63023]; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Pantazaki AA, 2010, APPL MICROBIOL BIOT, V88, P939, DOI 10.1007/s00253-010-2802-1; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Portwood J.T., 1995, SOC PETROLEUM ENG, DOI [10.2118/29518-MS, DOI 10.2118/29518-MS]; Ren HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023258; Sen R, 2008, PROG ENERG COMBUST, V34, P714, DOI 10.1016/j.pecs.2008.05.001; Shibulal B, 2014, SCI WORLD J, DOI 10.1155/2014/309159; Stephens J, 1996, DEFC2294BC14962 MISS; Torsaeter O., 2003, EXPT RESERVOIR ENG L; Wang LY, 2012, BIOGEOSCIENCES, V9, P4645, DOI 10.5194/bg-9-4645-2012; Wang LY, 2014, APPL MICROBIOL BIOT, V98, P4209, DOI 10.1007/s00253-013-5472-y; Youssef N, 2007, APPL ENVIRON MICROB, V73, P1239, DOI 10.1128/AEM.02264-06; Youssef N, 2009, ADV APPL MICROBIOL, V66, P141, DOI 10.1016/S0065-2164(08)00806-X; Zhou J, 1996, APPL ENVIRON MICROB, V62, P16; Zou CJ, 2014, BIOCHEM ENG J, V90, P49, DOI 10.1016/j.bej.2014.05.007	54	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0198050	10.1371/journal.pone.0198050	http://dx.doi.org/10.1371/journal.pone.0198050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496176	Green Submitted, gold, Green Published			2022-12-26	WOS:000451763800001
J	Schilde, LM; Kosters, S; Steinbach, S; Schork, K; Eisenacher, M; Galozzi, S; Turewicz, M; Barkovits, K; Mollenhauer, B; Marcus, K; May, C				Schilde, Lukas M.; Koesters, Steffen; Steinbach, Simone; Schork, Karin; Eisenacher, Martin; Galozzi, Sara; Turewicz, Michael; Barkovits, Katalin; Mollenhauer, Brit; Marcus, Katrin; May, Caroline			Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; PARKINSONS-DISEASE; BIOLOGICAL VARIATION; ALZHEIMERS-DISEASE; CSF FLOW; IDENTIFICATION; MARKERS; PROTEOMICS; DIAGNOSIS; BLOOD	Cerebrospinal fluid is investigated in biomarker studies for various neurological disorders of the central nervous system due to its proximity to the brain. Currently, only a limited number of biomarkers have been validated in independent studies. The high variability in the protein composition and protein abundance of cerebrospinal fluid between as well as within individuals might be an important reason for this phenomenon. To evaluate this possibility, we investigated the inter-and intraindividual variability in the cerebrospinal fluid proteome globally, with a specific focus on disease biomarkers described in the literature. Cerebrospinal fluid from a longitudinal study group including 12 healthy control subjects was analyzed by label-free quantification (LFQ) via LC-MS/MS. Data were quantified via MaxQuant. Then, the intra-and interindividual variability and the reference change value were calculated for every protein. We identified and quantified 791 proteins, and 216 of these proteins were abundant in all samples and were selected for further analysis. For these proteins, we found an interindividual coefficient of variation of up to 101.5% and an intraindividual coefficient of variation of up to 29.3%. Remarkably, these values were comparably high for both proteins that were published as disease biomarkers and other proteins. Our results support the hypothesis that natural variability greatly impacts cerebrospinal fluid protein biomarkers because high variability can lead to unreliable results. Thus, we suggest controlling the variability of each protein to distinguish between good and bad biomarker candidates, e.g., by utilizing reference change values to improve the process of evaluating potential biomarkers in future studies.	[Schilde, Lukas M.; Koesters, Steffen; Steinbach, Simone; Schork, Karin; Eisenacher, Martin; Galozzi, Sara; Turewicz, Michael; Barkovits, Katalin; Marcus, Katrin; May, Caroline] Ruhr Univ Bochum, Med Proteom Ctr, Univ Str, Bochum, Germany; [Mollenhauer, Brit] Paracelsus Elena Klin, Klin Str, Kassel, Germany; [Mollenhauer, Brit] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany	Ruhr University Bochum; University of Gottingen	Marcus, K (corresponding author), Ruhr Univ Bochum, Med Proteom Ctr, Univ Str, Bochum, Germany.	Katrin.Marcus@rub.de	Schork, Karin/AAU-9708-2021	Schork, Karin/0000-0003-3756-4347; Turewicz, Michael/0000-0003-0737-1114	Deutsche Parkinson Gesellschaft; European Union (NISCI) [681094]; German Federal Ministry of Ecucation and Research (WTZ with Brasil) [FKZ 01DN14023]; HUPO Brain Proteome Project (HBPP); PURE; federal German state; German Federal Ministry of Ecucation and Research [FKZ 031 A 534A]; Medical Faculty at RUB (FoRUM); project of Northrhine Westfalia	Deutsche Parkinson Gesellschaft; European Union (NISCI); German Federal Ministry of Ecucation and Research (WTZ with Brasil); HUPO Brain Proteome Project (HBPP); PURE; federal German state; German Federal Ministry of Ecucation and Research; Medical Faculty at RUB (FoRUM); project of Northrhine Westfalia	This work was supported by the Deutsche Parkinson Gesellschaft, Medical Faculty at RUB (FoRUM), the European Union (NISCI, GA no. 681094), the German Federal Ministry of Ecucation and Research (WTZ with Brasil, FKZ 01DN14023), the HUPO Brain Proteome Project (HBPP), PURE, a project of Northrhine Westfalia, a federal German state and by de. NBI, a project of the German Federal Ministry of Ecucation and Research [FKZ 031 A 534A]. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Ahrens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079380; Babic M, 2014, CROAT MED J, V55, P347, DOI 10.3325/cmj.2014.55.347; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Begcevic I, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9111-3; Byrne LM, 2016, J HUNTINGTONS DIS, V5, P1, DOI 10.3233/JHD-160196; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Bont JM, 2006, CLIN CHEM, V52, P1501, DOI 10.1373/clinchem.2006.069294; Doherty Carolynne M, 2014, Ulster Med J, V83, P93; Fang Q, MOL CELL PROTEOMICS, P451; FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409; Fraser CG, 2004, CLIN CHEM LAB MED, V42, P758, DOI 10.1515/CCLM.2004.128; Gomez-Rio M, 2016, CURR ALZHEIMER RES, V13, P469, DOI 10.2174/1567205013666151116141603; Halbgebauer S, 2016, MOVEMENT DISORD, V31, P848, DOI 10.1002/mds.26635; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Heywood WE, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0059-y; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Huhmer AF, 2006, DIS MARKERS, V22, P3; Jia Y, CLIN PROTEOMICS, P9; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kang JH, 2016, ACTA NEUROPATHOL, V131, P935, DOI 10.1007/s00401-016-1552-2; Kroksveen AC, 2012, ACTA NEUROL SCAND, V126, P90, DOI 10.1111/ane.12029; Kroksveen AC, 2013, J PROTEOMICS, V78, P312, DOI 10.1016/j.jprot.2012.09.037; Magdalinou NK, 2017, PARKINSONISM RELAT D, V37, P65, DOI 10.1016/j.parkreldis.2017.01.016; Matejcikova Z, 2015, J NEURAL TRANSM, V122, P273, DOI 10.1007/s00702-014-1244-9; Meijers WC, 2017, EUR J HEART FAIL, V19, P357, DOI 10.1002/ejhf.669; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Mollenhauer B, 2013, NEUROLOGY, V81, P1226, DOI 10.1212/WNL.0b013e3182a6cbd5; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]; Paterson RW, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.194; Perrin RJ, PLOS ONE; Plum S, 2013, J PROTEOMICS, V94, P202, DOI 10.1016/j.jprot.2013.07.015; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rosen C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-20; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Schrag A, 2015, LANCET NEUROL, V14, P57, DOI 10.1016/S1474-4422(14)70287-X; Schutzer SE, PLOS ONE; Simon MJ, 2016, BBA-MOL BASIS DIS, V1862, P442, DOI 10.1016/j.bbadis.2015.10.014; Simonsen AH, 2017, ALZHEIMERS DEMENT, V13, P274, DOI 10.1016/j.jalz.2016.09.008; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Stoop MP, 2010, MOL CELL PROTEOMICS, V9, P2063, DOI 10.1074/mcp.M900877-MCP200; Thal LJ, 2006, ALZ DIS ASSOC DIS, V20, P6, DOI 10.1097/01.wad.0000191420.61260.a8; Trombetta BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193707; Turewicz M, 2017, J BIOTECHNOL, V261, P116, DOI 10.1016/j.jbiotec.2017.06.005; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; Ward MA, 2011, ALZHEIMERS DEMENT, V7, DOI [10.1016/j.jalz.2011.05.405, DOI 10.1016/J.JALZ.2011.05.405]; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058	53	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0206478	10.1371/journal.pone.0206478	http://dx.doi.org/10.1371/journal.pone.0206478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496192	Green Submitted, gold, Green Published			2022-12-26	WOS:000451763800016
J	Yuk, HD; Jeong, CW; Kwak, C; Kim, HH; Ku, JH				Yuk, Hyeong Dong; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon			Should intravesical Bacillus Calmette-Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk nonmuscle invasive bladder cancer?	PLOS ONE			English	Article							CARCINOMA IN-SITU; FORMAL METAANALYSIS; MITOMYCIN-C; MAINTENANCE; THERAPY; TRIAL; T1; TA; PROGRESSION	We evaluated the effect of intravesical Bacillus Calmette-Guerin (BCG) and BCG maintenance therapy on the prognosis of patients with T0 after repeat transurethral resection of bladder mass (TURBT). This retrospective analysis involved 427 patients who underwent repeat TURBT within 6 weeks after initial TURBT from 2007 to 2016. Repeat TURBT was performed in patients with high-risk criteria. Patients who achieved T0 after repeat TURBT did or did not receive intravesical BCG therapy. Patients were divided into three groups: non-BCG, BCG induction, and BCG maintenance groups. The study included 106 patients who achieved T0 after repeat TURBT. The median follow-up was 63 months. There were no significant differences in T stage among the three groups. High grade ratio (p = 0.001) and concomitant CIS ratio (p = 0.037) were significantly higher in the BCG maintenance than in the other two groups. The recurrence rates in the non-BCG, BCG induction, and BCG maintenance groups were 46.2%, 28.3%, and 19.2%, respectively (p = 0.043). Recurrence-free survival was significantly higher in the BCG maintenance group than in the BCG induction group (p = 0.032). Progression-free survival was also higher in the BCG maintenance group than in the BCG induction group, but the difference was not significant (p = 0.056). Multivariate Cox regression analysis showed that only intravesical BCG maintenance therapy was significantly associated with recurrence (hazard ratio 0.016, p = 0.016). In high risk NMIBC patients, intravesical BCG maintenance treatment is required even at T0 after repeat TURBT. Intravesical BCG maintenance therapy of patients with T0 after TURBT reduces recurrence.	[Yuk, Hyeong Dong] Inje Univ, Dept Urol, Sanggye Paik Hosp, Seoul, South Korea; [Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	Inje University; Seoul National University (SNU); Seoul National University Hospital	Ku, JH (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	kuuro70@snu.ac.kr		Yuk, Hyeong Dong/0000-0002-5874-9167	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2016R1A2B4011623, 2015R1A2A2A01006813]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (Grant number: 2016R1A2B4011623) to JHK and (Grant number: 2015R1A2A2A01006813) to CK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; BADALAMENT RA, 1987, J CLIN ONCOL, V5, P441, DOI 10.1200/JCO.1987.5.3.441; Bohle A, 2004, UROLOGY, V63, P682, DOI 10.1016/j.urology.2003.11.049; Bohle A, 2003, J UROLOGY, V169, P90, DOI 10.1016/S0022-5347(05)64043-8; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Clark PE, 2016, J NATL COMPR CANC NE, V14, P1213, DOI 10.6004/jnccn.2016.0131; HERR HW, 1988, J CLIN ONCOL, V6, P1450, DOI 10.1200/JCO.1988.6.9.1450; Hinotsu S, 2011, BJU INT, V108, P187, DOI 10.1111/j.1464-410X.2010.09891.x; HUDSON MA, 1987, J UROLOGY, V138, P295, DOI 10.1016/S0022-5347(17)43125-9; Koga H, 2010, INT J UROL, V17, P759, DOI 10.1111/j.1442-2042.2010.02584.x; Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5; Martinez-Pineiro JA, 2002, BJU INT, V89, P671, DOI 10.1046/j.1464-410X.2002.02722.x; Miladi M, 2003, EUR UROL, V43, P241, DOI 10.1016/S0302-2838(03)00040-X; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Oddens J, 2013, EUR UROL, V63, P462, DOI 10.1016/j.eururo.2012.10.039; PAGANO F, 1991, J UROLOGY, V146, P32, DOI 10.1016/S0022-5347(17)37707-8; Quan YJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008300; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1016/S0022-5347(05)64273-5; Yalcinkaya F., 1998, International Urology and Nephrology, V30, P41, DOI 10.1007/BF02550276	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208267	10.1371/journal.pone.0208267	http://dx.doi.org/10.1371/journal.pone.0208267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496283	Green Published, Green Submitted, gold			2022-12-26	WOS:000451763800123
J	Boergens, KM; Kapfer, C; Helmstaedter, M; Denk, W; Borst, A				Boergens, Kevin M.; Kapfer, Christoph; Helmstaedter, Moritz; Denk, Winfried; Borst, Alexander			Full reconstruction of large lobula plate tangential cells in Drosophila from a 3D EM dataset	PLOS ONE			English	Article							MOTION-SENSITIVE NEURONS; VISUAL INTERNEURONS; OPTIC FLOW; RECEPTIVE-FIELDS; HORIZONTAL CELLS; NEURAL CIRCUIT; FLY; ORGANIZATION; SYSTEM; ARCHITECTURE	With the advent of neurogenetic methods, the neural basis of behavior is presently being analyzed in more and more detail. This is particularly true for visually driven behavior of Drosophila melanogaster where cell-specific driver lines exist that, depending on the combination with appropriate effector genes, allow for targeted recording, silencing and optogenetic stimulation of individual cell-types. Together with detailed connectomic data of large parts of the fly optic lobe, this has recently led to much progress in our understanding of the neural circuits underlying local motion detection. However, how such local information is combined by optic flow sensitive large-field neurons is still incompletely understood. Here, we aim to fill this gap by a dense reconstruction of lobula plate tangential cells of the fly lobula plate. These neurons collect input from many hundreds of local motion-sensing T4/T5 neurons and connect them to descending neurons or central brain areas. We confirm all basic features of HS and VS cells as published previously from light microscopy. In addition, we identified the dorsal and the ventral centrifugal horizontal, dCH and vCH cell, as well as three VSlike cells, including their distinct dendritic and axonal projection area.	[Boergens, Kevin M.; Helmstaedter, Moritz] Max Planck Inst Brain Res, Frankfurt, Germany; [Kapfer, Christoph; Denk, Winfried; Borst, Alexander] Max Planck Inst Neurobiol, Martinsried, Germany	Max Planck Society; Max Planck Society	Boergens, KM (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.; Borst, A (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.	kevin.boergens@brain.mpg.de; borst@neuro.mpg.de			Bernstein Center for Computational Neuroscience Munich [01GQ1004E]	Bernstein Center for Computational Neuroscience Munich	Funded by Bernstein Center for Computational Neuroscience Munich - Project A1 - Neural circuits for motion detection: From 3D-reconstruction to computational modeling. Grant number 01GQ1004E. Grant recipient A. Borst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behnia R, 2015, CURR OPIN NEUROBIOL, V34, P125, DOI 10.1016/j.conb.2015.03.010; BISHOP CA, 1981, J NEUROBIOL, V12, P281, DOI 10.1002/neu.480120308; Boergens KM, 2017, NAT METHODS, V14, P691, DOI 10.1038/nmeth.4331; Borst A, 2015, NAT NEUROSCI, V18, P1067, DOI 10.1038/nn.4050; Borst A, 2014, NAT REV NEUROSCI, V15, P590, DOI 10.1038/nrn3799; Buschbeck EK, 1997, J COMP NEUROL, V383, P282; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; Cuntz H, 2007, P NATL ACAD SCI USA, V104, P10229, DOI 10.1073/pnas.0703697104; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; ECKERT H, 1983, J INSECT PHYSIOL, V29, P547, DOI 10.1016/0022-1910(83)90020-3; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Elyada YM, 2009, NAT NEUROSCI, V12, P327, DOI 10.1038/nn.2269; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Gauck V, 1997, J COMP NEUROL, V381, P489; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 2005, J COMP PHYSIOL A, V191, P445, DOI 10.1007/s00359-005-0605-0; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2007, J NEUROSCI, V27, P1992, DOI 10.1523/JNEUROSCI.4393-06.2007; HAUSEN K, 1980, CELL TISSUE RES, V208, P371; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; HEISENBERG M, 1978, J COMP PHYSIOL, V124, P287, DOI 10.1007/BF00661379; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Hopp E, 2014, J COMP PHYSIOL A, V200, P359, DOI 10.1007/s00359-014-0893-3; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Mauss AS, 2015, CELL, V162, P351, DOI 10.1016/j.cell.2015.06.035; Mauss AS, 2014, J NEUROSCI, V34, P2254, DOI 10.1523/JNEUROSCI.3938-13.2014; Namiki S, 2018, ELIFE, V7, DOI 10.7554/eLife.34272; Ohyama T, 2015, NATURE, V520, P633, DOI 10.1038/nature14297; PIERANTONI R, 1976, CELL TISSUE RES, V171, P101; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rajashekhar KP, 2004, J BIOSCIENCES, V29, P93, DOI 10.1007/BF02702566; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; STRAUSFELD NJ, 1985, CELL TISSUE RES, V240, P601, DOI 10.1007/BF00216350; STRAUSFELD NJ, 1985, CELL TISSUE RES, V242, P531; STRAUSFELD NJ, 1990, J COMP NEUROL, V302, P954, DOI 10.1002/cne.903020419; Takemura SY, 2017, ELIFE, V6, DOI 10.7554/eLife.24394; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; WARZECHA AK, 1993, J NEUROPHYSIOL, V69, P329, DOI 10.1152/jn.1993.69.2.329; Wasserman SM, 2015, CURR BIOL, V25, P467, DOI 10.1016/j.cub.2014.12.012; Wertz A, 2009, J COMP PHYSIOL A, V195, P1107, DOI 10.1007/s00359-009-0481-0; Zheng Z., 2017, BIORXIV, DOI [10.1101/140905, DOI 10.1101/140905]	53	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0207828	10.1371/journal.pone.0207828	http://dx.doi.org/10.1371/journal.pone.0207828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485333	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800082
J	Sambamurthy, N; Zhou, C; Nguyen, V; Smalley, R; Hankenson, KD; Dodge, GR; Scanzello, CR				Sambamurthy, Nisha; Zhou, Cheng; Vu Nguyen; Smalley, Ryan; Hankenson, Kurt D.; Dodge, George R.; Scanzello, Carla R.			Deficiency of the pattern-recognition receptor CD14 protects against joint pathology and functional decline in a murine model of osteoarthritis	PLOS ONE			English	Article							MACROPHAGES; INFLAMMATION; INDUCTION; SYSTEM; CELLS; PAIN; ACTIVATION; BIOMARKERS; RESPONSES; LIGAND	Objective CD14 is a monocyte/macrophage pattern-recognition receptor that modulates innate inflammatory signaling. Soluble CD14 levels in knee OA synovial fluids are associated with symptoms and progression of disease. Here we investigate the role of this receptor in development of OA using a murine joint injury model of disease. Methods 10-week-old Male C57BL/6 (WT) and CD14-deficient (CD14(-/-)) mice underwent destabilization of the medial meniscus (DMM) surgery to induce OA. Joint histopathology was used to examine cartilage damage, and microCT to evaluate subchondral bone (SCB) remodeling at 6 and 19 weeks after surgery. Synovial and fat pad expression of macrophage markers (F4/80, CD11c, CD68, iNOS, CCR7, CD163 and CD206) was assessed by flow cytometry and droplet digital (dd) PCR. Changes in locomotive activity indicative of joint pain were evaluated longitudinally up to 16 weeks by automated behavioral analysis. Results Early cartilage damage scores 6 weeks post-DMM were similar in both strains (Mean score +/- SEM WT: 4.667 +/- 1.38, CD14(-/-): 4.6 +/- 0.6), but at 19 weeks were less severe in CD14(-/-)(6.0 +/- 0.46) than in WT mice (13.44 +/- 2.5, p = 0.0002). CD14(-/-) mice were protected from both age-related and post-surgical changes in SCB mineral density and trabecular thickness. In addition, CD14(-/-) mice were protected from decreases in climbing activity (p = 0.015 vs. WT, 8 weeks) observed after DMM. Changes in synovial/fat pad expression of CCR7, a marker of M1 macrophages, were slightly reduced post-DMM in the absence of CD14, while expression of CD68 (pan-macrophage marker) and CD163 (M2 marker) were unchanged. Conclusion CD14 plays an important role in progression of structural and functional features of OA in the DMM model, and may provide a new target for therapeutic development.	[Sambamurthy, Nisha; Zhou, Cheng; Vu Nguyen; Smalley, Ryan; Dodge, George R.; Scanzello, Carla R.] Corporal Michael J Crescenz Dept Vet Affairs Med, Translat Musculoskeletal Res Ctr, Philadelphia, PA 19104 USA; [Sambamurthy, Nisha; Zhou, Cheng; Vu Nguyen; Scanzello, Carla R.] Univ Penn, Perelman Sch Med, Div Rheumatol, Philadelphia, PA 19104 USA; [Smalley, Ryan; Dodge, George R.] Univ Penn, Perelman Sch Med, Dept Orthoped Surg, Philadelphia, PA 19104 USA; [Hankenson, Kurt D.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan	Scanzello, CR (corresponding author), Corporal Michael J Crescenz Dept Vet Affairs Med, Translat Musculoskeletal Res Ctr, Philadelphia, PA 19104 USA.; Scanzello, CR (corresponding author), Univ Penn, Perelman Sch Med, Div Rheumatol, Philadelphia, PA 19104 USA.	cscanz@pennmedicine.upenn.edu	Scanzello, Carla R/AAE-4348-2019; Hankenson, Kurt/AFS-9417-2022; Hankenson, Kurt/ABI-1547-2020	Scanzello, Carla R/0000-0002-9290-188X; Hankenson, Kurt/0000-0001-6361-143X; 	T32 training grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR-007442]; University of Pennsylvania Perelman School of Medicine [K08AR057859/NIAMS]; Penn Center for Musculoskeletal Diseases [P30-AR-069619/NIAMS]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR057859, T32AR007442, P30AR069619] Funding Source: NIH RePORTER	T32 training grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); University of Pennsylvania Perelman School of Medicine; Penn Center for Musculoskeletal Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Nisha Sambamurthy was supported by T32 training grant (AR-007442) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The work in this manuscript was supported by funding from the University of Pennsylvania Perelman School of Medicine, a K-award to Dr. Scanzello (K08AR057859/NIAMS), and a pilot award from the Penn Center for Musculoskeletal Diseases (P30-AR-069619/NIAMS). This work was additionally supported using resources and facilities at the Corporal Michael J.Crescenz VA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Amano S, 2009, J CELL PHYSIOL, V221, P40, DOI 10.1002/jcp.21827; BAZIL V, 1991, J IMMUNOL, V147, P1567; Blom AB, 2004, OSTEOARTHR CARTILAGE, V12, P627, DOI 10.1016/j.joca.2004.03.003; Borges PD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174294; Cao L, 2009, NEUROSCIENCE, V158, P896, DOI 10.1016/j.neuroscience.2008.10.004; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Chu CR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3845; Daghestani HN, 2015, OSTEOARTHR CARTILAGE, V23, P1890, DOI 10.1016/j.joca.2015.02.009; Daghestani HN, 2015, ARTHRITIS RHEUMATOL, V67, P956, DOI 10.1002/art.39006; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Ferenbach D, 2008, KIDNEY INT, V74, P5, DOI 10.1038/ki.2008.189; Finberg RW, 2006, IMMUNITY, V24, P127, DOI 10.1016/j.immuni.2006.01.010; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Inglis JJ, 2008, ARTHRITIS RHEUM-US, V58, P3110, DOI 10.1002/art.23870; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; Kraus VB, 2016, OSTEOARTHR CARTILAGE, V24, P1613, DOI 10.1016/j.joca.2016.04.010; Landmann R, 2000, MICROBES INFECT, V2, P295, DOI 10.1016/S1286-4579(00)00298-7; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Li XL, 2004, ARTHRITIS RES THER, V6, pR273, DOI 10.1186/ar1175; Lieberthal J, 2015, OSTEOARTHR CARTILAGE, V23, P1825, DOI 10.1016/j.joca.2015.08.015; Lloyd-Jones KL, 2008, J IMMUNOL, V181, P1446, DOI 10.4049/jimmunol.181.2.1446; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lorenz J, 2014, METHODS MOL BIOL, V1194, P401, DOI 10.1007/978-1-4939-1215-5_23; Luo JL, 2015, CELL MOL LIFE SCI, V72, P3201, DOI 10.1007/s00018-015-1904-4; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Miller RE, 2016, OSTEOARTHR CARTILAGE, V24, P299, DOI 10.1016/j.joca.2015.09.005; Miller RE, 2015, ARTHRITIS RHEUMATOL, V67, P2933, DOI 10.1002/art.39291; Miller RE, 2012, P NATL ACAD SCI USA, V109, P20602, DOI 10.1073/pnas.1209294110; Nair A, 2012, ARTHRITIS RHEUM-US, V64, P2268, DOI 10.1002/art.34495; Nicholson GC, 2000, CLIN SCI, V99, P133, DOI 10.1042/CS19990355; Osterberga A, 2017, JOINT BONE SPINE, V84, P71, DOI 10.1016/j.jbspin.2015.11.012; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Scanzello CR, 2017, CURR OPIN RHEUMATOL, V29, P79, DOI 10.1097/BOR.0000000000000353; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; SUMMERS KL, 1995, J RHEUMATOL, V22, P1326; Sun AJR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183693; Sun XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055984; Utomo L, 2016, OSTEOARTHR CARTILAGE, V24, P1623; Van de Weerd HA, 2001, BEHAV PROCESS, V53, P11, DOI 10.1016/S0376-6357(00)00135-2; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; Wiersinga WJ, 2008, J INFECT DIS, V198, P1388, DOI 10.1086/592220; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023	47	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206217	10.1371/journal.pone.0206217	http://dx.doi.org/10.1371/journal.pone.0206217			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4EO	30485272	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800015
J	Bbole, I; Zhao, JL; Tang, SJ; Katongo, C				Bbole, Ian; Zhao, Jin-Liang; Tang, Shou-Jie; Katongo, Cyprian			Mitochondrial genome annotation and phylogenetic placement of Oreochromis andersonii and O. macrochir among the cichlids of southern Africa	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; MOLECULAR PHYLOGENETICS; AUTOMATIC ANNOTATION; FISHES; TILAPIA; PHYLOGEOGRAPHY; EVOLUTION; CLASSIFICATION; HYBRIDIZATION; PERCIFORMES	Genetic characterization of southern African cichlids has not received much attention. Here, we describe the mitogenome sequences and phylogenetic positioning of Oreochromis andersonii and O. macrochir among the African cichlids. The complete mitochondrial DNA sequences were determined for O. andersonii and O. macrochir, two important aquaculture and fisheries species endemic to southern Africa. The complete mitogenome sequence lengths were 16642 bp and 16644 bp for O. andersonii and O. macrochir respectively. The general structural organization follows that of other teleost species with 13 protein-coding genes, 2 rRNAs, 22 tRNAs and a non-coding control region. Phylogenetic placement of the two species among other African cichlids was performed using Maximum Likelihood (ML) and Bayesian Markov-Chain-Monte-Carlo (MCMC). The consensus trees confirmed the relative positions of the two cichlid species with O. andersonii being very closely related to O. mossambicus and O. macrochir showing a close relation to both species. Among the 13 mitochondrial DNA protein coding genes ND6 may have evolved more rapidly and COIII was the most conserved. There are signs that ND6 may have been subjected to positive selection in order for these cichlid lineages to diversify and adapt to new environments. More work is needed to characterize the southern Africa cichlids as they are important species for capture fisheries, aquaculture development and understanding biogeographic history of African cichlids. Bio-conservation of some endangered cichlids is also essential due to the threat by invasive species.	[Bbole, Ian] Dept Fisheries, Mansa, Zambia; [Bbole, Ian; Zhao, Jin-Liang; Tang, Shou-Jie] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China; [Zhao, Jin-Liang] Shanghai Ocean Univ, Minist Agr, CREEFN, Shanghai, Peoples R China; [Zhao, Jin-Liang] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Katongo, Cyprian] Univ Zambia, Biol Sci Dept, Lusaka, Zambia	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University; University of Zambia	Bbole, I (corresponding author), Dept Fisheries, Mansa, Zambia.; Bbole, I (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China.	ibbole@gmail.com		Bbole, Ian/0000-0001-7432-3257	China Agriculture Research System [CARS-46]	China Agriculture Research System	The laboratory work was supported by China Agriculture Research System (CARS-46) granted to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, FRESHWATER FISHES SO; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bbole I, 2015, J ECOL NAT ENV, V6, P215; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Canonico GC, 2005, AQUAT CONSERV, V15, P463, DOI 10.1002/aqc.699; Castellana S, 2011, GENOME BIOL EVOL, V3, P1067, DOI 10.1093/gbe/evr040; Chen LY, 2016, MITOCHONDRIAL DNA A, V27, P3567, DOI 10.3109/19401736.2015.1074221; Crayon-Thomas E., 1994, TECHNICAL CONSULTATI; D'Amato ME, 2007, CONSERV GENET, V8, P475, DOI 10.1007/s10592-006-9186-x; Deines AM, 2014, AFR J AQUAT SCI, V39, P23, DOI 10.2989/16085914.2013.864965; Dunz AR, 2013, MOL PHYLOGENET EVOL, V68, P64, DOI 10.1016/j.ympev.2013.03.015; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egger B, 2015, HYDROBIOLOGIA, V748, P171, DOI 10.1007/s10750-014-1919-0; Faber JE, 1998, MOL PHYLOGENET EVOL, V10, P310, DOI 10.1006/mpev.1998.0530; Feresu-Shonhiwa F, 1998, J FISH BIOL, V53, P1178, DOI 10.1111/j.1095-8649.1998.tb00241.x; Fischer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067048; Froese R, 2016, DATABASE FISHBASE; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He AY, 2011, MITOCHONDR DNA, V22, P171, DOI 10.3109/19401736.2011.636439; He AY, 2011, MOL BIOL REP, V38, P2015, DOI 10.1007/s11033-010-0324-7; Hu XX, 2016, MITOCHONDRIAL DNA A, V27, P2379, DOI 10.3109/19401736.2015.1028039; Hulsey CD, 2013, MOL ECOL RESOUR, V13, P347, DOI 10.1111/1755-0998.12066; Iwasaki W, 2013, MOL BIOL EVOL, V30, P2531, DOI 10.1093/molbev/mst141; Katongo C, 2005, HYDROBIOLOGIA, V542, P221, DOI 10.1007/s10750-004-1389-x; Katongo C, 2007, MOL PHYLOGENET EVOL, V45, P326, DOI 10.1016/j.ympev.2007.02.011; Kefi AS, 2013, TURK J FISH AQUAT SC, V13, P503, DOI 10.4194/1303-2712-v13_3_13; Kefi AS, J AQUAC RES DEV; Kinaro ZO, 2016, MITOCHONDRIAL DNA A, V27, P2455, DOI 10.3109/19401736.2015.1033695; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Kocher TD, 1998, GENETICS, V148, P1225; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li YL, 2013, GENE, V517, P169, DOI 10.1016/j.gene.2012.12.096; Lind CE, 2012, REV AQUACULT, V4, P125, DOI 10.1111/j.1753-5131.2012.01068.x; Liu Y, 2009, MAR GENOM, V2, P133, DOI 10.1016/j.margen.2009.07.003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lv Y, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060282; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; Meyer BS, 2015, MOL PHYLOGENET EVOL, V83, P56, DOI 10.1016/j.ympev.2014.10.009; Miya M, 2015, ICHTHYOL RES, V62, P29, DOI 10.1007/s10228-014-0440-9; Musuka C.G., 2012, INT J BIOFLUX SOC, V5, P79; Nagl S, 2001, MOL PHYLOGENET EVOL, V20, P361, DOI 10.1006/mpev.2001.0979; Ning T, 2010, GENET MOL RES, V9, P144, DOI 10.4238/vol9-1gmr705; Nsonga A., 2014, INT J FISH AQUAT STU, V2, P102; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Qi DS, 2016, MITOCHONDRIAL DNA A, V27, P4284, DOI 10.3109/19401736.2015.1082097; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6; Schwarzer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-186; SODSUK PK, 1995, J FISH BIOL, V47, P321, DOI 10.1006/jfbi.1995.0137; Trewavas E., 1983, TILAPIINE FISHES GEN, DOI [DOI 10.5962/BHL.TITLE.123198, 10.1016/j.foodcont.2016.07.004]; Tweddle D, 2015, FISHERIES MANAG ECOL, V22, P99, DOI 10.1111/fme.12107; Tweddle D, 2007, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2007.RLTS.T60623A12385801.en, DOI 10.2305/IUCN.UK.2007.RLTS.T60623A12385801.EN]; Villela LCV, 2017, GENETICA, V145, P51, DOI 10.1007/s10709-016-9945-7; Wang CH, 2012, MOL BIOL REP, V39, P6337, DOI 10.1007/s11033-012-1455-9; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; Yue GH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-242; Zhang XY, 2009, MOL BIOL REP, V36, P981, DOI 10.1007/s11033-008-9271-y; Zhao J, 2017, MITOCHONDRIAL DNA A, V28, P279, DOI 10.3109/19401736.2015.1118079	64	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0203095	10.1371/journal.pone.0203095	http://dx.doi.org/10.1371/journal.pone.0203095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481181	gold, Green Submitted, Green Published			2022-12-26	WOS:000451440000002
J	Jonsson, TJ; Schafer, HL; Herling, AW; Bronstrup, M				Jonsson, Thomas J.; Schaefer, Hans-Ludwig; Herling, Andreas W.; Broenstrup, Mark			A metabolome-wide characterization of the diabetic phenotype in ZDF rats and its reversal by pioglitazone	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AMINO-ACID-METABOLISM; PPAR-ALPHA AGONIST; OXIDATIVE STRESS; PEROXISOME PROLIFERATOR; INSULIN SENSITIVITY; GENE-EXPRESSION; SUGAR-TRANSPORT; FATTY RAT; ROSIGLITAZONE	Type 2 diabetes (T2D) is a complex metabolic disease associated with alterations in glucose, lipid and protein metabolism. In order to characterize the biochemical phenotype of the Zucker diabetic fatty (ZDF) rat, the most common animal model for the study of T2D, and the impact of the insulin sensitizer pioglitazone, a global, mass spectrometry-based analysis of the metabolome was conducted. Overall, 420 metabolites in serum, 443 in the liver and 603 in the intestine were identified at study end. In comparison to two control groups, obese diabetic ZDF rats showed characteristic metabolic signatures that included hyperglycemia, elevated beta-oxidation, dyslipidemia-featured by an increase in saturated and monounsaturated fatty acids and a decrease of medium chain and of polyunsaturated fatty acids in serum-and decreased amino acid levels, consistent with their utilization in hepatic gluconeogenesis. A 13-week treatment with the PPAR gamma agonist pioglitazone reversed most of these signatures: Pioglitazone improved glycemic control and the fatty acid profile, elevated amino acid levels in the liver, but decreased branched chain amino acids in serum. The hitherto most comprehensive metabolic profiling study identified a biochemical blueprint for the ZDF diabetic model and captured the impact of genetic, nutritional and pharmacological perturbations. The in-depth characterization on the molecular level deepens the understanding and further validates the ZDF rat as a suitable preclinical model of diabetes in humans.	[Jonsson, Thomas J.] Metabolon Inc, Durham, NC USA; [Schaefer, Hans-Ludwig; Herling, Andreas W.] Sanofi R&D, Ind Pk Hoechst, Frankfurt, Germany; [Broenstrup, Mark] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Broenstrup, Mark] German Ctr Infect Res DZIF, Braunschweig, Germany	Metabolon; Sanofi-Aventis; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research	Bronstrup, M (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.; Bronstrup, M (corresponding author), German Ctr Infect Res DZIF, Braunschweig, Germany.	mark.broenstrup@helmholtz-hzi.de	Brönstrup, Mark/AAP-7598-2020	Brönstrup, Mark/0000-0002-8971-7045				Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Ament Z, 2012, GENOME MED, V4, DOI 10.1186/gm331; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Bhutta HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122273; Bouillon R, 2015, NAT REV ENDOCRINOL, V11, P681, DOI 10.1038/nrendo.2015.142; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; CSAKY TZ, 1981, DIABETES, V30, P568, DOI 10.2337/diabetes.30.7.568; DEBNAM ES, 1990, J PHYSIOL-LONDON, V424, P13, DOI 10.1113/jphysiol.1990.sp018052; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Dello SAWG, 2013, CLIN NUTR, V32, P325, DOI 10.1016/j.clnu.2012.10.008; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Eckland DA, 2000, EXP CLIN ENDOCR DIAB, V108, pS234, DOI 10.1055/s-2000-8525; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Garama DJ, 2015, MOL CELL BIOL, V35, P3646, DOI 10.1128/MCB.00541-15; Gillies PS, 2000, DRUGS, V60, P333, DOI 10.2165/00003495-200060020-00009; Griffen SC, 2001, DIABETES, V50, P63, DOI 10.2337/diabetes.50.1.63; Gumieniczek A, 2008, PHARMAZIE, V63, P377, DOI 10.1691/ph.2008.7695; Harmon JS, 2001, DIABETES, V50, P2481, DOI 10.2337/diabetes.50.11.2481; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; He HM, 2014, TOXICOL SCI, V138, P468, DOI 10.1093/toxsci/kfu015; Hempe J, 2012, LAB ANIM-UK, V46, P32, DOI 10.1258/la.2011.010165; Horakova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043764; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Hwang J, 2007, VASC PHARMACOL, V46, P456, DOI 10.1016/j.vph.2007.01.007; Hyogo H, 2002, J BIOL CHEM, V277, P34117, DOI 10.1074/jbc.M203912200; Irving BA, 2015, METABOLISM, V64, P720, DOI 10.1016/j.metabol.2015.01.008; Kakazu E, 2013, HEPATOL INT, V7, P577, DOI 10.1007/s12072-012-9395-y; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Kus V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027126; Kwak HC, 2015, BIOCHEM PHARMACOL, V96, P256, DOI 10.1016/j.bcp.2015.05.014; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Liu Y, 2013, J PROTEOME RES, V12, P5634, DOI 10.1021/pr400587y; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Meierhofer D, 2014, J PROTEOME RES, V13, P5592, DOI 10.1021/pr5005828; Minnich A, 2001, AM J PHYSIOL-ENDOC M, V280, pE270, DOI 10.1152/ajpendo.2001.280.2.E270; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nerby CL, 2009, CLIN BIOCHEM, V42, P158, DOI 10.1016/j.clinbiochem.2008.08.086; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Niedenfuhr S, 2015, CURR OPIN BIOTECH, V34, P82, DOI 10.1016/j.copbio.2014.12.003; Olefsky J. M., 1995, ENDOCRINOLOGY, V2; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Potenza MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE685, DOI 10.1152/ajpendo.00291.2009; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Radonjic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056122; Rull A, 2014, J PROTEOME RES, V13, P1731, DOI 10.1021/pr401230s; Samino S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11496; Sato D, 2016, EUR J PHARMACOL, V773, P71, DOI 10.1016/j.ejphar.2016.01.012; Schafer HL, 2012, ACTA PHARMACOL SIN, V33, P82, DOI 10.1038/aps.2011.165; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; Singh RK, 2016, DIABETES METAB SYND, V10, P102, DOI 10.1016/j.dsx.2015.08.016; Smith U, 2001, INT J CLIN PRACT, P13; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; THOMSON ABR, 1981, DIABETES, V30, P247, DOI 10.2337/diabetes.30.3.247; TOMITA T, 1992, PANCREAS, V7, P367, DOI 10.1097/00006676-199205000-00015; VanPatten S, 2001, AM J PHYSIOL-GASTR L, V281, pG393, DOI 10.1152/ajpgi.2001.281.2.G393; Vinaixa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029052; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Yamanouchi T, 1996, LANCET, V347, P1514, DOI 10.1016/S0140-6736(96)90672-8; Yang KJ, 2010, LIFE SCI, V87, P405, DOI 10.1016/j.lfs.2010.08.002; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	81	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0207210	10.1371/journal.pone.0207210	http://dx.doi.org/10.1371/journal.pone.0207210			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481177	Green Published, Green Submitted, gold			2022-12-26	WOS:000451440000009
J	Varnava, M; Sumida, I; Mizuno, H; Shiomi, H; Suzuki, O; Yoshioka, Y; Ogawa, K				Varnava, Maria; Sumida, Iori; Mizuno, Hirokazu; Shiomi, Hiroya; Suzuki, Osamu; Yoshioka, Yasuo; Ogawa, Kazuhiko			A new plan quality objective function for determining optimal collimator combinations in prostate cancer treatment with stereotactic body radiation therapy using CyberKnife	PLOS ONE			English	Article							ROBOTIC RADIOSURGERY; NORMAL TISSUE; HDR BRACHYTHERAPY; TUMOR; COMPLICATION; RADIOTHERAPY; INDEX; IMRT	Stereotactic body radiation therapy with CyberKnife for prostate cancer has long treatment times compared with conventional radiotherapy. This arises the need for designing treatment plans with short execution times. We propose an objective function for plan quality evaluation, which was used to determine an optimal combination between small and large collimators based on short treatment times and clinically acceptable dose distributions. Data from 11 prostate cancer patients were used. For each patient, 20 plans were created based on all combinations between one small (circle divide 10-25 mm) and one large (circle divide 35-60 mm) Iris collimator size. The objective function was assigned to each combination as a penalty, such that plans with low penalties were considered superior. This function considered the achievement of dosimetric planning goals, tumor control probability, normal tissue complication probability, relative seriality parameter, and treatment time. Two methods were used to determine the optimal combination. First, we constructed heat maps representing the mean penalty values and standard deviations of the plans created for each collimator combination. The combination giving a plan with the smallest mean penalty and standard deviation was considered optimal. Second, we created two groups of superior plans: group A plans were selected by histogram analysis and group B plans were selected by choosing the plan with the lowest penalty from each patient. In both groups, the most used small and large collimators were assumed to represent the optimal combination. The optimal combinations obtained from the heat maps included the 25 mm as a small collimator, giving small/large collimator sizes of 25/35, 25/40, 25/50, and 25/60 mm. The superior-group analysis indicated that 25/50 mm was the optimal combination. The optimal Iris combination for prostate cancer treatment using CyberKnife was determined to be a collimator size between 25 mm (small) and 50 mm (large).	[Varnava, Maria; Sumida, Iori; Mizuno, Hirokazu; Shiomi, Hiroya; Ogawa, Kazuhiko] Osaka Univ, Dept Radiat Oncol, Grad Sch Med, Suita, Osaka, Japan; [Shiomi, Hiroya] Miyakojima IGRT Clin, Miyakojima Ku, Osaka, Japan; [Suzuki, Osamu] Osaka Univ, Dept Carbon Ion Radiotherapy, Grad Sch Med, Suita, Osaka, Japan; [Yoshioka, Yasuo] Japanese Fdn Canc Res, Dept Radiat Oncol, Canc Inst Hosp, Koto Ku, Tokyo, Japan	Osaka University; Osaka University; Japanese Foundation for Cancer Research	Sumida, I (corresponding author), Osaka Univ, Dept Radiat Oncol, Grad Sch Med, Suita, Osaka, Japan.	mvarnava@radonc.med.osaka-u.ac.jp; sumida@radonc.med.osaka-u.ac.jp		Sumida, Iori/0000-0001-7669-0325				Adamus-Gorka Magdalena, 2011, Cancers (Basel), V3, P2421, DOI 10.3390/cancers3022421; Akagi Y, 1999, INT J RADIAT ONCOL, V43, P525, DOI 10.1016/S0360-3016(98)00433-7; Anbumani S, 2014, J BUON, V19, P297; Blanck O, 2016, J APPL CLIN MED PHYS, V17, P313, DOI 10.1120/jacmp.v17i3.6151; Ceylan C, 2010, REP PRACT ONCOL RADI, V15, P181, DOI 10.1016/j.rpor.2010.10.003; Deb P, 2009, AUSTRALAS PHYS ENG S, V32, P51, DOI 10.1007/BF03178629; Descovich M, 2013, J APPL CLIN MED PHYS, V14, P162, DOI 10.1120/jacmp.v14i5.4333; DOANE DP, 1976, AM STAT, V30, P181, DOI 10.2307/2683757; Echner GG, 2009, PHYS MED BIOL, V54, P5359, DOI 10.1088/0031-9155/54/18/001; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Fowler JF, 2013, ANTICANCER RES, V33, P1009; Fowler JF, 2005, ACTA ONCOL, V44, P265, DOI 10.1080/02841860410002824; Fuller DB, 2009, INT J RADIAT ONCOL, V75, pS685, DOI 10.1016/j.ijrobp.2009.07.1563; Fuller DB, 2008, INT J RADIAT ONCOL, V70, P1588, DOI 10.1016/j.ijrobp.2007.11.067; Fuller DB, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00321; Gay HA, 2007, PHYS MEDICA, V23, P115, DOI 10.1016/j.ejmp.2007.07.001; Gehlenborg N, 2012, NAT METHODS, V9, P213, DOI 10.1038/nmeth.1902; HOLM S, 1979, SCAND J STAT, V6, P65; Jameson MG, 2015, J MED RADIAT SCI, V62, P168, DOI 10.1002/jmrs.107; Janowski E, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0241-3; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; Kathriarachchi V, 2016, J MED PHYS, V41, P135, DOI 10.4103/0971-6203.181638; Koh DH, 2014, KOREAN J UROL, V55, P172, DOI 10.4111/kju.2014.55.3.172; Langer M, 1998, INT J RADIAT ONCOL, V41, P451, DOI 10.1016/S0360-3016(98)00057-1; Miszczyk L, 2015, CENT EUR J UROL, V68, P289, DOI 10.5173/ceju.2015.582; Park YK, 2014, J APPL CLIN MED PHYS, V15, P316, DOI 10.1120/jacmp.v15i4.4941; Poll JJ, 2008, MED PHYS, V35, P2294, DOI 10.1118/1.2919090; Rana S, 2014, ANN MED HEALTH SCI R, V4, P167, DOI 10.4103/2141-9248.129023; Rana S., 2013, J SOLID TUMORS, V3; Seppala J, 2017, TECHNOL CANCER RES T, V16, P238, DOI 10.1177/1533034616682156; Sumida I, 2015, INT J RADIAT ONCOL, V92, P779, DOI 10.1016/j.ijrobp.2015.02.041; van de Water S, 2013, PHYS MED BIOL, V58, P6969, DOI 10.1088/0031-9155/58/19/6969; van de Water S, 2011, MED PHYS, V38, P1397, DOI 10.1118/1.3549765; Van de Werf E, 2009, RADIOTHER ONCOL, V93, P137, DOI 10.1016/j.radonc.2009.07.007	34	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208086	10.1371/journal.pone.0208086	http://dx.doi.org/10.1371/journal.pone.0208086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481228	gold, Green Published, Green Submitted			2022-12-26	WOS:000451440000042
J	Park, SM; Kim, GU; Kim, HJ; Kim, H; Chang, BS; Lee, CK; Yeom, JS				Park, Sang-Min; Kim, Gang-Un; Kim, Ho-Joong; Kim, Hyoungmin; Chang, Bong-Soon; Lee, Choon-Ki; Yeom, Jin S.			Low handgrip strength is closely associated with chronic low back pain among women aged 50 years or older: A cross-sectional study using a national health survey	PLOS ONE			English	Article							SARCOPENIA; PREVALENCE; CONSENSUS	Object This study aimed to analyze the association between low handgrip strength (HGS) and low back pain (LBP) according to physical activity (PA) in the general population aged over 50 years. Methods Nationwide health surveys and examinations were performed in a cross-sectional representative of the Korean general population (n = 7,550 in 2014, n = 7,380 in 2015). Chronic LBP status was determined by self-reported survey responses with respect to the occurrence of LBP for more than 30 days during the previous 3 months. Maximal HGS was determined as the maximal strength of the dominant hand, and low HGS was defined as measurement in the lower 20th percentile of HGS measurements for the general population. High PA was defined as muscle-strengthening exercise for at least 3 days within 1 week. Demographics, medical history, and other variables were used to analyze adjusted weighted logistic regression models with propensity score matching. After propensity score matching, 429 participants were included in each group. Results Analysis was confined to those aged 50-89 years who responded to the chronic LBP survey and had no missing data on HGS. Low HGS and LBP showed significant association in the crude logistic regression model. In the multiple logistic regression model, after adjusting for confounding factors, low HGS was significantly associated with LBP in women with low PA (adjusted odds ratio [aOR]: 1.75, p = 0.047). In the logistic regression model after propensity score matching, low HGS was also significantly related to LBP in women with low PA (aOR: 3.12, p = 0.004). Conclusions Our study showed the relationship between low HGS and LBP using a cross-sectional Korean population-based health survey. Low HGS in women aged over 50 years with low PA was significantly associated with the presence of LBP.	[Park, Sang-Min; Kim, Ho-Joong; Yeom, Jin S.] Seoul Natl Univ, Coll Med, Spine Ctr, Seoul, South Korea; [Park, Sang-Min; Kim, Ho-Joong; Kim, Hyoungmin; Lee, Choon-Ki; Yeom, Jin S.] Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Park, Sang-Min; Kim, Ho-Joong; Yeom, Jin S.] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea; [Kim, Gang-Un] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Orthoped Surg, Seoul, South Korea; [Kim, Hyoungmin; Chang, Bong-Soon; Lee, Choon-Ki] Seoul Natl Univ Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inje University; Seoul National University (SNU); Seoul National University Hospital	Yeom, JS (corresponding author), Seoul Natl Univ, Coll Med, Spine Ctr, Seoul, South Korea.; Yeom, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea.; Yeom, JS (corresponding author), Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea.	highcervical@gmail.com	Park, Sang Min/V-9194-2019	Yeom, Jin S/0000-0002-8241-5335; Kim, Hyoungmin/0000-0002-4500-9653				Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bohannon RW, 2015, CURR OPIN CLIN NUTR, V18, P465, DOI 10.1097/MCO.0000000000000202; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cheon YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173036; Cho KH, 2014, ANN REHABIL MED-ARM, V38, P234, DOI 10.5535/arm.2014.38.2.234; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Ganesan S, 2017, ASIAN SPINE J, V11, P610, DOI 10.4184/asj.2017.11.4.610; Granic A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149699; Hong JY, 2017, ASIAN SPINE J, V11, P653, DOI 10.4184/asj.2017.11.4.653; Iizuka Y, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0759-z; INDAHL A, 1995, SPINE, V20, P473, DOI 10.1097/00007632-199502001-00011; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Park Hyoung-Moo, 2016, J Bone Metab, V23, P243, DOI 10.11005/jbm.2016.23.4.243; Punnett L, 2005, AM J IND MED, V48, P459, DOI 10.1002/ajim.20232; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Shiri R, 2018, AM J EPIDEMIOL, V187, P1093, DOI 10.1093/aje/kwx337; Smuck M, 2014, SPINE J, V14, P209, DOI 10.1016/j.spinee.2013.11.010; Tanishima S, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1807-7; Yoo JI, 2017, J KOREAN MED SCI, V32, P868, DOI 10.3346/jkms.2017.32.5.868; Yoo JI, 2016, J KOREAN MED SCI, V31, P1479, DOI 10.3346/jkms.2016.31.9.1479	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207759	10.1371/journal.pone.0207759	http://dx.doi.org/10.1371/journal.pone.0207759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475880	Green Published, Green Submitted, gold			2022-12-26	WOS:000451325700063
J	Shi, YJ; Gao, H; Pappas, G; Chen, QL; Li, M; Xu, J; Lai, SJ; Liao, QH; Yang, WW; Yi, ZT; Rouzi, Z; Yu, HJ				Shi, Yujing; Gao, Hui; Pappas, Georgios; Chen, Qiulan; Li, Mei; Xu, Jun; Lai, Shengjie; Liao, Qiaohong; Yang, Wenwen; Yi, Zhongtao; Rouzi, Zulaguli; Yu, Hongjie			Clinical features of 2041 human brucellosis cases in China	PLOS ONE			English	Article							RELAPSE	Background Human brucellosis has become a major public health problem in China. However, the available clinical data on brucellosis cases are limited. Methods We retrospectively reviewed medical charts of 2041 patients with confirmed human brucellosis and prospectively recorded their outcomes by telephone interview. These patients were admitted to the Sixth People's Hospital of the Xinjiang Uygur Autonomous region between 1st January and 31st December 2014. Data on these patients were collected from hospital medical records. Results Many patients presented with fatigue (67%), fever ( 64%), arthralgia (63%) and sweating (54%). High erythrocyte sedimentation rate (ESR) (69%), high C-reactive protein (CRP) (39%), high alanine aminotransferase (ALT) (33%) and high aspartate aminotransferase (AST) (20%) were the most common laboratory findings, especially in acute patients. There was evidence of focal involvement in 90% of patients. A total of 61.5% of brucellosis patients recovered. Multivariate logistic regression analyses suggested that the risk factors key to unfavorable prognosis were: age. 45 years (OR = 1.75, 95% CI 1.36-2.24), back pain (OR = 1.50, 95% CI 1.16-1.94) and joint tenderness (OR = 1.73, 95% CI 1.13-2.65). The increasing duration of the illness increased the risk of poor prognosis. Conclusion Patients with brucellosis showed different characteristics in different clinical stages. In China, the chronicity rate of human brucellosis is high. The risk of poor prognosis is increased in patients aged 45 years or older, patients who have had brucellosis for a substantial period of time, and patients with back pain or joint tenderness. The clinical management of brucellosis should be improved to include sensitive diagnostic methods for subacute and chronic brucellosis.	[Shi, Yujing; Chen, Qiulan; Lai, Shengjie; Liao, Qiaohong; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Gao, Hui; Li, Mei; Xu, Jun; Yi, Zhongtao; Rouzi, Zulaguli] Sixth Peoples Hosp Xinjiang Uygur Autonomous Reg, Urumqi, Peoples R China; [Pappas, Georgios] Univ Hosp Ioannina, Ioannina, Greece; [Lai, Shengjie; Yu, Hongjie] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Sch Publ Hlth, Shanghai, Peoples R China; [Lai, Shengjie; Yang, Wenwen; Yu, Hongjie] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China	Chinese Center for Disease Control & Prevention; University Hospital Ioannina; Fudan University	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.; Yu, HJ (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Sch Publ Hlth, Shanghai, Peoples R China.; Yu, HJ (corresponding author), Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China.	cfetpyhj@vip.sina.com	Yu, Hongjie/GZK-5351-2022; Pappas, Georgios/A-1525-2008; Pappas, Georgios/AAQ-1893-2021	Pappas, Georgios/0000-0002-8425-6091; Lai, Shengjie/0000-0001-9781-8148	National Science Fund for Distinguished Young Scholars [81525023]; China CDC's Key Laboratory of Surveillance and Early-warning on Infectious Disease, Emergency Response Mechanism Operation Program, Chinese Center for Disease Control and Prevention [131031001000015001]; United States National Institutes of Health (Comprehensive International Program for Research on AIDS grant) [U19 AI51915]; Sanofi Pasteur; GlaxoSmithKline; bioMerieux Diagnostic Product (Shanghai); Yichang HEC Changjiang Pharmaceutical Company; National Natural Science Fund [81773498]; Ministry of Science and Technology of China [2016ZX10004222-009];  [18XD1400300]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China CDC's Key Laboratory of Surveillance and Early-warning on Infectious Disease, Emergency Response Mechanism Operation Program, Chinese Center for Disease Control and Prevention; United States National Institutes of Health (Comprehensive International Program for Research on AIDS grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); bioMerieux Diagnostic Product (Shanghai); Yichang HEC Changjiang Pharmaceutical Company; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 	This study was supported by the grants from: the National Science Fund for Distinguished Young Scholars (grant no. 81525023) (http://www.nsfc.gov.cn/), China CDC's Key Laboratory of Surveillance and Early-warning on Infectious Disease (http://www.chinacdc.cn/), Emergency Response Mechanism Operation Program, Chinese Center for Disease Control and Prevention (131031001000015001), the United States National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915) and Shanghai Academic/Technology Research Leader (No. 18XD1400300). H.Y. has received investigator-initiated research funding from Sanofi Pasteur, GlaxoSmithKline, bioMerieux Diagnostic Product (Shanghai), and Yichang HEC Changjiang Pharmaceutical Company. S.L. is supported by the grants from the National Natural Science Fund (No. 81773498) and the Ministry of Science and Technology of China (2016ZX10004222-009). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed in this publication are those of the authors and are not necessarily endorsed by the funding agencies.	Alavi SM, 2009, PAK J MED SCI, V25, P46; ARIZA J, 1995, CLIN INFECT DIS, V20, P1241, DOI 10.1093/clinids/20.5.1241; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Buzgan T, 2010, INT J INFECT DIS, V14, pE469, DOI 10.1016/j.ijid.2009.06.031; China MOHO. Ministry of Health of People's Republic of China, 2013, DIAGN TREATM GUID HU; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Demirtuerk N, 2008, TROP DOCT, V38, P59, DOI 10.1258/td.2006.006266; Doern GV, 2000, CLIN INFECT DIS, V30, P166, DOI 10.1086/313586; Eini P, 2012, J RES HEALTH SCI, V12, P105; Erdem H, 2014, CHEST; Farazi AA, 2014, ARAK MED U J; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; del Pozo JSG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032090; GOTUZZO E, 1986, J INFECT DIS, V153, P122, DOI 10.1093/infdis/153.1.122; Gur A, 2003, YONSEI MED J, V44, P33, DOI 10.3349/ymj.2003.44.1.33; Hagebusch OE, 1941, AM J CLIN PATHOL; Hasanjani RMR, 2004, EPIDEMIOL INFECT, V132, P1109, DOI DOI 10.1017/S0950268804002833; Hashemi SH, 2007, INT J INFECT DIS, V11, P496, DOI 10.1016/j.ijid.2007.01.008; Hu L, 2011, J MED PEST CONTROL, P125; Kokoglu OF, 2006, TROP DOCT, V36, P49, DOI 10.1258/004947506775598752; Lai SJ, 2017, EMERG INFECT DIS, V23, P184, DOI 10.3201/eid2302.151710; Memish Z, 2000, J INFECTION, V40, P59, DOI 10.1053/jinf.1999.0586; Minas M, 2007, JPN J INFECT DIS, V60, P362; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Peng ZB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0884-1; Reza HRM, 2015, GLOBAL J HLTH SCI, V8, P53370; SHARDA DC, 1986, CLIN PEDIATR, V25, P492, DOI 10.1177/000992288602501002; Shi Y J, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P435, DOI 10.3760/cma.j.issn.0254-6450.2017.04.005; Skalsky K, 2008, BMJ-BRIT MED J, V336, P701, DOI 10.1136/bmj.39497.500903.25; Solera J, 1998, J INFECTION, V36, P85, DOI 10.1016/S0163-4453(98)93342-4; Wei ZhiYun, 2015, Chinese Journal of Endemiology, V34, P455; WEKSLER ME, 1983, MED CLIN N AM, V67, P263, DOI 10.1016/S0025-7125(16)31203-2; WHO, 2006, BRUCELLOSIS HUMANS A; Wu Y., 2012, INFECT DIS INFORM, V25, P22	35	24	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0205500	10.1371/journal.pone.0205500	http://dx.doi.org/10.1371/journal.pone.0205500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30476930	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700007
J	Blais, S; Patenaude, J; Doyon, M; Bouchard, L; Perron, P; Hivert, MF; Dallaire, F				Blais, Samuel; Patenaude, Julie; Doyon, Myriam; Bouchard, Luigi; Perron, Patrice; Hivert, Marie-France; Dallaire, Frederic			Effect of gestational diabetes and insulin resistance on offspring's myocardial relaxation kinetics at three years of age	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; ASYMPTOMATIC INFANTS; MOTHERS; HYPERGLYCEMIA; RECOMMENDATIONS; DYSFUNCTION; PREGNANCY	Purpose Scientific evidence on the long-term impact of gestational diabetes mellitus (GDM) on offspring's myocardial relaxation is scarce. Studies have linked GDM with transient ventricular hypertrophy in newborns resulting in diastolic dysfunction, but long-term assessment is lacking. The main objective of this study was to evaluate myocardial relaxation in 3-year-old children in relation to the degree of insulin resistance of their mother during pregnancy. Methods We prospectively assessed myocardial relaxation by echocardiography imaging on 106 children at 3 years of age. Subjects were divided into 3 groups [GDM, insulin resistance (IR) and normoglycemic (CTRL)], based on their mother's 75g-OGTT and HOMA-IR results at second trimester screening. We collected information on children adiposity and body size, maternal characteristics and maternal and cord blood measurement of C-peptide and insulin. Results The study population comprised 29 children from GDM mothers, 36 children from IR mothers and 41 CTRL children. Compared to the CTRL group, we found that a higher proportion of children in the IR group and the GDM group met the criteria for impaired myocardial relaxation, but this did not reach statistical significance (odds ratio adjusted for heart rate and body surface area of 1.4 [0.2-9.5] and 3.5 [0.6-20.6], respectively). Conclusion We did not detect an increased risk of impaired myocardial relaxation at three years of age in children exposed in-utero to IR and GDM, compared to children from normoglycemic mothers.	[Blais, Samuel; Dallaire, Frederic] Univ Sherbrooke, Dept Pediat, Sherbrooke, PQ, Canada; [Blais, Samuel; Patenaude, Julie; Doyon, Myriam; Perron, Patrice; Hivert, Marie-France; Dallaire, Frederic] CHUS, Ctr Rech, Sherbrooke, PQ, Canada; [Patenaude, Julie; Perron, Patrice; Hivert, Marie-France] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Bouchard, Luigi] Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ, Canada; [Bouchard, Luigi] ECOGENE 21 Biocluster, Chicoutimi, PQ, Canada; [Hivert, Marie-France] Massachusetts Gen Hosp, Diabet Ctr, Boston, MA 02114 USA; [Hivert, Marie-France] Harvard Med Sch, Dept Populat Med, Harvard Pilgr Hlth Care Inst, Boston, MA USA	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Dallaire, F (corresponding author), Univ Sherbrooke, Dept Pediat, Sherbrooke, PQ, Canada.; Dallaire, F (corresponding author), CHUS, Ctr Rech, Sherbrooke, PQ, Canada.	frederic.a.dallaire@usherbrooke.ca	Hivert, Marie-France/GWN-0455-2022	Doyon, Myriam/0000-0001-9787-7367; Dallaire, Frederic/0000-0002-0489-2523; Blais, Samuel/0000-0003-0891-1098	Centre de recherche du CHUS (programme d'aide de financement interne); Fonds de Recherche du Quebec -Sante operating grant [20697]; Canadian Institute of Health Research (CIHR) [MOP 115071]; FRQ-S; ADA Pathways Accelerator Award [1-15-ACE-2]; Centre de recherche Mere-Enfant of Sherbrooke's University; CIHR master's scholarship; FRQ-S master's scholarship; Diabete Quebec	Centre de recherche du CHUS (programme d'aide de financement interne); Fonds de Recherche du Quebec -Sante operating grant; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); FRQ-S; ADA Pathways Accelerator Award; Centre de recherche Mere-Enfant of Sherbrooke's University; CIHR master's scholarship; FRQ-S master's scholarship; Diabete Quebec	The study was supported by the Centre de recherche du CHUS (programme d'aide de financement interne), by the Fonds de Recherche du Quebec -Sante operating grant (FRQ-S #20697 recipient: MFH, URL: www.frqs.gouv.qc.ca), and by the Canadian Institute of Health Research (CIHR #MOP 115071, recipient: MFH, URL: www.cihr-irsc.gc.ca).LB and FD are junior research scholars from the FRQ-S and members of the FRQS-funded Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke. MFH is the recipient an ADA Pathways Accelerator Award (#1-15-ACE-2, URL: www.diabetes.org/pathway/program/grant-information.html).JP was supported by the FRQ-S, Diabete Quebec (URL: www.diabete.qc.ca) and the Centre de recherche Mere-Enfant of Sherbrooke's University. SB was supported by a CIHR master's scholarship and a FRQ-S master's scholarship.	Al-Biltagi M, 2015, PEDIATR CARDIOL, V36, P445, DOI 10.1007/s00246-014-1033-0; APPLETON CP, 1988, J AM COLL CARDIOL, V12, P426, DOI 10.1016/0735-1097(88)90416-0; Barnes-Powell LL, 2007, NEONATAL NETW, V26, P283, DOI 10.1891/0730-0832.26.5.283; Dallaire F, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002167; Dallaire F, 2015, PEDIATR CARDIOL, V36, P667, DOI 10.1007/s00246-014-1063-7; Demiroren K, 2005, J PERINAT MED, V33, P232, DOI 10.1515/JPM.2005.042; Dervisoglu P, 2018, J OBSTET GYNAECOL, V38, P408, DOI 10.1080/01443615.2017.1410536; Foster BJ, 2016, J AM SOC ECHOCARDIOG, V29, P441, DOI 10.1016/j.echo.2015.12.011; Frommelt PC, 2009, ECHOCARDIOGRAPHY PED, P95; Garcia-Flores J, 2011, EUR J OBSTET GYN R B, V154, P24, DOI 10.1016/j.ejogrb.2010.08.002; Garza C, 2004, FOOD NUTR BULL, V25, pS3; Guillemette L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010031; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Kozak-Barany A, 2004, EARLY HUM DEV, V77, P13, DOI 10.1016/j.earlhumdev.2003.11.006; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MEHTA S, 1991, DIABETES, V40, P56, DOI 10.2337/diab.40.2.S56; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Miranda JO, 2018, J AM SOC ECHOCARDIOG, V31, P333, DOI 10.1016/j.echo.2017.11.007; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rijpert M, 2011, EXP DIABETES RES, DOI 10.1155/2011/564316; Thompson D, 2013, CAN J DIABETES, V37, pS168, DOI 10.1016/j.jcjd.2013.01.044; Zablah JE, 2017, PEDIATR CARDIOL, V38, P801, DOI 10.1007/s00246-017-1584-y; Zielinsky P, 2012, EARLY HUM DEV, V88, P273, DOI 10.1016/j.earlhumdev.2012.02.006	25	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207632	10.1371/journal.pone.0207632	http://dx.doi.org/10.1371/journal.pone.0207632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462720	Green Published, gold, Green Submitted			2022-12-26	WOS:000451054800071
J	Fauk, NK; Kustanti, CY; Wulandari, R; Damayani, AD; Mwanri, L				Fauk, Nelsensius Klau; Kustanti, Christina Yeni; Wulandari, Ririn; Damayani, Ayi Diah; Mwanri, Lillian			Societal determinants of HIV vulnerability among clients of female commercial sex workers in Indonesia	PLOS ONE			English	Article							CONDOM USE; SOCIAL DETERMINANTS; VIRAL-HEPATITIS; RISK BEHAVIORS; PREVALENCE; KNOWLEDGE; NETWORK; POPULATION; PREVENTION; HIV/AIDS	This study aimed to explore societal determinants of HIV vulnerability among the clients of female commercial sex workers (FCSWs) in Belu and Malaka districts, Indonesia. A qualitative inquiry using in-depth interviews was employed to collect data from participants (n = 42) recruited using a purposive and snowball sampling technique. Data analysis was guided by a qualitative data analysis framework. The study results revealed several societal determinants that supported vulnerability to HIV infection among the participants. They included low education level and sexual health literacy including the lack of knowledge and information about HIV transmission and prevention. Additional determinants identified were limited source of HIV/AIDS-related information, availability of and ease of accessibility of brothels and FCSWs, peer influence, and high mobility of the study participants. Findings of this study indicate the needs and call for interventions that aim to protect both FCSWs and their clients, through provision of HIV/AIDS and sexual health education and information and improvement in the availability and accessibility of condoms.	[Fauk, Nelsensius Klau] Inst Resource Governance & Social Change, Kupang, Nusa Tenggara T, Indonesia; [Fauk, Nelsensius Klau; Mwanri, Lillian] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Kustanti, Christina Yeni] Bethesda Yakkum Hlth Sci Inst, Kota Yogyakarta, Daerah Istimewa, Indonesia; [Wulandari, Ririn] Malahayati Univ, Publ Hlth Fac, Kemiling, Bandar Lampung, Indonesia; [Damayani, Ayi Diah] Poltekkes Pangkal Pinang, Midwifery Dept, Bangka Tengah, Indonesia	Flinders University South Australia	Fauk, NK (corresponding author), Inst Resource Governance & Social Change, Kupang, Nusa Tenggara T, Indonesia.; Fauk, NK (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia.	nelsen_kalu@yahoo.com	Fauk, Nelsensius/L-8024-2015; Mwanri, Lillian/AGG-3711-2022	Fauk, Nelsensius/0000-0002-1325-2640; Mwanri, Lillian/0000-0002-5792-7785; Kustanti, Christina Yeni/0000-0002-9914-6127				Barnett A., 2006, MPSPACK TUTORIAL; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Couture MC, 2008, SEX TRANSM DIS, V35, P849, DOI 10.1097/OLQ.0b013e318177ec5c; Couture MC, 2010, AIDS CARE, V22, P253, DOI 10.1080/09540120903111478; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Dunkle KL, 2010, PUBLIC HEALTH REP, V125, P90, DOI 10.1177/00333549101250S413; FAJANS P, 1995, SOC SCI MED, V41, P409, DOI 10.1016/0277-9536(94)00327-P; FAJANS P, 1994, AIDS CARE, V6, P459, DOI 10.1080/09540129408258661; Fauk N, 2014, INT J APPL PHARM SCI, V3, P291; Fauk NK, 2017, INT J HUM RIGHTS HEA, V10, P132, DOI 10.1108/IJHRH-01-2017-0002; Fauk NK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178736; Fauk NK, 2015, INT J HUM RIGHTS HEA, V8, P144, DOI 10.1108/IJHRH-10-2014-0028; Fauk NK, 2018, AM MENS HLTH SPECIAL, P1; Fauk NK, 2014, INT J RES SOC SCI, V4, P578; Fauk NK., 2017, GLOBAL J HLTH SCI, V9, P47; Ford K, 2002, AIDS EDUC PREV, V14, P496, DOI 10.1521/aeap.14.8.496.24113; Gemert CV, 2013, AIDS EDUC PREV, V25, P232, DOI 10.1521/aeap.2013.25.3.232; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; Jin X, 2010, JAIDS-J ACQ IMM DEF, V53, P131, DOI 10.1097/QAI.0b013e3181b3552a; Kementrian Kesehatan Republik Indonesia, 2019, IND PEMB KES MAS 201, P1; KPAD Belu, 2018, LAP DAT HIV AIDS KAB; McLaughlin MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054531; Miller GA, 2004, SEX TRANSM DIS, V31, P337, DOI 10.1097/00007435-200406000-00003; Nguyen NT, 2009, AIDS BEHAV, V13, P881, DOI 10.1007/s10461-008-9463-4; Papworth E, 2013, AIDS S3, V16, P1; Ramanathan S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005166; REINKING D, 1994, PATIENT EDUC COUNS, V24, P289, DOI 10.1016/0738-3991(94)90072-8; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; SABEL CF, 1993, HUM RELAT, V46, P1133, DOI 10.1177/001872679304600907; Schneider JA, 2007, AIDS CARE, V19, P1171, DOI 10.1080/09540120701336392; Sharpe TT, 2010, PUBLIC HEALTH REP, V125, P11, DOI 10.1177/00333549101250S404; Shaw R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-200; Shaw SY, 2013, SEX TRANSM DIS, V40, P482, DOI 10.1097/OLQ.0b013e3182904a9a; Suryawanshi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073470; Thorpe L, 1997, AIDS CARE, V9, P181, DOI 10.1080/09540129750125208; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Voeten HACM, 2002, SEX TRANSM DIS, V29, P444, DOI 10.1097/00007435-200208000-00003; Volkmann T, 2014, ARCH SEX BEHAV, V43, P719, DOI 10.1007/s10508-013-0149-2; WHO, 2012, UND MOD TRANSM MOD N; Wilkinson W., 2005, SOCIAL DETERMINANTS, V2nd; World Health Organization, 2014, EX SUMM GLOB UPD HLT; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b	42	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207647	10.1371/journal.pone.0207647	http://dx.doi.org/10.1371/journal.pone.0207647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB4VL	30462714	gold, Green Published, Green Submitted			2022-12-26	WOS:000451054800072
J	Jeong, E; Park, N; Choi, Y; Park, RW; Yoon, D				Jeong, Eugene; Park, Namgi; Choi, Young; Park, Rae Woong; Yoon, Dukyong			Machine learning model combining features from algorithms with different analytical methodologies to detect laboratory-event- related adverse drug reaction signals	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORDS; DATABASE	Background The importance of identifying and evaluating adverse drug reactions (ADRs) has been widely recognized. Many studies have developed algorithms for ADR signal detection using electronic health record (EHR) data. In this study, we propose a machine learning (ML) model that enables accurate ADR signal detection by integrating features from existing algorithms based on inpatient EHR laboratory results. Materials and methods To construct an ADR reference dataset, we extracted known drug-laboratory event pairs represented by a laboratory test from the EU-SPC and SIDER databases. All possible drug-laboratory event pairs, except known ones, are considered unknown. To detect a known drug-laboratory event pair, three existing algorithms-CERT, CLEAR, and PACE- were applied to 21-year inpatient EHR data. We also constructed ML models (based on random forest, L1 regularized logistic regression, support vector machine, and a neural network) that use the intermediate products of the CERT, CLEAR, and PACE algorithms as inputs and determine whether a drug-laboratory event pair is associated. For performance comparison, we evaluated the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), Fl-measure, and area under receiver operating characteristic (AUROC). Results All measures of ML models outperformed those of existing algorithms with sensitivity of 0.593-0.793, specificity of 0.619-0.796, NPV of 0.645-0.727, PPV of 0.680-0.777, F1-measure of 0.629-0.709, and AUROC of 0.737-0.816. Features related to change or distribution of shape were considered important for detecting ADR signals. Conclusions Improved performance of ML models indicated that applying our model to EHR data is feasible and promising for detecting more accurate and comprehensive ADR signals. Conclusions Improved performance of ML models indicated that applying our model to EHR data is feasible and promising for detecting more accurate and comprehensive ADR signals.	[Jeong, Eugene; Park, Namgi; Choi, Young; Park, Rae Woong; Yoon, Dukyong] Ajou Univ, Dept Biomed Informat, Sch Med, Suwon, Gyeonggi Do, South Korea; [Park, Namgi] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Choi, Young; Park, Rae Woong; Yoon, Dukyong] Ajou Univ, Dept Biomed Sci, Grad Sch Med, Suwon, Gyeonggi Do, South Korea	Ajou University; Ewha Womans University; Ajou University	Yoon, D (corresponding author), Ajou Univ, Dept Biomed Informat, Sch Med, Suwon, Gyeonggi Do, South Korea.; Yoon, D (corresponding author), Ajou Univ, Dept Biomed Sci, Grad Sch Med, Suwon, Gyeonggi Do, South Korea.	d.yoon.ajou@gmail.com		Choi, Young/0000-0002-8314-6130; Yoon, Dukyong/0000-0003-1635-8376	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0982, HI17C0970, HG18C0067]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (grant numbers: HI16C0982, HI17C0970, and HG18C0067). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SR, 2003, J GEN INTERN MED, V18, P57, DOI 10.1046/j.1525-1497.2003.20130.x; Andrade RJ, 2002, EUR J GASTROEN HEPAT, V14, P887, DOI 10.1097/00042737-200208000-00014; [Anonymous], 2017, J BIOMED SEMANT, V8, P11, DOI [10.1186/s13326-017-0115-3, DOI 10.1186/S13326-017-0115-3]; Harpaz R, 2012, CLIN PHARMACOL THER, V91, P1010, DOI 10.1038/clpt.2012.50; Jagannatha A. N., 2016, P 2016 C N AM CHAPT, V2016, P473; Jimenez-Saenz M, 2010, GASTROENTEROL HEPATO, V33, P66, DOI 10.1016/j.gastrohep.2009.06.003; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Lee S, 2017, J AM MED INFORM ASSN, V24, P697, DOI 10.1093/jamia/ocw168; Li Y, 2014, J AM MED INFORM ASSN, V21, P308, DOI 10.1136/amiajnl-2013-001718; Liu M, 2013, J AM MED INFORM ASSN, V20, P420, DOI 10.1136/amiajnl-2012-001119; Maro JC, 2014, PHARMACOEPIDEM DR S, V23, P839, DOI 10.1002/pds.3618; Miller TP, 2017, BRIT J HAEMATOL, V177, P283, DOI 10.1111/bjh.14538; Mohammad F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092199; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Newe A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136131; Pacurariu AC, 2017, PHARMACOEPIDEM DR S, V26, P327, DOI 10.1002/pds.4128; Park MY, 2011, PHARMACOEPIDEM DR S, V20, P598, DOI 10.1002/pds.2139; Rasmussen LV, 2014, J BIOMED INFORM, V51, P280, DOI 10.1016/j.jbi.2014.06.007; Tham MY, 2018, PHARMACOEPIDEM DR S, V27, P87, DOI 10.1002/pds.4340; Vallejo I, 2000, MED CLIN-BARCELONA, V115, P719, DOI 10.1016/S0025-7753(00)71672-1; WHO, 2002, IMP PHARM SAF MON ME; Yoon D, 2012, CLIN PHARMACOL THER, V91, P467, DOI 10.1038/clpt.2011.248; Yoon D, 2016, PHARMACOEPIDEM DR S, V25, P307, DOI 10.1002/pds.3893; Yoon D, 2016, HEALTHC INFORM RES, V22, P54, DOI 10.4258/hir.2016.22.1.54; Yoon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075214; Zhao J, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0311-6; Zhao J, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/1472-6947-15-S4-S1	27	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207749	10.1371/journal.pone.0207749	http://dx.doi.org/10.1371/journal.pone.0207749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HB4VL	30462745	gold, Green Submitted, Green Published			2022-12-26	WOS:000451054800080
J	Hatakeyama, H; Morino, T; Ishii, T; Kanzaki, M				Hatakeyama, Hiroyasu; Morino, Taisuke; Ishii, Takuya; Kanzaki, Makoto			Cooperative actions of Tbc1d1 and AS160/Tbc1d4 in GLUT4-trafficking activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transporter type 4 (GLUT4); GTPase activating protein (GAP); membrane trafficking; microscopic imaging; signal transduction; insulin; AMP-activated kinase (AMPK); Akt PKB	PHOSPHOTYROSINE-BINDING DOMAIN; STIMULATED GLUCOSE-UPTAKE; ACTIVATED PROTEIN-KINASE; RAT SKELETAL-MUSCLE; 160 KDA AS160; GLUT4 TRANSLOCATION; AKT SUBSTRATE; INSULIN; PHOSPHORYLATION; TRAFFICKING	AS160 and Tbc1d1 are key Rab GTPase-activating proteins (RabGAPs) that mediate release of static GLUT4 in response to insulin or exercise-mimetic stimuli, respectively, but their cooperative regulation and its underlying mechanisms remain unclear. By employing GLUT4 nanometry with cell-based reconstitution models, we herein analyzed the functional cooperative activities of the RabGAPs. When both RabGAPs are present, Tbc1d1 functionally dominates AS160, and stimuli-inducible GLUT4 release relies on Tbc1d1-evoking proximal stimuli, such as AICAR and intracellular Ca2+. Detailed functional assessments with varying expression ratios revealed that AS160 modulates sensitivity to external stimuli in Tbc1d1-mediated GLUT4 release. For example, Tbc1d1-governed GLUT4 release triggered by Ca2+ plus insulin occurred more efficiently than that in cells with little or no AS160. Series of mutational analyses revealed that these synergizing actions rely on the phosphotyrosine-binding 1 (PTB1) and calmodulin-binding domains of Tbc1d1 as well as key phosphorylation sites of both AS160 (Thr(642)) and Tbc1d1 (Ser(237) and Thr(596)). Thus, the emerging cooperative governance relying on the multiple regulatory nodes of both Tbc1d1 and AS160, functioning together, plays a key role in properly deciphering biochemical signals into a physical GLUT4 release process in response to insulin, exercise, and the two in combination.	[Hatakeyama, Hiroyasu] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808579, Japan; [Hatakeyama, Hiroyasu; Kanzaki, Makoto] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 9808579, Japan; [Morino, Taisuke; Ishii, Takuya; Kanzaki, Makoto] Tohoku Univ, Dept Informat & Intelligent Syst, Sendai, Miyagi 9808579, Japan	Tohoku University; Tohoku University; Tohoku University	Kanzaki, M (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, 6-6-04-110 Aoba, Sendai, Miyagi 9808579, Japan.	makoto.kanzaki.b1@tohoku.ac.jp	Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955	Japan Society for the Promotion of Science [17H02076]; Japan Agency for Medical Research and Development Grant [18058831]; Japan Diabetes Society; Program for Fostering Researchers for the Next Generation in the Project for Establishing a Consortium for the Development of Human Resources in Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development Grant(Japan Agency for Medical Research and Development (AMED)); Japan Diabetes Society; Program for Fostering Researchers for the Next Generation in the Project for Establishing a Consortium for the Development of Human Resources in Science and Technology	This work was supported in part by Japan Society for the Promotion of Science Grant 17H02076 (to M. K.), Japan Agency for Medical Research and Development Grant 18058831 (to M. K.), a grant from the Japan Diabetes Society (to H. H.), and the Program for Fostering Researchers for the Next Generation in the Project for Establishing a Consortium for the Development of Human Resources in Science and Technology (to H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Balsevich G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01783-y; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Cheng KKY, 2014, DIABETES, V63, P3748, DOI 10.2337/db14-0337; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Funai K, 2009, AM J PHYSIOL-ENDOC M, V297, pE242, DOI 10.1152/ajpendo.00194.2009; Funai K, 2008, J APPL PHYSIOL, V105, P1788, DOI 10.1152/japplphysiol.90838.2008; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Hatakeyama H, 2017, J PHYSIOL-LONDON, V595, P5603, DOI 10.1113/JP273985; Hatakeyama H, 2013, MOL BIOL CELL, V24, P809, DOI 10.1091/mbc.E12-10-0725; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; JAMES DE, 1985, J CLIN INVEST, V76, P657, DOI 10.1172/JCI112019; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Kane S, 2005, BIOCHEM BIOPH RES CO, V335, P175, DOI 10.1016/j.bbrc.2005.07.056; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Kramer HF, 2007, DIABETES, V56, P2854, DOI 10.2337/db07-0681; Mafakheri S, 2018, J BIOL CHEM, V293, P17853, DOI 10.1074/jbc.RA118.005040; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Oki K, 2018, APPL PHYSIOL NUTR ME, V43, P795, DOI 10.1139/apnm-2017-0858; Pehmoller C, 2012, DIABETES, V61, P2743, DOI 10.2337/db11-1572; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Thomas EC, 2018, BIOCHEM J, V475, P2969, DOI 10.1042/BCJ20180475; Treebak JT, 2010, AM J PHYSIOL-CELL PH, V298, pC377, DOI 10.1152/ajpcell.00297.2009; Vendelbo MH, 2014, J APPL PHYSIOL, V117, P289, DOI 10.1152/japplphysiol.00044.2014; Woo JR, 2017, INT J BIOL MACROMOL, V103, P965, DOI 10.1016/j.ijbiomac.2017.05.119	37	13	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1161	1172		10.1074/jbc.RA118.004614	http://dx.doi.org/10.1074/jbc.RA118.004614			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30482843	Green Published, hybrid			2022-12-26	WOS:000457879500009
J	Thompson, AL				Thompson, Arthur Lewis			Are tones in the expressive lexicon iconic? Evidence from three Chinese languages	PLOS ONE			English	Article								Recent advances in the literature have focused on sketching phonosemantic mappings of imitative or iconic utterances by relying on vowels and consonants, leaving the suprasegmental information unexplored. To begin bridging this gap, this study looks at the interaction of lexical tone and iconicity by comparing sound symbolic (i.e., mimetic, expressive, ideophonic) strata and general (i.e., arbitrary, prosaic, non-iconic) strata from three Chinese languages (Mandarin, Taiwanese Southern Min, Hong Kong Cantonese) using corpus-based means. For all three languages the distribution of tones in the sound symbolic strata are skewed so that the majority of syllables are largely confined to two tonal categories per language, one of which is high level, while the general strata exhibit no such tonal bias. These results indicate that phonological systematicity at the prosodic level might play an important role in demarcating an iconic class of words. This cross-linguistic tendency towards high tone mappings may be derived from phonotactic strategies to facilitate prosodic foregrounding of iconic utterances as well as an embodiment of expressive voice and marked pitch use like that of Infant Directed Speech.	[Thompson, Arthur Lewis] Univ Hong Kong, Dept Linguist, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Thompson, AL (corresponding author), Univ Hong Kong, Dept Linguist, Hong Kong, Hong Kong, Peoples R China.	u3003503@hku.hk		Thompson, Arthur Lewis/0000-0002-9460-7326				Akio Nasu, 2007, NIHONGOGAKU, V26, P4; Akita K., 2017, J LINGUIST, P1; Akita Kimi, 2009, THESIS; Akita Kimi, 2013, JAPANESEKOREAN LINGU, V20, P115; Alpher Barry., 2001, IDEOPHONES, P57, DOI DOI 10.1075/TSL.44.03ALP; [Anonymous], 2017, CHINA NEW DICT; Attridge Derek, 1988, PECULIAR LANGUAGE LI; Bauer R., 1985, CAHIERS LINGUISTIQUE, VXIV.1, P99; Bauer R. S, 1997, MODERN CANTONESE PHO, P49; BLADON RAW, 1977, ARCH LINGUIST, V8, P158; Bodomo A., 2008, COMMUNICATION UNPUB; Childs GT, 2014, PRAGMAT SOC, V5, P341, DOI 10.1075/ps.5.3.02chi; de Saussure F., 1916, COURS LINGUISTIQUE G; Dingemanse M, 2018, GLOSSA-UK, V3, DOI 10.5334/gjgl.444; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Dingemanse M, 2013, GESTURE, V13, P143, DOI 10.1075/gest.13.2.02din; Duanmu S, 2007, PHONOLOGY STANDARD C; FERNALD A, 1993, CHILD DEV, V64, P637; Fischer Andreas, 1999, FORM MIMING MEANING, P123, DOI DOI 10.1075/ILL.1.12FIS; Assaneo MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028317; Gong L.-.Y., 1991, XIANGSHENGCI CIDIAN; Hamano Shoko., 1998, SOUND SYMBOLIC SYSTE; Hinton L., 1994, SOUND SYMBOLISM; Hung H.S.W., 2007, THESIS; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; Kirby JamesP., 2007, P INT C PHON SCI 16, P1389; Kruspe N., 2004, A GRAMMAR OF SEMELAI; Leung MT, 2004, BEHAV RES METH INS C, V36, P500, DOI 10.3758/BF03195596; Li Jinger, 2007, XIANDAI HANYU NISHEN; Lin Philip T, 2015, TAIWANESE GRAMMAR CO; Lockwood G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01246; Masuda K., 2002, THESIS; Nasu Akio, 2004, JAPANESE LINGUISTICS, V16, P69; Ogura T, 2006, STUDIES LANGUAGE SCI, P103; Ohtake Y, 2013, JPN PSYCHOL RES, V55, P390, DOI 10.1111/jpr.12029; Oswalt Robert L., 1994, SOUND SYMBOLISM, P293, DOI [10.1017/CBO9780511751806.020, DOI 10.1017/CB09780511751806.020]; Rhodes Richard, 1994, SOUND SYMBOLISM, P276, DOI [10.1017/CBO9780511751806.019, DOI 10.1017/CB09780511751806.019]; Saji N., 2013, ONOMATOPE KENKYU NOS, P151; Schmidtke DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00080; Shi F-Z, 2006, TAIYU SHUNJIAN RUMEN; Suzuki Y., 2013, ONOMATOPE KENKYU NOS, P167; Thomas Van Hoey, 2018, COGNITIVE SEMANTICS, V4, P230; Thompson PD, 2011, Q J EXP PSYCHOL, V64, P2392, DOI 10.1080/17470218.2011.605898; Tsou B. K-Y, 2017, STUDIES QUADRA SYLLA; Tsou B. K- Y, 2017, 22 INT C YUE DIAL; van de Weijer J., 2014, LINGUISTICS NETHERLA, V2014, P180, DOI [10.1075/avt.31.13wei, DOI 10.1075/AVT.31.13WEI]; Van Hoey Thomas, 2015, THESIS KU LEUVEN LEU; Wang H. S., 1998, STUDIA LINGUISTICA S, P259; Wiener S, 2016, LANG SPEECH, V59, P59, DOI 10.1177/0023830915578000; Wu K-S, 2003, TONGIONG TAIWANESE D; Wu Soli, 2000, GUO TAI DUIZHAO HUOY; Yip PC., 2000, CHINESE LEXICON COMP	54	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0204270	10.1371/journal.pone.0204270	http://dx.doi.org/10.1371/journal.pone.0204270			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0NQ	30513090	gold, Green Published, Green Submitted			2022-12-26	WOS:000452204800003
J	Merz, CNB; Olson, MB; Kelsey, SF; Bittner, V; Reis, SE; Reichek, N; Handberg, E				Merz, C. Noel Bairey; Olson, Marian B.; Kelsey, Sheryl F.; Bittner, Vera; Reis, Steven E.; Reichek, Nathaniel; Handberg, Eileen			Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study	PLOS ONE			English	Article							BODY-WEIGHT; HEART-DISEASE; OLDER WOMEN; MORTALITY; OVERWEIGHT; RISK; VARIABILITY; MEN; INTERVENTION; FLUCTUATIONS	Background We previously reported in a cross-sectional analysis an adverse relationship between weight cycling and HDL-cholesterol but not angiographic obstructive coronary artery disease (CAD) among women undergoing coronary angiography for suspected ischemia in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). We now examine the relationship between weight cycling and prospective adverse cardiovascular outcome in this group. Methods 795 women enrolled between 1996-2001 in the WISE undergoing coronary angiography for evaluation of suspected ischemia and followed for a median of 6.0 years (interquartile range = 3.4 years). Adverse outcome was defined as a composite of all-cause death, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, and hospitalization for heart failure. Weight cycling was defined as the intentional loss of at least 10 lbs. (4.5 kgs.) at least three times during the women's lifetime. Results Women (n = 224) who reported a history of weight cycling were younger; more often white and better educated compared those without this history. At baseline, women with a weight cycling history had lower HDL-C values, higher body mass index, larger waist circumferences and higher values for fasting blood sugar, but no difference in obstructive CAD prevalence or severity. There was an inverse relationship between weight cycling and adverse composite cardiovascular outcome, whereby fewer of women with a history of weight cycling experienced an adverse outcome as compared to non-cyclers (21% vs 29%, respectively, p = 0.03). Conclusions Despite an adverse association with HDL-cholesterol in women undergoing coronary angiography for suspected ischemia, weight cycling was associated with a lower adverse outcome rate in women with suspected ischemia.	[Merz, C. Noel Bairey] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA; [Olson, Marian B.; Kelsey, Sheryl F.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Bittner, Vera] Univ Alabama Birmingham, Dept Med, Div Cardiol, Birmingham, AL 35294 USA; [Reis, Steven E.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Reichek, Nathaniel] St Francis Hosp, Roslyn, NY USA; [Handberg, Eileen] Univ Florida, Div Cardiovasc Med, Gainesville, FL USA	Cedars Sinai Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida	Merz, CNB (corresponding author), Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA.	Noel.BaireyMerz@cshs.org		Bairey Merz, C. Noel/0000-0002-9933-5155; Handberg, Eileen/0000-0002-7805-9577	National Heart, Lung and Blood Institute [N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164]; GCRC from the National Center for Research Resources [MO1-RR00425]; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc., Laurence Harbor, NJ; Edythe L. Broad Women's Heart Research Fellowship, Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; Linda Joy Pollin Women's Heart Health Program; National Institute on Aging [U01HL64829, U01HL649141, U01HL649241, T32HL69751, 1R03AG032631]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GCRC from the National Center for Research Resources; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc., Laurence Harbor, NJ; Edythe L. Broad Women's Heart Research Fellowship, Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; Linda Joy Pollin Women's Heart Health Program; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by contracts from the National Heart, Lung and Blood Institute, nos. N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164, grants U01HL64829, U01HL649141, U01HL649241, T32HL69751, 1R03AG032631 from the National Institute on Aging, GCRC grant MO1-RR00425 (to CNBM) from the National Center for Research Resources and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ, The Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA, and QMED, Inc., Laurence Harbor, NJ, the Edythe L. Broad Women's Heart Research Fellowship, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, and the Linda Joy Pollin Women's Heart Health Program.	Arant CB, 2004, J AM COLL CARDIOL, V43, P2009, DOI 10.1016/j.jacc.2004.01.038; ATKINSON RL, 1994, JAMA-J AM MED ASSOC, V272, P1196, DOI 10.1001/jama.272.15.1196; Bangalore S, 2017, NEW ENGL J MED, V376, P1332, DOI 10.1056/NEJMoa1606148; Barrett-Connor E, 2013, GLOB HEART, V8, P95, DOI 10.1016/j.gheart.2012.12.002; BLAIR SN, 1993, ANN INTERN MED, V119, P749, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00024; BODEN WE, 2000, AM J CARDIOL, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8; CRIQUI MH, 1993, NEW ENGL J MED, V328, P1220, DOI 10.1056/NEJM199304293281702; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Field AE, 2009, ARCH INTERN MED, V169, P881, DOI 10.1001/archinternmed.2009.67; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; French SA, 1997, INT J OBESITY, V21, P217, DOI 10.1038/sj.ijo.0800390; FRENCH SA, 1995, INT J OBESITY, V19, P22; Gregg EW, 2003, ANN INTERN MED, V138, P383, DOI 10.7326/0003-4819-138-5-200303040-00007; HAMM P, 1989, AM J EPIDEMIOL, V129, P312, DOI 10.1093/oxfordjournals.aje.a115135; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; JEFFERY RW, 1992, AM J CLIN NUTR, V55, P641, DOI 10.1093/ajcn/55.3.641; LaRosa JC, 1997, ARCH INTERN MED, V157, P961, DOI 10.1001/archinte.157.9.961; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453; Olson MB, 2000, J AM COLL CARDIOL, V36, P1565, DOI 10.1016/S0735-1097(00)00901-3; Reynolds MW, 1999, J AM GERIATR SOC, V47, P1409, DOI 10.1111/j.1532-5415.1999.tb01558.x; Rzehak P, 2007, EUR J EPIDEMIOL, V22, P665, DOI 10.1007/s10654-007-9167-5; Statistics N. C. F. H., 2013, HLTH US 2012 SPEC FE; STENSVOLD I, 1993, BMJ-BRIT MED J, V307, P1318, DOI 10.1136/bmj.307.6915.1318; Wallner SJ, 2004, INT J OBESITY, V28, P1143, DOI 10.1038/sj.ijo.0802736; Wannamethee SG, 2000, AM J EPIDEMIOL, V151, P667, DOI 10.1093/oxfordjournals.aje.a010261; Will JC, 2002, AM J PUBLIC HEALTH, V92, P1245, DOI 10.2105/AJPH.92.8.1245; WILLIAMSON DF, 1992, AM J PUBLIC HEALTH, V82, P1251, DOI 10.2105/AJPH.82.9.1251; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; WING RR, 1995, ARCH INTERN MED, V155, P1416, DOI 10.1001/archinte.155.13.1416	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207223	10.1371/journal.pone.0207223	http://dx.doi.org/10.1371/journal.pone.0207223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC6BO	30507935	Green Submitted, Green Published, gold			2022-12-26	WOS:000451886500005
J	Naraine, MD; Fels, DI; Whitfield, M				Naraine, Mala D.; Fels, Deborah I.; Whitfield, Margot			Impacts on quality: Enjoyment factors in blind and low vision audience entertainment ratings: A qualitative study	PLOS ONE			English	Article							AUDIO DESCRIPTION; INCLUSION; LANGUAGE	Audio description (AD) is one of the main methods that people who are blind or low vision (B/LV) use to access film, television, and theatre content. AD is a second audio track inserted into the space(s) where speech is absent, which tends to be only a few seconds. Contained in that second track is an audio description of the important visual information contained within a specific scene. However, as there is insufficient time to describe all visual information, decisions about what is important to describe and how to present that information (style) to optimize a B/LV viewer's entertainment experience are required. Most research to date has considered only short-term, single-episode experiences to gauge viewers' reactions to the AD content. In addition, this research typically has used a monotone, single style of audio description, which is defined as "the conventional style" in this paper. We use an integrative style instead, that is defined as 'AD designed to fit a specific show", and differed between shows. We carried out a within-subjects longitudinal study with eight episodes of a dark comedy, using different description styles and describers in order to assess viewer engagement and preferences for AD describer style, language use, timing, and fit to the show. Twenty-four blind participants viewed and rated all eight episodes. Major findings included that most participants found the integrative style entertaining, a fit with the specific episodes, and enjoyable. Some participants, however, preferred the conventional style and struggled with the language and topic of a dark comedy and its associated descriptions.	[Naraine, Mala D.] Ctr Res Work Disabil Policy, Toronto, ON, Canada; [Fels, Deborah I.; Whitfield, Margot] Ryerson Univ, Ted Rogers Sch Informat Technol Management, Inclus Media & Design Ctr, Toronto, ON, Canada	Toronto Metropolitan University	Fels, DI (corresponding author), Ryerson Univ, Ted Rogers Sch Informat Technol Management, Inclus Media & Design Ctr, Toronto, ON, Canada.	dfels@ryerson.ca			Social Sciences and Humanities Research Council of Canada [833-2007-1021]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Social Sciences and Humanities Research Council of Canada grant number 833-2007-1021, URL: http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper M., 2015, DIGIT CULT EDUCTION, V4; Alper M, 2013, J EARLY CHILD LIT, V13, P175, DOI 10.1177/1468798411430101; Aspevig K, 2011, CAN J COMMUN, V36, P359; Bachmeier C, 2014, IRIS PLUS, V3; Bergson Henri, 2008, LAUGHTER ESSAY MEANI; Bordwell D, 2001, FILM ART INTRO, V6; Ellis G, 2016, PALGR STUD TRANSL, P35, DOI 10.1057/978-1-137-56917-2_3; Fels DI, 2006, J VISUAL IMPAIR BLIN, V100, P295; Fels Deborah I., 2006, UNIVERSAL ACCESS INF, V5, P73; Fels DI, 2011, FICCDAT TOR JUNE; Fryer L, 2013, PERSPECT STUD TRANSL, V21, P412, DOI 10.1080/0907676X.2012.693108; Gagnon L, 2006, APPL CONTENT BASED V, P8; Government of Canada CR and TC (CRTC), 2008, TV ACC PEOPL VIS IMP; Kincaid J, 1975, FLESCH KINCAID GRADE; Kozloff Sarah, 2000, OVERHEARING FILM DIA; Lopez M, 2018, BR J VIS IMPAIR; Maxwell N, 2011, BLACK COMEDY PRINCIP; Musburger R. B., 2012, INTRO MEDIA PRODUCTI; Newman L, 2017, INFORM SYST J, V27, P559, DOI 10.1111/isj.12106; Ofcom, 2015, OFC COD TEL ACC SERV, P1; Orero P., 2007, MEDIA ALL SUBTITLING, P111; Caro MR, 2016, PERSPECT STUD TRANSL, V24, P606, DOI 10.1080/0907676X.2015.1120760; Ramos M, 2015, TRANSLATOR, V21, P68, DOI 10.1080/13556509.2014.994853; Raney AA, 2006, PSYCHOLOGY OF ENTERTAINMENT, P137; Rea P., PRODUCING DIRECTING; Romero-Fresco P, 2013, J SPEC TRANSL, P201; Smith J., 2016, FILM ART INTRO; Snyder Joel, 2005, INT C SERIES, V1282, P935, DOI [10.1016/ j. ics.2005.05.215, DOI 10.1016/J.ICS.2005.05.215]; Sourbati M, 2012, MEDIA CULT SOC, V34, P571, DOI 10.1177/0163443712442702; Sueroj K, 2016, PALGR STUD TRANSL, P205, DOI 10.1057/978-1-137-56917-2_11; Szarkowska A, 2013, J VISUAL IMPAIR BLIN, V107, P383, DOI 10.1177/0145482X1310700507; Udo JP, 2010, UNIVERSAL ACCESS INF, V9, P63, DOI 10.1007/s10209-009-0156-1; Udo JP, 2010, DISABIL SOC, V25, P231, DOI 10.1080/09687590903537497; Udo JP, 2009, J VISUAL IMPAIR BLIN, V103, P178, DOI 10.1177/0145482X0910300307; Udo JP, 2009, J ENG DES; Vladica F., 2012, THESIS; Walczak A, 2017, BRIT J VISUAL IMPA, V35, P6, DOI 10.1177/0264619616661603; Weigand M, 2013, COMM COM INF SC, V397, P190; Weston J., 2003, FILM DIRECTORS I; Whitfield M, 2013, DES J, V16, P219, DOI 10.2752/175630613X13584367984983; Winseck D, 2002, MEDIA CULT SOC, V24, P795, DOI 10.1177/016344370202400604; Xue Fei, 2011, AUDIO DESCRIPTION CH	42	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0208165	10.1371/journal.pone.0208165	http://dx.doi.org/10.1371/journal.pone.0208165			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC6BO	30507973	Green Published, gold, Green Submitted			2022-12-26	WOS:000451886500027
J	Moro, LN; Amin, G; Furmento, V; Waisman, A; Garate, X; Neiman, G; La Greca, A; Velazque, NLS; Luzzani, C; Sevlever, GE; Vichera, G; Miriuka, SG				Natalia Moro, Lucia; Amin, Guadalupe; Furmento, Veronica; Waisman, Ariel; Garate, Ximena; Neiman, Gabriel; La Greca, Alejandro; Santin Velazque, Natalia Lucia; Luzzani, Carlos; Sevlever, Gustavo E.; Vichera, Gabriel; Gabriel Miriuka, Santiago			MicroRNA characterization in equine induced pluripotent stem cells	PLOS ONE			English	Article							GENERATION; EXPRESSION; MOUSE; DIFFERENTIATION; TARGETS; IDENTIFICATION; FIBROBLASTS; DERIVATION; INDUCTION; MIR-302	Cell reprogramming has been well described in mouse and human cells. The expression of specific microRNAs has demonstrated to be essential for pluripotent maintenance and cell differentiation, but not much information is available in domestic species. We aim to generate horse iPSCs, characterize them and evaluate the expression of different microRNAs (miR-302a,b,c,d, miR-205, miR-145, miR-9, miR-96, miR-125b and miR-296). Two equine iPSC lines (L2 and L3) were characterized after the reprogramming of equine fibroblasts with the four human Yamanaka's factors (OCT-4/SOX-2/c-MYC/KLF4). The pluripotency of both lines was assessed by phosphatase alkaline activity, expression of OCT-4, NANOG and REX1 by RT-PCR, and by immunofluorescence of OCT-4, SOX-2 and c-MYC. In vitro differentiation to embryo bodies (EBs) showed the capacity of the iPSCs to differentiate into ectodermal, endodermal and mesodermal phenotypes. MicroRNA analyses resulted in higher expression of the miR-302 family, miR-9 and miR-96 in L2 and L3 vs. fibroblasts (p<0.05), as previously shown in human pluripotent cells. Moreover, downregulation of miR-145 and miR-205 was observed. After differentiation to EBs, higher expression of miR-96 was observed in the EBs respect to the iPSCs, and also the expression of miR-205 was induced but only in the EB-L2. In addition, in silico alignments of the equine microRNAs with mRNA targets suggested the ability of miR-302 family to regulate cell cycle and epithelial mesenchymal transition genes, miR-9 and miR-96 to regulate neural determinant genes and miR-145 to regulate pluripotent genes, similarly as in humans. In conclusion, we could obtain equine iPSCs, characterize them and determine for the first time the expression level of microRNAs in equine pluripotent cells.	[Natalia Moro, Lucia; Amin, Guadalupe; Furmento, Veronica; Waisman, Ariel; Garate, Ximena; Neiman, Gabriel; La Greca, Alejandro; Santin Velazque, Natalia Lucia; Luzzani, Carlos; Sevlever, Gustavo E.; Gabriel Miriuka, Santiago] Fdn FLENI, CONICET, LIAN, Buenos Aires, DF, Argentina; [Vichera, Gabriel] Kheiron Biotech, Pilar, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Miriuka, SG (corresponding author), Fdn FLENI, CONICET, LIAN, Buenos Aires, DF, Argentina.	smiriuka@fleni.org.ar	Miriuka, Santiago/ABE-9614-2020; Miriuka, Santiago/AAM-4051-2020	Miriuka, Santiago/0000-0003-2402-3920; Waisman, Ariel/0000-0002-6860-9512	Fundacion FLENI; Fundacion Perez Companc;  [FONCYT: PICT-2011-1927];  [PICT-2015-1469];  [PICT-2015-1708];  [PID-2014-0052];  [CONICET: PIP2015-2017]	Fundacion FLENI; Fundacion Perez Companc; ; ; ; ; 	This work was possible thanks to the following grants: FONCYT: PICT-2011-1927, PICT-2015-1469, PICT-2015-1708 and PID-2014-0052; CONICET: PIP2015-2017. The Fundacion FLENI, Fundacion Perez Companc also contributed financially to the realization of this work. Author Gabriel Vichera is employed by Kheiron Biotech. Kheiron Biotech provided support in the form of salary for author GV and participated in the collection of data but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anand AAP, 2018, BMC DEV BIOL, V18, DOI 10.1186/s12861-017-0159-8; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Balzano F, 2018, MOLECULES, V23, DOI 10.3390/molecules23020282; Barta T, 2016, STEM CELLS, V34, P246, DOI 10.1002/stem.2220; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blomberg LA, 2012, REPROD DOMEST ANIM, V47, P80, DOI 10.1111/j.1439-0531.2012.02059.x; Breton A, 2013, STEM CELLS DEV, V22, P611, DOI 10.1089/scd.2012.0052; Broeckx S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085917; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Drozd AM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0112-3; Du XG, 2015, STEM CELLS, V33, P3228, DOI 10.1002/stem.2089; Du ZW, 2013, DEVELOPMENT, V140, P2611, DOI 10.1242/dev.092809; Egusa H, 2014, STEM CELLS DEV, V23, P2156, DOI 10.1089/scd.2013.0344; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Esteves CL, 2014, VET J, V202, P533, DOI 10.1016/j.tvjl.2014.08.026; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Geburek F, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0564-8; Greve TS, 2013, ANNU REV CELL DEV BI, V29, P213, DOI 10.1146/annurev-cellbio-101512-122343; Guest DJ, 2007, STEM CELLS DEV, V16, P789, DOI 10.1089/scd.2007.0032; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Khodadadi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/429160; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lee EM, 2016, CELL TRANSPLANT, V25, P2003, DOI 10.3727/096368916X691691; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li N, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0551-0; Li XH, 2006, STEM CELLS DEV, V15, P523, DOI 10.1089/scd.2006.15.523; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Morgado AL, 2016, STEM CELLS, V34, P1386, DOI 10.1002/stem.2309; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Olivera R, 2018, STEM CELLS CLONING, V11, P13, DOI 10.2147/SCCAA.S151763; Olivera R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164049; Questa M, 2016, STEM CELL RES, V16, P300, DOI 10.1016/j.scr.2015.12.026; Saito S, 2002, FEBS LETT, V531, P389, DOI 10.1016/S0014-5793(02)03550-0; Smith RKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075697; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Sumer H, 2011, J ANIM SCI, V89, P2708, DOI 10.2527/jas.2010-3666; Tan SL, 2012, GENES CELLS, V17, P952, DOI 10.1111/gtc.12009; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Whitworth DJ, 2014, STEM CELLS DEV, V23, P1515, DOI 10.1089/scd.2013.0461; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121; Wu S, 2014, P NATL ACAD SCI USA, V111, P10678, DOI 10.1073/pnas.1409933111; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu WL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S4; Yang CS, 2013, MOL BIOSYST, V9, P10, DOI 10.1039/c2mb25088h; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158655; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	58	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2018	13	12							e0207074	10.1371/journal.pone.0207074	http://dx.doi.org/10.1371/journal.pone.0207074			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6BO	30507934	gold, Green Published, Green Submitted			2022-12-26	WOS:000451886500003
J	Chen, YH; Wang, WM; Kao, TW; Chiang, CP; Hung, CT; Chen, WL				Chen, Yi-Hsien; Wang, Wei-Ming; Kao, Tung-Wei; Chiang, Chien-Ping; Hung, Chih-Tsung; Chen, Wei-Liang			Inverse relationship between serum vitamin D level and measles antibody titer: A cross-sectional analysis of NHANES, 2001-2004	PLOS ONE			English	Article							MUCOSAL IMMUNE-RESPONSES; D DEFICIENCY; INFLUENZA VACCINE; D-RECEPTOR; SUNLIGHT; RUBELLA; IMMUNIZATION; INFECTIONS; PREVENTION; DISEASE	Background In recent years, researchers have illuminated many non-skeletal actions of vitamin D including host defense against various pathogens and vaccine immunology. The purpose of our study was to explore the potential association between serum vitamin D levels and measles antibody titers. Methods The biochemical profiles and de-identified information were accessed from the 2001 to 2004 National Health and Nutrition Examination Survey (NHANES). Participants were divided into quartiles according to their measles antibody titers. Results A total of 5,681 participants were analyzed in our study. Participants in the highest quartile of measles antibody titer had significantly lower serological levels of 25-hydroxyvitamin D [25(OH)D] than those in the lower quartiles (53.90 vs. 58.70 nmol/L, a decrease of 8.18%) (p < 0.001). After full adjustment of confounders, the adjusted beta coefficient of 25(OH)D was -0.006 (p < 0.001). A decreasing tendency of 25(OH) D among quartiles of measles antibody titers was obvious (p for trend <0.001). The negative association in seropositive subjects remained statistically significant only in non-Hispanic black population before adjustment for age, gender, and other covariates (p<0.05). Conclusion Our study highlights the negative association between serum 25(OH)D levels and measles antibody titers.	[Chen, Yi-Hsien; Wang, Wei-Ming; Chiang, Chien-Ping; Hung, Chih-Tsung] Triserv Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Chen, Yi-Hsien; Wang, Wei-Ming; Kao, Tung-Wei; Chiang, Chien-Ping; Hung, Chih-Tsung; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Kao, Tung-Wei; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Kao, Tung-Wei; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Taiwan University	Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.	weiliang0508@gmail.com		Chen, Yi-Hsien/0000-0002-7019-2357; Hung, Chih-Tsung/0000-0001-7138-7757				Al-Khalidi B, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0237-6; ALROY I, 1995, MOL CELL BIOL, V15, P5789; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1229; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Chocano-Bedoya P, 2009, NUTR REV, V67, P289, DOI 10.1111/j.1753-4887.2009.00195.x; Dayan G., 2004, Morbidity and Mortality Weekly Report, V53, P713; Enioutina EY, 1999, VACCINE, V17, P3050, DOI 10.1016/S0264-410X(99)00147-4; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Heijstek MW, 2012, ANN RHEUM DIS, V71, P948, DOI 10.1136/annrheumdis-2011-200637; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; Holick MF, 2001, LANCET, V357, P4, DOI 10.1016/S0140-6736(00)03560-1; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Itoh M, 2002, J CLIN MICROBIOL, V40, P1733, DOI 10.1128/JCM.40.5.1733-1738.2002; Ivanov AP, 2006, J INFECT DIS, V193, P598, DOI 10.1086/499970; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Kriesel JD, 1999, VACCINE, V17, P1883, DOI 10.1016/S0264-410X(98)00476-9; Lang PO, 2013, CURR TOP MED CHEM, V13, P2541, DOI 10.2174/15680266113136660181; Lin ZT, 2016, CURR TOP MED CHEM, V16, P1242, DOI 10.2174/1568026615666150915111557; Linder N, 2011, J TROP PEDIATRICS, V57, P299, DOI 10.1093/tropej/fmp104; Liu GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075951; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; McQuillan GM, 2007, J INFECT DIS, V196, P1459, DOI 10.1086/522866; Moe SM, 2001, AM J KIDNEY DIS, V38, P792, DOI 10.1053/ajkd.2001.27697; Ovsyannikova IG, 2012, PHARMACOGENET GENOM, V22, P20, DOI 10.1097/FPC.0b013e32834df186; Papania MJ, 2004, J INFECT DIS, V189, pS61, DOI 10.1086/381557; Principi N, 2013, HUM VACC IMMUNOTHER, V9, P969, DOI 10.4161/hv.23540; Ramondetti F, 2012, DIABETIC MED, V29, P761, DOI 10.1111/j.1464-5491.2011.03529.x; Rosenau BJ, 2009, J RHEUMATOL, V36, P893, DOI 10.3899/jrheum.080856; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wu CJ, 2018, CLIN CHIM ACTA, V481, P42, DOI 10.1016/j.cca.2018.02.028; Yetley EA, 2010, J NUTR, V140, p2030S, DOI 10.3945/jn.110.121483; Zimmerman RK, 2015, HUM VACC IMMUNOTHER, V11, P2345, DOI 10.1080/21645515.2015.1062955; Zitt E, 2012, VACCINE, V30, P931, DOI 10.1016/j.vaccine.2011.11.086	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2018	13	11							e0207798	10.1371/journal.pone.0207798	http://dx.doi.org/10.1371/journal.pone.0207798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC6AO	30500845	Green Submitted, Green Published, gold			2022-12-26	WOS:000451883700017
J	Sluch, VM; Chamling, X; Wenger, C; Duan, YK; Rice, DS; Zack, DJ				Sluch, Valentin M.; Chamling, Xitiz; Wenger, Claire; Duan, Yukan; Rice, Dennis S.; Zack, Donald J.			Highly efficient scarless knock-in of reporter genes into human and mouse pluripotent stem cells via transient antibiotic selection	PLOS ONE			English	Article							GENERATION; TALEN; LHX2; RNA	Pluripotent stem cells (PSCs) edited with genetic reporters are useful tools for differentiation analysis and for isolation of specific cell populations for study. Reporter integration into the genome is now commonly achieved by targeted DNA nuclease-enhanced homology directed repair (HDR). However, human PSCs are known to have a low frequency of gene knock-in (KI) by HDR, making reporter line generation an arduous process. Here, we report a methodology for scarless KI of large fluorescent reporter genes into PSCs by transient selection with puromycin or zeocin. With this method, we can perform targeted KI of a single reporter gene with up to 65% efficiency, as well as simultaneous KI of two reporter genes into different loci with up to 11% efficiency. Additionally, we demonstrate that this method also works in mouse PSCs.	[Sluch, Valentin M.; Rice, Dennis S.] Novartis Inst BioMed Res, Dept Ophthalmol, Cambridge, MA USA; [Chamling, Xitiz; Duan, Yukan; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Wenger, Claire; Zack, Donald J.] Johns Hopkins Univ, Sch Med Baltimore, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Solomon H Snyder Dept Neurosci,Inst Genet Med, Baltimore, MD 21205 USA	Novartis; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med Baltimore, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Solomon H Snyder Dept Neurosci,Inst Genet Med, Baltimore, MD 21205 USA.	dzack@jhmi.edu		Bell, Claire/0000-0002-0294-2291; chamling, xitiz/0000-0001-6401-7715	National Institutes of Health [5P30EY001765, T32EY007143]; Maryland Stem Cell Research Fund; Foundation Fighting Blindness; BrightFocus Foundation; Research to Prevent Blindness; Guerrieri Family Foundation; NATIONAL EYE INSTITUTE [T32EY007143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund; Foundation Fighting Blindness(European Commission); BrightFocus Foundation(BrightFocus Foundation); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Guerrieri Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, 5P30EY001765, T32EY007143, Dr Donald J Zack; Maryland Stem Cell Research Fund, Dr Donald J Zack; Foundation Fighting Blindness, Dr Donald J Zack; BrightFocus Foundation, Dr Donald J Zack; Research to Prevent Blindness, Dr Donald J Zack; Guerrieri Family Foundation, Dr Donald J Zack.	Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Bhise NS, 2013, INT J NANOMED, V8, P4641, DOI 10.2147/IJN.S53830; Chamling X, 2016, INVEST OPHTH VIS SCI, V57, DOI 10.1167/iovs.15-18590; Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001; da Cruz L, 2018, NAT BIOTECHNOL, V36, P1, DOI 10.1038/nbt.4114; Den Hartogh SC, 2015, STEM CELLS, V33, P56, DOI 10.1002/stem.1842; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Guo Q, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20358-5; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Kashani AH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4097; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Maruotti J, 2015, P NATL ACAD SCI USA, V112, P10950, DOI 10.1073/pnas.1422818112; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Mitzelfelt KA, 2017, STEM CELL REP, V8, P491, DOI 10.1016/j.stemcr.2017.01.021; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakatake Y, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-64; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; Petris G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15334; Phillips MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20813-3; Roy A, 2013, J NEUROSCI, V33, P6877, DOI 10.1523/JNEUROSCI.4216-12.2013; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Shy BR, 2016, NUCLEIC ACIDS RES, V44, P7997, DOI 10.1093/nar/gkw685; Sluch VM, 2017, STEM CELL TRANSL MED, V6, P1972, DOI 10.1002/sctm.17-0059; Sluch VM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16595; Sluch VM, 2014, DEV OPHTHALMOL, V53, P111, DOI 10.1159/000358409; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Steyer B, 2018, STEM CELL REP, V10, P642, DOI 10.1016/j.stemcr.2017.12.004; Tetreault N, 2009, DEV BIOL, V327, P541, DOI 10.1016/j.ydbio.2008.12.022; Volkner M, 2016, STEM CELL REP, V6, P525, DOI 10.1016/j.stemcr.2016.03.001; Wahlin KJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00774-9; Wang G, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.152; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8; Zhu ZR, 2015, STEM CELL REP, V4, P1103, DOI 10.1016/j.stemcr.2015.04.016	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0201683	10.1371/journal.pone.0201683	http://dx.doi.org/10.1371/journal.pone.0201683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496180	Green Submitted, Green Published, gold			2022-12-26	WOS:000451763800005
J	Su, YC; Peng, P; Elgar, MA; Smith, DR				Su, Yong-Chao; Peng, Po; Elgar, Mark Adrian; Smith, Deborah Roan			Dual pathways in social evolution: Population genetic structure of group-living and solitary species of kleptoparasitic spiders (Argyrodinae: Theridiidae)	PLOS ONE			English	Article							WEB-BUILDING SPIDERS; KIN SELECTION; HOST; BEHAVIOR; ARANEAE; RELATEDNESS; BENEFITS; AGGREGATIONS; PHYLOGENY; DISPERSAL	Group-living behavior is taxonomically widespread but rare in spiders. The conventional view is that the main pathways to group-living in spiders are either sub-social, where extended maternal care leads to prolonged sibling association; or communal living, where individuals aggregate to exploit a common resource. Female egg-sac guarding behavior occurs throughout kleptoparasitic spiders in the subfamily Argyrodinae (Theridiidae), while individuals in group-living species cohabit in the resource rich webs of their host spiders. These attributes fit both sub-social and communal routes to group-living, which offers new insights to study the early stages of social evolution. We investigated whether members of kleptoparasitic groups in natural populations comprise related individuals by comparing the population structure of two group-living species, Argyrodes miniaceus and A. cf. fissifrons, and two solitary species, A. fasciatus and Neospintharus trigonum. We found that: (1) genetic-spatial autocorrelation in group-living species was highest among spiders sharing the same host web and declined steeply with increasing distance, but no significant autocorrelation at any scale for solitary species; (2) there was high relatedness among group members in two cases of group-living species, which indicated relatedness was not an adhesive agent in most of the groups, but no high relatedness in solitary species; and (3) the host web boundary was not the sole predictor of genetic structures in group-living species. These results suggest that population genetic structure in the group-living species is caused by limited dispersal of group members that is favored by ecological conditions, including the nature and size of resources. In contrast, the absence of genetic structuring in populations of solitary species indicates a high level of dispersal with individual interactions unlikely to have fitness benefits.	[Su, Yong-Chao] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Grad Inst Med, Kaohsiung, Taiwan; [Su, Yong-Chao; Smith, Deborah Roan] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Peng, Po; Elgar, Mark Adrian] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia	Kaohsiung Medical University; University of Kansas; University of Melbourne	Su, YC (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Grad Inst Med, Kaohsiung, Taiwan.; Su, YC (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	ycsu527@kmu.edu.tw	Smith, Deborah/V-1676-2019	Smith, Deborah/0000-0002-2581-5009; Su, Yong-Chao/0000-0002-5296-7227; Elgar, Mark/0000-0003-0861-6064	American Arachnological Society; Entomology Endowment of Entomology Program at the University of Kansas; US-Israel Binational Science Foundation [2006353]; Kaohsiung Medical University Research Foundation [KMU-Q107006]; Ministry of Science and Technology, Taiwan [MOST107-2621-B-037-001-MY2]; Australian Government Research Training Program; National Geographic Society	American Arachnological Society; Entomology Endowment of Entomology Program at the University of Kansas; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Kaohsiung Medical University Research Foundation; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Australian Government Research Training Program(Australian Government); National Geographic Society(National Geographic Society)	We are grateful for the funding support for DNA fingerprinting from the Student Research Grant of the American Arachnological Society, Entomology Endowment of Entomology Program at the University of Kansas to YCS, and the US-Israel Binational Science Foundation to Y. Lubin and D. Smith (2006353); YCS is supported by the Kaohsiung Medical University Research Foundation (KMU-Q107006) and Ministry of Science and Technology, Taiwan (MOST107-2621-B-037-001-MY2). PP is supported by a scholarship from the Australian Government Research Training Program and the National Geographic Society (to MAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; Agnarsson I, 2004, ZOOL J LINN SOC-LOND, V141, P447, DOI 10.1111/j.1096-3642.2004.00120.x; Agnarsson I, 2013, J EVOLUTION BIOL, V26, P27, DOI 10.1111/jeb.12022; Agnarsson I, 2003, J ARACHNOL, V31, P344, DOI 10.1636/s02-21; Agnarsson I, 2011, NATURWISSENSCHAFTEN, V98, P163, DOI 10.1007/s00114-010-0750-3; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Aviles Leticia, 1997, P476; Aviles L, 2017, COMPARATIVE SOCIAL EVOLUTION, P188; Begon M., 1986, P1; Berger-Tal R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13284; Bilde Trine, 2011, P275; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Bourke AFG, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0362; Buskirk R.E., 1981, P281; CANGIALOSI KR, 1990, J ARACHNOL, V18, P347; CANGIALOSI KR, 1990, BEHAV ECOL SOCIOBIOL, V27, P49; Clarke K. R., 2001, CHANGES MARINE COMMU; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; DAndrea M., 1987, ITAL J ZOOL, V3, P1; ELGAR MA, 1994, J ANIM ECOL, V63, P880, DOI 10.2307/5265; ELGAR MA, 1989, ANIM BEHAV, V37, P1052, DOI 10.1016/0003-3472(89)90152-8; Elgar MA, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00124; Elgar Mark A., 1993, Memoirs of the Queensland Museum, V33, P411; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Friedel A, 2017, INSECT SOC, V64, P465, DOI 10.1007/s00040-017-0559-6; Garrick RC, 2017, PEERJ, V5, DOI 10.7717/peerj.3127; Green JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12663; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hass CC, 2002, BEHAV ECOL SOCIOBIOL, V51, P570, DOI 10.1007/s00265-002-0463-5; Henaut Y, 2000, J NAT HIST, V34, P747, DOI 10.1080/002229300299390; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUFF DR, 1993, THEOR APPL GENET, V86, P927, DOI 10.1007/BF00211043; Johannesen J, 2012, BEHAV ECOL SOCIOBIOL, V66, P1387, DOI 10.1007/s00265-012-1394-4; LARCHER SF, 1985, J ARACHNOL, V13, P43; Marshall JAR, 2011, TRENDS ECOL EVOL, V26, P325, DOI 10.1016/j.tree.2011.04.008; McElreath R., 2008, MATH MODELS SOCIAL E; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Miyashita T, 2002, J ARACHNOL, V30, P31, DOI 10.1636/0161-8202(2002)030[0031:PDOTSO]2.0.CO;2; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Queller DC, 2016, PHILOS SCI, V83, P861, DOI 10.1086/687870; Queller DC, 1997, BEHAV ECOL SOCIOBIOL, V40, P3, DOI 10.1007/s002650050310; Rao D, 2010, ISR J ECOL EVOL, V56, P21, DOI 10.1560/IJEE.56.1.21; Ritland K, 2000, MOL ECOL, V9, P1195, DOI 10.1046/j.1365-294x.2000.00971.x; ROELOFFS R, 1988, EVOLUTION, V42, P173, DOI 10.1111/j.1558-5646.1988.tb04117.x; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruch J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-257; RYPSTRA AL, 1985, J ARACHNOL, V13, P71; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; Schneider JM, 2008, P NATL ACAD SCI USA, V105, P10843, DOI 10.1073/pnas.0804126105; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; Smith DR, 2016, ECOL EVOL, V6, P5479, DOI 10.1002/ece3.2200; SMITH DRR, 1983, BEHAV ECOL SOCIOBIOL, V13, P107, DOI 10.1007/BF00293800; Su Y-C, 2012, GANG THIEVES EVOLUTI; Su YC, 2014, INVERTEBR SYST, V28, P415, DOI 10.1071/IS14010; THORNHILL R, 1980, ANIM BEHAV, V28, P405, DOI 10.1016/S0003-3472(80)80049-2; Toth AL, 2017, ANNU REV ENTOMOL, V62, P419, DOI 10.1146/annurev-ento-031616-035601; Uetz George W., 1997, P458; UETZ GW, 1982, SCIENCE, V217, P547, DOI 10.1126/science.217.4559.547; UETZ GW, 1988, BEHAV ECOL SOCIOBIOL, V22, P265, DOI 10.1007/BF00299841; van der Wurff AWG, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.24.e105; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Whitehouse M, 2002, J ARACHNOL, V30, P238, DOI 10.1636/0161-8202(2002)030[0238:APSAII]2.0.CO;2; Whitehouse Mary, 2011, P348; WHITEHOUSE MEA, 1988, J ARACHNOL, V16, P349; Whitehouse MEA, 2005, BIOL REV, V80, P347, DOI 10.1017/S1464793104006694; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Wilson E.O., 1975, P1; WISE DH, 1982, J ARACHNOL, V10, P111	75	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2018	13	11							e0208123	10.1371/journal.pone.0208123	http://dx.doi.org/10.1371/journal.pone.0208123			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC4HL	30496248	Green Published, gold			2022-12-26	WOS:000451763800097
J	Overholt, L; Wohl, DA; Fischer, WA; Westreich, D; Tozay, S; Reeves, E; Pewu, K; Adjasso, D; Hoover, D; Merenbloom, C; Johnson, H; Williams, G; Conneh, T; Diggs, J; Buller, A; McMillian, D; Hawks, D; Dube, K; Brown, J				Overholt, Luc; Wohl, David Alain; Fischer, William A., II; Westreich, Daniel; Tozay, Sam; Reeves, Edwina; Pewu, Korto; Adjasso, David; Hoover, David; Merenbloom, Carson; Johnson, Harrietta; Williams, Gerald; Conneh, Tonia; Diggs, Joseph; Buller, Alexandria; McMillian, Darrius; Hawks, Darrel; Dube, Karine; Brown, Jerry			Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study	PLOS ONE			English	Article							VIRUS DISEASE; HIV; TRANSMISSION	Background Survivors of the 2014-2016 West Africa Ebola epidemic have been reported to suffer high levels of stigmatization after return to their communities. We sought to characterize the stigma encountered by a cohort of Ebola survivors in Liberia over time. Methods Ebola-related stigma was assessed from June 2015 to August 2017 in 299 adolescent and adult Liberian Ebola Survivor Cohort participants at three month intervals using adapted HIV stigma scales scored from 0 to 10 according to the proportion of answers indicating stigmatization. Findings The median time from Ebola Virus Disease (EVD) to study entry was 393 days (IQR 336492). Participants (43% female) had a median age of 31 (IQR 25-40) years. Mean self-reported stigma levels were greater at baseline (6.28 +/- 0.15 [IQR: 4.38-8.75]) compared to the first post-baseline visit (0.60 +/- 0.10 [IQR: 0-0]; p<0.0001). During follow-up, stigma levels were stable. Baseline stigma significantly increased during enrollment and following clusters of Ebola re-emergence in Liberia. Survivors encountered primarily enacted and perceived external stigma rather than internalized stigma. Conclusions Ebola-related stigma was prevalent among Liberian survivors more than a year after EVD recovery. Self-reported stigma was greater in the period before cohort enrollment; however, some degree of stigmatization persisted years after EVD. Transient rises in stigma wereobserved following episodic Ebola re-emergence of EVD in Liberia. During future EVD outbreaks, enhanced public health interventions designed to prevent and mitigate Ebola-related stigma that is enacted and external should be implemented to support survivor recovery and community re-integration.	[Overholt, Luc] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Wohl, David Alain; Fischer, William A., II; Westreich, Daniel; Merenbloom, Carson; McMillian, Darrius; Hawks, Darrel; Dube, Karine] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA; [Tozay, Sam; Reeves, Edwina; Pewu, Korto; Johnson, Harrietta; Williams, Gerald; Conneh, Tonia; Diggs, Joseph; Brown, Jerry] Eternal Love Winning Africa Hosp, Paynesville, Liberia; [Adjasso, David; Hoover, David] Clin Res Management Inc, Hinckley, OH USA; [Buller, Alexandria] Abilene Christian Univ, Coll Arts & Sci, Abilene, TX 79699 USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Abilene Christian University	Wohl, DA (corresponding author), Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA.	wohl@med.unc.edu		Merenbloom, Carson/0000-0001-8948-9217; Buller, Alexandria/0000-0001-5153-7631; Westreich, Daniel/0000-0003-3069-1650	Bill and Melinda Gates Foundation [K23AI121516, R01 AI123535, K24DA037101]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, R01AI123535, K23AI121516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA037101] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by Bill and Melinda Gates Foundation - no grant number - grant was awarded to Clinical Research Management. https://www.gatesfoundation.org/.National Institute for Health - K23AI121516 (WF), R01 AI123535 (WF and DAW), and K24DA037101 (DAW). https://www.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Burki TK, 2016, LANCET INFECT DIS, V16, P780, DOI 10.1016/S1473-3099(15)00259-5; Corrigan Patrick W, 2002, World Psychiatry, V1, P16; Dadun, 2017, LEPROSY REV, V88, P23; Dearden L., 2015, INDEPENDENT; Delamou A, 2017, TROP MED INT HEALTH, V22, P254, DOI 10.1111/tmi.12825; Denis-Ramirez E, 2017, CHILD YOUTH SERV REV, V73, P445, DOI 10.1016/j.childyouth.2016.11.025; Doucleff M., 2015, NPR; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Farge E., 2015, REUTERS; Goffman E, 1974, STIGMA NOTES MANAGEM; Hugo M, 2015, EMERG MED OPEN ACCES; Jeyaseelan L, 2013, AIDS BEHAV, V17, P434, DOI 10.1007/s10461-011-0128-3; Karamouzian M, 2015, INT J HEALTH POLICY, V4, P55, DOI 10.15171/ijhpm.2014.128; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Nanyonga M, 2016, CLIN INFECT DIS, V62, P125, DOI 10.1093/cid/civ795; Qureshi AI, 2015, CLIN INFECT DIS, V61, P1035, DOI 10.1093/cid/civ453; Rabelo I, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00142; Reinius M, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0691-z; Samb S., 2016, REUTERS; Van Bortel T, 2016, B WORLD HEALTH ORGAN, V94, P210, DOI 10.2471/BLT.15.158543; Van Noorden R., 2016, NATURE NEWS; Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254; Vetter Pauline, 2016, Lancet Infect Dis, V16, pe82, DOI 10.1016/S1473-3099(16)00077-3; WHO, 2015, EB SIT REP; Wolitski RJ, 2009, AIDS BEHAV, V13, P1222, DOI 10.1007/s10461-008-9455-4; World Health Organization, 2015, FLAR EB LIB; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001	29	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2018	13	11							e0206595	10.1371/journal.pone.0206595	http://dx.doi.org/10.1371/journal.pone.0206595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HC4EO	30485311	Green Submitted, Green Published, gold			2022-12-26	WOS:000451755800023
J	Kamtchum-Tatuene, J; Al-Bayati, Z; Mwandumba, HC; Solomon, T; Christmas, SE; Benjamin, LA				Kamtchum-Tatuene, Joseph; Al-Bayati, Zaid; Mwandumba, Henry Charles; Solomon, Tom; Christmas, Stephen E.; Benjamin, Laura A.			Serum concentration of anti-Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi	PLOS ONE			English	Article							IMMUNOGLOBULIN-G ANTIBODY; ANTIRETROVIRAL THERAPY; CYTOMEGALOVIRUS; MORTALITY; DISEASE; RISK; CMV; COINFECTION; AFRICA; BURDEN	Background Studies in high-income settings have shown association between Cytomegalovirus (CMV) infection and adverse cardiovascular outcome, especially in HIV infection. We aimed to study the association between serum concentration of anti-CMV IgG and ischaemic stroke in HIV-infected Malawians. Methods Our sample was derived from a case-control stroke study in Malawi. Serum concentration of anti-CMV IgG was measured using enzyme-linked immunosorbent assay. Multivariable logistic regression was used to study the association between high concentrations of antiCMV IgG (above the third tertile) and ischaemic stroke while adjusting for cardiovascular risk factors. Results Overall, 139 HIV-positive adults (48.2% women; 48 ischaemic stroke cases and 91 controls; median age: 45 years) were included. The median CD4+ count was 136 and 401 cell/mm 3 (IQR: [75-278] and [230-533]) in cases and controls, respectively. High concentration of anti-CMV IgG was associated with ischaemic stroke in the univariable model (OR = 2.56 [1.23-5.34]) but not after adjusting for duration of antiretroviral therapy (ART), CD4+ count, and other cardiovascular risk factors (OR = 0.94 [0.29-3.08]). Low CD4+ count was an independent predictor of stroke. There was a negative correlation between serum concentration of anti-CMV IgG and CD4+ count (rho =-0.30, p < 0.001). Conclusions High concentration of anti-CMV IgG is not independently associated with ischaemic stroke in HIV-infected Malawians. Larger cohort studies are needed to further investigate the role of humoral response to CMV in the pathophysiology of HIV-associated stroke.	[Kamtchum-Tatuene, Joseph; Al-Bayati, Zaid; Solomon, Tom; Christmas, Stephen E.; Benjamin, Laura A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Mwandumba, Henry Charles] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Mwandumba, Henry Charles] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Kamtchum-Tatuene, Joseph] Univ Alberta, Fac Med & Dent, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Benjamin, Laura A.] UCL, Inst Neurol, London, England	University of Liverpool; University of Malawi; Liverpool School of Tropical Medicine; University of Alberta; University of London; University College London	Benjamin, LA (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.; Benjamin, LA (corresponding author), UCL, Inst Neurol, London, England.	l.benjamin@liverpool.ac.uk	TATUENE, Joseph KAMTCHUM/W-3028-2017	TATUENE, Joseph KAMTCHUM/0000-0002-1041-4202; Benjamin, Laura/0000-0002-9685-1664; Solomon, Tom/0000-0001-7266-6547	Wellcome Trust [106829/Z/15/Z, 089672/Z/09/A]; MRC [G116/194, MR/P020526/1, MC_PC_15096] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Wellcome Trust research grants awarded to JKT (grant number 106829/Z/15/Z) and LB (grant number 089672/Z/09/A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adland E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01016; Bates M, 2016, J VIRUS ERAD, V2, P136; Benjamin LA, 2017, J INFECT DIS, V216, P545, DOI 10.1093/infdis/jix340; Benjamin LA, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000254; Benjamin LA, 2016, NEUROLOGY, V86, P324, DOI 10.1212/WNL.0000000000002278; Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3; Cowan LT, 2016, STROKE, V47, P1612, DOI 10.1161/STROKEAHA.116.012890; Emery VC, 2015, J INFECT DIS, V211, P169, DOI 10.1093/infdis/jiu419; Freeman ML, 2016, CURR HIV-AIDS REP, V13, P10, DOI 10.1007/s11904-016-0297-9; Gianella S, 2016, J INFECT DIS, V214, pS67, DOI 10.1093/infdis/jiw217; Gianella S, 2014, J INFECT DIS, V209, P452, DOI 10.1093/infdis/jit434; Gkrania-Klotsas E, 2013, CLIN INFECT DIS, V56, P1421, DOI 10.1093/cid/cit083; Gomez-Mora E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184433; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hunt PW, 2016, J INFECT DIS, V214, pS44, DOI 10.1093/infdis/jiw275; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Nikitskaya E, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003759; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Preiksaitis JK, 2016, CLIN INFECT DIS, V63, P583, DOI 10.1093/cid/ciw370; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Sico JJ, 2015, NEUROLOGY, V84, P1933, DOI 10.1212/WNL.0000000000001560; Valsamakis A, 2016, CLIN INFECT DIS, V63, P590, DOI 10.1093/cid/ciw375; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Wilson EMP, 2013, IMMUNOL REV, V254, P343, DOI 10.1111/imr.12064; World Health Organization, 2016, CONS GUID US ANT DRU, DOI [10.1016/j.jped.2014.04.007, DOI 10.1016/J.JPED.2014.04.007]	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2018	13	11							e0208040	10.1371/journal.pone.0208040	http://dx.doi.org/10.1371/journal.pone.0208040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB9UV	30481210	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000451440000039
J	Su, XJ; Wang, WZ; Xia, T; Gao, LP; Shen, GA; Pang, YZ				Su, Xiaojia; Wang, Wenzhao; Xia, Tao; Gao, Liping; Shen, Guoan; Pang, Yongzhen			Characterization of a heat responsive UDP: Flavonoid glucosyltransferase gene in tea plant (Camellia sinensis)	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; NATURAL VARIATION; HEADING DATE; GREEN TEA; GLYCOSYLTRANSFERASES; ANTHOCYANINS; EXPRESSION; CLONING; TASTE	Tea plant (Camellia sinensis) accumulates abundant flavonoid glycosides that are the major bioactive ingredients in tea. Biosynthesis of flavonoid glycosides are catalyzed by UDP-glucosyltransferases (UGTs) that are widely present in plants. Among one hundred and seventy-eight UGTs genes that we have previously identified in tea plant, few of them have been functionally characterized. In the present study, we further identified UGT73A17 gene that is responsible for the biosynthesis of a broad range of flavonoid glycosides. Sequence analysis revealed that the deduced UGT73A17 protein showed high identity with 7-O-glycosyltransferases at amino acid level and it was clustered into the clade containing several 7-O-glycosyltransferases from other plant species. Enzymatic assays revealed that the recombinant UGT73A17 protein (rUGT73A17) exhibited activity toward flavonols (kaempferol, quercetin, and myricetin), flavones (apigenin, luteolin, and tricetin), flavanone (naringenin), isoflavones (genistein) and epicatechin gallate, yielding 7-O-glucosides as the major in vitro products. In particular, rUGT73A17 displayed higher activity at high temperatures (eg. 50 degrees C) than at low temperatures, which was consistent with its relatively high expression level at high temperatures. Two amino acid substitutions at I296L and V466A improved the enzymatic activity of rUGT73A17. Our study demonstrated that UGT73A17 is responsible for the biosynthesis of a broad range of flavonoid glucosides, which is also involved in heat response and quality of tea plant.	[Su, Xiaojia; Pang, Yongzhen] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Su, Xiaojia] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Wang, Wenzhao; Xia, Tao; Gao, Liping] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Shen, Guoan] Inst Med Plant Dev, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Chinese Academy of Sciences; Institute of Botany, CAS; Anhui Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS	Pang, YZ (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	pangyongzhen@caas.cn		Pang, Yongzhen/0000-0002-2336-7476	National Natural Science Foundation of China [31670305, 31570306]; Major State Basic Research and Development Program of China [2014CB138703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research and Development Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31670305 and 31570306) and the Major State Basic Research and Development Program of China (2014CB138703).; This work was supported by the National Natural Science Foundation of China (31670305 and 31570306) and the Major State Basic Research and Development Program of China (2014CB138703).	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Belhadj A, 2008, PLANT PHYSIOL BIOCH, V46, P493, DOI 10.1016/j.plaphy.2007.12.001; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Cui LL, 2016, J EXP BOT, V67, P2285, DOI 10.1093/jxb/erw053; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Hirotani M, 2000, PLANTA, V210, P1006, DOI 10.1007/PL00008158; Huve K, 2011, PLANT CELL ENVIRON, V34, P113, DOI 10.1111/j.1365-3040.2010.02229.x; Isayenkova J, 2006, PHYTOCHEMISTRY, V67, P1598, DOI 10.1016/j.phytochem.2006.06.026; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Kanwar Jyoti, 2012, Front Biosci (Elite Ed), V4, P111; KITAO S, 1995, BIOSCI BIOTECH BIOCH, V59, P2167, DOI 10.1271/bbb.59.2167; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Kubo A, 2004, ARCH BIOCHEM BIOPHYS, V429, P198, DOI 10.1016/j.abb.2004.06.021; Lu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034021; Luo KW, 2014, J NUTR BIOCHEM, V25, P395, DOI 10.1016/j.jnutbio.2013.11.013; Mierziak J, 2014, MOL BREEDING, V34, P1917, DOI 10.1007/s11032-014-0149-5; Moon YH, 2006, J MOL CATAL B-ENZYM, V40, P1, DOI 10.1016/j.molcatb.2006.01.030; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; Nagashima S, 2004, PLANTA, V218, P456, DOI 10.1007/s00425-003-1118-0; Naito Y, 2009, J CARDIOVASC PHARM, V54, P385, DOI 10.1097/FJC.0b013e3181b6e7a1; Ohgami S, 2014, PLANT BIOTECHNOL-NAR, V31, P573, DOI 10.5511/plantbiotechnology.14.1027a; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Rossetti D, 2009, FOOD HYDROCOLLOID, V23, P1984, DOI 10.1016/j.foodhyd.2009.03.001; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Scharbert S, 2005, J AGR FOOD CHEM, V53, P5377, DOI 10.1021/jf050294d; Su XJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02085; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wei XJ, 2013, GENET MOL RES, V12, P3845, DOI 10.4238/2013.September.23.2; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yin QG, 2017, PLANT CELL PHYSIOL, V58, P1558, DOI 10.1093/pcp/pcx081; Yin QG, 2017, J EXP BOT, V68, P594, DOI 10.1093/jxb/erw420; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Zhang Q, 2012, BIOL PLANTARUM, V56, P97, DOI 10.1007/s10535-012-0022-5; Zhang X, 2016, MOLECULES, V21, DOI 10.3390/molecules21050620; Zhao XQ, 2017, J AGR FOOD CHEM, V65, P2074, DOI 10.1021/acs.jafc.6b05619	42	15	16	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2018	13	11							e0207212	10.1371/journal.pone.0207212	http://dx.doi.org/10.1371/journal.pone.0207212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB8GM	30475819	Green Submitted, Green Published, gold			2022-12-26	WOS:000451325700018
J	Shenstone, E; Cooper, J; Rice, B; Bohn, M; Jamann, TM; Lipka, AE				Shenstone, Esperanza; Cooper, Julian; Rice, Brian; Bohn, Martin; Jamann, Tiffany M.; Lipka, Alexander E.			An assessment of the performance of the logistic mixed model for analyzing binary traits in maize and sorghum diversity panels	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POPULATION-STRUCTURE; LOCI; RELATEDNESS; SELECTION; DISSECT	The logistic mixed model (LMM) is well-suited for the genome-wide association study (GWAS) of binary agronomic traits because it can include fixed and random effects that account for spurious associations. The recent implementation of a computationally efficient model fitting and testing approach now makes it practical to use the LMM to search for markers associated with such binary traits on a genome-wide scale. Therefore, the purpose of this work was to assess the applicability of the LMM for GWAS in crop diversity panels. We dichotomized three publicly available quantitative traits in a maize diversity panel and two quantitative traits in a sorghum diversity panel, and them performed a GWAS using both the LMM and the unified mixed linear model (MLM) on these dichotomized traits. Our results suggest that the LMM is capable of identifying statistically significant marker-trait associations in the same genomic regions highlighted in previous studies, and this ability is consistent across both diversity panels. We also show how subpopulation structure in the maize diversity panel can underscore the LMM's superior control for spurious associations compared to the unified MLM. These results suggest that the LMM is a viable model to use for the GWAS of binary traits in crop diversity panels and we therefore encourage its broader implementation in the agronomic research community.	[Shenstone, Esperanza; Cooper, Julian; Rice, Brian; Bohn, Martin; Jamann, Tiffany M.; Lipka, Alexander E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Lipka, AE (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	alipka@illinois.edu	Bohn, Martin/AAW-4043-2020; Jamann, Tiffany/S-7392-2019	Bohn, Martin/0000-0003-2364-6229; Jamann, Tiffany/0000-0002-7288-0866				Agresti A, 2011, CATEGORICAL DATA ANA, P206; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchet S, 2017, GENETICS, V206, P573, DOI 10.1534/genetics.116.198499; Brown PJ, 2008, GENETICS, V180, P629, DOI 10.1534/genetics.108.092239; Chakravarti A., 2014, WILEY STATSREF STAT, DOI [10.1002/9781118445112.stat05408, DOI 10.1002/9781118445112.STAT05408]; Chen AH, 2016, G3-GENES GENOM GENET, V6, P2365, DOI 10.1534/g3.116.029090; Chen H, 2016, AM J HUM GENET, V98, P653, DOI 10.1016/j.ajhg.2016.02.012; Coffman CJ, 2005, GENETICS, V170, P1281, DOI 10.1534/genetics.104.033910; Cook JP, 2012, PLANT PHYSIOL, P158; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Diepenbrock CH, 2017, PLANT CELL, V29, P2374, DOI 10.1105/tpc.17.00475; Ding YZ, 2017, PLANT PHYSIOL, V175, P1455, DOI 10.1104/pp.17.00879; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Silva FFE, 2017, SCI AGR, V74, P1, DOI [10.1590/1678-992x-2016-0023, 10.1590/1678-992X-2016-0023]; Hogg R.V., 1995, INTRO MATH STAT, P269; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036807; Lipka AE, 2013, G3-GENES GENOM GENET, P3; Lipka AE, 2015, CURR OPIN PLANT BIOL, V24, P110, DOI 10.1016/j.pbi.2015.02.010; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lobreaux S, 2015, GENOMICS, V105, P69, DOI 10.1016/j.ygeno.2014.12.001; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Ogura T, 2015, CURR OPIN PLANT BIOL, V23, P98, DOI 10.1016/j.pbi.2014.11.008; Owens BF, 2014, GENETICS, V198, P1699, DOI 10.1534/genetics.114.169979; Peiffer JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067066; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Visscher PM, 1996, GENET RES, V68, P55, DOI 10.1017/S0016672300033887; Wang S, 2016, BIOINFORMATICS, V32, P211, DOI 10.1093/bioinformatics/btv563; Wright S., 1934, ANAL VARIABILITY NUM, P19; Xu SZ, 2010, THEOR APPL GENET, V121, P47, DOI 10.1007/s00122-010-1290-0; Xu SZ, 1996, GENETICS, V143, P1417; Yi NJ, 1999, HEREDITY, V82, P668, DOI 10.1046/j.1365-2540.1999.00529.x; Yi NJ, 1999, GENETICS, V153, P1029; Yi NJ, 2000, GENETICS, V155, P1391; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang XY, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1441-7; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	48	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2018	13	11							e0207752	10.1371/journal.pone.0207752	http://dx.doi.org/10.1371/journal.pone.0207752			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB4VL	30462727	Green Published, Green Submitted, gold			2022-12-26	WOS:000451054800083
